FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sridharan, I
   Ma, Y
   Kim, T
   Kobak, W
   Rotmensch, J
   Wang, R
AF Sridharan, Indumathi
   Ma, Yin
   Kim, Taeyoung
   Kobak, William
   Rotmensch, Jacob
   Wang, Rong
TI Structural and mechanical profiles of native collagen fibers in vaginal
   wall connective tissues
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Fibro-muscle; Tissue elasticity; Atomic force microscopy
ID ATOMIC-FORCE MICROSCOPY; BIOMECHANICAL PROPERTIES; POSTMENOPAUSAL WOMEN;
   ELASTIC PROPERTIES; I COLLAGEN; FIBRILS; CELLS; BONE; PROLIFERATION;
   PROLAPSE
AB Collagen, an ubiquitous biomaterial, confers robustness and resilience to connective tissues. In this study, we analyzed the structure and elasticity profile of collagen from the vaginal wall connective tissue of healthy pre-menopausal (pre-M) and postmenopausal (post-M) women. The histological staining assisted study with an atomic force microscope renders the examination of native collagen fibers on site of the connective tissue from nanoscopic scale to microscopic scale with high spatial resolution. Our results suggest that during menopause, collagen's structure and elasticity are subject to changes at all levels of organization- between individual collagen fibers, between collagen and muscle, and between collagen and other matrix elements. The systematic analysis of the native structure and mechanical properties of collagen within a tissue provides a potential way to study non-fatal conditions such as pelvic organ prolapse and other genito-urinary disorders, where the initial symptoms are subtle and multivariate, and where early detection of patient's condition may allow better non-invasive interventions and reduce the number of women undergoing surgical correction of these common disorders. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Sridharan, Indumathi; Ma, Yin; Kim, Taeyoung; Wang, Rong] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA.
   [Kobak, William] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA.
   [Rotmensch, Jacob] Rush Univ, Sch Med, Dept Obstet & Gynecol, Chicago, IL 60612 USA.
RP Wang, R (reprint author), IIT, Dept Biol & Chem Sci, 3101 S Dearborn St, Chicago, IL 60616 USA.
EM wangr@iit.edu
FU Rush University Medical School; Department of Obstetrics and Gynecology
   at University of Illinois, Chicago
FX This work was supported by Dr. Rotmensch's Grateful Patient Fund at Rush
   University Medical School. Funding was also supplied by a development
   grant from the Department of Obstetrics and Gynecology at University of
   Illinois, Chicago.
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Alperin M, 2006, CURR OPIN OBSTET GYN, V18, P544, DOI 10.1097/01.gco.0000242958.25244.ff
   Chung KH, 2010, LANGMUIR, V26, P3629, DOI 10.1021/la903073v
   Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680
   Davila GW, 2009, PELVIC FLOOR DYSFUNC, P295
   Falconer C, 1996, MATURITAS, V24, P197, DOI 10.1016/S0378-5122(96)82010-X
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027
   FOWLKES JB, 1995, MED PHYS, V22, P1771, DOI 10.1118/1.597633
   Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u
   Goh JTW, 2002, INT UROGYNECOL J PEL, V13, P76, DOI 10.1007/s001920200019
   Graham HK, 2010, MATRIX BIOL, V29, P254, DOI 10.1016/j.matbio.2010.01.008
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Heim AJ, 2006, APPL PHYS LETT, V89, P181902
   Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031
   Ian NS., 1965, INT J ENG SCI, V3, P47
   Irie T, 2010, CONNECT TISSUE RES, V51, P179, DOI 10.3109/03008200903204669
   Kerkhof MH, 2009, INT UROGYNECOL J, V20, P461, DOI 10.1007/s00192-008-0737-1
   Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2
   Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570
   Lei LL, 2007, INT UROGYNECOL J, V18, P603, DOI 10.1007/s00192-006-0214-7
   Lerner R. M., 1988, Acoustical Imaging. Vol.19. Proceedings of the 16th International Symposium, P317
   Li HB, 2010, ACCOUNTS CHEM RES, V43, P1331, DOI 10.1021/ar100057a
   Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078
   Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5
   OXLUND H, 1986, CONNECT TISSUE RES, V15, P65, DOI 10.3109/03008208609001974
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   Raub CB, 2010, ACTA BIOMATER, V6, P4657, DOI 10.1016/j.actbio.2010.07.004
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Roylance DK, 1996, MECH MAT
   Saddiq ZA, 2009, J BIOMED MATER RES A, V89A, P697, DOI 10.1002/jbm.a.32007
   Sokolov I, 2006, NANOMED-NANOTECHNOL, V2, P31, DOI 10.1016/j.nano.2005.12.002
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Suresh S, 2007, NAT NANOTECHNOL, V2, P748, DOI 10.1038/nnano.2007.397
   Tinelli A, 2010, MENOPAUSE, V17, P204, DOI 10.1097/gme.0b013e3181b0c2ae
   Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x
   Trabucco E, 2007, MATURITAS, V58, P395, DOI 10.1016/j.maturitas.2007.09.010
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   VanLandingham MR, 1999, COMPOS PART A-APPL S, V30, P75, DOI 10.1016/S1359-835X(98)00098-0
   Viidik A, 1973, Int Rev Connect Tissue Res, V6, P127
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776
NR 44
TC 9
Z9 9
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 5
BP 1520
EP 1527
DI 10.1016/j.biomaterials.2011.11.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 895CO
UT WOS:000300474000030
PM 22112762
DA 2018-10-19
ER

PT J
AU Hofer, M
   Winter, G
   Myschik, J
AF Hofer, Markus
   Winter, Gerhard
   Myschik, Julia
TI Recombinant spider silk particles for controlled delivery of protein
   drugs
SO BIOMATERIALS
LA English
DT Article
DE Biomimetic material; Spider silk; Nanoparticle; Lysozyme; Drug delivery
ID BIODEGRADABLE MICROSPHERES; CHITOSAN NANOPARTICLES; GELATIN
   NANOPARTICLES; RELEASE; FIBROIN; PHARMACEUTICALS; BIOMATERIALS;
   PERMEABILITY; INSTABILITY; FORMULATION
AB The engineered and recombinant spider silk protein eADF4(C16) has been shown to be a promising biomaterial for the use as drug delivery system. In previous studies, eADF4(C16) particles were loaded with low molecular weight drugs exhibiting a positive net-charge and sufficient hydrophobicity. Here, we demonstrate that also macromolecular drugs like proteins can be loaded on eADF4(C16) particles. Using lysozyme as a model protein, remarkably high loading of up to 30% [w/w] was feasible and high loading efficiencies of almost 100% were obtained. Furthermore, using confocal laser scanning microscopy, it is demonstrated that fluorescently labeled lysozyme is not only adsorbed to the negatively charged particles' surface, but also diffusing into the matrix of eADF4(C16) particles. The release of lysozyme is shown to be dependent on the ionic strength and pH of the release medium. To improve the long-term stability of eADF4(C16) containing dispersions, lyophilization is shown as a suitable tool. Disaccharides (sucrose, trehalose) and mannitol served as stabilizers to prevent aggregation and/or particle degradation during freeze-drying. The slowly biodegradable eADF4(C16) particles are a promising new particulate drug carrier system for the delivery of susceptible drugs like therapeutic proteins. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Hofer, Markus; Winter, Gerhard; Myschik, Julia] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-81377 Munich, Germany.
RP Myschik, J (reprint author), Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, Butenandtstr 5, D-81377 Munich, Germany.
EM julia.myschik@cup.uni-muenchen.de
RI Winter, Gerhard/F-7126-2014
FU Federal Ministry of Education and Research, Germany [13N11341]
FX The authors wish to thank AMSilk GmbH (Martinsried, Germany) for kindly
   providing the eADF4(C16) spider silk protein and Lin Romer and Ute
   Slotta for their scientific support as well as Janek Kibat for his
   contributions to this project during his bachelor thesis on
   freeze-drying of eADF4(C16) particles. This work was partly supported by
   a grant from the Federal Ministry of Education and Research, Germany
   (grant number: 13N11341).
CR Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.conrel.2005.11.014
   Brunner A, 1999, PHARMACEUT RES, V16, P847, DOI 10.1023/A:1018822002353
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   Edlund U, 2002, ADV POLYM SCI, V157, P67
   Estey T, 2006, J PHARM SCI-US, V95, P1626, DOI 10.1002/jps.20625
   Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   Hermanson KD, 2007, PHYS CHEM CHEM PHYS, V9, P6442, DOI 10.1039/b709808a
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Humenik M, 2011, POLYMERS-BASEL, V3, P640, DOI 10.3390/polym3010640
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Prokop A, 2002, BIOTECHNOL BIOENG, V78, P459, DOI 10.1002/bit.10195
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Tang XL, 2004, PHARM RES, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Van Tomme SR, 2005, J CONTROL RELEASE, V110, P67, DOI 10.1016/j.jconrel.2005.09.005
   Vollrath F, 2002, IN VIVO, V16, P229
   Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zillies JC, 2008, EUR J PHARM BIOPHARM, V70, P514, DOI 10.1016/j.ejpb.2008.04.026
NR 37
TC 56
Z9 60
U1 2
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 5
BP 1554
EP 1562
DI 10.1016/j.biomaterials.2011.10.053
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 895CO
UT WOS:000300474000034
PM 22079006
DA 2018-10-19
ER

PT J
AU Junge, K
   Binnebosel, M
   von Trotha, KT
   Rosch, R
   Klinge, U
   Neumann, UP
   Jansen, PL
AF Junge, Karsten
   Binneboesel, Marcel
   von Trotha, Klaus T.
   Rosch, Raphael
   Klinge, Uwe
   Neumann, Ulf P.
   Jansen, Petra Lynen
TI Mesh biocompatibility: effects of cellular inflammation and tissue
   remodelling
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Review
DE Mesh biocompatability; Foreign body reaction; Inflammation
ID INGUINAL-HERNIA REPAIR; RANDOMIZED CLINICAL-TRIAL; PREMATURE STOP
   MUTATIONS; ABDOMINAL-WALL DEFECTS; GELATIN HYDROGEL FILMS; ALGINATE-PLL
   CAPSULES; FOREIGN-BODY RESPONSE; INCISIONAL HERNIA; IN-VITRO; LONG-TERM
AB Mesh biocompatibility is basically determined by the foreign body reaction (FBR). In contrast to physiological wound healing and scar formation, the FBR at the host-tissue/biomaterial interface is present for the lifetime of the medical device. The cellular interactions at the mesh/tissue interface proceed over time ending up in a chronic inflammatory process. The time course of the FBR has been studied extensively and consists of three crucial steps that are protein absorption, cell recruitment and, finally, fibrotic encapsulation and extracellular matrix formation. Each of these steps involves a complex cascade of immune modulators including soluble mediators and various cell types. Recent research has focused on the cellular and molecular interactions of the distinct phases of the FBR offering a new basis for therapeutical strategies. The highly dynamic process of the FBR is considerably influenced by the biomaterial composition. Modifications of the type of polymer, the material weight, the filament structure and the pore size are realized and have substantial effects on the in vivo biocompatibility. Moreover, modern mesh technology aims to utilize the available implants as carrier systems for bioactive drugs. Studies in animal models account for the efficiency of these drugs that aim to reduce mesh-related infections or to minimize FBR by influencing inflammation or extracellular matrix remodelling. A thorough understanding of the molecular mechanisms of FBR provides a sophisticated background for the development of new biomaterials at least as carrier systems for bioactive reagents to reduce inflammation and to improve clinical outcome.
C1 [Junge, Karsten; Binneboesel, Marcel; von Trotha, Klaus T.; Rosch, Raphael; Klinge, Uwe; Neumann, Ulf P.; Jansen, Petra Lynen] Univ Hosp RWTH Aachen, Dept Gen Visceral & Transplantat Surg, D-52074 Aachen, Germany.
RP Junge, K (reprint author), Univ Hosp RWTH Aachen, Dept Gen Visceral & Transplantat Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM kjunge@ukaachen.de
CR AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   ASCH HL, 1978, J INFECT DIS, V138, P257, DOI 10.1093/infdis/138.2.257
   Athanasiou K A, 1995, Clin Podiatr Med Surg, V12, P475
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   Badiou W, 2010, INT UROGYNECOL J PEL
   Bandyk Dennis F, 2002, Semin Vasc Surg, V15, P268, DOI 10.1016/S0895-7967(02)70026-4
   Bellon JM, 1999, J AM COLL SURGEONS, V188, P466, DOI 10.1016/S1072-7515(99)00029-0
   Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8
   Bellon JM, 2000, WORLD J SURG, V24, P528, DOI 10.1007/s002689910085
   Bellon JM, 2008, J INVEST SURG, V21, P280, DOI 10.1080/08941930802029937
   Bellon JM, 2007, AM J SURG, V194, P68, DOI 10.1016/j.amjsurg.2006.11.016
   Bellon JM, 2007, J LAPAROENDOSC ADV S, V17, P160, DOI 10.1089/lap.2006.0028
   BERGER K, 1981, ANN SURG, V193, P477
   Bertheville B, 2006, BIOMATERIALS, V27, P1246, DOI 10.1016/j.biomaterials.2005.09.014
   Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024
   Binnebosel M, 2010, LANGENBECK ARCH SURG, V395, P413, DOI 10.1007/s00423-010-0601-x
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P103
   Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
   Bragdon CR, 1996, J ARTHROPLASTY, V11, P945, DOI 10.1016/S0883-5403(96)80136-7
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   Bringman S, 2006, BRIT J SURG, V93, P1056, DOI 10.1002/bjs.5403
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
   Chelala E, 2010, HERNIA, V14, P123, DOI 10.1007/s10029-010-0637-4
   Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   Conze J, 2004, Hernia, V8, P365, DOI 10.1007/s10029-004-0268-8
   Conze J, 2005, SURG ENDOSC, V19, P798, DOI 10.1007/s00464-004-2192-5
   Conze J, 2010, CHIRURG, V81, P192, DOI 10.1007/s00104-009-1817-6
   Conze J, 2006, VISZERALCHIRURGIE, V41, P246
   Conze J, 2008, J BIOMED MATER RES B, V87B, P321, DOI 10.1002/jbm.b.31106
   Conze J, 2007, LANGENBECK ARCH SURG, V392, P453, DOI 10.1007/s00423-006-0065-1
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cozad MJ, 2010, J BIOMED MATER RES B, V94B, P455, DOI 10.1002/jbm.b.31675
   Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013
   Deng X, 2000, MED BIOL ENG COMPUT, V38, P219, DOI 10.1007/BF02344780
   Deysine M, 2004, NEW ENGL J MED, V351, P193
   Deysine M, 1998, SURG CLIN N AM, V78, P1105, DOI 10.1016/S0039-6109(05)70372-8
   Di Vita G, 2005, LANGENBECK ARCH SURG, V390, P306, DOI 10.1007/s00423-004-0534-3
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Dubay DA, 2004, ANN SURG, V240, P179, DOI 10.1097/01.sla.0000131576.12153.ab
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Eichhorn SJ, 2005, J ROY SOC INTERFACE, V2, P309, DOI 10.1098/rsif.2005.0039
   Emans P, 2009, ANN BIOMED ENG, V37, P410, DOI 10.1007/s10439-008-9608-7
   Engelsman AF, 2010, ANN SURG, V251, P133, DOI 10.1097/SLA.0b013e3181b61d9a
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   ESPADASTORRE C, 1995, ANAL CHEM, V67, P3108, DOI 10.1021/ac00114a003
   Franklin M E Jr, 2002, Hernia, V6, P171
   Franz MG, 2001, J SURG RES, V97, P109, DOI 10.1006/jsre.2001.6083
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Frosch KH, 2002, CELLS TISSUES ORGANS, V170, P214, DOI 10.1159/000047925
   Gallant ND, 2007, J BIOMECH, V40, P1301, DOI 10.1016/j.jbiomech.2006.05.018
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GILBERT AI, 1993, SURG GYNECOL OBSTET, V177, P126
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gruber-Blum S, 2010, BR J SURG
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Horstmann R, 2006, WORLD J SURG, V30, P1742, DOI 10.1007/s00268-005-0242-3
   Jacob BP, 2007, SURG ENDOSC, V21, P629, DOI 10.1007/s00464-006-9157-9
   Jansen PL, 2007, FASEB J, V21, P1047, DOI 10.1096/fj.06-6755com
   Jenkins ED, 2010, SURG ENDOSC, V24, P3002, DOI 10.1007/s00464-010-1076-0
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003
   Junge K, 2006, Hernia, V10, P492, DOI 10.1007/s10029-006-0148-5
   Junge K, 2005, Hernia, V9, P212, DOI 10.1007/s10029-004-0315-5
   Junge K, 2005, BIOMATERIALS, V26, P787, DOI 10.1016/j.biomaterials.2004.02.070
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Junge K, 2001, Hernia, V5, P113
   Junge K, 2007, LANGENBECKS ARCH SUR
   Junge K, 2009, J INVEST SURG, V22, P256, DOI 10.1080/08941930802713092
   Junge K, 2009, SURG ENDOSC, V23, P327, DOI 10.1007/s00464-008-9923-y
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z
   Klinge U, 2004, Hernia, V8, P300, DOI 10.1007/s10029-004-0262-1
   Klinge U, 2008, BRIT J SURG, V95, P539, DOI 10.1002/bjs.6159
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Klinge U, 2002, J BIOMED MATER RES, V63, P129, DOI 10.1002/jbm.10119
   Klinge U, 2002, J BIOMED MATER RES, V63, P765, DOI 10.1002/jbm.10449
   Klinge U, 1998, EUR J SURG, V164, P951
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klinge Uwe, 2005, Hernia, V9, P1, DOI 10.1007/s10029-004-0294-6
   Klosterhalfen B, 2005, EXPERT REV MED DEVIC, V2, P103, DOI 10.1586/17434440.2.1.103
   Korenkov M, 2005, HERNIA
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Kumar S, 1999, BRIT J SURG, V86, P1482
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lange B, 2003, Surg Endosc, V17, P157
   LAZORTHES F, 1992, SURG GYNECOL OBSTET, V175, P569
   Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Li AG, 2007, J BIOMED MATER RES A, V82A, P498, DOI 10.1002/jbm.a.31168
   LIEBERT TC, 1976, J BIOMED MATER RES, V10, P939, DOI 10.1002/jbm.820100611
   Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862
   LOURY JN, 1983, PRESSE MED, V12, P2116
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MAAREK JM, 1984, J BIOMED MATER RES, V18, P881, DOI 10.1002/jbm.820180804
   MARTAKOS P, 1995, ASAIO J, V41, pM735, DOI 10.1097/00002480-199507000-00110
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Maruoka S, 2006, CURR EYE RES, V31, P599, DOI 10.1080/02713680600813854
   Mary C, 1998, ASAIO J, V44, P199, DOI 10.1097/00002480-199805000-00015
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McQueen M M, 1990, J Arthroplasty, V5, P169, DOI 10.1016/S0883-5403(06)80236-6
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148
   Muhl T, 2008, J BIOMED MATER RES B, V84B, P176, DOI 10.1002/jbm.b.30859
   Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471
   Murphy JL, 2010, BIOMACROMOLECULES
   MURRAY WR, 1984, CLIN ORTHOP RELAT R, P89
   Musella M, 2001, EUR J SURG, V167, P130
   Nienhuijs S, 2007, AM J SURG, V194, P394, DOI 10.1016/j.amjsurg.2007.02.012
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Orenstein SB, 2010, HERNIA, V14, P511, DOI 10.1007/s10029-010-0680-1
   Otto J, 2010, J INVEST SURG, V23, P190, DOI 10.3109/08941931003739741
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park JY, 2007, BULL HOSP JT DIS, V65, pS4
   Pratesi C, 2001, J CHEMOTHERAPY, V13, P123, DOI 10.1179/joc.2001.13.Supplement-2.123
   Ravi A, 2007, INFLAMM BOWEL DIS, V13, P97, DOI 10.1002/ibd.20011
   Reilingh TSD, 2007, J SURG RES, V140, P27, DOI 10.1016/j.jss.2006.08.011
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   Riepe G, 1997, EUR J VASC ENDOVASC, V13, P540, DOI 10.1016/S1078-5884(97)80062-7
   Rios A, 2001, Hernia, V5, P148
   Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y
   Robson MC, 2004, WOUND REPAIR REGEN, V12, P38, DOI 10.1111/j.1067-1927.2004.012109.x
   Rosch R, 2003, EUR SURG RES, V35, P445, DOI 10.1159/000072230
   Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x
   Saberski ER, 2010, HERNIA
   Sacha Pawel Tomasz, 1999, Medycyna Doswiadczalna i Mikrobiologia, V51, P399
   Sano A, 1998, ADV DRUG DELIV REV, V31, P247
   Schaffer M, 2006, J INVEST SURG, V19, P371, DOI 10.1080/08941930600985710
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Schug-Pass C, 2009, SURG ENDOSC, V23, P487, DOI 10.1007/s00464-008-0085-8
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Taylor EW, 1997, WORLD J SURG, V21, P811, DOI 10.1007/s002689900311
   Tekos A, 2003, SKIN PHARMACOL APPL, V16, P252, DOI 10.1159/000070848
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Tsukada H, 2004, J THORAC CARDIOV SUR, V127, P877, DOI 10.1016/S0022-5223(03)01317-5
   Uchegbu IF, 1998, J PHARM PHARMACOL, V50, P453, DOI 10.1111/j.2042-7158.1998.tb06185.x
   URBAN E, 1994, ASAIO J, V40, P145
   USHER F C, 1958, Am Surg, V24, P969
   VANDERLEI B, 1989, BRIT J SURG, V76, P803, DOI 10.1002/bjs.1800760813
   VANT RM, 2003, ANN SURG, V237, P123
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   VINARD E, 1988, J BIOMED MATER RES, V22, P633, DOI 10.1002/jbm.820220705
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Voskerician G, 2010, J MATER SCI-MATER M, V21, P1989, DOI 10.1007/s10856-010-4037-1
   Vrijland WW, 2000, SURG ENDOSC-ULTRAS, V14, P960, DOI 10.1007/s004640000180
   VROMAN L, 1971, FED PROC, V30, P1494
   Ward WK, 2008, J BIOMAT SCI-POLYM E, V19, P1065, DOI 10.1163/156856208784909408
   Wassenaar EB, 2010, HERNIA, V14, P137, DOI 10.1007/s10029-009-0568-0
   Welty G, 2001, Hernia, V5, P142
   Weyhe D, 2008, ANZ J SURG, V78, P55, DOI 10.1111/j.1445-2197.2007.04362.x
   Weyhe D, 2007, WORLD J SURG, V31, P234, DOI 10.1007/s00268-006-0123-4
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   White TJ, 1998, AM SURGEON, V64, P276
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Wrzesniok D, 2002, EUR J PHARMACOL, V446, P7, DOI 10.1016/S0014-2999(02)01793-4
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143
   Yu Q, 2000, GENE DEV, V14, P163
   Zellin G, 1996, BIOMATERIALS, V17, P695, DOI 10.1016/0142-9612(96)86739-1
   Zhang Y, 2006, J MATER SCI-MATER M, V17, P437, DOI [10.1007/s10856-006-8471-z, 10.1007/s10856-006-8471-7]
   Zinther NB, 2010, HERNIA, V14, P499, DOI 10.1007/s10029-010-0676-x
NR 195
TC 42
Z9 43
U1 1
U2 54
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1435-2443
EI 1435-2451
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD FEB
PY 2012
VL 397
IS 2
BP 255
EP 270
DI 10.1007/s00423-011-0780-0
PG 16
WC Surgery
SC Surgery
GA 895JX
UT WOS:000300493600013
PM 21455703
DA 2018-10-19
ER

PT J
AU Yoon, JYS
   Deyhle, H
   Gbureck, U
   Vorndran, E
   Beckmann, F
   Muller, B
AF Yoon, Jin Yu Simon
   Deyhle, Hans
   Gbureck, Uwe
   Vorndran, Elke
   Beckmann, Felix
   Mueller, Bert
TI Three-dimensional morphology and mechanics of bone scaffolds fabricated
   by rapid prototyping
SO INTERNATIONAL JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
DE Tr-calcium phosphate; Bone scaffold; Micro computed tomography; 3D
   morphology; Young's modulus
ID MICRO-COMPUTED TOMOGRAPHY; SYNCHROTRON-RADIATION; CALCIUM-PHOSPHATE;
   OSTEOPOROSIS; RESOLUTION; IMPLANTS
AB Alpha-beta-tri-calcium phosphate is a promising biomaterial to fabricate scaffolds for the reconstruction of osseous defects. In the present study, we demonstrate that three-dimensional printing allows tailoring the porosity and the mechanical properties of nature-analogue designed scaffolds. Sophisticated software tools applied to the acquired tomography data were used to characterize the printing quality and the porosity by means of the distance transform, the radial density distribution and the accessibility by virtual spheres. Analyzing the stress-strain curves of the scaffolds, the Young's modulus and the ultimate compressive strength were obtained. To reach mechanical properties comparable to those of jaw bone, the scaffolds were treated with phosphoric acid. Depending on the design, the compressive strength of the bone scaffolds lies between 30 and 60 MPa and their Young's modulus is between 50 and 140 MPa. Hence, prototypes for clinical trials can be fabricated in near future.
C1 [Yoon, Jin Yu Simon; Deyhle, Hans; Mueller, Bert] Univ Basel, Biomat Sci Ctr, CH-4031 Basel, Switzerland.
   [Gbureck, Uwe; Vorndran, Elke] Univ Wurzburg, Dept Funct Mat Med & Dent, Wurzburg, Germany.
   [Beckmann, Felix] Helmholtz Zentrum Geesthacht, Inst Mat Res, Geesthacht, Germany.
RP Muller, B (reprint author), Univ Basel, Univ Basel Hosp, Biomat Sci Ctr, CH-4031 Basel, Switzerland.
EM bert.mueller@stud.unibas.ch
RI Muller, Bert/A-6838-2008; Gbureck, Uwe/G-1430-2012; Deyhle,
   Hans/A-2768-2013; Vorndran, Elke/G-6226-2012; Beckmann,
   Felix/E-1940-2016
OI Muller, Bert/0000-0003-4078-9109; Beckmann, Felix/0000-0002-2266-9173
CR Beckmann F, 2008, PROC SPIE, V7078, DOI 10.1117/12.794617
   Chua CK, 2010, RAPID PROTOTYPING: PRINCIPLES AND APPLICATIONS, 3RD EDITION, P1
   DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4
   Erdogan O, 2007, ORAL SURG ORAL MED O, V104, P738, DOI 10.1016/j.tripleo.2007.04.008
   Fierz FC, 2008, BIOMATERIALS, V29, P3799, DOI 10.1016/j.biomaterials.2008.06.012
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x
   Gbureck U, 2007, ADV MATER, V19, P795, DOI 10.1002/adma.200601370
   Hajnal J.V., 2001, MED IMAGE REGISTRATI, DOI [10.1201/9781420042474, DOI 10.1201/9781420042474]
   Honiball J.R., 2010, THESIS U STELLENBOSC
   Kak A. C., 1988, PRINCIPLES COMPUTERI
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Klammert U, 2009, ACTA BIOMATER, V5, P727, DOI 10.1016/j.actbio.2008.08.019
   Kothe U., 1999, HDB COMPUTER VISION
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   Mehrban N, 2011, ADV APPL CERAM, V110, P162, DOI 10.1179/1743676110Y.0000000012
   Muller B, 2007, INT J MATER RES, V98, P613, DOI 10.3139/146.101507
   Muller B, 2012, INT J MATER RES, V103, P242, DOI 10.3139/146.110663
   Muller B, 2006, MICROSC MICROANAL, V12, P97, DOI 10.1017/S1431927606060168
   Muller B, 2002, BIOMOL ENG, V19, P73, DOI 10.1016/S1389-0344(02)00014-X
   Muller Bert, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7401, DOI 10.1117/12.825487
   Muller B, 2002, P SOC PHOTO-OPT INS, V4503, P178, DOI 10.1117/12.452843
   O'Mahony AM, 2000, CLIN ORAL IMPLAN RES, V11, P415, DOI 10.1034/j.1600-0501.2000.011005415.x
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   Thurner P, 2004, NUCL INSTRUM METH B, V225, P599, DOI 10.1016/j.nimb.2004.05.027
   Tuli T., 2007, INT J ORAL MAX SURG, V36, P1082, DOI [10.1016/j.ijom.2007.08.460, DOI 10.1016/J.IJOM.2007.08.460]
NR 27
TC 6
Z9 6
U1 0
U2 47
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 1862-5282
J9 INT J MATER RES
JI Int. J. Mater. Res.
PD FEB
PY 2012
VL 103
IS 2
BP 200
EP 206
DI 10.3139/146.110661
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 895AD
UT WOS:000300467700011
DA 2018-10-19
ER

PT J
AU Artzi, Z
   Wasersprung, N
   Weinreb, M
   Steigmann, M
   Prasad, HS
   Tsesis, I
AF Artzi, Zvi
   Wasersprung, Nadav
   Weinreb, Miron
   Steigmann, Marius
   Prasad, Hari S.
   Tsesis, Igor
TI Effect of Guided Tissue Regeneration on Newly Formed Bone and Cementum
   in Periapical Tissue Healing after Endodontic Surgery: An In Vivo Study
   in the Cat
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Apical periodontitis; apicectomy; bovine bone mineral; guided tissue
   regeneration; surgical endodontics; xenograft
ID NANOCRYSTALLINE HYDROXYAPATITE PASTE; INTRABONY PERIODONTAL DEFECTS;
   BOVINE BONE; PERIRADICULAR SURGERY; HISTOLOGIC EVALUATION;
   CALCIUM-SULFATE; QUANTITATIVE EXPRESSION; MORPHOMETRIC-ANALYSIS;
   SURGICAL ENDODONTICS; FENESTRATION DEFECTS
AB Introduction: The purpose of this study was to evaluate the influence of anorganic bovine bone as a grafted biomaterial on newly formed bone and cementum in periapical regions after surgical endodontic treatment in cats. Methods: After inducing apical periodontitis in 9 cats, root canal and surgical endodontic treatment were performed on 72 roots of first and second maxillary premolars. Bone defects were treated with biomaterial particles + a membrane, biomaterial only, a membrane only, or left unfilled (control). Histomorphometry on nondecalcified sections were performed at 3 and 6 months after surgery. Analysis of variance with repeated measures was used within 2 and 3 subject factors to analyze newly formed bone, cementum, biomaterial conduction, and resorption. Results: At each time period, bone formation was greater at the grafted membrane-protected sites than in the grafted-unprotected sites. At 6 months, the bone area fraction at membrane nongrafted sites was greater than in the grafted-protected sites. The new cementum was significantly greater at 6 months than at 3 months and greater at the grafted membrane-protected sites over the unprotected ones at 6 months. Statistically, the grafted biomaterial, the membrane, and the time contributed significantly to the amount of new bone (P < .05) with no significant interaction. Biomaterial osteoconduction was significantly affected by the time. All 3 variables showed a significant interaction on new cementum. Conclusions: There was significantly more bone formation after surgical endodontic treatment when membrane and bone grafts were used as compared with bone grafts only or unfilled control sites. However, it appears that the key factor to the enhanced tissue regeneration is the membrane and not the grafted biomaterial. (J Endod 2012;38:163-169)
C1 [Artzi, Zvi; Wasersprung, Nadav] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Periodontol & Dent Implantol, IL-69978 Tel Aviv, Israel.
   [Weinreb, Miron] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.
   [Steigmann, Marius] Boston Univ, Dept Oral & Maxillofacial Surg, Boston, MA 02215 USA.
   [Prasad, Hari S.] Univ Minnesota, Dept Oral Pathol, Minneapolis, MN USA.
   [Tsesis, Igor] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Endondontol, IL-69978 Tel Aviv, Israel.
RP Artzi, Z (reprint author), Tel Aviv Univ, Sch Dent Med, Dept Periodontol & Dent Implantol, IL-69978 Tel Aviv, Israel.
EM zviartzi@tau.ac.il
FU Botiss Biomaterials GmbH Germany; Tel Aviv University
FX Supported by a grant from Botiss Biomaterials GmbH Germany and by the
   Alpha Omega Research Fund, Tel Aviv University.
CR Andreasen J O, 1972, Int J Oral Surg, V1, P148, DOI 10.1016/S0300-9785(72)80005-X
   Apaydin ES, 2004, J ENDODONT, V30, P17, DOI 10.1097/00004770-200401000-00003
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2003, J PERIODONTOL, V74, P1143, DOI 10.1902/jop.2003.74.8.1143
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Artzi Z, 2006, J PERIODONTOL, V77, P1658, DOI 10.1902/jop.2006.060041
   Baek SH, 2001, ORAL SURG ORAL MED O, V91, P710, DOI 10.1067/moe.2001.115393
   BARKHORDAR RA, 1986, ORAL SURG ORAL MED O, V61, P201, DOI 10.1016/0030-4220(86)90188-X
   Bashutski JD, 2009, J ENDODONT, V35, P321, DOI 10.1016/j.joen.2008.11.023
   BECKCOON RJ, 1991, ORAL SURG ORAL MED O, V71, P483, DOI 10.1016/0030-4220(91)90436-G
   Britain SK, 2005, J PERIODONTOL, V76, P450, DOI 10.1902/jop.2005.76.3.450
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   CATON JG, 1987, J PERIODONTOL, V58, P546, DOI 10.1902/jop.1987.58.8.546
   CHOI SY, 1993, J PERIODONTOL, V64, P878, DOI 10.1902/jop.1993.64.9.878
   Dietrich T, 2003, ORAL SURG ORAL MED O, V95, P474, DOI 10.1067/moe.2003.39
   Dominiak M, 2009, J PHYSIOL PHARMACOL, V60, P51
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Douthitt JC, 2001, J ENDODONT, V27, P404, DOI 10.1097/00004770-200106000-00009
   Bernabe PFE, 2010, ORAL SURG ORAL MED O, V109, P309, DOI 10.1016/j.tripleo.2009.07.019
   Garrett K, 2002, J ENDODONT, V28, P503, DOI 10.1097/00004770-200207000-00003
   Grimm J, 2001, ARCH ORTHOP TRAUM SU, V121, P158, DOI 10.1007/s004020000194
   Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605
   GUTMANN JL, 1985, INT ENDOD J, V18, P8, DOI 10.1111/j.1365-2591.1985.tb00415.x
   Gutmann JL, 1991, SURG ENDODONTICS
   HARRISON JW, 1992, J ENDODONT, V18, P76, DOI 10.1016/S0099-2399(06)81375-0
   Houser BE, 2001, INT J PERIODONT REST, V21, P161
   Huber FX, 2006, ARCH ORTHOP TRAUM SU, V126, P533, DOI 10.1007/s00402-006-0170-1
   Kim S, 2006, J ENDODONT, V32, P601, DOI 10.1016/j.joen.2005.12.010
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Lin L, 2010, J ENDODONT, V36, P618, DOI 10.1016/j.joen.2009.12.012
   Maguire H, 1998, J ENDODONT, V24, P720, DOI 10.1016/S0099-2399(98)80161-1
   Murashima Y, 2002, INT ENDOD J, V35, P768, DOI 10.1046/j.1365-2591.2002.00565.x
   NYMAN S, 1987, J PERIODONTAL RES, V22, P252, DOI 10.1111/j.1600-0765.1987.tb01581.x
   Pecora G, 2001, INT ENDOD J, V34, P189, DOI 10.1046/j.1365-2591.2001.00369.x
   PECORA G, 1995, INT ENDOD J, V28, P41, DOI 10.1111/j.1365-2591.1995.tb00155.x
   Pecora G, 1997, Dent Clin North Am, V41, P585
   SALMAN L, 1992, Journal of Oral Implantology, V18, P24
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P72, DOI 10.1111/j.1600-051X.2006.01007.x
   STASSEN LFA, 1994, BRIT J ORAL MAX SURG, V32, P83, DOI 10.1016/0266-4356(94)90133-3
   Stavropoulos A, 2005, CLIN ORAL INVEST, V9, P271, DOI 10.1007/s00784-005-0002-7
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tal H, 2005, INT J PERIODONT REST, V25, P509
   Taschieri S, 2008, INT J PERIODONT REST, V28, P265
   Taschieri S, 2007, J ORAL MAXIL SURG, V65, P1121, DOI 10.1016/j.joms.2006.10.022
   Tobon S, 2002, INT ENDOD J, V35, P635, DOI 10.1046/j.1365-2591.2002.00523.x
   Tsesis I, 2006, J ENDODONT, V32, P412, DOI 10.1016/j.joen.2005.10.051
   Tsesis I, 2009, J ENDODONT, V35, P1505, DOI 10.1016/j.joen.2009.07.025
   von Arx T, 2003, INT J PERIODONT REST, V23, P157
   Vouros I, 2004, J CLIN PERIODONTOL, V31, P908, DOI 10.1111/j.1600-051X.2004.00583.x
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
   Yoshikawa G, 2002, INT ENDOD J, V35, P255, DOI 10.1046/j.1365-2591.2002.00473.x
NR 52
TC 5
Z9 10
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD FEB
PY 2012
VL 38
IS 2
BP 163
EP 169
DI 10.1016/j.joen.2011.10.002
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 891DE
UT WOS:000300195900007
PM 22244630
DA 2018-10-19
ER

PT J
AU Kou, PM
   Pallassana, N
   Bowden, R
   Cunningham, B
   Joy, A
   Kohn, J
   Babensee, JE
AF Kou, Peng Meng
   Pallassana, Narayanan
   Bowden, Rebeca
   Cunningham, Barry
   Joy, Abraham
   Kohn, Joachim
   Babensee, Julia E.
TI Predicting biomaterial property-dendritic cell phenotype relationships
   from the multivariate analysis of responses to polymethacrylates
SO BIOMATERIALS
LA English
DT Article
DE Dendritic cells; Polymethacrylate; Combinatorial library; Material
   properties; Principal component analysis; Partial linear squares
   regression
ID HOST TISSUE RESPONSES; T-CELLS; POLY(LACTIC-CO-GLYCOLIC ACID);
   COMBINATORIAL LIBRARIES; POLYMERIC BIOMATERIALS; FIBRINOGEN ADSORPTION;
   ADSORBED PROTEINS; IMMUNE-RESPONSES; IN-VITRO; SURFACES
AB Dendritic cells (DCs) play a critical role in orchestrating the host responses to a wide variety of foreign antigens and are essential in maintaining immune tolerance. Distinct biomaterials have been shown to differentially affect the phenotype of DCs, which suggested that biomaterials may be used to modulate immune response toward the biologic component in combination products. The elucidation of biomaterial property-DC phenotype relationships is expected to inform rational design of immuno-modulatory biomaterials. In this study, DC response to a set of 12 polymethacrylates (pMAs) was assessed in terms of surface marker expression and cytokine profile. Principal component analysis (PCA) determined that surface carbon correlated with enhanced DC maturation, while surface oxygen was associated with an immature DC phenotype. Partial square linear regression, a multivariate modeling approach, was implemented and successfully predicted biomaterial-induced DC phenotype in terms of surface marker expression from biomaterial properties with R-prediction(2) = 0.76. Furthermore, prediction of DC phenotype was effective based on only theoretical chemical composition of the bulk polymers with R-prediction(2) = 0.80. These results demonstrated that immune cell response can be predicted from biomaterial properties, and computational models will expedite future biomaterial design and selection. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kou, Peng Meng; Bowden, Rebeca; Babensee, Julia E.] Emory Univ, Georgia Inst Technol, Atlanta, GA 30332 USA.
   [Kou, Peng Meng; Bowden, Rebeca; Babensee, Julia E.] Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Kou, Peng Meng; Babensee, Julia E.] Georgia Inst Technol, Parker H Petit Inst Bioengn& Biosci, Atlanta, GA 30332 USA.
   [Pallassana, Narayanan; Cunningham, Barry; Joy, Abraham; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Babensee, JE (reprint author), Georgia Tech, Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Institutes of Health [EB004633]; NIH at NJ Center for
   Biomaterials, Rutgers University [EB001046]
FX The authors thank Dr. Melissa L Kemp of Georgia Institute of Technology
   for helpful discussion on multivariate analysis and critical review of
   the manuscript, Dr. Manu O. Platt of Georgia Institute of Technology for
   access to the Simca P+ software, and Dr. Rana Sodhi for performing the
   XPS measurements and analysis. This research was supported by the
   National Institutes of Health grants EB004633 (JEB), and the 96-well pMA
   testbed was developed under NIH grant EB001046 (RESBIO) at NJ Center for
   Biomaterials, Rutgers University.
CR Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042
   Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Chang DT, 2009, CELL MOL BIOENG, V2, P573, DOI 10.1007/s12195-009-0088-0
   Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103
   Eriksson L, 2006, MULTI AND MEGAVARIAT
   Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187
   Ghosh J, 2011, POLYMER, V52, P2650, DOI 10.1016/j.polymer.2011.04.014
   Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1
   Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kholodovych V, 2008, POLYMER, V49, P2435, DOI 10.1016/j.polymer.2008.03.032
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kou PM, 2010, ACTA BIOMATER, V6, P2621, DOI 10.1016/j.actbio.2010.01.023
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Livingstone DJ, 2003, QSAR COMB SCI, V22, P510, DOI 10.1002/qsar.200310003
   Martens H, MULTIVARIATE ANAL QU
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   Rojas R, 2009, J POLYM SCI POL CHEM, V47, P49, DOI 10.1002/pola.23119
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1329, DOI 10.1002/jbm.a.32457
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Smith JR, 2005, QSAR COMB SCI, V24, P99, DOI 10.1002/qsar.200420062
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   Smith JR, 2004, J CHEM INF COMP SCI, V44, P1088, DOI 10.1021/ci0499774
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thacker RI, 2008, EXP MOL PATHOL, V84, P122, DOI 10.1016/j.yexmp.2008.01.001
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
NR 50
TC 27
Z9 28
U1 0
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 6
BP 1699
EP 1713
DI 10.1016/j.biomaterials.2011.10.066
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 888EI
UT WOS:000299986200002
PM 22136715
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gaetani, R
   Doevendans, PA
   Metz, CHG
   Alblas, J
   Messina, E
   Giacomello, A
   Sluijtera, JPG
AF Gaetani, Roberto
   Doevendans, Peter A.
   Metz, Corina H. G.
   Alblas, Jacqueline
   Messina, Elisa
   Giacomello, Alessandro
   Sluijtera, Joost P. G.
TI Cardiac tissue engineering using tissue printing technology and human
   cardiac progenitor cells
SO BIOMATERIALS
LA English
DT Article
DE Cardiac progenitor cells; Tissue printing; Alginate; Cardiac tissue
   engineering
ID STEM-CELLS; MYOCARDIAL-INFARCTION; ALGINATE BIOMATERIAL; HUMAN HEART;
   RAT HEARTS; IN-VITRO; REPAIR; MODEL; CARDIOMYOCYTES; REGENERATION
AB Tissue engineering is emerging as a potential therapeutic approach to overcome limitations of cell therapy, like cell retention and survival, as well as to mechanically support the ventricular wall and thereby prevent dilation. Tissue printing technology (TP) offers the possibility to deliver, in a defined and organized manner, scaffolding materials and living cells. The aim of our study was to evaluate the combination of TP, human cardiac-derived cardiomyocyte progenitor cells (hCMPCs) and biomaterials to obtain a construct with cardiogenic potential for in vitro use or in vivo application. With this approach, we were able to generate an in vitro tissue with homogenous distribution of cells in the scaffold. Cell viability was determined after printing and showed that 92% and 89% of cells were viable at I and 7 days of culturing, respectively. Moreover, we demonstrated that printed hCMPCs retained their commitment for the cardiac lineage. In particular, we showed that 3D culture enhanced gene expression of the early cardiac transcription factors Nkx2.5, Gata-4 and Mef-2c as well as the sarcomeric protein TroponinT. Printed cells were also able to migrate from the alginate matrix and colonize a matrigel layer, thereby forming tubular-like structures. This indicated that printing can be used for defined cell delivery, while retaining functional properties. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Gaetani, Roberto] Univ Med Ctr Utrecht, HCLU, Dept Cardiol, Div Heart & Lungs, NL-3584 CX Utrecht, Netherlands.
   [Gaetani, Roberto; Doevendans, Peter A.; Sluijtera, Joost P. G.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands.
   [Gaetani, Roberto; Messina, Elisa; Giacomello, Alessandro] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, Dept Mol Med, Rome, Italy.
   [Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthopaed, NL-3584 CX Utrecht, Netherlands.
RP Gaetani, R (reprint author), Univ Med Ctr Utrecht, HCLU, Dept Cardiol, Div Heart & Lungs, Heidelberglaan 100,Mailbox G 02-523, NL-3584 CX Utrecht, Netherlands.
EM R.Gaetani@umcutrecht.nl
RI Messina, Elisa/I-5401-2018
OI Messina, Elisa/0000-0002-1654-9001; Alblas,
   Jacqueline/0000-0002-2996-9697; Sluijter, Joost/0000-0003-2088-9102
FU Novartis Foundation for Cardiovascular Excellence; Bekalis price; van
   Ruyvenstichting; Pasteur Institute, Cenci-Bolognetti Foundation;
   Netherlands Ministry of Economic Affairs; Netherlands Ministry of
   Education, Culture and Science
FX This project was supported by Novartis Foundation for Cardiovascular
   Excellence (JS), a Bekalis price (PD), van Ruyvenstichting (JS), a
   Pasteur Institute, Cenci-Bolognetti Foundation (RG), and the Smart Mix
   Program of the Netherlands Ministry of Economic Affairs and the
   Netherlands Ministry of Education, Culture and Science (JA).
CR Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2113, DOI [10.1089/ten.tea.2011.0019, 10.1089/ten.TEA.2011.0019]
   Fedorovich NE, 2010, TISSUE ENG PT A, V16, P2355, DOI [10.1089/ten.tea.2009.0603, 10.1089/ten.TEA.2009.0603]
   Gaetani R., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P91
   Gaetani R, 2010, J CELL MOL MED, V14, P1071, DOI 10.1111/j.1582-4934.2010.01078.x
   Gaetani R, 2009, CARDIOVASC RES, V82, P411, DOI 10.1093/cvr/cvp067
   Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003
   Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618
   Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Sluijter JPG, 2004, CARDIOVASC RES, V61, P186, DOI 10.1016/j.cardiores.2003.09.028
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229
   Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Udelson James E, 2003, Rev Cardiovasc Med, V4 Suppl 3, pS3
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   van Vliet P, 2008, NETH HEART J, V16, P163, DOI 10.1007/BF03086138
   Vrijsen KR, 2010, J CELL MOL MED, V14, P1064, DOI 10.1111/j.1582-4934.2010.01081.x
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 32
TC 129
Z9 139
U1 3
U2 145
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 6
BP 1782
EP 1790
DI 10.1016/j.biomaterials.2011.11.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 888EI
UT WOS:000299986200010
PM 22136718
DA 2018-10-19
ER

PT J
AU Seidel, N
   Sitterberg, J
   Vornholt, W
   Bakowsky, U
   Keusgen, M
   Kissel, T
AF Seidel, Nina
   Sitterberg, Johannes
   Vornholt, Wolfgang
   Bakowsky, Udo
   Keusgen, Michael
   Kissel, Thomas
TI Predicting protein instability in sustained protein delivery systems
   using spectral-phase interference
SO BIOMATERIALS
LA English
DT Article
DE Biomolecular interaction analysis (BIA); Biosensor; Bovine serum albumin
   (BSA); Poly(ethylene carbonate) (PEC); Protein delivery; Protein
   adsorption
ID POLYSTYRENE LATEX-PARTICLES; SOLID-LIQUID INTERFACES; HUMAN
   SERUM-ALBUMIN; POLYMER SURFACES; GLOBULAR-PROTEINS; PLGA FILMS;
   ADSORPTION; KINETICS; BIOSENSORS; STABILITY
AB Biodegradable and non-biodegradable polymers represent promising materials for sustained protein delivery systems. However, structural protein instabilities due to interactions with the polymer surface are often observed. Aim of the present study was to analyze and predict these instabilities by determination of adsorption pattern and extent via biomolecular interaction analysis. A new optical method based on spectral-phase interference successfully demonstrated its suitability for this new application scope. It was characterized in terms of sensitivity, reproducibility and dynamic range using bovine serum albumin (BSA) as model compound. For protein polymer interaction studies, materials with different wettabilities and zeta potential were selected and successfully applied on the sensor chip: Glass, poly(styrene), poly(lactic acid), poly(lactic-co-glycolic acid), and poly(ethylene carbonate). Concentration dependent adsorption curves revealed two principal adsorption patterns based on the connection between BSA spreading and supply rate. This connection was stronger influenced by polymer hydrophobicity than surface charge. Association, dissociation and binding rate constants in the range from 015 to 34.19 x 10(-6) M were obtained. Atomic force microscopy images of the films before and after adsorption confirmed the previous elaborated model. Poly(ethylene carbonate) emerged as highly promising biomaterial for protein delivery due to its favorable adsorption behavior based on low polymer protein interactions. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Seidel, Nina; Sitterberg, Johannes; Bakowsky, Udo; Kissel, Thomas] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany.
   [Vornholt, Wolfgang; Keusgen, Michael] Univ Marburg, Dept Pharmaceut Chem, D-35032 Marburg, Germany.
RP Kissel, T (reprint author), Univ Marburg, Dept Pharmaceut & Biopharm, Ketzerbach 63, D-35032 Marburg, Germany.
EM kissel@staff.uni-marburg.de
OI Bakowsky, Udo/0000-0002-3895-0453
FU Novartis Pharma AG, Basel, Switzerland
FX We gratefully thank Novartis Pharma AG, Basel, Switzerland for providing
   PEC and especially Holger Petersen and Catherine Curdy for their
   support. The SPI device was kindly provided by Senova GmbH, Weimar,
   Germany.
CR BRASH JL, 1977, ANN NY ACAD SCI, V283, P356, DOI 10.1111/j.1749-6632.1977.tb41781.x
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253
   DEZELIC G, 1971, EUR J BIOCHEM, V23, P575, DOI 10.1111/j.1432-1033.1971.tb01656.x
   DIJT JC, 1990, COLLOID SURFACE, V51, P141, DOI 10.1016/0166-6622(90)80138-T
   Edwards PR, 1997, ANAL BIOCHEM, V246, P1, DOI 10.1006/abio.1996.9922
   GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Hartmann M, 2006, BIOSENS BIOELECTRON, V22, P28, DOI 10.1016/j.bios.2005.11.027
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034
   Keusgen M, 2002, NATURWISSENSCHAFTEN, V89, P433, DOI 10.1007/s00114-002-0358-3
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894
   Meadows D, 1996, ADV DRUG DELIVER REV, V21, P179, DOI 10.1016/S0169-409X(96)00406-1
   MICHAELI I, 1980, J COLLOID INTERF SCI, V77, P586, DOI 10.1016/0021-9797(80)90337-9
   Miller R, 2007, SOFT COLLOIDS, VV
   Miller R, 2005, SOFT COLLOIDS, VV
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   MORRISSEY BW, 1977, ANN NY ACAD SCI, V283, P50, DOI 10.1111/j.1749-6632.1977.tb41752.x
   Nikitin PI, 2003, SENSOR ACTUAT B-CHEM, V90, P46, DOI 10.1016/S0925-4005(03)00020-0
   Nikitin PI, 2000, QUANTUM ELECTRON+, V30, P1099, DOI 10.1070/QE2000v030n12ABEH001876
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   NORDE W, 1992, Clinical Materials, V11, P85, DOI 10.1016/0267-6605(92)90032-O
   NORDE W, 1992, J DISPER SCI TECHNOL, V13, P363, DOI 10.1080/01932699208943322
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   NORDE W, 1995, POLYM ADVAN TECHNOL, V6, P518, DOI 10.1002/pat.1995.220060713
   NORMAN ME, 1992, BIOMATERIALS, V13, P841, DOI 10.1016/0142-9612(92)90177-P
   Oesterberg E., 1993, COLLOID SURF A, V77, P159
   Paddle BM, 1996, BIOSENS BIOELECTRON, V11, P1079, DOI 10.1016/0956-5663(96)82333-5
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RUDEE ML, 1985, J BIOMED MATER RES, V19, P57, DOI 10.1002/jbm.820190106
   Schubert DW, 2003, MATER RES INNOV, V7, P314, DOI 10.1007/s10019-003-0270-2
   Sklodowska A, 1999, BIOL P ONLINE, V1
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4
   Tanimoto S, 1999, COLLOID POLYM SCI, V277, P130, DOI 10.1007/s003960050377
   Paragkumar NT, 2006, APPL SURF SCI, V253, P2758, DOI 10.1016/j.apsusc.2006.05.047
   Unger F, 2007, J CONTROL RELEASE, V117, P312, DOI 10.1016/j.jconrel.2006.11.003
   UYEN HMW, 1990, J BIOMED MATER RES, V24, P1599, DOI 10.1002/jbm.820241205
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   van der Veen M, 2007, COLLOID SURFACE B, V54, P136, DOI 10.1016/j.colsurfb.2006.08.017
   Van Tassel PR, 1998, J COLLOID INTERF SCI, V207, P317, DOI 10.1006/jcis.1998.5781
   VanTassel PR, 1997, J CHEM PHYS, V106, P761, DOI 10.1063/1.473164
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Zhang Zhi-Hong, 2007, Biotechnology Journal, V2, P743, DOI 10.1002/biot.200600231
NR 50
TC 5
Z9 5
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 6
BP 1929
EP 1938
DI 10.1016/j.biomaterials.2011.11.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 888EI
UT WOS:000299986200025
PM 22136720
DA 2018-10-19
ER

PT J
AU Lu, LX
   Wang, YY
   Mao, X
   Xiao, ZD
   Huang, NP
AF Lu, Lan-Xin
   Wang, Yan-Yan
   Mao, Xi
   Xiao, Zhong-Dang
   Huang, Ning-Ping
TI The effects of PHBV electrospun fibers with different diameters and
   orientations on growth behavior of bone-marrow-derived mesenchymal stem
   cells
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID IN-VIVO; OSTEOGENIC DIFFERENTIATION; COLLAGEN IMMOBILIZATION; POLY
   3-HYDROXYBUTYRATE; MECHANICAL-PROPERTIES; NANOFIBROUS STRUCTURE;
   COMPOSITE SCAFFOLDS; MICROBIAL POLYESTER; PROLIFERATION; MATRIX
AB Microenvironments in which cells live play an important role in the attachment, growth and interactions of cells. To mimic the natural structure of extracellular matrices, electrospinning was applied to fabricate biomaterials into ultrafine fibers. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), a biocompatible and biodegradable polyester, has been shown to be an excellent biomaterial candidate for tissue engineering. In this study, five types of PHBV fibrous scaffolds with different diameters and orientations were obtained by changing solvents, concentration of electrospun solution and collector. Three kinds of scaffolds with good continuity and suitable mechanical properties, selected according to the morphology and mechanical properties of the scaffolds, were used for studying the influence of fiber diameter and orientation on growth behavior of bone-marrow-derived mesenchymal stem cells (MSCs). The results indicated that the random-oriented nanofibrous scaffold is most favorable for cell growth compared to other scaffolds, while the microfibrous scaffold resulted in the lowest viability of MSCs. The orientation of nanofibers showed a distinct effect on cell morphology by guiding cell skeleton extension. Both the random-oriented and aligned PHBV nanofibrous scaffolds showed to be good candidates for applications in tissue engineering.
C1 [Lu, Lan-Xin; Wang, Yan-Yan; Xiao, Zhong-Dang; Huang, Ning-Ping] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Mao, Xi] Southeast Univ, Sch Med, Lab Dev Genes & Human Dis, Nanjing 210009, Peoples R China.
RP Huang, NP (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM nphuang@seu.edu.cn
FU National Science Foundation of China [30870626]; Ministry of Science and
   Technology of China [2008DFA51180]; SRF
FX This work was supported by the National Science Foundation of China (no
   30870626), the International Cooperation Program awarded by the Ministry
   of Science and Technology of China (2008DFA51180) and the project
   sponsored by SRF for ROCS, SEM.
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cheng ML, 2008, POLYMER, V49, P546, DOI 10.1016/j.polymer.2007.11.049
   Choi JS, 2004, INT J BIOL MACROMOL, V34, P249, DOI 10.1016/j.ijbiomac.2004.06.001
   Chronakis IS, 2006, POLYMER, V47, P1597, DOI 10.1016/j.polymer.2006.01.032
   Chu XH, 2009, BIOTECHNOL LETT, V31, P347, DOI 10.1007/s10529-008-9892-1
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Guan DH, 2008, APPL SURF SCI, V255, P324, DOI 10.1016/j.apsusc.2008.06.093
   Gursel I, 2001, BIOMATERIALS, V22, P73, DOI 10.1016/S0142-9612(00)00170-8
   Han I, 2007, ARTIF ORGANS, V31, P801, DOI 10.1111/j.1525-1594.2007.00466.x
   Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Ke Y, 2010, ACTA BIOMATER, V6, P1329, DOI 10.1016/j.actbio.2009.10.026
   Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Kwon OH, 2007, BIOMED MATER, V2, pS52, DOI 10.1088/1748-6041/2/1/S08
   Lee IS, 2004, MACROMOL RES, V12, P374, DOI 10.1007/BF03218414
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liang QC, 2009, CANCER LETT, V273, P164, DOI 10.1016/j.canlet.2008.08.011
   Liu JO, 2010, J BIOMED MATER RES A, V94A, P603, DOI 10.1002/jbm.a.32730
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Mao X, 2005, TISSUE CELL, V37, P349, DOI 10.1016/j.tice.2005.05.003
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   REUSCH RN, 1995, CAN J MICROBIOL, V41, P50, DOI 10.1139/m95-167
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Seoul C, 2003, J POLYM SCI POL PHYS, V41, P1572, DOI 10.1002/polb.10511
   Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014
   Song JH, 2008, J MATER SCI-MATER M, V19, P2925, DOI 10.1007/s10856-008-3420-7
   Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166
   Sultana N, 2008, J MATER SCI-MATER M, V19, P2555, DOI 10.1007/s10856-007-3214-3
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Tesema Y, 2005, J APPL POLYM SCI, V98, P1916, DOI 10.1002/app.22352
   Uyar T, 2008, POLYMER, V49, P5336, DOI 10.1016/j.polymer.2008.09.025
   Uyar T, 2009, EUR POLYM J, V45, P1032, DOI 10.1016/j.eurpolymj.2008.12.024
   Wang LY, 2009, J MACROMOL SCI A, V46, P765, DOI 10.1080/10601320903004517
   Wang YJ, 2009, J BIOMED MATER RES A, V88A, P616, DOI 10.1002/jbm.a.31858
   Wei X, 2009, J BIOMED MATER RES A, V90A, P894, DOI 10.1002/jbm.a.32146
   Williams S. F., 2000, US Patent Appl, Patent No. 661948
   Xie JW, 2008, MACROMOL RAPID COMM, V29, P1775, DOI 10.1002/marc.200800381
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xing ZC, 2010, BIOMACROMOLECULES, V11, P1248, DOI 10.1021/bm1000372
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yu BY, 2008, DESALINATION, V234, P204, DOI 10.1016/j.desal.2007.09.087
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhong Y, 2009, CARCINOGENESIS, V30, P158, DOI 10.1093/carcin/bgn255
NR 60
TC 28
Z9 29
U1 2
U2 68
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2012
VL 7
IS 1
AR 015002
DI 10.1088/1748-6041/7/1/015002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 888NZ
UT WOS:000300011900006
PM 22262727
DA 2018-10-19
ER

PT J
AU Tang, S
   Zhao, JJ
   Xu, SY
   Li, JF
   Teng, Y
   Quan, DP
   Guo, XD
AF Tang, Shuo
   Zhao, Jingjing
   Xu, Shuyun
   Li, Jingfeng
   Teng, Yu
   Quan, Daping
   Guo, Xiaodong
TI Bone induction through controlled release of novel BMP-2-related peptide
   from PTMC11-F127-PTMC11 hydrogels
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MORPHOGENETIC PROTEIN-2; DRUG-RELEASE; IN-VITRO; DELIVERY; BMP-2;
   REGENERATION; DEGRADATION; BEHAVIOR; COLLAGEN; GROWTH
AB Bone morphogenetic protein 2 (BMP-2) is the most powerful osteogenic factor; its effectiveness in enhancing osteoblastic activation has been confirmed both in vitro and in vivo. We developed a novel peptide (designated P24) derived from the 'knuckle' epitope of BMP-2 and found it also had osteogenic bioactivity to some extent. The main objective of this study was to develop a controlled release system based on poly(trimethylene carbonate)-F127-poly(trimethylene carbonate) (PTMC11-F127-PTMC11) hydrogels for the P24 peptide, to promote bone formation. By varying the copolymer concentrations, we demonstrated that P24/PTMC11-F127-PTMC11 hydrogels were an efficient system for the sustained release of P24 over 21-35 days. The P24-loaded hydrogels elevated alkaline phosphatase activity and promoted the expression of osteocalcin mRNA in bone marrow stromal cells (BMSCs) in vitro. Radiographic and histological examination showed that P24-loaded hydrogels could induce more effective ectopic bone formation in vivo than P24-free hydrogels. These results indicate that the PTMC11-F127-PTMC11 hydrogel is a suitable carrier for the controlled release of P24, and is a promising injectable biomaterial for the induction of bone regeneration.
C1 [Tang, Shuo; Li, Jingfeng; Teng, Yu; Guo, Xiaodong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Peoples R China.
   [Zhao, Jingjing] Huazhong Univ Sci & Technol, Tongji Med Coll, Puai Hosp, Dept Orthopaed, Wuhan 430022, Peoples R China.
   [Xu, Shuyun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Resp, Wuhan 430030, Peoples R China.
   [Quan, Daping] Sun Yat Sen Univ, Sch Chem & Chem Engn, Inst Polymer Sci, Guangzhou 510275, Guangdong, Peoples R China.
RP Guo, XD (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Peoples R China.
EM gxdwh@yahoo.com.cn
RI Xu, Shuyun/G-7081-2014; guo, xiaodong/K-2600-2013
FU National Natural Science Foundation of China [30973027, 81171684]; '863'
   Key Project of the National High Technology Research and Development
   Program of China [2006AA02A124]
FX The authors are grateful for the financial support from the National
   Natural Science Foundation of China (projects 30973027, 81171684), the
   '863' Key Project of the National High Technology Research and
   Development Program of China (grant no 2006AA02A124).
CR Arca T, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025006
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Nguyen DH, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055004
   Derakhshandeh K, 2010, DRUG DES DEV THER, V4, P255
   Gottfried ON, 2008, NEUROSURGERY, V63, P380, DOI 10.1227/01.NEU.0000324990.04818.13
   GUZMAN M, 1992, INT J PHARM, V80, P119, DOI 10.1016/0378-5173(92)90269-8
   Hirayama F, 1999, ADV DRUG DELIVER REV, V36, P125, DOI 10.1016/S0169-409X(98)00058-1
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Huynh DP, 2009, J CONTROL RELEASE, V137, P20, DOI 10.1016/j.jconrel.2009.02.021
   Kang HZ, 2011, LANGMUIR, V27, P399, DOI 10.1021/la1037553
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kim SY, 2000, J CONTROL RELEASE, V65, P345, DOI 10.1016/S0168-3659(99)00207-2
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lee JH, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015008
   Li JF, 2010, BIOTECHNOL BIOPROC E, V15, P725, DOI 10.1007/s12257-009-3130-0
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Martinez-Sanz E, 2011, J CONTROL RELEASE, V152, P232, DOI 10.1016/j.jconrel.2011.02.003
   Matsumoto J, 1999, INT J PHARM, V185, P93, DOI 10.1016/S0378-5173(99)00153-2
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Natu MV, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025003
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Schmidmaier G, 2008, INJURY, V39, pS37, DOI 10.1016/S0020-1383(08)70014-7
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015
   Shimazu C, 2006, J ORAL REHABIL, V33, P609, DOI 10.1111/j.1365-2842.2005.01593.x
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tian Xiao-bin, 2009, Orthop Surg, V1, P322, DOI 10.1111/j.1757-7861.2009.00045.x
   Villavicencio AT, 2005, J NEUROSURG-SPINE, V3, P436, DOI 10.3171/spi.2005.3.6.0436
   Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178
   Wenzel JGW, 2002, J CONTROL RELEASE, V85, P51, DOI 10.1016/S0168-3659(02)00271-7
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Xiong XY, 2003, MACROMOLECULES, V36, P9979, DOI 10.1021/ma035292d
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Yuan Q, 2007, KEY ENG MATER, V334-335, P1261, DOI 10.4028/www.scientific.net/KEM.334-335.1261
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
NR 49
TC 9
Z9 10
U1 4
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2012
VL 7
IS 1
AR 015008
DI 10.1088/1748-6041/7/1/015008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 888NZ
UT WOS:000300011900012
PM 22287556
DA 2018-10-19
ER

PT J
AU Belfiore, LA
   Floren, ML
   Belfiore, CJ
AF Belfiore, Laurence A.
   Floren, Michael L.
   Belfiore, Carol J.
TI Electric-field-enhanced nutrient consumption in dielectric biomaterials
   that contain anchorage-dependent cells
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE Fick's 2nd law; Unsteady state diffusion; Reaction-diffusion equation;
   Electric-field-enhanced diffusion; Intra-tissue diffusion; Viscoelastic
   biomaterial; Complex dielectric constant; Electric Damkohler number;
   Deborah number; von Karman-Pohlhausen profile method; Mass transfer
   boundary layer thickness
ID ELECTROMAGNETIC-FIELDS; IN-VIVO; DIFFUSION; TISSUE; BONE; GROWTH;
   DIFFERENTIATION; STIMULATION; ADHESION; VITRO
AB This research contribution addresses electric-field stimulation of intra-tissue mass transfer and cell proliferation in viscoelastic biomaterials. The unsteady state reaction-diffusion equation is solved according to the von Karman-Pohlhausen integral method of boundary layer analysis when nutrient consumption and tissue regeneration occur in response to harmonic electric potential differences across a parallel-plate capacitor in a dielectric-sandwich configuration. The partial differential mass balance with diffusion and electro-kinetic consumption contains the Damkohler (Lambda(2)) and Deborah (De) numbers. Zero-field and electric-field-sensitive Damkohler numbers affect nutrient boundary layer growth. Diagonal elements of the 2nd-rank diffusion tensor are enhanced in the presence of weak electric fields, in agreement with the formalism of equilibrium and nonequilibrium thermodynamics. Induced dipole polarization density within viscoelastic biomaterials is calculated via the real and imaginary components of the complex dielectric constant, according to the Debye equation, to quantify electro-kinetic stimulation. Rates of nutrient consumption under zero-field conditions are described by third-order kinetics that include local mass densities of nutrients, oxygen, and attached cells. Thinner nutrient boundary layers are stabilized at shorter dimensionless diffusion times when the zero-field intra-tissue Damkohler number increases above its initial-condition-sensitive critical value [i.e., {Lambda(2)(zero-field)}(critical) >= 53, see Eq. (23)], such that the biomaterial core is starved of essential ingredients required for successful proliferation. When tissue regeneration occurs above the critical electric-field-sensitive intra-tissue Damkohler number, the electro-kinetic contribution to nutrient consumption cannot be neglected. The critical electric-field-sensitive intra-tissue Damkohler number is proportional to the Deborah number. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Belfiore, Laurence A.; Floren, Michael L.; Belfiore, Carol J.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
RP Belfiore, LA (reprint author), Univ Trent, Dept Mat Engn & Ind Technol, Via Mesiano 77, I-38050 Trento, Italy.
EM belfiore@engr.colostate.edu
FU Provincia Autonoma di Trento
FX LA Belfiore gratefully acknowledges the Provincia Autonoma di Trento for
   research support during his extended sabbatical at the University of
   Trento. Professor Matt Kipper in the Department of Chemical and
   Biological Engineering at Colorado State University has been a source of
   inspirational support throughout all of these tissue-based bioreactor
   simulations. Michael Floren, a PhD student in the Department of
   Materials Engineering and Industrial Technologies at the University of
   Trento, is acknowledged for helpful discussions about cell proliferation
   in porous biomaterials.
CR Bader DL, 2005, BIOREACTORS FOR TISSUE ENGINEERING: PRINCIPLES, DESIGN AND OPERATION, P165, DOI 10.1007/1-4020-3741-4_7
   Bailey JE, 1986, BIOCH ENG FUNDAMENTA
   Bandyopadhyay T, 2004, ISRAEL J CHEM, V44, P119, DOI 10.1560/HW5C-CM22-EYNY-1FKF
   Baronas R., 2010, MATH MODELING BIOSEN
   Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260
   BASSETT CA, 1964, NATURE, V204, P652, DOI 10.1038/204652a0
   BASSETT CAL, 1968, J CELL BIOL, V39, pA9
   BASSETT CAL, 1974, SCIENCE, V184, P575
   Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009
   Belfiore L.A., 2003, TRANSPORT PHENOMENA
   Belfiore L.A., 2010, PHYS PROPERTIES MACR
   Belfiore LA, 2011, BIOPHYS CHEM, V158, P1, DOI 10.1016/j.bpc.2011.04.008
   Belfiore LA, 2011, BIOPHYS CHEM, V155, P65, DOI 10.1016/j.bpc.2011.02.005
   Bendahmane M, 2006, NETW HETEROG MEDIA, V1, P185, DOI 10.3934/nhm.2006.1.185
   Bird R.B., 2002, TRANSPORT PHENOMENA
   BOURGUIGNON GJ, 1987, FASEB J, V1, P398
   Bryksin VV, 2003, J PHYS-CONDENS MAT, V15, P1415, DOI 10.1088/0953-8984/15/9/305
   Busalmen JP, 2005, APPL ENVIRON MICROB, V71, P6235, DOI 10.1128/AEM.71.10.6235-6240.2005
   de Groot S.R., 1984, NONEQUILIBRIUM THERM, P143
   Debnath L., 2005, NONLINEAR PARTIAL DI
   Doran P. M., 1995, BIOPROCESS ENG, P276
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   GOODMAN R, 1983, SCIENCE, V220, P1283, DOI 10.1126/science.6857248
   Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100
   Grzybowski B., 2009, CHEM MOTION REACTION
   Henshaw JW, 2007, BIOELECTROCHEMISTRY, V71, P233, DOI 10.1016/j.bioelechem.2007.07.005
   Jackson J. D., 1975, CLASSICAL ELECTRODYN, P33
   John K., 2010, MATH COMPUTATIONAL B, P29
   KISHIDA A, 1991, BIOMATERIALS, V12, P786, DOI 10.1016/0142-9612(91)90031-5
   Kleinert P, 2003, PHYS LETT A, V317, P315, DOI 10.1016/j.physleta.2003.08.051
   Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23
   Landau L.D., 1984, ELECTROSTATICS DIELE, V8
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   LEVY DD, 1972, CLIN ORTHOP RELAT R, P218
   Magin RL, 2010, COMPUT MATH APPL, V59, P1586, DOI 10.1016/j.camwa.2009.08.039
   MAROUDAS NG, 1973, NATURE, V244, P353, DOI 10.1038/244353a0
   MARSH G, 1946, J CELL COMPAR PHYSL, V27, P139, DOI 10.1002/jcp.1030270303
   Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389
   Pathi P, 2005, BIOTECHNOL BIOENG, V89, P743, DOI 10.1002/bit.20367
   Pirt S.J., 1975, PRINCIPLES MICROBE C
   Prakash J, 2010, INT J ENG SCI, V48, P693, DOI 10.1016/j.ijengsci.2010.02.004
   Rose SF, 2004, BIOMATERIALS, V25, P5125, DOI 10.1016/j.biomaterials.2003.12.016
   Sherratt JA, 2009, EUR J APPL MATH, V20, P123, DOI 10.1017/S0956792508007742
   Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299
   Spadaro JA, 1997, BIOELECTROMAGNETICS, V18, P193, DOI 10.1002/(SICI)1521-186X(1997)18:3<193::AID-BEM1>3.0.CO;2-Y
   Truskey G.A., 2009, TRANSPORT PHENOMENA
   Tsai MT, 2007, BIOELECTROMAGNETICS, V28, P519, DOI 10.1002/bem.20336
   VANTURNHOUT J, 1971, POLYM J, V2, P173, DOI 10.1295/polymj.2.173
   Vodovnik L., 1992, CELLULAR ENG MED BIO, V30, P21
   Yonemori K, 1996, BONE, V19, P173, DOI 10.1016/8756-3282(96)00169-X
   Zakari M, 1998, PHYSICA A, V253, P205, DOI 10.1016/S0378-4371(97)00654-7
   ZENGO AN, 1976, J DENT RES, V55, P383, DOI 10.1177/00220345760550031601
NR 52
TC 0
Z9 0
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD FEB
PY 2012
VL 161
BP 8
EP 16
DI 10.1016/j.bpc.2011.10.003
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 890CL
UT WOS:000300122600002
PM 22196748
DA 2018-10-19
ER

PT J
AU Heris, HK
   Rahmat, M
   Mongeau, L
AF Heris, Hossein K.
   Rahmat, Meysam
   Mongeau, Luc
TI Characterization of a Hierarchical Network of Hyaluronic Acid/Gelatin
   Composite for use as a Smart Injectable Biomaterial
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE cell adhesion; hierarchical networks; hybrid microgels; smart drug
   delivery; tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; VOCAL FOLD; EXTRACELLULAR-MATRIX; GELATIN
   MICROSPHERES; HYBRID MICROGELS; CELL-MIGRATION; TISSUE-REPAIR;
   HYDROGELS; ACID; DELIVERY
AB Hybrid HA/Ge hydrogel particles are embedded in a secondary HA network to improve their structural integrity. The internal microstructure of the particles is imaged through TEM. CSLM is used to identify the location of the Ge molecules in the microgels. Through indentation tests, the Young's modulus of the individual particles is found to be 22 +/- 2.5 kPa. The overall shear modulus of the composite is 75 +/- 15 Pa at 1 Hz. The mechanical properties of the substrate are found to be viable for cell adhesion. The particles' diameter at pH=8 is twice that at pH=5. The pH sensitivity is found to be appropriate for smart drug delivery. Based on their mechanical and structural properties, HAGe hierarchical materials may be well suited for use as injectable biomaterials for tissue reconstruction.
C1 [Heris, Hossein K.; Rahmat, Meysam; Mongeau, Luc] McGill Univ, Dept Mech Engn, Montreal, PQ H3A 2K6, Canada.
RP Mongeau, L (reprint author), McGill Univ, Dept Mech Engn, 817 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.
EM luc.mongeau@mcgill.ca
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827; Mongeau, Luc/0000-0003-0344-227X
FU National Institute on Deafness and other Communication Disorders
   [DC005788]; Canadian Institute of Health Research [MOP 84495]
FX This research was supported by grant number DC005788 from the National
   Institute on Deafness and other Communication Disorders, and the
   Canadian Institute of Health Research grant No. MOP 84495. The authors
   acknowledge the assistance of Professors Rosaire Mongrain, Hojatollah
   Vali, Francois Barthelat, David Junker, Subhasis Ghoshal, Maryam
   Tabrizian, and Dr. Sam Daniel in providing access to their experimental
   facilities.
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Anderson TD, 2004, J VOICE, V18, P392, DOI 10.1016/j.jvoice.2002.002.04.001
   Banquy X, 2009, SOFT MATTER, V5, P3984, DOI 10.1039/b821583a
   Bhattacharya S, 2007, SMALL, V3, P650, DOI 10.1002/smll.200600590
   Busch S, 2003, ADV FUNCT MATER, V13, P189, DOI 10.1002/adfm.200390029
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Caldararu H, 1999, PHYS CHEM CHEM PHYS, V1, P5689, DOI 10.1039/a906186j
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   EASTOE JE, 1955, BIOCHEM J, V61, P589, DOI 10.1042/bj0610589
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Ethirajan A, 2008, BIOMACROMOLECULES, V9, P2383, DOI 10.1021/bm800377w
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Harrington W. F., 1962, ADV PROTEIN CHEM, V16, P1
   Hashmi SM, 2009, SOFT MATTER, V5, P3682, DOI 10.1039/b906051k
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kim SW, 2004, J BIOMED MATER RES A, V71A, P308, DOI 10.1002/jbm.a.30160
   Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Lekka M, 2004, LANGMUIR, V20, P9968, DOI 10.1021/la048389h
   Lim S.T., 2001, AAPS PHARMSCITECH, V2, P1
   Liu KK, 2006, J PHYS D APPL PHYS, V39, pR189, DOI 10.1088/0022-3727/39/11/R01
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   Ogawa K, 2003, LANGMUIR, V19, P3178, DOI 10.1021/la0267185
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Pavesio A, 1997, Med Device Technol, V8, P20
   Prestwich G.D., 2007, TISSUE ENG, V585, P125
   Rahmat M, 2010, J PHYS CHEM C, V114, P15029, DOI 10.1021/jp104993f
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730
   Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Suslick KS, 1999, ANNU REV MATER SCI, V29, P295, DOI 10.1146/annurev.matsci.29.1.295
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tan SS, 2004, LANGMUIR, V20, P7015, DOI 10.1021/la049597c
   Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Varga I, 2001, J PHYS CHEM B, V105, P9071, DOI 10.1021/jp004600w
   Xu SQ, 2003, ADV FUNCT MATER, V13, P468, DOI 10.1002/adfm.200304338
   Yang ZG, 2008, MACROMOL RAPID COMM, V29, P751, DOI 10.1002/marc.200700872
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zawko SA, 2010, LAB CHIP, V10, P379, DOI 10.1039/b917493a
NR 59
TC 28
Z9 28
U1 6
U2 67
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB
PY 2012
VL 12
IS 2
BP 202
EP 210
DI 10.1002/mabi.201100335
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 886BN
UT WOS:000299825500006
PM 22147507
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kurland, NE
   Drira, Z
   Yadavalli, VK
AF Kurland, Nicholas E.
   Drira, Zouheir
   Yadavalli, Vamsi K.
TI Measurement of nanomechanical properties of biomolecules using atomic
   force microscopy
SO MICRON
LA English
DT Review
DE Atomic force microscopy; Nanoindentation; Protein; Biomolecule; Young's
   modulus
ID INDIVIDUAL AMYLOID FIBRILS; SCANNING PROBE MICROSCOPE;
   LANGMUIR-BLODGETT-FILMS; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES;
   INSTRUMENTED INDENTATION; INTERMEDIATE-FILAMENTS; NANOSCALE
   MEASUREMENTS; BIOLOGICAL-MATERIALS; COLLAGEN FIBRILS
AB The capabilities of atomic force microscopy (AFM) have been rapidly expanding beyond topographical imaging to now allow for the analysis of a wide range of properties of diverse materials. The technique of nanoindentation, traditionally performed via dedicated indenters can now be reliably achieved using AFM instrumentation, enabling mechanical property determination at the nanoscale using the high spatial and force resolutions of the AFM. In the study of biological systems, from biomolecules to complexes, this technique provides insight into how mesoscale properties and functions may arise from a myriad of single biomolecules. In vivo and in situ analyses of native structures under physiological conditions as well as the rapid analysis of molecular species under a variety of experimental treatments are made possible with this technique. As a result, AFM nanoindentation has emerged as a critical tool for the study of biological systems in their natural state, further contributing to both biomaterial design and pharmacological research. In this review, we detail the theory and progression of AFM-based nanoindentation, and present several applications of this technique as it has been used to probe biomolecules and biological nanostructures from single proteins to complex assemblies. We further detail the many challenges associated with mechanical models and required assumptions for model validity. AFM nanoindentation capabilities have provided an excellent improvement over conventional nanomechanical tools and by integration of topographical data from imaging, enabled the rapid extraction and presentation of mechanical data for biological samples. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kurland, Nicholas E.; Drira, Zouheir; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, 601 W Main St, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu
OI Yadavalli, Vamsi/0000-0002-8879-1948
CR Afrin R, 2005, PROTEIN SCI, V14, P1447, DOI 10.1110/ps.041282305
   Ahearne M., 2008, APPL TOPICS TISSUE E, V4
   Akhremitchev BB, 1999, LANGMUIR, V15, P5630, DOI 10.1021/la980585z
   Alberts B, 2002, MOL BIOL CELL
   Alkorta J, 2008, ACTA MATER, V56, P884, DOI 10.1016/j.actamat.2007.10.039
   Angker L, 2006, J MATER RES, V21, P1893, DOI 10.1557/JMR.2006.0257
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Baclayon M, 2010, SOFT MATTER, V6, P5273, DOI 10.1039/b923992h
   Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010
   Bei H., 2005, PHYS REV LETT, V95
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bowen WR, 2000, BIOTECHNOL LETT, V22, P893, DOI 10.1023/A:1005604028444
   Briscoe BJ, 1998, J PHYS D APPL PHYS, V31, P2395, DOI 10.1088/0022-3727/31/19/006
   Bui VC, 2008, SURF INTERFACE ANAL, V40, P1323, DOI 10.1002/sia.2899
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Bykov V, 1998, APPL PHYS A-MATER, V66, P499, DOI 10.1007/s003390050703
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chakrabarty S, 2010, POLYMER, V51, P5756, DOI 10.1016/j.polymer.2010.09.053
   Chizhik SA, 2001, MACROMOL SYMP, V167, P167, DOI 10.1002/1521-3900(200103)167:1<167::AID-MASY167>3.0.CO;2-I
   Colton RJ, 2004, J VAC SCI TECHNOL B, V22, P1609, DOI 10.1116/1.1760754
   Constantinides G, 2008, J BIOMECH, V41, P3285, DOI 10.1016/j.jbiomech.2008.08.015
   Cuellar JL, 2010, J GEN VIROL, V91, P2449, DOI 10.1099/vir.0.021212-0
   Davis J. R., 2004, TENSILE TESTING
   De Pablo PJ, 2003, PHYS REV LETT, V91
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Dintwa E, 2008, GRANUL MATTER, V10, P209, DOI 10.1007/s10035-007-0078-7
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Donhauser ZJ, 2010, BIOPHYS J, V99, P1668, DOI 10.1016/j.bpj.2010.06.065
   Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Engel A, 1999, TRENDS CELL BIOL, V9, P77, DOI 10.1016/S0962-8924(98)01415-9
   FEIGNER H, 1996, J CELL SCI, V109, P509
   Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8
   Garcia-Manyes S, 2007, BBA-BIOMEMBRANES, V1768, P1190, DOI 10.1016/j.bbamem.2007.02.004
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   Golovin Y, 2008, PHYS SOLID STATE+, V50, P2205, DOI 10.1134/S1063783408120019
   Grant CA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937001
   Guo S, 2008, LANGMUIR, V24, P880, DOI 10.1021/la7018605
   Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724
   Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030
   Haque F, 2003, SURF ENG, V19, P255, DOI 10.1179/026708403225007464
   Harmon ME, 2003, LANGMUIR, V19, P10660, DOI 10.1021/la030232m
   He LH, 2008, J MECH BEHAV BIOMED, V1, P18, DOI 10.1016/j.jmbbm.2007.05.001
   Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X
   HEUBERGER M, 1995, NANOTECHNOLOGY, V6, P12, DOI 10.1088/0957-4484/6/1/003
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Ikai A, 2005, BIOPHYS CHEM, V116, P187, DOI 10.1016/j.bpc.2005.04.003
   Ikai A, 2007, CURR NANOSCI, V3, P17, DOI 10.2174/157341307779940535
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101
   Ivanovska I, 2007, P NATL ACAD SCI USA, V104, P9603, DOI 10.1073/pnas.0703166104
   Jalili N, 2004, MECHATRONICS, V14, P907, DOI 10.1016/j.mechatronics.2004.04.005
   Janmey PA, 1998, PHYSIOL REV, V78, P763
   JANMEY PA, 1994, J BIOL CHEM, V269, P32503
   Johnson K. L., 1985, CONTACT MECH
   Jones DB, 2002, CHEM ENG SCI, V57, P1711, DOI 10.1016/S0009-2509(02)00057-X
   Kasas S, 2008, PFLUG ARCH EUR J PHY, V456, P13, DOI 10.1007/s00424-008-0448-y
   Kaufman JD, 2008, J MATER RES, V23, P1472, DOI 10.1557/JMR.2008.0185
   Kaufman JD, 2009, J MECH BEHAV BIOMED, V2, P312, DOI 10.1016/j.jmbbm.2008.08.004
   Kim JJ, 2002, SCIENCE, V295, P654
   Kinney JH, 1999, ARCH ORAL BIOL, V44, P813, DOI 10.1016/S0003-9969(99)00080-1
   Klapperich C, 2001, J TRIBOL-T ASME, V123, P624, DOI 10.1115/1.1330736
   Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lewis G, 2008, J BIOMED MATER RES B, V87B, P286, DOI 10.1002/jbm.b.31092
   Li XD, 2003, NANO LETT, V3, P1495, DOI 10.1021/nl034525b
   Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008
   Lin DC, 2008, SOFT MATTER, V4, P669, DOI 10.1039/b714637j
   Liu KF, 2009, J MECH BEHAV BIOMED, V2, P355, DOI 10.1016/j.jmbbm.2008.12.001
   Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9
   Luo JJ, 2003, COMPOS SCI TECHNOL, V63, P1607, DOI 10.1016/S0266-3538(03)00060-5
   Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z
   Martens JC, 2008, PFLUG ARCH EUR J PHY, V456, P95, DOI 10.1007/s00424-007-0419-8
   Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103
   Nayak A, 2009, J PHYS CHEM B, V113, P3669, DOI 10.1021/jp806600g
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Park B, 2010, SOFT MATTER, V6, P3898, DOI 10.1039/B927260G
   Park JG, 2002, APPL PHYS LETT, V81, P4625, DOI 10.1063/1.1528281
   Parlinska-Wojtan M, 2008, SCRIPTA MATER, V59, P364, DOI 10.1016/j.scriptamat.2008.04.008
   Parra A, 2007, LANGMUIR, V23, P2747, DOI 10.1021/la062864p
   Perkins M, 2007, INT J PHARM, V332, P168, DOI 10.1016/j.ijpharm.2006.09.032
   PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634
   RADMACHER M, 1994, BIOPHYS J, V66, P2159, DOI 10.1016/S0006-3495(94)81011-2
   RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068
   RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roos WH, 2010, NAT PHYS, V6, P733, DOI 10.1038/NPHYS1797
   Roos WH, 2009, ADV MATER, V21, P1187, DOI 10.1002/adma.200801709
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Sanches RP, 2009, MICRON, V40, P502, DOI 10.1016/j.micron.2008.12.001
   Schuh CA, 2006, MATER TODAY, V9, P32, DOI 10.1016/S1369-7021(06)71495-X
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114
   SUDA H, 1995, BIOCHEM BIOPH RES CO, V211, P219, DOI 10.1006/bbrc.1995.1799
   Sumomogi T, 1998, APPL PHYS A-MATER, V66, pS299, DOI 10.1007/s003390051150
   Sun PL, 2010, MAT SCI ENG A-STRUCT, V527, P2985, DOI 10.1016/j.msea.2010.01.040
   Swadener JG, 2001, J BIOMED MATER RES, V57, P108, DOI 10.1002/1097-4636(200110)57:1<108::AID-JBM1148>3.0.CO;2-6
   Swanstrom R, 1997, RETROVIRUSES
   Sweers K, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-270
   Tan EPS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2051802
   TATARA Y, 1989, J ENG MATER-T ASME, V111, P163, DOI 10.1115/1.3226449
   Thurner PJ, 2009, WIRES NANOMED NANOBI, V1, P624, DOI 10.1002/wnan.56
   Tranchida D, 2005, POLYMER, V46, P4032, DOI 10.1016/j.polymer.2005.03.055
   VanLandingham MR, 2003, J RES NATL INST STAN, V108, P249, DOI 10.6028/jres.108.024
   Vinckier A, 1996, J VAC SCI TECHNOL B, V14, P1427, DOI 10.1116/1.589113
   Wenger MPE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384006
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   Wilder EA, 2006, MACROMOLECULES, V39, P4138, DOI 10.1021/ma060266b
   Willner I, 2010, NANO LETT, V10, P3805, DOI 10.1021/nl102083j
   Withers JR, 2006, ADV COLLOID INTERFAC, V120, P57, DOI 10.1016/j.cis.2006.03.002
   Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601
   Yadavalli VK, 2010, INT J BIOL MACROMOL, V46, P458, DOI 10.1016/j.ijbiomac.2010.02.012
   Zhao LM, 2005, APPL ENVIRON MICROB, V71, P955, DOI 10.1128/AEM.71.2.955-960.2005
   Zhou XF, 2010, CHINESE SCI BULL, V55, P1608, DOI 10.1007/s11434-010-3201-9
NR 122
TC 57
Z9 58
U1 3
U2 117
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD FEB
PY 2012
VL 43
IS 2-3
BP 116
EP 128
DI 10.1016/j.micron.2011.07.017
PG 13
WC Microscopy
SC Microscopy
GA 883AP
UT WOS:000299605300004
PM 21890365
DA 2018-10-19
ER

PT J
AU Kang, KW
   Pereda, MD
   Canafoglia, ME
   Bilmes, P
   Llorente, C
   Bonetto, R
AF Kang, K. W.
   Pereda, M. D.
   Canafoglia, M. E.
   Bilmes, P.
   Llorente, C.
   Bonetto, R.
TI Uncertainty studies of topographical measurements on steel surface
   corrosion by 3D scanning electron microscopy
SO MICRON
LA English
DT Review
DE Biomedical devices; 3D SEM; Stereo pair; Corrosion pit; Height maps;
   Uncertainty
ID SHAPE-RECONSTRUCTION; STAINLESS-STEEL; SEM; ROUGHNESS; ALIGNMENT;
   BEHAVIOR; IMAGES; GAN
AB Pitting corrosion is a damage mechanism quite serious and dangerous in both carbon steel boiler tubes for power plants which are vital to most industries and stainless steels for orthopedic human implants whose demand, due to the increase of life expectation and rate of traffic accidents, has sharply increased. Reliable methods to characterize this kind of damage are becoming increasingly necessary, when trying to evaluate the advance of damage and to establish the best procedures for component inspection in order to determine remaining lives and failure mitigation.
   A study about the uncertainties on the topographies of corrosion pits from 3D SEM images, obtained at low magnifications (where errors are greater) and different stage tilt angles were carried out using an in-house software previously developed. Additionally, measurements of pit depths on biomaterial surfaces, subjected to two different surface treatments on stainless steels, were carried out. The different depth distributions observed were in agreement with electrochemical measurements. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kang, K. W.; Pereda, M. D.; Bilmes, P.; Llorente, C.] UNLP, Fac Ingn, LIMF, La Plata, Buenos Aires, Argentina.
   [Canafoglia, M. E.] UNLP, Fac Ciencias Exactas, Ctr Quim Inorgan CEQUINOR, La Plata, Buenos Aires, Argentina.
   [Canafoglia, M. E.] UNLP, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina.
   [Llorente, C.] CICPBA, Buenos Aires, DF, Argentina.
   [Bonetto, R.] UNLP, Fac Ingn & Ciencias Exactas, Ctr Invest & Desarrollo Ciencias Aplicadas Dr Jor, CINDECA CONICET, La Plata, Buenos Aires, Argentina.
RP Kang, KW (reprint author), UNLP, Fac Ingn, LIMF, Calle 1 & 47, La Plata, Buenos Aires, Argentina.
EM adriana.kang@ing.unlp.edu.ar
FU Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET);
   Agencia Nacional de Promocion Cientifica y Tecnologica (ANCYPT);
   Universidad Nacional de La Plata (UNLP)
FX The authors acknowledge Mariela Theiller and Mario Sanchez of the
   Electron Microscopy Laboratory of the CINDECA for technical support in
   the acquisition of SEM images. Also, they acknowledge the Consejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia
   Nacional de Promocion Cientifica y Tecnologica (ANCYPT) and Universidad
   Nacional de La Plata (UNLP) for financial support.
CR [Anonymous], 2000, 581 API
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   API, 2000, 579 API
   Azar V, 2010, SURF COAT TECH, V204, P3546, DOI 10.1016/j.surfcoat.2010.04.015
   Azevedo CRF, 2010, ENG FAIL ANAL, V17, P286, DOI 10.1016/j.engfailanal.2009.06.010
   Bariani P, 2005, PRECIS ENG, V29, P219, DOI 10.1016/j.precisioneng.2004.08.002
   Barranco V, 2010, SURF COAT TECH, V204, P3783, DOI 10.1016/j.surfcoat.2010.04.051
   Bonetto RD, 2006, MICROSC MICROANAL, V12, P178, DOI 10.1017/S143192760606003X
   Chen X, 2010, ANAL BIOCHEM, V403, P63, DOI 10.1016/j.ab.2010.04.003
   Choules B., 2009, MED DEVICE MAT, P19
   Davies PA, 2001, J MICROSC-OXFORD, V204, P29, DOI 10.1046/j.1365-2818.2001.00922.x
   Drzazga W, 2006, MEAS SCI TECHNOL, V17, P28, DOI 10.1088/0957-0233/17/1/006
   Fatikow S., 2009, P IEEE INT C INF AUT, P806
   Heitz E, 2006, ANAL METHODS CORROSI, P444
   Hortola P, 2009, MICRON, V40, P409, DOI 10.1016/j.micron.2008.09.008
   Huang Z, 2004, J MICROSC-OXFORD, V216, P206, DOI 10.1111/j.0022-2720.2004.01418.x
   IKEUCHI K, 1981, ARTIF INTELL, V17, P141, DOI 10.1016/0004-3702(81)90023-0
   Jahnisch M, 2007, INT J OPTOMECHATRONI, V1, P4, DOI 10.1080/15599610701232630
   Lane G. S., 1972, Use of the scanning electron microscope, P219
   LANE GS, 1969, J PHYS E SCI INSTRUM, V2, P565, DOI 10.1088/0022-3735/2/7/303
   Malboubi M., 2009, ENG LETT, V17, P5
   Marinello F, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/6/065705
   Ostadi H, 2010, PRECIS ENG, V34, P798, DOI 10.1016/j.precisioneng.2010.03.011
   Ostadi H, 2009, MICROELECTRON ENG, V86, P1021, DOI 10.1016/j.mee.2009.01.056
   Paluszynski J., 2008, J MICROSC-OXFORD, V233, P10
   Pintus R, 2005, MICROELECTRON RELIAB, V45, P1581, DOI 10.1016/j.microrel.2005.07.063
   Pintus R, 2008, IEEE T INSTRUM MEAS, V57, P989, DOI 10.1109/TIM.2007.911580
   Piping Inspection Code, 1998, 570 API
   Pohler O.E.M, 1986, FAILURE ANAL PREVENT, V11, P670
   Ponz E, 2006, MICROSC MICROANAL, V12, P170, DOI 10.1017/S1431927606060028
   Stampfl J, 1996, APPL PHYS A-MATER, V63, P341, DOI 10.1007/BF01567324
   Sun CM, 2002, INT J COMPUT VISION, V47, P99, DOI 10.1023/A:1014585622703
   Vynnyk T., 2010, J EUR OPT SOC-RAPID, V5
   Walker CGH, 2005, SPRINGER PROC PHYS, V107, P495
   Wang TS, 2006, SURF COAT TECH, V200, P4777, DOI 10.1016/j.surfcoat.2005.04.046
   Wilde B.E., 1971, ELECTROCHIM ACTA, V16, P1971
   Wzorek M, 2009, MICRON, V40, P37, DOI 10.1016/j.micron.2008.02.012
   Wzorek M, 2010, J MICROSC-OXFORD, V237, P242, DOI 10.1111/j.1365-2818.2009.03232.x
NR 38
TC 10
Z9 10
U1 1
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD FEB
PY 2012
VL 43
IS 2-3
BP 387
EP 395
DI 10.1016/j.micron.2011.10.005
PG 9
WC Microscopy
SC Microscopy
GA 883AP
UT WOS:000299605300040
PM 22051087
DA 2018-10-19
ER

PT J
AU Zelzer, M
   Albutt, D
   Alexander, MR
   Russell, NA
AF Zelzer, Mischa
   Albutt, Darren
   Alexander, Morgan R.
   Russell, Noah A.
TI The Role of Albumin and Fibronectin in the Adhesion of Fibroblasts to
   Plasma Polymer Surfaces
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE allylamine; cell adhesion; hexane; protein adsorption; protein
   displacement
ID TISSUE-ENGINEERING SCAFFOLDS; PROTEIN ADSORPTION; CELL-ADHESION;
   BIOMEDICAL APPLICATIONS; POLY(D,L-LACTIC ACID); CHEMICAL GRADIENTS;
   CONFORMATION; COATINGS; MODEL
AB Plasma polymer coatings are widely applied to the modification of biomaterial surfaces. In order to understand the role of the surface in the adhesion of cells to these materials, it is necessary to understand how protein adsorption is influenced by the plasma polymer surface chemistry. In coated scaffolds, plasma polymerised allylamine has been found to encourage fibroblast adhesion while plasma polymerised hexane reduces cell adhesion. To study the role of proteins in this process, albumin and fibronectin are pre-adsorbed individually, competitively or sequentially to the plasma polymer surfaces before seeding them with a culture of 3T3 fibroblasts. Significant dependence upon the protein pre-adsorption was seen in the adhered cell numbers. In situ measurements of protein adsorption using a quartz crystal microbalance help to elucidate the factors that govern the observed cellular response. The measured protein adsorption is rationalised in terms of our knowledge of the surface chemistry of these plasma polymers. We found that high cell adhesion is related to the ability of fibronectin to displace albumin. This ability is reduced on the hydrophobic plasma polymer as well as by adsorbing albumin and fibronectin sequentially.
C1 [Albutt, Darren; Russell, Noah A.] Univ Nottingham, Sch Biol, Inst Biophys Imaging & Opt Sci, Nottingham NG7 2RD, England.
   [Albutt, Darren; Russell, Noah A.] Univ Nottingham, Sch Elect & Elect Engn, Inst Biophys Imaging & Opt Sci, Nottingham NG7 2RD, England.
   [Zelzer, Mischa; Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
RP Russell, NA (reprint author), Univ Nottingham, Sch Biol, Inst Biophys Imaging & Opt Sci, Univ Pk, Nottingham NG7 2RD, England.
EM noah.russell@nottingham.ac.uk
RI Alexander, Morgan/C-2506-2009
OI Alexander, Morgan/0000-0001-5182-493X; Russell, N/0000-0002-0998-6094
FU EPSRC [GR/S55026/0];  [EP/H022112/1]; Engineering and Physical Sciences
   Research Council [EP/H022112/1]
FX We thank Tim Smith, Thomas Wong and Cheryl Ban for performing and
   analysing cell culture experiments. Funding from the EPSRC for MZ (Grant
   GR/S55026/0) and EP/H022112/1 is gratefully acknowledged.
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   Colley HE, 2009, PLASMA PROCESS POLYM, V6, P831, DOI 10.1002/ppap.200900040
   Forch R, 2007, CHEM VAPOR DEPOS, V13, P280, DOI 10.1002/cvde.200604035
   Giamblanco N, 2011, LANGMUIR, V27, P312, DOI 10.1021/la104127q
   Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Kao P, 2011, BIOMATERIALS, V32, P969, DOI 10.1016/j.biomaterials.2010.09.075
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Low SP, 2010, J ADHES SCI TECHNOL, V24, P2215, DOI 10.1163/016942410X507993
   Majani R, 2010, BIOMATERIALS, V31, P6764, DOI 10.1016/j.biomaterials.2010.05.049
   Messina GML, 2009, COLLOID SURFACE B, V70, P76, DOI 10.1016/j.colsurfb.2008.12.013
   Mishra G, 2010, LANGMUIR, V26, P3720, DOI 10.1021/la902930z
   MOSHER DF, 1985, BIOPOLYMERS, V24, P199, DOI 10.1002/bip.360240116
   Neu B, 2006, BBA-GEN SUBJECTS, V1760, P1772, DOI 10.1016/j.bbagen.2006.09.005
   Pedersen RH, 2010, MICROELECTRON ENG, V87, P1112, DOI 10.1016/j.mee.2009.11.043
   Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Thissen H, 2006, BIOMATERIALS, V27, P35, DOI 10.1016/j.biomaterials.2005.05.037
   Thompson K. E., 2010, 483 BD BIOSC
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Whittle JD, 2002, J MATER CHEM, V12, P2726, DOI 10.1039/b201471h
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zelzer M., 2009, J PHYS CHEM B, V114, P569
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
NR 36
TC 33
Z9 33
U1 0
U2 47
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD FEB
PY 2012
VL 9
IS 2
BP 149
EP 156
DI 10.1002/ppap.201100054
PG 8
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 889DP
UT WOS:000300054000005
DA 2018-10-19
ER

PT J
AU Hu, S
   Cao, LL
   Sun, ZL
   Xiang, J
   Lu, M
   Sun, W
AF Hu, Song
   Cao, Lili
   Sun, Zhaolan
   Xiang, Jun
   Lu, Ming
   Sun, Wei
TI Application of NiMoO4 Nanorods for the Direct Electrochemistry and
   Electrocatalysis of Hemoglobin with Carbon Ionic Liquid Electrode
SO ELECTROANALYSIS
LA English
DT Article
DE Hemoglobin; NiMoO4 nanorods; Ionic liquid; Carbon paste electrode;
   Electrochemistry
ID BY-LAYER FILMS; HEME-PROTEINS; GOLD NANOPARTICLES; PASTE ELECTRODE;
   COMPOSITE FILM; MYOGLOBIN; BIOSENSOR; CHITOSAN; NANOTUBES; NAFION
AB In this paper NiMoO4 nanorods were synthesized and used to accelerate the direct electron transfer of hemoglobin (Hb). By using an ionic liquid (IL) 1-butylpyridinium hexafluorophosphate (BPPF6) modified carbon paste electrode (CILE) as the basic electrode, NiMoO4 nanorods and Hb composite biomaterial was further cast on the surface of CILE and fixed by chitosan (CTS) to establish a modified electrode denoted as CTS/NiMoO4-Hb/CILE. UV-vis and FT-IR spectroscopic results showed that Hb in the film retained its native structures without any conformational changes. Electrochemical behaviors of Hb entrapped in the film were carefully investigated by cyclic voltammetry with a pair of well-defined and quasi-reversible redox voltammetric peaks appearing in phosphate buffer solution (PBS, pH 3.0), which was attributed to the direct electrochemistry of the electroactive center of Hb heme Fe(III)/Fe(II). The results were ascribed to the specific characteristic of NiMoO4 nanorods, which accelerated the direct electron transfer rate of Hb with the underlying CILE. The electrochemical parameters of Hb in the composite film were further carefully calculated with the results of the electron transfer number (n) as 1.08, the charge transfer coefficient (a) as 0.39 and the electron-transfer rate constant (ks) as 0.82 s-1. The Hb modified electrode showed good electrocatalytic ability toward the reduction of trichloroacetic acid (TCA) in the concentration range from 0.2 to 26.0 mmol/L with a detection limit of 0.072 mmol/L (3s), and H2O2 in the concentration range from 0.1 to 426.0 mu mol/L with a detection limit of 3.16 x 10(-8) mol/L (3s).
C1 [Cao, Lili; Sun, Zhaolan; Lu, Ming; Sun, Wei] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Shandong Prov Key Lab Biochem Anal, Qingdao 266042, Peoples R China.
   [Hu, Song; Xiang, Jun] Huazhong Univ Sci & Technol, State Key Lab Coal Combust, Wuhan 430074, Peoples R China.
RP Sun, W (reprint author), Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Shandong Prov Key Lab Biochem Anal, Qingdao 266042, Peoples R China.
EM sunwei@qust.edu.cn
RI Xiang, Jun/C-5472-2016
FU Natural Science Foundation of China [50976043]; Foundation of the State
   Key Laboratory of Coal Combustion of Huazhong University of Science and
   Technology [FSKLCC1010]; Foundation of the State Key Laboratory of Clean
   Energy Utilization of Zhejiang University
FX We are grateful to the financial support of the Natural Science
   Foundation of China (No. 50976043), the Foundation of the State Key
   Laboratory of Coal Combustion of Huazhong University of Science and
   Technology (FSKLCC1010) and the Foundation of the State Key Laboratory
   of Clean Energy Utilization of Zhejiang University.
CR Bard A. J., 1980, ELECTROCHEMICAL METH
   Bindhu LV, 2003, J APPL POLYM SCI, V88, P1456, DOI 10.1002/app.11815
   Buzzeo MC, 2004, ANAL CHEM, V76, P4583, DOI 10.1021/ac040042w
   Cao DF, 2003, ANALYST, V128, P1268, DOI 10.1039/b308242c
   Fan CH, 2001, ANAL CHEM, V73, P2850, DOI 10.1021/ac001397s
   Feng JJ, 2005, ANAL BIOCHEM, V342, P280, DOI 10.1016/j.ab.2005.04.040
   Gao RF, 2010, ELECTROANAL, V22, P1084, DOI 10.1002/elan.200900373
   GEORGE P, 1953, BIOCHEM J, V55, P236, DOI 10.1042/bj0550236
   He P, 2004, LANGMUIR, V20, P10260, DOI 10.1021/la0484801
   He PL, 2004, LANGMUIR, V20, P722, DOI 10.1021/la035006r
   Huang H, 2002, ANAL BIOCHEM, V308, P141, DOI 10.1016/S0003-2697(02)00242-7
   Kafi AKM, 2006, THIN SOLID FILMS, V499, P420, DOI 10.1016/j.tsf.2005.06.073
   KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010
   LAVIRON E, 1974, J ELECTROANAL CHEM, V52, P355, DOI 10.1016/0368-1874(74)85053-7
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Liu CY, 2009, BIOSENS BIOELECTRON, V24, P2149, DOI 10.1016/j.bios.2008.11.007
   Lu HY, 2006, ELECTROANAL, V18, P379, DOI 10.1002/elan.200503420
   Lu XB, 2007, J MATER CHEM, V17, P1427, DOI 10.1039/b615467k
   Luo XL, 2006, ELECTROANAL, V18, P1131, DOI 10.1002/elan.200603513
   Maleki N, 2006, ANAL CHEM, V78, P3820, DOI 10.1021/ac060070+
   Moghaddam AB, 2008, BIOPHYS CHEM, V134, P25, DOI 10.1016/j.bpc.2008.01.001
   Nassar AEF, 1997, J PHYS CHEM B, V101, P2224, DOI 10.1021/jp962896t
   Pang JT, 2003, BIOSENS BIOELECTRON, V19, P441, DOI 10.1016/S0956-5663(3)00223-9
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   Qiao K, 2008, ELECTROCHIM ACTA, V53, P4654, DOI 10.1016/j.electacta.2008.01.068
   Ray A, 2005, LANGMUIR, V21, P7456, DOI 10.1021/la050422s
   Shan D, 2007, ELECTROCHEM COMMUN, V9, P529, DOI 10.1016/j.elecom.2006.10.032
   Sun W, 2008, ELECTROCHIM ACTA, V53, P8217, DOI 10.1016/j.electacta.2008.06.021
   Sun W, 2008, ELECTROANAL, V20, P1048, DOI 10.1002/elan.200704131
   Sun W, 2007, ELECTROCHEM COMMUN, V9, P1159, DOI 10.1016/j.elecom.2007.01.003
   Sun W, 2007, J PHYS CHEM B, V111, P4560, DOI 10.1021/jp067933n
   Sun W, 2010, TALANTA, V80, P2177, DOI 10.1016/j.talanta.2009.11.026
   Sun W, 2009, ELECTROANAL, V21, P2454, DOI 10.1002/elan.200904650
   Sun W, 2009, J PHYS CHEM C, V113, P11294, DOI 10.1021/jp8114594
   Sun W, 2009, BIOELECTROCHEMISTRY, V75, P170, DOI 10.1016/j.bioelechem.2009.03.012
   Wang JX, 2002, ANAL CHEM, V74, P1993, DOI 10.1021/ac010978u
   Wang SF, 2005, LANGMUIR, V21, P9260, DOI 10.1021/la050947k
   Wang Y, 2007, TALANTA, V72, P1134, DOI 10.1016/j.talanta.2007.01.026
   Xiao W, 2010, CHEM MATER, V22, P746, DOI 10.1021/cm9012014
   Yang J, 1999, BIOELECTROCH BIOENER, V48, P117, DOI 10.1016/S0302-4598(98)00222-0
   Yang MH, 2004, SENSOR ACTUAT B-CHEM, V101, P269, DOI 10.1016/j.snb.2004.01.003
   Yu P, 2005, LANGMUIR, V21, P9000, DOI 10.1021/la051089v
   Zhai ZQ, 2009, J CHIN CHEM SOC-TAIP, V56, P561, DOI 10.1002/jccs.200900083
   Zhang H, 2006, J PHYS CHEM B, V110, P2171, DOI 10.1021/jp055301f
   Zhao GC, 2004, ANAL BIOCHEM, V329, P160, DOI 10.1016/j.ab.2004.02.028
   Zhao LY, 2006, ANAL BIOANAL CHEM, V384, P414, DOI 10.1007/s00216-005-0204-5
   Zhao S, 2006, BIOELECTROCHEMISTRY, V69, P158, DOI 10.1016/j.bioelechem.2006.01.001
   Zhou H, 2006, J CHEM TECHNOL BIOT, V81, P58, DOI 10.1002/jctb.1357
NR 48
TC 7
Z9 8
U1 0
U2 56
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1040-0397
J9 ELECTROANAL
JI Electroanalysis
PD FEB
PY 2012
VL 24
IS 2
BP 278
EP 285
DI 10.1002/elan.201100508
PG 8
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 884WG
UT WOS:000299738900012
DA 2018-10-19
ER

PT J
AU Sicchieri, LG
   Crippa, GE
   de Oliveira, PT
   Beloti, MM
   Rosa, AL
AF Sicchieri, Luciana Goncalves
   Crippa, Grasiele Edilaine
   de Oliveira, Paulo Tambasco
   Beloti, Marcio Mateus
   Rosa, Adalberto Luiz
TI Pore size regulates cell and tissue interactions with PLGA-CaP scaffolds
   used for bone engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bone tissue engineering; pore size; PLGA-CaP; scaffold
ID BMP-INDUCED OSTEOGENESIS; PHOSPHATE SCAFFOLD; STROMAL CELLS; IN-VIVO;
   DIFFERENTIATION; MARROW; BIOMATERIALS; EXPRESSION; CHALLENGES; POROSITY
AB A common subject in bone tissue engineering is the need for porous scaffolds to support cell and tissue interactions aiming at repairing bone tissue. As poly(lactide-co-glycolide)calcium phosphate (PLGACaP) scaffolds can be manufactured with different pore sizes, the aim of this study was to evaluate the effect of pore diameter on osteoblastic cell responses and bone tissue formation. Scaffolds were prepared with 85% porosity, with pore diameters in the ranges 470590, 590850 and 8501200 mu m. Rat bone marrow stem cells differentiated into osteoblasts were cultured on the scaffolds for up to 10 days to evaluate cell growth, alkaline phosphatase (ALP) activity and the gene expression of the osteoblast markers RUNX2, OSX, COL, MSX2, ALP, OC and BSP by real-time PCR. Scaffolds were implanted in critical size rat calvarial defects for 2, 4, and 8 weeks for histomorphometric analysis. Cell growth and ALP activity were not affected by the pore size; however, there was an increase in the gene expression of osteoblastic markers with the increase in the pore sizes. At 2 weeks all scaffolds displayed a similar amount of bone and blood vessels formation. At 4 and 8 weeks much more bone formation and an increased number of blood vessels were observed in scaffolds with pores of 470590 mu m. These results show that PLGACaP is a promising biomaterial for bone engineering. However, ideally, combinations of larger (similar to 1000 mu m) and smaller (similar to 500 mu m) pores in a single scaffold would optimize cellular and tissue responses during bone healing. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Sicchieri, Luciana Goncalves; Crippa, Grasiele Edilaine; de Oliveira, Paulo Tambasco; Beloti, Marcio Mateus; Rosa, Adalberto Luiz] Univ Sao Paulo, Sch Dent Ribeirao Preto, Cell Culture Lab, BR-05508 Sao Paulo, Brazil.
RP Rosa, AL (reprint author), Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM adalrosa@forp.usp.br
RI Tambasco de Oliveira, Paulo/F-9749-2010; Rosa, Adalberto/A-6314-2008;
   Beloti, Marcio/E-7473-2012
OI Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Rosa,
   Adalberto/0000-0002-6495-2778; Beloti, Marcio/0000-0003-0149-7189
FU Sao Paulo Research Foundation (FAPESP, Brazil); National Council for
   Scientific and Technological Development (CNPq, Brazil)
FX This research was supported by grants from the Sao Paulo Research
   Foundation (FAPESP, Brazil) and the National Council for Scientific and
   Technological Development (CNPq, Brazil). The authors thank Fabiola
   Singaretti Oliveira, Roger Rodrigo Fernandes and Junia Ramos for
   technical assistance.
CR Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Assis AF, 2009, CLIN ORAL IMPLAN RES, V20, P240
   Beloti MM, 2009, J BIOMATER APPL, V23, P481, DOI 10.1177/0885328208094082
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 1996, CONNECT TISSUE RES, V35, P63, DOI 10.3109/03008209609029175
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909
   Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kim K, 2010, TISSUE ENG, V29, P1
   Kol'chugina I B, 2009, J IMMUNOL METHODS, V64, P28
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Lickorish D, 2004, EUR J CELLS MAT, V13, P12
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Roosa SMM, 2010, J BIOMED MATER RES A, V92A, P359, DOI 10.1002/jbm.a.32381
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
NR 32
TC 57
Z9 60
U1 0
U2 28
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD FEB
PY 2012
VL 6
IS 2
BP 155
EP 162
DI 10.1002/term.422
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 882HD
UT WOS:000299553500008
PM 21446054
DA 2018-10-19
ER

PT J
AU Coda, A
   Lamberti, R
   Martorana, S
AF Coda, A.
   Lamberti, R.
   Martorana, S.
TI Classification of prosthetics used in hernia repair based on weight and
   biomaterial
SO HERNIA
LA English
DT Review
DE Prosthetic; Classification; Weight; Biomaterial; Common language
ID MOSQUITO NET; INGUINAL HERNIOPLASTY; POLYPROPYLENE MESH; COMMERCIAL
   MESH; HEAVY-WEIGHT; LIGHTWEIGHT; NYLON; MARLEX; MODEL
AB The aim of this study was to classify the polymeric prosthetics used for hernia repair based on biomaterial composition and weight in an effort to clarify to surgeons what kinds of material they are dealing with and to provide a standardized system of categorization.
   An intensive research effort was carried out on prosthetics that are commercially available worldwide. We conducted a search of the medical literature and companies' websites to find the weights and thicknesses of commercially available prosthetics. Where these data were lacking, we contacted manufacturers directly in order to render the research more complete. A total of 166 products were considered for classification based on biomaterial properties. Among these, a homogeneous group of 80 polypropylene monofilament knitted or woven prosthetics was selected for classification based on weight. Weights were provided for 70 prosthetics (87%), and both the weight and thickness was provided for 40 prosthetics (50%).
   Classification based on weight: Ultra-light < 35 g/m(2), Light a parts per thousand yen35 < 70 g/m(2), Standard a parts per thousand yen70 < 140 g/m(2), Heavy a parts per thousand yen140 g/m(2). Classification based on biomaterial composition: simple (prosthetics made of one pure biomaterial); composite (prosthetics made of two or more different layers); combined (prosthetics made of two materials knitted or woven together); and biologic.
   Weight and biomaterial classifications were proposed after an extensive analysis of commercially available prosthetics. The need for a common terminology is important to avoid misunderstandings among clinicians and technicians.
C1 [Coda, A.] Clin Cellini, Dept Surg, Turin, Italy.
   [Lamberti, R.; Martorana, S.] Herniamesh Srl, Turin, Italy.
RP Coda, A (reprint author), Clin Cellini, Dept Surg, Turin, Italy.
EM andrea.coda@hernia-repair.it
CR Anderson JR, 2006, ANN C BRIT HERN SOC
   [Anonymous], 2007, SIGNIFICANCE MESH TH
   Aquaviva D, 1944, EXTRAITS B SOC CHIR
   Clarke MG, 2009, HERNIA, V13, P155, DOI 10.1007/s10029-008-0460-3
   Cobb WS, 2009, HERNIA, V13, P1, DOI 10.1007/s10029-008-0428-3
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   Earle DB, 2008, SURG CLIN N AM, V88, P179, DOI 10.1016/j.suc.2007.11.002
   Holzheimer RG, 2004, EUR J MED RES, V9, P323
   Horstmann R, 2006, WORLD J SURG, V30, P1
   Karsten J, 2002, WORLD J SURG, V26, P1472
   Khan LR, 2010, HERNIA, V14, P39, DOI 10.1007/s10029-009-0558-2
   KING MW, 1994, PROSTHESES ABDOMINAL, P191
   Klinge U., 2001, ABDOMINAL WALL HERNI, P286
   Klingensmith ME, 2007, WASHINGTON MANUAL SU, P442
   Klosterhalfen B, 2005, EXPERT REV MED DEVIC, V2, P103, DOI 10.1586/17434440.2.1.103
   Kraft B, 2006, SURG LAPARO ENDO PER, V16, P448
   Lauscher JC, 2008, J LAPAROENDOSC ADV S, V18, P6
   Maloney GE, 1948, LANCET, V2, P45
   Melick DW, 1942, ANN SURG, V115, P475, DOI 10.1097/00000658-194203000-00018
   Schmidbauer S, 2005, EUR J MED RES, V10, P247
   Schug-Pass C, 2008, SURG ENDOSC, V22, P1100, DOI 10.1007/s00464-007-9585-1
   Schumpelick Volker, 2006, J Minim Access Surg, V2, P117
   Smietanski M, 2009, HERNIA, V13, P239, DOI 10.1007/s10029-008-0465-y
   Tamme C, 2005, SURG ENDOSC, V19, P1125, DOI 10.1007/s00464-004-8219-0
   Udwadia TE, 2007, WORLD J SURG, V31, P858, DOI 10.1007/s00268-006-0820-z
   USHER F C, 1958, Am Surg, V24, P969
   USHER FC, 1961, ARCH SURG-CHICAGO, V82, P771, DOI 10.1001/archsurg.1961.01300110133017
   USHER FC, 1958, ARCH SURG-CHICAGO, V76, P997, DOI 10.1001/archsurg.1958.01280240155026
   Wilhelm TJ, 2007, EUR SURG RES, V39, P312, DOI 10.1159/000104402
   Zagdoun J, 1959, ACAD CHIRURG SE 1125, P747
   Zieren J, 2002, J LAPAROENDOSC ADV A, V12, P249, DOI 10.1089/109264202760268014
NR 31
TC 54
Z9 58
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
J9 HERNIA
JI Hernia
PD FEB
PY 2012
VL 16
IS 1
BP 9
EP 20
DI 10.1007/s10029-011-0868-z
PG 12
WC Surgery
SC Surgery
GA 881WL
UT WOS:000299521900002
PM 21837484
DA 2018-10-19
ER

PT J
AU Wang, BY
   Fu, SZ
   Ni, PY
   Peng, JR
   Zheng, L
   Luo, F
   Liu, H
   Qian, ZY
AF Wang, Bei-Yu
   Fu, Shao-Zhi
   Ni, Pei-Yan
   Peng, Jing-Rong
   Zheng, Lan
   Luo, Feng
   Liu, Hao
   Qian, Zhi-Yong
TI Electrospun polylactide/poly(ethylene glycol) hybrid fibrous scaffolds
   for tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue engineering; electrospinning; fibrous scaffold; degradable;
   biocompatibility
ID MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); POLY(LACTIC-CO-GLYCOLIC
   ACID); SURFACE MODIFICATION; POLYMER BLENDS; NANOFIBERS; CELL;
   POLY(EPSILON-CAPROLACTONE); FIBERS; CRYSTALLIZATION
AB The biodegradable polylactide/poly(ethylene glycol) (PLA/PEG) hybrid membranes were fabricated via electrospinning of PLA/PEG solution. Their structures and properties were investigated by scanning electron microscopy, differential scanning calorimetry, and water contact angle. In vitro hydrolytic degradation showed that PEG content influenced the degradation rate of the PLA/PEG hybrid mats. The mechanical property was measured by tensile test and the result revealed that the addition of PEG had an obvious plasticization on PLA matrix. In-vitro biocompatibility was investigated by culturing cell on the scaffolds and MTT assay. The results indicated that the cell could attach and proliferate on the membranes, so confirmed that the PLA/PEG hybrid membrane had good biocompatibility, and it could be a promising biomaterial for tissue engineering applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Wang, Bei-Yu; Fu, Shao-Zhi; Ni, Pei-Yan; Peng, Jing-Rong; Zheng, Lan; Luo, Feng; Qian, Zhi-Yong] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
   [Wang, Bei-Yu; Liu, Hao] Sichuan Univ, W China Med Sch, W China Hosp, Dept Orthoped, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com
RI Fu, ShaoZhi/L-4019-2017
OI Fu, ShaoZhi/0000-0002-8666-4304
FU National 863 project [2007AA021902]; New Century Excellent Talents in
   University [NCET-08-0371]
FX Contract grant sponsor: National 863 project; contract grant number:
   2007AA021902; Contract grant sponsor: New Century Excellent Talents in
   University; contract grant number: NCET-08-0371
CR Baiardo M, 2003, J APPL POLYM SCI, V90, P1731, DOI 10.1002/app.12549
   Chen RS, 2007, J BIOMED MATER RES A, V83A, P241, DOI 10.1002/jbm.a.31475
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Fu SZ, 2010, J PHYS CHEM C, V114, P18372, DOI 10.1021/jp106488t
   Fu SZ, 2009, J PHYS CHEM B, V113, P16518, DOI 10.1021/jp907974d
   Fu SZ, 2010, J NANOSCI NANOTECHNO, V10, P1
   Jacobsen S, 1999, POLYM ENG SCI, V39, P1303, DOI 10.1002/pen.11517
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim JH, 2009, MAT SCI ENG C-BIO S, V29, P1725, DOI 10.1016/j.msec.2009.01.023
   Kulinski Z, 2006, BIOMACROMOLECULES, V7, P2128, DOI 10.1021/bm060089m
   Kulinski Z, 2005, POLYMER, V46, P10290, DOI 10.1016/j.polymer.2005.07.101
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lai WC, 2004, POLYMER, V45, P3073, DOI 10.1016/j.polymer.2004.03.003
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Li XR, 2010, COLLOID POLYM SCI, V288, P1113, DOI 10.1007/s00396-010-2235-5
   Lin Y, 2006, ACTA BIOMATER, V2, P155, DOI 10.1016/j.actbio.2005.10.002
   Liu XH, 2005, J BIOMED NANOTECHNOL, V1, P54, DOI 10.1166/jbn.2005.013
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517
   Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039
   Patra SN, 2009, J MATER SCI, V44, P647, DOI 10.1007/s10853-008-3050-y
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pinar Y, 2009, BIOMATERIALS, V30, P3551
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   Shalumon KT, 2009, CARBOHYD POLYM, V77, P863, DOI 10.1016/j.carbpol.2009.03.009
   Sheth M, 1997, J APPL POLYM SCI, V66, P1495, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3
   Stitzel JD, 2000, INT SAMPE TECH CONF, V32, P205
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Xu XL, 2007, EUR POLYM J, V43, P3187, DOI 10.1016/j.eurpolymj.2007.05.024
   Xu XL, 2010, J APPL POLYM SCI, V118, P588, DOI 10.1002/app.32415
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 40
TC 28
Z9 28
U1 4
U2 75
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2012
VL 100A
IS 2
BP 441
EP 449
DI 10.1002/jbm.a.33264
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 867TV
UT WOS:000298478400018
PM 22105865
DA 2018-10-19
ER

PT J
AU Holmes, CA
   Tabrizian, M
AF Holmes, Christina A.
   Tabrizian, Maryam
TI Enhanced MC3T3 preosteoblast viability and adhesion on polyelectrolyte
   multilayer films composed of glycol-modified chitosan and hyaluronic
   acid
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glycol-chitosan; hyaluronan; layer-by-layer deposition; MC3T3
   preosteoblast adhesion
ID BIOMEDICAL APPLICATIONS; GENE DELIVERY; EXPONENTIAL-GROWTH; OSTEOBLAST
   GROWTH; CROSS-LINKING; NANOPARTICLES; BIOMATERIAL; ELASTICITY; COATINGS;
   MASS
AB Layer-by-layer polyelectrolyte films made of the naturally derived polysaccharides chitosan (CHI) and hyaluronic acid (HA) constitute a well-studied system for the development of cell-responsive biointerfaces. However, many cell lines exhibit decreased adhesion to CHI/HA multilayer films, particularly as the number of bilayers is increased. Here, our group demonstrates that films composed of glycol-modified chitosan exhibit significantly improved MC3T3 preosteoblast adhesion and viability compared to corresponding films consisting of unmodified CHI. These differences in cellular adhesion are likely due to differences in surface topography and roughness, as measured via atomic force microscopy (AFM), as well as in film chemistry and the water solubility of the cation, since both types of films exhibited similar: thickness, as measured via quartz crystal microbalance and AFM; wettability, as measured via contact angle; and serum protein adsorption, as measured via the bicinchoninic acid assay. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
C1 [Holmes, Christina A.; Tabrizian, Maryam] McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada.
   [Holmes, Christina A.; Tabrizian, Maryam] McGill Univ, Ctr Biorecognit & Biosensors, Montreal, PQ H3A 2B4, Canada.
   [Tabrizian, Maryam] McGill Univ, Fac Dent, Montreal, PQ H3A 2B4, Canada.
RP Tabrizian, M (reprint author), McGill Univ, Dept Biomed Engn, Duff Med Sci Bldg,3775 Univ Str, Montreal, PQ H3A 2B4, Canada.
EM maryam.tabrizian@mcgill.ca
OI Holmes, Christina/0000-0003-0736-0503
FU National Science and Engineering Research Council of Canada; Canadian
   Institutes of Health Research; Le Fonds Quebecois de la Recherche sur la
   Nature et les Technologies (through the Centre for Biorecognition and
   Biosensors)
FX Contract grant sponsors: National Science and Engineering Research
   Council of Canada Discovery Grant; Canadian Institutes of Health
   Research; Le Fonds Quebecois de la Recherche sur la Nature et les
   Technologies (through the Centre for Biorecognition and Biosensors);
   National Science and Engineering Research Council of Canada Graduate
   Scholarship (C.A.H.)
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e
   Brandrup J, 1975, POLYM HDB 5
   De Geest BG, 2009, SOFT MATTER, V5, P282, DOI 10.1039/b808262f
   Dimitrova M, 2007, ADV FUNCT MATER, V17, P233, DOI 10.1002/adfm.200600155
   Eisenbarth E, 2006, J BIOMED MATER RES A, V79A, P166, DOI 10.1002/jbm.a.30823
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Knight DK, 2007, J BIOMED MATER RES A, V83A, P787, DOI 10.1002/jbm.a.31430
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kujawa P, 2005, J AM CHEM SOC, V127, P9224, DOI 10.1021/ja044385n
   Kujawa P, 2007, BIOMACROMOLECULES, V8, P3169, DOI 10.1021/bm7006339
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Mansouri S, 2009, LANGMUIR, V25, P14071, DOI 10.1021/la9016799
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Meyer F, 2006, BBA-BIOMEMBRANES, V1758, P419, DOI 10.1016/j.bbamem.2005.11.015
   Miao Z, 2008, PMSE PREPRINTS, V98, P777
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2005, J AM CHEM SOC, V127, P1626, DOI 10.1021/ja045077s
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yoo HS, 2005, J CONTROL RELEASE, V103, P235, DOI 10.1016/j.jconrel.2004.11.033
   Zhu HG, 2005, J BIOMAT SCI-POLYM E, V16, P761, DOI 10.1163/1568562053992450
   Zhu HG, 2004, J BIOMED MATER RES B, V71B, P159, DOI 10.1002/jbm.b.30080
NR 37
TC 7
Z9 7
U1 1
U2 40
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2012
VL 100A
IS 2
BP 518
EP 526
DI 10.1002/jbm.a.33305
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 867TV
UT WOS:000298478400026
PM 22125271
DA 2018-10-19
ER

PT J
AU Boanini, E
   Torricelli, P
   Fini, M
   Sima, F
   Serban, N
   Mihailescu, IN
   Bigi, A
AF Boanini, Elisa
   Torricelli, Paola
   Fini, Milena
   Sima, Felix
   Serban, Natalia
   Mihailescu, Ion N.
   Bigi, Adriana
TI Magnesium and strontium doped octacalcium phosphate thin films by matrix
   assisted pulsed laser evaporation
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE Octacalcium phosphate coating; Strontium; Magnesium; MAPLE; Osteoblast
ID SILICON-SUBSTITUTED HYDROXYAPATITE; ELECTROCHEMICAL DEPOSITION;
   OSTEOBLAST RESPONSE; IONIC SUBSTITUTIONS; BONE REGENERATION; IN-VITRO;
   COATINGS; TITANIUM; CHEMISTRY; CARBONATE
AB Octacalcium phosphate (OCP) is a promising alternative to hydroxyapatite as biomaterial for hard tissue repair. In this study we successfully applied Matrix Assisted Pulsed Laser Evaporation (MAPLE) to deposit Mg and Sr doped OCP (MgOCP and SrOCP), as well as OCP, thin films on titanium substrates. OCP, Mg-substituted and Sr-substituted OCP were synthesized in aqueous medium, then were suspended in deionised water, frozen at liquid nitrogen temperature and used as targets for MAPLE experiments. The depositions were carried out using a KrF* excimer laser source (lambda = 248 nm, T(FWHM) = 25 ns) in mild conditions of temperature and pressure. The results of X-ray diffraction, infrared spectroscopy, scanning electron microscopy and energy dispersive spectroscopy investigations revealed that the OCP thin films are deposited in the form of cauliflower-like aggregates and droplets, as well as crystal fragments, with a homogeneous distribution of magnesium and strontium on the surface of the coatings. Human osteoblast-like MG-63 cells were cultured on the different biomaterials up to 14 days. MgOCP and SrOCP coatings promote osteoblast proliferation and differentiation with respect to OCP. Under these experimental conditions, the production of procollagen-type I, transforming growth factor-beta 1, alkaline phosphatase and osteocalcin indicated that the level of differentiation of the cells grown on the different coatings increased in the order OCP<MgOCP<SrOCP. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Boanini, Elisa; Bigi, Adriana] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Torricelli, Paola; Fini, Milena] Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Lab Preclin Surg Studies, Bologna, Italy.
   [Sima, Felix; Serban, Natalia; Mihailescu, Ion N.] Natl Inst Lasers Plasma & Radiat Phys, Bucharest 77125, Romania.
RP Bigi, A (reprint author), Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
EM adriana.bigi@unibo.it
RI Fini, Milena/J-4808-2016; Bigi, adriana/R-6341-2016; MIHAILESCU
   (Serban), Natalia/C-5879-2011; Mihailescu, Ion/A-5403-2011; TORRICELLI,
   PAOLA/J-5298-2016; SIMA, Felix Nicolae/C-2734-2011
OI Fini, Milena/0000-0002-3732-3570; Bigi, adriana/0000-0003-2668-8627;
   TORRICELLI, PAOLA/0000-0001-7494-9970; Boanini,
   Elisa/0000-0003-3754-0273
FU MIUR;  [PN09390101]
FX This research was carried out with the financial support of MIUR. The
   Romanian authors acknowledge with thanks the financial support of this
   work by PN09390101.
CR Barenholdt O, 2009, BONE, V45, P200, DOI 10.1016/j.bone.2009.04.196
   Barinov S. M., 2010, Inorganic Materials: Applied Research, V1, P175, DOI 10.1134/S2075113310030019
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bigi A, 1999, J INORG BIOCHEM, V75, P145, DOI 10.1016/S0162-0134(99)00047-1
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Bigi A, 2009, BIOMATERIALS, V30, P6168, DOI 10.1016/j.biomaterials.2009.07.066
   BLAKE GM, 1986, EUR J NUCL MED, V12, P447
   Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Boanini E, 2010, CRYST GROWTH DES, V10, P3612, DOI 10.1021/cg100494f
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   Chiesa R, 2003, J Appl Biomater Biomech, V1, P91
   Giordano C, 2004, J Appl Biomater Biomech, V2, P35
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Hijon N, 2006, ACTA BIOMATER, V2, P567, DOI 10.1016/j.actbio.2006.05.004
   Iliescu M, 2004, THIN SOLID FILMS, V453, P157, DOI 10.1016/j.tsf.2003.11.279
   Kamakura S, 2007, J BIOMED MATER RES A, V83A, P725, DOI 10.1002/jbm.a.31332
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112
   Lin SJ, 2003, J BIOMED MATER RES A, V66A, P819, DOI 10.1002/jbm.a.10072
   Lu X, 2008, SURF COAT TECH, V202, P3142, DOI 10.1016/j.surfcoat.2007.11.024
   Mabilleau G, 2010, ACTA BIOMATER, V6, P1555, DOI 10.1016/j.actbio.2009.10.035
   Marie P.J., 2001, CALCIFIED TISSUE INT, V69, P21
   MATHEW M, 1988, J CRYST SPECTROSC, V18, P235, DOI 10.1007/BF01194315
   Mihailescu I.N., 2009, LASER SURFACE INTERA, P235
   Muller L, 2007, BIOMOL ENG, V24, P462, DOI 10.1016/j.bioeng.2007.07.011
   Munir G, 2011, J R SOC INTERFACE, V8, P678, DOI 10.1098/rsif.2010.0548
   Murakami Y, 2010, ACTA BIOMATER, V6, P1542, DOI 10.1016/j.actbio.2009.10.023
   Oliveira AL, 2007, J BIOMED MATER RES B, V83B, P258, DOI 10.1002/jbm.b.30791
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Percival M., 1999, APPL NUTR SCI REP, V5, P1
   Socol G, 2004, BIOMATERIALS, V25, P2539, DOI 10.1016/j.biomaterials.2003.09.044
   SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407
   Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002
   Thian ES, 2007, MAT SCI ENG C-BIO S, V27, P251, DOI 10.1016/j.msec.2006.05.016
   Wang XP, 2010, ACTA BIOMATER, V6, P962, DOI 10.1016/j.actbio.2009.08.038
   Xia W, 2010, ACTA BIOMATER, V6, P1591, DOI 10.1016/j.actbio.2009.10.030
   Xue WC, 2007, SURF COAT TECH, V201, P4685, DOI 10.1016/j.surfcoat.2006.10.012
   Zhang EL, 2009, SURF COAT TECH, V203, P1075, DOI 10.1016/j.surfcoat.2008.09.038
   Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6
NR 46
TC 41
Z9 41
U1 5
U2 67
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0162-0134
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD FEB
PY 2012
VL 107
IS 1
BP 65
EP 72
DI 10.1016/j.jinorgbio.2011.11.003
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 879VV
UT WOS:000299361900009
PM 22178667
DA 2018-10-19
ER

PT J
AU Pettinicchio, M
   Traini, T
   Murmura, G
   Caputi, S
   Degidi, M
   Mangano, C
   Piattelli, A
AF Pettinicchio, Marzia
   Traini, Tonino
   Murmura, Giovanna
   Caputi, Sergio
   Degidi, Marco
   Mangano, Carlo
   Piattelli, Adriano
TI Histologic and histomorphometric results of three bone graft substitutes
   after sinus augmentation in humans
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Bone grafted material; Bone regeneration; Bovine bone; Electron
   microscopy; Sinus augmentation
ID CELL-BINDING PEPTIDE; POROUS HYDROXYAPATITE; FLOOR ELEVATION; DENTAL
   IMPLANTS; P-15 PEPTIDE; BIO-OSS; MATRIX; BIO-OSS((R)); REGENERATION;
   SKELETON
AB The aim of this study was to compare the histological behavior of three bone graft materials placed in human. The comparison was made among Bio-OssA (R) (BO), EngiporeA (R) (EP), and PepGen P-15A (R) (P-15). Five biopsies for each group of biomaterial, retrieved 6 months after sinus lift augmentation, were analyzed. The investigation was carried out using light microscope (LM), scanning electron microscope (SEM) with an energy dispersive spectrometer (EDS), and circularly polarized light microscope (CPLM). Under LM, the amount of newly formed bone was significantly higher in BO than P-15 (P < .05), while the amount of residual graft material was significantly higher in P-15 than BO (P < .05). The extension of marrow spaces was significantly higher in EP than both BO and P-15 (P < .05). SEM-EDS analysis showed a Ca/P ratio of 1.8 for BO, 2.2 for EP, and 1.5 for P-15. Under CPLM, BO showed no significant difference for transverse (18.4 A +/- 2.7%) and longitudinal (16.3 A +/- 1.8%) bone collagen fibers (P = .195); EP showed a significant difference between transverse (4 A +/- 0.7%) and longitudinal (7.6 A +/- 2.5%) bone collagen fibers (P = .015); finally, P-15 showed no significant difference for transverse (3.8 A +/- 1.6%) and longitudinal (4.9 A +/- 1.2%) bone collagen fibers (P = .279). No investigated biomaterial was completely resorbed, but all the residual particles demonstrated a close bone integration to form a hybrid tissue. BO particles appeared perfectly osseointegrated in the trabecular bone. EP showed a tendency to concentrate the bone apposition into the microporosities; P-15 particles appeared bridged by newly formed bone trabeculae.
C1 [Pettinicchio, Marzia; Traini, Tonino; Murmura, Giovanna; Caputi, Sergio; Piattelli, Adriano] Univ G dAnnunzio, Dept Oral Sci Nano & Biotechnol, I-66100 Chieti, Italy.
RP Traini, T (reprint author), Univ G dAnnunzio, Dept Oral Sci Nano & Biotechnol, Via Vestini 31, I-66100 Chieti, Italy.
EM t.traini@unich.it
OI Traini, Tonino/0000-0002-0265-8709
CR Barboza EP, 2002, J PERIODONTOL, V73, P1153, DOI 10.1902/jop.2002.73.10.1153
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Blomqvist JE, 1998, ORAL SURG ORAL MED O, V86, P268, DOI 10.1016/S1079-2104(98)90170-6
   DAVIES JE, 2000, BONE ENG, V1, P1
   Degidi M, 2004, J ORAL IMPLANTOL, V30, P276
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Fiorellini J P, 1994, Periodontol 2000, V4, P98, DOI 10.1111/j.1600-0757.1994.tb00010.x
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   Hahn Jack, 2003, Implant Dent, V12, P170
   Hanks T, 2004, BIOMATERIALS, V25, P4831, DOI 10.1016/j.biomaterials.2003.12.007
   Healy KE, 2000, BONE ENG, V24, P268
   Krauser J T, 2000, Implant Dent, V9, P298, DOI 10.1097/00008505-200009040-00004
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Mangano C, 2003, INT J ORAL MAXILLOF, V18, P20
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   Nanci A, 2000, BONE ENG, P305
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Radhakrishnan Sujatha, 2004, J Int Acad Periodontol, V6, P101
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   RIPAMONTI U, 1993, MATRIX, V13, P491, DOI 10.1016/S0934-8832(11)80115-0
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Ripamonti U., 1990, HDB BIOACTIVE CERAMI, VII, P245
   Scarano Antonio, 2003, Implant Dent, V12, P318, DOI 10.1097/01.ID.0000095467.48241.68
   Spector M., 1998, TISSUE ENG APPL MAXI, P3
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Tatum O H Jr, 1993, N Y State Dent J, V59, P43
   Tatum OH, 1986, DENT CLIN N AM, V30, P207
   Thorwarth M, 2005, BIOMATERIALS, V26, P5648, DOI 10.1016/j.biomaterials.2005.02.023
   Thorwarth M, 2005, BIOCHEM BIOPH RES CO, V329, P789, DOI 10.1016/j.bbrc.2005.01.157
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Trasatti C, 2004, J ENDODONT, V30, P213, DOI 10.1097/00004770-200404000-00007
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yuan H, 1997, BIOMED ENG-APP BAS C, V9, P274
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
NR 48
TC 20
Z9 21
U1 0
U2 11
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD FEB
PY 2012
VL 16
IS 1
BP 45
EP 53
DI 10.1007/s00784-010-0484-9
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 877IU
UT WOS:000299172000006
PM 21046419
DA 2018-10-19
ER

PT J
AU Kishore, V
   Uquillas, JA
   Dubikovsky, A
   Alshehabat, MA
   Snyder, PW
   Breur, GJ
   Akkus, O
AF Kishore, Vipuil
   Uquillas, Jorge Alfredo
   Dubikovsky, Alexandra
   Alshehabat, Musa A.
   Snyder, Paul W.
   Breur, Gert J.
   Akkus, Ozan
TI In vivo response to electrochemically aligned collagen bioscaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tendon; tissue engineering; collagen; in vivo; granulomatous
   inflammation
ID MESENCHYMAL STEM-CELLS; RABBIT PATELLAR TENDON; CRUCIATE LIGAMENT
   RECONSTRUCTION; MARROW STROMAL CELLS; CROSS-LINKING; GRANULOMATOUS
   REACTION; SUPRASPINATUS TENDON; BIOLOGICAL TISSUE; VITRO EVALUATION;
   ACHILLES-TENDON
AB Collagen-based biomaterials are a viable option for tendon reconstruction and repair. However, the weak mechanical strength of collagen constructs is a major limitation. We have previously reported a novel methodology to form highly oriented electrochemically aligned collagen (ELAC) threads with mechanical properties converging on those of the natural tendon. In this study, we assessed the in vivo response of rabbit patellar tendon (PT) to braided ELAC bioscaffolds. Rabbit PTs were incised longitudinally and the ELAC bioscaffold was inlaid in one limb along the length of the tendon. The contralateral limb served as the sham-operated control. Rabbits were euthanized at 4 or 8 months postoperatively. High-resolution radiographs revealed the absence of ectopic bone formation around the bioscaffolds. Four months post-implantation, the histological sections showed that the ELAC bioscaffold underwent limited degradation and was associated with a low-grade granulomatous inflammation. Additionally, quantitative histology revealed that the cross-sectional areas of PTs with the ELAC bioscaffold were 29% larger compared with the controls. Furthermore, ELAC-treated PTs were significantly stiffer compared with the controls. The volume fraction of the tendon fascicle increased in the ELAC-treated PT compared with the controls. By 8 months, the ELAC bioscaffold was mostly absorbed and the enlargement in the area of tendons with implants subsided along with the resolution of the granulomatous inflammation. We conclude that ELAC is biocompatible and biodegradable and has the potential to be used as a biomaterial for tendon tissue engineering applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 100B: 400408, 2012.
C1 [Kishore, Vipuil; Uquillas, Jorge Alfredo; Dubikovsky, Alexandra; Akkus, Ozan] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Alshehabat, Musa A.; Snyder, Paul W.; Breur, Gert J.] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA.
RP Akkus, O (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
EM ozan.akkus@case.edu
RI Kishore, Vipuil/A-4959-2013; Kishore, Vipuil/F-8968-2016
OI Kishore, Vipuil/0000-0002-2559-1789; Uquillas,
   Jorge/0000-0003-0731-4312; Akkus, Ozan/0000-0003-3523-3421
FU Alfred Mann Institute, Purdue University; National Institute of Health
   [NIH 1R21AR056060]; National Science Foundation [CBET-0754442]
FX Contract grant sponsor: Alfred Mann Institute, Purdue University;
   Contract grant sponsor: National Institute of Health; contract grant
   number: NIH 1R21AR056060; Contract grant sponsor: National Science
   Foundation; contract grant number: CBET-0754442
CR Alcalay J, 2003, DERMATOL SURG, V29, P859, DOI 10.1046/j.1524-4725.2003.29233.x
   AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257
   Atkinson TS, 1998, J SURG RES, V79, P25, DOI 10.1006/jsre.1998.5387
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   BARR RJ, 1984, J AM ACAD DERMATOL, V10, P652, DOI 10.1016/S0190-9622(84)80273-X
   BEYNNON BD, 1995, AM J SPORT MED, V23, P452, DOI 10.1177/036354659502300414
   BURKS RT, 1990, AM J SPORT MED, V18, P146, DOI 10.1177/036354659001800207
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cushing M V, 1999, Am J Orthop (Belle Mead NJ), V28, P263
   Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295
   Fujii K, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P229, DOI 10.1007/BF01845593
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   Gurkan UA, 2010, J BIOMED MATER RES A, V94A, P1070, DOI 10.1002/jbm.a.32783
   Harris MT, 2004, J ORTHOPAED RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369
   Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448
   Karaoglu S, 2008, J ORTHOP RES, V26, P255, DOI 10.1002/jor.20471
   Kartus J, 2001, ARTHROSCOPY, V17, P971, DOI 10.1053/jars.2001.28979
   Koob TJ, 2001, J BIOMED MATER RES, V56, P31, DOI 10.1002/1097-4636(200107)56:1<31::AID-JBM1065>3.0.CO;2-N
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   KRACKOW KA, 1988, ORTHOPEDICS, V11, P909
   KUMAGAI J, 1994, J RHEUMATOL, V21, P2096
   KUMAGAI J, 1994, J ANAT, V185, P279
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   Lee SB, 2000, CLIN BIOMECH, V15, P241, DOI 10.1016/S0268-0033(99)00086-8
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Miyashita H, 1997, ARCH ORTHOP TRAUM SU, V116, P454, DOI 10.1007/s004020050162
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   OVERHOLT MA, 1993, CUTIS, V51, P95
   Praemer A, 1992, AM ACAD ORTHOP SURG
   Proctor CS, 1997, J BONE JOINT SURG AM, V79A, P997, DOI 10.2106/00004623-199707000-00005
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   SWANSON NA, 1983, J DERMATOL SURG ONC, V9, P377, DOI 10.1111/j.1524-4725.1983.tb00819.x
   Tomita F, 2001, ARTHROSCOPY, V17, P461, DOI 10.1053/jars.2001.24059
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Williams LN, 2008, BIORHEOLOGY, V45, P577, DOI 10.3233/BIR-2008-0509
   Williams RJ, 1997, ORTHOPEDICS, V20, P554
   Yokoya S, 2008, AM J SPORT MED, V36, P1298, DOI 10.1177/0363546508314416
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
NR 51
TC 26
Z9 27
U1 0
U2 20
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2012
VL 100B
IS 2
BP 400
EP 408
DI 10.1002/jbm.b.31962
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 872EV
UT WOS:000298792500011
PM 22179969
DA 2018-10-19
ER

PT J
AU Hallmann, L
   Mehl, A
   Ulmer, P
   Reusser, E
   Stadler, J
   Zenobi, R
   Stawarczyk, B
   Ozcan, M
   Hammerle, CHF
AF Hallmann, Lubica
   Mehl, Albert
   Ulmer, Peter
   Reusser, Eric
   Stadler, Johannes
   Zenobi, Renato
   Stawarczyk, Bogna
   Oezcan, Mutlu
   Haemmerle, Christoph H. F.
TI The influence of grain size on low-temperature degradation of dental
   zirconia
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE dental zirconia (Y-TZP); degradation; grain size; air abrasion; tensile
   stress
ID YTTRIA-STABILIZED ZIRCONIA; Y-TZP CERAMICS; TRANSFORMATION; WATER;
   SPECTROSCOPY; BIOMATERIAL; FUTURE; ZRO2
AB The purpose of this study was to evaluate the influence of grain size and air abrasion on low-temperature degradation (LTD) of yttria stabilized tetragonal zirconia polycrystalline (Y-TZP). Disc-shaped specimens were sintered at 1350, 1450, and 1600 degrees C. Air abrasion was performed with different abrasive particles. The specimens were stored for 2 h at 134 degrees C under 2.3 bar water vapor pressure. All specimens were characterized by X-ray powder diffraction analysis (XRD), Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), atomic force microscopy (AFM), and field emission scanning electron microscopy (FESEM). Y-TZP sintered at a temperature of 1350 degrees C did not undergo the tm phase transformation during accelerated aging. The diffusion-controlled tm phase transformation initiated with the specimens sintered at 1450 degrees C. This transformation was remarkable for the specimens sintered at 1600 degrees C. X-ray photoelectron spectroscopy (XPS) measurements did not confirm the generation of Zr-OH and Y-OH bonds. No increase of yttrium concentration on the grain boundaries of Y-TZP was detected, which could be responsible for the destabilization of dental zirconia ceramics. A slight increase of diffusion-controlled tm phase transformations was observed for all abraded specimens sintered at 1350 and 1450 degrees C. The size of abrasive particles did not play a crucial role on LTD of Y-TZP. The retardation of diffusion-controlled tm phase transformation was evident for all abraded specimens sintered at 1600 degrees C by comparison to non-abraded specimens. Conclusion: The LTD of Y-TZP can be suppressed when the sintering temperature is set between 1350 and 1450 degrees C. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 100B: 447456, 2012.
C1 [Hallmann, Lubica; Stawarczyk, Bogna; Oezcan, Mutlu; Haemmerle, Christoph H. F.] Univ Zurich, Ctr Dent Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland.
   [Mehl, Albert] Univ Zurich, Ctr Dent Med, Clin Prevent Dent Periodontol & Cariol, Zurich, Switzerland.
   [Ulmer, Peter; Reusser, Eric] Swiss Fed Inst Technol, Inst Geochem & Petrol, Zurich, Switzerland.
   [Stadler, Johannes; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland.
RP Hallmann, L (reprint author), Univ Zurich, Ctr Dent Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland.
EM lubica.hallmann@zzm.uzh.ch
RI Stadler, Johannes/A-3928-2009; Ulmer, Peter/G-4694-2018
OI Ulmer, Peter/0000-0001-9131-0669; Stawarczyk, Bogna/0000-0003-1732-3255
CR BARR TL, 1991, J VAC SCI TECHNOL A, V9, P1793, DOI 10.1116/1.577464
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Daramola AD, 2010, J PHYS CHEM B, V114, P9323
   Duong T, 2009, J AM CERAM SOC, V92, P2731, DOI 10.1111/j.1551-2916.2009.03271.x
   Fabris S, 2002, ACTA MATER, V50, P5171, DOI 10.1016/S1359-6454(02)00385-3
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   Guo X, 1999, J PHYS CHEM SOLIDS, V60, P539, DOI 10.1016/S0022-3697(98)00301-1
   Hughes EA, 1995, J EUR CERAM SOC, V15, P1125
   Kawata K, 2006, SOLID STATE IONICS, V177, P1687, DOI 10.1016/j.ssi.2006.02.030
   Kellya R.J., 2008, DENT MATER, V24, P289
   Kim KB, 1997, PHYS STATUS SOLIDI B, V203, P557
   Kosmac T, 2008, J EUR CERAM SOC, V28, P1085, DOI 10.1016/j.jeurceramsoc.2007.09.013
   Kumari L, 2009, CRYST GROWTH DES, V9, P3874, DOI 10.1021/cg800711m
   Kushima A, 2010, J MATER CHEM, V20, P4809, DOI 10.1039/c000259c
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Li MJ, 2003, PHYS CHEM CHEM PHYS, V5, P5326, DOI 10.1039/b310284j
   Li SY, 1995, APPL SURF SCI, V89, P263
   Lopez FE, 2001, J MATER CHEM, V11, P1891
   Lung KYC, 2010, APPL SURF SCI, V257, P1228
   Maczka M, 1999, J PHYS CHEM SOLIDS, V60, P1909, DOI 10.1016/S0022-3697(99)00221-8
   Merle T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144302
   Moser ME, 1993, FRESEN J ANAL CHEM, V346, P255
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Quintard EP, 2002, J AM CERAM SOC, V85, P1745
   Sato H, 2010, J CERAM SOC JPN, V118, P508, DOI 10.2109/jcersj2.118.508
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Scherrer SS, 2011, DENT MATER, V27, pE28, DOI 10.1016/j.dental.2010.10.003
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
   Zhang Y, 2006, INT J PROSTHODONT, V19, P442
NR 32
TC 28
Z9 28
U1 2
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2012
VL 100B
IS 2
BP 447
EP 456
DI 10.1002/jbm.b.31969
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 872EV
UT WOS:000298792500017
PM 22121144
DA 2018-10-19
ER

PT J
AU Deeken, CR
   Faucher, KM
   Matthews, BD
AF Deeken, Corey R.
   Faucher, Keith M.
   Matthews, Brent D.
TI A review of the composition, characteristics, and effectiveness of
   barrier mesh prostheses utilized for laparoscopic ventral hernia repair
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Review
DE Absorbable barrier; Adhesions; Laparoscopy; Mesh; Permanent barrier;
   Ventral hernia
ID SUBSEQUENT ABDOMINAL-SURGERY; ADHESION FORMATION;
   POLYTETRAFLUOROETHYLENE MESH; FATTY-ACIDS; REGENERATED CELLULOSE;
   POLYPROPYLENE MESH; INCISIONAL HERNIA; TISSUE-RESPONSE; COMPLICATIONS;
   DEGRADATION
AB The objective of this review was to provide an overview of the components that comprise each of the eight barrier mesh prostheses commonly utilized for LVHR and to review the current literature related to the characteristics and effectiveness of these materials to guide the general surgeon in selecting the most appropriate material for LVHR.
   Composite prostheses with permanent barriers (Bard (TM) Composix (TM) E/X, Bard (TM) Composix (TM) L/P, and DUALMESH(A (R)) Biomaterial) were compared to composite prostheses with absorbable barriers (C-QUR (TM) Mesh, PROCEED (TM) Surgical Mesh, Bard (TM) Sepramesh (TM) IP Composite, Parietex (TM) Composite, and PHYSIOMESH (TM)) using scanning electron microscopy and a review of the current preclinical and clinical literature.
   Clinical studies and preclinical animal models have attempted to determine the adhesion characteristics and effectiveness of barrier mesh prostheses available for ventral hernia repair applications. However, it is difficult to make any definitive statements about the adhesion characteristics and effectiveness of these materials because all meshes were not included in all studies and likewise not compared under identical conditions. Overall, Parietex (TM) Composite and DUALMESH(A (R)) Biomaterial were cited most frequently for improvement of adhesion characteristics, followed closely by Bard (TM) Sepramesh (TM) IP Composite and C-QUR (TM) Mesh. Bard (TM) Composix (TM), PROCEED (TM) Surgical Mesh, and uncoated polypropylene were cited most frequently as having the most tenacious and extensive adhesions.
   Differences observed between the various barrier prostheses are likely attributable to the chemical composition of the barrier or the conditions required for resorption and metabolism of the barrier components. It is likely that the components of these barriers incite a wide range of inflammatory responses resulting in the range of adhesion coverage and tenacity observed in the preclinical and clinical studies reviewed. Clinical trials are needed to more appropriately define the clinical effectiveness of these barriers.
C1 [Deeken, Corey R.; Matthews, Brent D.] Washington Univ, Sch Med, Dept Surg, Sect Minimally Invas Surg, St Louis, MO 63110 USA.
   [Faucher, Keith M.] Atrium Med Corp, Hudson, NH USA.
RP Deeken, CR (reprint author), Washington Univ, Sch Med, Dept Surg, Sect Minimally Invas Surg, 660 S Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA.
EM deekenc@wudosis.wustl.edu
FU Atrium Medical Corporation; Ethicon EndoSurgery; Karl Storz Endoscopy;
   Stryker Endoscopy; W.L. Gore & Associates, Incorporated
FX Dr. Deeken is a consultant for Atrium Medical Corporation and Davol
   Incorporated. Dr. Faucher is an employee of Atrium Medical Corporation.
   Dr. Matthews is a consultant for Atrium Medical Corporation and Ethicon
   Incorporated. He also receives honoraria and research/equipment support
   from Atrium Medical Corporation, Ethicon EndoSurgery, Karl Storz
   Endoscopy, Stryker Endoscopy, and W.L. Gore & Associates, Incorporated.
CR [Anonymous], 2006, COMP L P INSTR US
   [Anonymous], 2007, 010 ATR MED CORP
   [Anonymous], 2010, Parietex composite instructions for use, Patent No. 09463313
   [Anonymous], 2008, Gore DUALMESH PLUS biomaterial instructions for use, Patent No. 20030073663
   [Anonymous], 2007, PARIETEX COMPOSITE I
   [Anonymous], 2011, PHYSIOMESH INSTR US
   [Anonymous], 2005, Sepramesh IP composite instructions for use, Patent No. 6391939
   Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102
   Arnaud J P, 2003, Hernia, V7, P85, DOI 10.1007/s10029-003-0116-2
   Ashton W, 1968, BARD COMPOSIX E X ME, Patent No. 3364200
   Ashton W. H., 1968, United States Patent, Patent No. [3364200, 3,364,200]
   Boardman F, 1993, SEPRAMESH IP COMPOSI, Patent No. 5180398
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Burger JWA, 2004, ANN SURG, V240, P578
   CAMPBELL MK, 1995, BIOCHEMISTRY
   Chelala E, 2010, HERNIA, V14, P123, DOI 10.1007/s10029-010-0637-4
   Cobb WS, 2003, AM SURGEON, V69, P784
   Deeken CR, 2011, SURG ENDOSC, V25, P1541, DOI 10.1007/s00464-010-1432-0
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V198, P331
   Duffy A J, 2004, Hernia, V8, P358, DOI 10.1007/s10029-004-0258-x
   Earle DB, 2008, SURG CLIN N AM, V88, P179, DOI 10.1016/j.suc.2007.11.002
   Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303
   Fox C, 1991, C QUR MESH INSTRUCTI, Patent No. 5019096
   Fox CL, 1991, United States Patent, Patent No. [5019096, US5019096 A 1991]
   Gaertner WB, 2010, HERNIA, V14, P375, DOI 10.1007/s10029-010-0659-y
   Gonzalez R, 2004, Hernia, V8, P213
   Gray SH, 2008, ARCH SURG-CHICAGO, V143, P582, DOI 10.1001/archsurg.143.6.582
   Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020
   Halm JA, 2007, WORLD J SURG, V31, P423, DOI 10.1007/s00268-006-0317-9
   Heniford BT, 2003, ANN SURG, V238, P391, DOI 10.1097/01.sla.0000086662.49499.ab
   Jacob BP, 2007, SURG ENDOSC, V21, P629, DOI 10.1007/s00464-006-9157-9
   Jenkins ED, 2010, SURG ENDOSC, V24, P3002, DOI 10.1007/s00464-010-1076-0
   Jixiong Y, 2003, US patent, Patent No. [20030190851, 5180398]
   KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23
   Kayaoglu HA, 2005, J INVEST SURG, V18, P89, DOI 10.1080/08941930590926357
   Koehler Richard H, 2003, JSLS, V7, P335
   LAURENT TC, 1987, ACTA OTO-LARYNGOL, P7
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
   McGinty JJ, 2005, SURG ENDOSC, V19, P786, DOI 10.1007/s00464-004-8174-9
   NARY FH, 2002, BRAZ DENT J, V13, P86
   Novitsky YW, 2007, J SURG RES, V140, P6, DOI 10.1016/j.jss.2006.09.015
   Ory F, 2002, GORE DUALMESH PLUS B, Patent No. 09463313
   Pierce RA, 2007, SURG ENDOSC, V21, P378, DOI 10.1007/s00464-006-9115-6
   Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479
   Pillai CKS, 2010, J BIOMATER APPL, V25, P291, DOI 10.1177/0885328210384890
   Ratner B.D., 2004, BIOMATERIALS SCI
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Tayot J, 2002, PROCEED SURG MESH IN, Patent No. 6391939
   THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27
   Tingstedt B, 2007, EUR SURG RES, V39, P259, DOI 10.1159/000102591
   Turaev A. S., 1995, CHEM NAT COMPD, V31, P254
   USHER F C, 1958, Am Surg, V24, P969
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   Wassenaar EB, 2010, HERNIA, V14, P137, DOI 10.1007/s10029-009-0568-0
   Wiseman D, 2003, DUALMESH BIOMATERIAL, Patent No. 20030073663
   YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316
NR 60
TC 48
Z9 49
U1 2
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD FEB
PY 2012
VL 26
IS 2
BP 566
EP 575
DI 10.1007/s00464-011-1899-3
PG 10
WC Surgery
SC Surgery
GA 878YK
UT WOS:000299293500042
PM 21898010
DA 2018-10-19
ER

PT J
AU Lee, JH
   Gu, YX
   Wang, H
   Lee, WY
AF Lee, Joung-Hyun
   Gu, Yexin
   Wang, Hongjun
   Lee, Woo Y.
TI Microfluidic 3D bone tissue model for high-throughput evaluation of
   wound-healing and infection-preventing biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Micropatterning; Antibacterial; Calcium phosphate; Bone tissue
   engineering; Osteoblast
ID STAPHYLOCOCCUS-EPIDERMIDIS; IN-VITRO; BIOFILMS; GENTAMICIN; MECHANISMS;
   SCAFFOLDS; IMPLANTS; SURFACES; CELLS
AB We report the use of a microfluidic 3D bone tissue model, as a high-throughput means of evaluating the efficacy of biomaterials aimed at accelerating orthopaedic implant-related wound-healing while preventing bacterial infection. As an example of such biomaterials, inkjet-printed micropatterns were prepared to contain antibiotic and biphasic calcium phosphate (BCP) nanoparticles dispersed in a poly(D,L-lactic-co-glycolic) acid matrix. The micropatterns were integrated with a microfluidic device consisting of eight culture chambers. The micropatterns immediately and completely killed Staphylococcus epidermidis upon inoculation, and enhanced the calcified extracellular matrix production of osteoblasts. Without antibiotic elution, bacteria rapidly proliferated to result in an acidic microenvironment which was detrimental to osteoblasts. These results were used to demonstrate the tissue model's potential in: (i) significantly reducing the number of biomaterial samples and culture experiments required to assess in vitro efficacy for wound-healing and infection prevention and (ii) in situ monitoring of dynamic interactions of biomaterials with bacteria as wells as with tissue cells simultaneously. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Lee, Joung-Hyun; Gu, Yexin; Wang, Hongjun; Lee, Woo Y.] Stevens Inst Technol, Hoboken, NJ 07030 USA.
RP Lee, WY (reprint author), Stevens Inst Technol, Hoboken, NJ 07030 USA.
EM wlee@stevens.edu
FU National Science Foundation [DMR 1005902]
FX This investigation was sponsored by the Biomaterials program of the
   National Science Foundation (DMR 1005902). We thank Prof. Xingdong
   Zhang, Sichuan University, China, for the BCP nanoparticles and Dr.
   Tseng-Ming Chou at Stevens for his help with the SEM characterization.
CR Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004
   Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Elaine NM, 2004, HUMAN ANATOMY PHYSL, P183
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gu YX, 2012, ACTA BIOMATER, V8, P424, DOI 10.1016/j.actbio.2011.08.006
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Jee W., 2001, BONE MECH HDB, P68
   Jevon M, 1999, INFECT IMMUN, V67, P2677
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   KIERSZENBAUM AL, 2002, HISTOLOGY CELL BIOL, P118
   Lee JH, 2008, BIOMED MICRODEVICES, V10, P489, DOI 10.1007/s10544-007-9157-0
   Lee JH, 2011, TISSUE ENG PART C-ME, V17, P39, DOI [10.1089/ten.tec.2010.0285, 10.1089/ten.TEC.2010.0285]
   Lee JH, 2010, ACTA BIOMATER, V6, P4422, DOI 10.1016/j.actbio.2010.05.021
   LEWIS K, 2005, BIOKHIMIYA, V70, P327
   Lucke M, 2005, BONE, V36, P770, DOI 10.1016/j.bone.2005.01.008
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Monzon M, 2001, J ANTIMICROB CHEMOTH, V48, P793, DOI 10.1093/jac/48.6.793
   Nakamura Norimasa, 1996, Wound Repair and Regeneration, V4, P87, DOI 10.1046/j.1524-475X.1996.40115.x
   Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Saginur R, 2006, ANTIMICROB AGENTS CH, V50, P55, DOI 10.1128/AAC.50.1.55-61.2006
   Sanchez E, 2001, EUR J PHARM BIOPHARM, V52, P151, DOI 10.1016/S0939-6411(01)00169-2
   Shen JA, 2010, J BIOMED MATER RES B, V95B, P330, DOI 10.1002/jbm.b.31717
   Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182
NR 30
TC 41
Z9 42
U1 2
U2 102
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 4
BP 999
EP 1006
DI 10.1016/j.biomaterials.2011.10.036
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864XI
UT WOS:000298273400001
PM 22061488
DA 2018-10-19
ER

PT J
AU Seib, FP
   Maitz, MF
   Hu, XA
   Werner, C
   Kaplan, DL
AF Seib, F. Philipp
   Maitz, Manfred F.
   Hu, Xiao
   Werner, Carsten
   Kaplan, David L.
TI Impact of processing parameters on the haemocompatibility of Bombyx mori
   silk films
SO BIOMATERIALS
LA English
DT Article
DE Silk; Blood compatibility; PLGA; Bombyx mori
ID IN-VITRO; MECHANICAL-BEHAVIOR; CELL RESPONSES; FIBROIN; BIOMATERIAL;
   ACTIVATION; SCAFFOLDS; CONSTRUCTION; PERICARDIUM; COAGULATION
AB Silk has traditionally been used for surgical sutures due to its lasting strength and durability; however, the use of purified silk proteins as a scaffold material for vascular tissue engineering goes beyond traditional use and requires application-orientated biocompatibility testing. For this study, a library of Bombyx mori silk films was generated and exposed to various solvents and treatment conditions to reflect current silk processing techniques. The films, along with clinically relevant reference materials, were exposed to human whole blood to determine silk blood compatibility. All substrates showed an initial inflammatory response comparable to polylactide-co-glycolide (PLGA), and a low to moderate haemostasis response similar to polytetrafluoroethylene (PTFE) substrates. In particular, samples that were water annealed at 25 degrees C for 6 h demonstrated the best blood compatibility based on haemostasis parameters (e.g. platelet decay, thrombin-antithrombin complex, platelet factor 4, granulocytes-platelet conjugates) and inflammatory parameters (e.g. C3b, C5a, CD11b, surface-associated leukocytes). Multiple factors such as treatment temperature and solvent influenced the biological response, though no single physical parameter such as beta-sheet content, isoelectric point or contact angle accurately predicted blood compatibility. These findings, when combined with prior in vivo data on silk, support a viable future for silk-based vascular grafts. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Seib, F. Philipp; Hu, Xiao; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Maitz, Manfred F.; Werner, Carsten] Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
   [Kaplan, David L.] Dept Chem & Biol Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St Medford, Medford, MA 02155 USA.
EM werner@ipfdd.de; David.Kaplan@tufts.edu
RI Maitz, Manfred/E-6749-2010; Umlauf, Ursula/D-3356-2014; Werner,
   Carsten/F-8127-2010; Hu, Xiao/F-2403-2012
OI Maitz, Manfred/0000-0002-0671-048X; Werner, Carsten/0000-0003-0189-3448;
   Hu, Xiao/0000-0002-2579-2820; Seib, Philipp/0000-0002-1955-1975
FU NIH (Tissue Engineering Resource Center) [P41 EB002520-05]; German
   Cancer Aid
FX The authors would like to thank Dr. Ralf Zimmermann for electrokinetic
   analysis, Grit Ebert for technical assistance and Kate Sander for
   editing this manuscript. This work was supported by NIH grant P41
   EB002520-05 (Tissue Engineering Resource Center) (DLK), FPS is supported
   by a Mildred Scheel Postdoctoral fellowship from the German Cancer Aid.
CR Bordenave L, 2008, EXPERT REV MED DEVIC, V5, P337, DOI 10.1586/17434440-5.3-337
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   CHANGDRAN KB, 1995, BIOMEDICAL ENG HDB, P648
   CHRISTENSON JT, 1987, INT ANGIOL, V6, P81
   Devine C, 2004, J VASC SURG, V40, P924, DOI 10.1016/j.jvs.2004.08.033
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang FH, 2008, ARTIF ORGANS, V32, P932, DOI 10.1111/j.1525-1594.2008.00655.x
   Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Maitz MF, 2009, J BIOMED MATER RES B, V90B, P18, DOI 10.1002/jbm.b.31247
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Motta A, 2009, J BIOMAT SCI-POLYM E, V20, P1875, DOI 10.1163/156856208X399936
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Paez JMG, 2001, J BIOMATER APPL, V16, P68, DOI 10.1106/3JXM-UTPN-PXTG-72DT
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   Pan CJ, 2007, J BIOMED MATER RES A, V82A, P740, DOI 10.1002/bjm.a.31108
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Santin M, 2002, J BIOACT COMPAT POL, V17, P195, DOI 10.1106/0883911`02026326
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Streller U, 2003, J BIOMED MATER RES B, V66B, P379, DOI 10.1002/jbm.b.10016
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Villalona GA, 2010, TISSUE ENG PART B-RE, V16, P341, DOI 10.1089/ten.TEB.2009.0527
   Wang S, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044106
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Werner C, 2001, COLLOID SURFACE A, V192, P205, DOI 10.1016/S0927-7757(01)00725-7
NR 39
TC 33
Z9 34
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2012
VL 33
IS 4
BP 1017
EP 1023
DI 10.1016/j.biomaterials.2011.10.063
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864XI
UT WOS:000298273400003
PM 22079005
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vignoletti, F
   Matesanz, P
   Rodrigo, D
   Figuero, E
   Martin, C
   Sanz, M
AF Vignoletti, Fabio
   Matesanz, Paula
   Rodrigo, Daniel
   Figuero, Elena
   Martin, Conchita
   Sanz, Mariano
TI Surgical protocols for ridge preservation after tooth extraction. A
   systematic review
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Review
DE bone grafts; bone regeneration; bone substitutes; dental implants; ridge
   preservation; systematic review; tooth extraction
ID IMMEDIATE IMPLANT PLACEMENT; DRIED BONE ALLOGRAFT; POLYGLYCOLIDE SPONGE;
   BIOACTIVE GLASS; SOCKETS; DOG; COLLAGEN; HUMANS; AUGMENTATION;
   EPIDEMIOLOGY
AB Objective: This systematic review aims to evaluate the scientific evidence on the efficacy in the surgical protocols designed for preserving the alveolar ridge after tooth extraction and to evaluate how these techniques affect the placement of dental implants and the final implant supported restoration.
   Material and methods: A thorough search in MEDLINE-PubMed, Embase and the Cochrane Central Register of controlled trials (CENTRAL) was conducted up to February 2011. Randomized clinical trials and prospective cohort studies with a follow-up of at least 3 months reporting changes on both the hard and soft tissues (height and/or width) of the alveolar process (mm or %) after tooth extraction were considered for inclusion.
   Results: The screening of titles and abstracts resulted in 14 publications meeting the eligibility criteria. Data from nine of these 14 studies could be grouped in the meta-analyses. Results from the meta-analyses showed a statistically significant greater ridge reduction in bone height for control groups as compared to test groups (weighted mean differences, WMD = -1.47 mm; 95% CI [-1.982, -0.953]; P < 0.001; heterogeneity: I-2 = 13.1%; chi(2) P-value = 0.314) and a significant greater reduction in bone width for control groups compared to the test groups (WMD = -1.830 mm; 95% CI [-2.947, -0.732]; P = 0.001; heterogeneity: I-2 = 0%; chi(2) P-value = 0.837). Subgroup analysis was based on the surgical protocol used for the socket preservation (flapless/flapped, barrier membrane/no membrane, primary intention healing/no primary healing) and on the measurement method utilized to evaluate morphological changes. Meta-regression analyses demonstrated a statistically significant difference favoring the flapped subgroup in terms of bone width (meta-regression; slope = 2.26; 95% IC [1.01; 3.51]; P = 0.003).
   Conclusions: The potential benefit of socket preservation therapies was demonstrated resulting in significantly less vertical and horizontal contraction of the alveolar bone crest. The scientific evidence does not provide clear guidelines in regards to the type of biomaterial, or surgical procedure, although a significant positive effect of the flapped surgery was observed. There are no data available to draw conclusions on the consequences of such benefits on the long-term outcomes of implant therapy.
C1 [Vignoletti, Fabio; Matesanz, Paula; Rodrigo, Daniel; Figuero, Elena; Martin, Conchita; Sanz, Mariano] Univ Complutense, ETEP Res Grp, E-28040 Madrid, Spain.
RP Sanz, M (reprint author), Univ Complutense Madrid, Fac Odontol, Plaza Ramon y Cajal, E-28040 Madrid, Spain.
EM marianosanz@odon.ucm.es
RI Figuero, Elena/G-8364-2017; Sanz, Mariano/G-8244-2017; Martin,
   Conchita/G-3599-2015
OI Figuero, Elena/0000-0002-3129-1416; Sanz, Mariano/0000-0002-6293-5755;
   Martin, Conchita/0000-0003-3997-6900; Vignoletti,
   Fabio/0000-0002-4574-3671
CR Aimetti M, 2009, INT J ORAL MAX IMPL, V24, P901
   AMLER M H, 1960, J Am Dent Assoc, V61, P32
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P9, DOI 10.1111/j.1600-0501.2010.01937.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Becker W, 1999, Clin Implant Dent Relat Res, V1, P27, DOI 10.1111/j.1708-8208.1999.tb00088.x
   Blanco J, 2010, CLIN ORAL IMPLAN RES, V21, P624, DOI 10.1111/j.1600-0501.2009.01885.x
   Block Michael S, 2006, Atlas Oral Maxillofac Surg Clin North Am, V14, P1, DOI 10.1016/j.cxom.2005.11.006
   Bolouri A, 2001, Compend Contin Educ Dent, V22, P955
   Bolouri A, 2001, COMPEND CONTIN ED DE, V22, P960
   Bolouri A, 2001, COMPEND CONTIN ED DE, V22, P962
   Bolouri A, 2001, COMPEND CONTIN ED DE, V22, P966
   Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Casado PL, 2010, IMPLANT DENT, V19, P314, DOI 10.1097/ID.0b013e3181dec322
   Crespi R, 2009, J PERIODONTOL, V80, P210, DOI [10.1902/jop.2009.080400, 10.1902/jop.2009.080400 ]
   Devlin H, 1997, J BONE MINER RES, V12, P2061, DOI 10.1359/jbmr.1997.12.12.2061
   Devlin H, 2002, INT J ORAL MAX SURG, V31, P641, DOI 10.1054/ijom.2002.0292
   Esposito M, 2001, INT J ORAL MAX IMPL, V16, P783
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P906, DOI 10.1111/j.1600-051X.2008.01305.x
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Higgins J, 2011, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hoad-Reddick G, 1994, Eur J Prosthodont Restor Dent, V3, P61
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   JOHNSON K, 1969, Australian Dental Journal, V14, P241
   KUBOKI Y, 1988, J DENT RES, V67, P944, DOI 10.1177/00220345880670061101
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Oghli AA, 2010, QUINTESSENCE INT, V41, P605
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Serino G, 2008, CLIN ORAL IMPLAN RES, V19, P26, DOI 10.1111/j.1600-0501.2007.01311.x
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tarnow D P, 1996, J Esthet Dent, V8, P12, DOI 10.1111/j.1708-8240.1996.tb00904.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Tobias A, 1999, STATA TECH B, V47, P15
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   van Kesteren CJ, 2010, INT J ORAL MAX IMPL, V25, P562
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Yilmaz S, 1998, J CLIN PERIODONTOL, V25, P832, DOI 10.1111/j.1600-051X.1998.tb02378.x
NR 55
TC 173
Z9 181
U1 7
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2012
VL 23
SU 5
SI SI
BP 22
EP 38
DI 10.1111/j.1600-0501.2011.02331.x
PG 17
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 869LZ
UT WOS:000298600900003
PM 22211304
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Usha, R
   Sreeram, KJ
   Rajaram, A
AF Usha, R.
   Sreeram, K. J.
   Rajaram, A.
TI Stabilization of collagen with EDC/NHS in the presence of L-lysine: A
   comprehensive study
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Collagen; L-Lysine; EDC/NHS; Self assembly process; Rheological
   characterization; Powder X-ray diffraction
ID DERMAL SHEEP COLLAGEN; CROSS-LINKED COLLAGEN; RAT TAIL TENDON; FIBRIL
   FORMATION; 1-ETHYL-3-(3-DIMETHYLAMINOPROPYL)-CARBODIIMIDE EDC; IN-VITRO;
   LINKING AGENTS; GLUTARALDEHYDE; CARBODIIMIDE; STABILITY
AB This paper reports the effect of L-lysine on the conformational, theological, and thermal properties of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) cross linked collagen and investigates the influence of L-lysine on the self assembly processes of collagen. In the absence of L-lysine, the theological characterization of collagen cross linked with EDC/NHS showed an increase in shearing stress with shearing speed indicating that the collagen chains become rigid and the molecules are reluctant to flow. On the other hand, the increase in shearing stress with shearing speed is comparatively much less in the presence of L-lysine indicating a greater flexibility of the collagen molecules. The self assembly processes of collagen treated with EDC/NHS in the absence and presence of L-lysine were characterized using powder XRD, FT-IR, polarizing optical microscopy and kinetic studies. XRD studies show an increase in peak intensity and sharpness in the presence of L-lysine indicating the enhancement of crystallinity of collagen nano-fibrils. FT-IR results suggest that the incorporation of L-lysine in the EDC/NHS cross linking favors the molecular stability of collagen. From the present study, it is possible to conclude that the pre-treatment of collagen with L-lysine enhances EDC/NHS cross linking and can be used for biomaterial applications. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Usha, R.; Rajaram, A.] Cent Leather Res Inst, Biophys Lab, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
   [Sreeram, K. J.] Cent Leather Res Inst, Chem Lab, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
RP Usha, R (reprint author), Cent Leather Res Inst, Biophys Lab, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
EM usharamamoorthy54@yahoo.co.in
RI Kalarical Janardhanan, Sreeram/B-1650-2008
OI Kalarical Janardhanan, Sreeram/0000-0003-1748-8754
CR Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Chen YH, 2011, KOREA-AUST RHEOL J, V23, P41, DOI 10.1007/s13367-011-0006-6
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Everaerts F, 2006, J HEART VALVE DIS, V15, P269
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Gilles M.A., 1990, ANAL BIOCHEM, V184, P246
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   Gratzer PF, 2001, J BIOMED MATER RES, V58, P172, DOI 10.1002/1097-4636(2001)58:2<172::AID-JBM1004>3.0.CO;2-9
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Haroun MA, 2009, THERMOCHIM ACTA, V484, P4, DOI 10.1016/j.tca.2008.11.008
   HEY KB, 1990, BIOTECHNOL APPL BIOC, V12, P85
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   Human H, 2002, BIOMATERIALS, V23, P2099
   JAKOBSEN RJ, 1983, SCIENCE, V220, P1288, DOI 10.1126/science.6857249
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   Li H, 2003, MACROMOL BIOSCI, V3, P344, DOI 10.1002/mabi.200350002
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Marinucci L, 2003, J BIOMED MATER RES A, V67A, P504, DOI 10.1002/jbm.a.10082
   Marzec E, 2008, BIOPHYS CHEM, V132, P89, DOI 10.1016/j.bpc.2007.10.012
   Mohd Nasir N. F., 2006, AM J BIOCH BIOTECHNO, V2, P175
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nimni M. E., 1988, BIOCHEMISTRY, VI
   Osborne CS, 1999, BIOMATERIALS, V20, P283, DOI 10.1016/S0142-9612(98)00179-3
   Otsuka M, 2006, J BIOMED MATER RES B, V79B, P176, DOI 10.1002/jbm.b.30528
   Park S.N., 2003, BIOMATERIALS, V24, P1431
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Raspanti M, 2007, BIOMACROMOLECULES, V8, P2087, DOI 10.1021/bm070091t
   Rault I., 1994, J BIOMED MATER RES, V28, P159
   Saito H, 2004, MAT SCI ENG C-BIO S, V24, P781, DOI 10.1016/j.msec.2004.08.039
   SILVER FH, 1983, COLLAGEN REL RES, V3, P393
   SIMIONESCU A, 1991, J BIOMED MATER RES, V25, P1495, DOI 10.1002/jbm.820251207
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P570, DOI 10.1016/j.ijbiomac.2010.08.004
   Sirbu R., 2011, J BIOL LIFE SCI, V7, P158
   Song Q, 2009, MATER SCI FORUM, V610-613, P1360, DOI 10.4028/www.scientific.net/MSF.610-613.1360
   Stamov D, 2008, BIOMATERIALS, V29, P1, DOI 10.1016/j.biomaterials.2007.09.009
   Tenkumo T., 2009, NANOMEDICINE, V1, P26
   Usha R, 2010, INT J BIOL MACROMOL, V47, P402, DOI 10.1016/j.ijbiomac.2010.06.009
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   Walton RS, 2010, J MATER SCI-MATER M, V21, P451, DOI 10.1007/s10856-009-3910-2
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   White JF, 2002, J STRUCT BIOL, V137, P23, DOI 10.1006/jsbi.2002.4460
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zhang M, 2010, KOREA-AUST RHEOL J, V22, P119
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
NR 64
TC 36
Z9 40
U1 6
U2 116
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2012
VL 90
BP 83
EP 90
DI 10.1016/j.colsurfb.2011.10.002
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 868JC
UT WOS:000298518600014
PM 22019452
DA 2018-10-19
ER

PT J
AU Luo, E
   Hu, J
   Bao, CY
   Li, YF
   Tu, QS
   Murray, D
   Chen, JK
AF Luo, En
   Hu, Jing
   Bao, Chongyun
   Li, Yunfeng
   Tu, Qisheng
   Murray, Dana
   Chen, Jake
TI Sustained release release of adiponectin improves osteogenesis around
   hydroxyapatite implants by suppressing osteoclast activity in
   ovariectomized rabbits
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adiponectin; Osteogenesis; Hydroxyapatite; Osteoclast; Ovariectomy
ID FIBROBLAST-GROWTH-FACTOR; MAPK SIGNALING PATHWAY; BONE-RESORPTION;
   IN-VIVO; INSULIN-RESISTANCE; HUMAN OSTEOBLASTS; CELLS; RATS;
   OSTEOPOROSIS; DIFFERENTIATION
AB Lack of estrogen could lead to decreased bone mass and increased risk for osteoporosis, which has a negative influence on biomaterial implantation. Adiponectin (APN), an adipose-derived hormone, has been shown to increase bone density by inhibiting osteoclast formation and promoting the formation of osteoblasts. This study was designed to investigate the direct effects of APN released from the Matrigel controlled-release system on the activity of rabbit mature osteoclasts and osteoclast precursor RAW264.7 cells in vitro, and to determine its effects by improving osteogenesis around the hydroxyapatite (HA) implant in ovariectomized (OVX) rabbits. APN + Matrigel + HA, APN + HA, Matrigel + HA and HA were implanted into mandibular defects of OVX rabbits. At 4 weeks after implantation, the mandibles were examined by histology, microcomputed tomography and biomechanical testing. The results demonstrated that Matrigel extended the length of APN released to achieve long-term persistence. The sustained release of APN suppressed the osteoclastic activity both in vitro and in vivo, and improved the pen-implant osteogenesis in OVX rabbits, while the short-term APN treatment did not. Sustained release of APN may be an effective strategy to improve the restoration of bone defects by the use of HA materials under osteoporotic conditions in which osteoclasts are highly activated. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Luo, En; Tu, Qisheng; Murray, Dana; Chen, Jake] Tufts Univ, Sch Dent Med, Dept Gen Dent, Div Oral Biol, Boston, MA 02111 USA.
   [Luo, En; Hu, Jing; Bao, Chongyun; Li, Yunfeng] Sichuan Univ, State Key Lab Oral Dis, W China Sch Stomatol, Chengdu 610041, Peoples R China.
RP Chen, JK (reprint author), Tufts Univ, Sch Dent Med, Dept Gen Dent, Div Oral Biol, Boston, MA 02111 USA.
EM JK.Chen@tufts.edu
FU National Science Foundation of China [30973346]
FX This study was supported by Grants from the National Science Foundation
   of China(No. 30973346). The Program for New Century Excellent Talents in
   University (NCET-10-0597) and NIH (Nos. DE16710 and DE21464) to J.C.
CR Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486
   Bellido M, 2010, J DENT RES, V89, P360, DOI 10.1177/0022034510363082
   Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z
   Castaneda S, 2008, J BONE MINER METAB, V26, P53, DOI 10.1007/s00774-007-0797-1
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Gao Y, 2009, J CONTROL RELEASE, V139, P15, DOI 10.1016/j.jconrel.2009.05.032
   Gao Y, 2009, BONE, V44, P225, DOI 10.1016/j.bone.2008.10.054
   Garnero P, 2009, BONE, V44, P461, DOI 10.1016/j.bone.2008.11.006
   GILSANZ V, 1988, AM J PHYSIOL, V255, pE416
   Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667
   Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8
   Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200
   Jiang XW, 2011, J ORTHOP RES, V29, P1081, DOI 10.1002/jor.21355
   KANEHISA J, 1990, BONE, V11, P287, DOI 10.1016/8756-3282(90)90082-A
   Kondo Y, 2001, J BONE MINER METAB, V19, P352, DOI 10.1007/s007740170004
   Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED
   Kurth AHA, 2005, BONE, V37, P204, DOI 10.1016/j.bone.2004.12.017
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144
   Lerner UH, 2006, J DENT RES, V85, P584, DOI 10.1177/154405910608500703
   Ley CD, 2004, MICROVASC RES, V68, P161, DOI 10.1016/j.mvr.2004.06.002
   Li YF, 2010, OSTEOPOROSIS INT, V21, P1889, DOI 10.1007/s00198-009-1140-6
   Liang HX, 2010, BONE, V47, P197, DOI 10.1016/j.bone.2010.05.023
   Lugero G G, 2000, Implant Dent, V9, P303, DOI 10.1097/00008505-200009040-00005
   Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021
   Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707
   Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724
   Nakajima A, 2009, J BONE MINER RES, V24, P1162, DOI [10.1359/JBMR.090205, 10.1359/jbmr.090205]
   Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210
   Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026
   Saito T, 2002, BIOMATERIALS, V23, P2711, DOI 10.1016/S0142-9612(02)00003-0
   Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890
   Sodunke TR, 2007, BIOMATERIALS, V28, P4006, DOI 10.1016/j.biomaterials.2007.05.021
   Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405
   Valverde P, 2005, J BONE MINER RES, V20, P1669, DOI 10.1359/JBMR.050511
   Vashi AV, 2006, TISSUE ENG, V12, P3035, DOI 10.1089/ten.2006.12.3035
   Warabi S, 2001, CYTOTECHNOLOGY, V35, P25, DOI 10.1023/A:1008159332152
   Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639
   Wu XJ, 2003, ENDOCRINOLOGY, V144, P5545, DOI 10.1210/en.2003-0296
   Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130
   Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037
   Yamaguchi N, 2007, FEMS IMMUNOL MED MIC, V49, P28, DOI 10.1111/j.1574-695X.2006.00164.x
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yokota T, 2000, BLOOD, V96, P1723
NR 44
TC 24
Z9 29
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2012
VL 8
IS 2
BP 734
EP 743
DI 10.1016/j.actbio.2011.10.029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902YZ
UT WOS:000301081400029
PM 22061107
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ravindran, S
   Gao, Q
   Kotecha, M
   Magin, RL
   Karol, S
   Bedran-Russo, A
   George, A
AF Ravindran, Sriram
   Gao, Qi
   Kotecha, Mrignayani
   Magin, Richard L.
   Karol, Sachin
   Bedran-Russo, Ana
   George, Anne
TI Biomimetic Extracellular Matrix-Incorporated Scaffold Induces Osteogenic
   Gene Expression in Human Marrow Stromal Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION;
   IN-VITRO; VITAMIN-D; CHITOSAN; GROWTH; CARTILAGE; PROTEIN;
   MINERALIZATION
AB Engineering biomaterials mimicking the biofunctionality of the extracellular matrix (ECM) is important in instructing and eliciting cell response. The native ECM is highly dynamic and has been shown to support cellular attachment, migration, and differentiation. The advantage of synthesizing an ECM-based biomaterial is that it mimics the native cellular environment. However, the ECM has tissue-specific composition and patterned arrangement. In this study, we have employed biomimetic strategies to develop a novel collagen/ chitosan template that is embedded with the native ECM of differentiating human marrow stromal cells (HMSCs) to facilitate osteoblast differentiation. The scaffold was characterized for substrate stiffness by magnetic resonance imaging and nanoindentation and by immunohistochemical analysis for the presence of key ECM proteins. Gene expression analysis showed that the ECM scaffold supported osteogenic differentiation of undifferentiated HMSCs as significant changes were observed in the expression levels of growth factors, transcription factors, proteases, receptors, and ECM proteins. Finally, we demonstrate that the scaffold had the ability to nucleate calcium phosphate polymorphs to form a mineralized matrix. The results from this study suggest that the three-dimensional native ECM scaffold directly controls cell behavior and supports the osteogenic differentiation of mesenchymal stem cells.
C1 [Ravindran, Sriram; Gao, Qi; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.
   [Kotecha, Mrignayani; Magin, Richard L.] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA.
   [Karol, Sachin; Bedran-Russo, Ana] Univ Illinois, Dept Restorat Dent, Chicago, IL 60612 USA.
RP George, A (reprint author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.
EM anneg@uic.edu
RI Bedran-Russo, Ana/B-6149-2017
OI GEORGE, ANNE/0000-0002-9008-7642
FU NIH [DE 11657, EB007537]; Brodie Endowment fund
FX This project was funded by the NIH grant DE 11657 (to A. G.), EB007537
   (to R. L. M.), and the Brodie Endowment fund. The authors thank Kristina
   Jarosius of the UIC Research Resources Center Electron Microscopy
   Facility for her technical assistance.
CR Bae H, 2010, J BONE JOINT SURG AM, V92A, P427, DOI 10.2106/JBJS.H.01400
   Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V
   Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725
   CHEN Y, 1992, J BIOL CHEM, V267, P24871
   Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513
   Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498
   Coburn CT, 2001, J MOL NEUROSCI, V16, P117, DOI 10.1385/JMN:16:2-3:117
   Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0
   Di Cesare PE, 2000, J ORTHOPAED RES, V18, P713, DOI 10.1002/jor.1100180506
   Dietrich O, 2010, EUR J RADIOL, V76, P314, DOI 10.1016/j.ejrad.2010.02.018
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   DZIEDZICGOCLAWSKA A, 1992, BONE MINER, V19, P127, DOI 10.1016/0169-6009(92)90921-Y
   Ebisawa T, 1999, J CELL SCI, V112, P3519
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729
   George A, 2010, NANO TODAY, V5, P254, DOI 10.1016/j.nantod.2010.05.005
   GORDON MY, 1988, BRIT J HAEMATOL, V70, P1, DOI 10.1111/j.1365-2141.1988.tb02425.x
   Hamilton R., 2001, ANAT REC, V231, P218
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200
   HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602
   Hino J, 2012, INT J OBESITY, V36, P725, DOI 10.1038/ijo.2011.124
   Hocking AM, 1998, MATRIX BIOL, V17, P1
   Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003
   June RK, 2008, BIOCHEM BIOPH RES CO, V377, P57, DOI 10.1016/j.bbrc.2008.09.067
   Kim KW, 2003, J FOOD PROTECT, V66, P1495, DOI 10.4315/0362-028X-66.8.1495
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Lee TC, 2006, NEUROSURGERY, V58, P373, DOI 10.1227/01.NEU.0000199725.03186.F6
   Li WG, 2010, TISSUE ENG PART C-ME, V16, P1407, DOI [10.1089/ten.tec.2009.0777, 10.1089/ten.TEC.2009.0777]
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060
   Pai A, 2008, MAGN RESON IMAGING, V26, P1215, DOI 10.1016/j.mri.2008.02.017
   Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]
   Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   TAYLOR DG, 1985, PHYS MED BIOL, V30, P345, DOI 10.1088/0031-9155/30/4/009
   Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   Woll NL, 2006, STEM CELLS DEV, V15, P865, DOI 10.1089/scd.2006.15.865
   Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhang ZY, 2003, MECH DEVELOP, V120, P1469, DOI 10.1016/j.mod.2003.09.002
NR 57
TC 37
Z9 38
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2012
VL 18
IS 3-4
BP 295
EP 309
DI 10.1089/ten.tea.2011.0136
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 888KV
UT WOS:000300003300008
PM 21867449
OA Green Published
DA 2018-10-19
ER

PT J
AU Shamloo, A
   Xu, H
   Heilshorn, S
AF Shamloo, Amir
   Xu, Hui
   Heilshorn, Sarah
TI Mechanisms of Vascular Endothelial Growth Factor-Induced Pathfinding by
   Endothelial Sprouts in Biomaterials
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PEPTIDE GELS AFFECTS; EXTRACELLULAR-MATRIX; CELL-MIGRATION; IN-VITRO;
   CAPILLARY MORPHOGENESIS; MICROFLUIDIC PLATFORM; ENGINEERED TISSUES;
   NETWORK FORMATION; DELIVERY-SYSTEMS; HOST VASCULATURE
AB A critical property of biomaterials for use in regenerative medicine applications is the ability to promote angiogenesis, the formation of new vascular networks, to support regenerating tissues. Recent studies have demonstrated that a complex interplay exists between biomechanical and biochemical regulators of endothelial cell sprouting, an early step in angiogenesis. Here, we use a microfluidic platform to study the pathfinding behaviors induced by various stable vascular endothelial growth factor (VEGF) gradients during sprouting morphogenesis within biomaterials. Quantitative, time-lapse analysis of endothelial sprouting demonstrated that the ability of VEGF to regulate sprout orientation during several stages of sprouting morphogenesis (initiation, elongation, and turning navigation) was biomaterial dependent. Identical VEGF gradients induced different types of coordinated cell movements depending on the density of the surrounding collagen/fibronectin matrix. In denser matrices, sprouts were more likely to have an initial orientation aligned parallel to the VEGF gradient. In contrast, in less dense matrices, sprouts were more likely to initially misalign with the VEGF gradient; however, these sprouts underwent significant turning and navigation to eventually reorient to be parallel to the VEGF gradient. These less dense matrices required shallower VEGF gradients and demonstrated lower activating VEGF thresholds to induce proper sprout alignment and pathfinding. These results encourage the future use of microfluidic platforms to probe fundamental aspects of matrix effects on angiogenesis, to screen biomaterials for angiogenic potential, and to design ex vivo tissues with aligned vascular networks.
C1 [Xu, Hui; Heilshorn, Sarah] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Shamloo, Amir] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.
RP Heilshorn, S (reprint author), Stanford Univ, Dept Mat Sci & Engn, 476 Lomita Mall,McCullough Bldg, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
RI 李, 涵/B-4995-2012
FU NIH [1DP2 OD006477, 1R21 NS058600]; NSF [EFRI-CBE-0735551, DMR-0846363];
   National Academies Keck Futures Initiative [CS10]; Stanford Training
   Program in Mechanisms and Innovation in Vascular Disease, NIH
   [1T32HL098049-01A1]
FX The authors acknowledge funding from NIH 1DP2 OD006477, NIH 1R21
   NS058600, NSF EFRI-CBE-0735551, NSF DMR-0846363, and National Academies
   Keck Futures Initiative CS10. HX acknowledges support from the Stanford
   Training Program in Mechanisms and Innovation in Vascular Disease, NIH
   1T32HL098049-01A1.
CR Bonvin C, 2010, BIOTECHNOL BIOENG, V105, P982, DOI 10.1002/bit.22608
   Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x
   Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012
   Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440
   Haas TL, 2005, CAN J PHYSIOL PHARM, V83, P1, DOI 10.1139/Y04-120
   Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee P, 2006, BIOMED MICRODEVICES, V8, P35, DOI 10.1007/s10544-006-6380-z
   Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655
   Mammoto A., 2008, METHOD ENZYMOL, P227
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Moon JJ, 2007, FASEB J, V21, pA748
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h
   Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820
   Sun GM, 2009, REGEN MED, V4, P435, DOI 10.2217/RME.09.1
   Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122
   Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f
   Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P13897, DOI 10.1073/pnas.0606087103
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
NR 68
TC 25
Z9 25
U1 1
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2012
VL 18
IS 3-4
BP 320
EP 330
DI 10.1089/ten.tea.2011.0323
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 888KV
UT WOS:000300003300010
PM 21888475
OA Green Published
DA 2018-10-19
ER

PT J
AU Bergeron, E
   Leblanc, E
   Drevelle, O
   Giguere, R
   Beauvais, S
   Grenier, G
   Faucheux, N
AF Bergeron, Eric
   Leblanc, Elisabeth
   Drevelle, Olivier
   Giguere, Randy
   Beauvais, Sabrina
   Grenier, Guillaume
   Faucheux, Nathalie
TI The Evaluation of Ectopic Bone Formation Induced by Delivery Systems for
   Bone Morphogenetic Protein-9 or Its Derived Peptide
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; BIOMATERIAL CARRIERS;
   PENETRANT DIFFUSION; SWELLABLE POLYMERS; CRYSTAL-STRUCTURE; COLLAGEN
   SPONGES; IN-VIVO; BMP-2; REGENERATION
AB We have earlier shown that a peptide derived from the bone morphogenetic protein-9 (pBMP-9) stimulates mouse preosteoblasts MC3T3-E1 differentiation in vitro. Here, we evaluated the effects of two delivery systems (DSs) for pBMP-9, one based on collagen and the other on chitosan. The release kinetics of BMP-9 (used as control) and pBMP-9 from these DSs were first determined in vitro by using enzyme-linked immunosorbent assay and high performance liquid chromatography assays, respectively. Micro-computerized tomography and histological analysis were then performed to study in vivo the ectopic ossification induced by both DSs containing these molecules in C57BL/ 6 mouse quadriceps. We found that collagen DS released in vitro about 35% of its BMP-9 within 1 h, whereas chitosan DS released 80%. The pBMP-9 was released from both DSs more slowly for up to 10 days. These release kinetics seemed to fit the Korsmeyer-Peppas model. Only chitosan DS containing BMP-9 induced strong bone formation in all mice quadriceps within 24 days. All mice quadriceps treated by pBMP-9 trapped in this DS also favored bone structures that started to mineralize. However, pBMP-9 in collagen DS failed to promote ectopic ossification within 24 days in vivo. This study highlights the importance to optimize carrier, thus improving the efficiency of pBMP-9 in vivo.
C1 [Bergeron, Eric; Drevelle, Olivier; Giguere, Randy; Beauvais, Sabrina; Faucheux, Nathalie] Univ Sherbrooke, Lab Cell Biomat Biohybrid Syst, Dept Chem Engn & Biotechnol Engn, Fac Engn, Sherbrooke, PQ J1K 2R1, Canada.
   [Leblanc, Elisabeth; Grenier, Guillaume] Univ Sherbrooke, Res Ctr Ageing, Sherbrooke, PQ J1K 2R1, Canada.
   [Leblanc, Elisabeth; Grenier, Guillaume; Faucheux, Nathalie] Univ Sherbrooke, Etienne Lebel Clin Res Ctr, Sherbrooke, PQ J1K 2R1, Canada.
   [Leblanc, Elisabeth; Grenier, Guillaume; Faucheux, Nathalie] Univ Sherbrooke, Dept Orthopaed Surg, Fac Med, Sherbrooke, PQ J1K 2R1, Canada.
RP Faucheux, N (reprint author), Univ Sherbrooke, Lab Cell Biomat Biohybrid Syst, Dept Chem Engn & Biotechnol Engn, Fac Engn, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada.
EM nathalie.faucheux@usherbrooke.ca
RI Bergeron, Eric/G-6544-2011
OI Drevelle, Olivier/0000-0002-3759-6931
FU National Science and Engineering Research of Canada (NSERC); Fonds de la
   recherche en sante du Quebec (FRSQ); Canadian Institute of Health and
   Research (CIHR); Fondation pour la Recherche et l'Enseignement en
   Orthopedie de Sherbrooke (FREOS)
FX The authors thank Dr. Owen Parkes for editing the English text, Isabelle
   Arsenault for technical assistance with the HPLC, and Renee Bernatchez
   and Yongjun Xiao for microCT and histology analysis at the Centre for
   Bone and Periodontal Research. Dr. Sophie Roux and Dr. Manuela Pelmus
   contributed to helpful discussion of the histology data. The authors
   also thank Prof. Bernard Marcos for his advice on release kinetics
   models. This research was supported through National Science and
   Engineering Research of Canada (NSERC) program. E. B. was supported by a
   Fonds de la recherche en sante du Quebec (FRSQ) fellowship. E. L.
   received a Canadian Institute of Health and Research (CIHR) and
   Fondation pour la Recherche et l'Enseignement en Orthopedie de
   Sherbrooke (FREOS) scholarship.
CR Akman AC, 2009, ARTIF ORGANS, V34, P65
   ANDREW JG, 1994, ACTA ORTHOP SCAND, V65, P462, DOI 10.3109/17453679408995493
   Bergeron E, 2007, J MATER SCI-MATER M, V18, P255, DOI 10.1007/s10856-006-0687-4
   Bergeron E, 2009, TISSUE ENG PT A, V15, P3341, DOI [10.1089/ten.tea.2009.0189, 10.1089/ten.TEA.2009.0189]
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200
   Burkus JK, 2004, ORTHOPEDICS, V27, P723
   Canter HI, 2010, ANN PLAS SURG, V64, P342, DOI 10.1097/SAP.0b013e3181a73045
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Celeste AJ, 1994, J BONE MINER RES  S1, V9, pS136
   Chen YP, 2009, J BIOMED MATER RES A, V91A, P296, DOI 10.1002/jbm.a.32246
   Dash S, 2010, ACTA POL PHARM, V67, P217
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Duan ZX, 2007, J HUAZHONG UNIV SCI, V27, P179, DOI 10.1007/s11596-007-0219-6
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kanakaris NK, 2008, INJURY, V39, pS83, DOI 10.1016/S0020-1383(08)70019-6
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756
   Kirkwood Keith, 2003, J Oral Implantol, V29, P57, DOI 10.1563/1548-1336(2003)029<0057:IVMSWS>2.3.CO;2
   Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   Kloesch B., 2007, EUR CELLS MATER, V14, P70
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P409, DOI 10.1002/polb.1986.090240215
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P395, DOI 10.1002/polb.1986.090240214
   Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311
   Luca L, 2010, J CONTROL RELEASE, V147, P38, DOI 10.1016/j.jconrel.2010.06.011
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Niu XF, 2009, J MICROENCAPSUL, V26, P297, DOI 10.1080/02652040802319742
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P579
   Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x
   Schett G, 2011, EUR J CLIN INVEST, V41, P1361, DOI 10.1111/j.1365-2362.2011.02545.x
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Suttapreyasri S, 2006, INT J ORAL MAX SURG, V35, P444, DOI 10.1016/j.ijom.2006.01.021
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wu B., 2008, BIOMED MATER, V3, P7
   Yuan Q, 2007, J WUHAN UNIV TECHNOL, V22, P701, DOI 10.1007/s11595-006-4701-y
NR 64
TC 28
Z9 28
U1 1
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2012
VL 18
IS 3-4
BP 342
EP 352
DI 10.1089/ten.tea.2011.0008
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 888KV
UT WOS:000300003300012
PM 21902464
DA 2018-10-19
ER

PT J
AU Dobre, LM
   Stoica-Guzun, A
   Stroescu, M
   Jipa, IM
   Dobre, T
   Ferdes, M
   Ciumpiliac, S
AF Dobre, Loredana-Mihaela
   Stoica-Guzun, Anicuta
   Stroescu, Marta
   Jipa, Iuliana Mihaela
   Dobre, Tanase
   Ferdes, Mariana
   Ciumpiliac, Stefana
TI Modelling of sorbic acid diffusion through bacterial cellulose-based
   antimicrobial films
SO CHEMICAL PAPERS
LA English
DT Article; Proceedings Paper
CT 38th International Conference of the
   Slovak-Society-of-Chemical-Engineering
CY MAY 23-27, 2011
CL Tatranske Matliare, SLOVAKIA
SP Slovak Soc Chem Engn
DE antimicrobial packaging; sorbic acid; bacterial cellulose; poly(vinyl
   alcohol)
ID MICROBIAL CELLULOSE; CONTROLLED-RELEASE; POTASSIUM SORBATE; LYSOZYME;
   KINETICS
AB Antimicrobial packaging protects the product from the external environment and microbial contamination, conferring numerous advantages on human health. Interest in biopolymers as packaging materials has considerably increased recently. Bacterial cellulose is an interesting biomaterial produced as nanofibrils by Acetobacter xylinium and is a promising candidate due to its remarkable properties. New composite materials with antimicrobial properties were developed in this work, containing poly(vinyl alcohol) (PVA) as polymer matrix and ground bacterial cellulose (BC) as reinforcing fibres. Sorbic acid was used as an antimicrobial agent because it is a preservative recognised in the food industry. The materials obtained were studied using Fourier-transformed infrared spectroscopy (FTIR). The swelling rate of the composites was also measured. Release experiments of sorbic acid from the composite films into water were performed and the mass transfer phenomena were investigated using Fick's law of diffusion. The antimicrobial effect was tested against Escherichia coli K12-MG1655. The results obtained indicated that the new biocomposite films could be promising antimicrobial food packaging materials.
C1 [Dobre, Loredana-Mihaela; Stoica-Guzun, Anicuta; Stroescu, Marta; Jipa, Iuliana Mihaela; Dobre, Tanase; Ferdes, Mariana; Ciumpiliac, Stefana] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Chem Engn, Bucharest 011061, Romania.
RP Dobre, LM (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Dept Chem Engn, Polizu 13, Bucharest 011061, Romania.
EM loredana_mihaela_dobre@yahoo.com
OI Jipa, Iuliana/0000-0003-0597-0789
CR Buonocore GG, 2003, J FOOD SCI, V68, P1365, DOI 10.1111/j.1365-2621.2003.tb09651.x
   Choi JH, 2005, LWT-FOOD SCI TECHNOL, V38, P417, DOI 10.1016/j.lwt.2004.07.004
   Crank J, 1975, MATH DIFFUSION
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Del Nobile MA, 2008, J FOOD ENG, V89, P57, DOI 10.1016/j.jfoodeng.2008.04.004
   Flores S, 2007, EUR FOOD RES TECHNOL, V225, P375, DOI 10.1007/s00217-006-0427-5
   Gemili S, 2009, J FOOD ENG, V90, P453, DOI 10.1016/j.jfoodeng.2008.07.014
   Han J. H., 2003, Novel food packaging techniques, P50, DOI 10.1533/9781855737020.1.50
   HAN JH, 2007, ADV THERMAL NONTHERM, P167
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7
   Markin V. S., 1998, PHARM CHEM J, V3, P54, DOI [10.1007/BF02539231, DOI 10.1007/BF0253]
   Mastromatteo M, 2009, INNOV FOOD SCI EMERG, V10, P222, DOI 10.1016/j.ifset.2008.11.010
   Mastromatteo M, 2011, J FOOD ENG, V104, P373, DOI 10.1016/j.jfoodeng.2010.12.032
   Min S., 2007, Packaging for nonthermal processing of food. 2005 IFT (Institute of Food Technologists) annual meeting, "Advances in Packaging Technology Required for Implementation on Novel Food Processes" and "Active Packaging for Nonthermal Processing", New Orleans, Louisiana, USA, 15-20 July 2005, P29, DOI 10.1002/9780470277720.ch3
   Petersen K, 1999, TRENDS FOOD SCI TECH, V10, P52, DOI 10.1016/S0924-2244(99)00019-9
   Redl A, 1996, J FOOD SCI, V61, P116, DOI 10.1111/j.1365-2621.1996.tb14739.x
   Rothstein SN, 2009, BIOMATERIALS, V30, P1657, DOI 10.1016/j.biomaterials.2008.12.002
   Souza MP, 2010, CHEM PAP, V64, P475, DOI 10.2478/s11696-010-0017-7
   Uz M, 2011, LWT-FOOD SCI TECHNOL, V44, P2302, DOI 10.1016/j.lwt.2011.05.003
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   Yoshida CMP, 2010, LWT-FOOD SCI TECHNOL, V43, P584, DOI 10.1016/j.lwt.2009.10.005
   Zhu GQ, 2010, CHEM PAP, V64, P776, DOI 10.2478/s11696-010-0069-8
NR 24
TC 11
Z9 11
U1 1
U2 37
PU VERSITA
PI WARSAW
PA SOLIPSKA 14A-1, 02-482 WARSAW, POLAND
SN 0366-6352
J9 CHEM PAP
JI Chem. Pap.
PD FEB
PY 2012
VL 66
IS 2
BP 144
EP 151
DI 10.2478/s11696-011-0086-2
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 852ND
UT WOS:000297363800009
DA 2018-10-19
ER

PT J
AU Razmovski, R
   Vucurovic, V
AF Razmovski, Radojka
   Vucurovic, Vesna
TI Bioethanol production from sugar beet molasses and thick juice using
   Saccharomyces cerevisiae immobilized on maize stem ground tissue
SO FUEL
LA English
DT Article
DE Bioethanol; Molasses; Thick juice; Maize stem; Immobilized cells
ID FUEL ETHANOL-PRODUCTION; TEA FUNGAL BIOMASS; CELL IMMOBILIZATION;
   YEAST-CELLS; FERMENTATION; BIOSORPTION; ACID; BIOMATERIAL; BIOCATALYST;
   BAGASSE
AB The potential of by-products and intermediate products of sugar beet processing as raw materials for bioethanol production in Vojvodina region has a big scope in view of the demand of ethanol as an alternative for fossil fuels. Also, from ecological point of view, use of agricultural waste as carriers for cells immobilization is justifiable. The biocatalyst prepared by immobilization of Saccharomyces cerevisiae on maize stem ground tissue was used for batch fermentation of sugar beet molasses and thick juice under normal and very high gravity (VHG) conditions. Cell immobilization was observed by electron microscopy. The carrier was effective for cell immobilization and provided strength and stability to the yeast cell mass and functioned as a fortification against toxins and inhibitors, enabling efficient ethanol fermentation, particularly in VHG conditions. Three different initial glucose concentrations were tested: 100, 150 and 300 g/l. The maximum ethanol concentration of 83.20 g/l for molasses and 132.39 g/l for thick juice were achieved in VHG fermentation by immobilized cells, whereas the free yeast cells were unsuccessful in the same media. Taking into consideration significant process parameters sugar beet thick juice was found to be economically favorable, compared to molasses, particularly in the VHG fermentation process. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Razmovski, Radojka; Vucurovic, Vesna] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia.
RP Vucurovic, V (reprint author), Univ Novi Sad, Fac Technol, Blvd Cara Lazara 1, Novi Sad 21000, Serbia.
EM vvvesna@uns.ac.rs
FU Ministry of Science and Technological Development of the Republic of
   Serbia [TR-31002]
FX Financial support of the Project TR-31002 from the Ministry of Science
   and Technological Development of the Republic of Serbia is highly
   acknowledged.
CR AOAC International, 2000, OFF METH AN AOAC INT
   Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002
   Bai FW, 2009, BIOTECHNOL BIOENG, V102, P113, DOI 10.1002/bit.22043
   Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015
   Basha CA, 2008, ELECTROCHIM ACTA, V54, P474, DOI 10.1016/j.electacta.2008.07.040
   BUZAS Z, 1989, BIOTECHNOL BIOENG, V34, P882, DOI 10.1002/bit.260340620
   Cardona CA, 2007, BIORESOURCE TECHNOL, V98, P2415, DOI 10.1016/j.biortech.2007.01.002
   Chandel AK, 2009, BIORESOURCE TECHNOL, V100, P2404, DOI 10.1016/j.biortech.2008.11.014
   Coppola F, 2009, BIOMASS BIOENERG, V33, P1626, DOI 10.1016/j.biombioe.2009.08.003
   Dodic S, 2009, BIOMASS BIOENERG, V33, P822, DOI 10.1016/j.biombioe.2009.01.002
   Farmakis L, 2007, FOOD RES INT, V40, P717, DOI 10.1016/j.foodres.2007.01.009
   Fujii N, 1999, PROCESS BIOCHEM, V34, P147, DOI 10.1016/S0032-9592(98)00085-5
   Hernandez L, 2009, INT J HYDROGEN ENERG, V34, P7041, DOI 10.1016/j.ijhydene.2008.07.089
   Iqbal M, 2005, LETT APPL MICROBIOL, V40, P178, DOI 10.1111/j.1472-765X.2004.01646.x
   Kourkoutas Y, 2006, LWT-FOOD SCI TECHNOL, V39, P980, DOI 10.1016/j.lwt.2006.02.024
   Laopaiboon L, 2009, BIORESOURCE TECHNOL, V100, P4176, DOI 10.1016/j.biortech.2009.03.046
   Malbasa R, 2008, FOOD CHEM, V108, P926, DOI 10.1016/j.foodchem.2007.11.069
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Nigam JN, 2000, J BIOTECHNOL, V80, P189, DOI 10.1016/S0168-1656(00)00246-7
   Nikolic S, 2009, FUEL, V88, P1602, DOI 10.1016/j.fuel.2008.12.019
   Ogbonna JC, 2001, BIORESOURCE TECHNOL, V76, P1, DOI 10.1016/S0960-8524(00)00084-5
   Pan HF, 2010, BIOTECHNOL LETT, V32, P235, DOI 10.1007/s10529-009-0134-y
   Peinado RA, 2006, ENZYME MICROB TECH, V40, P79, DOI 10.1016/j.enzmictec.2005.10.040
   Phisalaphong M, 2007, J BIOSCI BIOENG, V104, P214, DOI 10.1263/jbb.104.214
   Plessas S, 2007, BIORESOURCE TECHNOL, V98, P860, DOI 10.1016/j.biortech.2006.03.014
   Razmouski R, 2008, ECOL ENG, V34, P179, DOI 10.1016/j.ecoleng.2008.07.020
   Razmovski R, 2008, AFR J BIOTECHNOL, V7, P1693
   Razmovski R, 2007, ROM BIOTECH LETT, V12, P3241
   Razmovski R, 2002, FOLIA MICROBIOL, V47, P507, DOI 10.1007/BF02818789
   Razmovski R, 1996, FOLIA MICROBIOL, V41, P201, DOI 10.1007/BF02814700
   RAZMOVSKI R, 2004, ROUM BIOTECHNOL LETT, V9, P1821
   Razmovski Radojka, 1997, Acta Microbiologica et Immunologica Hungarica, V44, P249
   Reddy LV, 2008, PROCESS BIOCHEM, V43, P748, DOI 10.1016/j.procbio.2008.02.020
   Reddy LVA, 2006, PROCESS BIOCHEM, V41, P726, DOI 10.1016/j.procbio.2005.08.011
   Rodriguez LA, 2010, INT J HYDROGEN ENERG, V35, P5914, DOI 10.1016/j.ijhydene.2009.12.112
   RYCHTERA M, 1987, 4 C BIOT, P107
   Santos DT, 2008, J FOOD ENG, V86, P542, DOI 10.1016/j.jfoodeng.2007.11.004
   Srichuwong S, 2009, BIOMASS BIOENERG, V33, P890, DOI 10.1016/j.biombioe.2009.01.012
   Tsakiris A, 2004, FOOD CHEM, V87, P11, DOI 10.1016/j.foodchem.2003.10.010
   Verbelen PJ, 2006, BIOTECHNOL LETT, V28, P1515, DOI 10.1007/s10529-006-9132-5
   Vucurovic V, 2008, CHEM IND CHEM ENG Q, V14, P235, DOI 10.2298/CICEQ0804235V
   Walter A, 2008, BIOMASS BIOENERG, V32, P730, DOI 10.1016/j.biombioe.2008.01.026
   Wang FQ, 2007, BIOTECHNOL LETT, V29, P233, DOI 10.1007/s10529-006-9220-6
   Wu XR, 2010, IND CROP PROD, V31, P164, DOI 10.1016/j.indcrop.2009.10.006
   Yu JL, 2007, J BIOTECHNOL, V129, P415, DOI 10.1016/j.jbiotec.2007.01.039
   Yu JL, 2010, RENEW ENERG, V35, P1130, DOI 10.1016/j.renene.2009.11.045
   Zhaoxin Lu, 2002, J Agric Food Chem, V50, P2798
NR 47
TC 34
Z9 34
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0016-2361
J9 FUEL
JI Fuel
PD FEB
PY 2012
VL 92
IS 1
BP 1
EP 8
DI 10.1016/j.fuel.2011.07.046
PG 8
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA 855NY
UT WOS:000297572600001
DA 2018-10-19
ER

PT J
AU Siedlecki, CA
   Scheetz, BM
   Xu, LC
AF Siedlecki, Christopher A.
   Scheetz, Bryan M.
   Xu, Li-Chong
TI Effects of Biomaterial Chemical Heterogeneity on Fibrinogen
   Activity-Platelet Adhesion Relationships
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the Biophysical-Society
CY FEB 25-29, 2012
CL San Diego, CA
SP Biophys Soc
C1 [Siedlecki, Christopher A.; Scheetz, Bryan M.; Xu, Li-Chong] Penn State Univ, Hershey, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 31
PY 2012
VL 102
IS 3
SU 1
BP 716A
EP 716A
DI 10.1016/j.bpj.2011.11.3883
PG 1
WC Biophysics
SC Biophysics
GA 179ZF
UT WOS:000321561205087
OA Bronze
DA 2018-10-19
ER

PT J
AU Hass, JL
   Garrison, EM
   Wicher, SA
   Knapp, B
   Bridges, N
   Mcllroy, DN
   Arrizabalaga, G
AF Hass, Jamie L.
   Garrison, Erin M.
   Wicher, Sarah A.
   Knapp, Ben
   Bridges, Nathan
   Mcllroy, D. N.
   Arrizabalaga, Gustavo
TI Synthetic osteogenic extracellular matrix formed by coated silicon
   dioxide nanosprings
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE nanosprings; nanomaterials; osteoblasts; osseointegration;
   calcification; bone regeneration
ID ATOMIC LAYER DEPOSITION; ORTHOPEDIC IMPLANTS; TITANIUM SURFACES; GROWTH;
   DIFFERENTIATION; STRATEGIES; NANOWIRES; CULTURES; CELLS
AB Background: The design of biomimetic materials that parallel the morphology and biology of extracellular matrixes is key to the ability to grow functional tissues in vitro and to enhance the integration of biomaterial implants into existing tissues in vivo. Special attention has been put into mimicking the nanostructures of the extracellular matrix of bone, as there is a need to find biomaterials that can enhance the bonding between orthopedic devices and this tissue.
   Methods: We have tested the ability of normal human osteoblasts to propagate and differentiate on silicon dioxide nanosprings, which can be easily grown on practically any surface. In addition, we tested different metals and metal alloys as coats for the nanosprings in tissue culture experiments with bone cells.
   Results: Normal human osteoblasts grown on coated nanosprings exhibited an enhanced rate of propagation, differentiation into bone forming cells and mineralization. While osteoblasts did not attach effectively to bare nanowires grown on glass, these cells propagated successfully on nanosprings coated with titanium oxide and gold. We observed a 270 fold increase in the division rate of osteoblasts when grow on titanium/gold coated nanosprings. This effect was shown to be dependent on the nanosprings, as the coating by themselves did not alter the growth rate of osteoblast. We also observed that titanium/zinc/gold coated nanosprings increased the levels of osteoblast production of alkaline phosphatase seven folds. This result indicates that osteoblasts grown on this metal alloy coated nanosprings are differentiating to mature bone making cells. Consistent with this hypothesis, we showed that osteoblasts grown on the same metal alloy coated nanosprings have an enhanced ability to deposit calcium salt.
   Conclusion: We have established that metal/metal alloy coated silicon dioxide nanosprings can be used as a biomimetic material paralleling the morphology and biology of osteogenic extracellular matrix. The coated nanosprings enhance normal human osteoblasts cellular behaviors needed for improving osseointegration of orthopedic materials. Thus, metal-coated nanosprings represent a novel biomaterial that could be exploited for improving success rates of orthopedic implant procedures.
C1 [Hass, Jamie L.; Knapp, Ben; Bridges, Nathan; Mcllroy, D. N.] Univ Idaho, Dept Phys, Moscow, ID 83844 USA.
   [Garrison, Erin M.; Wicher, Sarah A.; Arrizabalaga, Gustavo] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.
RP Hass, JL (reprint author), Univ Idaho, Dept Phys, Moscow, ID 83844 USA.
EM hass0681@vandals.uidaho.edu
FU University of Idaho; NIH from INBRE of the National Center [P20
   RR016454]; NIH [R01 AI 89808-01]; Higher Education Research Council of
   Idaho; University of Idaho BanTech
FX We would like to acknowledge Franklin Bailey, Ann Norton and Tom
   Williams for their technical support. This work was supported by a
   development grant from the University of Idaho. NIH Grant Number P20
   RR016454 from the INBRE Program of the National Center funded J.H. for
   Research Resources. The laboratory of G.A. is also funded by NIH grant
   R01 AI 89808-01. This work was also partly funded by funds from the
   Higher Education Research Council of Idaho and by the University of
   Idaho BanTech.
CR Balasundaram G, 2006, NANOMEDICINE-UK, V1, P169, DOI 10.2217/17435889.1.2.169
   Banks WJ, 1981, APPL VET HISTOLOGY
   Beaux MF, 2006, J BIOMED NANOTECHNOL, V2, P23, DOI 10.1166/jbn.2006.001
   Behari J., 2009, BIOPHYSICAL BONE BEH
   Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330
   Brauer DS, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045007
   Callister WD, 2007, MAT SCI ENG INTRO
   Cicero G, 2005, J AM CHEM SOC, V127, P6830, DOI 10.1021/ja042963u
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Coelho MJ, 2000, BIOMATERIALS, V21, P1087, DOI 10.1016/S0142-9612(99)00284-7
   Collazos-Castro JE, 2009, THIN SOLID FILMS, V518, P160, DOI 10.1016/j.tsf.2009.06.048
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Elam JW, 2002, REV SCI INSTRUM, V73, P2981, DOI 10.1063/1.1490410
   Elam JW, 2011, CHEM MATER, V15, P1020
   Enderle J, 2005, INTRO BIOMATERIALS
   George SM, 2011, J PHYS CHEM, V100, P13121
   Guziewicz E, 2009, ACTA PHYS POL A, V116, P814, DOI 10.12693/APhysPolA.116.814
   Hall B, 1990, BONE, V1
   Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020925
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Kim JH, 2010, J NANOSCI NANOTECHNO, V10, P3581, DOI 10.1166/jnn.2010.2235
   Kourkoumelis N, 2010, THESCIENTIFICWORLDJO, V10, P402, DOI 10.1100/tsw.2010.43
   LaLonde AD, 2005, J MATER RES, V20, P3021, DOI 10.1557/JMR.2005.0368
   MARKOWITZ K, 1992, ORAL SURG ORAL MED O, V73, P729, DOI 10.1016/0030-4220(92)90020-Q
   McIlroy DN, 2004, J PHYS-CONDENS MAT, V16, pR415, DOI 10.1088/0953-8984/16/12/R02
   Niehaus AJ, 2009, AM J VET RES, V70, P1416, DOI 10.2460/ajvr.70.11.1416
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Price RL, 2004, NANOTECHNOLOGY, V15, P892, DOI 10.1088/0957-4484/15/8/004
   Schilke KF, 2010, BIOTECHNOL PROGR, V26, P1597, DOI 10.1002/btpr.476
   Schmidt M, 2001, ARCH ORTHOP TRAUM SU, V121, P403, DOI 10.1007/s004020100262
   Stadtlander C, 2007, MODERN RES ED TOPICS, V1, P122
   STEWART AK, 1964, J NUTR, V82, P287, DOI 10.1093/jn/82.2.287
   Streicher RM, 2007, NANOMEDICINE-UK, V2, P861, DOI 10.2217/17435889.2.6.861
   Thangakumaran S, 2009, Indian J Dent Res, V20, P7
   Timalsina YP, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/9/095005
   Wang LD, 2006, NANOTECHNOLOGY, V17, pS298, DOI 10.1088/0957-4484/17/11/S12
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Yang Y, 2004, BIOMATERIALS ORTHOPE
   Zhang ZY, 2010, NANOSCALE, V2, P582, DOI 10.1039/b9nr00317g
NR 39
TC 6
Z9 6
U1 1
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD JAN 27
PY 2012
VL 10
AR 6
DI 10.1186/1477-3155-10-6
PG 12
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 893AZ
UT WOS:000300328900001
PM 22284364
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Liao, XX
   Zhang, XW
AF Liao, Xiaoxia
   Zhang, Xuewu
TI Preparation, characterization and cytotoxicity of carbon
   nanotube-chitosan-phycocyanin complex
SO NANOTECHNOLOGY
LA English
DT Article
ID CELLS IN-VIVO; PHOTODYNAMIC THERAPY; THERMAL ABLATION; CANCER-THERAPY;
   C-PHYCOCYANIN; TUMOR; DELIVERY; AGENTS; VITRO; TRANSPORTERS
AB Photodynamic therapy (PDT) or photothermal therapy (PTT) using nanomaterials has shown great prospect for cancer treatment. Phycocyanin (PC) is a photoharvesting pigment and is also an attractive candidate for PDT. The multiwalled carbon nanotube (MWNT) is a potent candidate for PTT due to its extraordinary photo-to-thermal energy conversion efficiency upon excitation with near-infrared (NIR) light. To date, although MWNT-CS complexes have been well studied, no report about the reconjugation of MWNT-CS with phycocyanin is available in the literature. Here, by using water-soluble chitosan (CS), we prepared and characterized a novel biomaterial, MWNT-CS-PC, with the potential for PDT and PTT. The cytotoxicity experiments found that MWNT-CS-PC exhibited cell growth inhibition activity. Moreover, with irradiation of NIR light (808 nm) or visible light (532 nm), the photoinduced cytotoxicity was indeed enhanced. These results suggest that MWNT-CS-PC may potentially serve as a future photodynamic and photothermal therapy for cancer.
C1 [Liao, Xiaoxia; Zhang, Xuewu] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou 510640, Peoples R China.
RP Zhang, XW (reprint author), S China Univ Technol, Coll Light Ind & Food Sci, 381 Wushan Rd, Guangzhou 510640, Peoples R China.
EM snow_dance@sina.com
FU Scientific and Technological Research and Development Program of
   Guangdong Province [2009B090300271]
FX The work was supported by the Scientific and Technological Research and
   Development Program of Guangdong Province (2009B090300271).
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003
   Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727
   Baek SH, 2008, COLLOID SURFACE A, V316, P292, DOI 10.1016/j.colsurfa.2007.09.021
   Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s
   Burke A, 2009, P NATL ACAD SCI USA, V106, P12897, DOI 10.1073/pnas.0905195106
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Fisher JW, 2010, CANCER RES, V70, P9855, DOI 10.1158/0008-5472.CAN-10-0250
   Ghosh S, 2009, ACS NANO, V3, P2667, DOI 10.1021/nn900368b
   Gottesman Michael M., 2002, NAT REV CANCER, V2, P48
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607
   Hu XG, 2006, J PHYS CHEM B, V110, P853, DOI 10.1021/jp055834o
   Huang NN, 2010, LASER SURG MED, V42, P638, DOI 10.1002/lsm.20968
   Iancu C, 2011, INT J NANOMED, V6, P129, DOI 10.2147/IJN.S15841
   Jang B, 2011, ACS NANO, V5, P1086, DOI 10.1021/nn102722z
   Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118
   Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kang B, 2009, SMALL, V5, P1292, DOI 10.1002/smll.200801820
   Kim DG, 2007, KEY ENG MATER, V342-343, P469, DOI 10.4028/www.scientific.net/KEM.342-343.469
   Li B, 2010, ACTA BIOCH BIOPH SIN, V42, P80, DOI 10.1093/abbs/gmp104
   Liao XX, 2011, CHROMATOGRAPHIA, V73, P291, DOI 10.1007/s10337-010-1874-5
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Long DW, 2008, INT J MOL SCI, V9, P120, DOI 10.3390/ijms9020120
   Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0
   Marches R, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/9/095101
   Numata M, 2004, CHEM LETT, V33, P232, DOI 10.1246/cl.2004.232
   Panchapakesan B., 2005, NANOBIOTECHNOLOGY, V1, P133, DOI DOI 10.1385/NBT:1:2:133
   Pardhasaradhi BVV, 2003, MOL CANCER THER, V2, P1165
   Peltonen L, 2007, CURR NANOSCI, V4, P101
   Rai P, 2010, ADV DRUG DELIVER REV, V62, P1094, DOI 10.1016/j.addr.2010.09.002
   Rozhkova EA, 2009, NANO LETT, V9, P3337, DOI 10.1021/nl901610f
   Salam MA, 2011, J ALLOY COMPD, V509, P2582, DOI 10.1016/j.jallcom.2010.11.094
   Stern JM, 2008, J UROLOGY, V179, P748, DOI 10.1016/j.juro.2007.09.018
   Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Zhang SP, 2000, FREE RADICAL RES, V33, P489, DOI 10.1080/10715760000301031
NR 40
TC 22
Z9 24
U1 2
U2 43
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD JAN 27
PY 2012
VL 23
IS 3
AR 035101
DI 10.1088/0957-4484/23/3/035101
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 877HQ
UT WOS:000299168800001
PM 22173212
DA 2018-10-19
ER

PT J
AU Tsioris, K
   Raja, WK
   Pritchard, EM
   Panilaitis, B
   Kaplan, DL
   Omenetto, FG
AF Tsioris, Konstantinos
   Raja, Waseem K.
   Pritchard, Eleanor M.
   Panilaitis, Bruce
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Fabrication of Silk Microneedles for Controlled-Release Drug Delivery
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE drug delivery; microneedles; protein stability; biopolymers; silk
   microfabrication
ID POLYMER MICRONEEDLES; MECHANICAL-PROPERTIES; SUSTAINED-RELEASE; FIBROIN
   FILMS; MICROSTRUCTURES; BIOMATERIALS; TRANSPORT; PROTEINS; ROBUST; SKIN
AB Microneedles are emerging as a minimally invasive drug delivery alternative to hypodermic needles. Current material systems utilized in microneedles impose constraints hindering the further development of this technology. In particular, it is difficult to preserve sensitive biochemical compounds (such as pharmaceuticals) during processing in a single microneedle system and subsequently achieve their controlled release. A possible solution involves fabricating microneedles systems from the biomaterial silk fibroin. Silk fibroin combines excellent mechanical properties, biocompatibility, biodegradability, benign processing conditions, and the ability to preserve and maintain the activity of biological compounds entrained in its material matrix. The degradation rate of silk fibroin and the diffusion rate of the entrained molecules can be controlled simply by adjusting post-processing conditions. This combination of properties makes silk an ideal choice to improve on existing issues associated with other microneedle-based drug delivery system. In this study, a fabrication method to produce silk biopolymer microstructures with the high aspect ratios and mechanical properties required to manufacture microneedle systems is reported. Room temperature and aqueous-based micromolding allows for the bulk loading of these microneedles with labile drugs. The drug release rate is decreased 5.6-fold by adjusting the post-processing conditions of the microneedles, mainly by controlling the silk protein secondary structure. The release kinetics are quantified in an in vitro collagen hydrogel model, which allows tracking of the model drug. Antibiotic loaded silk microneedles are manufactured and used to demonstrate a 10-fold reduction of bacterial density after their application. The processing strategies developed in this study can be expanded to other silk-based structural formats for drug delivery and biologicals storage applications.
C1 [Tsioris, Konstantinos; Raja, Waseem K.; Pritchard, Eleanor M.; Panilaitis, Bruce; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Tsioris, K (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM Fiorenzo.Omenetto@Tufts.edu
RI raja, waseem/B-6537-2012
FU U.S. Army Research Laboratory; U.S. Army Research Office [W911
   NF-07-1-0618]; DARPA-DSO; Air Force Office of Scientific Research
   [FA9550-10-1-0172]
FX K.T. and W.K.R. contributed equally to this work. This material is based
   upon work supported in part by the U.S. Army Research Laboratory and the
   U.S. Army Research Office under contract number W911 NF-07-1-0618 and by
   the DARPA-DSO, as well as the Air Force Office of Scientific Research
   (FA9550-10-1-0172).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amsden JJ, 2009, OPT EXPRESS, V17, P21271, DOI 10.1364/OE.17.021271
   Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032
   Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746
   CHEN JY, 1994, POLYMER, V35, P2853, DOI 10.1016/0032-3861(94)90317-4
   CULLANDER C, 1992, ADV DRUG DELIVER REV, V8, P291, DOI 10.1016/0169-409X(92)90006-C
   Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010
   Donnelly RF, 2009, DRUG DEV IND PHARM, V35, P1242, DOI 10.1080/03639040902882280
   Forslind B, 1997, MICROSC RES TECHNIQ, V38, P373, DOI 10.1002/(SICI)1097-0029(19970815)38:4<373::AID-JEMT5>3.0.CO;2-K
   Fritz L, 1997, POLYMER, V38, P1035, DOI 10.1016/S0032-3861(96)00600-3
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kemp JM, 2002, VACCINE, V20, P1089, DOI 10.1016/S0264-410X(01)00444-3
   Kim YC, 2011, PHARM RES-DORDR, V28, P135, DOI 10.1007/s11095-010-0134-6
   Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013
   Kwak HH, 2009, J CONTROL RELEASE, V137, P160, DOI 10.1016/j.jconrel.2009.03.014
   Lee JW, 2011, SMALL, V7, P531, DOI 10.1002/smll.201001091
   Liu XY, 2009, MATER LETT, V63, P263, DOI 10.1016/j.matlet.2008.10.006
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu S., 2009, BIOMACROMOLECULES, P217
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Montagna W., 1974, STRUCTURE FUNCTION S
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Putthanarat S, 2004, POLYMER, V45, P8451, DOI 10.1016/j.polymer.2004.10.014
   Sionkowska A, 2005, POLYM DEGRAD STABIL, V88, P261, DOI 10.1016/j.polymdegradstab.2004.08.018
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sullivan SP, 2008, ADV MATER, V20, P933, DOI 10.1002/adma.200701205
   Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182
   Tsioris K, 2011, ADV MATER, V23, P2015, DOI 10.1002/adma.201004771
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wightman G, 2010, FORENSIC SCI INT, V200, P41, DOI 10.1016/j.forsciint.2010.03.025
   Wolfe DB, 2010, METHODS MOL BIOL, V583, P81, DOI 10.1007/978-1-60327-106-6_3
   You X., 2010, P IEEE INT C NAN MED, P144
NR 40
TC 104
Z9 111
U1 18
U2 213
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN 25
PY 2012
VL 22
IS 2
BP 330
EP 335
DI 10.1002/adfm.201102012
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 878JD
UT WOS:000299251800010
DA 2018-10-19
ER

PT J
AU Bajaj, G
   Van Alstine, WG
   Yeo, Y
AF Bajaj, Gaurav
   Van Alstine, William G.
   Yeo, Yoon
TI Zwitterionic Chitosan Derivative, a New Biocompatible Pharmaceutical
   Excipient, Prevents Endotoxin-Mediated Cytokine Release
SO PLOS ONE
LA English
DT Article
ID POLYVINYL PYRROLIDONE HYDROGEL; WATER-SOLUBLE CHITOSAN;
   PHOTOCROSSLINKABLE CHITOSAN; GLYCOL CHITOSAN; DNA NANOPARTICLES;
   MOLECULAR-WEIGHT; GENE DELIVERY; IN-VITRO; CHITIN; MICE
AB Chitosan is a cationic polymer of natural origin and has been widely explored as a pharmaceutical excipient for a broad range of biomedical applications. While generally considered safe and biocompatible, chitosan has the ability to induce inflammatory reactions, which varies with the physical and chemical properties. We hypothesized that the previously reported zwitterionic chitosan (ZWC) derivative had relatively low pro-inflammatory potential because of the aqueous solubility and reduced amine content. To test this, we compared various chitosans with different aqueous solubilities or primary amine contents with respect to the intraperitoneal (IP) biocompatibility and the propensity to induce proinflammatory cytokine production from macrophages. ZWC was relatively well tolerated in ICR mice after IP administration and had no pro-inflammatory effect on naive macrophages. Comparison with other chitosans indicates that these properties are mainly due to the aqueous solubility at neutral pH and relatively low molecular weight of ZWC. Interestingly, ZWC had a unique ability to suppress cytokine/chemokine production in macrophages challenged with lipopolysaccharide (LPS). This effect is likely due to the strong affinity of ZWC to LPS, which inactivates the pro-inflammatory function of LPS, and appears to be related to the reduced amine content. Our finding warrants further investigation of ZWC as a functional biomaterial.
C1 [Bajaj, Gaurav; Yeo, Yoon] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   [Van Alstine, William G.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.
   [Yeo, Yoon] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
RP Yeo, Y (reprint author), Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
EM yyeo@purdue.edu
FU National Institutes of Health [R21 CA135130]; Lilly Endowment, Inc.
FX This work was supported by National Institutes of Health R21 CA135130
   and a grant from the Lilly Endowment, Inc., to the College of Pharmacy,
   Purdue University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2010, USP33NF28 US PHARM C
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Baldrick P, 2009, REGUL TOXICOL PHARM
   Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117
   Canali MM, 2010, VACCINE, V28, P5718, DOI 10.1016/j.vaccine.2010.06.027
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   Chellat F, 2005, BIOMATERIALS, V26, P961, DOI 10.1016/j.biomaterials.2004.04.006
   Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023
   Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   Hall JC, 1998, GASTROENTEROLOGY, V114, P185, DOI 10.1016/S0016-5085(98)70646-8
   HIRANO S, 1994, ABSTR PAP AM CHEM S, V207, P118
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Kawashima Y, 2000, PHARM DEV TECHNOL, V5, P77, DOI 10.1081/PDT-100100522
   Kim MS, 2002, NEUROSCI LETT, V321, P105, DOI 10.1016/S0304-3940(02)00066-6
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   LEE J, 1995, J IMMUNOL, V155, P2158
   LIU HT, 2009, BASIC CLIN PHARMACOL, V106, P362, DOI DOI 10.1111/J.1742-7843.2009.00493.X
   Mathews S, 2006, J BIOMED MATER RES A, V79A, P147, DOI 10.1002/jbm.a.30710
   Min KH, 2008, J CONTROL RELEASE, V127, P208, DOI 10.1016/j.jconrel.2008.01.013
   Minami S, 1998, CARBOHYD POLYM, V36, P151, DOI 10.1016/S0144-8617(98)00015-0
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Mori T, 1998, J BIOMED MATER RES, V43, P469
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Nam KS, 2007, J MICROBIOL BIOTECHN, V17, P2042
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Park JH, 2004, J CONTROL RELEASE, V95, P579, DOI 10.1016/j.jconrel.2003.12.020
   Park K, 2007, J CONTROL RELEASE, V122, P305, DOI 10.1016/j.jconrel.2007.04.009
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Qin CQ, 2006, FOOD CHEM TOXICOL, V44, P855, DOI 10.1016/j.fct.2005.11.009
   RAGHOEBAR M, 1987, AGENTS ACTIONS, V22, P314, DOI 10.1007/BF02009062
   Risbud M, 2001, CELL TRANSPLANT, V10, P195
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Roy K, 1999, NAT MED, V5, P387
   Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x
   Sagnella S, 2005, COLLOID SURFACE B, V42, P147, DOI 10.1016/j.colsurfb.2004.07.001
   Tanaka Y, 1997, BIOMATERIALS, V18, P591, DOI 10.1016/S0142-9612(96)00182-2
   USAMI Y, 1994, J VET MED SCI, V56, P1215, DOI 10.1292/jvms.56.1215
   van der Merwe SM, 2004, EUR J PHARM BIOPHARM, V58, P225, DOI 10.1016/j.ejpb.2004.03.023
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wiegand C, 2010, SKIN PHARMACOL PHYS, V23, P164, DOI 10.1159/000276996
   Xu P, 2010, BIOMACROMOLECULES
   Yeo Y, 2006, J BIOMED MATER RES A, V78A, P668, DOI 10.1002/jbm.a.30740
   Yoon HJ, 2007, BIOCHEM BIOPH RES CO, V358, P954, DOI 10.1016/j.bbrc.2007.05.042
NR 53
TC 28
Z9 30
U1 3
U2 43
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2012
VL 7
IS 1
AR e30899
DI 10.1371/journal.pone.0030899
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 910LV
UT WOS:000301639600065
PM 22292072
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Liu, C
   Zeng, JB
   Li, SL
   He, YS
   Wang, YZ
AF Liu, Cong
   Zeng, Jian-Bing
   Li, Shao-Long
   He, Yi-Song
   Wang, Yu-Zhong
TI Improvement of biocompatibility and biodegradability of poly(ethylene
   succinate) by incorporation of poly(ethylene glycol) segments
SO POLYMER
LA English
DT Article
DE Poly(ethylene succinate); Poly(ethylene glycol); In vitro
   biocompatibility
ID POLY(BUTYLENE SUCCINATE); POLY(ESTER URETHANE)S; DRUG-DELIVERY;
   DEGRADATION; POLY(EPSILON-CAPROLACTONE); BIOMATERIAL; ATTACHMENT;
   COPOLYMERS; POLYMERS; BEHAVIOR
AB Poly(ethylene glycol) (PEG) segments were incorporated into poly(ethylene succinate) (PES) by chain-extension reaction of PEG with PES using 1,6-hexamethylene diisocyanate as a chain-extender, forming a poly(ester ether urethane) (PEEU). The chemical structures and molecular weights of the PEEUs were determined by H-1 NMR and GPC, respectively. The composition dependence of thermal transitions, crystallization, hydrophilicity, in vitro biocompatibility, in vitro biodegradation and tensile properties of the PEEUs were systematically investigated. The glass transition temperature and degree of crystallinity of PEEU decreased with increase of PEG content. The hydrophilicity increased with PEG content as proved by the decreased water contact angle and increased water absorption. The results of cell culturing suggested that the in vitro biocompatibility increased with PEG content. Hydrolytic degradation demonstrated that degradation rate of PEEU increased with PEG content, which was caused by the increased hydrophilicity and decreased degree of crystallinity with increase of PEG content. The tensile results proved that the tensile strength and modulus decreased while elongation at break increased with PEG content. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Liu, Cong; Zeng, Jian-Bing; Li, Shao-Long; He, Yi-Song; Wang, Yu-Zhong] Sichuan Univ, Ctr Degradable & Flame Retardant Polymer Mat, Natl Engn Lab Ecofriendly Polymer Mat Sichuan, State Key Lab Polymer Mat Engn,Coll Chem, Chengdu 610064, Peoples R China.
RP Zeng, JB (reprint author), Sichuan Univ, Ctr Degradable & Flame Retardant Polymer Mat, Natl Engn Lab Ecofriendly Polymer Mat Sichuan, State Key Lab Polymer Mat Engn,Coll Chem, 29 Wangjiang Rd, Chengdu 610064, Peoples R China.
EM zengjianing@scu.edu.cn; yzwang@scu.edu.cn
RI Wang, Yu-Zhong/E-3633-2013; Zeng, Jian-Bing/G-9583-2016
OI Wang, Yu-Zhong/0000-0001-7535-7635; Zeng, Jian-Bing/0000-0003-1822-446X
FU National Natural Science Foundation of China [20904034, 51121001];
   Specialized Research Fund for the Doctoral Program of Higher Education
   [20110181130008]; Program of International S T Cooperation
   [2011DFA51420]; Program for Changjiang Scholars and Innovative Research
   Teams in University of China [IRT 1026]
FX This work has been supported by National Natural Science Foundation of
   China (20904034 and 51121001), the Specialized Research Fund for the
   Doctoral Program of Higher Education (20110181130008), Program of
   International S & T Cooperation (2011DFA51420) and the Program for
   Changjiang Scholars and Innovative Research Teams in University of China
   (IRT 1026).
CR ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Han SI, 2005, ADV FUNCT MATER, V15, P367, DOI 10.1002/adfm.200400079
   Hariraksapitak P, 2008, POLYMER, V49, P2678, DOI 10.1016/j.polymer.2008.04.006
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lee SI, 2001, POLYM DEGRAD STABIL, V72, P81, DOI 10.1016/S0141-3910(00)00205-6
   Li HY, 2008, J MATER SCI-MATER M, V19, P67, DOI 10.1007/s10856-007-3170-y
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Li X, 2005, BIOMACROMOLECULES, V6, P2740, DOI 10.1021/bm050234g
   Li ZBA, 2009, J BIOMAT SCI-POLYM E, V20, P1179, DOI 10.1163/156856209X452944
   Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Park EK, 2005, J CONTROL RELEASE, V109, P158, DOI 10.1016/j.jconrel.2005.09.039
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Tsutsumi C, 2003, MACROMOL SYMP, V197, P431, DOI 10.1002/masy.200350737
   Wang HY, 2010, ACTA BIOMATER, V6, P154, DOI 10.1016/j.actbio.2009.07.026
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Xu J, 2010, J BIOTECHNOL, V5, P1149
   Yang J, 2004, BIOMACROMOLECULES, V5, P209, DOI 10.1021/bm0343242
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Zeng JB, 2009, POLYMER, V50, P1178, DOI 10.1016/j.polymer.2009.01.001
   Zeng JB, 2009, IND ENG CHEM RES, V48, P1706, DOI 10.1021/ie801391m
NR 29
TC 14
Z9 16
U1 1
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JAN 24
PY 2012
VL 53
IS 2
BP 481
EP 489
DI 10.1016/j.polymer.2011.12.003
PG 9
WC Polymer Science
SC Polymer Science
GA 883BK
UT WOS:000299607400027
DA 2018-10-19
ER

PT J
AU Anderson, KD
   Young, SL
   Jiang, H
   Jakubiak, R
   Bunning, TJ
   Naik, RR
   Tsukruk, VV
AF Anderson, Kyle D.
   Young, Seth L.
   Jiang, Hao
   Jakubiak, Rachel
   Bunning, Timothy J.
   Naik, Rajesh R.
   Tsukruk, Vladimir V.
TI Plasma-Enhanced Copolymerization of Amino Acid and Synthetic Monomers
SO LANGMUIR
LA English
DT Article
ID CHEMICAL-VAPOR-DEPOSITION; SELF-ASSEMBLED MONOLAYERS; NANOCOMPOSITE
   THIN-FILMS; POLY(2-HYDROXYETHYL METHACRYLATE); BIOMEDICAL APPLICATIONS;
   TITANIA NANOPARTICLES; OPTICAL-PROPERTIES; POLYMERIZED FILMS; PEPTIDE
   NANOTUBES; PHOTONIC FILMS
AB In this paper we report the use of plasma-enhanced chemical vapor deposition (PECVD) for the simultaneous deposition and copolymerization of an amino acid with other organic and inorganic monomers. We investigate the fundamental effects of plasma-enhanced copolymerization on different material chemistries in stable ultrathin coatings of mixed composition with an amino acid component. This study serves to determine the feasibility of a direct, facile method for integrating biocompatible/active materials into robust polymerized coatings with the ability to plasma copolymerize a biological molecule (L-tyrosine) with different synthetic materials in a dry, one-step process to form ultrathin coatings of mixed composition. This process may lead to a method of interfacing biologic systems with synthetic materials as a way to enhance the biomaterial tissue interface and preserve biological activity within composite films.
C1 [Anderson, Kyle D.; Young, Seth L.; Tsukruk, Vladimir V.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Jiang, Hao; Jakubiak, Rachel; Bunning, Timothy J.; Naik, Rajesh R.] USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, Dayton, OH 45433 USA.
RP Tsukruk, VV (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM vladimir@mse.gatech.edu
FU Department of Defense; Air Force Office of Scientific Research
   [FA9550-08-1-0446, FA9550-09-1-0162]; Air Force Research Laboratory
FX This work was supported by the Department of Defense (Doll) through the
   National Defense Science & Engineering Graduate Fellowship (NDSEG)
   program. This research is also supported by the Air Force Office of
   Scientific Research (Grants FA9550-08-1-0446 and FA9550-09-1-0162), as
   well as the Air Force Research Laboratory. We also thank R. Blake Weber
   for technical assistance.
CR Adler-Abramovich L, 2009, NAT NANOTECHNOL, V4, P849, DOI [10.1038/NNANO.2009.298, 10.1038/nnano.2009.298]
   Ahn KH, 2003, SURF COAT TECH, V171, P198, DOI 10.1016/S0257-8972(03)00271-8
   Alf ME, 2010, ADV MATER, V22, P1993, DOI 10.1002/adma.200902765
   Alvarez R, 2010, J APPL PHYS, V108, DOI 10.1063/1.3483242
   Anderson KD, 2010, ACS APPL MATER INTER, V2, P2269, DOI 10.1021/am1003365
   Anderson KD, 2010, CHEM MATER, V22, P3259, DOI 10.1021/cm100500d
   Anderson KD, 2009, SMALL, V5, P741, DOI 10.1002/smll.200801843
   Aparicio FJ, 2011, ADV MATER, V23, P761, DOI 10.1002/adma.201003088
   Aparicio FJ, 2009, PLASMA PROCESS POLYM, V6, P17, DOI 10.1002/ppap.200800092
   Barranco A, 2006, LANGMUIR, V22, P6719, DOI 10.1021/la053304d
   Biederman H., 2004, PLASME POLYM FILMS, P13
   Blaszczyk-Lezak I, 2009, J PHYS CHEM C, V113, P431, DOI 10.1021/jp807634j
   Borras A, 2007, J ELECTROCHEM SOC, V154, P152
   Bose RK, 2010, BIOMACROMOLECULES, V11, P2116, DOI 10.1021/bm100498a
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   Chen HY, 2011, LANGMUIR, V27, P34, DOI 10.1021/la101623n
   Choi I, 2011, J AM CHEM SOC, V133, P9592, DOI 10.1021/ja203106c
   Choukourov A, 2005, J PHYS CHEM B, V109, P23086, DOI 10.1021/jp0535691
   Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328
   Enlow JO, 2008, POLYMER, V49, P4042, DOI 10.1016/j.polymer.2008.07.013
   FICTORIE CP, 1994, J VAC SCI TECHNOL A, V12, P1108, DOI 10.1116/1.579173
   Forch R, 2007, CHEM VAPOR DEPOS, V13, P280, DOI 10.1002/cvde.200604035
   FRIEDRICH J, 2005, PLASMA PROCESS POLYM, P10
   Grace LI, 2002, J MOL SPECTROSC, V215, P204, DOI 10.1006/jmsp.2002.8639
   Grant JT, 2005, VACUUM, V80, P12, DOI 10.1016/j.vacuum.2005.07.022
   HAALAND P, 1992, APPL PHYS LETT, V61, P34, DOI 10.1063/1.107659
   Hernandez-Perez MA, 2007, J PHYS CONF SER, V59, P724, DOI 10.1088/1742-6596/59/1/154
   HESS DW, 1990, J VAC SCI TECHNOL A, V8, P1677, DOI 10.1116/1.576829
   Im SG, 2011, AICHE J, V57, P276, DOI 10.1002/aic.12522
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Jiang H, 2005, POLYMER, V46, P8178, DOI 10.1016/j.polymer.2005.06.051
   Jiang H, 2003, CHEM MATER, V15, P340, DOI 10.1021/cm0206542
   Jiang H, 2004, CHEM MATER, V16, P1292, DOI 10.1021/cm035226q
   Jiang H, 2008, CHEM VAPOR DEPOS, V14, P286, DOI 10.1002/cvde.200806684
   Jiang H, 2007, THIN SOLID FILMS, V515, P3513, DOI 10.1016/j.tsf.2006.10.126
   Jiang H, 2009, J MATER CHEM, V19, P2234, DOI 10.1039/b816814h
   Johnson EM, 2001, POLYMER, V42, P7215, DOI 10.1016/S0032-3861(01)00142-2
   Karaman M, 2008, CHEM MATER, V20, P2262, DOI 10.1021/cm703107d
   Khan HU, 2010, ADV MATER, V22, P4452, DOI 10.1002/adma.201000790
   Kharlampieva E, 2009, ADV FUNCT MATER, V19, P2303, DOI 10.1002/adfm.200801825
   KUZUYA M, 1991, J POLYM SCI POL CHEM, V29, P1, DOI 10.1002/pola.1991.080290102
   Lahann J, 2006, POLYM INT, V55, P1361, DOI 10.1002/pi.2098
   Lau KKS, 2006, THIN SOLID FILMS, V501, P211, DOI 10.1016/j.tsf.2005.07.208
   Lee NH, 2003, LANGMUIR, V19, P1295, DOI 10.1021/la020432i
   LeMieux MC, 2006, NANO LETT, V6, P730, DOI 10.1021/nl0525305
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   Luzinov I, 2000, LANGMUIR, V16, P504, DOI 10.1021/la990500+
   Mari-Buye N, 2009, ADV FUNCT MATER, V19, P1276, DOI 10.1002/adfm.200801561
   McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255
   Pan YV, 2001, BIOMACROMOLECULES, V2, P32, DOI 10.1021/bm0000642
   PASHLEY MD, 1984, COLLOID SURFACE, V12, P69, DOI 10.1016/0166-6622(84)80090-6
   Peri SR, 2010, POLYMER, V51, P4390, DOI 10.1016/j.polymer.2010.07.026
   Peri SR, 2010, POLYMER, V51, P3971, DOI 10.1016/j.polymer.2010.06.055
   Pfluger CA, 2009, MACROMOL RAPID COMM, V30, P126, DOI 10.1002/marc.200800647
   Pietrement O, 2000, J COLLOID INTERF SCI, V226, P166, DOI 10.1006/jcis.2000.6808
   QUINN CP, 1995, BIOMATERIALS, V16, P389, DOI 10.1016/0142-9612(95)98856-9
   Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139
   Singamaneni S, 2008, ADV MATER, V20, P653, DOI 10.1002/adma.200701667
   Singamaneni S, 2007, ADV MATER, V19, P4248, DOI 10.1002/adma.200701419
   Singamaneni S, 2007, CHEM MATER, V19, P129, DOI 10.1021/cm0622093
   Singamaneni S, 2010, ADV MATER, V22, P1369, DOI 10.1002/adma.200902893
   Singamaneni S, 2010, ADV MATER, V22, P1263, DOI 10.1002/adma.200903052
   Slocik JM, 2006, ADV MATER, V18, P2095, DOI 10.1002/adma.200600077
   Spear RL, 2007, COLLOID SURFACE B, V60, P158, DOI 10.1016/j.colsurfb.2007.05.025
   Sreenivasan R, 2009, CHEM VAPOR DEPOS, V15, P77, DOI 10.1002/cvde.200800040
   Sweers K, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-270
   Tamirisa PA, 2006, MACROMOLECULES, V39, P7092, DOI 10.1021/ma060944u
   Tamirisa PA, 2006, THIN SOLID FILMS, V515, P2618, DOI 10.1016/j.tsf.2006.03.021
   Tarducci C, 2002, CHEM MATER, V14, P2541, DOI 10.1021/cm010939z
   Tenhaeff WE, 2008, ADV FUNCT MATER, V18, P979, DOI 10.1002/adfm.200701479
   Tsukruk VV, 1999, LANGMUIR, V15, P3029, DOI 10.1021/la981632q
   Tsukruk VV, 1998, LANGMUIR, V14, P446, DOI 10.1021/la970367q
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   YASUDA H, 1985, PLASMAS POLYM, P6
NR 75
TC 10
Z9 10
U1 0
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 24
PY 2012
VL 28
IS 3
BP 1833
EP 1845
DI 10.1021/la204416h
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 879XP
UT WOS:000299366500022
PM 22176716
DA 2018-10-19
ER

PT J
AU Cheng, K
   Malliaras, K
   Shen, DL
   Tseliou, E
   Ionta, V
   Smith, J
   Galang, G
   Sun, BM
   Houde, C
   Marban, E
AF Cheng, Ke
   Malliaras, Konstantinos
   Shen, Deliang
   Tseliou, Eleni
   Ionta, Vittoria
   Smith, Jeremy
   Galang, Giselle
   Sun, Baiming
   Houde, Christiane
   Marban, Eduardo
TI Intramyocardial Injection of Platelet Gel Promotes Endogenous Repair and
   Augments Cardiac Function in Rats With Myocardial Infarction
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE biomaterials; endogenous recruitment; myocardial infarction
ID VENTRICULAR-FUNCTION; STEM-CELLS; TISSUE; MATRIX; REGENERATION
AB Objectives This study sought to explore the therapeutic potential of platelet gel for the treatment of myocardial infarction.
   Background Cardiac dysfunction after acute myocardial infarction is a major cause of heart failure. Current therapy relies on prompt reperfusion and blockage of secondary maladaptive pathways by small molecules. Platelet gels are biomaterials rich in cytokines and growth factors, which can be manufactured in an autologous manner and are effective in various models of wound healing. However, the potential utility of platelet gel in cardiac regeneration has yet to be tested.
   Methods Platelet gel was derived from syngeneic rats and its morphology, biocompatibility, secretion of beneficial factors, and in vivo degradation profile were characterized.
   Results After delivery into infarcted rat hearts, the gel was efficiently infiltrated by cardiomyocytes and endothelial cells. Gel-treated hearts exhibited enhanced tissue protection, greater recruitment of endogenous regeneration, higher capillary density, and less compensatory myocyte hypertrophy. The cardiac function of control-injected animals deteriorated over the 6-week time course, while that of platelet gel-injected animals did not. In addition, the gel did not exacerbate inflammation in the heart.
   Conclusions Intramyocardial injection of autologous platelet gel ameliorated cardiac dysfunction after myocardial infarction. The striking functional benefits, the simplicity of manufacturing, and the potentially autologous nature of this biomaterial provide impetus for further translation. (J Am Coll Cardiol 2012;59:256-64) (C) 2012 by the American College of Cardiology Foundation
C1 [Cheng, Ke; Malliaras, Konstantinos; Shen, Deliang; Tseliou, Eleni; Ionta, Vittoria; Smith, Jeremy; Galang, Giselle; Sun, Baiming; Houde, Christiane; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.
   [Shen, Deliang] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China.
RP Marban, E (reprint author), Cedars Sinai Heart Inst, 8700 Beverly Blvd,1090 Davis Bldg, Los Angeles, CA 90048 USA.
EM eduardo.marban@csmc.edu
OI Ionta, Vittoria/0000-0003-2711-3622
FU National Institutes of Health; California Institute of Regenerative
   Medicine; Cedars-Sinai Board of Governors Heart Stem Cell Center
FX This work was supported by research grants from the National Institutes
   of Health, the California Institute of Regenerative Medicine, and the
   Cedars-Sinai Board of Governors Heart Stem Cell Center. Dr. Malliaras
   has relationships with Capricor Inc. Dr. Marban is a founder and equity
   holder in Capricor Inc. Capricor provided no funding for the present
   study. Dr. Marban is the Mark S. Siegel Family Professor of the
   Cedars-Sinai Medical Center. All other authors have reported they have
   no relationships relevant to the contents of this paper to disclose.
CR Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003
   Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dozza B, 2011, J ORTHOP RES, V29, P961, DOI 10.1002/jor.21333
   Driver VR, 2006, OSTOMY WOUND MANAG, V52, P68
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/C1RCULATIONAHA.109.930404, 10.1161/CIRCULATIONAHA.109.930404]
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lia XH, 2008, CORONARY ARTERY DIS, V19, P363, DOI 10.1097/MCA.0b013e3282fc6165
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Migrino RQ, 1997, CIRCULATION, V96, P116
   Mishra A, 2011, CARDIOVASC REVASCULA, V12, P158, DOI 10.1016/j.carrev.2010.08.005
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Yan L, 2011, MOL BIOL REP, V38, P2695, DOI 10.1007/s11033-010-0412-8
   Zhang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010498
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 29
TC 25
Z9 29
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD JAN 17
PY 2012
VL 59
IS 3
BP 256
EP 264
DI 10.1016/j.jacc.2011.10.858
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 876NZ
UT WOS:000299115700009
PM 22240131
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Ariga, K
   Vinu, A
   Yamauchi, Y
   Ji, QM
   Hill, JP
AF Ariga, Katsuhiko
   Vinu, Ajayan
   Yamauchi, Yusuke
   Ji, Qingmin
   Hill, Jonathan P.
TI Nanoarchitectonics for Mesoporous Materials
SO BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN
LA English
DT Review
ID AIR-WATER-INTERFACE; SILICA THIN-FILMS; LANGMUIR-BLODGETT-FILMS;
   LIQUID-CRYSTALLINE PHASES; CARBON MOLECULAR-SIEVES; STRONG
   MAGNETIC-FIELD; ORDERED MESOSTRUCTURED SILICA; PORE-ENGINEERED
   NANOCARBON; SELF-ASSEMBLED MONOLAYERS; POROUS ALUMINA MEMBRANE
AB Although mesoporous materials have well-defined pore structures, these fine materials can surprisingly be produced by employing a set of conventional and simple procedures such as mixing, heating, filtration, and washing, using low-cost materials. They can be regarded as easy-to-make bulk nanostructured materials. Mesoporous materials have great potential for use in both macroscopic applications and nanotechnology. In this account, we introduce examples of recent developments in mesoporous materials involving innovations in their components and structural designs and concentrating on our own recent progress. These examples include syntheses of mesoporous silica, metal oxides, semiconductive materials, metals, alloys, organic composites, biomaterial composites, carbon, carbon nitride, and boron nitride, as innovative components. As structural innovations for mesoporous materials, various film preparations, pore alignments, and hierarchic structures are described together with their related functions including sensing and controlled release of target molecules.
C1 [Ariga, Katsuhiko; Vinu, Ajayan; Yamauchi, Yusuke; Ji, Qingmin; Hill, Jonathan P.] Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.
   [Ariga, Katsuhiko; Hill, Jonathan P.] CREST, JST, Tsukuba, Ibaraki 3050044, Japan.
   [Vinu, Ajayan] Univ Queensland, AIBN, Brisbane, Qld 4072, Australia.
   [Yamauchi, Yusuke] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.
   [Yamauchi, Yusuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan.
RP Ariga, K (reprint author), Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM ARIGA.Katsuhiko@nims.go.jp; a.vinu@uq.edu.au; YAMAUCHI.Yusuke@nims.go.jp
RI Yamauchi, Yusuke/D-2780-2015; Hill, Jonathan/B-9332-2011; Vinu,
   Ajayan/H-9814-2012; ARIGA, Katsuhiko/H-2695-2011
OI Yamauchi, Yusuke/0000-0001-7854-927X; Hill,
   Jonathan/0000-0002-4229-5842; Vinu, Ajayan/0000-0002-7508-251X; 
FU World Premier International Research Center (WPI) Initiative on
   Materials Nanoarchitectonics, MEXT, Japan; JST, CREST
FX This work was in part supported by World Premier International Research
   Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan and
   JST, CREST. We thank all the people throughout the world who have
   supported recovery in Japan after the earthquakes in March, 2011.
CR Acharaya S, 2009, J NANOSCI NANOTECHNO, V9, P3, DOI 10.1166/jnn.2009.J076
   Acharya S, 2009, ADV MATER, V21, P2959, DOI 10.1002/adma.200802648
   Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892
   Alam S, 2011, CHEM-ASIAN J, V6, P834, DOI 10.1002/asia.201000456
   Alam S, 2009, ANGEW CHEM INT EDIT, V48, P7358, DOI 10.1002/anie.200901570
   Alberius PCA, 2002, CHEM MATER, V14, P3284, DOI 10.1021/cm011209u
   Angelova A, 2011, ACCOUNTS CHEM RES, V44, P147, DOI 10.1021/ar100120v
   Aono Masakazu, 2000, 1 INT S NAN US SUPR
   Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i
   Ariga K, 2000, J AM CHEM SOC, V122, P7835, DOI 10.1021/ja000924m
   Ariga K, 2005, LANGMUIR, V21, P976, DOI 10.1021/la0477845
   Ariga K, 2004, J NANOSCI NANOTECHNO, V4, P23, DOI 10.1166/jnn.2004.048
   Ariga K, 2004, CHEM REC, V3, P297, DOI 10.1002/tcr.10071
   Ariga K, 1999, LANGMUIR, V15, P3875, DOI 10.1021/la981047p
   Ariga K, 2001, PHYS CHEM CHEM PHYS, V3, P3442, DOI 10.1039/b100974p
   Ariga K, 1997, J MATER CHEM, V7, P1155, DOI 10.1039/a700081b
   Ariga K, 1997, J AM CHEM SOC, V119, P2224, DOI 10.1021/ja963442c
   Ariga K., 2004, T MAT RES SOC JPN, V29, P3179
   Ariga K, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014109
   Ariga K, 2008, ANGEW CHEM INT EDIT, V47, P7254, DOI 10.1002/anie.200802820
   Ariga K, 2008, PHYS STATUS SOLIDI A, V205, P1249, DOI 10.1002/pssa.200778174
   Ariga K, 2007, COORDIN CHEM REV, V251, P2562, DOI 10.1016/j.ccr.2007.02.024
   Ariga K, 2008, CURR OPIN COLLOID IN, V13, P23, DOI 10.1016/j.cocis.2007.08.01
   Ariga K, 2007, J AM CHEM SOC, V129, P11022, DOI 10.1021/ja074870t
   Ariga K, 2007, CURR OPIN COLLOID IN, V12, P106, DOI 10.1016/j.cocis.2007.05.008
   Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a
   Ariga K, 2006, SOFT MATTER, V2, P465, DOI 10.1039/b602732f
   Ariga K, 2006, J NANOSCI NANOTECHNO, V6, P2278, DOI 10.1166/jnn.2006.503
   Ariga K, 2006, CURR NANOSCI, V2, P197
   Ariga K, 2002, INT J NANOSCI SER, V1, P521, DOI 10.1142/S0219581X02000607
   Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016
   Ariga K, 2011, SUPRAMOL CHEM, V23, P183, DOI 10.1080/10610278.2010.521830
   Ariga K, 2011, EXPERT OPIN DRUG DEL, V8, P633, DOI 10.1517/17425247.2011.566268
   Ariga K, 2011, J NANOSCI NANOTECHNO, V11, P1, DOI 10.1166/jnn.2011.3839
   Ariga K, 2011, CHEM SCI, V2, P195, DOI 10.1039/c0sc00300j
   Ariga K, 2010, ADV POLYM SCI, V229, P51, DOI 10.1007/12_2009_42
   Ariga K, 2010, ADV COLLOID INTERFAC, V154, P20, DOI 10.1016/j.cis.2010.01.005
   Ariga K, 2010, NANOSCALE, V2, P198, DOI 10.1039/b9nr00105k
   Ariga K, 2010, J INORG ORGANOMET P, V20, P1, DOI 10.1007/s10904-009-9324-2
   Ariga K, 2009, SOFT MATTER, V5, P3562, DOI 10.1039/b909397d
   Ariga K, 2008, ADV SCI LETT, V1, P28, DOI 10.1166/asl.2008.011
   Ariga K, 2009, J PORPHYR PHTHALOCYA, V13, P22, DOI 10.1142/S1088424609000061
   Ariga K, 2009, EXPERT OPIN BIOL TH, V9, P307, DOI [10.1517/14712590802715772, 10.1517/14712590802715772 ]
   Ariga K, 2008, MACROMOL BIOSCI, V8, P981, DOI 10.1002/mabi.200800102
   Armatas GS, 2006, SCIENCE, V313, P817, DOI 10.1126/science.1130101
   Armatas GS, 2006, NATURE, V441, P1122, DOI 10.1038/nature04833
   Asefa T, 1999, NATURE, V402, P867
   Asefa T, 2003, J AM CHEM SOC, V125, P11662, DOI 10.1021/ja036080z
   Attard GS, 1997, SCIENCE, V278, P838, DOI 10.1126/science.278.5339.838
   Attard GS, 2001, CHEM MATER, V13, P1444, DOI 10.1021/cm000850d
   ATTARD GS, 1995, NATURE, V378, P366, DOI 10.1038/378366a0
   Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151
   Ba JH, 2005, ADV MATER, V17, P2509, DOI 10.1002/adma.200501018
   BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242
   Balasubramanian VV, 2009, MICROPOR MESOPOR MAT, V121, P18, DOI 10.1016/j.micromeso.2008.12.024
   Bally M, 2010, SMALL, V6, P2481, DOI 10.1002/smll.201000644
   Bartlett PN, 2002, PHYS CHEM CHEM PHYS, V4, P3835, DOI 10.1039/b201845d
   Bartlett PN, 2001, J ELECTROCHEM SOC, V148, pC119, DOI 10.1149/1.1342178
   BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Bellomo EG, 2006, J AM CHEM SOC, V128, P2276, DOI 10.1021/ja056227h
   Bhaumik A, 2001, J AM CHEM SOC, V123, P691, DOI 10.1021/ja002481s
   Bian ZF, 2011, ANGEW CHEM INT EDIT, V50, P1105, DOI 10.1002/anie.201004972
   Blin JL, 2005, CHEM MATER, V17, P1479, DOI 10.1021/cm048033r
   Boissiere C, 2011, ADV MATER, V23, P599, DOI 10.1002/adma.201001410
   Boo H, 2004, J AM CHEM SOC, V126, P4524, DOI 10.1021/ja0398316
   Bordoloi A, 2009, CATAL COMMUN, V10, P1398, DOI 10.1016/j.catcom.2009.03.005
   Bourlinos AB, 2001, J PHYS CHEM B, V105, P7432, DOI 10.1021/jp010286+
   Braun PV, 1996, NATURE, V380, P325, DOI 10.1038/380325a0
   Brezesinski T, 2006, ADV FUNCT MATER, V16, P1433, DOI 10.1002/adfm.200600064
   Brieler FJ, 2004, J AM CHEM SOC, V126, P797, DOI 10.1021/ja038960j
   Canioni R, 2011, J MATER CHEM, V21, P1226, DOI 10.1039/c0jm02381g
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha X, 1996, J AM CHEM SOC, V118, P9545, DOI 10.1021/ja961526f
   CHA XA, 1995, J AM CHEM SOC, V117, P11833, DOI 10.1021/ja00153a003
   Charvet R, 2009, J AM CHEM SOC, V131, P18030, DOI 10.1021/ja907414z
   Chavez VL, 2010, ACTA BIOMATER, V6, P3035, DOI 10.1016/j.actbio.2010.02.005
   Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529
   Che S, 2003, NAT MATER, V2, P801, DOI 10.1038/nmat1022
   Che S, 2006, J NANOSCI NANOTECHNO, V6, P1557, DOI 10.1166/jnn.2006.252
   Che SN, 2003, ANGEW CHEM INT EDIT, V42, P3930, DOI 10.1002/anie.200351752
   Cheetham AK, 2006, CHEM COMMUN, P4780, DOI 10.1039/b610264f
   Chen CE, 2011, ANGEW CHEM INT EDIT, V50, P882, DOI 10.1002/anie.201005471
   Chen XY, 2010, J NANOSCI NANOTECHNO, V10, P1482, DOI 10.1166/jnn.2010.2034
   Chen Y, 2006, CHEM LETT, V35, P1352, DOI 10.1246/cl.2006.1352
   Chen ZX, 2010, EUR J INORG CHEM, P3745, DOI 10.1002/ejic.201000349
   Chen ZX, 2010, CRYST GROWTH DES, V10, P2775, DOI 10.1021/cg100316s
   Cho EB, 2011, CHEM MATER, V23, P1971, DOI 10.1021/cm200166f
   Choi M, 2003, NAT MATER, V2, P473, DOI 10.1038/nmat923
   Coll C, 2011, ANGEW CHEM INT EDIT, V50, P2138, DOI 10.1002/anie.201004133
   Collin JP, 1998, EUR J INORG CHEM, P1
   Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Crepaldi EL, 2003, J AM CHEM SOC, V125, P9770, DOI 10.1021/ja030070g
   Crepaldi EL, 2002, CHEM MATER, V14, P3316, DOI 10.1021/cm021151z
   Crepaldi EL, 2001, CHEM COMMUN, P1582, DOI 10.1039/b104623n
   D'Souza F, 2009, J AM CHEM SOC, V131, P16138, DOI 10.1021/ja9048306
   Da'na E, 2011, CHEM ENG J, V167, P91, DOI 10.1016/j.cej.2010.12.005
   Dag O, 2001, ADV FUNCT MATER, V11, P213
   Datta KKR, 2011, J NANOSCI NANOTECHNO, V11, P3959, DOI 10.1166/jnn.2011.4138
   Datta KKR, 2011, J NANOSCI NANOTECHNO, V11, P3084, DOI 10.1166/jnn.2011.4155
   Datta KKR, 2010, ANGEW CHEM INT EDIT, V49, P5961, DOI 10.1002/anie.201001699
   Datta KKR, 2011, CHEM-EUR J, V17, P3390, DOI 10.1002/chem.201002419
   Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785
   Davis RJ, 1997, CHEM MATER, V9, P2311, DOI 10.1021/cm970314u
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Deng YH, 2007, J AM CHEM SOC, V129, P1690, DOI 10.1021/ja067379v
   Deng YH, 2010, ADV FUNCT MATER, V20, P3658, DOI 10.1002/adfm.201001202
   Deschner T, 2011, J MATER CHEM, V21, P5620, DOI 10.1039/c0jm04382f
   Ding SJ, 2011, J AM CHEM SOC, V133, P21, DOI 10.1021/ja108720w
   Doi Y, 2010, CHEM COMMUN, V46, P6365, DOI 10.1039/c0cc01196g
   Doi Y, 2010, CHEM LETT, V39, P777, DOI 10.1246/cl.2010.777
   Dou YQ, 2011, J POWER SOURCES, V196, P1608, DOI 10.1016/j.jpowsour.2010.09.005
   DUBOIS M, 1993, LANGMUIR, V9, P673, DOI 10.1021/la00027a011
   EBARA Y, 1994, LANGMUIR, V10, P2267, DOI 10.1021/la00019a040
   Ebert F, 2003, MACROMOLECULES, V36, P8685, DOI 10.1021/ma034760g
   El-Safty S, 2011, J MATER CHEM, V21, P5593, DOI 10.1039/c0jm03269g
   Emons TT, 2002, J AM CHEM SOC, V124, P8516, DOI 10.1021/ja0125826
   Endo A, 2006, AICHE J, V52, P1275, DOI 10.1002/aic.10703
   Evans SAG, 2002, ANAL CHEM, V74, P1322, DOI 10.1021/ac011052p
   Fan FT, 2010, ACCOUNTS CHEM RES, V43, P378, DOI 10.1021/ar900210g
   Fan J, 2006, CHEM MATER, V18, P6391, DOI 10.1021/cm062359d
   Fang Y, 2010, ANGEW CHEM INT EDIT, V49, P7987, DOI 10.1002/anie.201002849
   Firouzi A, 1997, J AM CHEM SOC, V119, P9466, DOI 10.1021/ja971267+
   Froba M, 1997, CHEM COMMUN, P1729, DOI 10.1039/a703634e
   Fuertes AB, 2005, J MATER CHEM, V15, P1079, DOI 10.1039/b416007j
   Fuertes AB, 2004, CARBON, V42, P3049, DOI 10.1016/j.carbon.2004.06.020
   Fujii N, 2010, MACROMOLECULES, V43, P3947, DOI 10.1021/ma100473j
   Fujii Y, 2006, B CHEM SOC JPN, V79, P413, DOI 10.1246/bcsj.79.413
   Fujii Y, 2006, B CHEM SOC JPN, V79, P561, DOI 10.1246/bcsj.79.561
   Fujita S, 2008, CHEM MATER, V20, P891, DOI 10.1021/cm702271v
   Fujiwara M, 2005, ANAL CHEM, V77, P8138, DOI 10.1021/ac0516638
   Fukasawa Y, 2011, CHEM-ASIAN J, V6, P103, DOI 10.1002/asia.201000523
   Fukasawa Y, 2010, CHEM LETT, V39, P236, DOI 10.1246/cl.2010.236
   Fukuda K, 2001, J MOL CATAL B-ENZYM, V11, P971, DOI 10.1016/S1381-1177(00)00012-6
   Fukumoto H, 2005, ADV MATER, V17, P1035, DOI 10.1002/adma.200401418
   Fukuoka A, 2003, CHEM COMMUN, P284, DOI 10.1039/b210828c
   Fukuoka A, 2009, CHEM REC, V9, P224, DOI 10.1002/tcr.200900004
   Fukuoka A, 2009, CHEM LETT, V38, P1026, DOI 10.1246/cl.2009.1026
   Gabriel T, 2002, ELECTROCHEM COMMUN, V4, P610, DOI 10.1016/S1388-2481(02)00390-9
   Galarneau A, 2007, MICROPOR MESOPOR MAT, V104, P103, DOI 10.1016/j.micromeso.2007.01.017
   Gao F, 2003, ADV MATER, V15, P739, DOI 10.1002/adma.200304758
   Garcia-Bennett AE, 2004, CHEM MATER, V16, P813, DOI 10.1021/cm035074z
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Gierszal KP, 2005, J PHYS CHEM B, V109, P23263, DOI 10.1021/jp054562m
   Goettmann F, 2006, ANGEW CHEM INT EDIT, V45, P4467, DOI 10.1002/anie.200600412
   Grosso D, 2001, ADV MATER, V13, P1085, DOI 10.1002/1521-4095(200107)13:14<1085::AID-ADMA1085>3.0.CO;2-Q
   Grosso D, 2004, NAT MATER, V3, P787, DOI 10.1038/nmat1206
   Gu D, 2010, CHEM MATER, V22, P4828, DOI 10.1021/cm101648y
   Gu D, 2010, ADV MATER, V22, P833, DOI 10.1002/adma.200902550
   Guan S, 2000, J AM CHEM SOC, V122, P5660, DOI 10.1021/ja000839e
   Guerin S, 2001, ELECTROCHEM COMMUN, V3, P544, DOI 10.1016/S1388-2481(01)00211-9
   Gujar TP, 2010, J NANOSCI NANOTECHNO, V10, P8124, DOI 10.1166/jnn.2010.3040
   Hadjiivanov KI, 1996, CHEM SOC REV, V25, P61, DOI 10.1039/cs9962500061
   Hakim SH, 2009, CHEM MATER, V21, P2027, DOI 10.1021/cm801691g
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Han BH, 2005, CHEM MATER, V17, P3160, DOI 10.1021/cm047770k
   Han SJ, 2003, MICROPOR MESOPOR MAT, V58, P131, DOI 10.1016/S1387-1811(02)00611-X
   Han Y, 2006, CHEM MATER, V18, P643, DOI 10.1021/cm0520618
   Hao N, 2011, MATER LETT, V65, P624, DOI 10.1016/j.matlet.2010.11.054
   Hao N, 2010, MICROPOR MESOPOR MAT, V132, P543, DOI 10.1016/j.micromeso.2010.04.008
   Hao N, 2010, APPL SURF SCI, V256, P5334, DOI 10.1016/j.apsusc.2009.12.073
   Hao N, 2010, J COLLOID INTERF SCI, V346, P429, DOI 10.1016/j.jcis.2010.01.074
   Haque E, 2010, J MATER CHEM, V20, P10801, DOI 10.1039/c0jm02974b
   Hartmann M, 2005, CHEM MATER, V17, P4577, DOI 10.1021/cm0485658
   Hartmann M, 2002, LANGMUIR, V18, P8010, DOI 10.1021/la025782j
   Hartmann M, 2010, J MATER CHEM, V20, P844, DOI 10.1039/b907869j
   Hasegawa T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.015204
   Hatton BD, 2005, ADV FUNCT MATER, V15, P823, DOI 10.1002/adfm.200400221
   Hayashi A, 2009, CHEM LETT, V38, P346, DOI 10.1246/cl.2009.346
   Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m
   He L, 2010, IND ENG CHEM RES, V49, P4175, DOI 10.1021/ie901886c
   Hernandez R, 2004, J AM CHEM SOC, V126, P3370, DOI 10.1021/ja039424u
   Hill JP, 2007, J PHYS CHEM C, V111, P16174, DOI 10.1021/jp0745945
   Hill JP, 2006, PHYS CHEM CHEM PHYS, V8, P5034, DOI 10.1039/b608935f
   Hill JP, 2006, CHEM COMMUN, P2320, DOI 10.1039/b517668a
   Hill JP, 2010, CHEM COMMUN, V46, P7933, DOI 10.1039/c0cc03167d
   Hill JP, 2009, PHYS CHEM CHEM PHYS, V11, P6038, DOI 10.1039/b822802g
   Hill JP, 2009, SYNTHETIC MET, V159, P765, DOI 10.1016/j.synthmet.2008.12.016
   Hillhouse HW, 1997, CHEM MATER, V9, P1505, DOI 10.1021/cm970140g
   Hoffmann F, 2011, CHEM SOC REV, V40, P608, DOI 10.1039/c0cs00076k
   Horiuchi Y, 2008, CHEM LETT, V37, P748, DOI 10.1246/cl.2008.748
   Horiuchi Y, 2011, PHYS CHEM CHEM PHYS, V13, P6309, DOI 10.1039/c0cp02215b
   Hoshikawa Y, 2010, CHEM MATER, V22, P12, DOI 10.1021/cm902239a
   Huang CH, 2010, CHEM MATER, V22, P1760, DOI 10.1021/cm903207q
   Huang YL, 2011, ANGEW CHEM INT EDIT, V50, P661, DOI 10.1002/anie.201004572
   Ijichi K, 2011, MATER LETT, V65, P828, DOI 10.1016/j.matlet.2010.11.064
   Ikawa N, 2011, MICROPOR MESOPOR MAT, V141, P56, DOI 10.1016/j.micromeso.2009.09.019
   Ikawa N, 2009, J MATER CHEM, V19, P4906, DOI 10.1039/b815154g
   Ikawa N, 2009, J NANOSCI NANOTECHNO, V9, P627, DOI 10.1166/jnn.2009.J072
   Ikeda A, 1997, CHEM REV, V97, P1713, DOI 10.1021/cr960385x
   Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a
   Inagaki S, 2005, STUD SURF SCI CATAL, V158, P533
   INAGAKI S, 1993, J CHEM SOC CHEM COMM, P680, DOI 10.1039/c39930000680
   Inagaki S, 1999, J AM CHEM SOC, V121, P9611, DOI 10.1021/ja9916658
   Inagaki S, 2009, CHEM LETT, V38, P918, DOI 10.1246/cl.2009.918
   Inagaki S, 2009, B CHEM SOC JPN, V82, P606, DOI 10.1246/bcsj.82.606
   Inumaru K, 2010, CHEM LETT, V39, P1215, DOI 10.1246/cl.2010.1215
   Ji QM, 2008, ADV MATER, V20, P4027, DOI 10.1002/adma.200801064
   Ji Q, 2008, J AM CHEM SOC, V130, P2376, DOI 10.1021/ja076139s
   Ji QM, 2010, ANGEW CHEM INT EDIT, V49, P9737, DOI 10.1002/anie.201004929
   Ji QM, 2009, ADV FUNCT MATER, V19, P1792, DOI 10.1002/adfm.200801762
   Ji QM, 2009, J AM CHEM SOC, V131, P4220, DOI 10.1021/ja9010354
   JIANG T, 1994, ADV MATER, V6, P860, DOI 10.1002/adma.19940061114
   Jiang T, 1998, J MATER CHEM, V8, P1099, DOI 10.1039/a709054d
   Jin HY, 2006, ADV MATER, V18, P593, DOI 10.1002/adma.200502038
   Jin X, 2009, ANGEW CHEM INT EDIT, V48, P7884, DOI 10.1002/anie.200903674
   Johnson SA, 1999, SCIENCE, V283, P963, DOI 10.1126/science.283.5404.963
   Johnson SA, 1998, J MATER CHEM, V8, P13, DOI 10.1039/a706791g
   Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046
   Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e
   Jun YS, 2009, ADV MATER, V21, P4270, DOI 10.1002/adma.200803500
   Jung C, 2011, NAT NANOTECHNOL, V6, P86, DOI 10.1038/nnano.2010.258
   Jung D, 2010, CATAL TODAY, V157, P378, DOI 10.1016/j.cattod.2010.03.004
   Jung D, 2010, INT J MOL SCI, V11, P762, DOI 10.3390/ijms11020762
   Jung D, 2009, J MATER SCI, V44, P6747, DOI 10.1007/s10853-009-3917-6
   Kalita P, 2010, CHEM-EUR J, V16, P2843, DOI 10.1002/chem.200902531
   Kapoor MP, 2006, B CHEM SOC JPN, V79, P1463, DOI 10.1246/bcsj.79.1463
   Kapoor MP, 2010, MICROPOR MESOPOR MAT, V128, P187, DOI 10.1016/j.micromeso.2009.08.019
   Kapoor MP, 2002, CHEM MATER, V14, P3509, DOI 10.1021/cm020345b
   Katagiri K, 2002, LANGMUIR, V18, P6709, DOI 10.1021/la025772i
   Katagiri K, 2002, J AM CHEM SOC, V124, P7892, DOI 10.1021/ja0259281
   Khan NA, 2011, CHEM COMMUN, V47, P1306, DOI 10.1039/c0cc04759g
   Kikuchi J, 2001, J MOL CATAL B-ENZYM, V11, P977, DOI 10.1016/S1381-1177(00)00019-9
   Kikuchi J, 1999, CHEM LETT, P253
   Kikuchi J, 1999, CHEM COMMUN, P547, DOI 10.1039/a900083f
   Kim CH, 2004, LANGMUIR, V20, P5157, DOI 10.1021/la49602c
   Kim J, 2008, ADV MATER, V20, P478, DOI 10.1002/adma.200701726
   Kim TW, 2011, ACS NANO, V5, P360, DOI 10.1021/nn101740e
   Kim TW, 2003, ANGEW CHEM INT EDIT, V42, P4375, DOI 10.1002/anie.200352224
   Kimura T, 2003, POLYM J, V35, P823, DOI 10.1295/polymj.35.823
   Kimura T, 2010, CHEM-EUR J, V16, P12069, DOI 10.1002/chem.201001251
   Kimura T, 2009, ADV FUNCT MATER, V19, P511, DOI 10.1002/adfm.200800647
   Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610
   Kleitz F, 2003, CHEM COMMUN, P2136, DOI 10.1039/b306504a
   Knoll W, 2010, ADV POLYM SCI, V224, P87, DOI 10.1007/12_2009_27
   Koganti VR, 2005, J PHYS CHEM B, V109, P3279, DOI 10.1021/jp045037a
   Koh CW, 2008, CHEM-ASIAN J, V3, P862, DOI 10.1002/asia.200700331
   Koh JK, 2011, ADV MATER, V23, P1641, DOI 10.1002/adma.201004715
   Kondo JN, 2000, B CHEM SOC JPN, V73, P1123, DOI 10.1246/bcsj.73.1123
   Koo JB, 2010, J CATAL, V276, P327, DOI 10.1016/j.jcat.2010.09.024
   Koo SM, 2007, CHEM LETT, V36, P906, DOI 10.1246/cl.2007.906
   Kosonen H, 2006, ADV MATER, V18, P201, DOI 10.1002/adma.200401110
   Kowalchuk CM, 2004, INORG CHEM, V43, P173, DOI 10.1021/ic0300868
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Krithiga T, 2005, J MOL CATAL A-CHEM, V237, P238, DOI 10.1016/j.molcata.2005.05.008
   Kruk M, 2003, CHEM MATER, V15, P2815, DOI 10.1021/cm034087+
   Kubota Y, 2010, TOP CATAL, V53, P492, DOI 10.1007/s11244-010-9477-9
   Kumaresan L, 2011, J HAZARD MATER, V186, P1183, DOI 10.1016/j.jhazmat.2010.11.124
   Kuroda K, 2004, STUD SURF SCI CATAL, V148, P73
   Kuroda Y, 2010, CHEM COMMUN, V46, P1827, DOI 10.1039/b921016d
   Kyotani T, 1997, CHEM MATER, V9, P609, DOI 10.1021/cm960430h
   Kyotani T, 2000, CARBON, V38, P269, DOI 10.1016/S0008-6223(99)00142-6
   Labuta J, 2011, CHEM-EUR J, V17, P3558, DOI 10.1002/chem.201100052
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lai P, 2008, CHEM COMMUN, P1338, DOI 10.1039/b717461f
   Layek K, 2011, ADV SYNTH CATAL, V353, P606, DOI 10.1002/adsc.201000591
   Lee B, 2002, J AM CHEM SOC, V124, P11256, DOI 10.1021/ja026838z
   Lee D, 2005, ADV MATER, V17, P2828, DOI 10.1002/adma.200500793
   Lee EZ, 2010, ANGEW CHEM INT EDIT, V49, P9706, DOI 10.1002/anie.201004975
   Lee J, 2001, J AM CHEM SOC, V123, P5146, DOI 10.1021/ja015510n
   Lee J, 2000, ADV MATER, V12, P359, DOI 10.1002/(SICI)1521-4095(200003)12:5<359::AID-ADMA359>3.0.CO;2-1
   Lee J, 1999, CHEM COMMUN, P2177, DOI 10.1039/a906872d
   Lee J, 2006, ADV MATER, V18, P2073, DOI 10.1002/adma.200501576
   Lee JS, 2002, J AM CHEM SOC, V124, P1156, DOI 10.1021/ja012333h
   Lee PS, 2011, J AM CHEM SOC, V133, P493, DOI 10.1021/ja107942n
   Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324
   Li JQ, 1998, ADV MATER, V10, P946, DOI 10.1002/(SICI)1521-4095(199808)10:12<946::AID-ADMA946>3.0.CO;2-C
   Li Q, 2011, CARBON, V49, P1248, DOI 10.1016/j.carbon.2010.11.043
   Li Q, 2010, PHYS CHEM CHEM PHYS, V12, P10996, DOI 10.1039/c004469e
   Li Q, 2010, NANO RES, V3, P632, DOI 10.1007/s12274-010-0023-7
   Li Q, 2010, MICROPOR MESOPOR MAT, V135, P95, DOI 10.1016/j.micromeso.2010.06.016
   Liu G, 2010, J MATER CHEM, V20, P831, DOI [10.1039/B909930A, 10.1039/b909930a]
   Liu HJ, 2010, J MATER CHEM, V20, P4223, DOI 10.1039/b925776d
   Liu J, 2010, MICROPOR MESOPOR MAT, V130, P26, DOI 10.1016/j.micromeso.2009.10.008
   Liu JJ, 2011, PHYS CHEM CHEM PHYS, V13, P3758, DOI 10.1039/c0cp01276a
   Liu J, 2011, SMALL, V7, P425, DOI 10.1002/smll.201001402
   Liu X, 2010, CHEM-ASIAN J, V5, P1232, DOI 10.1002/asia.200900737
   Logudurai R, 2010, J NANOSCI NANOTECHNO, V10, P329, DOI 10.1166/jnn.2010.1526
   Lu AH, 2003, ADV MATER, V15, P1602, DOI 10.1002/adma.200305176
   Lu QY, 2004, J AM CHEM SOC, V126, P8650, DOI 10.1021/ja0488378
   Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699
   Lu YF, 2000, J AM CHEM SOC, V122, P5258, DOI 10.1021/ja9935862
   Luo Z, 2011, ANGEW CHEM INT EDIT, V50, P640, DOI 10.1002/anie.201005061
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1995, J CHEM SOC CHEM COMM, P2313, DOI 10.1039/c39950002313
   LVOV Y, 1994, CHEM LETT, P2323, DOI 10.1246/cl.1994.2323
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   Lyu YY, 2004, J AM CHEM SOC, V126, P2310, DOI 10.1021/ja0390348
   Ma RZ, 2010, ADV MATER, V22, P5082, DOI 10.1002/adma.201001722
   Macwan DP, 2011, J MATER SCI, V46, P3669, DOI 10.1007/s10853-011-5378-y
   Mal NK, 2003, CHEM MATER, V15, P3385, DOI 10.1021/cm0343296
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   Mandal M, 2010, J PHYS CHEM C, V114, P20091, DOI 10.1021/jp1069187
   Mandal S, 2010, J AM CHEM SOC, V132, P14415, DOI 10.1021/ja107589m
   Mandal S, 2010, J NANOSCI NANOTECHNO, V10, P21, DOI 10.1166/jnn.2010.1503
   Markham ML, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1844035
   Martini IB, 2007, NAT NANOTECHNOL, V2, P647, DOI 10.1038/nnano.2007.294
   Maruo T, 2008, THIN SOLID FILMS, V516, P4771, DOI 10.1016/j.tsf.2007.08.124
   Matsuoka M, 2010, J NANOSCI NANOTECHNO, V10, P314, DOI 10.1166/jnn.2010.1509
   Matsusaki M, 2009, EXPERT OPIN DRUG DEL, V6, P1207, DOI 10.1517/17425240903280414
   Mehdi A, 2011, CHEM SOC REV, V40, P563, DOI 10.1039/b920516k
   Melde BJ, 1999, CHEM MATER, V11, P3302, DOI 10.1021/cm9903935
   Meng Y, 2005, ANGEW CHEM INT EDIT, V44, P7053, DOI 10.1002/anie.200501561
   Meng Y, 2006, CHEM MATER, V18, P4447, DOI 10.1021/cm060921u
   Michinobu T, 2006, J AM CHEM SOC, V128, P14478, DOI 10.1021/ja066429t
   Michinobu T, 2011, PHYS CHEM CHEM PHYS, V13, P4895, DOI 10.1039/c0cp01990a
   Miyahara M, 2006, THIN SOLID FILMS, V499, P13, DOI 10.1016/j.tsf.2005.07.046
   Miyahara M, 2007, MAT SCI ENG C-BIO S, V27, P232, DOI 10.1016/j.msec.2006.05.012
   Miyahara M, 2006, J NANOSCI NANOTECHNO, V6, P1765, DOI 10.1166/jnn.2006.221
   Miyasaka K, 2010, ANGEW CHEM INT EDIT, V49, P8867, DOI 10.1002/anie.201003875
   Miyata H, 2005, CHEM MATER, V17, P5323, DOI 10.1021/cm0504992
   Miyata H, 2004, NAT MATER, V3, P651, DOI 10.1038/nmat1184
   Miyata H, 2003, CHEM MATER, V15, P1334, DOI 10.1021/cm020870a
   Miyata H, 2002, CHEM MATER, V14, P766, DOI 10.1021/cm010412m
   Miyata H, 2000, CHEM MATER, V12, P49, DOI 10.1021/cm990506k
   Miyata H, 2007, MICROPOR MESOPOR MAT, V101, P296, DOI 10.1016/j.micromeso.2006.12.023
   Mizoshita N, 2011, CHEM SOC REV, V40, P789, DOI 10.1039/c0cs00010h
   Molenkamp WC, 2004, J AM CHEM SOC, V126, P4476, DOI 10.1021/ja039296
   Mori T, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-304
   Mori T, 2010, J AM CHEM SOC, V132, P12868, DOI 10.1021/ja106653a
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Murakami M, 2007, SOLID STATE NUCL MAG, V31, P193, DOI 10.1016/j.ssnmr.2007.04.003
   Murakami M, 2006, CHEM LETT, V35, P986, DOI 10.1246/cl.2006.986
   Na K, 2011, CHEM MATER, V23, P1273, DOI 10.1021/cm103245m
   Nagamine S, 2001, MICROPOR MESOPOR MAT, V49, P57, DOI 10.1016/S1387-1811(01)00403-6
   Naik SP, 2004, CHEM LETT, V33, P1078, DOI 10.1246/cl.2004.1078
   Nakanishi T, 2008, ADV MATER, V20, P443, DOI 10.1002/adma.200701537
   Nakanishi T, 2006, J AM CHEM SOC, V128, P6328, DOI 10.1021/ja061450f
   Nandhakumar IS, 2004, CHEM COMMUN, P1374, DOI 10.1039/b403423f
   Nelson PA, 2002, CHEM MATER, V14, P524, DOI 10.1021/cm011021a
   Nguyen TD, 2005, P NATL ACAD SCI USA, V102, P10029, DOI 10.1073/pnas.0504109102
   Nishiyama N, 2003, CHEM MATER, V15, P1006, DOI 10.1021/cm021011p
   Ockwig NW, 2005, ACCOUNTS CHEM RES, V38, P176, DOI 10.1021/ar020022l
   Oda Y, 2004, CHEM MATER, V16, P3860, DOI 10.1021/cm0494296
   Ogawa M, 1996, CHEM COMMUN, P1149, DOI 10.1039/cc9960001149
   OGAWA M, 1994, J AM CHEM SOC, V116, P7941, DOI 10.1021/ja00096a079
   Ohtani O, 2005, CHEM LETT, V34, P1342, DOI 10.1246/cl.2005.1342
   Okabe A, 2002, ANGEW CHEM INT EDIT, V41, P3414, DOI 10.1002/1521-3773(20020916)41:18<3414::AID-ANIE3414>3.0.CO;2-T
   OKAHATA Y, 1988, LANGMUIR, V4, P1373, DOI 10.1021/la00084a030
   OKAHATA Y, 1989, THIN SOLID FILMS, V180, P65, DOI 10.1016/0040-6090(89)90055-2
   Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3
   Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9
   Onda M, 1996, J AM CHEM SOC, V118, P8524, DOI 10.1021/ja960991+
   Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H
   Orilall MC, 2011, CHEM SOC REV, V40, P520, DOI 10.1039/c0cs00034e
   Osenar P, 1996, ADV MATER, V8, P1022, DOI 10.1002/adma.19960081220
   Otani W, 2007, CHEM-EUR J, V13, P1731, DOI 10.1002/chem.2006010199
   Oveisi H, 2010, J MATER CHEM, V20, P10120, DOI 10.1039/c0jm02006k
   Oveisi H, 2011, CHEM LETT, V40, P420, DOI 10.1246/cl.2011.420
   Oveisi H, 2010, CHEM-ASIAN J, V5, P1978, DOI 10.1002/asia.201000351
   Paraknowitsch JP, 2010, ADV MATER, V22, P87, DOI 10.1002/adma.200900965
   Parambadath S, 2011, MICROPOR MESOPOR MAT, V141, P94, DOI 10.1016/j.micromeso.2010.10.051
   Park S, 2003, ANAL CHEM, V75, P3046, DOI 10.1021/ac0263465
   Park SS, 2007, CHEM MATER, V19, P2709, DOI 10.1021/cm070092s
   Park SS, 2010, J MATER CHEM, V20, P7854, DOI 10.1039/c0jm01278e
   Park SS, 2010, CHEM MATER, V22, P18, DOI 10.1021/cm901684m
   Petit M, 2009, ORG ELECTRON, V10, P1187, DOI 10.1016/j.orgel.2009.05.026
   Pidol L, 2002, J MATER CHEM, V12, P557, DOI 10.1039/b109192c
   Platschek B, 2006, ANGEW CHEM INT EDIT, V45, P1134, DOI 10.1002/anie.200503301
   Polarz S, 2005, J AM CHEM SOC, V127, P12028, DOI 10.1021/ja0516514
   Qiu HB, 2011, CHEM SOC REV, V40, P1259, DOI 10.1039/c0cs00002g
   Radhakrishnan L, 2011, CHEM MATER, V23, P1225, DOI 10.1021/cm102921y
   Radhakrishnan L, 2010, CHEM-ASIAN J, V5, P1290, DOI 10.1002/asia.201000113
   Radu DR, 2004, J AM CHEM SOC, V126, P1640, DOI 10.1021/ja038222v
   Rapp A, 1999, J PHYS CHEM B, V103, P1705, DOI 10.1021/jp984021f
   Reimhult E, 2010, BIOTECHNOL GENET ENG, V27, P185, DOI 10.1080/02648725.2010.10648150
   Richman EK, 2008, NAT MATER, V7, P712, DOI 10.1038/nmat2257
   ROBERTS GG, 1985, ADV PHYS, V34, P475, DOI 10.1080/00018738500101801
   Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b
   Ruiz-Hitzky E, 2011, CHEM SOC REV, V40, P801, DOI 10.1039/c0cs00052c
   Ruiz-Hitzky E, 2010, ADV MATER, V22, P323, DOI 10.1002/adma.200901134
   Ryoo R, 1999, J PHYS CHEM B, V103, P7743, DOI 10.1021/jp991673a
   Sadasivan S, 2005, SMALL, V1, P103, DOI 10.1002/smll.200400039
   Sakakibara K, 2011, SMALL, V7, P1288, DOI 10.1002/smll.201002350
   Sakka Y, 2005, J CERAM SOC JPN, V113, P26, DOI 10.2109/jcersj.113.26
   Sakka Y, 2006, J CERAM SOC JPN, V114, P371, DOI 10.2109/jcersj.114.371
   Sanchez C, 2011, CHEM SOC REV, V40, P696, DOI 10.1039/c0cs00136h
   Sang LC, 2011, PHYS CHEM CHEM PHYS, V13, P6689, DOI 10.1039/c0cp02273j
   Saramat A, 2007, EUR PHYS J D, V43, P209, DOI 10.1140/epjd/e2007-00124-7
   Sathish M, 2009, J AM CHEM SOC, V131, P6372, DOI 10.1021/ja902061r
   Sawant DP, 2008, CHEM-EUR J, V14, P3200, DOI 10.1002/chem.200701562
   Sayari A, 2000, CHEM MATER, V12, P3857, DOI 10.1021/cm000479u
   Schmidt-Winkel P, 1999, J AM CHEM SOC, V121, P254, DOI 10.1021/ja983218i
   Selvam P, 2011, J PHYS CHEM C, V115, P1922, DOI 10.1021/jp107121d
   Sen T, 2009, MICROPOR MESOPOR MAT, V120, P246, DOI 10.1016/j.micromeso.2008.11.012
   She L, 2011, J MATER CHEM, V21, P795, DOI 10.1039/c0jm02226h
   Shibata H, 2005, J AM CHEM SOC, V127, P16396, DOI 10.1021/ja0552601
   Shimura N, 2004, B CHEM SOC JPN, V77, P1599, DOI 10.1246/bcsj.77.1599
   Shundo A, 2009, J AM CHEM SOC, V131, P9494, DOI 10.1021/ja903371d
   Shyue JJ, 2005, J AM CHEM SOC, V127, P12736, DOI 10.1021/ja0536365
   Siqueira JR, 2010, BIOSENS BIOELECTRON, V25, P1254, DOI 10.1016/j.bios.2009.09.043
   Sivaranjani K, 2011, J MATER CHEM, V21, P2639, DOI 10.1039/c0jm03825c
   Smarsly B, 2004, CHEM MATER, V16, P2948, DOI 10.1021/cm0495966
   Solberg SM, 2006, J PHYS CHEM B, V110, P15261, DOI 10.1021/jp061691+
   Soler-Illia GJAA, 2011, CHEM SOC REV, V40, P1107, DOI 10.1039/c0cs00208a
   Soler-illia GJD, 2002, CHEM REV, V102, P4093, DOI 10.1021/cr0200062
   Song LY, 2010, J PHYS CHEM C, V114, P9618, DOI 10.1021/jp1003825
   Song LY, 2010, ACS NANO, V4, P189, DOI 10.1021/nn9012884
   Srinivasu P, 2008, ADV FUNCT MATER, V18, P640, DOI 10.1002/adfm.200701027
   Srinivasu P, 2008, MICROPOR MESOPOR MAT, V108, P340, DOI 10.1016/j.micromeso.2007.03.048
   Srinivasu P, 2007, J NANOSCI NANOTECHNO, V7, P3250, DOI 10.1166/jnn.2007.919
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Such GK, 2011, CHEM SOC REV, V40, P19, DOI 10.1039/c0cs00001a
   Sun D, 2006, NATURE, V441, P1126, DOI 10.1038/nature04891
   Sun JM, 2006, J MATER CHEM, V16, P1507, DOI 10.1039/b602374f
   Suzuki T, 2008, J PHYS CHEM C, V112, P1831, DOI 10.1021/jp077276e
   Suzuki T, 2007, J MATER CHEM, V17, P4762, DOI 10.1039/b710211a
   Suzuki T, 2006, CHEM MATER, V18, P4888, DOI 10.1021/cm061475d
   Suzuki TS, 2006, SCI TECHNOL ADV MAT, V7, P356, DOI 10.1016/j.stam.2006.01.014
   Suzuki TS, 2006, J CERAM SOC JPN, V114, P59, DOI 10.2109/jcersj.114.59
   Suzuki TS, 2001, ADV ENG MATER, V3, P490, DOI 10.1002/1527-2648(200107)3:7<490::AID-ADEM490>3.0.CO;2-O
   Tadokoro M, 2009, J NANOSCI NANOTECHNO, V9, P391, DOI 10.1166/jnn.2009.J042
   Tagusagawa C, 2010, CHEM MATER, V22, P3072, DOI 10.1021/cm903767n
   Tagusagawa C, 2010, ANGEW CHEM INT EDIT, V49, P1128, DOI 10.1002/anie.200904791
   Takai A, 2010, J PHYS CHEM C, V114, P7586, DOI 10.1021/jp910288x
   Takai A, 2010, J AM CHEM SOC, V132, P208, DOI 10.1021/ja9062844
   Takai A, 2009, CHEM MATER, V21, P3414, DOI 10.1021/cm9011926
   Tan JC, 2011, CHEM SOC REV, V40, P1059, DOI 10.1039/c0cs00163e
   Tanaka M, 2011, CATAL LETT, V141, P283, DOI 10.1007/s10562-010-0458-1
   Tanaka S, 2006, THIN SOLID FILMS, V495, P186, DOI 10.1016/j.tsf.2005.08.218
   Tanaka S, 2005, CHEM LETT, V34, P1148, DOI 10.1246/cl.2005.1148
   Tanaka S, 2004, CHEM LETT, V33, P1408, DOI 10.1246/cl.2004.1408
   Tanaka S, 2004, J AM CHEM SOC, V126, P4854, DOI 10.1021/ja039267z
   Tanaka S, 2006, CHEM MATER, V18, P5461, DOI 10.1021/cm0614463
   TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865
   Tang WP, 2011, CHEM LETT, V40, P116, DOI 10.1246/cl.2011.116
   TANORI J, 1995, COLLOID POLYM SCI, V273, P886, DOI 10.1007/BF00657639
   Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190
   Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f
   Tian BZ, 2003, NAT MATER, V2, P159, DOI 10.1038/nmat838
   Tian YQ, 2010, CHEM-EUR J, V16, P1137, DOI 10.1002/chem.200902729
   Tiberg F, 2011, J DRUG DELIV SCI TEC, V21, P101, DOI 10.1016/S1773-2247(11)50009-7
   Tolbert SH, 1997, SCIENCE, V278, P264, DOI 10.1126/science.278.5336.264
   Tomczak MM, 2005, J AM CHEM SOC, V127, P12577, DOI 10.1021/ja0524503
   Trau M, 1997, NATURE, V390, P674
   Uemura T, 2010, TOP CURR CHEM, V293, P155, DOI 10.1007/128_2009_6
   Urade VN, 2005, J PHYS CHEM B, V109, P10538, DOI 10.1021/jp051229+
   Urata C, 2009, CHEM COMMUN, P5094, DOI 10.1039/b908625k
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   VARTULI JC, 1994, CHEM MATER, V6, P2317, DOI 10.1021/cm00048a018
   Vinu A, 2008, MICROPOR MESOPOR MAT, V109, P398, DOI 10.1016/j.micromeso.2007.05.037
   Vinu A, 2007, MICROPOR MESOPOR MAT, V100, P20, DOI 10.1016/j.micromeso.2006.10.008
   Vinu A, 2005, J MATER CHEM, V15, P5122, DOI 10.1039/b507456h
   Vinu A, 2005, CHEM MATER, V17, P5887, DOI 10.1021/cm051780j
   Vinu A, 2005, CHEM MATER, V17, P5339, DOI 10.1021/cm050883z
   Vinu A, 2005, ADV MATER, V17, P1648, DOI 10.1002/adma.200401643
   Vinu A, 2005, J NANOSCI NANOTECHNO, V5, P542, DOI 10.1166/jnn.2005.073
   Vinu A, 2005, CHEM LETT, V34, P674, DOI 10.1246/cl.2005.674
   Vinu A, 2005, MICROPOR MESOPOR MAT, V80, P195, DOI 10.1016/j.micromeso.2004.12.012
   Vinu A, 2005, J NANOSCI NANOTECHNO, V5, P347, DOI 10.1166/jnn.2005.089
   Vinu A, 2005, J PHYS CHEM B, V109, P6436, DOI 10.1021/jp050454o
   Vinu A, 2005, J MOL CATAL A-CHEM, V230, P151, DOI 10.1016/j.molcata.2004.12.018
   Vinu A, 2004, MICROPOR MESOPOR MAT, V76, P91, DOI 10.1016/j.micromeso.2004.07.036
   Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u
   Vinu A, 2004, J PHYS CHEM B, V108, P7323, DOI 10.1021/jp037303a
   Vinu A, 2005, CATAL TODAY, V102, P189, DOI 10.1016/j.cattod.2005.02.028
   Vinu A, 2003, J PHYS CHEM B, V107, P8297, DOI 10.1021/jp035246f
   Vinu A, 2008, ADV FUNCT MATER, V18, P816, DOI 10.1002/adfm.200700783
   Vinu A, 2007, J NANOSCI NANOTECHNO, V7, P828, DOI 10.1166/jnn.2007.511
   Vinu A, 2007, CHEM MATER, V19, P4367, DOI 10.1021/cm070657k
   Vinu A, 2007, CHEM LETT, V36, P770, DOI 10.1246/cl.2007.770
   Vinu A, 2007, J MATER CHEM, V17, P1819, DOI 10.1039/b613899c
   Vinu A, 2006, SCI TECHNOL ADV MAT, V7, P753, DOI 10.1016/j.stam.2006.10.007
   Vinu A, 2006, J POROUS MAT, V13, P379, DOI 10.1007/s10934-006-8034-1
   Vinu A, 2006, J NANOSCI NANOTECHNO, V6, P1510, DOI 10.1166/jnn.2006.253
   Vinu A, 2008, CHEM-EUR J, V14, P11529, DOI 10.1002/chem.200801304
   Vivero-Escoto JL, 2010, SMALL, V6, P1952, DOI 10.1002/smll.200901789
   Wahab MA, 2010, SOFT MATER, V8, P183, DOI 10.1080/15394451003708598
   Wakayama Y, 2007, SURF SCI, V601, P3984, DOI 10.1016/j.susc.2007.04.068
   Walcarius A, 2007, NAT MATER, V6, P602, DOI 10.1038/nmat1951
   Wan K, 2004, B CHEM SOC JPN, V77, P1409, DOI 10.1246/bcsj.77.1409
   Wan Y, 2006, ACCOUNTS CHEM RES, V39, P423, DOI 10.1021/ar050091a
   Wang CHK, 2011, TRENDS BIOTECHNOL, V29, P119, DOI 10.1016/j.tibtech.2010.11.005
   Wang DH, 2005, CHEM COMMUN, P166, DOI 10.1039/b411915k
   Wang L, 2010, J AM CHEM SOC, V132, P13636, DOI 10.1021/ja105640p
   Wang LN, 2006, MICROPOR MESOPOR MAT, V91, P156, DOI 10.1016/j.mircomeso.2005.11.042
   Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813
   Wang YJ, 2006, ADV MATER, V18, P795, DOI 10.1002/adma.200501901
   Wang Y, 2010, CHEMSUSCHEM, V3, P435, DOI 10.1002/cssc.200900284
   Wang Y, 2010, ANGEW CHEM INT EDIT, V49, P3356, DOI 10.1002/anie.201000120
   Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023
   Weiss PS, 2007, ACS NANO, V1, P1, DOI [10.1021/nn700131b, 10.1021/nn700274t]
   Weng W, 2010, ANGEW CHEM INT EDIT, V49, P3956, DOI 10.1002/anie.200907008
   Whitcombe MJ, 2011, CHEM SOC REV, V40, P1547, DOI 10.1039/c0cs00049c
   Whitehead AH, 1999, CHEM COMMUN, P331, DOI 10.1039/a808775j
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Wu CW, 2007, ANGEW CHEM INT EDIT, V46, P5364, DOI 10.1002/anie.200700689
   Wu SM, 2011, ADV FUNCT MATER, V21, P93, DOI 10.1002/adfm.201001520
   Wu YY, 2004, NAT MATER, V3, P816, DOI 10.1038/nmat1230
   Wu ZX, 2010, LANGMUIR, V26, P10277, DOI 10.1021/la100455w
   Wu ZX, 2010, MICROPOR MESOPOR MAT, V128, P165, DOI 10.1016/j.micromeso.2009.08.020
   Xi XB, 2011, ANGEW CHEM INT EDIT, V50, P1154, DOI 10.1002/anie.201004885
   Xia YD, 2006, CHEM MATER, V18, P140, DOI 10.1021/cm0522634
   Xia YD, 2004, ADV MATER, V16, P1553, DOI 10.1002/adma.200400391
   Xie YS, 2011, CHEM COMMUN, V47, P2285, DOI 10.1039/c0cc04855k
   Yamauchi Y, 2008, J AM CHEM SOC, V130, P10165, DOI 10.1021/ja7107036
   Yamauchi Y, 2006, J MATER CHEM, V16, P3693, DOI 10.1039/b608780a
   Yamauchi Y, 2009, CHEM COMMUN, P5689, DOI 10.1039/b909251j
   Yamauchi Y, 2009, CHEM-ASIAN J, V4, P1059, DOI 10.1002/asia.200900052
   Gor GY, 2010, LANGMUIR, V26, P13021, DOI 10.1021/la1019247
   Yamaguchi A, 2004, NAT MATER, V3, P337, DOI 10.1038/nmat1107
   Yamauchi Y, 2006, J MATER CHEM, V16, P2229, DOI 10.1039/b601678b
   Yamauchi Y, 2005, ELECTROCHEM COMMUN, V7, P1364, DOI 10.1016/j.elecom.2005.09.020
   Yamauchi Y, 2005, J MATER CHEM, V15, P1137, DOI 10.1039/b418478e
   Yamauchi Y, 2004, J MATER CHEM, V14, P2935, DOI 10.1039/b406265e
   Yamauchi Y, 2008, ANGEW CHEM INT EDIT, V47, P5371, DOI 10.1002/anie.200801381
   Yamauchi Y, 2008, CHEM-ASIAN J, V3, P664, DOI 10.1002/asia.200700350
   Yamauchi Y, 2008, CHEM MATER, V20, P1004, DOI 10.1021/cm701985f
   Yamauchi Y, 2007, ELECTROCHIM ACTA, V53, P604, DOI 10.1016/j.electacta.2007.07.036
   Yamauchi Y, 2007, CHEM-ASIAN J, V2, P1505, DOI 10.1002/asia.200700244
   Yamauchi Y, 2007, CHEM MATER, V19, P1335, DOI 10.1021/cm062539n
   Yamauchi Y, 2006, ELECTROCHEM COMMUN, V8, P1677, DOI 10.1016/j.elecom.2006.08.005
   Yamauchi Y, 2006, SCI TECHNOL ADV MAT, V7, P438, DOI 10.1016/j.stam.2006.05.004
   Yamauchi Y, 2009, CHEM REC, V9, P321, DOI 10.1002/tcr.200900022
   Yamauchi Y, 2009, ANGEW CHEM INT EDIT, V48, P7792, DOI 10.1002/anie.200902934
   Yamauchi Y, 2009, B CHEM SOC JPN, V82, P1039, DOI 10.1246/bcsj.82.1039
   Yamauchi Y, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/025005
   Yan WF, 2005, CHEM MATER, V17, P1923, DOI 10.1021/cm048118s
   YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988
   Yang CM, 2003, CHEM MATER, V15, P275, DOI 10.1021/cm020822q
   Yang H, 1996, NATURE, V379, P703, DOI 10.1038/379703a0
   Yang HF, 2005, J MATER CHEM, V15, P1217, DOI 10.1039/b414402c
   Yang JP, 2010, J COLLOID INTERF SCI, V342, P579, DOI 10.1016/j.jcis.2009.10.037
   Yang PD, 2000, SCIENCE, V287, P465, DOI 10.1126/science.287.5452.465
   Yang PD, 1998, NATURE, V396, P152
   Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244
   Yang PD, 2001, ADV MATER, V13, P427, DOI 10.1002/1521-4095(200103)13:6<427::AID-ADMA427>3.3.CO;2-3
   Yang W, 2011, J AM CHEM SOC, V133, P206, DOI 10.1021/ja108039j
   Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E
   Yoon JW, 2010, ANGEW CHEM INT EDIT, V49, P5949, DOI 10.1002/anie.201001230
   Yoshikawa T, 2002, B CHEM SOC JPN, V75, P2589, DOI 10.1246/bcsj.75.2589
   Yoshitake H, 2010, J MATER CHEM, V20, P4537, DOI 10.1039/b927567c
   Yuan ZY, 2006, J MATER CHEM, V16, P663, DOI 10.1039/b512304f
   ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836
   Zeng TY, 2009, CATAL TODAY, V147, pS41, DOI 10.1016/j.cattod.2009.07.029
   Zeng TY, 2010, CHEM LETT, V39, P680, DOI 10.1246/cl.2010.680
   Zhai YP, 2011, CARBON, V49, P545, DOI 10.1016/j.carbon.2010.09.055
   Zhang QM, 2004, J AM CHEM SOC, V126, P988, DOI 10.1021/ja0395l5r
   Zhang SL, 2010, CHEM MATER, V22, P3433, DOI 10.1021/cm1002274
   Zhang X, 2006, SCRIPTA MATER, V54, P1651, DOI 10.1016/j.scriptamat.2006.01.011
   Zhang ZD, 2005, CHEM LETT, V34, P182, DOI 10.1246/cl.2005.182
   Zhang ZR, 2002, J AM CHEM SOC, V124, P12294, DOI 10.1021/ja0208299
   Zhao D, 2011, ACCOUNTS CHEM RES, V44, P123, DOI 10.1021/ar100112y
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
   Zhao JK, 2004, CHEM LETT, V33, P842, DOI 10.1246/cl.2004.842
   Zhu CL, 2011, J AM CHEM SOC, V133, P1278, DOI 10.1021/ja110094g
   Zhu KK, 2003, CHEM COMMUN, P98, DOI 10.1039/b210065g
   Zhu XW, 2006, J CERAM SOC JPN, V114, P979, DOI 10.2109/jcersj.114.979
NR 550
TC 799
Z9 799
U1 33
U2 892
PU CHEMICAL SOC JAPAN
PI TOKYO
PA 1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN
SN 0009-2673
EI 1348-0634
J9 B CHEM SOC JPN
JI Bull. Chem. Soc. Jpn.
PD JAN 15
PY 2012
VL 85
IS 1
BP 1
EP 32
DI 10.1246/bcsj.20110162
PG 32
WC Chemistry, Multidisciplinary
SC Chemistry
GA 895AU
UT WOS:000300469400001
OA Bronze
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Thaveedeetrakul, A
   Witit-anun, N
   Boonamnuayvitaya, V
AF Thaveedeetrakul, Arisara
   Witit-anun, Nirun
   Boonamnuayvitaya, Virote
TI The role of target-to-substrate distance on the DC magnetron sputtered
   zirconia thin films' bioactivity
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Zirconium dioxide; Magnetron sputtering; Simulated body fluid; Thin
   film; Hydroxyapatite
ID SIMULATED BODY-FLUID; ZRO2 FILMS; OPTICAL-PROPERTIES; STAINLESS-STEEL;
   DEPOSITION; COATINGS; BIOMATERIAL; BEHAVIOR; GROWTH
AB Zirconium dioxide thin films were deposited on 316L-stainless steel type substrates using DC unbalanced magnetron sputtering. The process parameter of this work was the target-to-substrate distance (d(t-s)), which was varied from 60 to 120 mm. The crystal structure and surface topography of zirconium dioxide thin films were characterized by X-ray diffraction (XRD) and atomic force microscopy (AFM). The results demonstrate that all of the ZrO2 thin films are composed monoclinic phase. The film sputtered at short d(t-s) (60 mm) shows a rather heterogeneous, uneven surface. The grain size, roughness, and thickness of thin films were decreased by increasing d(t-s). The bioactivity was assessed by investigating the formation of hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) on the thin film surface soaked in simulated body fluids (SBF) for 7 days. XRD and scanning electron microscopy (SEM) were used to verify the formation of apatite layers on the samples. Bone-like apatites were formed on the surface of the ZrO2 thin film in SBF immersion experiments. A nanocrystalline hydroxyapatite (HA) with a particle size of 2-4 mu m was deposited. Higher crystallinity of HA on the surface was observed when the distance d(t-s) increased to more than 80 mm. Therefore, it seems that a d(t-s) greater than 80 mm is an important sputtering condition for inducing HA on the zirconia film. (C) 2011 Elsevier B. V. All rights reserved.
C1 [Thaveedeetrakul, Arisara; Boonamnuayvitaya, Virote] King Mongkuts Univ Technol Thonburi, Dept Chem Engn, Bangkok, Thailand.
   [Witit-anun, Nirun] Burapha Univ, Dept Phys, Chon Buri, Thailand.
   [Witit-anun, Nirun] Minist Educ, CHE, Thailand Ctr Excellence Phys, Bangkok, Thailand.
RP Boonamnuayvitaya, V (reprint author), King Mongkuts Univ Technol Thonburi, Dept Chem Engn, Bangkok, Thailand.
EM virote.boo@kmutt.ac.th
FU Royal Golden Jubilee of Thailand Research Fund; Department of Chemical
   Engineering at King Mongkut's University of Technology Thonburi;
   National Research University of Thailand, Office of the Higher Education
   Commission
FX This work was supported by the Royal Golden Jubilee of Thailand Research
   Fund, the Department of Chemical Engineering at King Mongkut's
   University of Technology Thonburi, and the National Research University
   Project of Thailand, Office of the Higher Education Commission.
CR Alper A.M., 1970, HIGH TEMPERATURE O 2
   Amezaga-Madrid P, 2008, THIN SOLID FILMS, V516, P8282, DOI 10.1016/j.tsf.2008.03.022
   Balamurugan A, 2003, MATER LETT, V57, P4202, DOI 10.1016/S0167-577X(03)00290-8
   Bermudez-Reyes B., 2008, J AD TECH, V4, P141
   Carter CB, 2007, CERAMIC MAT SCI ENG
   Chen IM, 2005, THIN SOLID FILMS, V491, P339, DOI 10.1016/j.tsf.2005.06.096
   Chen ML, 2007, APPL SURF SCI, V253, P7942, DOI 10.1016/j.apsusc.2007.02.065
   Chen ZX, 2005, MAT SCI ENG B-SOLID, V117, P81, DOI 10.1016/j.mseb.2004.10.025
   Cheng GJ, 2005, MAT SCI ENG C-BIO S, V25, P541, DOI 10.1016/j.msec.2005.05.002
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Cullity B. D., 2001, ELEMENTS XRAY DIFFRA
   Gao PT, 2001, APPL SURF SCI, V173, P84, DOI 10.1016/S0169-4332(00)00888-6
   Heimann R. B., 2008, PLASMA SPRAY COATING
   Hembram KPSS, 2007, PHYSICA B, V399, P21, DOI [10.1016/j.physb.2007.05.022, 10.1016/j.phvsb.2007.05.022]
   Huang AP, 2005, MAT SCI ENG B-SOLID, V121, P244, DOI 10.1016/j.mseb.2005.04.002
   Huijuan Y., 2010, WUHAN U J NAT SCI, V15, P440
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2008, WOODHEAD PUBL MATER, P1
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Morks MR, 2008, J MECH BEHAV BIOMED, V1, P165, DOI 10.1016/j.jmbbm.2007.09.002
   Nagarajan S, 2009, J SOL-GEL SCI TECHN, V52, P188, DOI 10.1007/s10971-009-2024-0
   Ong J.L., 2006, SURF MODIFICATION BI, P67
   Pamu D, 2009, THIN SOLID FILMS, V517, P1587, DOI 10.1016/j.tsf.2008.09.074
   Park J. H., 2001, CHEM VAPOR DEPOSITIO
   Paterson MJ, 1996, SURF COAT TECH, V86, P153, DOI 10.1016/S0257-8972(96)03029-0
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ryu HS, 2005, CURR APPL PHYS, V5, P512, DOI 10.1016/j.cap.2005.01.022
   Satas D., 2001, COATINGS TECHNOLOGY
   Shi J.Z., 2009, VACUUM, V83, P249
   Tjong SC, 2004, MAT SCI ENG R, V45, P1, DOI 10.1016/j.mser.2004.07.001
   Uchida M, 2002, J CERAM SOC JPN, V110, P710, DOI 10.2109/jcersj.110.710
   Venkataraj S, 2002, J APPL PHYS, V92, P3599, DOI 10.1063/1.1503858
   Wang GC, 2008, SURF COAT TECH, V202, P5824, DOI 10.1016/j.surfcoat.2008.06.109
   Wasa K., 1992, HDB SPUTTER DEPOSITI
   Yeh SW, 2007, MATER CHEM PHYS, V105, P127, DOI 10.1016/j.matchemphys.2007.04.018
   Zhang HH, 2009, VACUUM, V83, P1311, DOI 10.1016/j.vacuum.2009.04.041
   Zhao S, 2008, OPT MATER, V30, P910, DOI 10.1016/j.optmat.2007.04.001
NR 37
TC 14
Z9 15
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 15
PY 2012
VL 258
IS 7
BP 2612
EP 2619
DI 10.1016/j.apsusc.2011.10.104
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 877FI
UT WOS:000299162300064
DA 2018-10-19
ER

PT J
AU Lavertu, M
   Darras, V
   Buschmann, MD
AF Lavertu, Marc
   Darras, Vincent
   Buschmann, Michael D.
TI Kinetics and efficiency of chitosan reacetylation
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Polysaccharide; Biomaterial; Reacetylation; Acetic anhydride;
   Kinetics; Hydrolysis; Efficiency
ID PARTIALLY DEACETYLATED CHITINS; N-ACETYLATED CHITOSANS; METHANOL-WATER;
   IONIZABLE COMPOUNDS; MOLECULAR-WEIGHT; ACID; PH; DEGRADATION;
   HYDROLYSIS; IONIZATION
AB Chitosan reacetylation kinetics and efficiency were studied in water-methanol (MeOH) mixtures. The polymer was dissolved using acetic acid and acetic anhydride was used for reacetylation. Combining second-order kinetics and acid-base dissociation equations of chitosan, and using acetic anhydride hydrolysis rates determined by conductivity measurements, reacetylation reaction rate constants of 187, 108,46 min(-1) M(-1) were found in 0.50 and 80% MeOH (v/v), respectively. Contrary to previous literature, it was found that improvement in reacetylation efficiency in the presence of MeOH is mainly due to an increase of acetic acid pK(a) by MeOH that limits the ionization of the polymer in the course of the reaction rather than to a decreased acetic anhydride hydrolysis rate, as previously thought. Based on these insights, the model developed in this study was able to predict the significantly reduced efficiency of the reaction for a large extent of reacetylation, without requiring any steric hindrance from the acetyl group. Conditions to maximize the reaction efficiency for a large extent of reacetylation were identified. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Lavertu, Marc; Darras, Vincent; Buschmann, Michael D.] Ecole Polytech, Dept Chem Engn, Inst Biomed Engn, Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.
RP Lavertu, M (reprint author), Ecole Polytech, Dept Chem Engn, Inst Biomed Engn, Stn Ctr Ville, POB 6079, Montreal, PQ H3C 3A7, Canada.
EM marc.lavertu@polymtl.ca
RI DARRAS, Vincent/O-6212-2014
OI DARRAS, Vincent/0000-0003-4272-6849; Buschmann,
   Michael/0000-0002-2242-6198
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Fonds Quebecois de la Recherche sur la Nature et les Technologies
   (FQRNT)
FX We would like to acknowledge Sarah Dupuis who performed some
   reacetylation experiments and chitosan solubility tests and Isabelle
   Richard for acetic anhydride hydrolysis measurements. Support from the
   Natural Sciences and Engineering Research Council of Canada (NSERC) and
   from the Fonds Quebecois de la Recherche sur la Nature et les
   Technologies (FQRNT) is acknowledged.
CR AIBA S, 1991, INT J BIOL MACROMOL, V13, P40, DOI 10.1016/0141-8130(91)90008-I
   AIBA S, 1994, CARBOHYD RES, V261, P297, DOI 10.1016/0008-6215(94)84025-3
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   ALBRIGHT PS, 1946, J AM CHEM SOC, V68, P1061, DOI 10.1021/ja01210a043
   Asprey SP, 1996, CHEM ENG SCI, V51, P4681, DOI 10.1016/0009-2509(96)00306-5
   BACARELLA AL, 1955, J ORG CHEM, V20, P747, DOI 10.1021/jo01124a007
   Berger J, 2005, INT J PHARM, V288, P197, DOI 10.1016/j.ijpharm.2004.07.037
   Bosch E, 1996, ANAL CHEM, V68, P3651, DOI 10.1021/ac960104l
   Canals I, 2001, J CHROMATOGR A, V911, P191, DOI 10.1016/S0021-9673(00)01271-1
   CLELAND FA, 1956, AICHE J, V2, P489, DOI 10.1002/aic.690020414
   Dal Pozzo A, 2000, CARBOHYD POLYM, V42, P201, DOI 10.1016/S0144-8617(99)00134-4
   Filion D, 2007, BIOMACROMOLECULES, V8, P3224, DOI 10.1021/bm700520m
   HIRANO S, 1975, POLYMER, V16, P622, DOI 10.1016/0032-3861(75)90159-7
   Inczedy J, 1998, COMPENDIUM ANAL NOME
   Knaul JZ, 1998, CAN J CHEM, V76, P1699, DOI 10.1139/cjc-76-11-1699
   KURITA K, 1977, MAKROMOL CHEM, V178, P3197
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Lavertu M, 2008, BIOMACROMOLECULES, V9, P640, DOI 10.1021/bm700745d
   MAGHAMI GG, 1988, MAKROMOL CHEM, V189, P195
   March J., 1992, ADV ORGANIC CHEM REA
   Martinez A, 2004, J TEXTURE STUD, V35, P53, DOI 10.1111/j.1745-4603.2004.tb00822.x
   MOORE GK, 1980, INT J BIOL MACROMOL, V2, P78, DOI 10.1016/0141-8130(80)90032-X
   Nguyen S, 2009, CARBOHYD POLYM, V75, P528, DOI 10.1016/j.carbpol.2008.08.013
   Ottoy MH, 1996, CARBOHYD POLYM, V29, P17
   PARK JW, 1983, B KOR CHEM SOC, V4, P68
   Qun G, 2007, J APPL POLYM SCI, V104, P2720, DOI 10.1002/app.25711
   SASHIWA H, 1993, CARBOHYD RES, V242, P167, DOI 10.1016/0008-6215(93)80031-9
   SASHIWA H, 1991, CARBOHYD POLYM, V16, P291, DOI 10.1016/0144-8617(91)90114-R
   SHEDLOVSKY T, 1956, J PHYS CHEM-US, V60, P151, DOI 10.1021/j150536a003
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   Xu XL, 2009, J APPL POLYM SCI, V111, P1523, DOI 10.1002/app.29043
NR 33
TC 20
Z9 20
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 15
PY 2012
VL 87
IS 2
BP 1192
EP 1198
DI 10.1016/j.carbpol.2011.08.096
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 865IU
UT WOS:000298305400029
DA 2018-10-19
ER

PT J
AU Xu, F
   Li, J
   Jain, V
   Tu, RS
   Huang, QR
   Nanda, V
AF Xu, Fei
   Li, Ji
   Jain, Vikas
   Tu, Raymond S.
   Huang, Qingrong
   Nanda, Vikas
TI Compositional Control of Higher Order Assembly Using Synthetic Collagen
   Peptides
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID REVERSIBLE HYDROGELS; DESIGNED PEPTIDE; TRIPLE HELICES; DRUG-DELIVERY;
   BIOMATERIAL; STABILITY; FIBER
AB We present the case of a two-component collagen peptide hydrogel that self-assembles through non-covalent electrostatic interactions. Natural collagen materials, such as those of connective tissue or the basement membrane, assemble in a hierarchic fashion. Similarly, the synthetic peptides presented here proceed from monomer to trimer to fiber and, finally, to a hydrogel. By varying stoichiometry and concentration, we are able to dissect the stages of higher order assembly. Insight gained from this study will improve the molecular design of biomimetic materials.
C1 [Xu, Fei; Nanda, Vikas] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.
   [Xu, Fei; Nanda, Vikas] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.
   [Li, Ji; Huang, Qingrong] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
   [Jain, Vikas; Tu, Raymond S.] CUNY City Coll, Dept Chem Engn, New York, NY 10031 USA.
RP Nanda, V (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.
EM nanda@cabm.rutgers.edu
OI Nanda, Vikas/0000-0003-2786-8347; Xu, Fei/0000-0003-1077-0431
FU NIH HHS [DP2 OD006478, DP2 OD006478-01]
CR Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gauba V, 2007, J AM CHEM SOC, V129, P15034, DOI 10.1021/ja075854z
   Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640
   Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222
   KADLER KE, 1990, BIOCHEM J, V268, P339, DOI 10.1042/bj2680339
   Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   Nagarkar RP, 2008, J AM CHEM SOC, V130, P4466, DOI 10.1021/ja710295t
   Nowak AP, 2003, J AM CHEM SOC, V125, P15666, DOI 10.1021/ja0381050
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   O'Grady JE, 2003, ADV DRUG DELIVER REV, V55, P1699, DOI 10.1016/j.addr.2003.08.006
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Przybyla DE, 2008, J AM CHEM SOC, V130, P12610, DOI 10.1021/ja804942w
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990
   Roe R.-J., 2000, METHODS XRAY NEUTRON
   Xu F, 2010, BIOCHEMISTRY-US, V49, P2307, DOI 10.1021/bi902077d
   Zimenkov Y, 2006, J AM CHEM SOC, V128, P6770, DOI 10.1021/ja0605974
NR 26
TC 25
Z9 25
U1 4
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 11
PY 2012
VL 134
IS 1
BP 47
EP 50
DI 10.1021/ja2077894
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 903AB
UT WOS:000301084200013
PM 22171825
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gasik, M
   Van Mellaert, L
   Pierron, D
   Braem, A
   Hofmans, D
   De Waelheyns, E
   Anne, J
   Harmand, MF
   Vleugels, J
AF Gasik, Michael
   Van Mellaert, Lieve
   Pierron, Dorothee
   Braem, Annabel
   Hofmans, Dorien
   De Waelheyns, Evelien
   Anne, Jozef
   Harmand, Marie-Francoise
   Vleugels, Jozef
TI Reduction of Biofilm Infection Risks and Promotion of Osteointegration
   for Optimized Surfaces of Titanium Implants
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID COATINGS
AB Titanium-based implants are widely used in modern clinical practice; however, complications associated with implants due to bacterial-induced infections arise frequently, caused mainly by staphylococci, streptococci, Pseudomonas spp. and coliform bacteria. Although increased hydrophilicity of the biomaterial surface is known to be beneficial in minimizing the biofilm, quantitative analyses between the actual implant parameters and bacterial development are scarce. Here, the results of in vitro studies of Staphylococcus aureus and Staphylococcus epidermidis proliferation on uncoated and coated titanium materials with different roughness, porosity, topology, and hydrophilicity are shown. The same materials have been tested in parallel with respect to human osteogenic and endothelial cell adhesion, proliferation, and differentiation. The experimental data processed by meta-analysis are indicating the possibility of decreasing the biofilm formation by 80-90% for flat substrates versus untreated plasma-sprayed porous titanium and by 65-95% for other porous titanium coatings. It is also shown that optimized surfaces would lead to 10-50% enhanced cell proliferation and differentiation versus reference porous titanium coatings. This presents an opportunity to manufacture implants with intrinsic reduced infection risk, yet without the additional use of antibacterial substances.
C1 [Gasik, Michael] Aalto Univ Fdn, Sch Chem Technol, FIN-00076 Aalto, Finland.
   [Van Mellaert, Lieve; Hofmans, Dorien; De Waelheyns, Evelien; Anne, Jozef] Katholieke Univ Leuven, Rega Inst Med Res, Bacteriol Lab, B-3000 Louvain, Belgium.
   [Pierron, Dorothee; Harmand, Marie-Francoise] LEMI, F-33650 Martillac, France.
   [Braem, Annabel; Vleugels, Jozef] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
RP Gasik, M (reprint author), Aalto Univ Fdn, Sch Chem Technol, POB 16200, FIN-00076 Aalto, Finland.
EM michael.gasik@aalto.fi
RI Braem, Annabel/A-4343-2017; Van Mellaert, Lieve/Q-4975-2017; Vleugels,
   Jozef/C-8262-2017; Gasik, Michael/G-2224-2013
OI Braem, Annabel/0000-0002-4890-0177; Van Mellaert,
   Lieve/0000-0002-8584-8160; Vleugels, Jozef/0000-0003-4432-4675; Gasik,
   Michael/0000-0002-5782-7987; Anne, Jozef/0000-0002-0493-2644
FU European Commission [026501-2]
FX Financial support of the European Commission under FP6 integrated
   project No. 026501-2 "MEDDELCOAT" is gratefully acknowledged.
   Disclosure: The authors confirm that there are no known conflicts of
   interest associated with this publication and there has been no
   significant financial support for this work that could have influenced
   its outcome.
CR Battiti R., 2008, REACTIVE SEARCH INTE
   Bischof M., 2010, OPEN PHARMACOECON HL, V2, P25
   Black J., 1999, BIOL PERFORMANCE BIO
   Braem A., 2009, <IT>UK Patent </IT>, Patent No. [GB0915577.1, 09155771]
   Braem A, 2011, ADV ENG MATER, V13, P509, DOI 10.1002/adem.201100011
   Branke J., 2008, MULTIOBJECTIVE OPTIM
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Celik H H, 2011, J BIOMATER NANOBIOTE, V2, P98
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Drnovsek N, 2009, SURF COAT TECH, V203, P1462, DOI 10.1016/j.surfcoat.2008.11.031
   Frojd V., 2010, THESIS U MALMO SWEDE
   Gasik M., 2010, ENGINSOFT NEWS, V3, P23
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   LEONHARDT A, 1995, J DENT RES, V74, P1607, DOI 10.1177/00220345950740091701
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Nagahara S, 1996, J BIOMED MATER RES, V32, P677, DOI 10.1002/(SICI)1097-4636(199612)32:4<677::AID-JBM22>3.0.CO;2-9
   Neirinck B, 2008, ADV ENG MATER, V10, P246, DOI 10.1002/adem.200700273
   Orlandini L., 2007, ARTICULARIS, V4, P13
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Quackenbush J., 2001, NAT REV GENET, V2, P419
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Vilamitjana-Amedee J., 1993, CELL DEV BIOL ANIM A, V29A, P699
   von Recum A.F., 1998, HDB BIOMATERIALS EVA
   Waselau M., 2002, THESIS U ZURICH SWIT
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
NR 27
TC 19
Z9 19
U1 2
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN 11
PY 2012
VL 1
IS 1
BP 117
EP 127
DI 10.1002/adhm.201100006
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092GY
UT WOS:000315109300013
PM 23184696
OA Bronze
DA 2018-10-19
ER

PT J
AU Venugopal, JR
   Prabhakaran, MP
   Mukherjee, S
   Ravichandran, R
   Dan, K
   Ramakrishna, S
AF Venugopal, Jayarama Reddy
   Prabhakaran, Molamma P.
   Mukherjee, Shayanti
   Ravichandran, Rajeswari
   Dan, Kai
   Ramakrishna, Seeram
TI Biomaterial strategies for alleviation of myocardial infarction
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE biomaterials; hydrogels; injectables; cardiomyocytes; mesenchymal stem
   cells; myocardial infarction
ID MESENCHYMAL STEM-CELLS; IMPROVES CARDIAC-FUNCTION; LEFT-VENTRICULAR
   FUNCTION; AUTOLOGOUS SKELETAL MYOBLASTS; SHEET MANIPULATION TECHNIQUE;
   MARROW-DERIVED ANGIOBLASTS; CORD BLOOD-CELLS; MECHANICAL-PROPERTIES;
   HEART-FAILURE; IN-VIVO
AB World Health Organization estimated that heart failure initiated by coronary artery disease and myocardial infarction (MI) leads to 29 per cent of deaths worldwide. Heart failure is one of the leading causes of death in industrialized countries and is expected to become a global epidemic within the twenty-first century. MI, the main cause of heart failure, leads to a loss of cardiac tissue impairment of left ventricular function. The damaged left ventricle undergoes progressive 'remodelling' and chamber dilation, with myocyte slippage and fibroblast proliferation. Repair of diseased myocardium with in vitro-engineered cardiac muscle patch/injectable biopolymers with cells may become a viable option for heart failure patients. These events reflect an apparent lack of effective intrinsic mechanism for myocardial repair and regeneration. Motivated by the desire to develop minimally invasive procedures, the last 10 years observed growing efforts to develop injectable biomaterials with and without cells to treat cardiac failure. Biomaterials evaluated include alginate, fibrin, collagen, chitosan, self-assembling peptides, biopolymers and a range of synthetic hydrogels. The ultimate goal in therapeutic cardiac tissue engineering is to generate biocompatible, non-immunogenic heart muscle with morphological and functional properties similar to natural myocardium to repair MI. This review summarizes the properties of biomaterial substrates having sufficient mechanical stability, which stimulates the native collagen fibril structure for differentiating pluripotent stem cells and mesenchymal stem cells into cardiomyocytes for cardiac tissue engineering.
C1 [Venugopal, Jayarama Reddy; Prabhakaran, Molamma P.; Mukherjee, Shayanti; Ravichandran, Rajeswari; Dan, Kai; Ramakrishna, Seeram] Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Healthcare & Energy Mat Lab, Singapore, Singapore.
RP Venugopal, JR (reprint author), Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Healthcare & Energy Mat Lab, Singapore, Singapore.
EM nnijrv@nus.edu.sg; seeram@nus.edu.sg
RI Prabhakaran, Molamma/M-8630-2013; Ravichandran, Rajeswari/C-9313-2012
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU NRF [R-398-001-065-592]; Nanoscience and Nanotechnology Initiative,
   Faculty of Engineering, National University of Singapore, Singapore
FX This study was supported by NRF-Technion grant (R-398-001-065-592), and
   Nanoscience and Nanotechnology Initiative, Faculty of Engineering,
   National University of Singapore, Singapore.
CR Akins RE, 1999, TISSUE ENG, V5, P103, DOI 10.1089/ten.1999.5.103
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Baig MK, 1999, HEART LUNG, V28, P87, DOI 10.1053/hl.1999.v28.a97762
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   BING OHL, 1971, CIRC RES, V28, P234, DOI 10.1161/01.RES.28.2.234
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   Brehm Michael, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS101
   Brown MA, 2008, BIOTECHNOL PROGR, V24, P907, DOI [10.1002/btpr.11, 10.1021/bp.11]
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Caspi O, 2006, EUR HEART J SUPPL, V8, pE43, DOI 10.1093/eurheartj/sul031
   Chachques JC, 2002, J CARDIAC SURG, V17, P194, DOI 10.1111/j.1540-8191.2002.tb01199.x
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217
   Chachques Juan C, 2005, Asian Cardiovasc Thorac Ann, V13, P287
   Chachques JC, 2011, CARDIOL RES PRACT, DOI 10.4061/2011/806795
   CHAPMAN D, 1990, CIRC RES, V67, P787, DOI 10.1161/01.RES.67.4.787
   Chen CH, 2008, CARDIOVASC RES, V80, P88, DOI 10.1093/cvr/cvn149
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Choi YS, 2010, BIOMATERIALS, V31, P2236, DOI 10.1016/j.biomaterials.2009.11.097
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   CHUONG CJ, 1991, AM J PHYSIOL, V260, pH1224
   Coats AJS, 2009, INT J CARDIOL, V131, P149, DOI 10.1016/j.ijcard.2008.11.048
   Cortes-Morichetti M, 2007, TISSUE ENG, V13, P2681, DOI 10.1089/ten.2006.0447
   Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dib N, 2009, JACC-CARDIOVASC INTE, V2, P9, DOI 10.1016/j.jcin.2008.11.003
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Eschenhagen T, 2006, CIRC RES, V98, P573, DOI 10.1161/01.RES.0000215627.13049.5d
   ESCHENHAGEN T, 2002, BASIC RES CARDIOL S1, V97, P146, DOI DOI 10.1007/S003950200043
   Farahmand P, 2008, CIRCULATION, V118, pS130, DOI 10.1161/CIRCULATIONAHA.107.757617
   Flachskampf FA, 2000, J AM SOC ECHOCARDIOG, V13, P277, DOI 10.1067/mje.2000.103878
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84
   Gojo S, 2003, EXP CELL RES, V288, P51, DOI 10.1016/S0014-4827(03)00132-0
   Graham HK, 2008, ACTA PHYSIOL, V194, P3, DOI 10.1111/j.1748-1716.2008.01881.x
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hein S, 2001, J NUCL CARDIOL, V8, P188, DOI 10.1067/mnc.2001.113331
   Henning RJ, 2004, CELL TRANSPLANT, V13, P729, DOI 10.3727/000000004783983477
   Herpel E, 2006, HISTOPATHOLOGY, V48, P736, DOI 10.1111/j.1365-2559.2006.02398.x
   Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   IRUELAARISPE ML, 1991, DEV BIOL, V144, P107, DOI 10.1016/0012-1606(91)90483-J
   Itabashi Y, 2005, ARTIF ORGANS, V29, P95, DOI 10.1111/j.1525-1594.2005.29020.x
   Itescu S, 2002, ANN HEMATOL, V81, pS21
   Jane-Lise S, 2000, Heart Fail Rev, V5, P239
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kitamura M, 2001, CLIN CARDIOL, V24, P325, DOI 10.1002/clc.4960240413
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2006, EUR J CARDIO-THORAC, V29, P50, DOI 10.1016/j.ejcts.2005.10.015
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kumudine C, 1999, POLYM DATA HDB, P70
   Lanza R, 2004, CIRC RES, V94, P820, DOI 10.1161/01.RES.0000120863.53562.DF
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2005, CYTOTHERAPY, V7, P251, DOI 10.1080/14653240510027163
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041
   LONG CS, 1991, CELL REGUL, V2, P1081
   MacCarthy PA, 2001, CIRCULATION, V104, P2967, DOI 10.1161/hc4901.100382
   MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7
   Marsano A, 2008, IEEE ENG MED BIO, P3590, DOI 10.1109/IEMBS.2008.4649982
   Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Mazo M, 2011, J CARDIOVASC TRANSL, V4, P145, DOI 10.1007/s12265-010-9246-y
   Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Misof K, 1997, J CLIN INVEST, V100, P40, DOI 10.1172/JCI119519
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mukherjee S, 2011, ADV FUNCT MATER, V21, P2291, DOI 10.1002/adfm.201002434
   Muller-Ehmsen Jochen, 2002, Congest Heart Fail, V8, P220, DOI 10.1111/j.1527-5299.2002.00292.x
   Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296
   NAG AC, 1979, J ANAT, V129, P541
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Okura H, 2010, TISSUE ENG PART C-ME, V16, P417, DOI [10.1089/ten.tec.2009.0362, 10.1089/ten.TEC.2009.0362]
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa T., 2003, J THORAC CARDIOVASC, V126, P2113, DOI [10.1016/j.jtcvs.2003.03.002, DOI 10.1016/J.JTCVS.2003.03.002]
   Pagani FD, 2003, J AM COLL CARDIOL, V41, P879, DOI 10.1016/S0735-1097(03)00081-0
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Perin EC, 2004, CURR OPIN HEMATOL, V11, P399, DOI 10.1097/01.moh.0000143359.77689.aa
   Pezzin APT, 2003, J APPL POLYM SCI, V88, P2744, DOI 10.1002/app.11984
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2005, J SERB CHEM SOC, V70, P541, DOI 10.2298/JSC0503541R
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Rajnoch C, 2001, J THORAC CARDIOV SUR, V121, P871, DOI 10.1067/mtc.2001.112937
   RAMSAY BA, 1993, APPL ENVIRON MICROB, V59, P1242
   Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Reinlib L, 2000, CIRCULATION, V101, pE182
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rigol M, 2010, J CARD FAIL, V16, P357, DOI 10.1016/j.cardfail.2009.12.006
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321
   Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217
   Severs NJ, 2000, BIOESSAYS, V22, P188, DOI 10.1002/(SICI)1521-1878(200002)22:2<188::AID-BIES10>3.0.CO;2-T
   Shachar M, 2003, HEART FAIL REV, V8, P271, DOI 10.1023/A:1024729919743
   Shafy A, 2009, J THORAC CARDIOV SUR, V138, P994, DOI 10.1016/j.jtcvs.2009.02.025
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Takaoka H, 2002, AM J PHYSIOL-HEART C, V282, pH2190, DOI 10.1152/ajpheart.00759.2001
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   WEBER KT, 1988, CIRC RES, V62, P757, DOI 10.1161/01.RES.62.4.757
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yildirim Y, 2007, CIRCULATION, V116, pI16, DOI 10.1161/CIRCULATIONAHA.106.679688
   YIN FCP, 1980, CIRC RES, V46, P292, DOI 10.1161/01.RES.46.2.292
   Zachar V, 2011, EXPERT OPIN BIOL TH, V11, P775, DOI 10.1517/14712598.2011.570258
   ZHANG JC, 1995, J THORAC CARDIOV SUR, V109, P1059, DOI 10.1016/S0022-5223(95)70188-5
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zimmermann Wolfram-Hubertus, 2007, Trends Cardiovasc Med, V17, P134, DOI 10.1016/j.tcm.2007.02.007
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 168
TC 103
Z9 106
U1 2
U2 70
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JAN 7
PY 2012
VL 9
IS 66
BP 1
EP 19
DI 10.1098/rsif.2011.0301
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 852CE
UT WOS:000297322800001
PM 21900319
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Li, WL
   Wang, JJ
   Chi, HX
   Wei, GZ
   Zhang, J
   Dai, LX
AF Li, Wenli
   Wang, Jianjun
   Chi, Hengxuan
   Wei, Guangzhao
   Zhang, Jian
   Dai, Lixing
TI Preparation and Antibacterial Activity of Polyvinyl Alcohol/Regenerated
   Silk Fibroin Composite Fibers Containing Ag Nanoparticles
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE poly(vinyl alcohol); regenerated silk fibroin; electrospinning; Ag
   nanoparticles; nanofibers
ID POLY(VINYL ALCOHOL) NANOFIBERS; SILVER NANOPARTICLES; IONIC LIQUIDS;
   FILMS; REGENERATION; MORPHOLOGY; CELLULOSE; NANOCOMPOSITES;
   NANOCRYSTALS; BIOMATERIAL
AB Polyvinyl alcohol (PVA)/regenerated silk fibroin (SF)/AgNO3 composite nanofibers were prepared by electrospinning. A large number of nanoparticles containing silver were generated in situ and well-dispersed nanoparticles were confirmed by transmission electron microscopy (TEM) intuitionally. Ultraviolet (UV)-visible spectroscopy and X-ray diffraction (XRD) patterns indicated that nanoparticles containing Ag were present both in blend solution and in composite nanofibers after heat treatment and after subsequent UV irradiation. By annealing the nanofibers, Ag+ therein was reduced so as to produce nanoparticles containing silver. By combining heat treatment with UV irradiation, Ag+ was transformed into Ag clusters and further oxidized into Ag3O4 and Ag2O2. Especially size of the nanoparticles increased with heat treatment and subsequent UV irradiation. This indicated that the nanoparticles containing silver could be regulated by heat treatment and UV irradiation. The antimicrobial activity of heat-treated composite nanofibers was evaluated by Halo test method and the resultant nanofibers showed very strong antimicrobial activity. (C) 2011 Wiley Periodicals, Inc. J Appl Polym Sci 123: 20-25, 2012
C1 [Li, Wenli; Wang, Jianjun; Chi, Hengxuan; Wei, Guangzhao; Zhang, Jian; Dai, Lixing] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Jiangsu, Peoples R China.
RP Dai, LX (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Dushuhu Campus, Suzhou 215123, Jiangsu, Peoples R China.
EM dailixing@suda.edu.cn
FU Chinese National Basic Research Program (973 Program) [2005CB623902];
   Chinese National Science Foundation [20874068]; National Engineering
   Laboratory for Modem Silk, Soochow University
FX Contract grant sponsor: Chinese National Basic Research Program (973
   Program); contract grant number: 2005CB623902.; Contract grant sponsor:
   Chinese National Science Foundation; contract grant number: 20874068.;
   Contract grant sponsor: Innovation fund of National Engineering
   Laboratory for Modem Silk, Soochow University.
CR Barakat NAM, 2008, LANGMUIR, V24, P11982, DOI 10.1021/la802084h
   Chen C, 2006, NANOTECHNOLOGY, V17, P466, DOI 10.1088/0957-4484/17/2/021
   Chen Y, 2008, CARBOHYD POLYM, V73, P8, DOI 10.1016/j.carbpol.2007.10.015
   Dai LX, 2002, J APPL POLYM SCI, V86, P2342, DOI 10.1002/app.11260
   Dong GP, 2009, APPL SURF SCI, V255, P7623, DOI 10.1016/j.apsusc.2009.04.039
   Dubois V, 2001, J PHYS CHEM B, V105, P9363, DOI 10.1021/jp0045888
   Gong P, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/28/285604
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hong KH, 2006, J POLYM SCI POL PHYS, V44, P2468, DOI 10.1002/polb.20913
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin W. J., 1903, MACROMOL RAPID COMM, V2005, P26
   Jin WJ, 2007, SYNTHETIC MET, V157, P454, DOI 10.1016/j.synthmet.2007.05.011
   Kang YO, 2006, J NON-CRYST SOLIDS, V352, P463, DOI 10.1016/j.jnoncrysol.2006.01.043
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Lee HK, 2005, MATER LETT, V59, P2977, DOI 10.1016/j.matlet.2005.05.005
   Li D., 2004, ADV MATER, V2062, P16
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lim SK, 2006, MACROMOL MATER ENG, V291, P1265, DOI 10.1002/mame.200600264
   Lu HW, 2003, MATER CHEM PHYS, V81, P104, DOI 10.1016/S0254-0584(03)00147-0
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Qin CX, 2009, MATER LETT, V63, P1239, DOI 10.1016/j.matlet.2009.02.038
   Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037
   Subramanian V, 2004, J AM CHEM SOC, V126, P4943, DOI 10.1021/ja0315199
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Tomczak N, 2005, MACROMOLECULES, V38, P7863, DOI 10.1021/ma051049y
   Turner MB, 2004, BIOMACROMOLECULES, V5, P1379, DOI 10.1021/bm049748q
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang A, 2004, POLYMER, V45, P5505, DOI 10.1016/j.polymer.2004.06.013
   Wang SD, 2009, J APPL POLYM SCI, V113, P2675, DOI 10.1002/app.30346
   Wang ZY, 2007, CHEM J CHINESE U, V28, P1756
   Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004
   Wu J, 2004, BIOMACROMOLECULES, V5, P266, DOI 10.1021/bm034398d
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   [杨辉 Yang Hui], 2002, [硅酸盐学报, Journal of the Chinese Silicate Society], V30, P585
   Yang QB, 2003, SYNTHETIC MET, V137, P973, DOI 10.1016/S0379-6779(02)00963-3
   Yao C, 2009, POLYM INT, V58, P396, DOI 10.1002/pi.2544
   Ye XY, 2007, APPL SURF SCI, V253, P6264, DOI 10.1016/j.apsusc.2007.01.111
   YIN G, 2009, J APPL POLYM SCI, V111, P1471
   Zhang F, 2009, POLYMER, V50, P279, DOI 10.1016/j.polymer.2008.10.053
NR 44
TC 15
Z9 15
U1 3
U2 104
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 5
PY 2012
VL 123
IS 1
BP 20
EP 25
DI 10.1002/app.34434
PG 6
WC Polymer Science
SC Polymer Science
GA 840KB
UT WOS:000296437600003
DA 2018-10-19
ER

PT J
AU Sivakumar, PM
   Cometa, S
   Alderighi, M
   Prabhawathi, V
   Doble, M
   Chiellini, F
AF Sivakumar, Ponnurengam Malliappan
   Cometa, Stefania
   Alderighi, Michele
   Prabhawathi, Veluchamy
   Doble, Mukesh
   Chiellini, Federica
TI Chalcone embedded polyurethanes as a biomaterial: Synthesis,
   characterization and antibacterial adhesion
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Polyurethane; Chalcone; Bacterial adhesion; SEM EDAX; AFM
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERIC BIOMATERIALS;
   SOLID-SURFACES; INFECTIONS; MECHANISM; BACTERIA; ATTACHMENT; BEHAVIOR;
   WATER; QSAR
AB An antibacterial dimethylamino-chalcone embedded multiblock copolymer (PCL-PEG) was synthesized and characterized using FT-IR, (1)H NMR, SEM and SEC and the compound was characterized using FT-IR, (1)H NMR, and (13)C NMR. A 10% copolymer composite was prepared and casted as film to be used as a biomaterial and the copolymer films without the compound acted as control. TGA, DSC, AFM, SEM and EDAX analysis were performed for the above samples. Surface roughness (R(a)) of the copolymer composite film was less when compared to the copolymer film which indicated the proper distribution of chalcone in the composite film. copolymer composite film was hydrophilic compared to copolymer film. Antibacterial adhesion studies were performed for copolymer composite polymer film and evaluated using CFU measurement. and SEM analysis. Copolymer composite film shows promising antibacterial adhesion compared to the copolymer film. Hence the copolymer composite film can be used as a new biomaterial endowed with antibacterial properties. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Sivakumar, Ponnurengam Malliappan; Prabhawathi, Veluchamy; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
   [Sivakumar, Ponnurengam Malliappan; Cometa, Stefania; Alderighi, Michele; Chiellini, Federica] Univ Pisa, Lab Bioact Polymer Mat Biomed & Environm Applicat, UdR INSTM, Dept Chem & Ind Chem, Pisa, Italy.
RP Sivakumar, PM (reprint author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM sivamedchem@yahoo.co.in
RI Chiellini, Federica/F-3233-2010
OI Chiellini, Federica/0000-0003-4680-9975; Doble,
   Mukeshd/0000-0002-4335-0698; Sivakumar, Ponnurengam
   Malliappan/0000-0002-5880-9596
CR BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973
   Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2
   Cometa S, 2010, POLYM DEGRAD STABIL, V95, P2013, DOI 10.1016/j.polymdegradstab.2010.07.007
   Cometa S, 2010, MACROMOL BIOSCI, V10, P317, DOI 10.1002/mabi.200900284
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Grapski JA, 2001, BIOMATERIALS, V22, P2239, DOI 10.1016/S0142-9612(00)00412-9
   Khandwekar AP, 2009, J MED BIOL ENG, V29, P84
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   LIN J, 1977, AUST J CHEM, V30, P629, DOI 10.1071/CH9770629
   Liu CB, 2008, J BIOMED MATER RES B, V84B, P165, DOI 10.1002/jbm.30858
   Liu Y, 2008, J APPL POLYM SCI, V110, P3172, DOI 10.1002/app.28904
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   Nava-Ortiz CAB, 2010, ACTA BIOMATER, V6, P1398, DOI 10.1016/j.actbio.2009.10.039
   Nielsen SF, 2005, J MED CHEM, V48, P2667, DOI 10.1021/jm049424k
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2
   PRINGLE JH, 1983, APPL ENVIRON MICROB, V45, P811
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Schulin T, 2001, CLIN MICROBIOL INFEC, V7, P1, DOI 10.1046/j.1469-0691.2001.00053.x
   Selvakumar N, 2007, EUR J MED CHEM, V42, P538, DOI 10.1016/j.ejmech.2006.10.013
   Shao W, 2010, SURF COAT TECH, V204, P1288, DOI 10.1016/j.surfcoat.2009.10.015
   Sivakumar PM, 2007, BIOORG MED CHEM LETT, V17, P1695, DOI 10.1016/j.bmcl.2006.12.112
   Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037
   Sivakumar PM, 2010, APPL SURF SCI, V256, P6018, DOI 10.1016/j.apsusc.2010.03.112
   Sivakumar PM, 2009, CHEM BIOL DRUG DES, V74, P68, DOI 10.1111/j.1747-0285.2009.00828.x
   Sivakumar PM, 2009, CHEM BIOL DRUG DES, V73, P403, DOI 10.1111/j.1747-0285.2009.00793.x
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Zhao Q, 2007, APPL SURF SCI, V253, P8674, DOI 10.1016/j.apsusc.2007.04.044
   Zhou SB, 2003, BIOMATERIALS, V24, P3563, DOI 10.1016/S0142-9612(03)00207-2
NR 33
TC 16
Z9 16
U1 3
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 4
PY 2012
VL 87
IS 1
BP 353
EP 360
DI 10.1016/j.carbpol.2011.07.061
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 852WU
UT WOS:000297389000047
DA 2018-10-19
ER

PT B
AU Stylianou, A
   Yova, D
   Politopoulos, K
AF Stylianou, A.
   Yova, D.
   Politopoulos, K.
BE Paipetis, AS
   Matikas, TE
   Aggelis, DG
   VanHemelrijck, D
TI Atomic force microscopy quantitative and qualitative nanoscale
   characterization of collagen thin films
SO EMERGING TECHNOLOGIES IN NON-DESTRUCTIVE TESTING V
LA English
DT Proceedings Paper
CT 5th International Conference on Emerging Technologies in Non-Destructive
   Testing (NDT)
CY SEP 19-21, 2011
CL Ioannina, GREECE
SP Univ Ioannina, Dept Mat Sci & Engn
ID AFM; TECHNOLOGY; SCAFFOLDS; MATRICES; BIOLOGY; CELLS
AB Collagen is the most abundant protein in mammals and is a basic component of the extracellular matrix. Due to its unique properties it is widely used as biomaterial, scaffold and culture substrate for cell and tissue regeneration studies. As the majority of the biological reactions occur on surfaces or interfaces and collagen fiber structure can trigger cell response it is of great importance to nanostructure collagen thin films. Collagen nanobiomaterials present improved surface characteristics and as a result they have wide applications in biomedicine, in fields where it is very critical to pre-determined the topography of the surfaces. Surface characterization in the nanoscale could be performed with Atomic Force Microscopy (AFM), which is a powerful tool and offers quantitative and qualitative information. Its ability of high resolution imaging and non destructive characterization under different conditions make it very attractive for biological samples investigation. The aim of this paper was to characterize the collagen fibers of the thin films formed on different substrates (glass, mica, polystyrene particle surfaces) and correlate their morphology with the characteristics of the used substrates, the formation methodologies (spin coating, hydrodynamic flow) and the original collagen solution. The clarification of the role that different parameters play in the formation of the films will enable the design and control of collagen based nanobiomaterials with pre-determined characteristics. The results demonstrated that AFM can be used to characterize nanostructured collagen thin films which, under appropriate control of a number of parameters (e.g. substrate, solution concentration, film formation procedure) it is possible to be formed with reproducible and pre-determined characteristics. These nanostructured films and the offered information by AFM imaging could be used in order to fully clarify the relationship between collagen surface nano-characteristics and cells behaviour. These films could be applied to direct cellular processes or cover non-biological surfaces, offering them biocompatibility, in a variety of medical applications. Additionally, these nanostructured patterns could model collagen rich tissues and facilitate the study their optical properties, like the generation of Second Harmonic.
C1 [Stylianou, A.; Yova, D.; Politopoulos, K.] Natl Tech Univ Athens, Sch Elect & Comp Engn, Biomed Opt & Appl Biophys Lab, Athens, Greece.
RP Stylianou, A (reprint author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Biomed Opt & Appl Biophys Lab, Athens, Greece.
OI Politopoulos, Konstantinos/0000-0003-4126-2149; Stylianou,
   Andreas/0000-0002-1641-1854
CR Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Beard J.D., 2011, J PHYS C SERIES, V286
   Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Elliott JT, 2005, MATRIX BIOL, V24, P489, DOI 10.1016/j.matbio.2005.07.005
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Gadegaard N, 2006, BIOTECH HISTOCHEM, V81, P87, DOI 10.1080/10520290600783143
   Hasirci V, 2006, J BIOMAT SCI-POLYM E, V17, P1241, DOI 10.1163/156856206778667442
   Horcas I., 2007, REV SCI INSTRUMENTS, V78
   Hsu YM, 2009, J BIOMED MATER RES B, V91B, P737, DOI 10.1002/jbm.b.31450
   Jiang FZ, 2004, MICROSC RES TECHNIQ, V64, P435, DOI 10.1002/jemt.20101
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Morris V. J., 2008, ATOMIC FORCE MICROSC
   Plant A.L., 2009, BBA-MOL CELL RES, V793, P839
   Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064
   Silver FH, 2009, J ENG FIBER FABR, V4, P9
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2010, 12 MED C MED BIOL EN, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Sun M, 2008, LANGMUIR, V24, P5418, DOI 10.1021/la703292h
   Tong WD, 2002, J BIOMED MATER RES, V61, P346, DOI 10.1002/jbm.10165
NR 25
TC 4
Z9 4
U1 0
U2 6
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-415-62131-1
PY 2012
BP 415
EP 420
PG 6
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BIF19
UT WOS:000327989800065
DA 2018-10-19
ER

PT B
AU Berg, RJ
   Saigal, A
   James, TP
AF Berg, Robert J.
   Saigal, Anil
   James, Thomas P.
GP ASME
TI A NOVEL DEVICE TO INVESTIGATE THE EFFECT OF RESIDUAL TENSION IN NATURAL
   TISSUE IMPLANTS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2011, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 11-17, 2011
CL Denver, CO
SP Amer Soc Mech Engn
DE Tissue; Collagen; Strain; Tensometer
ID REPAIR
AB Natural collagen tissue implants derived from fetal bovine dermis are an attractive alternative to polymers for use in soft tissue repair. Constitutive relationships for this material are typically determined in vitro on a universal testing machine. However, upon implementation, tissue remodeling may cause the material properties to change rapidly. The literature indicates that the level of in vivo strain and the corresponding stress field may promote either tissue adaptation or undesirable resorption. The present work investigates a novel device for eventual use as an implantable tensometer. The device is not intended to be a substitute for material characterization on a universal testing machine, but rather a new device, representing a basic mechanical system that would facilitate the development of an even smaller instrument on the scale to be implanted in laboratory animals. An instrument of this type would enable the in vivo characterization of biomaterials under a prescribed load. The new device uses springs to generate a force on the biomaterial sample. Results show that the device creates a diminishing force that reaches quasi-static equilibrium displacement with acellular collagen implants (n=11) of varying cross sectional areas under different loads. Reaching an equilibrium displacement is an essential starting point for an implantable instrument. Changes from the equilibrium position may forecast a threshold stress to initiate resorption. In addition, knowledge on resorption rate may be obtained.
C1 [Berg, Robert J.; Saigal, Anil; James, Thomas P.] Tufts Univ, Lab Biomech Studies, Medford, MA 02155 USA.
RP Berg, RJ (reprint author), Tufts Univ, Lab Biomech Studies, 200 Coll Ave, Medford, MA 02155 USA.
EM thomas.james@tufts.edu
CR AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Gaertner M. E., 2007, J GASTROINTESTIONAL, V11, P1275
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Zerris VA, 2007, J BIOMED MATER RES B, V83B, P580, DOI 10.1002/jbm.b.30831
NR 5
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5488-4
PY 2012
BP 167
EP 171
PG 5
WC Engineering, Biomedical; Engineering, Mechanical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGX47
UT WOS:000324505000022
DA 2018-10-19
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI FINITE ELEMENT MODELING OF BURNISHING AND THE EFFECTS OF PROCESS
   PARAMETERS ON SURFACE INTEGRITY OF ORTHOPEDIC IMPLANTS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2011, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 11-17, 2011
CL Denver, CO
SP Amer Soc Mech Engn
DE Burnishing; finite element; surface integrity; magnesium; biomaterial;
   orthopedic implants
ID RESIDUAL-STRESS STABILITY; PLASTICITY; BEHAVIOR; ALLOYS
AB Hydrostatic burnishing is mainly a ceramic ball supported by a pressurized cushion of hydraulic oil and pushed against the workpiece surface. As the ball rolls along the surface it produces a unique combination of three physical effects in the surface layer: i) work hardening and increased hardness, ii) burnishing and decreased roughness, and iii) increased compressive residual stresses. This process has gained an increasingly great attention in automotive, aerospace, and especially medical device manufacturing industries. However, most of the research in hydrostatic burnishing has been performed experimentally and there is still lack of numerical studies providing fundamental understanding of the mechanics and the way process parameters interact with surface integrity characteristics particularly surface roughness and residual stresses. Understanding the correlation between process parameters and surface integrity is critical in efficiently adjusting the surface integrity in order to achieve proper biodegradation rate in human body after implantation. In this study, the dynamic mechanical behavior of the material is simulated using internal state variable (ISV) plasticity model. A semi-infinite, two-dimensional, plane strain FE model is developed and the ISV material model is incorporated into it using a user defined material subroutine. The effects of burnishing pressure and feed on surface roughness and residual stresses are investigated. The simulation results are validated with experimental measurements of residual stresses and surface roughness.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Beres W., 2004, ASME C P TURB EXP PO, V4, P809
   Black AJ, 1997, INT J MECH SCI, V39, P629, DOI 10.1016/S0020-7403(96)00068-9
   Bouzid W S, 2005, INT J ADV MANUF TECH, V25, P460
   DENKENA B, 2007, ANN CIRP, V56, P113, DOI DOI 10.1016/J.CIRP.2007.05.029
   Disegi J., 2010, P MPMD C 2009 MINN M, P220
   Guo Y.B., 2010, ANN CIRP, V59, P151
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Hassel T., 2007, P 7 INT C MG ALL THE, P432
   Hassel T., 2007, MAGNESIUM, P789
   Juijerm P, 2007, SCRIPTA MATER, V56, P745, DOI 10.1016/j.scriptamat.2007.01.021
   Klocke F, 2011, P I MECH ENG B-J ENG, V225, P2, DOI 10.1243/09544054JEM2044
   Korzynski M, 2009, J MATER PROCESS TECH, V209, P625, DOI 10.1016/j.jmatprotec.2008.02.037
   Lathrop J.F., 1996, SAND978218 SANDIA
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Nikitin I, 2007, MAT SCI ENG A-STRUCT, V465, P176, DOI 10.1016/j.msea.2007.02.004
   NOYAN IC, 1987, RESIDUAL STRESS MEAS
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Prevey PS, 2004, INT J FATIGUE, V26, P975, DOI 10.1016/j.ijfatigue.2004.01.010
   Prevey PS., 1986, ASM HDB, V10, P380
   Rottger K., 2002, THESIS WZL GERMANY
   Salahshoor M., 2011, P ASME MSEC CORV OR
   Sartkulvanich P, 2007, J MANUF SCI E-T ASME, V129, P705, DOI 10.1115/1.2738121
   Schuh A, 2007, J BIOMED MATER RES B, V81B, P330, DOI 10.1002/jbm.b.30669
   Seemikeri C. Y., 2008, J MANUF SCI E-T ASME, V130
   SKALSKI K, 1995, INT J MECH SCI, V37, P461, DOI 10.1016/0020-7403(94)00083-V
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   YEN YC, 2005, ANN CIRP, V54, P237
   Zhuang W, 2004, P I MECH ENG C-J MEC, V218, P663, DOI 10.1243/095440604774202303
NR 29
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5488-4
PY 2012
BP 489
EP 498
PG 10
WC Engineering, Biomedical; Engineering, Mechanical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGX47
UT WOS:000324505000068
DA 2018-10-19
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI SURFACE MODIFICATION OF BIODEGRADABLE MAGNESIUM-CALCIUM IMPLANTS BY
   BURNISHING
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2011, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 11-17, 2011
CL Denver, CO
SP Amer Soc Mech Engn
DE Burnishing; magnesium; biomaterial; surface integrity; biocompatibility;
   orthopedic implant
ID RESIDUAL-STRESS STABILITY; STAINLESS-STEEL AISI-304; DEGRADATION
   BEHAVIOR; TI-6AL-4V ALLOY; BONE-RESORPTION; FATIGUE; CORROSION;
   PERFORMANCE; RESISTANCE
AB Magnesium-Calcium (MgCa) alloys have shown very promising potential to make biodegradable metallic orthopedic implants. Biodegradable metallic implants relieve the need for second surgery and avoid stress shielding common with permanent metallic implants. Moreover, they provide enough strength in load carrying orthopedic applications as opposed to polymeric counterparts. High degradation rate of these alloys is the pressing issue resulting in subcutaneous hydrogen bubbles and high pH values and ultimately imbalance in physiological reactions. Surface modification techniques has been implemented to enhance the biocompatibility of these alloys by matching their corrosion rate with bone healing rate and absorption rate of corrosion by-products. Low plasticity burnishing (LPB) is a novel technique that makes wide range of surface integrity characteristics and consequently corrosion rates attainable. This is instrumental in developing proper degradation rates with respect to local healing and absorptions rates present in each application. Besides, LPB can be applied on already available CNC machining centers and in that sense is very flexible. Hence, studying the effects of LPB process parameters on surface integrity is important. In this paper, effects of burnishing passes and their pattern on surface topography, surface roughness, surface/subsurface microhardness, microstructure, and surface residual stresses of MgCa0.8 (wt%) implants are investigated.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Aksakal B, 2008, J MATER SCI-MATER M, V19, P2097, DOI 10.1007/s10856-007-3304-2
   Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Bozdana AT, 2008, MATER SCI TECH-LOND, V24, P1378, DOI 10.1179/174328408X302431
   Brinksmeier E., 2008, ANN CIRP, V57, P541
   Byrne G, 2003, CIRP ANN-MANUF TECHN, V52, P483, DOI 10.1016/S0007-8506(07)60200-5
   Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006
   Denkena B, 2007, ADV MATER RES-SWITZ, V22, P67, DOI 10.4028/www.scientific.net/AMR.22.67
   DENKENA B, 2007, ANN CIRP, V56, P113, DOI DOI 10.1016/J.CIRP.2007.05.029
   Denkena B, 2005, P 5 EUSP INT C MONTP
   Disegi J. A., 2009, P ASM MPMD C EXP MIN
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gill CM, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/17/174005
   Guo Y., 2009, P ASM MPMP C EXP MIN
   Guo Y.B., 2010, ANN CIRP, V59, P151
   Hassel T., 2007, P 7 INT C MG ALL THE, P432
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Isaksson H., 2003, BIOENG C, P1041
   Jayaraman N., 2007, P ASIP PALM SPER CA
   Juijerm P, 2007, SCRIPTA MATER, V56, P745, DOI 10.1016/j.scriptamat.2007.01.021
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   de Lacalle LNL, 2007, INT J ADV MANUF TECH, V32, P958, DOI [10.1007/s00170-005-0402-5, 10.1007/S00170-005-0402-5]
   Massalski T.B., 1990, ASM INT, V1, P927
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nikitin I, 2008, MAT SCI ENG A-STRUCT, V491, P297, DOI 10.1016/j.msea.2008.03.034
   Nikitin I, 2008, SCRIPTA MATER, V58, P239, DOI 10.1016/j.scriptamat.2007.09.045
   Nikitin I, 2007, MAT SCI ENG A-STRUCT, V465, P176, DOI 10.1016/j.msea.2007.02.004
   Prevey P., 2009, P ASM MPMD C EXP MIN
   Prevey PS, 2007, MATER SCI FORUM, V539-543, P3807, DOI 10.4028/www.scientific.net/MSF.539-543.3807
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Prevey PS, 2004, INT J FATIGUE, V26, P975, DOI 10.1016/j.ijfatigue.2004.01.010
   Rao DS, 2008, MATER MANUF PROCESS, V23, P295, DOI 10.1080/10426910801937306
   Scheel J. E., 2009, DOD CORR C GAYL NAT
   Schuh A., 2006, J BIOMED MATER RES B, DOI [10.1002/jbmb, DOI 10.1002/JBMB]
   Seemikeri CY, 2008, TRIBOL INT, V41, P724, DOI 10.1016/j.triboint.2008.01.003
   Seemikeri CY, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896121
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Tsuji N, 2008, MAT SCI ENG A-STRUCT, V488, P139, DOI 10.1016/j.msea.2007.11.079
   Tsuji N, 2009, MAT SCI ENG A-STRUCT, V499, P482, DOI 10.1016/j.msea.2008.09.008
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 45
TC 0
Z9 0
U1 0
U2 6
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5488-4
PY 2012
BP 609
EP 617
PG 9
WC Engineering, Biomedical; Engineering, Mechanical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGX47
UT WOS:000324505000087
DA 2018-10-19
ER

PT B
AU Khoda, B
   Koc, B
AF Khoda, Bashir
   Koc, Bahattin
GP ASME
TI DEFORMATION MODELING OF SOFT TISSUE SCAFFOLDS FOR WOUND HEALING
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2011, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 11-17, 2011
CL Denver, CO
SP Amer Soc Mech Engn
DE Porosity; synthetic tissue membrane; variational filament distance
ID HYBRID SCAFFOLDS; HYDROGELS; DESIGN; ALGINATE
AB Within tissue engineering (TE), one of the major research theme is on synthetic scaffold design. Most research emphasis on the material that has to be biocompatible and biodegradable over time and shows proper cell attachment properties. And traditional scaffold fabrication technique use chemical process resulting in uncontrolled porosity along the structure. Development of Solid Free Form (SFF) technique and improvement in some biomaterial properties provides the leverage of using these techniques to fabricate controlled and interconnected porous scaffold structure. These improved membrane/scaffolds are mostly regular porous structure and when applied in wound area various forces like bandage, contraction and self weight act upon that and cause deformation. As a result, the geometry and the designed porosity changes which eventually alters the desired choreographed functionality such as material concentration, design parameters, cytokines distribution over the wound device geometry. This balance often presents a tradeoff between a denser scaffold providing better mechanical function and a more porous scaffold providing better biofactor delivery, cell proliferation, pathways for nutrients and waste transportation. In this work, a novel scaffold modeling approach of "desired porosity with variational filament distance" has been proposed that will minimize the change in effective porosity with the designed porosity and thus will give a better functionality of such membrane providing both structural integrity and proper bioreactor environment. The proposed methodology has been implemented in this paper and illustrative examples are provided. Also a comparison result of measured effective porosity has been presented between proposed design model and conventional fixed filament distance scaffolds membrane.
C1 [Khoda, Bashir; Koc, Bahattin] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
RP Khoda, B (reprint author), SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
EM bahattinkoc@sabanciuniv.edu
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Hadjizadeh A., 2009, J BIOMED MATER RES A, V93A, P1140
   Hong H, 2008, ASAIO J, V54, P627, DOI 10.1097/MAT.0b013e31818965d3
   Hong H, 2007, COMPOS PART B-ENG, V38, P311, DOI 10.1016/j.compositesb.2006.05.005
   Khoda A., 2011, BIOFABRICATION, V3, P1
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Liu KJR, 2005, IEEE SIGNAL PROC MAG, V22, P2
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Ng KW, 2005, J BIOMED MATER RES A, V75A, P425, DOI 10.1002/jbm.a.30454
   Risbud MV, 2002, J MATER SCI LETT, V21, P1191, DOI 10.1023/A:1016564201212
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Sogutlu S., 2007, COMPUT AIDED DESIGN, V4, P661
   Wang QG, 2010, EUR CELLS MATER, V19, P86, DOI 10.22203/eCM.v019a09
NR 17
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5488-4
PY 2012
BP 619
EP 624
PG 6
WC Engineering, Biomedical; Engineering, Mechanical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGX47
UT WOS:000324505000088
DA 2018-10-19
ER

PT B
AU Khandaker, MPH
   Li, YL
   Tarantini, S
AF Khandaker, M. P. H.
   Li, Yanling
   Tarantini, Stefano
GP ASME
TI INTERFACIAL FRACTURE STRENGTH MEASUREMENT OF TISSUE-BIOMATERIAL SYSTEMS
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2011, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 11-17, 2011
CL Denver, CO
SP Amer Soc Mech Engn
ID BONE-CEMENT; PMMA; ARTHROPLASTIES; NANOPARTICLES; TOUGHNESS
AB The interfacial mechanics at the bone-implant interface is a critical issue for implant fixation and the filling of bone defects created by tumors and/or their excision. The present study is based on the hypothesis that the differences of the surface roughness at bone/implant interface due to incorporation of micro and nano nanoparticle additives may have significant influence on the quality of bone/implant union. This research studied poly Methyl MethAcrylate (PMMA) bone cement with and without MgO additives as different implant materials. The aims of this research were to determine the influences of a magnesium oxide (MgO) additive particle size to PMMA bone cement on the bonding strength between bone and bone cement specimens. The scope of work for this study were: (1) to quantify elastic properties (Young's modulus and Poisson's ratio) of bone cement specimens, (2) to determine whether inclusion of MgO particles with PMMA has any influence on the interface strength between bone and PMMA, and (3) to quantify the effect of surface roughness on the interface fracture strength between bone and PMMA. This study found that the mean interface strength for bone-PMMA is significantly less than the mean interface strengths of bone-PMMA with microsize MgO particles and bone-PMMA with nanosize MgO particles.
C1 [Khandaker, M. P. H.; Li, Yanling; Tarantini, Stefano] Univ Cent Oklahoma, Dept Psychol, Edmond, OK 73034 USA.
RP Khandaker, MPH (reprint author), Univ Cent Oklahoma, Dept Psychol, Edmond, OK 73034 USA.
EM mkhandaker@uco.edu; yli11@uco.edu; starantini@uco.edu
CR Barralet JE, 2004, J MATER SCI-MATER M, V15, P407, DOI 10.1023/B:JMSM.0000021111.48592.ab
   Bellare A, 2003, MATER SCI FORUM, V426-4, P3133, DOI 10.4028/www.scientific.net/MSF.426-432.3133
   Graham J, 2003, J BONE JOINT SURG AM, V85A, P1901, DOI 10.2106/00004623-200310000-00006
   Heo SJ, 2007, KEY ENG MATER, V342-343, P373, DOI 10.4028/www.scientific.net/KEM.342-343.373
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Lewis G, 2008, J BIOMED MATER RES B, V84B, P301, DOI 10.1002/jbm.b.30873
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Mann KA, 1997, J BIOMED MATER RES, V38, P211, DOI 10.1002/(SICI)1097-4636(199723)38:3<211::AID-JBM5>3.0.CO;2-S
   Ohashi KL, 1998, J ORTHOPAED RES, V16, P705, DOI 10.1002/jor.1100160612
   Ricker A, 2008, INT J NANOMED, V3, P125
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Wang XD, 2000, J BIOMED MATER RES, V53, P664, DOI 10.1002/1097-4636(2000)53:6<664::AID-JBM8>3.0.CO;2-W
NR 12
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5488-4
PY 2012
BP 625
EP 630
PG 6
WC Engineering, Biomedical; Engineering, Mechanical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGX47
UT WOS:000324505000089
DA 2018-10-19
ER

PT B
AU Khoda, B
   Ozbolat, IT
   Koc, B
AF Khoda, Bashir
   Ozbolat, Ibrahim T.
   Koc, Bahattin
GP ASME
TI MODELING AND FABRICATION OF HOLLOWED SCAFFOLDS WITH INTERCONNECTED
   VARIATIONAL POROSITY ARCHITECTURE
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2011, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 11-17, 2011
CL Denver, CO
SP Amer Soc Mech Engn
DE Continuous deposition path; scaffold architecture; gradient porosity;
   Bio-fabrication
ID FREE-FORM FABRICATION; DESIGN; BIOMATERIALS
AB This paper presents a novel computer-aided modeling of 3D hollowed tissue scaffolds with a controlled internal architecture. Functionally gradient variational porosity architecture is proposed with continuous material deposition planning scheme. The complex internal architecture of scaffolds is discritized into sub-regions accumulated from ruling lines that are generated from outer to inner features. The desired pore size and hence the porosity have been achieved by geometrically partitioning those sub-regions based on the area while meeting the tissue scaffold design constraint. Thus the desired controlled variational porosity along the scaffold architecture has been achieved with the combination of two geometrically oriented consecutive layers. A continuous, interconnected and optimized tool-path has been generated for both layers aiming at the standard solid free form fabrication process. A zigzag pattern tool-path has been proposed for accumulated sub-region layer. And a concentric spiral like optimal tool-path pattern has been derived for the successive layer to ensure fabricatable continuity along the structure. A micro-nozzle biomaterial deposition system driven by NC motion control has been used to fabricate sample designed structure with desired pore size and porosity level. Besides proper characterization of the fabrication sample has been performed to validate the proposed methodology. Moreover a comparative study between proposed design and conventional cartesian coordinate scaffolds has been performed. The results demonstrate significant reduction in design error with the proposed method.
C1 [Khoda, Bashir; Koc, Bahattin] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
RP Khoda, B (reprint author), SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
EM bahattinkoc@sabanciuniv.edu
CR Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Gomez C., 2007, UNIT CELL BASED MULT
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Karande T. S., 2007, EFFECT SCAFFOLD ARCH
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Khoda A., 2011, BIOFABRICATION, V3, P1
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Papenburg BJ, 2009, THESIS U TWENTE NETH
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 16
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5488-4
PY 2012
BP 969
EP 980
PG 12
WC Engineering, Biomedical; Engineering, Mechanical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGX47
UT WOS:000324505000141
DA 2018-10-19
ER

PT B
AU Reategui, E
   Reynolds, E
   Kasinkas, L
   Aggarwal, A
   Sadowsky, MJ
   Aksan, A
   Wackett, LP
AF Reategui, Eduardo
   Reynolds, Erik
   Kasinkas, Lisa
   Aggarwal, Amit
   Sadowsky, Michael J.
   Aksan, Alptekin
   Wackett, Lawrence P.
GP ASME
TI REACTIVE BIOMATERIAL FOR THE TREATMENT OF HERBICIDE CONTAMINATED
   DRINKING WATER: ATRAZINE DECHLORINATION
SO PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, PTS A AND B
LA English
DT Proceedings Paper
CT ASME Summer Bioengineering Conference (SBC)
CY JUN 20-23, 2012
CL Fajardo, PR
C1 [Reategui, Eduardo; Kasinkas, Lisa; Aksan, Alptekin] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
RP Reategui, E (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
RI Aksan, Alptekin/C-1579-2014; Sadowsky, Michael/J-2507-2016
OI Aksan, Alptekin/0000-0001-9891-1715; Sadowsky,
   Michael/0000-0001-8779-2781; Reategui, Eduardo/0000-0002-8271-8205
CR Kauffmann C., 1998, J BIOTECHNOL, V62, P168
   LeBaron HM, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P1
   Macias-Flores A., 2009, WORLD J MICROB BIOT, V25, P1995
   Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709
   Perullini M, 2011, J MATER CHEM, V21, P4546, DOI 10.1039/c0jm03948a
   Reategui E, 2009, J PHYS CHEM B, V113, P13048, DOI 10.1021/jp903294q
   Strong LC, 2000, ENVIRON MICROBIOL, V2, P91, DOI 10.1046/j.1462-2920.2000.00079.x
NR 7
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4480-9
PY 2012
BP 347
EP 348
PG 2
WC Engineering, Biomedical; Engineering, Mechanical
SC Engineering
GA BHD11
UT WOS:000325036600173
DA 2018-10-19
ER

PT B
AU Qin, ZP
   Shah, N
   Akkin, T
   Chan, WCW
   Bischof, JC
AF Qin, Zhenpeng
   Shah, Neha
   Akkin, Taner
   Chan, Warren C. W.
   Bischof, John C.
GP ASME
TI THERMAL ANALYSIS MEASUREMENT OF GOLD NANOPARTICLE INTERACTIONS WITH CELL
   AND BIOMATERIAL
SO PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, PTS A AND B
LA English
DT Proceedings Paper
CT ASME Summer Bioengineering Conference (SBC)
CY JUN 20-23, 2012
CL Fajardo, PR
ID THERAPY
C1 [Qin, Zhenpeng; Bischof, John C.] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
RP Qin, ZP (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
RI Qin, Zhenpeng/N-6036-2015
OI Qin, Zhenpeng/0000-0003-3406-3045; Akkin, Taner/0000-0003-4660-8591
CR Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Goel R, 2009, NANOMEDICINE-UK, V4, P401, DOI 10.2217/NNM.09.21
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Jordan A., 1999, J MAGN MAGN MAT, V201
   Khlebtsov B, 2006, NANOTECHNOLOGY, V17, P5167, DOI 10.1088/0957-4484/17/20/022
   Khlebtsov N., 2010, CHEM SOC REV, V40, P1647
   Qin Z., 2012, CHEM SOC REV
   Qin Z., 2010, ASME 2010 SUMM BIOEN
   Shah NB, 2010, MOL PHARM, V8, P176, DOI DOI 10.1021/MP1002587
   Smith JD, 2006, J AM CHEM SOC, V128, P12892, DOI 10.1021/ja063579v
NR 10
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4480-9
PY 2012
BP 469
EP 470
PG 2
WC Engineering, Biomedical; Engineering, Mechanical
SC Engineering
GA BHD11
UT WOS:000325036600234
DA 2018-10-19
ER

PT J
AU Julich-Gruner, KK
   Neffe, AT
   Lendlein, A
AF Julich-Gruner, Konstanze K.
   Neffe, Axel T.
   Lendlein, Andreas
TI Synthesis and characterization of oligo(ethylene glycol)s functionalized
   with desaminotyrosine or desaminotyrosyltyrosine
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Biomaterial; Hydrogel; Oligo(ethylene glycol); Physical crosslinks
ID DRUG-DELIVERY; MEDICINE; GELATIN; HYDROGELS; POLYMER
AB Purpose: The aromatic compounds desaminotyrosine (DAT) and desaminotyrosyltyrosine (DATT) have been successfully used to functionalize gelatin in order to form physically crosslinked networks via pi-pi interactions and hydrogen bonds of the introduced phenol moieties. Here, it was explored whether this concept can be applied to a synthetic polymer not engaging in additional interactions such as triple helix formation in gelatin, enabling a network to form by physical interactions mainly related to the terminal functional groups. Oligo(ethylene glycol) (OEG) was chosen as hydrophilic synthetic polymer for the backbone structure.
   Methods: Linear OEG (M-P = 3 kDa) and four-arm OEG (M-n = 5 kDa) with amino functionalities as endgroups were functionalized with DAT and DATT using EDC center dot HCl and NHS as activating agents. The compounds were characterized by NMR, IR spectroscopy, and MALDI. Rheological behavior of aqueous solutions of the polymers was studied. The critical micelle concentration (CMC) was determined by a fluorescence spectroscopic analysis using the hydrophobic fluorescent dye pyrene.
   Results: DATT-functionalized linear OEG, four-arm DAT-functionalized OEG and four-arm DATT-functionalized OEG were synthesized with degrees of functionalization of 60-95 mol%. All compounds were water soluble, and rheological measurements revealed a decrease in storage modulus G' and loss modulus G '' compared to unfunctionalized OEG. Moreover, the CMC of linear OEG-DATT could be determined.
   Conclusions: The syntheses of OEG functionalized with the aromatic compounds DAT and DATT was reported. The polymers showed the properties of a surfactant.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Neffe, Axel/H-6997-2013; Lendlein, Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Lendlein, Andreas/0000-0003-4126-4670
FU Bundesministerium fur Bildung und Forschung (BMBF) through project
   Poly4Bio BB [0315696A]
FX This work was financially supported by the Bundesministerium fur Bildung
   und Forschung (BMBF) through project Poly4Bio BB (0315696A).
CR Hamley IW, 2011, MACROMOL BIOSCI, V11, P1068, DOI 10.1002/mabi.201100022
   Jung F, 2012, CLIN HEMORHEOL MICRO, V50, P55, DOI 10.3233/CH-2011-1443
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Licciardi M, 2010, INT J PHARMACEUT, V396, P219, DOI 10.1016/j.ijpharm.2010.06.021
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Neffe AT, 2011, ACTA BIOMATER, V7, P1693, DOI 10.1016/j.actbio.2010.11.025
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Tanzi MC, 2011, J APPL BIOMATER BIOM, V9, P87, DOI 10.5301/JABB.2011.8563
   Tzokova N, 2009, LANGMUIR, V25, P11082, DOI 10.1021/la901413n
   Tzokova N, 2009, LANGMUIR, V25, P2479, DOI 10.1021/la8035659
   Vert M, 2011, MACROMOL BIOSCI, V11, P1653, DOI 10.1002/mabi.201100224
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
NR 17
TC 5
Z9 5
U1 0
U2 15
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2012
VL 10
IS 3
BP 170
EP 176
DI 10.5301/JABFM.2012.10342
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 219UV
UT WOS:000324537200002
PM 23242871
DA 2018-10-19
ER

PT J
AU Li, WZ
   Pierce, BF
   Scharnagl, N
   Wischke, C
   Sisson, AL
   Lendlein, A
AF Li, Wenzhong
   Pierce, Benjamin Franklin
   Scharnagl, Nico
   Wischke, Christian
   Sisson, Adam Lee
   Lendlein, Andreas
TI Influence of co-monomer ratio on the chemical properties and
   cytotoxicity of poly[acrylonitrile-co-(N-vinylpyrrolidone)]
   nanoparticles
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 2nd Seminar on Advanced Functional Polymers for Medicine (AFPM)
CY JUL 04-06, 2012
CL Vico Equense, ITALY
DE Biocompatibility; Biomaterials; Mini emulsion; Nanoparticles
ID ACRYLONITRILE-BASED POLYMERS; OIL-SOLUBLE INITIATORS; MINIEMULSION
   POLYMERIZATION; MEMBRANES; COPOLYMERIZATION; HEMOCOMPATIBILITY; SYSTEMS;
   STATES; WATER
AB Purpose. A system of nanoparticles with varying hydrophilicities may include promising biomaterial candidates as they offer various cellular uptake properties and a range of drug encapsulation efficacies, which would be advantageous in regenerative therapies. Therefore, a model system of nanoparticles with varying hydrophilicities was synthesized and assessed for its candidacy as a biomaterial.
   Methods. Here, acrylonitrile (AN) was copolymerized with N-vinylpyrrolidone (NVP) in a mini-emulsion to form a family of nanoparticles, thereby enabling the systematic variation of the copolymer hydrophilicity. The nanoparticles based on these copolymers were prepared and characterized using H-1-NMR, dynamic light scattering, differential scanning calorimetry, and thermal gravimetric analysis. Finally, the cytotoxicity of the nanoparticles was assessed by conducting indirect tests using L929 fibroblasts.
   Results. The nanoparticles showed well controlled NVP/AN molar ratios as determined by H-1 NMR, well defined diameters ranging from approximately 100 nm to 200 nm, and increasing glass transition temperatures with increasing molar NVP content. Finally, L929 fibroblasts only slightly changed their morphology upon incubation with material eluates.
   Conclusions. Poly[acrylonitrile-co-(N-vinylpyrrolidone)] nanoparticles with varying amounts of NVP were shown to be a promising model system for further biological assessment.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013; Wischke, Christian/K-9651-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Wischke,
   Christian/0000-0001-5531-9033
CR ALDUNCIN JA, 1994, MACROMOLECULES, V27, P2256, DOI 10.1021/ma00086a041
   ALDUNCIN JA, 1991, J POLYM SCI POL CHEM, V29, P1265, DOI 10.1002/pola.1991.080290905
   Blythe PJ, 1999, J POLYM SCI POL CHEM, V37, P4449, DOI 10.1002/(SICI)1099-0518(19991201)37:23<4449::AID-POLA22>3.0.CO;2-S
   Boese G, 2007, TISSUE ENG, V13, P2995, DOI 10.1089/ten.2006.0442
   Boguslavsky L, 2005, J COLLOID INTERF SCI, V289, P71, DOI 10.1016/j.jcis.2005.03.063
   Debuigne A, 2005, MACROMOLECULES, V38, P5452, DOI 10.1021/ma047726q
   DELGADO J, 1986, J POLYM SCI POL CHEM, V24, P861, DOI 10.1002/pola.1986.080240505
   Feldstein MM, 2000, POLYMER, V41, P5339, DOI 10.1016/S0032-3861(99)00688-6
   Fox T.G., 1956, B AM PHYS SOC, V1, P123
   Gudiksen KL, 2006, P NATL ACAD SCI USA, V103, P7968, DOI 10.1073/pnas.0602816103
   Hou C, 2005, J APPL POLYM SCI, V96, P483, DOI 10.1002/app.21457
   Hou C, 2003, J APPL POLYM SCI, V89, P422, DOI 10.1002/app.12104
   Jeon HJ, 2011, POLYMER, V52, P3905, DOI 10.1016/j.polymer.2011.07.022
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Landfester K, 2000, MACROMOL RAPID COMM, V21, P820, DOI 10.1002/1521-3927(20000801)21:12<820::AID-MARC820>3.0.CO;2-9
   Lorenz S, 2010, MACROMOL BIOSCI, V10, P1034, DOI 10.1002/mabi.201000099
   Tanzi MC, 2011, J APPL BIOMATER BIOM, V9, P87, DOI 10.5301/JABB.2011.8563
   Wan LS, 2007, ACTA BIOMATER, V3, P183, DOI 10.1016/j.actbio.2006.09.007
   Wan LS, 2006, J APPL POLYM SCI, V102, P4577, DOI 10.1002/app.25045
   Wan LS, 2006, MACROMOL BIOSCI, V6, P364, DOI 10.1002/mabi.200600017
   Wan LS, 2005, POLYMER, V46, P7715, DOI 10.1016/j.polymer.2005.05.147
   Wan LS, 2005, MACROMOL BIOSCI, V5, P229, DOI 10.1002/mabi.200400157
NR 22
TC 2
Z9 2
U1 0
U2 9
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2012
VL 10
IS 3
BP 308
EP 314
DI 10.5301/JABFM.2012.10430
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 219UV
UT WOS:000324537200022
PM 23258562
DA 2018-10-19
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI FINITE ELEMENT ANALYSIS OF RESIDUAL STRESSES IN HIGH-SPEED DRY CUTTING
   OF BIODEGRADABLE MAGNESIUM-CALCIUM ALLOY
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, 2012
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
   (MSEC2012)
CY JUN 04-08, 2012
CL Univ Notre Dame, Notre Dame, IN
SP ASME, Mfg Engn Div
HO Univ Notre Dame
DE High speed machining; Magnesium; Implant; Biomaterial; FEA
ID MACHINED LAYER; SURFACE; MODEL; TOOL; FRICTION; GEOMETRY; BEHAVIOR
AB Magnesium-Calcium (Mg-Ca) alloys have become attractive biodegradable orthopedic implant biomaterials recently. Residual stresses are proven to be very influential on degradation rate of these alloys in human anatomy. Due to time and cost inhibitive reasons, development of finite element models to predict residual stress profiles under various cutting regimes is highly desirable. In this context, a finite element model of orthogonal cutting without explicit chip formation is developed by adopting plowing depth approach in order to predict process induced residual stresses in high speed dry cutting of Mg-Ca0.8 (wt %) using diamond tools. Mechanical properties of Mg-Ca0.8 alloy at high strain rates and large strains are determined using split-Hopkinson pressure bar test. Internal state variable (ISV) plasticity model is implemented to model the material behavior under cutting regimes. The residual stress evolution process and effects of plowing speed and plowing depth on residual stress profiles are studied. Residual stress measurements are performed utilizing X-ray diffraction technique for validation purposes.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Anurag S., 2008, THESIS U ALABAMA ALA
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bammann DJ, 1993, STRUCTURAL CRASHWORT, P1
   Brinksmeier B., 1982, ANN CIRP, V31, P491
   Caruso S, 2010, INT J MATER FORM, V3, P515, DOI 10.1007/s12289-010-0820-2
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Ee KC, 2005, INT J MECH SCI, V47, P1611, DOI [10.1016/j.ijmecsci.2005.06.001, 10.1016/j.ijmensci.2005.06.001]
   Grzesik W, 2003, INT J MACH TOOL MANU, V43, P1311, DOI 10.1016/S0890-6955(03)00160-3
   Guo YB, 2009, CIRP ANN-MANUF TECHN, V58, P81, DOI 10.1016/j.cirp.2009.03.110
   Guo YB, 2005, TRANS N AMER MANUFAC, V33, P469
   Jacobus K, 2001, J MANUF SCI E-T ASME, V123, P537, DOI 10.1115/1.1372197
   Jacobus K, 2000, J MANUF SCI E-T ASME, V122, P20, DOI 10.1115/1.538906
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liang SY, 2007, CIRP ANN-MANUF TECHN, V56, P65, DOI 10.1016/j.cirp.2007.05.018
   Liu CR, 2000, INT J MECH SCI, V42, P1069, DOI 10.1016/S0020-7403(99)00042-9
   Outeiro JC, 2008, CIRP ANN-MANUF TECHN, V57, P77, DOI 10.1016/j.cirp.2008.03.076
   Palmer W. B., 1963, P 4 INT MACH TOOL DE, P61
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Sasahara H, 2004, INT J MACH TOOL MANU, V44, P815, DOI 10.1016/j.ijmachtools.2004.01.002
   Sasahara H, 1996, J MATER PROCESS TECH, V62, P448, DOI 10.1016/S0924-0136(96)02451-X
   Schulze V, 2010, CIRP ANN-MANUF TECHN, V59, P117, DOI 10.1016/j.cirp.2010.03.064
   Spear H. E., 1994, SYNTHETIC DIAMOND EM
   STRENKOWSKI JS, 1985, J ENG IND-T ASME, V107, P349, DOI 10.1115/1.3186008
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Yang XP, 2002, INT J MECH SCI, V44, P703, DOI 10.1016/S0020-7403(02)00008-5
   Zong WJ, 2007, INT J ADV MANUF TECH, V32, P666, DOI 10.1007/s00170-005-0388-z
NR 26
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5499-0
PY 2012
BP 397
EP 404
PG 8
WC Engineering, Mechanical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGW25
UT WOS:000324347700045
DA 2018-10-19
ER

PT B
AU Gong, HB
   Kontsos, A
   Kim, Y
   Lelkes, PI
   Zhang, QW
   Yao, DG
   Hazeli, K
   Zhou, JG
AF Gong, Haibo
   Kontsos, Antonios
   Kim, Yoontae
   Lelkes, Peter I.
   Zhang, Qingwei
   Yao, Donggang
   Hazeli, Kavan
   Zhou, Jack G.
GP ASME
TI MICRO CHARACTERIZATION OF MG AND MG ALLOY FOR BIODEGRADABLE ORTHOPEDIC
   IMPLANTS APPLICATION
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, 2012
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
   (MSEC2012)
CY JUN 04-08, 2012
CL Univ Notre Dame, Notre Dame, IN
SP ASME, Mfg Engn Div
HO Univ Notre Dame
DE Magnesium; AZ61; immersion test; degradation behavior; biocompatibility;
   EAhy926; tensile property
ID IN-VITRO; METAL-IONS; MAGNESIUM; CELLS; CORROSION; CHROMIUM; COBALT;
   TITANIUM; RELEASE
AB Magnesium as a candidate metallic biomaterial for biodegradable orthopedic implants was evaluated in-vitro in terms of degradation behavior, biocompatibility and mechanical property both in macro- and micro-scale. Micro structure of pure Mg and AZ61 after degradation in both simulated body fluid (SBF) and cell culture environment were analyzed. Different from AZ61, pure Mg degraded at a higher rate and attracted large amount of salt precipitation which formed a layer covering the surface. Much less pitting degradation and salt deposition were observed on both pure Mg and AZ61 in cell culture environment compared to in SBF. After culturing for 7 days, EAhy926 cells growing on AZ61 showed significant higher proliferation rate as of cells growing on pure Mg. Higher proliferation rates indicated that cells grew better on slow-degrading AZ61 than on fast-degrading pure Mg. Cells growing on AZ61 proliferated much better and assembled together to form a consistent tissue-like micro-structure, while cells spread and reached out on the surface of pure Mg, possibly due to low cell density and lack of cellular communication. The elastic modulus and tensile yield strength of magnesium are closer to those of natural bone than other commonly used metallic biomaterials. It was shown that Mg was biodegradable, biocompatible and had appropriate mechanical strength, thus Mg and its alloys showed great potential for deployment in a new generation of biodegradable orthopedic implants.
C1 [Gong, Haibo; Kontsos, Antonios; Kim, Yoontae; Zhang, Qingwei; Hazeli, Kavan; Zhou, Jack G.] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Gong, HB (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
EM hg67@drexel.edu; akontsos@drexel.edu; yk373@drexel.edu;
   pil22@drexel.edu; qzhang@coe.drexel.edu; yao@gatech.edu;
   kh447@drexel.edu; zhoug@coe.drexel.edu
RI Yao, Donggang/B-4444-2014
OI Hazeli, Kavan/0000-0003-0756-1399
CR Allen MJ, 1997, J BONE JOINT SURG BR, V79B, P475, DOI 10.1302/0301-620X.79B3.7415
   Andrea H., 2001, MUTAT RES-FUND MOL M, V475, P113
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Jurgen V., 2003, MOL ASPECTS MED, V24, P27
   Lhotka C, 2003, J ORTHOP RES, V21, P189, DOI 10.1016/S0736-0266(02)00152-3
   Martin HJ, 2011, CORROS SCI, V53, P1348, DOI 10.1016/j.corsci.2010.12.025
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niki Y, 2003, BIOMATERIALS, V24, P1447, DOI 10.1016/S0142-9612(02)00531-8
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Toshitada O., 2001, NUTRITION, V17, P679
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   Wang L, 2012, MATER DESIGN, V33, P345, DOI 10.1016/j.matdes.2011.02.019
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
NR 20
TC 1
Z9 1
U1 0
U2 7
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5499-0
PY 2012
BP 891
EP 895
PG 5
WC Engineering, Mechanical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BGW25
UT WOS:000324347700103
DA 2018-10-19
ER

PT J
AU Galler, KM
   Hartgerink, JD
   Cavender, AC
   Schmalz, G
   D'Souza, RN
AF Galler, Kerstin M.
   Hartgerink, Jeffrey D.
   Cavender, Adriana C.
   Schmalz, Gottfried
   D'Souza, Rena N.
TI A Customized Self-Assembling Peptide Hydrogel for Dental Pulp Tissue
   Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID EXFOLIATED DECIDUOUS TEETH; STEM-CELLS; IN-VIVO; GROWTH; VITRO;
   TRANSPLANTATION; REGENERATION; MIGRATION; TOOTH
AB Root canal therapy is common practice in dentistry. During this procedure, the inflamed or necrotic dental pulp is removed and replaced with a synthetic material. However, recent research provides evidence that engineering of dental pulp and dentin is possible by using biologically driven approaches. As tissue engineering strategies hold the promise to soon supersede conventional root canal treatment, there is a need for customized scaffolds for stem cell delivery or recruitment. We hypothesize that the incorporation of dental pulp-derived stem cells with bioactive factors into such a scaffold can promote cell proliferation, differentiation, and angiogenesis. In this study, we used a cell adhesive, enzyme-cleavable hydrogel made from self-assembling peptide nanofibers to encapsulate dental pulp stem cells. The growth factors (GFs) fibroblast growth factor basic, transforming growth factor beta 1, and vascular endothelial growth factor were incorporated into the hydrogel via heparin binding. Release profiles were established, and the influence of GFs on cell morphology and proliferation was assessed to confirm their bioactivity after binding and subsequent release. Cell morphology and spreading in three-dimensional cultures were visualized by using cell tracker and histologic stains. Subcutaneous transplantation of the hydrogel within dentin cylinders into immunocompromised mice led to the formation of a vascularized soft connective tissue similar to dental pulp. These data support the use of this novel biomaterial as a highly promising candidate for future treatment concepts in regenerative endodontics.
C1 [Galler, Kerstin M.; Schmalz, Gottfried] Univ Regensburg, Dept Restorat Dent & Periodontol, D-93053 Regensburg, Germany.
   [Cavender, Adriana C.; D'Souza, Rena N.] Texas A&M, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA.
   [Hartgerink, Jeffrey D.] Rice Univ, Dept Chem, Houston, TX USA.
   [Hartgerink, Jeffrey D.] Rice Univ, Dept Bioengn, Houston, TX USA.
RP Galler, KM (reprint author), Univ Regensburg, Dept Restorat Dent & Periodontol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.
EM kerstin.galler@klinik.uni-regensburg.de; rdsouza@bcd.tamhsc.edu
RI Hartgerink, Jeffrey/G-4275-2016
OI Hartgerink, Jeffrey/0000-0002-3186-5395; D'Souza,
   Rena/0000-0002-1505-5173
FU NIDCR NIH HHS [R01 DE021798]
CR Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Gusman H, 2002, EUR J ORAL SCI, V110, P353, DOI 10.1034/j.1600-0722.2002.21347.x
   He HX, 2008, CELL BIOL INT, V32, P827, DOI 10.1016/j.cellbi.2008.03.013
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]
   Iohara K, 2009, REGEN MED, V4, P377, DOI 10.2217/RME.09.5
   Melin M, 2000, J DENT RES, V79, P1689, DOI 10.1177/00220345000790090901
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Nakashima M, 2011, Adv Dent Res, V23, P313, DOI 10.1177/0022034511405323
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Sakai VT, 2010, J DENT RES, V89, P791, DOI 10.1177/0022034510368647
   SEGERS VF, 2007, DRUG DISCOV TODAY, V12, P56
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x
   Shimabukuro Y, 2009, J ENDODONT, V35, P1529, DOI 10.1016/j.joen.2009.08.010
   SJOGREN U, 1990, J ENDODONT, V16, P498
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426
   van Blitterswijk CA, 2008, ACAD PR SER BIOM ENG, pXIII
   Zhao S, 2000, HISTOCHEM J, V32, P489, DOI 10.1023/A:1004100518245
NR 29
TC 109
Z9 112
U1 5
U2 49
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2012
VL 18
IS 1-2
BP 176
EP 184
DI 10.1089/ten.tea.2011.0222
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 876ML
UT WOS:000299111500017
PM 21827280
OA Green Published
DA 2018-10-19
ER

PT J
AU Hsu, SH
   Huang, GS
   Lin, SYF
   Feng, F
   Ho, TT
   Liao, YC
AF Hsu, Shan-hui
   Huang, Guo-Shiang
   Lin, Susan Yun Fan
   Feng, Fuh
   Ho, Tung-Tso
   Liao, Yuan-Ching
TI Enhanced Chondrogenic Differentiation Potential of Human Gingival
   Fibroblasts by Spheroid Formation on Chitosan Membranes
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; GAP-JUNCTIONS; NEURAL CREST; INTERCELLULAR
   COMMUNICATION; REGENERATIVE MEDICINE; ES CELLS; TRAFFICKING; EXPRESSION;
   ROCK; PLURIPOTENCY
AB Human gingival fibroblasts (HGF) were recently found to be a source of mesenchymal stem cells. Their behavior on a biomaterial has not been reported so far. The effect of culturing HGF on chitosan membranes on their chondrogenic differentiation was investigated in this study. HGF were first cultured on chitosan membranes and spheroid formation of HGF was observed. Next, HGF on chitosan were induced with chondrogenesis induction medium and their chondrogenic differentiation potential was expressed by assessing the expression of chondrogenesis related genes at both mRNA and protein levels by reverse transcription-polymerase chain reaction (RT-PCR) and immunostaining, respectively. We discovered that the chondrogenic differentiation potential of HGF could be enhanced simply by culturing HGF on chitosan membranes. Expression of neural crest and stemness genes were also analyzed by RT-PCR to evaluate the stemness and self-renewal of HGF spheroids. We found that spheroid formation helped to increase and maintain the expression of stemness genes in HGF. To understand the aspects of the chitosan membranes that induced spheroid formation of HGF, mechanical and physical properties of the chitosan membranes were examined. The migration of HGF on chitosan membranes was also monitored to speculate the process of spheroid formation. In addition, the roles of the Rho/Rho-associated kinase (ROCK) pathway and connexin 43 (Cx43) in spheroid formation were explored. Treatment of HGF cultured on chitosan with the ROCK-activity inhibitor Y27632 clearly inhibited spheroid formation, suggesting that the Rho/ROCK pathway was involved in spheroid formation. The increased Cx43 activity of HGF spheroids on chitosan indicated that the gap junction intercellular communication was regulated by spheroid formation. It was concluded that culturing HGF on chitosan may activate the Rho/ROCK pathway, which led to spheroid formation and gap junction regulation. These changes may contribute to the enhanced chondrogenic differentiation potential of HGF on chitosan.
C1 [Hsu, Shan-hui; Huang, Guo-Shiang; Lin, Susan Yun Fan; Ho, Tung-Tso; Liao, Yuan-Ching] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
   [Hsu, Shan-hui] Natl Taiwan Univ, Rehabil Engn Res Ctr, Taipei 10617, Taiwan.
   [Hsu, Shan-hui; Ho, Tung-Tso] Natl Chung Hsing Univ, Inst Biomed Engn, Taichung 40227, Taiwan.
   [Feng, Fuh] Forward Dent Grp, Taichung, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
EM shhsu@ntu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU National Science Council, Taiwan
FX This work was supported by the National Science Council, Taiwan.
CR Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang JC, 2009, BIOMATERIALS, V30, P6265, DOI 10.1016/j.biomaterials.2009.07.064
   Chang JC, 2009, BIOMATERIALS, V30, P1937, DOI 10.1016/j.biomaterials.2008.12.039
   Chen RS, 2009, ACTA BIOMATER, V5, P1064, DOI 10.1016/j.actbio.2008.11.023
   Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554
   Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019
   Denef C, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2007.01616.x
   Duval N, 2002, J CELL SCI, V115, P3241
   Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839
   Fournier BPJ, 2010, TISSUE ENG PT A, V16, P2891, DOI [10.1089/ten.tea.2009.0796, 10.1089/ten.TEA.2009.0796]
   Guo YH, 2003, AM J PHYSIOL-LUNG C, V285, pL1213, DOI 10.1152/ajplung.00066.2003
   Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033
   Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899
   Martin PEM, 2001, J CELL SCI, V114, P3845
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007
   Mitrano TI, 2010, J PERIODONTOL, V81, P917, DOI 10.1902/jop.2010.090566
   Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3
   Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI 10.1089/ten.TEA.2009.0810
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Naus CCG, 1999, ADV EXP MED BIOL, V468, P373
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199
   Paulson AF, 2000, J CELL SCI, V113, P3037
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Rossello Ricardo A, 2010, Commun Integr Biol, V3, P53
   Rouach N, 2006, EUR J NEUROSCI, V23, P1453, DOI 10.1111/j.1460-9568.2006.04671.x
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Santos A, 2010, CYTOTHERAPY, V12, P924, DOI 10.3109/14653241003774011
   Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005
   Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tocci Angelo, 2003, Hematol J, V4, P92, DOI 10.1038/sj.thj.6200232
   Todorova MG, 2008, J CELL PHYSIOL, V214, P354, DOI 10.1002/jcp.21203
   Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126
   Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200
   Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9
   Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543
   Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318
NR 46
TC 24
Z9 24
U1 1
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2012
VL 18
IS 1-2
BP 67
EP 79
DI 10.1089/ten.tea.2011.0157
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 876ML
UT WOS:000299111500007
PM 21770867
DA 2018-10-19
ER

PT B
AU Salam, A
   Venditti, RA
   Pawlak, JJ
   El-tahlawy, K
   Ayoub, A
AF Salam, Abdus
   Venditti, Richard A.
   Pawlak, Joel J.
   El-tahlawy, Khaled
   Ayoub, Ali
BE Jin, Y
   Wang, Z
   Wu, W
TI EXTRACTION AND UTILIZATION OF HEMICELLULOSES FOR NEW BIOMATERIAL
   APPLICATIONS
SO PROCEEDING OF THE 4TH INTERNATIONAL CONFERENCE ON PULPING, PAPERMAKING
   AND BIOTECHNOLOGY (ICPPB '12), VOLS. I AND II
LA English
DT Proceedings Paper
CT 4th International Conference on Pulping, Papermaking and Biotechnology
   (ICPPB' 12)
CY NOV 07-09, 2012
CL Nanjing Forestry Univ, Nanjing, PEOPLES R CHINA
SP Nanjing Forestry Univ, Jiangsu Prov Key Lab Pulp & Paper Sci & Technol, Univ Tokyo, N Carolina State Univ, China Tech Assoc Paper Ind, Tech Assoc Pulp & Paper Ind, Japan Tech Assoc Pulp & Paper Ind, Jingsu Tech Assoc Paper Ind
HO Nanjing Forestry Univ
DE hemicellulose; extraction; ionic liquid; water absorbency; packaging
ID BIOMASS; ENERGY
AB Hemicellulose material is an abundant, relatively under-utilized polymeric material present in lignocellulosic materials. In this research, an alkaline treatment was applied to wood and grasses in order to extract hemicelluloses to subsequently produce novel materials. An extraction at 75 degrees C recovered 23% of the biomass as a predominantly hemicellulose material with a number average degree of polymerization of similar to 450 determined by gel permeation chromatography. These hemicelluloses were modified separately with different agents (monomers, polymers) such as citric acid, succinic anhydride, sodium monochloracetate and chitosan for improved absorbency applications. This report also describes the use of an ionic liquid to acetylate hemicellulose without the need of a catalyst as reactive solvents for their eco-friendliness (green application) enhanced thermal stability and higher reaction rates for hemicelluloses modified. The new products were characterized by FTIR spectroscopy, Nuclear Magnetic Resonance, thermal properties analysis, saline absorbency and surface area analysis. The results obtained indicate promising combinations between the effective extraction of hemicellulose from different biomass and environmentally friendly processes to generate the next generation of hemicellulose modified with high degree of polymerization for use in various industrial applications.
C1 [Salam, Abdus; Venditti, Richard A.; Pawlak, Joel J.; El-tahlawy, Khaled; Ayoub, Ali] N Carolina State Univ, Coll Nat Resources, Dept Forest Biomat, Raleigh, NC 27695 USA.
RP Venditti, RA (reprint author), N Carolina State Univ, Coll Nat Resources, Dept Forest Biomat, Raleigh, NC 27695 USA.
EM richard_venditti@ncsu.edu
CR COUSINS WJ, 1978, WOOD SCI TECHNOL, V12, P161, DOI 10.1007/BF00372862
   Hoogwijk M, 2003, BIOMASS BIOENERG, V25, P119, DOI 10.1016/S0961-9534(02)00191-5
   Lange JP, 2007, BIOFUEL BIOPROD BIOR, V1, P39, DOI 10.1002/bbb.7
   McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3
NR 4
TC 0
Z9 0
U1 0
U2 2
PU NANJING FORESTRY UNIV
PI NANJING
PA LONGPAN RD, NANJING, JIANGSU 210037, PEOPLES R CHINA
BN 978-7-5019-9043-6
PY 2012
BP 885
EP 890
PG 6
WC Biotechnology & Applied Microbiology; Materials Science, Paper & Wood
SC Biotechnology & Applied Microbiology; Materials Science
GA BGL38
UT WOS:000323396200178
DA 2018-10-19
ER

PT J
AU Salgado, CL
   Sanchez, EMS
   Zavaglia, CAC
   Almeida, AB
   Granja, PL
AF Salgado, Christiane L.
   Sanchez, Elisabete M. S.
   Zavaglia, Cecilia A. C.
   Almeida, Ana Beatriz
   Granja, Pedro L.
TI Injectable Biodegradable Polycaprolactone-Sebacic Acid Gels for Bone
   Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MARROW STROMAL CELLS; OF-THE-ART; IN-VITRO; ALGINATE MICROSPHERES;
   POLY(L-LACTIC ACID); DEGRADATION; SCAFFOLDS; VIVO; BIOCOMPATIBILITY;
   DIFFERENTIATION
AB Tissue engineering constitutes a promising alternative technology to transplantation medicine by creating viable substitutes for failing tissues or organs. The ability to manipulate and reconstitute tissue function has tremendous clinical implications and will most likely play a key role in cell and gene therapies in the coming years. In the present work, a novel injectable and biodegradable biomaterial is reported that could be injected on the human body with a surgical syringe. The material prepared is a blend of polycaprolactone (PCL), a biodegradable and elastic biomedical polymer, and sebacic acid, a natural polymer part of castor oil with low molecular weight to accelerate the slow degradation rate of PCL. The biocompatibility of the blend was evaluated in vitro and its in vivo behavior was also assessed through subcutaneous and bone implantation in rats to evaluate its tissue-forming ability and degradation rate. The results allowed the conclusion that the gel is biocompatible, promotes the differentiation of mesenchymal stem cells, and presents an adequate degradation rate for use in bone tissue engineering. In vivo the gel blends promoted tissue regeneration and adverse reactions were not observed on subcutaneous and bone implants.
C1 [Salgado, Christiane L.] Univ Porto, DEMM, Fac Engn, INEB Inst Engn Biomed, P-4200465 Oporto, Portugal.
   [Salgado, Christiane L.] Univ Porto FEUP, Fac Engn, Oporto, Portugal.
   [Sanchez, Elisabete M. S.; Zavaglia, Cecilia A. C.; Granja, Pedro L.] State Univ Campinas UNICAMP R Mendeleyev, Sch Mech Engn, Campinas, SP, Brazil.
   [Almeida, Ana Beatriz; Granja, Pedro L.] Soc Brasileira Pesquisa & Assistencia Reabilitaca, Campinas, SP, Brazil.
RP Salgado, CL (reprint author), Univ Porto, DEMM, Fac Engn, INEB Inst Engn Biomed, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
EM chris@fe.up.pt
RI Granja, Pedro/B-1685-2008; Salgado, Christiane/K-5498-2013; Biofabris,
   Inct/I-2418-2013
OI Granja, Pedro/0000-0003-2761-4929; Salgado,
   Christiane/0000-0002-3844-1667; 
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   [CAPES-4633-06-7]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico [CNPq-142956/2005-8]
FX Authors are grateful to Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES-4633-06-7) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq-142956/2005-8) for
   funding and the scholarship for Dr. Salgado.
CR Albertsson AC, 1997, MACROMOLECULAR DESIG, P739
   ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   Barbanti SH, 2004, J MATER SCI-MATER M, V15, P1315, DOI 10.1007/s10856-004-5740-6
   Barrias CC, 2005, J BIOMED MATER RES A, V72A, P57, DOI 10.1002/jbm.a.30217
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chu C-C, 2000, BIOMEDICAL ENG HDB, P1
   Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Evangelista M.B., 2011, BIOMACROMOLECULES
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   ISO, 1999, IN VITR METH 5, V10993-5
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Li SM, 2000, J MATER SCI-MATER M, V11, P227, DOI 10.1023/A:1008920326988
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Modi S, 2006, EUR J PHARM BIOPHARM, V64, P277, DOI 10.1016/j.ejpb.2006.05.013
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNER BD, 1995, BIOMATERIALS SCI INT
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salgado C.L., 2009, Brazilian submitted patent, Patent No. [PI 018080059526, 018080059526]
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648
   Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101
   ULUDAG H, 1994, BIOTECHNOL BIOENG, V44, P1199, DOI 10.1002/bit.260441007
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
NR 40
TC 13
Z9 13
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2012
VL 18
IS 1-2
BP 137
EP 146
DI 10.1089/ten.tea.2011.0294
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 876ML
UT WOS:000299111500013
PM 21902607
DA 2018-10-19
ER

PT B
AU Meehan, R
   Saigal, A
   James, TP
AF Meehan, Riley
   Saigal, Anil
   James, Thomas P.
BE SilvaGomes, JF
   Vaz, MAP
TI DEVELOPMENT OF AN IMPLANTALBE TENSOMETER FOR IN VIVO STRAIN MEASURMENT
   OF BIOLOGICAL MATERIALS
SO ICEM15: 15TH INTERNATIONAL CONFERENCE ON EXPERIMENTAL MECHANICS
LA English
DT Proceedings Paper
CT 15th International Conference on Experimental Mechanics (ICEM)
CY JUL 22-27, 2012
CL Univ Porto, Fac Engn (FEUP), Porto, PORTUGAL
SP Portuguese Assoc Expt Mech (APAET), European Soc Expt Mech (EURASEM), Amer Soc Expt Mech (SEM), British Soc Strain Measurement (BSSM), Japanese Soc Mech Engn (JSME), Int Measurement Confederat (IMEKO), Assoc Francaise Mecanique (AFM), European Assoc Dynam Mat (DYMAT), Inst Engenharia Mecanica & Gestao Ind (INEGI), Lab Biomecanica Porto (LABIOMEP), Lab Nacl Engenharia Civil (LNEC), Fundacao Ciencia & Tecnologia (FCT), DYN CORK Tech Ind, Lda, Amorim Cork Composites, Comissao Coordenacao & Desenvolvimento Reg Norte (CCDRN), Camara Municipal Porto (CMP), Guimaraes, Teatro Nacl S Joao, ABREU PCO
HO Univ Porto, Fac Engn (FEUP)
ID BONE STRAIN; REPAIR; HERNIA; BIOMATERIALS; TISSUES
AB This paper describes the development and experimental application of a new instrument capable of loading a biomaterial sample in tension while implanted inside a laboratory animal. It is hypothesized that real-time strain measurement of an implant under a prescribed tensile load can indicate the rate of host remodeling, either by implant adaptation or resorption. Development of an implantable tensometer is the first step towards testing this hypothesis. The new instrument resembles a miniature universal testing machine, constructed entirely of stainless steel and using springs as the potential energy source. In vitro testing was conducted with fetal bovine collagen tissue to determine strain after simulated degradation with mild acid. Strain measurements revealed initial sample elongation during the degradation process, followed by establishment of a new equilibrium position. For natural tissue implants, it may be possible to use this instrument to determine a threshold stress that initiates resorption by cellular remodeling.
C1 [Meehan, Riley; Saigal, Anil; James, Thomas P.] Tufts Univ, Dept Mech Engn, Lab Biomech Studies, Medford, MA 02155 USA.
RP Meehan, R (reprint author), Tufts Univ, Dept Mech Engn, Lab Biomech Studies, Medford, MA 02155 USA.
EM thomas.james@tufts.edu
CR AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Berg RJ, 2011, P ASME INT MECH ENG
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   de Jong WC, 2010, J BIOMECH, V43, P587, DOI 10.1016/j.jbiomech.2009.09.036
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Perusek GP, 2001, J BIOMECH, V34, P385, DOI 10.1016/S0021-9290(00)00197-4
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Whan G, 2003, J BIOMECH, V36, P1669, DOI 10.1016/S0021-9290(03)0173-8
   Yeon SB, 2001, J AM COLL CARDIOL, V38, P555, DOI 10.1016/S0735-1097(01)01397-3
   Zerris VA, 2007, J BIOMED MATER RES B, V83B, P580, DOI 10.1002/jbm.b.30831
NR 15
TC 0
Z9 0
U1 0
U2 0
PU INEGI-INST ENGENHARIA MECANICA E GESTAO INDUSTRIAL
PI PORTO
PA CAMPUS DA FEUP, RUA DR ROBERTO FRIAS, 400, PORTO, 4200-465, PORTUGAL
BN 978-972-8826-26-0
PY 2012
AR UNSP 2842
PG 8
WC Engineering, Multidisciplinary; Engineering, Mechanical; Materials
   Science, Multidisciplinary; Materials Science, Characterization &
   Testing
SC Engineering; Materials Science
GA BFO20
UT WOS:000320722901112
DA 2018-10-19
ER

PT S
AU Altunbas, A
   Pochan, DJ
AF Altunbas, Aysegul
   Pochan, Darrin J.
BE Deming, T
TI Peptide-Based and Polypeptide-Based Hydrogels for Drug Delivery and
   Tissue Engineering
SO PEPTIDE-BASED MATERIALS
SE Topics in Current Chemistry
LA English
DT Review; Book Chapter
DE Biomaterial; Drug delivery; Hydrogel; Peptide; Polypeptide;
   Self-assembly; Tissue engineering
ID ELASTIN-LIKE POLYPEPTIDE; HYBRID BLOCK-COPOLYMERS; PROTEIN-BASED
   MATERIALS; SPIDER SILK PROTEINS; BETA-SHEET FIBRILS; DE-NOVO DESIGN;
   COILED-COIL; AMPHIPHILE NANOFIBERS; REVERSIBLE HYDROGELS; GROWTH-FACTOR
AB Bio-inspired materials chemistry is an interdisciplinary field in which biological functions and structures are used as inspirations to construct a wide variety of new synthetic materials and devices. Peptide sequences that provide structural, mechanical, chemical, or biological function can be borrowed from nature and fused into synthetic poly(amino acid) chains without replicating the entire natural biomolecular sequence. Supramolecular self-assembly of such rationally designed peptidic sequences is emerging as a promising route to novel biofunctional materials. This chapter highlights recent progress in bio-inspired peptide and polypeptide hydrogels that have potential biomedical and pharmaceutical applications. The focus is on synthetic or biosynthetic poly(amino acid) hydrogels based on alpha-helical coiled-coils, beta-sheets, dipeptides, peptide amphiphiles, elastin-like peptides, and on hybrids of organic polypeptides or polymers functionalized with peptides.
C1 [Altunbas, Aysegul; Pochan, Darrin J.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
RP Pochan, DJ (reprint author), Univ Delaware, Dept Mat Sci & Engn, 201 DuPont Hall, Newark, DE 19716 USA.
EM aysegul@udel.edu; pochan@udel.edu
CR Adams DJ, 2010, SOFT MATTER, V6, P3707, DOI 10.1039/c000813c
   Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 1997, J MATER CHEM, V7, P1135, DOI 10.1039/a701088e
   Alberts B, 1994, MOL BIOL CELL
   Altunbas A, 2010, ACS NANO, V4, P181, DOI 10.1021/nn901226h
   Amblard M, 2005, SPRINGER PROTOCOLS
   Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n
   Arias FJ, 2006, BIOTECHNOL LETT, V28, P687, DOI 10.1007/s10529-006-9045-3
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Ayres L, 2003, MACROMOLECULES, V36, P5967, DOI 10.1021/ma025727h
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   Bidwell GL, 2007, BIOCHEM PHARMACOL, V73, P620, DOI 10.1016/j.bcp.2006.10.028
   BLANCO FJ, 1993, J AM CHEM SOC, V115, P5887, DOI 10.1021/ja00066a092
   Bowman CN, 2008, AICHE J, V54, P2775, DOI 10.1002/aic.11678
   BRACK A, 1981, J AM CHEM SOC, V103, P6319, DOI 10.1021/ja00411a009
   BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0
   Branco M, 2009, BIOPOLYMERS, V92, P318
   Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133
   Brown AEX, 2007, BIOPHYS J, V92, pL39, DOI 10.1529/biophysj.106.101261
   Bull SR, 2005, BIOCONJUGATE CHEM, V16, P1343, DOI 10.1021/bc050153h
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043
   Cao Y, 2008, CHEM COMMUN, P4144, DOI 10.1039/b806684a
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Collier JH, 2004, ADV MATER, V16, P907, DOI 10.1002/adma.200306379
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Deming TJ, 2010, NAT MATER, V9, P535, DOI 10.1038/nmat2789
   Dong H, 2008, J AM CHEM SOC, V130, P13691, DOI 10.1021/ja8037323
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Dujardin E, 2002, ADV MATER, V14, P775, DOI 10.1002/1521-4095(20020605)14:11<775::AID-ADMA775>3.0.CO;2-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Farmer RS, 2005, BIOMACROMOLECULES, V6, P1531, DOI 10.1021/bm049216+
   Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Gauthier MA, 2008, CHEM COMMUN, P2591, DOI 10.1039/b719689j
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Grzybowski BA, 2009, SOFT MATTER, V5, P1110, DOI 10.1039/b819321p
   Gunasekaran K, 1997, PROTEIN ENG, V10, P1131, DOI 10.1093/protein/10.10.1131
   Guzman F, 2007, ELECTRON J BIOTECHN, V10, P279, DOI 10.2225/vol10-issue2-fulltext-13
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   HAQUE TS, 1994, J AM CHEM SOC, V116, P4105, DOI 10.1021/ja00088a067
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hentschel J, 2006, J AM CHEM SOC, V128, P7722, DOI 10.1021/ja060759w
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hule RA, 2008, FARADAY DISCUSS, V139, P251, DOI 10.1039/b717616c
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Jing P, 2008, BIOMACROMOLECULES, V9, P2438, DOI 10.1021/bm800459v
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kessel S, 2007, ANGEW CHEM INT EDIT, V46, P9023, DOI 10.1002/anie.200703752
   Kiick KL, 2007, POLYM REV, V47, P1, DOI 10.1080/15583720601109545
   Kim W, 2010, ANGEW CHEM INT EDIT, V49, P4257, DOI 10.1002/anie.201001356
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kramer JR, 2010, J AM CHEM SOC, V132, P15068, DOI 10.1021/ja107425f
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Lamm MS, 2008, ADV MATER, V20, P447, DOI 10.1002/adma.200701413
   Lamm MS, 2005, J AM CHEM SOC, V127, P16692, DOI 10.1021/ja05472ff
   LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Liebmann T, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-88
   Liu B, 2009, BIOMACROMOLECULES, V10, P3182, DOI 10.1021/bm900908g
   Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103
   Liu S, 2008, MACROMOLECULES, V41, P764, DOI 10.1021/ma702128a
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0
   Loschonsky S, 2008, BIOMACROMOLECULES, V9, P543, DOI 10.1021/bm7010714
   Lowik DWPM, 2007, ADV MATER, V19, P1191, DOI 10.1002/adma.200602295
   LUAN CH, 1990, BIOPOLYMERS, V29, P1699, DOI 10.1002/bip.360291403
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416
   Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   Meegan JE, 2004, ADV FUNCT MATER, V14, P31, DOI 10.1002/adfm.200304477
   Mei Y, 2004, J AM CHEM SOC, V126, P3472, DOI 10.1021/ja039583d
   Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Mitra A, 2005, J CONTROL RELEASE, V102, P191, DOI 10.1016/j.jconrel.2004.09.023
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Nettles DL, 2010, TISSUE ENG PT A, V16, P11, DOI 10.1089/ten.tea.2009.0134
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Niece KL, 2008, BIOMATERIALS, V29, P4501, DOI 10.1016/j.biomaterials.2008.07.049
   Nilsson BL, 2005, ANNU REV BIOPH BIOM, V34, P91, DOI 10.1146/annurev.biophys.34.040204.144700
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Petrie TA, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P133, DOI 10.1007/978-0-387-98161-1_7
   Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Pouget E, 2007, NAT MATER, V6, P434, DOI 10.1038/nmat1912
   Pradhan S, 2010, REGEN MED, V5, P961, DOI 10.2217/RME.10.61
   PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824
   Rajagopal K, 2006, EUR BIOPHYS J BIOPHY, V35, P162, DOI 10.1007/s00249-005-0017-7
   Rajagopal K, 2005, BIOPOLYMERS, V80, P487
   Rajagopal K, 2009, BIOMACROMOLECULES, V10, P2619, DOI 10.1021/bm900544e
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Ramachandran S, 2005, BIOMACROMOLECULES, V6, P1316, DOI 10.1021/bm049284w
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   Reynhout IC, 2005, CHEM COMMUN, P602, DOI 10.1039/b413973a
   ROMANO NH, 2010, BIOCHIM BIOPHYS ACTA, V1810, P339
   Rughani RV, 2010, MACROMOLECULES, V43, P7924, DOI 10.1021/ma1014808
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Ryan SJ, 2007, J AM CHEM SOC, V129, P10255, DOI 10.1021/ja073717w
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sharma N, 2009, ANGEW CHEM INT EDIT, V48, P7078, DOI 10.1002/anie.200901621
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shen W, 2005, STRUCTURE DYNAMICS P
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Standley SM, 2010, CANCER RES, V70, P3020, DOI 10.1158/0008-5472.CAN-09-3267
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tiefenbrunn TK, 2010, BIOPOLYMERS, V94, P95, DOI 10.1002/bip.21337
   Top A, 2010, ADV DRUG DELIVER REV, V62, P1530, DOI 10.1016/j.addr.2010.05.002
   Tse J.R., 2010, CURRENT PROTOCOLS CE
   Tzokova N, 2009, LANGMUIR, V25, P11082, DOI 10.1021/la901413n
   URRY DW, 1986, BIOPOLYMERS, V25, pS209
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Vandermeulen GWM, 2005, MACROMOLECULES, V38, P761, DOI 10.1021/ma0485538
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Vegners R, 1995, J Pept Sci, V1, P371, DOI 10.1002/psc.310010604
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Wu K, 2008, MACROMOL CHEM PHYS, V209, P467, DOI 10.1002/macp.200700486
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   Yamamoto M, 1999, J BIOACT COMPAT POL, V14, P474, DOI 10.1177/088391159901400603
   Yamaoka T, 2003, BIOMACROMOLECULES, V4, P1680, DOI 10.1021/bm0341201
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   YANG JJ, 1994, BIOCHEMISTRY-US, V33, P7345, DOI 10.1021/bi00189a040
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   Yang JY, 2006, MACROMOL BIOSCI, V6, P201, DOI 10.1002/mabi.200500208
   Yang ZM, 2007, J MATER CHEM, V17, P850, DOI 10.1039/b611255b
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yucel T, 2008, MACROMOLECULES, V41, P5763, DOI 10.1021/ma702840q
   Yuwono VM, 2007, LANGMUIR, V23, P5033, DOI 10.1021/la0629835
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 180
TC 66
Z9 67
U1 10
U2 188
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-1022
BN 978-3-642-27139-7
J9 TOP CURR CHEM
JI Top. Curr. Chem.
PY 2012
VL 310
BP 135
EP 167
DI 10.1007/128_2011_206
D2 10.1007/978-3-642-27139-7
PG 33
WC Chemistry, Multidisciplinary; Polymer Science
SC Chemistry; Polymer Science
GA BFV56
UT WOS:000321557500006
PM 21809190
DA 2018-10-19
ER

PT B
AU Fonte, M
   Saigal, A
AF Fonte, Matthew
   Saigal, Anil
GP ASME
TI CRYSTALLOGRAPHIC TEXTURE OF NITINOL AND ITS EFFECTS ON MACROPHAGE
SO PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS
   AND EXPOSITION 2010, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
   (IMECE)
CY NOV 12-18, 2010
CL Vancouver, CANADA
SP Amer Soc Mech Engineers
ID SURFACE
AB The use of Nitinol for medical purposes was first reported in the late 1960's. Today Nitinol is commonly used for the manufacture of stents, which are primarily used in peripheral and coronary bypass graft interventions. The application of NiTi in orthopedics is an exciting prospect but one that has yet to be realized. Nitinol's unique mechanical behavior is derived from the coordinated atomic movements manifesting in phase transformations from cubic austenite to monoclinic martensite. These phase transformations are solid-to-solid phase transformations that occur without diffusion or plasticity, potentially making them reversible. They involve changes in the crystalline structure that can be induced by changes in either temperature or stress. In addition to phase transformations, Nitinol's mechanical strength is strongly dependent on the alloy composition and the method in which the material is processed, i.e. rolled, drawn, extruded, or forged. The mechanical work, combined with the intermediate heat treatment steps, contribute to modify microstructure, transformation temperatures and mechanical properties. These manufacturing processing steps lead to texturing (crystallographic alignment) of the material. Alignment of the atomic planes from texture in the polycrystalline material have a marked influence on the mechanical response by either limiting or promoting phase transformations and shape recovery strains.
   Nitinol is an established biomaterial, whose biocompatibility is heavily grounded on the inertness of titanium based oxides that usually dominate the surface exterior. Surfaces that vary significantly in their chemistry, topography and corrosion resistance have different degrees of biocompatibility. As such, a better understanding of the biological response of NiTi's surfaces with different crystallographic textures in needed. In the present research, a macrophage study is performed whereby 6 plates that are highly textured NiTi with different surface finishes are incubated with cells for approximately 3 days and then tumor necrosis factor (TNF), a pro-inflammatory cytokine production and cellular proliferation are assessed.
C1 [Fonte, Matthew; Saigal, Anil] Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
RP Fonte, M (reprint author), Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
EM mfonte@flowform.com
CR [Anonymous], 2006, THR REG
   [Anonymous], 2009, AM AC ORTH SURG ANN
   [Anonymous], 2009, NAT HOSP DISCH SURV
   Chun YW, 2009, ANN BIOMED ENG, V37, P2034, DOI 10.1007/s10439-009-9722-1
   Kim JY, 2009, J BIOMED MATER RES A, V88A, P419, DOI 10.1002/jbm.a.31799
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Skalak R., 1987, HDB BIOENGINEERING
   Vojtech D., 2008, APPL SURF SCI, P1
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
NR 12
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4426-7
PY 2012
BP 1
EP 8
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Engineering, Mechanical
SC Biotechnology & Applied Microbiology; Engineering
GA BFJ68
UT WOS:000320140200001
DA 2018-10-19
ER

PT B
AU Paulino, AT
   Belfiore, LA
   Kipper, MJ
   Tambourgi, EB
AF Paulino, Alexandre T.
   Belfiore, Laurence A.
   Kipper, Matt J.
   Tambourgi, Elias B.
BE Correia, C
   Fred, A
   Gamboa, H
   Gabriel, J
TI POLYSSACHARIDE-BASED MAGNETIC HYDROGELS AS POTENTICAL VECTORS FOR
   EXTERNAL-CONTROLLED SOLUTE RELEASE
SO BIODEVICES: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOMEDICAL
   ELECTRONICS AND DEVICES
LA English
DT Proceedings Paper
CT International Conference on Biomedical Electronics and Devices
   (BIODEVICES)
CY FEB 01-04, 2012
CL PORTUGAL
DE Magnetic hydrogel; Polysaccharide; External-controlled solute release
ID DRUG-DELIVERY; POLYMERS; BIOMATERIAL; INSULIN; DEVICES
AB This work describes the synthesis of polysaccharide-based magnetic hydrogels with the introduction of magnetite nanoparticles in the polymer network. The magnetic hydrogels were characterized by Fourier-transform infrared spectroscopy (FTIR) and magnetization curves. FTIR analysis confirmed the efficiency of the polysaccharide-modifying process. The amounts of diffused water into or out-of a hydrogel network were measured. The degree of swelling of the polysaccharide-based magnetic hydrogels was less than that found for the regular polysaccharide-based hydrogels and there was no variation in the water diffusion mechanism. The absence of hysteresis loops and coercivity observed through magnetization curves indicated that magnetic hydrogels can be applied in external-controlled solute release.
C1 [Paulino, Alexandre T.; Tambourgi, Elias B.] Univ Estadual Campinas, Separat Proc Lab, Dept Chem Syst Engn, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Separat Proc Lab, Dept Chem Syst Engn, Sch Chem Engn, Av Albert Einstein,500 Bloco A,Cidade Univ, BR-13083852 Campinas, SP, Brazil.
RI Paulino, Alexandre/B-8075-2013; Tambourgi, Elias/E-1863-2012
OI Paulino, Alexandre/0000-0001-7076-2797; Tambourgi,
   Elias/0000-0002-4734-9723
CR Arizaga A, 2010, J COLLOID INTERF SCI, V348, P668, DOI 10.1016/j.jcis.2010.05.051
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   Chaterji S, 2007, PROG POLYM SCI, V32, P1083, DOI 10.1016/j.progpolymsci.2007.05.018
   Chatterjee J, 2003, COLLOID POLYM SCI, V281, P892, DOI 10.1007/s00396-003-0916-z
   Deligkaris K, 2010, SENSOR ACTUAT B-CHEM, V147, P765, DOI 10.1016/j.snb.2010.03.083
   Dorkoosh FA, 2002, INT J PHARM, V247, P47, DOI 10.1016/S0378-5173(02)00361-7
   Dorkoosh FA, 2002, EUR J PHARM SCI, V15, P433, DOI 10.1016/S0928-0987(02)00028-3
   Hallinan DT, 2010, MACROMOLECULES, V43, P4667, DOI 10.1021/ma100047z
   Jiang GQ, 2010, J MACROMOL SCI A, V47, P663, DOI 10.1080/10601325.2010.483360
   Mahkam M, 2010, J BIOACT COMPAT POL, V25, P406, DOI 10.1177/0883911510369038
   Morelli A, 2010, MACROMOL CHEM PHYS, V211, P821, DOI 10.1002/macp.200900562
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Paulino AT, 2011, POLYM INT, V60, P1324, DOI 10.1002/pi.3084
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
NR 15
TC 0
Z9 0
U1 0
U2 1
PU SCITEPRESS
PI SETUBAL
PA AV D MANUELL, 27A 2 ESQ, SETUBAL, 2910-595, PORTUGAL
BN 978-989-8425-91-1
PY 2012
BP 263
EP 268
DI 10.5220/0003870802630268
PG 6
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BFN92
UT WOS:000320663300042
DA 2018-10-19
ER

PT S
AU Kim, K
   Yoon, DM
   Mikos, AG
   Kasper, FK
AF Kim, Kyobum
   Yoon, Diana M.
   Mikos, Antonios G.
   Kasper, F. Kurtis
BE Kasper, C
   Witte, F
   Portner, R
TI Harnessing Cell-Biomaterial Interactions for Osteochondral Tissue
   Regeneration
SO TISSUE ENGINEERING III: CELL-SURFACE INTERACTIONS FOR TISSUE CULTURE
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Biomaterials; Cartilage; Cells; Tissue engineering
ID MESENCHYMAL STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; HUMAN DERMAL
   FIBROBLASTS; BONE MORPHOGENETIC PROTEIN-2; ARTICULAR-CARTILAGE REPAIR;
   INJECTABLE HYDROGEL COMPOSITES; CHONDROGENESIS IN-VITRO; MARROW STROMAL
   CELLS; BIODEGRADABLE NANOFIBROUS SCAFFOLDS; RAAV-MEDIATED OVEREXPRESSION
AB Articular cartilage that is damaged or diseased often requires surgical intervention to repair the tissue; therefore, tissue engineering strategies have been developed to aid in cartilage regeneration. Tissue engineering approaches often require the integration of cells, biomaterials, and growth factors to direct and support tissue formation. A variety of cell types have been isolated from adipose, bone marrow, muscle, and skin tissue to promote cartilage regeneration. The interaction of cells with each other and with their surrounding environment has been shown to play a key role in cartilage engineering. In tissue engineering approaches, biomaterials are commonly used to provide an initial framework for cell recruitment and proliferation and tissue formation. Modifications of the properties of biomaterials, such as creating sites for cell binding, altering their physicochemical characteristics, and regulating the delivery of growth factors, can have a significant influence on chondrogenesis. Overall, the goal is to completely restore healthy cartilage within an articular cartilage defect. This chapter aims to provide information about the importance of cell-biomaterial interactions for the chondrogenic differentiation of various cell populations that can eventually produce functional cartilage matrix that is indicative of healthy cartilage tissue.
C1 [Kim, Kyobum; Yoon, Diana M.; Mikos, Antonios G.; Kasper, F. Kurtis] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Kasper, FK (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM kasper@rice.edu
FU NIAMS NIH HHS [R01 AR057083, R01 AR048756, R01-AR048756, R01-AR057083,
   R21-AR056076, R21 AR056076]
CR Adachi N, 2002, J RHEUMATOL, V29, P1920
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Bae SE, 2010, J CONTROL RELEASE, V143, P23, DOI 10.1016/j.jconrel.2009.12.024
   Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bigdeli N, 2009, STEM CELLS, V27, P1812, DOI 10.1002/stem.114
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Buckwalter J A, 1983, Instr Course Lect, V32, P349
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Buckwalter JA, 1994, J AM ACAD ORTHOP SUR, V2, P192
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Casper ME, 2010, OSTEOARTHR CARTILAGE, V18, P981, DOI 10.1016/j.joca.2010.04.009
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chang JC, 2009, BIOMATERIALS, V30, P6265, DOI 10.1016/j.biomaterials.2009.07.064
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Choi YS, 2008, BIOTECHNOL LETT, V30, P593, DOI 10.1007/s10529-007-9584-2
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Coates EE, 2010, ANN BIOMED ENG, V38, P3371, DOI 10.1007/s10439-010-0096-1
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Cucchiarini M, 2005, MOL THER, V12, P229, DOI 10.1016/j.ymthe.2005.03.012
   Cucchiarini M, 2009, GENE THER, V16, P1363, DOI 10.1038/gt.2009.91
   CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005
   de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9
   Deng Y, 2007, ARTHRITIS RHEUM, V56, P168, DOI 10.1002/art.22300
   Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   EYRE DR, 1987, J RHEUMATOL, V14, P25
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fan HB, 2008, BIOMACROMOLECULES, V9, P927, DOI 10.1021/bm7013203
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Fell HB, 1925, J MORPHOL PHYSIOL, V40, P417, DOI 10.1002/jmor.1050400302
   Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565
   Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101
   FRANZEN A, 1981, BIOCHEM J, V197, P669, DOI 10.1042/bj1970669
   Freemont AJ, 2006, EUR J RADIOL, V57, P32, DOI 10.1016/j.ejrad.2005.08.008
   French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Fukuda A, 2005, BIOMATERIALS, V26, P4301, DOI 10.1016/j.biomaterials.2004.11.007
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Guo X, 2010, ACTA BIOMATER, V6, P2920, DOI 10.1016/j.actbio.2010.02.046
   Guo X, 2010, ACTA BIOMATER, V6, P39, DOI 10.1016/j.actbio.2009.07.041
   Guo X, 2009, BIOMATERIALS, V30, P2741, DOI 10.1016/j.biomaterials.2009.01.048
   Hamilton DW, 2006, TISSUE ENG, V12, P189, DOI 10.1089/ten.2006.12.189
   Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HEINEGARD D, 1974, J BIOL CHEM, V249, P4250
   Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.tea.2010.0499, 10.1089/ten.TEA.2010.0499]
   Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013
   Huang X, 2007, BIOMATERIALS, V28, P3091, DOI 10.1016/j.biomaterials.2007.03.017
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   Ivkovic A, 2010, GENE THER, V17, P779, DOI 10.1038/gt.2010.16
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   JANNERS MY, 1970, DEV BIOL, V23, P136, DOI 10.1016/S0012-1606(70)80011-2
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Jiang YZ, 2010, TISSUE ENG PT A, V16, P1621, DOI 10.1089/ten.TEA.2009.0681
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Kaufmann D, 2008, MACROMOL BIOSCI, V8, P577, DOI 10.1002/mabi.200700234
   Kawaguchi Jitsutaro, 2006, V330, P135
   Khalafi A, 2007, J ORTHOP RES, V25, P293, DOI 10.1002/jor.20329
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   KULYK WM, 1989, DEVELOPMENT, V106, P449
   Kuo YC, 2011, COLLOID SURFACE B, V84, P63, DOI 10.1016/j.colsurfb.2010.12.021
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee JW, 2004, BIOMATERIALS, V25, P1901, DOI 10.1016/j.biomaterials.2003.08.037
   Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2009, J TISSUE ENG REGEN M, V3, P1, DOI 10.1002/term.127
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lin YF, 2005, J CELL MOL MED, V9, P929, DOI 10.1111/j.1582-4934.2005.tb00389.x
   Liu XW, 2011, INT J ORAL MAX SURG, V40, P184, DOI 10.1016/j.ijom.2010.10.003
   Liu X, 2007, BIOTECHNOL LETT, V29, P1685, DOI 10.1007/s10529-007-9457-8
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   Madry H, 2010, ARCH ORTHOP TRAUM SU, V130, P1311, DOI 10.1007/s00402-010-1130-3
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Masuoka K, 2006, J BIOMED MATER RES B, V79B, P25, DOI 10.1002/jbm.30507
   Matsuki K, 2008, J ORTHOP SCI, V13, P524, DOI 10.1007/s00776-008-1281-z
   Merceron C, 2010, BIO-MED MATER ENG, V20, P159, DOI 10.3233/BME-2010-0627
   Midwood KS, 2001, J PATHOL, V195, P631, DOI 10.1002/path.985
   Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003
   Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004
   MIURA Y, 1994, CLIN ORTHOP RELAT R, P271
   Miyakoshi N, 2005, ARCH ORTHOP TRAUM SU, V125, P683, DOI 10.1007/s00402-005-0052-y
   Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253
   MOLLENHAUER J, 1984, J CELL BIOL, V98, P1572, DOI 10.1083/jcb.98.4.1572
   Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229
   Nakayama J, 2009, INT ORTHOP, V33, P275, DOI 10.1007/s00264-007-0459-x
   Nawata M, 2005, ARTHRITIS RHEUM-US, V52, P155, DOI 10.1002/art.20713
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391
   Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249
   Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100
   OBERLENDER SA, 1994, DEVELOPMENT, V120, P177
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Pagnotto MR, 2007, GENE THER, V14, P804, DOI 10.1038/sj.gt.3302938
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Park JS, 2011, BIOMATERIALS, V32, P1495, DOI 10.1016/j.biomaterials.2010.11.003
   Park JS, 2009, BIOMATERIALS, V30, P4796, DOI 10.1016/j.biomaterials.2009.05.054
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Park JS, 2010, J BIOMED MATER RES A, V92A, P988, DOI 10.1002/jbm.a.32341
   Park JS, 2009, J BIOMED MATER RES A, V91A, P408, DOI 10.1002/jbm.a.32271
   Park JS, 2009, TISSUE ENG PT A, V15, P2163, DOI 10.1089/ten.tea.2008.0532
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Siebert CH, 2006, ARCH ORTHOP TRAUM SU, V126, P247, DOI 10.1007/s00402-005-0061-x
   Singh M, 2011, J BIOMED MATER RES A, V98A, P412, DOI 10.1002/jbm.a.33129
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SUMMERBELL D, 1972, NATURE-NEW BIOL, V239, P24
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tanaka H, 2004, TISSUE ENG, V10, P633, DOI 10.1089/107632704323061988
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326
   TOOLE BP, 1972, P NATL ACAD SCI USA, V69, P1384, DOI 10.1073/pnas.69.6.1384
   Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014
   Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421
   van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008
   Varghese S, 2006, ADV POLYM SCI, P95, DOI 10.1007/12_072
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687
   Villanueva I, 2009, ACTA BIOMATER, V5, P2832, DOI 10.1016/j.actbio.2009.05.039
   Vlacic-Zischke J, 2011, BIOMATERIALS, V32, P665, DOI 10.1016/j.biomaterials.2010.09.025
   Vonwil D, 2010, EUR CELLS MATER, V20, P316
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Wong M, 1996, J ORTHOPAED RES, V14, P424, DOI 10.1002/jor.1100140313
   Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103
   WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15
   Yang IH, 2004, YONSEI MED J, V45, P891
   Yang Z, 2009, STEM CELLS DEV, V18, P929, DOI 10.1089/scd.2008.0219
   Yin S, 2010, TISSUE ENG PT A, V16, P1633, DOI [10.1089/ten.tea.2009.0570, 10.1089/ten.TEA.2009.0570]
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoon YM, 2000, J BIOL CHEM, V275, P12353, DOI 10.1074/jbc.275.16.12353
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   Zheng L, 2010, J BIOMED MATER RES A, V93A, P783, DOI 10.1002/jbm.a.32588
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1
NR 215
TC 2
Z9 2
U1 2
U2 8
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
EI 1616-8542
BN 978-3-642-28282-9; 978-3-642-28281-2
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2012
VL 126
BP 67
EP 104
DI 10.1007/10_2011_107
D2 10.1007/978-3-642-28282-9
PG 38
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BFR82
UT WOS:000321103500004
PM 21975954
OA Green Accepted
DA 2018-10-19
ER

PT S
AU Witte, F
   Bartsch, I
   Willbold, E
AF Witte, Frank
   Bartsch, Ivonne
   Willbold, Elmar
BE Kasper, C
   Witte, F
   Portner, R
TI Designing the Biocompatibility of Biohybrids
SO TISSUE ENGINEERING III: CELL-SURFACE INTERACTIONS FOR TISSUE CULTURE
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Artificial organs; Biocompatibility; Biohybrid; Biomaterial; Drug
   delivery; Tissue engineering
ID EMBRYONIC STEM-CELLS; IN-VITRO; REGENERATIVE MEDICINE; TITANIUM
   IMPLANTS; BIOMATERIALS; DIFFERENTIATION; SYSTEM; CARDIOMYOCYTES;
   MEMBRANES; HYDROGELS
AB Biohybrid has been used as a fashionable term in scientific publications during the past years to describe a functional unit consisting of a bioactive and a structural component. The bioactive part of the biohybrid could consist of cells or bioactive molecules, while the structural part is of biological or non-biological origin. Biohybrids are currently used as implants and transplants in regenerative medicine or in vitro applications such as assays, biosensors or bioreactors. However, a clear definition of a biohybrid has not been given yet. This chapter reviews the current applications of biohybrids and identifies the challenges of biohybrids in in vivo applications. A classification of biohybrids according to their functional use and application is provided.
C1 [Witte, Frank; Bartsch, Ivonne; Willbold, Elmar] Hannover Med Sch, Lab Biomech & Biomat, Orthopaed Clin, D-30625 Hannover, Germany.
   [Witte, Frank; Bartsch, Ivonne; Willbold, Elmar] Hannover Med Sch, Ctr Biocompatibil & Implant Immunol, CrossBIT, D-30625 Hannover, Germany.
RP Witte, F (reprint author), Hannover Med Sch, Lab Biomech & Biomat, Orthopaed Clin, Anna von Borries Str 1-7, D-30625 Hannover, Germany.
EM witte.frank@mh-hannover.de
OI Witte, Frank/0000-0001-9154-6217
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Avila G, 2009, IMPLANT DENT, V18, P17, DOI 10.1097/ID.0b013e318192cb7d
   Bartholoma P, 2005, J BIOMOL SCREEN, V10, P814, DOI 10.1177/1087057105280070
   Bartsch I, 2010, ANN M EUR SOC BIOM T
   Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249
   Bruellhoff K, 2010, INT J ARTIF ORGANS, V33, P646
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Ding F, 2008, NEPHRON EXP NEPHROL, V109, pE118, DOI 10.1159/000142936
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Faucheux N, 2004, BIOMATERIALS, V25, P2501, DOI 10.1016/j.biomaterials.2003.09.036
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Galvan V, 2007, CLIN INTERV AGING, V2, P605
   Gonez LJ, 2010, MOL CELL ENDOCRINOL, V323, P55, DOI 10.1016/j.mce.2009.12.014
   Guaccio A, 2011, BIOTECHNOL BIOENG, V108, P1965, DOI 10.1002/bit.23113
   Hanjaya-Putra D, 2009, BIOTECHNOL PROGR, V25, P2, DOI [10.1021/bp.129, 10.1002/btpr.129]
   Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19
   Jin K, 2007, J NEUROIMMUNE PHARM, V2, P236, DOI 10.1007/s11481-007-9076-0
   Kettenmann H., 1995, NEUROGLIA
   Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1
   Layer PG, 2001, NEUROREPORT, V12, pA39, DOI 10.1097/00001756-200105250-00001
   Lei L, 2011, EXPERT OPIN DRUG DEL, V8, P813, DOI 10.1517/17425247.2011.572068
   Luo GM, 2009, ACS APPL MATER INTER, V1, P2262, DOI 10.1021/am900430v
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Messenger MP, 2011, ADV MATER, V23, pH10, DOI 10.1002/adma.201100254
   Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403
   MOSCONA A, 1952, J ANAT, V86, P287
   Niebruegge S, 2008, TISSUE ENG PT A, V14, P1591, DOI 10.1089/ten.tea.2007.0247
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Petzold C, 2011, J BIOMED MATER RES A, V96A, P83, DOI 10.1002/jbm.a.32960
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Reininger-Mack A, 2002, TRENDS BIOTECHNOL, V20, P56, DOI 10.1016/S0167-7799(01)01880-7
   Rodriguez-Granillo A, 2011, WORLD J CARDIOL, V3, P84, DOI 10.4330/wjc.v3.i3.84
   Rozga J, 2010, ANN TRANSPL, V15, P92
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Saito A, 2011, HEMODIAL INT, V15, P183, DOI 10.1111/j.1542-4758.2011.00530.x
   Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x
   Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668
   Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sommerhage F, 2010, BIOSENS BIOELECTRON, V26, P155, DOI 10.1016/j.bios.2010.05.031
   Stieglitz T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065005
   Sumi S., 2010, J HEPATOBILIARY PA, V18, P6
   Thorey F, 2011, J APPL BIOMATER BIOM, V9, P26, DOI 10.5301/JABB.2011.7731
   Venkatesh Siddarth, 2005, Expert Opin Drug Deliv, V2, P1085, DOI 10.1517/17425247.2.6.1085
   Venkatesh S, 2007, BIOMATERIALS, V28, P717, DOI 10.1016/j.biomaterials.2006.09.007
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   Wu CS, 2009, BIOSENS BIOELECTRON, V24, P1498, DOI 10.1016/j.bios.2008.07.065
   Ye SH, 2005, BIOMATERIALS, V26, P5032, DOI 10.1016/j.biomaterials.2005.01.049
   Zilberman Meital, 2010, Handb Exp Pharmacol, P299, DOI 10.1007/978-3-642-00477-3_11
NR 55
TC 1
Z9 1
U1 2
U2 10
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
EI 1616-8542
BN 978-3-642-28282-9; 978-3-642-28281-2
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2012
VL 126
BP 285
EP 296
DI 10.1007/10_2011_114
D2 10.1007/978-3-642-28282-9
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BFR82
UT WOS:000321103500011
PM 21989489
DA 2018-10-19
ER

PT S
AU Wiegandt, K
   Goepfert, C
   Portner, R
   Janssen, R
AF Wiegandt, K.
   Goepfert, C.
   Poertner, R.
   Janssen, R.
BE Kasper, C
   Witte, F
   Portner, R
TI Interaction of Cartilage and Ceramic Matrix
SO TISSUE ENGINEERING III: CELL-SURFACE INTERACTIONS FOR TISSUE CULTURE
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Bioceramics; Cartilage; Hydroxyapatite; Osteochondral implants; Surface
   structure
ID TISSUE-ENGINEERED CARTILAGE; SURFACE-ROUGHNESS; IN-VITRO; OSTEOBLAST
   ADHESION; CALCIUM-PHOSPHATE; CELL BEHAVIOR; ARTICULAR CHONDROCYTES;
   CARRIER-CONSTRUCTS; RELATIVE INFLUENCE; DIFFERENTIATION
AB As subchondral bone is often affected during cartilage injuries, the aim of research is to generate osteochondral implants in vitro using tissue engineering techniques. These constructs consist of a cartilage layer grown on top of a bone phase. In clinical applications, phosphate ceramics have gained acceptance as bone substitute materials because of their great affinity to natural bone. Furthermore, the interaction between cartilage and the underlying bone equivalent is essential for the development and success of osteochondral implants. Here, the influence of a carrier containing hydroxyapatite on the quality of cartilage constructs generated in vitro is investigated. Attempts are made to explain the effects described, by considering chemical and physical properties of the biomaterial.
C1 [Wiegandt, K.; Janssen, R.] Hamburg Univ Technol, Inst Adv Ceram, Hamburg, Germany.
   [Goepfert, C.; Poertner, R.] Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany.
RP Janssen, R (reprint author), Hamburg Univ Technol, Inst Adv Ceram, Hamburg, Germany.
EM janssen@tuhh.de
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Boyan BD, 1999, J ORTHOP RES, V17, P446, DOI 10.1002/jor.1100170322
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brown A, 2011, BIOTECHNOL BIOENG, V108, P1148, DOI 10.1002/bit.23022
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Martinez EC, 2007, J MATER SCI-MATER M, V18, P1627, DOI 10.1007/s10856-007-3038-1
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4
   dos Santos EA, 2009, J BIOMED MATER RES A, V89A, P510, DOI 10.1002/jbm.a.31991
   Elter P, 2011, EUR BIOPHYS J BIOPHY, V40, P317, DOI 10.1007/s00249-010-0649-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Goepfert C, 2004, CYTOTHERAPY, P270
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hamilton DW, 2005, CELL BIOL INT, V29, P605, DOI 10.1016/j.cellbi.2005.03.013
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Heyland J, 2006, BIOTECHNOL LETT, V28, P1641, DOI 10.1007/s10529-006-9144-1
   Hoenig E, 2011, TISSUE ENG PT A, V17, P1401, DOI [10.1089/ten.TEA.2010.0395, 10.1089/ten.tea.2010.0395]
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KUETTNER KE, 1991, J RHEUMATOL, V18, P46
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Luppa D, 2000, KCS, V1, P29
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Moroni L, 2010, MRS BULL, V35, P584, DOI 10.1557/mrs2010.526
   Nagel-Heyer S, 2005, BIOPROC BIOSYST ENG, V27, P273, DOI 10.1007/s00449-005-0419-z
   Nagel-Heyer S, 2005, BIOTECHNOL LETT, V27, P187, DOI 10.1007/s10529-004-7859-4
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684
   Pennisi CP, 2011, COLLOID SURFACE B, V85, P189, DOI 10.1016/j.colsurfb.2011.02.028
   Petersen JP, 2008, J MATER SCI-MATER M, V19, P2029, DOI 10.1007/s10856-007-3291-3
   Petersen JP, 2003, EUR J TRAUMA, P1
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SCHWARTZ Z, 1993, J BIOMED MATER RES, V27, P1029, DOI 10.1002/jbm.820270808
   Spiteri CG, 2006, J BIOMED MATER RES A, V78A, P676, DOI 10.1002/jbm.a.30746
   Teixeira CC, 2006, TISSUE ENG, V12, P2283, DOI 10.1089/ten.2006.12.2283
   Toh WS, 2011, MOL PHARM
   Uvehammer J, 2001, KNEE JOINT KINEMATIC
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Wiegandt K, 2009, EINFLUSS HYDROSTATIS
   Wiegandt Katharina, 2008, Open Biomed Eng J, V2, P64, DOI 10.2174/1874120700802010064
   Wiegandt Katharina, 2007, Open Biomed Eng J, V1, P85, DOI 10.2174/1874120700701010085
   Wu JZ, 2002, J BIOMECH, V35, P931, DOI 10.1016/S0021-9290(02)00050-7
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
NR 59
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
EI 1616-8542
BN 978-3-642-28282-9; 978-3-642-28281-2
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2012
VL 126
BP 297
EP 315
DI 10.1007/10_2011_105
D2 10.1007/978-3-642-28282-9
PG 19
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology
SC Cell Biology; Biotechnology & Applied Microbiology
GA BFR82
UT WOS:000321103500012
PM 22160177
DA 2018-10-19
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI RESIDUAL STRESS PROFILES IN HIGH SPEED MACHINING AND MICROFORMING OF
   BIODEGRADABLE ORTHOPEDIC IMPLANTS
SO PROCEEDINGS OF THE ASME/STLE INTERNATIONAL JOINT TRIBOLOGY CONFERENCE -
   2011
LA English
DT Proceedings Paper
CT ASME/STLE International Joint Tribology Conference
CY OCT 24-26, 2011
CL Los Angeles, CA
SP ASME, Tribol Div, Soc Tribologists & Lubricat Engineers
ID SURFACE; ALLOYS
AB Biodegradable magnesium-calcium alloy is an attractive orthopedic biomaterial compared to permanent metallic alloys. However, the critical issue is that magnesium-calcium alloy corrodes too fast in the human organism. Hook-shaped compressive residual stress profiles, induced by various surface modification techniques in near surface zone, are proven to slower the degradation rate. This guarantees the presence of the implant in-vivo till the metabolic reactions leading to healing are over. The knowledge on how process parameters affect residual stress profiles is fundamental in successfully engineering the implants surface. Majority of surface modification techniques fall into two broad categories of cutting and forming operations. This study investigates the effects of process parameters in high speed face milling, representing a cutting operation, and low plasticity burnishing, as a micro forming process, on residual stress and microhardness profiles.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Salahshoor, M (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
CR Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, ADV MATER RES-SWITZ, V22, P67, DOI 10.4028/www.scientific.net/AMR.22.67
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Hassel T, 2007, P 7 INT C MG ALL THE, P789
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
NR 7
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5474-7
PY 2012
BP 31
EP 33
PG 3
WC Engineering, Mechanical
SC Engineering
GA BFI64
UT WOS:000320008100008
DA 2018-10-19
ER

PT J
AU Kucharska, M
   Niekraszewicz, A
   Kardas, I
   Marcol, W
   Wlaszczuk, A
   Larysz-Brysz, M
   Lewin-Kowalik, J
AF Kucharska, Magdalena
   Niekraszewicz, Antoni
   Kardas, Iwona
   Marcol, Wieslaw
   Wlaszczuk, Adam
   Larysz-Brysz, Magdalena
   Lewin-Kowalik, Joanna
TI Developing a Model of Peripheral Nerve Graft Based on Natural Polymers
SO FIBRES & TEXTILES IN EASTERN EUROPE
LA English
DT Article
DE biopolymers; peripheral nerve; prosthesis; chitosan
ID SCIATIC-NERVE; ALGINATE GEL; IN-VIVO; REGENERATION; CHITOSAN; INJURY;
   DOG
AB Presented are the results of investigations into the preparation of a peripheral nerve prosthesis. The prosthesis is built up of a multichannel core having a diameter of 2 to 5 mm. The core prepared by freeze drying is housed in a polymeric sleeve. The prosthesis core is made of microcrystalline chitosan (MCCh) while the sleeve is prepared from poly(DL-lactide-co-glycolide) copolymer. The usefulness of the prepared biomaterial was assessed by in vivo testing on animals
C1 [Kucharska, Magdalena; Niekraszewicz, Antoni; Kardas, Iwona] Inst Biopolymers & Chem Fibres, PL-90570 Lodz, Poland.
   [Marcol, Wieslaw; Wlaszczuk, Adam; Larysz-Brysz, Magdalena; Lewin-Kowalik, Joanna] Med Univ Silesia, Dept Physiol, PL-40752 Katowice, Poland.
RP Kucharska, M (reprint author), Inst Biopolymers & Chem Fibres, Ul M Sklodowskiej Curie 19-27, PL-90570 Lodz, Poland.
EM biomater@ibwch.lodz.pl
FU Ministry of Science and High Education [N N507 4612 33]
FX The investigation were carried out within the research project No N N507
   4612 33 supported by the Ministry of Science and High Education.
CR Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y
   HERT AM, 2003, BRIT ASS PLASTIC SUR, V56, P444
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Itoh S, 2003, SCI TECHNOL ADV MAT, V4, P261, DOI 10.1016/S1468-6996(03)00049-4
   LU X, 1991, J NEUROSCI, V11, P972
   Marcol W, 2011, MICROSURG, V31, P642, DOI 10.1002/micr.20945
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Qiang AO, 2005, TSINGHUA SCI TECHNOL, V10, P435
   Rosales-Cortes M, 2003, J BIOMATER APPL, V18, P15, DOI 10.1177/088532803033204
   SANTOS FX, 1995, MICROSURG, V16, P71, DOI 10.1002/micr.1920160206
   Stoll G, 1999, BRAIN PATHOL, V9, P313
   STRUSZCZYK H, 1987, J APPL POLYM SCI, V33, P171
   Struszczyk H., 1989, Polish Patent, Patent No. [P-281975, 281975]
   Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   WILLIAMS LR, 1988, CURRENT STATUS PERIP, P111
   WINDEBANK AJ, 1986, BRAIN RES, V385, P197, DOI 10.1016/0006-8993(86)91567-2
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202
   Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6
   2010, Patent No. 391898
NR 23
TC 4
Z9 4
U1 0
U2 9
PU INST CHEMICAL FIBRES
PI LODZ
PA UL M SKLODOWSKIEJ-CURIE 19/27, 90-570 LODZ, POLAND
SN 1230-3666
J9 FIBRES TEXT EAST EUR
JI Fibres Text. East. Eur.
PY 2012
VL 20
IS 6B
BP 115
EP 120
PG 6
WC Materials Science, Textiles
SC Materials Science
GA 147XB
UT WOS:000319202800020
DA 2018-10-19
ER

PT S
AU Zhou, Y
   Fang, YH
   Zeng, GN
   Zheng, CY
   Ai, N
   Wang, TG
   Bao, HJ
   Zhou, HY
AF Zhou, Yan
   Fang, Yuanhao
   Zeng, Ganning
   Zheng, Chongying
   Ai, Ning
   Wang, Tiegan
   Bao, Haijun
   Zhou, Hongyan
BE Yang, WJ
TI Adsorption of Zn2+ by Sargassum Horneri and desorption at simulated
   marine environment
SO SUSTAINABLE CITIES DEVELOPMENT AND ENVIRONMENT, PTS 1-3
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Civil, Architectural and Hydraulic
   Engineering (ICCAHE 2012)
CY AUG 10-12, 2012
CL Zhangjiajie, PEOPLES R CHINA
SP Changsha Univ Sci & Technol, Hunan Univ, Xiangtan Univ, Nanhua Univ, Hunan Univ Sci & Technol, Hunan City Univ
DE Sargassum horneri; adsorption; desorption; Zinc
ID BIOSORPTION; ALGAE
AB The adsorption of Zn2+ from simulated seawater onto biomaterial derived from the macroalgae Sargassum horneri was investigated via batch experiments. The highest adsorption rate was 96.9%, which found in the lower Zn2+ concentration solution where pH was 8.0 and temperature was 15 degrees C, and the maximum adsorption capacity of dead Sargassum homeri particle to Zn2+ could arrive to more than 0.20 mg.g(-1). Sargassum horneri pretreated with CaCl2 can increase the adsorption rate. Infrared analysis results showed that carboxylic acid groups have an important contribution to Zn2+ adsorption. The adsorption equilibrium of Zn2+ could be represented by pseudo-second-order model and the capacity of dead alga for Zn2+ was approximately constant. Conclusions could be drawn that Sargassum horneri is a kind of efficient biosorbent for the treatment of waste waters containing heavy metals. It was because Zn2+ can easily be desorbed by competition between the hydrogen ions and metal ions on the cell surface binding sites, that hydrochloric acid was proved to have economic feasibility.
C1 [Fang, Yuanhao; Zeng, Ganning; Bao, Haijun] Zhejiang Univ Technol, Coll Chem Engn & Mat Sci, Hangzhou, Zhejiang, Peoples R China.
   [Zhou, Yan; Zheng, Chongying] Aquat Prod Qual Inspect Ctr Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.
   [Zeng, Ganning] State Key Lab Satellite Ocean Environm Dynam, Hangzhou, Zhejiang, Peoples R China.
   [Ai, Ning] Zhejiang Province Key Lab Biofuel, Hangzhou, Zhejiang, Peoples R China.
   [Wang, Tiegan] Zhejiang Mariculture Res Inst, Hangzhou, Zhejiang, Peoples R China.
RP Zeng, GN (reprint author), Zhejiang Univ Technol, Coll Chem Engn & Mat Sci, Hangzhou, Zhejiang, Peoples R China.
EM gnzeng@zjut.edu.cn
FU Zhejiang Provincial Natural Science Foundation [LY12D06004]; Science and
   Technological Program of Zhejiang [2011C23071]; Key Scientific and
   Technological Innovation Team Program of Zhejiang [2010R50028]; Ocean
   and Islands of Zhejiang [2008.334005.193725]
FX This work was supported by Zhejiang Provincial Natural Science
   Foundation (LY12D06004), Science and Technological Program of Zhejiang
   Province (2011C23071), The Key Scientific and Technological Innovation
   Team Program of Zhejiang Province (2010R50028), Management Program of
   Ocean and Islands of Zhejiang Province (2008.334005.193725).
CR Aytas S, 2011, DESALINATION, V280, P354, DOI 10.1016/j.desal.2011.07.023
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Gao Kunshan, 1997, Phycological Research, V45, P55, DOI 10.1111/j.1440-1835.1997.tb00062.x
   Giusti L, 2001, ENVIRON INT, V26, P275, DOI 10.1016/S0160-4120(00)00117-3
   Jha B, 2009, BIODEGRADATION, V20, P1, DOI 10.1007/s10532-008-9194-2
   [江用彬 JIANG Yongbin], 2007, [地理科学进展, Progress in geography], V26, P56
   Kadukova J, 2005, ENVIRON INT, V31, P227, DOI 10.1016/j.envint.2004.09.020
   Luning K, 2003, J APPL PHYCOL, V15, P115, DOI 10.1023/A:1023807503255
   Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571
   Pan Jin-fen, 2000, Chinese Journal of Oceanology and Limnology, V18, P260
   Rajfur M, 2010, BIOELECTROCHEMISTRY, V80, P81, DOI 10.1016/j.bioelechem.2010.03.005
   Sun JZ, 2010, ACTA ECOLOGICA SINIC, V30, P106
   TSEZOS M, 1984, BIOTECHNOL BIOENG, V26, P973, DOI 10.1002/bit.260260823
   Wang Xian, 2006, ACTA OCEANOL SIN, V25, P153
   Zheng Shenghua, 2005, OCEAN TECHNOLOGY, V24, P70
NR 15
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-485-3
J9 APPL MECH MATER
PY 2012
VL 209-211
BP 1093
EP +
DI 10.4028/www.scientific.net/AMM.209-211.1093
PN 1-3
PG 3
WC Engineering, Environmental; Engineering, Civil
SC Engineering
GA BFD16
UT WOS:000319231000211
DA 2018-10-19
ER

PT S
AU Fiorica, C
   Rigogliuso, S
   Palumbo, FS
   Pitarresi, G
   Giammona, G
   Ghersi, G
AF Fiorica, Calogero
   Rigogliuso, Salvatrice
   Palumbo, Fabio S.
   Pitarresi, Giovanna
   Giammona, Gaetano
   Ghersi, Giulio
BE Bardone, E
   Brucato, A
   Keshavarz, T
   Pierucci, S
   Klemes, JJ
TI A Fibrillar Biodegradable Scaffold for Blood Vessels Tissue Engineering
SO IBIC2012: INTERNATIONAL CONFERENCE ON INDUSTRIAL BIOTECHNOLOGY
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 3rd International Conference on Industrial Biotechnology (IBIC)
CY JUN 24-27, 2012
CL Palermo, ITALY
SP Italian Assoc Chemical Engn (AIDIC), Biotech Working Grp
ID HEPARIN
AB In recent years there has been a growing interest for the development of tubular scaffolds employed to assist the replacement of small blood vessels. Materials designed for this purpose need to be biodegradable, have good mechanical properties and improve cell adhesion, proliferation and differentiation. To obtain biomaterials with these properties, electrospinning seems to be one of the most useful technique. Several biodegradable synthetic polymers or constituents of the extracellular matrix (ECM) have been electrospun showing optimal mechanical properties and biodegradability. However, such polymers are lacking in versatile chemical structure affordable to immobilize growth factors or chemokines. The glycosaminoglycan heparin is able to bind several growth factors like vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) and, when grafted onto the scaffold surface it is able to attract cells thus improving their proliferation and differentiation. Aim of this research was the production and the preliminary in vitro biological characterization of a new biodegradable material, obtained by electrospun a polyaminoacid-graft-polyester copolymer. The electrospun biomaterial has been successfully grafted with heparin exploiting the better chemical reactivity of the polyaminoacid portions of the graft copolymer. Then its morphology has been investigated by scanning electron microscopy (SEM) and the potential biodegradability of the material has been studied until 60 days. Preliminary biological data in vitro, on human endothelial cells, show a good compatibility of the scaffold obtained by electrospinning, with regard to cell adhesion and proliferation. Experiments are in progress to evaluate the effects of heparin on cell differentiation.
C1 [Fiorica, Calogero; Rigogliuso, Salvatrice; Palumbo, Fabio S.; Pitarresi, Giovanna; Giammona, Gaetano; Ghersi, Giulio] Univ Palermo, Dipartimento Sci & Tecnol Mol & Biomol, I-90123 Palermo, Italy.
RP Fiorica, C (reprint author), Univ Palermo, Dipartimento Sci & Tecnol Mol & Biomol, Via Archirafi 32, I-90123 Palermo, Italy.
EM gaetano.giammona@unipa.it
OI Ghersi, Giulio/0000-0001-7250-9808; Fiorica,
   Calogero/0000-0002-5169-4036
CR Ishihara M., 1998, GLYCOSCI GLYCOTECHNO, V10, P223
   Jayson GC, 1997, BRIT J CANCER, V75, P9, DOI 10.1038/bjc.1997.3
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Nottelet B, 2009, J BIOMED MATER RES A, V89A, P865, DOI 10.1002/jbm.a.32023
   Pooyan P, 2012, J MECH BEHAV BIOMED, V7, P50, DOI 10.1016/j.jmbbm.2011.09.009
   Sheridan WS, 2012, J MECH BEHAV BIOMED, V8, P58, DOI 10.1016/j.jmbbm.2011.12.003
   SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
NR 8
TC 3
Z9 3
U1 0
U2 10
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-18-1
J9 CHEM ENGINEER TRANS
PY 2012
VL 27
BP 403
EP 408
DI 10.3303/CET1227068
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA BFE70
UT WOS:000319509400068
DA 2018-10-19
ER

PT S
AU Rosli, ZM
   Mahamud, Z
   Juoi, JM
   Nayan, N
   Loon, KW
   Yusuf, Y
   Ab Maulod, HE
AF Rosli, Zulkifli Mohd
   Mahamud, Zainab
   Juoi, Jariah Mohamad
   Nayan, Nafarizal
   Loon, Kwan Wai
   Yusuf, Yusliza
   Ab Maulod, Hairul Effendy
BE Abdullah, MMA
   Jamaludin, L
   Razak, RA
   Yahya, Z
   Hussin, K
TI Corrosion behavior of AZ91 Mg-Alloy coated with AlN and TiN in NaCl and
   Hank's solution
SO ADVANCED MATERIALS ENGINEERING AND TECHNOLOGY
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Materials Engineering and
   Technology (ICAMET 2012)
CY NOV 28-30, 2012
CL Penang, MALAYSIA
SP Ctr Excellence Geopolymer & Green Technol, Univ Malaysia Perlis, Sch Mat Engn, King Abdul Aziz City Sci & Technol, Univ Cambridge, SMaRT@UNSW, Univ New S Wales, Norton Univ, Univ Malaysia Sarawak, Univ Putra Malaysia, Inst Adv Technol
DE AZ91 Mg Alloys; PVD magnetron sputtering; AlN; TiN; electrochemical
   corrosion test
ID MAGNESIUM ALLOY; PVD COATINGS; ZE41
AB Magnesium alloys create increasing interest in structural application where weight reduction is vast concern. However, its low corrosion resistance especially in atmosphere environment restricts their wide application. In this study, AlN and TiN were coated on AZ91 Mg alloy using PVD magnetron sputtering. AlN and TiN existence is confirmed via grazing angle x-ray diffraction (GA-XRD). The corrosion behaviors of uncoated and coated AZ91 Mg alloy in3.5% NaCl and Hank's solutions were investigated using a potentiostat during electrochemical corrosion test. AlN and TiN coated samples showed better performance in Hank's solution with TiN coated samples have the least corrosion rate (penetration rate=0.040mm/yr and mass loss rate=0.191g/m(2)d) in Hank's solution. These create interest to further works on exploring the potential of coated AZ91 Mg alloy in biomaterial application.
C1 [Rosli, Zulkifli Mohd; Mahamud, Zainab; Juoi, Jariah Mohamad; Loon, Kwan Wai; Yusuf, Yusliza; Ab Maulod, Hairul Effendy] Univ Teknikal Malaysia Melaka, Fac Mfg Engn, Durian Tunggal 76100, Melaka, Malaysia.
   [Nayan, Nafarizal] Univ Hussein Onn Malaysia, Fac Elect & Elect Engn, Raja, Malaysia.
RP Rosli, ZM (reprint author), Univ Teknikal Malaysia Melaka, Fac Mfg Engn, Durian Tunggal 76100, Melaka, Malaysia.
EM zmr@utem.edu.my; zainab.mahamud86@gmail.com; jariah@utem.edu.my;
   nafa@uthm.edu.my; kwailoon86@gmail.com; yusliza@utem.edu.my;
   hairuleffendy@utem.edu.my
RI mohd rosli, zulkifli/O-9449-2016
OI mohd rosli, zulkifli/0000-0002-3109-6231; Nayan,
   Nafarizal/0000-0002-9962-5283; Yusliza, Yusuf/0000-0001-8772-4041; Ab
   Maulod, Hairul Effendy/0000-0003-3138-8020
CR Abidin NIZ, 2011, CORROS SCI, V53, P3542, DOI 10.1016/j.corsci.2011.06.030
   Altun H, 2008, MATER CHARACT, V59, P266, DOI 10.1016/j.matchar.2007.01.004
   Altun H, 2007, MATER CHARACT, V58, P917, DOI 10.1016/j.matchar.2006.09.007
   Altun H, 2006, MATER DESIGN, V27, P1174, DOI 10.1016/j.matdes.2005.02.004
   Chunha L., CORROSION TIN TIAL N
   Guo K.W., 2010, RECENT PAT CORROS SC, V2, P13, DOI DOI 10.2174/1877610801002010013
   Hoche H, 2005, SURF COAT TECH, V193, P223, DOI [10.1016/j.surfcoat.2004.08.147, 10.1016/j.surfcaot.2004.08.147]
   Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4
   Nemcova A., 2009, MAT ENG, V16
   Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005
   Rebholz C, 2006, THIN SOLID FILMS, V514, P81, DOI 10.1016/j.tsf.2006.02.038
   Xin YC, 2009, SURF COAT TECH, V203, P2554, DOI 10.1016/j.surfcoat.2009.02.074
   Yang LJ, 2010, CORROS SCI, V52, P345, DOI 10.1016/j.corsci.2009.09.020
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
   Zhu LQ, 2006, SURF COAT TECH, V200, P2834, DOI 10.1016/j.surfcoat.2004.11.042
NR 15
TC 1
Z9 1
U1 1
U2 16
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-571-3
J9 ADV MATER RES-SWITZ
PY 2012
VL 626
BP 275
EP +
DI 10.4028/www.scientific.net/AMR.626.275
PG 2
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing
SC Materials Science
GA BFC27
UT WOS:000319169500056
DA 2018-10-19
ER

PT S
AU Chaleat, CM
   Nikolic, M
   Truss, RW
   Tan, I
   McGlashan, SA
   Halley, PJ
AF Chaleat, C. M.
   Nikolic, M.
   Truss, R. W.
   Tan, I.
   McGlashan, S. A.
   Halley, P. J.
BE Smith, PB
   Gross, RA
TI Thermoplastic Starch Polymer Blends and Nanocomposites
SO BIOBASED MONOMERS, POLYMERS, AND MATERIALS
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT 241st National Meeting and Exposition of the American-Chemical-Society
   (ACS)
CY MAR 27-31, 2011
CL Anaheim, CA
SP Amer Chem Soc
ID MOISTURE-CONTENT; EXTRUSION; GELATINIZATION; TEMPERATURE; PRODUCTS;
   PLASTICS; MAIZE
AB This paper reviews the development of bio-based thermoplastic starch polymer blends and nanocomposites at the University of Queensland. Starch-based thermoplastics are relatively cheap and more importantly manufactured using a renewable biomaterial. However traditionally most thermoplastic starch polymers suffer from low water resistance and loss of mechanical properties when in contact with water. This paper will highlight the development of thermoplastic starch polymer blends and nanocomposite materials to overcome some of the challenges of thermoplastic starch. Specifically we will highlight understandings in the genetics-structure-property-biodegradation relationships for thermoplastic starch polymers, developments in blends, nanocomposite materials and reactive extrusion and highlights of scale-up of film blowing and injection molding grades.
C1 [Chaleat, C. M.; Halley, P. J.] AIBN, Uq, Qld 4072, Australia.
RP Chaleat, CM (reprint author), AIBN, Uq, Qld 4072, Australia.
EM p.halley@uq.edu.au
RI Halley, Peter/F-8435-2014
OI Halley, Peter/0000-0001-8014-6613; Nikolic, Melissa/0000-0002-4448-476X;
   Chaleat, Celine/0000-0002-0403-7236
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   Chaleat CM, 2008, CARBOHYD POLYM, V74, P366, DOI 10.1016/j.carbpol.2008.03.002
   Chaleat CM, 2008, CARBOHYD POLYM, V71, P535, DOI 10.1016/j.carbpol.2007.06.029
   Chivrac F, 2008, BIOMACROMOLECULES, V9, P896, DOI 10.1021/bm7012668
   Dennis HR, 2001, POLYMER, V42, P9513, DOI 10.1016/S0032-3861(01)00473-6
   Funke U, 1998, POLYM DEGRAD STABIL, V59, P293, DOI 10.1016/S0141-3910(97)00163-8
   Halley P., 2002, [No title captured], Patent No. [W0200283784-A1, 200283784]
   Halley P., 2002, [No title captured], Patent No. [EP1392770-A4, 1392770]
   Halley P., 2002, [No title captured], Patent No. [US7094817-B2, 7094817]
   Halley P., 2002, [No title captured], Patent No. [US2004122135-A1, 2004122135]
   Halley P., 2002, [No title captured], Patent No. [AU2002248988-A1, 2002248988]
   Halley P. J., 2008, ACS S SERIES, V978
   KOJIMA Y, 1993, J MATER RES, V8, P1185, DOI 10.1557/JMR.1993.1185
   LeBaron PC, 2001, CHEM MATER, V13, P3760, DOI 10.1021/cm010982m
   Li G, 2008, MACROMOL CHEM PHYSIC, V209, P991, DOI 10.1002/macp.200700637
   Maliger RB, 2006, POLYM ENG SCI, V46, P248, DOI 10.1002/pen.20479
   McGlashan SA, 2003, POLYM INT, V52, P1767, DOI 10.1002/pi.1287
   Russo MAL, 2007, BIOMACROMOLECULES, V8, P296, DOI 10.1021/bm060791i
   Russo MAL, 2009, CARBOHYD POLYM, V77, P442, DOI 10.1016/j.carbpol.2008.12.033
   Russo MAL, 2009, BIORESOURCE TECHNOL, V100, P1705, DOI 10.1016/j.biortech.2008.09.026
   SHOGREN RL, 1993, STARCH-STARKE, V45, P276, DOI 10.1002/star.19930450806
   Tan I., 2005, THESIS U QUEENSLAND
   Tan I, 2008, CARBOHYD POLYM, V72, P272, DOI 10.1016/j.carbpol.2007.08.018
   Tan I, 2007, BIOMACROMOLECULES, V8, P885, DOI 10.1021/bm060988a
   vanSoest JJG, 1997, TRENDS BIOTECHNOL, V15, P208, DOI 10.1016/S0167-7799(97)01021-4
   Walenta E, 2001, MACROMOL MATER ENG, V286, P462, DOI 10.1002/1439-2054(200108)286:8<462::AID-MAME462>3.0.CO;2-A
   Willett JL, 1997, POLYMER, V38, P5983, DOI 10.1016/S0032-3861(97)00155-9
NR 27
TC 3
Z9 3
U1 1
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2767-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1105
BP 323
EP 334
PG 12
WC Biotechnology & Applied Microbiology; Polymer Science
SC Biotechnology & Applied Microbiology; Polymer Science
GA BEZ91
UT WOS:000318959800019
DA 2018-10-19
ER

PT B
AU Ayob, SNSA
   Hashim, U
AF Ayob, Sharipah Nadzirah Syed Ahmad
   Hashim, U.
GP IEEE
TI The Synthesis and Fabrication of Titanium Dioxide Nanowires-Based
   Biosensor
SO 2012 10TH IEEE INTERNATIONAL CONFERENCE ON SEMICONDUCTOR ELECTRONICS
   (ICSE)
LA English
DT Proceedings Paper
CT 10th IEEE International Conference on Semiconductor Electronics (ICSE)
CY SEP 19-21, 2012
CL Kuala Lumpur, MALAYSIA
SP IEEE, Electron Devices Soc, Univ Kebangsaan Malaysia, Inst Microengineering & Nanoelectron (IMEN), TM Res & Dev Sdn Bhd, Silterra Sdn Bhd, IEEE Malaysia Sect, Electron Devices Chapter
DE Titanium dioxide nanowires; Biosensors; Sol-gel method; Simple
   fabrication process
AB A better performance and low cost biosensor is believed can be formed when Titanium dioxide (TiO2) nanowires working together with Aurum (Au) Inter Digitated Electrode (IDE). The use of TiO2 nanowires for DNA application can be considered as a new exploration in research and development field. Bottom-up approach of the sol-gel method is used to grow TiO2 nanowires while the topdown simple lithography method is used to fabricate Aurum (Au) interdigitated electrodes (IDEs). Thus, the combination of both bottom-up and top-down approaches are able to form a very high sensitivity of the sensor. Biomaterial DNA application on the modified surface of TiO2 nanowires cause it to form a biosensor.
C1 [Ayob, Sharipah Nadzirah Syed Ahmad; Hashim, U.] Univ Malaysia Perlis, Inst Nano Elect Engn, Nanostruct Lab On Chip Res Grp, Kangar 01000, Perlis Malaysia, Malaysia.
RP Ayob, SNSA (reprint author), Univ Malaysia Perlis, Inst Nano Elect Engn, Nanostruct Lab On Chip Res Grp, Kangar 01000, Perlis Malaysia, Malaysia.
EM shnadzirahsaa@gmail.com; uda@unimap.edu.my
OI hashim, uda/0000-0001-5118-6069; Scopus, UniMAP/0000-0003-1327-8215
CR Ahmad Dr. A., 2007, PAK ENG C 70 ANN SES
   Guo L, 2012, SENSOR ACTUAT B-CHEM, V166, P12, DOI 10.1016/j.snb.2011.08.049
   Kumar A, 2010, J PHYS CHEM C, V114, P7787, DOI 10.1021/jp100491h
   Shankar KS, 2005, MAT SCI ENG C-BIO S, V25, P738, DOI 10.1016/j.msec.2005.06.054
   Sheng YG, 2008, OPT MATER, V30, P1310, DOI 10.1016/j.optmat.2007.06.010
   Tamaki J, 2006, SENSOR ACTUAT B-CHEM, V117, P353, DOI 10.1016/j.snb.2005.11.005
NR 6
TC 2
Z9 2
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-2396-3
PY 2012
BP 145
EP 148
PG 4
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA BEH22
UT WOS:000316563400035
DA 2018-10-19
ER

PT J
AU Bojar, W
   Kucharska, M
   Bubak, G
   Ciach, T
   Koperski, L
   Jastrzebski, Z
   Gruber, BM
   Krzyszton-Russjan, J
   Marczewska, J
   Anuszewska, EL
   Drozd, E
   Brynk, T
AF Bojar, Witold
   Kucharska, Martyna
   Bubak, Grzegorz
   Ciach, Tomasz
   Koperski, Lukasz
   Jastrzebski, Zenon
   Gruber, Beata M.
   Krzyszton-Russjan, Jolanta
   Marczewska, Jadwiga
   Anuszewska, Elzbieta L.
   Drozd, Ewa
   Brynk, Tomasz
TI Formation and preclinical evaluation of a new alloplastic injectable
   bone substitute material
SO ACTA OF BIOENGINEERING AND BIOMECHANICS
LA English
DT Article
DE alginate; bone substitute material; chitosan; guided bone regeneration;
   beta-tricalcium phosphate
ID CHITOSAN
AB Alloplastic bone substitute materials are raising some more interest as an alternative for autologic transplants and xenogenic materials especially in oral surgery over the last few years. These non-immunogenic and completely resorbable biomaterials are the basis for complete and predictable guided bone regeneration. In the majority of cases, such a material is chosen because of its convenient application by surgeons.
   The main objective of our project was to design and fabricate an osteoconductive, injectable and readily tolerable by human tissues biomaterial for guided bone regeneration. For this purpose, a self-setting composite consisting of chitosan/tricalcium phosphate micro-particles and sodium alginate was made. The material obtained was characterized by microsphere and agglomerate morphology and microstructure. Its features relating to setting time and mechanical properties were precisely investigated. Our material was also evaluated according to PN-EN ISO 10993 Biological evaluation of medical devices, i.e., the in vitro tests for genotoxicity and cytotoxicity were conduced. Then, the following examinations were performed: subchronic systemic toxicity, skin sensitization, irritation and delayed-type hypersensitivity and local effects after implantation.
   The material tested showed a high degree of cytocompatibility, fulfilled the requirements of International Standards and seemed to be a "user friendly" material for oral surgeons.
C1 [Bojar, Witold] Natl Med Inst, Med Devices Dept, PL-00725 Warsaw, Poland.
   [Kucharska, Martyna; Bubak, Grzegorz; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00661 Warsaw, Poland.
   [Koperski, Lukasz] Med Univ Warsaw, Dept Pathol, Warsaw, Poland.
   [Gruber, Beata M.; Krzyszton-Russjan, Jolanta; Marczewska, Jadwiga; Anuszewska, Elzbieta L.; Drozd, Ewa] Natl Med Inst, Biochem & Biopharmaceut Dept, Warsaw, Poland.
   [Brynk, Tomasz] Warsaw Univ Technol, Fac Mat Sci & Engn, PL-00661 Warsaw, Poland.
RP Bojar, W (reprint author), Natl Med Inst, Med Devices Dept, Ul Chelmska 30-34, PL-00725 Warsaw, Poland.
EM bojar@il.waw.pl
RI Bubak, Grzegorz/I-3808-2018
OI Bubak, Grzegorz/0000-0001-7938-4016; Ciach, Tomasz/0000-0002-8726-8944;
   Brynk, Tomasz/0000-0002-5825-4789
FU Foundation of Polish Science within the framework of Innovative Economy
   Operational Programme
FX This work was financially supported by the Foundation of Polish Science
   within the framework of Innovative Economy Operational Programme.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bojar W, 2009, ADV CLIN EXP MED, V18, P615
   Horovitz RA, 2009, TITANIUM, V1, P1
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
NR 8
TC 9
Z9 9
U1 0
U2 6
PU WROCLAW UNIV TECHNOLOGY
PI WROCLAW
PA WROCLAW UNIV TECHNOLOGY, MECHANICAL DEPT, WYBRZEZE WYSPIANSKIEGO 27,
   WROCLAW, 50-370, POLAND
SN 1509-409X
J9 ACTA BIOENG BIOMECH
JI Acta Bioeng. Biomech.
PY 2012
VL 14
IS 1
BP 39
EP 44
PG 6
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 142DJ
UT WOS:000318776300005
PM 22742431
DA 2018-10-19
ER

PT S
AU Wang, JB
   Shang, ZY
   Yuan, ZS
   Zhou, J
   Feng, ZW
   Miao, WD
   Zhu, M
AF Wang, Jiangbo
   Shang, Zaiyan
   Yuan, Zhishan
   Zhou, Jin
   Feng, Zhaowei
   Miao, Weidong
   Zhu, Ming
BE Cui, CX
   Li, YL
   Yuan, ZH
TI Study on the mechanical property and microstructure of surgical
   implanted Ti-6Al-7Nb titanium alloy
SO ADVANCED ENGINEERING MATERIALS II, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Engineering Materials and
   Technology (AEMT)
CY JUL 06-08, 2012
CL Zhuhai, PEOPLES R CHINA
SP Hebei Univ Technol, Inner Mongolia Univ Technol, Korea Maritime Univ
DE Biocompatability; Biomaterial; Ti-6Al-7Nb Titanium Alloy; Orthopedic
   Application; Mechanical Property; Microstructure
ID BEHAVIOR
AB Ti-6Al-7Nb titanium alloy is attractive to medical device industry for orthopedic applications, such as total hip replacement systems, fracture fixation plates, intermedullary rods and nails, spinal devices, screws, and wires. Substituting Niobium for Vanadium as the beta stabilizing element, Ti-6Al-7Nb titanium alloy shows higher biocompatability than Ti-6Al-4V titanium alloy. The present research is designed to investigate the influence of annealling temper on the mechanical properties and microstructures of Ti-6Al-7Nb titanium alloy, by optical microscopic (OM) and scanning electron microscopic (SEM), and tensile test. The results show that the microstructures after recrystalization heat treatment comprise a mount of equiaxed alpha grains in the matrix of equiaxed beta phase with alpha (hcp)/ beta (bcc) platelets. The microstructures with partial recrystalization alpha phase possess better mechanical properties which conform to the ASTM F 1295 standard and ISO 5832-11 standard. Compared with Ti-6Al-4V titanium alloy and CP titanium alloy, Ti-6Al-7Nb titanium alloy is suitable to be used as implanted biomaterial devices to replace ill-functioning or missing tissues or organs.
C1 [Wang, Jiangbo; Shang, Zaiyan; Yuan, Zhishan; Zhou, Jin; Feng, Zhaowei; Miao, Weidong; Zhu, Ming] Grikin Adv Mat Co Ltd, Gen Res Inst Nonferrous Met, Beijing 102200, Peoples R China.
RP Wang, JB (reprint author), Grikin Adv Mat Co Ltd, Gen Res Inst Nonferrous Met, 33 Chaoqian Rd, Beijing 102200, Peoples R China.
EM wangjiangbo@grikin.com; szy@grikin.com; yuanzs@163.com; zj@grikin.com;
   fzw@grikin.com; mwd@grikin.com; zm@grikin.com
CR Ajeel S A, 2007, ENG TECHNOLOGY, V25, P431
   Assis SL, 2007, MATER CORROS, V58, P329, DOI 10.1002/maco.200604027
   Barbosa PF, 2000, P I MECH ENG L-J MAT, V214, P23, DOI 10.1243/1464420001544708
   Jin Z., 2008, THESIS NE U SHENYANG
   [李士凯 Li Shikai], 2007, [稀有金属, Chinese Journal of Rare Metals], V31, P709
   Lindemann J, 1999, MAT SCI ENG A-STRUCT, V263, P137, DOI 10.1016/S0921-5093(98)01172-1
   Lutjering G., 2007, TITANIUM
   Lutjering G., 2003, TITANIUM
   Mall S, 2004, MAT SCI ENG A-STRUCT, V383, P334, DOI 10.1016/j.msea.2004.05.019
   Niu Z. J., 2006, TITANIUM IND PROGR, V23, P23
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Sanders B., 1981, HEAT TREATING TITANI, V4, P763
   Wang G. S., 2001, CHINESE J RARE METAL, V25, P395
   Yuan Z. S., 2005, J MAT ENG, V9, P37
   Zhu HL, 2005, SCRIPTA MATER, V52, P45, DOI 10.1016/j.scriptamat.2004.08.027
NR 15
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-446-4
J9 ADV MATER RES-SWITZ
PY 2012
VL 535-537
BP 945
EP 949
DI 10.4028/www.scientific.net/AMR.535-537.945
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEU39
UT WOS:000318195200194
DA 2018-10-19
ER

PT S
AU Li, P
   Shen, XR
   Duan, ZW
   Wang, ZH
AF Li, Peng
   Shen, Xuan-Ri
   Duan, Zhou-Wei
   Wang, Zhang-Han
BE Cui, CX
   Li, YL
   Yuan, ZH
TI Preparation of transglutaminase cross-linked Tilapia scale collagen
   microspheres containing L-ascorbic acid
SO ADVANCED ENGINEERING MATERIALS II, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Engineering Materials and
   Technology (AEMT)
CY JUL 06-08, 2012
CL Zhuhai, PEOPLES R CHINA
SP Hebei Univ Technol, Inner Mongolia Univ Technol, Korea Maritime Univ
DE Collagen; Microencapsulation; Tilapia; L-ascorbic acid;
   Transglutaminase; biomaterial
ID I COLLAGEN
AB With the goal to develop biocompatible material collagen extracted from tilapia scale as coating material to encapsulate bioactive compounds, a microsphere containing L-ascorbic acid as a model is developed, using natural nontoxic transglutaminase (TG) as cross-linking agent. Ultrasonic wave was applied in the process to assist preparing microcapsule. Factors of emulsifier, TG, ratio of L-ascorbic acid and collagen, incubation temperature were discussed. The formulation from orthogonal experiment was of the optimal encapsulation efficiency 81.17%.It is found that the collagen extracted from tilapia scale is a potential biomaterial.
C1 [Li, Peng; Shen, Xuan-Ri; Duan, Zhou-Wei; Wang, Zhang-Han] Hainan Univ, Coll Food Sci & Technol, Haikou 570228, Peoples R China.
RP Li, P (reprint author), Hainan Univ, Coll Food Sci & Technol, Haikou 570228, Peoples R China.
EM limay2010@163.com; shenxuand2009@163.com
CR Chen Junhui, 2008, BIOCH EXPT, P212
   Chen Ray-Neng, 2005, BIOMATERIALS, V20, P42229
   Geesin Jeffrey C., 1992, ARCH BIOCHEM BIOPHYS, V189, P6
   JoseFonseca M., 1996, BIOCHIM BIOPHYS ACTA, V2, P259
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meena C, 1999, P INDIAN AS-CHEM SCI, V111, P319
   Nomura Y, 2001, BIOMACROMOLECULES, V2, P105, DOI 10.1021/bm000085w
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Sakaguchi M, 2000, J ALLERGY CLIN IMMUN, V106, P579, DOI 10.1067/mai.2000.108499
   Xie Hiyi, 2010, CHINESE J CHEM ENG, V18, P149
   Zhang Su-ning, 2008, CHINA SURFACTANT DET, V5, P308
NR 11
TC 1
Z9 1
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-446-4
J9 ADV MATER RES-SWITZ
PY 2012
VL 535-537
BP 2307
EP 2311
DI 10.4028/www.scientific.net/AMR.535-537.2307
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEU39
UT WOS:000318195201115
DA 2018-10-19
ER

PT S
AU Jin, HY
   Liu, Y
   Liu, X
   Wang, DP
   Liu, J
   Zhang, HM
   Zong, CY
   Zhao, H
   Feng, XQ
   Yin, H
   An, Y
AF Jin, Huanyu
   Liu, Yu
   Liu, Xing
   Wang, Dapeng
   Liu, Jian
   Zhang, Hemei
   Zong, Chunyan
   Zhao, Hua
   Feng, Xiaoqing
   Yin, Hua
   An, Yan
BE Cui, CX
   Li, YL
   Yuan, ZH
TI Effect of gamma irradiation on the biocompatibility and biodegradation
   of silk fibroin in vivo
SO ADVANCED ENGINEERING MATERIALS II, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Engineering Materials and
   Technology (AEMT)
CY JUL 06-08, 2012
CL Zhuhai, PEOPLES R CHINA
SP Hebei Univ Technol, Inner Mongolia Univ Technol, Korea Maritime Univ
DE silk fibroin; biocompatibility; biodegradation
AB Silk fibroin has been a raw material for many artificial biomaterials for a long term, because of it good mechanical property and fantastic biocompatibility. As a natural protein, it has more excellences than other chemically synthetical materials. In present, silk fibroin is used to manufacture bone repair material, artificial blood vessel, microcapsules and so on. However, silk fibroin-based biomaterial is not good enough in biodegradation. In our research, we exposed the silk fibroin film under the gamma ray irradiation with the doses of 25kGy and 50kGy and implanted the film subsequently on the back of SD rats. At dates (7th, 14th, 28th, 56th, 84th) after implantation, we got the tissue with the implanted film and had the pathological analysis accordingly. The results show that the immune cells infiltration and inflammation decreased within a month. And the immune reaction decreased more quickly in the 50kGy group. And cracks of the silk fibroin film appeared earlier in the 50kGy group. From above observation, it is indicated that the silk fibroin film with a higher dose had better biocompatibility than others. And the silk biodegradation was accelerated by the higher gamma ray dose. Therefore, we can conclude that the gamma ray is able to improve the biocompatibility of silk fibroin and accelerated the biodegradation of it.
C1 [Jin, Huanyu; Liu, Xing; Wang, Dapeng; Liu, Jian; Zhang, Hemei; Zong, Chunyan; Zhao, Hua; Feng, Xiaoqing; An, Yan] Soochow Univ, Dept Med, Coll Publ Hlth, Suzhou 215123, Peoples R China.
RP An, Y (reprint author), Soochow Univ, Dept Med, Coll Publ Hlth, Suzhou 215123, Peoples R China.
EM jhy0513jn@163.com; dranyan@126.com
CR Lin T, 2011, AAPS PHARMSCITECH, V12, P172, DOI 10.1208/s12249-010-9565-y
   Lu Shenzhou, 2007, SILK, P58
   Nuan Xiying, 2006, J INT BIOMEDICAL ENG, V29, P296
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pra HD, 2005, BIOMATERIALS, V26, P1987
   Wang Linting, 2009, N SERICULTURE, V30, P1
   Zheng ZH, 2010, J APPL POLYM SCI, V116, P461, DOI 10.1002/app.31522
NR 7
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-446-4
J9 ADV MATER RES-SWITZ
PY 2012
VL 535-537
BP 2361
EP 2364
DI 10.4028/www.scientific.net/AMR.535-537.2361
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEU39
UT WOS:000318195201127
DA 2018-10-19
ER

PT S
AU Abidi, IH
   Khalid, FA
AF Abidi, Irfan Haider
   Khalid, F. Ahmad
BE Munir, A
   Khan, ZM
TI Sintering and Morphology of Porous Structure in NiTi Shape Memory Alloys
   for Biomedical Applications
SO ADVANCED MATERIALS FOR APPLIED SCIENCE AND TECHNOLOGY II
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 9th International Bhurban Conference on Applied Sciences and Technology
CY JAN 09-12, 2012
CL Islamabad, PAKISTAN
DE Shape memory alloys; Superelasticity; Porous NIT alloy; NiTi;
   Biomaterial
ID SOLID-STATE REPLICATION; ELEMENTAL POWDERS; SUPERELASTIC PROPERTIES;
   SPACE-HOLDER; FOAMS; TINI; BEHAVIOR; BONE
AB The combination of attractive properties of porous NiTi shape memory alloys like high recoverable strain due to superelasticity and shape memory effect, good corrosion resistance, improved biocompatibilty, low density and stiffness along with its porous structure similar to that of bone make them best materials for biomedical implants. In current study porous NiTi SMAs have been fabricated successfully by space holder technique via pressureless sintering using NaCl powder as a spacer. Various volume fractions of NaCl powders have been involved to study their effect on the pore characteristics as well as on mechanical properties of foam. Porous NiTi with average porosity in the range of 44.3%-63.5% have been fabricated having average pore size 419 mu m which were very appropriate for various biomedical implants. Porous NiTi SMAs exhibited superelasticity at room temperature and shape memory effect was also determined. Maximum recoverable strain of 6.79% was demonstrated by the porous NiTi alloy with 44.3% porosity and it was diminishing with increasing porosity. Compression strength and elastic modulus have shown a decreasing trend with increasing porosity content. Elastic modulus of porous NiTi extends from 1.38 to 5.42GPa depending upon the pore volume which was very much comparable to that of various kinds of bones.
C1 [Abidi, Irfan Haider; Khalid, F. Ahmad] GIK Inst Engn Sci & Technol, Fac Mat Sci & Engn, Topi, KPK, Pakistan.
RP Abidi, IH (reprint author), GIK Inst Engn Sci & Technol, Fac Mat Sci & Engn, Topi, KPK, Pakistan.
EM khalid@giki.edu.pk
CR Aydogmus T, 2009, J ALLOY COMPD, V478, P705, DOI 10.1016/j.jallcom.2008.11.141
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P1996, DOI 10.1016/j.actbio.2008.06.005
   Bansiddhi A, 2007, INTERMETALLICS, V15, P1612, DOI 10.1016/j.intermet.2007.06.013
   Elahinia M. H., 2011, PROGR MAT SCI
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Greiner C, 2005, ACTA BIOMATER, V1, P705, DOI 10.1016/j.actbio.2005.07.005
   Hosseini SA, 2009, MAT SCI ENG C-MATER, V29, P2203, DOI 10.1016/j.msec.2009.05.006
   Ipek Nakas G., 2011, J MECH BEHAV BIOMEDI
   KATZ JL, 1987, J BIOMECH, V20, P1063, DOI 10.1016/0021-9290(87)90024-8
   Kaya M, 2010, MATER SCI TECH-LOND, V26, P522, DOI 10.1179/174328409X410809
   Kohl M, 2011, MAT SCI ENG A-STRUCT, V528, P2454, DOI 10.1016/j.msea.2010.11.055
   Li BY, 1999, SCI CHINA SER E, V42, P94, DOI 10.1007/BF02917064
   Li DS, 2009, J ALLOY COMPD, V474, pL1, DOI 10.1016/j.jallcom.2008.06.043
   Li YH, 2002, J ALLOY COMPD, V345, P271, DOI 10.1016/S0925-8388(02)00412-7
   McNeese MD, 2000, MAT SCI ENG A-STRUCT, V280, P334, DOI 10.1016/S0921-5093(99)00550-X
   Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001
   Sadrnezhaad SK, 2009, MATER DESIGN, V30, P4483, DOI 10.1016/j.matdes.2009.05.034
   Scalzo O, 2009, METALL MATER TRANS A, V40A, P2061, DOI 10.1007/s11661-009-9906-1
   Schwartz M., 2002, ENCY SMART MAT, V1
   Tang C., 2011, MAT SCI ENG A
   Tay BY, 2008, J MATER PROCESS TECH, V202, P359, DOI 10.1016/j.jmatprotec.2007.09.037
   Xiong JY, 2008, J MECH BEHAV BIOMED, V1, P269, DOI 10.1016/j.jmbbm.2007.09.003
   Ye B, 2010, MAT SCI ENG A-STRUCT, V528, P691, DOI 10.1016/j.msea.2010.09.054
   Yuan B, 2006, MAT SCI ENG A-STRUCT, V438, P657, DOI 10.1016/j.msea.2005.12.077
   Zanotti C, 2010, INTERMETALLICS, V18, P14, DOI 10.1016/j.intermet.2009.06.001
   Zhao XK, 2009, MATER LETT, V63, P2402, DOI 10.1016/j.matlet.2009.07.069
   Zhao Y, 2005, ACTA MATER, V53, P337, DOI 10.1016/j.actamat.2004.09.029
   Zhu SL, 2005, MAT SCI ENG A-STRUCT, V408, P264, DOI 10.1016/j.msea.2005.08.012
   Zhu SL, 2004, MATER LETT, V58, P2369, DOI 10.1016/j.matlet.2004.02.017
   Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025
NR 30
TC 1
Z9 1
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-483-9
J9 ADV MATER RES-SWITZ
PY 2012
VL 570
BP 87
EP 95
DI 10.4028/www.scientific.net/AMR.570.87
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEQ62
UT WOS:000317696600010
DA 2018-10-19
ER

PT S
AU Chen, JS
   Hu, XG
   Wang, XY
   Xu, YF
   Hu, EZ
AF Chen, Jinsi
   Hu, Xianguo
   Wang, Xiangyang
   Xu, Yufu
   Hu, Enzhu
BE Zhang, H
   Jin, D
   Zhao, XJ
TI Kinetic Investigations of Biodiesel from Cottonseed Oil and Ethanol by
   Transesterification in Biomaterial and its Application
SO ADVANCED RESEARCH ON ENERGY MATERIALS AND MATERIAL APPLICATION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Energy Materials and Material Application
   (EMMA 2012)
CY SEP 17-18, 2012
CL Wuhan, PEOPLES R CHINA
SP Int Sci & Educ Res Assoc, Beijing Gireida Educ Res Ctr, VIP, Informat Conf Ctr
DE cottonseed oil; kinetics; biodiesel; transesterification; activation
   energy
AB The kinetics of transesterification for biodiesel produced by cottonseed oil and ethanol in catalyst (potassium hydroxide) was investigated. The reaction of transesterification can be described by pseudo second order model for the initial stages of the reaction, followed by zero order reaction. The reaction rate constants for transestentcation of cottonseed oil with ethanol at 40 degrees C, 60 degrees C and 78 degrees C are 0.0996, 0.1126and0.1286 L.mol(-1)/min(-1) respectively, and the activation energy of transesterification is 21.6075kJ/mol.
C1 [Chen, Jinsi; Hu, Xianguo; Wang, Xiangyang; Xu, Yufu; Hu, Enzhu] Hefei Univ Technol, Sch Mech & Automot Engn, Hefei 230009, Peoples R China.
RP Chen, JS (reprint author), Hefei Univ Technol, Sch Mech & Automot Engn, Hefei 230009, Peoples R China.
EM jinsi_chen@126.com; xghu@hfut.edu.cn
RI Hu, Xianguo/I-7355-2016
OI Hu, Xianguo/0000-0001-8239-7950
CR [陈和 Chen He], 2005, [化工学报, Journal of Chemical Industry and Engineering (China)], V56, P1971
   Chen J. S., 2011, ICMREE2011 P 2011 IN, V1, P288
   Darnoko D, 2000, J AM OIL CHEM SOC, V77, P1263, DOI 10.1007/s11746-000-0198-y
   Diasakou M, 1998, FUEL, V77, P1297, DOI 10.1016/S0016-2361(98)00025-8
   Encinar JM, 2007, FUEL PROCESS TECHNOL, V88, P513, DOI 10.1016/j.fuproc.2007.01.002
   Guan GQ, 2009, CHEM ENG J, V146, P302, DOI 10.1016/j.cej.2008.10.009
   Iigigu A., 1994, APPL BIOCHEM BIOTECH, V45-46, P103
   Joshi HC, 2008, J AM OIL CHEM SOC, V85, P357, DOI 10.1007/s11746-008-1200-7
   Kudiana D., 2001, FUEL, V80, P693
   [刘世英 LIU Shiying], 2007, [中国油脂, China Oils and Fats], V32, P38
   Liu W. W., 2005, RENEW ENERG, V13, P17
   Sharma YC, 2008, FUEL, V87, P2355, DOI 10.1016/j.fuel.2008.01.014
   [邬国英 Wu Guoying], 2003, [高校化学工程学报, Journal of Chemical Engineering of Chinese Universities], V17, P314
   [张静雅 ZHANG Jingya], 2008, [中国油脂, China Oils and Fats], V33, P46
NR 14
TC 3
Z9 3
U1 2
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-504-1
J9 ADV MATER RES-SWITZ
PY 2012
VL 578
BP 73
EP 77
DI 10.4028/www.scientific.net/AMR.578.73
PG 5
WC Energy & Fuels; Materials Science, Multidisciplinary
SC Energy & Fuels; Materials Science
GA BEP60
UT WOS:000317631500015
DA 2018-10-19
ER

PT S
AU Lei, SJ
   Pan, SY
AF Lei, Shengjiao
   Pan, Siyi
BE Zhang, H
   Jin, D
   Zhao, XJ
TI Improvement of the activity of naringinase by covalent immobilization on
   sodium alginate in biomaterial engineering and its applications
SO ADVANCED RESEARCH ON ENERGY MATERIALS AND MATERIAL APPLICATION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Energy Materials and Material Application
   (EMMA 2012)
CY SEP 17-18, 2012
CL Wuhan, PEOPLES R CHINA
SP Int Sci & Educ Res Assoc, Beijing Gireida Educ Res Ctr, VIP, Informat Conf Ctr
DE Naringinase; Naringin; Immobilization; Debittering
ID ALPHA-L-RHAMNOSIDASE; JUICE
AB Naringinase using different methods to immobilize in alginate sodium have been studied. The results showed that adopting 3% sodium alginate as carrier and using the method of covalent immobilization through 2.0% glutaraldehyde were optimized. The retained activity of immobilized naringinase could reach 129.64% under optimal conditions. Moreover, the retained activity of immobilized naringinase increases with decreasing concentration of naringinase solution. This is a promising result of lowering production cost for future application of immobilized naringinase in biomaterial engineering. On seven consecutive repeated use of immobilized naringinase, 90% retained activity were observed. Michaelis constant (Kin) and maximum reaction velocity (Vm) were calculated for the free and immobilized enzyme systems. Effects of temperature and pH on enzyme activity were estimated.
C1 [Lei, Shengjiao] China Three Gorges Univ, Coll Chem & Life Sci, Yichang City, Peoples R China.
   [Pan, Siyi] Huazhong Agr Univ China, Coll Food Sci & Technol, Wuhan, Peoples R China.
RP Lei, SJ (reprint author), China Three Gorges Univ, Coll Chem & Life Sci, Yichang City, Peoples R China.
EM leishengjiao@yahoo.cn; pansy_111@hotmail.com
CR Birgisson H, 2007, ENZYME MICROB TECH, V40, P1181, DOI 10.1016/j.enzmictec.2006.08.026
   Davis D. W., 1947, ANAL CHEM, V19, P46
   LOZANO P, 1988, PROCESS BIOCHEM, V23, P75
   Mansour EH, 2003, J SCI FOOD AGR, V83, P446, DOI 10.1002/jsfa.1390
   Park JK, 2000, BIOTECHNOL ADV, V18, P303, DOI 10.1016/S0734-9750(00)00040-9
   Prakash S, 2002, J SCI FOOD AGR, V82, P394, DOI 10.1002/jsfa.1059
   Puri M, 2005, J CHEM TECHNOL BIOT, V80, P1160, DOI 10.1002/jctb.1303
   Puri M, 1996, ENZYME MICROB TECH, V18, P281, DOI 10.1016/0141-0229(95)00100-X
   Russo J, 2007, J BIOTECHNOL, V131, pS93, DOI 10.1016/j.jbiotec.2007.07.161
   Soria F, 2004, BIOTECHNOL LETT, V26, P1265, DOI 10.1023/B:BILE.0000044870.99039.19
   Spagna G, 2001, ENZYME MICROB TECH, V28, P427, DOI 10.1016/S0141-0229(00)00340-9
   Zverlov VV, 2000, MOL MICROBIOL, V35, P173, DOI 10.1046/j.1365-2958.2000.01691.x
NR 12
TC 1
Z9 2
U1 2
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-504-1
J9 ADV MATER RES-SWITZ
PY 2012
VL 578
BP 187
EP +
DI 10.4028/www.scientific.net/AMR.578.187
PG 2
WC Energy & Fuels; Materials Science, Multidisciplinary
SC Energy & Fuels; Materials Science
GA BEP60
UT WOS:000317631500042
DA 2018-10-19
ER

PT S
AU Mi, TG
   Zhao, Y
   Dong, CQ
   Cheng, WL
AF Mi, TengGe
   Zhao, Ying
   Dong, ChangQing
   Cheng, WeiLiang
BE Zhang, H
   Jin, D
   Zhao, XJ
TI An experiment on solid circulation characteristics of a dual circulating
   fluidized bed based on biomaterial properties and mechanics properties
SO ADVANCED RESEARCH ON ENVIRONMENTAL SCIENCE AND MATERIAL APPLICATION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Environmental Science and Material
   Application (ESME 2012)
CY OCT 13-14, 2012
CL Beijing, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP, Informat Conf Ctr
DE solid circulation rate; dual fluidized bed; circulating fluidized bed;
   bubble fluidized bed
AB In this paper, a dual fluidized bed has been established. The effect of bed material build-up height and gas velocity on the solid circulation rate of CFB (circulating fluidized bed) and BFB (bubble fluidized bed) has been studied. The results show that the solid circulation rate is increased with the increasing of gas velocity U-c and the bed material build-up height. Bed material build-up height of BFB and CFB is changed with the changing of gas velocity U-c. The bed material heights of CFB and BFB have been also investigated in this experiment.
C1 [Mi, TengGe; Zhao, Ying; Dong, ChangQing; Cheng, WeiLiang] North China Elect Power Univ, Natl Engn Lab Biomass Power Generat Equipment, Beijing 102206, Peoples R China.
RP Mi, TG (reprint author), North China Elect Power Univ, Natl Engn Lab Biomass Power Generat Equipment, Beijing 102206, Peoples R China.
EM mitengge@163.com; zhaoying_1999@sohu.co; cqdong1@163.com;
   cheng_w_l@163.com
CR Chen GuanYi, 2006, J GAS HEAT UNPUB
   de Andres J. M., 2011, J FUEL PROCESS UNPUB
   Gonzalez J. F., 2008, J FUEL PROCESS UNPUB
   Goransson K., 2011, J RENEWABLE SU UNPUB
   Srinivasakannan C., 2010, J ENERGY SOURC UNPUB
   Wang JianNan, 2010, J T GUANGZHOU UNPUB
   Wilson L., 2010, J FUEL PROCESS UNPUB
   Wu ChuangZhi, 2009, J T CHINESE SO UNPUB
NR 8
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-541-6
J9 ADV MATER RES-SWITZ
PY 2012
VL 600
BP 261
EP 264
DI 10.4028/www.scientific.net/AMR.600.261
PG 4
WC Engineering, Environmental; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BEP48
UT WOS:000317630300058
DA 2018-10-19
ER

PT J
AU Haghipour, S
   Rostami, S
AF Haghipour, Siamak
   Rostami, Sayana
TI Estimation of chemical resistance of PFM dental ceramics by neural
   network
SO LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION
LA English
DT Article
DE Neural networks; chemical resistance; porcelain; ICP; PFM
AB artificial neural networks are one of the intelligent systems that apply experimental data in order to obtain the hidden rule among data and model the system. Despite the high ability of neural networks, this method has limited application in biomaterial engineering so that it has not been used for estimating the chemical resistance of dental ceramics. The purpose of this research is to determine the mass concentration of ions eluted from dental ceramics emerged in an acid and draw on the results to develop a feed forward back propagation neural network to simulated the mechanism of elution of this type of ceramics. By designing such an intelligent system, it is possible to investigate and determine the eluted ions from each type of dental porcelains in a long period of time and anytime without the necessity of doing long experiments and high cost. Furthermore, this system is able to change the composition of each porcelain as software in a simulated media and compute the changes of ion's elution and consequently draw on the best possible combination for a particular powder. Because of high correction coefficient and low normalized root mean square error ( NRMSE) between the measured data and the estimate data, it is concluded that the artificial neural network has a great potential in investigating the model of the system and it is high ability in modeling the mechanism of the elution in dental ceramics [Siamak haghipour, Sayana rostami. Estimation of chemical resistance of PFM dental ceramics by neural network. Life Sci J 2012;9(4):2986-2996]. (ISSN: 1097-8135). http://www.lifesciencesite.com. 439
C1 [Haghipour, Siamak; Rostami, Sayana] Islamic Azad Univ, Tabriz Branch, Dept Biomed Engn, Tabriz, Iran.
RP Haghipour, S (reprint author), Islamic Azad Univ, Tabriz Branch, Dept Biomed Engn, Tabriz, Iran.
EM haghipour@iaut.ac.ir
FU Tabriz Branch, Islamic Azad University
FX The authors would like to thank Tabriz Branch, Islamic Azad University
   for the financial support of this research, which is based on a research
   project contract.
CR American National Standard/American Dental Association, 1991, 69 AM NAT STAND AM D
   Golden R. M., 1996, MATH METHODS NEURAL
   International Organization for Standardization, 1995, 6872 ISO
   The MathWorks, 2006, NEUR NETW TOOLB
   van Noort R., 2007, INTRO DENT MAT
   Zivko-Babic J., 2004, P 28 ANN C EPA, P102
   Zivko-Babic J., 2003, P 17 INT RES EXP C, P257
   Zivko-Babic J, 2008, DENT MATER, V24, P18, DOI 10.1016/j.dental.2007.01.008
NR 8
TC 0
Z9 0
U1 0
U2 3
PU MARSLAND PRESS
PI LANSING
PA PO BOX 21126, LANSING, MI 48909 USA
SN 1097-8135
J9 LIFE SCI J
JI Life Sci. J.
PY 2012
VL 9
IS 4
BP 2986
EP 2996
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 113RM
UT WOS:000316685600070
DA 2018-10-19
ER

PT S
AU Shen, TF
   Lu, MG
   Liang, LY
AF Shen, Tengfei
   Lu, Mangeng
   Liang, Liyan
BE Sun, T
TI Microporous Bio-membrane Materials Based on High Molecular Weight
   Polylactide and Low Molecular Weight Poly(ethylene glycol)
SO METALLURGY TECHNOLOGY AND MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Machine Design and Manufacturing Engineering
   (ICMDME 2012)
CY MAY 11-12, 2012
CL Jeju Island, SOUTH KOREA
DE Biomaterials; Membrane; Microporous; Morphology
ID TISSUE; RELEASE
AB In this work, microporous membrane biomaterials based on high weight molecular polylactide (PLA) and low molecular weight poly(ethylene glycol) (PEG) using rapid solvent evaporation method were prepared and investigated. The effect of PEG segments added on the thermal and degradation behaviors was studied. According to the results, produced PLA/PEG biomaterial has lower glass transition temperature (T-g) in comparison with neat PLA. It was also found that the degradation rates of the PLA/PEG biomaterials were significantly increased with adding of PEG, which explained by increasing hydrophilic groups. For better porous fixation, CL-blocked polyisocyanate (CL-bp), which was synthesized from reaction of isophorone diisocyanate (IPDI) with dimethylol propionic acid (DMPA) and Trimethylolpropane (TMP) followed by addition of caprolactam (CL), were introduced. The microporous forms were observed by the scanning electron microscope (SEM), which showed the mean diameters of prepared PLA/PEG microporous were around 10 mu m.
C1 [Shen, Tengfei; Lu, Mangeng; Liang, Liyan] Chinese Acad Sci, Guangzhou Inst Chem, Guangzhou 510650, Guangdong, Peoples R China.
RP Shen, TF (reprint author), Chinese Acad Sci, Guangzhou Inst Chem, Guangzhou 510650, Guangdong, Peoples R China.
EM tfshen@gic.ac.cn; mglu@gic.ac.cn; lyliang@gic.ac.cn
CR Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lloyd D. R., 1990, J MEMBRANE SCI, V52
   Mulders M., 1991, BASIC PRINCIPLES MEM, P55258
   Ren J, 2005, MATER LETT, V59, P2655, DOI 10.1016/j.matlet.2005.04.013
   Sant S, 2005, J CONTROL RELEASE, V107, P203, DOI 10.1016/j.jconrel.2005.02.017
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Zhu AP, 2007, APPL SURF SCI, V253, P3247, DOI 10.1016/j.apsusc.2006.07.036
NR 11
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-471-6
J9 ADV MATER RES-SWITZ
PY 2012
VL 567
BP 123
EP 126
DI 10.4028/www.scientific.net/AMR.567.123
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BES52
UT WOS:000317940900027
DA 2018-10-19
ER

PT S
AU Venkatesan, J
   Kim, SK
AF Venkatesan, Jayachandran
   Kim, Se Kwon
BE Babu, DR
TI Nanostructured Hydroxyapatite-Chitosan Composite Biomaterial for Bone
   Tissue engineering
SO RECENT TRENDS IN ADVANCED MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Recent Trends in Advanced Materials (ICRAM
   2012)
CY FEB 20-22, 2012
CL Vellore, INDIA
SP VIT Univ, Dept Sci & Technol, Defence Res & Dev Org, Council Sci Ind Res, Board Res Nucl Sci, Minist Earth Sci
DE Natural hydroxyapatite; chitosan; scaffolds and bone tissue engineering
AB In the recent years, significant developments have been achieved with chitosan and hydroxyapatite (HAp) scaffolds for bone tissue engineering. In the present study, chitosan/nanostructured hydroxyapatite (Chitosan/nHAp) has been prepared and subsequently characterized physicochemically for bone graft substitution. The nano sized HAp particles were uniformly distributed in the chitosan matrix, which was confirmed, by Fourier Transform Infrared Spectroscopy, Thermal Gravimetric Analysis, X-Ray Diffraction and Scanning Electron Microscopy analysis. The pore size of the chitosan/nHAp scaffold was found to be 18-372 mu m which is suitable for cell attachment and nutrient supplement. Thus, we are suggesting that Chitosan/nHAp could be promising biomaterials for bone tissue engineering.
C1 [Venkatesan, Jayachandran] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
   [Kim, Se Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Busan 608737, South Korea.
RP Venkatesan, J (reprint author), Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
EM venkatjchem@gmail.com; sknkim@pknu.ac.kr
RI Jayachandran, Venkatesan/B-8857-2013
OI Jayachandran, Venkatesan/0000-0002-6881-2297; Kim,
   Se-Kwon/0000-0001-6507-9539
CR Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Je JY, 2005, BIOORGAN MED CHEM, V13, P6551, DOI 10.1016/j.bmc.2005.07.004
   Jeon YJ, 2000, FOOD REV INT, V16, P159, DOI 10.1081/FRI-100100286
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7
   Pallela R, 2012, J BIOMED MATER RES A, V100A, P486, DOI 10.1002/jbm.a.33292
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Tang XJ, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044115
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Venkatesan J, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035003
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Yuan H, 2008, J NANJING MED U, V22, P372
NR 14
TC 2
Z9 2
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-521-8
J9 ADV MATER RES-SWITZ
PY 2012
VL 584
BP 212
EP +
DI 10.4028/www.scientific.net/AMR.584.212
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BEO35
UT WOS:000317550700044
DA 2018-10-19
ER

PT S
AU Nyanhongo, GS
   Prasetyo, EN
   Acero, EH
   Guebitz, GM
AF Nyanhongo, Gibson S.
   Prasetyo, Endry Nugroho
   Acero, Enrique Herrero
   Guebitz, Georg M.
BE Liebner, F
   Rosenau, T
TI Advances in the Application of Oxidative Enzymes in Biopolymer Chemistry
   and Biomaterial Research
SO FUNCTIONAL MATERIALS FROM RENEWABLE SOURCES
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Functional Materials from Natural Resources
CY MAR 27-29, 2011
CL Anaheim, CA
SP ACS, Div Cellulose and Renewable Mat
ID SUPERCRITICAL CARBON-DIOXIDE; LIPASE-CATALYZED ESTERIFICATION;
   FREE-RADICAL POLYMERIZATION; IONIC LIQUIDS; ENZYMATIC-SYNTHESIS;
   HORSERADISH-PEROXIDASE; CONDUCTING POLYANILINE; PHENOLIC-COMPOUNDS;
   ORGANIC-SOLVENTS; KRAFT PULP
AB Enzymatic polymer synthesis is fast emerging as an alternative tool to chemical catalysts driven by advances in enzyme molecular engineering, increasing knowledge in enzyme reaction engineering and the desire to fulfill the goals of sustainable development. Among the enzymes actively exploited in polymer chemistry are oxidative enzymes, especially fungal laccases and peroxidases. The most fascinating features of these enzymes are their ability to generate reactive species which undergo non-enzymatic coupling and polymerization reactions. This chapter therefore summarizes the different approaches and strategies used in order to produce the desired functional polymers with oxidative enzymes. This is important given the multidisciplinary nature of enzyme polymer synthesis, which requires the integration of chemical engineering principles and enzyme catalysis. This chapter will therefore provide scientists from different backgrounds with an enzyme-based platform for developing functional polymers. (C) 2012 American Chemical Society
C1 [Nyanhongo, Gibson S.; Prasetyo, Endry Nugroho; Acero, Enrique Herrero; Guebitz, Georg M.] Graz Univ Technol, Inst Environm Biotechnol, A-8010 Graz, Austria.
RP Nyanhongo, GS (reprint author), Graz Univ Technol, Inst Environm Biotechnol, Petersgasse 12-1, A-8010 Graz, Austria.
EM nugrohoprasetyo@tugraz.at
CR Alcalde M., 2007, IND ENZYMES STRUCTUR, P459
   Amaral P, 2009, INT J MOL SCI, V10, P5217, DOI 10.3390/ijms10125217
   Angerer PS, 2005, MACROMOLECULES, V38, P6248, DOI 10.1021/ma050082h
   Aracri E, 2010, BIORESOURCE TECHNOL, V101, P8211, DOI 10.1016/j.biortech.2010.05.080
   Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y
   Azevedo M., 2001, J MOL CATAL B-ENZYM, V5, P147
   BARFOED M, 1999, Patent No. 5972042
   Brondani D, 2009, SENSOR ACTUAT B-CHEM, V140, P252, DOI 10.1016/j.snb.2009.04.037
   Bruno F. F., 2001, MACROMOLECULES, V12, P1417
   Calafell M, 2007, BIOCATAL BIOTRANSFOR, V25, P336, DOI 10.1080/10242420701379874
   Call HP, 1997, J BIOTECHNOL, V53, P163, DOI 10.1016/S0168-1656(97)01683-0
   Cantone S, 2007, GREEN CHEM, V9, P954, DOI 10.1039/b618893a
   Chandra R.P., 2001, TAPP PULP C, P1041
   Chandra RP, 2002, PROGR BIOTECHNOL, V21, P165, DOI 10.1016/S0921-0423(02)80018-1
   Chandra RP, 2003, ACS SYM SER, V855, P66, DOI 10.1021/bk-2003-0855.ch004
   Chandra RP, 2002, ENZYME MICROB TECH, V30, P855, DOI 10.1016/S0141-0229(02)00020-0
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Chen TH, 2003, LANGMUIR, V19, P9382, DOI 10.1021/la0347098
   Chen TH, 2002, BIOPOLYMERS, V64, P292, DOI 10.1002/bip.10196
   Chen TH, 2001, BIOMACROMOLECULES, V2, P456, DOI 10.1021/bm000125w
   Cholli AL, 2005, PURE APPL CHEM, V77, P339, DOI 10.1351/pac200577010339
   Chung JE, 2003, BIOTECHNOL LETT, V25, P1993, DOI 10.1023/B:BILE.0000004391.27564.8e
   Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003
   Cruz-Silva R, 2005, EUR POLYM J, V41, P1129, DOI 10.1016/j.eurpolymj.2004.11.012
   Cruz-Silva R, 2007, EUR POLYM J, V43, P3471, DOI 10.1016/j.eurpolymj.2007.05.027
   Desentis-Mendoza RM, 2006, BIOMACROMOLECULES, V7, P1845, DOI 10.1021/bm060189p
   Eker B, 2009, J MOL CATAL B-ENZYM, V59, P177, DOI 10.1016/j.molcatb.2009.02.018
   Elegir G, 2008, ENZYME MICROB TECH, V43, P84, DOI 10.1016/j.enzmictec.2007.10.003
   Elegir G, 2007, APPL MICROBIOL BIOT, V77, P809, DOI 10.1007/s00253-007-1203-6
   Felby C, 1997, HOLZFORSCHUNG, V51, P281, DOI 10.1515/hfsg.1997.51.3.281
   FELBY C, 1998, ACS SYM SER, V687, P88
   Flores-Loyola E., 2005, EUR POLYM J, V41, P1129
   Franzoi AC, 2009, ANAL CHIM ACTA, V639, P90, DOI 10.1016/j.aca.2009.03.012
   Franzoi AC, 2009, TALANTA, V77, P1322, DOI 10.1016/j.talanta.2008.09.010
   Govar C. J., 2002, ACS SYM SER, V840, P231
   Gronqvist S, 2006, HOLZFORSCHUNG, V60, P503, DOI 10.1515/HF.2006.083
   HAMMOND DA, 1985, APPL BIOCHEM BIOTECH, V11, P393, DOI 10.1007/BF02798672
   HAYASHI Y, 1979, J BIOL CHEM, V254, P9101
   Hinckley G, 2002, BIOTECHNOL LETT, V24, P2083, DOI 10.1023/A:1021305229969
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Kalra B, 2000, BIOMACROMOLECULES, V1, P501, DOI 10.1021/bm005576v
   Karamyshev AV, 2003, ENZYME MICROB TECH, V33, P556, DOI 10.1016/S0141-0229(03)00163-7
   KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475
   Kim YJ, 2004, MACROMOL BIOSCI, V4, P497, DOI 10.1002/mabi.200300078
   Kim YJ, 2003, MACROMOLECULES, V36, P5058, DOI 10.1021/ma0342022
   Kim YJ, 2008, POLYMER, V49, P4791, DOI 10.1016/j.polymer.2008.08.065
   KLIBANOV AM, 1977, BIOTECHNOL BIOENG, V19, P1351, DOI 10.1002/bit.260190908
   Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719
   KLYOSOV AA, 1975, EUR J BIOCHEM, V59, P3, DOI 10.1111/j.1432-1033.1975.tb02417.x
   Kobayashi S, 2009, CHEM REV, V109, P5288, DOI 10.1021/cr900165z
   Kragl U, 2002, CURR OPIN BIOTECH, V13, P565, DOI 10.1016/S0958-1669(02)00353-1
   Krieger N, 2004, FOOD TECHNOL BIOTECH, V42, P279
   Kudanga T, 2008, ENG LIFE SCI, V8, P297, DOI 10.1002/elsc.200800011
   Kudanga T, 2011, ENZYME MICROB TECH, V48, P195, DOI 10.1016/j.enzmictec.2010.11.007
   Kudanga T, 2010, PROCESS BIOCHEM, V45, P1557, DOI 10.1016/j.procbio.2010.06.008
   Kudanga T, 2010, ENZYME MICROB TECH, V46, P272, DOI 10.1016/j.enzmictec.2009.10.015
   Kudanga T, 2010, BIORESOURCE TECHNOL, V101, P2793, DOI 10.1016/j.biortech.2009.12.002
   Kudanga T, 2009, J MOL CATAL B-ENZYM, V61, P143, DOI 10.1016/j.molcatb.2009.06.003
   Kuhne G, 1999, HOLZ ROH WERKST, V57, P264, DOI 10.1007/s001070050054
   Kumar A, 2007, SYNLETT, P411, DOI 10.1055/s-2007-967951
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Li KC, 2005, MACROMOL RAPID COMM, V26, P529, DOI 10.1002/marc.200400594
   Liu N, 2009, ENZYME MICROB TECH, V44, P89, DOI 10.1016/j.enzmictec.2008.10.014
   Liu W, 2002, LANGMUIR, V18, P9696, DOI 10.1021/la0206357
   Liu W, 1999, J AM CHEM SOC, V121, P11345, DOI 10.1021/ja9926156
   Lozano P, 2010, GREEN CHEM, V12, P555, DOI 10.1039/B919088K
   Lund M, 2001, ENZYME MICROB TECH, V28, P760, DOI 10.1016/S0141-0229(01)00339-8
   Ma HL, 2009, J MOL CATAL B-ENZYM, V57, P89, DOI 10.1016/j.molcatb.2008.07.006
   MAGNUSON DK, 1984, J SOLUTION CHEM, V13, P583, DOI 10.1007/BF00647226
   MARTINEK K, 1981, BIOCHIM BIOPHYS ACTA, V657, P277, DOI 10.1016/0005-2744(81)90151-0
   Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X
   Martinez AT, 2005, INT MICROBIOL, V8, P195
   Marzorati M, 2005, GREEN CHEM, V7, P310, DOI 10.1039/b416668j
   Matsuda T, 2003, TETRAHEDRON-ASYMMETR, V14, P2087, DOI 10.1016/S0957-4166(03)00431-2
   Matsuda T, 2001, TETRAHEDRON LETT, V42, P8319, DOI 10.1016/S0040-4039(01)01785-3
   Michizoe Y, 2005, J BIOSCI BIOENG, V99, P642, DOI 10.1263/jbb.99.642
   MILSTEIN O, 1994, APPL MICROBIOL BIOT, V40, P760
   Moccelini SK, 2011, BIOSENS BIOELECTRON, V26, P3549, DOI 10.1016/j.bios.2011.01.043
   Moniruzzaman M, 2010, BIOCHEM ENG J, V48, P295, DOI 10.1016/j.bej.2009.10.002
   Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112
   Mustafa R, 2005, FOOD RES INT, V38, P995, DOI 10.1016/j.foodres.2005.02.019
   NIMZ H, 1972, Patent No. 2221353
   NIMZ HH, 1976, HOLZFORSCHUNG, V30, P33, DOI 10.1515/hfsg.1976.30.2.33
   Nugroho Prasetyo N., 2011, P BIOCH, V46, P1019
   Nyanhongo GS, 2009, J HAZARD MATER, V165, P285, DOI 10.1016/j.jhazmat.2008.09.107
   Nyanhongo GS, 2011, ADV BIOCHEM ENG BIOT, V125, P47, DOI 10.1007/10_2010_86
   Nyanhongo GS, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P155, DOI 10.1007/978-3-642-12627-7_7
   Nyanhongo GS, 2002, WATER RES, V36, P1449, DOI 10.1016/S0043-1354(01)00365-7
   Ogushi Y, 2007, J BIOSCI BIOENG, V104, P30, DOI 10.1263/jbb.104.30
   Ogushi Y, 2009, MACROMOL BIOSCI, V9, P262, DOI 10.1002/mabi.200800263
   Okrasa K, 2003, TETRAHEDRON-ASYMMETR, V14, P2487, DOI 10.1016/S0957-4166(03)00578-0
   Osma Johann F, 2010, Enzyme Res, V2010, P918761, DOI 10.4061/2010/918761
   Park S, 2003, CURR OPIN BIOTECH, V14, P432, DOI 10.1016/S0958-1669(03)00100-9
   Peng Y, 2009, J POLYM SCI POL CHEM, V47, P1627, DOI 10.1002/pola.23271
   Prasetyo EN, 2011, PROCESS BIOCHEM, V46, P1019, DOI 10.1016/j.procbio.2010.12.017
   Premachandran RS, 1996, MACROMOLECULES, V29, P6452, DOI 10.1021/ma960468f
   RAO AM, 1993, BIOTECHNOL BIOENG, V41, P531, DOI 10.1002/bit.260410505
   REINHAMMAR BR, 1972, BIOCHIM BIOPHYS ACTA, V275, P245, DOI 10.1016/0005-2728(72)90045-X
   Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006
   Rodriguez O, 2011, IONIC LIQUIDS: APPLICATIONS AND PERSPECTIVES, P499
   Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002
   Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b
   Schroeder Marc, 2007, Biotechnology Journal, V2, P334, DOI 10.1002/biot.200600209
   Sgalla S, 2007, J MOL CATAL B-ENZYM, V44, P144, DOI 10.1016/j.molcatb.2006.10.002
   Sheldon RA, 2002, GREEN CHEM, V4, P147, DOI 10.1039/b110008b
   Shin H, 2001, MACROMOL MATER ENG, V286, P691, DOI 10.1002/1439-2054(20011101)286:11<691::AID-MAME691>3.0.CO;2-A
   Singh A, 2000, BIOMACROMOLECULES, V1, P592, DOI 10.1021/bm005537j
   Suurnakki A., 2011, BIOTECHNOLOGY LIGNOC
   Tee KL, 2008, GREEN CHEM, V10, P117, DOI 10.1039/b714674d
   Tzanov T, 2003, APPL BIOCHEM BIOTECH, V111, P1, DOI 10.1385/ABAB:111:1:1
   Unbehaun H, 2000, ACTA BIOTECHNOL, V20, P305, DOI 10.1002/abio.370200311
   Unbehaun H, 1999, HOLZ ROH WERKST, V57, P92, DOI 10.1007/PL00002632
   van Rantwijk F, 2003, TRENDS BIOTECHNOL, V21, P131, DOI 10.1016/S0167-7799(03)00008-8
   van Rantwijk F, 2007, CHEM REV, V107, P2757, DOI 10.1021/cr050946x
   Villarroya S, 2008, GREEN CHEM, V10, P863, DOI 10.1039/b804080j
   WAN YY, 2008, CHINESE CHEM LETT, V19, P333
   Widsten P, 2010, PROCESS BIOCHEM, V45, P1072, DOI 10.1016/j.procbio.2010.03.022
   Widsten P, 2009, HOLZFORSCHUNG, V63, P545, DOI 10.1515/HF.2009.090
   Witayakran S, 2009, ENZYME MICROB TECH, V44, P176, DOI 10.1016/j.enzmictec.2008.10.011
   Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z
   Wong KKY, 2003, APPITA J, V56, P308
   Wong KKY, 2000, BIOTECHNOL PROGR, V16, P1025, DOI 10.1021/bp000064d
   Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063
   Yang Z, 2005, ENZYME MICROB TECH, V37, P19, DOI 10.1016/j.enzmictec.2005.02.014
   Yang Z, 2009, J BIOTECHNOL, V144, P12, DOI 10.1016/j.jbiotec.2009.04.011
   Yoshida S, 1997, J MOL CATAL B-ENZYM, V2, P243, DOI 10.1016/S1381-1177(96)00058-6
   ZAKS A, 1984, SCIENCE, V224, P1249, DOI 10.1126/science.6729453
   ZAKS A, 1988, J BIOL CHEM, V263, P3194
   Zapp E, 2011, SENSOR ACTUAT B-CHEM, V155, P331, DOI 10.1016/j.snb.2011.04.015
   Zaragoza-Gasca P, 2010, POLYM ADVAN TECHNOL, V21, P454, DOI 10.1002/pat.1452
   Zhao H, 2005, J MOL CATAL B-ENZYM, V37, P16, DOI 10.1016/j.molcatb.2005.08.007
NR 131
TC 1
Z9 1
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2788-0
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1107
BP 329
EP 349
PG 21
WC Biotechnology & Applied Microbiology; Materials Science, Paper & Wood;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Materials Science
GA BEI96
UT WOS:000316771300018
DA 2018-10-19
ER

PT S
AU Victor, SP
   Sharma, CP
AF Victor, Sunita Prem
   Sharma, Chandra P.
BE Horbett, T
   Brash, JL
   Norde, W
TI Protein-Bioceramic Interactions at the Interface
SO PROTEINS AT INTERFACES III: STATE OF THE ART
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Proteins at Interfaces 3 - State of the Art
CY MAR 25-29, 2012
CL San Diego, CA
SP ACS, Div Colloid and Surface Chem
ID BOVINE SERUM-ALBUMIN; CALCIUM-PHOSPHATE CERAMICS; BONE MORPHOGENETIC
   PROTEIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-VITRO; HYDROXYAPATITE
   PARTICLES; OCTACALCIUM PHOSPHATE; INDUCED OSTEOGENESIS; ADSORBED
   PROTEIN; DENTAL ENAMEL
AB Calcium phosphate based ceramics are indispensable in biomaterial and hard tissue application due to their chemical similarity to the mineral component of mammalian bones and teeth. Their interfacial behaviour with proteins determines cellular responses that play a pivotal role in determining the degree of biocompatibility. The control of the cell response to artificial hard tissue substitutes is of crucial importance in terms of biocompatibility. The selective nature of protein adsorption and the functionality of the adsorbed bio molecule are influenced by the physicochemical characteristic of the calcium phosphate material. This chapter focuses on the various factors like ionic composition, surface activity, monolayer adsorption, pH, solution strength and temperature that determine the kinetics of protein adsorption. It also includes the selective adsorption of proteins in competition to nonadhesive proteins to different calcium phosphate surfaces. These interfacial phenomena with the cell adhesion on protein adsorbed calcium phosphate surfaces indicate biocompatibility due to surface properties and have great potential to revolutionize the field of hard tissue engineering.
C1 [Victor, Sunita Prem; Sharma, Chandra P.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Thiruvananthapuram 695012, Kerala, India.
RP Victor, SP (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Thiruvananthapuram 695012, Kerala, India.
EM sharmacp@sctimst.ac.in
OI Victor, Sunita/0000-0001-5700-6532
CR Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92
   Akazawa T, 1998, J MATER SCI, V33, P1927, DOI 10.1023/A:1004373809449
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Austen K. F., 2002, LANGMUIR, V25, P5018
   Barnthip N, 2009, BIOMATERIALS, V30, P6495, DOI 10.1016/j.biomaterials.2009.08.016
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bender SA, 2000, BIOMATERIALS, V21, P299, DOI 10.1016/S0142-9612(99)00183-0
   BEUMER S, 1995, BLOOD, V86, P3452
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Chevalier E, 2008, J PHARM SCI-US, V97, P1135, DOI 10.1002/jps.21059
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   Daculsi G, 1999, BONE, V25, P59
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Deb S, 2005, BIOMATERIALS, V26, P3713, DOI 10.1016/j.biomaterials.2004.09.065
   Dee K.C., 2004, CELL MOL BIOL, V8, P419
   Diegmueller JJ, 2009, CRYST GROWTH DES, V9, P5220, DOI 10.1021/cg900750z
   dos Santos F. A., 2008, J MATER SCI-MATER M, V6, P2307
   DRIESSENS FCM, 1988, ADV BIOMATER, V8, P105
   Elangovan S, 2007, LANGMUIR, V23, P11200, DOI 10.1021/la7013978
   Feng B, 2002, BIOMATERIALS, V23, P2499, DOI 10.1016/S0142-9612(01)00384-2
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Fujii E, 2006, ACTA BIOMATER, V2, P69, DOI 10.1016/j.actbio.2005.09.002
   GEORGE A, 1993, J BIOL CHEM, V268, P12624
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Groot K. D., 1980, BIOMATERIALS, V1, P47
   Grunwald C, 2004, PHYS CHEM CHEM PHYS, V6, P4358, DOI 10.1039/b405543h
   HAY DI, 1979, J DENT RES, V58, P930, DOI 10.1177/00220345790580024701
   Hench L.L., 1991, J AM CERAM SOC, V74, P1482
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hughes Wassell Diana T., 1995, Biomaterials, V16, P697
   Iafisco M, 2008, LANGMUIR, V24, P4924, DOI 10.1021/la703381h
   Iijima M, 2004, J MATER CHEM, V14, P2189, DOI 10.1039/b401961j
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   JURIAANSE AC, 1980, J COLLOID INTERF SCI, V76, P220, DOI 10.1016/0021-9797(80)90288-X
   JURIAANSE AC, 1981, ARCH ORAL BIOL, V26, P91, DOI 10.1016/0003-9969(81)90076-5
   KANDORI K, 1995, COLLOID SURFACE A, V94, P225, DOI 10.1016/0927-7757(94)02969-5
   KANDORI K, 1995, J COLLOID INTERF SCI, V174, P124, DOI 10.1006/jcis.1995.1373
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   Kandori K, 2000, PHYS CHEM CHEM PHYS, V2, P2015, DOI 10.1039/a909396f
   Kandori K, 2005, CALCIFIED TISSUE INT, V76, P194, DOI 10.1007/s00223-004-0102-4
   Kandori K, 2009, J PHYS CHEM B, V113, P11016, DOI 10.1021/jp904481z
   Kannan S, 2005, J SOLID STATE CHEM, V178, P3190, DOI 10.1016/j.jssc.2005.08.003
   KAWASAKI T, 1986, EUR J BIOCHEM, V155, P249, DOI 10.1111/j.1432-1033.1986.tb09483.x
   KAWASAKI T, 1985, EUR J BIOCHEM, V152, P361, DOI 10.1111/j.1432-1033.1985.tb09206.x
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   Kondo A, 1996, J COLLOID INTERF SCI, V177, P214, DOI 10.1006/jcis.1996.0023
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kumar TSS, 2000, BIOMATERIALS, V21, P1623
   Latour R. A., 2005, BIOMATER BIOMED ENG, V1, P270
   Lindh L, 2002, BIOFOULING, V18, P87, DOI 10.1080/08927010290000110
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Low S B, 1998, Dent Implantol Update, V9, P65
   Malmsten M, 1998, J COLLOID INTERF SCI, V207, P186, DOI 10.1006/jcis.1998.5763
   Mavropoulos E, 2003, MATER CHARACT, V50, P203, DOI 10.1016/S1044-5803(03)00093-7
   Monteiro MM, 2003, J BIOMED MATER RES A, V65A, P299, DOI 10.1002/jbm.a.10479
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   NORDE W, 1995, CELL MATER, V5, P97
   Obadia L, 2003, BIOMATERIALS, V24, P1265, DOI 10.1016/S0142-9612(02)00446-5
   Ohta K, 2001, J BIOMED MATER RES, V55, P409, DOI 10.1002/1097-4636(20010605)55:3<409::AID-JBM1030>3.0.CO;2-Z
   ONO I, 1995, PLAST RECONSTR SURG, V95, P1265, DOI 10.1097/00006534-199506000-00019
   ONO I, 1995, J CRANIOFAC SURG, V6, P238, DOI 10.1097/00001665-199505000-00011
   Orly M. I., 1989, CALCIFIED TISSUE INT, V45, P20
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Paul W, 2010, INT J APPL CERAM TEC, V7, P129, DOI 10.1111/j.1744-7402.2009.02442.x
   Ponsonnet V., 2002, J MAT SCI ENG, V21, P157
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   REYNOLDS EC, 1983, INFECT IMMUN, V39, P1285
   Rolla G., 1977, J SWED DENT, V1, P241
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Schakenraad J. M., 1991, BIOFOULING, V4, P61
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   SHIMABAYASHI S, 1991, CHEM PHARM BULL, V39, P2183
   Shimabayashi S., 1992, CHEM PHARM BULL, V38, P1810
   Silva R. A., 2010, LANGMUIR, V26, P14
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   Sunita P. V., 2011, J MATER SCI-MATER M, V22, P2219
   Sunita P. V., 2011, COLLOID SURFACE B, V85, P221, DOI [10.1016/j.colsurfb.2011.02.032, DOI 10.1016/J.COLSURFB.2011.02.032]
   Tagaya M, 2011, J PHYS CHEM C, V115, P22523, DOI 10.1021/jp208104z
   Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   Takashima S, 2002, KEY ENG MAT, V218-2, P175, DOI 10.4028/www.scientific.net/KEM.218-220.175
   Takemoto S, 2004, J BIOMED MATER RES A, V69A, P544, DOI 10.1002/jbm.a.30039
   TANAKA H, 1989, CHEM PHARM BULL, V37, P2897
   Tsortos A, 1996, J COLLOID INTERF SCI, V177, P257, DOI 10.1006/jcis.1996.0029
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VEERMAN ECL, 1988, ADV BIOMATER, V8, P331
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   WHICHER SJ, 1978, J BIOMED MATER RES, V12, P181, DOI 10.1002/jbm.820120205
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Xie J, 2002, BIOMATERIALS, V23, P3609, DOI 10.1016/S0142-9612(02)00090-X
   Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028
   Xu HKHK, 2004, J ORTHOPAED RES, V22, P535, DOI 10.1016/j.orthres.2003.09.010
   Yan WQ, 1998, J BIOMED MATER RES, V42, P258, DOI 10.1002/(SICI)1097-4636(199811)42:2<258::AID-JBM10>3.0.CO;2-F
   Yang Y, 2010, LANGMUIR, V26, P9848, DOI 10.1021/la100192z
   Yongoli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yuana H., 2010, P NATL ACAD SCI USA, V31, P13614
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhu X., 2006, J BIOMED MATER RES B, V2, P65
   Zhu XD, 2007, J MATER SCI-MATER M, V18, P2243, DOI 10.1007/s10856-006-0057-2
   Zhu XD, 2010, ACTA BIOMATER, V6, P1536, DOI 10.1016/j.actbio.2009.10.032
   Zhu XD, 2009, ACTA BIOMATER, V5, P1311, DOI 10.1016/j.actbio.2008.11.024
   Zhu XD, 2007, J BIOMED MATER RES B, V82B, P65, DOI 10.1002/jbm.b.30706
NR 117
TC 0
Z9 0
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2796-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1120
BP 55
EP 76
PG 22
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA BEI65
UT WOS:000316717400003
DA 2018-10-19
ER

PT S
AU Roehrich, A
   Ash, J
   Zane, A
   Masica, DL
   Gray, JJ
   Goobes, G
   Drobny, G
AF Roehrich, Adrienne
   Ash, Jason
   Zane, Ariel
   Masica, David L.
   Gray, Jeffrey J.
   Goobes, Gil
   Drobny, Gary
BE Horbett, T
   Brash, JL
   Norde, W
TI Solid-State NMR Studies of Biomineralization Peptides and Proteins
SO PROTEINS AT INTERFACES III: STATE OF THE ART
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Proteins at Interfaces 3 - State of the Art
CY MAR 25-29, 2012
CL San Diego, CA
SP ACS, Div Colloid & Surface Chem
ID CALCIUM-PHOSPHATE PRECIPITATION; SILICA NANOSPHERE FORMATION;
   NUCLEAR-MAGNETIC-RESONANCE; HUMAN SALIVARY PROTEINS; BETA-AMYLOID
   FIBRILS; ANGLE-SPINNING NMR; BASIC-AMINO-ACIDS; CHEMICAL-SHIFT; C-13
   NMR; IN-VITRO
AB Nature has evolved sophisticated strategies for engineering hard tissues through the interaction of proteins, and ultimately cells, with inorganic mineral phases. The remarkable material properties of shell, bone and teeth thus result from the activities of proteins that function at the organic-inorganic interface. A better understanding of the biomolecular mechanisms used to promote or retard the formation of mineral-based structures could provide important design principles for the development of calcification inhibitors and promoters in orthopedics, cardiology, urology, and dentistry. In addition to investigating the molecular-level basis for the recognition of biomineral surfaces and the control of hard tissue growth by proteins, the development of materials using biomimetic principles has potential applications in catalysis, biosensors, electronic devices, chromatographic separations, to name only a few.
   Despite the high level of interest in elucidating and controlling the structure of proteins at material and biomineral interfaces, there is a decided lack of molecular-level structure information available for proteins at biomaterial interfaces in general, and in particular for mammalian proteins that directly control calcification processes in hard tissue. The most fundamental questions regarding the secondary and tertiary structures of proteins adsorbed to material surfaces, how proteins catalyze the formation of biomineral composites, or how proteins interact at biomaterial interfaces, remain unanswered, largely due to a lack of methods capable of providing high resolution structural information for proteins adsorbed to material surfaces under physiologically relevant conditions (i.e. fully hydrated).
   In order to develop a better understanding of the structure and interactions of proteins in biomaterials, we have begun to utilize solid-state NMR techniques to determine the molecular structure and dynamics of proteins and peptides on inorganic crystal surfaces and within biomineral composites. In this review, we will highlight recent work that is providing insight into the structure and crystal recognition mechanisms of a salivary protein model system, as well as the structure and interactions of a peptide which catalyzes the formation of biosilica composites.
C1 [Roehrich, Adrienne; Ash, Jason; Zane, Ariel; Goobes, Gil; Drobny, Gary] Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.
   [Masica, David L.; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
   [Goobes, Gil] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel.
   [Ash, Jason] Merck, Ctr Mat Sci & Engn, Rahway, NJ 07065 USA.
RP Roehrich, A (reprint author), Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.
EM drobny@chem.washington.edu
FU National Institutes of Health [R01 DEI2554]
FX We would like to acknowledge Matt Power for his contributions to data
   collection on the R5. Work was supported by the National Institutes of
   Health (R01 DEI2554).
CR ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0
   [Anonymous], 2007, HDB BIOMINERALIZATIO
   Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330
   BARNETT BL, 1979, ACTA CRYSTALLOGR B, V35, P1212, DOI 10.1107/S0567740879005938
   Ben Shir I, 2010, J PHYS CHEM B, V114, P5989, DOI 10.1021/jp100114v
   CAMPBELL AA, 1989, CALCIFIED TISSUE INT, V45, P122, DOI 10.1007/BF02561411
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   CHIANG CH, 1982, J COLLOID INTERF SCI, V86, P26, DOI 10.1016/0021-9797(82)90037-6
   COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328
   FERNANDEZ VL, 1992, J AM CHEM SOC, V114, P9634, DOI 10.1021/ja00050a051
   Franks WT, 2008, P NATL ACAD SCI USA, V105, P4621, DOI 10.1073/pnas.0712393105
   Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103
   Goobes R, 2006, BIOCHEMISTRY-US, V45, P5576, DOI 10.1021/bi052321z
   Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a
   Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1
   Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z
   JENSEN JL, 1992, J DENT RES, V71, P1569, DOI 10.1177/00220345920710090501
   JOHNSSON M, 1991, ARCH ORAL BIOL, V36, P631, DOI 10.1016/0003-9969(91)90014-L
   KAPLAN S, 1973, J CHEM PHYS, V59, P5681, DOI 10.1063/1.1679920
   Kent MS, 2009, LANGMUIR, V25, P305, DOI 10.1021/la801794e
   Knecht MR, 2004, LANGMUIR, V20, P4728, DOI 10.1021/la0494019
   Knecht MR, 2003, CHEM COMMUN, P3038, DOI 10.1039/b309074d
   Korukottu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002359
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497
   Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Lopez-Garcia M., 2008, HDB BIOMINERALIZATIO, P109
   Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902
   Masica DL, 2011, J PHYS CHEM C, V115, P13775, DOI 10.1021/jp202965h
   Masica DL, 2010, STRUCTURE, V18, P1678, DOI 10.1016/j.str.2010.09.013
   Masica DL, 2009, BIOPHYS J, V96, P3082, DOI 10.1016/j.bpj.2009.01.033
   Mermut O, 2006, J AM CHEM SOC, V128, P3598, DOI 10.1021/ja056031h
   MINAGUCHI K, 1989, J DENT RES, V68, P2, DOI 10.1177/00220345890680010201
   Nadaud PS, 2007, BIOMOL NMR ASSIGN, V1, P117, DOI 10.1007/s12104-007-9041-0
   Naik RR, 2003, CHEM COMMUN, P238, DOI 10.1039/b210635c
   Ndao M, 2010, SURF SCI, V604, pL39, DOI 10.1016/j.susc.2010.02.026
   Ndao M, 2009, LANGMUIR, V25, P12136, DOI 10.1021/la901647n
   Neville F, 2011, LANGMUIR, V27, P279, DOI 10.1021/la1033492
   Nieuwkoop AJ, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3211103
   Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   Patwardhan SV, 2006, BIOMACROMOLECULES, V7, P491, DOI 10.1021/bn050717k
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Pouget E, 2007, NAT MATER, V6, P434, DOI 10.1038/nmat1912
   Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200
   Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100
   Raj PA, 1998, BIOPOLYMERS, V45, P51, DOI 10.1002/(SICI)1097-0282(199801)45:1<51::AID-BIP5>3.0.CO;2-Y
   RICHARDSON CF, 1993, ARCH ORAL BIOL, V38, P997, DOI 10.1016/0003-9969(93)90113-Z
   Rodriguez F, 2004, BIOMACROMOLECULES, V5, P261, DOI 10.1021/bm034232c
   SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Sandhage KH, 2005, INT J APPL CERAM TEC, V2, P317, DOI 10.1111/j.1744-7402.2005.02035.x
   SCHLESINGER DH, 1977, J BIOL CHEM, V252, P1689
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   Schrofel A, 2011, J NANOPART RES, V13, P3207, DOI 10.1007/s11051-011-0221-6
   SCHWARTZ SS, 1992, CALCIFIED TISSUE INT, V50, P511, DOI 10.1007/BF00582164
   Shaw WJ, 2000, J AM CHEM SOC, V122, P1709, DOI 10.1021/ja9842823
   Shaw WJ, 2000, J AM CHEM SOC, V122, P7118, DOI 10.1021/ja000878q
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Srinivasan S., COMMUNICATION UNPUB
   Takegoshi K, 2003, J CHEM PHYS, V118, P2325, DOI 10.1063/1.1534105
   Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6
   van der Wel PCA, 2010, BIOCHEMISTRY-US, V49, P9457, DOI 10.1021/bi100077x
   Wenzl S, 2008, ANGEW CHEM, V120, P1753
   WIKIEL K, 1994, ARCH ORAL BIOL, V39, P715, DOI 10.1016/0003-9969(94)90099-X
   Xu H, 2010, CHEM MATER, V22, P5165, DOI 10.1021/cm101019p
   Zech SG, 2005, J AM CHEM SOC, V127, P8618, DOI 10.1021/ja0503128
   Zhan JH, 2005, ADV FUNCT MATER, V15, P2005, DOI 10.1002/adfm.200500274
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
NR 77
TC 6
Z9 6
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2796-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1120
BP 77
EP +
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA BEI65
UT WOS:000316717400004
DA 2018-10-19
ER

PT S
AU Szott, LM
   Horbett, TA
AF Szott, Luisa M.
   Horbett, Thomas A.
BE Horbett, T
   Brash, JL
   Norde, W
TI Mechanisms of the Foreign Body Response to RFGD Plasma-Generated
   PEO-Like Films
SO PROTEINS AT INTERFACES III: STATE OF THE ART
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Proteins at Interfaces 3 - State of the Art
CY MAR 25-29, 2012
CL San Diego, CA
SP ACS, Div Colloid & Surface Chem
ID INTEGRIN ALPHA(M)BETA(2) MAC-1; HOST TISSUE RESPONSES; GLYCOL DIMETHYL
   ETHER; COMPLEMENT ACTIVATION; SURFACE-CHEMISTRY; FIBRINOGEN ADSORPTION;
   MONOCYTE ADHESION; BIOMATERIAL SURFACES; LEUKOCYTE ADHESION;
   POLYETHYLENE OXIDE
AB Monocyte-derived macrophages play a central role in the foreign body response (FBR) to biomaterials through their interaction with adsorbed proteins on the material's surface. Fibrinogen (Fg) is a key adhesion protein in the FBR, and much effort has been spent on generating materials that reduce or eliminate its adsorption. However, although ultralow Fg adsorption (< 5 ng/cm(2)) and almost complete monocyte adhesion resistance was achieved with poly(ethylene oxide) (PEO)-like tetraglyme coatings in vitro, no effect on macrophage adhesion or fibrous capsule formation in mouse in vivo studies was observed. In order to better understand the mechanisms of the FBR to tetraglyme, the role of complement proteins and adsorbed Fg state and their effect on monocyte adhesion in vitro were investigated.
C1 [Szott, Luisa M.] PROFUSA Inc, 1219 18th St, San Francisco, CA 94107 USA.
   [Horbett, Thomas A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Horbett, Thomas A.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Szott, LM (reprint author), PROFUSA Inc, 1219 18th St, San Francisco, CA 94107 USA.
EM lizzy.szott@profusacorp.com
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   Baron S., 1996, MED MICROBIOLOGY
   Didisheim P., 1996, BIOMATERIALS SCI INT, P133
   Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44
   Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123
   Fuss C, 2001, J VASC INTERV RADIOL, V12, P677, DOI 10.1016/S1051-0443(07)61437-7
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   Gorbet MB, 2005, J BIOMED MATER RES A, V74A, P511, DOI 10.1002/jbm.a.30354
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Hirata I, 2000, COLLOID SURFACE B, V18, P285, DOI 10.1016/S0927-7765(99)00154-X
   Horbett T. A., 1999, BMES BULL, V13, P5
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Janatova J, 2000, ASAIO J, V46, pS53, DOI 10.1097/00002480-200011000-00038
   JANEWAY C, 2001, IMMUNOBIOLOGY
   Jang HS, 2006, COLLOID SURFACE B, V50, P141, DOI 10.1016/j.colsurfb.2006.03.024
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b
   Kuby J, 1997, IMMUNOLOGY
   Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   MAZZONE A, 1995, HAEMATOLOGICA, V80, P161
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MOORE FD, 1988, ANN SURG, V208, P95, DOI 10.1097/00000658-198807000-00014
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Pechik I, 2006, BIOCHEMISTRY-US, V45, P3588, DOI 10.1021/bi0525369
   Peracchia MT, 1997, LIFE SCI, V61, P749, DOI 10.1016/S0024-3205(97)00539-0
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Rabb H, 2002, AM J KIDNEY DIS, V39, P587, DOI 10.1053/ajkd.2002.31416
   Ratner B. D., 1996, SURFACE ANAL TECHNIQ
   Reichert W, 2011, J BIOMED MATER RES A, V96A, P275, DOI 10.1002/jbm.a.32969
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Su Jianzhong, 2011, Open Access Bioinformatics, V2011, P19
   Su JZ, 2011, INT J COMPUT MATH, V88, P610, DOI 10.1080/00207161003640035
   Szott LM, 2010, J BIOMED MATER RES A, V95A, P1252, DOI 10.1002/jbm.a.32944
   Szott LM, 2011, J BIOMED MATER RES A, V96A, P150, DOI 10.1002/jbm.a.32954
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tsai WB, 2003, J BIOMED MATER RES A, V67A, P1255, DOI 10.1002/jbm.a.20024
   Ugarova TP, 2003, BIOCHEMISTRY-US, V42, P9365, DOI 10.1021/bi034057k
   Ugarova TP, 2001, ANN NY ACAD SCI, V936, P368
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   Varela MP, 2001, BLOOD PURIFICAT, V19, P370, DOI 10.1159/000046967
   Yakovlev S, 2005, BIOCHEMISTRY-US, V44, P617, DOI 10.1021/bi048266w
   Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h
NR 65
TC 1
Z9 1
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 978-0-8412-2796-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1120
BP 321
EP +
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA BEI65
UT WOS:000316717400014
DA 2018-10-19
ER

PT S
AU Baker, DW
   Tang, LP
AF Baker, David W.
   Tang, Liping
BE Horbett, T
   Brash, JL
   Norde, W
TI Effect of Microtopography on Fibrocyte Responses and Fibrotic Tissue
   Reactions at the Interface
SO PROTEINS AT INTERFACES III: STATE OF THE ART
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Proteins at Interfaces 3 - State of the Art
CY MAR 25-29, 2012
CL San Diego, CA
SP ACS, Div Colloid & Surface Chem
ID FOREIGN-BODY REACTIONS; CIRCULATING FIBROCYTES; SURFACE-CHEMISTRY;
   INFLAMMATORY RESPONSES; COLLOIDAL LITHOGRAPHY; EXTRACELLULAR-MATRIX;
   CELLULAR-RESPONSES; PERIPHERAL-BLOOD; COLLAGEN; CELLS
AB Governing the biomaterial mediated tissue response is critically importance for the future design and improvement of many medical implants. As such, an enormous amount of research effort has been placed on seeking a means to alter or control implant associated tissue reactions. Ultimately, the numerous strategies attempted boil down to a single notion of manipulating proteins and cells at the material interface. While the mechanisms and processes governing such reactions are not entirely understood, surface modification techniques have become the primary strategy, encompassing a wide variety of methods to improve the biomaterial interaction. While methods such as surface chemistry, functionality, and hydophobicity have all lead to various degrees of improvement, surface topography may be the largest contributor to combat adverse tissue and cellular reactions. We focus our discussion on the recent advances of surface topography manipulation and its effect on specific cellular responses both in vitro and in vivo. In particular we and others have found that micropillar topography has a profound effect on cellular morphology, migration, differentiation, and expression in vitro. The resultant influence of micropillar arrays on tissue responses in vivo however have only just begun to be investigated. Surprisingly, our own research has revealed that fibrocytes, circulating fibroblasts, but not macrophages are mostly responsible for micropillar-mediated tissue responses in vivo. A better understanding of the interactions between fibrocytes and micropillar topography may provide critical information for improving implant safety and function.
C1 [Baker, David W.; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
RP Baker, DW (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM ltang@uta.edu
CR Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Baker DW, 2011, BIOMACROMOLECULES, V12, P997, DOI 10.1021/bm1013487
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BUCALA R, 1994, MOL MED, V1, P71
   Chen H, 2009, COLLOID SURFACE B, V71, P275, DOI 10.1016/j.colsurfb.2009.02.018
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chesney J, 1998, J IMMUNOL, V160, P419
   Clark HR, 1999, BIOTECHNOL PROGR, V15, P259, DOI 10.1021/bp990003j
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Feinberg AW, 2008, J BIOMED MATER RES A, V86A, P522, DOI 10.1002/jbm.a.31626
   Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lensen MC, 2008, PURE APPL CHEM, V80, P2479, DOI 10.1351/pac200880112479
   LIN CQ, 1993, FASEB J, V7, P737
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Ng CKM, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0021-2
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Patel AA, 2010, BIOMED MICRODEVICES, V12, P287, DOI 10.1007/s10544-009-9384-7
   Patil Siddhesh D, 2004, Diabetes Technol Ther, V6, P887, DOI 10.1089/dia.2004.6.887
   Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997
   Prantl L, 2007, PLAST RECONSTR SURG, V120, P275, DOI 10.1097/01.prs.0000264398.85652.9a
   Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005
   Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x
   Sargeant Alene, 2006, J Surg Orthop Adv, V15, P111
   Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024
   Steedman MR, 2010, BIOMED MICRODEVICES, V12, P363, DOI 10.1007/s10544-009-9392-7
   Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132
   Sutherland J, 2005, J ANAT, V206, P581, DOI 10.1111/j.1469-7580.2005.00415.x
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Thomopoulos S, 2007, J BIOMECH ENG-T ASME, V129, P642, DOI [10.1115/1.2768104, 10.1115/1.2768378]
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Walboomers XF, 1998, J BIOMED MATER RES, V42, P634, DOI 10.1002/(SICI)1097-4636(19981215)42:4<634::AID-JBM21>3.3.CO;2-F
   Wilkinson A, 2011, ACTA BIOMATER, V7, P2919, DOI 10.1016/j.actbio.2011.03.026
NR 56
TC 2
Z9 2
U1 2
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
EI 1947-5918
BN 978-0-8412-2796-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1120
BP 339
EP 353
PG 15
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA BEI65
UT WOS:000316717400015
DA 2018-10-19
ER

PT S
AU Fu, Y
   Kao, WJ
AF Fu, Yao
   Kao, Weiyuan John
BE Horbett, T
   Brash, JL
   Norde, W
TI Proteomic Approaches To Characterize Surface-Bound Proteins and
   Material-Mediated Cellular Proteins
SO PROTEINS AT INTERFACES III: STATE OF THE ART
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Proteins at Interfaces 3 - State of the Art
CY MAR 25-29, 2012
CL San Diego, CA
SP ACS, Div Colloid & Surface Chem
ID SPECTROMETRY-BASED PROTEOMICS; IONIZATION-MASS-SPECTROMETRY;
   QUANTITATIVE PROTEOMICS; PLATELET-ADHESION; HUMAN SERUM; RECORDING
   ELLIPSOMETER; ADHERENT MACROPHAGES; PLASMA-MEMBRANE; IN-VITRO;
   BIOMATERIAL
AB Proteins at the biomaterial interface include surface-adsorbed proteins and soluble proteins secreted by cells adherent or attached to biomaterial interfaces. These proteins carry multiple functions such as directing cell adhesion, proliferation, differentiation, and migration. The identification of proteins at the material interface will help elucidate the impact of proteins in mediating cell-material interaction, host response, and cell signaling pathway. The aim of this chapter is to provide an overview of the application of proteomic tools to analyze proteins at the material interface. Two main analytical methods, protein microarrays and mass spectrometry (MS), have been reviewed and their applications in proteomic study of biomaterial-related proteins were discussed in case studies. In sum, proteomics provides a viable approach to survey global proteome of surface-adsorbed proteins and soluble proteins from adherent cells at the biomaterial interface. (C) 2012 American Chemical Society
C1 [Fu, Yao; Kao, Weiyuan John] Univ Wisconsin, Sch Med & Publ Hlth, Sch Pharm, Madison, WI 53705 USA.
RP Fu, Y (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Sch Pharm, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   AGGELER J, 1982, J CELL BIOL, V94, P613, DOI 10.1083/jcb.94.3.613
   Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927
   Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Austin RJ, 2011, J PROTEOME RES, V10, P5251, DOI 10.1021/pr200551e
   Azarkan M, 2007, J CHROMATOGR B, V849, P81, DOI 10.1016/j.jchromb.2006.10.056
   Backovic A, 2007, J PROTEOME RES, V6, P376, DOI 10.1021/pr0603755
   Bally M, 2011, ANAL BIOCHEM, V416, P145, DOI 10.1016/j.ab.2011.05.030
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cattelino A, 1999, MOL BIOL CELL, V10, P373, DOI 10.1091/mbc.10.2.373
   Chang KP, 2011, J PROTEOME RES, V10, P4935, DOI 10.1021/pr200311p
   Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   COHEN CM, 1977, J CELL BIOL, V75, P119, DOI 10.1083/jcb.75.1.119
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Coombs KM, 2011, EXPERT REV PROTEOMIC, V8, P659, DOI [10.1586/EPR.11.55, 10.1586/epr.11.55]
   Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y
   Derhami K, 2001, J BIOMED MATER RES, V56, P234, DOI 10.1002/1097-4636(200108)56:2<234::AID-JBM1090>3.3.CO;2-R
   Derhami K, 2000, J BIOMED MATER RES, V52, P315, DOI 10.1002/1097-4636(200011)52:2<315::AID-JBM10>3.0.CO;2-2
   Din S, 2007, NAT CLIN PRACT GASTR, V4, P372, DOI 10.1038/ncpgasthep0872
   Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661
   Drees Frauke, 2005, Methods Mol Biol, V294, P303
   Elbert D. L., 2011, COMPREHENSIVE BIOMAT, V3
   FELTKAMP CA, 1991, J CELL SCI, V100, P579
   Francolini I, 2012, ACTA BIOMATER, V8, P549, DOI 10.1016/j.actbio.2011.10.024
   Gonzalez-Gonzalez M, 2012, EUR J PHARM SCI, V45, P499, DOI 10.1016/j.ejps.2011.07.009
   Griesser HJ, 2004, BIOMATERIALS, V25, P4861, DOI 10.1016/j.biomaterials.2004.01.049
   Guo J, 2011, J PROTEOMICS, V74, P2360, DOI 10.1016/j.jprot.2011.07.013
   Gygi SP, 2000, CURR OPIN CHEM BIOL, V4, P489, DOI 10.1016/S1367-5931(00)00121-6
   Hale John E., 2003, Briefings in Functional Genomics & Proteomics, V2, P185
   Hamada I, 2008, MOL IMMUNOL, V46, P225, DOI 10.1016/j.molimm.2008.08.276
   Hamilton JA, 2003, J LEUKOCYTE BIOL, V73, P702, DOI 10.1189/jlb.0103037
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Huang ZL, 2012, TOXICOLOGY, V291, P56, DOI 10.1016/j.tox.2011.10.023
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278
   Ji JY, 2000, J CHROMATOGR B, V745, P197, DOI 10.1016/S0378-4347(00)00192-4
   Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029
   Jiang XG, 2008, PROTEOMICS, V8, P686, DOI 10.1002/pmic.200700617
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kuyama H, 2004, MOL CELL PROTEOMICS, V3, pS289
   Lehnert M, 2011, LANGMUIR, V27, P7743, DOI 10.1021/la200908h
   Leitner A, 2004, J CHROMATOGR B, V813, P1, DOI 10.1016/j.jchromb.2004.09.057
   Leng JP, 2011, J AM SOC MASS SPECTR, V22, P1204, DOI 10.1007/s13361-011-0129-5
   Lescuyer P, 2004, ELECTROPHORESIS, V25, P1125, DOI 10.1002/elps.200305792
   LIMBER GK, 1975, THROMB RES, V6, P421, DOI 10.1016/0049-3848(75)90158-9
   Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2
   Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 2000, SCIENCE, V289, P1760
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Maxeiner H, 1998, J EXP MED, V188, P2257, DOI 10.1084/jem.188.12.2257
   McArthur SL, 2001, BIOMATERIALS, V22, P3295, DOI 10.1016/S0142-9612(01)00166-1
   Mograbi B, 1999, EUR CYTOKINE NETW, V10, P79
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Nand A, 2012, PROTEIN CELL, V3, P84, DOI 10.1007/s13238-012-2012-y
   Neto AI, 2011, SOFT MATTER, V7, P4147, DOI 10.1039/c1sm05169e
   Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427
   Oughlis S, 2011, J CHROMATOGR B, V879, P3681, DOI 10.1016/j.jchromb.2011.10.006
   Paulo Joao A., 2012, Yale Journal of Biology and Medicine, V85, P59
   Power KA, 2010, BIOMATERIALS, V31, P6667, DOI 10.1016/j.biomaterials.2010.05.029
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Samgina TY, 2011, J AM SOC MASS SPECTR, V22, P2246, DOI 10.1007/s13361-011-0247-0
   Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176
   Schmidt D, 2011, ACTA BIOMATER, V7, P515, DOI 10.1016/j.actbio.2010.08.022
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Sivaraman B, 2012, LANGMUIR, V28, P2745, DOI 10.1021/la204777x
   Sohn CH, 2012, J AM CHEM SOC, V134, P2672, DOI 10.1021/ja2099003
   Stoevesandt O, 2009, EXPERT REV PROTEOMIC, V6, P145, DOI 10.1586/EPR.09.2
   STRUPAT K, 1991, INT J MASS SPECTROM, V111, P89, DOI 10.1016/0168-1176(91)85050-V
   Sze SK, 2002, P NATL ACAD SCI USA, V99, P1774, DOI 10.1073/pnas.251691898
   Talapatra A, 2002, PHARMACOGENOMICS, V3, P527, DOI 10.1517/14622416.3.4.527
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tang CK, 2012, LAB CHIP, V12, P281, DOI 10.1039/c1lc20833k
   Taylor M, 2008, MACROMOL RAPID COMM, V29, P1298, DOI 10.1002/marc.200800171
   Tong WY, 2010, MOL CELL PROTEOMICS, V9, P2089, DOI 10.1074/mcp.M110.001966
   Valaskovic GA, 1996, SCIENCE, V273, P1199, DOI 10.1126/science.273.5279.1199
   VROMAN L, 1967, THROMB DIATH HAEMOST, V18, P510, DOI 10.1055/s-0038-1655060
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   VROMAN L, 1964, THROMB DIATH HAEMOST, V10, P455, DOI 10.1055/s-0038-1654798
   VROMAN L, 1980, BLOOD, V55, P156
   Wang XT, 2011, J BIOMAT SCI-POLYM E, V22, P1343, DOI 10.1163/092050610X508400
   Ward WW, 2009, CURR ANAL CHEM, V5, P85, DOI 10.2174/157341109787846171
   WEATHERSBY PK, 1976, T AM SOC ART INT ORG, V22, P242
   Weinberger SR, 2002, ELECTROPHORESIS, V23, P3182, DOI 10.1002/1522-2683(200209)23:18<3182::AID-ELPS3182>3.0.CO;2-5
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   Wilkins M, 2009, EXPERT REV PROTEOMIC, V6, P599, DOI 10.1586/EPR.09.81
   Wu SL, 2007, J PROTEOME RES, V6, P4230, DOI 10.1021/pr070313u
   Xiong Q, 2012, J PROTEOME RES, V11, P2078, DOI 10.1021/pr201079y
   YING SC, 1993, J IMMUNOL, V150, P169
   Zarate X, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-32
   Zuckerman ST, 2008, J BIOMED MATER RES A, V85A, P513, DOI 10.1002/jbm.a.31306
   Zuckerman ST, 2009, BIOMATERIALS, V30, P3825, DOI 10.1016/j.biomaterials.2009.04.007
   Zuckerman ST, 2006, BIOMATERIALS, V27, P3745, DOI 10.1016/j.biomaterials.2006.02.028
NR 102
TC 0
Z9 0
U1 2
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2796-5
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1120
BP 809
EP 837
PG 29
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA BEI65
UT WOS:000316717400037
DA 2018-10-19
ER

PT S
AU Stylianou, A
   Yova, D
   Politopoulos, K
AF Stylianou, A.
   Yova, D.
   Politopoulos, K.
BE Kyriacou, E
   Promponas, V
   Loizou, C
   Schizas, CN
   Pattichis, CS
TI Atomic Force Microscopy Surface Nanocharacterization of UV-Irradiated
   Collagen Thin Films
SO IEEE 12TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS & BIOENGINEERING
SE IEEE International Conference on Bioinformatics and Bioengineering
LA English
DT Proceedings Paper
CT 12th IEEE International Conference on BioInformatics and BioEngineering
   (BIBE)
CY NOV 11-13, 2012
CL Larnaca, CYPRUS
SP IEEE, Cyprus Presidency Council European Union, IEEE Comp Soc, Univ Cyprus, Biol & AI Fdn (BAIF), Frederick Univ, Hellen Soc Computat Biol & Bioinformat (HSCBB), Tech Univ Cyprus, IEEE Engn Med & Biol Soc (IEEE EMBS), Int Federat Med & Biol Engn (IFMBE)
DE Atomic Force Microscopy; UV; Collagen; Nanocharacterization;
   Fluorescence
ID ULTRAVIOLET-RADIATION; BIOMATERIAL; AFM
AB Collagen, the most abundant protein in mammals, is a basic component of the extracellular matrix and due to its unique properties it is widely used as biomaterial, scaffold and culture substrate for cell and tissue regeneration studies. Due to human skin chronic exposure to sun light and since UV rays are used as sterilizing and cross-linking methods the clarification of the UV light-collagen interactions are very crucial. Moreover, since the majority of the biological reactions occur on surfaces or interfaces the influence of UV light on the surface of collagen-based materials attracts the scientific interest, especially in the biomaterials science. Surface-nanoscale characterization could be performed with Atomic Force Microscopy (AFM), which is a powerful tool and offers quantitative and qualitative information. Its ability of high resolution imaging and non-destructive characterization makes it very attractive for biological samples investigation. The aim of this paper was to determine the surface properties and alterations of collagen thin films after UV-irradiations using AFM techniques. Furthermore, it was aimed to investigate the possible different influence on the surface when the collagen solution or the thin films were irradiated. In this paper topographic AFM images were acquired from thin films, formed from both irradiated and non-irradiated collagen solutions, with spin coating procedure. The results demonstrated that the UV irradiation have different results when it is applied in the collagen solution or in the film after the spin coating methodology. For short irradiation times (<120 min) UV caused only rather small changes in the morphology of the studied films although fluorescence and absorption studies confirmed collagen photodegradation. The surface roughness and topography altered after 3 and 7 hours, respectively, while the fibrous structure was completely destroyed after 15 hours. Surface roughness of the films depends on whether the solution was irradiated or the film and on the time irradiation. The fully clarification of the role of the UV light on collagen thin films will enable the proper design and control of collagen based nanobiomaterials with appropriate and improved surface properties.
C1 [Stylianou, A.; Yova, D.; Politopoulos, K.] Natl Tech Univ Athens, Biomed Opt & Appl Biophys Lab, Sch ECE, Div Electromagnet Electroopt & Elect Mat, Athens, Greece.
RP Stylianou, A (reprint author), Natl Tech Univ Athens, Biomed Opt & Appl Biophys Lab, Sch ECE, Div Electromagnet Electroopt & Elect Mat, Athens, Greece.
EM styliand@mail.ntua.gr
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Au AY, 2012, J BIOMED MATER RES A, V100A, P342, DOI 10.1002/jbm.a.33277
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943
   Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081
   Fathima NN, 2008, COLLOID SURFACE B, V62, P11, DOI 10.1016/j.colsurfb.2007.09.006
   Fathima NN, 2007, J APPL POLYM SCI, V104, P3642, DOI 10.1002/app.26129
   Fessel G, 2012, J ORTHOP RES, V30, P973, DOI 10.1002/jor.22014
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Gaspar A, 2011, J Med Life, V4, P172
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Ionita I, 2010, ROM REP PHYS, V62, P634
   Jariashvili K, 2012, BIOPOLYMERS, V97, P189, DOI 10.1002/bip.21725
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Metreveli NO, 2010, ECOTOX ENVIRON SAFE, V73, P448, DOI 10.1016/j.ecoenv.2009.12.005
   Morris V. J., 2008, ATOMIC FORCE MICROSC
   Plant A.L., 2009, BBA-MOL CELL RES, V793, P839
   Sherratt MJ, 2010, J PATHOL, V222, P32, DOI 10.1002/path.2730
   Silver FH, 2009, J ENG FIBER FABR, V4, P9
   Sionkowska A., 2009, MATER SCI FORUM, V706-709, P595
   Sionkowska A, 2008, APPL SURF SCI, V255, P2030, DOI 10.1016/j.apsusc.2008.06.200
   Sionkowska A, 2009, APPL SURF SCI, V255, P4135, DOI 10.1016/j.apsusc.2008.10.108
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2011, EM TECHN NOND TEST 5, P415
   Stylianou A., 2011, IFMBE P, V37, P1058
   Stylianou A, 2010, IFMBE P, V29, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Stylianou A., 2009, INT C INF TECHN APPL
   Torikai A, 1999, J APPL POLYM SCI, V73, P1259, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1259::AID-APP20>3.0.CO;2-#
   Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
NR 32
TC 3
Z9 3
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2471-7819
BN 978-1-4673-4358-9; 978-1-4673-4357-2
J9 IEEE INT C BIOINF BI
PY 2012
BP 603
EP 608
PG 6
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BDW49
UT WOS:000315332900113
DA 2018-10-19
ER

PT S
AU Kontomaris, SV
   Stylianou, A
   Yova, D
   Politopoulos, K
AF Kontomaris, S., V
   Stylianou, A.
   Yova, D.
   Politopoulos, K.
BE Kyriacou, E
   Promponas, V
   Loizou, C
   Schizas, CN
   Pattichis, CS
TI Mechanical Properties of Collagen Fibrils on Thin Films by Atomic Force
   Microscopy Nanoindentation
SO IEEE 12TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS & BIOENGINEERING
SE IEEE International Conference on Bioinformatics and Bioengineering
LA English
DT Proceedings Paper
CT 12th IEEE International Conference on BioInformatics and BioEngineering
   (BIBE)
CY NOV 11-13, 2012
CL Larnaca, CYPRUS
SP IEEE, Cyprus Presidency Council European Union, IEEE Comp Soc, Univ Cyprus, Biol & AI Fdn (BAIF), Frederick Univ, Hellen Soc Computat Biol & Bioinformat (HSCBB), Tech Univ Cyprus, IEEE Engn Med & Biol Soc (IEEE EMBS), Int Federat Med & Biol Engn (IFMBE)
DE AFM; collagen fibrils; nanoindentation; UV
ID ARTICULAR-CARTILAGE; ELASTIC-MODULUS; INDENTATION
AB Atomic Force Microscopy (AFM) is a powerful tool as far as surface characterization is concerned, due to its ability to relate high resolution imaging with mechanical properties. Furthermore biological samples, such as collagen, can be studied by AFM with a non-destructive manner. Collagen is the most abundant protein in mammals and because of its unique properties is widely used as biomaterial. Due to the human skin chronic exposure to sun light and since UV-rays are used in sterilizing and cross linking methods of collagen based biomaterials, the investigation of the influence of UV light on collagen, is crucial. The purpose of this paper was to investigate the topographic features and the mechanical properties of collagen fibrils prior and post ultraviolet (UV) by using the AFM indentation method. Hence, load-displacement curves were obtained on collagen fibrils in order to calculate the Young modulus for each case. Each curve presented, was the average of 10 curves. The results showed that Young modulus value increased after 4 hours of UV irradiation from 0.5 GPa to 1.53 GPa. After 8 hours of UV irradiation the Young modulus value was calculated equal to 3.2 GPa. These experiments yielded a clear stiffening of collagen fibrils as a result of UV exposure. Moreover, after 8 hours of UV exposure, collagen fibrillar structure started to deform and the characteristic D-band of collagen fibrils deteriorated. The investigation of the alterations of the modulus under UV irradiation, will contribute to the clarification of the impact that different physical and chemical parameters have on the mechanical properties of collagen-based materials. In addition, this will enable the design and development of biomaterials with improved properties.
C1 [Kontomaris, S., V; Stylianou, A.; Yova, D.; Politopoulos, K.] Natl Tech Univ Athens, Biomed Opt & Appl Biophys Lab, Sch ECE, Div Electromagnet Electroopt & Elect Mat, Athens, Greece.
RP Kontomaris, SV (reprint author), Natl Tech Univ Athens, Biomed Opt & Appl Biophys Lab, Sch ECE, Div Electromagnet Electroopt & Elect Mat, Athens, Greece.
EM steliosk@central.ntua.gr
CR Chung KH, 2010, LANGMUIR, V26, P3629, DOI 10.1021/la903073v
   Fessel G, 2012, J ORTHOP RES, V30, P973, DOI 10.1002/jor.22014
   Fischer-Cripps A C, 2009, IBIS HDB NANOINDENTA
   Gaspar A, 2011, J Med Life, V4, P172
   Grant CA, 2012, J MECH BEHAV BIOMED, V5, P165, DOI 10.1016/j.jmbbm.2011.08.020
   Heim AJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2367660
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Sionkowska A, 2006, POLYM DEGRAD STABIL, V91, P3026, DOI 10.1016/j.polymdegradstab.2006.08.009
   Sirghi L., 2010, FORMATEX MICROSCOPY, V1, P433
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/NNANO.2008.410, 10.1038/nnano.2008.410]
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2011, EM TECHN NOND TEST 5, P415
   Stylianou A, 2010, IFMBE P, V29, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Stylianou A., 2009, INT C INF TECHN APPL
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
NR 18
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2471-7819
BN 978-1-4673-4358-9; 978-1-4673-4357-2
J9 IEEE INT C BIOINF BI
PY 2012
BP 609
EP 614
PG 6
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BDW49
UT WOS:000315332900114
DA 2018-10-19
ER

PT S
AU Mahardika, M
   Arifvianto, B
   Suyitno
   Wibowo, A
   Prihandana, GS
AF Mahardika, Muslim
   Arifvianto, Budi
   Suyitno
   Wibowo, Anton
   Prihandana, Gunawan Setia
BE Gaol, FL
TI Design and Analysis of Dynamics Compression Plate by Finite Element
   Analysis
SO INTERNATIONAL CONFERENCE ON ADVANCES SCIENCE AND CONTEMPORARY
   ENGINEERING 2012
SE Procedia Engineering
LA English
DT Proceedings Paper
CT International Conference on Advances Science and Contemporary
   Engineering (ICASCE)
CY OCT 24-25, 2012
CL Jakarta, INDONESIA
DE Biomaterial; DCP; Finite Element Analysis
ID MECHANICAL ATTRITION TREATMENT; AISI 316L; SURFACE-ROUGHNESS;
   MICROHARDNESS; WETTABILITY; FIXATION
AB In the manufacturing industry, especially in manufacturing of medical devices such as DCP (Dynamics Compression Plate) is now has highly demand in Indonesia, since many earthquakes occurred in recent year. The early fixation plate was made from 316L stainless steel since it has good corrosion resistance. This research is conducted in order to design and analysis of DCP plate by FEM (Finite Element Model) performed by CATIA software. It was conducted by first, constructing three dimensional solid models in CAD (Computer Aided Design) Solid Modeler, its geometric information was used by the FEM to create mesh areas. Nodes and elements were then generated from the mesh volume. Design and analysis of DCP was done in two many types. The design of DCP was performed in 6 holes and two different types; type I and type II. Type I and type II has different thickness of 3 mm and 4 mm, and also different in the width. The variation of width are equal to 0%, 20%, 30% and 40% bigger than initial dimension. Based on the analytical results, highest stress is in the edge part of inner holes. Thus the inner hole regions are the most likely areas for plate failure. (C) 2012 Elsevier B. V ... Selection and peer-review under responsibility of Bin Nusantara University
C1 [Mahardika, Muslim; Arifvianto, Budi; Suyitno; Wibowo, Anton; Prihandana, Gunawan Setia] Gadjah Mada Univ, Dept Mech & Ind Engn, Ctr Innovat Med Equipments & Devices CIMEDs, Yogyakarta 55281, Indonesia.
RP Prihandana, GS (reprint author), Gadjah Mada Univ, Dept Mech & Ind Engn, Ctr Innovat Med Equipments & Devices CIMEDs, Jl Grafika 2, Yogyakarta 55281, Indonesia.
EM dr064588@gmail.com
RI Prihandana, Gunawan/N-4804-2018; Arifvianto, Budi/D-9344-2013
OI Prihandana, Gunawan Setia/0000-0003-3709-2036
CR Apivatthakakul T, 2007, INJURY, V38, P1318, DOI 10.1016/j.injury.2007.05.005
   Arifvianto B, 2011, KEY ENG MATER, V462-463, P738, DOI 10.4028/www.scientific.net/KEM.462-463.738
   Arifvianto B, 2011, MATER CHEM PHYS, V125, P418, DOI 10.1016/j.matchemphys.2010.10.038
   Callister Jr Wiliam D, 1993, MECHANICAL PROPERTIE, P107
   Dogan H, 2002, MATER DESIGN, V23, P605, DOI 10.1016/S0261-3069(02)00066-3
   Ganesh VK., 2005, BIOMEDICAL ENG ONLIN, P1
   Luo CF, 2005, MOD RHEUMATOL, V15, P169
   Saidpour SH, 2006, ANN BIOMED ENG, V34, P1157, DOI 10.1007/s10439-006-9102-z
   Uhthoff HK, 2006, J ORTHOP SCI, V11, P118, DOI 10.1007/s00776-005-0984-7
NR 9
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2012
VL 50
BP 129
EP 133
DI 10.1016/j.proeng.2012.10.016
PG 5
WC Engineering, Multidisciplinary
SC Engineering
GA BDS19
UT WOS:000314664700016
DA 2018-10-19
ER

PT S
AU Donkov, N
   Safonov, V
   Zykova, A
   Smolik, J
   Rogovska, R
   Goltsev, A
   Dubrava, T
   Rossokha, I
   Georgieva, V
AF Donkov, N.
   Safonov, V.
   Zykova, A.
   Smolik, J.
   Rogovska, R.
   Goltsev, A.
   Dubrava, T.
   Rossokha, I.
   Georgieva, V.
BA DimovaMalinovska, D
   Nesheva, D
   Pecheva, E
   Petrov, AG
   Primatarowa, MT
BF DimovaMalinovska, D
   Nesheva, D
   Pecheva, E
   Petrov, AG
   Primatarowa, MT
TI Nanoscale surface modification of plastic substrates for advanced tissue
   engineering applications
SO 17TH INTERNATIONAL SCHOOL ON CONDENSED MATTER PHYSICS (ISCMP): OPEN
   PROBLEMS IN CONDENSED MATTER PHYSICS, BIOMEDICAL PHYSICS AND THEIR
   APPLICATIONS
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 17th International School on Condensed Matter Physics (ISCMP) - Open
   Problems in Condensed Matter Physics, Biomedical Physics and their
   Applications
CY SEP 02-07, 2012
CL Varna, BULGARIA
SP Bulgarian Acad Sci, Inst Solid State Phys
ID MESENCHYMAL STEM-CELLS
AB Modified surface properties such as composition, nano roughness, wettability have effect on the most important processes at biomaterial interface. The research of stem cells (MSCs) adhesive potential, morphology, phenotypical characteristics on oxide coated and plastic substrate with different surface parameters was made. The oxide coatings deposition on plastic substrates shifts the surface properties at the more hydrophilic region and results in next positive cell/biomaterial response in vitro tests. The MSCs marker number increases on the oxide nano structural surface of plastic substrates.
C1 [Donkov, N.] Bulgarian Acad Sci, Emil Djakov Inst Elect, Sofia, Bulgaria.
   [Safonov, V.; Zykova, A.] Kharkov Inst Phys & Technol, NSC, Kharkov, Ukraine.
   [Smolik, J.] Inst Sustainable Technol, NRC, Radom, Poland.
   [Goltsev, A.; Dubrava, T.; Rossokha, I.] Inst Problems Cryobiol & Cryomed NASU, Kharkov, Ukraine.
   [Georgieva, V.] Bulgarian Acad Sci, Georgi Nadjakov Inst Solid State Phys, Sofia 1784, Bulgaria.
RP Donkov, N (reprint author), Bulgarian Acad Sci, Emil Djakov Inst Elect, Sofia, Bulgaria.
EM nikolaidd@abv.bg
FU Bulgarian Academy of Sciences; National Ukrainian Academy of Sciences
FX The study was supported by the Program for Cooperation between Bulgarian
   Academy of Sciences and the National Ukrainian Academy of Sciences.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   DHAYAL M, 2008, J APPL SURFACE SCI, V254, P3331, DOI DOI 10.1016/J.APSUSC.2007.11.026
   Donkov N, 2010, Journal of Physics: Conference Series, V223, DOI 10.1088/1742-6596/223/1/012030
   Fibbe WE, 2003, ANN NY ACAD SCI, V996, P235, DOI 10.1111/j.1749-6632.2003.tb03252.x
   Hammer D A, 1987, J BIOPHYS, V52, P475
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Safonov V, 2012, J PHYS CONF SER, V356, DOI 10.1088/1742-6596/356/1/012046
   Zykova A., 2007, PROBLEMS ATOMIC SCI, V13, P200
NR 10
TC 1
Z9 1
U1 0
U2 5
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2012
VL 398
AR 012031
DI 10.1088/1742-6596/398/1/012031
PG 5
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA BDQ56
UT WOS:000314465000031
OA Bronze
DA 2018-10-19
ER

PT J
AU Zychowicz, M
   Mehn, D
   Ruiz, A
   Frontczak-Baniewicz, M
   Rossi, F
   Buzanska, L
AF Zychowicz, Marzena
   Mehn, Dora
   Ruiz, Ana
   Frontczak-Baniewicz, Malgorzata
   Rossi, Francois
   Buzanska, Leonora
TI Patterning of human cord blood-derived stem cells on single cell posts
   and lines: implications for neural commitment
SO ACTA NEUROBIOLOGIAE EXPERIMENTALIS
LA English
DT Article
DE neural stem cells; microcontact printing; single cell positioning;
   fibronectin; poly-L-lysine; neural commitment
ID GAP-JUNCTIONS; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX;
   IN-VITRO; DIFFERENTIATION; PROLIFERATION; SURFACES; BIOMATERIALS;
   NEOCORTEX; NEURONS
AB Using stem cells (SC) in new strategies for clinical treatment requires control of stem cell fate decision and the ability to govern their patterning and commitment in tissue engineering. Neural stem cells and other adult SC can respond to the different components of the microenvironment and their spatial arrangement in the stem cell niche. It has been shown previously by our group that different composition and architecture of patterned bioactive domains influence the developmental response of neural stem cells. In the present report we verify the commitment and differentiation of neural stem cells derived from human cord blood (HUCB-NSC) by a single cell patterning system. Microcontact printing technology was used to generate single cell positioning areas of different geometry: 10 mu m-thin lines and 10 mu m-width one cell posts. The commitment and differentiation of HUCB-NSC cells cultured on different surfaces were dependent on the geometry and the type of biomaterial present in bioactive domains Fibronectin promoted neuronal protrusion outgrowth (beta-tubulin III and MAP-2 positive cells) and gap junction development (Cx43 marker) between cells growing on lines while poly-L-lysine promoted HUCB-NSC differentiation into astrocytic, glial fibrillary acidic protein expressing (GFAP positive) cell phenotype. Here we also demonstrate by scanning electron microscopy that morphology of cells on the patterned surface is highly dependent upon the type of biomolecules used for printing. These kinds of platforms can be used for investigating the influence of spatial organization of environment on the SC fate decision and for studying the molecular processes occurring in a single cell.
C1 [Zychowicz, Marzena; Buzanska, Leonora] Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland.
   [Mehn, Dora; Ruiz, Ana; Rossi, Francois] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Nanobiosci Unit, Ispra, Italy.
   [Frontczak-Baniewicz, Malgorzata] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.
RP Buzanska, L (reprint author), Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland.
EM buzanska@imdik.pan.pl
OI Rossi, Francois/0000-0003-3090-1398; Ruiz, Ana/0000-0002-2657-645X
FU Polish Ministry of Scientific Research and Higher Education [N
   N302597838, N N302221138 MMRC]; European Commission Joint Research
   Centre NanoBioscience Action
FX Sponsored by Polish Ministry of Scientific Research and Higher Education
   grants No: N N302597838 and N N302221138 MMRC statuory fund, and
   European Commission Joint Research Centre NanoBioscience Action.
CR Bretagnol F, 2006, ACTA BIOMATER, V2, P165, DOI 10.1016/j.actbio.2005.11.002
   Buzanska L, 2009, ACTA NEUROBIOL EXP, V69, P1
   Buzanska L, 2006, STEM CELLS DEV, V15, P391, DOI 10.1089/scd.2006.15.391
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8
   Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109
   Fritsche E, 2011, METHODS MOL BIOL, V758, P99, DOI 10.1007/978-1-61779-170-3_7
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Habich A, 2011, ACTA NEUROBIOL EXP, V71, P1
   Janowski M, 2011, ACTA NEUROBIOL EXP, V71, P24
   Jurga M, 2009, TISSUE ENG PART C-ME, V15, P365, DOI 10.1089/ten.tec.2008.0485
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lo CW, 1996, J BIOENERG BIOMEMBR, V28, P379, DOI 10.1007/BF02110114
   McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113
   Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931
   Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Parsons XH, 2011, JOVE-J VIS EXP, V28, pe3273
   Rao Shreyas S, 2009, Front Neuroeng, V2, P6, DOI 10.3389/neuro.16.006.2009
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016
   Ruiz A., 2009, Micro and Nanosystems, V1, P50, DOI 10.2174/1876402910901010050
   Ruiz A, 2008, BIOMATERIALS, V29, P4766, DOI 10.1016/j.biomaterials.2008.08.017
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Sutor B, 2005, BBA-BIOMEMBRANES, V1719, P59, DOI 10.1016/j.bbamem.2005.09.005
   Szymczak P, 2010, ACTA NEUROBIOL EXP, V70, P325
   Taverna E, 2012, NAT NEUROSCI, V15, P329, DOI 10.1038/nn.3008
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   Wang G, 2010, ACTA BIOMATER, V6, P3630, DOI 10.1016/j.actbio.2010.03.039
   YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540
   Zychowicz M, 2011, ACTA NEUROBIOL EXP, V71, P12
NR 41
TC 10
Z9 10
U1 0
U2 4
PU NENCKI INST EXPERIMENTAL BIOLOGY
PI WARSAW
PA UL PASTEURA 3, 02-093 WARSAW, POLAND
SN 0065-1400
J9 ACTA NEUROBIOL EXP
JI Acta Neurobiol. Exp.
PY 2012
VL 72
IS 4
BP 325
EP 336
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 087CI
UT WOS:000314738500002
PM 23377264
DA 2018-10-19
ER

PT S
AU Nguyen, TY
   Garcia, S
   Liew, CG
   Liu, HN
AF Thanh Yen Nguyen
   Garcia, Salvador
   Liew, Chee Gee
   Liu, Huinan
GP IEEE
TI Effects of magnesium on growth and proliferation of human embryonic stem
   cells
SO 2012 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 34th Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBS)
CY AUG 28-SEP 01, 2012
CL San Diego, CA
SP IEEE, Engn Med & Biol Soc (EMBS), CAS, SMC, PubMed, MEDLINE
AB The effects of magnesium on the growth and proliferation of human embryonic stem cells (hESCs) was explored to advance magnesium as an implant biomaterial. When magnesium ions from magnesium salt were added to the culture media at 10, 100, 250, 500, 750, and 1000 ppm (0.4, 4, 10, 20, 30, 40 mM) the rate of increase in viable cell coverage over time was higher for the larger doses of magnesium salt. Thus, the addition of magnesium ions exerted a positive effect on viable cell coverage. When hESCs were cultured with pure magnesium metal strips through transwell inserts, the cells underwent an initial increase in viable cell coverage, followed by rapid cell death within the first 24 hours. This initial increase in viable cell coverage corresponded to the colonies dispersing and losing their tightly packed morphologies. The cell death may be attributed to an increased alkalinity in the culture media incubated with the magnesium metal strips. In conclusion, since the degradation of magnesium results in both magnesium ions and OH- ions (an increase of pH), controlling the degradation of magnesium to obtain the perfect balance of ions is critical for advancing magnesium as an implant biomaterial.
C1 [Liew, Chee Gee; Liu, Huinan] Univ Calif Riverside, Riverside, CA 92521 USA.
   [Garcia, Salvador] Calif State Univ San Bernardino, San Bernardino, CA 92407 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
OI Liu, Huinan/0000-0001-9366-6204
FU NSF [CBET 1125801]; University of California
FX The authors would like to thank the NSF BRIGE award ( CBET 1125801) and
   the University of California for financial support. We would also like
   to thank the Central Facility for Advanced Microscopy and Microanalysis
   as well as the Stem Cell Core Facility at the University of California,
   Riverside for the use of SEM FEI XL30 and Nikon Biostation CT.
CR Chatterjee P, 2011, JOVE-J VIS EXP, DOI 10.3791/3110
   Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290
   Kehoe S., INJURY UNPUB
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Shi G., 2010, STEM CELL RES THER, V1
   Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543
NR 6
TC 7
Z9 7
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-1787-1
J9 IEEE ENG MED BIO
PY 2012
BP 723
EP 726
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BDH78
UT WOS:000313296500176
PM 23365994
DA 2018-10-19
ER

PT S
AU Li, CY
   Wu, ZZ
   Hartings, JA
   Rajan, N
   Chahine, N
   Cheyuo, C
   Wang, P
   Wu, PM
   Golanov, EV
   Ahn, CH
   Narayan, RK
AF Li, Chunyan
   Wu, Zhizhen
   Hartings, Jed A.
   Rajan, Neena
   Chahine, Nadeen
   Cheyuo, Cletus
   Wang, Ping
   Wu, Pei-Ming
   Golanov, Eugene V.
   Ahn, Chong H.
   Narayan, Raj K.
GP IEEE
TI Brain-Friendly Amperometric Enzyme Biosensor Based on Encapsulated
   Oxygen Generating Biomaterial
SO 2012 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 34th Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBS)
CY AUG 28-SEP 01, 2012
CL San Diego, CA
SP IEEE, Engn Med & Biol Soc (EMBS), CAS, SMC, PubMed, MEDLINE
ID INJURY; PATHOPHYSIOLOGY
AB A novel first-generation Clark-type biosensor platform that can eliminate the oxygen dependence has been presented. Sufficient oxygen to drive the enzymatic reaction under hypoxic conditions was produced by encapsulated oxygen generating biomaterial, calcium peroxide. The catalase immobilized in chitosan matrix was coated on top of the groove to decompose residual hydrogen peroxide to oxygen. A glucose biosensor was developed on the proposed platform as proof of concept. Under hypoxic conditions, developed glucose biosensors maintained their sensitivity response around 84% of their response at oxygen tension of 151mmHg. The sensitivity deviation was less than 5.3% with the oxygen tension traversed from 0 to 57 mmHg. Under oxygen tension of 8.3mmHg, the sensitivity of 37.130nA/mM and the linear coefficient of R-2=0.9968 were obtained with the glucose concentration varying from 0.05 to 10mM. This new platform is particularly attractive for injured brain monitoring.
C1 [Li, Chunyan; Wu, Pei-Ming; Golanov, Eugene V.; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoroing Lab, Manhasset, NY 11030 USA.
RP Li, CY (reprint author), Feinstein Inst Med Res, Cushing Neuromonitoroing Lab, Manhasset, NY 11030 USA.
EM cli11@nshs.edu
RI Chahine, Nadeen/O-5496-2015
OI Golanov, Eugene/0000-0003-0220-822X; Hartings, Jed/0000-0001-8583-3471;
   Chahine, Nadeen/0000-0002-0478-6042
CR Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733
   Chaudhary A, 2010, ANALYST, V135, P2620, DOI 10.1039/c0an00109k
   Frey O, 2010, BIOSENS BIOELECTRON, V26, P477, DOI 10.1016/j.bios.2010.07.073
   Karathanou A, 2011, J NEUROSURG SCI, V55, P173
   Li CY, 2009, BIOSENS BIOELECTRON, V25, P173, DOI 10.1016/j.bios.2009.06.032
   Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f
   Northup A, 2008, J HAZARD MATER, V152, P1164, DOI 10.1016/j.jhazmat.2007.07.096
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Praveen S Solomon, 2003, Diabetes Technol Ther, V5, P393, DOI 10.1089/152091503765691893
   Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x
   Tipnis Ritesh, 2007, J Diabetes Sci Technol, V1, P193
   Yang HS, 2004, LAB CHIP, V4, P42, DOI 10.1039/b309899k
   Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005
NR 13
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-1787-1
J9 IEEE ENG MED BIO
PY 2012
BP 6003
EP 6006
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BDH78
UT WOS:000313296506051
PM 23367297
DA 2018-10-19
ER

PT S
AU Kurtulus, O
   Seker, E
AF Kurtulus, Ozge
   Seker, Erkin
GP IEEE
TI Nanotopography Effects on Astrocyte Attachment to Nanoporous Gold
   Surfaces
SO 2012 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 34th Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBS)
CY AUG 28-SEP 01, 2012
CL San Diego, CA
SP IEEE, Engn Med & Biol Soc (EMBS), CAS, SMC, PubMed, MEDLINE
ID MECHANICAL-PROPERTIES; TOPOGRAPHY; INTERFACES; DELIVERY
AB Nanoporous gold, synthesized by a self-assembly process, is a new biomaterial with desirable attributes, including tunable nanotopography, drug delivery potential, electrical conductivity, and compatibility with conventional microfabrication techniques. This study reports on the effect of nanotopography in guiding cellular attachment on nanoporous gold surfaces. While the changes in topography do not affect adherent cell density, average cell area displays a non-monotonic dependence on nanotopography.
C1 [Kurtulus, Ozge] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
RP Kurtulus, O (reprint author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
EM okurtulus@ucdavis.edu; eseker@ucdavis.edu
OI Seker, Erkin/0000-0003-2401-3562
CR Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Dias Velasco F. R, 1980, IEEE T SYST MAN CYB, V10, P771, DOI DOI 10.1109/TSMC.1980.4308400
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   Fine D, 2010, LAB CHIP, V10, P3074, DOI [10.1039/c0lc00013b, 10.1039/c01c00013b]
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Gultepe E, 2010, ADV DRUG DELIVER REV, V62, P305, DOI 10.1016/j.addr.2009.11.003
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   INGBER DE, 1993, J CELL SCI, V104, P613
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Liu Z, 2006, J PHYS CHEM B, V110, P4318, DOI 10.1021/jp056940t
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Roco MC, 2003, CURR OPIN BIOTECH, V14, P337, DOI 10.1016/S0958-1669(03)00068-5
   Seker E, 2007, ACTA MATER, V55, P4593, DOI 10.1016/j.actamat.2007.03.018
   Seker E, 2012, ADV HEALTHC MATER, V1, P172, DOI 10.1002/adhm.201200002
   Seker E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125504
   Shulga OV, 2007, CHEM MATER, V19, P3902, DOI 10.1021/cm070238n
   Snyder J, 2010, NAT MATER, V9, P904, DOI [10.1038/nmat2878, 10.1038/NMAT2878]
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Weissmuller J, 2009, MRS BULL, V34, P577, DOI 10.1557/mrs2009.157
   Wong IY, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70105-X
NR 24
TC 3
Z9 3
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4577-1787-1
J9 IEEE ENG MED BIO
PY 2012
BP 6568
EP 6571
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BDH78
UT WOS:000313296506186
PM 23367434
DA 2018-10-19
ER

PT S
AU Edwards, JV
   French, AD
   Jacks, T
   Rajasekaran, K
AF Edwards, J. Vincent
   French, Alfred D.
   Jacks, Thomas
   Rajasekaran, K.
BE Rajasekaran, K
   Cary, JW
   Jaynes, JM
   Montesinos, E
TI pH-Directed Self-Assembling Helical Peptide Conformation
SO SMALL WONDERS: PEPTIDES FOR DISEASE CONTROL
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT Symposium on Small Wonders: Peptides for Disease Control Held at the
   240th National Meeting of the American-Chemical-Society
CY AUG 22-26, 2010
CL Boston, MA
SP Amer Chem Soc, Div Agr Food Chem (ACS-AGFD), AgroMed LLC, Amer Chem Soc (ACS)
ID EFFICIENT GENE-TRANSFER; INFLUENZA HEMAGGLUTININ; MEMBRANE-FUSION;
   MAMMALIAN-CELLS; DNA COMPLEXES; IN-VITRO; IDENTIFICATION; DELIVERY;
   AGONIST; ANALOGS
AB The beta-sheet and alpha-helix peptide conformation are two of the most fundamentally ordered secondary structures found in proteins and peptides. They also give rise to self-assembling motifs that form macromolecular channels and nanostructures. Through design these conformations can yield enhanced membrane activity. The self-assembling properties of the beta-sheet and helical peptide motifs have found many applications as antimicrobials and in biomaterials with potential in regenerative medicine. In a delivery or biomaterial system these two conformational motifs can confer nano-strucutral properties that are useful in implantable biomaterials, and non-viral gene formulations. Influenza hemagglutinin (HA) fusion peptides, which were first reported by Wiley et al., possess lytic properties of HA that allow it to gain endosome entry through conformational transition, and is required for membrane fusion activity. The helical peptide's active conformation is formed by way of a pH-triggered change in conformation that is endosomolytic as originally found in HA mutants. Here we discuss helix design properties of some pH-triggered lytic peptides while maintaining a conformation with minimum amino acid chain length requirements.
C1 [Edwards, J. Vincent; French, Alfred D.; Jacks, Thomas; Rajasekaran, K.] ARS USDA, So Reg Res Ctr, New Orleans, LA 70124 USA.
RP Edwards, JV (reprint author), ARS USDA, So Reg Res Ctr, 1100 Robert E Lee Blvd, New Orleans, LA 70124 USA.
EM vince.edwards@ars.usda.gov
CR Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9
   Branski LK, 2007, GENE THER, V14, P1, DOI 10.1038/sj.gt.3302837
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   EDWARDS JV, 1994, INT J PEPT PROT RES, V43, P374
   Edwards JV, 1999, J PEPT RES, V54, P536, DOI 10.1034/j.1399-3011.1999.00134.x
   EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504
   Gelain F, 2008, INT J NANOMED, V3, P415
   Gottschalk S, 1996, GENE THER, V3, P448
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0
   Jenssen H, 2011, EXPERT OPIN DRUG DIS, V6, P171, DOI 10.1517/17460441.2011.545817
   Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X
   LEGENDRE JY, 1993, P NATL ACAD SCI USA, V90, P893, DOI 10.1073/pnas.90.3.893
   Lehto T, 2011, MOL THER, V19, P1457, DOI 10.1038/mt.2011.10
   Ma X. P., 2008, ADV DRUG DEL REV, V60, P184
   MADDRELL SHP, 1989, J CELL SCI, V94, P601
   MALIKAYIL JA, 1992, BIOCHEMISTRY-US, V31, P7043, DOI 10.1021/bi00146a004
   McLean L. R., 1999, U.S. Patent, Patent No. [5,861,481, 5861481]
   MCLEAN LR, 1991, BIOCHEMISTRY-US, V30, P31, DOI 10.1021/bi00215a005
   Mertz Patricia M., 1996, Journal of Burn Care and Rehabilitation, V17, P199, DOI 10.1097/00004630-199605000-00004
   PLANK C, 1994, J BIOL CHEM, V269, P12918
   Rajasekaran K, 2001, J AGR FOOD CHEM, V49, P2799, DOI 10.1021/jf010154d
   Rogues B. P., 2001, J PEPT SCI, V7, P63
   Sakai N, CHEM COMMUN, P2514
   SCHILLER PW, 1982, NATURE, V297, P74, DOI 10.1038/297074a0
   Skehel JJ, 1995, COLD SPRING HARB SYM, V60, P573, DOI 10.1101/SQB.1995.060.01.061
   Smith LC, 1998, ADV DRUG DELIVER REV, V30, P115, DOI 10.1016/S0169-409X(97)00111-7
   Stahl M, 2006, DRUG DISCOV TODAY, V11, P326, DOI 10.1016/j.drudis.2006.02.008
   Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873
   TAYLOR JW, 1986, PHARMACOL REV, V38, P291
   WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0
   Wilke M, 1996, GENE THER, V3, P1133
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   Woody R. W., 1985, CONFORMATION BIOL DR, P16
NR 36
TC 2
Z9 2
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2748-4
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2012
VL 1095
BP 203
EP 213
PG 11
WC Agricultural Engineering; Food Science & Technology
SC Agriculture; Food Science & Technology
GA BDE91
UT WOS:000312971600010
DA 2018-10-19
ER

PT J
AU Umashankara, M
   Nanda, M
   Sonar, M
   Ganesh, KN
AF Umashankara, M.
   Nanda, Manaswini
   Sonar, Mahesh
   Ganesh, Krishna N.
TI 4(R/S)-Amino/Guanidino-substituted Proline Peptides: Design, Synthesis
   and DNA Transfection Properties
SO CHIMIA
LA English
DT Article
DE 4-Aminoproline peptides; Cationic collagen mimetics; Cell penetrating
   peptides; 4-Guanidino proline peptides
ID COLLAGEN TRIPLE-HELIX; CONFORMATIONAL STABILITY; MOLECULAR-STRUCTURE;
   ANALOGS
AB Collagen is a major structural protein found in the connective tissues of higher organisms and mammals and its biomechanical properties are related to the high thermal stability of its triple helical structure. The primary structure of collagen is composed of the repeating tripeptide motif of Pro-Hyp-Gly, where Hyp is 4R-hydroxy proline. Cationic collagen mimetics consisting of [Pro(X)-Pro(Y)-Gly](6) where Pro(X) and Pro(Y) are 4(R/S)-amino/guanidine proline have been synthesized and shown to form triplexes more stable than the unmodified collagen peptide [Pro-Hyp-Gly](6). The origin of hyperstability is due to conformational pre-organization of proline pucker arising from the electronegativity of the cationic group. These cationic collagen peptides are shown to be effective cell penetrating and plasmid DNA transfecting agents. The results have potential for design of new collagen mimetics for biomaterial applications and efficient cell penetrating agents for drug delivery applications.
C1 [Ganesh, Krishna N.] Indian Inst Sci Educ & Res, Pune 411008, Maharashtra, India.
   [Umashankara, M.; Nanda, Manaswini; Sonar, Mahesh; Ganesh, Krishna N.] Natl Chem Lab, Div Organ Chem, Pune 411008, Maharashtra, India.
RP Ganesh, KN (reprint author), Indian Inst Sci Educ & Res, Pune 411008, Maharashtra, India.
EM kn.ganesh@iiserpune.ac.in
CR [Anonymous], 2002, EFF TRANSF REAG HDB
   Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BROWN FR, 1972, J MOL BIOL, V63, P85, DOI 10.1016/0022-2836(72)90523-2
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Erdmann RS, 2011, ANGEW CHEM INT EDIT, V50, P6835, DOI 10.1002/anie.201008118
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W
   Fuchs SM, 2006, CELL MOL LIFE SCI, V63, P1819, DOI 10.1007/s00018-006-6170
   Geisler I. M., 2011, J PHARM RES, V28, P2797
   Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   HAASNOOT CAG, 1981, BIOPOLYMERS, V20, P1211, DOI 10.1002/bip.1981.360200610
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   INOUYE K, 1982, ARCH BIOCHEM BIOPHYS, V219, P198, DOI 10.1016/0003-9861(82)90149-7
   Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189
   Kersteen EA, 2001, BIOPOLYMERS, V59, P24, DOI 10.1002/1097-0282(200107)59:1<24::AID-BIP1002>3.0.CO;2-N
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729
   Masotti A, 2009, COLLOID SURFACE B, V68, P136, DOI 10.1016/j.colsurfb.2008.09.017
   Mitra R, 2012, J ORG CHEM, V77, P5696, DOI 10.1021/jo300860f
   Mitra R, 2011, CHEM COMMUN, V47, P1198, DOI 10.1039/c0cc03988h
   Mooney SD, 2002, BIOPOLYMERS, V64, P63, DOI 10.1002/bip.10123
   NAGARAJAN V, 1999, BIOCHEM, V125, P310
   Nanda M, 2012, J ORG CHEM, V77, P4131, DOI 10.1021/jo300070p
   Nimni M. E., 2004, J BIOMED MATER RES, V21, P741
   Olsen CA, 2007, ORG LETT, V9, P1549, DOI 10.1021/ol070316c
   Pozo-Rodriguez A., 2009, J CONTROL RELEASE, V133, P52, DOI DOI 10.1016/J.JCONREL.2008.09.004
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012
   Quan JM, 2004, J THEOR COMPUT CHEM, V3, P225, DOI 10.1142/S0219633604001008
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046
   Sonar MV, 2010, ORG LETT, V12, P5390, DOI 10.1021/ol1021993
   Umashankara M, 2003, CHEM COMMUN, P2606, DOI 10.1039/b308581c
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   Werkmeister J. A., 1992, COLLAGEN BIOMATERIAL
NR 39
TC 3
Z9 3
U1 0
U2 11
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2012
VL 66
IS 12
BP 936
EP 940
DI 10.2533/chimia.2012.936
PN 1
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 066QM
UT WOS:000313235300008
PM 23394278
DA 2018-10-19
ER

PT J
AU Schmahl, WW
   Griesshaber, E
   Kelm, K
   Goetz, A
   Jordan, G
   Ball, A
   Xu, DY
   Merkel, C
   Brand, U
AF Schmahl, Wolfgang W.
   Griesshaber, Erika
   Kelm, Klemens
   Goetz, Andreas
   Jordan, Guntram
   Ball, Alex
   Xu, Dayin
   Merkel, Casjen
   Brand, Uwe
TI Hierarchical structure of marine shell biomaterials: biomechanical
   functionalization of calcite by brachiopods
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE-CRYSTALLINE MATERIALS
LA English
DT Article
DE Biomineralization; Calcite; Texture; Raman spectroscopy; Hierarchical
   composite; Vital effect
ID FRACTURE-MECHANICS; OCEAN CHEMISTRY; HARD TISSUES; CARBONATE;
   ARCHITECTURE; DESIGN; NACRE; BONE; BIOMINERALIZATION; MICROSTRUCTURE
AB Biologic structural materials for skeletons or teeth show a hierarchical architecture, where organic macromolecules and mineral substance form a hybrid composite material with its components inter-weaved on many length scales. On the nanostructure level brachiopods form hybrid composite mesocrystals of calcite with occluded organic molecules. On the microstructure level several types of materials are produced, on which the electron back-scatter diffraction (EBSD) technique gives insight in texture and architecture. We describe the calcite single-crystal fiber composite architecture of the secondary layer involving organic matrix membranes, the competitive-growth texture of the columnar layer and the nanostructuring of the primary layer. In the overall skeleton the organic biopolymers provide flexibility and tensile strength while the mineral provides a high elastic modulus, compressive strength, hardness and resistance to abrasion. The hierarchical composite architecture, from the nanostructure to the macroscopic level provides fracture toughness. The morphogenesis of the biomaterial as a whole and of the mineral crystals is guided by the organic matrix and most probably involves amorphous calcium carbonate (ACC) precursors. In this paper we review the hierarchical architecture of rhynchonelliform brachiopod shells, which is very distinct from mollusk nacre.
C1 [Schmahl, Wolfgang W.; Griesshaber, Erika; Goetz, Andreas; Jordan, Guntram; Xu, Dayin; Merkel, Casjen] Ludwig Maximilians Univ Munchen, GeoBioCenterLMU, Munich, Germany.
   [Schmahl, Wolfgang W.; Griesshaber, Erika; Goetz, Andreas; Jordan, Guntram; Xu, Dayin; Merkel, Casjen] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Munich, Germany.
   [Kelm, Klemens] DLR Inst Werkstoff Forsch, Cologne, Germany.
   [Ball, Alex] Nat Hist Museum, London SW7 5BD, England.
   [Brand, Uwe] Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada.
RP Schmahl, WW (reprint author), Ludwig Maximilians Univ Munchen, GeoBioCenterLMU, Munich, Germany.
EM wolfgang.schmahl@lrz.uni-muenchen.de
FU German Research Council (DFG)
FX We are grateful to E. Kessler, T. Westphal, D. Dettmer and R. Enders for
   the skilful preparation of samples. We would like to thank A. Bitner,
   Warszawa, Poland, C. Luter, Berlin, Germany, and N. Hiller,
   Christchurch, New Zealand, for brachiopod samples, and A. Ziegler, Ulm,
   for continuous advice. Financial support by the German Research Council
   (DFG) is gratefully acknowledged.
CR Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381
   Al-Sawalmih A, 2008, ADV FUNCT MATER, V18, P3307, DOI 10.1002/adfm.200800520
   Alberts B, 2008, MOL BIOL CELL
   Auclair AC, 2003, CHEM GEOL, V202, P59, DOI 10.1016/S0009-2541(03)00233-X
   Barthelat F, 2007, EXP MECH, V47, P311, DOI 10.1007/s11340-007-9040-1
   Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9
   Buening Nancy, 2001, Paleontological Society Papers, V7, P117
   CARPENTER SJ, 1995, GEOCHIM COSMOCHIM AC, V59, P3749, DOI 10.1016/0016-7037(95)00291-7
   CARPENTER SJ, 1992, GEOCHIM COSMOCHIM AC, V56, P1837, DOI 10.1016/0016-7037(92)90314-9
   Chuang SH, 1996, J ROY SOC NEW ZEAL, V26, P119, DOI 10.1080/03014223.1996.9517507
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   CURREY JD, 1974, J ZOOL, V173, P395
   Currey JD, 1999, J EXP BIOL, V202, P3285
   Currey JD, 2006, BONES STRUCTURE MECH
   Cusack M, 2008, J STRUCT BIOL, V164, P96, DOI 10.1016/j.jsb.2008.06.010
   CUSACK M, 2000, TREND COMPAR BIOCHEM, V6, P47
   Dalbeck P, 2006, CRYST GROWTH DES, V6, P2558, DOI 10.1021/cg068008t
   Fabritius H, 2005, J STRUCT BIOL, V150, P190, DOI 10.1016/j.jsb.2005.01.004
   Fabritius H., 2003, J STRUCT BIOL, P281
   Fabritius HO, 2009, ADV MATER, V21, P391, DOI 10.1002/adma.200801219
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Gaspard D, 2008, EARTH ENV SCI T R SO, V98, P415, DOI 10.1017/S1755691007078401
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   Goetz AJ, 2011, ACTA BIOMATER, V7, P2237, DOI 10.1016/j.actbio.2011.01.035
   Goetz AJ, 2009, EUR J MINERAL, V21, P303, DOI 10.1127/0935-1221/2009/0021-1922
   Griesshaber E, 2012, BIOINSPIR BIOMIM NAN, V1, P133, DOI 10.1680/bbn.11.00018
   Griesshaber E, 2010, SEMIN SOC ESP MINERA, V7, P20
   Griesshaber E, 2007, AM MINERAL, V92, P722, DOI 10.2138/am.2007.2220
   Griesshaber E, 2009, EUR J MINERAL, V21, P715, DOI 10.1127/0935-1221/2009/0021-1950
   HILLER N, 1988, LETHAIA, V21, P177, DOI 10.1111/j.1502-3931.1988.tb00809.x
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kamat S, 2000, NATURE, V405, P1036
   Katti K, 2005, J MATER SCI, V40, P1749, DOI 10.1007/s10853-005-0678-8
   LOWENSTAM HA, 1961, J GEOL, V69, P241, DOI 10.1086/626740
   Luter C, 2008, FOSS STRATA, P311
   Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856
   Merkel C, 2009, J STRUCT BIOL, V168, P396, DOI 10.1016/j.jsb.2009.08.014
   MUCCI A, 1983, GEOCHIM COSMOCHIM AC, V47, P217, DOI 10.1016/0016-7037(83)90135-7
   Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150
   Parkinson D, 2005, CHEM GEOL, V219, P193, DOI 10.1016/j.chemgeo.2005.02.002
   Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008
   Rodriguez-Navarro A, 2000, EUR J MINERAL, V12, P609
   Rudwick M. J. S., 1959, Geological Magazine, V96, P1
   Rudwick M. J. S., 1970, LIVING FOSSIL BRACHI
   Sarikaya M., 1995, BIOMIMETICS DESIGN P
   Schmahl WW, 2008, MINERAL MAG, V72, P541, DOI 10.1180/minmag.2008.072.2.541
   Schmahl W. W., 2010, SEMIN SOC ESP MINERA, V7, P5
   Schmahl WW, 2012, Z KRIST-CRYST MATER, V227, P604, DOI 10.1524/zkri.2012.1479
   Schmahl WW, 2004, EUR J MINERAL, V16, P693, DOI 10.1127/0935-1221/2004/0016-0693
   Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9
   von Allmen K, 2010, CHEM GEOL, V269, P210, DOI 10.1016/j.chemgeo.2009.09.019
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803
   Williams A., 1968, Special Papers in Palaeontology, VNo. 2, P1
   Williams A., 2000, BRACHIOPODA REVISED
   Xu AW, 2008, ADV MATER, V20, P1333, DOI 10.1002/adma.200701723
   Xu AW, 2007, J MATER CHEM, V17, P415, DOI 10.1039/b611918m
   Ziegler A, 2005, MICRON, V36, P137, DOI 10.1016/j.micron.2004.09.006
NR 59
TC 23
Z9 23
U1 2
U2 55
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2194-4946
EI 2196-7105
J9 Z KRIST-CRYST MATER
JI Z. Krist.-Cryst. Mater.
PY 2012
VL 227
IS 11
BP 793
EP 804
DI 10.1524/zkri.2012.1542
PG 12
WC Crystallography
SC Crystallography
GA 069WV
UT WOS:000313468700010
OA Bronze
DA 2018-10-19
ER

PT S
AU Takahashi, M
   Heo, YJ
   Shibata, H
   Satou, H
   Kawanishi, T
   Okitsu, T
   Takeuchi, S
AF Takahashi, M.
   Heo, Y. J.
   Shibata, H.
   Satou, H.
   Kawanishi, T.
   Okitsu, T.
   Takeuchi, S.
GP IEEE
TI NANO-PATTERNED HYDROGEL REDUCED INFLAMMATORY EFFECTS IN SUBCUTANEOUS
   TISSUE
SO 2012 IEEE 25TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL
   SYSTEMS (MEMS)
SE Proceedings IEEE Micro Electro Mechanical Systems
LA English
DT Proceedings Paper
CT 25th IEEE International Conference on Micro Electro Mechanical Systems
   (MEMS)
CY JAN 29-FEB 02, 2012
CL Paris, FRANCE
SP IEEE, Robot & Automat Soc (RA), Reg Nord-Pas Calais
ID BIOCOMPATIBILITY; BIOMATERIALS; ADHESION
AB We present a nano-patterned poly-acrylamide (PAAm) hydrogel that can reduce inflammatory effects after subcutaneous implantation. Although hydrogel is considered as an excellent biomaterial for implants due to its biocompatibility, hydrogel still induces inflammation after implantation. To enhance biocompatibility for subcutaneous implantable sensors, we modified hydrogel surface with nano-patterns using simple molding process. To test the anti-inflammatory effect, we implanted the samples to rat's back. Since macrophages play an important role in the immune response and development of encapsulation after inflammation reaction, we counted macrophages neighboring the implanted nano-patterned hydrogels after 3 and 7 days and measured thickness of encapsulation after 21 days from implantation. We found that the sample with the line-and-space pattern of 600 nm in space successfully suppressed the inflammation reaction. Therefore, nano-patterned hydrogel is promising for long-term subcutaneous implantable sensors.
C1 [Takahashi, M.; Heo, Y. J.; Kawanishi, T.; Okitsu, T.; Takeuchi, S.] Life Beans Ctr, Beans Project, Tokyo, Japan.
   [Heo, Y. J.; Okitsu, T.; Takeuchi, S.] Univ Tokyo, Tokyo 1138654, Japan.
   [Takahashi, M.; Shibata, H.; Satou, H.; Kawanishi, T.] TERUMO Co R & D Headquarters, Tokyo, Japan.
RP Takahashi, M (reprint author), Life Beans Ctr, Beans Project, Tokyo, Japan.
EM mtakahas@iis.u-tokyo.ac.jp
FU new energy and industrial technology development organization (NEDO)
FX We thank Ms. Mayumi Ishizaka for her support to implant samples to rat's
   back. This work was supported by the new energy and industrial
   technology development organization (NEDO). The nanomolds were made
   using the University of Tokyo VLSI design and education center (VDEC)'s
   8 inch EB writer F5112 + VD01 donated by advantest cooperation.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   COURTNEY JM, 1995, ARTIF ORGANS, V19, P852, DOI 10.1111/j.1525-1594.1995.tb02440.x
   Heo Y. J., 2011, PNAS, V108
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Mercanzini A, 2010, J CONTROL RELEASE, V145, P196, DOI 10.1016/j.jconrel.2010.04.025
NR 8
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1084-6999
BN 978-1-4673-0325-5
J9 PROC IEEE MICR ELECT
PY 2012
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BDE04
UT WOS:000312912800245
DA 2018-10-19
ER

PT S
AU Liu, H
   Zhu, MY
   Cheng, WJ
AF Liu, Hua
   Zhu, MinYing
   Cheng, WenJun
BE Zhang, H
   Jin, D
TI Fast Setting Calcium Phosphate-chitosan Composites for Bone Substitute
   Materials
SO ADVANCED RESEARCH ON MATERIAL ENGINEERING, CHEMISTRY, BIOINFORMATICS II
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Material Engineering, Chemistry,
   Bioinformatics (MECB 2012)
CY JUL 14-15, 2012
CL Xian, PEOPLES R CHINA
SP Int Sci & Educ Res Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE Calcium phosphate; Chitosan; Bone substitute material; Osteoinductivity
ID SCAFFOLD
AB We developed a calcium phosphate cement that could be molded into any desired shape due to its chewing-gum-like consistency after mixing. The powder component of the cement consists of tricalcium phosphate (TCP). The liquid component consists of chitosan, citric acid and glucose solution. In this study, we used four groups of cement to investigate the mechanical properties and biocompatibility of the new biomaterial in vivo. The setting times of the cements were 5-30 min. X-ray diffraction analysis showed that the products were hydroxyapatite (HA) and dicalcium phosphate anhydrous. When the concentration of citric acid was increased, the compressive strength of specimen increased. The animal experiments showed that the material was nontoxic and osteoinductivity.
C1 [Liu, Hua] Guangdong Pharmaceut Univ, Coll Med Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhu, MinYing] Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Peoples R China.
   [Cheng, WenJun] South Hosp, Dept Orthoped & Traumatol, Guangzhou 510515, Peoples R China.
RP Liu, H (reprint author), Guangdong Pharmaceut Univ, Coll Med Informat Engn, Guangzhou 510006, Guangdong, Peoples R China.
EM liuhuajnu@yahoo.com.cn; mshongli@126.com; csylzh96@163.com
FU Natural Science Foundation of Guangdong Province [10451022401005182];
   Science and Technology Plan of Guangdong Province [2009B010900034];
   National Science Foundation for Post-doctoral Scientists of China
   [20100470914]
FX This study was supported by the Natural Science Foundation of Guangdong
   Province (Grant No. 10451022401005182), the Science and Technology Plan
   of Guangdong Province (Grant No. 2009B010900034) and the National
   Science Foundation for Post-doctoral Scientists of China (Grant No.
   20100470914).
CR Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Chow L. C., 1991, J CERAM SOC JPN, V99, P954
   CHOW LC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P127
   Liu H, 2006, ACTA BIOMATER, V2, P557, DOI 10.1016/j.actbio.2006.03.007
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   MONMA H, 1997, J JPN SOC BIOMATER, V15, P24
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
NR 10
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-434-1
J9 ADV MATER RES-SWITZ
PY 2012
VL 531
BP 88
EP +
DI 10.4028/www.scientific.net/AMR.531.88
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BDA23
UT WOS:000312276800021
DA 2018-10-19
ER

PT S
AU Deng, C
   Wang, B
   Zhang, CD
   Zhi, W
   Weng, J
AF Deng, Chi
   Wang, Bao
   Zhang, Chengdong
   Zhi, Wei
   Weng, Jie
BE Zhang, H
   Jin, D
TI Study of in vitro reaction between bone cell and Poly (vinyl
   alcohol)-Matrix composite biomaterials
SO ADVANCED RESEARCH ON MATERIAL ENGINEERING, CHEMISTRY, BIOINFORMATICS II
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Material Engineering, Chemistry,
   Bioinformatics (MECB 2012)
CY JUL 14-15, 2012
CL Xian, PEOPLES R CHINA
SP Int Sci & Educ Res Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE In vitro reaction; bone cell; composite; biomaterial
ID SURFACE MODIFICATION
AB Aim of the study is to investigate the in vitro reaction between rat bone cell and poly (vinyl alcohol) (PVA)-matrix composites. Sample of Hydroxyapatite (HA) /PVA gel composites were prepared by the in situ growth method and Experiments of Alamar Blue Activity and Alkaline Phosphatase Assay were carefully made in our lab. SEM results displays that PVA-matrix composites containing HA fillers and pure PVA as a control group have an excellent biocompatible bone reaction in vitro with rat bone cells and HA filler particles in composites promote reaction between bone cell and composites. In vitro biology experiment resulted proves that adhesion, growth and differentiation of bone cells on all PVA-matrix composites are promoted by HA filler particles.
C1 [Deng, Chi] Leshan Normal Univ, Inst Silicon Mat, Leshan 614000, Sichuan, Peoples R China.
   [Deng, Chi; Wang, Bao; Zhang, Chengdong; Zhi, Wei; Weng, Jie] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key lab Adv Technol Mat, Chengdu 610031, Sichuan, Peoples R China.
RP Deng, C (reprint author), Leshan Normal Univ, Inst Silicon Mat, Leshan 614000, Sichuan, Peoples R China.
EM dc003cn@163.com
FU National Natural Science Foundation of China [30870630]; National Basic
   Research Program of China [2012CB933 602]; Science and Technology Pillar
   Project of Sichuan [2008JY0062]; Young Teacher Start-up Foundation
   Project of Leshan Normal University
FX This work was supported by National Natural Science Foundation of China
   (30870630), National Basic Research Program of China (973 Program,
   2012CB933 602) and Science and Technology Pillar Project of Sichuan
   (2008JY0062) and Young Teacher Start-up Foundation Project of Leshan
   Normal University.
CR Deng C, 2011, INT J POLYM MATER, V60, P969, DOI 10.1080/00914037.2011.553847
   Deng C, 2010, J MATER SCI-MATER M, V21, P3059, DOI 10.1007/s10856-010-4158-6
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Liu Y.R., 2006, J ETHNO, V111, P573
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Silvio L.D., 1998, J MATER SCI-MATER M, V9, P845
NR 6
TC 0
Z9 0
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-434-1
J9 ADV MATER RES-SWITZ
PY 2012
VL 531
BP 296
EP +
DI 10.4028/www.scientific.net/AMR.531.296
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BDA23
UT WOS:000312276800070
DA 2018-10-19
ER

PT S
AU Kasemanankul, P
   Witit-Anun, N
   Chaiyakun, S
   Limsuwan, P
AF Kasemanankul, P.
   Witit-Anun, N.
   Chaiyakun, S.
   Limsuwan, P.
BE Tunkasiri, T
TI Influence of The Substrate Bias Voltage on The Structure of Rutile TiO2
   Films Prepared by Dual Cathode DC Unbalanced Magnetron Sputtering
SO BIOMATERIALS AND APPLICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT Chiang Mai International Conference on Biomaterials & Applications
   (CMICBA 2011)
CY AUG 09-10, 2011
CL Chiang Mai, THAILAND
DE sputtering; rutile; TiO2; substrate bias voltage; thin film
ID CHEMICAL-VAPOR-DEPOSITION; TEMPERATURE; GROWTH
AB Rutile TiO2 films are normally used as biomaterial that synthesized on unheated stainless steel type 316L and glass slide substrates by dual cathode DC unbalanced magnetron sputtering. The influence of the substrate bias voltages (V-sb), from 0 V to -150V, on the structure of the as-deposited films was investigated. The crystal structure was characterized by grazing-incidence X-ray diffraction (GIXRD) technique, the film's thickness and surface morphology was evaluated by atomic force microscopy (AFM) technique, respectively. The results show that the as-deposited films were transparent and have high transmittance in visible regions. The crystal structure of as-deposited films show the XRD patterns of rutile (110) with V-sb, at 0V and shifted to rutile (101) with increasing V-sb. The films roughness (R-rms) and the thickness were 3.0 nm to 5.7 nm and 420 nm to 442 nm, respectively.
C1 [Kasemanankul, P.; Limsuwan, P.] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Phys, Bangkok 10140, Thailand.
   [Witit-Anun, N.; Chaiyakun, S.] Burapha Univ, Dept Phys, Fac Sci, Chon Buri 20131, Thailand.
   [Kasemanankul, P.; Witit-Anun, N.; Chaiyakun, S.; Limsuwan, P.] Thailand Ctr Excellence Phys, Minist Educ, Bangkok 10400, Thailand.
RP Kasemanankul, P (reprint author), King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Phys, Bangkok 10140, Thailand.
EM Kasemanankul.p@gmail.com
CR Amor SB, 2003, MATER CHEM PHYS, V77, P903, DOI 10.1016/S0254-0584(02)00189-X
   Aubry E, 2008, SURF COAT TECH, V202, P4980, DOI 10.1016/j.surfcoat.2008.04.097
   CABALLERO A, 1995, J APPL PHYS, V77, P591, DOI 10.1063/1.359043
   Chaiyakun S, 2009, APPL PHYS A-MATER, V95, P579, DOI 10.1007/s00339-008-4954-8
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Kasemanankul P, 2009, MATER CHEM PHYS, V117, P288, DOI 10.1016/j.matchemphys.2009.06.002
   Kokubo T, 2007, J EUR CERAM SOC, V27, P1553, DOI 10.1016/j.jeurceramsoc.2006.04.015
   Okimura K, 2001, SURF COAT TECH, V135, P286, DOI 10.1016/S0257-8972(00)00999-3
   OKIMURA K, 1995, JPN J APPL PHYS 1, V34, P4950, DOI 10.1143/JJAP.34.4950
   SHIBATA A, 1993, JPN J APPL PHYS 1, V32, P5666, DOI 10.1143/JJAP.32.5666
   Song PK, 2004, JPN J APPL PHYS 2, V43, pL442, DOI 10.1143/JJAP.43.L442
   Sun HF, 2008, J NON-CRYST SOLIDS, V354, P1440, DOI [10.1016/j.jnoncrysol.2007.01.108, 10.1016/j.jnoncrysol.200/.01.108]
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   WINDOW B, 1986, J VAC SCI TECHNOL A, V4, P453, DOI 10.1116/1.573904
   Witit-Anun N, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.051101
   Zhang YY, 2007, J CRYST GROWTH, V300, P551, DOI 10.1016/j.jcrysgro.2007.01.008
NR 16
TC 0
Z9 0
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-406-8
J9 ADV MATER RES-SWITZ
PY 2012
VL 506
BP 82
EP +
DI 10.4028/www.scientific.net/AMR.506.82
PG 2
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BDB42
UT WOS:000312463400020
DA 2018-10-19
ER

PT S
AU Yodkhum, K
   Phaechamud, T
AF Yodkhum, K.
   Phaechamud, T.
BE Tunkasiri, T
TI Thermal Analysis Of Chitosan-Lactate And Chitosan-Aluminum monostearate
   Composite System
SO BIOMATERIALS AND APPLICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT Chiang Mai International Conference on Biomaterials & Applications
   (CMICBA 2011)
CY AUG 09-10, 2011
CL Chiang Mai, THAILAND
DE chitosan; aluminum monostearate; thermal analysis; thermal degradation
ID DEGRADATION; KINETICS
AB Chitosan possess many attractive properties for applying as biomaterials. For some application, biomaterial devices have to be sterilized using high temperature, e.g. stream sterilizing process. However, thermal degradation behavior of chitosan has been reported previously. Many researchers have attempted to improve thermal degradation behavior of chitosan by synthesize chitosan derivatives or blending chitosan with other polymers or additives. However, chitosan derivatives found to be less thermal stability than chitosan itself. On the contrary, adding some lipid additive could improve thermal stability of chitosan. In this study, protecting effect of aluminum monostearate (Alst) on thermal stability of chitosan was investigated employing thermal analysis techniques, e.g. thermogravimetry (TG), differential scanning calorimetry (DSC) and hot-stage microscope. Lactic acid solution (2% w/v) was used as solvent for dissolving chitosan. Chitosan solution, named as chtiosan-lactate (CL) and chitosan solution contained 2.5% w/w Alst (CLAlst) were prepared and fabricated into sponges using freeze drying technique. Degradation temperature of CLAlst system investigated from TO was shifted to the higher temperature comparing that of CL which indicated that Alst could improve thermal stability of chitosan after processed as biomaterial. From DSC result, small endothermic peak was observed around 60-70 degrees C for CLAlst whereas that of CL did not exhibit any peak. Melting behavior of the sponges observed under hot-stage microscope was demonstrated that chitosan was decomposed whereas Alst dispersed in chitosan backbone was gradually melted.
C1 [Yodkhum, K.; Phaechamud, T.] Silpakorn Univ, Dept Pharmaceut Technol, Fac Pharm, Nakhon Pathom 73000, Thailand.
RP Yodkhum, K (reprint author), Silpakorn Univ, Dept Pharmaceut Technol, Fac Pharm, Nakhon Pathom 73000, Thailand.
EM marskotchamon@gmail.com; thawatchaienator@gmail.com
CR ALLAN GG, 1981, J THERM ANAL, V21, P113, DOI 10.1007/BF01913705
   Cardenas G, 2004, J CHIL CHEM SOC, V49, P291, DOI 10.4067/S0717-97072004000400005
   de Britto D, 2007, THERMOCHIM ACTA, V465, P73, DOI 10.1016/j.tca.2007.09.008
   Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032
   Lopez FA, 2008, J THERM ANAL CALORIM, V91, P633, DOI 10.1007/s10973-007-8321-3
   Luan XS, 2006, EUR J PHARM SCI, V27, P143, DOI 10.1016/j.ejps.2005.09.002
   Oungbho K, 1997, INT J PHARM, V156, P229, DOI 10.1016/S0378-5173(97)00201-9
   PENICHECOVAS C, 1993, POLYM DEGRAD STABIL, V39, P21, DOI 10.1016/0141-3910(93)90120-8
   Qu X, 2000, POLYMER, V41, P4841, DOI 10.1016/S0032-3861(99)00704-1
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shen-Kun L, 2004, MACROMOL RES, V12, P466
   Tirkistani FAA, 1998, POLYM DEGRAD STABIL, V61, P161, DOI 10.1016/S0141-3910(97)00145-6
   WANJUN T, 2005, POLYM DEGRAD STABIL, V87, P389, DOI DOI 10.1016/J.P0LYMDEGRADSTAB.2004.08.006
NR 13
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-406-8
J9 ADV MATER RES-SWITZ
PY 2012
VL 506
BP 278
EP 281
DI 10.4028/www.scientific.net/AMR.506.278
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BDB42
UT WOS:000312463400069
DA 2018-10-19
ER

PT S
AU Chen, CJ
   Zhang, M
AF Chen, Changjun
   Zhang, Min
BE Chen, WZ
   Li, Q
   Chen, YL
   Dai, PQ
   Jiang, ZY
TI Fabrication Methods of Porous Tantalum Metal Implants for Use as
   Biomaterials
SO NEW MATERIALS AND PROCESSES, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Manufacturing Science and Engineering
   (ICMSE 2012)
CY MAR 27-29, 2012
CL Xiamen, PEOPLES R CHINA
SP Fujian Univ Technol, Xiamen Univ, Fuzhou Univ, Huaqiao Univ, Univ Wollongong, Fujian Mech Engn Soc, Hong Kong Ind Technol Res Ctr
DE Porous tantalum; biomaterials; bone ingrowth; laser cladding
AB Porous tantalum, a new low modulus metal with a characteristic appearance similar to cancellous/trabecular bone, is currently available for use in several orthopedic applications (hip and knee arthroplasty, spine surgery, and bone graft substitute). The open-cell structure of repeating dodecahedrons is produced via carbon vapor deposition/infiltration of commercially pure tantalum onto a vitreous carbon scaffolding. This transition metal maintains several interesting biomaterial properties, including: a high volumetric porosity (70-80%), low modulus of elasticity (3MPa), and high frictional characteristics. Tantalum has excellent biocompatibility and is safe to use in vivo as evidenced by its historical and current use in pacemaker electrodes, cranioplasty plates and as radiopaque markers. The bioactivity and biocompatibility of porous tantalum stems from its ability to form a self-passivating surface oxide layer. This surface layer leads to the formation of a bone-like apatite coating in vivo and affords excellent bone and fibrous in-growth properties allowing for rapid and substantial bone and soft tissue attachment. Tantalum-chondrocyte composites have yielded successful early results in vitro and may afford an option for joint resurfacing in the future. The development of porous tantalum is in its early stages of evolution and the following represents a review of its biomaterial properties and fabrication methods for applications as implant biomaterials.
C1 [Chen, Changjun; Zhang, Min] Soochow Univ, Sch Mech & Elect Engn, Laser Proc Res Ctr, Suzhou 215021, Peoples R China.
RP Chen, CJ (reprint author), Soochow Univ, Sch Mech & Elect Engn, Laser Proc Res Ctr, Suzhou 215021, Peoples R China.
EM chenchangjun@suda.edu.cn; zhangmin7822@suda.edu.cn
FU National Nature Science Foundation of China [50801050, 51104110]
FX The authors would like to acknowledge the financial support of this
   research by National Nature Science Foundation of China
   (50801050,51104110).
CR Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bobyn JD, 1999, P AAOS AN CA
   FITZPATRICK DA, 1997, P 21 ANN AM SOC BIOM
   KRYGIER JJ, 1999, P SIROT SYDN AUSTR
NR 6
TC 3
Z9 3
U1 1
U2 22
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-371-9
J9 ADV MATER RES-SWITZ
PY 2012
VL 476-478
BP 2063
EP +
DI 10.4028/www.scientific.net/AMR.476-478.2063
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BDA25
UT WOS:000312277301063
DA 2018-10-19
ER

PT S
AU Liu, LL
   Yi, FC
   Cai, W
AF Liu, Li Li
   Yi, Fa Cheng
   Cai, Wei
BE Chen, WZ
   Li, Q
   Chen, YL
   Dai, PQ
   Jiang, ZY
TI Synthesis and Characterization of a Biodegradable Poly
   (glycerol-glycol-sebacate) Terpolymer
SO NEW MATERIALS AND PROCESSES, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Manufacturing Science and Engineering
   (ICMSE 2012)
CY MAR 27-29, 2012
CL Xiamen, PEOPLES R CHINA
SP Fujian Univ Technol, Xiamen Univ, Fuzhou Univ, Huaqiao Univ, Univ Wollongong, Fujian Mech Engn Soc, Hong Kong Ind Technol Res Ctr
DE biodegradable; biomaterial; poly (glycol-glycerol-sebacate)
ID PERIODONTAL-LIGAMENT; ELASTOMER; RESPONSES; INVITRO
AB A biodegradable poly (glycerol-glycol-sebacate) terpolymer (PGGS) with different composition is prepared by a three-step method. The structure and properties of the PGGS terpolymers were characterized by means of attenuated total reflectance-Fourier transform infrared (ATR-FTIR), differential scanning calorimeter (DSC) and X-ray diffraction (XRD) methods. The experiment results indicate that the the composition of terpolymers have an obvious influence on the structure of PGGS terpolymers. The degradation rate increases with the increasing crosslink degree of PGGS.
C1 [Liu, Li Li; Yi, Fa Cheng] SW Univ Sci & Technol, Sch Mat Sci & Engn, 59 Qinglong Rd, Mianyang 621010, Peoples R China.
   [Liu, Li Li; Cai, Wei] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Liu, LL (reprint author), SW Univ Sci & Technol, Sch Mat Sci & Engn, 59 Qinglong Rd, Mianyang 621010, Peoples R China.
EM liulili@swust.edu.cn; yfc66@163.com; weicai@hit.edu.cn
FU Research Foundation Project of Doctors [10zx7116]; State Administration
   of Science Technology and Industry program [B3120110001]
FX This work was financially supported by the Research Foundation Project
   of Doctors (10zx7116), State Administration of Science Technology and
   Industry program (B3120110001).
CR Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Cai W, 2008, MATER LETT, V62, P2171, DOI 10.1016/j.matlet.2007.11.042
   CHIBA M, 1993, J BIOMECH, V26, P561, DOI 10.1016/0021-9290(93)90017-9
   Cicoira F, 2006, ADV MATER, V18, P169, DOI 10.1002/adma.200501639
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   KOMATSU K, 1993, ARCH ORAL BIOL, V38, P369, DOI 10.1016/0003-9969(93)90207-3
   Misof K, 1997, BIOPHYS J, V72, P1376, DOI 10.1016/S0006-3495(97)78783-6
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WANG YD, 2003, BIOMED MAT RES A, V66, P192, DOI DOI 10.1002/JBM.A.10534
NR 10
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-371-9
J9 ADV MATER RES-SWITZ
PY 2012
VL 476-478
BP 2075
EP +
DI 10.4028/www.scientific.net/AMR.476-478.2075
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BDA25
UT WOS:000312277301066
DA 2018-10-19
ER

PT J
AU Pedersen, H
AF Pedersen, Helena
TI Education, animals, and the commodity form
SO CULTURE AND ORGANIZATION
LA English
DT Article
DE education; animals; biocommodity; Marx; posthumanism
ID STUDENTS; GENETICS; CATTLE; BODY; MEAT; COWS
AB What would biocommodities say if they could teach? This article investigates what kind of work education performs in biocommoditization processes. It makes two contributions to scholarship on commoditization. First, it integrates education into Marx's formula for the circulation of capital through the commodity form. Second, it provides a case study of veterinary education to develop Helmreich's unfinished worksheet of biocommoditization, that is, the adaptation of Marx's formula to biocapital accumulation (BCB'). With the material embeddedness of veterinary education in the animal commodity form as an empirical example viewed through a synthesis of Marxist and posthumanist analyses, this article works through each component of Helmreich's BCB' chain (animal material, animal commodity, animal capital), with particular attention to its interplay with educational practice. In the end, education emerges as a vitalizing guide among other organic and inorganic actants that channel student traffic into the animal economy. This channeling of student traffic is, however, complicated by an element of indeterminacy always already accompanying the education process as well as the transformation of biomaterial into capital.
C1 Malmo Univ, Fac Educ & Soc, Dept Sci Environm & Soc, SE-20506 Malmo, Sweden.
RP Pedersen, H (reprint author), Malmo Univ, Fac Educ & Soc, Dept Sci Environm & Soc, SE-20506 Malmo, Sweden.
EM helena.pedersen@mah.se
CR ADAMS CJ, 2002, SEXUAL POLITICS MEAT
   Alaimo S., 2008, MAT FEMINISMS
   Algers B., 2009, P SWEDISH U AGR SCI
   Arluke A, 1996, J CONTEMP ETHNOGR, V25, P201, DOI 10.1177/089124196025002002
   Armstrong P, 2007, KNOWING ANIMALS, P105
   Best S., 2005, AI SOC, V20, P6
   Biesta G.J.J., 2006, LEARING DEMOCRATIC E
   BIESTA GJJ, 1998, EDUC THEORY, V48, P499, DOI DOI 10.1111/J.1741-5446.1998.00499.X
   Blokhuis H.J., 2008, TRENDS FOOD SCI TECH, V19, P75
   Boyd W, 2001, TECHNOL CULT, V42, P631, DOI 10.1353/tech.2001.0150
   Callard FJ, 1998, ENVIRON PLANN D, V16, P387, DOI 10.1068/d160387
   Cole Matthew, 2011, Animals (Basel), V1, P83, DOI 10.3390/ani1010083
   Debord Guy, 1994, SOC SPECTACLE
   Desmond Jane, 1999, STAGING TOURISM BODI
   DuPuis M, 2002, NATURES PERFECT FOOD
   EMEL J, 1998, ANIMAL GEOGRAPHIES P, P1
   Forsman B., 1992, THESIS GOTEBORGS U G
   Foucault M, 1990, WILL KNOWLEDGE HIST, V1
   Franklin S, 2007, ANIMALS READER ESSEN, P349
   Freire P, 2001, PEDAGOGY OPPRESSED
   Glenn Cathy B., 2004, J COMMUNICATION INQU, V28, P63
   Gough Noel, 2004, EDUC PHILOS THEORY, V36, P253, DOI DOI 10.1111/J.1469-5812.2004.00066.X
   Grasseni C, 2005, SOC ANIM, V13, P33, DOI 10.1163/1568530053966652
   Harvey D, 1998, ENVIRON PLANN D, V16, P401, DOI 10.1068/d160401
   Helmreich Stephan, 2008, SCI CULTURE, V17, P463, DOI DOI 10.1080/09505430802519256
   Hicks N.L., 1994, INT ENCY ED, P1660
   Holloway L, 2007, ENVIRON PLANN D, V25, P1041, DOI 10.1068/d77j
   Holloway L, 2005, ENVIRON PLANN D, V23, P883, DOI 10.1068/d59j
   Holloway L, 2009, T I BRIT GEOGR, V34, P394, DOI 10.1111/j.1475-5661.2009.00347.x
   Hribal Jason, 2010, FEAR ANIMAL PLANET H, P1
   Hultman K, 2010, INT J QUAL STUD EDUC, V23, P525, DOI 10.1080/09518398.2010.500628
   Jonsson Hakan, 2005, MJOLK KULTURANALYS M
   Kiaer Christina, 2005, IMAGINE POSSESSIONS
   Kramer C., 2005, THINKING ANIMALS NEW, P138
   Lewis TE, 2010, CULT THEORY CRIT, V51, P223, DOI 10.1080/14735784.2010.515399
   Lingis A., 1994, COMMUNITY THOSE WHO
   Lury C., 2009, ACSIS C CULT STUD SW
   Marx K, 1992, CAPITAL, V2
   Marx K., 1867, CAPITAL, V1
   Nibert David, 2002, ANIMAL RIGHTS HUMAN
   Noske Barbara, 1997, BOUNDARIES HUMANS AN
   Pedersen H., 2008, GLOBAL HARMS ECOLOGI, P131
   Pedersen H., 2010, ANIMALS SCH PROCESS
   Pedersen H., 2011, CANADIAN J ENV ED, V16, P14
   Pedersen H, 2012, STUD PHILOS EDUC, V31, P365, DOI 10.1007/s11217-011-9281-4
   Pedersen H, 2010, DISCOURSE-ABINGDON, V31, P237, DOI 10.1080/01596301003679750
   SCHULTZ TW, 1961, AM ECON REV, V51, P1
   Shukaitis S., 2010, CALL PAPERS CULTURE
   Shukin N., 2009, ANIMAL RENDERING LIF
   SMITH AC, 1989, SOC PSYCHOL QUART, V52, P56, DOI 10.2307/2786904
   Thacker Eugene, 2005, GLOBAL GENOME BIOTEC
   Ufkes F. M., 1998, ANIMAL GEOGRAPHIES P, P241
   WATTS M, 2000, ANIMAL SPACES BEASTL, P292
   Willard BE, 2002, J POP CULT, V36, P105
   Williams Anna, 2004, INT J SOCIOLOGY SOCI, V24, P45
   Willis P., 1999, CRITICAL ED NEW INFO, P139
   WORLD BANK, 1999, ED SECT STRAT
NR 57
TC 3
Z9 3
U1 1
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1475-9551
J9 CULT ORGAN
JI Cult. Organ.
PY 2012
VL 18
IS 5
SI SI
BP 415
EP 432
DI 10.1080/14759551.2012.728395
PG 18
WC Management
SC Business & Economics
GA 055UZ
UT WOS:000312444600006
DA 2018-10-19
ER

PT S
AU Anjum, SS
   Rao, J
   Nicholls, JR
AF Anjum, S. S.
   Rao, J.
   Nicholls, J. R.
BE Sachse, S
   Njuguna, J
TI Polymer (PTFE) and shape memory alloy (NiTi) intercalated
   nano-biocomposites
SO INTERNATIONAL CONFERENCE ON STRUCTURAL NANO COMPOSITES (NANOSTRUC 2012)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT International Conference on Structural Nano Composites (NANOSTRUC)
CY JUL 02-04, 2012
CL Cranfield Univ, ENGLAND
SP Nephh, Seventh Framework Programme, Ecoshell, Agilent Technologies, JM Bioconnect, EATON, Gerhardt, Fritsch, Nanotechnol Knowledge Transfer Network, Nanotechnol Ind Assoc (NIA), Amer Elements, Cranfield Nano
HO Cranfield Univ
ID BIODEGRADABLE POLYMERS; DEPOSITION; BIOMATERIALS; COATINGS; FILMS
AB Engineering on a nano-scale has been undertaken to mimic a biomaterial by forming an intercalated nano-composite structure by PVD sputtering of a polymer with a nickel-titanium (NiTi) shape memory alloy (SMA). A PTFE polymer has been selected due to its elastic properties, low interactions with water, optimum surface energies, stability and chemical resistance. NiTi SMAs allow the coatings to be energy absorbent and thus suitable in load bearing situations. The coatings are aimed to constantly withstand variable adverse biological environments whilst maintaining their characteristics. The nano-intercalated structures have been characterised for their wettability, friction coefficients, chemical composition, and morphology. Intercalation of a polymer with energy-absorbing alloys uncovers a set of material systems that will offer characteristics such as self-healing of hierarchal tissue in the body. The reformation of PTFE following sputter deposition was confirmed by FTIR spectra. According to SEM analysis PTFE shows a promising surface interaction with NiTi, forming stable coatings. Surface interactions are evident by the hydrophobic behaviour of films as the composite's water contact angle is around 86 degrees, which lies in-between that of PTFE and NiTi. The nano composite films are lubricious and have a measured CoF below 0.2 which does not vary with layer thickness.
C1 [Anjum, S. S.; Rao, J.; Nicholls, J. R.] Cranfield Univ, Sch Appl Sci, Cranfield MK43 0AL, Beds, England.
RP Anjum, SS (reprint author), Cranfield Univ, Sch Appl Sci, Cranfield MK43 0AL, Beds, England.
OI Nicholls, John/0000-0002-0295-2609
CR [Anonymous], 2004, TECHN RES MAN PROF C
   [Anonymous], 2007, COEFFICIENT FRICTION
   Bartolo P, 2008, BIOMATERIALS PROTOTY
   Bhushan B., 1991, HDB TRIBOLOGY, P1356
   Biederman H, 2003, SURF COAT TECH, V174, P27, DOI 10.1016/S0257-8972(03)00573-5
   Bodas DS, 2005, APPL SURF SCI, V245, P202, DOI 10.1016/j.apsusc.2004.10.023
   Drabik M, 2010, PLASMA PROCESS POLYM, V7, P544, DOI 10.1002/ppap.200900164
   Jia ZN, 2012, COMPOS PART B-ENG, V43, P2072, DOI 10.1016/j.compositesb.2012.01.014
   Khang Gilson, 2007, MANUALS BIOMEDICAL R, V4, P1
   Kwong HY, 2007, APPL SURF SCI, V253, P8841, DOI 10.1016/j.apsusc.2007.04.036
   Liu CZ, 2001, SURF COAT TECH, V139, P111, DOI 10.1016/S0257-8972(00)01160-9
   Lloyd Andrew W, 2002, Med Device Technol, V13, P18
   MFatima V. S., 2001, SURFACE COATINGS TEC, V142, P934
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Otsuka K., 1999, SHAPE MEMORY MAT
   PISKIN E, 1995, J BIOMAT SCI-POLYM E, V6, P775, DOI 10.1163/156856295X00175
   Rao J, 2005, DIAM RELAT MATER, V14, P1805, DOI 10.1016/j.diamond.2005.06.015
   Rao J, 2010, SURF COAT TECH, V204, P2331, DOI 10.1016/j.surfcoat.2009.12.025
   Selvakumar N., 2010, J APPL PHYS, V108
   Williams D., 2001, WILEY ENCY ELECT ELE
NR 20
TC 1
Z9 1
U1 2
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2012
VL 40
AR 012006
DI 10.1088/1757-899X/40/1/012006
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Composites
SC Materials Science
GA BDB05
UT WOS:000312413700006
OA Bronze
DA 2018-10-19
ER

PT J
AU Karagkiozaki, V
   Karagiannidis, PG
   Kalfagiannis, N
   Kavatzikidou, P
   Patsalas, P
   Georgiou, D
   Logothetidis, S
AF Karagkiozaki, Varvara
   Karagiannidis, Panagiotis G.
   Kalfagiannis, Nikolaos
   Kavatzikidou, Paraskevi
   Patsalas, Panagiotis
   Georgiou, Despoina
   Logothetidis, Stergios
TI Novel nanostructured biomaterials: implications for coronary stent
   thrombosis
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE platelets; cell viability; titanium boron nitride; atomic force
   microscopy; carbon nanotubes
ID ATOMIC-FORCE MICROSCOPY; DRUG-ELUTING STENTS; THIN-FILMS; CARBON
   NANOTUBES; PLATELET-ADHESION; PLASMA-PROTEINS; BORON-NITRIDE;
   ACTIVATION; COATINGS; HEMOCOMPATIBILITY
AB Background: Nanomedicine has the potential to revolutionize medicine and help clinicians to treat cardiovascular disease through the improvement of stents. Advanced nanomaterials and tools for monitoring cell-material interactions will aid in inhibiting stent thrombosis. Although titanium boron nitride (TiBN), titanium diboride, and carbon nanotube (CNT) thin films are emerging materials in the biomaterial field, the effect of their surface properties on platelet adhesion is relatively unexplored.
   Objective and methods: In this study, novel nanomaterials made of amorphous carbon, CNTs, titanium diboride, and TiBN were grown by vacuum deposition techniques to assess their role as potential stent coatings. Platelet response towards the nanostructured surfaces of the samples was analyzed in line with their physicochemical properties. As the stent skeleton is formed mainly of stainless steel, this material was used as reference material. Platelet adhesion studies were carried out by atomic force microscopy and scanning electron microscopy observations. A cell viability study was performed to assess the cytocompatibility of all thin film groups for 24 hours with a standard immortalized cell line.
   Results: The nanotopographic features of material surface, stoichiometry, and wetting properties were found to be significant factors in dictating platelet behavior and cell viability. The TiBN films with higher nitrogen contents were less thrombogenic compared with the biased carbon films and control. The carbon hybridization in carbon films and hydrophilicity, which were strongly dependent on the deposition process and its parameters, affected the thrombogenicity potential. The hydrophobic CNT materials with high nanoroughness exhibited less hemocompatibility in comparison with the other classes of materials. All the thin film groups exhibited good cytocompatibility, with the surface roughness and surface free energy influencing the viability of cells.
C1 [Karagkiozaki, Varvara; Karagiannidis, Panagiotis G.; Kalfagiannis, Nikolaos; Kavatzikidou, Paraskevi; Georgiou, Despoina; Logothetidis, Stergios] Aristotle Univ Thessaloniki, Dept Phys, Lab Thin Films Nanosyst & Nanometrol LTFN, GR-54124 Thessaloniki, Greece.
   [Karagkiozaki, Varvara] Aristotle Univ Thessaloniki, AHEPA Hosp, GR-54124 Thessaloniki, Greece.
   [Patsalas, Panagiotis] Univ Ioannina, Dept Mat Sci & Engn, GR-45110 Ioannina, Epirus, Greece.
RP Logothetidis, S (reprint author), Aristotle Univ Thessaloniki, Dept Phys, Lab Thin Films Nanosyst & Nanometrol LTFN, GR-54124 Thessaloniki, Greece.
EM logot@auth.gr
OI Kalfagiannis, Nikolaos/0000-0002-4030-5525; Karagiannidis,
   Panagiotis/0000-0002-2709-4161
FU project entitled 'Exploitation of research results on Nanotechnology'
FX The authors would like to thank E Diamanti and D Gourni for their
   contribution to the preparation of the CNTs/DLC. They would also like to
   acknowledge the project entitled 'Exploitation of research results on
   Nanotechnology' for its financial support.
CR Allison DP, 2010, WIRES NANOMED NANOBI, V2, P618, DOI 10.1002/wnan.104
   Anselme K, 2010, ACTA BIOMATER, V6, P824
   Aouadi SM, 2004, SURF COAT TECH, V183, P369, DOI 10.1016/j.surfcoat.2003.08.091
   Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023
   Chibowski E, 2002, ADV COLLOID INTERFAC, V98, P245, DOI 10.1016/S0001-8686(01)00097-5
   Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41
   Colombo A, 2004, EUR HEART J, V25, P895, DOI 10.1016/j.ehj.2004.04.004
   FRITZ M, 1994, BIOPHYS J, V66, P1328, DOI 10.1016/S0006-3495(94)80963-4
   Garcia-Gonzalez L, 2007, J MATER PROCESS TECH, V186, P362, DOI 10.1016/j.jmatprotec.2007.01.002
   Hara H, 2006, ADV DRUG DELIVER REV, V58, P377, DOI 10.1016/j.addr.2006.01.022
   HARTWIG JH, 2002, PLATELETS, P37
   Henriques SS, 2012, J CELL SCI
   Holzschuh H, 2004, THIN SOLID FILMS, V469, P92, DOI 10.1016/j.tsf.2004.08.077
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Karagkiozaki V, 2009, EUR J NANOMED, V2, P14
   Karagkiozaki V, 2008, EUR J NANOMED, V1, P24, DOI 10.3884/0001.6
   Karagkiozaki V, 2008, MATER SCI ENG B-ADV, V152, P16, DOI 10.1016/j.mseb.2008.06.013
   Karagkiozaki V, 2008, INT J NANOMED, V3, P461
   Karagkiozaki V, 2009, NANOMED-NANOTECHNOL, V5, P64, DOI 10.1016/j.nano.2008.07.005
   Karagkiozaki VC, 2010, INT J NANOMED, V5, P239
   Kim JY, 2009, J BIOMED MATER RES A, V88A, P419, DOI 10.1002/jbm.a.31799
   Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011
   Linneweber J, 2007, ARTIF ORGANS, V31, P345, DOI 10.1111/j.1525-1594.2007.00391.x
   Logothetidis S, 2007, DIAM RELAT MATER, V16, P1847, DOI 10.1016/j.diamond.2007.05.012
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lousinian S, 2007, BIOMOL ENG, V24, P107, DOI 10.1016/j.bioeng.2006.05.014
   Lousinian S, 2008, MATER SCI ENG B-ADV, V152, P12, DOI 10.1016/j.mseb.2008.06.014
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Menard-Moyon C, 2010, CHEM BIOL, V17, P107, DOI 10.1016/j.chembiol.2010.01.009
   Mitsakakis K, 2007, BIOMOL ENG, V24, P119, DOI 10.1016/j.bioeng.2006.05.013
   Muller DJ, 2002, TRENDS BIOTECHNOL, V20, pS45, DOI 10.1016/S0167-7799(02)02000-0
   Muller J, 2008, CHEM RES TOXICOL, V21, P1698, DOI 10.1021/tx800101p
   Nakano K, 2009, JACC-CARDIOVASC INTE, V2, P277, DOI 10.1016/j.jcin.2008.08.023
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   Smith Elliot J, 2006, J Interv Cardiol, V19, P493, DOI 10.1111/j.1540-8183.2006.00199.x
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Tulloch AW, 2011, J SURG RES, V171, P317, DOI 10.1016/j.jss.2010.01.014
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Vallance P, 2001, HEART, V85, P342, DOI 10.1136/heart.85.3.342
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yang Z, 2010, NANOMED-NANOTECHNOL, V6, P427, DOI 10.1016/j.nano.2009.11.007
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 45
TC 22
Z9 22
U1 0
U2 35
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 6063
EP 6076
DI 10.2147/IJN.S34320
PG 14
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 056JV
UT WOS:000312485800001
PM 23269867
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Wang, W
   Cao, JD
   Lan, P
AF Wang, Wei
   Cao, Jianda
   Lan, Ping
BE Chen, WZ
   Liu, XJ
   Dai, P
   Chen, YL
   Jiang, Z
TI Swelling Behaviors and Water States of Fibrous Membranes Electrospun
   from PHBV-g-PVP
SO ADVANCED COMPOSITE MATERIALS, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 3rd International Conference on Manufacturing Science and Engineering
   (ICMSE 2012)
CY MAR 27-29, 2012
CL Xiamen, PEOPLES R CHINA
SP Fujian Univ Technol, Xiamen Univ, Fuzhou Univ, Huaqiao Univ, Univ Wollongong, Fujian Mech Engn Soc, Hong Kong Ind Technol Res Ctr
DE electrospun fibrous membrane; swelling; water state; PHBV; PVP
ID NANOFIBERS
AB Fibrous membranes with a fiber diameter between 320 and 460 nm were electrospun from poly(3-hydroxybutyrate-co-3-hydroxyvalerate)-graft-poly(N-vinylpyrrolidone) (PHBV-g-PVP) and their specific water absorption behaviors were investigated for biomaterial purposes. Water swelling experiments indicate that all samples have a great capacity for water uptake, while a remarkable overshoot occurs for the membranes electrospun from PHBV-g-PVP other than those from PHBV. DSC characterization indicates that only non-freezable bound water and free water can be distinguished in all electrospun membranes.
C1 [Wang, Wei; Cao, Jianda; Lan, Ping] Jiaxing Univ, Coll Mat & Text Engn, Hangzhou 314001, Zhejiang, Peoples R China.
RP Wang, W (reprint author), Jiaxing Univ, Coll Mat & Text Engn, Hangzhou 314001, Zhejiang, Peoples R China.
EM zjxuwangwei@163.com; dacao88@163.com; lanping007@126.com
CR Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   FUSHIMI H, 1991, POLYMER, V32, P241, DOI 10.1016/0032-3861(91)90009-8
   HIGUCHI A, 1985, POLYMER, V26, P1207, DOI 10.1016/0032-3861(85)90254-X
   HIGUCHI A, 1985, POLYMER, V26, P1833, DOI 10.1016/0032-3861(85)90011-4
   Jang K., 2011, J NANOSCI NANOTECHNO, V11, P6120
   Kim SJ, 2004, J APPL POLYM SCI, V92, P1467, DOI 10.1002/app.13717
   Liu L, 2011, ADV MATER RES-SWITZ, V221, P657, DOI 10.4028/www.scientific.net/AMR.221.657
   McKee MG, 2006, SCIENCE, V311, P353, DOI 10.1126/science.1119790
   Prabhakaran MP, 2011, J NANOSCI NANOTECHNO, V11, P3039, DOI 10.1166/jnn.2011.3753
   Shi Y. M., 2001, POLYMER, V42, P9955
   Wan LS, 2006, MACROMOL BIOSCI, V6, P364, DOI 10.1002/mabi.200600017
   Wang W, 2007, IRAN POLYM J, V16, P195
   Zhang H, 2011, ADV MATER RES-SWITZ, V148-149, P1138, DOI 10.4028/www.scientific.net/AMR.148-149.1138
   Zhu MF, 2006, J MATER SCI, V41, P3793, DOI 10.1007/s10853-005-5910-z
NR 14
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-373-3
J9 ADV MATER RES-SWITZ
PY 2012
VL 482-484
BP 1478
EP 1482
DI 10.4028/www.scientific.net/AMR.482-484.1478
PG 5
WC Materials Science, Composites
SC Materials Science
GA BCR18
UT WOS:000311059600307
DA 2018-10-19
ER

PT S
AU Ming, JF
   Zuo, BQ
   Jiang, YX
AF Ming, Jinfa
   Zuo, Baoqi
   Jiang, Yaoxing
BE Kao, JCM
   Hou, M
   Chen, R
TI Calcium Ion Treatment Behavior of Silk Fibroin/Sodium Alginate Scaffolds
SO FRONTIER OF NANOSCIENCE AND TECHNOLOGY II
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Frontiers of Nanoscience and Technology
   (ICFNST 2012)
CY JUL 26-27, 2012
CL Hong Kong, PEOPLES R CHINA
SP Int Frontiers Sci & Technol Res Assoc, Hong Kong Control Engn & Informat Sci Res Assoc
DE Silk Fibroin; Sodium Alginate; Scaffold; Calcium Ion
ID ELECTROLYTE
AB The silk fibroin/sodium alginate scaffolds were prepared using lyophilization method. And then, the blend scaffolds were treated with calcium ions. The morphology of the blend scaffolds exhibited a thin layer structure before calcium ions treatment, and much more rod-like structure appeared at the layer surface with adding the increase content of sodium alginate in the blend scaffolds. After calcium ions treatment, much more rod-like structure disappeared after adding 30% sodium alginate or more in the blend scaffolds. Wide angle X-ray diffraction and Fourier transform infrared analysis results confirmed the crystal structure of silk fibroin was not influenced by adding the different content of sodium alginate, exhibiting the silk I and silk II structure co-existed in the blend scaffolds. And the same time, the average mass loss value of the blend scaffolds was higher than the pure silk fibroin scaffold, reaching 9.884%, 11.2%, and 8.626%, respectively, when the blend scaffolds contained 10%, 30%, and 50% sodium alginate, respectively. Thus, the silk fibroin/sodium alginate scaffolds should be a useful biomaterial applicable for a wide range of tissue engineering.
C1 [Ming, Jinfa; Zuo, Baoqi; Jiang, Yaoxing] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Ming, JF (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM jinfa.ming@gmail.com; bqzuo@suda.edu.cn; jiangyaoxing@suda.edu.cn
CR Curtis RA, 2002, BIOPHYS CHEM, V98, P249, DOI 10.1016/S0301-4622(02)00071-6
   Grigsby JJ, 2001, BIOPHYS CHEM, V91, P231, DOI 10.1016/S0301-4622(01)00173-9
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Rusa CC, 2005, MACROMOLECULES, V38, P5640, DOI 10.1021/ma050340a
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Smith I.O., 2011, TISSUE ENG, V1, P31
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 13
TC 0
Z9 0
U1 2
U2 16
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-429-7
J9 ADV MATER RES-SWITZ
PY 2012
VL 528
BP 107
EP 112
DI 10.4028/www.scientific.net/AMR.528.107
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BDA20
UT WOS:000312276500023
DA 2018-10-19
ER

PT S
AU Xie, F
   Liu, ZM
AF Xie, Fang
   Liu, Zuomin
BE Zeng, JM
   Kim, YH
   Chen, YF
TI Effect of Negative Poisson's Ratios of Auxetic UHMWPE on the Contact
   Mechanics in Artificial Hip Joint Replacement
SO NEW MATERIALS, APPLICATIONS AND PROCESSES, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical, Material and Metallurgical
   Engineering (ICCMME 2011)
CY DEC 23-25, 2011
CL Beihai, PEOPLES R CHINA
SP Guangxi Univ, China, Wuhan Univ Sci & Technol, Queensland Univ Technol
DE auxetic UHMWPE; contact mechanics; finite element method
ID MOLECULAR-WEIGHT POLYETHYLENE; STRESS; WEAR; CUPS
AB With the development of functional and structural materials, increasing interests have been shown in the field of biomaterials with a negative Poisson's ratio (auxetic), which exhibit the unusual property of becoming thinner when compressed. This unusual property makes it potentially a synthetic replacement biomaterial with adequate mechanical property and wear resistance. In this study, the potential of applying the auxetic ultra-high molecular weight polyethylene (UHMWPE) for the artificial hip joint was discussed. The contact mechanics characteristics in artificial hip joint replacement under different Poisson's ratios of -1<mu <= 0.5 were investigated and compared using the finite element method. The results show that Poisson's ratio had great effect on the contact mechanics in artificial hip joint replacement. Therefore, the future work should focus on tailoring an auxetic UHMWPE with a suitable Poisson's ratio for artificial hip joint replacements.
C1 [Xie, Fang] Nanyang Inst Technol, Nanyang 473004, Henan Province, Peoples R China.
   [Xie, Fang; Liu, Zuomin] Wuhan Univ Technol, Inst Tribol, Wuhan 430070, Peoples R China.
RP Xie, F (reprint author), Nanyang Inst Technol, Nanyang 473004, Henan Province, Peoples R China.
EM xiefangnyit@163.com; liuzm98@263.net
FU National Natural Science Foundation of China [50775168]; Ministry of
   Education Doctoral Foundation of China [20070497105]; foundation of the
   China Scholarship Council
FX The authors are very grateful to Prof. Z. M. Jin, from University of
   Leeds, UK, for the discussion and providing the help of English language
   grammar. This work was supported by the National Natural Science
   Foundation of China (50775168), the Ministry of Education Doctoral
   Foundation of China (20070497105) and the foundation of the China
   Scholarship Council.
CR Alderson A, 2007, P I MECH ENG G-J AER, V221, P565, DOI 10.1243/09544100JAERO185
   BARTEL DL, 1985, J BIOMECH ENG-T ASME, V107, P193, DOI 10.1115/1.3138543
   Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3
   EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0
   FORTES MA, 1989, MAT SCI ENG A-STRUCT, V122, P227, DOI 10.1016/0921-5093(89)90634-5
   FROLICH LM, 1994, J ZOOL, V232, P231, DOI 10.1111/j.1469-7998.1994.tb01571.x
   JIN ZM, 1994, MED ENG PHYS, V16, P398, DOI 10.1016/1350-4533(90)90006-T
   Jin ZM, 1999, P I MECH ENG H, V213, P317, DOI 10.1243/0954411991535158
   Kang L, 2009, J BIOMECH, V42, P912, DOI 10.1016/j.jbiomech.2009.01.005
   LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038
   LEES C, 1991, Bio-Medical Materials and Engineering, V1, P19
   Mazzucco D, 2003, WEAR, V254, P514, DOI 10.1016/S0043-1648(03)00135-2
   Stavroulakis GE, 2005, PHYS STATUS SOLIDI B, V242, P710, DOI 10.1002/pssb.200460388
   VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2
   WILLIAMS JL, 1982, J BIOMECH ENG-T ASME, V104, P50, DOI 10.1115/1.3138303
NR 15
TC 4
Z9 4
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-309-2
J9 ADV MATER RES-SWITZ
PY 2012
VL 399-401
BP 1559
EP +
DI 10.4028/www.scientific.net/AMR.399-401.1559
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BCI67
UT WOS:000310249301006
DA 2018-10-19
ER

PT S
AU Izman, S
   Hassan, MA
   Abdul-Kadir, MR
   Abdullah, MR
   Anwar, M
   Shah, A
   Daud, R
AF Izman, S.
   Hassan, M. A.
   Abdul-Kadir, Mohammed Rafiq
   Abdullah, M. R.
   Anwar, Mahmood
   Shah, A.
   Daud, R.
BE Zeng, JM
   Kim, YH
   Chen, YF
TI Effect of Pretreatment Process on Thermal Oxidation of Biomedical Grade
   Cobalt Based Alloy
SO NEW MATERIALS, APPLICATIONS AND PROCESSES, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical, Material and Metallurgical
   Engineering (ICCMME 2011)
CY DEC 23-25, 2011
CL Beihai, PEOPLES R CHINA
SP Guangxi Univ, China, Wuhan Univ Sci & Technol, Queensland Univ Technol
DE Biomaterial; Co-Cr-Mo; thermal oxidation; hardness; wear; pretreatment;
   implant
ID COCRMO ALLOY; MICROSTRUCTURE; LAYER; CR
AB Wear on Co-Cr-Mo biomedical implants is still a major issue especially for applications in articulation joints like in total ankle, knee and hip arthroplasty. Generation of excessive wear particles can coagulate in body tissues which later cause inflammation, bone loss and necrosis. Modification of implant surfaces is a common technique for increasing the hardness and thus minimizing these effects. hi this study, thermal oxidation method was carried out on the Co-Cr-Mo to investigate the effects of different pretreatment processes and surface roughness on the hardness of oxide layer formed. Prior to oxidation process, all samples were annealed and pickled to remove residual stress and oxide scales respectively. The oxidation process was done inside furnace under atmospheric condition for 3 hours at 1160 degrees C. The metallic compositions, surface morphology and hardness of the oxide layer formed on the substrate were verified using X-ray diffraction (XRD), scanning electron microscope and micro-Vickers hardness analysis respectively. It is found that mechanical pretreatment provides oxide/carbide layer with higher hardness than chemical pretreatment method. It is believed that remnants of polishing diamond pastes trapped in roughness valleys react with metal matrix and later transform into carbides during oxidation process. In contrast, initial surface roughness of the substrate has no significant effect on the hardness of oxide/carbide layer.
C1 [Izman, S.; Abdullah, M. R.; Anwar, Mahmood; Shah, A.] Univ Teknologi Malaysia, Fac Mech Engn, Skudai 81310, Johor, Malaysia.
   [Hassan, M. A.; Daud, R.] Univ Malaysia Pahang, Fac Mech Engn, Pahang 26300, Malaysia.
   [Abdul-Kadir, Mohammed Rafiq] Univ Teknol Malaysia, Fac Biomed Engn, Skudai 81310, Malaysia.
RP Izman, S (reprint author), Univ Teknologi Malaysia, Fac Mech Engn, Skudai 81310, Johor, Malaysia.
EM izman@mail.fkm.utm.my; masszee@ump.edu.my; rafiq@biomedical.utm.my;
   ruslan@fkm.utm.my; amahmood2@live.utm.my; ashah8@live.utm.my;
   rosdidaud@ump.edu.my
RI sudin, izman/A-6746-2015; Abdul Kadir, Mohammed/D-1117-2010; Abdullah,
   Arman Shah/K-7919-2012; Daud, Rosdi/K-2508-2016
OI Abdullah, Arman Shah/0000-0003-0142-6487; Anwar, Dr.
   Mahmood/0000-0002-7380-9439
FU Ministry of Higher Education (MOHE), Malaysia and Faculty of Mechanical
   Engineering, UTM for funding [78611, Q.J130000.7124.02H60]
FX Authors would like to express highest gratitude to Ministry of Higher
   Education (MOHE), Malaysia and Faculty of Mechanical Engineering, UTM
   for funding via project vote nos. 78611 & Q.J130000.7124.02H60 and
   providing their facilities for conducting this research respectively.
CR Aoh JN, 2001, WEAR, V250, P611, DOI 10.1016/S0043-1648(01)00668-8
   Blau PJ, 2009, WEAR, V267, P380, DOI 10.1016/j.wear.2008.12.082
   Izman S, 2011, ADV MATER RES-SWITZ, V197-198, P219, DOI 10.4028/www.scientific.net/AMR.197-198.219
   Lutz J, 2010, SURF COAT TECH, V204, P3043, DOI 10.1016/j.surfcoat.2010.01.048
   Michel G, 2011, SURF COAT TECH, V205, P3708, DOI 10.1016/j.surfcoat.2011.01.027
   Mu D, 2010, MATER DESIGN, V31, P3933, DOI 10.1016/j.matdes.2010.03.024
   Ostwald C, 2004, CORROS SCI, V46, P1113, DOI 10.1016/j.corsci.2003.09.004
   Ozturk O, 2006, SURF COAT TECH, V200, P5687, DOI 10.1016/j.surfcoat.2005.08.113
   Pichon L, 2010, SURF COAT TECH, V204, P2913, DOI 10.1016/j.surfcoat.2010.01.050
   Wang QL, 2010, J BIONIC ENG, V7, P337, DOI 10.1016/S1672-6529(10)60265-X
   Wang QL, 2010, SURF COAT TECH, V205, P2654, DOI 10.1016/j.surfcoat.2010.10.031
   Zhang ZG, 2006, APPL SURF SCI, V253, P881, DOI 10.1016/j.apsusc.2006.01.027
   Zou Y., 2009, J ACHIEVEMENTS MAT M, P369
NR 13
TC 5
Z9 5
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-309-2
J9 ADV MATER RES-SWITZ
PY 2012
VL 399-401
BP 1564
EP +
DI 10.4028/www.scientific.net/AMR.399-401.1564
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BCI67
UT WOS:000310249301007
DA 2018-10-19
ER

PT S
AU Woo, KD
   Park, SH
   Kim, JY
   Kim, SM
   Kang, DS
AF Woo, Kee-Do
   Park, Sang-Hoon
   Kim, Ji-Young
   Kim, Sang-Mi
   Kang, Dong-Soo
BE Zeng, JM
   Kim, YH
   Chen, YF
TI Mechanical Properties of Ti-Nb-X-CPP Biomaterial Fabricated by Spark
   plasma Sintering
SO NEW MATERIALS, APPLICATIONS AND PROCESSES, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical, Material and Metallurgical
   Engineering (ICCMME 2011)
CY DEC 23-25, 2011
CL Beihai, PEOPLES R CHINA
SP Guangxi Univ, China, Wuhan Univ Sci & Technol, Queensland Univ Technol
DE biomaterial; sintering; power metallurgy; SPS; calcium phosphate
ID BETA-TITANIUM-ALLOY; SN; SUPERELASTICITY; MICROSTRUCTURE; MODULUS; ZR
AB Ti-6A1-4V ELI (Extra Low Interstitial) alloy have been widely used as alternative bone due to its excellent biocompatibility, although it still has many problems such as high elastic modulus and toxic. Therefore, biomaterial with low elastic modulus and nontoxic has to be developed. In this study, the raw materials which are nontoxic elements such as Nb and Mo were mixed and milled in a mixing machine (24h) and a high energy mechanical ball milling machine (1h, 4h and 8h) respectively. Ti-Nb-Mo-CPP composites were fabricated by spark plasma sintering (SPS) at 1000 degrees C under 70MPa using mixed and milled powders. The effects of CPP contents and milling time on biocompatibility and mechanical property have been investigated. By X-ray diffraction (XRD), chemical reaction during the sintering was occurred and revealed new phases, Ti2O, CaO, CaTiO3, and TixPy. Vickers hardness of composites increases with increase milling time and addition of HA contents. Biocompatibility of HA added Ti-Nb-Si alloys were improved.
C1 [Woo, Kee-Do; Park, Sang-Hoon; Kim, Ji-Young; Kim, Sang-Mi; Kang, Dong-Soo] Chonbuk Natl Univ, Div Adv Mat Engn, Res Ctr Ind Technol, Jeonju 561756, Chonbuk, South Korea.
RP Woo, KD (reprint author), Chonbuk Natl Univ, Div Adv Mat Engn, Res Ctr Ind Technol, Jeonju 561756, Chonbuk, South Korea.
EM kdwoo@jbnu.ac.kr; plakken@naver.com; bluedays7@nate.com;
   sangmi1014@naver.com; jnl1213@naver.com
CR Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   ISHIYAMA S, 1991, ISIJ INT, V31, P807, DOI 10.2355/isijinternational.31.807
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Laheurte P, 2005, MAT SCI ENG A-STRUCT, V396, P223, DOI 10.1016/j.msea.2005.01.022
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nag S, 2007, ACTA BIOMATER, V3, P369, DOI 10.1016/j.actbio.2006.08.005
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
NR 9
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-309-2
J9 ADV MATER RES-SWITZ
PY 2012
VL 399-401
BP 1592
EP 1595
DI 10.4028/www.scientific.net/AMR.399-401.1592
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BCI67
UT WOS:000310249301013
DA 2018-10-19
ER

PT S
AU Reyna-Valencia, A
   Chevallier, P
   Mantovani, D
AF Reyna-Valencia, Alejandra
   Chevallier, Pascale
   Mantovani, Diego
BE Chandra, T
   Ionescu, M
   Mantovani, D
TI Development of a Collagen/Clay Nanocomposite Biomaterial
SO THERMEC 2011, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Processing and Manufacturing of Advanced
   Materials
CY AUG 01-05, 2011
CL Quebec City, CANADA
SP Minerals, Metals & Mat Soc
DE collagen scaffolds; nanoparticles; nanocomposites; hydrogels;
   structure-property relationships
ID SILICATE; DESIGN; PH
AB Collagen hydrogels are widely used as three-dimensional scaffolds for cells and tissue in culture environments. These materials, which consist of crosslinked biopolymer (protein-based) networks in aqueous media, are particularly suitable for recreating part of the extra-cellular matrix, but their poor mechanical properties represent a major limitation. One strategy to enhance the strength of this kind of hydrogels might be to incorporate clay nanoscopic particles. In fact, it has been observed that the charged surface of clay nanosheets can interact with certain functional groups belonging to polymer molecules, yielding stronger networks. Moreover, clay particles are recognized to be biocompatible. In the present work, the gelation process and the resulting morphological and mechanical properties of collagen/laponite clay nanocomposite hydrogels were invastigated. Upon gelation, the biopolymer molecules assemble into nanoscale fibrils, which bundle into fibers and entangle into a three-dimensional network. The network characteristics depend on tunable parameters such as pH and clay concentration.
C1 [Reyna-Valencia, Alejandra; Chevallier, Pascale; Mantovani, Diego] Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1V 0A6, Canada.
RP Reyna-Valencia, A (reprint author), Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1V 0A6, Canada.
EM alejandra.reyna.1@ulaval.ca; pascale.chevallier@crsfa.ulaval.ca;
   diego.mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
FU Natural Sciences and Engineering Research Council; Canadian Institutes
   of Health Research; Fonds Quebecois de la Recherche sur la Nature et les
   Technologies; Fonds de la Recherche en Sante du Quebec
FX This work was partially supported by Natural Sciences and Engineering
   Research Council, the Canadian Institutes of Health Research, the Fonds
   Quebecois de la Recherche sur la Nature et les Technologies and the
   Fonds de la Recherche en Sante du Quebec.
CR Achilli M, 2010, MACROMOL BIOSCI, V10, P307, DOI 10.1002/mabi.200900248
   Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Arguelles-Monal, 2002, ACS S SERIES
   ATALA A, 2002, METHODS TISSUE ENG
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Carretero MI, 2006, DEV CLAY SCI, V1, P717, DOI 10.1016/S1572-4352(05)01024-X
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Johnson JA, 2010, PROG POLYM SCI, V35, P332, DOI 10.1016/j.progpolymsci.2009.12.002
   Koob TJ, 2004, ENCY BIOMATERIALS BI
   Lowenstam H.A, 1989, BIOMINERALISATION, P336
   MESSERSMITH PB, 1994, CHEM MATER, V6, P1719, DOI 10.1021/cm00046a026
   OLMO N, 1985, COLLAGEN REL RES, V5, P9
   OLMO N, 1987, BIOMATERIALS, V8, P67, DOI 10.1016/0142-9612(87)90033-0
   Rajan N., 2006, NATURE PROTOCOLS, V1, P1
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Sander E.A., 2008, COLLAGEN STRUCTURE M
   THENG BKG, 1979, FORMATION PROPERTIES
   Tombacz E, 2004, PROG COLL POL SCI S, V125, P206, DOI 10.1007/b14303
   Utracki L. A., 2004, CLAY CONTAINING POLY
   Wess TJ, 2008, COLLAGEN STRUCTURE M
   Wong E.Y.L., 2009, 27 ANN C CAN BIOM SO
NR 22
TC 2
Z9 2
U1 2
U2 16
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 706-709
BP 461
EP +
DI 10.4028/www.scientific.net/MSF.706-709.461
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBW89
UT WOS:000308517300072
DA 2018-10-19
ER

PT S
AU Huang, HQ
   Guan, RQ
   Zhao, T
   Zhao, ZY
   Cao, FR
AF Huang, Hong-qian
   Guan, Ren-quo
   Zhao, Tong
   Zhao, Zhan-yong
   Cao, Fu-rong
BE Chandra, T
   Ionescu, M
   Mantovani, D
TI Preparation of HA-coated Mg-4.0Zn-1.0Ca-0.6Zr(wt%) alloy and its
   biodegradation behaviors
SO THERMEC 2011, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Processing and Manufacturing of Advanced
   Materials
CY AUG 01-05, 2011
CL Quebec City, CANADA
SP Minerals, Metals & Mat Soc
DE HA coating; biological implantation materials; biodegradation; magnesium
   alloys
ID MAGNESIUM
AB Magnesium and magnesium alloys, as biomaterials, possess many properties that are superior to those of other metals. However, magnesium and magnesium alloys have strong chemical activity and porous and brittle surface oxide film, as degradable implantation materials, their degradation rates are too fast. Hydroxyapatite(HA) has good biocompatibility and biological activity and has become one of the replacement materials of biomedical stiff hemopoietic tissue, but the application of HA biomaterial is hindered because HA is brittle and has low strength. Integrating good mechanical properties of metallic materials with excellent biological performance of HA, the composite obtained by coating HA to the surface of metallic matrix is ideal rehabilitation material of bone tissue. In the present study, a new Mg-4.0Zn-1.0Ca-0.6Zr(wt%) was designed according to the requirements of biocompatibility. The microstructures and the mechanical properties of the new alloy were investigated by experiment. The excellent mechanical properties fully meet the service requirements of human bone tissue for mechanical property. Flat and dense hydroxyapatite coating was prepared on the surface of magnesium alloy matrix by preceding alkali heat treatment, electrodeposition and post alkali heat treatment. The Structure and constituent of HA coating and the biodegradation behavior of HA-coated Mg-4.0Zn-1.0Ca-0.6Zr (wt%) alloy were evaluated. Resuls showed that the degradation rate of HA-coated Mg-4.0Zn-1.0Ca-0.6Zr(wt%) alloy in SBF biomimetic solution decreased obviously and tended to be stable after 10 days. As degradable implantation materials, HA-coated Mg-4.0Zn-1.0Ca-0.6Zr(wt%) alloy fully meets the service requirements of human bone tissue.
C1 [Huang, Hong-qian; Guan, Ren-quo; Zhao, Zhan-yong; Cao, Fu-rong] NE Univ Shenyang, Sch Met & Mat, Shenyang 110819, Peoples R China.
   [Zhao, Tong] Hosp Liaoning Univ Tradit Chinese Med, Shenyang 110032, Peoples R China.
RP Huang, HQ (reprint author), NE Univ Shenyang, Sch Met & Mat, Shenyang 110819, Peoples R China.
EM hghgqn@163.com; guanrg@smm.neu.edu.cn; zhaotong@126.com; syuzzy@126.com;
   cfr-lff@163.com
FU National Natural Science Foundation of China [51034002, 50974038,
   51074049]; New Century Excellent Talents in University [NCET-06-0285]
FX Authors thanks for the supports of National Natural Science Foundation
   of China under Grant Nos. 51034002, 50974038 and 51074049, and the
   Program for New Century Excellent Talents in University under Grant No.
   NCET-06-0285
CR Kojima Y, 2001, MATER TRANS, V42, P1154, DOI 10.2320/matertrans.42.1154
   Lhotka C, 2003, J ORTHOP RES, V21, P189, DOI 10.1016/S0736-0266(02)00152-3
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Lin FH, 2002, BIOMATERIALS, V23, P1981, DOI 10.1016/S0142-9612(01)00325-8
   Mao L., 2002, MICROELEMENT HLTH RE, V19, P72
   Masayuki I., 2002, BIOMATERIALS, V23, P833
   MURRAY MGS, 1995, J MATER SCI, V30, P3061, DOI 10.1007/BF01209218
   Rita C., 2002, BIOMATERIALS, V23, P2283
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Zhang E, 2005, SCRIPTA MATER, V53, P523, DOI 10.1016/j.scriptamat.2005.05.009
NR 10
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 706-709
BP 498
EP +
DI 10.4028/www.scientific.net/MSF.706-709.498
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBW89
UT WOS:000308517300079
DA 2018-10-19
ER

PT S
AU Kobayashi, S
   Ui, M
   Araikawa, H
   Sakamoto, T
   Nakai, K
AF Kobayashi, Sengo
   Ui, Michiko
   Araikawa, Hayato
   Sakamoto, Tatsuaki
   Nakai, Kiyomichi
BE Chandra, T
   Ionescu, M
   Mantovani, D
TI Effect of heat treatments of bioactive nacre on HAp formation in SBF
SO THERMEC 2011, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Processing and Manufacturing of Advanced
   Materials
CY AUG 01-05, 2011
CL Quebec City, CANADA
SP Minerals, Metals & Mat Soc
DE nacre; biomaterial; heat treatment; hydroxyapatite; bioactive; titanium;
   simulated body fluid; transmission electron microscopy
ID MECHANICAL CHARACTERIZATION; SHELL; BONE; BIOMINERALIZATION; COMPOSITES;
   INTERFACE; IMPLANTS; LAYERS; PEARL; SHEEP
AB Formation of hydroxyapatite (HAp) in simulated body fluid (SBF) on heated nacre has been examined. Nacre is known as composite layer of aragonite platelets and organic materials. Nacre was obtained from the shell of Akoya pearl oyster after removing its prismatic layer. The nacre was heated up to 300 degrees C in air and then soaked in SBF. Nacre heated at 300 degrees C lost iridescent color and became brittle, implying that organic materials which plays a role as glue between aragonite platelets mostly disappeared by heating at 300 degrees C. Formation of HAp particles on nacre in SBF was easier than that on pure Ti. Maximum formation rate of HAp particles was obtained on the nacre heated at 200 degrees C. The amount of HAp particles formed on the nacre heated at 300 degrees C is the smallest. The organic materials in nacre play a critical role for HAp formation on nacre in SBF.
EM kobayashi.sengo@eng.ehime-u.ac.jp; sakamoto.tatsuaki@eng.ehime-u.ac.jp;
   nakai.kiyomichi@eng.ehime-u.ac.jp
CR Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   Bourrat X., 2005, BIOMIN 2005 9 INT S, P6
   Bourrat X, 2007, CRYSTENGCOMM, V9, P1205, DOI 10.1039/b709388h
   Dauphin Y, 2003, J BIOL CHEM, V278, P15168, DOI 10.1074/jbc.M204375200
   Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036
   Frederic M., 2007, HDB BIOMINERALIZATIO, P273
   FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0
   Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011
   Gries K, 2009, ACTA BIOMATER, V5, P3038, DOI 10.1016/j.actbio.2009.04.017
   Huang ZW, 2009, MAT SCI ENG C-MATER, V29, P1803, DOI 10.1016/j.msec.2009.02.007
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Li XD, 2004, NANO LETT, V4, P613, DOI 10.1021/nl049962k
   Li XD, 2007, JOM-US, V59, P71, DOI 10.1007/s11837-007-0043-2
   Li XD, 2006, NANO LETT, V6, P2301, DOI 10.1021/nl061775u
   NAKAHARA H, 1982, Venus the Japanese Journal of Malacology, V41, P33
   Nudelman F, 2007, FARADAY DISCUSS, V136, P9, DOI 10.1039/b704418f
   Wang R, 2004, J MATER SCI, V39, P4961, DOI 10.1023/B:JMSC.0000035346.59232.49
   WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   YOSHIOKA S, 1985, GEOCHEM J, V19, P245, DOI 10.2343/geochemj.19.245
NR 22
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 706-709
BP 526
EP 531
DI 10.4028/www.scientific.net/MSF.706-709.526
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBW89
UT WOS:000308517300084
DA 2018-10-19
ER

PT S
AU Nakai, M
   Niinomi, M
   Zhao, XL
   Zhao, XF
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Zhao, Xiaoli
   Zhao, Xingfeng
BE Chandra, T
   Ionescu, M
   Mantovani, D
TI Young's Modulus Changeable Titanium Alloys for Orthopaedic Applications
SO THERMEC 2011, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Processing and Manufacturing of Advanced
   Materials
CY AUG 01-05, 2011
CL Quebec City, CANADA
SP Minerals, Metals & Mat Soc
DE Biomaterial; Beta-type titanium alloy; Young's modulus; Omega phase;
   Deformation-induced phase transformation
ID BIOMEDICAL APPLICATIONS
AB A novel biomedical titanium alloy with the ability to undergo self adjustment in its Young's modulus was developed. In spinal fixation devices, the Young's modulus of the metallic implant rod should be sufficiently high to suppress springback for the surgeon, but should also be sufficiently low to prevent stress shielding for the patient. Therefore, deformation-induced omega phase transformation was introduced into beta-type titanium alloys so that the Young's modulus of only the deformed part would increase during operation, while that of the non-deformed part would remain low. The increase in the Young's modulus due to cold rolling was investigated for a binary Ti-12Cr alloy (mass%). Microstructural observation and Young's modulus measurement reveal that the Ti-12Cr alloy undergoes deformation-induced omega phase transformation and exhibits the increase in the Young's modulus by deformation.
C1 [Nakai, Masaaki; Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan.
   [Zhao, Xiaoli; Zhao, Xingfeng] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Kyoto, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan.
EM nakai@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jp;
   zhaoxiaoli@imr.tohoku.ac.jp; zhao-xingfeng@imr.tohoku.ac.jp
FU Industrial Technology Research; New Energy and Industrial Technology
   Development Organization (NEDO); 18th ISIJ Research Promotion; Iron and
   Steel Institute of Japan (ISIJ)
FX This work was financially supported in part by the Industrial Technology
   Research Grant Program in 2009 from the New Energy and Industrial
   Technology Development Organization (NEDO) and the 18th ISIJ Research
   Promotion Grant from the Iron and Steel Institute of Japan (ISIJ).
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   HANADA S, 1986, J MATER SCI, V21, P4131, DOI 10.1007/BF01106518
   HANADA S, 1986, METALL TRANS A, V17, P1409, DOI 10.1007/BF02650122
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Sakaguchi N, 2003, J JPN I MET, V67, P681, DOI 10.2320/jinstmet1952.67.11_681
   Steib JP, 2004, SPINE, V29, P193, DOI 10.1097/01.BRS.0000107233.99835.A4
NR 11
TC 1
Z9 1
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 706-709
BP 557
EP +
DI 10.4028/www.scientific.net/MSF.706-709.557
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBW89
UT WOS:000308517300090
DA 2018-10-19
ER

PT S
AU Rimondini, L
   Demarosi, F
   Foltran, I
   Quirici, N
AF Rimondini, Lia
   Demarosi, Federica
   Foltran, Ismaela
   Quirici, Nadia
BE Chandra, T
   Ionescu, M
   Mantovani, D
TI RECONSTITUTED EXTRACELLULAR MATRIX IMPROVE OSTEOBLASTIC DIFFERENTIATION
   ONTO TITANIUM SURFACES
SO THERMEC 2011, PTS 1-4
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Processing and Manufacturing of Advanced
   Materials
CY AUG 01-05, 2011
CL Quebec City, CANADA
SP Minerals, Metals & Mat Soc
DE Electrospinning Extracellular matrix; Stem cell; Osteoblast; Titanium;
   cell Differentiation; Cell proliferation
ID TISSUE
AB Electrospinning technique is an efficient processing method to manufacture micro- and nano-sized fibrous structures by electrostatic force for different applications. In biomaterial field, electrospinning technique has been successfully utilized to prepare new drug delivery materials and tissue engineering scaffolds. Fiber mats of biodegradable polymers having a diameter in the nano- to submicro-scale can be considered to mimic the nanofibrous structure of native extracellular matrix (ECM).
   Native extracellular matrix, constituted of proteins and polysaccharides improving cells growth in its nanofibrous porous structure, controls not only the cell phenotype, but the whole structure of the biological tissues.
   In the present study we investigated the effect of electrospun reconstituted collagen fibers onto metals for oral implants devices manufacturing as far as the osteoblastic differentiation potential of stem cells and cytofunctionality of osteoblasts in-vitro. The cells cultured onto titanium samples coated with ECM constituents showed faster osteoblastic differentiation and more efficient deposition of mineralized matrix in comparison with those onto uncoated substrates.
C1 [Rimondini, Lia; Demarosi, Federica; Foltran, Ismaela] Univ Piemonte Orientale, Dept Med Sci, Via Solaroli 17, I-28100 Novara, Italy.
   [Quirici, Nadia] Fondazione Matarelli, Via Vanvitelli 32, I-20100 Milan, Italy.
RP Rimondini, L (reprint author), Univ Piemonte Orientale, Dept Med Sci, Via Solaroli 17, I-28100 Novara, Italy.
EM lia.rimondini@med.unipmn.it; federica.demarosi@lepabri.it;
   ismaela.foltran@med.unipmn.it; nadiaquirici@fastwebnet.it
CR Brown SA, 2010, PLAST RECONSTR SURG, V126, P1936, DOI 10.1097/PRS.0b013e3181f44790
   Foltran I, 2008, MACROMOL SYMP, V269, P111, DOI 10.1002/masy.200850914
   Hemmat S, 2010, FACIAL PLAST SURG, V26, P343, DOI 10.1055/s-0030-1265015
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56
   Parma B, 2002, [No title captured], Patent No. [WO 02097990, 02097990]
   Rimondini L, 2009, Minerva Stomatol, V58, P483
   Tuzlakoglu K, 2009, TISSUE ENG PART B-RE, V15, P17, DOI 10.1089/ten.teb.2008.0016
NR 8
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 706-709
BP 584
EP +
DI 10.4028/www.scientific.net/MSF.706-709.584
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBW89
UT WOS:000308517300095
DA 2018-10-19
ER

PT J
AU Ravichandran, R
   Venugopal, JR
   Sundarrajan, S
   Mukherjee, S
   Ramakrishna, S
AF Ravichandran, Rajeswari
   Venugopal, Jayarama Reddy
   Sundarrajan, Subramanian
   Mukherjee, Shayanti
   Ramakrishna, Seeram
TI Minimally invasive cell-seeded biomaterial systems for
   injectable/epicardial implantation in ischemic heart disease
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE cardiac-tissue engineering; injectable system; myocardial infarction;
   biomaterials
ID EMBRYONIC STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; ACUTE
   MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; LEFT-VENTRICULAR FUNCTION;
   SKELETAL MYOBLAST TRANSPLANTATION; TISSUE ENGINEERING APPLICATIONS;
   IMPROVES CARDIAC-FUNCTION; ASSEMBLING PEPTIDE NANOFIBERS; HUMAN
   ADIPOSE-TISSUE
AB Myocardial infarction (MI) is characterized by heart-wall thinning, myocyte slippage, and ventricular dilation. The injury to the heart-wall muscle after MI is permanent, as after an abundant cell loss the myocardial tissue lacks the intrinsic capability to regenerate. New therapeutics are required for functional improvement and regeneration of the infarcted myocardium, to overcome harmful diagnosis of patients with heart failure, and to overcome the shortage of heart donors. In the past few years, myocardial tissue engineering has emerged as a new and ambitious approach for treating MI. Several left ventricular assist devices and epicardial patches have been developed for MI. These devices and acellular/cellular cardiac patches are employed surgically and sutured to the epicardial surface of the heart, limiting the region of therapeutic benefit. An injectable system offers the potential benefit of minimally invasive release into the myocardium either to restore the injured extracellular matrix or to act as a scaffold for cell delivery. Furthermore, intramyocardial injection of biomaterials and cells has opened new opportunities to explore and also to augment the potentials of this technique to ease morbidity and mortality rates owing to heart failure. This review summarizes the growing body of literature in the field of myocardial tissue engineering, where biomaterial injection, with or without simultaneous cellular delivery, has been pursued to enhance functional and structural outcomes following MI. Additionally, this review also provides a complete outlook on the tissue-engineering therapies presently being used for myocardial regeneration, as well as some perceptivity into the possible issues that may hinder its progress in the future.
C1 [Venugopal, Jayarama Reddy] Natl Univ Singapore, Fac Engn, Ctr Nanofibers & Nanotechnol, Healthcare & Energy Mat Lab, Singapore 117576, Singapore.
   [Ravichandran, Rajeswari; Sundarrajan, Subramanian; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Venugopal, JR (reprint author), Natl Univ Singapore, Fac Engn, Ctr Nanofibers & Nanotechnol, Healthcare & Energy Mat Lab, Block E3,05-12,2 Engn Dr 3, Singapore 117576, Singapore.
EM nnijrv@nus.edu.sg; seeram@nus.edu.sg
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-065-592]; Ministry of Education
   [R-265-000-318-112]; NUSNNI, National University of Singapore, Singapore
FX This study was supported by NRF-Technion (R-398-001-065-592), Ministry
   of Education (R-265-000-318-112), and NUSNNI, National University of
   Singapore, Singapore.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   ALBINI A, 1992, INT J CANCER, V52, P234, DOI 10.1002/ijc.2910520214
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Badylak SF, 2002, HEART SURG FORUM, V6, pE20
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baig MK, 1999, HEART LUNG, V28, P87, DOI 10.1053/hl.1999.v28.a97762
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   Bartunek J, 2007, AM J PHYSIOL-HEART C, V292, pH1095, DOI 10.1152/ajpheart.01009.2005
   Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com
   Behfar A, 2005, STEM CELL BIOL DEV P
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Beitnes JO, 2011, EXPERT REV CARDIOVAS, V9, P1015, DOI [10.1586/ERC.11.108, 10.1586/erc.11.108]
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Bing OHL, 1997, J MOL CELL CARDIOL, V29, P2335, DOI 10.1006/jmcc.1997.0465
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   BORG TK, 1983, DEV BIOL, V97, P417, DOI 10.1016/0012-1606(83)90098-2
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caspi O, 2006, EUR HEART J SUPPL, V8, pE43, DOI 10.1093/eurheartj/sul031
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chang AC, 2006, HEART FAILURE CHILDR
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chi NH, 2012, BIOMATERIALS, V33, P5541, DOI 10.1016/j.biomaterials.2012.04.030
   Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008
   Chiu LLY, 2012, FRONT BIOSCI-LANDMRK, V17, P1533, DOI 10.2741/4002
   Choi YS, 2010, BIOMATERIALS, V31, P2236, DOI 10.1016/j.biomaterials.2009.11.097
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, TRANSPL IMMUNOL, V15, P91, DOI 10.1016/j.trim.2005.09.004
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dib N, 2002, J ENDOVASC THER, V9, P313, DOI 10.1583/1545-1550(2002)009<0313:ETOASM>2.0.CO;2
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Doss MX, 2004, J CELL MOL MED, V8, P465, DOI 10.1111/j.1582-4934.2004.tb00471.x
   EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2001.1391
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fukada J, 2001, TRANSPLANT INT, V14, P311, DOI 10.1111/j.1432-2277.2001.tb00065.x
   Fukuda K, 2003, CYTOTECHNOLOGY, V41, P165, DOI 10.1023/A:1024882908173
   Gao Lian-ru, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P582
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Genovese JA, 2009, FRONT BIOSCI-LANDMRK, V14, P2996, DOI 10.2741/3429
   Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095
   Grinnemo KH, 2006, ANN MED, V38, P144, DOI 10.1080/07853890500422982
   Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21
   Guo XM, 2006, CIRCULATION, V113, P2229, DOI 10.1161/CIRCULATIONAHA.105.583039
   Hamano K, 2001, JPN CIRC J, V65, P845, DOI 10.1253/jcj.65.845
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Herrmann JL, 2010, SHOCK, V33, P24, DOI 10.1097/SHK.0b013e3181b7d137
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hocht-Zeisberg E, 2004, EUR HEART J, V25, P749, DOI 10.1016/j.ehj.2004.01.017
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124
   Katritsis DG, 2007, EUROPACE, V9, P167, DOI 10.1093/europace/eul184
   Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0
   Kutschka I, 2007, J HEART LUNG TRANSPL, V26, P273, DOI 10.1016/j.healun.2006.11.604
   Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297
   Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1997, CIRCULATION, V96, P179
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P62, DOI 10.1016/S0022-5223(00)70218-2
   Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036
   Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   MARELLI D, 1992, TRANSPLANT P, V24, P2995
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4
   Menard C, 2005, LANCET, V366, P1005, DOI 10.1016/S0140-6736(05)67380-1
   Menard C, 2004, J CELL BIOCHEM, V93, P681, DOI 10.1002/jcb.20259
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosi.2005.10.009
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Min JY, 2002, J APPL PHYSIOL, V92, P288
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Mukherjee S, 2011, ADV FUNCT MATER, V21, P2291, DOI 10.1002/adfm.201002434
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154
   Nunes SS, 2011, J CARDIOVASC TRANSL, V4, P592, DOI 10.1007/s12265-011-9307-x
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Packer M, 2002, J CARD FAIL, V8, P193, DOI 10.1054/jcaf.2002.128001
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47
   Pouly J, 2004, CIRCULATION, V110, P1626, DOI 10.1161/01.CIR.0000142861.55862.15
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ravichandran R, INT J CARDIOL
   Ravichandran R, 2011, TISSUE ENG PT A, V17, P1363, DOI [10.1089/ten.tea.2010.0441, 10.1089/ten.TEA.2010.0441]
   Ravichandran R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385102
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   ROBINSON TF, 1988, CIRC RES, V63, P577, DOI 10.1161/01.RES.63.3.577
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sarig U, 2011, EXPERT OPIN BIOL TH, V11, P1055, DOI 10.1517/14712598.2011.578574
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Schenke-Layland K, 2009, J SURG RES, V153, P217, DOI 10.1016/j.jss.2008.03.019
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Sesti C, 2005, J AM COLL CARDIOL, V46, P1662, DOI 10.1016/j.jacc.2005.08.012
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smaill BH, 1991, THEORY HEART
   Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011
   Solheim S, 2008, AM HEART J, V155, pe1
   SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stile RA, 2004, J BIOMAT SCI-POLYM E, V15, P865, DOI 10.1163/1568562041271129
   Stokke BT, 2000, MACROMOLECULES, V33, P1853, DOI 10.1021/ma991559q
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Tambara K, 2003, CIRCULATION, V108, P259, DOI 10.1161/01.cir.0000087430.17543.b8
   Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072
   Taylor DA, 2002, CIRCULATION, V106, P2, DOI 10.1161/01.CIR.0000024386.99599.4A
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tomfscot A, 2007, STEM CELLS, V25, P2200, DOI 10.1634/stemcells.2007-0133
   Tomita S, 1999, CIRCULATION, V100, P247
   Torrent-Guasp F, 2001, J THORAC CARDIOV SUR, V122, P389, DOI 10.1067/mtc.2001.113745
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50
   Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wang HB, 2012, J CELL MOL MED, V16, P1310, DOI 10.1111/j.1582-4934.2011.01409.x
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu KH, 2006, EUR J CARDIO-THORAC, V30, P770, DOI 10.1016/j.ejcts.2006.08.003
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JC1200522326
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zhang Y, 2008, CIRC-CARDIOVASC IMAG, V1, P197, DOI 10.1161/CIRCIMAGING.108.781120
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 231
TC 17
Z9 17
U1 0
U2 27
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 5969
EP 5994
DI 10.2147/IJN.S37575
PG 26
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 052FV
UT WOS:000312184000001
PM 23271906
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Mallampati, R
   Valiyaveettil, S
AF Mallampati, Ramakrishna
   Valiyaveettil, Suresh
TI Application of tomato peel as an efficient adsorbent for water
   purification-alternative biotechnology?
SO RSC ADVANCES
LA English
DT Article
ID LOW-COST ADSORBENT; AQUEOUS-SOLUTION; ACTIVATED CARBON; HEAVY-METALS;
   WASTE-WATER; RICE HUSK; ISOTHERM ANALYSIS; BASIC DYE; ADSORPTION;
   REMOVAL
AB Heavy metal ions and dissolved organic compounds in waste water are known to adversely affect human health, aquatic life and the overall ecosystem. Many hazardous pollutants need to be removed from drinking water; however, such technologies are not accessible for economically disadvantaged people around the world. Naturally abundant tomato peels or other biomembranes are used as an efficient biomaterial to remove toxic metal ions and organic pollutants from aqueous solution. The functional groups and morphologies of the tomato peels were characterized using FT-IR and FESEM, respectively. Factors such as pH, nature and amount of adsorbent used for extraction were studied to establish the optimum conditions. The maximum adsorption capacity was observed at different pH values for different pollutants. The equilibrium adsorption data were interpreted by using Freundlich and Langmuir isotherms and the adsorption mechanism was investigated by kinetic studies. Results showed that tomato peels have good potential as an efficient adsorbent to remove various pollutants from water.
C1 [Mallampati, Ramakrishna; Valiyaveettil, Suresh] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
RP Mallampati, R (reprint author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
EM chmsv@nus.edu.sg
FU Environment and Water Industry Programme Office (EWI) under the National
   Research Foundation of Singapore [PUBPP 21100/36/2, R-706-002-013-290,
   R-143-000-458-750, R-143-000-458-731]; National University of Singapore
FX The authors thank the Environment and Water Industry Programme Office
   (EWI) under the National Research Foundation of Singapore (PUBPP
   21100/36/2, NUS WBS no. R-706-002-013-290, R-143-000-458-750,
   R-143-000-458-731) for their financial support of the work. RM also
   thanks the National University of Singapore for a scholarship for
   graduate studies.
CR Bhatnagar A, 2010, BIOCHEM ENG J, V48, P181, DOI 10.1016/j.bej.2009.10.005
   Bhattacharyya KG, 2011, DESALINATION, V272, P66, DOI 10.1016/j.desal.2011.01.001
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Denizli A, 2005, BIORESOURCE TECHNOL, V96, P59, DOI 10.1016/j.biortech.2003.11.029
   Duran C, 2011, J CHEM ENG DATA, V56, P2136, DOI 10.1021/je101204j
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Fernandes A, 2004, DYES PIGMENTS, V61, P287, DOI 10.1016/j.jdyepig.2003.11.008
   Orozco AMF, 2008, J HAZARD MATER, V150, P46, DOI 10.1016/j.jhazmat.2007.04.043
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gunay A, 2007, J HAZARD MATER, V146, P362, DOI 10.1016/j.jhazmat.2006.12.034
   Gupta VK, 2006, J COLLOID INTERF SCI, V303, P80, DOI 10.1016/j.jcis.2006.07.036
   Hamdaoui O, 2007, J HAZARD MATER, V147, P401, DOI 10.1016/j.jhazmat.2007.01.023
   Hameed BH, 2008, J HAZARD MATER, V158, P499, DOI 10.1016/j.jhazmat.2008.01.098
   Hameed BH, 2008, COLLOID SURFACE A, V316, P78, DOI 10.1016/j.colsurfa.2007.08.033
   Han RP, 2007, J HAZARD MATER, V141, P156, DOI 10.1016/j.jhazmat.2006.06.107
   Hetzroni A, 2011, POSTHARVEST BIOL TEC, V59, P80, DOI 10.1016/j.postharvbio.2010.08.008
   Jezierska B, 2009, FISH PHYSIOL BIOCHEM, V35, P625, DOI 10.1007/s10695-008-9284-4
   Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649
   Jung MW, 2001, MICROCHEM J, V70, P123, DOI 10.1016/S0026-265X(01)00109-6
   Kennedy LJ, 2007, CHEM ENG J, V132, P279, DOI 10.1016/j.cej.2007.01.009
   Krishnani KK, 2008, J HAZARD MATER, V153, P1222, DOI 10.1016/j.jhazmat.2007.09.113
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Langmuir I., 1918, J AM CHEM SOC, V40, P136
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li JM, 2009, BIORESOURCE TECHNOL, V100, P1168, DOI 10.1016/j.biortech.2008.09.015
   Mahanta N, 2012, J MATER CHEM, V22, P1985, DOI 10.1039/c1jm15018a
   Mahmoodi NM, 2006, J COLLOID INTERF SCI, V295, P159, DOI 10.1016/j.jcis.2005.08.007
   Mallampati R, 2012, J NANOSCI NANOTECHNO, V12, P618, DOI 10.1166/jnn.2012.5365
   MANJU GN, 1998, WATER RES, V32, P30662
   Mansour SA, 2011, NATO SCI PEACE SEC A, P73, DOI 10.1007/978-94-007-1100-6_6
   Mittal A, 2007, J HAZARD MATER, V148, P229, DOI 10.1016/j.jhazmat.2007.02.028
   Mohanty K, 2006, IND ENG CHEM RES, V45, P5165, DOI 10.1021/ie060257r
   Navarro-Gonzalez I, 2011, FOOD RES INT, V44, P1528, DOI 10.1016/j.foodres.2011.04.005
   Ngah WSW, 2008, BIORESOURCE TECHNOL, V99, P3935, DOI 10.1016/j.biortech.2007.06.011
   Prahas D, 2008, CHEM ENG J, V140, P32, DOI 10.1016/j.cej.2007.08.032
   Radhika M, 2006, J HAZARD MATER, V138, P116, DOI 10.1016/j.jhazmat.2006.05.045
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Verma VK, 2010, GLOBAL NEST J, V12, P190
   Wang SL, 2007, J HAZARD MATER, V147, P313, DOI 10.1016/j.jhazmat.2007.01.031
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   WEBER WJ, 1965, WATER RESOUR RES, V1, P361, DOI 10.1029/WR001i003p00361
NR 41
TC 21
Z9 21
U1 2
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2012
VL 2
IS 26
BP 9914
EP 9920
DI 10.1039/c2ra21108d
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 051OL
UT WOS:000312136800028
DA 2018-10-19
ER

PT S
AU Saju, KK
   Sreejith, PS
AF Saju, K. K.
   Sreejith, P. S.
BE Jobbagy, A
TI Prediction of Bone Implant Interface Based on a Molecular Level
   Interaction
SO 5TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND
   BIOLOGICAL ENGINEERING, PTS 1 AND 2
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 5th European Conference of the International Federation for Medical and
   Biological Engineering
CY SEP 14-18, 2011
CL Budapest, HUNGARY
DE Molecular orbital approach; Orthopedic implants; HOMO; LUMO
ID FIXATION; INGROWTH; CEMENT
AB Uncontrolled interactions between synthetic materials and human tissues are a major concern for implants and tissue engineering. It is well recognized that osteoblasts (bone cells) preferentially adhere to specific amino acid sequences such as arginine-glycine-aspartic acid (RGD) and heparin-sulphate ligand binding regions in adsorbed proteins. Accordingly, how specific amino acid sequences are exposed in adsorbed proteins to associate with binding to integrin receptors in cell membranes is critical to whether cell adhesion will occur on an implant surface. The abundance of positive binding sites to electron deficient sites of the protein molecules presents a strong case for adhesion of these cell adhesion ligands on to a biomaterial surface. This paper reviews the study based on a molecular orbital interactive method for prediction of the biocompatibility of implants based on a protein-biomaterial surface interaction.
C1 [Saju, K. K.; Sreejith, P. S.] Cochin Univ Sci & Technol, Kochi, India.
RP Saju, KK (reprint author), Cochin Univ Sci & Technol, Kochi, India.
CR Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Breme J., 1998, METALS BIOMATERIALS, P37
   Bretne J., 1998, METALS BIOMATERIALS, P1
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   HEINER JP, 1994, J ORTHOP RES, V12, P657, DOI 10.1002/jor.1100120508
   JACOBS JJ, 2000, BIOL RESPONSE ORTHOP, P401
   Jayadas N. H., CALCULATIONS TRIBOLO, DOI [10.1115/1.2197853, DOI 10.1115/1.2197853]
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P15
   Pilliar RM, 2005, ORTHOP CLIN N AM, V36, P113, DOI 10.1016/j.ocl.2004.08.001
   Saju KK, 2009, P I MECH ENG H, V223, P1049, DOI 10.1243/09544119JEIM568
   Saju K K, J ENG MED IN PRESS, DOI [10.1243/09544119JEIM4817, DOI 10.1243/09544119JEIM817]
   SCHATZKER J, 1975, CLIN ORTHOP RELAT R, P257
   Stuart B, 2008, BIOCOMPATIBILITY TOT, DOI [10.1002/jbm.a.32063, DOI 10.1002/JBM.A.32063]
   Willert HG, 1999, J LONG-TERM EFF MED, V9, P113
   Williams David, 2003, Med Device Technol, V14, P10
   WILLIAMS DF, 1976, MED PROG TECHNOL, V4, P31
   Wright T., 2001, IMPLANT WEAR TOTAL J
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
NR 23
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-23507-8
J9 IFMBE PROC
PY 2012
VL 37
BP 385
EP 388
PG 4
WC Engineering, Biomedical
SC Engineering
GA BCP21
UT WOS:000310938200100
DA 2018-10-19
ER

PT S
AU Haga, S
   Takezawa, T
   Ozawa, T
   Remington, SJ
   Morita, N
   Ozaki, M
AF Haga, S.
   Takezawa, T.
   Ozawa, T.
   Remington, S. J.
   Morita, N.
   Ozaki, M.
BE Jobbagy, A
TI 'Collagen Vitrigel Sheet' as a Novel Drug Delivery Bio-material
SO 5TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND
   BIOLOGICAL ENGINEERING, PTS 1 AND 2
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 5th European Conference of the International Federation for Medical and
   Biological Engineering
CY SEP 14-18, 2011
CL Budapest, HUNGARY
DE vitrigel; HGF; ischemia/reperfusion; biomaterial
ID IN-VIVO; MEMBRANE USEFUL; ISCHEMIA/REPERFUSION; INHIBITION; CELLS; RAC1;
   HGF
AB Background/Aims. Ischemia/reperfusion (I/R)-induced injury is an acute injury mainly caused by surgical procedures. And HGF (hepatocyte growth factor) is known to protect against I/R-injury effectively. The sufficient dose of HGF must be topically delivered to the target organ to minimize the organ damage on surgery (reperfusion) and the dose of drug. For this purpose, we developed a novel technology for converting a fragile disk of the conventional type-I collagen gel into a strong and transparent 'vitrigel membrane', based on a concept for the vitrification of heat-denatured proteins.
   In the present study, we examined the efficacy of the newly designed 'HGF-containing collagen vitrigel sheet' as an effective drug delivery system in mouse liver I/R model.
   Materials and methods. Male C57Black6 mice were subjected to 60 min-liver ischemia (middle and left liver lobes) and reperfusion. Immediately after liver ischemia, the ischemic liver lobes were covered by collagen vitrigel sheet containing (3 mu g/ml). Reperfused liver injury was evaluated by biochemical/histological methods and bio-imaging of hepatic oxidative stress (redox-sensitive GFP probe) and apoptosis (bioluminescent caspase-3 activity probe).
   Results. Collagen vitrigel sheet (containing hHGF) released hHGF until 96 hr in vitro and successfully delivered hHGF to the liver tissue suffering I/R. This effectively protected liver from I/R-induced injury. Blood biochemistry showed reduced levels of serum GOT/GPT/LDH, and liver histology revealed reduced necrotic area in the hHGF-treated liver. Oxidative stress and caspase-3 activity of the liver were examined by bio-imaging, which revealed that hHGF delivered by vitrigel sheet significantly reduced oxidative stress and apoptotic cell death in the post-ischemic liver.
   Conclusions. hHGF-containing collagen vitrigel sheet protected liver from I/R-induced injury. Collagen vitrigel sheet may have good therapeutic potential in topical drug delivery in various clinical settings.
C1 [Haga, S.; Ozaki, M.] Hokkaido Univ, Sch Med, Dept Mol Surg, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.
   [Haga, S.] JSPS, Tokyo, Japan.
   [Takezawa, T.] Transgen Anim Res Ctr, Natl Inst Agrobiolog Sci, Tsukuba, Ibaraki, Japan.
   [Ozawa, T.] Univ Tokyo, Sch Sci, Dept Chem, Tokyo, Japan.
   [Remington, S. J.] Howard Hughes Med Inst, Inst Mol Biol, Eugene, OR 97403 USA.
   [Morita, N.] Bioprod Res Inst, Adv Ind Sci & Technol, Sapporo, Hokkaido, Japan.
RP Ozaki, M (reprint author), Hokkaido Univ, Sch Med, Dept Mol Surg, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.
EM ozaki-m@med.hokudai.ac.jp
RI Morita, Naoki/M-6399-2018
OI Morita, Naoki/0000-0002-5758-4014
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [17659396, 19659317, 20249060, 23249066]; JSPS
FX We thank Ms. Rumi Igarashi for her excellent technical support. This
   work was supported by a Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science, and Technology of Japan
   (#17659396, 19659317, 20249060 and 23249066 to MO) and JSPS grant for
   Young Scientists (SH).
CR Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538
   Michalopoulos G K, 1995, Prog Clin Biol Res, V391, P179
   Ohmichi H, 1996, AM J PHYSIOL-LUNG C, V270, pL1031
   Oreopoulos GD, 2004, HEPATOLOGY, V40, P211, DOI 10.1002/hep.20281
   Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172
   Ozaki M, 2000, FASEB J, V14, P418
   Takayama Y, 2003, J BIOL CHEM, V278, P22112, DOI 10.1074/jbc.M300894200
   Takezawa T, 2004, CELL TRANSPLANT, V13, P463, DOI 10.3727/000000004783983882
   Takezawa T, 2007, CELLS TISSUES ORGANS, V185, P237, DOI 10.1159/000101325
   Takezawa T, 2007, J BIOTECHNOL, V131, P76, DOI 10.1016/j.jbiotec.2007.05.033
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-23507-8
J9 IFMBE PROC
PY 2012
VL 37
BP 1354
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BCP21
UT WOS:000310938200349
DA 2018-10-19
ER

PT S
AU Moreira, AC
   Rouxinol, RLM
   Santos, PAD
   Fernandes, CP
   Ribeiro, AA
   Balestra, RM
   De Oliveira, MV
AF Moreira, Anderson Camargo
   Marques Rouxinol, Ricardo Leo
   de Azevedo Santos, Pedro Alvim
   Fernandes, Celso Peres
   Ribeiro, Alexandre Antunes
   Balestra, Roseli Marins
   De Oliveira, Marize Varella
BE Salgado, L
   Ambrozio, F
TI THREE-DIMENSIONAL STOCHASTIC MODELING AND X-RAY MICROTOMOGRAPHY APPLIED
   TO TITANIUM SCAFFOLDS: A COMPARATIVE APPROACH
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE Scaffold; Titanium; X-ray microtomography; 3D Image; Truncated Gaussian
ID POROUS-MEDIA
AB The performance of biomaterial scaffolds for bone tissue engineering, as porous titanium implants, is strongly dependent of its structural features. A reliable structural characterization of this kind of implant is very important. The most of image analysis techniques just supplies 2D information about the structure of specimens. X-ray microtomography is imaging technique that can produce 3D images of samples, however, stochastic models can also estimate properties of porous materials in 3D. This work presents the evaluation of a 3D model (using a truncated Gaussian method) in comparison to 3D microtomography volume, both from a titanium scaffold sample. In order to compare, geometrical parameters were measured for both 3D volumes. By the results, the truncated Gaussian 3D method reproduced a model with similar values to the microtomography volume, showing a good agreement among data, which suggests the use of this technique to estimate physical parameters of titanium scaffolds
C1 [Moreira, Anderson Camargo; de Azevedo Santos, Pedro Alvim; Fernandes, Celso Peres] Univ Fed Santa Catarina, Lab Meios Porosos & Propriedades Termofis, Depto Eng Mecan, BR-88040900 Florianopolis, SC, Brazil.
   [Marques Rouxinol, Ricardo Leo] Univ Fed Santa Catarina, Depto Eng Eletrica, EEL, BR-88040900 Florianopolis, SC, Brazil.
   [Ribeiro, Alexandre Antunes; Balestra, Roseli Marins; De Oliveira, Marize Varella] Inst Nacl Tecnol, Lab Technol Pos, BR-20081312 Rio De Janeiro, Brazil.
RP Moreira, AC (reprint author), Univ Fed Santa Catarina, Lab Meios Porosos & Propriedades Termofis, Depto Eng Mecan, BR-88040900 Florianopolis, SC, Brazil.
EM anderson@lmpt.ufsc.br; leo_rouxinol@yahoo.com.br;
   pedroazevedosantos@gmail.com; celso@lmpt.ufsc.br;
   alexandre.antunes@int.gov.br; roseli.balestra@int.gov.br;
   marize.varella@int.gov.br
RI Fernandes, Celso/O-9228-2014; Camargo Moreira, Anderson/O-1943-2018
OI Fernandes, Celso/0000-0001-9815-4398; Camargo Moreira,
   Anderson/0000-0003-1229-3616
FU "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro" (FAPERJ); CAPES; CNPq
FX The authors thank to Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ), CAPES and CNPq for financial
   support.
CR Appoloni CR, 2007, NUCL INSTRUM METH A, V580, P629, DOI 10.1016/j.nima.2007.05.027
   Farrier LM, 2005, MATER CHARACT, V55, P179, DOI 10.1016/j.matchar.2005.04.009
   Ioannidis M.A., 1995, PETR COMP C HOUST TX
   Joshi M.Y., 1974, THESIS
   Landis EN, 2010, MATER CHARACT, V61, P1305, DOI 10.1016/j.matchar.2010.09.012
   Li H., 2007, JAP MAT T, V45-4, P1124
   Liang ZR, 1998, J PETROL SCI ENG, V21, P273, DOI 10.1016/S0920-4105(98)00077-1
   Moreira AC, 2010, ADV APPL CERAM, V109, P416, DOI 10.1179/174367510X12722693956158
   Oliveira M.V., 2008, MATER SCI FORUM, V591-593, P36
   Pilliar R.M., 2003, BIOIMPLANT INTERFACE
   QUIBLIER JA, 1984, J COLLOID INTERF SCI, V98, P84, DOI 10.1016/S0021-9797(84)80012-0
   Rak ZS, 2006, J MATER PROCESS TECH, V175, P358, DOI 10.1016/j.jmatprotec.2005.04.006
NR 12
TC 0
Z9 0
U1 2
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 67
EP +
DI 10.4028/www.scientific.net/MSF.727-728.67
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100012
DA 2018-10-19
ER

PT S
AU Barbosa, LP
   Souza, EC
   Salgado, L
   Costa, I
AF Barbosa, L. P.
   Souza, Elki C.
   Salgado, L.
   Costa, I.
BE Salgado, L
   Ambrozio, F
TI EFFECT OF THE SINTERING ATMOSPHERE ON THE CORROSION RESISTANCE OF
   TITANIUM FOR APPLICATION AS BIOMATERIAL
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE corrosion; titanium; powder metallurgy; sintering atmosphere; vacuum
ID POROUS TITANIUM; BEHAVIOR
AB In this work, the effect of sintering atmosphere on the corrosion resistance of sintered titanium has been evaluated in 0.9 % aqueous NaCl solution to simulate physiological environment. Corrosion tests were performed on titanium porous sintered under vacuum and vacuum plus dynamic argon. The results showed better passive properties associated to the titanium sintered under argon plus vacuum atmosphere than to the vacuum sintered titanium. The better corrosion resistance of the argon plus vacuum sintered titanium was attributed to the formation of a thin passive film on the titanium surface during sintering due the low oxygen content present in this atmosphere.
C1 [Barbosa, L. P.; Souza, Elki C.; Costa, I.] IPEN, Av Prof Lineu Prestes 2242, BR-05422970 Usp, SP, Brazil.
   [Barbosa, L. P.; Souza, Elki C.; Costa, I.] Cidade Univ, BR-07750000 Usp, SP, Brazil.
   [Salgado, L.] BRATS, ., BR-07750000 Cajamar, SP, Brazil.
RP Barbosa, LP (reprint author), IPEN, Av Prof Lineu Prestes 2242, BR-05422970 Usp, SP, Brazil.
EM luzinete_barbosa@yahoo.com.br; elkicsouza@yahoo.com.br;
   lucio@brats.com.br; icosta@ipen.br
RI Souza, Elki/K-3161-2016
OI Souza, Elki/0000-0003-2063-7423
CR Anokhin VM, 1998, MAT SCI ENG A-STRUCT, V243, P269, DOI 10.1016/S0921-5093(97)00812-5
   Arslan H, 2008, J APPL ELECTROCHEM, V38, P853, DOI 10.1007/s10800-008-9523-5
   Barbosa L, 2010, MATER SCI FORUM, V660-661, P188, DOI 10.4028/www.scientific.net/MSF.660-661.188
   Blackwood DJ, 2002, CORROS SCI, V44, P395, DOI 10.1016/S0010-938X(01)00080-4
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Covington L.C., CORROSION, V81, P7
   Holland L., 1963, VACUUM DEPOSITION TH, P122
   Oliveira M.V., 2002, Mat. Res., V5, P269, DOI 10.1590/S1516-14392002000300009
   Seah KHW, 1998, CORROS SCI, V40, P547, DOI 10.1016/S0010-938X(97)00152-2
   SEAH KHW, 1995, CORROS SCI, V37, P1333, DOI 10.1016/0010-938X(95)00033-G
   TEOH SH, 1993, BIOMATERIALS, V14, P407, DOI 10.1016/0142-9612(93)90142-O
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
NR 13
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 85
EP +
DI 10.4028/www.scientific.net/MSF.727-728.85
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100015
DA 2018-10-19
ER

PT S
AU Duvaizem, JH
   Fajardo, AM
   Barbosa, LP
   Bressiani, AH
   Takiishi, H
AF Duvaizem, J. H.
   Fajardo, A. M.
   Barbosa, L. P.
   Bressiani, A. H.
   Takiishi, H.
BE Salgado, L
   Ambrozio, F
TI PRODUCTION OF Ti-13Nb-13Zr ALLOY BY PM FOR BIOMEDICAL APPLICATIONS USING
   ZIRCONIUM OXIDE GRINDING BOWL AND BALLS
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE biomaterial; Ti-Nb-Zr alloys; Ti alloys; powder metallurgy; HD
AB In this present work Ti-13Nb-13Zr alloy was produced by PM using planetary ball mill with zirconium oxide grinding bowl and balls to reduce contamination. The effect of milling time upon microstructure and microhardness was studied. Powders have been produced by hydrogenation of Ti, Nb and Zr at 1MPa. Milling speed was 200 rpm during 90 to 360 min. Sintering was carried out at 1150 degrees C during 10h. Powder size distribution was analyzed using CILAS equipment and chemically characterized by X-Ray Fluorescence (XRF). Microhardness was determined by means of a Vickers microhardness tester. Microstructure and phases were analyzed employing scanning electron microscopy (SEM) and X-Ray diffraction.
C1 [Duvaizem, J. H.; Fajardo, A. M.; Barbosa, L. P.; Bressiani, A. H.; Takiishi, H.] Energet & Nucl Res Inst, BR-05508000 Sao Paulo, Brazil.
RP Duvaizem, JH (reprint author), Energet & Nucl Res Inst, Av Lineu Prestes 2242, BR-05508000 Sao Paulo, Brazil.
EM jduvaizem@ipen.br; luzinete@ipen.br; abressia@ipen.br; takiishi@ipen.br
RI Bressiani, Ana/I-1402-2012
CR Duvaizem J. H., 2009, THESIS I PESQ ENERG
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Laheurte P, 2010, J MECH BEHAV BIOMED, V3, P565, DOI 10.1016/j.jmbbm.2010.07.001
   Majumdar P, 2008, WEAR, V264, P1015, DOI 10.1016/j.wear.2007.08.005
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
NR 5
TC 0
Z9 0
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 102
EP 107
DI 10.4028/www.scientific.net/MSF.727-728.102
PG 6
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100018
DA 2018-10-19
ER

PT S
AU Aguiar, AA
   Lima, NB
   de Rossi, W
   Samad, RE
   Vieira, ND
   Braga, FJC
AF Aguiar, A. A.
   Lima, N. B.
   de Rossi, W.
   Samad, R. E.
   Vieira, N. D.
   Braga, F. J. C.
BE Salgado, L
   Ambrozio, F
TI Effects of Femtosecond Laser Irradiation on the Surfaces of Alumina and
   Alumina-Zirconia Composites
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE biomaterial; femtolaser; alumina; zirconia; apatite; biomimetic
AB Alumina and zirconia-alumina composite has been micro-structured in air using femtosecond laser. The threshold fluence of 6.2 J.cm(-2) found in this work is close to that found published in literature [1]. In the case of Al-Zr, the threshold fluence is 2.2 J.cm(-2).Surface femtosecond laser treatment increase the apatite deposition by biomimetic method on alumina and alumina-zirconia composite and depends on the condition of laser treatments.
C1 [Aguiar, A. A.; Lima, N. B.; de Rossi, W.; Samad, R. E.; Vieira, N. D.; Braga, F. J. C.] CNEN SP, IPEN, Sao Paulo, Brazil.
RP Aguiar, AA (reprint author), CNEN SP, IPEN, Sao Paulo, Brazil.
EM mandaabati@hotmail.com; nblima@ipen.br; wderossi@ipen.br;
   resamad@ipen.br; nilsondv@ipen.br; fjcbraga@ipen.br
RI Samad, Ricardo/A-8203-2008; Vieira, Nilson/G-4649-2012; de Rossi,
   Wagner/J-8344-2013
OI Samad, Ricardo/0000-0001-7762-8961; Vieira, Nilson/0000-0003-0092-9357;
   de Rossi, Wagner/0000-0003-1371-7521
CR Aguiar A.A., 2007, THESIS USP SAO PAULO
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Garcia R.H.L., 2005, 5 INT LAT AM C POWD
   Hao L, 2004, J MATER SCI-MATER M, V15, P967, DOI 10.1023/B:JMSM.0000042682.20595.74
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kim SH, 2009, APPL SURF SCI, V255, P9717, DOI 10.1016/j.apsusc.2009.04.058
   Moraes MCCS, 2004, MAT RES, V7, P643
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Semak VV, 1998, SURFACE ENGN SER, V1, P35
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
NR 11
TC 0
Z9 0
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 603
EP 608
DI 10.4028/www.scientific.net/MSF.727-728.603
PG 6
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100106
DA 2018-10-19
ER

PT S
AU Santos, DV
   Casadei, APM
   Pereira, RV
   Aragones, A
   Salmoria, GV
   Fredel, MF
AF Santos, Diego Vieira
   Marzagao Casadei, Ana Paula
   Pereira, R., V
   Aragones, A.
   Salmoria, G., V
   Fredel, M. F.
BE Salgado, L
   Ambrozio, F
TI Development of Polymer/nanoceramic Composite Material with Potential
   Application in Biomedical Engineering
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE biomaterial; bioresorbable composite; poli(L-lactic acid) (PLLA);
   Hidroxyapatite (HA)
ID HYDROXYAPATITE HA PARTICLES; L-LACTIDE PLLA; BIORESORBABLE DEVICES;
   FORGED COMPOSITES
AB The rise of human life expectancy results in the increasing of elderly population and consequently the diseases of old age, which are mostly related with bone degenerative diseases. These problems also affect young individuals, commonly due to accidents (automobile and work). This fact has stimulated the research and development of materials that can replace or regenerate the damaged bone. From the engineering view, bone is a composite material consisting of an organic matrix (collagen), reinforced by an inorganic component (hydroxyapatite). The search for a suitable material, with properties tailored to the needs of the bone metabolism, as well as the adequate way of material processing, which ensures the maintenance or improvement of their initial properties, motivated this research. In this work was developed composite materials, based on bioresorbable polymer (PLLA) and phosphocalcic nanoceramic (HA). The composites were characterized by scanning electron microscopy (microstructure) and dynamical mechanical analyses (mechanical behavior). The results indicated these materials as promising for applications in the medical and dental manufacturing devices (plates and screws) by injection molding, and also for scaffolds by rapid manufacturing, in the tissue engineering area.
C1 [Santos, Diego Vieira; Marzagao Casadei, Ana Paula; Pereira, R., V; Fredel, M. F.] Univ Fed Santa Catarina, Dept Mech Engn, CERMAT, Florianopolis, SC, Brazil.
   [Aragones, A.] Univ Fed Santa Catarina, Odontol Dept, Florianopolis, SC, Brazil.
   [Salmoria, G., V] Univ Fed Santa Catarina, Dept Engn Mech, CIMJECT, Florianopolis, SC, Brazil.
RP Santos, DV (reprint author), Univ Fed Santa Catarina, Dept Mech Engn, CERMAT, Florianopolis, SC, Brazil.
EM diego.vieirasantos@gmail.com; casadeiap@hotmail.com; mfredel@emc.ufsc.br
RI FREDEL, MARCIO/K-6583-2012
CR Casadei A.P.M, 2010, CERAMIC ENG SCI P, V30, P169
   Deplaine H, 2010, COMPOS SCI TECHNOL, V70, P1805, DOI 10.1016/j.compscitech.2010.06.009
   Jayabalan M, 2010, ACTA BIOMATER, V6, P763, DOI 10.1016/j.actbio.2009.09.015
   Kumar AP, 2009, PROG POLYM SCI, V34, P479, DOI 10.1016/j.progpolymsci.2009.01.002
   Mizutani Y, 2005, POLYMER, V46, P3789, DOI 10.1016/j.polymer.2005.03.037
   Motta A.C., 2006, POLIMEROS, V26, P32
   Orefice R.L., 2006, FUNDAMENTOS APLICACO
   Park J. B., 2002, BIOMATERIALS PRINCIP
   Salmoria GV, 2009, POLYM TEST, V28, P648, DOI 10.1016/j.polymertesting.2009.05.008
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   Stares S.L., 2010, THESIS
   Wilberforce SIJ, 2011, ACTA BIOMATER, V7, P2176, DOI 10.1016/j.actbio.2011.02.006
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
NR 14
TC 3
Z9 3
U1 1
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 1142
EP +
DI 10.4028/www.scientific.net/MSF.727-728.1142
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100203
DA 2018-10-19
ER

PT S
AU Silva, AC
   Aparecida, AH
   Braga, FJC
AF Silva, A. C.
   Aparecida, A. H.
   Braga, F. J. C.
BE Salgado, L
   Ambrozio, F
TI Dispersed hydroxyapatite bioglass 45S5 composites: comparative
   evaluation of the use of bovine bone and synthetic hydroxyapatite
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE Hydroxyapatite; Biomaterials for bone replacement; bioglass
AB The bovine bone and sintetic hydroxyapatite (HA) bioceramics are reference materials to employment as a bone substitute, however, their slow rate of degradation and its low rate of bioactivity index (Ib) are presented as limiting factors for application as bone graft. In contrast, the bioglass is a resorbable and osteoinductive material, the present work objective the development of composites of dispersed bovine bone or sintetic HA in silicate-phosphate bioglass, seeking to obtain a biomaterial with properties suitable for application as bone grafts. The composites were prepared by mixing between the powder components followed by sintering for 1h. Were used HA and bioglass (45S5) with particle size <240 mu m. The tested proportions of HA/45S5 were 20/80, 30/70 and 40/60 (wt%). The composites characterization was made employing scanning electron microscopy, Infra-Red Spectrometry and hydrolytic resistance test. The test results indicate the potential use of the materials developed for applications such as bone graft.
C1 [Silva, A. C.; Aparecida, A. H.] Consulmat Prod Tecn Ind & Comercio Ltda, Rua Juan Lopes 159, Sao Carlos, SP, Brazil.
   [Silva, A. C.; Braga, F. J. C.] Unesp, IPEN, Sao Carlos, SP, Brazil.
   [Aparecida, A. H.] Unesp, Inst Quimica Araraquara, Sao Carlos, SP, Brazil.
RP Silva, AC (reprint author), Consulmat Prod Tecn Ind & Comercio Ltda, Rua Juan Lopes 159, Sao Carlos, SP, Brazil.
EM dasilva.ac@uol.com.br
FU Capes/Finep project PNPD/FINEP [2462095]; Fapesp [96/09604-9,
   99/01924-2, 0002483-9]
FX The authors would like to acknowledge the financial support and
   scholarships from Capes/Finep project PNPD/FINEP n.o 2462095 and to
   Fapesp, projects: 96/09604-9, 99/01924-2 & 0002483-9.
CR Day DE, 1998, J NON-CRYST SOLIDS, V241, P1, DOI 10.1016/S0022-3093(98)00759-5
   Guastaldi AC, 2010, QUIM NOVA, V33, P1352, DOI 10.1590/S0100-40422010000600025
   Hench L.L., 1996, J CERAM INT, V22, P493
   Hench L.L., 1993, ADV SERIES CERAMICS, V1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Herliansyah MK, 2007, MATER SCI FORUM, V561-565, P1441, DOI 10.4028/www.scientific.net/MSF.561-565.1441
   Li D, 2009, J NON-CRYST SOLIDS, V355, P874, DOI 10.1016/j.jnoncrysol.2009.04.026
   Miyahara R. Y., 2007, Cerâmica, V53, P234, DOI 10.1590/S0366-69132007000300004
   NAKAMURA S, 1990, THERMOCHIM ACTA, V165, P57, DOI 10.1016/0040-6031(90)80206-E
NR 9
TC 2
Z9 2
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 1147
EP +
DI 10.4028/www.scientific.net/MSF.727-728.1147
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100204
DA 2018-10-19
ER

PT S
AU Santos, FA
   dos Santos, C
   Rodrigues, D
   Pinatti, DG
   Davim, E
   Fernandes, MHFV
AF Santos, Felipe Antunes
   dos Santos, Claudinei
   Rodrigues, Durval, Jr.
   Pinatti, Daltro Garcia
   Davim, Erika
   Fernandes, Maria Helena F. V.
BE Salgado, L
   Ambrozio, F
TI Lithium Disilicate Bioceramic Obtained from Alternative Silica Source,
   the Rice Husk
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE Lithium disilicate; biomaterial; glass-ceramic; differential thermal
   analysis; rice husk silica; dental prosthesis
ID NONISOTHERMAL CRYSTALLIZATION; KINETICS; GLASS; P2O5
AB The crystallization process of lithium disilicate glass-ceramic with SiO2 from rice husk silica replacing the high-purity SiO2 starting powder has been investigated in this work. Glasses were developed at the stoichiometric composition of 66%.molSiO(2):33%.molLiO(2) using commercial SiO2 and the one obtained by thermochemical treatment of rice husk. The influence of rice husk-SiO2 on crystallization process to different granulometry, microstructure and kinetic behavior was determined and discussed. Investigations were carried out by means of differential thermal analysis (DTA), X-ray fluorescence (XRF), X-ray diffractometry (XRD) and scanning electron microscopy (SEM). Amorphous and transparent glasses were obtained after melting. The lithium disilicate glass-ceramic crystallization peaks (Tp) are between 550 to 660 degrees C to different granulometry (<63 mu m, 63 mu m < x < 250 mu m and 1mm < x < 2mm) and DTA heat rates (5; 10; 15; and 20 degrees C/min) in both glasses from different silica sources, and the formed phase was Li2Si2O5 as the crystalline phase after DTA thermal analysis as XRD confirmation. Improve in mechanical properties were estimated by morphological analysis of the microstructure modification in increasing the heat treatments temperature by SEM. The increase of glass substitution for crystalline phase was also observed with SEM images to both glass-ceramics from different silica sources.
C1 [Santos, Felipe Antunes; dos Santos, Claudinei; Rodrigues, Durval, Jr.; Pinatti, Daltro Garcia] Univ Sao Paulo, Escola Engn Lorena, Gleba Al-6,S-N Mondesir,PC 116, Lorena, SP, Brazil.
   [dos Santos, Claudinei] UNIFOA MeMAT, V. Redonda, Brazil.
   [Davim, Erika; Fernandes, Maria Helena F. V.] UA Campus Univ Santiago, 3810-193 Aveiro, Portugal.
RP Santos, FA (reprint author), Univ Sao Paulo, Escola Engn Lorena, Gleba Al-6,S-N Mondesir,PC 116, Lorena, SP, Brazil.
EM felipeantunes@usp.br; claudinei@demar.eel.usp.br;
   durval@demar.eel.usp.br; pinatti@demar.eel.usp.br; erikadavim@ua.pt;
   helena.fernandes@ua.pt
RI Fernandes, Maria Helena/K-6917-2014; Rodrigues Jr., Durval/I-9475-2012;
   Davim, Erika/K-3243-2013
OI Rodrigues Jr., Durval/0000-0001-6522-1777; V Fernandes, Maria
   Helena/0000-0002-1240-2512; Davim, Erika/0000-0002-7763-7005
FU CNPq; FAPESP; CAPES; University of Sao Paulo (USP); Institute of Nuclear
   an Energy Research (IPEN); University of Aveiro (UA)
FX The authors acknowledge the CNPq, FAPESP, CAPES, University of Sao Paulo
   (USP), Institute of Nuclear an Energy Research (IPEN) and University of
   Aveiro (UA) by their respective supports, in the laboratory structure
   and financial ways.
CR Al-Heniti SH, 2009, J ALLOY COMPD, V484, P177, DOI 10.1016/j.jallcom.2009.05.076
   Arora A, 2008, PHYSICA B, V403, P1738, DOI 10.1016/j.physb.2007.10.001
   Arvind A, 2008, J PHYS CHEM SOLIDS, V69, P2622, DOI 10.1016/j.jpcs.2008.06.003
   Goharian P, 2010, J NON-CRYST SOLIDS, V356, P208, DOI 10.1016/j.jnoncrysol.2009.11.015
   Kim SJ, 2004, SOLID STATE COMMUN, V131, P129, DOI 10.1016/j.ssc.2004.04.033
   Oliveira AL, 1998, J AM CERAM SOC, V81, P3270, DOI 10.1111/j.1151-2916.1998.tb02767.x
   Popescu C, 1996, THERMOCHIM ACTA, V285, P309, DOI 10.1016/0040-6031(96)02916-4
   Wen G, 2007, ACTA MATER, V55, P3583, DOI 10.1016/j.actamat.2007.02.009
   Yuan ZZ, 2006, J ALLOY COMPD, V407, P163, DOI 10.1016/j.jallcom.2005.06.022
NR 9
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 1158
EP +
DI 10.4028/www.scientific.net/MSF.727-728.1158
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100206
DA 2018-10-19
ER

PT S
AU Antonini, LM
   Mielczarski, RG
   Pigatto, C
   Muller, IL
   Malfatti, CD
AF Antonini, Leonardo Marasca
   Mielczarski, Rafael Gomes
   Pigatto, Caroline
   Mueller, Iduvirges Lourdes
   Malfatti, Celia de Fraga
BE Salgado, L
   Ambrozio, F
TI The influence of the operating parameters of titanium electropolishing
   to obtain nanostructured titanium surfaces
SO ADVANCED POWDER TECHNOLOGY VIII, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Latin American Conference on Powder Technology
CY NOV 06-09, 2011
CL Florianopolis, BRAZIL
SP Abbott, Air Prod, Ametek, Basf, Brats, Brutt, BS Metalurg, Citra, CTGAS, Dorst GIG, Engefor, GKN, GM, Grp Setorial M P, Haver, Hoganas, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, OMG, Shimadzu, Zoz
DE Electropolishing; Atomic Force Microscopy; Roughness; Titanium;
   Nanostructures; Biomaterial
ID CELLS
AB Titanium and Ti alloys have been widely used as biomaterial due to their mechanical properties and high in vitro and in vivo cytocompatibility. Studies have showed that the acceleration of the osseointegration process is associated to the modification of the surface morphology. The aim of this work is to study the influence of the operating parameters of titanium electropolishing to obtain nanostructured titanium surfaces. The titanium electropolishing was carried out with different temperatures (7 degrees C, 18 degrees C and 25 degrees C), current density of 0.19 A/cm(2) and electropolishing time of 8 minutes. After the electropolishing process the titanium samples were characterized by Atomic Force Microscopy, profilometry (mechanical profilometer) and contact angle measurements. Preliminary results showed that the Ti nanostructured surfaces formation, strongly depends on the control of operating parameters.
C1 [Antonini, Leonardo Marasca; Mielczarski, Rafael Gomes; Pigatto, Caroline; Mueller, Iduvirges Lourdes; Malfatti, Celia de Fraga] Univ Fed Rio Grande do Sul, LAPEC Lab Pesquisa Corrosao, BR-91501970 Porto Alegre, RS, Brazil.
RP Antonini, LM (reprint author), Univ Fed Rio Grande do Sul, LAPEC Lab Pesquisa Corrosao, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM lmantonini@yahoo.com.br; mielczarski_gomes@hotmail.com;
   carolpigatto@gmail.com; celia.malfatti@ufrgs.br; celia.malfatti@ufrgs.br
RI MALFATTI, CELIA/O-4102-2018
OI MALFATTI, CELIA/0000-0002-0819-479X
CR Carvalho Daniel Rey de, 2010, Braz. Dent. J., V21, P3, DOI 10.1590/S0103-64402010000100001
   Isaac J, 2010, EUR CELLS MATER, V20, P178
   Klein MO, 2010, CLIN ORAL IMPLAN RES, V21, P642, DOI 10.1111/j.1600-0501.2009.01883.x
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
NR 6
TC 0
Z9 0
U1 0
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2012
VL 727-728
BP 1638
EP 1642
DI 10.4028/www.scientific.net/MSF.727-728.1638
PG 5
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCM72
UT WOS:000310714100292
DA 2018-10-19
ER

PT J
AU Schulz, C
   von Rusten-Lange, M
   Kruger, A
   Lendlein, A
   Jung, F
AF Schulz, C.
   von Ruesten-Lange, M.
   Krueger, A.
   Lendlein, A.
   Jung, F.
TI Viability and function of primary human endothelial cells on smooth
   poly(ether imide) films
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterial; Poly(ether imide); biocompatibility; endothelialization
ID SHEAR-STRESS PATTERNS; ELUTING STENTS; IN-VITRO; PLASMA;
   BIOCOMPATIBILITY; BIOMATERIALS; EXPRESSION; ADHESION; IL-6;
   THROMBOXANE-A2
AB Poly(ether imide) (PEI) is being explored as potential biomaterial for cardiovascular applications. Different studies showed that human umbilical venous endothelial cells (HUVEC) are able to adhere and proliferate on PEI membranes (R-q = 13.20 +/- 1.58 nm). Arecently published study revealed evidence for much lower platelet adhesion on very smooth PEI-films (R-q = 2.37 +/- 1.40 nm).
   Therefore, we explored whether primary human venous endothelial cells (HUVEC) are able to adhere and proliferate on such very smooth PEI-films compared to tissue-cultured polystyrene (TCP) as reference material.
   Cytotoxicity testing revealed that PEI had a slight cytotoxic effect on HUVEC accompanied by a marginal reduced integrity of the plasma membrane and a significant lower mitochondrial activity. However long-term seeding experiments up to eleven days exhibited that HUVEC were able to proliferate on the PEI-films till confluence (TCP 96,190 +/- 18,289 cells/cm(2); PEI 91,590 +/- 19,583 cells/cm(2)). Further studies are planned to monitor the influence of shear force on the endothelial cell monolayer in a dynamic test system to determine its stability in view of shear resistant endothelialization of PEI for cardiovascular devices.
C1 [Lendlein, A.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Lendlein, A.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Jung, Friedrich/L-1301-2013; Kruger, Anne/K-9539-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670
CR ALLY AI, 1980, PROSTAG LEUKOTR ESS, V4, P431, DOI 10.1016/0161-4630(80)90051-8
   Alobaid N, 2005, CLIN HEMORHEOL MICRO, V33, P209
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Arbogast H P, 2005, Hamostaseologie, V25, P394
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6
   FUSE S, 1994, CIRCULATION, V90, P2952, DOI 10.1161/01.CIR.90.6.2952
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Grinnel F., 1982, J BIOL CHEM, V57, P4888
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hunter WL, 2006, ADV DRUG DELIVER REV, V58, P347, DOI 10.1016/j.addr.2006.01.013
   International Standards Organization, 1999, ISO109935
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   KAAPA P, 1982, ARCH DIS CHILD, V57, P459, DOI 10.1136/adc.57.6.459
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710
   McLarty AJ, 1998, ANN THORAC SURG, V65, P1442, DOI 10.1016/S0003-4975(98)00031-9
   Murray C. J. L., 1996, GLOBAL BURDEN DIS CO
   Muxel S, 2010, CLIN HEMORHEOL MICRO, V45, P109, DOI 10.3233/CH-2010-1288
   Nilsen EM, 1998, GUT, V42, P635, DOI 10.1136/gut.42.5.635
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   PELUSO G, 1994, J MATER SCI-MATER M, V5, P738, DOI 10.1007/BF00120367
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   Rajabalian S., 1993, IRANIAN BIOMEDICAL J, V7, P147
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159
   SLOTMAN GJ, 1988, J SURG ONCOL, V38, P33, DOI 10.1002/jso.2930380110
   SMITH HS, 1979, CANCER RES, V39, P4138
   Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5
   Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496
   Tzoneva R, 2008, J BIOMAT SCI-POLYM E, V19, P837, DOI 10.1163/156856208784613523
   Urschel K, 2012, CLIN HEMORHEOL MICRO, V50, P143, DOI 10.3233/CH-2011-1450
   Urschel K, 2010, CLIN HEMORHEOL MICRO, V46, P203, DOI 10.3233/CH-2010-1346
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VIINIKKA L, 1980, PROSTAGLANDINS, V20, P759, DOI 10.1016/0090-6980(80)90114-8
   WAAGE A, 1990, EUR J IMMUNOL, V20, P2439, DOI 10.1002/eji.1830201112
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
NR 43
TC 5
Z9 5
U1 0
U2 2
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 267
EP 282
DI 10.3233/CH-2012-1604
PG 16
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800020
PM 22975947
DA 2018-10-19
ER

PT J
AU Kruger, A
   Braune, S
   Kratz, K
   Lendlein, A
   Jung, F
AF Krueger, A.
   Braune, S.
   Kratz, K.
   Lendlein, A.
   Jung, F.
TI The influence of poly(n-butyl acrylate) networks on viability and
   function of smooth muscle cells and vascular fibroblasts
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Cardiovascular disease; atherosclerosis; polymer-based biomaterial;
   cPnBA
ID COMMON CAROTID-ARTERY; ELASTIC PROPERTIES; ENDOTHELIAL-CELLS; ADHESION;
   DISEASE; ATHEROSCLEROSIS; PROLIFERATION; INTERLEUKIN-1; SURFACES;
   BINDING
AB Background: The patency of small-diameter vascular prostheses is limited by several factors such as thrombogenicity, which is strongly influenced by surface roughness and chemical composition, or a mechanical mismatch between the elastic modulus of an artery and of the vascular prosthesis. A confluent layer of endothelial cells onto the inner surface of vascular prostheses could improve the hemocompatibility of the device. Biomaterials with adjustable elastic properties could be tailored to the values of human arteries so that a prothesis mismatch could be avoided.
   It was recently demonstrated that a co-culture of endothelial cells with angiogenically stimulated monocytes (aMO2) shows an accelerated formation of a functional confluent endothelial cell monolayer on soft hydrophobic poly(n-butyl acrylate) (cPnBA) networks. In addition, the cell compatibility with vascular smooth muscle cells and aortic fibroblasts, which are other important cell types of the vessel wall, is essential for a vascular prosthesis material and must therefore be explored.
   Purpose: Here we investigated the interaction of human vascular smooth muscle cells and aortic fibroblasts with cPnBA04 and cPnBA73.
   Material and methods: Human primary vascular smooth muscle cells and aortic fibroblasts were seeded on the two cPnBAs with different elastic moduli (cPnBA04 - 250 kPa and cPnBA73 - 1100 kPa) over 72 h. A live-dead staining (fluorescein diacetate/propium iodide) was performed to determine the morphology and viability of adherent cells. Furthermore, the extracellular matrix components, the actin cytoskeleton, the cell-material-contacts and the cytokine profiles were analysed.
   Results: Both cell types adhered and were viable on cPnBA04 and cPnBA73. The level of pro-inflammatory cytokine secretion (IFN-gamma and TNF-alpha) by smooth muscle cells and vascular fibroblasts was comparable to that of cells cultivated on a control material. The release of these cytokines by human fibroblasts was higher on cPnBA73 compared to cPnBA04. Both cell types secreted an extracellular matrix comparable to cells seeded on a control material.
   Conclusion: The study revealed, that cPnBA with varying elastic moduli are not only suitable for the cultivation of endothelial cells, but also for human vascular smooth muscle cells and aortic fibroblasts. Therefore, cPnBA could be a potential candidate material for the development of cardiovascular prostheses.
C1 [Jung, F.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Kratz, Karl/K-7115-2013; Kruger, Anne/K-9539-2013; Jung,
   Friedrich/L-1301-2013; Lendlein, Andreas/K-9553-2013; Braune,
   Steffen/D-2315-2015
OI Kratz, Karl/0000-0002-9229-4266; Jung, Friedrich/0000-0001-8098-7180;
   Lendlein, Andreas/0000-0003-4126-4670; 
FU Bundesministerium fur Bildung und Forschung (BMBF) [0315696A]
FX The authors thank Susanne Reinhold, Christopher Hortig and Jessica
   Reinert for the technical support and the Bundesministerium fur Bildung
   und Forschung (BMBF) for funding within project number 0315696A
   "Poly4Bio BB".
CR [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1, DOI 10.3233/CH-2010-1256A
   Brown MA, 2007, BIOMATERIALS, V28, P3928, DOI 10.1016/j.biomaterials.2007.05.009
   Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202
   Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P180, DOI 10.1002/pat.1733
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640
   Dossus L, 2011, INT J CANCER, V129, P2032, DOI 10.1002/ijc.25840
   Fahed AC, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/793953
   Gerthoffer William T, 2002, Mol Interv, V2, P447, DOI 10.1124/mi.2.7.447
   Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x
   Goldmann WH, 2012, CELL BIOL INT, V36, P649, DOI 10.1042/CBI20120184
   Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455
   GRINNELL F, 1972, ARCH BIOCHEM BIOPHYS, V153, P193, DOI 10.1016/0003-9861(72)90436-5
   Guyton RA, 2006, ANN THORAC SURG, V81, P1949, DOI 10.1016/j.athoracsur.2006.03.020
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kones R, 2011, DRUG DES DEV THER, V5, P325, DOI 10.2147/DDDT.S14934
   LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Mayer A, 2011, CLIN HEMORHEOL MICRO, V49, P423, DOI 10.3233/CH-2011-1492
   Met R, 2008, CARDIOVASC INTER RAD, V31, P687, DOI 10.1007/s00270-008-9331-7
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024
   Ouyang Ping, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P50
   Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473
   PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765
   PATEL DJ, 1970, CIRC RES, V27, P149, DOI 10.1161/01.RES.27.2.149
   Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963
   RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464
   Watanabe J, 2002, BIOMATERIALS, V23, P4041, DOI 10.1016/S0142-9612(02)00122-9
   World Health Organization, 2011, CARD DIS
NR 45
TC 5
Z9 5
U1 1
U2 12
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 283
EP 294
DI 10.3233/CH-2012-1605
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800021
PM 22960303
DA 2018-10-19
ER

PT J
AU Ruder, C
   Sauter, T
   Kratz, K
   Peter, J
   Jung, F
   Lendlein, A
   Zohlnhofer, D
AF Rueder, Constantin
   Sauter, Tilman
   Kratz, Karl
   Peter, Jan
   Jung, Friedrich
   Lendlein, Andreas
   Zohlnhoefer, Dietlind
TI Smooth muscle and endothelial cell behaviour on degradable
   copolyetheresterurethane films
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Endothelialization; drug eluting stent; degradable polymer; cell
   selectivity
ID DRUG-ELUTING STENTS; IN-VITRO; SURFACE-FEATURES; ADHESION; VIABILITY;
   POLYMERS; TITANIUM; SURGERY
AB Stent thrombosis and restenosis after drug-eluting stent (DES) implantation remains a relevant problem in the cardiovascular field. The polymer-based biomaterial (e. g. stent coating) requirements are comprehensive, since the polymeric material ideally should ensure an effective re-endothelialization by recruiting endothelial cells (EC) and endothelial progenitor cells (EPC). Simultaneously, the polymer should effectively prevent adherence of smooth muscle cells (SMC) and thereby inhibiting restenosis.
   The aim of this study was to gain a basic understanding on the interaction of SMC and human umbilical vein endothelial cells (HUVEC) with nonporous polymer films. A multifunctional copolyetheresterurethane (PDC) was chosen as candidate material: PDC consists of poly(p-dioxanone) (PPDO) and poly(epsilon-caprolactone)-segments (PCL). In our study it was compared to the degradable PPDO homopolymer and poly(vinylidene fluoride-co-hexafluoropropene) (PVDF), an established coating material of DES in clinical applications intended for longterm applications. The films were analyzed according to their thermomechanical and surface properties before being examined in contact with HUVEC and SMC concerning cell viability, proliferation and adhesion.
   Experimental results showed that adhesion could be improved for HUVEC on PDC compared to PPDO and PVDF. In contrast, SMC attachment is largely suppressed on PDC polymeric films indicating a cell-specific response of HUVEC towards PDC. In conclusion, PDC represents a promising candidate material for future cardiovascular applications like e. g. biodegradable (PDC) stent coatings.
C1 [Rueder, Constantin; Sauter, Tilman; Kratz, Karl; Peter, Jan; Jung, Friedrich; Lendlein, Andreas; Zohlnhoefer, Dietlind] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.
   [Sauter, Tilman; Kratz, Karl; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Teltow, Germany.
   [Zohlnhoefer, Dietlind] Charite, Dept Cardiol, Campus Virchow Klinikum, Berlin, Germany.
RP Ruder, C (reprint author), Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM constantin.rueder@charite.de
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013; Sauter,
   Tilman/A-8856-2013; Jung, Friedrich/L-1301-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670;
   Jung, Friedrich/0000-0001-8098-7180
FU Berlin-Brandenburg School for Regenerative Therapies [DFG-GSC 203]
FX We would like to thank Mr. Schossig as well as Ms. Pieper for their
   technical support during the preparation and production of the
   scaffold/cell SEM images. We thank the FACS core facility of the BCRT
   led by Mrs. Kunkel. Mr. Sauter is grateful to the Berlin-Brandenburg
   School for Regenerative Therapies (DFG-GSC 203) for a fellowship.
CR Cohen DJ, 2012, CATHETER CARDIO INTE, V79, P198, DOI 10.1002/ccd.23147
   Dreyer L, 2011, CLIN HEMORHEOL MICRO, V49, P391, DOI 10.3233/CH-2011-1488
   Fadini GP, 2012, CLIN HEMORHEOL MICRO, V50, P293, DOI 10.3233/CH-2011-1437
   Grablowitz H, 2007, J MATER CHEM, V17, P4050, DOI 10.1039/b707104c
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Howard-Alpe GM, 2007, BRIT J ANAESTH, V98, P560, DOI 10.1093/bja/aem089
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Raimondo T, 2010, INT J NANOMED, V5, P647, DOI 10.2147/IJN.S13047
   Rodriguez-Granillo A, 2011, WORLD J CARDIOL, V3, P84, DOI 10.4330/wjc.v3.i3.84
   Ruder C, 2012, CLIN HEMORHEOL MICRO, V50, P101, DOI 10.3233/CH-2011-1447
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Schneider T, 2011, MACROMOL SYMP, V309-310, P28, DOI 10.1002/masy.201100057
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Velzenberger E, 2009, COLLOID SURFACE B, V68, P238, DOI 10.1016/j.colsurfb.2008.10.022
   Wakabayashi K., 2012, TRANSLATIONAL MED, VS7, P002, DOI [10.4172/2161-1025.S7-002, DOI 10.4172/2161-1025.S7-002]
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   2010, CLIN HEMORHEOLOGY MI, V44, P1
NR 25
TC 5
Z9 5
U1 1
U2 24
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 313
EP 323
DI 10.3233/CH-2012-1607
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800023
PM 22975944
DA 2018-10-19
ER

PT J
AU Schneider, T
   Kohl, B
   Sauter, T
   Kratz, K
   Lendlein, A
   Ertel, W
   Schulze-Tanzil, G
AF Schneider, Tobias
   Kohl, Benjamin
   Sauter, Tilman
   Kratz, Karl
   Lendlein, Andreas
   Ertel, Wolfgang
   Schulze-Tanzil, Gundula
TI Influence of fiber orientation in electrospun polymer scaffolds on
   viability, adhesion and differentiation of articular chondrocytes
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Chondrocytes; electrospinning; scaffold; differentiation; multiblock
   copolymer
ID SHAPE-MEMORY POLYMERS; BIOMEDICAL APPLICATIONS; IN-VITRO; CARTILAGE
AB Degradable polymers with a tailorable degradation rate might be promising candidate materials for biomaterial-based cartilage repair. In view of the poor intrinsic healing capability of cartilage, implantation of autologous chondrocytes seeded on a biocompatible slow degrading polymer might be an encouraging approach to improve cartilage repair in the future. This study was undertaken to test if the fiber orientation (random versus aligned) of two different degradable polymers and a polymer intended for long term applications could influence primary articular chondrocytes growth and ultrastructure.
   A degradable copoly(ether) esterurethane (PDC) was synthesized via co-condensation of poly(p-dioxanone) diol and poly(epsilon-caprolactone) diol using an aliphatic diisocyanate as linker. Poly(p-dioxanone) (PPDO) was applied as commercially available degradable polymer, while polyetherimide (PEI) was chosen as biomaterial enabling surface functionalization. The fibrous scaffolds of PDC and PPDO were obtained by electrospinning using 1,1,1,3,3,3 hexafluoro-2-propanol (HFP), while for PEI dimethyl acetamide (DMAc) was applied as solvent. Primary porcine articular chondrocytes were seeded at different cell densities on the fibrous polymer scaffolds and analyzed for viability (fluorescein diacetate/ethidiumbromide staining), for type II collagen synthesis (immunolabelling), ultrastructure and orientation on the fibers (SEM: scanning electron microscopy).
   Vital chondrocytes adhered on all electrospun scaffolds irrespective of random and aligned topologies. In addition, the chondrocytes produced the cartilage-specific type II collagen on all tested polymer topologies suggesting their differentiated functions. SEM revealed an almost flattened chondrocytes shape on scaffolds with random fiber orientation: whereby chondrocytes growth remained mainly restricted to the scaffold surface. On aligned fibers the chondrocytes exhibited a more spindle-shaped morphology with rougher cell surfaces but only a minority of the cells aligned according to the fibers. As a next step the reduction of the fiber diameter of electrospun scaffolds should be addressed as an important parameter to mimic cartilage ECM structure.
C1 [Schneider, Tobias; Kohl, Benjamin; Ertel, Wolfgang; Schulze-Tanzil, Gundula] Charite, Dept Orthopaed Trauma & Reconstruct Surg, D-14195 Berlin, Germany.
   [Schneider, Tobias] Univ Appl Sci, Munster, Germany.
   [Sauter, Tilman; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Teltow, Germany.
   [Sauter, Tilman; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, Teltow, Germany.
   [Sauter, Tilman; Lendlein, Andreas] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.
RP Schulze-Tanzil, G (reprint author), Charite, Dept Special Orthopaed Trauma & Reconstruct Surg, FEM, Campus Benjamin Franklin,Garystr 5, D-14195 Berlin, Germany.
EM gundula.schulze-tanzil@charite.de
RI Sauter, Tilman/A-8856-2013; Lendlein, Andreas/K-9553-2013; Kratz,
   Karl/K-7115-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Kratz, Karl/0000-0002-9229-4266;
   Kohl, Benjamin/0000-0002-2298-6830
FU focus area nanoscale of the Freie Universitat of Berlin;
   Berlin-Brandenburg School for Regenerative Therapies [DFG-GSC 203];
   Sonnenfeld foundation
FX The present study was partially funded by a starting grant from the
   focus area nanoscale of the Freie Universitat of Berlin and the
   Sonnenfeld foundation. T. Sauter is grateful to the Berlin-Brandenburg
   School for Regenerative Therapies (DFG-GSC 203) for a fellowship. The
   authors would further like to thank B. Hiebl, M. Schossig and T. Becker
   for support with regard to cytotoxicity testing, preparation of SEM
   images and conduction of electrospinning experiments.
CR Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36
   Altankov G, 2005, J BIOMAT SCI-POLYM E, V16, P23, DOI 10.1163/1568562052843320
   [Anonymous], 1995, U S PHARMACOPOEIA TH, P2391
   CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jung F, 2010, CLIN HEMORHEOL MICRO, V45, P79, DOI 10.3233/CH-2010-1312
   Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216
   Kratz K, 2011, INT J ARTIF ORGANS, V34, P225, DOI 10.5301/IJAO.2011.6404
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Luetzow K., 2006, ARTIF ORGANS, V30, P764
   Luetzow K, 2011, MACROMOL SYMP, V309-310, P76, DOI 10.1002/masy.201100051
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   Nemeth N, 2012, CLIN HEMORHEOL MICRO, V51, P43, DOI 10.3233/CH-2011-1507
   Noriega E.S., 2011, CELLS TISSUES ORGANS, V195, P207
   Schlegel W, 2008, INT J MOL MED, V22, P691, DOI 10.3892/ijmm_00000074
   Schneider T, 2011, MACROMOL SYMP, V309-310, P28, DOI 10.1002/masy.201100057
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
NR 20
TC 19
Z9 20
U1 7
U2 55
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 325
EP 336
DI 10.3233/CH-2012-1608
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800024
PM 22975946
DA 2018-10-19
ER

PT J
AU Tzoneva, R
   Seifert, B
   Behl, M
   Lendlein, A
AF Tzoneva, Rumiana
   Seifert, Barbara
   Behl, Marc
   Lendlein, Andreas
TI Elastic multiblock copolymers for vascular regeneration: Protein
   adsorption and hemocompatibility
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Hemocompatibility; degradable elastic polymer; protein adsorption;
   coagulation; thrombin formation; platelet adhesion/activation;
   shape-memory polymer
ID SHAPE-MEMORY POLYMERS; BIOMEDICAL APPLICATIONS; POLYPROPYLENE SURFACES;
   BIOMATERIAL SURFACES; THROMBUS FORMATION; IN-VITRO; BLOOD; MEMBRANES;
   PLASMA; TISSUE
AB Hemocompatibility of elastic multiblock copolymers PDC, based on poly(p-dioxanone) (PPDO)/poly(epsilon-caprolactone)-segments, capable of a shape-memory effect, and PDD, based on PPDO/poly((adipinate-alt-1,4-butanediol)-co(adipinate-alt-ethylene glycol)-co-adipinate-alt-diethylene glycol)-segments, was studied in order to assess their suitability for an application aiming at blood vessels regeneration. The results were compared with polypropylene (PP) which is a widely used blood-contacting material for devices as blood oxygenators and dialysis tubes. Protein adsorption studies showed diverse blood plasma proteins in a relatively high amount on both elastic polymers compared to the poor amount of plasma proteins adsorbed on PP. Study of the coagulation system revealed high thrombin formation on PDC and no difference in plasma kallikrein activation between elastic multiblock copolymers and the reference PP. Activation of complement system was higher for PDC followed by PDD and lower for PP. However, platelet adhesion and activation were hardly suppressed on the multiblock copolymers compared to the PP surface, where the number of adhered platelets and the activation rate were significant. The present results reveal that the tested multiblock copolymers with improved elastic properties and shape-memory capability (PDC) show low thrombogenicity and are promising candidates for vascular tissue engineering.
C1 [Tzoneva, Rumiana] Bulgarian Acad Sci, Dept Electroinduced & Adhes Properties, Inst Biophys & Biomed Engn, BU-1113 Sofia, Bulgaria.
   [Seifert, Barbara; Behl, Marc; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Teltow, Germany.
   [Seifert, Barbara; Behl, Marc; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, Teltow, Germany.
   [Behl, Marc; Lendlein, Andreas] Tianjin Univ, Helmholtz Zentrum Geesthacht, Joint Lab Biomat & Regenerat Med, Tianjin 300072, Peoples R China.
RP Tzoneva, R (reprint author), Bulgarian Acad Sci, Dept Electroinduced & Adhes Properties, Inst Biophys & Biomed Engn, Acad G Bonchev St,Bl 21, BU-1113 Sofia, Bulgaria.
EM tzoneva@bio21.bas.bg
RI Lendlein, Andreas/K-9553-2013; Behl, Marc/K-9429-2013; Seifert,
   Barbara/K-7569-2012
OI Lendlein, Andreas/0000-0003-4126-4670; Behl, Marc/0000-0002-1507-0277; 
FU DFG [436/BUL112/21/05, 436/BUL112/27/06]; DAAD bilateral scientific
   grant [D/08/020620]; Bulgarian Scientific Fund [DAAD: DO 02-326]
FX The authors thank Michael Zierke and Steffen Kelch for the synthesis of
   the multiblock copolymers. This study was financially supported by DFG
   (436/BUL112/21/05 and 436/BUL112/27/06), DAAD bilateral scientific grant
   (D/08/020620), and Bulgarian Scientific Fund (DAAD: DO 02-326).
CR [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1
   Basaran O, 2003, TRANSPLANT P, V35, P2578, DOI 10.1016/j.transproceed.2003.09.089
   Battig A, 2011, CLIN HEMORHEOL MICRO, V48, P161, DOI 10.3233/CH-2011-1391
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001
   GRIGIONI M, 2003, VASCULAR GRAFTS EXPT, P41
   Groth T, 1997, J BIOMAT SCI-POLYM E, V8, P797, DOI 10.1163/156856297X00326
   Grunkemeier JM, 2001, J BIOMAT SCI-POLYM E, V12, P1, DOI 10.1163/156856201744416
   Hiebl B, 2010, CLIN HEMORHEOL MICRO, V46, P233, DOI 10.3233/CH-2010-1350
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kawamoto N, 1998, J BIOMAT SCI-POLYM E, V9, P543, DOI 10.1163/156856298X00037
   Kawamoto N, 1997, J BIOMAT SCI-POLYM E, V8, P859, DOI 10.1163/156856297X00056
   Kim JK, 2005, J BIOMED MATER RES A, V75A, P199, DOI 10.1002/jbm.a.30424
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Leithauser B, 2010, CLIN HEMORHEOL MICRO, V45, P311, DOI 10.3233/CH-2010-1314
   Lemm W., 1992, REFERENCE MAT EUROPE
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, CLIN HEMORHEOL MICRO, V32, P105
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Onuma Y, 2007, Minerva Cardioangiol, V55, P579
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Song YY, 2008, ANAL BIOANAL CHEM, V390, P333, DOI 10.1007/s00216-007-1666-4
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Tzoneva R, 2002, J BIOMAT SCI-POLYM E, V13, P1033, DOI 10.1163/156856202760319171
   Tzoneva R, 2011, J BIOMAT SCI-POLYM E, V22, P2205, DOI 10.1163/092050610X537147
   Vorp DA, 2005, FRONT BIOSCI, V10, P768, DOI 10.2741/1571
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
NR 31
TC 5
Z9 5
U1 3
U2 36
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 337
EP 348
DI 10.3233/CH-2012-1609
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800025
PM 22975945
DA 2018-10-19
ER

PT J
AU Braune, S
   Alagoz, G
   Seifert, B
   Lendlein, A
   Jung, F
AF Braune, S.
   Alagoez, G.
   Seifert, B.
   Lendlein, A.
   Jung, F.
TI Automated image-based analysis of adherent thrombocytes on polymer
   surfaces
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Hemocompatibility; thrombocytes; biomaterial; high-throughput;
   image-based automation
ID IN-VITRO; VASCULAR GRAFTS; SHAPE CHANGE; BIOMATERIALS; PLATELETS;
   HEMOCOMPATIBILITY; MICROSCOPY; CELLS
AB A dataset of 439 confocal laser scanning microscopic images was analyzed to investigate the potential of an image-based automated analysis for identifying and assessing adherent thrombocytes on polymer surfaces. Parameters for image optimization of glutardialdehyde induced fluorescence images were classified and data mining was performed using the Java image processing software ImageJ. Previously reported analysis required that each thrombocyte had to be identified interactively and outlined manually. Now, we were able to determine the number and area of adherent thrombocytes with high accuracy (spearman correlation coefficient r=0.98 and r=0.99) using a two-stage filter-set, including a rolling ball background subtraction-and a watershed segmentation-algorithm. Furthermore, we could proof a significant correlation between these parameters (spearman correlation coefficient r=0.97), determining both as suitable predictors for the evaluation of material induced thrombogenicity. The here reported image-based automated analysis can be successfully applied to identify and measure adherent thrombocytes on polymer surfaces and, thus, might be successfully integrated in a high-throughput screening process to evaluate biomaterial hemocompatibility.
C1 [Lendlein, A.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Lendlein, A.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Jung, Friedrich/L-1301-2013; Lendlein, Andreas/K-9553-2013; Seifert,
   Barbara/K-7569-2012; Braune, Steffen/D-2315-2015
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; 
CR Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36
   ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   [Anonymous], 2006, NUCLEUS COUNTER PLUG
   [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Breddin HK, 2003, VASA-J VASCULAR DIS, V32, P123, DOI 10.1024/0301-1526.32.3.123
   Castle M., 2007, ROLLING BALL BACKGRO
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1173
   Gachkovskii VF, 1967, J STRUCT CHEM, V8, P318
   Gao DW, 2010, J MEMBRANE SCI, V364, P331, DOI 10.1016/j.memsci.2010.08.031
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Jaafar IH, 2011, ACTA BIOMATER, V7, P1588, DOI 10.1016/j.actbio.2010.12.007
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8
   Rasband WS, 2012, IMAGEJ
   Sage D., 2008, GRAYLEVEL WATERSHED
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   STERNBERG SR, 1983, COMPUTER, V16, P22
   Vos K.D., 2001, CELL COUNTER
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
NR 31
TC 8
Z9 8
U1 1
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 349
EP 355
DI 10.3233/CH-2012-1610
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800026
PM 22975943
DA 2018-10-19
ER

PT J
AU Wang, WW
   Ma, N
   Kratz, K
   Xu, X
   Li, ZD
   Roch, T
   Bieback, K
   Jung, F
   Lendlein, A
AF Wang, Weiwei
   Ma, Nan
   Kratz, Karl
   Xu, Xun
   Li, Zhengdong
   Roch, Toralf
   Bieback, Karen
   Jung, Friedrich
   Lendlein, Andreas
TI The influence of polymer scaffolds on cellular behaviour of bone marrow
   derived human mesenchymal stem cells
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Mesenchymal stem cells; polymer surface; cell-material interaction; cell
   adhesion; proliferation; apoptosis
ID POLY(ETHER IMIDE) MEMBRANES; BIOMATERIAL SURFACE-CHEMISTRY;
   OSTEOBLAST-LIKE CELLS; PROTEIN ADSORPTION; OSTEOGENIC DIFFERENTIATION;
   MATRIX STIFFNESS; ADIPOSE-TISSUE; IN-VITRO; POLYSTYRENE; CULTURE
AB Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types. Therefore, they are widely explored in regenerative medicine. The interaction of MSCs with biomaterials is of great importance for cell proliferation, differentiation and function, and can be strongly influenced by numerous factors, such as the chemical nature and the mechanical properties of the material surface.
   In this study, we investigated the interaction of bone marrow derived human MSCs with different amorphous and transparent polymers namely polystyrene (PS), polycarbonate (PC), poly(ether imide) (PEI), polyetherurethane (PEU) and poly(styrene-co-acrylonitrile) (PSAN). To ensure that the MSCs were solely in contact to the testing material we applied polymeric inserts, which were prepared from the aforementioned polymers via injection molding. The explored inserts exhibited a similar wettability with advancing contact angles ranging from 84 +/- 7 degrees (PEU) to 99 +/- 5 degrees (PS) and a surface roughness of R-q <= 0.86 mu m. The micromechanical properties determined by AFM indentation varied from 6 +/- 1 GPa (PEU) to 24 +/- 5 GPa (PSAN).
   Cells presented different adhesion rates on the polymer surfaces 24 hours after seeding (45 +/- 7% (PS), 63 +/- 1% (PC), 75 +/- 4% (PEI), 69 +/- 2% (PEU) and 61 +/- 5% (PSAN)). The cells could proliferate on the polymer surfaces, and the fold change of cell number after 16 days of culture reached to 1.93 +/- 0.07 (PS), 3.38 +/- 0.11 (PC), 3.65 +/- 0.04 (PEI), 2.24 +/- 0.15 (PEU) and 3.36 +/- 0.09 (PSAN). Differences in cell apoptosis could be observed during the culture. After 7 days, the apoptosis of cells on PC, PEI and PSAN decreased to a level comparable to that on standard tissue culture plate (TCP). All of the tested polymers exhibited low cytotoxicity and allowed high cell viability. Compared to cells on TCP, cells on PC and PEI showed similar morphology, distribution as well as F-actin cytoskeleton organization, whereas cells on PSAN were distributed less evenly and cells on PEU were less oriented. Cells were more likely to form clusters on PS. Conclusively, we demonstrated the influence of polymer substrates on the cellular behaviour of MSCs, which could be included in the development of novel design concepts based on polymeric biomaterials.
C1 [Wang, Weiwei; Ma, Nan; Kratz, Karl; Xu, Xun; Li, Zhengdong; Roch, Toralf; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Wang, Weiwei; Ma, Nan; Kratz, Karl; Xu, Xun; Li, Zhengdong; Roch, Toralf; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
   [Bieback, Karen] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, German Red Cross Blood Serv Baden Wurttemberg Hes, D-6900 Heidelberg, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Ma, Nan/L-1282-2013; Lendlein, Andreas/K-9553-2013; Jung,
   Friedrich/L-1301-2013; Roch, Toralf/K-9531-2013; Kratz, Karl/K-7115-2013
OI Ma, Nan/0000-0003-4006-1003; Lendlein, Andreas/0000-0003-4126-4670;
   Jung, Friedrich/0000-0001-8098-7180; Kratz, Karl/0000-0002-9229-4266;
   Roch, Toralf/0000-0003-2948-8700
FU German Federal Ministry of Education and Research (BMBF) [0315696A
   'Poly4Bio BB']; Helmholtz Association
FX This work was supported by German Federal Ministry of Education and
   Research (BMBF project number 0315696A 'Poly4Bio BB') and Helmholtz
   Association. The authors thank Ms. Angelika Ritschel, Ms. Ruth Hesse,
   Ms. Anja Muller-Heyn, Mrs. Manuela Keller, Mr. Robert Jeziorski and Mr.
   Oliver Frank for their technical assistance.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   Albrecht W, 2007, J MEMBRANE SCI, V291, P10, DOI 10.1016/j.memsci.2006.12.014
   Bacakova L, 2000, J BIOMED MATER RES, V49, P369, DOI 10.1002/(SICI)1097-4636(20000305)49:3<369::AID-JBM10>3.0.CO;2-W
   Beeres SLMA, 2005, J AM COLL CARDIOL, V46, P1943, DOI 10.1016/j.jacc.2005.07.055
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P180, DOI 10.1002/pat.1733
   Danmark S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035011
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Ferencz R, 2012, POLYM TEST, V31, P425, DOI 10.1016/j.polymertesting.2012.01.003
   Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652
   Gehmert S, 2011, CLIN HEMORHEOL MICRO, V48, P5, DOI 10.3233/CH-2011-1397
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Guo L, 2008, BIOMATERIALS, V29, P23, DOI [10.1016/j.biomaterials.2007.08.043, 10.1016/j.biomaterials.2007-08.043]
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Joy A, 2011, LANGMUIR, V27, P1891, DOI 10.1021/la103722m
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   KLEINSOYER C, 1989, BIOMATERIALS, V10, P85, DOI 10.1016/0142-9612(89)90036-7
   Kommareddy KP, 2010, BIOINTERPHASES, V5, P45, DOI 10.1116/1.3431524
   Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   MAJNO G, 1995, AM J PATHOL, V146, P3
   Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   Mimura S, 2011, INT J DEV BIOL, V55, P181, DOI 10.1387/ijdb.103232sm
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nitschke M, 2012, COLLOID SURFACE B, V90, P41, DOI 10.1016/j.colsurfb.2011.09.034
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Onyiriuka E, 1996, J ADHES SCI TECHNOL, V10, P617, DOI 10.1163/156856196X00670
   Ozawa K, 2008, J AUTOIMMUN, V30, P121, DOI 10.1016/j.jaut.2007.12.008
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]
   Ramazani SAA, 2009, MAT SCI ENG C-BIO S, V29, P1491, DOI 10.1016/j.msec.2008.11.019
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Reiser J, 2005, EXPERT OPIN BIOL TH, V5, P1571, DOI 10.1517/14712598.5.12.1571
   Ringden O, 2007, LEUKEMIA, V21, P2271, DOI 10.1038/sj.leu.2404833
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302
   Sun YY, 2012, J ELECTRON MATER, V41, P519, DOI 10.1007/s11664-011-1800-0
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Tanaka T, 2009, J BIOMED MATER RES A, V91A, P428, DOI 10.1002/jbm.a.32253
   Trimpert C, 2006, MACROMOL BIOSCI, V6, P274, DOI 10.1002/mabi.200500238
   Tzoneva R, 2008, J MATER SCI-MATER M, V19, P3203, DOI 10.1007/s10856-008-3456-8
   Tzoneva R, 2008, J BIOMAT SCI-POLYM E, V19, P837, DOI 10.1163/156856208784613523
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Wang WW, 2011, J CELL MOL MED, V15, P1989, DOI 10.1111/j.1582-4934.2010.01130.x
   Wang Y, 2012, BIOMATERIALS, V33, P485, DOI 10.1016/j.biomaterials.2011.09.089
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   2010, CLIN HEMORHEOLOGY MI, V44, P1
NR 62
TC 19
Z9 20
U1 1
U2 28
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 357
EP 373
DI 10.3233/CH-2012-1611
PG 17
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800027
PM 22975951
DA 2018-10-19
ER

PT J
AU Roch, T
   Kruger, A
   Kratz, K
   Ma, N
   Jung, F
   Lendlein, A
AF Roch, Toralf
   Krueger, Anne
   Kratz, Karl
   Ma, Nan
   Jung, Friedrich
   Lendlein, Andreas
TI Immunological evaluation of polystyrene and poly(ether imide) cell
   culture inserts with different roughness
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Immuno-compatibility; endotoxins; surface roughness; biomaterial;
   polystyrene; poly(ether imide)
ID TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; SURFACES; COMPLEMENT;
   ENDOTOXIN; IMMUNITY; INNATE; BIOMATERIALS; ACTIVATION; MODULUS
AB For the successful clinical and biological application of polymers, their interaction with cells, tissues, and body fluids has to be well characterized.
   In order to investigate how the physical, chemical, and mechanical properties of candidate biomaterials influence cell behaviours, the testing sample is usually placed in commercially available cell culture plates. Thus, not only the testing sample itself but also the culture dish material might influence the cell behaviour. Therefore, an insert system was created to exclude this influence and allow investigations of the testing material solely. In this study micropatterned inserts prepared from polystyrene (PS) as well as from poly(ether imide) (PEI) with three different roughness levels of i) R-q=0.12 mu m (PS) and 0.23 mu m (PEI); ii) R-q = 3.52 mu m (PS) and 3.92 mu m (PEI); and iii) R-q = 16.04 mu m (PS) and 22.65 mu m (PEI) were explored with regard of their immuno-compatibility including the determination of potential contaminations with endotoxins or other microbial products.
   The endotoxin levels of the inserts were determined to be less than 0.07 EU/mL, which is well below the U. S. Food and Drug Administration limit of 0.5 EU/mL and the survival of murine macrophages cultured in the inserts was not impaired. Activation of early immune mechanisms such as complement activation and the generation of reactive oxygen species could not be observed. All tested materials had no influence on the cytokine secretion from cells of whole human blood.
   The investigated inserts were immuno-compatible and apparently free of contaminations with microbial products. The roughness of the inserts had no stimulatory or inhibitory effect on early immune mechanisms.
   Conclusively, the 24-well plate insert systems introduced in this study allow investigating the interactions of tailored surface properties such as roughness with many other cell types, without the disadvantage of the standard commercially available culture vessels influencing the biomaterial testing.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Kratz, Karl/K-7115-2013; Jung, Friedrich/L-1301-2013; Kruger,
   Anne/K-9539-2013; Ma, Nan/L-1282-2013; Roch, Toralf/K-9531-2013;
   Lendlein, Andreas/K-9553-2013
OI Kratz, Karl/0000-0002-9229-4266; Jung, Friedrich/0000-0001-8098-7180;
   Ma, Nan/0000-0003-4006-1003; Lendlein, Andreas/0000-0003-4126-4670;
   Roch, Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung (BMBF) [0315696A "Poly4Bio
   BB"]
FX The authors thank Robert Jeziorski, Dr. Thomas Weigel, Oliver Frank,
   Manuela Keller, Ruth Hesse, Anja Muller-Heyn and Angelika Ritschel for
   the technical support and the Bundesministerium fur Bildung und
   Forschung (BMBF) for funding within project number 0315696A "Poly4Bio
   BB".
CR [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1, DOI 10.3233/CH-2010-1256A
   [Anonymous], 16747198105 DIN
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   CHEN AR, 1985, J IMMUNOL, V135, P3978
   Chun YW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085104
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Engberg AE, 2011, J BIOMED MATER RES A, V97A, P74, DOI 10.1002/jbm.a.33030
   Ferencz R, 2012, POLYM TEST, V31, P425, DOI 10.1016/j.polymertesting.2012.01.003
   Furlani D, 2012, J CELL MOL MED, V16, P1094, DOI 10.1111/j.1582-4934.2011.01381.x
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grasbeck R., 1981, REFERENCE VALUES LAB
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Jabs A, 2010, CLIN HEMORHEOL MICRO, V45, P185, DOI 10.3233/CH-2010-1297
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Kamusewitz H, 2003, APPL PHYS A-MATER, V76, P899, DOI 10.1007/s00339-002-1972-9
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Liu TY, 2005, BIOMATERIALS, V26, P1437, DOI 10.1016/j.biomaterials.2004.04.039
   Miller Lloyd S, 2008, Adv Dermatol, V24, P71
   Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810
   NAGATA S, 1987, J ALLERGY CLIN IMMUN, V80, P24, DOI 10.1016/S0091-6749(87)80186-0
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915
   Quinn MT, 2009, J INNATE IMMUN, V1, P509, DOI 10.1159/000228158
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Richter J, 2010, CLIN HEMORHEOL MICRO, V46, P37, DOI 10.3233/CH-2010-1331
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Roch T., 2012, CLIN HEMORHEOL MICRO, DOI [10.3233/CH-2012, DOI 10.3233/CH-2012]
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Volk HD, 1996, INTENS CARE MED, V22, pS474, DOI 10.1007/BF01743727
   Wang WW, 2012, CLIN HEMORHEOL MICRO, V52, P357, DOI 10.3233/CH-2012-1611
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
NR 47
TC 14
Z9 14
U1 0
U2 23
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 52
IS 2-4
BP 375
EP 389
DI 10.3233/CH-2012-1612
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 034LM
UT WOS:000310874800028
PM 22975952
DA 2018-10-19
ER

PT S
AU Zhou, W
   Zheng, J
AF Zhou, Wei
   Zheng, Jun
BE Sung, WP
   Kao, JCM
   Chen, R
TI Direct observation of hydroxyapatite nanoparticles in vivo
SO FRONTIERS OF MANUFACTURING SCIENCE AND MEASURING TECHNOLOGY II, PTS 1
   AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Frontiers of Manufacturing Science and
   Measuring Technology (ICFMM 2012)
CY JUN 12-13, 2012
CL Xian, PEOPLES R CHINA
SP Control Engn & Informat Sci Res Assoc, Int Frontiers Sci & Technol Res Assoc, Trans Tech Publicat, Chin Yi Univ Technol
DE nano-hydroxyapatite; PET imaging; in vivo
ID BEHAVIOR
AB While nano-hydroxyapatite (nano-HAP) has been well known for series of amazing properties in chemical or physical, the controversy on the risks of its applications has also been existed. The worries of nano-HAP applications in preclinic and clinic indicate the blank researches of nano-HAP pharmacodynamics. It is important and necessary to trace and clarify the localizations of HAP nanoparticles in vivo. In the present paper, F-18 is used as radiotracer for Positron Emission Tomography (PET) imaging of HAP nanoparticles. Through the transverse plane slices and three-dimensional reconstruction pictures, it is very clear to observe the localization of nano-HAP in vivo at real time. Most nano-HAP particles were noted in organs lump, liver, spleen, stomach and existed for period of time. Therefore, PET can be a new powerful technique for tracing nano-biomaterial and their pharmacodynamics researches.
C1 [Zhou, Wei] Henan Univ Sci & Technol, Coll Med Technol & Engn, Luoyang 471000, Peoples R China.
   [Zheng, Jun] Huazhong Univ Sci & Technol, State Key Lab Mat Proc, Wuhan 430074, Peoples R China.
   [Zheng, Jun] Huazhong Univ Sci & Technol, Die & Mould Technol, Wuhan 430074, Peoples R China.
   [Zhou, Wei] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.
RP Zhou, W (reprint author), Henan Univ Sci & Technol, Coll Med Technol & Engn, Luoyang 471000, Peoples R China.
EM weizhou002@163.com
FU National Natural Science Foundation of China [30570493]; Doctoral
   Initiating Scientific Foundation from the Henan University of Science
   and Technology [2011QN053]
FX The authors would like to gratefully acknowledge the financial supports
   from the National Natural Science Foundation of China (No. 30570493),
   the Youth Foundation (No. 2011QN053) and the Doctoral Initiating
   Scientific Foundation from the Henan University of Science and
   Technology.
CR Barinov SM, 2004, J MATER SCI-MATER M, V15, P291, DOI 10.1023/B:JMSM.0000015490.32304.f4
   Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   Kreuter J, 2007, INT J PHARM, V331, P1, DOI 10.1016/j.ijpharm.2006.10.021
   Lappin G, 2003, NAT REV DRUG DISCOV, V2, P233, DOI 10.1038/nrd1037
   Zhang SM, 2006, KEY ENG MAT, V309-311, P577, DOI 10.4028/www.scientific.net/KEM.309-311.577
NR 5
TC 3
Z9 3
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-404-4
J9 ADV MATER RES-SWITZ
PY 2012
VL 503-504
BP 688
EP +
DI 10.4028/www.scientific.net/AMR.503-504.688
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCO29
UT WOS:000310816200160
DA 2018-10-19
ER

PT S
AU Woo, KD
   Park, SH
   Kim, JY
AF Woo, Kee Do
   Park, Sang Hoon
   Kim, Ji Young
BE Liu, P
TI Effect of Milling and Calcium Phosphate on Mechanical Properties of
   Nanostructured TiNbMo/CPP Biocomposites
SO MANAGEMENT, MANUFACTURING AND MATERIALS ENGINEERING, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Management, Manufacturing and Materials
   Engineering (ICMMM 2011)
CY DEC 08-10, 2011
CL Zhengzhou, PEOPLES R CHINA
SP Int Assoc Management Sci & Engn Technol
DE biomaterial; sintering; power metallurgy; SPS; calcium phosphate
ID BETA-TITANIUM-ALLOY; SN; SUPERELASTICITY; MICROSTRUCTURE; BIOMATERIALS;
   MODULUS; ZR
AB Ti-6Al-4V ELI (Extra Low Interstitial) alloy have been widely used as alternative bone due to its excellent biocompatibility, although it still has many problems such as high elastic modulus and toxic. Therefore, biomaterial with low elastic modulus and nontoxic has to be developed. In this study, the raw materials which are nontoxic elements such as Nb and Mo were mixed and milled in a mixing machine (24h) and a high energy mechanical ball milling machine (1h, 4h and 8h) respectively. Ti-Nb-Mo-CPP composites were fabricated by spark plasma sintering (SPS) at 1000 degrees C under 70MPa using mixed and milled powders. The effects of CPP contents and milling time on biocompatibility and mechanical property have been investigated. By X-ray diffraction (XRD), chemical reaction during the sintering was occurred and revealed new phases, Ti2O, CaO, CaTiO3, and TixPy. Vickers hardness of composites increases with increase milling time and addition of CPP contents. Biocompatibility of CPP added Ti-Nb-Mo alloys were improved.
C1 [Woo, Kee Do; Park, Sang Hoon; Kim, Ji Young] Chonbuk Natl Univ, Jeonju 561756, South Korea.
RP Woo, KD (reprint author), Chonbuk Natl Univ, Jeonju 561756, South Korea.
EM kdwoo@chonbuk.ac.kr; plakken84@naver.com; bluedays7@nate.com
CR Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   ISHIYAMA S, 1991, ISIJ INT, V31, P807, DOI 10.2355/isijinternational.31.807
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Laheurte P, 2005, MAT SCI ENG A-STRUCT, V396, P223, DOI 10.1016/j.msea.2005.01.022
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nag S, 2007, ACTA BIOMATER, V3, P369, DOI 10.1016/j.actbio.2006.08.005
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
NR 11
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-351-1
J9 ADV MATER RES-SWITZ
PY 2012
VL 452-453
BP 12
EP 15
DI 10.4028/www.scientific.net/AMR.452-453.12
PG 4
WC Engineering, Mechanical; Operations Research & Management Science;
   Materials Science, Multidisciplinary
SC Engineering; Operations Research & Management Science; Materials Science
GA BCC28
UT WOS:000309691400003
DA 2018-10-19
ER

PT J
AU Varoni, E
   Tschon, M
   Palazzo, B
   Nitti, P
   Martini, L
   Rimondini, L
AF Varoni, Elena
   Tschon, Matilde
   Palazzo, Barbara
   Nitti, Paola
   Martini, Lucia
   Rimondini, Lia
TI Agarose Gel as Biomaterial or Scaffold for Implantation Surgery:
   Characterization, Histological and Histomorphometric Study on Soft
   Tissue Response
SO CONNECTIVE TISSUE RESEARCH
LA English
DT Article
DE polysaccharide gel; biocompatibility; histocompatibility;
   histomorphometry; injectable biomaterial/scaffold
ID CARBOMER BASED HYDROGELS; BONE-GRAFTING MATERIAL; DERMAL FILLERS; FACIAL
   REJUVENATION; IN-VITRO; BIOCOMPATIBILITY; AUGMENTATION; BEHAVIOR; CELL;
   RECOMMENDATIONS
AB Maxillofacial, orthopedic, oral, and plastic surgery require materials for tissue augmentation, guided regeneration, and tissue engineering approaches. In this study, the aim was to develop and characterize a new extrudable hydrogel, based on agarose gel (AG; 1.5% wt) and to evaluate the local effects after subcutaneous implantation in comparison with collagen and hyaluronic acid. AG chemical-physical properties were ascertained through Fourier transform infrared (FT-IR) spectroscopy and rheological analysis. In vivo subcutaneous implants were performed, and histological and histomorphometric evaluations were done at 1, 4, 12, and 16 weeks. FT-IR confirmed that spectroscopic properties were the same for the baseline agarose and rheological characterization established that AG is a weak hydrogel. Subcutaneous AG implants induced new vessels and fibrous tissue formation rich in neutrophils; the capsule thickness around AG increased until the 12th week but remained thinner than those around hyaluronic acid and collagen. At 16 weeks, the thickness of the capsule significantly decreased around all materials. This study confirmed that 1.5% wt AG possesses some of the most important features of the ideal biocompatible material: safety, effectiveness, costless, and easily obtained with specific chemical and geometrical characters; the AG can represent a finely controllable and biodegradable polymeric system for cells and drug delivery applications.
C1 [Varoni, Elena; Rimondini, Lia] Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy.
   [Varoni, Elena] Univ Milan, Osped San Paolo Hosp, UOC Dent 2, Milan, Italy.
   [Tschon, Matilde; Martini, Lucia] Rizzoli Orthoped Inst, Res Inst Codivilla Putti, Lab Preclin & Surg Studies, Bologna, Italy.
   [Palazzo, Barbara; Nitti, Paola] GHIMAS SpA, MeLab, Cittadella Ric, Brindisi, Italy.
RP Rimondini, L (reprint author), Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy.
EM lia.rimondini@med.unipmn.it
OI Varoni, Elena Maria/0000-0002-7287-2188
FU Consorzio InterUniversitario per lo Studio della Chimica dei Metalli nei
   Sistemi Biologici (CIRMSC), Ministero dell' Istruzione, dell'Universita
   e della Ricerca (MIUR) (POR) [1291]; Rizzoli Orthopaedic Institute,
   Bologna-Italy
FX This study was partially supported by Consorzio InterUniversitario per
   lo Studio della Chimica dei Metalli nei Sistemi Biologici (CIRMSC),
   Ministero dell' Istruzione, dell'Universita e della Ricerca (MIUR) (POR
   no. 1291); Rizzoli Orthopaedic Institute, Bologna-Italy. Materials were
   provided by Ghimas S.p.A.
CR [Anonymous], 2007, OFFICIAL J EUROPEA L, V197
   [Anonymous], 2010, OFFICIAL J EUROPEA L
   [Anonymous], 1996, GUID CAR US LAB AN
   Beasley KL, 2009, FACIAL PLAST SURG, V25, P86, DOI 10.1055/s-0029-1220647
   Beer K, 2009, J DRUGS DERMATOL, V8, P1086
   Beer K, 2009, DERMATOL CLIN, V27, P427, DOI 10.1016/j.det.2009.08.011
   Cao Z, 2009, BIOMACROMOLECULES, V10, P2954, DOI 10.1021/bm900670n
   Carruthers JDA, 2008, PLAST RECONSTR SUR S, V121, p31S
   Carruthers J, 2009, J DRUGS DERMATOL, V8, P335
   Carruthers JDA, 2008, PLAST RECONSTR SURG, V121, p5S, DOI 10.1097/PRS.0b013e31816de8d0
   Christensen L, 2007, DERMATOL SURG, V33, pS168, DOI 10.1111/j.1524-4725.2007.33357.x
   Christensen LH, 2009, DERMATOL SURG, V35, P1612, DOI 10.1111/j.1524-4725.2009.01338.x
   Cohen JL, 2008, DERMATOL SURG, V34, pS92, DOI 10.1111/j.1524-4725.2008.34249.x
   Cregg JM, 2010, TISSUE ENG PART C-ME, V16, P167, DOI [10.1089/ten.tec.2009.0108, 10.1089/ten.TEC.2009.0108]
   Eppley BL, 2006, PLAST RECONSTR SURG, V118, p98E, DOI 10.1097/01.prs.0000232436.91409.30
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Fernandez-Cossio S, 2006, PLAST RECONSTR SURG, V117, P1789, DOI 10.1097/01.prs.0000214656.07273.b0
   Fernandez-Cossio S, 2007, PLAST RECONSTR SURG, V120, P1161, DOI 10.1097/01.prs.0000279475.99934.71
   Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P411, DOI 10.1016/j.biopha.2004.08.001
   Gold M, 2009, J COSMET DERMATOL-US, V8, P301, DOI 10.1111/j.1473-2165.2009.00464.x
   Grewal N, 2009, CONNECT TISSUE RES, V50, P14, DOI 10.1080/03008200802385981
   Gu Y, 2001, CELL TRANSPLANT, V10, P453
   Hoffman BE, 2010, J CELL PHYSIOL, V222, P695, DOI 10.1002/jcp.21994
   Iafisco M, 2010, INT J ARTIF ORGANS, V33, P765
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P297, DOI 10.1016/S1359-0286(02)00077-3
   Marczylo T, 2000, MUTAGENESIS, V15, P223, DOI 10.1093/mutage/15.3.223
   Rossi F, 2012, J APPL POLYM SCI, V123, P398, DOI 10.1002/app.34488
   Rossi F, 2011, INT J MOL SCI, V12, P3394, DOI 10.3390/ijms12063394
   Scarano A, 2009, ORAL SURG ORAL MED O, V108, pE11, DOI 10.1016/j.tripleo.2009.04.025
   Sclafani AP, 2009, DERMATOL SURG, V35, P1672, DOI 10.1111/j.1524-4725.2009.01346.x
   Sheehy EJ, 2011, J TISSUE ENG REGEN M, V5, P747, DOI 10.1002/term.385
   Suzawa Y, 2010, J BIOMED MATER RES A, V93A, P965, DOI 10.1002/jbm.a.32518
   Tabata M, 2005, J BIOMED MATER RES B, V75B, P378, DOI 10.1002/jbm.b.30316
   Tabata M, 2003, J BIOMED MATER RES B, V67B, P680, DOI 10.1002/jbm.b.10063
   Tschon M, 2007, INT J ARTIF ORGANS, V30, P352
   TSUNENAGA M, 1992, CONNECT TISSUE RES, V28, P113, DOI 10.3109/03008209209014231
   Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xu XL, 2005, J BIOMED MATER RES B, V75B, P289, DOI 10.1002/jbm.b.30299
NR 40
TC 25
Z9 27
U1 3
U2 30
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0300-8207
J9 CONNECT TISSUE RES
JI Connect. Tissue Res.
PY 2012
VL 53
IS 6
BP 548
EP 554
DI 10.3109/03008207.2012.712583
PG 7
WC Cell Biology; Orthopedics
SC Cell Biology; Orthopedics
GA 035XJ
UT WOS:000310986200017
PM 22800469
DA 2018-10-19
ER

PT S
AU Hung, JM
   Wu, CZ
   Ou, KL
   Liu, CM
   Peng, PW
AF Hung, J. M.
   Wu, C. Z.
   Ou, K. L.
   Liu, C. M.
   Peng, P. W.
BE Pan, F
   Chen, X
TI Researches of Mechanical properties and Biocompatibility on
   Nanocrystalline Diamond
SO 18TH INTERNATIONAL VACUUM CONGRESS (IVC-18)
SE Physics Procedia
LA English
DT Proceedings Paper
CT 18th International Vacuum Congress (IVC)
CY AUG 23-27, 2010
CL Beijing, PEOPLES R CHINA
SP Int Union Vacuum Sci, Tech & Applicat (IUVSTA), Chinese Vacuum Soc (CVS)
DE nanocrystalline diamond; microwave plasma; chemical vapor deposition;
   hydrogen
ID CH4/H-2 MICROWAVE PLASMAS; THIN-FILMS; ULTRANANOCRYSTALLINE DIAMOND;
   RAMAN-SPECTRA; DEPOSITION; GROWTH; CVD
AB Nanocrystalline diamond (NCD) films were synthesized using microwave plasma chemical vapor deposition procedure with the CH4/Ar/H-2 gas mixture on silicon substrate at moderate temperatures in the present study. The characteristics of NCD films were evaluated using scanning electron microscopy, Raman spectroscopy, transmission electron microscopy, optical emission spectroscopy and optical contact angle meter. The analytical results revealed that C-2 radial was the dominant species in the deposited process. From TEM observation the NCD films was formed via the etching of hydrocarbons and a small amount of hydrogen content additive into gas mixture could improve the aggregation of the nucleation film to form the NCD films. A (crystalline > amorphous-like > nanocrystalline structure) transition occurred during formation of NCD films. The more hydrophobic surfaces implied that NCD films were the potential biomaterial in the application of article heart valve or stent. (C) 2012 Published by Elsevier B.V. Selection and/or peer review under responsibility of Chinese Vacuum Society (CVS).
C1 [Hung, J. M.; Wu, C. Z.] Taipei Med Univ, Sch Dent, Taipei 110, Taiwan.
   [Ou, K. L.; Liu, C. M.; Peng, P. W.] Taipei Med Univ, Res Ctr Biomed Plants & Microsurg Devices, Taipei 110, Taiwan.
   [Ou, K. L.; Peng, P. W.] Taipei Med Univ, Res Ctr Biomed Devices, Taipei 110, Taiwan.
   [Ou, K. L.] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei 110, Taiwan.
   [Liu, C. M.] LungHwa Univ Sci & Technol, Dept Chem & Mat Engn, Taoyuan, Taiwan.
   [Liu, C. M.] LungHwa Univ Sci & Technol, Grad Sch Engn Technol, Taoyuan, Taiwan.
   [Peng, P. W.] Taipei Med univ, Sch Dent, Taipei, Taiwan.
RP Peng, PW (reprint author), Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei 110, Taiwan.
EM apon@tmu.edu.tw
FU Center of Excellence for Clinical Trial and Research in Neurology and
   Neurosurgery; Taipei Medical University-Wan Fang Hospital [DOH99
   TD-B-111-003]
FX The authors highly appreciated Wei-Hung Chang for participation in
   experiments. We highly acknowledge financial support of research by
   Center of Excellence for Clinical Trial and Research in Neurology and
   Neurosurgery, Taipei Medical University-Wan Fang Hospital under the
   grand number of DOH99 TD-B-111-003.
CR Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   Birrell J, 2005, DIAM RELAT MATER, V14, P86, DOI 10.1016/j.diamond.2004.07.012
   Chen M, 2002, J MATER PROCESS TECH, V129, P81, DOI 10.1016/S0924-0136(02)00580-0
   Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058
   Cheng HC, 2009, J ALLOY COMPD, V477, P931, DOI 10.1016/j.jallcom.2008.11.043
   Fox OJL, 2009, DIAM RELAT MATER, V18, P750, DOI 10.1016/j.diamond.2009.01.004
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Hiramatsu M, 2002, THIN SOLID FILMS, V407, P18, DOI 10.1016/S0040-6090(02)00006-8
   Hong SP, 2002, DIAM RELAT MATER, V11, P877, DOI 10.1016/S0925-9635(01)00634-3
   Lechleitner T, 2008, BIOMATERIALS, V29, P4275, DOI 10.1016/j.biomaterials.2008.07.023
   Lin T., 2000, APPL PHYS LETT
   Liu YK, 2004, DIAM RELAT MATER, V13, P1859, DOI 10.1016/j.diamond.2004.05.006
   Lombardi G, 2004, J APPL PHYS, V96, P6739, DOI 10.1063/1.1814174
   May P.W., 2006, J APPL PHYS AM I PHY
   May PW, 2006, DIAM RELAT MATER, V15, P345, DOI 10.1016/j.diamond.2005.06.044
   May PW, 2000, PHILOS T ROY SOC A, V358, P473, DOI 10.1098/rsta.2000.0542
   Miyake M, 2007, THIN SOLID FILMS, V515, P4258, DOI 10.1016/j.tsf.2006.02.048
   Popov C, 2007, DIAM RELAT MATER, V16, P735, DOI 10.1016/j.diamond.2006.12.001
   Ren Wei-hong, 2003, Zhonghua Kou Qiang Yi Xue Za Zhi, V38, P306
   Talin AA, 1996, APPL PHYS LETT, V69, P3842, DOI 10.1063/1.117123
   Tang W, 2003, THIN SOLID FILMS, V429, P63, DOI 10.1016/S0040-6090(03)00056-7
   Williams OA, 2006, DIAM RELAT MATER, V15, P654, DOI 10.1016/j.diamond.2005.12.009
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
   Zhou D, 1998, J APPL PHYS, V84, P1981, DOI 10.1063/1.368331
   Zhou D, 1998, J APPL PHYS, V83, P540, DOI 10.1063/1.366668
   Zhou HY, 2007, DIAM RELAT MATER, V16, P675, DOI 10.1016/j.diamond.2006.11.074
NR 26
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1875-3892
J9 PHYSCS PROC
PY 2012
VL 32
BP 696
EP 705
DI 10.1016/j.phpro.2012.03.620
PG 10
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Coatings & Films; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA BCM02
UT WOS:000310677500100
OA Other Gold
DA 2018-10-19
ER

PT S
AU Zhang, RH
   Yang, XL
   Liu, J
   Cheng, XZ
AF Zhang, Rui Hue
   Yang, Xiao Li
   Liu, Jin
   Cheng, Xian Zhong
BE Gao, S
TI Eggshell membrane biomaterials for adsorption and determination of
   Mn(II, VII) in environmental water
SO ADVANCED MATERIALS AND ENGINEERING MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Materials and Engineering Materials
   (ICAMEM 2011)
CY NOV 22-24, 2011
CL Shenyang, PEOPLES R CHINA
DE Eggshell membrane; adsorption; manganese(II,VII); Inductively coupled
   plasma mass spectrometry
ID SOLID-PHASE EXTRACTION; SPECTROMETRY; SAMPLES
AB A simple solid phase extraction procedure for adsorption and preconcentration of manganese(II, VII) in environmental water samples has been proposed prior to inductively coupled plasma mass spectrometry. The procedure presented based on quantitative recoveries of manganese >95%. In this work, the potential use of eggshell membrane(ESM), a typical biomaterial, as solid-phase extraction (SPE) adsorbent is evaluated for analysis of trace manganese. The analytical variables, pH, flow rate, sample volume, elution, coexisting ions for optimum recoveries of manganese (11) and manganese (VII) were investigated. The preconcentration factor was 60. The detection limit (3 sigma) of manganese was 0.031 ng L-1. The relative standard deviations of determination was found to be 3.21%. The procedure was successfully applied to the adsorption and determination of manganese in environmental water samples.
C1 [Zhang, Rui Hue; Liu, Jin; Cheng, Xian Zhong] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan 430023, Peoples R China.
   [Yang, Xiao Li] Wuhan Inst Geol & Mineral Resources, Wuhan 430205, Peoples R China.
RP Zhang, RH (reprint author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan 430023, Peoples R China.
EM Zhangrh1964@126.com; lab_yc@163.com; 2006liujin1@sina.com;
   whcxz502@163.com
FU The Hubei Provincial Natural Science Foundation of China [2008CDA100];
   Geological Survey of China [1212011120266]
FX This work was supported by The Hubei Provincial Natural Science
   Foundation of China (No. 2008CDA100) and the Geological Survey of China
   (No. 1212011120266)
CR Zou AM, 2008, J ANAL ATOM SPECTROM, V23, P412, DOI 10.1039/b714535g
   Cheng XZ, 2007, GEOSTAND GEOANAL RES, V31, P353
   Cheng XZ, 2011, ATOM SPECTROSC, V32, P175
   Cheng XZ, 2010, ADV MATER RES-SWITZ, V113-116, P22, DOI 10.4028/www.scientific.net/AMR.113-116.22
   HORST WJ, 1978, PLANT SOIL, V50, P287, DOI 10.1007/BF02107179
   Roth JA, 2002, NEUROTOXICOLOGY, V23, P147, DOI 10.1016/S0161-813X(01)00077-8
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Zhang YJ, 2010, TALANTA, V80, P1907, DOI 10.1016/j.talanta.2009.10.042
NR 8
TC 3
Z9 4
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-355-9
J9 ADV MATER RES-SWITZ
PY 2012
VL 457-458
BP 536
EP +
DI 10.4028/www.scientific.net/AMR.457-458.536
PG 2
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCA77
UT WOS:000309489700113
DA 2018-10-19
ER

PT S
AU Huo, PF
AF Huo, Peng Feng
BE Zhang, H
   Jin, D
TI The application research of biological materials in meniscus injuries
SO APPLIED MECHANICS, MATERIALS, INDUSTRY AND MANUFACTURING ENGINEERING
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 2nd International Conference on Mechanical Engineering, Industry and
   Manufacturing Engineering (MEIME 2012)
CY JUN 23-24, 2012
CL Hefei, PEOPLES R CHINA
SP ISER Assoc, Beijing Gireida Educ Res Ctr, VIP Informat Conf Ctr
DE Biological materials; meniscus; injuries; application
ID KNEE-JOINT; IMPLANTS
AB The intervention means for rehabilitation of meniscus injury using artificial biomaterials were increasingly sophisticated, which provide brand new research directions for rehabilitation of meniscus injuries. However, it is difficult to select the desired implant due to existent a series of problems, including the biocompatibility, shape matching, adhesion, toughness, strength of artificial biological materials to human body in the process of specific practical application. Nowadays, main biological materials for meniscus injuries including hyaluronic acid, collagen, gelatin, poly hydroxyl acid, lactic acid, calcium Polyphosphate-accumulating, Polytetrafluoroethylene, carbon fiber reinforced polymer that is not absorbed, and so on. The stem cells were induced redirect directionally or gene modified by transforming growth factor beta I. Make bone marrow mesenchymal stem cells differentiate into cartilage cells by adjusting the number of cell growth and differentiation, and being inoculated for biomaterial scaffold, which provides new research directions for meniscus injury rehabilitation.
EM tyxzhanghuan@163.com
CR Bhosale AM, 2007, KNEE, V14, P361, DOI 10.1016/j.knee.2007.07.002
   Hofstaetter JG, 2004, BIOCHEM BIOPH RES CO, V324, P667, DOI 10.1016/j.bbrc.2004.09.103
   Kisiday JD, 2010, ARCH BIOCHEM BIOPHYS, V494, P138, DOI 10.1016/j.abb.2009.11.022
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Meller R, 2009, ANN ANAT, V191, P575, DOI 10.1016/j.aanat.2009.08.005
   MESSNER K, 1994, BIOMATERIALS, V15, P243, DOI 10.1016/0142-9612(94)90046-9
   Nishimuta J.F., 2012, OSTEOARTHRI IN PRESS
   Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.biomech.2005.04.030
   Steadman JR, 2005, ARTHROSCOPY, V21, P515, DOI 10.1016/j.arthro.2005.01.006
NR 9
TC 0
Z9 0
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-410-5
J9 APPL MECH MATER
PY 2012
VL 164
BP 128
EP 131
DI 10.4028/www.scientific.net/AMM.164.128
PG 4
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BCM61
UT WOS:000310712000030
DA 2018-10-19
ER

PT J
AU Bhargava, S
   Doi, H
   Kondo, R
   Aoki, H
   Hanawa, T
   Kasugai, S
AF Bhargava, Srilatha
   Doi, Hisashi
   Kondo, Ryota
   Aoki, Hideki
   Hanawa, Takao
   Kasugai, Shohei
TI Effect of sandblasting on the mechanical properties of Y-TZP zirconia
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Zirconia; sandblasting; phase transformation; flexural strength; Weibull
   modulus
ID BIAXIAL FLEXURAL STRENGTH; SURFACE-TREATMENT; CERAMICS; PERFORMANCE;
   BIOMATERIAL; TITANIUM; RELIABILITY; ROUGHNESS; BEHAVIOR
AB Surface modification techniques affect phase transformation which in turn influences strength of zirconia biomaterial. The study aimed at evaluating the tetragonal to monoclinic (t-m) phase transition of zirconia occurring after sandblasting three different ceramic abrasive materials and its subsequent effect on the strength. Zirconia bars (n = 24) were sandblasted using silicon carbide (SiC), alumina (Al2O3) and zirconia (ZrO2) particles. After surface characterization by a scanning electron microscope (SEM) and a laser profilometer, the relative amount of transformed monoclinic (m) phase was analyzed by X-ray diffractometry (XRD) and its corresponding effect on the flexural strength and fatigue strength were determined. Data were analyzed using one-way analysis of variance ANOVA (p < 0.05). Furthermore, Weibull statistics was used to analyze the variability of flexural strength. The highest amount of monoclinic content was found after sandblasting with SiC consequently resulting in an increased flexural strength and fracture resistance under cyclic load conditions. Weibull modulus was reduced in all the groups with SiC blasting showing the least degradation of m values. The strengthening mechanism that is attributed to sandblasting procedure is influenced by the abrasive material used.
C1 [Bhargava, Srilatha] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138549, Japan.
   [Bhargava, Srilatha; Kasugai, Shohei] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Tokyo 1138549, Japan.
   [Doi, Hisashi; Kondo, Ryota; Hanawa, Takao] Tokyo Med & Dent Univ, Dept Met, Inst Biomat & Bioengn, Tokyo 1138549, Japan.
   [Aoki, Hideki] Int Apatite Inst, Tokyo, Japan.
RP Bhargava, S (reprint author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.
EM drsrihas@gmail.com
FU Global Center of Excellence (GCOE) Program, International Research
   Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical
   and Dental University, Tokyo, Japan
FX This study was supported by the Global Center of Excellence (GCOE)
   Program, International Research Center for Molecular Science in Tooth
   and Bone Diseases, Tokyo Medical and Dental University, Tokyo, Japan.
CR Aboushelib MN, 2010, J PROSTHET DENT, V104, P98, DOI 10.1016/S0022-3913(10)60100-X
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Bona D., 2003, DENT MATER, V19, P662
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Ferrario VF, 2004, J DENT, V32, P451, DOI 10.1016/j.jdent.2004.02.009
   Gravie R., 1975, NATURE, V258, P703
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guizzardi S, 2004, J PERIODONTOL, V75, P273, DOI 10.1902/jop.2004.75.2.273
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Karakoca S, 2009, J BIOMED MATER RES B, V91B, P930, DOI 10.1002/jbm.b.31477
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2008, J EUR CERAM SOC, V28, P1085, DOI 10.1016/j.jeurceramsoc.2007.09.013
   Lugi V., 2010, DENT MATER, V26, P807
   Luthardt RG, 2004, DENT MATER, V20, P655, DOI 10.1016/j.dental.2003.08.007
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Okiyama S, 2003, J ORAL REHABIL, V30, P278, DOI 10.1046/j.1365-2842.2003.01009.x
   Ortiz AL, 2008, ACTA MATER, V56, P413, DOI 10.1016/j.actamat.2007.10.003
   Pick B, 2010, DENT MATER, V26, P83, DOI 10.1016/j.dental.2009.09.002
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2007, DENT MATER, V23, P1018, DOI 10.1016/j.dental.2006.09.003
   Skovgaard M, 2010, J EUR CERAM SOC, V30, P2749, DOI 10.1016/j.jeurceramsoc.2010.05.025
   Wang H, 2008, DENT MATER, V24, P633, DOI 10.1016/j.dental.2007.06.030
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Yilmaz H, 2007, J PROSTHET DENT, V98, P120, DOI 10.1016/S0022-3913(07)60045-6
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
NR 29
TC 11
Z9 12
U1 0
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2012
VL 22
IS 6
BP 383
EP 398
DI 10.3233/BME-2012-0727
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 031WV
UT WOS:000310674200005
PM 23114467
DA 2018-10-19
ER

PT S
AU Yoruc, ABH
   Karakas, A
   Elkoca, O
   Ipek, YK
AF Yoruc, A. Binnaz Hazer
   Karakas, Aysu
   Elkoca, Oktay
   Ipek, Yeliz Koca
BE Yigit, F
   Hashmi, MSJ
TI Zirconia-Hydroxyapatite Composite Coating on Cp-Ti Implants by
   Biomimetic Method
SO MATERIALS AND MANUFACTURING TECHNOLOGIES XIV
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 14th International Conference on Advances in Materials and Processing
   Technologies (AMPT)
CY JUL 13-16, 2011
CL Istanbul, TURKEY
SP Turkish Airlines, TTNET, Gedik Hold, Istanbul Dev Agcy
DE Dip-coating; Sol-gel; Biomimetic; Zirconia-Hydroxyapatite composite;
   cp-Ti
ID CALCIUM HYDROXYAPATITE; TITANIUM
AB Hydroxyapatite (HA) is the major component of the natural hard tissues such as teeth and bone. It has been studied extensively as a candidate biomaterial for its use in prosthetic applications. However, the main weakness of this material lies in its poor mechanical strength which makes it unsuitable for load-bearing applications. On the other hand zirconia (ZrO2) powder has been widely studied because of its high strength and fracture toughness and good biocompatibility. Therefore, the addition of zirconia phase into HA will improve the mechanical properties and biocompatibility of HA ceramics. The present study focused on coating of HA-ZrO2 on commercially pure titanium (cp-Ti) using novel biomimetic sol-gel method. The HA-ZrO2 coatings produced with BSG method were exhibited highly crystalline and pure structure. The coating thickness of the samples was not significantly influenced by the change in gelatin concentration and volume. It was concluded that the suggested coating method is a useful method to produce a biomimetic coating layer on the cp-Ti sample surfaces.
C1 [Yoruc, A. Binnaz Hazer; Karakas, Aysu] Yildiz Tech Univ, Sci & Technol Applicat & Res Ctr, TR-34220 Istanbul, Turkey.
   [Ipek, Yeliz Koca] Marmara Univ, Fac Engn, Dept Chem Engn, Istanbul 34722, Turkey.
RP Yoruc, ABH (reprint author), Yildiz Tech Univ, Sci & Technol Applicat & Res Ctr, TR-34220 Istanbul, Turkey.
EM afife.hazar@gmail.com; aysukarakas@gmail.com; oelkoca@gmail.com;
   kocayeliz@gmail.com
FU Y.ld.z Technical University; Science and Technology Application and
   Research Center; Scientific Research Project Foundation [29-07-02-KAP01]
FX This study was supported by the Y.ld.z Technical University, Science and
   Technology Application and Research Center, and in part, by the
   Scientific Research Project Foundation within the scope of the project
   number is 29-07-02-KAP01.
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Aydin M., 2006, BIOCERAMICS, V18, P309
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Besra Laxmidhar, 2003, PROGR MAT SCI, V24, P4541
   Buyuksagis A., 2009, ELECT J MACHINE TECH, V6, P21
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   Kuromoto NK, 2007, MATER CHARACT, V58, P114, DOI [10.1016/j.matchar.2006.03.020, 10.1016/j.matchar.2006.06.020]
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Teuberova Z, 2007, LASER PHYS, V17, P45, DOI 10.1134/S1054660X07010094
   Vasconcelos HC, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9766-z
   Yoshida K, 2006, J EUR CERAM SOC, V26, P515, DOI 10.1016/j.jeurceramsoc.2005.07.047
NR 14
TC 0
Z9 0
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-346-7
J9 ADV MATER RES-SWITZ
PY 2012
VL 445
BP 685
EP +
DI 10.4028/www.scientific.net/AMR.445.685
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCB24
UT WOS:000309565300116
DA 2018-10-19
ER

PT J
AU Christine, C
   Koubemba, M
   Shakir, S
   Clavier, S
   Ehret-Sabatier, L
   Saupe, F
   Orend, G
   Charbonniere, LJ
AF Christine, Caline
   Koubemba, Michaelle
   Shakir, Shakir
   Clavier, Severine
   Ehret-Sabatier, Laurence
   Saupe, Falk
   Orend, Gertraud
   Charbonniere, Loic J.
TI Synthesis of an activated phosphonated bifunctional chelate with
   potential for PET imaging and radiotherapy
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Article
ID MRI-CONTRAST AGENTS; TENASCIN-C; BIOLOGICAL EVALUATION; PENDANT ARMS;
   ACID; COMPLEXATION; RADIOPHARMACEUTICALS; LUMINESCENT; COPPER(II);
   COPPER-64
AB The synthesis of a phosphonated acyclic bifunctional chelate L* for the labeling of biomaterial is described. L* is based on a pyridine backbone, functionalized in ortho positions by aminomethyl-bis-methylphosphonic acids, and, in the para position, by a side chain containing a reactive NHS carbamate function. The stability of L* in aqueous solutions at different pH values was studied by mass spectrometry, showing the activated function to be sensitive to hydrolysis above neutral pH. The reactivity of L* towards amine functions was tested using ethylamine under different conditions of pH and concentrations, and by the labeling of two reference peptides containing both an N-terminal amino function and a e-amino group of a lysine residue in the backbone, and a supplementary thiol group of a cysteine residue for one of these two peptides. The results showed the coupling to be efficient at pH 8.0, with a total selectivity for the terminal amine function with respect to lysine and cysteine. The labeling was further performed on B28-13, a mouse monoclonal antibody specifically recognizing tenascin-C protein in human cancer. The labeled antibody was characterized by means of mass spectrometry and spectrofluorimetry, unraveling a labeling ratio of one chelate per antibody. Finally, the affinity of the labeled antibody towards its target was controlled by immunofluorescence staining experiments on human colon cancer biopsies, confirming the affinity of the labeled peptide for tenascin-C.
C1 [Christine, Caline; Koubemba, Michaelle; Shakir, Shakir; Charbonniere, Loic J.] Univ Strasbourg, CNRS, UMR 7178, Lab Ingn Mol Appl Anal,IPHC,ECPM, F-67087 Strasbourg, France.
   [Shakir, Shakir; Clavier, Severine; Ehret-Sabatier, Laurence] Univ Strasbourg, CNRS, UMR 7178, Lab Spectrometrie Masse Bioorgan,IPHC,ECPM, F-67087 Strasbourg, France.
   [Saupe, Falk; Orend, Gertraud] INSERM, U682, F-67200 Strasbourg, France.
RP Christine, C (reprint author), Univ Strasbourg, CNRS, UMR 7178, Lab Ingn Mol Appl Anal,IPHC,ECPM, 25 Rue Becquerel, F-67087 Strasbourg, France.
EM caline.christine@unistra.fr; l.charbonn@unistra.fr
RI Orend, Gertraud/E-8446-2015
OI Orend, Gertraud/0000-0003-2522-1195
FU Centre National de la Recherche Scientifique; Universite de Strasbourg
   [UMR 7178 CNRS-Universite de Strasbourg]; Fondation des Treilles; INCa;
   ANR; Contrat d'interface with the Hospital of Hautepierre (Strasbourg,
   France)
FX This work was supported by the Centre National de la Recherche
   Scientifique and the Universite de Strasbourg (UMR 7178 CNRS-Universite
   de Strasbourg). FS was supported by Fondation des Treilles. GO
   gratefully acknowledges the INCa, the ANR, and the Contrat d'interface
   with the Hospital of Hautepierre (Strasbourg, France) for financial
   support.
CR Abada S, 2011, RADIOCHIM ACTA, V99, P663, DOI 10.1524/ract.2011.1823
   Abada S, 2012, CHEM COMMUN, V48, P4085, DOI 10.1039/c2cc30757j
   Abada S, 2010, DALTON T, V39, P9055, DOI 10.1039/c0dt00453g
   Aime S, 2000, CHEM-EUR J, V6, P2609, DOI 10.1002/1521-3765(20000717)6:14<2609::AID-CHEM2609>3.0.CO;2-S
   Ait-Mohand S, 2011, BIOCONJUGATE CHEM, V22, P1729, DOI 10.1021/bc2002665
   Bass LA, 2000, BIOCONJUGATE CHEM, V11, P527, DOI 10.1021/bc990167l
   Bernier N, 2011, DALTON T, V40, P4514, DOI 10.1039/c0dt01191f
   Bhattacharyya S, 2011, DALTON T, V40, P6112, DOI 10.1039/c1dt10379b
   Bonnet CS, 2010, CHEM COMMUN, V46, P124, DOI 10.1039/b918881a
   Boswell CA, 2009, BIOORGAN MED CHEM, V17, P548, DOI 10.1016/j.bmc.2008.11.073
   Chiquet-Ehrismann R., 2011, PERSP BIOL, V3
   de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p
   Ferdani R, 2012, DALTON T, V41, P1938, DOI 10.1039/c1dt11743b
   Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v
   Guo YJ, 2012, BIOCONJUGATE CHEM, V23, P1470, DOI 10.1021/bc300092n
   Lima LMP, 2012, INORG CHEM, V51, P6916, DOI 10.1021/ic300784v
   Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006
   Lukes I, 2001, COORDIN CHEM REV, V216, P287, DOI 10.1016/S0010-8545(01)00336-8
   Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6
   Mishra AK, 2005, CHEM LETT, V34, P1098, DOI 10.1246/cl.2005.1098
   Morpurgo M, 1999, J BIOCHEM BIOPH METH, V38, P17, DOI 10.1016/S0165-022X(98)00027-X
   Nono K. Nchimi, 2011, INORG CHEM, V50, P1689
   Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017
   Pellegatti L, 2008, CHEM COMMUN, P6591, DOI 10.1039/b817343e
   Qaim SM, 2007, RADIOCHIM ACTA, V95, P67, DOI 10.1524/ract.2007.95.2.67
   Regueiro-Figueroa M, 2011, INORG CHEM, V50, P4125, DOI 10.1021/ic2001915
   SCHENK S, 1995, INT J CANCER, V61, P443, DOI 10.1002/ijc.2910610402
   Shokeen M, 2009, ACCOUNTS CHEM RES, V42, P832, DOI 10.1021/ar800255q
   SMITHJONES PM, 1991, BIOCONJUGATE CHEM, V2, P415, DOI 10.1021/bc00012a006
   Stigers DJ, 2010, DALTON T, V39, P1699, DOI 10.1039/b920871b
   Sun XK, 2003, J BIOL INORG CHEM, V8, P217, DOI 10.1007/s00775-002-0408-5
   Svobodova I, 2009, EUR J INORG CHEM, P3577, DOI 10.1002/ejic.200900358
   Tournier EJM, 1998, ANAL CHIM ACTA, V361, P33, DOI 10.1016/S0003-2670(98)00008-7
   Vilaivan T, 2006, TETRAHEDRON LETT, V47, P6739, DOI 10.1016/j.tetlet.2006.07.097
   Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768
   Wadas TJ, 2010, CHEM REV, V110, P2858, DOI 10.1021/cr900325h
   Wang TM, 2000, J HETEROCYCLIC CHEM, V37, P687, DOI 10.1002/jhet.5570370403
   Zeglis BM, 2011, DALTON T, V40, P6168, DOI 10.1039/c0dt01595d
NR 38
TC 13
Z9 13
U1 0
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PY 2012
VL 10
IS 46
BP 9183
EP 9190
DI 10.1039/c2ob26452h
PG 8
WC Chemistry, Organic
SC Chemistry
GA 033PH
UT WOS:000310809800011
PM 23086384
DA 2018-10-19
ER

PT S
AU Jin, HY
   Yin, H
   Liu, Y
   An, Y
AF Jin, Huanyu
   Yin, Hua
   Liu, Yu
   An, Yan
BE Deng, XC
   Dong, XF
TI The effect of gamma ray on the mechanical and molecular structure
   changes of silk fibroin
SO PROGRESS IN NEW MATERIALS AND MECHANICS RESEARCH
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Computer-aided Material and Engineering
   (ICCME 2012)
CY MAR 17-18, 2012
CL Hangzhou, PEOPLES R CHINA
SP Inst Elect & Informat Technol, Zhejiang Econ & Trade Polytechn
DE silk fibroin; gamma ray; breaking strength; elongation
AB Silk fibroin is regarded as a biomaterial for a long time. The fantastic biocompatibility of silk fibroin makes it a hot spot in the biomedical area and many researches has chosen it as a basic material to create new biomaterials. However, it has a long biodegradation period in body. Gamma ray is a method to accelerate degradation of other material in some experiments. This research combines silk fibroin with gamma ray and tries to figure out whether gamma ray can make the biodegradation of silk fibroin shorten. In this article, we give various doses of gamma ray to silk fibroin films and take some measurements about the mechanical and molecular structure of post-radiated silk fibroin, thus to choose an appropriate dose for the future research.
C1 [Jin, Huanyu; An, Yan] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou 215123, Peoples R China.
   [Jin, Huanyu; Yin, Hua; Liu, Yu; An, Yan] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Yin, Hua; Liu, Yu] Suzhou Univ, Coll Text & Clothing Engn, Suzhou 215006, Peoples R China.
RP An, Y (reprint author), Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou 215123, Peoples R China.
EM jhy0513jn@163.com; yinhua75@suda.edu.cn; liuyu@suda.edu.cn;
   dranyan@126.com
FU National Engineering Laboratory for Modern Silk of Soochow University
   Foundation [SS115801]; Jiangsu Provincial Key Laboratory of Radiation
   Medicine and Protection Foundation [KJS0927]
FX This work was financially supported by the National Engineering
   Laboratory for Modern Silk of Soochow University Foundation (SS115801)
   and Jiangsu Provincial Key Laboratory of Radiation Medicine and
   Protection Foundation (KJS0927).
CR Lu Shenzhou, 2007, BIOL PROPERTIES SILK, V12, P58
   Wang Linting, 2009, N SERICULTURE, V30, P1
   Xiong SY, 2011, ADV MATER RES-SWITZ, V197-198, P27, DOI 10.4028/www.scientific.net/AMR.197-198.27
   Zheng Zhonghou, 2007, PREPARATION PROPERTI
   [朱正华 Zhu Zhenghua], 2002, [膜科学与技术, Membrane Science and Technology], V22, P48
NR 5
TC 0
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-403-7
J9 ADV MATER RES-SWITZ
PY 2012
VL 502
BP 269
EP +
DI 10.4028/www.scientific.net/AMR.502.269
PG 2
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA BCA17
UT WOS:000309371700055
DA 2018-10-19
ER

PT J
AU Benson, K
   Prasetyanto, EA
   Galla, HJ
   Kehr, NS
AF Benson, Kathrin
   Prasetyanto, Eko Adi
   Galla, Hans-Joachim
   Kehr, Nermin Seda
TI Self-assembled monolayers of bifunctional periodic mesoporous
   organosilicas for cell adhesion and cellular patterning
SO SOFT MATTER
LA English
DT Article
ID SELECTIVE FUNCTIONALIZATION; ORGANIC FUNCTIONALITY; SILICA
   NANOPARTICLES; EXTRACELLULAR-MATRIX; CHANNEL WALLS; PMOS; BIOMATERIALS;
   PRECURSORS; SURFACTANT; FRAMEWORKS
AB Periodic mesoporous organosilicas (PMOs), an important class of inorganic-organic functional hybrid materials, find numerous potential applications in nano-and biotechnologies due to their porous nature, large surface area (internal and external surfaces) and the structural diversity of their organosilica frameworks. In this contribution we report on the selective functionalization of both the internal and the external surfaces of PMOs with a fluorescent dye and bioactive molecules, respectively. Subsequently we used these unique bifunctionalized PMO nanoparticles for the preparation of non-patterned and patterned self-assembled monolayers (SAMs) on glass. In cell experiments we showed that these new biomaterial surfaces enhance cell adhesion. We were able to determine the position of the inside dye substituted PMOs of the biomolecule functionalized surface in relation to the position of the stained cells by fluorescence microscopy as well. Patterned SAMs of bifunctionalized PMOs lead to selective cellular patterning along the stripes (texture of the surface).
C1 [Prasetyanto, Eko Adi; Kehr, Nermin Seda] Univ Munster, Inst Phys, D-48149 Munster, Germany.
   [Prasetyanto, Eko Adi; Kehr, Nermin Seda] Univ Munster, CeNTech, D-48149 Munster, Germany.
   [Benson, Kathrin; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany.
RP Kehr, NS (reprint author), Univ Munster, Inst Phys, Heisenbergstr 11, D-48149 Munster, Germany.
EM seda@uni-muenster.de
RI Prasetyanto, Eko Adi/B-9125-2009
OI Prasetyanto, Eko Adi/0000-0002-7641-861X
FU  [SFB 858]
FX N. S. Kehr thanks the SFB 858 for funding. We are grateful to Dr Andreas
   Schafer for XPS, Mark Weiss and Tobias Placke for N<INF>2</INF>-sorption
   measurements respectively.
CR Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Asefa T, 1999, NATURE, V402, P867
   Bai HJ, 2009, LANGMUIR, V25, P10402, DOI 10.1021/la900944c
   Bao XY, 2004, APPL SURF SCI, V237, P380, DOI 10.1016/j.apsusc.2004.06.072
   Beretta M, 2010, CHEM COMMUN, V46, P2495, DOI 10.1039/b923485c
   Bruhwiler D, 2009, J MATER CHEM, V19, P8040, DOI 10.1039/b907308f
   Busby M, 2008, ADV MATER, V20, P1614, DOI 10.1002/adma.200702354
   Cai WY, 2008, ANAL CHEM, V80, P5401, DOI 10.1021/ac800430m
   Cauda V, 2009, J AM CHEM SOC, V131, P11361, DOI 10.1021/ja809346n
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Cheng K, 2007, J AM CHEM SOC, V129, P9674, DOI 10.1021/ja070598b
   Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8
   Cucinotta F, 2009, ADV MATER, V21, P1142, DOI 10.1002/adma.200801751
   Dag O, 2001, ADV FUNCT MATER, V11, P213
   de Juan F, 2000, ADV MATER, V12, P430, DOI 10.1002/(SICI)1521-4095(200003)12:6<430::AID-ADMA430>3.0.CO;2-3
   Gao JS, 2009, J MATER CHEM, V19, P8580, DOI 10.1039/b909002a
   Gartmann N, 2009, ANGEW CHEM INT EDIT, V48, P6354, DOI 10.1002/anie.200902436
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gleason NJ, 2003, LANGMUIR, V19, P513, DOI 10.1021/la026534q
   Goto Y, 2002, CHEM COMMUN, P2410, DOI 10.1039/b207825b
   Guo W, 2010, CHEM-EUR J, V16, P8641, DOI 10.1002/chem.201000980
   Guo WP, 2005, MICROPOR MESOPOR MAT, V85, P32, DOI 10.1016/j.micromeso.2005.06.004
   Hatton B, 2005, ACCOUNTS CHEM RES, V38, P305, DOI 10.1021/ar040164a
   Hatton BD, 2005, ADV FUNCT MATER, V15, P823, DOI 10.1002/adfm.200400221
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   Hua L., 2002, ADV MATER, V14, P830
   Hunks WJ, 2005, J MATER CHEM, V15, P3716, DOI 10.1039/b504511h
   Hunks WJ, 2005, ADV FUNCT MATER, V15, P259, DOI 10.1002/adfm.200400294
   Inagaki S, 1999, J AM CHEM SOC, V121, P9611, DOI 10.1021/ja9916658
   Kecht J, 2008, CHEM MATER, V20, P7207, DOI 10.1021/cm801484r
   Kehr N. S., 2010, MICROPOR MESOPOR MAT, V144, P9
   Kehr NS, 2010, ADV FUNCT MATER, V20, P2248, DOI 10.1002/adfm.201000205
   Kehr NS, 2010, NANOSCALE, V2, P601, DOI 10.1039/b9nr00285e
   Kilian KA, 2008, ANGEW CHEM INT EDIT, V47, P2697, DOI 10.1002/anie.200704784
   Kim MS, 2011, J MATER CHEM, V21, P8766, DOI 10.1039/c1jm10440c
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Landskron K, 2005, ANGEW CHEM INT EDIT, V44, P2107, DOI 10.1002/anie.200462279
   Liang YC, 2005, CHEM COMMUN, P525, DOI 10.1039/b411146j
   Lin CX, 2009, MICROPOR MESOPOR MAT, V117, P213, DOI 10.1016/j.micromeso.2008.06.023
   Lu YF, 2000, J AM CHEM SOC, V122, P5258, DOI 10.1021/ja9935862
   Melde BJ, 1999, CHEM MATER, V11, P3302, DOI 10.1021/cm9903935
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Morell J, 2005, CHEM MATER, V17, P804, DOI 10.1021/cm048302d
   Qiao SZ, 2006, PROG SOLID STATE CH, V34, P249, DOI 10.1016/j.progsolidstchem.2005.11.023
   Qiao SZ, 2005, CHEM MATER, V17, P6172, DOI 10.1021/cm051735b
   Rebbin V, 2004, MICROPOR MESOPOR MAT, V72, P99, DOI 10.1016/j.micromeso.2004.04.018
   Ruiz AZ, 2006, ANGEW CHEM INT EDIT, V45, P5282, DOI 10.1002/anie.200504286
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Tan B, 2007, ADV FUNCT MATER, V17, P2500, DOI 10.1002/adfm.200600635
   Wan JJ, 2010, LANGMUIR, V26, P7444, DOI 10.1021/la9041698
   Wang ST, 2009, ANGEW CHEM INT EDIT, V48, P8970, DOI 10.1002/anie.200901668
   Wang WD, 2010, ADV MATER, V22, P99, DOI 10.1002/adma.200901498
   WAYNE R, 1992, J CELL SCI, V101, P611
   Wight AP, 2002, CHEM REV, V102, P3589, DOI 10.1021/cr010334m
   Wilson CG, 2009, BIOMATERIALS, V30, P5639, DOI 10.1016/j.biomaterials.2009.07.011
   Yang QH, 2004, J CATAL, V228, P265, DOI 10.1016/j.jcat.2004.09.007
   Zhang SG, 2004, J MATER CHEM, V14, P2082, DOI 10.1039/b406136e
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zheng HP, 2004, LANGMUIR, V20, P7215, DOI 10.1021/la049856y
NR 60
TC 19
Z9 19
U1 0
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 42
BP 10845
EP 10852
DI 10.1039/c2sm26563j
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 033VL
UT WOS:000310829400007
DA 2018-10-19
ER

PT S
AU Dubuc, D
   Grenier, K
   Poupot, M
   Fournie, JJ
AF Dubuc, David
   Grenier, Katia
   Poupot, Mary
   Fournie, Jean-Jacques
GP IEEE
TI Broadband Microwave Biosensing Based on InterDigitated Capacitor for
   Lab-On-Chip Applications
SO 2012 IEEE 10TH INTERNATIONAL NEW CIRCUITS AND SYSTEMS CONFERENCE
   (NEWCAS)
SE IEEE International New Circuits and Systems Conference
LA English
DT Proceedings Paper
CT 10th IEEE International New Circuits and Systems Conference (NEWCAS)
CY JUN 17-20, 2012
CL Montreal, CANADA
SP IEEE, IEEE Circuits & Syst Soc, CMC Microsyst, UQAM, Dept Informatique, Polytechnique Montreal, Regroupement Strategique Microsysteme Quebec
AB This paper presents an innovative biosensing technique based on the interaction between biomaterial and microwave electromagnetic (EM) waves, which probes the bioparameters of investigated biological samples. Thanks to microtechnologies, this approach is able to sense biomaterials down to living cells size without invasivity. Broadband dielectric spectroscopy of living cells suspension is consequently demonstrated sketching a rich EM signature. Capacitive contrasts of 4% and 12% between cells suspension and pure medium are measured at 20 and 40GHz respectively. This analyzing technique consequently represents a promising integrated solution compatible with Lab-on-Chip (LoC) applications.
C1 [Dubuc, David; Grenier, Katia] CNRS, LAAS, 7 Ave Colonel Roche, F-31077 Toulouse, France.
   [Dubuc, David; Grenier, Katia] Universite Toulouse, INSA, LAAS,ISAE, UPS,INP, F-31077 Toulouse, France.
   [Poupot, Mary; Fournie, Jean-Jacques] INSERM, CHU Purpan, U563 BAT B, F-31024 Toulouse, France.
RP Dubuc, D (reprint author), CNRS, LAAS, 7 Ave Colonel Roche, F-31077 Toulouse, France.
EM dubuc@laas.fr; grenier@laas.fr
RI Poupot, Mary/F-8570-2013; Fournie, jean-jacques/J-7805-2013
OI Fournie, jean-jacques/0000-0001-6542-6908
CR Denef N, 2004, 34TH EUROPEAN MICROWAVE CONFERENCE, VOLS 1-3, CONFERENCE PROCEEDINGS, P669
   Facer GR, 2001, APPL PHYS LETT, V78, P996, DOI 10.1063/1.1347020
   Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001
   Grenier K., IEEE RWS 2010
   Grenier K, 2009, IEEE T MICROW THEORY, V57, P3246, DOI 10.1109/TMTT.2009.2034226
   Miled M.A., NEWCAS 2010
NR 6
TC 3
Z9 3
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2472-467X
BN 978-1-4673-0859-5
J9 IEEE INT NEW CIRC
PY 2012
BP 529
EP 532
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BCK13
UT WOS:000310372500133
DA 2018-10-19
ER

PT S
AU Wang, JJ
   Hu, WP
AF Wang, Jingjing
   Hu, Weiping
BE Xu, B
   Li, HY
TI Application Study on Biological Materials in Interior Design
SO ADVANCED MATERIALS AND ITS APPLICATION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Materials and its Application (AMA
   2012)
CY APR 28-29, 2012
CL Changsha, PEOPLES R CHINA
SP Wuhan Inst Technol, Beijing Mat Res Ctr, Int Mat Res Soc
DE Biomaterial; Interior; Environmental protection; Function
AB The recognition for materials is the prerequisite and guarantee of Interior design, but traditional materials in the Interior have high pollution, flat colors, disadvantages such as poor functionality and styling, in the paper, we mainly study on biomaterials and its application in interior design, and try to solve these problems, it has important significance for improving people's living conditions and environmental protection as an important material.
C1 [Wang, Jingjing; Hu, Weiping] Kunming Univ Sci & Technol, Facul Art & Commun, Kunming, Peoples R China.
RP Wang, JJ (reprint author), Kunming Univ Sci & Technol, Facul Art & Commun, Kunming, Peoples R China.
EM foreverbubblegum@live.cn; yncaid@sina.com
CR [Anonymous], 1999, EXT WALLS BIOL ACT R
   Feng Qingling, 2009, OVERVIEW BIOL MAT
   Hou Lin, 2006, INTERIOR DESIGN PUBL
   Liu Zheren, 2006, INTERIOR DECORATION
   Liu Zhuojun, 2000, HAZARDS FACTORS THEI
   Wang Decai, 2006, HAZARDOUS SUBSTANCE
NR 6
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-375-7
J9 ADV MATER RES-SWITZ
PY 2012
VL 460
BP 321
EP 324
DI 10.4028/www.scientific.net/AMR.460.321
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ35
UT WOS:000309153300070
DA 2018-10-19
ER

PT S
AU Assadian, M
   Idris, MH
   Mehraban, S
   Jafari, S
   Kadir, MRA
AF Assadian, Mahtab
   Idris, Mohd Hasbullah
   Mehraban, Saleh
   Jafari, Sajjad
   Kadir, Mohammed Rafiq Abdul
BE Fan, W
TI Effect of HF Concentration on Corrosion Resistance of Biomedical
   Implants
SO ADVANCED MATERIALS RESEARCH II, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Advanced Material Research (ICAMR 2012)
CY JAN 07-08, 2012
CL Chengdu, PEOPLES R CHINA
SP Singapore Inst Elect, Sci & Engn Inst
DE Magnesium; acid treatment; biodegradable implant; corrosion resistance
ID MAGNESIUM; ALLOYS
AB This work compared the variation of weight of Mg 1%Ca as cast in different concentrations of hydrofluoric acid (HF) such as 45% - 40% - 35% - 25% - 20% - 13% - 7% for 24 h at room temperature to be utilized in biomaterial application like hip, knee implants that have effect on corrosion resistance. By immersion Mg 1%Ca alloys in HF, the layer of MgF2 was constituted on the surface of alloy and this layer improves the corrosion and causes weight gain. The results show that in order to get a better corrosion resistance, surface treatment should be done in 40% of HF, because the weight gain is more than other HF concentrations.
C1 [Assadian, Mahtab; Idris, Mohd Hasbullah; Mehraban, Saleh; Jafari, Sajjad] Univ Teknol Malaysia, Fac Mech Engn, Dept Mat Engn, Skudai 81310, Johor, Malaysia.
   [Kadir, Mohammed Rafiq Abdul] Univ Teknol Malaysia, Fac Biomed Engn & Hlth Sci, Dept Biomech & Biomed Mat, Skudai 81310, Johor, Malaysia.
RP Assadian, M (reprint author), Univ Teknol Malaysia, Fac Mech Engn, Dept Mat Engn, Skudai 81310, Johor, Malaysia.
EM Mahtab.assadian@gmail.com; hsbullah@fkm.utm.my;
   saleh.mehraban@gmail.com; sajjad.jafary.1365@gmail.com;
   rafiq@biomedical.utm.my
CR Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   da Conceicao TF, 2010, THIN SOLID FILMS, V518, P5209, DOI 10.1016/j.tsf.2010.04.114
   Elsentriecy H.H., 2007, SURF COAT TECH, V202, P2007
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Supplit R, 2007, CORROS SCI, V49, P3015, DOI 10.1016/j.corsci.2007.02.006
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 8
TC 0
Z9 0
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-363-4
J9 ADV MATER RES-SWITZ
PY 2012
VL 463-464
BP 837
EP +
DI 10.4028/www.scientific.net/AMR.463-464.837
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBT80
UT WOS:000308114100161
DA 2018-10-19
ER

PT S
AU Hu, RH
   Yan, CF
   Lim, JK
AF Hu, Rui-Hua
   Yan, Cun-Fu
   Lim, Jae-kyoo
BE Wen, YX
   Lei, FH
TI Porous Ti-6Al-4V Fabricated by Powder Sintering and its Property
   Evaluation
SO ADVANCES IN CHEMICAL ENGINEERING, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical, Material and Metallurgical
   Engineering (ICCMME 2011)
CY DEC 23-25, 2011
CL Beihai, PEOPLES R CHINA
SP Guangxi Univ, China, Wuhan Univ Sci & Technol, Queensland Univ Technol
DE Titanium alloys; Biomaterial; Microstructure; Sintering
ID TITANIUM; SCAFFOLDS; SLURRIES
AB Porous titanium alloys are frequently used as bio-implant scaffold. In this research, porous Ti-6Al-4V was fabricated by using powder sintering method with ammonium bicarbonate powders as space holder. The space holder decomposes to gases like ammonia, carbon dioxide and water at comparatively low temperature. The advantages of this pore holder and its decomposition products are that they have no contamination to host powders, and harmless to sintering machine. Green bodies with different weight ratio of pore holder and host powder are prepared, and then the pore holders are fully removed by heating at 200 degrees C. Porosity, density, compressive strength and modulus of the sintered porous Ti-6Al-4V are tested.
C1 [Hu, Rui-Hua; Yan, Cun-Fu] Huanghe Sci & Technol Coll, Sch Engn, Zhengzhou, Peoples R China.
   [Lim, Jae-kyoo] Chonbuk Natl Univ, Dept Mech Design, Mat & Fracture Mech Lab, Jeonju, South Korea.
RP Hu, RH (reprint author), Huanghe Sci & Technol Coll, Sch Engn, Zhengzhou, Peoples R China.
EM Ruihuahu926@hotmail.com; jklim@chonbuk.ac.kr
CR Cachinho SCP, 2007, POWDER TECHNOL, V178, P109, DOI 10.1016/j.powtec.2007.04.014
   Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   Yook SW, 2008, MATER LETT, V62, P4506, DOI 10.1016/j.matlet.2008.08.010
NR 5
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-308-5
J9 ADV MATER RES-SWITZ
PY 2012
VL 396-398
BP 257
EP +
DI 10.4028/www.scientific.net/AMR.396-398.257
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BBY63
UT WOS:000308830100054
DA 2018-10-19
ER

PT S
AU Paraguassu, GM
   Lino, MDMD
   de Carvalho, FB
   Cangussu, MC
   Pinheiro, ALB
   Ramalho, LMP
AF Paraguassu, Gardenia Matos
   Martinez da Costa Lino, Maira Doria
   de Carvalho, Fabiola Bastos
   Cangussu, Maria Cristina
   Barbosa Pinheiro, Antonio Luiz
   Pedreira Ramalho, Luciana Maria
BE Longo, L
TI Evaluation of Laser Photobiomodulation on Healing of Bone Defects
   Grafted with Bovine Bone in Diabetic Rats
SO ADVANCES IN LASEROLOGY - SELECTED PAPERS OF LASER FLORENCE 2011: A
   WINDOW ON THE LASER MEDICINE WORLD
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT Annual Congress of the International-Academy-Laser-Medicine-and-Surgery
   (Laser Florence)
CY NOV 04-05, 2011
CL Firenze, ITALY
SP Int Acad Laser Med & Surg (IALMS), Int Soc Laser Surg & Med (ISLSM), World Federat Laser Surg & Med Societies (WFLSMS), Int Photo Therapy Assoc (IPTA), Inst Laser Med Florence (ILM), Italian Hlth Off, Florence Med Assoc, Florence Convent Bur, L Club Firenze Stibbert, Kiwanis Club Tuscany
DE Diabetes Mellitus; Bone Defect; Inorganic Bovine Bone; Low Level Laser
   Therapy (LLLT)
ID LIGHT; REPAIR; REGENERATION; IRRADIATION; TISSUE
AB Previous studies have shown positive effects of Low Level Laser Therapy (LLLT) on the repair of bone defects, but there is a few that associates bone healing in the presence of a metabolic disorder such as Diabetes Mellitus, a systemic disorder associated to impair of the repair of different tissues. The aim of this study was to assess, histologically, the repair of surgical defects created in the femur of diabetic and non-diabetic rats treated or not with LLLT (lambda 780nm, 70mW, CW, circle divide similar to 0.4mm, 16J/cm(2) per session) associated or not to the use of a biomaterial. Surgical tibial bone defects were created in 60 animals that were divided into 4 groups: Group B (non-diabetic + biomaterial); Group BL (non-diabetic + biomaterial + LLLT); Group BD (diabetic + biomaterial); Group BDL (diabetic + biomaterial + LLLT). The irradiated group received 16 J/cm(2) per session divided into 4 points around the defect, being the first irradiation carried out immediately after surgery and repeated every 48h for 14 days. The animals were killed 15, 21 and 30 days after surgery. The specimens underwent a semi-quantitative analysis. The results showed inflammation more intense in the BD and BDL groups than in the B and BL groups in the period of 15 days (p = 0.02), however the cortical repair in the BDL group was below 25% in more than half of the specimens, while in the BD group, the repair was more than to 25% in all specimens. At 30 days, both osteoblastic activity and collagen deposition were significantly higher in the B group when compared to the BD group (p=0.04). Bone deposition was significantly higher in the BL group (p=0.023) than in BDL group. It is concluded that LLLT has a positive biomodulative effect in the early stages of the healing process of bone defects grafted with biomaterial in diabetic and non-diabetic rats.
C1 [Paraguassu, Gardenia Matos; Martinez da Costa Lino, Maira Doria; de Carvalho, Fabiola Bastos; Barbosa Pinheiro, Antonio Luiz; Pedreira Ramalho, Luciana Maria] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Cangussu, Maria Cristina] Univ Fed Bahia, Sch Dent, Oral Epidemiol & Pub Hlth, BR-40110150 Salvador, BA, Brazil.
   [Cangussu, Maria Cristina] Univ Camilo Castelo Branco, BR-12245230 Sao Paulo, Brazil.
RP Paraguassu, GM (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
CR Akyol UK, 2010, PHOTOMED LASER SURG, V28, P411, DOI 10.1089/pho.2008.2478
   Barreto E.C., 2006, THESIS
   Bergman SA, 2007, ORAL SURG ORAL MED O, V103, P731, DOI 10.1016/j.tripleo.2006.11.029
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Dortbudak O, 2002, CLIN ORAL IMPLAN RES, V13, P288, DOI 10.1034/j.1600-0501.2002.130308.x
   Follak N, 2004, BONE, V35, P144, DOI 10.1016/j.bone.2004.03.011
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Guzzardella G.A., 2003, ORAL IMPL RES, V14, P116
   Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072
   Merli LAD, 2005, PHOTOMED LASER SURG, V23, P212, DOI 10.1089/pho.2005.23.212
   Oliveira PC, 2010, PHOTOMED LASER SURG, V28, P613, DOI 10.1089/pho.2009.2675
   Pinheiro A L, 1997, J Clin Laser Med Surg, V15, P181
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2009, PHOTOMED LASER SURG, V27, P833, DOI 10.1089/pho.2009.2716
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Schwartz Z, 2008, CLIN ORAL IMPLAN RES, V19, P1233, DOI 10.1111/j.1600-0501.2008.01582.x
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Vestergaard P, 2009, CURR OPIN ENDOCRINOL, V16, P125, DOI 10.1097/MED.0b013e328325d155
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
NR 20
TC 1
Z9 1
U1 0
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1098-5
J9 AIP CONF PROC
PY 2012
VL 1486
BP 47
EP 52
DI 10.1063/1.4757822
PG 6
WC Optics; Physics, Applied
SC Optics; Physics
GA BCK82
UT WOS:000310509300004
DA 2018-10-19
ER

PT S
AU Wang, Y
   Ban, LT
   Li, Z
   Wu, JX
AF Wang, Yu
   Ban, Litong
   Li, Zheng
   Wu, Jiaxin
BE Chen, R
   Sung, WP
TI Optimization of culture conditions for improving the biomass of Agaricus
   brunnescens
SO BIOTECHNOLOGY, CHEMICAL AND MATERIALS ENGINEERING, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Biotechnology, Chemical and Materials
   Engineering (CBCME 2011)
CY DEC 28-29, 2011
CL Kunming, PEOPLES R CHINA
DE Agaricus brunnescens; Exopolysaccharide; Optimization; Culture
   conditions
ID EXOPOLYSACCHARIDE PRODUCTION
AB Agaricus brunnescens is a producer for novel biomaterial (exopolysaccharide of Agaricus brunnescens). In this paper, the optimization of culture conditions for the biomass of Agaricus brunnescens through orthogonal methods was reported. The optimal conditions for enhancing production was: inoculum size 10 %, broth volume 100 mL in a 250 mL flask, pH 6.0. This optimization strategy in shake flask culture lead to an biomass 0.8 g/L, which was considerably higher than that obtained in preliminary studied.
C1 [Wang, Yu; Ban, Litong] Tianjin Agr Univ, Dept Agron, Tianjin, Peoples R China.
   [Li, Zheng] Tianjin Polytech Univ, Sch Text, Tianjin, Peoples R China.
   [Wu, Jiaxin] China Animal Husb Ind Co Ltd, Beijing, Peoples R China.
RP Wang, Y (reprint author), Tianjin Agr Univ, Dept Agron, Tianjin, Peoples R China.
EM wytjac@163.com; banlitong@126.com; lizheng@tjpu.edu.cn;
   icebergwujiaxin@163.com
CR [Anonymous], 1990, BIOTECHNOLOGY BIOENG, V36, P778
   CASTLE AJ, 1987, APPL ENVIRON MICROB, V53, P816
   Chang XW, 2010, CATAL TODAY, V158, P198, DOI 10.1016/j.cattod.2010.02.009
   Fang QH, 2002, BIOCHEM ENG J, V10, P61, DOI 10.1016/S1369-703X(01)00158-9
   Hao LM, 2010, APPL BIOCHEM BIOTECH, V160, P621, DOI 10.1007/s12010-008-8507-6
   JODON MH, 1982, CRYOBIOLOGY, V19, P602, DOI 10.1016/0011-2240(82)90189-4
   Liu C., 2000, EDIBLE FUNGI, V22, P24
   MAY B, 1982, EXP MYCOL, V6, P283, DOI 10.1016/0147-5975(82)90121-9
   ROYSE DJ, 1982, MYCOLOGIA, V74, P93, DOI 10.2307/3792632
   Wang Y., CHINA BREWI IN PRESS
NR 10
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-307-8
J9 ADV MATER RES-SWITZ
PY 2012
VL 393-395
BP 859
EP +
DI 10.4028/www.scientific.net/AMR.393-395.859
PG 2
WC Biotechnology & Applied Microbiology; Engineering, Chemical; Materials
   Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA BCA40
UT WOS:000309430600185
DA 2018-10-19
ER

PT S
AU Martins, JRS
   Nogueira, RA
   de Araujo, RO
   Grandini, CR
AF Severino Martins Junior, Jose Roberto
   Nogueira, Renata Abdallah
   de Araujo, Raul Oliveira
   Grandini, Carlos Roberto
BE Ochsner, A
   Murch, GE
   Shokuhfar, A
   Delgado, JMPQ
TI Diffusion of Oxygen and Nitrogen in the Ti-15Mo Alloy used for
   Biomedical Applications
SO DIFFUSION IN SOLIDS AND LIQUIDS VII
SE Defect and Diffusion Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Diffusion in Solids and Liquids (DSL
   2011)
CY JUN 26-30, 2011
CL Algarve, PORTUGAL
DE Titanium alloys; diffusion; mechanical spectroscopy; biomaterials
ID TI-MO ALLOYS
AB The Ti-15Mo alloy is a promising material for use as a biomaterial because of its excellent corrosion resistance and its good combination of mechanical properties, such as fatigue, hardness, and wears resistance. This alloy has a body-centered predominantly cubic crystalline structure and the addition of interstitial atoms, such as oxygen and nitrogen, strongly alters its mechanical properties. Mechanical spectroscopy is a powerful tool to study the interaction of interstitial elements with the matrix metal or substitutional solutes, providing information such as the distribution and the concentration of interstitial elements. The objective of this paper is to study of the effects of heavy interstitial elements, such as oxygen and nitrogen, on the anelastic properties of the Ti-15Mo alloy by using mechanical spectroscopy measurements. In this study, the diffusion coefficients, pre-exponential factors, and activation energies were calculated for the oxygen in the Ti-15Mo alloy.
C1 [Severino Martins Junior, Jose Roberto; Nogueira, Renata Abdallah; de Araujo, Raul Oliveira; Grandini, Carlos Roberto] Univ Estadual Paulista, Lab Anelasticidade & Biomat, UNESP, BR-17033360 Bauru, SP, Brazil.
RP Martins, JRS (reprint author), Univ Estadual Paulista, Lab Anelasticidade & Biomat, UNESP, BR-17033360 Bauru, SP, Brazil.
EM jrsmjr@fc.unesp.br; abdallah@fc.unesp.br; raularaujo@fc.unesp.br;
   betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008; Martins Junior, Jose
   Roberto/E-2190-2014
OI Grandini, Carlos Roberto/0000-0002-3336-309X; 
CR Almeida LH, 2004, MAT SCI ENG A-STRUCT, V370, P96, DOI 10.1016/j.msea.2003.08.085
   ASTM, 2008, STAND SPEC WROUGHT T
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   Grandini CR, 2009, DEFECT DIFFUS FORUM, V283-286, P30, DOI 10.4028/www.scientific.net/DDF.283-286.30
   Grandini CR, 2009, DEFECT DIFFUS FORUM, V283-286, P38, DOI 10.4028/www.scientific.net/DDF.283-286.38
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Leyens C., 2005, TITANIUM TITANIUM AL
   Lu H, 2011, MAT SCI ENG A-STRUCT, V528, P3358, DOI 10.1016/j.msea.2010.12.104
   Nogueira RA, 2008, J MATER SCI, V43, P5977, DOI 10.1007/s10853-008-2706-y
   Nowick A. S., 1972, ANELASTIC RELAXATION
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Puskar A., 2001, INTERNAL FRICTION MA
   Martins JRS, 2011, MATER RES-IBERO-AM J, V14, P107, DOI 10.1590/S1516-14392011005000013
   Snoek JL, 1941, PHYSICA, V8, P711, DOI 10.1016/S0031-8914(41)90517-7
   WELLER M, 1981, ACTA METALL MATER, V29, P1047, DOI 10.1016/0001-6160(81)90056-0
NR 15
TC 2
Z9 2
U1 0
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1012-0386
J9 DEFECT DIFFUS FORUM
PY 2012
VL 326-328
BP 696
EP 701
DI 10.4028/www.scientific.net/DDF.326-328.696
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BCA15
UT WOS:000309370400118
DA 2018-10-19
ER

PT S
AU Nogueira, RA
   Grandini, CR
AF Nogueira, Renata Abdallah
   Grandini, Carlos Roberto
BE Ochsner, A
   Murch, GE
   Shokuhfar, A
   Delgado, JMPQ
TI Oxygen Diffusion in Ti-20Mo Alloys, used as Biomaterial, Measured by
   Mechanical Spectroscopy
SO DIFFUSION IN SOLIDS AND LIQUIDS VII
SE Defect and Diffusion Forum
LA English
DT Proceedings Paper
CT 7th International Conference on Diffusion in Solids and Liquids (DSL
   2011)
CY JUN 26-30, 2011
CL Algarve, PORTUGAL
DE Diffusion; Interstitial; Oxygen; Titanium
ID NITROGEN
AB Titanium alloys are favorable implant materials for orthopedic applications, due to their desirable properties such as good corrosion resistance, low elasticity modulus, and excellent biocornpatibility. The research on titanium alloys is concentrated in the beta type, as the Ti-20Mo alloys and the addition of interstitial elements in these metals cause changes in their mechanical properties. The mechanical spectroscopy measurements have been frequently used in order to verify the behavior of these interstitials atoms in metallic alloys. This paper presents the study of oxygen diffusion in Ti-20Mo alloys using mechanical spectroscopy measurements. A thermally activated relaxation structure was observed in the sample after oxygen doping. It was associated with the interstitial diffusion of oxygen atoms in a solid solution in the alloy. The diffusion coefficient for the oxygen diffusion in the alloy was obtained by the frequency dependence of the peak temperature and by using a simple mathematical treatment of the relaxation structure and the Arrhenius law.
C1 [Nogueira, Renata Abdallah; Grandini, Carlos Roberto] Univ Estadual Paulista, Lab Anelasticidade & Biomat, UNESP, BR-17033360 Bauru, SP, Brazil.
RP Nogueira, RA (reprint author), Univ Estadual Paulista, Lab Anelasticidade & Biomat, UNESP, BR-17033360 Bauru, SP, Brazil.
EM abdallah@fc.unesp.br; betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008
OI Grandini, Carlos Roberto/0000-0002-3336-309X
CR Blanter MS, 2007, SPRINGER SER MATER S, V90, pVII, DOI 10.1007/978-3-540-68758-0
   BROWNE KM, 1972, ACTA METALL MATER, V20, P507, DOI 10.1016/0001-6160(72)90006-5
   Collins E.W., 1989, PHYS METALLURGY TITA
   Mehrer H., 2007, DIFFUSION SOLIDS FUN
   Nogueira RA, 2008, J MATER SCI, V43, P5977, DOI 10.1007/s10853-008-2706-y
   Nowick A. S., 1972, ANELASTIC RELAXATION
   Snoek JL, 1941, PHYSICA, V8, P711, DOI 10.1016/S0031-8914(41)90517-7
   Song MH, 2008, SCRIPTA MATER, V59, P623, DOI 10.1016/j.scriptamat.2008.05.037
   WELLER M, 1981, ACTA METALL MATER, V29, P1047, DOI 10.1016/0001-6160(81)90056-0
NR 9
TC 2
Z9 2
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0386
J9 DEFECT DIFFUS FORUM
PY 2012
VL 326-328
BP 702
EP +
DI 10.4028/www.scientific.net/DDF.326-328.702
PG 2
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BCA15
UT WOS:000309370400119
DA 2018-10-19
ER

PT S
AU Lou, CW
   Huang, CC
   Chen, WC
   Hu, JJ
   Lu, CT
   Lin, JH
AF Lou, Ching-Wen
   Huang, Cheng-Chun
   Chen, Wen-Cheng
   Hu, Jin-Jia
   Lu, Chao-Tsang
   Lin, Jia-Horng
BE Sung, WP
   Kao, JCM
   Chen, R
TI Preliminary Studies in Composite Scaffolds of Calcium Phosphate Bone
   Cement with Polylactide
SO FRONTIERS OF MECHANICAL ENGINEERING AND MATERIALS ENGINEERING, PTS 1 AND
   2
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Frontiers of Mechanical Engineering and
   Materials Engineering (MEME 2012)
CY JUL 27-29, 2012
CL Hong Kong, PEOPLES R CHINA
SP Int Frontiers Sci & Technol Res Assoc, Hong Kong Control Engn & Informat Sci Res Assoc
DE Calcium phosphate bone cement; polylactide fiber; compressive strength
AB Calcium phosphate bone cement (CPC), a ceramic material, is commonly used as a biomaterial for the restoration of bone injuries. This study creates the composite scaffolds by mixing CPC with various amounts of polylactide fibers. Then, the resulting scaffolds are observed and tested in terms of the morphology, compressive strength, and fiber distribution, respectively, to explore the influence of the addition of polylactide fibers on the scaffolds. According to the experimental result, the compressive strength of the scaffolds increases as a result of an increase in the addition of fibers.
C1 [Lin, Jia-Horng] Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 407, Taiwan.
   [Lou, Ching-Wen; Huang, Cheng-Chun] Cent Taiwan Univ Sci & Technol, Inst Biomed Engn & Mat Sci, Taichung 406, Taiwan.
   [Chen, Wen-Cheng] Feng Chia Univ, Dept Fibers Composite Mat, Adv Med Devices& Composite Lab, Taichung, Taiwan.
   [Hu, Jin-Jia] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Lu, Chao-Tsang] Ctr Taiwan Univ Sci Technol, Inst Life Sci, Taichung, Taiwan.
   [Lin, Jia-Horng] China Med Univ, Sch Chinese Med, Taichung, Taiwan.
RP Lin, JH (reprint author), Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 407, Taiwan.
EM wencchen@fcu.edu.tw; jhlin@fcu.edu.tw
RI Chen, wen/P-4496-2018
OI Chen, wen/0000-0002-5581-9991
FU National Science Council of the Taiwan; NSC [100-2622-E-166-001-CC3]
FX This work would especially like to thank National Science Council of the
   Taiwan, for financially supporting this research under Contract NSC
   100-2622-E-166-001-CC3.
CR Hench L.L., 1970, INVESTIGATION PROSTH
   Jayakumar R, 2011, INT J BIOL MACROMOL, V49, P274, DOI 10.1016/j.ijbiomac.2011.04.020
   Jayakumar R, 2011, INT J BIOL MACROMOL, V48, P336, DOI 10.1016/j.ijbiomac.2010.12.010
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Peter M, 2009, CARBOHYD POLYM, V78, P926, DOI 10.1016/j.carbpol.2009.07.016
   Wang JC, 2010, J DENT, V38, P158, DOI 10.1016/j.jdent.2009.10.001
NR 6
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-441-9
J9 APPL MECH MATER
PY 2012
VL 184-185
BP 1098
EP +
DI 10.4028/www.scientific.net/AMM.184-185.1098
PG 2
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BCI88
UT WOS:000310257500229
DA 2018-10-19
ER

PT S
AU Lou, CW
   Li, MH
   Chen, WC
   Hu, JJ
   Lu, CT
   Lin, JH
AF Lou, Ching-Wen
   Li, Mei-Hui
   Chen, Wen-Cheng
   Hu, Jin-Jia
   Lu, Chao-Tsang
   Lin, Jia-Horng
BE Sung, WP
   Kao, JCM
   Chen, R
TI Preliminary Study of the Application of PET Knitted Fabrics in
   Artificial Bone Scaffold
SO FRONTIERS OF MECHANICAL ENGINEERING AND MATERIALS ENGINEERING, PTS 1 AND
   2
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Frontiers of Mechanical Engineering and
   Materials Engineering (MEME 2012)
CY JUL 27-29, 2012
CL Hong Kong, PEOPLES R CHINA
SP Int Frontiers Sci & Technol Res Assoc, Hong Kong Control Engn & Informat Sci Res Assoc
DE Polyethylene terephthalate (PET); filament; plied yarn; knitted fabric
ID TRANSARTICULAR SCREW FIXATION; 3-D FIBROUS MATRIX; POLYETHYLENE CABLE;
   FUSION; CELLS
AB Having good mechanical strength, biocompatibility, and workability, polyethylene terephthalate (PET) is often used as a biomaterial. In this study, PET filaments with various deniers are made into plied yarn with various coefficients of twist. The plied yarn is then made into PET knitted fabrics. Mechanical property tests are performed to determine the differences among the various PET knitted fabrics. Finally, by using cell culture, the PET knitted fabrics are analyzed and evaluated with their cell attachment.
C1 [Lin, Jia-Horng] Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 407, Taiwan.
   [Lou, Ching-Wen; Li, Mei-Hui] Cent Taiwan Univ Sci & Technol, Inst Biomed Engn & Mat Sci, Taichung 406, Taiwan.
   [Chen, Wen-Cheng] Feng Chia Univ, Dept Fiber & Composite Mat, Adv Med Device & Composite Lab, Taichung 407, Taiwan.
   [Hu, Jin-Jia] Natl Cheng Kung Univ, Dept Biomed Engn, Taichung, Taiwan.
   [Lu, Chao-Tsang] Cent Taiwan Univ Sci & Technol, Inst Life Sci, Taichung 406, Taiwan.
   [Lin, Jia-Horng] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan.
RP Lin, JH (reprint author), Feng Chia Univ, Dept Fiber & Composite Mat, Lab Fiber Applicat & Mfg, Taichung 407, Taiwan.
EM wencchen@fcu.edu.tw; jhlin@fcu.edu.tw
RI Chen, wen/P-4496-2018
OI Chen, wen/0000-0002-5581-9991
FU National Science Council of the Taiwan [NSC 100-2622-E-166-001-CC3]
FX This work would especially like to thank National Science Council of the
   Taiwan, for financially supporting this research under Contract NSC
   100-2622-E-166-001-CC3.
CR Chen CN, 2003, BIOTECHNOL PROGR, V19, P1574, DOI 10.1021/bp034024w
   Erli H.J., 2003, BIOMED ENG ONLINE, V2, P1
   Ito H, 2008, SPINE, V33, P1655, DOI 10.1097/BRS.0b013e31817b5c07
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Li M. H., 2011, 11 AS TEXT C, V11, P110
   Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311
   Lou CW, 2011, ADV MATER RES-SWITZ, V287-290, P2669, DOI 10.4028/www.scientific.net/AMR.287-290.2669
   Ma T, 1999, BIOTECHNOL PROGR, V15, P715, DOI 10.1021/bp990072y
   Ma T, 2000, BIOTECHNOL BIOENG, V70, P606, DOI 10.1002/1097-0290(20001220)70:6<606::AID-BIT2>3.0.CO;2-H
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   RADING J, 1995, AM J SPORT MED, V23, P316, DOI 10.1177/036354659502300311
   Yonezawa I, 2005, J SPINAL DISORD TECH, V18, P392, DOI 10.1097/01.bsd.0000167127.16576.02
NR 12
TC 4
Z9 4
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-441-9
J9 APPL MECH MATER
PY 2012
VL 184-185
BP 1501
EP +
DI 10.4028/www.scientific.net/AMM.184-185.1501
PG 2
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BCI88
UT WOS:000310257500313
DA 2018-10-19
ER

PT S
AU Yang, DZ
   Feng, YK
   Behl, M
   Lendlein, A
   Zhao, HY
   Khan, M
   Guo, JT
AF Yang, Dazhi
   Feng, Yakai
   Behl, Marc
   Lendlein, Andreas
   Zhao, Haiyang
   Khan, Musammir
   Guo, Jintang
BE Lendlein, A
   Behl, M
   Feng, Y
   Guan, Z
   Xie, T
TI Biomimetic Hemo-compatible Surfaces of Polyurethane by Grafting
   Copolymer Brushes of Poly(ethylene glycol) and Poly(phosphorylcholine
   methacrylate)
SO MULTIFUNCTIONAL POLYMER-BASED MATERIALS
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium V on Multifunctional Polymer-based Materials at the MRS Fall
   Meeting and Exhibit
CY NOV 28-DEC 02, 2011
CL Boston, MA
SP IBM Zurich, Helmholtz-Zentrum Geesthacht GmbH, MRS
ID POLYMERIZATION; CHAIN
AB Polyurethanes (PU) have been widely used as biomaterial in recent years, while thrombus may still occur when contacting with blood especially for extended period of time. Poly(ethylene glycol) (PEG) and phosphorylcholine (PC)-based polymers are commonly employed for surface modification to create protein repellent surfaces. PC-based polymers have been investigated as biomimetic materials because PC is the major component in the outer layer of cell membranes. In this study, the biomimetic copolymer brush of PEG-b-poly(2-methacryloyloxyethyl phosphorylcholine) on PU surfaces was synthesized via atom transfer radical polymerization (ATRP) with a surface initiator. The flexible PEG chain was 200 g.mol-1, while the poly(2-methacryloyloxyethyl phosphorylcholine) (poly(MPC)) chain length was controlled by the ratio of monomer to sacrificial initiator in solution. The topology of the modified surfaces was characterized by the phase image of atomic force microscopy (AFM) to study the synergy effect between PEG chains and poly(MPC) chains. The unmodified and modified surfaces were characterized by Fourier transform infrared (FTIR), X-ray photoelectron spectroscopy (XPS), water contact angle and platelet adhesion. The results demonstrated that efficient grafting of PEG-b-poly(MPC) brushes on the surfaces was achieved. The PU surfaces modified with PEG and phosphorylcholine zwitterionic brushes showed effective resistance to platelet adhesion and high hemocompatibility in vitro. These PEG and PC-grafted PU materials might be potentially applied in blood-contacting materials or devices due to their good mechanical and hemocompatible properties.
C1 [Yang, Dazhi; Feng, Yakai; Zhao, Haiyang; Khan, Musammir; Guo, Jintang] Tianjin Univ, Sch Chem Engn & Technol, Weijin Rd 92, Tianjin 300072, Peoples R China.
RP Yang, DZ (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Weijin Rd 92, Tianjin 300072, Peoples R China.
RI feng, yakai/F-3854-2015; Lendlein, Andreas/K-9553-2013; Behl,
   Marc/K-9429-2013
OI feng, yakai/0000-0002-4511-0874; Lendlein, Andreas/0000-0003-4126-4670;
   Behl, Marc/0000-0002-1507-0277
FU Ministry if Education of P. R. China; International Cooperation from
   Minisry if Science and Technology if China [2008DFA51170]; Tianjin
   Univeristy-Helmholtz-Zentrum Geesthacht Joint Laboratory for
   Biomaterials and Regenerative Medidine; MOST; German Federal Ministry of
   Education and Research (BMBF) [0314596]
FX This work has been financially supported by Ministry if Education of P.
   R. China, and by the International Cooperation from Minisry if Science
   and Technology if China (Grant No. 2008DFA51170) as well as by the
   Tianjin Univeristy-Helmholtz-Zentrum Geesthacht Joint Laboratory for
   Biomaterials and Regenerative Medidine, which is financed by MOST and
   the German Federal Ministry of Education and Research (BMBF) (Grant No.
   0314596).
CR Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Guo JT, 2011, J APPL POLYM SCI, V122, P1084, DOI 10.1002/app.34214
   Jin ZL, 2009, COLLOID SURFACE B, V70, P53, DOI 10.1016/j.colsurfb.2008.12.005
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Zhao HY, 2011, J APPL POLYM SCI, V119, P3717, DOI 10.1002/app.32997
   Zheng J, 2004, LANGMUIR, V20, P8931, DOI 10.1021/la036345n
NR 7
TC 0
Z9 0
U1 0
U2 32
PU MATERIALS RESEARCH SOC
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 978-1-60511-380-7
J9 MATER RES SOC SYMP P
PY 2012
VL 1403
BP 171
EP 176
DI 10.1557/opl.2012.702
PG 6
WC Materials Science, Characterization & Testing; Polymer Science
SC Materials Science; Polymer Science
GA BCB15
UT WOS:000309561200026
DA 2018-10-19
ER

PT J
AU Nayak, JP
   Bera, J
AF Nayak, J. P.
   Bera, J.
TI Bioactivity Characterization of Amorphous Silica Ceramics Derived from
   Rice Husk Ash
SO SILICON
LA English
DT Article
DE Rice husk ash; Amorphous silica; Bioactivity; Apatite; Biodegradability
ID DRUG-DELIVERY; APATITE; HYDROXYAPATITE; WOLLASTONITE; BEHAVIOR
AB Rice husk ash has been used to prepare amorphous silica bioactive ceramics. Three varieties of silica powders, namely brown ash, white ash and silica gel containing 96.0, 99.8 and 99.9% silica respectively, were used to prepare silica ceramics. The bioactivity and biodegradability properties of these ceramics were evaluated. The formation of crystalline apatite was observed on all the specimens in simulated body fluid. The phase composition, morphology and calcium/phosphorous ratio of the apatite layer formed were evaluated by X-ray Diffraction, Scanning Electron Microscopy and Energy Dispersive Spectroscopy. Controlled biodegradability of amorphous silica in Tris buffer solution was found. These results suggest that the amorphous silica derived from rice husk ash is a promising and cost effective biomaterial.
C1 [Nayak, J. P.; Bera, J.] Natl Inst Technol, Dept Ceram Engn, Rourkela 769008, Odisha, India.
RP Bera, J (reprint author), Natl Inst Technol, Dept Ceram Engn, Rourkela 769008, Odisha, India.
EM jbera@rediffmail.com
OI Bera, Japes/0000-0003-1895-4358
FU Ministry of Environment and Forests, Government of India, New Delhi
   [19/50/2004 RE]
FX The authors are thankful to the Ministry of Environment and Forests,
   Government of India, New Delhi for providing the research grant vide
   sanction no. 19/50/2004 RE.
CR Asuncion MZ, 2005, J MATER CHEM, V15, P2114, DOI 10.1039/b502178b
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   Ferrer ML, 2006, CHEM MATER, V18, P1458, DOI 10.1021/cm0522275
   HAMAD MA, 1981, THERMOCHIM ACTA, V48, P343, DOI 10.1016/0040-6031(81)80255-9
   Hench LL, 1996, INTRO MAT MED
   Kobayashi M, 1998, J BIOMED MATER RES, V42, P223, DOI 10.1002/(SICI)1097-4636(199811)42:2<223::AID-JBM7>3.0.CO;2-R
   Koch O.G., 1974, HDB SPURENANALYSE, P1105
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   Kortesuo P, 2000, BIOMATERIALS, V21, P193, DOI 10.1016/S0142-9612(99)00148-9
   KRISHNARAO RV, 1991, J AM CERAM SOC, V74, P2869, DOI 10.1111/j.1151-2916.1991.tb06856.x
   Lafon JP, 2002, KEY ENG MATER, V15, P477
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Lluch AV, 2009, POLYMER, V50, P2874, DOI 10.1016/j.polymer.2009.04.022
   Nagata F, 2003, KEY ENG MAT, V240-2, P167, DOI 10.4028/www.scientific.net/KEM.240-242.167
   Nayak JP, 2009, PHASE TRANSIT, V82, P879, DOI 10.1080/01411590903471564
   Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Ryu HS, 2002, KEY ENG MATER, V15, P261
   Sacks MD, 1985, CERAM ENG SCI P, V6, P1109
   Sarangi M, 2009, SILICON-NETH, V1, P103, DOI 10.1007/s12633-009-9015-1
   Tas AC, 2000, BIOMATERIALS, V21, P1429
NR 24
TC 4
Z9 4
U1 2
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1876-990X
J9 SILICON-NETH
JI Silicon
PD JAN
PY 2012
VL 4
IS 1
SI SI
BP 57
EP 60
DI 10.1007/s12633-010-9058-3
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 023DM
UT WOS:000310013100008
DA 2018-10-19
ER

PT J
AU Zhang, M
   Matinlinna, JP
AF Zhang, Meng
   Matinlinna, Jukka Pekka
TI E-Glass Fiber Reinforced Composites in Dental Applications
SO SILICON
LA English
DT Article
DE Fiber reinforced composite; Resin matrix; E-glass fiber; Biomechanical
   properties; Biomaterial; Dental material
ID RESTORATIVE MATERIALS; MECHANICAL-PROPERTIES; CLINICAL REPORT
AB Fiber reinforced composites (FRCs) are more and more widely applied in dentistry to substitute for metallic restorations: periodontal splints, fixed partial dentures, endodontic posts, orthodontic appliances, and some other indirect restorations. In general in FRCs, the fiber reinforcement provides the composite structure with better biomechanical performance due to their superior properties in tension and flexure. Nowadays, the E-glass fiber is most frequently used because of its chemical resistance and relatively low cost. Growing interest is being paid to enhance its clinical performance. Moreover, various techniques are utilized to reinforce the adhesion between the fiber and the matrix. Oral conditions set special requirements and challenges for the clinical applications of FRCs. The biomechanical properties of dental materials are of high importance in dentistry, and given this, there is on-going scientific interest to develop E-glass fiber reinforced composite systems. FRCs are generally biocompatible and their toxicity is not a concern.
C1 [Zhang, Meng; Matinlinna, Jukka Pekka] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
RP Matinlinna, JP (reprint author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
EM jpmat@hku.hk
OI Matinlinna, Jukka/0000-0001-7656-0678
CR Behr M, 2003, Clin Oral Investig, V7, P135, DOI 10.1007/s00784-003-0211-x
   Blake A., 1985, HDB MECH MAT STRUCTU
   Bunsell AR, 2005, FUNDAMENTALS FIBRE R
   Campo EA, 2008, PDL HANDB SER, P1
   Chawla KK, 2001, ENCY MAT SCI TECHNOL, P3160
   Culy G, 1998, AUST DENT J, V43, P1, DOI 10.1111/j.1834-7819.1998.tb00142.x
   Darvell BW, 2006, GLOSSARY TERMS DENT
   Darvell BW, 2006, MAT SCI DENTISTRY
   Datsko J., 1997, MAT SELECTION DESIGN
   DEVEKEY RC, 1970, J MATER SCI, V5, P183, DOI 10.1007/BF00554638
   Feinman R A, 1997, Pract Periodontics Aesthet Dent, V9, P925
   Freilich M. A., 2002, JADA CONTINUING ED
   Gale MS, 1999, J DENT, V27, P89, DOI 10.1016/S0300-5712(98)00037-2
   Garoushi S, 2007, LIBYAN J MED, P40
   Goldberg JA, 1998, J DENT RES, V77, P226
   Heravi F., 2007, Journal of Dentistry of Tehran University of Medical Sciences, V4, P53
   Karmaker A, Fiber reinforced composite post, patent application number, Patent No. 20090246738
   Kermanshah H, 2010, OPER DENT, V35, P238, DOI 10.2341/09-136-S
   Lassila LVJ, 2004, DENT MATER, V20, P29, DOI 10.1016/S0109-5641(03)00065-4
   Li L, 2006, ENGLISH MAT SCI ENG
   Li W, 2004, BIOMATERIALS, V25, P4987, DOI 10.1016/j.biomaterials.2004.01.010
   Mallick PK, 2008, FIBER REINFORCED COP
   Matinlinna JP, 2007, J ORAL REHABIL, V34, P622, DOI 10.1111/j.1365-2842.2005.01569.x
   Matinlinna JP, 2004, INT J PROSTHODONT, V17, P155
   Matinlinna JP, 2009, SILANES OTHER COUPLI, V5, P107
   Matinlinna Jukka P, 2007, J Contemp Dent Pract, V8, P1
   OYSAED H, 1988, J DENT RES, V67, P1289, DOI 10.1177/00220345880670100901
   Rudo ND, 1999, DENT CLIN N AM, V43, P7
   Schmalz G, 2009, BIOCOMPATIBILITY DEN
   Segerstrom S, 2009, DENT MATER, V25, P845, DOI 10.1016/j.dental.2008.12.007
   Soares CAM, 1999, MECH COMPOSITE MAT S
   Sperling L. H., 1994, INTERPENETRATING POL, P3, DOI 10.1021/ba-1994-0239.ch001
   Strassler HE, 2008, INSIDE DENTISTRY
   Strassler Howard E, 2007, Dent Clin North Am, V51, P507, DOI 10.1016/j.cden.2006.12.004
   Thwe MM, 2002, COMPOS PART A-APPL S, V33, P43, DOI 10.1016/S1359-835X(01)00071-9
   Valiathan A., 2006, TRENDS BIOMATER ARTI, V20, P16
   Vallittu PK, 2009, ADHESION ASPECTS IN DENTISTRY, P63
   Vallittu PK, 1999, J PROSTHET DENT, V82, P132, DOI 10.1016/S0022-3913(99)70145-9
   Vallittu PK, 2001, 2 INT S FIBR REINF P
   van Noort R., 2007, INTRO DENT MAT
   Wataha JC, 2003, DENT MATER, V19, P25, DOI 10.1016/S0109-5641(02)00012-X
   Wiley J, 1988, FIBERGLASS REPAIR CO
   Willershausen B, 2001, EUR J MED RES, V6, P433
   Zhang M, 2011, J ADHES SCI TECHNOL, V25, P2687, DOI 10.1163/016942411X556051
NR 44
TC 37
Z9 37
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1876-990X
EI 1876-9918
J9 SILICON-NETH
JI Silicon
PD JAN
PY 2012
VL 4
IS 1
SI SI
BP 73
EP 78
DI 10.1007/s12633-011-9075-x
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 023DM
UT WOS:000310013100010
OA Bronze
DA 2018-10-19
ER

PT S
AU Woodrow, KA
   Bennett, KM
   Lo, DD
AF Woodrow, Kim A.
   Bennett, Kaila M.
   Lo, David D.
BE Yarmush, ML
TI Mucosal Vaccine Design and Delivery
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE mucosal immunity; mucosal adjuvant; particulate delivery; biomaterial
   vaccine vectors
ID VIRUS-LIKE PARTICLES; HEAT-LABILE ENTEROTOXINS; HUMAN CERVICAL-MUCUS;
   TOLL-LIKE RECEPTORS; EPITHELIAL M-CELLS; CD8(+) T-CELLS; DENDRITIC
   CELLS; IMMUNE-RESPONSES; DRUG-DELIVERY; IN-VIVO
AB Mucosal surfaces are a major portal of entry for many human pathogens that are the cause of infectious diseases worldwide. Vaccines capable of eliciting mucosal immune responses can fortify defenses at mucosal front lines and protect against infection. However, most licensed vaccines are administered parenterally and fail to elicit protective mucosal immunity. Immunization by mucosal routes may be more effective at inducing protective immunity against mucosal pathogens at their sites of entry. Recent advances in our understanding of mucosal immunity and identification of correlates of protective immunity against specific mucosal pathogens have renewed interest in the development of mucosal vaccines. Efforts have focused on efficient delivery of vaccine antigens to mucosal sites that facilitate uptake by local antigen-presenting cells to generate protective mucosal immune responses. Discovery of safe and effective mucosal adjuvants are also being sought to enhance the magnitude and quality of the protective immune response.
C1 [Woodrow, Kim A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Bennett, Kaila M.; Lo, David D.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.
   [Bennett, Kaila M.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
RP Woodrow, KA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM woodrow@uw.edu; david.lo@ucr.edu
FU NIAID NIH HHS [R01 AI063426]
CR Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x
   Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111
   Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200
   Alpar HO, 2005, ADV DRUG DELIVER REV, V57, P411, DOI 10.1016/j.addr.2004.09.004
   ALVING CR, 1991, J IMMUNOL METHODS, V140, P1, DOI 10.1016/0022-1759(91)90120-5
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Azizi A, 2010, VACCINE, V28, P4015, DOI 10.1016/j.vaccine.2010.04.018
   Baaten BJG, 2010, VACCINE, V28, P4130, DOI 10.1016/j.vaccine.2010.04.026
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Bagwe RP, 2001, CRIT REV THER DRUG, V18, P77
   Bandyopadhyay A, 2011, BIOMATERIALS, V32, P3094, DOI 10.1016/j.biomaterials.2010.12.054
   Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895
   Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833
   Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596
   Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015
   Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220
   Boyaka PN, 2001, J IMMUNOL, V166, P2283, DOI 10.4049/jimmunol.166.4.2283
   Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x
   Burton DR, 2010, P NATL ACAD SCI USA, V107, P17859, DOI 10.1073/pnas.1012923107
   Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015
   Chabot S, 2005, VACCINE, V23, P1374, DOI 10.1016/j.vaccine.2004.09.010
   Chabot SM, 2007, VACCINE, V25, P5348, DOI 10.1016/j.vaccine.2007.05.029
   Chadwick S, 2010, ADV DRUG DELIVER REV, V62, P394, DOI 10.1016/j.addr.2009.11.012
   Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499
   Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007
   CLARK MA, 1993, J HISTOCHEM CYTOCHEM, V41, P1679, DOI 10.1177/41.11.7691933
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010
   CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188
   Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110
   Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013
   Cyr SL, 2007, VACCINE, V25, P3228, DOI 10.1016/j.vaccine.2007.01.037
   Cyr SL, 2007, VACCINE, V25, P5378, DOI 10.1016/j.vaccine.2007.05.004
   Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   des Rieux A, 2006, J CONTROL RELEASE, V116, P1, DOI 10.1016/j.jconrel.2006.08.013
   Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474
   Drulis-Kawa Z, 2010, INT J PHARMACEUT, V387, P187, DOI 10.1016/j.ijpharm.2009.11.033
   Drummond DC, 2000, PROG LIPID RES, V39, P409, DOI 10.1016/S0163-7827(00)00011-4
   Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x
   Eriksson K, 2002, CURR OPIN IMMUNOL, V14, P666, DOI 10.1016/S0952-7915(02)00384-9
   Felnerova D, 2004, CURR OPIN BIOTECH, V15, P518, DOI 10.1016/j.copbio.2004.10.005
   Fife KH, 2004, VACCINE, V22, P2943, DOI 10.1016/j.vaccine.2003.11.058
   Flanary S, 2009, BIOCONJUGATE CHEM, V20, P241, DOI 10.1021/bc800317a
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Foster N, 1998, VACCINE, V16, P536, DOI 10.1016/S0264-410X(97)00222-3
   Fraser CK, 2007, EXPERT REV VACCINES, V6, P559, DOI 10.1586/14760584.6.4.559
   Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010
   Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324
   Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3
   GLUCK R, 1994, LANCET, V344, P160, DOI 10.1016/S0140-6736(94)92758-8
   Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07
   Guy B, 2001, VACCINE, V19, P1794, DOI 10.1016/S0264-410X(00)00386-8
   Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681
   Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010
   Hanson JA, 2008, NATURE, V455, P85, DOI 10.1038/nature07197
   Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634
   Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Jakobsen H, 1999, INFECT IMMUN, V67, P5892
   Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101
   Jansen KU, 2004, ANNU REV MED, V55, P319, DOI 10.1146/annurev.med.55.091902.103520
   Jensen VB, 1998, INFECT IMMUN, V66, P3758
   JOFFRET ML, 1990, VACCINE, V8, P385, DOI 10.1016/0264-410X(90)90099-8
   Jones T, 2004, VACCINE, V22, P3691, DOI 10.1016/j.vaccine.2004.03.035
   Joseph A, 2006, VACCINE, V24, P3990, DOI 10.1016/j.vaccine.2005.12.017
   Jung T, 2000, EUR J PHARM BIOPHARM, V50, P147, DOI 10.1016/S0939-6411(00)00084-9
   Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x
   Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522
   Karmali PP, 2007, MED RES REV, V27, P696, DOI 10.1002/med.20090
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kersten GFA, 2003, VACCINE, V21, P915, DOI 10.1016/S0264-410X(02)00540-6
   Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301
   Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104
   Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107
   Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002
   Lassalle V, 2007, MACROMOL BIOSCI, V7, P767, DOI 10.1002/mabi.200700022
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Romero EL, 2011, WIRES NANOMED NANOBI, V3, P356, DOI 10.1002/wnan.131
   Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005
   Lowe RS, 1997, J INFECT DIS, V176, P1141, DOI 10.1086/514105
   Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013
   Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6
   Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222
   Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083
   Mahato RI, 2005, ADV DRUG DELIVER REV, V57, P699, DOI 10.1016/j.addr.2004.12.005
   Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954
   Mallapragada SK, 2008, INT J PHARMACEUT, V364, P265, DOI 10.1016/j.ijpharm.2008.06.030
   Manocha M, 2005, VACCINE, V23, P5599, DOI 10.1016/j.vaccine.2005.06.031
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Martin M, 2001, INFECT IMMUN, V69, P4486, DOI 10.1128/IAI.69.7.4486-4492.2001
   Martin M, 2000, INFECT IMMUN, V68, P281, DOI 10.1128/IAI.68.1.281-287.2000
   Maslanka SE, 1998, INFECT IMMUN, V66, P2453
   Masopust D, 2004, IMMUNOL RES, V29, P151, DOI 10.1385/IR:29:1-3:151
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   McCluskie MJ, 2000, VACCINE, V19, P950, DOI 10.1016/S0264-410X(00)00215-2
   McElrath MJ, 2011, IMMUNITY, V34, P146, DOI 10.1016/j.immuni.2011.02.014
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Menger FM, 1998, CURR OPIN CHEM BIOL, V2, P726, DOI 10.1016/S1367-5931(98)80110-5
   Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Moser C, 2007, EXPERT REV VACCINES, V6, P711, DOI 10.1586/14760584.6.5.711
   Nagayasu A, 1999, ADV DRUG DELIVER REV, V40, P75, DOI 10.1016/S0169-409X(99)00041-1
   Neidleman JA, 2000, IMMUNOLOGY, V101, P154, DOI 10.1046/j.1365-2567.2000.00090.x
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3
   Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275
   Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901
   NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070
   O'Hagan DT, 2001, BIOMOL ENG, V18, P69, DOI 10.1016/S1389-0344(01)00101-0
   Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107
   Ogay ID, 2006, CYTOTECHNOLOGY, V51, P89, DOI 10.1007/s10616-006-9022-7
   Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4
   Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210
   PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302
   Perez C, 2001, J CONTROL RELEASE, V75, P211, DOI 10.1016/S0168-3659(01)00397-2
   Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Radulovic S, 2011, ALLERGY, V66, P740, DOI 10.1111/j.1398-9995.2011.02583.x
   Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359
   Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033
   Rajapaksa Thejani E., 2010, Current Immunology Reviews, V6, P29
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Read RC, 2005, VACCINE, V23, P4367, DOI 10.1016/j.vaccine.2005.04.021
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
   Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373
   Rosada RS, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-38
   Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107
   Ryan EJ, 1999, INFECT IMMUN, V67, P6270
   SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1
   Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007
   Sato A, 2007, BIOMATERIALS, V28, P1434, DOI 10.1016/j.biomaterials.2006.11.010
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shakweh M, 2005, EUR J PHARM BIOPHARM, V61, P1, DOI 10.1016/j.ejpb.2005.04.006
   Sharma S, 2009, J PHARM SCI-US, V98, P812, DOI 10.1002/jps.21493
   Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029
   Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001
   Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004
   Stanley M, 2006, VACCINE, V24, P106, DOI 10.1016/j.vaccine.2006.05.110
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   STEINMAN RM, 1972, J CELL BIOL, V55, P186, DOI 10.1083/jcb.55.1.186
   Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107
   Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664
   Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173
   Takamura S, 2004, GENE THER, V11, P628, DOI 10.1038/sj.gt.3302193
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Turk MJ, 2002, BBA-BIOMEMBRANES, V1559, P56, DOI 10.1016/S0005-2736(01)00441-2
   Vajdy M, 2004, IMMUNOL CELL BIOL, V82, P617, DOI 10.1111/j.1440-1711.2004.01288.x
   Vajdy M., 2008, IMMUNITY MUCOSAL PAT
   van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005
   Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833
   Wang DN, 2001, ADV EXP MED BIOL, V491, P485
   Wei B, 2008, EUR J IMMUNOL, V38, P3411, DOI 10.1002/eji.200838432
   WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809
   Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309
   Whitacre CC, 2000, GASTROENTEROLOGY, V119, P260, DOI 10.1053/gast.2000.9192
   Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300
   Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597
   Woodrow KA, 2009, TISSUE ENG PT A, V15, P1169, DOI 10.1089/ten.tea.2008.0265
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
   XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309
   Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267
   Yih TC, 2006, J CELL BIOCHEM, V97, P1184, DOI 10.1002/jcb.20796
   Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007
   Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045
   Zurbriggen R, 2000, PROG LIPID RES, V39, P3, DOI 10.1016/S0163-7827(99)00017-X
NR 178
TC 89
Z9 90
U1 1
U2 63
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3514-4
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2012
VL 14
BP 17
EP 46
DI 10.1146/annurev-bioeng-071811-150054
PG 30
WC Engineering, Biomedical
SC Engineering
GA BCG25
UT WOS:000310145300002
PM 22524387
DA 2018-10-19
ER

PT S
AU Underhill, GH
   Galie, P
   Chen, CS
   Bhatia, SN
AF Underhill, Gregory H.
   Galie, Peter
   Chen, Christopher S.
   Bhatia, Sangeeta N.
BE Schekman, R
TI Bioengineering Methods for Analysis of Cells In Vitro
SO ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 28
SE Annual Review of Cell and Developmental Biology
LA English
DT Review; Book Chapter
DE microfabrication; biomaterial; high-throughput; extracellular matrix;
   mechanobiology
ID EMBRYONIC STEM-CELLS; SELF-ASSEMBLED MONOLAYERS; CELLULAR TRACTION
   FORCES; HIGH-THROUGHPUT ANALYSIS; BREAST EPITHELIAL-CELLS; CLICK-BASED
   HYDROGELS; SMOOTH-MUSCLE-CELLS; LONG-TERM CULTURES; BASEMENT-MEMBRANE;
   MICROFLUIDIC CHANNELS
AB Efforts in the interdisciplinary field of bioengineering have led to innovative methods for investigating the complexities of cell responses in vitro. These approaches have emphasized the reduction of complex multicomponent cellular microenvironments into distinct individual signals as a means to both (a) better construct mimics of in vivo microenvironments and (b) better deconstruct microenvironments to study them. Microtechnology tools, together with advances in biomaterials, have been fundamental to this progress by enabling the tightly controlled presentation of environmental cues and the improved systematic analysis of cellular perturbations. In this review, we describe bioengineering approaches for controlling and measuring cell-environmental interactions in vitro, including strategies for high-throughput analysis. We also describe the mechanistic insights gained by the use of these novel tools, with associated applications ranging from fundamental biological studies, in vitro modeling of in vivo processes, and cell-based therapies.
C1 [Underhill, Gregory H.; Bhatia, Sangeeta N.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.
   [Bhatia, Sangeeta N.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.
   [Galie, Peter; Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Bhatia, Sangeeta N.] Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA.
RP Underhill, GH (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM sbhatia@mit.edu
OI Galie, Peter/0000-0001-5161-4924
FU NIBIB NIH HHS [EB008396, EB08396, EB00262]; NIDDK NIH HHS [DK56966,
   DK85713]; NIGMS NIH HHS [GM74048]; Howard Hughes Medical Institute
CR Adzima BJ, 2011, NAT CHEM, V3, P256, DOI 10.1038/NCHEM.980
   Albrecht DR, 2010, INTEGR BIOL-UK, V2, P278, DOI 10.1039/b923699f
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Allen JW, 2005, TOXICOL SCI, V84, P110, DOI 10.1093/toxsci.kfi052
   Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410
   Brafman DA, 2009, INTEGR BIOL, V1, P513, DOI 10.1039/b912926j
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Carpenedo RL, 2007, STEM CELLS, V25, P2224, DOI 10.1634/stemcells.2006-0523
   Chamuleau RAFM, 2009, WORLD J GASTRO SURG, V1, P21, DOI 10.4240/wjgs.v1.i1.21
   Chan EWL, 2008, ANGEW CHEM INT EDIT, V47, P6267, DOI 10.1002/anie.200800166
   Chan V, 2012, LAB CHIP, V12, P88, DOI 10.1039/c1lc20688e
   Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d
   Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p
   Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Chin LK, 2011, LAB CHIP, V11, P1856, DOI 10.1039/c0lc00651c
   Chiu JJ, 2009, ANN MED, V41, P19, DOI 10.1080/07853890802186921
   Cho CH, 2010, BIOTECHNIQUES, V48, P47, DOI 10.2144/000113317
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   Cimetta E, 2009, METHODS, V47, P81, DOI 10.1016/j.ymeth.2008.10.015
   Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003
   Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deisboeck TS, 2011, ANNU REV BIOMED ENG, V13, P127, DOI 10.1146/annurev-bioeng-071910-124729
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Dillmore WS, 2004, LANGMUIR, V20, P7223, DOI 10.1021/la049826v
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112
   DUNN JCY, 1989, FASEB J, V3, P174
   Dvir T, 2006, TISSUE ENG, V12, P2843, DOI 10.1089/ten.2006.12.2843
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]
   Eschbach E, 2005, J CELL BIOCHEM, V95, P243, DOI 10.1002/jcb.20360
   Fedorovich NE, 2011, TRENDS BIOTECHNOL, V29, P601, DOI 10.1016/j.tibtech.2011.07.001
   Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661
   Ferrenq I, 1997, ACTA BIOTHEOR, V45, P267, DOI 10.1023/A:1000684025534
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Ge XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011355
   GERLACH JC, 1994, TRANSPLANTATION, V58, P984, DOI 10.1097/00007890-199411150-00002
   Ghibaudo M, 2011, LAB CHIP, V11, P805, DOI [10.1039/c0lc00221f, 10.1039/c01c00221f]
   Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198
   Gruene M, 2011, TISSUE ENG PART C-ME, V17, P79, DOI [10.1089/ten.tec.2010.0359, 10.1089/ten.TEC.2010.0359]
   Gudjonsson T, 2002, J CELL SCI, V115, P39
   GUGUENGUILLOUZO C, 1983, MOL CELL BIOCHEM, V53-4, P35
   Guidry C, 1996, INVEST OPHTH VIS SCI, V37, P740
   Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   Hong H, 2008, J BIOMAT SCI-POLYM E, V19, P1279, DOI 10.1163/156856208786052380
   Hong SH, 2010, STEM CELL RES, V5, P120, DOI 10.1016/j.scr.2010.04.007
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   Kaji H, 2004, LANGMUIR, V20, P16, DOI 10.1021/la035537f
   Kamei KI, 2009, LAB CHIP, V9, P555, DOI 10.1039/b809105f
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kikuchi K, 2009, BIOTECHNOL BIOENG, V103, P552, DOI 10.1002/bit.22253
   Kikuchi Y, 2008, LANGMUIR, V24, P13084, DOI 10.1021/la8024414
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h
   King KR, 2008, LAB CHIP, V8, P107, DOI 10.1039/b716962k
   King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f
   Kirouac DC, 2006, CURR OPIN BIOTECH, V17, P538, DOI 10.1016/j.copbio.2006.07.003
   Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71
   Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Kuzuya M, 1996, EXP CELL RES, V226, P336, DOI 10.1006/excr.1996.0234
   Kwon CH, 2011, ANAL CHEM, V83, P4118, DOI 10.1021/ac200267t
   LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j
   Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1082/blood-2003-10-3537
   Lecault V, 2011, NAT METHODS, V8, P581, DOI [10.1038/NMETH.1614, 10.1038/nmeth.1614]
   LeCluyse EL, 1996, ADV DRUG DELIVER REV, V22, P133, DOI 10.1016/S0169-409X(96)00418-8
   LEE J, 1994, J CELL BIOL, V127, P1957, DOI 10.1083/jcb.127.6.1957
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Legant WR, 2009, P NATL ACAD SCI USA, V106, P10097, DOI 10.1073/pnas.0900174106
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Li B, 2007, CELL MOTIL CYTOSKEL, V64, P509, DOI 10.1002/cm.20200
   Li CY, 2011, LAB CHIP, V11, P2967, DOI 10.1039/c1lc20318e
   Li Y, 2007, ANGEW CHEM INT EDIT, V46, P1094, DOI 10.1002/anie.200603844
   Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Lin F, 2004, LAB CHIP, V4, P164, DOI 10.1039/b313600k
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Lindstrom S, 2009, LAB CHIP, V9, P3465, DOI 10.1039/b912596e
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu Y, 2011, ANAL CHEM, V83, P8286, DOI 10.1021/ac202117g
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085
   Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   McKenna BK, 2011, NAT METHODS, V8, P401, DOI [10.1038/NMETH.1595, 10.1038/nmeth.1595]
   Mei Y, 2008, SMALL, V4, P1600, DOI 10.1002/smll.200800363
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016
   Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   MOK SS, 1994, J BIOL CHEM, V269, P33021
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000
   Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0
   Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680
   Niebruegge S, 2009, BIOTECHNOL BIOENG, V102, P493, DOI 10.1002/bit.22065
   Nishiyama Y, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3002759
   Oh SKW, 2005, BIOTECHNOL BIOENG, V91, P523, DOI 10.1002/bit.20650
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Ohmuro-Matsuyama Y, 2008, ANGEW CHEM INT EDIT, V47, P7527, DOI 10.1002/anie.200802731
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Ostrovidov S, 2012, ANAL CHEM, V84, P1302, DOI 10.1021/ac202256c
   Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pavlovich AL, 2011, EXP CELL RES, V317, P1872, DOI 10.1016/j.yexcr.2011.03.017
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Peltier J, 2010, IET SYST BIOL, V4, P1, DOI 10.1049/iet-syb.2009.0011
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Petersen S, 2008, ANGEW CHEM INT EDIT, V47, P3192, DOI 10.1002/anie.200704857
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Raghavan S, 2010, J CELL SCI, V123, P2877, DOI 10.1242/jcs.055079
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   ROJKIND M, 1980, J CELL BIOL, V87, P255, DOI 10.1083/jcb.87.1.255
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417
   Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9
   Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p
   Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Shah SS, 2009, ACS APPL MATER INTER, V1, P2592, DOI 10.1021/am900508m
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   Stabley DR, 2012, NAT METHODS, V9, P64, DOI [10.1038/NMETH.1747, 10.1038/nmeth.1747]
   Stahl PJ, 2010, BIOMACROMOLECULES, V11, P2336, DOI 10.1021/bm100465q
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   STREULI CH, 1990, J CELL BIOL, V110, P1405
   Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820
   Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thomas RJ, 2006, EUR CELLS MATER, V11, P16, DOI 10.22203/eCM.v011a03
   Thomson H, 2007, TRENDS BIOTECHNOL, V25, P224, DOI 10.1016/j.tibtech.2007.03.003
   Torisawa YS, 2009, INTEGR BIOL-UK, V1, P649, DOI 10.1039/b915965g
   Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109
   Tserepi A, 2005, J APPL PHYS, V98, DOI 10.1063/1.2136421
   Tsuda Y, 2006, BIOCHEM BIOPH RES CO, V348, P937, DOI 10.1016/j.bbrc.2006.07.138
   Tuleuova N, 2010, CELL MOL BIOENG, V3, P337, DOI 10.1007/s12195-010-0148-5
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang Y. K., 2011, STEM CELLS DEV, V21, P1176
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Wood DK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002738
   Wood DK, 2010, P NATL ACAD SCI USA, V107, P10008, DOI 10.1073/pnas.1004056107
   Woodrow KA, 2009, TISSUE ENG PT A, V15, P1169, DOI 10.1089/ten.tea.2008.0265
   Wright D, 2008, J BIOMED MATER RES A, V85A, P530, DOI 10.1002/jbm.a.31281
   Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340
   Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac051632
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yang MT, 2007, ADV MATER, V19, P3119, DOI 10.1002/adma.200701956
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zhang R, 2009, BIOMATERIALS, V30, P6193, DOI 10.1016/j.biomaterials.2009.07.055
   Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270
NR 236
TC 22
Z9 22
U1 0
U2 70
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1081-0706
BN 978-0-8243-3128-3
J9 ANNU REV CELL DEV BI
JI Annu. Rev. Cell Dev.Biol.
PY 2012
VL 28
BP 385
EP 410
DI 10.1146/annurev-cellbio-101011-155709
PG 26
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA BCH90
UT WOS:000310224200016
PM 23057744
DA 2018-10-19
ER

PT S
AU Vamze, J
   Pilmane, M
   Skagers, A
AF Vamze, J.
   Pilmane, M.
   Skagers, A.
GP IOP
TI The expression of cytokines and beta -defensin 2,-3,-4 in rabbit bone
   tissue after hydroxyapatite (HAp), alpha-Tricalcium phosphate
   (alpha-TCP) and polymethylmethacrylate (PMMA) implantation
SO INTERNATIONAL CONFERENCE ON FUNCTIONAL MATERIALS AND NANOTECHNOLOGIES
   (FM&NT2012)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT International Conference on Functional Materials and Nanotechnologies
   (FMandNT)
CY APR 17-20, 2012
CL Univ Latvia, Inst Solild State Phys (ISSP UL), Riga, LATVIA
SP Mat Sci & Informat Technol Latvia, Natl Res Programme
HO Univ Latvia, Inst Solild State Phys (ISSP UL)
ID DISEASE
AB Bone loss induced by inflammation is one of the complications after biomaterial implantation. There is no much data on expression of cytokines and defensins into the bone tissue around the implants in literature. The aim of this work was to investigate the distribution and appearance of interleukin (IL)-1, IL-6, IL-8, IL-10 and beta - defensin (BD)-2, BD-3, BD-4 after the implantation of different biomaterials. Bone developing zones, signs of bone-implant contact and low expression of pro-inflammatory cytokine IL-1, IL-6 and anti-inflammatory cytokine IL-10 in experimental tissue with pure HAp and unburned HAp implants indicate a potential advantage of this material in terms of its biocompatibility over the other materials used in our study.
C1 [Vamze, J.; Pilmane, M.] Riga Stradins Univ, Inst Anat & Anthropol, Kronvalda 9, LV-1010 Riga, Latvia.
   [Skagers, A.] Riga Stradins Univ, Dept Oral & Maxillofacial Surg, LV-1007 Riga, Latvia.
RP Vamze, J (reprint author), Riga Stradins Univ, Inst Anat & Anthropol, Kronvalda 9, LV-1010 Riga, Latvia.
EM j.vamze@inbox.lv
CR Bissell J, 2004, J ORAL PATHOL MED, V33, P278, DOI 10.1111/j.0904-2512.2004.00143.x
   Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250
   Haake S K, 2002, CLIN PERIODONTOLOGY, P162
   Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   Kiernan JA, 2008, HISTOLOGICAL HISTOCH, P141
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   PILMANE M, 1995, THORAX, V50, P551, DOI 10.1136/thx.50.5.551
   Schmidt C, 2003, BIOMATERIALS, V24, P4191, DOI 10.1016/S0142-9612(03)00317-X
NR 9
TC 0
Z9 0
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2012
VL 38
AR 012025
DI 10.1088/1757-899X/38/1/012025
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BCB66
UT WOS:000309665200025
DA 2018-10-19
ER

PT S
AU Laroui, H
   Sitaraman, SV
   Merlin, D
AF Laroui, Hamed
   Sitaraman, Shanthi V.
   Merlin, Didier
BE Duzgunes, N
TI GASTROINTESTINAL DELIVERY OF ANTI-INFLAMMATORY NANOPARTICLES
SO NANOMEDICINE: INFECTIOUS DISEASES, IMMUNOTHERAPY, DIAGNOSTICS,
   ANTIFIBROTICS, TOXICOLOGY AND GENE MEDICINE
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID DOUBLE-STRANDED-RNA; IN-VITRO; COLON CARCINOGENESIS;
   CAENORHABDITIS-ELEGANS; CROHNS-DISEASE; DRUG-DELIVERY; GENE DELIVERY;
   CHITOSAN; CANCER; INTERFERENCE
AB The concept of nanomedicine has risen to be the future of medicine. Advantages of using nanoobjects as vectors for drug delivery systems are numerous, such as fewer side effects due to a low drug dose, and high specificity between drug and target. Unlike systemic therapy, targeting a specific target is more efficient and less costly. In inflammatory bowel disease, including ulcerative colitis and Crohn disease, the colon represents the targeted organ. A large number of drugs are candidates for loading into nanoparticles (NPs). Small molecules, such as tripeptides and siRNA, or larger molecules, such as proteins (hormones, antibodies (Ab), etc.), can be encapsulated alone or in a complex form inside the NPs. In our studies, once NPs are synthesized and loaded with anti-inflammatory compounds, they are delivered to the colon. An efficient technique has been developed for specific NP targeting to digestive tract regions, including the colon, using a hydrogel based on electrostatic interactions between positive ions and negative polysaccharides. An in situ double cross-linking process, mediated by Ca2+ and SO42-, of chitosan and alginate administered to the mouse gastrointestinal (GI) tract by double gavage, is used for gel formation. When the drug is given in NPs, NPs are targeted to the colon, and NP degradation by aggressive environmental conditions in the GI tract is significantly reduced. Using a biomaterial (hydrogel) associated with nanotechnology, lower doses of drug can be loaded efficiently and delivered to the colon to reduce colonic inflammation.
C1 [Laroui, Hamed; Merlin, Didier] Georgia State Univ, Dept Biol, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA.
   [Sitaraman, Shanthi V.] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.
   [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA.
RP Laroui, H (reprint author), Georgia State Univ, Dept Biol, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA.
FU NIDDK NIH HHS [R01-DK55850, R01-DK-071594]
CR Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803
   Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774
   Bais D, 2005, J COLLOID INTERF SCI, V290, P546, DOI 10.1016/j.jcis.2005.04.044
   Ballard CE, 2002, CURR MED CHEM, V9, P471, DOI 10.2174/0929867023371049
   Becker AL, 2011, ACS NANO, V5, P1335, DOI 10.1021/nn103044z
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Boddohi S, 2009, BIOMACROMOLECULES, V10, P1402, DOI 10.1021/bm801513e
   Bromberg Lev, 2005, Expert Opin Drug Deliv, V2, P1003, DOI 10.1517/17425247.2.6.1003
   Camma C, 1997, GASTROENTEROLOGY, V113, P1465, DOI 10.1053/gast.1997.v113.pm9352848
   Chaudhary A, 2011, EUR J PHARM BIOPHARM, V78, P134, DOI 10.1016/j.ejpb.2011.01.004
   Chuah AM, 2009, J FOOD SCI, V74, pN1, DOI 10.1111/j.1750-3841.2008.00985.x
   Crouzier T, 2009, BIOMACROMOLECULES, V10, P433, DOI 10.1021/bm8012378
   de Guzman RC, 2008, J MICROENCAPSUL, V25, P487, DOI 10.1080/02652040802054745
   DeCarlo AA, 2006, J DENT RES, V85, P122, DOI 10.1177/154405910608500203
   Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Eslamian M, 2009, RECENT PAT NANOTECH, V3, P99, DOI 10.2174/187221009788490068
   Ewe K, 1999, DIGEST DIS SCI, V44, P1434, DOI 10.1023/A:1026664105112
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Froidevaux S, 2002, BIOPOLYMERS, V66, P161, DOI 10.1002/bip.10256
   Garg A, 2011, CURR PHARM BIOTECHNO, V12, P1135, DOI 10.2174/138920111796117328
   Gautier S., 2008, International Journal of Cosmetic Science, V30, P459, DOI 10.1111/j.1468-2494.2008.00470.x
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Gou ML, 2011, NANOSCALE, V3, P1558, DOI 10.1039/c0nr00758g
   Hammond SM, 2000, NATURE, V404, P293
   Harada-Shiba M, 2002, GENE THER, V9, P407, DOI 10.1038/sj.gt/3301665
   Hiorth M, 2010, EUR J PHARM BIOPHARM, V75, P245, DOI 10.1016/j.ejpb.2010.02.012
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   ITOH H, 1988, DIS COLON RECTUM, V31, P459, DOI 10.1007/BF02552617
   Jeong YI, 2001, J CONTROL RELEASE, V71, P175, DOI 10.1016/S0168-3659(01)00211-5
   Kabbaj M, 2001, J DRUG TARGET, V9, P317, DOI 10.3109/10611860108998768
   Kinget R, 1998, J DRUG TARGET, V6, P129, DOI 10.3109/10611869808997888
   Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039
   Koornstra JJ, 2005, CANCER EPIDEM BIOMAR, V14, P1608, DOI 10.1158/1055-9965.EPI-05-0112
   KORNBLUTH A, 2010, AM J GASTROENTEROL, V105, P524, DOI DOI 10.1038/AJG.2009.727
   Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727
   KUDO T, 1980, GANN, V71, P260
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   Lamprecht A, 2005, J CONTROL RELEASE, V104, P337, DOI 10.1016/j.jconrel.2005.02.011
   Laroui H, 2007, BIOMACROMOLECULES, V8, P3879, DOI 10.1021/bm700836y
   Laroui H, 2011, AM J PHYSIOL-GASTR L, V300, pG371, DOI 10.1152/ajpgi.00466.2010
   Laroui H, 2011, BIOMATERIALS, V32, P1218, DOI 10.1016/j.biomaterials.2010.09.062
   Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003
   LASIC DD, 1992, NATURE, V355, P279, DOI 10.1038/355279a0
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lemarchand C, 2006, BIOMATERIALS, V27, P108, DOI 10.1016/j.biomaterials.2005.04.041
   Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004
   LEVITT MD, 1987, GASTROENTEROLOGY, V92, P383, DOI 10.1016/0016-5085(87)90132-6
   Li LL, 2002, INT J PHARM, V237, P77, DOI 10.1016/S0378-5173(02)00029-7
   Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168
   Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X
   Mazumder MAJ, 2009, BIOMACROMOLECULES, V10, P1365, DOI 10.1021/bm801330j
   Metz KM, 2009, ENVIRON SCI TECHNOL, V43, P1598, DOI 10.1021/es802217y
   NARISAWA T, 1983, CARCINOGENESIS, V4, P1225, DOI 10.1093/carcin/4.10.1225
   Navarro G, 2009, NANOMED-NANOTECHNOL, V5, P287, DOI 10.1016/j.nano.2008.12.007
   Neu M, 2006, BIOMACROMOLECULES, V7, P3428, DOI 10.1021/bm060788z
   Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a
   Pardue Erin L, 2008, Organogenesis, V4, P203
   POLLARD M, 1981, P SOC EXP BIOL MED, V167, P161
   Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007
   RAO CV, 1991, CANCER RES, V51, P4528
   Raynaud J, 2008, BIOMACROMOLECULES, V9, P1014, DOI 10.1021/bm701101n
   REDDY BS, 1990, CANCER RES, V50, P2562
   REDDY BS, 1987, CANCER RES, V47, P5340
   Reis CP, 2008, DRUG DELIV, V15, P127, DOI [10.1080/10717540801905165, 10.1080/10717540801905165 ]
   Riviere K, 2011, J CONTROL RELEASE, V153, P288, DOI 10.1016/j.jconrel.2011.05.005
   ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355
   Rosenberg L., 1991, J NATL CANCER I, V83, P1182
   Salva E, 2010, PHARMAZIE, V65, P896, DOI 10.1691/ph.2010.0192
   Sato M, 2009, J INVEST DERMATOL, V129, P2233, DOI 10.1038/jid.2009.39
   Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2
   Sezer AD, 2006, J MICROENCAPSUL, V23, P513, DOI 10.1080/02652040600687563
   Sintov AC, 2010, J CONTROL RELEASE, V148, P168, DOI 10.1016/j.jconrel.2010.08.004
   Skewis LR, 2010, ACS APPL MATER INTER, V2, P35, DOI 10.1021/am900822f
   TAKAYA T, 1995, J PHARM PHARMACOL, V47, P474, DOI 10.1111/j.2042-7158.1995.tb05834.x
   Thankappan UP, 2011, BIOCONJUGATE CHEM, V22, P115, DOI 10.1021/bc1003108
   Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com
   Theiss AL, 2009, GASTROENTEROLOGY, V136, pA41
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002
   Tseng YC, 2009, ADV DRUG DELIVER REV, V61, P721, DOI 10.1016/j.addr.2009.03.003
   Vangsness CT, 2009, ARTHROSCOPY, V25, P86, DOI 10.1016/j.arthro.2008.07.020
   Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027
   WADDELL WR, 1983, J SURG ONCOL, V24, P83, DOI 10.1002/jso.2930240119
   Wagner E, 1999, ADV DRUG DELIVER REV, V38, P279, DOI 10.1016/S0169-409X(99)00033-2
   Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]
   Wiwattanapatapee R, 2003, J CONTROL RELEASE, V88, P1, DOI 10.1016/S0168-3659(02)00461-3
   WU GY, 1987, J BIOL CHEM, V262, P4429
   Yamamoto A, 2007, YAKUGAKU ZASSHI, V127, P621, DOI 10.1248/yakushi.127.621
   Yu X, 2011, BIOMACROMOLECULES, V12, P3205, DOI 10.1021/bm200681m
   Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0
   Zampa MF, 2007, BIOMACROMOLECULES, V8, P3408, DOI 10.1021/bm700528u
NR 92
TC 20
Z9 20
U1 0
U2 24
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 978-0-12-391858-1
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2012
VL 509
BP 101
EP 125
DI 10.1016/B978-0-12-391858-1.00006-X
PG 25
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BBU36
UT WOS:000308198000006
PM 22568903
DA 2018-10-19
ER

PT J
AU Rosenthal-Kim, EQ
   Puskas, JE
AF Rosenthal-Kim, Emily Q.
   Puskas, Judit E.
TI Green polymer chemistry: Living oxidative polymerization of dithiols
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE biodegradation; biomaterials; polymerization; redox reactivity; sulfur;
   sustainable chemistry
ID POLY(ETHYLENE OXIDE SULFIDE); INTRACELLULAR DRUG-DELIVERY;
   CAPILLARY-ELECTROPHORESIS; POLYALKYLENE DISULFIDES; COPOLYMER MICELLES;
   MOLECULAR-WEIGHT; REDOX STATUS; IN-VIVO; GLUTATHIONE; ENVIRONMENT
AB Reduction sensitivity and mild synthetic conditions make disulfide-bonded materials ideal for degradable biomaterial applications. Both the degradation and the synthetic advantages of disulfide-bonded biomaterials have been applied to drug delivery vesicles, protein conjugation, and hydrogel biomaterials, but the synthetic advantages are rarely seen in the creation of biopolymers. A greener and highly efficient oxidative system is presented for the polymerization dithiols to high-molecular-weight poly(disulfide) polymers. The application of this system to 2-[2-(2-sulfanylethoxy) ethoxy]ethanethiol (DODT) produced corresponding degradable poly(disulfide) polymers with molecular weights as high as M-n = 250 000 g/mol and with a polydispersity index (PDI) as low as 1.15.
C1 [Rosenthal-Kim, Emily Q.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Puskas, Judit E.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Rosenthal-Kim, EQ (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
FU National Science Foundation [DMR0804878]; Ohio Board of Regents;
   National Science Foundation
FX This material is based upon work supported by the National Science
   Foundation under Grant No. DMR0804878. We also wish to thank the
   Goodyear Corporation for the donation of the 300 MHz NMR instrument used
   in this work and the Ohio Board of Regents and the National Science
   Foundation for funds used to purchase the 500 MHz NMR instrument used in
   this work.
CR ALLEN TM, 1994, ADV DRUG DELIVER REV, V13, P285, DOI 10.1016/0169-409X(94)90016-7
   Arteel GE, 2001, ENVIRON TOXICOL PHAR, V10, P153, DOI 10.1016/S1382-6689(01)00078-3
   Augustine R. L., 1969, OXIDATION TECHNIQUES, V1, P247
   BALLINGER P, 1960, J AM CHEM SOC, V82, P795, DOI 10.1021/ja01489a008
   Bauhuber S, 2009, ADV MATER, V21, P3286, DOI 10.1002/adma.200802453
   Bindoli A, 2009, COORDIN CHEM REV, V253, P1692, DOI 10.1016/j.ccr.2009.02.026
   BONSIGNORE PV, 1960, J ORG CHEM, V25, P237, DOI 10.1021/jo01072a024
   Braunova A, 2007, MACROMOL CHEM PHYS, V208, P2642, DOI 10.1002/macp.200700315
   Brocchini S, 2008, ADV DRUG DELIVER REV, V60, P3, DOI 10.1016/j.addr.2007.06.014
   CADENAS E, 1995, METHOD ENZYMOL, V251, P106, DOI 10.1016/0076-6879(95)51114-8
   CANTIN AM, 1987, J APPL PHYSIOL, V63, P152
   Carru C, 2004, ELECTROPHORESIS, V25, P882, DOI 10.1002/elps.200305768
   Cerritelli S, 2007, BIOMACROMOLECULES, V8, P1966, DOI 10.1021/bm070085x
   CHEN YM, 2005, POLYMER, V46, P4619, DOI DOI 10.1016/J.POLYMER.2005.04.013
   Choi WM, 1998, J POLYM SCI POL CHEM, V36, P79, DOI 10.1002/(SICI)1099-0518(19980115)36:1<79::AID-POLA11>3.0.CO;2-A
   DANEHY JP, 1960, J AM CHEM SOC, V82, P2511, DOI 10.1021/ja01495a028
   Faber K., 2004, BIOTRANSFORMATIONS O, p[226, 378]
   FETTES EM, 1950, IND ENG CHEM, V42, P2217, DOI 10.1021/ie50491a020
   Goethals E.J., 1968, MACROMOL CHEM, V119, P249, DOI DOI 10.1002/MACP.1968.021190129
   HARMAN LS, 1984, J BIOL CHEM, V259, P5606
   Hisano N, 1998, J BIOMED MATER RES, V40, P115, DOI 10.1002/(SICI)1097-4636(199804)40:1<115::AID-JBM13>3.0.CO;2-N
   HOLDEN JW, 1977, AUST J CHEM, V30, P1387, DOI 10.1071/CH9771387
   HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295
   HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199
   Jacob C., 2006, J BIOL CHEM, V75, P1385
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Kishore K., 1995, ADV POLYM SCI, V121, P83
   Koo AN, 2008, CHEM COMMUN, P6570, DOI 10.1039/b815918a
   Koo H, 2005, B KOR CHEM SOC, V26, P2069
   Koo H, 2009, INT J PHARMACEUT, V374, P58, DOI 10.1016/j.ijpharm.2009.03.010
   Lee Y, 2005, BIOMACROMOLECULES, V6, P24, DOI 10.1021/bm0496581
   Lyon RP, 2001, J AM CHEM SOC, V123, P4408, DOI 10.1021/ja0040417
   MAMATHAMBIKA BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI DOI 10.1146/ANNUREV.CELLBI0.24.110707.175333
   MARVEL CS, 1957, J AM CHEM SOC, V79, P3089, DOI 10.1021/ja01569a027
   Matsumoto S, 2009, BIOMACROMOLECULES, V10, P119, DOI 10.1021/bm800985e
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Meng YZ, 2004, POLYM ADVAN TECHNOL, V15, P564, DOI 10.1002/pat.497
   Meng YZ, 2001, POLYMER, V42, P5215, DOI 10.1016/S0032-3861(01)00007-6
   Meng YZ, 1999, J APPL POLYM SCI, V74, P3069, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3069::AID-APP9>3.0.CO;2-I
   MORIYAMA Y, 1992, FEBS LETT, V302, P18, DOI 10.1016/0014-5793(92)80274-K
   MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0
   MUNDAY R, 1995, METHOD ENZYMOL, V251, P117, DOI 10.1016/0076-6879(95)51115-6
   Oae S., 1991, ORGANIC SULFUR CHEM
   Patrick J. C., 1951, U. S. Patent, Patent No. [2,553,206, 2553206]
   Patrick J. C, 1932, Method of Making Plastic Substances and Products Obtained Thereby U. S. Patent, Patent No. [1,890,191, 1890191]
   Patrick J. C., 1935, U.S. Patent, Patent No. [1,996,486, 1996486, 1996 486]
   Patrick J. C., 1944, U.S. Patent, Patent No. [2,363,614, 2363614, 2363 614]
   Pilka E. S., 2007, GPX3 HUMAN GLUTATHIO
   Puskas J. E., 2011, U.S. Patent Application, Patent No. 20110218298
   RANDALL LO, 1946, J BIOL CHEM, V164, P521
   Rosenthal E. Q., 2011, BIOMACROMOLECULES, V13, P154, DOI DOI 10.1021/BM201395T
   Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5
   Savvides SN, 1996, J BIOL CHEM, V271, P8101, DOI 10.1074/jbc.271.14.8101
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   SENTER PD, 1990, J ORG CHEM, V55, P2975, DOI 10.1021/jo00296a082
   Shen W., 2009, BIOMATERIALS, V30, P2180
   Shirley B. A., 1995, PROTEIN STABILITY FO
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191
   THORPE PE, 1987, CANCER RES, V47, P5924
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P9009, DOI 10.1021/ma021061f
   Wang XL, 2007, J CONTROL RELEASE, V120, P250, DOI 10.1016/j.jconrel.2007.05.014
   WHISTLER RL, 1967, J POLYM SCI A1, V5, P2111, DOI 10.1002/pol.1967.150050827
   WHITESIDES GM, 1977, J ORG CHEM, V42, P332, DOI 10.1021/jo00422a034
   Whittaker MR, 2006, MACROMOLECULES, V39, P9028, DOI 10.1021/ma061070e
   WILLNER D, 1993, BIOCONJUGATE CHEM, V4, P521, DOI 10.1021/bc00024a015
   Witczak ZJ, 2005, APPL MICROBIOL BIOT, V69, P237, DOI 10.1007/s00253-005-0156-x
   Wu ZM, 2009, EUR J PHARM SCI, V37, P198, DOI 10.1016/j.ejps.2009.01.010
   Yano Y., 1984, CHEM COMMUN, V5, P1031
   Yano Y., 1985, J CHEM SOC P2, V6, P753
   You YZ, 2007, BIOMACROMOLECULES, V8, P2038, DOI 10.1021/bm0702049
   Zhang JX, 2008, BIOMATERIALS, V29, P4521, DOI 10.1016/j.biomaterials.2008.08.008
   Zinellu A, 2005, ELECTROPHORESIS, V26, P1963, DOI 10.1002/elps.200400042
NR 74
TC 3
Z9 3
U1 2
U2 23
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PY 2012
VL 84
IS 10
BP 2121
EP 2133
DI 10.1351/PAC-CON-11-11-04
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA 017HO
UT WOS:000309581000015
OA Bronze
DA 2018-10-19
ER

PT J
AU Arca, T
   Proffitt, J
   Genever, P
AF Arca, Turkan
   Proffitt, Joanne
   Genever, Paul
TI Analysis of human mesenchymal stem cells on a cross-linked
   collagen-based surgical implant material
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Mesenchymal human stem cells; collagen implant material; regenerative;
   surgical
ID PORCINE DERMAL COLLAGEN; SOFT-TISSUE RECONSTRUCTION; ADIPOSE-DERIVED
   STEM; HERNIA REPAIR; RAT MODEL; IN-VITRO; MATRIX; LINKING; PERMACOL(TM);
   SCAFFOLDS
AB Biomimetic scaffolds, delivered to the patient with or without cell loading, can offer improved treatments for a range of damaged or diseased tissues. In this work we evaluated the capacity of a cross-linked collagen-based implant material (Permacol (TM)) to support the survival and growth of multipotent stromal cells or mesenchymal stem cells (MSCs) for potential applications in soft-tissue reconstruction and compared it to uncross-linked collagen. We showed, using confocal imaging, histology, quantitative analysis of seeding efficiencies by the MTT assay and Live/Dead analysis, that Permacol (TM) supported the adherence, growth and survival of MSCs preserving a healthy cell phenotype. MSCs infiltrated both matrices, although migration rates were significantly higher on uncross-linked matrices for some donors. Our work demonstrates that Permacol (TM) could maintain human MSCs in long-term culture supporting its use as a cell-seeded biomaterial for durable and strong repair in tissue reconstruction.
C1 [Arca, Turkan; Genever, Paul] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England.
RP Genever, P (reprint author), Univ York, Dept Biol, POB 373, York YO10 5YW, N Yorkshire, England.
EM paul.genever@york.ac.uk
OI Genever, Paul/0000-0002-5730-8976; Arca, Turkan/0000-0002-1700-0272
FU Covidien
FX We would like to thank the members of the Imaging and Cytometry
   Laboratory of the Technology Facility at the Biology Department of the
   University of York for their technical assistance. We are very grateful
   for the help of the staff and patients at Harrogate District Hospital
   for the donation of bone samples. We would like to thank to Covidien for
   funding.
CR Abhinav K, 2009, EJSO-EUR J SURG ONC, V35, P439, DOI 10.1016/j.ejso.2008.03.007
   Adedeji OA, 2002, BRIT J PLAST SURG, V55, P85, DOI 10.1054/bjps.2001.3711
   Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7
   Dyson JA, 2007, TISSUE ENG, V13, P2891, DOI 10.1089/ten.2007.0124
   Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849
   Faglen S, 2007, PLAST RECONSTR SURG, V120, p5S, DOI 10.1097/01.prs.0000248787.57587.dl
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Gentleman E, 2004, TISSUE ENG, V10, P421, DOI 10.1089/107632704323061780
   Hammond TM, 2008, BRIT J SURG, V95, P438, DOI 10.1002/bjs.5883
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Kaleya Ronald N, 2005, Hernia, V9, P269, DOI 10.1007/s10029-005-0003-0
   Kelley P, 2005, PLAST RECONSTR SURG, V116, P1780, DOI 10.1097/01.prs.0000186529.60982.60982.0a
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Ma L, 2004, J BIOMED MATER RES A, V71A, P334, DOI 10.1002/jbm.a.30170
   MacLeod TM, 2003, BRIT J PLAST SURG, V56, P775, DOI 10.1016/S0007-1226(03)00383-7
   Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ramshaw B., 2007, GEN SURG NEWS
   Shevchenko RV, 2008, WOUND REPAIR REGEN, V16, P198, DOI 10.1111/j.1524-475X.2008.00360.x
   Stosich MS, 2007, PLAST RECONSTR SURG, V119, P71, DOI 10.1097/01.prs.0000244840.80661.e7
   Wilshaw SP, 2009, J BIOMED MATER RES B, V88B, P49, DOI 10.1002/jbm.b.31148
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
NR 34
TC 1
Z9 2
U1 0
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2012
VL 22
IS 5
BP 261
EP 276
DI 10.3233/BME-2012-0716
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 016WZ
UT WOS:000309551800001
PM 23023143
DA 2018-10-19
ER

PT J
AU Lopez-Gonzalez, H
   Serrano-Gomez, J
   Olguin, MT
AF Lopez-Gonzalez, H.
   Serrano-Gomez, J.
   Olguin, M. T.
TI Ectodermis of paddle cactus (Opuntia spp.) as biosorbent of chromium
   (VI) from aqueous solutions
SO CHEMISTRY AND ECOLOGY
LA English
DT Article
DE chromium; adsorption; Opuntia; biomaterial; water pollution; heavy
   metals
ID WASTE-WATER; ADSORPTION; CR(VI); BIOSORPTION; REMOVAL; CHITOSAN;
   CHARCOAL; BIOMASS
AB The adsorption behaviour of chromium (CrO42- and/or HCrO4-) from aqueous solutions on ectodermis of Opuntia in a batch system is presented. Modification of the biosorbent, contact time, concentration of chromium in solution and pH and temperature of the aqueous media were the studied parameters. Chromium anion uptake was higher at pH 2 for biosorbents treated with formaldehyde or HCl. The adsorption data were fitted to the Freundlich and Langmuir isotherms. The thermodynamic parameters Delta H-0, Delta G(0) and Delta S-0 were estimated and the obtained results showed that the adsorption reaction was endothermic and spontaneous for both biomaterials.
C1 [Lopez-Gonzalez, H.; Serrano-Gomez, J.; Olguin, M. T.] Inst Nacl Invest Nucl, Mexico City 11801, DF, Mexico.
RP Olguin, MT (reprint author), Inst Nacl Invest Nucl, AP 18-1027, Mexico City 11801, DF, Mexico.
EM teresa.olguin@inin.gob.mx
FU ININ; CONACyT [131174-Q]
FX The authors acknowledge financial support from ININ and CONACyT
   (Project: 131174-Q). The authors are also grateful to the Technicians of
   the Chemistry Department for experimental support.
CR Ahalya N, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-10
   Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Aydin YA, 2009, CHEM ENG J, V151, P188, DOI 10.1016/j.cej.2009.02.010
   Babel S, 2004, CHEMOSPHERE, V54, P951, DOI 10.1016/j.chemosphere.2003.10.001
   Bai RS, 2002, WATER RES, V36, P1224, DOI 10.1016/S0043-1354(01)00330-X
   Barrera H, 2006, J HAZARD MATER, V136, P846, DOI 10.1016/j.jhazmat.2006.01.021
   Begum S, 2009, WATER AIR SOIL POLL, V9, P371
   Cervantes-Mayagoitia J.F, 1993, TRABAJO COMP PRODUCC
   DROUX M, 1987, ARCH BIOCHEM BIOPHYS, V252, P426, DOI 10.1016/0003-9861(87)90049-X
   Dubey SP, 2007, J HAZARD MATER, V145, P465, DOI 10.1016/j.jhazmat.2006.11.041
   Granados-Correa F, 2009, SEP SCI TECHNOL, V44, P924, DOI 10.1080/01496390802691240
   Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Kilislioglu A, 2002, RADIOCHIM ACTA, V90, P155, DOI 10.1524/ract.2002.90.3_2002.155
   Mahramanlioglu M, 2007, J RADIOANAL NUCL CH, V273, P621, DOI 10.1007/s10967-007-0921-7
   Mor S, 2007, BIORESOURCE TECHNOL, V98, P954, DOI 10.1016/j.biortech.2006.03.018
   Popuri SR, 2007, ELECTRON J BIOTECHN, V10, P1
   Puigdomenech I, 1998, PROGRAM MEDUSA MAKE
   ROMHELD V, 1987, PHYSIOL PLANTARUM, V70, P231, DOI 10.1111/j.1399-3054.1987.tb06137.x
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Ucun H, 2008, J HAZARD MATER, V153, P52, DOI 10.1016/j.jhazmat.2007.08.018
   Wang JX, 2005, ACTA PHARMACOL SIN, V26, P821, DOI 10.1111/j.1745-7254.2005.00128.x
   Yolcubal I, 2007, TURK J EARTH SCI, V16, P363
NR 23
TC 3
Z9 3
U1 2
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0275-7540
EI 1029-0370
J9 CHEM ECOL
JI Chem. Ecol.
PY 2012
VL 28
IS 5
BP 457
EP 467
DI 10.1080/02757540.2012.666530
PG 11
WC Biochemistry & Molecular Biology; Ecology; Environmental Sciences
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology
GA 008VN
UT WOS:000308984800004
DA 2018-10-19
ER

PT J
AU Vukelic, MD
   Mitic, ZJ
   Miljkovic, MS
   Zivkovic, JM
   Ignjatovic, NL
   Uskokovic, DP
   Zivanov-Curlis, JZ
   Vasiljevic, PJ
   Najman, SJ
AF Vukelic, Marija D.
   Mitic, Zarko J.
   Miljkovic, Miroslav S.
   Zivkovic, Jelena M.
   Ignjatovic, Nenad L.
   Uskokovic, Dragan P.
   Zivanov-Curlis, Jelena Z.
   Vasiljevic, Perica J.
   Najman, Stevo J.
TI Apatite formation on nanomaterial calcium
   phosphate/poly-DL-lactide-co-glycolide in simulated body fluid
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE EDS; IR spectroscopy; Nanomaterial; N-CP/PLGA; SEM
ID COMPOSITE BIOMATERIAL; DRUG-DELIVERY; BONE; GLASS; ACID;
   POLY(DL-LACTIDE-CO-GLYCOLIDE); SPECTROSCOPY; DEGRADATION; SUBSTITUTE;
   SCAFFOLDS
AB Simulated body fluid (SBF) is an artificial fluid which has ionic composition and ionic concentration similar to human blood plasma.
   Purpose: This paper compares the interaction between the nanomaterial containing calcium phosphate/poly-DL-lactide-co-glycolide (N-CP/PLGA) and SBF, in order to investigate whether and to what extent inorganic ionic composition of human blood plasma leads to the aforementioned changes in the material.
   Methods: N-CP/PLGA was incubated for 1, 2, 3, and 5 weeks in SBF. The surface of the material was analyzed on SEM-EDS and FTIR spectrometer, while SBF was subjected to pH and electrical conductivity measurement.
   Results: Our results indicate that dissolution of the polymer component of the material N-CP/PLGA and precipitation of the material similar to hydroxyapatite on its surface are based on the morphologic changes seen in this material.
   Conclusions: The mechanism of the apatite formation on the bioceramic surface was intensively studied and was considered crucial in designing the new biomaterials. The results obtained in this work indicate that N-CP/PLGA may be a good candidate for application to bone regeneration.
C1 [Vukelic, Marija D.; Zivkovic, Jelena M.; Zivanov-Curlis, Jelena Z.; Najman, Stevo J.] Univ Nis, Inst Biol & Human Genet, Fac Med, Nish 18000, Serbia.
   [Mitic, Zarko J.] Univ Nis, Dept Pharm, Fac Med, Nish 18000, Serbia.
   [Miljkovic, Miroslav S.] Univ Nis, Lab Elect Microscopy, Fac Med, Nish 18000, Serbia.
   [Ignjatovic, Nenad L.; Uskokovic, Dragan P.] SASA, Inst Tech Sci, Belgrade, Serbia.
   [Vasiljevic, Perica J.] Univ Nis, Biol & Ecol Dept, Fac Nat & Sci, Nish 18000, Serbia.
RP Vukelic, MD (reprint author), Univ Nis, Inst Biol & Human Genet, Fac Med, Blvd Dr Zoran Djindjic 81, Nish 18000, Serbia.
EM marijavukelic@medfak.ni.ac.rs
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Zivkovic, Jelena/0000-0002-4010-5742;
   Najman, Stevo/0000-0002-2411-9802; Vasiljevic,
   Perica/0000-0003-0006-7187
FU Ministry of Education and Science of Republic of Serbia [41017]
FX The work was performed within the context of project III 41017, funded
   by the Ministry of Education and Science of Republic of Serbia.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Bever M, 1986, ENCY MAT SCI ENG, P323
   Despopoulos A, 2003, COLOR ATLAS PHYSL, P88
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Gergely G, 2010, CENT EUR J CHEM, V8, P375, DOI 10.2478/s11532-010-0004-4
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   HENCH LL, 1982, BIOMATERIALS INTERFA, P87
   Herath T, 2010, J APPL BIOMATER BIOM, V8, P89
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic NL, 2010, J MATER SCI-MATER M, V21, P231, DOI 10.1007/s10856-009-3854-6
   Janicijevic JM, 2008, HEM IND, V62, P205, DOI 10.2298/HEMIND0803205J
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LeGeros R, 2002, CLIN ORTHOP RELAT R, V395, P8
   Miao X, 2005, MATER LETT, V59, P4000, DOI 10.1016/j.matlet.2005.07.062
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P409, DOI 10.1007/BF00120283
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Stevanovic M, 2007, COLLOID SURFACE B, V59, P215, DOI 10.1016/j.colsurfb.2007.05.011
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
NR 28
TC 5
Z9 5
U1 0
U2 13
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2012
VL 10
IS 1
BP 43
EP 48
DI 10.5301/JABFM.2012.9274
PG 6
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 017JQ
UT WOS:000309586600007
PM 22467049
DA 2018-10-19
ER

PT J
AU Raimondi, MT
   Eaton, SM
   Nava, MM
   Lagana, M
   Cerullo, G
   Osellame, R
AF Raimondi, Manuela T.
   Eaton, Shane M.
   Nava, Michele M.
   Lagana, Matteo
   Cerullo, Giulio
   Osellame, Roberto
TI Two-photon laser polymerization: from fundamentals to biomedical
   application in tissue engineering and regenerative medicine
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Review
DE Femtosecond; Laser; Polymerization; Scaffold; Stem cell niche;
   Two-photon
ID STEM-CELL-NICHE; FEMTOSECOND LASER; FABRICATION; SCAFFOLDS;
   MICROFABRICATION; RESOLUTION; BIOMATERIALS; MICROSCOPY; POLYMERS;
   DEVICES
AB Three-dimensional material microstructuring by femtosecond laser-induced two-photon polymerization is emerging as an important tool in biomedicine. During two-photon polymerization, a tightly focused femtosecond laser pulse induces a crosslinking photoreaction in the polymer confined within the focal volume. As a rapid-prototyping technique, two-photon polymerization enables the fabrication of truly arbitrary three-dimensional micro- and nano-structures directly from computer models, with a spatial resolution down to 100 nm. In this review, we discuss the fundamentals, experimental methods, and materials used for two-photon polymerization; in addition, we present some applications of this technology related to microfluidics and to biomaterial scaffolds for tissue engineering and regenerative medicine.
C1 [Raimondi, Manuela T.; Nava, Michele M.; Lagana, Matteo] Politecn Milan, Dept Struct Engn, LaBS, I-20133 Milan, Italy.
   [Eaton, Shane M.; Osellame, Roberto] Consiglio Nazl Ric IFN CNR, Inst Photon & Nanotechnol, Milan, Italy.
   [Cerullo, Giulio] Politecn Milan, Dept Phys, I-20133 Milan, Italy.
RP Raimondi, MT (reprint author), Politecn Milan, Dept Struct Engn, LaBS, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
EM manuela.raimondi@polimi.it
RI Osellame, Roberto/E-6076-2012; Eaton, Shane/A-2084-2008; Nava,
   Michele/L-8939-2017; Raimondi, Manuela Teresa/F-6606-2013
OI Osellame, Roberto/0000-0002-4457-9902; Eaton, Shane/0000-0003-0805-011X;
   Nava, Michele/0000-0001-8733-6364; Raimondi, Manuela
   Teresa/0000-0003-2585-7206; Cerullo, Giulio/0000-0002-9534-2702
CR Amato L, 2012, LAB CHIP, V12, P1135, DOI 10.1039/c2lc21116e
   Asnaghi MA, 2009, BIOMATERIALS, V30, P5260, DOI 10.1016/j.biomaterials.2009.07.018
   Becerra J, 2011, STEM CELL REV REP, V7, P248, DOI 10.1007/s12015-010-9195-5
   Bertoldi S, 2011, J APPL BIOMATER BIOM, V9, P165, DOI 10.5301/JABB.2011.8863
   Claeyssens F, 2009, LANGMUIR, V25, P3219, DOI 10.1021/la803803m
   Danilevicius P, 2011, LATVIAN J PHYS TECHN, V2, P32
   Deubel M, 2006, OPT LETT, V31, P805, DOI 10.1364/OL.31.000805
   Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041
   Doraiswamy A, 2006, ACTA BIOMATER, V2, P267, DOI 10.1016/j.actbio.2006.01.004
   Doraiswamy A, 2010, J NANOSCI NANOTECHNO, V10, P6305, DOI 10.1166/jnn.2010.2636
   Eaton SM, 2011, J NON-CRYST SOLIDS, V357, P2387, DOI 10.1016/j.jnoncrysol.2010.11.082
   Eijkel JCT, 2006, LAB CHIP, V6, P19, DOI 10.1039/b516903h
   Engelhardt S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025003
   Farsari M, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/12/124001
   Farsari M, 2009, NAT PHOTONICS, V3, P450, DOI 10.1038/nphoton.2009.131
   Fischer J, 2011, OPT MATER EXPRESS, V1, P614, DOI 10.1364/OME.1.000614
   Fischer J, 2010, ADV MATER, V22, P3578, DOI 10.1002/adma.201000892
   Gittard SD, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/041001
   Gittard SD, 2011, BIOMED OPT EXPRESS, V2, P3167, DOI 10.1364/BOE.2.003167
   HELL SW, 1994, OPT COMMUN, V106, P19, DOI 10.1016/0030-4018(94)90050-7
   Hidai H, 2009, BIOMED MICRODEVICES, V11, P643, DOI 10.1007/s10544-008-9274-4
   Jeon H, 2011, BIOMED MICRODEVICES, V13, P107, DOI 10.1007/s10544-010-9475-5
   Koroleva A, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/1/015001
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995
   Li LJ, 2009, SCIENCE, V324, P910, DOI 10.1126/science.1168996
   Lin CC, 2008, BIOMED MICRODEVICES, V10, P55, DOI 10.1007/s10544-007-9109-8
   Malinauskas M, 2010, LITH J PHYS, V50, P75, DOI 10.3952/lithjphys.50121
   Malinauskas M, 2010, OPT EXPRESS, V18, P10209, DOI 10.1364/OE.18.010209
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Ovsianikov A, 2007, APPL SURF SCI, V253, P6599, DOI 10.1016/j.apsusc.2007.01.058
   Ovsianikov A, 2011, ACTA BIOMATER, V7, P967, DOI 10.1016/j.actbio.2010.10.023
   Ovsianikov A, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014104
   Ovsianikov A, 2007, J TISSUE ENG REGEN M, V1, P443, DOI 10.1002/term.57
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w
   Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158
   Raimondi M T, 2004, J Appl Biomater Biomech, V2, P55
   Raimondi Manuela Teresa, 2006, Curr Drug Discov Technol, V3, P245
   Raimondi MT, 2012, J APPL BIOM IN PRESS
   Sakellari I, 2012, ACS NANO, V6, P2302, DOI 10.1021/nn204454c
   Schade R, 2010, INT J ARTIF ORGANS, V33, P219
   Schizas C, 2010, INT J ADV MANUF TECH, V48, P435, DOI 10.1007/s00170-009-2320-4
   Schlie S, 2007, J BIOMATER APPL, V22, P275, DOI 10.1177/0885328207077590
   Sima LE, 2013, J TISSUE ENG REGEN M, V7, P129, DOI 10.1002/term.507
   Stankevicius E, 2011, PHYSCS PROC, V12, P82, DOI 10.1016/j.phpro.2011.03.109
   Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319
   Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008
   Weiss T, 2011, ADV ENG MATER, V13, pB264, DOI 10.1002/adem.201080090
   Weiss T, 2009, ENG LIFE SCI, V9, P384, DOI 10.1002/elsc.200900002
   Wu SH, 2006, J PHOTOCH PHOTOBIO A, V181, P1, DOI 10.1016/j.photochem.2006.03.004
   Zhang WD, 2011, MRS BULL, V36, P1028, DOI 10.1557/mrs.2011.275
   Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899
NR 54
TC 58
Z9 58
U1 0
U2 98
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2012
VL 10
IS 1
BP 56
EP 66
DI 10.5301/JABFM.2012.9278
PG 11
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 017JQ
UT WOS:000309586600009
PM 22562455
DA 2018-10-19
ER

PT S
AU Weng, L
   Stout, DA
   Webster, TJ
AF Weng, L.
   Stout, D. A.
   Webster, T. J.
GP IEEE
TI Nanophase Magnesium for Orthopedic Applications
SO 2012 38TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 38th Annual Northeast Bioengineering Conference (NEBEC)
CY MAR 16-18, 2012
CL Temple Univ, Philadelphia, PA
SP Natl Sci Fdn (NSF), Temple Univ, Coll Engn, Temple Univ, Off Senior Vice Provost Res & Grad Educ, Temple Univ, Dept Bioengn, ACS Synthet Biol, IEEE - EMBS, AIMBE, Spectrum Chem, IEEE
HO Temple Univ
AB Magnesium has gained interest as a biomaterial for orthopedic applications because of its biocompatibility, biodegradability, and positive effect on bone formation. Likewise, studies have shown nanophase material increase osteoblast (bone-forming cell) function compared to conventional materials, but the two have not been studied together. The purpose of this study was to determine if altering magnesium surface features into the nanometer scale promotes greater osteoblast functions. Nanorough magnesium surfaces were created by a novel treatment with sodium hydroxide at 1N, 5N, and 10N concentrations for 10, 20, and 30 minutes. Material characterization by scanning electron microscopy showed increased roughness on all treated samples compared to the control magnesium. Contact angle measurements indicated greater hydrophilicity on treated magnesium and no significant effect of ultraviolet sterilization on the surface energy of the material. Osteoblasts were seeded onto treated and untreated surfaces and adhesion at 4hrs were assessed through the MTT assay. Results indicated increased osteoblast adhesion on nano-treated samples compared to untreated samples. These findings support previous studies indicating the promise of magnesium as a biomaterial for orthopedic applications and suggest further experiments examining the long-term effects of nanophase magnesium on osteoblast proliferation and function.
C1 [Weng, L.; Stout, D. A.; Webster, T. J.] Brown Univ, Sch Engn, Providence, RI 02912 USA.
RP Weng, L (reprint author), Brown Univ, Sch Engn, 182 Hope St, Providence, RI 02912 USA.
OI Stout, David/0000-0001-6640-8234
CR Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010
   Creedon A, 1999, BRIT J NUTR, V82, P63, DOI 10.1017/S0007114599001130
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Washburn NR, BIOMATERIALS, V25, P1215
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4673-1142-7
J9 NORTHEAST BIOENGIN C
PY 2012
BP 229
EP 230
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BBY91
UT WOS:000309001200115
DA 2018-10-19
ER

PT B
AU Guo, JJ
   Lee, KM
AF Guo, Jiajie
   Lee, Kok-Meng
GP IEEE
TI A Three-Dimensional Curvature-based Beam Model for Measuring Mechanical
   Properties on an Automated Bone Testing System
SO 2012 IEEE/ASME INTERNATIONAL CONFERENCE ON ADVANCED INTELLIGENT
   MECHATRONICS (AIM)
LA English
DT Proceedings Paper
CT IEEE/ASME International Conference on Advanced Intelligent Mechatronics
   (AIM)
CY JUL 11-14, 2012
CL Kaohsiung, TAIWAN
SP I-Rice - NSC, IEEE, IES, IEEE Robot & Automat Soc, Bur Foreign Trade, RDMA TW, ASME, DSC
ID CONTINUUM ROBOTS; DEFORMATION; DYNAMICS
AB Mechanically handling of compliant bio-structures has been attracting growing attention due to the needs to automate processing of natural products. To understand the effect of bio-structural deformation on the blade location/force in poultry industry where high yield breast meats are harvested at production speed, biomaterial properties must be obtained before a nominal bio-structure model can be built for lumped parameter control of the process. This paper proposes a simple yet effective approach for obtaining the mechanical properties of biomaterials with a beam-like structure. A 3D curvature based beam model (CBM) with all its state variables described in global coordinates is developed for analyzing the large deformation of a compliant beam. The computationally efficient model without significantly scarifying accuracy has been verified numerically against a finite-element model. To illustrate its practicality, the CBM with cantilever constraints has been employed to analytically determine the nominal values of the elastic modulus and fracture strength from eight chicken-clavicle samples. While this paper is written in the context of wing manipulation for automatic de-boning process, the method can be used in other bioengineering applications involving flexible beam-like elements.
C1 [Guo, Jiajie] HUST, SKL DMET, Sch Mech Sci & Eng, Wuhan 430074, Hubei, Peoples R China.
   [Lee, Kok-Meng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Lee, KM (reprint author), Georgia Inst Tech, Woodruff Sch Mech Eng, Atlanta, GA 30332 USA.
EM kokmeng.lee@me.gatech.edu
RI Guo, Jiajie/B-7207-2013
OI Guo, Jiajie/0000-0002-7740-6792
FU Georgia Agriculture Technology Research Program; National Natural
   Science Foundation of China (NSFC) [51121002]
FX This work was partially supported by the Georgia Agriculture Technology
   Research Program, and the National Natural Science Foundation of China
   (NSFC) under Grant No. 51121002. Chicken front halves were provided by
   Tyson Foods, Inc. and experiments were performed at the GTRI Food
   Processing Building. The authors thank Xianmin Chen (Univ. of Sci. and
   Tech. of China) for technical help in setting up the linear motor and
   the economical Rapid Control Prototyping (eRCP and cSPACE) system.
CR [Anonymous], 1998, CONSUMER REPORTS, P12
   Boyer F, 2012, IEEE T ROBOT, V28, P303, DOI 10.1109/TRO.2011.2171616
   Daley W., 1999, ADV INT MECH IEEE AS, P49
   Dupont PE, 2010, IEEE T ROBOT, V26, P209, DOI 10.1109/TRO.2009.2035740
   Frisch-Fay R, 1962, FLEXIBLE BARS
   Guggenheimer H. W, 1977, DIFFERENTIAL GEOMETR
   Guo J., 2008, INT S FLEX AUT ISFA
   Guo JJ, 2011, IEEE ASME INT C ADV, P1081
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   KELLER HB, 1968, NUMERICAL METHODS 2
   Lee K.-M., 2008, INT S FLEX AUT ISFA
   Pai PF, 2011, INT J SOLIDS STRUCT, V48, P3075, DOI 10.1016/j.ijsolstr.2011.07.003
   Pai PF, 1996, INT J SOLIDS STRUCT, V33, P1335, DOI 10.1016/0020-7683(95)00090-9
   PAI PF, 1994, INT J SOLIDS STRUCT, V31, P1309, DOI 10.1016/0020-7683(94)90123-6
   Rucker DC, 2011, IEEE T ROBOT, V27, P1033, DOI 10.1109/TRO.2011.2160469
   Shabana AA, 2001, J MECH DESIGN, V123, P606, DOI 10.1115/1.1410100
   Stoer J, 1993, INTRO NUMERICAL ANAL
   Webster RJ, 2010, INT J ROBOT RES, V29, P1661, DOI 10.1177/0278364910368147
NR 18
TC 0
Z9 0
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-2576-9
PY 2012
BP 683
EP 688
PG 6
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Robotics
SC Automation & Control Systems; Engineering; Robotics
GA BBZ04
UT WOS:000309064200115
DA 2018-10-19
ER

PT S
AU Zhang, WB
   Liu, WC
   Gu, WM
   Chen, L
   Shen, YH
AF Zhang, Weibin
   Liu, Waiching
   Gu, Weiming
   Chen, Lei
   Shen, Yuhui
BE Zhang, HM
   Wu, B
TI Strontium Modification of Biomaterial: the Effective Approach to Enhance
   the Bioactivity and Biocompatibility of Calcium Silicate
SO CHEMICAL ENGINEERING AND MATERIAL PROPERTIES, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Symposium on Chemical Engineering and Materials Properties
   (ISCEMP 2011)
CY NOV 04-06, 2011
CL Shenyang, PEOPLES R CHINA
SP Shenyang Univ Technol, Harbin Univ Sci & Technol
DE Calcium silicate; Strontium; Bioactivity; Biocompatibility
ID CERAMICS; RANELATE
AB Calcium silicate (CS), the recent developed biodegradable ceramic, shows potential in stimulating bone regeneration. However, the rapid degradation restricts its further application, that is, the cytotoxicity is highly suspicious. In this study, the attempt with the addition of strontium by partially replacing the site of calcium shows appropriate, not only enhancing the bioactivity of CS, but also promoting its biocompatibility. Thus, the modification of biomaterial by strontium seems to be an effective approach for biological application.
C1 [Zhang, Weibin; Shen, Yuhui] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Orthopaed & Traumatol,Dept Orthopae, Shanghai, Peoples R China.
   [Liu, Waiching] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Gu, Weiming; Chen, Lei] Chinese Acad Sci, Shanghai Inst Ceram, Beijing 100864, Peoples R China.
RP Shen, YH (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Orthopaed & Traumatol,Dept Orthopae, Shanghai, Peoples R China.
EM weibin@medmail.com.cn; crisliu@hku.hk; gwm@mail.sic.ac.cn;
   chenlei@mail.sic.ac.cn; yuhuiss@163.com
OI Liu, Wai Ching/0000-0003-3816-6236
FU Science and Technology Commission of Shanghai Municipality [09JC1415500,
   08411950600]; Natural Science Foundation of China [30730034, 50732002]
FX This work was funded by grants from Science and Technology Commission of
   Shanghai Municipality (Grant No.: 09JC1415500 and 08411950600) and
   Natural Science Foundation of China (Grant No.: 30730034, 50732002).
CR Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Habermann B, 2010, CALCIFIED TISSUE INT, V86, P82, DOI 10.1007/s00223-009-9317-8
   Hamdy NAT, 2009, RHEUMATOLOGY, V48, pIV9, DOI 10.1093/rheumatology/kep274
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Li ZY, 2009, J ORTHOP RES, V27, P758, DOI 10.1002/jor.20818
   Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105
   Reginster JY, 2009, BONE, V45, pS131, DOI 10.1016/j.bone.2009.07.042
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xue WC, 2009, ACTA BIOMATER, V5, P1686, DOI 10.1016/j.actbio.2009.01.012
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
NR 11
TC 2
Z9 2
U1 1
U2 14
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-333-7
J9 ADV MATER RES-SWITZ
PY 2012
VL 391-392
BP 195
EP +
DI 10.4028/www.scientific.net/AMR.391-392.195
PN 1-2
PG 3
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BBZ08
UT WOS:000309082700041
DA 2018-10-19
ER

PT S
AU Wang, GQ
   Niu, LP
AF Wang, Guo Qing
   Niu, Li Ping
BE Zhang, HM
   Wu, B
TI HAP/UHMWPE-coated Titanium Preparation of Biological Materials
SO CHEMICAL ENGINEERING AND MATERIAL PROPERTIES, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Symposium on Chemical Engineering and Materials Properties
   (ISCEMP 2011)
CY NOV 04-06, 2011
CL Shenyang, PEOPLES R CHINA
SP Shenyang Univ Technol, Harbin Univ Sci & Technol
DE Hydroxyapatite; Ti; Etch; Dipping; Biomaterial
ID HYDROXYAPATITE COATINGS; STRENGTH; PARTICLES; COMPOSITE
AB Hydroxyapatite (HAP) is known as a kind of bioactive and biocompatible material, HAP coatings are used to improve the biocompatibility of substrate by some researchers. In this paper, homogenous precipitation of hydroxyapatite was formed in the system of CaNa(2)EDTA -(NH4)(2)HPO4-NH4OH-H2O, and HAP powder was obtained after calcinations at 800 degrees C and grinding. Add HAP in UHMWPE o-xylene solution to get dipping solution and prepare HAP/UHMWPE-coated titanium by dipping coating process. Scratch test demonstrated that Ti-HAP/UHMWPE material started to shine metallic luster under 1.03 N, and adhesive strength is 32MPa. UHMWPE not only simplified the process of preparing HAP-coated material, but also enhanced the adhesive strength, which shows great potential in biomedical areas.
C1 [Wang, Guo Qing] Northeastern Univ, Coll Sci, Shenyang 110004, Peoples R China.
   [Niu, Li Ping] Northeastern Univ, Sch Met & Mat, Shenyang 110004, Peoples R China.
RP Wang, GQ (reprint author), Northeastern Univ, Coll Sci, Shenyang 110004, Peoples R China.
EM wgq20082003@yahoo.com.cn
CR Fang LM, 2007, COMPOS PART B-ENG, V38, P345, DOI 10.1016/j.compositesb.2006.05.004
   Guipont V, 2002, MAT SCI ENG A-STRUCT, V325, P9, DOI 10.1016/S0921-5093(01)01414-9
   Letic-Gavrilovic A, 2003, J MATER SCI-MATER M, V14, P95, DOI 10.1023/A:1022099208535
   Li TT, 1996, J MATER SCI-MATER M, V7, P355, DOI 10.1007/BF00154548
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   SADA E, 1991, CHEM ENG COMMUN, V103, P57, DOI 10.1080/00986449108910862
   Shi W, 2002, MAT SCI ENG A-STRUCT, V337, P104, DOI 10.1016/S0921-5093(02)00003-5
   Takeo H., 1987, J CERAM SOC JPN, V95, P8255
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   YOSHIO M, 1990, J CERAM SOC JPN, V98, P1255
NR 12
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-333-7
J9 ADV MATER RES-SWITZ
PY 2012
VL 391-392
BP 625
EP +
DI 10.4028/www.scientific.net/AMR.391-392.625
PN 1-2
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BBZ08
UT WOS:000309082700128
DA 2018-10-19
ER

PT J
AU Zhong, X
   Dehghani, F
AF Zhong, Xia
   Dehghani, Fariba
TI Fabrication of biomimetic poly(propylene carbonate) scaffolds by using
   carbon dioxide as a solvent, monomer and foaming agent
SO GREEN CHEMISTRY
LA English
DT Article
ID PORE-SIZE; PROPYLENE-OXIDE; IN-VITRO; CELLS; CO2; COPOLYMERIZATION;
   FIBROBLASTS; GENERATION; SURFACE
AB The aim of this study was to develop an environmentally friendly process for the fabrication of three dimensional (3D) biomimetic scaffolds from biodegradable poly(propylene carbonate) (PPC). Prior to production of scaffolds, PPC was synthesized using a one-pot process in which the zinc glutarate catalyst was first fabricated in a supercritical CO2 system. The scaffolds were then prepared by gas foaming/salt leaching followed by aminolysis and layer-by-layer (LBL) gelatin assembly on the surface. The pore size and interconnectivity were controlled by the variation of gas foaming process parameters such as temperature, CO2 pressure, depressurization rate and particle size of salt (NaCl). The pore size was within the range of 116 + 53 to 418 + 84 mu m and the porosity was between 69.8 and 92.3%. The results of micro-CT scan analysis demonstrated that porosity and pore interconnectivity were enhanced by increasing the pore size. However, the compressive modulus of hydrated scaffolds was decreased from 380 +/- 90 to 200 +/- 50 kPa, when the pore size was increased from 232 +/- 91 to 411 +/- 108 mu m. The results of fluorescence microscopy demonstrated that gelatin was uniformly deposited on the 3D scaffolds. Surface modification of hydrophobic PPC scaffolds substantially increased the fibroblast cells attachment, penetration, and proliferation. The results of this study demonstrated the feasibility of eliminating toxic organic solvents in the synthesis of a solid based catalyst and processing PPC polymer into tissue scaffolds. The clean technology developed will be of great value for large scale production of biodegradable PPC that can be used for many purposes such as packaging products and plastic bags. In addition, it was shown that PPC can be considered as an alternative biomaterial for tissue engineering applications.
C1 [Zhong, Xia; Dehghani, Fariba] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia.
RP Zhong, X (reprint author), Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia.
EM fariba.dehghani@sydney.edu.au
OI Dehghani, Fariba/0000-0002-7805-8101
FU Australian Research Council; University of Sydney
FX The authors acknowledge financial support from the Australian Research
   Council, the technical support of Ms Elizabeth Dobrinsky and Miss Narges
   B. Khabbaz. Ms Xia Zhong also acknowledges the University of Sydney for
   sponsoring her research scholarship.
CR Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Annabi N, 2011, J SUPERCRIT FLUID, V59, P157, DOI 10.1016/j.supflu.2011.06.010
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   Arora KA, 1998, MACROMOLECULES, V31, P4614, DOI 10.1021/ma971811z
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Collins NJ, 2010, ACTA BIOMATER, V6, P1055, DOI 10.1016/j.actbio.2009.08.013
   Dehghani F, 2011, CURR OPIN BIOTECH, V22, P661, DOI 10.1016/j.copbio.2011.04.005
   Ellis JL, 2008, BIOMACROMOLECULES, V9, P1027, DOI 10.1021/bm701343m
   Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   GOEL SK, 1994, POLYM ENG SCI, V34, P1137, DOI 10.1002/pen.760341407
   GOEL SK, 1994, POLYM ENG SCI, V34, P1148, DOI 10.1002/pen.760341408
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hwang Y, 2006, CATAL TODAY, V115, P288, DOI 10.1016/j.cattod.2006.02.061
   INOUE S, 1969, J POLYM SCI POL LETT, V7, P287, DOI 10.1002/pol.1969.110070408
   Ji CD, 2011, ACTA BIOMATER, V7, P1653, DOI 10.1016/j.actbio.2010.11.043
   Kazarian S. G., 2000, POLYM SCI SER C, V42, P78, DOI DOI 10.1080/03602549909351647
   Kemmere M. F., 2005, POLYM REACT ENG, P1
   Kokubo T., 1999, INTRO BIOCERAMICS, P75
   Lee PC, 2006, J APPL POLYM SCI, V102, P3376, DOI 10.1002/app.24868
   Lee SY, 2012, GREEN CHEM, V14, P1357, DOI 10.1039/c2gc35074b
   Lian ZY, 2006, J SUPERCRIT FLUID, V39, P107, DOI 10.1016/j.supflu.2006.02.001
   Luinstra GA, 2008, POLYM REV, V48, P192, DOI 10.1080/15583720701834240
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Salerno A, 2008, MACROMOL BIOSCI, V8, P655, DOI 10.1002/mabi.200700278
   Srokowski EM, 2008, J BIOMAT SCI-POLYM E, V19, P785, DOI 10.1163/156856208784522038
   Stafford CM, 1999, MACROMOLECULES, V32, P7610, DOI 10.1021/ma9902100
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Tsivintzelis I, 2007, J SUPERCRIT FLUID, V42, P265, DOI 10.1016/j.supflu.2007.02.009
   Wan Y, 2008, POLYM DEGRAD STABIL, V93, P1736, DOI 10.1016/j.polymdegradstab.2008.08.001
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Zhang J, 2006, ARTIF ORGANS, V30, P898, DOI 10.1111/j.1525-1594.2006.00322.x
   Zhong X, 2012, COLLOID SURFACE B, V93, P75, DOI 10.1016/j.colsurfb.2011.12.016
   Zhong X, 2011, J MATER SCI-MATER M, V22, P279, DOI 10.1007/s10856-010-4194-2
   Zhong X, 2010, APPL CATAL B-ENVIRON, V98, P101, DOI 10.1016/j.apcatb.2010.05.017
NR 41
TC 19
Z9 19
U1 5
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
J9 GREEN CHEM
JI Green Chem.
PY 2012
VL 14
IS 9
BP 2523
EP 2533
DI 10.1039/c2gc35608b
PG 11
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 992NT
UT WOS:000307785100024
DA 2018-10-19
ER

PT J
AU Nakai, M
   Niinomi, M
   Hieda, J
   Shibata, T
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Hieda, Junko
   Shibata, Toshiya
TI Microstructures and Mechanical Properties of Ternary Ti-10Cr-(V, Fe, Mo)
   Alloys with Self-tunable Young's Moduli for Biomedical Applications
SO ISIJ INTERNATIONAL
LA English
DT Article
DE beta-type titanium alloy; biomaterial; Young's modulus;
   deformation-induced omega phase transformation
ID SPINAL FIXATION APPLICATIONS; TI-CR ALLOYS; RETAINED BETA-PHASE;
   DEFORMATION-BEHAVIOR; TITANIUM-ALLOYS; HIGH-STRENGTH; OMEGA-PHASE;
   SUPERELASTICITY; PRODUCTS; BONE
AB Ternary beta-type Ti-10Cr-(V, Fe, Mo) alloys with self-tunable Young's moduli were subjected to solution treatment and cold rolling, and their microstructures and mechanical properties were investigated. During cold rolling, a band-like structure, which is considered to be {332},(beta)< 113 >(beta) mechanical twin, and deformation-induced omega phase are formed in alloys with certain chemical compositions. The number of bands increases with an increase in the cold-rolling reduction ratio and V content as well as with a decrease in Mo content. On the other land, the Young's modulus increases during cold rolling, and the increase in Young's modulus is considered to be caused by the deformation-induced omega phase transformation. Furthermore, the tensile strength decreases slightly and the elongation tends to increase with an increase in the alloying element contents, while the effect of the V and Mo contents on the trend in changing the number of mechanical twin is opposite. These tensile properties are derived from the complicated factors among the plastic deformation mode, the type of mechanical twinning, and deformation-induced omega phase transformation, depending on the beta stability and the kind of alloying element.
C1 [Nakai, Masaaki; Niinomi, Mitsuo; Hieda, Junko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Shibata, Toshiya] Tohoku Univ, Dept Mat Sci, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM nakai@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009
FU Iron & Steel Institute of Japan (ISIJ); Ministry of Education, Culture,
   Sports, Science and Technology (MEXT); New Energy and Industrial
   Technology Development Organization (NEDO)
FX This study was supported in part by the ISIJ Research Promotion Grant
   from the Iron & Steel Institute of Japan (ISIJ); the Global COE Program
   "Materials Integration International Center of Education and Research,
   Tohoku University" from the Ministry of Education, Culture, Sports,
   Science and Technology (MEXT); and the Industrial Technology Research
   Grant Program in 2009 from the New Energy and Industrial Technology
   Development Organization (NEDO).
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   HANADA S, 1986, J MATER SCI, V21, P4131, DOI 10.1007/BF01106518
   HANADA S, 1987, METALL TRANS A, V18, P265, DOI 10.1007/BF02646160
   HANADA S, 1986, J MATER SCI, V21, P866, DOI 10.1007/BF01117366
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Ho WF, 2009, J ALLOY COMPD, V468, P533, DOI 10.1016/j.jallcom.2008.01.046
   Inamura T, 2005, MATER TRANS, V46, P1597, DOI 10.2320/matertrans.46.1597
   Koike M, 2005, J MATER ENG PERFORM, V14, P778, DOI 10.1361/105994905X75600
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lin DJ, 2002, MATER CHEM PHYS, V76, P191, DOI 10.1016/S0254-0584(01)00511-9
   Mantani Y, 2000, J JPN I MET, V64, P934, DOI 10.2320/jinstmet1952.64.10_934
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Matsumoto H, 2007, MAT SCI ENG A-STRUCT, V448, P39, DOI 10.1016/j.msea.2006.11.022
   Nakai M, 2010, MAT JPN, V49, P437
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   PARIS HG, 1976, METALL TRANS A, V7, P273, DOI 10.1007/BF02644467
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Steib JP, 2004, SPINE, V29, P193, DOI 10.1097/01.BRS.0000107233.99835.A4
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Talling RJ, 2009, ACTA MATER, V57, P1188, DOI 10.1016/j.actamat.2008.11.013
   WOOD RM, 1963, ACTA METALL MATER, V11, P907, DOI 10.1016/0001-6160(63)90060-9
   Xing H., 2008, APPL PHYS LETT, V93
   Yang Y., 2009, APPL PHYS LETT, V94
   Zhao XL, 2011, J MECH BEHAV BIOMED, V4, P2009, DOI 10.1016/j.jmbbm.2011.06.020
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhao XL, 2011, ACTA BIOMATER, V7, P3230, DOI 10.1016/j.actbio.2011.04.019
   Zhao XF, 2012, ACTA BIOMATER, V8, P2392, DOI 10.1016/j.actbio.2012.02.010
   Zhao XF, 2012, ACTA BIOMATER, V8, P1990, DOI 10.1016/j.actbio.2012.02.004
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 32
TC 1
Z9 1
U1 1
U2 14
PU IRON STEEL INST JAPAN KEIDANREN KAIKAN
PI TOKYO
PA NIIKURA BLDG 2F, 2 KANDA-TSUKASACHO 2-CHOME, TOKYO, CHIYODA-KU 101-0048,
   JAPAN
SN 0915-1559
J9 ISIJ INT
JI ISIJ Int.
PY 2012
VL 52
IS 9
BP 1655
EP 1660
DI 10.2355/isijinternational.52.1655
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 013HZ
UT WOS:000309297800020
OA Bronze
DA 2018-10-19
ER

PT S
AU Ou, J
   Jiang, YM
   Zhang, ZH
AF Ou, Jun
   Jiang, Yumin
   Zhang, Zhanhe
BE Wang, D
TI Preparation and Characterization of Nano-beta-tricalcium Phosphate/silk
   Fibroin Scaffold for Tissue Engineering Applications
SO MATERIALS FOR ENVIRONMENTAL PROTECTION AND ENERGY APPLICATION, PTS 1 AND
   2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Materials for Environmental Protection and
   Energy Application (MEPEA)
CY SEP 27-28, 2011
CL Kuala Lumpur, MALAYSIA
DE Tissue engineering; Scaffold; beta-Tricalcium Phosphate; Silk Fibroin
ID BONE; ADHESION; CELLS
AB Silk fibroin (SF) and P-tricalcium phosphate (beta-TCP) had been used in biomedical applications for these years. The potential of silk and beta-TCP for application in tissue engineering is currently being explored. The purpose of this study was to prepare and characterize a 3D scaffold consisting of nano-beta-TCP/SF composite.
   XRD and FT-IR analysis showed that predominant crystalline phase of calcium phosphate was beta-TCP; a chelate effect between SF and Ca2+ was happened at complexing period of SF and beta-TCP. The compressive strength of nano-beta-TCP/SF composite was 42 MPa +/- 0.12 MPa. In vitro cell cultivation experiment showed that the composite was a good matrix for the growth of osteoblasts. Conclusion: the incorporation of SF into nano-beta-TCP can enhance both mechanical strength and bioactivity of the scaffold, which suggests that the beta-TCP/SF composite may be a potential biomaterial for tissue engineering.
C1 [Ou, Jun; Jiang, Yumin] Guilin Univ Technol, Dept Mat & Chem Eng, Guilin 541004, Peoples R China.
   [Zhang, Zhanhe] The Second Peoples Hosp Guilin, Dept Orthopaed, Guilin 541001, Peoples R China.
RP Ou, J (reprint author), Guilin Univ Technol, Dept Mat & Chem Eng, Guilin 541004, Peoples R China.
EM gloujun123@gmail.com; jiangyumin2@yahoo.cn; zzh941115@yahoo.com.cn
FU Guangxi Natural Science Foundation [0832021]
FX The authors gratefully acknowledge the financial support by the Fund for
   Guangxi Natural Science Foundation (0832021).
CR Bin X., 2006, J INORGANIC MAT, V2, P427
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Gil ES, 2007, MAT SCI ENG C-BIO S, V27, P426, DOI 10.1016/j.msec.2006.05.017
   Nourmohammadi J, 2008, J MATER SCI-MATER M, V19, P3507, DOI 10.1007/s10856-008-3501-7
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Wang G, 2010, J BONE JOINT SURG BR, V92B, P320, DOI 10.1302/0301-620X.92B2.22602
   Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150
   Yang H., 2007, FUHE CAILIAO XUEBAO, V24, P141
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 10
TC 0
Z9 0
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-256-9
J9 ADV MATER RES-SWITZ
PY 2012
VL 343-344
BP 882
EP +
DI 10.4028/www.scientific.net/AMR.343-344.882
PN 1-2
PG 2
WC Energy & Fuels; Engineering, Biomedical; Materials Science,
   Multidisciplinary
SC Energy & Fuels; Engineering; Materials Science
GA BCA22
UT WOS:000309383700146
DA 2018-10-19
ER

PT S
AU Sun, JY
   Wang, YM
   Chen, DH
   Tong, J
   Pan, CX
AF Sun, Jiyu
   Wang, Yueming
   Chen, Donghui
   Tong, Jin
   Pan, Chunxiang
BE Wang, D
TI Differential Constitutive Equation of Elytra Cuticle by Nanoindentation
SO MATERIALS FOR ENVIRONMENTAL PROTECTION AND ENERGY APPLICATION, PTS 1 AND
   2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Materials for Environmental Protection and
   Energy Application (MEPEA)
CY SEP 27-28, 2011
CL Kuala Lumpur, MALAYSIA
DE Nanoindentation; viscoelastic properties; biomaterial
ID MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES; BIOLOGICAL-MATERIALS;
   MODEL; BEHAVIOR; INDENTATION; TIME; LIGAMENTS; BONE
AB Due to size limits in the transverse direction, tensile testing is not appropriate to investigate the mechanical properties of elytra cuticle of the dung beetle (Copris ochus Motschulsky). However, nanoindentation testing can determine a material's anisotropic properties through a single indentation. En the present study, nanoindentation stress strain curves were used to characterize the complete mechanical behavior of dung beetle elytra cuticle. A differential constitutive equation has been developed with time-dependent spring constants k and viscosities To describe the complex viscoelastic behavior of dung beetle cuticle, a descriptive representation of the linear viscoelasticity law for the multilayer matrix has been formulated. A qualitative model for the relationship between cuticle structure and mechanical properties of elytra may help develop bionic composite materials for micro-aircraft, bionic tribology, bionic medical apparatus, and bionic organs (tissue engineering).
C1 [Sun, Jiyu; Wang, Yueming; Chen, Donghui; Tong, Jin] Jilin Univ, Key Lab Bion Engn, Minist Educ, Renmin St 5988, Changchun 130023, Peoples R China.
   [Pan, Chunxiang] Aviat Univ Air Force, Changchun, Peoples R China.
RP Sun, JY (reprint author), Jilin Univ, Key Lab Bion Engn, Minist Educ, Renmin St 5988, Changchun 130023, Peoples R China.
EM sjy@jlu.edu.cn
FU National Natural Science Foundation of China [30600131]; Science &
   Technology Development Projects of Jilin Province [20090147, 20090711];
   Basic Operation Foundation of Jilin University [200903271]; National
   Hi-tech Project (863 Project) [2009AA043604-2]; of Jilin University
FX *This work was supported by National Natural Science Foundation of China
   (grant no.30600131), by the Science & Technology Development Projects of
   Jilin Province (grant no.20090147, 20090711), by the Basic Operation
   Foundation of Jilin University (grant no.200903271), the National
   Hi-tech Project (863 Project) (grant no.2009AA043604-2) and by Project
   985 of Jilin University.
CR Ahearne M, 2007, ANN BIOMED ENG, V35, P1608, DOI 10.1007/s10439-007-9323-9
   Bembey AK, 2006, PHILOS MAG, V86, P5691, DOI 10.1080/14786430600660864
   Bergstrom JS, 2000, MECH MATER, V32, P627, DOI 10.1016/S0167-6636(00)00028-4
   Ehlers W, 2001, J BIOMECH ENG-T ASME, V123, P418, DOI 10.1115/1.1388292
   Fung YC, 1993, BIOMECHANICS MECH PR
   Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623
   Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135
   Holzapfel GA, 2002, EUR J MECH A-SOLID, V21, P441, DOI 10.1016/S0997-7538(01)01206-2
   Garcia JJ, 2006, J BIOMECH, V39, P2991, DOI 10.1016/j.jbiomech.2005.10.017
   Jeffrey E., 2006, ANN BIOMED ENG, V34, P1164
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Martinez E, 2003, APPL PHYS A-MATER, V77, P419, DOI 10.1007/s00339-002-1669-0
   Menig R, 2001, MAT SCI ENG A-STRUCT, V297, P203, DOI 10.1016/S0921-5093(00)01228-4
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Sun J.Y., 2007, P SPIE INT SOC OPTIC, V6831
   Sverdlik A, 2002, J BIOMECH ENG-T ASME, V124, P78, DOI 10.1115/1.1427699
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Vena P, 2006, J BIOMECH ENG-T ASME, V128, P449, DOI 10.1115/1.2187046
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Wu XY, 2006, BIOMATERIALS, V27, P5315, DOI 10.1016/j.biomaterials.2006.06.003
NR 21
TC 2
Z9 2
U1 0
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-256-9
J9 ADV MATER RES-SWITZ
PY 2012
VL 343-344
BP 1133
EP +
DI 10.4028/www.scientific.net/AMR.343-344.1133
PN 1-2
PG 3
WC Energy & Fuels; Engineering, Biomedical; Materials Science,
   Multidisciplinary
SC Energy & Fuels; Engineering; Materials Science
GA BCA22
UT WOS:000309383700185
DA 2018-10-19
ER

PT J
AU Mosneag, MG
AF Mosneag, Mihaela Gabriela
TI RESEARCHES REGARDING TECHNOLOGY TO CREATE THIN BIOCOMPATIBLE LAYERS
   BASED ON TiO2
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE biocompatibility; biomaterial
AB the term biomaterial will refer to implants for the replacement and restoration of live cells and their functions. Biomaterials include any type of material that is continuously or intermittently exposed to the fluids in the human body, although in some cases it may be located outside the human body. The suposficial heat treatment technologies focus on structural and/or composition modification on a controllable depth and have the effect of creating a film on the surface of the piece that has different properties than that in the core of the piec.
C1 Transilvania Univ Brasov, Brasov, Romania.
RP Mosneag, MG (reprint author), Transilvania Univ Brasov, Brasov, Romania.
FU Sectoral Operational Programme Human Resources Development (SOP HRD);
   European Social Fund; Romanian Government [POSDRU/88/1.5/S/59321]
FX This paper is supported by the Sectoral Operational Programme Human
   Resources Development (SOP HRD), financed from the European Social Fund
   and by the Romanian Government under the contract number
   POSDRU/88/1.5/S/59321
CR Aloman A., 2001, STUDY TITANIUM
   [Anonymous], 583221993 ISO
   Nica P, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/65001
NR 3
TC 0
Z9 0
U1 0
U2 1
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2012
VL 17
IS 12
BP 29
EP 30
PG 2
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 011DS
UT WOS:000309145500007
DA 2018-10-19
ER

PT J
AU Farahpour, MR
   Sharifi, D
   Gader, AAB
   Veshkini, A
   Soheil, A
AF Farahpour, M. R.
   Sharifi, D.
   Gader, A. A. B.
   Veshkini, A.
   Soheil, A.
TI Radiological evaluation of the effect of biphasic calcium phosphate
   scaffold (HA+TCP) with 5, 10 and 20 percentage of porosity on healing of
   segmental bone defect in rabbit radius
SO BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
LA English
DT Article
DE radiology; HA plus TCP; scaffold; bone healing; rabbit
ID BETA-TRICALCIUM PHOSPHATE; SUBSTITUTE; MATRIX; REPAIR; IMPLANTATION;
   COMPLEX; CEMENT; GRAFT
AB The objective of this study is to radiologically evaluate the effects of biphasic calcium phosphate scaffold with 5, 10 and 20 percentage of porosity on cortical bone repair in rabbits. In this study, 28 male white rabbits were examined. Rabbits were divided into four groups. After induction of general anesthesia, a segmental bone defect of 10 mm in length was created in the middle of the right radius shaft. In group A, the defect was stabilized with miniplate and 2 screws and left untreated. In groups B, C and D tricalcium phosphate scaffold mixed with hydroxyapatite (TCP+HA) with 5%, 10% and 20% porosity was used to fill the bone defect. Bone regeneration and HA+TCP scaffold resorption were assessed by X-ray at 1, 2 and 3 months after the surgery. In group A, 3 months after surgery, periosteal callus was not found but intercortical callus was observed. In groups B and C, 3 months after surgery medullary bridging callus and intercortical callus were found, periosteal callus was not found, TCP+HA scaffold were observed. In group D, 2 months after the surgery, medullary bridging callus and intercortical callus were found, 3 months later, periosteal callus was not found, most of scaffold had disappeared and were unclear and partial bone formation was recognized. Differences observed in radiological findings were significant between group A and groups B, C, D. Differences between groups B and C were not significant, but between group D and groups B and C were significant. The results of this study showed that TCP+HA scaffold is an osteoconductive and osteoinductive biomaterial. Scaffold of TCP+HA can increase the amount of newly formed bone and more rapid regeneration of bone defects. These results suggest TCP+HA scaffold may considerably be used in the treatment of cortical bone defect and other orthopaedic defects PCL (Tab. 2, Fig. 4, Ref. 20). Full Text in PDF www.elis.sk.
C1 [Farahpour, M. R.] Islamic Azad Univ Uromia Branch, Fac Vet Med, Dept Clin Sci, Uromia, Iran.
   [Sharifi, D.; Veshkini, A.] Univ Tehran, Fac Vet Med, Dept Clin Sci, Tehran, Iran.
   [Gader, A. A. B.; Soheil, A.] Islamic Azad Univ Sci & Res Branch, Fac Specialized Vet Med, Dept Radiol, Tehran, Iran.
RP Farahpour, MR (reprint author), Islamic Azad Univ Uromia Branch, Fac Vet Med, Dept Clin Sci, Uromia, Iran.
EM mrf78s@gmail.com
RI Farahpour, Mohammad Reza/C-5143-2017
OI Farahpour, Mohammad Reza/0000-0001-8631-071X
CR BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   BLOCK JE, 1995, MED HYPOTHESES, V45, P27, DOI 10.1016/0306-9877(95)90195-7
   Chazono M, J BIOMED MAT RES, V70, P542
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Daculsi G, 2006, KEY ENG MAT, V309-311, P1379, DOI 10.4028/www.scientific.net/KEM.309-311.1379
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Menon K V, 2005, EUR J ORTHOP SURG TR, V15, P205, DOI DOI 10.1007/S00590-005-0238-6
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   Ozturk A, 2006, INT ORTHOP, V30, P147, DOI 10.1007/s00264-006-0079-x
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Sharifi D, IRAN J VET IN PRESS
   Turner T. M., 2003, ORTHOPEDICS, V26, P577
   Weissman JL, 1996, AM J NEURORADIOL, V17, P1569
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 20
TC 3
Z9 3
U1 0
U2 7
PU COMENIUS UNIV
PI BRATISLAVA I
PA SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIA
SN 0006-9248
J9 BRATISL MED J
JI Bratisl. Med. J.
PY 2012
VL 113
IS 9
BP 529
EP 533
DI 10.4149/BLL_2012_119
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 011WV
UT WOS:000309197900003
PM 22979907
OA Bronze
DA 2018-10-19
ER

PT J
AU Gandhi, S
   Sethuraman, S
   Krishnan, UM
AF Gandhi, Sakthivel
   Sethuraman, Swaminathan
   Krishnan, Uma Maheswari
TI Synthesis, characterization and biocompatibility evaluation of iron
   oxide incorporated magnetic mesoporous silica
SO DALTON TRANSACTIONS
LA English
DT Article
ID PHYSICOCHEMICAL CHARACTERISTICS; MULTIFUNCTIONAL NANOPARTICLES;
   DRUG-DELIVERY; STEM-CELL; PARTICLES; HYPERTHERMIA; THERAPY; AGENTS;
   TUMORS; FIELD
AB On the basis of a thermal process, a facile, low cost, one-step approach for preparing iron oxide (Fe2O3) incorporated ordered magnetic mesoporous silica nanocomposites by a co-operative self-assembly approach is presented. Various mesostructured silica materials incorporated with different amounts of iron oxide (nSi/nFe = 1/1, 1/0.5, 1/0.25 and 1/0.123) at various pH (<1, 3, 5 and 7) were synthesized and characterized by electron microscopy and X-ray diffractometry. Further, the surface area and magnetic properties were evaluated using N-2-sorption analyses, and a superconducting quantum interference device interfaced with a vibrating sample magnetometer (SQUID-VSM) respectively. The transmission electron micrographs and nitrogen sorption analysis indicated that most of the Fe2O3 domains of several nanometers were embedded in the silica walls, rather than dispersed in the mesopores. The incorporation of iron oxide into the mesopores without compromising the structural and textural properties was achieved at pH < 1. These structures have great potential in diagnostics and therapeutics. However, the acceptance of this material by the biological host is a critical issue for such biomedical applications. In this study, we have also evaluated the in vivo biocompatibility of these magnetic mesoporous materials in a rat model. The histopathological results show that this magnetic material can be classified as a level 2 biomaterial that can be safely used for short term applications such as MRI imaging, hyperthermia, targeted drug delivery, etc.
C1 [Gandhi, Sakthivel; Sethuraman, Swaminathan; Krishnan, Uma Maheswari] SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat, Thanjavur 613401, India.
RP Krishnan, UM (reprint author), SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat, Thanjavur 613401, India.
EM umakrishnan@sastra.edu
OI Gandhi, Sakthivel/0000-0002-6867-1447
FU PG Teaching Programme [SR/NM/PG-16/2007]; Nano Mission Council; DST;
   SASTRA University
FX The authors wish to acknowledge PG Teaching Programme
   (SR/NM/PG-16/2007), Nano Mission Council, DST and SASTRA University for
   infrastructural and financial support.
CR Alam S, 2011, CHEM-ASIAN J, V6, P834, DOI 10.1002/asia.201000456
   Alam S, 2009, ANGEW CHEM INT EDIT, V48, P7358, DOI 10.1002/anie.200901570
   Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4
   Berry CC, 2005, J MATER CHEM, V15, P543, DOI 10.1039/b409715g
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Carturan G, 2004, J MATER CHEM, V14, P2087, DOI 10.1039/b401450b
   CATHERINE CB, 2003, J PHYS D, V36, pR198
   Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050
   Fenoglio I, 2011, ADV DRUG DELIVER REV, V63, P1186, DOI 10.1016/j.addr.2011.08.001
   Garcia C, 2003, ANGEW CHEM INT EDIT, V42, P1526, DOI 10.1002/anie.200250618
   Hafeli U. O., 2007, J MAGN CELL SEPARATI, V32, P163
   Hess DM, 2009, CHEM MATER, V21, P2125, DOI 10.1021/cm802748j
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   Joshi HM, 2009, J PHYS CHEM C, V113, P17761, DOI 10.1021/jp905776g
   Kim KJ, 2000, THIN SOLID FILMS, V360, P118, DOI 10.1016/S0040-6090(99)00562-3
   Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008
   Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d
   Li BS, 2012, J COLLOID INTERF SCI, V366, P114, DOI 10.1016/j.jcis.2011.09.055
   Li JS, 2008, J MEMBRANE SCI, V312, P186, DOI 10.1016/j.memsci.2007.12.055
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Lu CW, 2007, NANO LETT, V7, P149, DOI 10.1021/nl0624263
   Ma ZY, 2007, CHINA PART, V5, P1, DOI 10.1016/j.cpart.2006.11.001
   Matsumine A, 2007, CLIN EXP METASTAS, V24, P191, DOI 10.1007/s10585-007-9068-8
   Monte FD, 1997, LANGMUIR, V13, P3627
   Pereira C, 2010, DALTON T, V39, P2842, DOI 10.1039/b920853d
   Sethuraman S, 2006, J BIOMED MATER RES A, V77A, P679, DOI 10.1002/jbm.a.30620
   Tan EL, 2008, SENSORS-BASEL, V8, P6396, DOI 10.3390/s8106396
   Walling MA, 2009, INT J MOL SCI, V10, P441, DOI 10.3390/ijms10020441
   Wandelt K, 1982, SURF SCI REP, V2, P1, DOI 10.1016/0167-5729(82)90003-6
   Wang CT, 2006, J NON-CRYST SOLIDS, V352, P35, DOI 10.1016/j.jnoncrysol.2005.11.018
   Wang P, 2009, T NONFERR METAL SOC, V19, pS605, DOI 10.1016/S1003-6326(10)60117-3
   Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908
   Ward MD, 1999, CURR OPIN SOLID ST M, V4, P581, DOI 10.1016/S1359-0286(00)00013-9
   Xie J, 2012, THERANOSTICS, V2, P122, DOI 10.7150/thno.4051
   Yiu HHP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255606
   Yiu HHP, 2010, IEEE T NANOBIOSCI, V9, P165, DOI 10.1109/TNB.2010.2053770
   Yiu HHP, 2010, J BIOMED MATER RES A, V92A, P386, DOI 10.1002/jbm.a.32363
   Yoon TJ, 2005, ANGEW CHEM INT EDIT, V44, P1068, DOI 10.1002/anie.200461910
   You CC, 2007, NANO TODAY, V2, P34, DOI 10.1016/S1748-0132(07)70085-3
NR 39
TC 11
Z9 11
U1 0
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-9226
J9 DALTON T
JI Dalton Trans.
PY 2012
VL 41
IS 40
BP 12530
EP 12537
DI 10.1039/c2dt30853c
PG 8
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 011CR
UT WOS:000309141500024
PM 22955063
DA 2018-10-19
ER

PT J
AU Akhtar, S
   Shoaib, A
AF Akhtar, S.
   Shoaib, A.
TI BIOSORPTION, SOLUTION TO AS (V) POLLUTION
SO JOURNAL OF ANIMAL AND PLANT SCIENCES
LA English
DT Article
DE Metal; Arsenate; Adsorption; Agricultural waste
ID TRANSFORM INFRARED-SPECTROSCOPY; HEAVY-METALS; IR SPECTROSCOPY; REMOVAL;
   ADSORPTION
AB The study was focused on exploring role of six agricultural wastes viz., wheat (Triticum aestivum L.) and rice (Oryza sativa L.) husk, pea (Pisum sativum L.), peanut (Arachis hypogaea L.), and banana (Musa acuminata L.) peels and sohanjana (Moringa oleifera Lam.) leaves for adsorption of As (V) from aqueous solution. Batch experiments were performed by taking 0.1 g of oven dried biomass of biosorbent in 250 mL flask containing 100 mL of 1 mg L-1 of As(V) solution at 150 rpm for 1 hour. The experiment was laid out as a completely randomized design with three replicates. Results indicates that all six adsorbents hold significantly greater adsorption capacity (0.99 mg g(-1)) and efficiency (99%) for capturing As(V) from the aqueous solution. Fourier Transformed Infrared Spectroscopy (FTIR) study revealed the involvement of carbohydrates and proteins groups like hydroxyl, amine, amide and carbonyl in metal sequestration. Adsorption based experiments summarized that agricultural wastes are potential easily available low-cost biomaterial for adsorption of As(V) ions from the aqueous phase.
C1 [Akhtar, S.; Shoaib, A.] Univ Punjab, Inst Agr Sci, Lahore, Pakistan.
RP Akhtar, S (reprint author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.
EM aamnaa29@yahoo.com
FU Institute of Agricultural Sciences, University of the Punjab
FX We are very thankful to the Institute of Agricultural Sciences,
   University of the Punjab for the support to accomplish this research
   work.
CR Ahluwalia SS, 2005, ENG LIFE SCI, V5, P158, DOI 10.1002/elsc.200420066
   Al Rmalli SW, 2005, SCI TOTAL ENVIRON, V337, P23, DOI 10.1016/j.scitotenv.2004.06.008
   Amin MN, 2006, IND ENG CHEM RES, V45, P8105, DOI 10.1021/ie060344j
   Barros J., 2003, BRAZ J CHEM ENG, V20, P229
   Biplob K. B., 2006, J HAZARD MATER, V154, P1066
   Blokker P, 1998, ORG GEOCHEM, V29, P1453, DOI 10.1016/S0146-6380(98)00111-9
   Choong S.Y. Thomas, 2007, DESALINATION, V217, P139
   D'Souza L, 2008, ANAL CHEM INSIGHTS, V3, P135
   Demirbas A, 2008, J HAZARD MATER, V157, P220, DOI 10.1016/j.jhazmat.2008.01.024
   Dumas P, 2003, VIB SPECTROSC, V32, P3, DOI 10.1016/S0924-2031(03)00043-2
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   Feist PL, 2001, J CHEM EDUC, V78, P351, DOI 10.1021/ed078p351
   Fischer G, 2006, J MICROBIOL METH, V64, P63, DOI 10.1016/j.mimet.2005.04.005
   Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0
   IARC (International Agency for Research on Cancer), 1987, IARC MON EV CARC R S, V7, P1
   Israt J. M., 2008, INDIAN J CHEM TECHN, V15, P413
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Kumari P, 2005, J IND MICROBIOL BIOT, V32, P521, DOI 10.1007/s10295-005-0042-7
   Kundu S, 2006, CHEM ENG J, V122, P93, DOI 10.1016/j.cej.2006.06.002
   Lin-Fu J., 1980, LOW LEVEL LEAD EXPOS
   Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0
   Memon S. Q., 2008, P 1 TECH M MUSL WAT, V104- 109
   Naseem Z., 2010, J CHEM SOC PAKISTAN, V32, P259
   NEQS, 2000, NAT ENV QUAL STAND M
   Ofomaja AE, 2007, J HAZARD MATER, V139, P356, DOI 10.1016/j.jhazmat.2006.06.039
   Pagnanelli F, 2003, CHEM ENG SCI, V58, P4709, DOI 10.1016/j.ces.2003.08.001
   Ranjana D., 2008, HAZARD MAT, V166, P1050
   Roychowdhury T, 2002, CHEMOSPHERE, V49, P605, DOI 10.1016/S0045-6535(02)00309-0
   Shafique U., 2011, J TAIWAN INST CHEM E, V43, P256
   Sigee DC, 2002, EUR J PHYCOL, V37, P19, DOI 10.1017/S0967026201003444
   Torrie G. D., 1997, PRINCIPLES PROCEDURE
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   World Health Organization, 1971, INT STAND DRINK WAT
   Yee N, 2004, ENVIRON SCI TECHNOL, V38, P775, DOI 10.1021/es0346680
NR 34
TC 6
Z9 6
U1 0
U2 12
PU PAKISTAN AGRICULTURAL SCIENTISTS FORUM
PI LAHORE
PA UNIV VETERINARY & ANIMAL SCIENCES, LAHORE, 00000, PAKISTAN
SN 1018-7081
J9 J ANIM PLANT SCI
JI J. Anim. Plant Sci.
PY 2012
VL 22
IS 3
BP 659
EP 664
PG 6
WC Agriculture, Multidisciplinary; Biology; Veterinary Sciences
SC Agriculture; Life Sciences & Biomedicine - Other Topics; Veterinary
   Sciences
GA 008XI
UT WOS:000308989500024
DA 2018-10-19
ER

PT J
AU Jebahi, S
   Oudadesse, H
   el Feki, H
   Rebai, T
   Keskes, H
   Pellen, P
   el Feki, A
AF Jebahi, Samira
   Oudadesse, Hassane
   el Feki, Hafed
   Rebai, Tarek
   Keskes, Hassib
   Pellen, Pascal
   el Feki, Abdelfattah
TI Antioxidative/oxidative effects of strontium-doped bioactive glass as
   bone graft. In vivo assays in ovariectomised rats
SO JOURNAL OF APPLIED BIOMEDICINE
LA English
DT Article
DE oxidative stress; osteoporosis; strontium-substituted bioactive glasses;
   free radical; bone regeneration
ID OSTEOBLAST DIFFERENTIATION; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS;
   OSTEOPOROSIS; RANELATE; WOMEN; BIOMATERIALS; ACTIVATION; CATALASE;
   BEHAVIOR
AB Recently, oxidative stress has been identified as a pivotal pathological factor inducing bone osteoporosis. This phenomenon is responsible for low bone density. It alters bone quality and generates bone fractures. Strontium is found to induce osteoblast activity by stimulating bone formation and reducing bone resorption by restraining osteoclasts. Bioglass (BG) has been used to repair bone defects, and, in combination with strontium (BG-Sr), offers an opportunity to treat this disease. This study investigated the potential role of BG-Sr in improving antioxidant activity and regenerative bone capacity, The effects of both BG-Sr and BG were tested on osteoblast SaOS2 and endothelial EAhy926 cell proliferation in vitro. In vivo, BG-Sr and BG were implanted in the femoral condyles of Wistar rats and compared to that of control groups. Cell proliferation increased significantly by 120% at SaOS2 and 127% at EAhy926. Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPx) were significantly enhanced in BG-Sr treated rats compared to other groups. Moreover, a significant decrease of thiobarbituric acid-reactive substances (TBARs) was observed. The Ca/P ratio increase improved progressive bone mineralization. According to these results, BG-Sr ameliorated cell proliferation and developed an antioxidative defense against ROS. The histological findings highlight the BG-Sr implications in the osteoporosis treatment confirmed by bone construction. The development of BG-Sr as a therapeutic biomaterial protecting against oxidative stress might make an effective choice for application in tissue engineering.
C1 [Jebahi, Samira; Oudadesse, Hassane; Pellen, Pascal] Univ Rennes 1, UMR CNRS 6226, F-35042 Rennes, France.
   [Jebahi, Samira; el Feki, Abdelfattah] Sfax Fac Sci, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [el Feki, Hafed] Sfax Fac Sci, Sci Mat & Environement Lab, Sfax, Tunisia.
   [Rebai, Tarek; Keskes, Hassib] Sfax Fac Med, Histol Orthopaed & Traumatol Lab, Sfax, Tunisia.
RP Oudadesse, H (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu,263 Av Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Buege J. A., 1984, METHOD ENZYMOL, V105, P302
   Caverzasio J, 2011, CELL PHYSIOL BIOCHEM, V27, P243, DOI 10.1159/000327950
   Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3
   Collette J, 2010, OSTEOPOROSIS INT, V21, P233, DOI 10.1007/s00198-009-0940-z
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Hamdy N.A., 2009, RHEUMATOLOGY OXFO S4, V48, P9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   HOJJATIE B, 1990, J BIOMECH, V23, P1157, DOI 10.1016/0021-9290(90)90008-Q
   Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006
   Izquierdo-Barba I, 2008, CHEM MATER, V20, P3191, DOI DOI 10.1021/CM800172X
   Jallot E, 2000, J PHYS D APPL PHYS, V33, P2775, DOI 10.1088/0022-3727/33/21/316
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Jones JR, 2007, ELEMENTS, V3, P393, DOI 10.2113/GSELEMENTS.3.6.393
   Kaufmann EABE, 2000, TISSUE ENG, V6, P19, DOI 10.1089/107632700320856
   Kaviarasan K, 2008, J APPL BIOMED, V6, P165
   KONO Y, 1982, J BIOL CHEM, V257, P5751
   Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lusvardi G, 2009, ACTA BIOMATER, V5, P419, DOI 10.1016/j.actbio.2008.07.007
   MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Ovesen J, 2009, J TRACE ELEM MED BIO, V23, P1, DOI 10.1016/j.jtemb.2008.12.001
   Pagila DE, 1967, J LAB CLIN MED, V70, P158
   Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105
   Sadeghi N, 2008, DARU, V16, P51
   Saito T, 2002, BIOMATERIALS, V23, P2711, DOI 10.1016/S0142-9612(02)00003-0
   Sanchez-Rodriguez MA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-124
   SINET PM, 1981, ARCH BIOCHEM BIOPHYS, V212, P411, DOI 10.1016/0003-9861(81)90382-9
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Voigt W, 2005, METH MOLEC MED, V110, P39
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 42
TC 17
Z9 18
U1 1
U2 36
PU UNIV SOUTH BOHEMIA
PI CESKA BUDEJOVICE
PA FAC HEALTH & SOCIAL STUD, JIROVCOVA, CESKA BUDEJOVICE, 370 04, CZECH
   REPUBLIC
SN 1214-021X
J9 J APPL BIOMED
JI J. Appl. Biomed.
PY 2012
VL 10
IS 4
BP 195
EP 209
DI 10.2478/v10136-012-0009-8
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 012EJ
UT WOS:000309218000004
DA 2018-10-19
ER

PT J
AU Booth, BW
   Yang, CC
   Burg, KJL
AF Booth, Brian W.
   Yang, Chih-Chao
   Burg, Karen J. L.
TI Assessment of a Chitosan/Hyaluronan Injectable Composite for Fat
   Reconstruction
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Adipocyte; chitosan; composite; hyaluronic acid; injectable; tissue
   regeneration
ID SOFT-TISSUE AUGMENTATION; NERVE GROWTH-FACTOR; DERMAL FIBROBLASTS;
   STEM-CELLS; REGENERATION; SCAFFOLDS; RELEASE; BREAST; FUTURE
AB The long-term success of autologous fat transplants is dependent on numerous factors including tissue quality, tissue survivability and the expansion of the implanted cells. The addition of a biomaterial filler to an injectable gel implant matrix provides an anchor and scaffold for proliferating cells as well as a carrier for syringe delivery. Building on the tissue reconstruction concept which we first disclosed, i.e., an injectable composite comprised of beads in a gel, the present study uses an injectable composite comprised of fatty-acid-loaded chitosan/gelatin (FA-CG) beads (i.e., a degradable filler material with tissue bulking potential) and hyaluronic acid (HA, a matrix). Human and bovine preadipocytes were considered independently; however, in both cases the cells proliferated and differentiated equally when grown with the FA-CG/HA composite, as demonstrated by the production of lipids and triglycerides, as well as expression of the human adipocyte marker aP2. The preadipocyte/FA-CG/HA injectables formed stable complexes that remained intact, with little degradation and no measurable immune response, for 4 months after implantation into mice. These results suggest that FA-CG/HA composite is a suitable injectable matrix for preadipocyte transplantation, providing the basis for further studies investigating the suitability of this technique for larger-scale tissue implantation and regeneration. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Booth, Brian W.; Yang, Chih-Chao; Burg, Karen J. L.] Clemson Univ, Inst Biol Interfaces Engn, Clemson, SC 29634 USA.
   [Burg, Karen J. L.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Burg, KJL (reprint author), Clemson Univ, Inst Biol Interfaces Engn, Clemson, SC 29634 USA.
EM kburg@clemson.edu
FU Aesthetec
FX The authors acknowledge the assistance of Tina Parker of the Clemson
   University Godley-Snell Research Center and Aesthetec for providing
   funding for this work.
CR AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231
   Ashinoff R, 2000, CLIN PLAST SURG, V27, P479
   Atanassova P, 2001, CELLS TISSUES ORGANS, V169, P355, DOI 10.1159/000047902
   BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033
   Burg K. J., 2000, P T 2000 WORLD BIOM
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Jung H, 2011, CYTOTECHNOLOGY, V63, P57, DOI 10.1007/s10616-010-9327-4
   Klein AW, 2000, DERMATOL SURG, V26, P1096, DOI 10.1046/j.1524-4725.2000.t01-1-00512.x
   Lam SM, 2010, FACIAL PLAST SURG, V26, P488, DOI 10.1055/s-0030-1267723
   Langstein HN, 1999, SEMIN SURG ONCOL, V17, P52, DOI 10.1002/(SICI)1098-2388(199907/08)17:1<52::AID-SSU7>3.0.CO;2-I
   LoTempio MM, 2010, PLAST RECONSTR SURG, V126, P393, DOI 10.1097/PRS.0b013e3181de236a
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Mauney JR, 2005, BIOMATERIALS, V26, P6167, DOI 10.1016/j.biomaterials.2005.03.024
   Patrick C. W., 1998, FRONTIERS TISSUE ENG
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2001, ANN PLAS SURG, V47, P660, DOI 10.1097/00000637-200112000-00014
   Patrick CW, 2001, TISSUE ENG, V7, P303, DOI 10.1089/10763270152044161
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   SILBERT DF, 1972, J BIOL CHEM, V247, P1699
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Stuhlmeier KM, 2006, WIEN MED WOCHENSCHR, V156, P563, DOI 10.1007/s10354-006-0351-0
   Tan HP, 2010, ORGANOGENESIS, V6, P173, DOI 10.4161/org.6.3.12037
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
NR 28
TC 2
Z9 2
U1 1
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 18
BP 2303
EP 2320
DI 10.1163/156856211X615274
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 010WS
UT WOS:000309125800004
PM 22243997
DA 2018-10-19
ER

PT J
AU Obermeier, A
   Kuchler, S
   Matl, FD
   Pirzer, T
   Stemberger, A
   Mykhaylyk, O
   Friess, W
   Burgkart, R
AF Obermeier, A.
   Kuechler, S.
   Matl, F. D.
   Pirzer, T.
   Stemberger, A.
   Mykhaylyk, O.
   Friess, W.
   Burgkart, R.
TI Magnetic Drug Targeting as New Therapeutic Option for the Treatment of
   Biomaterial Infections
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Gentamicin; implant; magnetic nanoparticles; targeted drug delivery;
   biofilms
ID IN-VITRO; IMPLANTS; STRATEGIES; AGENTS; MAGNETOFECTION; NANOTECHNOLOGY;
   NANOPARTICLES; BIOFILMS; DELIVERY; SYSTEM
AB Implant-associated infections are a challenging problem in surgery. Bacteria in biofilms are difficult to treat as they are less susceptible to antibiotics or antiseptics which require high drug concentrations at the site of infection. We present a novel strategy to concentrate high antibiotic doses systemically at the target site using newly developed antibiotic-functionalized nanoparticles directed by a magnetic drug-targeting system. The important and effective antibiotic gentamicin served as antimicrobial substance and was ionically or covalently attached to magnetic nanoparticles. Subsequently, the particles were characterized thoroughly. Anti-infective properties with regard to Staphylococcus aureus and the degree of cytotoxicity concerning human umbilical vein endothelial cells were determined. The enrichment of the magnetic nanoparticles at the surface of model tubes in circulatory experiments was investigated. We describe a promising technique for the loading of magnetic nanoparticles to treat systemic infections. Gentamicin-coated magnetic nanoparticles reduced bacterial growth even beyond pathologically relevant concentrations within 24 h. Excellent concentration independent biocompatibility was found for the nanoparticles themselves and we demonstrate that the magnetic nanoparticles can be navigated and concentrated on surfaces of model implants using a permanent magnetic field. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Obermeier, A.; Matl, F. D.; Pirzer, T.; Stemberger, A.; Burgkart, R.] Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Unfallchirurg, D-81675 Munich, Germany.
   [Kuechler, S.; Friess, W.] Univ Munich, Dept Pharmaceut Sci Pharmaceut Technol, D-81377 Munich, Germany.
   [Mykhaylyk, O.] Tech Univ Munich, Klinikum Rechts Isar, Inst Expt Onkol & Therapieforsch, D-81675 Munich, Germany.
RP Obermeier, A (reprint author), Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Unfallchirurg, Ismaninger Str 22, D-81675 Munich, Germany.
EM andreas.obermeier@gmx.net
RI Mykhaylyk, Olga/F-9497-2011; Pirzer, Tobias/D-4737-2016; Obermeier,
   Andreas Karl-Werner/B-3020-2016
OI Mykhaylyk, Olga/0000-0001-7963-5321; Pirzer, Tobias/0000-0002-4603-8851;
   Obermeier, Andreas Karl-Werner/0000-0002-1774-5194; Hedtrich (born
   Kuchler), Sarah/0000-0001-6770-3657
FU Bayerische Forschungsstiftung
FX We would like to thank Dr.-Ing. B. Gleich for his great assistance in
   technical questions regarding highly focused magnetic fields and
   magnetic field forces for targeting. Furthermore we acknowledge Dipl.
   Wirtsch.-Ing. H. Stephan and Dipl. Phys. W. Kraus (Neue Magnetodyn GmbH)
   for their technical help, contributions and inspiring discussions.
   Special thanks to Dr. C. Bergemann (Chemicell GmbH), who kindly provides
   the TargetMag, FluidMag and SiMag ferrofluids. The authors did not
   receive any payments or benefits from a commercial party related
   directly or indirectly to the subject of this article. This work was
   partially supported by a grant from the Bayerische Forschungsstiftung.
CR Alexiou C, 2005, J MAGN MAGN MATER, V293, P389, DOI 10.1016/j.jmmm.2005.02.036
   Alexiou C, 2005, HNO, V53, P618, DOI 10.1007/s00106-004-1146-5
   Alexiou C, 2000, CANCER RES, V60, P6641
   Anderson JE, 2000, ASAIO J, V46, pS18, DOI 10.1097/00002480-200011000-00032
   BUNT TJ, 1983, SURGERY, V93, P733
   Chalmers RTA, 1999, BRIT J SURG, V86, P1433, DOI 10.1046/j.1365-2168.1999.01267.x
   Chemicell, 2008, COUPL PROT A1 SIMAG
   Chemicell, 2008, COUPL PROT FLUIDMAG
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Dames P, 2007, NAT NANOTECHNOL, V2, P495, DOI 10.1038/nnano.2007.217
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Di Marco M, 2007, INT J NANOMED, V2, P609
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Furuya EY, 2003, CURR OPIN PHARMACOL, V3, P464, DOI 10.1016/j.coph.2003.05.004
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   INADA Y, 1987, BIOCHEM BIOPH RES CO, V148, P392, DOI 10.1016/0006-291X(87)91123-5
   Iverson N, 2008, BIODRUGS, V22, P1, DOI 10.2165/00063030-200822010-00001
   Jain KK, 2008, MED PRIN PRACT, V17, P89, DOI 10.1159/000112961
   Kangarlu A, 2004, RADIOLOGE, V44, P19, DOI 10.1007/s00117-003-0993-5
   KHARDORI N, 1995, J IND MICROBIOL, V15, P141, DOI 10.1007/BF01569817
   Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4
   Leaper D, 2010, ANN ROY COLL SURG, V92, P453, DOI 10.1308/003588410X12699663905276
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Mykhaylyk O, 2007, NAT PROTOC, V2, P2391, DOI 10.1038/nprot.2007.352
   Mykhaylyk Olga, 2009, V487, P111, DOI 10.1007/978-1-60327-547-7_6
   Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828
   Raschke MJ, 2004, UNFALLCHIRURG, V107, P653, DOI 10.1007/s00113-004-0828-5
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Schmitt F, 2004, RADIOLOGE, V44, P31, DOI 10.1007/s00117-003-1000-x
   Tanenbaum Lawrence N, 2006, Magn Reson Imaging Clin N Am, V14, P1, DOI 10.1016/j.mric.2005.12.004
   TOWNE JB, 1994, J VASC SURG, V19, P226, DOI 10.1016/S0741-5214(94)70098-2
   Tschantz P., 1995, SWISS SURG, V3, P140
   VIROONCHATAPAN E, 1995, PHARMACEUT RES, V12, P1176, DOI 10.1023/A:1016216011016
NR 35
TC 5
Z9 5
U1 0
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 18
BP 2321
EP 2336
DI 10.1163/156856211X616183
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 010WS
UT WOS:000309125800005
PM 22182398
DA 2018-10-19
ER

PT J
AU Fuh, YK
   Chen, SZ
   Jang, JSC
AF Fuh, Yiin-Kuen
   Chen, Shengzhan
   Jang, Jason S. C.
TI Direct-write, Well-aligned Chitosan-Poly(ethylene oxide) Nanofibers
   Deposited via Near-field Electrospinning
SO JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE Well-aligned; chitosan-poly(ethylene oxide); nanofibers; near-field
   electrospinning
ID POLY(ETHYLENE OXIDE); CHITOSAN NANOFIBERS; POLYMER NANOFIBERS; FIBERS
AB A continuous near-field electrospinning (NFES) process has been demonstrated to be able to achieve direct-write and well-aligned chitosan/poly(ethylene oxide) nanofibers. The ability to precisely control and deposit chitosan-based nanofibers in a direct-write manner is favorable in manipulating cells attachment and proliferation at a preferred position. Experimental results show that fiber diameters can be reliably controlled in the range of 265-1255 nm by adjusting various operating parameters of the NFES processes. These prescribed patterns of nanofibers exceed tens of centimeters long and complex configurations such as grid arrays and arc shapes are assembled at specified separations as small as 5 mu m. FTIR analysis reveals that NFES nanofibers have a similar morphology and composition as conventional electrospinning counterpart and constitute all components formerly present in the polymer solution. The versatile functionality to fabricate chitosan-based nanofibers with controllable size and directional alignment as well as highly ordered and customized patterns may represent an ideal candidate of a functional biomaterial and in tissue-engineering scaffolds that are predominantly representative of extracellular matrix (ECM).
C1 [Fuh, Yiin-Kuen; Chen, Shengzhan; Jang, Jason S. C.] Natl Cent Univ, Dept Mech Engn, Chungli 32001, Taoyuan County, Taiwan.
   [Jang, Jason S. C.] Natl Cent Univ, Inst Mat Sci & Engn, Chungli 32001, Taoyuan County, Taiwan.
RP Fuh, YK (reprint author), Natl Cent Univ, Dept Mech Engn, Chungli 32001, Taoyuan County, Taiwan.
EM mikefuh@ncu.edu.tw
CR Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Caracciolo PC, 2009, J MATER SCI-MATER M, V20, P2129, DOI 10.1007/s10856-009-3768-3
   Carnell LS, 2009, SCRIPTA MATER, V60, P359, DOI 10.1016/j.scriptamat.2008.09.035
   Chang C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2975834
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Desai K, 2008, POLYMER, V49, P4046, DOI 10.1016/j.polymer.2008.07.012
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Giner S Torres, 2008, ENG LIFE SCI, V8, P303
   Haider S., 2010, POLYM ENG SCI, V10, P1887
   Han J, 2011, CARBOHYD POLYM, V83, P270, DOI 10.1016/j.carbpol.2010.07.057
   Homayoni H, 2009, CARBOHYD POLYM, V77, P656, DOI 10.1016/j.carbpol.2009.02.008
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Katta P, 2004, NANO LETT, V4, P2215, DOI 10.1021/nl0486158
   Kriegel C, 2009, POLYMER, V50, P189, DOI 10.1016/j.polymer.2008.09.041
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048
   Pawlowski KJ, 2003, POLYMER, V44, P1309, DOI 10.1016/S0032-3861(02)00859-5
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rinaldi M, 2009, J VAC SCI TECHNOL B, V27, P1829, DOI 10.1116/1.3154516
   Sawatari C, 1999, MACROMOLECULES, V32, P1949, DOI 10.1021/ma980900o
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P2665, DOI 10.1021/bm7006983
   Sun DH, 2006, NANO LETT, V6, P839, DOI 10.1021/nl0602701
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Zhang YZ, 2008, BIOMACROMOLECULES, V9, P136, DOI 10.1021/bm701130e
NR 26
TC 11
Z9 12
U1 4
U2 47
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI A
JI J. Macromol. Sci. Part A-Pure Appl. Chem.
PY 2012
VL 49
IS 10
BP 845
EP 850
DI 10.1080/10601325.2012.714676
PG 6
WC Polymer Science
SC Polymer Science
GA 008TP
UT WOS:000308979800006
DA 2018-10-19
ER

PT J
AU Raphel, J
   Parisi-Amon, A
   Heilshorn, SC
AF Raphel, Jordan
   Parisi-Amon, Andreina
   Heilshorn, Sarah C.
TI Photoreactive elastin-like proteins for use as versatile bioactive
   materials and surface coatings
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID 3D CELL-CULTURE; EXTRACELLULAR-MATRIX; CROSS-LINKING; STEM-CELLS;
   ESCHERICHIA-COLI; AMINO-ACID; IN-VITRO; TISSUE; BIOMATERIALS; HYDROGELS
AB Photocrosslinkable, protein-engineered biomaterials combine a rapid, controllable, cytocompatible crosslinking method with a modular design strategy to create a new family of bioactive materials. These materials have a wide range of biomedical applications, including the development of bioactive implant coatings, drug delivery vehicles, and tissue engineering scaffolds. We present the successful functionalization of a bioactive elastin-like protein with photoreactive diazirine moieties. Scalable synthesis is achieved using a standard recombinant protein expression host followed by site-specific modification of lysine residues with a heterobifunctional N-hydroxysuccinimide ester-diazirine crosslinker. The resulting biomaterial is demonstrated to be processable by spin coating, drop casting, soft lithographic patterning, and mold casting to fabricate a variety of two- and three-dimensional photocrosslinked biomaterials with length scales spanning the nanometre to millimetre range. Protein thin films proved to be highly stable over a three-week period. Cell-adhesive functional domains incorporated into the engineered protein materials were shown to remain active post-photo-processing. Human adipose-derived stem cells achieved faster rates of cell adhesion and larger spread areas on thin films of the engineered protein compared to control substrates. The ease and scalability of material production, processing versatility, and modular bioactive functionality make this recombinantly engineered protein an ideal candidate for the development of novel biomaterial coatings, films, and scaffolds.
C1 [Raphel, Jordan; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94035 USA.
   [Parisi-Amon, Andreina] Stanford Univ, Dept Bioengn, Stanford, CA 94035 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, 476 Lomita Mall,McCullough Bldg 246, Stanford, CA 94035 USA.
EM heilshorn@stanford.edu
FU NSF [DMR-0846363]; National Science Foundation Graduate Fellowship; NIH
   [R21-AR-062359, DP2-OD-006477]
FX The authors acknowledge funding from NSF DMR-0846363, NIH R21-AR-062359,
   NIH DP2-OD-006477 and a National Science Foundation Graduate Fellowship
   (A.P.-A). The authors thank Lydia-Marie Joubert and Bob Jones for
   assistance with SEM, Adam Sturlaugson for use of FTIR, and Reinhold
   Dauskardt and Krysta Biniek for assistance with mechanical tests.
CR Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Badie N, 2009, BIOPHYS J, V96, P3873, DOI 10.1016/j.bpj.2009.02.019
   Banta S, 2010, ANNU REV BIOMED ENG, V12, P167, DOI 10.1146/annurev-bioeng-070909-105334
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Bossi S., 2010, P 32 ANN INT C IEEE, P1527
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299
   Chow DC, 2006, BIOTECHNOL PROGR, V22, P638, DOI 10.1021/bp0503742
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Coin I, 2010, J PEPT SCI, V16, P223, DOI 10.1002/psc.1224
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Decker C, 2002, MACROMOL RAPID COMM, V23, P1067, DOI 10.1002/marc.200290014
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   GAMBI A, 1983, J MOL SPECTROSC, V98, P413, DOI 10.1016/0022-2852(83)90252-7
   Grieshaber SE, 2009, MACROMOLECULES, V42, P2532, DOI 10.1021/ma802791z
   Huang ZN, 2008, TISSUE ENG PT A, V14, P1853, DOI 10.1089/ten.tea.2007.0399
   Kim W, 2010, ADV DRUG DELIVER REV, V62, P1468, DOI 10.1016/j.addr.2010.04.007
   KRAMER W, 1989, J LIPID RES, V30, P1281
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Linnola RJ, 1999, J CATARACT REFR SURG, V25, P1486, DOI 10.1016/S0886-3350(99)00238-2
   Liu JC, 2008, BIOMACROMOLECULES, V9, P2984, DOI 10.1021/bm800469j
   Liu S, 2009, MACROMOLECULES, V42, P3, DOI 10.1021/ma801782q
   Liu Y, 2011, MACROMOL BIOSCI, V11, P1325, DOI 10.1002/mabi.201100119
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106
   Tang Y, 2001, J AM CHEM SOC, V123, P11089, DOI 10.1021/ja016652k
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Wang S, 2009, BIOMED MICRODEVICES, V11, P1127, DOI 10.1007/s10544-009-9329-1
   Williams C, 2011, BIOMATERIALS, V32, P410, DOI 10.1016/j.biomaterials.2010.08.105
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 45
TC 21
Z9 21
U1 0
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 37
BP 19429
EP 19437
DI 10.1039/c2jm31768k
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 996OK
UT WOS:000308099900010
PM 23015764
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gorth, DJ
   Puckett, S
   Ercan, B
   Webster, TJ
   Rahaman, M
   Bal, BS
AF Gorth, Deborah J.
   Puckett, Sabrina
   Ercan, Batur
   Webster, Thomas J.
   Rahaman, Mohamed
   Bal, B. Sonny
TI Decreased bacteria activity on Si3N4 surfaces compared with PEEK or
   titanium
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE silicon nitride; nanostructure; anti-infective; biofilm; protein
   adsorption
ID ADHESION IN-VITRO; OSTEOBLAST FUNCTIONS; NANOPHASE CERAMICS;
   STAINLESS-STEEL; ANTIBACTERIAL ACTIVITY; MICROBIAL ADHESION; ANODIZED
   TITANIUM; EXTERNAL FIXATION; CELL ATTACHMENT; SILICON-NITRIDE
AB A significant need exists for orthopedic implants that can intrinsically resist bacterial colonization. In this study, three biomaterials that are used in spinal implants - titanium (Ti), polyether-ether-ketone (PEEK), and silicon nitride (Si3N4) - were tested to understand their respective susceptibility to bacterial infection with Staphylococcus epidermidis, Staphlococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus. Specifically, the surface - chemistry, wettability, and nanostructured topography of respective biomaterials, and the effects on bacterial biofilm formation, colonization, and growth were investigated. Ti and PEEK were received with as-machined surfaces; both materials are hydrophobic, with net negative surface charges. Two surface finishes of Si3N4 were examined: as-fired and polished. In contrast to Ti and PEEK, the surface of Si3N4 is hydrophilic, with a net positive charge. A decreased biofilm formation was found, as well as fewer live bacteria on both the as- fired and polished Si3N4. These differences may reflect differential surface chemistry and surface nanostructure properties between the biomaterials tested. Because protein adsorption on material surfaces affects bacterial adhesion, the adsorption of fibronectin, vitronectin, and laminin on Ti, PEEK, and Si3N4 were also examined. Significantly greater amounts of these proteins adhered to Si3N4 than to Ti or PEEK. The findings of this study suggest that surface properties of biomaterials lead to differential adsorption of physiologic proteins, and that this phenomenon could explain the observed in-vitro differences in bacterial affinity for the respective biomaterials. Intrinsic biomaterial properties as they relate to resistance to bacterial colonization may reflect a novel strategy toward designing future orthopedic implants.
C1 [Bal, B. Sonny] Univ Missouri, Sch Med, Dept Orthopaed Surg, Columbia, MO 65221 USA.
   [Gorth, Deborah J.; Puckett, Sabrina; Ercan, Batur; Webster, Thomas J.] Brown Univ, Sch Engn, Providence, RI 02912 USA.
   [Gorth, Deborah J.; Puckett, Sabrina; Ercan, Batur; Webster, Thomas J.] Brown Univ, Dept Orthopaed, Providence, RI 02912 USA.
   [Rahaman, Mohamed] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO USA.
RP Bal, BS (reprint author), Univ Missouri, Sch Med, Dept Orthopaed Surg, Columbia, MO 65221 USA.
EM balb@health.missouri.edu
RI ERCAN, BATUR/A-1232-2016
OI ERCAN, BATUR/0000-0003-1657-1142; Bal, B. Sonny/0000-0002-9615-8632
CR American Society for Testing and Materials (ASTM), 2008, D733408 ASTM
   Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/biomaterials.2006.03.004
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bagno A, 2004, BIOMATERIALS, V25, P2437, DOI 10.1016/j.biomaterials.2003.09.018
   Baquero F, 1997, J ANTIMICROB CHEMOTH, V39, P1, DOI 10.1093/jac/39.suppl_1.1
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Charville GW, 2008, BIOMATERIALS, V29, P4039, DOI 10.1016/j.biomaterials.2008.07.005
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cohen A, 2007, NANOSCALE RES LETT, V2, P385, DOI 10.1007/s11671-007-9069-1
   Collins I, 2008, EUR SPINE J, V17, P445, DOI 10.1007/s00586-007-0559-8
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Ejiofor JU, 2004, INT J POWDER METALL, V40, P43
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gardner J, 2011, CLIN ORTHOP RELAT R, V469, P970, DOI 10.1007/s11999-010-1417-2
   GREEN SA, 1984, J BONE JOINT SURG AM, V66A, P1092, DOI 10.2106/00004623-198466070-00017
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hamilton V, 2007, POLYM INT, V56, P641, DOI 10.1002/pi.2181
   Hilbert LR, 2003, INT BIODETER BIODEGR, V52, P175, DOI 10.1016/S0964-8305(03)00104-5
   Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096
   IKEDA T, 1986, ANTIMICROB AGENTS CH, V30, P132, DOI 10.1128/AAC.30.1.132
   Jou CH, 2007, J APPL POLYM SCI, V104, P220, DOI 10.1002/app.25549
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   KIM SS, 1991, J AM CERAM SOC, V74, P1735, DOI 10.1111/j.1151-2916.1991.tb07175.x
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5
   Lewis JA, 2000, J AM CERAM SOC, V83, P2341
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Ma J, 2007, MAT SCI ENG C-BIO S, V27, P886, DOI 10.1016/j.msec.2006.10.005
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046
   Mendenhall S, 2011, ORTHOPEDIC NETWORK N, V22, P466
   Mezzasalma S, 1996, J COLLOID INTERF SCI, V180, P413, DOI 10.1006/jcis.1996.0320
   Miller D. C., 2005, Applied Bionics and Biomechanics, V2, P1, DOI 10.1533/abbi.2004.0001
   Moroni A, 2002, J ORTHOP TRAUMA, V16, P189, DOI 10.1097/00005131-200203000-00009
   Neumann H-G, 2012, US Patent Application Publication, Patent No. [2012/0024712, 20120024712]
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027
   Oosterbos CJM, 2002, J BIOMED MATER RES, V60, P339, DOI 10.1002/jbm.1288
   Puckett S, 2008, INT J NANOMED, V3, P229
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rajaee SS, 2012, SPINE, V37, P67, DOI 10.1097/BRS.0b013e31820cccfb
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Raulio M, 2008, J IND MICROBIOL BIOT, V35, P751, DOI 10.1007/s10295-008-0343-8
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004
   Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499
   Senthi S, 2011, INT ORTHOP, V35, P253, DOI 10.1007/s00264-010-1144-z
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
   Ward BC, 2007, MAT SCI ENG C-BIO S, V27, P575, DOI 10.1016/j.msec.2006.05.032
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2001, BIOMATERIALS, V22, P1
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Ziegler G, 2011, US Patent, Patent No. [7,906,132, 7906132]
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zlowodzki M, 2007, INT ORTHOP, V31, P409, DOI 10.1007/s00264-006-0187-7
NR 80
TC 51
Z9 52
U1 3
U2 56
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 4829
EP 4840
DI 10.2147/IJN.S35190
PG 12
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 000PV
UT WOS:000308400000001
PM 22973102
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Yilmazer, H
   Niinomi, M
   Nakai, M
   Hieda, J
   Akahori, T
   Todaka, Y
AF Yilmazer, H.
   Niinomi, M.
   Nakai, M.
   Hieda, J.
   Akahori, T.
   Todaka, Y.
BE Goto, T
   Fu, ZY
   Zhang, LM
TI Microstructure and mechanical properties of a biomedical beta-type
   titanium alloy subjected to severe plastic deformation after aging
   treatment
SO MATERIALS INTEGRATION
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 2nd International Symposium on Advanced Synthesis and Processing
   Technology for Materials (ASPT2011)/8th Materials Science School for
   Young Scientists (KINKEN-WAKATE2011)
CY DEC 01-02, 2011
CL Sendai, PEOPLES R CHINA
SP Wuhan Univ Technol, Tohoku Univ, Int Collaborat Ctr, Inst Mat Res, JSPS 124th Comm Adv Ceram, Natl Nat Sci Fdn of China, Japan Soc Powder Powder Met, Int Ceram Federat, Send Tourist & Convent Bur
DE Ti-29Nb-13Ta-4.6Zr; Metallic biomaterial; Severe plastic deformation;
   Microstructure; Mechanical hardness
ID HIGH-PRESSURE TORSION; X-RAY-DIFFRACTION; GRAIN-SIZE; ALUMINUM;
   MICROHARDNESS; EVOLUTION; FATIGUE; COPPER
AB Strengthening by grain refinement and increasing dislocation density through high-pressure torsion (HPT), which is an attractive technique to fabricate ultrafine grained and nanostructured metallic materials, is expected to provide beta-type Ti-29Nb-13Ta-4.6Zr (TNTZ) higher mechanical strength while maintaining low Young's modulus because they keep the original beta phase. However, the ductility shows reverse trend. Greater strength with enhanced ductility can be achieved by controlling precipitated phases through HPT processing after aging treatment. Aged TNTZ subjected to HPT processing at high N exhibits a homogeneous microstructure with ultrafine elongated grains having a high dislocation density and consequently non-equilibrium boundaries and distorted subgrains with non-uniform shapes and nanostructured intergranular precipitates of alpha phases. Therefore, the effect of HPT processing on the microstructure and mechanical hardness of TNTZ after aging treatment was systematically investigated in this study. TNTZ, which was subjected to aging treatment at 723 K for 259.2 ks in vacuum followed by water quenching, subjected to HPT processing at rotation numbers (N) of 1 to 20 under a pressure of around 1.25 GPa at room temperature. The microstructure of TNTZ(AT) consisted of precipitated needle-like omega phases in beta grains. However, TNTZ(AHPT) at N >= 10 comprises very fine alpha and small amount omega phases in ultrafine beta grains. Furthermore, the hardness of every TNTZ(AHPT) was totally much greater than that of TNTZ(AT). The hardness increased from the center to peripheral region of TNTZ(AHPT). In addition, the tensile strength of every TNTZ(AHPT) was greater than that of TNTZ(AT). The tensile strength of TNIZ(AHPT) increased, but the elongation decreased with increasing N and then both of them saturated at N >= 10.
C1 [Yilmazer, H.] Tohoku Univ, Sendai, Miyagi 9808579, Japan.
   [Niinomi, M.; Nakai, M.; Hieda, J.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan.
   [Akahori, T.] Meijo Univ, Fac Mat Sci & technol, Dept Mat Sci & Engn, Nagoya, Aichi 468, Japan.
   [Todaka, Y.] Toyohashi Univ Technol, Dept Prod Syst & Engn, Toyohashi, Aichi 4418580, Japan.
RP Yilmazer, H (reprint author), Tohoku Univ, Sendai, Miyagi 9808579, Japan.
EM hakan@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jp;
   nakai@imr.tohoku.ac.jp; hieda@imr.tohoku.ac.jp; akahori@meijo-u.ac.jp;
   todaka@me.tut.ac.jp
RI Yilmazer, Hakan/C-2911-2011; Todaka, Yoshikazu/D-3809-2015
OI Yilmazer, Hakan/0000-0001-5602-4966; 
FU Global COE Program "Materials Integration (International Center of
   Education and Research), Tohoku University"; Ministry of Education,
   Culture, Sports, Science and Technology (MEXT), Japan; Inter-University
   Cooperative Research Program "Highly-Functional Interface Science:
   Innovation of Biomaterials with Highly Functional Interface to the Host
   and Parasite, Tohoku University; Kyushu University," MEXT, Japan; Japan
   Society for the Promotion of Science and Technology Agency (JST), Japan
FX This work was supported in part by the Global COE Program "Materials
   Integration (International Center of Education and Research), Tohoku
   University"; the Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan; the Inter-University Cooperative Research
   Program "Highly-Functional Interface Science: Innovation of Biomaterials
   with Highly Functional Interface to the Host and Parasite, Tohoku
   University and Kyushu University," MEXT, Japan; and Grants-in-Aid for
   Young Scientists (B), the Japan Society for the Promotion of Science and
   Technology Agency (JST), Japan.
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Furuhara T, 2001, J MATER PROCESS TECH, V117, P318, DOI 10.1016/S0924-0136(01)00790-7
   Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064
   Horita Z, 2005, MAT SCI ENG A-STRUCT, V410, P422, DOI 10.1016/j.msea.2005.08.133
   Horita Z, 1996, J MATER RES, V11, P1880, DOI 10.1557/JMR.1996.0239
   Islamgaliev R. K., 2000, PROG MATER SCI, P45
   Iwahashi Y, 1998, METALL MATER TRANS A, V29, P2503, DOI 10.1007/s11661-998-0222-y
   Korznikov AV, 2001, ACTA MATER, V49, P663, DOI 10.1016/S1359-6454(00)00345-1
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li L, 2009, ACTA MATER, V57, P4988, DOI 10.1016/j.actamat.2009.07.002
   Mishra RS, 2001, MAT SCI ENG A-STRUCT, V298, P44, DOI 10.1016/S0921-5093(00)01338-1
   Nakai M., METALL MA A IN PRESS
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Sakai G, 2005, MAT SCI ENG A-STRUCT, V406, P268, DOI 10.1016/j.msea.2005.06.049
   Song X, 2011, MAT SCI ENG A-STRUCT, V528, P5600, DOI 10.1016/j.msea.2011.03.108
   Todaka Y, 2008, SCRIPTA MATER, V59, P615, DOI 10.1016/j.scriptamat.2008.05.015
   Ungar T, 1998, ACTA MATER, V46, P3693, DOI 10.1016/S1359-6454(98)00001-9
   Ungar T, 2004, SCRIPTA MATER, V51, P777, DOI 10.1016/j.scriptamat.2004.05.007
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Vorhauer A, 2004, SCRIPTA MATER, V51, P921, DOI 10.1016/j.scriptamat.2004.04.025
   Yilmazer H., INT J MICRO IN PRESS
   Zhao YS, 2008, J APPL CRYSTALLOGR, V41, P1095, DOI 10.1107/S0021889808031762
   Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002
   Zhilyaev AP, 2005, MAT SCI ENG A-STRUCT, V410, P277, DOI 10.1016/j.msea.2005.08.044
   Zhilyaev AP, 2001, SCRIPTA MATER, V44, P2753, DOI 10.1016/S1359-6462(01)00955-1
NR 27
TC 3
Z9 3
U1 1
U2 17
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03785-376-4
J9 KEY ENG MATER
PY 2012
VL 508
BP 152
EP +
DI 10.4028/www.scientific.net/KEM.508.152
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBW50
UT WOS:000308446300028
DA 2018-10-19
ER

PT J
AU Safdar, A
   He, HZ
   Wei, LY
   Snis, A
   de Paz, LEC
AF Safdar, A.
   He, H. Z.
   Wei, Liu-Ying
   Snis, A.
   de Paz, Luis E. Chavez
TI Effect of process parameters settings and thickness on surface roughness
   of EBM produced Ti-6Al-4V
SO RAPID PROTOTYPING JOURNAL
LA English
DT Article
DE Alloys; Surface roughness measurement; Manufacturing systems; Titanium;
   Ti-6Al-4V; Electron beam melting; Ra; Response surface methodology;
   Multiple regression model; Confocal microscope
ID MECHANICAL-PROPERTIES; CONFOCAL MICROSCOPY; TITANIUM; MICROSTRUCTURE
AB Purpose - Ti-6Al-4V is one of the most attractive materials being used in aerospace, automotive and medical implant industries. Electron beam melting (EBM) is one of the direct digital manufacturing methods to produce complex geometries of fully dense and near net shape parts. The EBM system provides an opportunity to built metallic objects with different processing parameter settings like beam current, scan speed, probe size on powder, etc. The purpose of this paper is to determine and understand the effect of part's thickness and variation in process parameter settings of the EBM system on surface roughness/topography of EBM fabricated Ti-6Al-4V metallic parts.
   Design/methodology/approach - A mathematical model based upon response surface methodology (RSM) is developed to study the variation of surface roughness with changing process parameter settings. Surface roughness of the test slabs produced with different parameter settings and thickness has been studied under confocal microscope. Response surface methodology was used to develop a multiple regression model to correlate the effect of variation in EBM process parameters settings and thickness of parts on surface roughness of EBM produced Ti-6Al-4V.
   Findings - It has been observed that every part produced by EBM system has detectable surface roughness. The surface roughness parameter Ra varies between 1-20 mu m for different samples depending upon the process parameter setting and thickness. The Ra value increases with increasing sample thickness and beam current, and decreases with increase in offset focus and scan speed.
   Originality/value - Surface roughness is related to wear and friction property of the material and hence is related to the life time and performance of the part. Surface roughness is an important property of any material to be considered as biomaterial. The surface roughness of the material depends upon the manufacturing method and environment and hence it is controllable either during fabrication or by post processing. From the 1st order regression model developed in this study, it is also evident that sample thickness, scan speed and beam current have relatively more effect on roughness value then the offset focus. With the model obtained equation, a designer can subsequently select the best combination of sample thickness and process parameter values to achieve desired surface roughness.
C1 [Safdar, A.; He, H. Z.; Wei, Liu-Ying] Malmo Univ, Div Mat Sci, Sch Technol, Malmo, Sweden.
   [de Paz, Luis E. Chavez] Malmo Univ, Dept Oral Biol, Malmo, Sweden.
   [Snis, A.] Arcam AB, Malmo, Sweden.
RP Safdar, A (reprint author), Malmo Univ, Div Mat Sci, Sch Technol, Malmo, Sweden.
EM adnan.safdar@mah.se
RI Chavez de Paz, Luis/Q-3473-2016
OI Chavez de Paz, Luis/0000-0001-9493-9294
CR Braddely N., 2007, THESIS, P8
   Chinga G, 2007, J MICROSC-OXFORD, V227, P254, DOI 10.1111/j.1365-2818.2007.01809.x
   Cooper K. P., 2009, SUPPL P TMS, V1
   Cormier D, 2004, RAPID PROTOTYPING J, V10, P35, DOI 10.1108/13552540410512516
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dinda GP, 2008, METALL MATER TRANS A, V39A, P2914, DOI 10.1007/s11661-008-9634-y
   Gaytan SM, 2009, MATER TECHNOL, V24, P180, DOI 10.1179/106678509X12475882446133
   Hovis DB, 2010, J MICROSC-OXFORD, V240, P173, DOI 10.1111/j.1365-2818.2010.03399.x
   Kalinyuk AN, 2003, MAT SCI ENG A-STRUCT, V346, P178, DOI 10.1016/S0921-5093(02)00518-X
   LANGE DA, 1993, J MATER SCI, V28, P3879, DOI 10.1007/BF00353195
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Montgomery DC, 2005, DESIGN ANAL EXPT RES
   Murr LE, 2009, MATER CHARACT, V60, P96, DOI 10.1016/j.matchar.2008.07.006
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Pai D, 2010, ARPN J ENGINE APPL S, V5, P23
   Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540
   Thomsen P, 2009, J BIOMED MATER RES B, V90B, P35, DOI 10.1002/jbm.b.31250
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
NR 19
TC 35
Z9 39
U1 3
U2 35
PU EMERALD GROUP PUBLISHING LIMITED
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1355-2546
J9 RAPID PROTOTYPING J
JI Rapid Prototyping J.
PY 2012
VL 18
IS 5
BP 401
EP 408
DI 10.1108/13552541211250391
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 006RF
UT WOS:000308835800007
DA 2018-10-19
ER

PT J
AU Chung, C
   Anderson, E
   Pera, RR
   Pruitt, BL
   Heilshorn, SC
AF Chung, Cindy
   Anderson, Erica
   Pera, Renee Reijo
   Pruitt, Beth L.
   Heilshorn, Sarah C.
TI Hydrogel crosslinking density regulates temporal contractility of human
   embryonic stem cell-derived cardiomyocytes in 3D cultures
SO SOFT MATTER
LA English
DT Article
ID SUBSTRATE STIFFNESS AFFECTS; CHONDROCYTE METABOLISM; MATRIX;
   DIFFERENTIATION; COLLAGEN; BIOMATERIAL; MYOCARDIUM; MODULATION;
   PHENOTYPE; MYOCYTES
AB Systematically tunable in vitro platforms are invaluable in gaining insight to stem cell-microenvironment interactions in three-dimensional cultures. Utilizing recombinant protein technology, we independently tune hydrogel properties to systematically isolate the effects of matrix crosslinking density on cardiomyocyte differentiation, maturation, and function. We show that contracting human embryonic stem cell-derived cardiomyocytes (hESC-CMs) remain viable within four engineered elastin-like hydrogels of varying crosslinking densities with elastic moduli ranging from 0.45 to 2.4 kPa. Cardiomyocyte phenotype and function was maintained within hESC embryoid bodies for up to 2 weeks. Interestingly, increased crosslinking density was shown to transiently suspend spontaneous contractility. While encapsulated cells began spontaneous contractions at day 1 in hydrogels of the lowest crosslinking density, onset of contraction was increasingly delayed at higher crosslinking densities for up to 6 days. However, once spontaneous contraction was restored, the rate of contraction was similar within all materials (71 +/- 8 beats per min). Additionally, all groups successfully responded to electrical pacing at both 1 and 2 Hz. This study demonstrates that encapsulated hESC-CMs respond to 3D matrix crosslinking density within elastin-like hydrogels and stresses the importance of investigating temporal cellular responses in 3D cultures.
C1 [Anderson, Erica; Pera, Renee Reijo] Inst Stem Cell Biol, Stanford, CA USA.
RP Heilshorn, SC (reprint author), McCullough Bldg,476 Lomita Mall, Stanford, CA USA.
EM heilshorn@stanford.edu
OI Pruitt, Beth L./0000-0002-4861-2124; Reijo Pera,
   Renee/0000-0002-6487-1329
FU AHA [10POST4190103]; Stanford Cardiovascular Institute Younger Grant;
   NSF [EFRI-CBE-0735551, DMR-084663]; NIH [1DP2OD006477, R33 HL089027];
   CIRM [RC1-00151-1]
FX The authors would like to thank Eric Chiao and Melanie Marchand from the
   Stanford Stem Cell Institute for Stem Cell Biology and Regenerative
   Medicine for hESC culture expertise. The authors acknowledge funding
   support from AHA 10POST4190103 (CC), Stanford Cardiovascular Institute
   Younger Grant, NSF EFRI-CBE-0735551, NSF DMR-084663, NIH 1DP2OD006477,
   NIH R33 HL089027, and CIRM RC1-00151-1.
CR Bajaj P, 2010, J BIOMED MATER RES A, V95A, P1261, DOI 10.1002/jbm.a.32951
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009
   Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Chaturvedi RR, 2010, CIRCULATION, V121, P979, DOI 10.1161/CIRCULATIONAHA.109.850677
   Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Evans N. D., 2009, EUR CELLS MATER, V18, P13
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Goldsmith EC, 2003, AM J PHYSIOL-HEART C, V284, pH2227, DOI 10.1152/ajpheart.00920.2002
   Hawkes SP, 2010, METHODS MOL BIOL, V622, P257, DOI 10.1007/978-1-60327-299-5_16
   HOWE RS, 1991, J ULTRAS MED, V10, P367, DOI 10.7863/jum.1991.10.7.367
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014
   Kandalam V, 2011, CIRCULATION, V124, P2094, DOI 10.1161/CIRCULATIONAHA.111.030338
   Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Lee PF, 2009, EXP CELL RES, V315, P396, DOI 10.1016/j.yexcr.2008.10.040
   Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   McCain ML, 2011, PFLUG ARCH EUR J PHY, V462, P89, DOI 10.1007/s00424-011-0951-4
   Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c
   Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033
   Sargent CY, 2009, TISSUE ENG PT A, V15, P331, DOI 10.1089/ten.tea.2008.0145
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Shi LF, 2006, J AM CHEM SOC, V128, P10378, DOI 10.1021/ja063509o
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Tracqui P, 2008, J THEOR BIOL, V255, P92, DOI 10.1016/j.jtbi.2008.07.036
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492
NR 37
TC 30
Z9 32
U1 1
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 39
BP 10141
EP 10148
DI 10.1039/c2sm26082d
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 007IU
UT WOS:000308882800024
PM 23226161
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Dev, SRS
   Raghavan, VGS
AF Dev, Satyanarayan R. S.
   Raghavan, Vijaya G. S.
TI Advancements in Drying Techniques for Food, Fiber, and Fuel
SO DRYING TECHNOLOGY
LA English
DT Article
DE Drying; Fiber; Food; Fuel
ID SHELF-LIFE EXTENSION; STEAM FLUIDIZED-BED; SINGLE-MODE CAVITY; HEAT-PUMP
   DRYERS; OSMOTIC DEHYDRATION; MASS-TRANSFER; SUPERHEATED-STEAM; SURFACE
   DISCOLORATION; PRESSURE PRETREATMENT; ANTIOXIDANT ACTIVITY
AB Removal of moisture from biological materials, popularly called drying, has numerous benefits, including ease of handling due to reduction in bulk, resulting in reduced handling costs. Moreover, drying prevents microbial growth and spoilage. Though different drying techniques share a common objective, conceptually they are different and require modification/adaptation based on the biomaterial that is dried. There have been significant scientific advancements in the past century in the field of drying of foods, fibers, and fuel. This article will provide an extensive review of various drying pretreatments and different hybrid drying techniques, including supercritical and fluidized bed concepts, microwave drying, superheated steam drying, and heat pump drying to meet tomorrow's food and energy needs.
C1 [Dev, Satyanarayan R. S.; Raghavan, Vijaya G. S.] McGill Univ, Dept Bioresource Engn, Ste Anne De Bellevue, PQ H9X3V9, Canada.
RP Dev, SRS (reprint author), McGill Univ, Dept Bioresource Engn, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X3V9, Canada.
EM satyanarayan.dev@gmail.com
OI Dev, Satyanarayan/0000-0003-2667-433X
FU Natural Science and Engineering Research Council (NSERC); Fonds de
   recherche du Quebec-Nature et technologies (FQRNT); Canadian
   International Development Agency (CIDA) of Canada
FX The authors are grateful to Dr. Kudra and the reviewers for their
   valuable comments and suggestions, which improved the quality of this
   article. The authors appreciate the dedication and enormous
   contributions of Dr. Mujumdar to the research and development of drying
   and gratefully acknowledge the financial support of research funding
   agencies Natural Science and Engineering Research Council (NSERC), Fonds
   de recherche du Quebec-Nature et technologies (FQRNT), and Canadian
   International Development Agency (CIDA) of Canada.
CR Achariyaviriya A., 2002, INT J AMBIENT ENERGY, V23, P212
   Ade-Omowaye B. I. O., 2003, Innovative Food Science & Emerging Technologies, V4, P177, DOI 10.1016/S1466-8564(03)00020-1
   Ade-Omowaye BIO, 2003, J FOOD ENG, V60, P89, DOI 10.1016/S0260-8774(03)00021-9
   African Post Harvest Losses Information System, EST POSTH LOSS 2003
   Alves-Filho O., 2004, 14 INT DRYING S IDS
   Azura E., 1996, FOOD RES INT, V29, P195
   Bajgai TR, 2006, J FOOD ENG, V74, P308, DOI 10.1016/j.jfoodeng.2005.03.023
   Baker C. G. J., 2005, Stewart Postharvest Review, V1, P8, DOI 10.2212/spr.2005.4.8
   Bantle M, 2011, DRY TECHNOL, V29, P1230, DOI 10.1080/07373937.2011.584256
   Bazyma L.A., 2005, STEWART POSTHARVEST, V1, P1
   Beaudry C, 2004, DRY TECHNOL, V22, P521, DOI 10.1081/DRT-120029999
   BOLIN HR, 1983, J FOOD SCI, V48, P202, DOI 10.1111/j.1365-2621.1983.tb14823.x
   BOLIN HR, 1991, J FOOD SCI, V56, P416, DOI 10.1111/j.1365-2621.1991.tb05293.x
   Brown M., 1999, Food Manufacture, V74, P34
   Brown ZK, 2008, INNOV FOOD SCI EMERG, V9, P280, DOI 10.1016/j.ifset.2007.07.003
   [Canadian Forestry Service Canadian Electrical Association], 1980, STUDY HOG FUEL DRYIN
   CARLIN F, 1990, J FOOD SCI, V55, P1033, DOI 10.1111/j.1365-2621.1990.tb01591.x
   Changrue V., 2004, 14 INT DRYING S IDS
   Charron J.-M., 1990, 34SZ2328376040 BIOEN
   Chou SK, 2001, TRENDS FOOD SCI TECH, V12, P359, DOI 10.1016/S0924-2244(01)00102-9
   Chu CP, 2001, WATER RES, V35, P2377, DOI 10.1016/S0043-1354(00)00539-X
   Chua KJ, 2000, DRY TECHNOL, V18, P907, DOI 10.1080/07373930008917744
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   CONWAY J, 1983, CAN I FOOD SC TECH J, V16, P25, DOI 10.1016/S0315-5463(83)72014-6
   Correa JLG, 2011, DRY TECHNOL, V29, P1556, DOI 10.1080/07373937.2011.582558
   Dev SRS, 2008, DRY TECHNOL, V26, P1238, DOI 10.1080/07373930802307167
   Devahastin S., 2008, DRYING TECHNOLOGIES, P160
   Di Matteo M, 2000, J FOOD ENG, V46, P83, DOI 10.1016/S0260-8774(00)00071-6
   Erle U., 2005, The microwave processing of foods, P142, DOI 10.1533/9781845690212.2.142
   FBT Inc., 1994, FLUID BED COMB GAS G
   Feng H, 1999, J FOOD PROCESS PRES, V23, P463, DOI 10.1111/j.1745-4549.1999.tb00398.x
   Filkova I, 1995, HDB IND DRYING, P263
   Frea W.J., 1984, P BIOM FUEL DRYING C, P56
   Fredrikson R.W., 1984, P BIOM FUEL DRYING, P1
   Gabas A.L., 2004, 14 INT DRYING S IDS
   Garcia-Perez JV, 2011, DRY TECHNOL, V29, P1499, DOI 10.1080/07373937.2011.576321
   [Georgia Institute of Technology Technology Applications Laboratory], 1984, IND WOOD EN HDB
   Grabowski S, 2003, HDB POSTHARVEST TECH, P653
   Gustavsson J., 2011, GLOBAL FOOD LOSSES F
   Hall CW, 1996, DRY TECHNOL, V14, P1419, DOI 10.1080/07373939608917154
   Hammami C, 1997, J FOOD ENG, V32, P133, DOI 10.1016/S0260-8774(97)00023-X
   Hawkes J., 1978, Journal of Food Processing and Preservation, V2, P265, DOI 10.1111/j.1745-4549.1978.tb00562.x
   Hawlader MNA, 2006, J FOOD ENG, V74, P392, DOI 10.1016/j.jfoodeng.2005.03.028
   HAYDAR M, 1980, J AGR FOOD CHEM, V28, P383, DOI 10.1021/jf60228a048
   Heinrich S, 1999, CHEM ENG PROCESS, V38, P131, DOI 10.1016/S0255-2701(98)00082-8
   HOGAN MR, 1983, T ASAE, V26, P1234
   HOWARD LR, 1994, J FOOD SCI, V59, P110, DOI 10.1111/j.1365-2621.1994.tb06909.x
   HOWARD LR, 1993, J FOOD SCI, V58, P1065, DOI 10.1111/j.1365-2621.1993.tb06113.x
   Hsuch L., 2003, FOOD CHEM, V83, P85
   Hulkkonen S., 1995, P 13 INT C FLUID BED, P391
   ISLAM MN, 1982, J FOOD TECHNOL, V17, P387, DOI 10.1127/0935-1221/2005/0017-0387
   JAYARAMAN KS, 1992, DRY TECHNOL, V10, P1, DOI 10.1080/07373939208916413
   Khin M. M., 2005, INT J FOOD ENG, V1, P1
   Khraisheh MAM, 2004, FOOD RES INT, V37, P497, DOI 10.1016/j.foodres.2003.11.010
   Kohayakawa M.N., 2004, 14 INT DRYING S IDS
   Kudra T, 2009, ADV DRYING TECHNOLOG
   Kudra T., 2009, ADV DRYING TECHNOLOG, P427
   LAZARIDES HN, 1995, J FOOD ENG, V25, P151, DOI 10.1016/0260-8774(94)00006-U
   Le Maguer M., 1998, INT S PROGR FOOD PRE
   Lee C.A., 1964, U.S. Patent, Patent No. 3150037
   Leeratanarak N, 2006, J FOOD ENG, V77, P635, DOI 10.1016/j.jfoodeng.2005.07.022
   LENART A, 1984, J FOOD TECHNOL, V19, P45
   Lenart A, 1996, DRY TECHNOL, V14, P391, DOI 10.1080/07373939608917104
   LERICI CR, 1985, J FOOD SCI, V50, P1217, DOI 10.1111/j.1365-2621.1985.tb10445.x
   Li ZY, 2011, DRY TECHNOL, V29, P652, DOI 10.1080/07373937.2010.521963
   Linderoth C.E., 1992, ALT FUELS 3 C WASH D
   MacCallum C., 1981, COST BENEFIT ANAL SY
   Mason T.J., 1996, ULTRASON SONOCHEM, V3, P253
   Mason T. J., 1998, ULTRASOUND FOOD PROC, P105
   Masters K, 2004, DRY TECHNOL, V22, P1351, DOI 10.1081/DRT-120038733
   Masters K., 1991, SPRAY DRYING HDB
   Mayor L, 2004, J FOOD ENG, V61, P373, DOI 10.1016/S0260-8774(03)00144-4
   McInerney JK, 2007, INNOV FOOD SCI EMERG, V8, P543, DOI 10.1016/j.ifset.2007.04.005
   Meda S.V., 2004, BIOSYST ENG, V88, P1
   Mothibe KJ, 2011, DRY TECHNOL, V29, P1611, DOI 10.1080/07373937.2011.602576
   Mudahar G. S., 1991, J FOOD SCI, V57, P526
   Mujumdar A, 2006, HDB IND DRYING
   Nijhuis HH, 1998, TRENDS FOOD SCI TECH, V9, P13, DOI 10.1016/S0924-2244(97)00007-1
   Nindo CI, 2003, LEBENSM-WISS TECHNOL, V36, P507, DOI 10.1016/S0023-6438(03)00046-X
   Nsonzi F, 1998, DRY TECHNOL, V16, P725, DOI 10.1080/07373939808917432
   Okos MR, 1992, HDB FOOD ENG, P437
   ONAYEMI O, 1987, PLANT FOOD HUM NUTR, V37, P291, DOI 10.1007/BF01092204
   Orsat V., 2005, The microwave processing of foods, P105, DOI 10.1533/9781845690212.2.105
   Orsat V., 2006, STEWART POSTHARVEST, V2, P4
   PAAKKONEN K, 1991, J FOOD SCI, V56, P1388, DOI 10.1111/j.1365-2621.1991.tb04781.x
   Palou E., 2006, HDB FOOD PRESERVATIO, P815
   Queiroz R, 2004, DRY TECHNOL, V22, P1603, DOI 10.1081/DRT-200025614
   Raghavan G.S.V., 1998, 11 INT DRYING S IDS
   Raghavan GSV, 2005, BRAZ J CHEM ENG, V22, P195, DOI 10.1590/S0104-66322005000200005
   Rahman M. S., 1999, HDB FOOD PRESERVATIO, P339
   Rastogi NK, 2008, J FOOD ENG, V88, P541, DOI 10.1016/j.jfoodeng.2008.03.016
   Rastogi NK, 2004, LEBENSM-WISS TECHNOL, V37, P43, DOI 10.1016/S0023-6438(03)00131-2
   Rastogi NK, 1998, J FOOD SCI, V63, P508, DOI 10.1111/j.1365-2621.1998.tb15774.x
   Rastogi NK, 1999, J FOOD SCI, V64, P1020, DOI 10.1111/j.1365-2621.1999.tb12272.x
   Regalado Carlos, 2004, Phytochemistry Reviews, V3, P243, DOI 10.1023/B:PHYT.0000047797.81958.69
   Rolle S., 1987, J FOOD QUALITY, V10, P157
   Sagar VR, 2007, ACTA HORTIC, P579, DOI 10.17660/ActaHortic.2007.735.75
   Seco JIFG, 2004, HOLZ ROH WERKST, V62, P261, DOI 10.1007/s00107-004-0483-0
   Shi JX, 1997, FOOD RES INT, V30, P669, DOI 10.1016/S0963-9969(98)00031-3
   Shishehgarha F, 2002, DRY TECHNOL, V20, P131, DOI 10.1081/DRT-120001370
   Singh S., 2008, AFRICAN J FOOD SCI, V2, P65
   Sosle V, 2003, DRY TECHNOL, V21, P539, DOI 10.1081/DRT-120018461
   Spencer R.M., 1996, U.S. Patent, Patent No. 5656238
   St George S.D., 2004, N CENTR ASAE CSAE C
   Kumar PS, 2006, J SCI IND RES INDIA, V65, P659
   Taechapairoj C, 2006, J FOOD ENG, V76, P411, DOI 10.1016/j.jfoodeng.2005.05.040
   Taiwo KA, 2002, J FOOD ENG, V52, P185, DOI 10.1016/S0260-8774(01)00102-9
   Talens P., 2000, P 12 INT DRYING S ID
   Tatemoto Y, 2007, CHEM ENG SCI, V62, P471, DOI 10.1016/j.ces.2006.09.016
   Tedjo W., 2002, J FOOD ENG, V56, P131
   Tokusoglu O., 2009, INNOV FOOD SCI EMERG, V11, P250
   TRIPATHI RN, 1989, J FOOD SCI TECH MYS, V26, P137
   Tulasidas TN, 1995, DRY TECHNOL, V13, P1949, DOI 10.1080/07373939508917058
   Tulasidas TN, 1995, DRY TECHNOL, V13, P1973, DOI 10.1080/07373939508917059
   TULASIDAS TN, 1993, T ASAE, V36, P1861
   Uddin M.S., 2004, 14 INT DRYING S IDS
   Vega-Galvez A, 2011, LWT-FOOD SCI TECHNOL, V44, P384, DOI 10.1016/j.lwt.2010.08.004
   Wang J, 2005, J FOOD ENG, V68, P505, DOI 10.1016/j.jfoodeng.2004.06.027
   Wang W., 2002, 13 INT DRYING S IDS
   Xian-Ju Song, 2007, Drying Technology, V25, P2021
   Yang DY, 2011, DRY TECHNOL, V29, P1325, DOI 10.1080/07373937.2011.592047
   Yucel U, 2010, J FOOD ENG, V98, P266, DOI 10.1016/j.jfoodeng.2010.01.006
NR 122
TC 34
Z9 36
U1 3
U2 33
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0737-3937
EI 1532-2300
J9 DRY TECHNOL
JI Dry. Technol.
PY 2012
VL 30
IS 11-12
SI SI
BP 1147
EP 1159
DI 10.1080/07373937.2012.692747
PG 13
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 995OR
UT WOS:000308020100005
DA 2018-10-19
ER

PT J
AU Ekinci, D
   Sisson, AL
   Lendlein, A
AF Ekinci, Duygu
   Sisson, Adam L.
   Lendlein, Andreas
TI Polyglycerol-based polymer network films for potential biomedical
   applications
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID WEIGHT HYPERBRANCHED POLYGLYCEROLS; CATIONIC-POLYMERIZATION;
   POLY(ETHYLENE GLYCOL); REGENERATIVE MEDICINE; GLYCIDYL ETHERS;
   HYDROGELS; PHOTOPOLYMERIZATION; ALTERNATIVES; MECHANISM; SCIENCE
AB Synthetic polymeric materials are established as being central to many modern approaches to medical treatments such as biomaterial induced tissue regeneration or drug eluting implants. Cytocompatible, antifouling materials, based on hydrophilic polymers such as poly(ethylene glycol), have been widely studied as a 'blank canvas' substrate; it is possible to apply various bioactive ligands to elicit specific tissue and cell responses. In recent years, branched polyglycerols have gained attention as a viable alternative to PEG as a protein-resistance providing chemical moiety. To this end we have embarked on the preparation of bulk polyglycerol-based films, which are readily synthesized from abundant starting materials, with the aim of evaluating their as yet undiscovered potential as macroscopic biomaterials. Herein we report syntheses, as well as mechanical, and rheological properties of a series of polyglycerol-based polymer networks. Polymeric films produced are highly crosslinked, have high thermal stability, and are flexible with thermal glass transition temperatures below body temperature.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Badawi HM, 2009, SPECTROCHIM ACTA A, V74, P558, DOI 10.1016/j.saa.2009.07.002
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chiniwalla P, 2003, J APPL POLYM SCI, V89, P568, DOI 10.1002/app.12234
   Crivello JV, 2006, J POLYM SCI POL CHEM, V44, P6435, DOI 10.1002/pola.21761
   Crivello JV, 2009, J POLYM SCI POL CHEM, V47, P866, DOI 10.1002/pola.23203
   Crivello JV, 2006, J POLYM SCI POL CHEM, V44, P3036, DOI 10.1002/pola.21419
   CRIVELLO JV, 1978, J POLYM SCI POL CHEM, V16, P2441, DOI 10.1002/pol.1978.170161004
   Dean KM, 2006, EUR POLYM J, V42, P2872, DOI 10.1016/j.eurpolymj.2006.04.013
   DEKTAR JL, 1990, J ORG CHEM, V55, P639, DOI 10.1021/jo00289a045
   Diez E, 2011, CHEM ENGINEER TRANS, V24, P553, DOI 10.3303/CET1124093
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   DWORAK A, 1995, MACROMOL CHEM PHYSIC, V196, P1963, DOI 10.1002/macp.1995.021960616
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Hirose Y, 2006, MACROMOLECULES, V39, P1779, DOI 10.1021/ma052216x
   Ishida H, 1996, POLYMER, V37, P4487, DOI 10.1016/0032-3861(96)00303-5
   Jian XX, 2009, POLYM BULL, V63, P225, DOI 10.1007/s00289-009-0080-9
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   Kainthan RK, 2006, MACROMOLECULES, V39, P7708, DOI 10.1021/ma0613483
   Kallukalam BC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015002
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kwisnek L, 2010, MACROMOLECULES, V43, P3859
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Meier MAR, 2007, CHEM SOC REV, V36, P1788, DOI 10.1039/b703294c
   Oudshoorn MHM, 2007, LANGMUIR, V23, P11819, DOI 10.1021/la701910d
   Oudshoorn MHM, 2006, BIOMATERIALS, V27, P5471, DOI 10.1016/j.biomaterials.2006.06.030
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Rana D, 2010, CHEM REV, V110, P2448, DOI 10.1021/cr800208y
   Shastri VP, 2010, MRS BULL, V35, P571, DOI 10.1557/mrs2010.524
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Sisson AL, 2010, SOFT MATTER, V6, P4968, DOI 10.1039/c0sm00149j
   Sisson AL, 2009, ANGEW CHEM INT EDIT, V48, P7540, DOI 10.1002/anie.200901583
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Steinhilber D, 2011, BIOMATERIALS, V32, P1311, DOI 10.1016/j.biomaterials.2010.10.010
   Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w
   Todd SJ, 2007, SOFT MATTER, V3, P547, DOI 10.1039/b618256a
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   TOKAR R, 1994, MACROMOLECULES, V27, P320, DOI 10.1021/ma00080a002
   Vargas EAT, 2010, ACTA BIOMATER, V6, P1069, DOI 10.1016/j.actbio.2009.09.018
   VANDENBERG EJ, 1985, J POLYM SCI POL CHEM, V23, P915, DOI 10.1002/pol.1985.170230401
   Weinhart M, 2011, CHEM COMMUN, V47, P1553, DOI 10.1039/c0cc04002a
   Wilms D, 2010, ACCOUNTS CHEM RES, V43, P129, DOI 10.1021/ar900158p
   Zhou HX, 2011, REACT FUNCT POLYM, V71, P356, DOI 10.1016/j.reactfunctpolym.2010.11.018
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 49
TC 9
Z9 9
U1 0
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 39
BP 21100
EP 21109
DI 10.1039/c2jm34271e
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 007MW
UT WOS:000308893400042
DA 2018-10-19
ER

PT S
AU Safonov, V
   Zykova, A
   Smolik, J
   Rogovska, R
   Donkov, N
   Goltsev, A
   Dubrava, T
   Rassokha, I
   Georgieva, V
AF Safonov, V.
   Zykova, A.
   Smolik, J.
   Rogovska, R.
   Donkov, N.
   Goltsev, A.
   Dubrava, T.
   Rassokha, I.
   Georgieva, V.
BE VanDeSanden, MCM
   Dimitrova, M
   Ghelev, C
TI Nanoscale biomaterial interface modification for advanced tissue
   engineering applications
SO 17TH INTERNATIONAL SUMMER SCHOOL ON VACUUM, ELECTRON, AND ION
   TECHNOLOGIES (VEIT 2011)
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 17th International Summer School on Vacuum, Electron, and Ion
   Technologies (VEIT)
CY SEP 19-23, 2011
CL BULGARIA
SP Eindhoven Univ Technol, Dept Appl Phys
ID SURFACE
AB Recently, various stem cells, including mesenchymal stem cells (MSCs), have been found to have considerable potential for application in tissue engineering and future advanced therapies due to their biological capability to differentiate into specific lineages. Modified surface properties, such as composition, nano-roughness and wettability, affect the most important processes at the biomaterial interface. The aim of the present is work is to study the stem cells' (MSCs) adhesive potential, morphology, phenotypical characteristics in in vitro tests, and to distinguish betwen the different factors influencing the cell/biomaterial interaction, such as nano-topography, surface chemistry and surface free energy.
C1 [Safonov, V.; Zykova, A.] Kharkov Inst Phys & Technol NSC, Kharkov, Ukraine.
   [Smolik, J.; Rogovska, R.] NRC, Inst Sustainable Technol, Radom, Poland.
   [Donkov, N.] Bulgarian Acad Sci, B-1784 Sofia, Bulgaria.
   [Goltsev, A.; Dubrava, T.; Rassokha, I.] NASU, Inst Problems Crybiol & Cryomed, Kharkov, Ukraine.
   [Georgieva, V.] Bulgarian Acad Sci, Georgi Nadjakov Inst Solid State Phys, B-1784 Sofia, Bulgaria.
RP Safonov, V (reprint author), Kharkov Inst Phys & Technol NSC, Kharkov, Ukraine.
EM ais@kharkov.ua
FU Targeted Research and Development Initiatives Program of the Science and
   Technology Center in Ukraine (STCU) [4974]; Program for Cooperation
   between the Bulgarian Academy of Science; National Ukrainian Academy of
   Science
FX The study was supported by grant 4974 Targeted Research and Development
   Initiatives Program of the Science and Technology Center in Ukraine
   (STCU) and by the Program for Cooperation between the Bulgarian Academy
   of Science and the National Ukrainian Academy of Science.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dhayal M, 2008, APPL SURF SCI, V254, P3331, DOI 10.1016/j.apsusc.2007.11.026
   Goltsev A, 2011, J NUMERICAL IN PRESS
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Safonov V, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012068
   Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zykova A., 2007, PROBLEMS ATOMIC SCI, V13, P200
NR 9
TC 4
Z9 4
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2012
VL 356
AR 012046
DI 10.1088/1742-6596/356/1/012046
PG 4
WC Physics, Applied; Physics, Multidisciplinary
SC Physics
GA BBQ60
UT WOS:000307884600047
OA Bronze
DA 2018-10-19
ER

PT J
AU Bilsel, Y
   Abci, I
AF Bilsel, Yilmaz
   Abci, Ilker
TI The search for ideal hernia repair; mesh materials and types
SO INTERNATIONAL JOURNAL OF SURGERY
LA English
DT Review
DE Hernia; Mesh; Prosthetic; Synthetic; Biomaterial; Bioprosthetic
ID RANDOMIZED CLINICAL-TRIAL; POLYPROPYLENE MESH; INCISIONAL HERNIA;
   INTRAABDOMINAL PROSTHETICS; EXPLANTED POLYPROPYLENE; PREPERITONEAL
   SPACE; TISSUE INTEGRATION; ADHESION FORMATION; COMPOSITE MESH;
   ABDOMINAL-WALL
AB Hernia surgery continues to draw the attention of surgeons, patients, and the industry. This strong interest has driven the establishment of professional medical societies with the sole purpose of furthering the understanding of hernias and hernia repair. In the more than 100 years of development, industry has played a major role in advancing the technology to perfect the performance of hernia repair with the hope of establishing the "best" technique and its associated technology. However, with the development of newer prosthetics and approaches to hernia repair, many surgeons do not fully understand the properties of the available prosthetics. The goal of this review is to highlight the different types of meshes in an effort to clarify to surgeons what types of materials are available to them and how to select an appropriate one for a given case. (C) 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
C1 [Bilsel, Yilmaz; Abci, Ilker] Hisar Intercontinental Hosp, Dept Gen Surg, TR-34768 Istanbul, Turkey.
RP Bilsel, Y (reprint author), Hisar Intercontinental Hosp, Dept Gen Surg, Alemdag Caddesi,Site Yolu Sokak 7, TR-34768 Istanbul, Turkey.
EM drbilsel@gmail.com
CR Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Aquaviva D, 1944, EXTRAITS B SOC CHIR, V17
   Bachman S, 2008, SURG CLIN N AM, V88, P101, DOI 10.1016/j.suc.2007.11.001
   Balique G, 2005, HERNIA, V9, P68
   Bellon JM, 2009, J BIOMED MATER RES B, V89B, P448, DOI 10.1002/jbm.b.31234
   Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024
   Binnebosel M, 2011, SEMIN IMMUNOPATHOL, V33, P235, DOI 10.1007/s00281-010-0237-5
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   Cobb WS, 2009, HERNIA, V13, P1, DOI 10.1007/s10029-008-0428-3
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   Cobb WS, 2005, J SURG RES, V129, P231, DOI 10.1016/j.jss.2005.06.015
   Conze J, 2005, BRIT J SURG, V92, P1488, DOI 10.1002/bjs.5208
   Costello CR, 2007, J BIOMED MATER RES B, V83B, P44, DOI 10.1002/jbm.b.30764
   Cozad MJ, 2010, J BIOMED MATER RES B, V94B, P455, DOI 10.1002/jbm.b.31675
   Deeken CR, 2011, J AM COLL SURGEONS, V212, P68, DOI 10.1016/j.jamcollsurg.2010.09.012
   El-Hayek Kevin M, 2010, J Long Term Eff Med Implants, V20, P159
   Goepel R, 1900, VERK DTSCH GES CHIR, V9, P174
   Gonzalez R, 2004, Hernia, V8, P213
   Gonzalez R, 2003, AM SURGEON, V69, P471
   Grevious MA, 2006, CLIN PLAST SURG, V33, P169, DOI 10.1016/j.cps.2005.12.005
   Harrell AG, 2006, AM SURGEON, V72, P808
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hodde J, 2007, ACTA CHIR BELG, V107, P641, DOI 10.1080/00015458.2007.11680139
   Klinge U, 1998, EUR J SURG, V164, P965
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klosterhalfen B, 2005, EXPERT REV MED DEVIC, V2, P103, DOI 10.1586/17434440.2.1.103
   Koch A, 2008, BRIT J SURG, V95, P1226, DOI 10.1002/bjs.6325
   KOONTZ AR, 1959, SURG GYNECOL OBSTET, V109, P321
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Pereira-Lucena CG, 2010, HERNIA, V14, P299, DOI 10.1007/s10029-009-0621-z
   Procter L, 2009, STUD MECHANOBIOL TIS, V1, P425
   Rodriguez M, 2011, J INVEST SURG, V24, P115, DOI 10.3109/08941939.2011.555059
   Saberski ER, 2011, HERNIA, V15, P47, DOI 10.1007/s10029-010-0731-7
   Schmidbauer S, 2005, EUR J MED RES, V10, P247
   Skandalakis JE, 2002, NYHUS CONDONS HERNIA, P39
   Voeller GR, 2003, AM SURGEON, V69, P476
   Voeller GR, 2006, AM SURGEON, V72, P813
NR 39
TC 53
Z9 55
U1 3
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1743-9191
J9 INT J SURG
JI Int. J. Surg.
PY 2012
VL 10
IS 6
BP 317
EP 321
DI 10.1016/j.ijsu.2012.05.002
PG 5
WC Surgery
SC Surgery
GA 990OH
UT WOS:000307639800010
PM 22588090
OA Bronze
DA 2018-10-19
ER

PT J
AU Wong, I
   Ding, XT
   Wu, CS
   Ho, CM
AF Wong, Ieong
   Ding, Xianting
   Wu, Chunsheng
   Ho, Chih-Ming
TI Accurate and effective live bacteria microarray patterning on thick
   polycationic polymer layers co-patterned with HMDS
SO RSC ADVANCES
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; BIOMATERIAL SURFACES; MOTILE BACTERIA;
   L-LYSINE; ADHESION; NANOPARTICLES; ARRAYS; CELLS
AB A new bacteria microarray patterning technique is developed by patterning thick polycationic polymers on a glass surface, which generates high-coverage and high-precision E. coli cell patterns. Cell immobilization efficiency is greatly improved, compared to that of the conventional monolayer surface patterning approach. Cell viability tests show very low cytotoxicity of polyethyleneimine (PEI). This advancement should further accelerate biomedical and bacteriological research on the micro scale.
C1 [Wong, Ieong; Ding, Xianting; Ho, Chih-Ming] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Sch Engn & Appl Sci, Los Angeles, CA 90095 USA.
   [Wu, Chunsheng] Zhejiang Univ, Dept Biomed Engn, MOE Key Lab Biomed Engn, Biosensor Natl Special Lab, Hangzhou 310027, Peoples R China.
RP Wong, I (reprint author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Sch Engn & Appl Sci, 420 Westwood Plaza, Los Angeles, CA 90095 USA.
EM chihming@ucla.edu
RI Ho, Chih-ming/I-6537-2012; Wu, Chunsheng/E-6224-2012
OI Wu, Chunsheng/0000-0002-2126-1651; Ho, Chih-Ming/0000-0001-7369-5446
FU Center for Cell Control through the NIH Roadmap for Nanomedicine
   [PN2EY018228]; Center for Scalable and Integrated Nanomanufacturing
   (SINAM) under the National Science Foundation [CMMI-0751621]
FX The authors thank Prof. James C. Liao at University of California, Los
   Angeles for providing the E. coli cells. This work was supported by the
   Center for Cell Control (PN2EY018228) through the NIH Roadmap for
   Nanomedicine and the Center for Scalable and Integrated
   Nanomanufacturing (SINAM) under the National Science Foundation
   (CMMI-0751621).
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bearinger JP, 2009, BIOTECHNIQUES, V46, P209, DOI 10.2144/000113073
   Belkin S, 2003, CURR OPIN MICROBIOL, V6, P206, DOI 10.1016/S1369-5274(03)00059-6
   Berg HC, 2000, PHILOS T R SOC B, V355, P491, DOI 10.1098/rstb.2000.0590
   Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212
   Cau JC, 2008, MICROELECTRON ENG, V85, P1143, DOI 10.1016/j.mee.2008.01.103
   Cerf A, 2008, COLLOID SURFACE B, V65, P285, DOI 10.1016/j.colsurfb.2008.04.016
   Colville K., 2009, LANGMUIR, V26, P2639
   Howell SW, 2003, LANGMUIR, V19, P436, DOI 10.1021/la026365+
   Ingham CJ, 2008, LAB CHIP, V8, P1604, DOI 10.1039/b804790a
   Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104
   Kar M, 2010, LANGMUIR, V26, P5772, DOI 10.1021/la903595x
   Koh WG, 2003, BIOMED MICRODEVICES, V5, P11, DOI 10.1023/A:1024455114745
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   Lee KB, 2007, BIOMATERIALS, V28, P5594, DOI 10.1016/j.biomaterials.2007.08.036
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Li N., 2008, JALA, V13, P237
   Li N, 2008, LAB CHIP, V8, P2105, DOI 10.1039/b810329a
   Lin J, 2002, BIOTECHNOL PROGR, V18, P1082, DOI 10.1021/bp025597w
   Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Parsek MR, 2008, CURR OPIN MICROBIOL, V11, P560, DOI 10.1016/j.mib.2008.09.015
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Rowan B, 2002, LANGMUIR, V18, P9914, DOI 10.1021/la020664h
   Rozhok S, 2005, SMALL, V1, P445, DOI 10.1002/smll.200400072
   Rozhok S, 2006, LANGMUIR, V22, P11251, DOI 10.1012/la0609726
   SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449
   Suh KY, 2004, BIOMED MICRODEVICES, V6, P223, DOI 10.1023/B:BMMD.0000042052.47444.9a
   Suo ZY, 2008, LANGMUIR, V24, P4161, DOI 10.1021/la7038653
   VAARA M, 1983, ANTIMICROB AGENTS CH, V24, P114, DOI 10.1128/AAC.24.1.114
   Weibel DB, 2005, LANGMUIR, V21, P6436, DOI 10.1021/la0471713c
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Xu LP, 2007, NANO LETT, V7, P2068, DOI 10.1021/nl070983z
NR 34
TC 4
Z9 4
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2012
VL 2
IS 20
BP 7673
EP 7676
DI 10.1039/c2ra20938a
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 989TV
UT WOS:000307584300009
PM 23418622
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Matos, CC
   de Assis, AM
   Quites, LV
   Matos, DC
AF Matos, Cynthia Casagrande
   de Assis, Alda Milagres
   Quites, Lucas Viana
   Matos, Daniela Casagrande
TI Analysis of the ergonomic usage of the ARMflex (R) in the odontological
   area
SO WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION
LA English
DT Article
DE applied ergonomics; odontological area; design; semi- immobilization;
   biomaterial
AB The aim of this paper is to analyze the importance and applicability of ARMflex (R) in the odontological area and its influence in preventing or stopping the involuntary habit of improperly positioning the hand under the face or under the pillow. The ergonomic usage of ARMflex (R) influences the design in odontological areas and innovates in the semi-immobilization of the patient to prevent future orthodontic problems.
C1 [Matos, Cynthia Casagrande] Univ Ouro Preto, Belo Horizonte, MG, Brazil.
   [de Assis, Alda Milagres; Quites, Lucas Viana] Univ Minas Gerais, Belo Horizonte, MG, Brazil.
   [Matos, Daniela Casagrande] Univ Estado Minas Gerais, Belo Horizonte, MG, Brazil.
RP Matos, CC (reprint author), Univ Ouro Preto, Guajajaras 329-906B, Belo Horizonte, MG, Brazil.
EM cynthiacasagrande@gmail.com; aldamassis@yahoo.com.br; quites@gmail.com;
   danielamatos.uemg@gmail.com
CR Orefice RL, 2006, BIOMATERIALS FUNDAME
   Palmer C., 1976, ERGONOMIA
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Williams DF, 1987, P CONS C EUR SOC BIO, V4
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1051-9815
J9 WORK
JI Work
PY 2012
VL 41
SU 1
BP 5462
EP 5464
DI 10.3233/WOR-2012-0853-5462
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 973LO
UT WOS:000306361805116
PM 22317585
DA 2018-10-19
ER

PT J
AU Teixeira, LSM
   Leijten, JCH
   Sobral, J
   Jin, R
   van Apeldoorn, AA
   Feijen, J
   van Blitterswijk, C
   Dijkstra, PJ
   Karperien, M
AF Teixeira, L. S. Moreira
   Leijten, J. C. H.
   Sobral, J.
   Jin, R.
   van Apeldoorn, A. A.
   Feijen, J.
   van Blitterswijk, C.
   Dijkstra, P. J.
   Karperien, M.
TI HIGH THROUGHPUT GENERATED MICRO-AGGREGATES OF CHONDROCYTES STIMULATE
   CARTILAGE FORMATION IN VITRO AND IN VIVO
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Aggregation; chondrocyte; chondrogenesis; biomaterial; cartilage repair;
   cell therapy
ID OSTEOARTHRITIC HUMAN CARTILAGE; HUMAN ARTICULAR CHONDROCYTES; TISSUE;
   IMPLANTATION; HYDROGELS; CLUSTERS; REPAIR; KNEE; PROLIFERATION; CULTURE
AB Cell-based cartilage repair strategies such as matrix-induced autologous chondrocyte implantation (MACI) could be improved by enhancing cell performance. We hypothesised that micro-aggregates of chondrocytes generated in high-throughput prior to implantation in a defect could stimulate cartilaginous matrix deposition and remodelling. To address this issue, we designed a micro-mould to enable controlled high-throughput formation of micro-aggregates. Morphology, stability, gene expression profiles and chondrogenic potential of micro-aggregates of human and bovine chondrocytes were evaluated and compared to single-cells cultured in micro-wells and in 3D after encapsulation in Dextran-Tyramine (Dex-TA) hydrogels in vitro and in vivo. We successfully formed micro-aggregates of human and bovine chondrocytes with highly controlled size, stability and viability within 24 hours. Micro-aggregates of 100 cells presented a superior balance in Collagen type I and Collagen type II gene expression over single cells and micro-aggregates of 50 and 200 cells. Matrix metalloproteinases 1, 9 and 13 mRNA levels were decreased in micro-aggregates compared to single-cells. Histological and biochemical analysis demonstrated enhanced matrix deposition in constructs seeded with micro-aggregates cultured in vitro and in vivo, compared to single-cell seeded constructs. Whole genome microarray analysis and single gene expression profiles using human chondrocytes confirmed increased expression of cartilage-related genes when chondrocytes were cultured in micro-aggregates. In conclusion, we succeeded in controlled high-throughput formation of micro-aggregates of chondrocytes. Compared to single cell-seeded constructs, seeding of constructs with micro-aggregates greatly improved neocartilage formation. Therefore, micro-aggregation prior to chondrocyte implantation in current MACI procedures, may effectively accelerate hyaline cartilage formation.
C1 [Teixeira, L. S. Moreira; Leijten, J. C. H.; van Apeldoorn, A. A.; Dijkstra, P. J.; Karperien, M.] Univ Twente, Fac Sci & Technol, Dept Dev BioEngn, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Sobral, J.; van Blitterswijk, C.] Univ Twente, Fac Sci & Technol, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [Jin, R.; Feijen, J.; Dijkstra, P. J.] Univ Twente, Fac Sci & Technol, Dept Polymer Chem & Biomat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
RP Karperien, M (reprint author), Univ Twente, Fac Sci & Technol, Dept Dev BioEngn, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.
EM h.b.j.karperien@utwente.nl
RI Leijten, Jeroen/G-5311-2011; Moreira Teixeira, Liliana/G-6293-2011; van
   Apeldoorn, Aart/I-2767-2012; Dijkstra, Pieter/N-9328-2013
OI Leijten, Jeroen/0000-0002-8063-207X; van Apeldoorn,
   Aart/0000-0002-2940-5699; van Blitterswijk, Clemens/0000-0003-2371-4615
FU DPTE (Dutch Program for Tissue Engineering) of the Netherlands Ministry
   of Economic Affairs; TeRM Smart Mix Program of the Netherlands Ministry
   of Economic Affairs; Netherlands Ministry of Education, Culture and
   Science
FX The authors gratefully acknowledge the support of the DPTE (Dutch
   Program for Tissue Engineering) and the TeRM Smart Mix Program of the
   Netherlands Ministry of Economic Affairs and the Netherlands Ministry of
   Education, Culture and Science. The authors report that no competing
   financial interests exist.
CR Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Aurich M, 2005, ARTHRITIS RHEUM, V52, P112, DOI 10.1002/art.20740
   Batty L, 2011, ANZ J SURG, V81, P18, DOI 10.1111/j.1445-2197.2010.05495.x
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Furukawa KS, 2003, CELL TRANSPLANT, V12, P475, DOI 10.3727/000000003108747037
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Hamilton DW, 2006, TISSUE ENG, V12, P189, DOI 10.1089/ten.2006.12.189
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Jin R, 2010, TISSUE ENG PT A, V16, P2429, DOI [10.1089/ten.tea.2009.0764, 10.1089/ten.TEA.2009.0764]
   Jones DG, 2006, J BONE JOINT SURG AM, V88A, P2502, DOI 10.2106/00004623-200611000-00025
   Kelm JM, 2004, TRENDS BIOTECHNOL, V22, P195, DOI 10.1016/j.tibtech.2004.02.002
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kouri JB, 1998, MICROSC RES TECHNIQ, V40, P22, DOI 10.1002/(SICI)1097-0029(19980101)40:1<22::AID-JEMT4>3.0.CO;2-Z
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Lee GM, 2000, OSTEOARTHR CARTILAGE, V8, P44, DOI 10.1053/joca.1999.0269
   Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528
   Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159
   McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501
   Penick KJ, 2005, BIOTECHNIQUES, V39, P687, DOI 10.2144/000112009
   Pfander D, 2001, Z ORTHOP GRENZGEB, V139, P375, DOI 10.1055/s-2001-17977
   Polacek M, 2010, J ORTHOP RES, V28, P1040, DOI 10.1002/jor.21067
   Poole A R, 1993, Agents Actions Suppl, V39, P3
   Schumacher BL, 2002, ANAT REC, V266, P241, DOI 10.1002/ar.10063
   Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850
   Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Teixeira LSM, 2012, BIOMATERIALS, V33, P3164, DOI 10.1016/j.biomaterials.2012.01.001
   Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005
   Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
NR 33
TC 44
Z9 44
U1 2
U2 21
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2012
VL 23
BP 387
EP 399
DI 10.22203/eCM.v023a30
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 989IT
UT WOS:000307554200030
PM 22665161
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Tai, HY
   Chou, SH
   Cheng, LP
   Yu, HT
   Don, TM
AF Tai, Hung-Yin
   Chou, Shiu-Huey
   Cheng, Liao-Ping
   Yu, Hung-Te
   Don, Trong-Ming
TI Asymmetric Composite Membranes from Chitosan and Tricalcium Phosphate
   Useful for Guided Bone Regeneration
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Chitosan; beta-tricalcium phosphate; asymmetric membrane; guided bone
   regeneration
ID IN-VIVO DEGRADATION; TISSUE REGENERATION; SCAFFOLDS; HYDROXYAPATITE;
   DEFECTS; VITRO; FILMS; BIOMATERIAL; DISSOLUTION; ATTACHMENT
AB To fulfill the properties of barrier membranes useful for guided bone tissue regeneration in the treatment of periodontitis, in this study a simple process combining lyophilization with preheating treatment to produce asymmetric barrier membranes from biodegradable chitosan (CS) and functional beta-tricalcium phosphate (TCP) was proposed. By preheating TCP/CS (3: 10, w/w) in an acetic acid solution at 40 degrees C, a skin layer that could greatly increase the mechanical properties of the membrane was formed. The asymmetric membrane with a skin layer had a modulus value almost 4-times that of the symmetric porous membrane produced only by lyophilization. This is beneficial for maintaining a secluded space for the bone regeneration, as well as to prevent the invasion of other tissues. The subsequent lyophilization at -20 degrees C then gave the rest of material an interconnected pore structure with high porosity (83.9-90.6%) and suitable pore size (50-150 mu m) which could promote the permeability and adhesiveness to bone cells, as demonstrated by the in vitro cell-culture of hFOB1.19 osteoblasts. Furthermore, the TCP particles added to CS could further increase the rigidity and the cell attachment and proliferation of hFOB1.19. The TCP/CS asymmetric composite membrane thus has the potential to be used as the barrier membrane for guided bone regeneration. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Tai, Hung-Yin; Cheng, Liao-Ping; Yu, Hung-Te; Don, Trong-Ming] Tamkang Univ, Dept Chem & Mat Engn, New Taipei City 25137, Taiwan.
   [Chou, Shiu-Huey] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City 24205, Taiwan.
RP Don, TM (reprint author), Tamkang Univ, Dept Chem & Mat Engn, New Taipei City 25137, Taiwan.
EM tmdon@mail.tku.edu.tw
OI Don, Trong-Ming/0000-0002-2577-2782
FU National Science Council in Taiwan
FX The authors would like to thank National Science Council in Taiwan for
   the financial support.
CR Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Azevedo H. S., 2004, BIODEGRADABLE SYSTEM, V12, P179
   Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CORTELLINI P, 1993, J PERIODONTOL, V64, P254, DOI 10.1902/jop.1993.64.4.254
   Don TM, 2005, CARBOHYD POLYM, V61, P334, DOI 10.1016/j.carbpol.2005.05.025
   Don TM, 2002, POLYM J, V34, P418, DOI 10.1295/polymj.34.418
   Don TM, 2002, J APPL POLYM SCI, V86, P3057, DOI 10.1002/app.11329
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Hamilton V, 2007, POLYM INT, V56, P641, DOI 10.1002/pi.2181
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Imbronito AV, 2002, BIOMATERIALS, V23, P4079, DOI 10.1016/S0142-9612(02)00145-X
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Jiang LY, 2009, J MATER SCI-MATER M, V20, P1645, DOI 10.1007/s10856-009-3720-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kuo SM, 2009, J APPL POLYM SCI, V112, P3127, DOI 10.1002/app.29664
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Liao F, 2010, J MATER SCI-MATER M, V21, P489, DOI 10.1007/s10856-009-3931-x
   Lim SM, 2008, J BIOMAT SCI-POLYM E, V19, P453, DOI 10.1163/156856208783719482
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mathieu LM, 2006, COMPOS SCI TECHNOL, V66, P1606, DOI 10.1016/j.compscitech.2005.11.012
   Nejati E, 2008, COMPOS PART A-APPL S, V39, P1589, DOI 10.1016/j.compositesa.2008.05.018
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Nublat C, 2006, J BIOMAT SCI-POLYM E, V17, P1333, DOI 10.1163/156856206778937262
   Osorio-Madrazo A, 2010, BIOMACROMOLECULES, V11, P1376, DOI 10.1021/bm1001685
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Teng SH, 2008, J BIOMED MATER RES B, V87B, P132, DOI 10.1002/jbm.b.31082
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 39
TC 4
Z9 4
U1 2
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 9
BP 1153
EP 1170
DI 10.1163/092050611X576657
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 987VF
UT WOS:000307445200002
PM 21619730
DA 2018-10-19
ER

PT J
AU Wongpanit, P
   Rujiravanit, R
AF Wongpanit, Panya
   Rujiravanit, Ratana
TI Combinatorial Effects of Charge Characteristics and Hydrophobicity of
   Silk Fibroin on the Sorption and Release of Charged Dyes
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Silk fibroin; electrostatic; hydrophobicity; release; partition
   coefficient
ID FIBROBLAST-GROWTH-FACTOR; HYALURONIC-ACID; IN-VITRO; DELIVERY;
   BIOMATERIAL; PROTEIN; FILMS; MICROSPHERES; ORGANIZATION; MECHANISM
AB The present study was designed to examine the influence of the charge characteristics of silk fibroin on the sorption and release of charged dyes by varying the pH values of the sorption and release media as well as types of charged dyes. Negatively charged dyes (phenol red and chromotrope 2R) and positively charged dyes (crystal violet and indoine blue) were used as the model compounds. Silk fibroin films were prepared by using a solution casting technique. The prepared films were then treated with an aqueous methanol solution or annealed with water to control their conformation. The sorption behavior of the model compounds made by the methanol-treated and water-annealed silk fibroin films was investigated. Compared to the water-annealed silk fibroin films, a higher hydrophobicity of the methanol-treated silk fibroin films caused a higher sorption of the hydrophobic dyes. The dye molecules had a fairly high affinity to the silk fibroin film, even though the dye and the matrix possessed the same charge. However, in the presence of two charged groups in a single dye molecule, the electrostatic repulsion become more dominant. Stronger interaction was observed when the charges of the film and the dye were opposite. The results of dye sorption and release experiments showed that the degree of synergism or competition between electrostatic and hydrophobic interactions directly depended on the charges and chemical structure of the dye molecules and the environmental pH conditions of the existing silk fibroin film. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Wongpanit, Panya; Rujiravanit, Ratana] Chulalongkorn Univ, Petr & Petrochem Coll, Bangkok 10330, Thailand.
   [Rujiravanit, Ratana] Chulalongkorn Univ, Ctr Petr Petrochem & Adv Mat, Bangkok 10330, Thailand.
RP Rujiravanit, R (reprint author), Chulalongkorn Univ, Petr & Petrochem Coll, Bangkok 10330, Thailand.
EM ratana.r@chula.ac.th
RI Wongpanit, Panya/E-2826-2013
FU Thailand Research Fund (TRF) (through the Royal Golden Jubilee PhD
   Program, i.e., a RGJ grant)
FX The authors would like to acknowledge Professor Dr. Pitt Supaphol and
   Dr. Orathai Pornsunthorntawee, the Petroleum and Petrochemical College,
   Chulalongkorn University, for the stimulating discussion. This work was
   supported by the Thailand Research Fund (TRF) (through the Royal Golden
   Jubilee PhD Program, i.e., a RGJ grant). The authors wish to thank Queen
   Sirikit Sericulture Center (Saraburi Province, Thailand) and Perfect
   Built Co., Ltd (Thailand) for supplying the essential materials for this
   study.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337
   AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   CHEN JY, 1994, POLYMER, V35, P2853, DOI 10.1016/0032-3861(94)90317-4
   Cheng Q, 2005, ANAL BIOANAL CHEM, V382, P80, DOI 10.1007/s00216-005-3150-3
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Gehrke SH, 1997, ANN NY ACAD SCI, V831, P179
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Khan MMR, 2007, CARBON, V45, P1035, DOI 10.1016/j.carbon.2006.12.015
   Konar N, 2001, POLYMERIC DRUGS AND DRUG DELIVERY SYSTEMS, P69
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Malay O, 2007, INT J BIOL MACROMOL, V40, P387, DOI 10.1016/j.ijbiomac.2006.09.017
   MITA K, 1994, J MOL EVOL, V38, P583
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Saitoh H, 2004, INT J BIOL MACROMOL, V34, P317, DOI [10.1016/j.ijbiomac.2004.09.003, 10.1016/j.ijbiomat.2004.09.003]
   Serizawa T, 2005, LANGMUIR, V21, P7739, DOI 10.1021/la0505263
   Tabata Y, 1998, BIOMATERIALS, V19, P1781, DOI 10.1016/S0142-9612(98)00089-1
   Tabata Y., 2005, INT C SER, V1284, P257
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wongpanit P, 2007, MACROMOL BIOSCI, V7, P1258, DOI 10.1002/mabi.200700074
   Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 39
TC 1
Z9 1
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 9
BP 1199
EP 1215
DI 10.1163/092050611X576972
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 987VF
UT WOS:000307445200005
PM 21639994
DA 2018-10-19
ER

PT J
AU Ahmed, T
   Marcal, H
   Johnson, S
   Brown, BN
   Foster, LJR
AF Ahmed, Tania
   Marcal, Helder
   Johnson, Scott
   Brown, Bryan N.
   Foster, L. John R.
TI Coalescence of Extracellular Matrix (ECM) from Porcine Urinary Bladder
   (UBM) with a Laser-Activated Chitosan-Based Surgical Adhesive
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Chitosan; extracellular matrix; adhesive; biomaterial; laser; SurgiLux;
   tissue engineering
ID BODY-WALL REPAIR; IN-VITRO; TISSUE-REPAIR; NANOFIBROUS SCAFFOLDS;
   DOG-MODEL; RECONSTRUCTION; VIVO; POLYHYDROXYBUTYRATE; BIOCOMPATIBILITY;
   PROLIFERATION
AB Urinary bladder matrix (UBM) has been extensively investigated as a naturally occurring biomaterial in therapeutic applications for tissue repair or regeneration, while other strategies involve biopolymers such as chitosan for tissue reconstruction. The coalescence of UBM with chitosan has considerable potential in enhancing tissue reconstruction. Characterisation of a novel, laser-activated, chitosan-based, thin-film surgical adhesive with UBM in various morphologies showed that the films had increased surface rugosities and crystallinities (R-a approx. 0.83 mu m, approx. 12% crystallinity) when compared to the chitosan adhesive alone (R-a = 0.74 mu m, 7% crystallinity). Tensile strength of the films was significantly increased by the addition of UBM in particulate form (12.1-32.4 MPa). Furthermore, tissue adhesion strengths using these hybrid biomaterials were maintained at approx. 15 kPa compared to 3 kPa for fibrin glue. Histological analysis demonstrated that laser irradiation of the UBM-chitosan adhesive biomaterial caused no thermal damage to tissue. Examination of the cellular response at the material interface showed that 3T3 fibroblasts maintained their regular morphology with enhanced growth compared to films of both chitosan and its adhesive form. These results suggest that coalescence of UBM with a chitosan-based adhesive supports the development of biomaterial devices for sutureless wound closure that could enhance tissue repair and reconstruction. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Ahmed, Tania; Marcal, Helder; Foster, L. John R.] Univ New S Wales, Biopolymer Res Grp, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Johnson, Scott; Brown, Bryan N.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA.
RP Foster, LJR (reprint author), Univ New S Wales, Biopolymer Res Grp, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
FU Australian Research Council [DP0772153]; Fulbright Senior Scholarship
FX The research reported in this manuscript was supported by an Australian
   Research Council project grant (DP0772153) and a Fulbright Senior
   Scholarship (2009) to L. J. R. F.
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S. F., 2006, CELL TRANSPLANT, V15, P29
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   Braye FM, 2001, BRIT J PLAST SURG, V54, P532, DOI 10.1054/bjps.2001.3620
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chang YY, 2004, BIOMATERIALS, V25, P3603, DOI 10.1016/j.biomaterials.2003.10.039
   DUBUISSON AS, 1993, MICROSURG, V14, P398, DOI 10.1002/micr.1920140609
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g
   Foster LJR, 2009, POLYM INT, V58, P1442, DOI 10.1002/pi.2682
   Foster LJR, 2005, POLYM DEGRAD STABIL, V87, P1, DOI 10.1016/j.polymdegradstab.2003.11.012
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Gilbert TW, 2008, J SURG RES, V147, P61, DOI 10.1016/j.jss.2007.04.035
   Greenberg James A, 2009, Rev Obstet Gynecol, V2, P146
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   Keen I, 2007, J BIOMAT SCI-POLYM E, V18, P1101, DOI 10.1163/156856207781554046
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2003, P SOC PHOTO-OPT INS, V5287, P83, DOI 10.1117/12.544880
   Lauto A, 2004, LASER SURG MED, V35, P140, DOI 10.1002/lsm.20081
   Lauto A, 2008, J CHEM TECHNOL BIOT, V83, P464, DOI 10.1002/jctb.1771
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Liu X., 2010, J BIOMAT SCI-POLYM E, V21, P1239
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MUZZARELLI RAA, 1999, CHITIN CHITINASES, P251
   Qian YF, 2011, J BIOMAT SCI-POLYM E, V22, P1099, DOI 10.1163/092050610X499447
   Reing J. E., 2008, TISSUE ENG PART A, V15, P605
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Scardino MS, 1999, J BIOMED MATER RES, V48, P315
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Vote BJT, 2000, CLIN EXP OPHTHALMOL, V28, P437, DOI 10.1046/j.1442-9071.2000.00351.x
   Wan Y, 2003, POLYMER, V44, P1057, DOI 10.1016/S0032-3861(02)00881-9
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444
   Woolnough CA, 2010, POLYM INT, V59, P658, DOI 10.1002/pi.2746
   Zhang KH, 2011, J BIOMAT SCI-POLYM E, V22, P1069, DOI 10.1163/092050610X498204
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 51
TC 1
Z9 1
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 12
BP 1521
EP 1538
DI 10.1163/092050611X585431
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 987VT
UT WOS:000307446600002
PM 21771393
DA 2018-10-19
ER

PT J
AU Wu, CT
   Chang, J
   Fan, W
AF Wu, Chengtie
   Chang, Jiang
   Fan, Wei
TI Bioactive mesoporous calcium-silicate nanoparticles with excellent
   mineralization ability, osteostimulation, drug-delivery and
   antibacterial properties for filling apex roots of teeth
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID IN-VITRO BIOACTIVITY; PERIODONTAL-LIGAMENT CELLS; TRICALCIUM SILICATE;
   APATITE LAYER; BIOLOGICAL-PROPERTIES; IONIC PRODUCTS; GLASS;
   PROLIFERATION; AKERMANITE; SCAFFOLDS
AB Bioactive materials are playing an important role in sealing apical root canals of teeth, inducing bone/cementum tissue regeneration and inhibiting bacterial viability. Conventional Ca(OH)(2) materials have limitations for filling apical root canals of teeth due to their low mineralization ability and potential cytotoxicity. The aim of this study is to prepare bioactive mesoporous calcium-silicate (MCS) nanoparticles for the potential application of filling an apical root canal of a tooth. The mesoporous structure, specific surface area, pore volume and morphology of MCS particles were characterized. The apatite-mineralization ability, in vitro osteogenesis, drug delivery and antibacterial properties were further investigated. The results showed that MCS nanoparticles (around 100 nm) with high specific surface area and pore volume were successfully prepared by a facile template method. The prepared MCS could be easily injected to fill the apical root canal of a tooth. MCS nanoparticles induced apatite-mineralization in DMEM solution, did not show cytotoxicity, and their ionic products could stimulate the proliferation of periodontal ligament cells (PDLCs). In contrast, conventional Ca(OH)(2) materials did not induce mineralization and showed significant cytotoxic effects on PDLCs. Furthermore, MCS extracts at low concentrations (12.5 and 25 mg mL(-1)) induced higher ALP activity of PDLCs than those at high concentrations (50 and 100 mg mL(-1)). In addition, MCS extracts significantly stimulated osteogenic gene expression (OPN, ALP and OCN) of PDLCs compared to a blank control, indicating the excellent osteostimulation property of MCS. MCS nanoparticles could be used for loading the antibiotic ampicillin due to their mesoporous microstructures, and the loaded ampicillin in MCS nanoparticles could be released with a slow and sustained release profile. Moreover, it was found that pure MCS nanoparticles revealed antibacterial effects, while the delivery of ampicillin from MCS nanoparticles further inhibited bacterial viability. Therefore, the results suggest that MCS nanoparticles are an advanced biomaterial with multiple functions for filling the apical root canal of a tooth due to their unique nanostructure, injectability, apatite-mineralization, osteostimulation, drug-delivery and antibacterial properties.
C1 [Wu, Chengtie; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Fan, Wei] Wuhan Univ, Key Lab Oral Biomed Engn, Minist Educ, Sch Stomatol, Wuhan 430079, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn; fwxj001@163.com
FU Shanghai Municipal Natural Science Foundation [12ZR1435300]; One Hundred
   Talent Project; SIC-CAS; Natural Science Foundation of China [81190132]
FX Authors would like to thank Shanghai Municipal Natural Science
   Foundation (12ZR1435300), One Hundred Talent Project, SIC-CAS and the
   Natural Science Foundation of China (Grant 81190132) for the support of
   research.
CR Andrew JS, 2010, ADV FUNCT MATER, V20, P4168, DOI 10.1002/adfm.201000907
   [Anonymous], 109935 ISOEN
   Balas F, 2003, J BIOMED MATER RES A, V66A, P364, DOI 10.1002/jbm.a.10579
   Basrani B, 2003, ORAL SURG ORAL MED O, V96, P618, DOI 10.1016/S1079-2104(03)00166-5
   Bin CV, 2012, J ENDODONT, V38, P495, DOI 10.1016/j.joen.2011.11.003
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   da Silva JM, 2011, ORAL SURG ORAL MED O, V111, P260, DOI 10.1016/j.tripleo.2010.08.016
   Dong Z, 2011, AUST DENT J, V56, P175, DOI 10.1111/j.1834-7819.2011.01321.x
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   GAZELIUS B, 1986, INT ENDOD J, V19, P202, DOI 10.1111/j.1365-2591.1986.tb00478.x
   He CL, 2010, ADV FUNCT MATER, V20, P3568, DOI 10.1002/adfm.201000993
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039
   Hong YL, 2010, ADV FUNCT MATER, V20, P1503, DOI 10.1002/adfm.200901627
   Horcajada P, 2004, SOLID STATE SCI, V6, P1295, DOI 10.1016/j.solidstatesciences.2004.07.026
   Izquierdo-Barba I, 2005, SOLID STATE SCI, V7, P983, DOI 10.1016/j.solidstatesciences.2005.04.003
   Li X, 2008, J MATER CHEM, V18, P4103, DOI 10.1039/b805114c
   Lin KL, 2006, MATER LETT, V60, P3007, DOI 10.1016/j.matlet.2006.02.034
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Loushine BA, 2011, J ENDODONT, V37, P673, DOI 10.1016/j.joen.2011.01.003
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Mohammadi G, 2010, COLLOID SURFACE B, V80, P34, DOI 10.1016/j.colsurfb.2010.05.027
   Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Varanasi VG, 2011, J BIOMED MATER RES A, V98A, P177, DOI 10.1002/jbm.a.33102
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Wu CT, 2008, J BIOMED MATER RES A, V86A, P402, DOI 10.1002/jbm.a.31623
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Wu CT, 2011, J MATER CHEM, V21, P18300, DOI 10.1039/c1jm12770e
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Wu CT, 2010, J BIOMED MATER RES A, V95A, P476, DOI 10.1002/jbm.a.32873
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Wu CT, 2004, MATER LETT, V58, P2415, DOI 10.1016/j.matlet.2004.02.039
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xue WC, 2005, BIOMATERIALS, V26, P3455, DOI 10.1016/j.biomaterials.2004.09.027
   Yun HS, 2010, MATER LETT, V64, P1850, DOI 10.1016/j.matlet.2010.04.053
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
   Zhao WY, 2004, MATER LETT, V58, P2350, DOI 10.1016/j.matlet.2004.02.045
   Zhou YH, 2012, ACTA BIOMATER, V8, P2307, DOI 10.1016/j.actbio.2012.03.012
   Zhu YF, 2011, J MATER CHEM, V21, P9208, DOI 10.1039/c1jm10838g
   Zhu YF, 2009, MICROPOR MESOPOR MAT, V118, P176, DOI 10.1016/j.micromeso.2008.08.046
NR 49
TC 48
Z9 49
U1 13
U2 109
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 33
BP 16801
EP 16809
DI 10.1039/c2jm33387b
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 981MR
UT WOS:000306972900017
DA 2018-10-19
ER

PT J
AU Lei, B
   Chen, XF
   Han, X
   Zhou, JA
AF Lei, Bo
   Chen, Xiaofeng
   Han, Xue
   Zhou, Jiaan
TI Versatile fabrication of nanoscale sol-gel bioactive glass particles for
   efficient bone tissue regeneration
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-VITRO; APATITE FORMATION; MICROSPHERES;
   NANOPARTICLES; SCAFFOLDS
AB There has been an increased interest in developing nanoscale biomaterials for bone tissue regeneration, due to the biomimetic nano-dimensions and properties compared to natural tissue (bone). Bioactive glass (BG) is regarded as an excellent biomaterial for use in bone regeneration, because of its bioactivity and osteoconductivity. Here, we develop bioactive glass nano-scale particles (NBGs) by sol-gel combining gelation-induced phase separation technology, and demonstrate the effect of bioactive glass dimensions on their physicochemical and biological properties. The micro/nanostructure, surface texture, and bioactive silicon species release were studied to indicate the physicochemical properties of NBGs. The bone-bonding ability was determined by investigating the apatite-forming bioactivity of NBGs. The effect of the micro/nanoscale interface on the attachment and proliferation of human marrow mesenchymal stem cells (hMSCs) was carried out to determine the biocompatibility of NBGs. All samples showed stable silicone release, and the nanoscale particles (40-800 nm) demonstrated a high apatite-forming ability. The biological results showed that all particle dimensions (40-2000 nm) supported hMSCs attachment and proliferation. The NBG with a nanoscale dimension of 40-180 nm significantly enhanced hMSCs proliferation. This study may provide a new route in the design of bioactive biomaterials' nano-interfaces for efficient bone tissue regeneration.
C1 [Lei, Bo; Chen, Xiaofeng; Han, Xue; Zhou, Jiaan] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.
   [Chen, Xiaofeng; Han, Xue; Zhou, Jiaan] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510640, Guangdong, Peoples R China.
   [Lei, Bo] Korea Univ, Dept Dent Lab Sci & Engn, Seoul 136703, South Korea.
RP Lei, B (reprint author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.
EM leiboaray@yahoo.com.cn
RI Lei, Bo/B-9463-2009
FU National Natural Science Foundation of China [51072055]; key project of
   the National Natural Science Foundation of China [50830101]; National
   973 project of China [2011CB606204]
FX This study was supported by National Natural Science Foundation of China
   (Grant no. 51072055), the key project of the National Natural Science
   Foundation of China (Grant no. 50830101) and the National 973 project of
   China (2011CB606204).
CR Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   BRINKER CJ, 1989, SOL GEL SCI
   Carvalho SM, 2012, J TISSUE ENG REGEN M, V6, P813, DOI 10.1002/term.488
   Catledge SA, 2004, J NANOSCI NANOTECHNO, V4, P986, DOI 10.1166/jnn.2004.137
   Chen XF, 2009, J NON-CRYST SOLIDS, V355, P791, DOI 10.1016/j.jnoncrysol.2009.02.005
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lei B., 2012, BIOMED MAT UNPUB
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Lei B, 2012, J AM CERAM SOC, V95, P30, DOI 10.1111/j.1551-2916.2011.04918.x
   Lei B, 2011, J MATER CHEM, V21, P12725, DOI 10.1039/c1jm11547b
   Lei B, 2011, J SOL-GEL SCI TECHN, V58, P656, DOI 10.1007/s10971-011-2441-8
   Lei B, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054103
   Lei B, 2010, MATER LETT, V64, P2293, DOI 10.1016/j.matlet.2010.07.066
   Lei B, 2010, J BIOMED MATER RES A, V94A, P1091, DOI 10.1002/jbm.a.32776
   Lei B, 2010, J AM CERAM SOC, V93, P32, DOI 10.1111/j.1551-2916.2009.03358.x
   Lei B, 2009, J NON-CRYST SOLIDS, V355, P2678, DOI 10.1016/j.jnoncrysol.2009.09.029
   Lei B, 2009, J NON-CRYST SOLIDS, V355, P2583, DOI 10.1016/j.jnoncrysol.2009.09.014
   Lei B, 2009, MATER LETT, V63, P1719, DOI 10.1016/j.matlet.2009.04.041
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Mailander V, 2009, BIOMACROMOLECULES, V10, P2379, DOI 10.1021/bm900266r
   Meirelles L, 2008, J BIOMED MATER RES A, V87A, P299, DOI 10.1002/jbm.a.31744
   Navarrete R. O., 2010, BIOMATERIALS, V31, P2728
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Tsigkou O., 2006, THESIS IMPERIAL COLL
NR 38
TC 38
Z9 39
U1 3
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 33
BP 16906
EP 16913
DI 10.1039/c2jm31384g
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 981MR
UT WOS:000306972900031
DA 2018-10-19
ER

PT J
AU Gross, KA
   Rodriguez-Lorenzo, LM
AF Gross, K. A.
   Rodriguez-Lorenzo, L. M.
TI Assessment of the micropore system in wood for drug delivery
SO JOURNAL OF THE AUSTRALIAN CERAMIC SOCIETY
LA English
DT Article
DE drug delivery; pore interconnectivity; biomaterial; ceramics; wood
ID SCANNING ELECTRON-MICROSCOPE; POROUS CERAMIC MATERIALS; LIQUID SUCTION;
   TEMPLATE
AB Drug delivery in biomaterials requires consideration of the pore network to store and deliver greater concentrations over an extended period of time. The porous structure in wood is used for delivery of water and therefore presents a possible pore architecture for storing fluids. The goal was to determine the pore characteristics of dried and pyrolysed wood and then investigate the ability to uptake water into the porous network. Balsa (Ochroma Pyramidale Urb) and oak (American: Quercus Alba and European: Quercus Robus) were selected based on the large pore size (100 - 200 mu m). The microstructure was characterized by scanning electron microscopy and the pore volume determined by mercury intrusion porosimetry. The open and closed porosity was determined by the Archimedes method. Wood was pyrolyzed in a non-oxiding atmosphere between 800 and 1400 degrees C, the pore structure evaluated and the water uptake determined. Oak provides an open porosity 2.8 times greater than balsa. Pyrolysis of the wood open the pits, connecting vertically oriented tracheids with the other channel systems in wood (vessels and rays) for greater pore interconnectivity. The uptake of water, as determined by a liquid permeability test shows an initial linear uptake of 60% of the total water capacity, followed by a slower uptake of the remaining volume. This study shows that American oak has a larger open porosity and that pore connectivity can be improved by pyrolysis at 800 degrees C. Such a bimodal interconnected pore structure may find use for drug delivery in biomaterials applications.
C1 [Gross, K. A.] Riga Tech Univ, Inst Biomat & Biomech, Riga, Latvia.
   [Gross, K. A.; Rodriguez-Lorenzo, L. M.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Rodriguez-Lorenzo, L. M.] ICTP CSIC, Biomat Grp, Madrid 28006, Spain.
RP Gross, KA (reprint author), Riga Tech Univ, Inst Biomat & Biomech, Riga, Latvia.
EM karlis-agris.gross@rtu.lv
RI Rodriguez-Lorenzo, Luis/A-1090-2008
OI Rodriguez-Lorenzo, Luis/0000-0002-4816-1087
FU Monash Research Fund; Marie Curie reintegration grant
FX This experimental work was supported by the Monash Research Fund. The
   Marie Curie reintegration grant is acknowledged for providing support to
   KAG during the preparation of the manuscript.
CR Baimark Y, 2012, J APPL POLYM SCI, V124, P3871, DOI 10.1002/app.35473
   BELTRAN V, 1989, BRIT CERAM TRANS J, V88, P219
   BELTRAN V, 1988, BRIT CERAM TRANS J, V87, P64
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Butterfield BG, 1980, 3 DIMENSIONAL STRUCT
   Chevalier E, 2008, J PHARM SCI-US, V97, P1135, DOI 10.1002/jps.21059
   DENTON EJ, 1959, NATURE, V184, P1330, DOI 10.1038/1841330a0
   EHRBURGER P, 1982, CARBON, V20, P433, DOI 10.1016/0008-6223(82)90044-6
   EXLEY RR, 1974, J MICROSC-OXFORD, V101, P21, DOI 10.1111/j.1365-2818.1974.tb03865.x
   EXLEY RR, 1977, J MICROSC-OXFORD, V110, P75, DOI 10.1111/j.1365-2818.1977.tb00016.x
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3
   Greil P, 2001, J EUR CERAM SOC, V21, P105, DOI 10.1016/S0955-2219(00)00179-5
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Ishizaki K., 1998, PROPERTIES EVALUATIO
   Langer R, 2003, SCI AM, V288, P50, DOI 10.1038/scientificamerican0403-50
   Matovic B, 2009, MATER MANUF PROCESS, V24, P1109, DOI 10.1080/10426910902979058
   Ota T, 2000, J AM CERAM SOC, V83, P1521, DOI 10.1111/j.1151-2916.2000.tb01421.x
   Rambo CR, 2008, J AM CERAM SOC, V91, P852, DOI 10.1111/j.1551-2916.2007.02223.x
   SHAFIZADEH F, 1983, CARBON, V21, P511, DOI 10.1016/0008-6223(83)90144-6
   Siau J.F., 1984, TRANSPORT PROCESES
   Sieber H, 2000, ADV ENG MATER, V2, P105, DOI 10.1002/(SICI)1527-2648(200003)2:3<105::AID-ADEM105>3.0.CO;2-P
   Singh M, 2002, ADV MATER PROCESS, V160, P39
   Sun BH, 2002, J POROUS MAT, V9, P275, DOI 10.1023/A:1021652930124
   Vogli E, 2002, J EUR CERAM SOC, V22, P2663, DOI 10.1016/S0955-2219(02)00131-0
   Yang JF, 2002, ACTA MATER, V50, P4831, DOI 10.1016/S1359-6454(02)00350-6
NR 26
TC 0
Z9 0
U1 0
U2 6
PU AUSTRALIAN CERAMIC SOCIETY
PI PERTH
PA C/O CURTIN UNIV TECHNOLOGY, GPO BOX U1987, PERTH, 6845 W A, AUSTRALIA
SN 0004-881X
J9 J AUST CERAM SOC
JI J. Aust. Ceram. Soc.
PY 2012
VL 48
IS 2
BP 173
EP 179
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 987NU
UT WOS:000307425000005
DA 2018-10-19
ER

PT J
AU Yamamoto, S
   Nonami, T
   Hase, H
   Kawamura, N
AF Yamamoto, Sho
   Nonami, Toru
   Hase, Hiroko
   Kawamura, Norihisa
TI Fundamental Study on Apatite Precipitate Ability of CaO-MgO-SiO2
   Compounders Employed Pseudo Body Solution of Application for
   Biomaterials
SO JOURNAL OF THE AUSTRALIAN CERAMIC SOCIETY
LA English
DT Article
DE diopside; apatite; pseudo body solution; CaO-MgO-SiO2 systems;
   biomaterial
ID DIOPSIDE; ALKOXIDE; TITANIUM
AB We examined the apatite precipitate ability of CaO-MgO-SiO2 compounders. Synthesized materials were Diopside, Akermanite, Pseudowollastonite, Forsterite and Protoenstatite. Materials were synthesized with solid solution method. Materials soaked to pseudo body solution stirred at 37 degrees C for 1 hour. Diopside, Pseudowollastonite and Protoenstatite precipitated apatite. These materials got precipitation on surface and had the peak of 31-32 degrees by X-ray diffraction patterns. In addition, Diopside, Pseudowollastonite and Protoenstatite eluted less magnesium. These experimental results seem to mean that less magnesium elution can cause more apatite precipitation. However, magnesium consists in vivo and has possibilities to improve biocompatibility. Diopside has ability of elute magnesium and precipitate apatite. In addition, Diopside can make hybrid with titanium. From these results we observed Diopside that could make hybrid with titanium by sol-gel method is appropriate for biomaterials.
C1 [Yamamoto, Sho; Nonami, Toru] Chukyo Univ, Grad Sch Comp & Cognit Sci, Aichi, Japan.
   [Nonami, Toru; Hase, Hiroko] Chukyo Univ, Sch Informat Sci & Technol, Aichi, Japan.
   [Kawamura, Norihisa] Kinjo Gakuin Univ, Dept Pharm, Nagoya, Aichi, Japan.
RP Yamamoto, S (reprint author), Chukyo Univ, Grad Sch Comp & Cognit Sci, Aichi, Japan.
EM h11001d@st.chukyo-u.ac.jp
CR Hase H, 2011, J AUST CERAM SOC, V47, P14
   Iwata NY, 2004, COLLOID SURFACE B, V33, P1, DOI 10.1016/j.colsurfb.2003.07.004
   Levin M., 1969, PHASE DIAGRAMS CERAM, V1, P210
   NONAMI T, 1992, MATER RES SOC SYMP P, V252, P87
   NONAMI T, 1995, J CERAM SOC JPN, V103, P703, DOI 10.2109/jcersj.103.703
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Okazaki M., 1986, J JAPANESE SOC DENT, V5, P571
   THIRADILOK S, 1978, ALA J MED SCI, V15, P144
   TORIYAMA M, 1991, NIPPON SERAM KYO GAK, V99, P1268
NR 9
TC 9
Z9 9
U1 1
U2 5
PU AUSTRALIAN CERAMIC SOCIETY
PI PERTH
PA C/O CURTIN UNIV TECHNOLOGY, GPO BOX U1987, PERTH, 6845 W A, AUSTRALIA
SN 0004-881X
J9 J AUST CERAM SOC
JI J. Aust. Ceram. Soc.
PY 2012
VL 48
IS 2
BP 180
EP 184
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 987NU
UT WOS:000307425000006
DA 2018-10-19
ER

PT J
AU Netzahuatl-Munoz, AR
   Morales-Barrera, L
   Cristiani-Urbina, MD
   Cristiani-Urbina, E
AF Rosa Netzahuatl-Munoz, Alma
   Morales-Barrera, Liliana
   del Carmen Cristiani-Urbina, Maria
   Cristiani-Urbina, Eliseo
TI HEXAVALENT CHROMIUM REDUCTION AND CHROMIUM BIOSORPTION BY Prunus
   serotina BARK
SO FRESENIUS ENVIRONMENTAL BULLETIN
LA English
DT Article
DE Prunus serotina bark; hexavalent chromium [Cr(VI)]; total chromium;
   biosorption; bioreduction
ID DEAD FUNGAL BIOMASS; AQUEOUS-SOLUTION; BREAKTHROUGH CURVES;
   ASPERGILLUS-NIGER; CR(VI) REDUCTION; ACTIVATED CARBON; PINUS-SYLVESTRIS;
   CONE BIOMASS; REMOVAL; ADSORPTION
AB The capacity of Prunus serotina bark to remove hexavalent chromium [Cr(VI)] and total chromium from acidic aqueous solutions was investigated. P. serotina bark exhibited high Cr(VI) removal capacity (93.61 mg g(-1)) as well as total chromium removal capacity (69.93 mg g(-1)). The mechanism of Cr(VI) removal by P. serotina bark implies two simultaneous processes: 1) the reduction of Cr(VI) to Cr(III) in the presence of P. serotina bark in an aqueous acidic solution, and 2) the biosorption of chromium ions. The kinetic model that satisfactorily described the chromium biosorption process from the Cr(VI) solution was the pseudo second-order model. The experimental results suggest that P. serotina bark biosorbed chromium ions predominantly by a chemical sorption phenomenon. The results of this work underline that P. serotina bark may be used as an effective and low-cost biomaterial for the removal of both Cr(VI) and total chromium from polluted water and wastewater.
C1 [Rosa Netzahuatl-Munoz, Alma; Morales-Barrera, Liliana; Cristiani-Urbina, Eliseo] Escuela Nacl Ciencias Biol, Inst Politecn Nacl, Dept Ingn Bioquim, Mexico City 11340, DF, Mexico.
   [Rosa Netzahuatl-Munoz, Alma] Univ Politecn Tlaxcala, Tepeyanco 90180, Tlaxcala, Mexico.
   [del Carmen Cristiani-Urbina, Maria] Univ Autonoma Chiapas, Tuxtla Gutierrez 29000, Chiapas, Mexico.
RP Cristiani-Urbina, E (reprint author), Escuela Nacl Ciencias Biol, Inst Politecn Nacl, Dept Ingn Bioquim, Prolongac Carpio & Plan Ayala S-N, Mexico City 11340, DF, Mexico.
EM ecristia@encb.ipn.mx
OI Netzahuatl-Munoz, Alma Rosa/0000-0003-1963-8357
FU Comision de Operacion y Fomento de Actividades Academicas; Instituto
   Politecnico Nacional (IPN), Mexico City, Mexico; Secretaria de
   Investigacion y Posgrado IPN; CONACyT [89868]
FX E. Cristiani-Urbina is a fellow holder of a grant from the Comision de
   Operacion y Fomento de Actividades Academicas, Instituto Politecnico
   Nacional (IPN), Mexico City, Mexico. The authors gratefully acknowledge
   the financial support provided by the Secretaria de Investigacion y
   Posgrado IPN, and CONACyT (project number 89868).
CR Abbas M, 2008, WATER AIR SOIL POLL, V191, P139, DOI 10.1007/s11270-007-9613-8
   Alveano Aguerrebere I., 2011, Food Chemistry, V124, P983, DOI 10.1016/j.foodchem.2010.07.040
   Aoyama M, 2003, BIORESOURCE TECHNOL, V89, P317, DOI 10.1016/S0960-8524(03)00069-5
   BUCHALTER L, 1969, J PHARM SCI-US, V58, P1272, DOI 10.1002/jps.2600581026
   Cabatingan LK, 2001, IND ENG CHEM RES, V40, P2302, DOI 10.1021/ie0008575
   Celik A, 2004, FRESEN ENVIRON BULL, V13, P124
   Cheung KH, 2007, INT BIODETER BIODEGR, V59, P8, DOI 10.1016/j.ibiod.2006.05.002
   Chou WL, 2010, FRESEN ENVIRON BULL, V19, P2848
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Clesceri LS, 1998, STANDARD METHODS EXA
   Cui LZ, 2006, FRESEN ENVIRON BULL, V15, P1442
   DEFLORA S, 1990, MUTAT RES, V238, P99, DOI 10.1016/0165-1110(90)90007-X
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6
   Fiol N, 2008, BIORESOURCE TECHNOL, V99, P5030, DOI 10.1016/j.biortech.2007.09.007
   FISHBEIN L, 1981, ENVIRON HEALTH PERSP, V40, P43, DOI 10.2307/3429220
   Fresnedo-Ramirez J, 2011, GENET RESOUR CROP EV, V58, P481, DOI 10.1007/s10722-010-9592-2
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056
   Hach Company, 2008, HACH WAT AN HDB
   Harkin J.M., 1971, FOREST
   Ho Y.S., 1998, T ICHEME B, V76, P332
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.hazmat.2005.05.003
   Khambhaty Y, 2009, CHEM ENG J, V145, P489, DOI 10.1016/j.cej.2008.05.002
   KINNIBURGH DG, 1986, ENVIRON SCI TECHNOL, V20, P895, DOI 10.1021/es00151a008
   Koutika LS, 2011, APPL ECOL ENV RES, V9, P73, DOI 10.15666/aeer/0901_073083
   KURTH EF, 1947, CHEM REV, V40, P33, DOI 10.1021/cr60125a003
   Liu CC, 2006, IND ENG CHEM RES, V45, P8891, DOI 10.1021/ie060978q
   Liu SX, 2007, J HAZARD MATER, V141, P315, DOI 10.1016/j.jhazmat.2006.07.006
   LOFROTH G, 1978, MUTAT RES, V53, P65
   Malkoc E, 2006, CHEM ENG J, V119, P61, DOI 10.1016/j.cej.2006.01.019
   Malkoc E, 2005, FRESEN ENVIRON BULL, V14, P509
   Martin-Lara MA, 2010, J ENVIRON ENG-ASCE, V136, P1389, DOI 10.1061/(ASCE)EE.1943-7870.0000281
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Morales-Barrera L, 2008, WATER AIR SOIL POLL, V187, P327, DOI 10.1007/s11270-007-9520-z
   Morales-Barrera L, 2010, FRESEN ENVIRON BULL, V19, P1640
   Oliveira RC, 2011, PROGRESS IN BIOMASS AND BIOENERGY PRODUCTION, P151
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Rahmani AR, 2011, FRESEN ENVIRON BULL, V20, P720
   Netzahuatl-Munoz AR, 2012, WATER AIR SOIL POLL, V223, P625, DOI 10.1007/s11270-011-0888-4
   Netzahuatl-Munoz AR, 2010, FRESEN ENVIRON BULL, V19, P2911
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   Sen A, 2010, IND CROP PROD, V31, P417, DOI 10.1016/j.indcrop.2010.01.002
   Stanin F. T., 2005, CHROMIUM 6 HDB, P165
   Suazo-Madrid A, 2011, J IND MICROBIOL BIOT, V38, P51, DOI 10.1007/s10295-010-0828-0
   Ucun H, 2002, BIORESOURCE TECHNOL, V85, P155, DOI 10.1016/S0960-8524(02)00086-X
   Vaghetti JCP, 2008, BIOCHEM ENG J, V42, P67, DOI 10.1016/j.bej.2008.05.021
   Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001
   Volesky B., 2003, SORPTION BIOSORPTION
NR 55
TC 8
Z9 8
U1 1
U2 4
PU PARLAR SCIENTIFIC PUBLICATIONS (P S P)
PI FREISING
PA ANGERSTR. 12, 85354 FREISING, GERMANY
SN 1018-4619
J9 FRESEN ENVIRON BULL
JI Fresenius Environ. Bull.
PY 2012
VL 21
IS 7
BP 1793
EP 1801
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 980IP
UT WOS:000306887100012
DA 2018-10-19
ER

PT J
AU Liu, D
   Matinlinna, JP
   Pow, EHN
AF Liu, Dan
   Matinlinna, Jukka P.
   Pow, Edmond H. N.
TI Insights into Porcelain to Zirconia Bonding
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Zirconia; porcelain; veneering; bonding; delamination; coefficient of
   thermal expansion; surface treatment; sandblasting
ID Y-TZP-ZIRCONIA; ALL-CERAMIC RESTORATIONS; FIXED PARTIAL DENTURES;
   VENEERING CERAMICS; DENTAL PROSTHESES; SHEAR-STRENGTH; DIFFERENT
   COMPONENTS; FLEXURAL STRENGTH; RESIN COMPOSITE; THERMAL MISFIT
AB The application of zirconia, ZrO2, as a biomaterial in medicine started in the early 1980s. Since then, numerous studies have been conducted on this special ceramic material to assess and discover its unique characteristics in practical biomedical applications. Also, zirconia has manifested its extraordinary advantages for use in dental clinical practice since the late 1990s, such as its excellent biocompatibility, good aesthetical appeal and outstanding biomechanical properties. With the development of fabrication methods and more extensive comprehension of this material, zirconia has been employed in more and more dental restorations from single crowns and root canal posts to long-span fixed dentures and, very recently, even as dental implants. However, there are still some drawbacks in its dental applications. Such drawbacks are its relatively weak bonding with porcelain when compared with metal-ceramic system, less reliable bonding with resin-based adhesives, and possible failures caused, e. g., by the effects of low temperature degradation. Although many studies have been carried out on porcelain to zirconia bonding, a thorough understanding of its real mechanism is still far from being achieved. The effects of different treatments before or during the veneering procedure are not clearly elucidated, thus they need further investigations. The aim of this article is to outline the characteristics of zirconia and descriptions of porcelain to zirconia interfacial bonding based on the research conducted in the past few years. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Matinlinna, Jukka P.] Univ Hong Kong, Dept Dent Mat Sci, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China.
RP Matinlinna, JP (reprint author), Univ Hong Kong, Dept Dent Mat Sci, Fac Dent, 34 Hosp Rd, Sai Ying Pun, Hong Kong, Peoples R China.
EM jpmat@hku.hk
OI Matinlinna, Jukka/0000-0001-7656-0678; Pow, Edmond Ho
   Nang/0000-0003-2640-8437
CR Aboushelib MN, 2005, DENT MATER, V21, P984, DOI 10.1016/j.dental.2005.03.013
   Aboushelib Moustafa N, 2008, J Prosthodont, V17, P9
   Aboushelib MN, 2008, J BIOMED MATER RES B, V87B, P139, DOI 10.1002/jbm.b.31083
   Aboushelib MN, 2008, INT J PROSTHODONT, V21, P237
   Aboushelib MN, 2007, DENT MATER, V23, P952, DOI 10.1016/j.dental.2006.06.036
   Aboushelib MN, 2006, DENT MATER, V22, P857, DOI 10.1016/j.dental.2005.11.014
   Aboushelib MN, 2009, J PROSTHODONT, V18, P211, DOI 10.1111/j.1532-849X.2008.00412.x
   Aboushelib Moustafa N, 2008, J Prosthodont, V17, P401, DOI 10.1111/j.1532-849X.2008.00306.x
   Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   Al-Dohan HM, 2004, J PROSTHET DENT, V91, P349, DOI 10.1016/j.prosdent.2004.02.009
   Anunmana C, 2010, DENT MATER, V26, P111, DOI 10.1016/j.dental.2009.09.003
   ANUSAVICE KJ, 1980, J DENT RES, V59, P608, DOI 10.1177/00220345800590030901
   Ashkanani HM, 2008, J PROSTHET DENT, V100, P274, DOI 10.1016/S0022-3913(08)60206-1
   BECHER PF, 1992, J AM CERAM SOC, V75, P493, DOI 10.1111/j.1151-2916.1992.tb07832.x
   Beuer F, 2008, BRIT DENT J, V204, P505, DOI 10.1038/sj.bdj.2008.350
   Bonfante EA, 2010, J DENT, V38, P707, DOI 10.1016/j.jdent.2010.04.001
   Choi Bu-Kyung, 2009, J Adv Prosthodont, V1, P129, DOI 10.4047/jap.2009.1.3.129
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   CLAUSSEN N, 1976, J AM CERAM SOC, V59, P49, DOI 10.1111/j.1151-2916.1976.tb09386.x
   Coli P, 2004, INT J PROSTHODONT, V17, P577
   Comlekoglu ME, 2008, J DENT, V36, P822, DOI 10.1016/j.jdent.2008.05.019
   de Kler M, 2007, J ORAL REHABIL, V34, P841, DOI 10.1111/j.1365-2842.2006.01675.x
   DELLABONA A, 1995, J DENT RES, V74, P1591, DOI 10.1177/00220345950740091401
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Fischer J, 2008, DENT MATER J, V27, P448, DOI 10.4012/dmj.27.448
   Fischer J, 2007, DENT MATER J, V26, P766, DOI 10.4012/dmj.26.766
   Fischer J, 2009, DENT MATER, V25, P419, DOI 10.1016/j.dental.2008.09.003
   Gostemeyer G, 2010, ACTA BIOMATER, V6, P4532, DOI 10.1016/j.actbio.2010.06.026
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guazzato M, 2010, AUST DENT J, V55, P306, DOI 10.1111/j.1834-7819.2010.01239.x
   Guess PC, 2008, DENT MATER, V24, P1556, DOI 10.1016/j.dental.2008.03.028
   Guess PC, 2009, INT J ESTHET DENT, V4, P262
   GUPTA TK, 1977, J MATER SCI, V12, P2421, DOI 10.1007/BF00553928
   Hamadouche M, 2000, J BONE JOINT SURG BR, V82B, P1095, DOI 10.1302/0301-620X.82B8.11744
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hjerppe J, 2008, ACTA ODONTOL SCAND, V66, P262, DOI 10.1080/00016350802247123
   Hjerppe J, 2010, SILICON-NETH, V2, P171, DOI 10.1007/s12633-010-9042-y
   Ho GW, 2011, J ADHES SCI TECHNOL, V25, P2671, DOI 10.1163/016942411X556042
   Jamaluddin O, 2004, Med J Malaysia, V59 Suppl B, P143
   Kawai Y, 2010, NANO BIOMED, V2, P31
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kim ST, 2010, SURF INTERFACE ANAL, V42, P576, DOI 10.1002/sia.3209
   Kwon J. E., 2009, DENT MATER, V25, pe42
   Liu YH, 2010, J EUR CERAM SOC, V30, P1297, DOI 10.1016/j.jeurceramsoc.2009.11.019
   Luthardt RG, 2004, DENT MATER, V20, P655, DOI 10.1016/j.dental.2003.08.007
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Masonis JL, 2004, J ARTHROPLASTY, V19, P898, DOI 10.1016/j.arth.2004.02.045
   MITTAL KL, 1977, POLYM ENG SCI, V17, P467, DOI 10.1002/pen.760170709
   Nakamura T, 2009, J PROSTHODONT RES, V53, P116, DOI 10.1016/j.jpor.2009.02.007
   Ozcan M, 2003, DENT MATER, V19, P725, DOI 10.1016/S0109-5641(03)00019-8
   Ozkurt Z, 2010, DENT MATER J, V29, P138
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Pilathadka S, 2007, Prague Med Rep, V108, P5
   Raigrodski AJ, 2006, J PROSTHET DENT, V96, P237, DOI 10.1016/j.prosdent.2006.08.010
   Reich S, 2005, EUR J ORAL SCI, V113, P174, DOI 10.1111/j.1600-0722.2004.00197.x
   Roza G., 2009, ZIRCONIUM UNDERSTAND
   Sailer I, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2007.01468.x
   Sailer I, 2009, INT J PROSTHODONT, V22, P553
   Saito A, 2010, J PROSTHET DENT, V104, P247, DOI 10.1016/S0022-3913(10)60133-3
   SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   Shao LQ, 2011, ADV MATER RES-SWITZ, V177, P186, DOI 10.4028/www.scientific.net/AMR.177.186
   Subbarao E. C., 1981, ADV CERAMICS, V3
   Swain MV, 2009, ACTA BIOMATER, V5, P1668, DOI 10.1016/j.actbio.2008.12.016
   Tagmatarchis A., 2003, THESIS U DENT SCH AT
   Taskonak B, 2005, BIOMATERIALS, V26, P3235, DOI 10.1016/j.biomaterials.2004.08.025
   Taskonak B, 2008, DENT MATER, V24, P1149, DOI 10.1016/j.dental.2008.01.004
   Tholey MJ, 2010, DENT MATER, V26, P545, DOI 10.1016/j.dental.2010.02.002
   Tholey MJ, 2009, DENT MATER, V25, P857, DOI 10.1016/j.dental.2009.01.006
   Tinschert J, 2008, INT J PROSTHODONT, V21, P217
   TWIGGS SW, 1986, J BIOMED MATER RES, V20, P293, DOI 10.1002/jbm.820200303
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   van Noort R., 2007, INTRO DENT MAT
   Lopez-Molla MV, 2010, MED ORAL PATOL ORAL, V15, pE919, DOI 10.4317/medoral.15.e919
   Von Steyern PV, 2005, J ORAL REHABIL, V32, P180, DOI 10.1111/j.1365-2842.2004.01437.x
   White SN, 2005, J PROSTHET DENT, V94, P125, DOI 10.1016/j.prosdent.2005.05.007
   Yin Jia-Yue, 2009, Hua Xi Kou Qiang Yi Xue Za Zhi, V27, P669
NR 81
TC 25
Z9 25
U1 1
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2012
VL 26
IS 8-9
BP 1249
EP 1265
DI 10.1163/156856111X593586
PG 17
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 978LR
UT WOS:000306743000015
DA 2018-10-19
ER

PT J
AU Singh, NK
   Singh, SK
   Dash, D
   Purkayastha, BPD
   Roy, JK
   Maiti, P
AF Singh, Narendra K.
   Singh, Sunil K.
   Dash, Debabrata
   Purkayastha, Biswa Pratim Das
   Roy, Jagat K.
   Maiti, Pralay
TI Nanostructure controlled anti-cancer drug delivery using
   poly(epsilon-caprolactone) based nanohybrids
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; POLYMER SCAFFOLDS; GRAPHENE OXIDE; TISSUE;
   BIOMATERIALS; RELEASE; BONE; BIODEGRADATION; THROMBOSIS; PLATELETS
AB We have focused on the generation of various nanostructures of poly(epsilon-caprolactone) (PCL) using surface modified layered silicate. The improved and diverse mechanical, thermal and surface properties have been explored depending upon the nanostructure of the nanohybrids. The incorporation of drug into those nanohybrids further alters the nanostructure and subsequent properties. The rate of biodegradation has been studied in detail, with plausible mechanisms in different enzyme media being suggested, their specificity and the tunability of the biodegradation rate was demonstrated, followed by their optimization. The scaffolds of PCL and its nanohybrids with and without drugs have been prepared through electrospinning to control the dimensions of the nanofibers and their controlled degradation. The in-depth studies of the biocompatibility in terms of cell adhesion, genotoxicity and hemocompatibility have been performed to verify the suitability of the nanohybrids for potential biomedical applications. The biocompatibility of the nanohybrids at the gene level has been tested by the subcellular localization of an important regulator of pro-apoptotic signalling cascade, HIPK2 in human epithelial cells, demonstrating the attuned nature of the particles under study within the biological system. The blood compatibilities of the pure PCL and its nanohybrids were studied by platelet aggregation, platelet adhesion, and in vitro hemolysis assay, elucidating the excellent hemocompatibility of the novel nanohybrids. Biocompatible and hemocompatible nanohybrids have been testified for drug delivery and show sustained and controlled release of anti-cancer drugs (dexamethasone) in the presence of two dimensional disc-like nanoparticles. Hence, the developed nanohybrids are a potential biomaterial, suitable for tissue engineering and drug delivery.
C1 [Singh, Narendra K.; Maiti, Pralay] Banaras Hindu Univ, Inst Technol, Sch Mat Sci & Engn, Varanasi 221005, Uttar Pradesh, India.
   [Singh, Sunil K.; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.
   [Purkayastha, Biswa Pratim Das; Roy, Jagat K.] Banaras Hindu Univ, Fac Sci, Dept Zool, Varanasi 221005, Uttar Pradesh, India.
RP Maiti, P (reprint author), Banaras Hindu Univ, Inst Technol, Sch Mat Sci & Engn, Varanasi 221005, Uttar Pradesh, India.
EM pmaiti.mst@itbhu.ac.in
RI Dash, Debabrata/F-3774-2014
FU Department of Biotechnology (DBT), New Delhi, Ministry of Science and
   Technology, Government of India [BT/PR-6929/BCE/08/433/2005]; CSIR; DST,
   India
FX The authors acknowledge the receipt of research funding from the
   Department of Biotechnology (DBT), New Delhi, Ministry of Science and
   Technology, Government of India (Project no.
   BT/PR-6929/BCE/08/433/2005). Narendra also acknowledges the receipt of
   funding for his fellowship from CSIR. The national facility of Scanning
   Confocal Microscopy under Prof. S. C. Lakhotia, Department of Zoology,
   BHU, supported by DST, India is also gratefully acknowledged. The
   authors also gratefully acknowledge Dr V. K. Parnaik, CCMB, Hyderabad,
   India who provided the SiHa Cell line for the work. The authors
   acknowledge Dr D. K. Avasthi of IUAC, New Delhi, Prof. N. Misra and
   Prof. R. M. Banik of IT, BHU for XRD, contact angle and UV-vis
   measurements, respectively.
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Bihari P, 2010, TOXICOLOGY, V269, P148, DOI 10.1016/j.tox.2009.08.011
   Bolland BJRF, 2008, BIOMATERIALS, V29, P3221, DOI 10.1016/j.biomaterials.2008.04.017
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Depan D, 2009, ACTA BIOMATER, V5, P93, DOI [10.1016/j.actbio.2008.08.007, 10.1016/j.aetbio.2008.08.007]
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515
   Kashanian S, 2010, ACTA BIOMATER, V6, P3566, DOI 10.1016/j.actbio.2010.03.031
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Maiti P, 2007, BIOMACROMOLECULES, V8, P3393, DOI 10.1021/bm700500t
   Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Murphy CA, 1996, APPL ENVIRON MICROB, V62, P456
   Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Qi RL, 2012, J BIOMAT SCI-POLYM E, V23, P299, DOI 10.1163/092050610X550340
   Qi RL, 2011, ANALYST, V136, P2897, DOI 10.1039/c0an01026j
   Qi X., 2010, J MATER CHEM, V20, P10622
   Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Semberova J, 2009, NANO LETT, V9, P3312, DOI 10.1021/nl901603k
   Shoaib M Harris, 2006, Pak J Pharm Sci, V19, P119
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t
   Singh NK, 2011, J MATER CHEM, V21, P15919, DOI 10.1039/c1jm12427g
   Singh NK, 2010, ACS APPL MATER INTER, V2, P69, DOI 10.1021/am900584r
   Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t
   Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p
   Thasneem YM, 2011, J BIOMED MATER RES A, V99A, P607, DOI 10.1002/jbm.a.33220
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Zakharchenko S, 2011, BIOMACROMOLECULES, V12, P2211, DOI 10.1021/bm2002945
NR 43
TC 23
Z9 23
U1 4
U2 83
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 34
BP 17853
EP 17863
DI 10.1039/c2jm32340k
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 985YF
UT WOS:000307305700066
DA 2018-10-19
ER

PT J
AU Luangbudnark, W
   Viyoch, J
   Laupattarakasem, W
   Surakunprapha, P
   Laupattarakasem, P
AF Luangbudnark, Witoo
   Viyoch, Jarupa
   Laupattarakasem, Wiroon
   Surakunprapha, Palakorn
   Laupattarakasem, Pisamai
TI Properties and Biocompatibility of Chitosan and Silk Fibroin Blend Films
   for Application in Skin Tissue Engineering
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID IN-VITRO BIOCOMPATIBILITY; PERMEATION PROPERTIES; REGENERATION;
   SCAFFOLDS; BIOMATERIALS; SUBSTITUTES; REPAIR; DEGRADATION; MEMBRANES;
   ACID
AB Chitosan/silk fibroin (CS/SF) blend films were prepared and evaluated for feasibility of using the films as biomaterial for skin tissue engineering application. Fourier transform infrared spectroscopy and differential scanning calorimetry analysis indicated chemical interaction between chitosan and fibroin. Chitosan enhanced beta-sheet conformation of fibroin and resulted in shifting of thermal degradation of the films. Flexibility, swelling index, and enzyme degradation were also increased by the chitosan content of the blend films. Biocompatibility of the blend films was determined by cultivation with fibroblast cells. All films showed no cytotoxicity by XTT assay. Fibroblast cells spread on CS/SF films via dendritic extensions, and cell-cell interactions were noted. Cell proliferation on CS/SF films was also demonstrated, and their phenotype was examined by the expression of collagen type I gene. These results showed possibility of using the CS/SF films as a supporting material for further study on skin tissue engineering.
C1 [Luangbudnark, Witoo; Laupattarakasem, Pisamai] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen 40002, Thailand.
   [Viyoch, Jarupa] Naresuan Univ, Dept Pharmaceut Technol, Fac Pharmaceut Sci, Phitsanulok 65000, Thailand.
   [Laupattarakasem, Wiroon] Khon Kaen Univ, Dept Orthopaed, Khon Kaen 40002, Thailand.
   [Surakunprapha, Palakorn] Khon Kaen Univ, Fac Med, Dept Surg, Khon Kaen 40002, Thailand.
RP Laupattarakasem, P (reprint author), Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen 40002, Thailand.
EM pisamai.lau@gmail.com
FU Thailand Research Fund through Royal Golden Jubilee Ph.D. Program
   [PHD/0024/2550]; Office of Research Affairs, Khon Kaen University,
   Thailand
FX This study was supported by the Thailand Research Fund through the Royal
   Golden Jubilee Ph.D. Program to W. Luangbudnark (Grant no.
   PHD/0024/2550) and by the financial support from the Office of Research
   Affairs, Khon Kaen University, Thailand.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   [Anonymous], 1999, 109935I ISO
   Aranaz I., 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Baimark Y, 2009, CURRENT RES CHEM, V1, P8
   Bettini R, 2008, EUR J PHARM BIOPHARM, V68, P74, DOI 10.1016/j.ejpb.2007.03.026
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Caner C, 1998, J FOOD SCI, V63, P1049, DOI 10.1111/j.1365-2621.1998.tb15852.x
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   de Moraes MA, 2010, POLYMERS-BASEL, V2, P719, DOI 10.3390/polym2040719
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Du CH, 2006, POLYM INT, V55, P377, DOI 10.1002/pi.1995
   Faikrua A, 2009, SCIENCEASIA, V35, P247, DOI 10.2306/scienceasia1513-1874.2009.35.247
   Gobin A., 2005, STRUCTURAL MECH CHAR
   Groeber F, 2011, ADV DRUG DELIVER REV, V63, P352, DOI 10.1016/j.addr.2011.01.005
   Gumusderelioglu M, 2011, J COLLOID INTERF SCI, V358, P444, DOI 10.1016/j.jcis.2011.03.026
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Kearney JN, 2001, BURNS, V27, P545, DOI 10.1016/S0305-4179(01)00020-1
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Khang G., 2007, MANUAL BIOMATERIALS
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kjm KM, 2006, J FOOD SCI, V71, pE119
   Kweon HY, 2001, POLYMER, V42, P6651, DOI 10.1016/S0032-3861(01)00104-5
   Lee KH, 2000, YONSEI MED J, V41, P774, DOI 10.3349/ymj.2000.41.6.774
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Miyaguchi Y, 2005, FOOD SCI TECHNOL RES, V11, P37, DOI 10.3136/fstr.11.37
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Neamnark A, 2008, EUR POLYM J, V44, P2060, DOI 10.1016/j.eurpolymj.2008.04.016
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Sashina ES, 2005, RUSS J APPL CHEM+, V78, P487, DOI 10.1007/s11167-005-0324-x
   Schultz GS, 2005, WORLD WIDE WOUNDS
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Theoret C, 2009, VET SURG, V38, P905, DOI 10.1111/j.1532-950X.2009.00585.x
   Tsai SP, 2007, J APPL POLYM SCI, V105, P1774, DOI 10.1002/app.26157
   Varghese S., 2006, HYDROGELS MUSCULOSKE
   Zhang KH, 2011, INT J MOL SCI, V12, P2187, DOI 10.3390/ijms12042187
   Zhang XD, 2008, INT J BIOL MACROMOL, V43, P456, DOI 10.1016/j.ijbiomac.2008.08.010
   Zhao QS, 2009, CARBOHYD POLYM, V76, P410, DOI 10.1016/j.carbpol.2008.11.020
NR 49
TC 25
Z9 28
U1 1
U2 40
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2012
AR 697201
DI 10.1100/2012/697201
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 982TF
UT WOS:000307067600001
PM 22701367
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sharma, HSS
   Carmichael, E
   Muhamad, M
   McCall, D
   Andrews, F
   Lyons, G
   McRoberts, WC
   Hornsby, PR
AF Sharma, H. S. S.
   Carmichael, E.
   Muhamad, M.
   McCall, D.
   Andrews, F.
   Lyons, G.
   McRoberts, W. C.
   Hornsby, P. R.
TI Biorefining of perennial ryegrass for the production of nanofibrillated
   cellulose
SO RSC ADVANCES
LA English
DT Article
ID THERMAL-ANALYSIS; WHEAT-STRAW; FIBERS; NANOCOMPOSITES; HEMICELLULOSE;
   MICROFIBRILS; NANOFIBRES; COMPOSITES; HYDROLYSIS; SUSPENSION
AB This study has demonstrated biorefining steps for ryegrass and silage at a pilot scale to extrude fibre cake for the production of nanofibrillated cellulose (NFC), a potentially green biomaterial for replacing conventional fillers in the manufacture of polymer composites. Further treatments of processed ryegrass fibres with mechanical shearing, microfluidising, hydrochloric acid (HCl)/sulphuric acid and a four stage {ethylenediaminetetra-acetic acid, sodium hydroxide, sodium hypochlorite and HCl} hydrolysis yielded 43.8, 36.1, 25.6 and 39.8 kg t(-1) DM of NFCs respectively. The NFCs were characterised using microscopy, X-ray diffraction, dynamic light scattering, spectroscopy and thermogravimetry. The NFC had diameters from 3.0-9.1 nm and length 308 nm-4.6 mm. NFC-polyvinyl alcohol composites containing NFC (5 wt%) exhibited enhanced Young's modulus and thermal stability by factors of 2.5 and 2 respectively compared with control. The mass, energy, water and chemical balances of the four process steps were assessed to evaluate technical feasibility and also to provide baseline production data for scaling up. The microfluidised product has been identified as the best NFC product, but production cost needs to be reduced.
C1 [McRoberts, W. C.] Agri Food & Biosci Inst, Food Chem Branch, Belfast BT9 5PX, Antrim, North Ireland.
   [Carmichael, E.; Muhamad, M.; Hornsby, P. R.] Queens Univ Belfast, Polymer Proc Res Ctr, Sch Mech & Mfg Engn, Belfast BT9 5AH, Antrim, North Ireland.
EM shekhar.sharma@afbini.gov.uk
RI Sharma, Shekhar/D-3366-2013
FU Department of Agriculture and Rural Development; Innovation Fund for
   Northern Ireland
FX We wish to acknowledge Department of Agriculture and Rural Development
   and Innovation Fund for Northern Ireland for financial support. We wish
   to thank Dr D. Cysneiros, Marie Curie researcher, Department of
   Microbiology, National University of Ireland, Galway for assistance
   during the development of protocols for pilot scale processing. In
   addition we wish to acknowledge Drs M. Camlin, T. Gilliland and Mr. G.
   Hoppe for comments, providing samples and Dr G. Brennan (QUB), Mr. S.
   McFarland (QUB) and Mr. M. Cleland for technical support.
CR Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X
   Azizi Samir M.A.S., 2005, BIOMACROMOLECULES, V6, P612, DOI DOI 10.1021/BM0493685
   Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864
   Bras J, 2011, CARBOHYD POLYM, V84, P211, DOI 10.1016/j.carbpol.2010.11.022
   Buschle-Diller G, 2005, COLLOID SURFACE A, V260, P63, DOI 10.1016/j.colsurfa.2005.02.031
   Chao M-J., 2011, J IND ENG CHEM, V17, P36
   Charlton A, 2009, CHEM ENG RES DES, V87, P1147, DOI 10.1016/j.cherd.2009.06.013
   Cheng Q, 2011, ADV COMPOSITE MAT
   Christian K., 1971, FLD STN REC DIV PL I, V10, P29
   Deepa B, 2011, BIORESOURCE TECHNOL, V102, P1988, DOI 10.1016/j.biortech.2010.09.030
   Dinand E., 1999, FOOD HYDROCOLLOIDS, V13, P3275
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Dufresne A, 2006, J NANOSCI NANOTECHNO, V6, P322, DOI 10.1166/jnn.2006.005
   Dufresne A, 1997, J APPL POLYM SCI, V64, P1185
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Halasz L, 2005, RESOUR CONSERV RECY, V44, P293, DOI 10.1016/j.resconrec.2005.01.009
   Hebeish A, 1981, CHEM TECHNOLOGY CELL
   Holmes W, 1980, GRASS ITS PRODUCTION
   Ibrahim MM, 2010, CARBOHYD POLYM, V81, P811, DOI 10.1016/j.carbpol.2010.03.057
   Jiang LQ, 2003, J COLLOID INTERF SCI, V260, P89, DOI 10.1016/S0021-9797(02)00176-5
   Kernaghan K, 2006, ENZYME MICROB TECH, V39, P1373, DOI 10.1016/j.enzmictec.2005.09.016
   Ketelaars J. J. M. H., 2002, 159 PLANT RES INT BV
   Kromus S, 2004, CHEM BIOCHEM ENG Q, V18, P7
   Liu CF, 2006, CARBOHYD RES, V341, P2677, DOI 10.1016/j.carres.2006.07.008
   Neureiter M, 2004, BIORESOURCE TECHNOL, V92, P21, DOI 10.1016/j.biortech.2003.08.001
   NGUYEN T, 1981, J MACROMOL SCI R M C, VC20, P1
   O'Keeffe S, 2011, BIOMASS BIOENERG, V35, P4712, DOI 10.1016/j.biombioe.2011.06.017
   O'Keeffe S, 2011, BIOMASS BIOENERG, V35, P4699, DOI 10.1016/j.biombioe.2011.06.051
   Pecora R., 1976, DYNAMIC LIGHT SCATTE
   Qua EH, 2011, J MATER SCI, V46, P6029, DOI 10.1007/s10853-011-5565-x
   Qua EH, 2009, J APPL POLYM SCI, V113, P2238, DOI 10.1002/app.30116
   RIES HE, 1970, NATURE, V226, P72, DOI 10.1038/226072b0
   Satyamurthy P, 2011, CARBOHYD POLYM, V83, P122, DOI 10.1016/j.carbpol.2010.07.029
   Sharma H. S. S., 2012, J APPL PHYCOL, DOI [10.1007/s10811-011-9744-6, DOI 10.1007/S10811-011-9744-6]
   Sharma H. S. S., 2005, AM ASS TEXT CHEM COL, V5, P56
   Sharma HSS, 2012, IND CROP PROD, V36, P476, DOI 10.1016/j.indcrop.2011.10.027
   Sharma HSS, 2011, CHEM ENG RES DES, V89, P2309, DOI 10.1016/j.cherd.2011.03.004
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   Siqueira G, 2010, CELLULOSE, V17, P1147, DOI 10.1007/s10570-010-9449-z
   Sun XF, 2005, CARBOHYD RES, V340, P97, DOI 10.1016/j.carres.2004.10.022
   Taniguchi T, 1998, POLYM INT, V47, P291, DOI 10.1002/(SICI)1097-0126(199811)47:3<291::AID-PI11>3.0.CO;2-1
   VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50
   Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X
   Xu F, 2007, PROCESS BIOCHEM, V42, P913, DOI 10.1016/j.procbio.2007.02.001
   Xu RL, 1998, LANGMUIR, V14, P2593, DOI 10.1021/la971404g
   Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013
   Zhang JG, 2007, CARBOHYD POLYM, V69, P607, DOI 10.1016/j.carbpol.2007.01.019
   Zimmermann T, 2004, ADV ENG MATER, V6, P754, DOI 10.1002/adem.200400097
NR 50
TC 13
Z9 13
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2012
VL 2
IS 16
BP 6424
EP 6437
DI 10.1039/c2ra20716h
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA 974FG
UT WOS:000306415100012
DA 2018-10-19
ER

PT J
AU Chen, B
   Jones, RR
   Mi, SL
   Foster, J
   Alcock, SG
   Hamley, IW
   Connon, CJ
AF Chen, Bo
   Jones, Roanne R.
   Mi, Shengli
   Foster, James
   Alcock, Simon G.
   Hamley, Ian W.
   Connon, Che J.
TI The mechanical properties of amniotic membrane influence its effect as a
   biomaterial for ocular surface repair
SO SOFT MATTER
LA English
DT Article
ID STEVENS-JOHNSON-SYNDROME; LIMBAL EPITHELIAL-CELLS; EX-VIVO EXPANSION;
   STEM-CELLS; CORNEAL EPITHELIUM; BASEMENT-MEMBRANE; CULTURED LIMBAL;
   CROSS-LINKING; IN-VITRO; TRANSPLANTATION
AB The human amniotic membrane (AM) is a tissue of fetal origin and has proven to be clinically useful as a biomaterial in the management of various ocular surface disorders including corneal stem cell transplantation. However, its success rate displays a degree of clinical unpredictability. We suggest that the measured variability inAMstiffness offers an explanation for the poor clinical reproducibility when it is used as a substrate for stem cell expansion and transplantation. Corneal epithelial stem cells were expanded upon AM samples possessing different mechanical stiffness. To investigate further the importance of biological substrate stiffness on cell phenotype we replaced AM with type I collagen gels of known stiffness. Substrate stiffness was measured using shear rheometry and surface topography was characterized using scanning electron microscopy and atomic force microscopy. The differentiation status of epithelial cells was examined using RT-PCR, immunohistochemistry and Western blotting. The level of corneal stem cell differentiation was increased in cells expanded upon AM with a high dynamic elastic shear modulus and cell expansion on type I collagen gels confirmed that the level of corneal epithelial stem cell differentiation was related to the substrate's mechanical properties. In this paper we provide evidence to show that the preparatory method of AM for clinical use can affect its mechanical properties and that these measured differences can influence the level of differentiation within expanded corneal epithelial stem cells.
C1 [Chen, Bo; Jones, Roanne R.; Mi, Shengli; Foster, James; Hamley, Ian W.; Connon, Che J.] Univ Reading, Sch Chem Food & Pharm, Reading RG6 6UB, Berks, England.
   [Mi, Shengli] Tsinghua Univ Shenzhen, Res Inst, Shenzhen, Peoples R China.
   [Alcock, Simon G.] Diamond Light Source Ltd, Opt & Metrol Grp, Oxford OX11 0DE, England.
RP Connon, CJ (reprint author), Univ Reading, Sch Chem Food & Pharm, Reading RG6 6UB, Berks, England.
EM c.j.connon@reading.ac.uk
RI Connon, Che/B-3128-2012; Hamley, Ian/D-1643-2009; Chen, Bo/A-3351-2015
OI Connon, Che/0000-0001-8264-6531; Hamley, Ian/0000-0002-4549-0926; 
FU Biotechnology and Biological Sciences Research Council of United
   Kingdom; University of Reading (RETF); Medical Research Council
   [G0900877]
FX The authors thank Dr Anna David for providing AM for this study. This
   study was financially supported by the Biotechnology and Biological
   Sciences Research Council of United Kingdom, and University of Reading
   (RETF).
CR Ang LPK, 2007, AM J OPHTHALMOL, V143, P178, DOI 10.1016/j.ajo.2006.07.050
   Ang LPK, 2006, ARCH OPHTHALMOL-CHIC, V124, P1543, DOI 10.1001/archopht.124.11.1543
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Benson-Martin J, 2006, EUR J OBSTET GYN R B, V128, P103, DOI 10.1016/j.ejogrb.2005.12.011
   Brown R. A., 2005, ADV FUNCT MATER, V15, P8
   Chen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013192
   Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Ciralsky J, 2010, OCUL IMMUNOL INFLAMM, V18, P275, DOI 10.3109/09273941003682300
   CLINCH TE, 1992, OPHTHALMOLOGY, V99, P634
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Connon CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001147
   DABIN I, 1991, J CELL PHYSIOL, V147, P396, DOI 10.1002/jcp.1041470303
   Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gabison EE, 2009, PROG RETIN EYE RES, V28, P19, DOI 10.1016/j.preteyeres.2008.11.001
   Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52
   Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   Hamley IW, 2010, J PHYS CHEM B, V114, P8244, DOI 10.1021/jp101374e
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Ji SZ, 2011, BIOMATERIALS, V32, P7801, DOI 10.1016/j.biomaterials.2011.06.076
   Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001
   KIM JC, 1995, CORNEA, V14, P473
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7
   Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165
   Kruse F E, 2008, Dev Ophthalmol, V41, P159, DOI 10.1159/000131087
   Li W, 2006, INVEST OPHTH VIS SCI, V47, P2381, DOI 10.1167/iovs.05-1491
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Mi S., 2010, TISSUE ENG PART A, P2091
   Mi S., 2011, TISSUE ENG A
   Mi SL, 2008, MOL REPROD DEV, V75, P1607, DOI 10.1002/mrd.20900
   Mi SL, 2011, J BIOMED MATER RES A, V99A, P1, DOI 10.1002/jbm.a.33152
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Pfister Roswell R., 1994, CLAO (Contact Lens Association of Ophthalmologists) Journal, V20, P64
   PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Sangwan VS, 2003, CORNEA, V22, P478, DOI 10.1097/00003226-200307000-00016
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891
   Shimazaki J, 2006, CORNEA, V25, P139, DOI 10.1097/01.ico.0000180083.59244.8f
   Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021
   Thomasen H, 2011, CURR EYE RES, V36, P247, DOI 10.3109/02713683.2010.542267
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   Vollers Sabrina S, 2005, Methods Mol Biol, V299, P11
   Wan PX, 2011, INVEST OPHTH VIS SCI, V52, P724, DOI 10.1167/iovs.10-5291
   Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Zhao B, 2008, INVEST OPHTH VIS SCI, V49, P3395, DOI 10.1167/iovs.07-1263
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 64
TC 19
Z9 19
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 32
BP 8379
EP 8387
DI 10.1039/c2sm26175h
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 979WY
UT WOS:000306855000016
DA 2018-10-19
ER

PT J
AU Song, W
   Wang, XL
   Lu, HX
   Kawazoe, N
   Chen, GP
AF Song, Wei
   Wang, Xinlong
   Lu, Hongxu
   Kawazoe, Naoki
   Chen, Guoping
TI Exploring adipogenic differentiation of a single stem cell on
   poly(acrylic acid) and polystyrene micropatterns
SO SOFT MATTER
LA English
DT Article
ID BIOMATERIAL SURFACE-CHEMISTRY; POLYMER-MODIFIED SURFACES; OSTEOGENIC
   DIFFERENTIATION; ACTIN CYTOSKELETON; INTEGRIN BINDING; ADIPOCYTE
   DIFFERENTIATION; IN-VITRO; APOPTOSIS; ADHESION; SUBSTRATE
AB Surface chemistry is an important property of biomaterials and plays a pivotal role in the interaction between stem cells and biomaterials. Comparing the effect of the surface chemistry at the single-cell level should elucidate the mechanism of the interaction. In this study, a micropatterning method was used to investigate the electrostatic effect derived from different chemical groups on the functions of individual human mesenchymal stem cells (MSCs). Differently sized circular micropatterns of negatively charged poly(acrylic acid) (PAAc) and neutral polystyrene (PSt) were created using UV photolithography. The PAAc and PSt micropatterns showed different effects on actin cytoskeleton organization and adipogenic differentiation of MSCs. The assembly and distribution of actin filaments for individual MSCs correlated with the degree of cell spreading as well as the surface charge of the underlying substrates. The adipogenic differentiation at the single-cell level was enhanced on the PAAc micropatterns, and decreased as the diameter of the circular micropattern increased. The micropatterning method allows for the construction of diverse micropatterns on various organic substrates with different physicochemical compositions or topographical features, and it enables the analysis of entire cell populations at the single-cell level, significantly facilitating the identification of the optimal surface parameters to manipulate the functions of stem cells.
C1 [Song, Wei; Wang, Xinlong; Lu, Hongxu; Kawazoe, Naoki; Chen, Guoping] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tissue Regenerat Mat Unit, Tsukuba, Ibaraki 3050044, Japan.
   [Song, Wei; Wang, Xinlong; Chen, Guoping] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.
RP Chen, GP (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tissue Regenerat Mat Unit, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM Guoping.CHEN@nims.go.jp
RI Lu, Hongxu/G-5576-2010; Song, Wei/P-1890-2015
OI Lu, Hongxu/0000-0001-6932-1900; Song, Wei/0000-0001-9791-9870
FU World Premier International Research Center Initiative on Materials
   Nanoarchitectonics from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan
FX This work was supported by the World Premier International Research
   Center Initiative on Materials Nanoarchitectonics from the Ministry of
   Education, Culture, Sports, Science and Technology, Japan.
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Guo L, 2008, BIOMATERIALS, V29, P23, DOI [10.1016/j.biomaterials.2007.08.043, 10.1016/j.biomaterials.2007-08.043]
   Guo LK, 2008, J BIOMED MATER RES A, V87A, P903, DOI 10.1002/jbm.a.31834
   Guvendiren M, 2010, BIOMATERIALS, V31, P6511, DOI 10.1016/j.biomaterials.2010.05.037
   Im GI, 2011, BIOMATERIALS, V32, P4385, DOI 10.1016/j.biomaterials.2011.02.054
   Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699
   Kawazoe N, 2009, J NANOSCI NANOTECHNO, V9, P230, DOI 10.1166/jnn.2009.J003
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kulms D, 2002, CELL DEATH DIFFER, V9, P598, DOI 10.1038/sj/cdd/4401002
   Lanniel M, 2011, SOFT MATTER, V7, P6501, DOI 10.1039/c1sm05167a
   Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006
   Liu JF, 2011, TISSUE ENG PT A, V17, P2343, DOI [10.1089/ten.tea.2011.0034, 10.1089/ten.TEA.2011.0034]
   Lode A, 2008, J TISSUE ENG REGEN M, V2, P400, DOI 10.1002/term.110
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234
   Ruiz A, 2008, BIOMATERIALS, V29, P4766, DOI 10.1016/j.biomaterials.2008.08.017
   Sart S, 2013, J TISSUE ENG REGEN M, V7, P537, DOI 10.1002/term.545
   Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668
   Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d
NR 44
TC 12
Z9 12
U1 1
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 32
BP 8429
EP 8437
DI 10.1039/c2sm25718a
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 979WY
UT WOS:000306855000022
DA 2018-10-19
ER

PT J
AU Baghbani, F
   Moztarzadeh, F
   Nazari, AG
   Kamran, AHR
   Tondnevis, F
   Nezafati, N
   Gholipourmalekabadi, M
   Mozafari, M
AF Baghbani, F.
   Moztarzadeh, F.
   Nazari, A. Gafari
   Kamran, A. H. Razavi
   Tondnevis, F.
   Nezafati, N.
   Gholipourmalekabadi, M.
   Mozafari, M.
TI BIOLOGICAL RESPONSE OF BIPHASIC HYDROXYAPATITE/TRICALCIUM PHOSPHATE
   SCAFFOLDS INTENDED FOR LOW LOAD-BEARING ORTHOPAEDIC APPLICATIONS
SO ADVANCED COMPOSITES LETTERS
LA English
DT Article
DE Biphasic composites; Hydroxyapatite; Tricalcium phosphate; In vitro; In
   vivo
ID BONE-FORMATION; NANOCOMPOSITE SCAFFOLDS; IN-VITRO; TISSUE; IMPLANTS;
   SURFACE; BIOMATERIALS; STABILITY; CARTILAGE; CERAMICS
AB In this study, a calcium phosphate scaffold of hydroxyapatite (HAp) and dicalcium phosphate dihydrate (DCPD) for application in osteoconductive and osteoinductive scaffolds was synthesized and characterized. The important note is that the prepared composites converted to HAp/tricalcium phosphate (TCP) after heat-treatment. This class of composites is interesting because porous HAp/TCP generally degrade more rapid than HAp due to the increased resorption rate of TCP. According to the obtained results, the values of elastic modulus, compressive strength and density of the samples reduced with increasing the percentage of the DCPD phase. It is worth mentioning that the mechanical properties of the prepared samples were near the natural compact bone. The samples were examined in vitro to confirm the apatite forming ability of the composites. Also, in vivo examination in a rabbit model was employed. After fully observation it was concluded that new bone formed on the pore walls, as osteoids and osteoclasts were evident two months postoperatively. Based on the obtained results, the prepared scaffolds seem to be a promising biomaterial for low weight bearing orthopaedic applications.
C1 [Baghbani, F.; Moztarzadeh, F.; Kamran, A. H. Razavi; Tondnevis, F.; Nezafati, N.; Mozafari, M.] Amirkabir Univ Technol, Ctr Excellence, Fac Biomed Engn, Biomat Grp, Tehran, Iran.
   [Baghbani, F.; Moztarzadeh, F.; Kamran, A. H. Razavi; Tondnevis, F.; Nezafati, N.; Mozafari, M.] Univ Brescia, Dept Mech & Ind Engn, I-25123 Brescia, Italy.
   [Gholipourmalekabadi, M.] Shahid Beheshti Univ Med Sci, Dept Biotechnol, Tehran, Iran.
RP Moztarzadeh, F (reprint author), Amirkabir Univ Technol, Ctr Excellence, Fac Biomed Engn, Biomat Grp, POB 15875-4413, Tehran, Iran.
EM moztarzadeh@aut.ac.ir
RI ghafarinazari, ali/F-5334-2015; Mozafari, Masoud/I-3061-2013;
   Gholipourmalekabadi, Mazaher/P-3019-2018
OI ghafarinazari, ali/0000-0001-6287-0640; Mozafari,
   Masoud/0000-0002-0232-352X; Gholipourmalekabadi,
   Mazaher/0000-0001-6287-6831; Moztarzadeh, Fathollah/0000-0001-9109-0264
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   AOBA T, 1984, J DENT RES, V63, P874, DOI 10.1177/00220345840630061201
   Asashina I, 1997, J MED DENT SCI, V44, P63
   BERMUDEZ O, 1993, J MATER SCI-MATER M, V4, P389, DOI 10.1007/BF00122197
   Boyan BD, 1999, CLIN PLAST SURG, V26, P629
   BRUDER SP, 1999, CLIN ORTHOP S, V367, pS68
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Elliott J. C., STRUCTURE CHEM APATI
   Fulmer MT, 1998, J MATER SCI-MATER M, V9, P197, DOI 10.1023/A:1008832006277
   Hamlekhan A, 2010, ADV COMPOS LETT, V19, P123
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kawai N, 1997, J BIOMED MATER RES, V37, P1
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Klein C. P., 1983, CERAMICS SURG, P356
   KUHN JL, 1989, J ORTHOPAED RES, V7, P876, DOI 10.1002/jor.1100070614
   LEGEROS R Z, 1989, Journal of Dental Research, V68, P215
   Legeros R.Z., 1990, HDB BIOACTIVE CERAMI, V2, P17
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   LEGEROS RZ, 1986, J DENT RES, V65, P293
   LI YB, 1994, BIOMATERIALS, V15, P835
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Mente PL, 1987, T 33 ANN M ORTH RES, P49
   Mozafari M, 2010, APPL SURF SCI, V257, P1740, DOI 10.1016/j.apsusc.2010.09.008
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nezafati N, 2011, CERAM INT, V37, P927, DOI 10.1016/j.ceramint.2010.11.002
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Poursamar SA, 2011, COLLOID SURFACE B, V84, P310, DOI 10.1016/j.colsurfb.2011.01.015
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Runkle J C, 1975, Bull Hosp Joint Dis, V36, P2
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   TOWNSEND PR, 1975, J BIOMECH, V8, P199, DOI 10.1016/0021-9290(75)90025-1
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Wang JX, 1998, BIOMATERIALS, V19, P1387, DOI 10.1016/S0142-9612(98)00014-3
   Wongkhantee S, 2006, J DENT, V34, P214, DOI 10.1016/j.jdent.2005.06.003
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   YAMAGUCHI K, 1995, BIOMATERIALS, V16, P983, DOI 10.1016/0142-9612(95)94905-Z
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 48
TC 13
Z9 13
U1 1
U2 7
PU ADCOTEC LTD
PI LONDON
PA PREMIER HOUSE, STE 501, 77 OXFORD ST, LONDON W1R 1RB, ENGLAND
SN 0963-6935
J9 ADV COMPOS LETT
JI Adv. Compos. Lett.
PY 2012
VL 21
IS 1
BP 16
EP 24
PG 9
WC Materials Science, Composites
SC Materials Science
GA 977AN
UT WOS:000306628600002
DA 2018-10-19
ER

PT J
AU Leal, MAL
   Martinez, RC
   Villanueva, RAC
   Flores, HEM
   Penagos, CDC
AF Lopez Leal, Maria Aranzazu
   Cortes Martinez, Raul
   Cuevas Villanueva, Ruth Alfaro
   Martinez Flores, Hector Eduardo
   Cortes Penagos, Consuelo de Jesus
TI ARSENATE BIOSORPTION BY IRON-MODIFIED PINE SAWDUST IN BATCH SYSTEMS:
   KINETICS AND EQUILIBRIUM STUDIES
SO BIORESOURCES
LA English
DT Article
DE Arsenate; Biosorption; Sawdust; pH; Kinetics; Isotherms
ID DIVALENT METAL-IONS; AQUEOUS-SOLUTIONS; DRINKING-WATER; ZEOLITIC TUFF;
   RICH TUFFS; REMOVAL; ADSORPTION; SORPTION; BIOMASS; AS(V)
AB The biosorption of As(V) from aqueous solutions by pine sawdust chemically modified with iron in batch systems was investigated. The loading process of Fe in this biomaterial was achieved by hydrolysis of two different ferric salts. This modification of sawdust is an attempt to improve As(V) biosorption for practical applications. The kinetics and maximum biosorption capacities of the unmodified and modified pine sawdust were evaluated. It was found that the pseudo-second order model described the As(V) biosorption kinetic data and the Langmuir-Freundlich equation described the arsenate sorption equilibrium. These results indicated that the sorption mechanism was chemisorption on a heterogeneous material. The pH effects governing biosorption capacities were also evaluated, showing a decrease as pH value rises, indicating that this biosorption process is highly pH-dependent. The estimated maximum biosorption capacities of As(V), based on the Langmuir-Freundlich fit to the data were, at pH 4, 4.4 mg/g of untreated sawdust, (UN-SW), 12.85 mg/g of ferric chloride modified sawdust (FeCl-SW), and 6 mg/g of ferric nitrate modified sawdust (FeNit-SW); and at pH 7, 2.6 mg/g of UN-SW, 5.9 mg/g of FeCl-SW, and 4.6 mg/g of FeNit-SW. Sorption capacities of iron-modified pine sawdust were evidently higher than other similar biosorbents previously reported.
C1 [Cortes Martinez, Raul; Martinez Flores, Hector Eduardo; Cortes Penagos, Consuelo de Jesus] Univ Michoacana, Fac Quim Farmacobiol, Morelia 58240, Michoacan, Mexico.
   [Lopez Leal, Maria Aranzazu; Cuevas Villanueva, Ruth Alfaro] Univ Michoacana, Inst Invest Quim Biol, Morelia 58240, Michoacan, Mexico.
RP Martinez, RC (reprint author), Univ Michoacana, Fac Quim Farmacobiol, Tzintzuntzan 173 Col Matamoros, Morelia 58240, Michoacan, Mexico.
EM raulcortesmtz@gmail.com
OI Martinez-Flores, Hector E./0000-0002-0044-9399
FU Coordinacion de la Investigacion Cientifica-UMSNH
FX The authors acknowledge financial support provided by Coordinacion de la
   Investigacion Cientifica-UMSNH and are grateful to the technical support
   of B. Villalobos-Castaneda and B. Cortes for style correction.
CR Alluri HK, 2007, AFR J BIOTECHNOL, V6, P2924
   Aryal M, 2010, CHEM ENG J, V162, P178, DOI 10.1016/j.cej.2010.05.026
   Bertocchi AF, 2006, J HAZARD MATER, V134, P112, DOI 10.1016/j.jhazmat.2005.10.043
   Bunnaul P., 1999, J AM WATER WORK ASS, V65, P548
   Calero M, 2009, BRAZ J CHEM ENG, V26, P265, DOI 10.1590/S0104-66322009000200004
   Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7
   Dupont L, 2007, ENVIRON CHEM LETT, V5, P125, DOI 10.1007/s10311-007-0092-3
   Dutta PK, 2004, J COLLOID INTERF SCI, V278, P270, DOI 10.1016/j.jcis.2004.06.015
   Goldberg S, 2001, J COLLOID INTERF SCI, V234, P204, DOI 10.1006/jcis.2000.7295
   Gu ZM, 2007, ENVIRON ENG SCI, V24, P113, DOI 10.1089/ees.2007.24.113
   Gu ZM, 2005, ENVIRON SCI TECHNOL, V39, P3833, DOI 10.1021/es048179r
   Guo XJ, 2005, ENVIRON SCI TECHNOL, V39, P6808, DOI 10.1021/es048080k
   Hansen HK, 2006, MINER ENG, V19, P486, DOI 10.1016/j.mineng.2005.08.018
   Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693
   Ho YS, 2002, WATER AIR SOIL POLL, V141, P1, DOI 10.1023/A:1021304828010
   Igwe J. C., 2006, AFR J BIOTECHNOL, V5, P1617
   Igwe JC, 2005, AFR J BIOTECHNOL, V4, P1109
   Ishikawa SI, 2004, BIOL TRACE ELEM RES, V102, P113, DOI 10.1385/BTER:102:1-3:113
   Jimenez-Cedillo MJ, 2009, J HAZARD MATER, V163, P939, DOI 10.1016/j.jhazmat.2008.07.049
   Solache-Rios MJ, 2010, J MEX CHEM SOC, V54, P59
   Kumari P, 2005, J IND MICROBIOL BIOT, V32, P521, DOI 10.1007/s10295-005-0042-7
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Lakshmipathiraj P, 2006, J HAZARD MATER, V136, P281, DOI 10.1016/j.jhazmat.2005.12.015
   LOW MJD, 1960, CHEM REV, V60, P267, DOI 10.1021/cr60205a003
   Macedo-Miranda MG, 2007, J INCL PHENOM MACRO, V59, P131, DOI 10.1007/s10847-007-9306-3
   Matis KA, 1999, NATO ADV SCI I E-APP, V362, P463
   Murugesan GS, 2006, BIORESOURCE TECHNOL, V97, P483, DOI 10.1016/j.biortech.2005.03.008
   Niu CH, 2007, WATER RES, V41, P2473, DOI 10.1016/j.watres.2007.03.013
   Onyango MS, 2003, J CHEM ENG JPN, V36, P477, DOI 10.1252/jcej.36.477
   Rau I, 2003, REACT FUNCT POLYM, V54, P85, DOI 10.1016/S1381-5148(02)00184-0
   Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p
   Reed BE, 2000, J ENVIRON ENG-ASCE, V126, P869, DOI 10.1061/(ASCE)0733-9372(2000)126:9(869)
   Sari A, 2010, SEP SCI TECHNOL, V45, P463, DOI 10.1080/01496390903526642
   Say R, 2003, SEPAR SCI TECHNOL, V38, P2039, DOI 10.1081/SS-120020133
   Serrano-Gomez J, 2010, J INCL PHENOM MACRO, V67, P153, DOI 10.1007/s10847-009-9691-x
   Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5
   Srinivasa-Rao P., 2007, WOOD SCI TECHNOL, V41, P427
   Stanic T, 2009, ENVIRON CHEM LETT, V7, P161, DOI 10.1007/s10311-008-0152-3
   Thirunavukkarasu OS, 2003, WATER AIR SOIL POLL, V142, P95, DOI 10.1023/A:1022073721853
   Valencia-Trejo E, 2010, J APPL SCI ENV SANIT, V5, P171
   Vijayaraghavan K, 2009, IND ENG CHEM RES, V48, P3589, DOI 10.1021/ie801570v
   Zhang FS, 2005, CHEMOSPHERE, V60, P319, DOI 10.1016/j.chemosphere.2004.12.019
   Zhang W, 2004, MINER ENG, V17, P517, DOI 10.1016/j.mineng.2003.11.020
NR 43
TC 4
Z9 4
U1 0
U2 6
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2012
VL 7
IS 2
BP 1389
EP 1404
PG 16
WC Materials Science, Paper & Wood
SC Materials Science
GA 975BM
UT WOS:000306481700003
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU He, ZQ
   Xiong, LZ
AF He, Zeqiang
   Xiong, Lizhi
TI Evaluation of Physical and Biological Properties of Polyvinyl
   Alcohol/Chitosan Blend Films
SO JOURNAL OF MACROMOLECULAR SCIENCE PART B-PHYSICS
LA English
DT Article
DE biological properties; chitosan; poly(vinyl alcohol); swelling behavior;
   wettability
ID L-LACTIC ACID; CHITOSAN; PVA; MICROSPHERES; HYDROGELS; BIOMATERIALS;
   BEHAVIOR; CARRIER; GROWTH
AB Polyvinyl alcohol/chitosan (PVA/Cs) blend films with various compositions were prepared using glutaraldehyde (GA) as a crosslinker. The hydrophilicity and swelling behavior of the PVA/Cs films were assessed, and the biological properties of the PVA/Cs films, including cell culture in the extract, cell cytotoxicity, and hemolytic and acute systemic toxicity tests were also investigated. The results showed that all composite films were hydrophilic materials with water contact angles changing from 45.3 +/- 1.1 degrees to 63.2 +/- 1.8 degrees when PVA content was varied from 100 to 0 wt%. The PVA/Cs films showed a significant reduction in swelling behavior as the chitosan content increased. Fibroblasts grown in PVA/Cs extract showed similar appearance with the cells cultured in the negative control medium, and the extract solution of PVA/Cs had no obvious cytotoxic effect. The hemolytic test suggested that the PVA/Cs, with a hemolytic index of 0.91%, did not have an obvious hemolytic reaction. There was no toxicosis or death observed in the acute systemic toxicity test. The results suggest that the complex of PVA and chitosan is a promising candidate biomaterial for tissue engineering.
C1 [He, Zeqiang; Xiong, Lizhi] Jishou Univ, Coll Biol & Environm Sci, Jishou 416000, Peoples R China.
RP He, ZQ (reprint author), Jishou Univ, Coll Biol & Environm Sci, Jishou 416000, Peoples R China.
EM hezeqiang2008@126.com
FU National Natural Science Foundation of China [51142001]; Hunan
   Provincial Natural Science Foundation of China; Research Foundation of
   Education Bureau of Hunan Province, China [11B099]; Planned Science and
   Technology Project of Hunan Province, China [2011TT2038]
FX This project was financially supported by the National Natural Science
   Foundation of China (No. 51142001), the Hunan Provincial Natural Science
   Foundation of China, the Research Foundation of Education Bureau of
   Hunan Province, China (No. 11B099), and the Planned Science and
   Technology Project of Hunan Province, China (No. 2011TT2038).
CR [Anonymous], 1992, 10993 ISO 4
   [Anonymous], 2006, 10993 ISO 11
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Cerchiara T, 2003, EUR J PHARM BIOPHARM, V56, P401, DOI 10.1016/S0939-6411(03)00135-8
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hassan CM, 2000, POLYMER, V41, P6729, DOI 10.1016/S0032-3861(00)00031-8
   He ZQ, 2011, J MACROMOL SCI B, V50, P1154, DOI 10.1080/00222348.2010.503106
   He ZQ, 2010, POLYM-PLAST TECHNOL, V49, P381, DOI 10.1080/03602550903532133
   He ZQ, 2009, POLYM-PLAST TECHNOL, V48, P1020, DOI 10.1080/03602550903092534
   Jung BO, 2006, J APPL POLYM SCI, V99, P3500, DOI 10.1002/app.22974
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Wang LC, 2009, J BIOMED MATER RES A, V91A, P1065, DOI 10.1002/jbm.a.32294
   Xiong LZ, 2010, POLYM-PLAST TECHNOL, V49, P1201, DOI 10.1080/03602559.2010.496412
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
NR 21
TC 8
Z9 8
U1 3
U2 27
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0022-2348
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2012
VL 51
IS 9
BP 1705
EP 1714
DI 10.1080/00222348.2012.657584
PG 10
WC Polymer Science
SC Polymer Science
GA 975QK
UT WOS:000306525800002
DA 2018-10-19
ER

PT J
AU Eap, S
   Ferrand, A
   Palomares, CM
   Hebraud, A
   Stoltz, JF
   Mainard, D
   Schlatter, G
   Benkirane-Jessel, N
AF Eap, Sandy
   Ferrand, Alice
   Palomares, Carlos Mendoza
   Hebraud, Anne
   Stoltz, Jean-Francois
   Mainard, Didier
   Schlatter, Guy
   Benkirane-Jessel, Nadia
TI Electrospun nanofibrous 3D scaffold for bone tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 4th China-France Biotherapy and Regenerative Medicine International
   Symposium
CY JUN 18-19, 2011
CL Wuhan, PEOPLES R CHINA
DE Tissue engineering; bone regeneration; electrospinning; 3D scaffold;
   nanofibers; polycaprolactone
AB Tissue engineering aims at developing functional substitutes for damaged tissues by mimicking natural tissues. In particular, tissue engineering for bone regeneration enables healing of some bone diseases. Thus, several methods have been developed in order to produce implantable biomaterial structures that imitate the constitution of bone. Electrospinning is one of these methods. This technique produces nonwoven scaffolds made of nanofibers which size and organization match those of the extracellular matrix. Until now, seldom electrospun scaffolds were produced with thickness exceeding one millimeter. This article introduces a new kind of electrospun membrane called 3D scaffold of thickness easily exceeding one centimeter. The manufacturing involves a solution of poly(e-caprolactone) in DMF/DCM system. The aim is to establish parameters for electrospinning in order to characterize these 3D scaffolds and, establish whether such scaffolds are potentially interesting for bone regeneration.
C1 [Eap, Sandy; Ferrand, Alice; Palomares, Carlos Mendoza; Benkirane-Jessel, Nadia] INSERM, Unite 977, F-67085 Strasbourg, France.
   [Ferrand, Alice; Hebraud, Anne; Schlatter, Guy] Univ Strasbourg, LIPHT EAC 4379, Lab Ingn Polymeres Hautes Technol, CNRS, Strasbourg, France.
   [Benkirane-Jessel, Nadia] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France.
   [Stoltz, Jean-Francois; Mainard, Didier; Benkirane-Jessel, Nadia] Hop Cent, Serv Chirurg, Nancy, France.
   [Stoltz, Jean-Francois; Mainard, Didier; Benkirane-Jessel, Nadia] CNRS, UMR 7561, Nancy, France.
RP Benkirane-Jessel, N (reprint author), INSERM, Unite 977, 11 Rue Humann, F-67085 Strasbourg, France.
EM nadia.jessel@inserm.fr
RI Benkirane-Jessel, Nadia/H-6438-2016; Hebraud, Anne/A-3593-2012
OI Hebraud, Anne/0000-0002-6018-1523; Mendoza, Carlos/0000-0002-7431-1296;
   Benkirane-Jessel, Nadia/0000-0003-3059-3559; Schlatter,
   Guy/0000-0003-3037-4129
FU Institut de Biologie Moleculaire des Plantes (IBMP)
FX The authors acknowledge the support of the Institut de Biologie
   Moleculaire des Plantes (IBMP).
CR Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Hutmacher D.W., 2000, SYNTHETIC BIOABSORBA
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Vaquette C., 2008, ELABORATION CARACTER
NR 7
TC 17
Z9 19
U1 0
U2 25
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2012
VL 22
IS 1-3
BP 137
EP 141
DI 10.3233/BME-2012-0699
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 970HN
UT WOS:000306119100017
PM 22766712
DA 2018-10-19
ER

PT J
AU Konwarh, R
   Pramanik, S
   Devi, KSP
   Saikia, N
   Boruah, R
   Maiti, TK
   Deka, RC
   Karak, N
AF Konwarh, Rocktotpal
   Pramanik, Sujata
   Devi, K. Sanjana P.
   Saikia, Nabanita
   Boruah, Ratan
   Maiti, Tapas Kumar
   Deka, Ramesh Chandra
   Karak, Niranjan
TI Lycopene coupled 'trifoliate' polyaniline nanofibers as multi-functional
   biomaterial
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID GREEN SILVER NANOPARTICLES; IN-VITRO; PROLIFERATION; SONICATION;
   NANOWIRES; SYSTEM; GROWTH; VIVO
AB Bio-conjugation seems to be an unparalleled avenue to tailor the shape-size-bioactivity accord of nanomaterials. In this backdrop, conjugation of tomato peel lycopene through the green chemistry tool of sonication, under statistically optimized parameters led to the morphological alteration of polyaniline (PAni) nanofiber from linear to biomimetic 'runner' morphology with trifoliate branching as observed under TEM. X-ray diffractogram was suggestive of alterations in the d-spacing and strain in the polymer backbone post lycopene binding. Post bio-conjugation, the semiconducting-behavior of the PAni nanofibers was retained although lycopene coupling resulted in a decrease in the former's conductivity. DMol3 was employed for the quantum molecular calculations of lycopene interacting with PAni (via non-covalent functionalization involving pi-pi stacking) and its solvation study. The contribution to HOMO came from the lycopene unit whereas the LUMO had contribution from the aromatic ring of PAni in the conjugated system. The bioactivity of the PAni nanofibers post bio-conjugation was attested by free radical scavenging and anti-lipid peroxidation of liver tissue homogenate. Epiflorescence microscopic imaging demonstrated the cytocompatibility with L929 normal cell line while the nuclear fragmentation and membrane blebbing of apoptotic HeLa cells vouched for the anticancer action of the conjugated system. Furthermore, the reported system exhibited a stimulatory effect on Cucumis sativus seed germination. Thus the study marshals in support of modulated morphology and desirable bio-action of nanoscaled biomaterials via bio-conjugation for advanced applications.
C1 [Konwarh, Rocktotpal; Pramanik, Sujata; Saikia, Nabanita; Deka, Ramesh Chandra; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Sonitpur 784028, Assam, India.
   [Devi, K. Sanjana P.; Maiti, Tapas Kumar] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Boruah, Ratan] Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
RP Karak, N (reprint author), Tezpur Univ, Dept Chem Sci, Sonitpur 784028, Assam, India.
EM karakniranjan@yahoo.com
RI Karak, Niranjan/A-1030-2014; Konwarh, Rocktotpal/F-2881-2011; Karak,
   Niranjan/F-2954-2011
OI Karak, Niranjan/0000-0002-3402-9536; Konwarh,
   Rocktotpal/0000-0003-4767-4531; SAIKIA, NABANITA/0000-0001-9648-2363;
   Saikia, Nabanita/0000-0002-8777-4898
FU Department of Biotechnology, Government of India
FX Mr R. Konwarh sincerely acknowledges the receipt of Senior Research
   Fellowship from the Department of Biotechnology, Government of India.
   SAIF, NEHU, Shillong is thankfully acknowledged for the TEM imaging.
CR ANDZELM J, 1995, J CHEM PHYS, V103, P9312, DOI 10.1063/1.469990
   Banerjee S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/4/045101
   Burgess LC, 2008, TOXICOL IN VITRO, V22, P1297, DOI 10.1016/j.tiv.2008.03.001
   Chattaraj PK, 2006, CHEM REV, V106, P2065, DOI 10.1021/cr040109f
   DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452
   Dhand C, 2009, ELECTROCHEM COMMUN, V11, P1482, DOI 10.1016/j.elecom.2009.05.034
   Fan Y, 2007, J AM CHEM SOC, V129, P5437, DOI 10.1021/ja067477g
   Ford NA, 2011, NUTR CANCER, V63, P256, DOI 10.1080/01635581.2011.523494
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guterman E., 2003, POLYM PREPR, V43, P766
   Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200
   Huang JX, 2004, J AM CHEM SOC, V126, P851, DOI 10.1021/ja0371754
   Kong KW, 2010, MOLECULES, V15, P959, DOI 10.3390/molecules15020959
   Konwarh R, 2012, ULTRASON SONOCHEM, V19, P292, DOI 10.1016/j.ultsonch.2011.07.010
   Konwarh R, 2011, COLLOID SURFACE B, V84, P338, DOI 10.1016/j.colsurfb.2011.01.024
   Konwarh R, 2011, CARBOHYD POLYM, V83, P1245, DOI 10.1016/j.carbpol.2010.09.031
   Konwarh R, 2010, COLLOID SURFACE B, V81, P578, DOI 10.1016/j.colsurfb.2010.07.062
   Konwarh R, 2010, APPL MICROBIOL BIOT, V87, P1983, DOI 10.1007/s00253-010-2658-4
   Konwarh R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225107
   Laslau C, 2010, PROG POLYM SCI, V35, P1403, DOI 10.1016/j.progpolymsci.2010.08.002
   Lee KH, 2009, MACROMOL THEOR SIMUL, V18, P287, DOI 10.1002/mats.200900010
   Lian FZ, 2007, CARCINOGENESIS, V28, P1567, DOI 10.1093/carcin/bgm076
   Lu XF, 2010, PROG POLYM SCI, V36, P671
   Ma YF, 2004, J AM CHEM SOC, V126, P7097, DOI 10.1021/ja039621t
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010
   Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031
   Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005
   PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Pramanik S, 2012, J APPL POLYM SCI, V126, P830, DOI 10.1002/app.36950
   Saiyed ZM, 2007, J BIOTECHNOL, V131, P240, DOI 10.1016/j.jbiotec.2007.06.017
   Serpen A, 2007, J AGR FOOD CHEM, V55, P7676, DOI 10.1021/jf071291z
   Shu B, 2006, J FOOD ENG, V76, P664, DOI 10.1016/j.jfoodeng.2005.05.062
   TOKUHIRO T, 1976, J PHYS CHEM-US, V80, P733, DOI 10.1021/j100548a015
   Wang Y, 2011, J ENVIRON SCI-CHINA, V23, P1038, DOI 10.1016/S1001-0742(10)60511-6
NR 36
TC 11
Z9 11
U1 0
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 30
BP 15062
EP 15070
DI 10.1039/c2jm32530f
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 971PI
UT WOS:000306215900038
DA 2018-10-19
ER

PT J
AU Hsueh, YY
   Chiang, YL
   Wu, CC
   Lin, SC
AF Hsueh, Yuan-Yu
   Chiang, Yi-Lun
   Wu, Chia-Ching
   Lin, Sheng-Che
TI Spheroid Formation and Neural Induction in Human Adipose-Derived Stem
   Cells on a Chitosan-Coated Surface
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Adipose-derived stem cells; Chitosan; Neurosphere; Neural induction
ID SPINAL-CORD-INJURY; STROMAL CELLS; IN-VITRO; 3-DIMENSIONAL CULTURE;
   BONE-MARROW; TISSUE; DIFFERENTIATION; NEUROSPHERES; REPAIR; SCAFFOLDS
AB The application of stem cells appears to have great therapeutic potential to facilitate nerve regeneration in patients with neurodegenerative disease or spinal cord injury. Human adipose-derived stem cells (hADSCs), a subset of multipotent mesenchymal stem cells, possess the great advantages of an abundant amount of cells, less ethical conflict and minimal invasive surgical procedures to obtain the cells. Chitosan, a naturally derived polysaccharide from chitin, has been widely studied to facilitate and guide the direction of nerve regeneration as a biomaterial for the neural tube. Chitosan also serves as a three-dimensional culture substrate to facilitate cellular sphere formation among various cells but is as yet unexplored in hADSCs. In this study, the ability of hADSCs to transdifferentiate from the mesenchymal into the neural lineage by seeding hADSCs on a chitosan-coated surface to form therapeutic cell spheres was investigated. The optimal seeding density (2 x 10(4) cells/cm(2)) and harvesting time (72 h) to obtain sphere formation were determined by cell viability on a chitosan-coated surface. Expression of neural lineage markers was observed by immunofluorescent staining of nestin, neurofilament heavy chain and glial fibrillary acidic protein. The neural induction potentials were also provoked by replating spheres from primary to tertiary passages. The effect of neural induction in hADSCs on a chitosan-coated surface may help to provide cell sources for facilitating nerve regeneration in future clinical applications. Copyright (C) 2012 S. Karger AG, Basel
C1 [Chiang, Yi-Lun; Wu, Chia-Ching] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 701, Taiwan.
   [Hsueh, Yuan-Yu; Lin, Sheng-Che] Natl Cheng Kung Univ, Div Plast Surg, Tainan 701, Taiwan.
   [Hsueh, Yuan-Yu] Natl Cheng Kung Univ, Inst Clin Med, Tainan 701, Taiwan.
   [Wu, Chia-Ching] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.
RP Wu, CC (reprint author), Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 701, Taiwan.
EM joshccwu@mail.ncku.edu.tw; fredlin@mail.ncku.edu.tw
FU National Science Council in Taiwan [NSC 99-2320-B-006-002-MY3]; National
   Cheng Kung University Hospital [20100078]
FX We thank the funding support of the National Science Council in Taiwan
   (NSC 99-2320-B-006-002-MY3) and the National Cheng Kung University
   Hospital (20100078).
CR Amaral IF, 2006, J BIOMED MATER RES A, V76A, P335, DOI 10.1002/jbm.a.30522
   Anghileri E, 2008, STEM CELLS DEV, V17, P909, DOI 10.1089/scd.2007.0197
   Ao Q., 2011, BIOMATERIALS, V3, P787
   Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Bunnell BA, 2006, BIOCHEM BIOPH RES CO, V343, P762, DOI 10.1016/j.bbrc.2006.03.033
   Chen MH, 2005, J BIOMED MATER RES A, V74A, P254, DOI 10.1002/jbm.a.30376
   Chen YH, 2009, TISSUE ENG PT A, V15, P2001, DOI 10.1089/ten.tea.2008.0251
   Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P59, DOI 10.1016/S1040-8428(00)00076-7
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X
   Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264
   Kang SK, 2006, STEM CELLS DEV, V15, P583, DOI 10.1089/scd.2006.15.583
   Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Lin SJ, 2005, BIOMATERIALS, V26, P1413, DOI 10.1016/j.biomaterials.2004.05.002
   Lin SJ, 2006, BIOMATERIALS, V27, P5079, DOI 10.1016/j.biomaterials.2006.05.035
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Matsumoto D., 2007, J CRANIOFAC SURG, V18, P60
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   Nagase T, 2007, J CRANIOFAC SURG, V18, P49, DOI 10.1097/01.scs.0000249357.66720.d2
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Radtke C, 2009, INT J DEV NEUROSCI, V27, P817, DOI 10.1016/j.ijdevneu.2009.08.006
   Ruijs AC, 2005, PLAST RECONSTR SURG, V116, P495
   Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   SANDFORD PA, 1991, ACS SYM SER, V467, P430
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Simoes M.J., 2008, BIOMATERIALS, V33, P4409
   Takezawa T, 2003, BIOMATERIALS, V24, P2267, DOI 10.1016/S0142-9612(03)00038-3
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Verma P, 2007, IN VITRO CELL DEV-AN, V43, P328, DOI 10.1007/s11626-007-9045-1
   Walsh S, 2009, NEUROSURGERY, V65, pA80, DOI 10.1227/01.NEU.0000335651.93926.2F
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008
   Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 48
TC 14
Z9 14
U1 1
U2 17
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2012
VL 196
IS 2
BP 117
EP 128
DI 10.1159/000332045
PG 12
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 969SX
UT WOS:000306079900003
PM 22327282
DA 2018-10-19
ER

PT J
AU Muhammad, KB
   Abas, WAW
   Kim, KH
   Pingguan-Murphy, B
   Zain, NM
   Akram, H
AF Muhammad, Kama Bistari
   Abas, Wan Abu Bakar Wan
   Kim, Kah Hwi
   Pingguan-Murphy, Belinda
   Zain, Norita Mohd
   Akram, Haris
TI In vitro comparative study of white and dark polycaprolactone
   trifumarate in situ cross-linkable scaffolds seeded with rat bone marrow
   stromal cells
SO CLINICS
LA English
DT Article
DE Bone Tissue Engineering; Polycaprolactone; Biodegradable Polymer; Bone
   Marrow; Mesenchymal Stem Cells
ID POLY(PROPYLENE FUMARATE); ORTHOPEDIC BIOMATERIAL; CALCIUM-PHOSPHATE;
   DEGRADATION; COMPOSITE; BIOCOMPATIBILITY; POLYANHYDRIDES; OLIGOMERS;
   NETWORKS; CEMENT
AB OBJECTIVE: Dark poly(caprolactone) trifumarate is a successful candidate for use as a bone tissue engineering scaffold. Recently, a white polymeric scaffold was developed that shows a shorter synthesis time and is more convenient for tissue-staining work. This is an in vitro comparative study of both the white and dark scaffolds.
   METHODS: Both white and dark poly(caprolactone) trifumarate macromers were characterized via Fourier transform infrared spectroscopy before being chemically cross-linked and molded into disc-shaped scaffolds. Biodegradability was assessed by percentage weight loss on days 7, 14, 28, 42 and 56 (n = 5) after immersion in 10% serum-supplemented medium or distilled water. Static cell seeding was employed in which isolated and characterized rat bone marrow stromal cells were seeded directly onto the scaffold surface. Seeded scaffolds were subjected to a series of biochemical assays and scanning electron microscopy at specified time intervals for up to 28 days of incubation.
   RESULTS: The degradation of the white scaffold was significantly lower compared with the dark scaffold but was within the acceptable time range for bone-healing processes. The deoxyribonucleic acid and collagen contents increased up to day 28 with no significant difference between the two scaffolds, but the glycosaminoglycan content was slightly higher in the white scaffold throughout 14 days of incubation. Scanning electron microscopy at days 1 and 14 revealed cellular growth and attachment.
   CONCLUSIONS: There was no cell growth advantage between the two forms, but the white scaffold had a slower biodegradability rate, suggesting that the newly synthesized poly(caprolactone) trifumarate is more suitable for use as a bone tissue engineering scaffold.
C1 [Muhammad, Kama Bistari; Abas, Wan Abu Bakar Wan; Pingguan-Murphy, Belinda; Zain, Norita Mohd; Akram, Haris] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.
   [Kim, Kah Hwi] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
RP Muhammad, KB (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.
EM bistari@um.edu.my
RI Pingguan-Murphy, Belinda/B-8332-2010
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141
FU University of Malaya [RG043/09AET, PS391/2010A]
FX We sincerely thank Mr. Mohd Fairuz Zainal Abidin from the Department of
   Chemistry and Mr. Chew Poh Wei for their technical assistance. This
   project was funded by the University of Malaya under the University of
   Malaya Research Grant (Project no.: RG043/09AET) and Postgraduate
   Research Grant (Project no.: PS391/2010A).
CR Ali G, 1999, J APPL POLYM SCI, V75, P1434
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Burdick JA, 2001, J POLYM SCI POL CHEM, V39, P683, DOI 10.1002/1099-0518(20010301)39:5<683::AID-POLA1040>3.0.CO;2-Z
   Chai YC, 2006, ASIAN J CELL BIOL, V1, P40
   Chai YC, 2004, INT FED MED BIOL ENG, P359
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Domb AJ, 1996, BIOMATERIALS, V17, P411, DOI 10.1016/0142-9612(96)89657-8
   Einhorn TA, 2003, GENE THER, V10, P529, DOI 10.1038/sj.gt.3302000
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Frazier DD, 1997, J BIOMED MATER RES, V35, P383, DOI 10.1002/(SICI)1097-4636(19970605)35:3<383::AID-JBM12>3.0.CO;2-G
   Freshney R. I., 2010, CULTURE ANIMAL CELLS
   HAM AW, 1971, BIOCH PHYSL BONE
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   Kopylov P, 1996, J HAND SURG-BRIT EUR, V21B, P768, DOI 10.1016/S0266-7681(96)80184-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Pavia DL, 2001, INTRO SPECTROSCOPY G
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475
   Poshusta AK, 2003, J BIOMED MATER RES A, V64A, P62, DOI 10.1002/jbm.a.10274
   ROSS MH, 1995, HISTOLOGY TEXT ATLAS
   Shastri VP, 2004, BIOMATERIALS, V25, P715, DOI 10.1016/S0142-9612(03)00563-5
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Smit TH, 2010, J MATER SCI-MATER M, V21, P871, DOI 10.1007/s10856-009-3921-z
   Strauss WM, 2001, PREPARATION GENOMIC
   Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Weatherford HL, 1933, CELL TISSUE RES, V17, P518
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
NR 36
TC 8
Z9 8
U1 1
U2 8
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
J9 CLINICS
JI Clinics
PY 2012
VL 67
IS 6
BP 629
EP 637
DI 10.6061/clinics/2012(06)14
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 968LK
UT WOS:000305982700014
PM 22760903
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Lien, CH
   Cho, KC
   Kuo, WS
   Lin, CY
   Chui, CL
   Chen, SJ
AF Lien, C. -H.
   Cho, K. -C.
   Kuo, W. -S.
   Lin, C. -Y.
   Chui, C. -L.
   Chen, S. -J.
BE VoDinh, T
   Lakowicz, JR
TI THREE-DIMENSIONAL GOLD NANORODS-DOPED MULTICOLOR MICROSTRUCTURES
SO PLASMONICS IN BIOLOGY AND MEDICINE IX
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Plasmonics in Biology and Medicine IX
CY JAN 22-24, 2012
CL San Francisco, CA
SP SPIE
DE multiphoton fabrication; gold nanorods; photothermal; microstructure
ID CANCER-CELLS; FABRICATION; MICROMACHINES; SCATTERING; PROTEINS
AB In this study, three-dimensional (3D) crosslinked bovine serum albumin (BSA) microstructures containing gold nanorods (AuNRs) at different absorption wavelengths were fabricated via multiphoton excited photochemistry using rose Bengal (RB) as the photoactivator. After the processing, a higher laser power, greater than the threshold of the AuNR photothermal damage at the matched wavelength for the longitudinal plasmon resonance of AuNR, is adopted to reshape the AuNRs into gold nanospheres at the designed positions of the 3D structure. As a result, 3D BSA microstructures containing different color AuNRs at the designed positions can be successfully fabricated. The AuNRs-doped BSA multicolor microstructures not only can be applied in biomedical scaffolds with plasmonic properties such as two-photon luminescence imaging and photothermal therapy but also can be a specific 3D biomaterial microdevice for plasmonic field.
C1 [Lien, C. -H.; Kuo, W. -S.; Lin, C. -Y.; Chui, C. -L.; Chen, S. -J.] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   [Cho, K. -C.] Natl Cheng Kung Univ, Inst Electroopt Sci & Engn, Tainan 701, Taiwan.
   [Chen, S. -J.] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan 701, Taiwan.
RP Lien, CH (reprint author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
EM sheanjen@mail.ncku.edu.tw
FU National Science Council (NSC) in Taiwan [NSC 99-2627-B-006-017, NSC
   99-3111-B-006-004, NSC 100-2623-E-006-016-D]
FX This work was supported by the National Science Council (NSC) in Taiwan
   with the grant numbers of NSC 99-2627-B-006-017, NSC 99-3111-B-006-004,
   and NSC 100-2623-E-006-016-D.
CR Aslan K, 2007, J FLUORESC, V17, P7, DOI 10.1007/s10895-006-0149-x
   Basu S, 2005, BIOMACROMOLECULES, V6, P1465, DOI 10.1016/bm049258y
   Durr NJ, 2007, NANO LETT, V7, P941, DOI 10.1021/nl062962v
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   Hill RT, 2005, J AM CHEM SOC, V127, P10707, DOI 10.1021/ja052211f
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Kuo WS, 2008, CHEM COMMUN, P4430, DOI 10.1039/b808871c
   Kuo WS, 2010, ANGEW CHEM INT EDIT, V49, P2711, DOI 10.1002/anie.200906927
   Kuo WS, 2010, OPT EXPRESS, V18, P27550, DOI 10.1364/OE.18.027550
   Kuo WS, 2009, CHEM COMMUN, P4853, DOI 10.1039/b907274h
   Lambert CR, 1999, J PHYS CHEM B, V103, P3737, DOI 10.1021/jp983812e
   Liao Q, 2009, LANGMUIR, V25, P4708, DOI 10.1021/la8036555
   LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718
   Link S, 2000, J PHYS CHEM B, V104, P6152, DOI 10.1021/jp000679t
   Nappa J., 2004, FARADAY DISCUSS, V269, P935
   NECKERS DC, 1989, PHOTOCHEM PHOTOBIOL, V47, P1
   Oldenburg AL, 2006, OPT EXPRESS, V14, P6724, DOI 10.1364/OE.14.006724
   Pins GD, 2006, J BIOMED MATER RES A, V78A, P194, DOI 10.1002/jbm.a.30680
   Pitts JD, 2000, MACROMOLECULES, V33, P1514, DOI 10.1021/ma9910437
   Singh AK, 2009, ACS NANO, V3, P1906, DOI 10.1021/nn9005494
   Sun ZB, 2008, ADV MATER, V20, P914, DOI 10.1002/adma.200702035
   Swartz MA, 2003, CURR OPIN BIOTECH, V14, P547, DOI 10.1016/j.copbio.2003.09.003
   Watanabe T, 2002, ADV FUNCT MATER, V12, P611, DOI 10.1002/1616-3028(20020916)12:9<611::AID-ADFM611>3.0.CO;2-3
   Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481
   Zhang Y, 2008, P NATL ACAD SCI USA, V105, P1798, DOI 10.1073/pnas.0709501105
NR 25
TC 0
Z9 0
U1 3
U2 17
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-0-8194-8877-0
J9 PROC SPIE
PY 2012
VL 8234
AR 82341R
DI 10.1117/12.914044
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Optics
SC Chemistry; Materials Science; Optics
GA BAZ37
UT WOS:000306169900042
DA 2018-10-19
ER

PT J
AU Amirnia, S
   Margaritis, A
   Ray, MB
AF Amirnia, Shahram
   Margaritis, Argyrios
   Ray, Madhumita B.
TI Adsorption of Mixtures of Toxic Metal Ions Using Non-viable Cells of
   Saccharomyces cerevisiae
SO ADSORPTION SCIENCE & TECHNOLOGY
LA English
DT Article
ID RESPONSE-SURFACE METHODOLOGY; HEAVY-METALS; AQUEOUS-SOLUTIONS;
   BREWERS-YEAST; BAKERS-YEAST; WASTE-WATER; BIOSORPTION; REMOVAL; CADMIUM;
   PB(II)
AB The use of waste biomaterial for the adsorption of heavy metal ions is an economically appealing alternative to conventional metal ion removal methods. In the present work, S. cerevisiae biomass has been shown to be capable of the simultaneous removal of more than 98% of Pb(II) ions, 60% of Zn(II) ions and up to 55% of Cu(II) ions from aqueous solutions in the 10-50 mg/l concentration range. Model equations describing the removal efficiency of each metal ion were determined using Response Surface Methodology (RSM) with respect to operating conditions such as pH, initial metal ion concentration and biomass dosage. Characterization of the metal ion-biomass interactions responsible for biosorption was studied employing zeta potential measurements, BET, FT-IR and EDX techniques; these indicated that the uptake of metal ions by non-living yeast was a surface adsorption phenomenon. The results proved the involvement of an ion-exchange mechanism between the adsorbing metal ions and the cell walls. In the presence of the complete range of metal ions studied, yeast cells were more selective towards Pb(II) ions.
C1 [Amirnia, Shahram; Margaritis, Argyrios; Ray, Madhumita B.] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Margaritis, A (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
EM amarg@uwo.ca
OI Margaritis, Argyrios/0000-0003-1838-560X
FU NSERC
FX This work was supported by NSERC Discovery Grants awarded to Drs. A.
   Margaritis and M.B. Ray.
CR Akar ST, 2009, J HAZARD MATER, V165, P126, DOI 10.1016/j.jhazmat.2008.09.089
   Akar T, 2005, BIOCHEM ENG J, V25, P227, DOI 10.1016/j.bcj.2005.05.006
   Aksu Z, 2003, CHEMOSPHERE, V50, P1075, DOI 10.1016/S0045-6535(02)00623-9
   Alluri HK, 2007, AFR J BIOTECHNOL, V6, P2924
   Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016
   Anderson M. J., 2005, RSM SIMPLIFIED OPTIM
   Ansari MI, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P283, DOI 10.1007/978-1-4419-7931-5_12
   Bayrock D, 1997, FOOD RES INT, V30, P407, DOI 10.1016/S0963-9969(98)00003-9
   Bueno BYM, 2008, MINER ENG, V21, P65, DOI 10.1016/j.mineng.2007.08.013
   Choi SB, 2006, J HAZARD MATER, V138, P378, DOI 10.1016/j.jhazmat.2006.05.059
   Cojocaru C, 2009, COLLOID SURFACE A, V335, P181, DOI 10.1016/j.colsurfa.2008.11.003
   Ferraz AI, 1999, BIOPROCESS ENG, V21, P431, DOI 10.1007/PL00009083
   Ferreira S, 2009, BIOCHEM ENG J, V45, P192, DOI 10.1016/j.bej.2009.03.012
   Ghorbani F, 2008, CHEM ENG J, V145, P267, DOI 10.1016/j.cej.2008.04.028
   Igwe JC, 2006, AFR J BIOTECHNOL, V5, P1167
   Kordialik-Bogacka E, 2011, CENT EUR J CHEM, V9, P348, DOI 10.2478/s11532-011-0008-8
   Kotrba P., 2011, MICROBIAL BIOSORPTIO
   Lesmana SO, 2009, BIOCHEM ENG J, V44, P19, DOI 10.1016/j.bej.2008.12.009
   Ma W, 2004, BIOCHEM ENG J, V18, P33, DOI 10.1016/S1369-703X(03)00118-9
   Machado MD, 2009, J APPL MICROBIOL, V106, P1792, DOI 10.1111/j.1365-2672.2009.04170.x
   Marques PASS, 2000, BIOPROCESS ENG, V23, P135
   Michalak I, 2010, MICROCHIM ACTA, V172, P65
   Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402
   Motsi T, 2009, INT J MINER PROCESS, V92, P42, DOI 10.1016/j.minpro.2009.02.005
   Naja G. M, 2009, HEAVY METALS ENV
   NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0
   Nriagu JO, 1990, ENVIRONMENT, V32, P7
   Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2
   Padmavathy V, 2003, PROCESS BIOCHEM, V38, P1389, DOI 10.1016/S0032-9592(02)00168-1
   Preetha B, 2007, J HAZARD MATER, V143, P506, DOI 10.1016/j.jhazmat.2006.09.077
   SCHECHER WD, 1994, MINEQL CHEM EQUILIBR
   Sengil IA, 2009, J HAZARD MATER, V166, P1488, DOI 10.1016/j.jhazmat.2008.12.071
   Srivastava S, 2010, ENVIRON SCI ENG, P1, DOI 10.1007/978-3-642-11329-1
   VOLESKY B, 1995, APPL MICROBIOL BIOT, V42, P797, DOI 10.1007/BF00171964
   Volesky B, 2007, International Journal of Technology Transfer and Commercialisation, V6, P196, DOI 10.1504/IJTTC.2007.017806
   Volesky B., 2003, SORPTION BIOSORPTION
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   Volesky Bohumil, 1990, BIOSORPTION HEAVY ME
   Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001
NR 39
TC 9
Z9 9
U1 0
U2 20
PU MULTI-SCIENCE PUBL CO LTD
PI BRENTWOOD
PA 5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND
SN 0263-6174
J9 ADSORPT SCI TECHNOL
JI Adsorpt. Sci. Technol.
PY 2012
VL 30
IS 1
BP 43
EP 63
DI 10.1260/0263-6174.30.1.43
PG 21
WC Chemistry, Applied; Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 966SF
UT WOS:000305857000004
OA Bronze
DA 2018-10-19
ER

PT J
AU Awad, HA
AF Awad, H. A.
TI Prospects of Tendon Tissue Engineering in Sports Medicine
SO DEUTSCHE ZEITSCHRIFT FUR SPORTMEDIZIN
LA English
DT Review
DE Tendon; mesenchymal stem cells; growth factors; biomaterial scaffolds;
   tissue engineering; regenerative medicine
ID MESENCHYMAL STEM-CELLS; ACHILLES-TENDON; ELECTROHYDRODYNAMIC
   ATOMIZATION; CHONDROGENIC DIFFERENTIATION; MECHANICAL STIMULATION; GDF-5
   DEFICIENCY; GENE-EXPRESSION; GROWTH-FACTORS; BONE-MARROW; CARTILAGE
AB The prevalence of tendon injury has been rising due, in part. to increased participation in recreational and competitive sports. Primary surgical repair still represents the gold standard in the treatment of these injuries. However, graft transplantation in scenarios that involve tissue loss still presents clinical challenges. While many biomaterial grafts have historically been used in tendon reconstruction and most have since fallen out of favor, advances in tissue engineering and fibrous scaffold fabrication have made the use of engineered grafts closer than ever to clinical translatability. Stem cells and biomaterials play a prominent role in tissue engineering as they provide the biological units and the scaffolding, respectively, to support the regeneration of the proper tendon structure, which is also guided by growth factors and signals that regulate wound healing or the development of the tissue during embryogenesis. In this review, we examine a biomimetic approach to engineer a tendon replacement that takes into account the mesenchymal origins of the tendon progenitors, factors that influence the differentiation of these cells within the framework of developmental biology of tendon, and scaffold fabrication technologies that have the potential to replicate the structure of the fibrous matrix in the design of the biomaterial scaffold. In doing so, the review presents current concepts and advances, and emerging evidence of paradigm shifts and technological breakthrough that will predictably be the subject of future research.
C1 Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Biomed Engn, Rochester, NY 14642 USA.
RP Awad, HA (reprint author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Biomed Engn, Box 665,601 Elmwood Ave, Rochester, NY 14642 USA.
EM hani_awad@urmc.rochester.edu
RI Awad, Hani/G-6976-2014
OI Awad, Hani/0000-0003-2197-2610
FU NIH [R01-AR056696]; Musculoskeletal Transplant Foundation (MTF)
FX The Author wishes to thank the organizers of the 42nd German Sports
   Medicine Congress for the opportunity to present this work in
   Frankfurt/Main. The Author also wishes to acknowledge funding by grants
   from the NIH (R01-AR056696) and the Musculoskeletal Transplant
   Foundation (MTF).
CR Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Carnell LS, 2008, MACROMOLECULES, V41, P5345, DOI 10.1021/ma8000143
   Carnell LS, 2009, SCRIPTA MATER, V60, P359, DOI 10.1016/j.scriptamat.2008.09.035
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Chhabra A, 2003, J ORTHOPAED RES, V21, P826, DOI 10.1016/S0736-0266(03)00049-4
   Chokalingam K, 2009, TISSUE ENG PT A, V15, P2561, DOI 10.1089/ten.TEA.2008.0451
   CHOW SP, 1983, HAND, V15, P136, DOI 10.1016/S0072-968X(83)80002-3
   Clark RT, 2001, CONNECT TISSUE RES, V42, P175, DOI 10.3109/03008200109005648
   Dahlgren LA, 2005, J ORTHOP RES, V23, P84, DOI 10.1016/j.orthres.2004.05.007
   Grande DA, 1999, CLIN ORTHOP RELAT R, pS176
   Guilak F, 2004, BIORHEOLOGY, V41, P389
   Hall RP, 2008, ANALYST, V133, P1347, DOI 10.1039/b806901h
   Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191
   Jacobs JJ, 2008, BURDEN MUSCULOSKELET
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mazzone MF, 2002, AM FAM PHYSICIAN, V65, P1805
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Mikic B, 2006, J ORTHOP RES, V24, P831, DOI 10.1002/jor.20092
   Mikic B, 2009, J ORTHOP RES, V27, P1603, DOI 10.1002/jor.20916
   Nirmalanandhan VS, 2007, J BIOMECH ENG-T ASME, V129, P919, DOI 10.1115/1.2800828
   Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72
   Pajala A, 2002, J BONE JOINT SURG AM, V84A, P2016, DOI 10.2106/00004623-200211000-00017
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Potenza A D, 1978, J Hand Surg Am, V3, P157
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342
   Raghavan SS, 2012, TISSUE ENG PT A, V18, P796, DOI [10.1089/ten.tea.2011.0422, 10.1089/ten.TEA.2011.0422]
   Randolph MA, 2003, CLIN PLAST SURG, V30, P519, DOI 10.1016/S0094-1298(03)00070-1
   Rickert M, 2001, GROWTH FACTORS, V19, P115, DOI 10.3109/08977190109001080
   Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400
   Schreiber RE, 2000, METH MOL B, V139, P301
   Sittinger M, 1999, Z RHEUMATOL, V58, P130, DOI 10.1007/s003930050162
   Smith L, 2012, CONNECT TISSUE RES, V53, P95, DOI 10.3109/03008207.2011.650804
   Smith RKW, 2006, VET REC, V158, P140, DOI 10.1136/vr.158.4.140-a
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   Tan Q, 2012, TISSUE ENG PT A, V18, P840, DOI [10.1089/ten.tea.2011.0362, 10.1089/ten.TEA.2011.0362]
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   van Osch GJVM, 2002, BIORHEOLOGY, V39, P215
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   WEBSTER DA, 1983, CLIN ORTHOP RELAT R, P301
   White DW, 2007, AM J SPORT MED, V35, P1308, DOI 10.1177/0363546507301256
   Williams GR, 2000, J ATHL TRAINING, V35, P300
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Wu YQ, 2008, J BIOMAT SCI-POLYM E, V19, P573, DOI 10.1163/156856208784089616
   Wu YQ, 2007, POLYMER, V48, P5653, DOI 10.1016/j.polymer.2007.07.023
   Yang Z, 1998, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V12, P164
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10
NR 58
TC 0
Z9 0
U1 1
U2 30
PU W W F VERLAGSGESELLSCHAFT GMBH
PI GREVEN
PA AM EGGENKAMP 37-39, 48268 GREVEN, GERMANY
SN 0344-5925
J9 DEUT Z SPORTMED
JI Dtsch. Z. Sportmed.
PY 2012
VL 63
IS 5
BP 132
EP 136
DI 10.5960/dzsm.2012.014
PG 5
WC Sport Sciences
SC Sport Sciences
GA 964DQ
UT WOS:000305674300004
DA 2018-10-19
ER

PT S
AU Montgomery, PC
   Montaner, D
   Salzenstein, F
AF Montgomery, P. C.
   Montaner, D.
   Salzenstein, F.
BE Gorecki, C
   Asundi, AK
   Osten, W
TI Tomographic analysis of medium thickness transparent layers using white
   light scanning interferometry and XZ fringe image processing
SO OPTICAL MICRO- AND NANOMETROLOGY IV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optical Micro- and Nanometrology IV
CY APR 16-18, 2012
CL Brussels, BELGIUM
SP SPIE, Brussels Photon Team (B-PHOT), Brussels-Capital Reg, Fonds Wetenschappelijk Onderzoek (FWO), Int Commiss Opt (ICO), Ville Bruxelles
DE White light scanning interferometry; interference microscopy;
   tomography; XZ image processing; medium thickness transparent layers
ID INTERFERENCE MICROSCOPY; INTERFACES
AB Medium thickness transparent layers are becoming increasingly important in various fields of materials science such as in micro-electronics, nanotechnologies, polymer science, biomaterials and chemistry. Such layers vary from simple, transparent layers to those that are much more complex, containing heterogeneous materials and very rough interfaces and requiring new types of characterization techniques. In this paper we present the application of white light scanning interferometry to the structural tomography of such layers. Due to the complexity of the fringe signals along the optical axis, we have developed 2D signal processing techniques of the XZ images to improve the robustness to noise. Knowing that the measurements are prone to artifacts we have also developed a cautious approach to the extraction of pertinent information. Thus, using a manual point Z-scan investigation in an XY image, initial information of the quality of the fringe signals and the appropriate signal processing necessary can be obtained and provide initial structural information. Then, optimized image processing can be performed on the XZ images to provide tomographic cross sections of the layer. Applications of the technique are given on transparent and insulating layers used in electronics and microelectronics, layers of hydroxyapatite (a biomaterial) and colloidal layers.
C1 [Montgomery, P. C.; Montaner, D.; Salzenstein, F.] CNRS, InESS, Lab Commun UDS, UMR 7163, F-67037 Strasbourg, France.
RP Montgomery, PC (reprint author), CNRS, InESS, Lab Commun UDS, UMR 7163, 23 Rue Loess, F-67037 Strasbourg, France.
EM paul.montgomery@iness.c-strasbourg.fr
CR Abdesselam M, 2011, NUCL INSTRUM METH B, V269, P140, DOI 10.1016/j.nimb.2010.10.002
   Benatmane A, 2004, EUR PHYS J-APPL PHYS, V27, P411, DOI 10.1051/epjap:2004119
   Benhaddou D, 2001, J MOD OPTIC, V48, P533, DOI 10.1080/09500340010001791
   Boudraa AO, 2005, OPT ENG, V44, DOI 10.1117/1.2128125
   CABER PJ, 1993, APPL OPTICS, V32, P3438, DOI 10.1364/AO.32.003438
   Coupland JM, 2010, STRAIN, V46, P69, DOI 10.1111/j.1475-1305.2008.00595.x
   Dubois A., 2004, APPL OPTICS, V43, P2874
   Halter E, 2010, APPL SURF SCI, V256, P6144, DOI 10.1016/j.apsusc.2010.02.019
   Kurban U., 2006, P 20 EUR C GOT SWED
   Montgomery PC, 1997, APPL PHYS LETT, V71, P1768, DOI 10.1063/1.119394
   Pecheva E, 2008, CHEM ENG J, V137, P144, DOI 10.1016/j.cej.2007.07.096
   Pecheva E, 2007, LANGMUIR, V23, P3912, DOI 10.1021/la061593f
   PERROT O, 1995, J NON-CRYST SOLIDS, V184, P257, DOI 10.1016/0022-3093(95)00008-9
   Pramatarova L, 2007, J OPTOELECTRON ADV M, V9, P236
   Schmit J, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/6/064001
   Tuzun O, 2008, THIN SOLID FILMS, V516, P6882, DOI 10.1016/j.tsf.2007.12.105
NR 16
TC 10
Z9 10
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9122-0
J9 PROC SPIE
PY 2012
VL 8430
AR 843014
DI 10.1117/12.927813
PG 9
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics
SC Engineering; Science & Technology - Other Topics; Optics
GA BAW27
UT WOS:000305704500035
DA 2018-10-19
ER

PT S
AU Qiu, JJ
   Mazumder, N
   Tsai, HR
   Hu, CW
   Kao, FJ
AF Qiu, Jianjun
   Mazumder, Nirmal
   Tsai, Han-Ruei
   Hu, Chih-Wei
   Kao, Fu-Jen
BE Enderlein, J
   Gryczynski, ZK
   Erdmann, R
   Koberling, F
   Gregor, I
TI Stokes Vector Formalism Based Second Harmonic Generation Microscopy
SO SINGLE MOLECULE SPECTROSCOPY AND SUPERRESOLUTION IMAGING V
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Single Molecule Spectroscopy and Superresolution Imaging V
CY JAN 21-22, 2012
CL San Francisco, CA
SP SPIE
DE Stokes vector; polarization; second harmonic generation; KDP; collagen
ID TIME-RESOLVED ELLIPSOMETRY; MUELLER-MATRIX; POLARIZATION; COLLAGEN;
   DECOMPOSITION; POLARIMETERS; CALIBRATION; LIGHT; STATE
AB In this study, we have developed a four-channel Stokes vector formalism based second harmonic generation (SHG) microscopy to map and analyze SHG signal. A four-channel Stokesmeter setup is calibrated and integrated into a laser scanning microscope to measure and characterize the SH's corresponding Stokes parameters. We are demonstrating the use of SH and its Stokes parameters to visualize the birefringence and crystalline orientation of KDP and collagen. We believe the developed method can reveal unprecedented information for biomedical and biomaterial studies.
C1 [Qiu, Jianjun; Mazumder, Nirmal; Tsai, Han-Ruei; Hu, Chih-Wei; Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei 11221, Taiwan.
RP Qiu, JJ (reprint author), Natl Yang Ming Univ, Inst Biophoton, Taipei 11221, Taiwan.
EM hustqjj@gmail.com; fjkao@ym.edu.tw
RI Mazumder, Nirmal/B-3913-2010
OI Mazumder, Nirmal/0000-0001-8068-6484
CR AZZAM RMA, 1985, OPT LETT, V10, P309, DOI 10.1364/OL.10.000309
   Baba JS, 2002, J BIOMED OPT, V7, P341, DOI 10.1117/1.1486248
   Becker W, 1999, REV SCI INSTRUM, V70, P1835, DOI 10.1063/1.1149677
   Berezhnyy, 2004, OPT EXPRESS, V12, P4635
   Bueno JM, 2002, OPT LETT, V27, P830, DOI 10.1364/OL.27.000830
   Cameron BD, 1998, OPT LETT, V23, P485, DOI 10.1364/OL.23.000485
   Chou CK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2824379
   Compain E, 1998, APPL OPTICS, V37, P5938, DOI 10.1364/AO.37.005938
   Compain E, 1999, APPL OPTICS, V38, P3490, DOI 10.1364/AO.38.003490
   Delplancke F, 1997, APPL OPTICS, V36, P5388, DOI 10.1364/AO.36.005388
   Doras C, 2011, OPT EXPRESS, V19, P15062, DOI 10.1364/OE.19.015062
   Foreman MR, 2009, J OPT SOC AM A, V26, P2470, DOI 10.1364/JOSAA.26.002470
   FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118
   Ghosh N, 2009, J BIOPHOTONICS, V2, P145, DOI 10.1002/jbio.200810040
   Ghosh N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960934
   Hecht E., 2001, OPTICS
   JELLISON GE, 1985, APPL OPTICS, V24, P2948, DOI 10.1364/AO.24.002948
   JELLISON GE, 1987, OPT LETT, V12, P766, DOI 10.1364/OL.12.000766
   Lackowicz J., 2006, PRINCIPLE FLUORESCEN
   Lara D, 2006, APPL OPTICS, V45, P1917, DOI 10.1364/AO.45.001917
   Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106
   Manhas S, 2006, OPT EXPRESS, V14, P190, DOI 10.1364/OPEX.14.000190
   Munro PRT, 2008, OPT LETT, V33, P2428, DOI 10.1364/OL.33.002428
   SHI YM, 1994, PHYS REV A, V49, P1999, DOI 10.1103/PhysRevA.49.1999
   Stoller P, 2002, J BIOMED OPT, V7, P205, DOI 10.1117/1.1431967
   Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7
   Sun CW, 2002, OPT EXPRESS, V10, P1347, DOI 10.1364/OE.10.001347
   Tiaho F, 2007, OPT EXPRESS, V15, P12286, DOI 10.1364/OE.15.012286
   Trefethen L. N., 1997, NUMERICAL LINEAR ALG
   Twietmeyer KM, 2008, OPT EXPRESS, V16, P21339, DOI 10.1364/OE.16.021339
   V Lihong, 2007, BIOMEDICAL OPTICS PR
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
NR 32
TC 0
Z9 0
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8871-8
J9 PROC SPIE
PY 2012
VL 8228
AR 82280C
DI 10.1117/12.907199
PG 8
WC Optics; Spectroscopy
SC Optics; Spectroscopy
GA BAV51
UT WOS:000305624900007
DA 2018-10-19
ER

PT J
AU Harms, C
   Helms, K
   Taschner, T
   Stratos, I
   Ignatius, A
   Gerber, T
   Lenz, S
   Rammelt, S
   Vollmar, B
   Mittlmeier, T
AF Harms, Christoph
   Helms, Kai
   Taschner, Tibor
   Stratos, Ioannis
   Ignatius, Anita
   Gerber, Thomas
   Lenz, Solvig
   Rammelt, Stefan
   Vollmar, Brigitte
   Mittlmeier, Thomas
TI Osteogenic capacity of nanocrystalline bone cement in a weight-bearing
   defect at the ovine tibial metaphysis
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE biocompatibility; bone ingrowth; hydroxyapatite; osseointegration;
   osteoconduction
ID IN-VIVO; HYDROXYAPATITE/COLLAGEN COMPOSITES; SUBSTITUTED HYDROXYAPATITE;
   POROUS HYDROXYAPATITE; GRAFTING SUBSTITUTE; CERAMICS; NANOBONE(R);
   INTERFACE; IMPLANTS; SULFATE
AB The synthetic material Nanobone (R) (hydroxyapatite nanocrystallines embedded in a porous silica gel matrix) was examined in vivo using a standardized bone defect model in the ovine tibial metaphysis. A standardized 6 x 12 x 24-mm bone defect was created below the articular surface of the medial tibia condyles on both hind legs of 18 adult sheep. The defect on the right side was filled with Nanobone (R), while the defect on the contralateral side was left empty. The tibial heads of six sheep were analyzed after 6, 12, and 26 weeks each. The histological and radiological analysis of the defect on the control side did not reveal any bone formation after the total of 26 weeks. In contrast, the microcomputed tomography analysis of the defect filled with Nanobone (R) showed a 55%, 72%, and 74% volume fraction of structures with bone density after 6, 12, and 26 weeks, respectively. Quantitative histomorphological analysis after 6, and 12 weeks revealed an osteoneogenesis of 22%, and 36%, respectively. Hematoxylin and eosin sections demonstrated multinucleated giant cells on the surface of the biomaterial and resorption lacunae, indicating osteoclastic resorptive activity. Nanobone (R) appears to be a highly potent bone substitute material with osteoconductive properties in a loaded large animal defect model, supporting the potential use of Nanobone (R) also in humans.
C1 [Harms, Christoph; Helms, Kai; Taschner, Tibor; Stratos, Ioannis; Mittlmeier, Thomas] Univ Rostock, Dept Trauma & Reconstruct Surg, D-18057 Rostock, Germany.
   [Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.
   [Gerber, Thomas] Univ Rostock, Dept Mat Res & Nanostruct, Inst Phys, D-18057 Rostock, Germany.
   [Lenz, Solvig] Univ Rostock, Dept Oral & Maxillofacial Plast Surg, D-18057 Rostock, Germany.
   [Rammelt, Stefan] Univ Hosp Carl Gustav Carus, Clin Trauma & Reconstruct Surg, Dresden, Germany.
   [Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany.
RP Harms, C (reprint author), Univ Rostock, Dept Trauma & Reconstruct Surg, Schillingallee 35, D-18057 Rostock, Germany.
EM christoph.harms@med.uni-rostock.de
RI Ignatius, Anita/M-6012-2013
OI Ignatius, Anita/0000-0002-4782-1979; Mittlmeier,
   Thomas/0000-0002-0536-8045
CR Abshagen K, 2009, J BIOMED MATER RES A, V91A, P557, DOI 10.1002/jbm.a.32237
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Canullo Luigi, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe7, DOI 10.1111/j.1708-8208.2008.00141.x
   Gerber T, 2006, EUR J TRAUMA, V32, P132
   Gerike W., 2006, Folia Morphologica, V65, P54
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Henkel K O, 2002, Mund Kiefer Gesichtschir, V6, P59
   Henkel KO, 2006, ORAL SURG ORAL MED O, V102, P606, DOI 10.1016/j.tripleo.2005.10.034
   Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Ignatius A, 1997, J MATER SCI-MATER M, V8, P753, DOI 10.1023/A:1018508511787
   Ignatius A, 2005, BIOMATERIALS, V26, P2325, DOI 10.1016/j.biomaterials.2004.07.029
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Magallanes-Perdomo M, 2010, ACTA BIOMATER, V6, P2254, DOI 10.1016/j.actbio.2009.12.027
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Rammelt S, 2007, J BIOMED MATER RES A, V83A, P313, DOI 10.1002/jbm.a.31243
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Rammelt S, 2004, EUR CELL MAT S2, V7, P82
   Schneiders W, 2009, J ORTHOP RES, V27, P15, DOI 10.1002/jor.20719
   Simon U, 2003, J BIOMECH, V36, P1079, DOI 10.1016/S0021-9290(03)00114-3
   Spies CKG, 2009, ARCH ORTHOP TRAUM SU, V129, P979, DOI 10.1007/s00402-008-0705-8
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Traykova T, 2004, KEY ENG MAT, V254-2, P679, DOI 10.4028/www.scientific.net/KEM.254-256.679
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Wippermann BW, 1997, CHIRURG, V68, P1286, DOI 10.1007/s001040050361
   Xu Weiguo, 2011, Int J Nanomedicine, V6, P1543, DOI 10.2147/IJN.S19743
   Xu WG, 2009, J BIOMED MATER RES B, V91B, P692, DOI 10.1002/jbm.b.31445
NR 32
TC 13
Z9 13
U1 0
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 2883
EP 2889
DI 10.2147/IJN.S29314
PG 7
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 960QW
UT WOS:000305404000001
PM 22745551
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Annaka, M
   Mortensen, K
   Matsuura, T
   Ito, M
   Nochioka, K
   Ogata, N
AF Annaka, Masahiko
   Mortensen, Kell
   Matsuura, Toyoaki
   Ito, Masaya
   Nochioka, Katsunori
   Ogata, Nahoko
TI Organic-inorganic nanocomposite gels as an in situ gelation biomaterial
   for injectable accommodative intraocular lens
SO SOFT MATTER
LA English
DT Article
ID CAPPED POLY(ETHYLENE OXIDE); CROSS-LINKED NETWORKS; VISCOELASTIC
   PROPERTIES; CATARACT-SURGERY; ENDOCAPSULAR POLYMERIZATION; DIBLOCK
   COPOLYMERS; NEUTRON-SCATTERING; AQUEOUS-SOLUTIONS; MOLECULAR-WEIGHT;
   POTENTIAL RISKS
AB We focus on the development of a novel injectable accommodative lens for intraocular applications, which is based on a thermosensitive hydrophobically modified poly(ethylene glycol) (HM-PEG) containing hydrophilized silica nanoparticles. We distinguished macroscopically, with changes in the temperature or concentration, two regions in the phase diagram for aqueous solution of HM-PEG: transparent sol and transparent gel. These changes occurred reversibly, without hysteresis, when the temperature was decreased. The temperature and concentration regime in which the gel formed are reduced by adding silica nanoparticles into the gel matrix. Small-angle neutron scattering measurements for nanocomposite gels provide good proof of a gel phase where the high shear-modulus is gained by a high inter-micellar correlation originating in the crystalline order. Under the condition of uniform distribution of silica nanoparticles with small size (2-5 nm) in the gel matrix, an increase in the refractive index up to 0.0667 was obtained for the nanocomposite gel compared with the native gel matrix without an increase in turbidity. This composite system could be formulated to match the modulus and the refractive index of the natural lens (similar to 1.411), and was easily extruded through a narrow-gauge needle. Rapid endocapsular gelation yielded an optically clear gel within the lens capsular bag. This technique enables us to validate methods to determine the biomechanics of the lens and its role in accommodation. The modification of the mechanical response and stability of the HM-PEG network by addition of silica nanoparticles was also investigated in detail.
C1 [Annaka, Masahiko; Ito, Masaya] Kyushu Univ, Dept Chem, Fukuoka 8128581, Japan.
   [Annaka, Masahiko] Kyushu Univ, IRCMS, Fukuoka 8190395, Japan.
   [Mortensen, Kell] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.
   [Mortensen, Kell] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark.
   [Matsuura, Toyoaki; Nochioka, Katsunori; Ogata, Nahoko] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara 6348522, Japan.
RP Annaka, M (reprint author), Kyushu Univ, Dept Chem, Fukuoka 8128581, Japan.
EM annaka@chem.kyushu-univ.jp
RI Mortensen, Kell/A-5066-2009
OI Mortensen, Kell/0000-0002-8998-9390
FU Ministry of Education, Culture, Science, Sports and Technology of Japan;
   UNIK Synthetic Biology and DANSCATT programs of the Danish Research
   Council;  [22350053];  [24655103]
FX The work was partly supported by a grant-in-aid (no. 22350053 and
   24655103) and a grant-in-aid for the Global COE Program, "Science for
   Future Molecular Systems" from the Ministry of Education, Culture,
   Science, Sports and Technology of Japan, and from the UNIK Synthetic
   Biology and DANSCATT programs of the Danish Research Council.
CR Agarwal P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041402
   Agarwal P, 2010, NANO LETT, V10, P111, DOI 10.1021/nl9029847
   Aliyar HA, 2005, BIOMACROMOLECULES, V6, P204, DOI 10.1021/bm049574c
   ANNABLE T, 1993, J RHEOL, V37, P695, DOI 10.1122/1.550391
   Annaka M, 2011, BIOMACROMOLECULES, V12, P4011, DOI 10.1021/bm201012f
   Avitabile T, 2001, CURR OPIN OPHTHALMOL, V12, P12, DOI 10.1097/00055735-200102000-00004
   Bandyopadhyay R, 2010, SOFT MATTER, V6, P1462, DOI 10.1039/b916342e
   Beaudoin E, 2003, LANGMUIR, V19, P2058, DOI 10.1021/la020730f
   Beaudoin E, 2002, MACROMOLECULES, V35, P7436, DOI 10.1021/ma011271
   Beaudoin E, 2002, J COLLOID INTERF SCI, V251, P398, DOI 10.1006/jcis.2002.8402
   BELLUCCI R, 1993, J CATARACT REFR SURG, V19, P32, DOI 10.1016/S0886-3350(13)80276-3
   Bellucci Roberto, 2005, Curr Opin Ophthalmol, V16, P33, DOI 10.1097/00055735-200502000-00006
   Bossard F, 2006, SOFT MATTER, V2, P510, DOI 10.1039/b601435f
   Cassagneau T, 2002, J AM CHEM SOC, V124, P8172, DOI 10.1021/ja0127382
   Chassenieux C, 1998, MACROMOLECULES, V31, P4035, DOI 10.1021/ma9802273
   CHIRILA TV, 1994, J CATARACT REFR SURG, V20, P675, DOI 10.1016/S0886-3350(13)80672-4
   Cloitre M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068303
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Dick H Burkhard, 2005, Curr Opin Ophthalmol, V16, P8, DOI 10.1097/00055735-200502000-00004
   Feher FJ, 1998, CHEM COMMUN, P323, DOI 10.1039/a707140j
   Fielding SM, 2000, J RHEOL, V44, P323, DOI 10.1122/1.551088
   Fine I. H., 2002, EYE WORLD       0924
   FISHER RF, 1986, T OPHTHAL SOC UK, V105, P208
   FISHER RF, 1972, J ANAT, V112, P207
   Francois J, 2003, LANGMUIR, V19, P10011, DOI 10.1021/la0208833
   Gohr K, 2000, MACROMOLECULES, V33, P2129, DOI 10.1021/ma991776r
   Gravel MC, 1999, APPL ORGANOMET CHEM, V13, P329, DOI 10.1002/(SICI)1099-0739(199904)13:4<329::AID-AOC870>3.0.CO;2-V
   GRAY PJ, 1992, BRIT J OPHTHALMOL, V76, P336, DOI 10.1136/bjo.76.6.336
   Herrmann WA, 1999, INVEST OPHTH VIS SCI, V40, pS989
   HETTLICH HJ, 1994, J CATARACT REFR SURG, V20, P115, DOI 10.1016/S0886-3350(13)80149-6
   KESSLER J, 1964, ARCH OPHTHALMOL-CHIC, V71, P412
   Kim SK, 2007, J ORAL REHABIL, V34, P389, DOI 10.1111/j.1365-2842.2006.01671.x
   KINNING DJ, 1984, MACROMOLECULES, V17, P1712, DOI 10.1021/ma00139a013
   KOH JY, 1988, J NEUROSCI, V8, P2153
   KORETZ JF, 1989, APPL OPTICS, V28, P1097, DOI 10.1364/AO.28.001097
   KORETZ JF, 1986, MATH MODELLING, V7, P1003, DOI 10.1016/0270-0255(86)90146-6
   Krag S, 2003, PROG RETIN EYE RES, V22, P749, DOI 10.1016/S1350-9462(03)00063-6
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Lee HN, 2009, SCIENCE, V323, P231, DOI 10.1126/science.1165995
   Lesiewska-Junk H, 2000, J CATARACT REFR SURG, V26, P562, DOI 10.1016/S0886-3350(99)00407-1
   Leyland M, 2003, OPHTHALMOLOGY, V110, P1789, DOI 10.1016/S0161-6420(03)00722-X
   Ma SOX, 2001, MACROMOLECULES, V34, P3294, DOI 10.1021/ma001772i
   MASKET S, 2004, CATARACT REFRACT JUL, P32
   MASON TG, 1995, PHYS REV LETT, V75, P2770, DOI 10.1103/PhysRevLett.75.2770
   Mattsson J, 2009, NATURE, V462, P83, DOI 10.1038/nature08457
   McLeod SD, 2003, BRIT J OPHTHALMOL, V87, P1083, DOI 10.1136/bjo.87.9.1083
   MILLER D, 1985, ANN OPHTHALMOL, V17, P540
   Minith W. W., 1996, BIOTECHNIQUES, V20, P498
   Montes-Mico R, 2004, OPHTHALMOLOGY, V111, P85, DOI 10.1016/S0161-6420(03)00862-5
   MORTENSEN K, 1992, PHYS REV LETT, V68, P2340, DOI 10.1103/PhysRevLett.68.2340
   Nijkamp MD, 2004, OPHTHALMOLOGY, V111, P1832, DOI 10.1016/j.ophtha.2004.05.023
   NISHI O, 1993, ARCH OPHTHALMOL-CHIC, V111, P1677, DOI 10.1001/archopht.1993.01090120099029
   Nishi O, 1998, ARCH OPHTHALMOL-CHIC, V116, P1358, DOI 10.1001/archopht.116.10.1358
   Nugent JL, 2010, ADV MATER, V22, P3677, DOI 10.1002/adma.201000898
   PAREL JM, 1986, GRAEF ARCH CLIN EXP, V224, P165, DOI 10.1007/BF02141492
   PEDERSEN JS, 1990, J APPL CRYSTALLOGR, V23, P321, DOI 10.1107/S0021889890003946
   Pedersen JS, 1996, MACROMOLECULES, V29, P1363, DOI 10.1021/ma9512115
   PERCIVAL SPB, 1993, J CATARACT REFR SURG, V19, P26, DOI 10.1016/S0886-3350(13)80275-1
   Pham QT, 1999, MACROMOLECULES, V32, P2996, DOI 10.1021/ma982007v
   Pineda-Fernandez A, 2004, J CATARACT REFR SURG, V30, P685, DOI 10.1016/S0886-3350(03)00664-3
   Preu H, 1999, PHYS CHEM CHEM PHYS, V1, P3321, DOI 10.1039/a902958c
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   Rana A, 2003, J CATARACT REFR SURG, V29, P2284, DOI 10.1016/S0886-3350(03)00812-5
   Renou F, 2007, MACROMOLECULES, V40, P4626, DOI 10.1021/ma070263e
   Richter-Mueksch S, 2002, J CATARACT REFR SURG, V28, P1957, DOI 10.1016/S0886-3350(02)01488-8
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Sim HG, 2003, J NON-NEWTON FLUID, V112, P237, DOI 10.1016/S0377-0257(03)00102-2
   Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738
   Stiakakis E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208302
   Stiakakis E, 2003, LANGMUIR, V19, P6645, DOI 10.1021/la034223p
   Strunz P, 2004, PHYSICA B, V350, pE783, DOI 10.1016/j.physb.2004.03.204
   Takeuchi H, 2001, J NEUROSURG, V94, P775, DOI 10.3171/jns.2001.94.5.0775
   TANAKA F, 1992, J NON-NEWTON FLUID, V43, P273, DOI 10.1016/0377-0257(92)80028-V
   TANAKA F, 1992, J NON-NEWTON FLUID, V43, P289, DOI 10.1016/0377-0257(92)80029-W
   TANAKA F, 1992, J NON-NEWTON FLUID, V43, P247, DOI 10.1016/0377-0257(92)80027-U
   von Helmholtz H., 1962, PHYSL OPTICS, V1
   Warren M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.205501
   Washington C, 2000, MACROMOLECULES, V33, P1289, DOI 10.1021/ma990730v
   Wold JE, 2003, J CATARACT REFR SURG, V29, P1878, DOI 10.1016/S0886-3350(03)00667-9
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Wyss HM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238303
   Yin GJ, 2008, J RHEOL, V52, P785, DOI 10.1122/1.2885738
   Yu HY, 2010, LANGMUIR, V26, P16801, DOI 10.1021/la102815r
NR 83
TC 11
Z9 11
U1 2
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 27
BP 7185
EP 7196
DI 10.1039/c2sm25534k
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 961QE
UT WOS:000305481000014
DA 2018-10-19
ER

PT B
AU Duailibi, SE
   Duailibi, MT
   Ferreira, LM
   Tanaka, FAO
   Vacanti, JP
   Yelick, PC
AF Duailibi, S. E.
   Duailibi, M. T.
   Ferreira, L. M.
   Tanaka, F. A. O.
   Vacanti, J. P.
   Yelick, P. C.
BE Bartolo, PJ
   DeLemos, ACS
   Tojeira, APO
   Pereira, AMH
   Mateus, AJ
   Mendes, ALA
   DosSantos, C
   Freitas, DMF
   Bartolo, HM
   Almeida, HD
   DosReis IM
   Dias, JR
   Domingos, MAN
   Alves, NMF
   Pereira, RFB
   Patricio, TMF
   Ferreira, TMD
TI Ultrastructural analysis of the hDSC interactions with biodegradable 3D
   scaffolds
SO INNOVATIVE DEVELOPMENTS ON VIRTUAL AND PHYSICAL PROTOTYPING
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Research and Rapid Prototyping
CY SEP 28-OCT 01, 2011
CL Polytechn Inst Leiria, Sch Technol & Management, Leiria, PORTUGAL
SP Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Global Alliance Rapid Prototyp Assoc
HO Polytechn Inst Leiria, Sch Technol & Management
ID BIOENGINEERED TEETH; TISSUE; TOOTH; CELLS; BONE
AB This study observed the behavior of hDSCs on 3 biodegradable 3D scaffolds surfaces coated with collagen: PGA; PHB; Silk and PCL. Based on the demonstrated ability for scaffold surfaces to dramatically influence cell viability and adhesion, in this study we characterize hDSC viability, affinity, and differentiation on 3D scaffolds. Isolated human tooth cells were obtained from patients scheduled extraction (CONEP-13083) and plated and expanded in standard tissue culture conditions. After 20 and 30 days, hDSCs were observed under inverted microscopy, followed by TEM and SEM analyses, which revealed the activity of hDSCs on each scaffold type, including cells adhesion on the biomaterial surface. The high cells activity was observed where we found more mitochondria and rugous endoplasmatic reticulum representing high energy and mRNA production for cells proliferation in similarity with the control group. The PGA and PHB exhibited the better hDSCs adhesion with 3D scaffold interface.
C1 [Duailibi, S. E.; Duailibi, M. T.; Ferreira, L. M.] Univ Fed Sao Paulo, UNIFESP CTCMol, Sao Paulo, Brazil.
RP Duailibi, SE (reprint author), Univ Fed Sao Paulo, UNIFESP CTCMol, Sao Paulo, Brazil.
CR Bohl KS, 1998, J BIOMAT SCI-POLYM E, V9, P749, DOI 10.1163/156856298X00127
   Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Duailibi SE, 2006, PERIODONTOL 2000, V41, P177, DOI 10.1111/j.1600-0757.2006.00165.x
   Kim S S, 1999, Semin Pediatr Surg, V8, P119
   Kim SS, 1998, ANN SURG, V228, P8, DOI 10.1097/00000658-199807000-00002
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lynch SE, 1999, SCI AM
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Young CS, 2005, TISSUE ENG, V11, P1599, DOI 10.1089/ten.2005.11.1599
   Young CS, 2005, ARCH ORAL BIOL, V50, P259, DOI 10.1016/j.archoralbio.2004.11.020
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
NR 17
TC 0
Z9 0
U1 0
U2 2
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-203-18141-6; 978-0-415-68418-7
PY 2012
BP 25
EP 28
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAT28
UT WOS:000305445600003
DA 2018-10-19
ER

PT B
AU Liu, MJJ
   Chou, SM
   Chua, CK
AF Liu, M. J. J.
   Chou, S. M.
   Chua, C. K.
BE Bartolo, PJ
   DeLemos, ACS
   Tojeira, APO
   Pereira, AMH
   Mateus, AJ
   Mendes, ALA
   DosSantos, C
   Freitas, DMF
   Bartolo, HM
   Almeida, HD
   DosReis IM
   Dias, JR
   Domingos, MAN
   Alves, NMF
   Pereira, RFB
   Patricio, TMF
   Ferreira, TMD
TI A novel protein-based scaffold with macro- and micro-structural features
   for tissue engineering applications
SO INNOVATIVE DEVELOPMENTS ON VIRTUAL AND PHYSICAL PROTOTYPING
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Research and Rapid Prototyping
CY SEP 28-OCT 01, 2011
CL Polytechn Inst Leiria, Sch Technol & Management, Leiria, PORTUGAL
SP Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Global Alliance Rapid Prototyp Assoc
HO Polytechn Inst Leiria, Sch Technol & Management
ID RAPID PROTOTYPING TECHNIQUES; SOLID FREEFORM FABRICATION; MESENCHYMAL
   STEM-CELLS; SILK FIBROIN; COLLAGEN SCAFFOLDS; PRINTING TECHNIQUE;
   STRUCTURE LIBRARY; PART 1; REGENERATION; MORPHOLOGY
AB Silk Fibroin (SF) protein, which is derived from the cocoons of the Bombyx Mori silkworms, has been used widely for biomedical applications, such as surgical sutures, owning to its high mechanical strength and biocompatibility. Recent advances in the Tissue Engineering (TE) field have acknowledged and recognized SF as a feasible candidate for tissue repair and regeneration; the regenerated form of SF protein in sponge networks has demonstrated potential for both soft and hard tissue replacements. However, adequate cell growth within the SF foams remained as a challenge to TE. Thus, in the present study, novel SF scaffolds with macro-channels were fabricated using the Additive Manufacturing (AM) or Rapid Prototyping (RP) technology. This work is, to our knowledge, the first generation of SF tissue constructs with both micro- and macro-scaled structures. The SF scaffolds were formed by casting aqueous SF solution to negative moulds made from a 3D inkjet printer. In vitro examinations of the scaffold specimens revealed that the indirect approach does not induce toxicity and were able to maintain the intrinsic properties of the naturally-derived biomaterial.
C1 [Liu, M. J. J.; Chou, S. M.; Chua, C. K.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Liu, MJJ (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RI Chou, Siaw Meng/A-3846-2011; NTU, S'gapore/F-4683-2012; Chua, Chee
   Kai/B-6171-2009
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   Cao T., 2003, TISSUE ENG, V9, P103
   Cheah CM, 2004, TISSUE ENG, V10, P595, DOI 10.1089/107632704323061951
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P302
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   He JK, 2008, VIRTUAL PHYS PROTOTY, V3, P159, DOI 10.1080/17452750802315033
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Lam CXF, 2008, VIRTUAL PHYS PROTOTY, V3, P193, DOI 10.1080/17452750802551298
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu CZ, 2008, J BIOMED MATER RES B, V85B, P519, DOI 10.1002/jbm.b.30975
   Liu CZ, 2007, RAPID PROTOTYPING J, V13, P163, DOI 10.1108/13552540710750915
   Liu M. J. J., 2010, 4 INT C PMI BELG
   Liu M. J. J., 2010, INT C CELL MOL BIOEN
   Liu MJJ, 2011, FIRST INTERNATIONAL SYMPOSIUM ON BIOENGINEERING (ISOB 2011), PROCEEDINGS, P330, DOI 10.3850/978-981-08-7615-9_TE08
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Naing MW, 2005, RAPID PROTOTYPING J, V11, P249, DOI 10.1108/13552540510612938
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788
   Pulkkinen H. J., 2010, OSTEOARTHRITIS CARTI, V18
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Ramanath HS, 2007, KEY ENG MATER, V334-335, P1241, DOI 10.4028/www.scientific.net/KEM.334-335.1241
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   SINGH BR, 2000, INFRARED ANAL PEPTID, P2
   Sudarmadji N, 2011, ACTA BIOMATER, V7, P530, DOI 10.1016/j.actbio.2010.09.024
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tan JY, 2010, VIRTUAL PHYS PROTOTY, V5, P45, DOI 10.1080/17452751003759144
   Tan KH, 2005, BIO-MED MATER ENG, V15, P113
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Xu S., 2007, RAPID PROTOTYPING J
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
   Yeong WY, 2007, J BIOMED MATER RES B, V82B, P260, DOI 10.1002/jbm.b.30729
   Yeong WY, 2006, RAPID PROTOTYPING J, V12, P229, DOI 10.1108/13552540610682741
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zeng W, 2008, RAPID PROTOTYPING J, V14, P280, DOI 10.1108/13552540810907947
NR 48
TC 0
Z9 0
U1 0
U2 21
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-203-18141-6
PY 2012
BP 43
EP 49
PG 7
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAT28
UT WOS:000305445600006
DA 2018-10-19
ER

PT B
AU Khoda, AKMB
   Ozbolat, IT
   Koc, B
AF Khoda, A. K. M. B.
   Ozbolat, I. T.
   Koc, B.
BE Bartolo, PJ
   DeLemos, ACS
   Tojeira, APO
   Pereira, AMH
   Mateus, AJ
   Mendes, ALA
   DosSantos, C
   Freitas, DMF
   Bartolo, HM
   Almeida, HD
   DosReis IM
   Dias, JR
   Domingos, MAN
   Alves, NMF
   Pereira, RFB
   Patricio, TMF
   Ferreira, TMD
TI Spatially varying porosity with continuous path plan for hollowed tissue
   scaffolds
SO INNOVATIVE DEVELOPMENTS ON VIRTUAL AND PHYSICAL PROTOTYPING
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Research and Rapid Prototyping
CY SEP 28-OCT 01, 2011
CL Polytechn Inst Leiria, Sch Technol & Management, Leiria, PORTUGAL
SP Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Global Alliance Rapid Prototyp Assoc
HO Polytechn Inst Leiria, Sch Technol & Management
ID FREE-FORM FABRICATION; DESIGN
AB In this paper, a bio-inspired scaffold design has been proposed by incorporating its functional (biological requirement) and fabrication constraint into the design processes. The proposed new methodology generates functionally gradient porosity along the hollowed scaffold architecture with desired level of control by combining two geometrically oriented consecutive layers. The resulting set of layers address the repeatable, interconnected and controllable pores. Modeling of the first layer starts with discretizing internal region by connecting ruling lines between internal and external features using a dynamic programming algorithm. These feature connecting ruling lines act as resolution for the proposed method. Then by accumulating those ruling lines, the region has been divided into equal area sub-regions. In the second layer, the desired pore size and hence the porosity has been achieved by geometrically partitioning those sub-regions. And thus the combined set of layers achieves the desired controlled variational porosity along the scaffold architecture. To ensure a continuous and interconnected tool path, optimized zigzag pattern followed by a concentric spiral like optimal layers are generated based on the required biological and mechanical properties. Several examples will be presented to demonstrate the proposed methodology. The designed examples will also be fabricated layer-by-layer using a micro-nozzle biomaterial deposition system.
C1 [Khoda, A. K. M. B.] SUNY Buffalo, Buffalo, NY 14260 USA.
RP Khoda, AKMB (reprint author), SUNY Buffalo, Buffalo, NY 14260 USA.
RI Koc, Bahattin/D-7277-2012
OI Koc, Bahattin/0000-0001-9073-8516
CR [Anonymous], 2008, 16 ITKSNAP
   [Anonymous], 2008, MIMICS
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Gomez C., 2007, UNIT CELL BASED MULT
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Karande T. S., 2007, EFFECT SCAFFOLD ARCH
   Khoda A., 2011, BIOFABRICAT IN PRESS
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 14
TC 0
Z9 0
U1 0
U2 3
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-203-18141-6
PY 2012
BP 73
EP 77
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAT28
UT WOS:000305445600010
DA 2018-10-19
ER

PT B
AU Lima, LL
   Ulbrich, CBL
   Zavaglia, CAC
   Bavaresco, VP
   Coelho, JGM
   Dias, CGBT
AF Lima, L. L.
   Ulbrich, C. B. L.
   Zavaglia, C. A. C.
   Bavaresco, V. P.
   Coelho, J. G. M.
   Dias, C. G. B. T.
BE Bartolo, PJ
   DeLemos, ACS
   Tojeira, APO
   Pereira, AMH
   Mateus, AJ
   Mendes, ALA
   DosSantos, C
   Freitas, DMF
   Bartolo, HM
   Almeida, HD
   DosReis IM
   Dias, JR
   Domingos, MAN
   Alves, NMF
   Pereira, RFB
   Patricio, TMF
   Ferreira, TMD
TI Rheological study of poly vinyl alcohol with two thermo-initiator for
   use in rapid prototyping
SO INNOVATIVE DEVELOPMENTS ON VIRTUAL AND PHYSICAL PROTOTYPING
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Research and Rapid Prototyping
CY SEP 28-OCT 01, 2011
CL Polytechn Inst Leiria, Sch Technol & Management, Leiria, PORTUGAL
SP Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Global Alliance Rapid Prototyp Assoc
HO Polytechn Inst Leiria, Sch Technol & Management
AB This study evaluated the rheological behavior of poly vinyl alcohol (PVA) with two thermal initiators for used in rapid protoyping (RP). The PVA has excellent biocompatible and lubrication properties, it is a versatile biomaterial which presents studies for the use in the treatment, replacement of cartilage and also as scaffold. The PVA is crosslinked to have different mechanical, chemical and physical properties. The RP technology has been used and studied in medical field to production of customized medical devices for each patient, and to production of biomodels for surgical plans. RP manufacturing technique allows the production of products with high precision and a very fast production. The rheological study was made to determine the optimal parameters for chemical crosslinking using the (PVA) aqueous solution in presence of potassium persulfate (KPS) and 4,4 - Azobis (4 - Cyanovaleric acid) (Azobis) as thermo initiators.
C1 [Lima, L. L.; Ulbrich, C. B. L.; Zavaglia, C. A. C.] Univ Estadual Campinas, DEMa FEM, LABIOMEC, Natl Inst S&T Biofabricat INCT BIOFABRIS, Campinas, SP, Brazil.
RP Lima, LL (reprint author), Univ Estadual Campinas, DEMa FEM, LABIOMEC, Natl Inst S&T Biofabricat INCT BIOFABRIS, Campinas, SP, Brazil.
CR Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015
   Jagur-Grodzinski J, 2010, POLYM ADVAN TECHNOL, V21, P27, DOI 10.1002/pat.1504
   Kishida A, 2002, HYDROGELS BIOMEDICAL, P13
   Souza AF, 2009, ENGENHARIA INTEGRADA
   Swieszkowski W, 2008, BIOMATERIALS CARTILA
   Wiria FE, 2008, J MATER SCI-MATER M, V19, P989, DOI 10.1007/s10856-007-3176-5
NR 6
TC 0
Z9 0
U1 1
U2 5
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-203-18141-6
PY 2012
BP 389
EP 395
PG 7
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAT28
UT WOS:000305445600057
DA 2018-10-19
ER

PT B
AU Ulbrich, CBL
   Zavaglia, CAC
   Paschoal, GHL
   Silva, JVL
   Zullo, JFD
AF Ulbrich, C. B. L.
   Zavaglia, C. A. C.
   Paschoal, G. H. L.
   Silva, J. V. L.
   Zullo, J. F. D.
BE Bartolo, PJ
   DeLemos, ACS
   Tojeira, APO
   Pereira, AMH
   Mateus, AJ
   Mendes, ALA
   DosSantos, C
   Freitas, DMF
   Bartolo, HM
   Almeida, HD
   DosReis IM
   Dias, JR
   Domingos, MAN
   Alves, NMF
   Pereira, RFB
   Patricio, TMF
   Ferreira, TMD
TI Use of rapid prototype techniques for large prosthetic cranioplasty
SO INNOVATIVE DEVELOPMENTS ON VIRTUAL AND PHYSICAL PROTOTYPING
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Research and Rapid Prototyping
CY SEP 28-OCT 01, 2011
CL Polytechn Inst Leiria, Sch Technol & Management, Leiria, PORTUGAL
SP Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Global Alliance Rapid Prototyp Assoc
HO Polytechn Inst Leiria, Sch Technol & Management
AB This work describes a set of procedures for the creation of a prosthetic 3D geometry based on virtual modeling from medical images. This technique uses engineering CAD tools and rapid prototype systems to create the best shape structure for filling a bone gap-cranioplasty - in a patient involved in a car accident. This application shows an engineering solution to create a prosthetic cranioplastic device according to the following procedures: creation of a virtual model using CAD systems; creation of physical model for the surgical planning using rapid prototype techniques; creation of moulds for the end model using rapid prototype techniques; and, finally, the creation of a prosthetic device using the appropriate biomaterial.
C1 [Ulbrich, C. B. L.; Zavaglia, C. A. C.] Univ Estadual Campinas, Dept Mat Engn, DEMA FEM UNICAMP, Campinas, SP, Brazil.
RP Ulbrich, CBL (reprint author), Univ Estadual Campinas, Dept Mat Engn, DEMA FEM UNICAMP, Campinas, SP, Brazil.
CR Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091
   Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268
   SALMI M, 2009, THESIS HELSINKI U TE
NR 3
TC 1
Z9 1
U1 0
U2 1
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-203-18141-6
PY 2012
BP 767
EP 769
PG 3
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Engineering; Materials Science
GA BAT28
UT WOS:000305445600114
DA 2018-10-19
ER

PT J
AU Bakan, HI
   Celis, JP
AF Bakan, H. I.
   Celis, J. P.
TI Fretting behaviour of 316L stainless steel produced by powder injection
   moulding
SO KOVOVE MATERIALY-METALLIC MATERIALS
LA English
DT Article
DE fretting; stainless steel; powder injection moulding; biomaterials
AB The biocompatible metals made available for powder injection moulding (PIM) are increasing, and as a result, the PIM process is becoming attractive for manufacturers of medical implants and surgical instruments. In addition, friction and wear properties play an important role in biomaterial applications. This study aimed to systematically investigate the fretting wear properties of 316L stainless steel parts produced by PIM under dry contact conditions. The fretting experiments were performed under gross-slip regime. The influence of a number of fretting test parameters on the friction and wear behaviour was investigated, as the contact frequency, the normal load, and number of reciprocating sliding cycles. Fretting tests were performed against corundum counter bodies. After the tests, the wear scars were examined by laser surface profilometry, scanning electron microscopy (SEM) and energy dispersive X-ray microanalysis. The results indicate that wear occurred predominantly by abrasion, plastic deformation, and cracking.
C1 [Bakan, H. I.] TUBITAK MAM Mat Inst, TR-41470 Gebze, Kocaeli, Turkey.
   [Celis, J. P.] Katholieke Univ Leuven, Dept Met & Mat Engn MTM, B-3001 Louvain, Belgium.
RP Bakan, HI (reprint author), TUBITAK MAM Mat Inst, POB 21, TR-41470 Gebze, Kocaeli, Turkey.
EM Halil.Bakan@mam.gov.tr
RI Bakan, Halil/F-7571-2018
FU TUBITAK MAM (The Scientific and Technological Research Council of
   Turkey, Marmara Research Centre)
FX Dr. Halil I. Bakan acknowledges TUBITAK MAM (The Scientific and
   Technological Research Council of Turkey, Marmara Research Centre) for
   the financial support allowing him to perform research at the Katholieke
   Universiteit Leuven, Dept. MTM, B-3001 Leuven (Belgium).
CR Bakan HI, 2001, POWDER METALL, V44, P235, DOI 10.1179/003258901666392
   Cruzado A, 2010, WEAR, V268, P1409, DOI 10.1016/j.wear.2010.02.017
   Davis J.R., 1994, ASM SPECIALTY HDB ST
   German R, 1997, INJECTION MOULDING M
   German RM, 2000, INT J POWDER METALL, V36, P31
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   JOHNSON JL, 2005, MED DEVICE MAT, V2, P325
   MOHRBACHER H, 1995, TRIBOL INT, V28, P269, DOI 10.1016/0301-679X(95)00005-O
   Ramalho A, 2003, TRIBOL LETT, V14, P187, DOI 10.1023/A:1022368414455
   Rybiak R, 2010, WEAR, V268, P413, DOI 10.1016/j.wear.2009.08.029
   Tomlin TA, 2000, INT J POWDER METALL, V36, P53
   Zhu MH, 2009, TRIBOL INT, V42, P1360, DOI 10.1016/j.triboint.2009.04.007
NR 12
TC 0
Z9 0
U1 0
U2 10
PU REDAKCIA KOVOVE MATERIALY
PI BRATISLAVA 38
PA UL RACIANSKA 75, PO BOX 95, 830 08 BRATISLAVA 38, SLOVAKIA
SN 0023-432X
J9 KOVOVE MATER
JI Kov. Mater.-Met. Mater.
PY 2012
VL 50
IS 1
BP 33
EP 38
DI 10.4149/km_2012_1_33
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 956TY
UT WOS:000305113200003
OA Bronze
DA 2018-10-19
ER

PT J
AU Kojic, N
   Panzer, MJ
   Leisk, GG
   Raja, WK
   Kojic, M
   Kaplan, DL
AF Kojic, Nikola
   Panzer, Matthew J.
   Leisk, Gary G.
   Raja, Waseem K.
   Kojic, Milos
   Kaplan, David L.
TI Ion electrodiffusion governs silk electrogelation
SO SOFT MATTER
LA English
DT Article
ID BOMBYX-MORI SILK; POLY(ETHYLENE OXIDE); FIBROIN; MECHANOTRANSDUCTION;
   BIOMATERIAL; TRANSPORT; HYDROGELS; CHAIN
AB Silk electrogelation involves the transition of an aqueous silk fibroin solution to a gel state (E-gel) in the presence of an electric current. The process is based on local pH changes as a result of water electrolysis - generating H+ and OH- ions at the (+) and (-) electrodes, respectively. Silk fibroin has a pI = 4.2 and when local pH < pI, E-gel forms. An experimental system was constructed that allowed the measurement of E-gel growth and pH distribution for an applied current. To explain the observed rectangular pH profile of pH(gel) approximate to 4 surrounded by pH(silk-solution) approximate to 10, a finite-element ion electrodiffusion model was developed. The model relies on electrodiffusion of the generated H+ and OH- ions. Initially, inputs into the model were the measured E-gel and voltage curves. The governing ion electrodiffusion equations were solved and the calculated pH matched the experimental pH profile, indicating that ion electrodiffusion dictates local pH changes and E-gel growth. Furthermore, the model predicted the constant currents (2 mA and 3 mA) necessary for two hypothetical E-gel growth curves and these results were then validated experimentally. The model thus shows how ion electrodiffusion governs the electrogelation process and also provides predictable outcomes for fundamental and practical E-gel applications.
C1 [Kojic, Nikola; Raja, Waseem K.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Panzer, Matthew J.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Leisk, Gary G.] Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
   [Kojic, Milos] Methodist Hosp, Dept Nanomed, Res Inst, Houston, TX 77030 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Panzer, Matthew/D-6269-2011
FU NIH [DE017207, EB003210, EB002520]; AFOSR; Ministry of Education and
   Science of Serbia [OI 174028, III 41007]
FX This work was supported by the NIH (DE017207, EB003210 and EB002520),
   the AFOSR, and the Ministry of Education and Science of Serbia (Grants
   OI 174028 and III 41007).
CR Cussler E. L., 2009, DIFFUSION MASS TRANS
   Hughes T., 1987, FINITE ELEMENT METHO
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Johnson EK, 2010, J AM CHEM SOC, V132, P5130, DOI 10.1021/ja909579p
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kirby B.J., 2010, MICRO NANOSCALE FLUI
   Kishore V, 2012, J BIOMED MATER RES B, V100B, P400, DOI 10.1002/jbm.b.31962
   Kojic M, 2011, J SERB SOC COMPUT ME, V5, P101
   Kojic M., 2010, PAK FINITE ELEMENT P
   Kojic M., 2008, COMPUTER MODELING BI
   Kojic N, 2006, BIOPHYS J, V90, P4261, DOI 10.1529/biophysj.105.078345
   Kojic N, 2004, BIOMACROMOLECULES, V5, P1698, DOI 10.1021/bm034280x
   Kojic N, 2006, COMMUN NUMER METH EN, V22, P1003, DOI [10.1002/cnm.869, 10.1002/enm.869]
   Kojic N, 2010, BIOPHYS J, V99, P3517, DOI 10.1016/j.bpj.2010.09.044
   Kojic N, 2010, FASEB J, V24, P1604, DOI 10.1096/fj.09-145367
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Michelman-Ribeiro A., 2006, NONLINEAR SOFT MATTE, V73, P1
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Servoli E, 2008, MACROMOL BIOSCI, V8, P827, DOI 10.1002/mabi.200800057
   SILLEN CWMP, 1982, INT J HYDROGEN ENERG, V7, P577, DOI 10.1016/0360-3199(82)90038-6
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Ziemys A, 2011, J COMPUT PHYS, V230, P5722, DOI 10.1016/j.jcp.2011.03.054
NR 33
TC 31
Z9 31
U1 3
U2 44
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 26
BP 6897
EP 6905
DI 10.1039/c2sm25783a
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 958RJ
UT WOS:000305257800006
PM 22822409
OA Green Accepted
DA 2018-10-19
ER

PT S
AU Althaus, J
   Urwyler, P
   Padeste, C
   Heuberger, R
   Deyhle, H
   Schift, H
   Gobrecht, J
   Pieles, U
   Scharnweber, D
   Peters, K
   Muller, B
AF Althaus, Jasmin
   Urwyler, Prabitha
   Padeste, Celestino
   Heuberger, Roman
   Deyhle, Hans
   Schift, Helmut
   Gobrecht, Jens
   Pieles, Uwe
   Scharnweber, Dieter
   Peters, Kirsten
   Mueller, Bert
BE Lakhtakia, A
   MartinPalma, RJ
TI Micro- and nanostructured polymer substrates for biomedical applications
SO BIOINSPIRATION, BIOMIMETICS, AND BIOREPLICATION 2012
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Bioinspiration, Biomimetics and Bioreplication
CY MAR 12-15, 2012
CL San Diego, CA
SP SPIE, Amer Soc Mech Engn
DE Injection molding; embossing; PEEK film; plasma treatment; anisotropy;
   zeta-potential; XPS; mesenchymal stem cells
ID SURFACES; MICROCANTILEVERS; BIOMATERIALS; READOUT; SENSOR; CELLS; PEEK
AB Polymer implants are interesting alternatives to the contemporary load-bearing implants made from metals. Polyetheretherketone (PEEK), a well-established biomaterial for example, is not only iso-elastic to bone but also permits investigating the surrounding soft tissues using magnetic resonance imaging or computed tomography, which is particularly important for cancer patients. The commercially available PEEK bone implants, however, require costly coatings, which restricts their usage. As an alternative to coatings, plasma activation can be applied. The present paper shows the plasma-induced preparation of nanostructures on polymer films and on injection-molded micro-cantilever arrays and the associated chemical modifications of the surface. In vitro cell experiments indicate the suitability of the activation process. In addition, we show that microstructures such as micro-grooves 1 mu m deep and 20 mu m wide cause cell alignment. The combination of micro-injection molding, simultaneous microstructuring using inserts/bioreplica and plasma treatments permits the preparation of polymer implants with nature-analogue, anisotropic micro-and nanostructures.
C1 [Althaus, Jasmin; Urwyler, Prabitha; Deyhle, Hans; Mueller, Bert] Univ Basel, Univ Hosp, Biomat Sci Ctr, CH-4031 Basel, Switzerland.
   [Althaus, Jasmin; Urwyler, Prabitha; Padeste, Celestino; Schift, Helmut; Gobrecht, Jens] Paul Scherrer Inst, Lab Micro & Nanotechnol, CH-5232 Villigen, Switzerland.
RP Althaus, J (reprint author), Univ Basel, Univ Hosp, Biomat Sci Ctr, CH-4031 Basel, Switzerland.
EM bert.mueller@unibas.ch
RI Urwyler, Prabitha/B-2378-2015; Muller, Bert/A-6838-2008; Deyhle,
   Hans/A-2768-2013
OI Urwyler, Prabitha/0000-0002-7641-8898; Muller, Bert/0000-0003-4078-9109;
   Padeste, Celestino/0000-0001-7577-5781; Heuberger,
   Roman/0000-0003-1474-2040
CR Althaus J., 2012, J NANOPHOTO IN PRESS
   Althaus J, 2012, EUR J NANOMED, V4, P7, DOI 10.1515/ejnm-2011-0001
   Battiston FM, 2001, SENSOR ACTUAT B-CHEM, V77, P122, DOI 10.1016/S0925-4005(01)00683-9
   Beamson G., 1992, HIGH RESOLUTION XPS
   Calleja M, 2005, ULTRAMICROSCOPY, V105, P215, DOI 10.1016/j.ultramic.2005.06.039
   Chan CM, 1996, SURF SCI REP, V24, P3
   CLARK DT, 1978, J POLYM SCI POL CHEM, V16, P3173, DOI 10.1002/pol.1978.170161212
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   GRUNDKE K, 1995, J ADHES SCI TECHNOL, V9, P327, DOI 10.1163/156856195X00536
   Ha SW, 1997, SURF COAT TECH, V96, P293, DOI 10.1016/S0257-8972(97)00179-5
   JONES C, 1990, CARBON, V28, P509, DOI 10.1016/0008-6223(90)90046-2
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Koser J, 2011, EUR CELLS MATER, V21, P479
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Muller B, 2001, SURF REV LETT, V8, P169, DOI 10.1016/S0218-625X(01)00085-9
   Muller B, 2010, EUR J NANOMED, V3, P30, DOI 10.3884/0003.1.8
   Olla M, 2006, SURF INTERFACE ANAL, V38, P964, DOI 10.1002/sia.2362
   Park J, 2005, ANAL CHEM, V77, P6571, DOI 10.1021/ac0507800
   Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570
   Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4
   Thaysen J, 2002, J PHYS D APPL PHYS, V35, P2698, DOI 10.1088/0022-3727/35/21/302
   Urwyler P, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0006-6
   Urwyler P, 2011, SENSOR ACTUAT A-PHYS, V172, P2, DOI 10.1016/j.sna.2010.12.007
   Urwyler P, 2010, PROCEDIA ENGINEER, V5, P347, DOI 10.1016/j.proeng.2010.09.119
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Zhang XR, 2004, APPL PHYS LETT, V85, P2423, DOI 10.1063/1.1791731
NR 27
TC 4
Z9 4
U1 0
U2 28
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8996-8
J9 PROC SPIE
PY 2012
VL 8339
AR 83390Q
DI 10.1117/12.915235
PG 16
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BAM73
UT WOS:000304769300021
DA 2018-10-19
ER

PT J
AU Bloisi, F
   Barra, M
   Cassinese, A
   Vicari, LRM
AF Bloisi, Francesco
   Barra, Mario
   Cassinese, Antonio
   Vicari, Luciano Rosario Maria
TI Matrix-Assisted Pulsed Laser Thin Film Deposition by Using Nd:YAG Laser
SO JOURNAL OF NANOMATERIALS
LA English
DT Review
ID CHEMICAL SENSOR APPLICATIONS; EVAPORATION MAPLE TECHNIQUE;
   SUBSTRATE-TEMPERATURE; LYSOZYME FILMS; POLYMER; DEPENDENCE;
   NANOPARTICLES; GROWTH
AB Matrix-Assisted Pulsed Laser Evaporation (MAPLE) is a deposition technique, developed from Pulsed Laser Deposition (PLD) especially well suited for producing organic/polymeric thin films, which can take advantage from using Nd:YAG laser. Depending on the relative values of light absorption coefficients of the solvent and of the molecules to be deposited, laser energy is directly absorbed by the solvent or is transferred to it, providing a softer desorption mechanism with respect to PLD. In PLD ultraviolet laser radiation is commonly used, but in MAPLE, since easily damaged molecules are usually involved, the use of Nd: YAG laser offers the advantage to allow selecting laser wavelength from ultraviolet (266 nm or 355 nm, corresponding to 4.66 eV or 3.49 eV photon energies, resp.) to visible (532 nm, 2.33 eV) to infrared (1064 nm, 1.17 eV). In this paper, the MAPLE technique is described in details, together with a survey of current and possible future applications for both organic and biomaterial deposition taking into account the advantages of using an Nd: YAG laser. Beside other results, we have experimental confirmation that MAPLE applications are not limited to transparent molecules highly soluble in light absorbing solvent, thus allowing deposition of poorly soluble light absorbing molecules suspended in a light transparent liquid.
C1 [Cassinese, Antonio] Univ Naples Federico II, CNR SPIN, I-80125 Naples, Italy.
   Univ Naples Federico II, Dept Phys Sci, I-80125 Naples, Italy.
RP Cassinese, A (reprint author), Univ Naples Federico II, CNR SPIN, Piazzale Tecchio 80, I-80125 Naples, Italy.
EM cassinese@na.infn.it
RI Barra, mario/E-1811-2011; Bloisi, Francesco/A-4296-2008; VICARI, Luciano
   Rosario Mari/L-6131-2015; antonio, cassinese/J-7274-2012
OI Barra, mario/0000-0002-1990-0119; Bloisi, Francesco/0000-0002-9714-9244;
   VICARI, Luciano Rosario Mari/0000-0003-1835-6411; antonio,
   cassinese/0000-0002-5866-223X
FU EU [264098]; regional project FARO Fabrication of Organic Transistors
   for Bio-Sensing Applications
FX Financial support from EU FP7 project MAMA Grant Agreement no. 264098
   and from the regional project FARO Fabrication of Organic Transistors
   for Bio-Sensing Applications is gratefully acknowledged.
CR Barra M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2809357
   Bloisi F, 2008, THIN SOLID FILMS, V516, P1594, DOI 10.1016/j.tsf.2007.03.159
   Bloisi F, 2007, MAT SCI ENG C-BIO S, V27, P1185, DOI 10.1016/j.msec.2006.12.005
   Bloisi F, 2011, APPL PHYS A-MATER, V105, P619, DOI 10.1007/s00339-011-6603-x
   Bloisi F, 2011, J APPL PHYS, V110, DOI 10.1063/1.3602084
   Bubb DM, 2007, APPL SURF SCI, V253, P6465, DOI 10.1016/j.apsusc.2007.01.109
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Califano V, 2009, EUR PHYS J-APPL PHYS, V48, DOI 10.1051/epjap/2009130
   Califano V, 2008, APPL SURF SCI, V254, P7143, DOI 10.1016/j.apsusc.2008.05.295
   Califano V, 2009, PHYS STATUS SOLIDI A, V206, P2166, DOI 10.1002/pssa.200881783
   Califano V, 2009, ADV ENG MATER, V11, P685, DOI 10.1002/adem.200900092
   Califano V, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2830660
   Caricato AP, 2008, APPL PHYS A-MATER, V93, P651, DOI 10.1007/s00339-008-4724-7
   Caricato AP, 2007, APPL SURF SCI, V253, P6471, DOI 10.1016/j.apsusc.2007.01.113
   Caricato AP, 2010, APPL PHYS A-MATER, V101, P759, DOI 10.1007/s00339-010-5990-8
   Caricato AP, 2009, SENSORS-BASEL, V9, P2682, DOI 10.3390/s90402682
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Cristescu R, 2004, APPL PHYS A-MATER, V79, P1023, DOI 10.1007/s00339-004-2619-9
   Eason R., 2007, PULSED LASER DEPOSIT
   ESENALIEV RO, 1994, APPL PHYS B-LASERS O, V59, P73, DOI 10.1007/BF01081730
   Fitz-Gerald JM, 2005, APPL PHYS A-MATER, V80, P1109, DOI 10.1007/s00339-003-2392-1
   Frycek R, 2006, THIN SOLID FILMS, V495, P308, DOI 10.1016/j.tsf.2005.08.178
   Gutierrez-Llorente A, 2003, APPL PHYS A-MATER, V77, P785, DOI 10.1007/s00339-003-2147-z
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Houser EJ, 2006, APPL SURF SCI, V252, P4871, DOI 10.1016/j.apsusc.2005.07.159
   Hunter CN, 2008, SURF COAT TECH, V203, P300, DOI 10.1016/j.surfcoat.2008.09.003
   Leveugle E, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783898
   Leveugle E, 2007, APPL SURF SCI, V253, P6456, DOI 10.1016/j.apsusc.2007.01.057
   Luches A, 2011, APPL PHYS B-LASERS O, V105, P503, DOI 10.1007/s00340-011-4519-y
   Pique A, 2003, SURF COAT TECH, V163, P293, DOI 10.1016/S0257-8972(02)00606-0
   Pique A, 2002, APPL SURF SCI, V186, P408, DOI 10.1016/S0169-4332(01)00704-8
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Purice A, 2007, APPL SURF SCI, V253, P6451, DOI 10.1016/j.apsusc.2007.01.066
   Purice A, 2007, CHEM PHYS LETT, V435, P350, DOI 10.1016/j.cplett.2006.12.078
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Rodrigo K, 2006, APPL SURF SCI, V252, P4824, DOI 10.1016/j.apsusc.2005.07.143
   Roviello A, 2007, J POLYM SCI POL CHEM, V45, P1758, DOI 10.1002/pola.21943
   Sellinger AT, 2006, J VAC SCI TECHNOL A, V24, P1618, DOI 10.1116/1.2167980
   Sellinger A, 2008, APPL PHYS A-MATER, V92, P821, DOI 10.1007/s00339-008-4582-3
   Sellinger AT, 2007, J PHYS CONF SER, V59, P314, DOI 10.1088/1742-6596/59/1/066
   Smausz T, 2009, THIN SOLID FILMS, V517, P4299, DOI 10.1016/j.tsf.2008.11.141
   Stamatin L, 2005, APPL SURF SCI, V248, P422, DOI 10.1016/j.apsusc.2005.03.060
   Wu PK, 2003, REV SCI INSTRUM, V74, P2546, DOI 10.1063/1.1544081
NR 44
TC 2
Z9 2
U1 0
U2 38
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-4110
J9 J NANOMATER
JI J. Nanomater.
PY 2012
AR 395436
DI 10.1155/2012/395436
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 954XB
UT WOS:000304980200001
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Jeong, J
   Lee, SW
   Min, KS
   Shin, S
   Jun, SB
   Kim, SJ
AF Jeong, Joonsoo
   Lee, Seung Woo
   Min, Kyou Sik
   Shin, Soowon
   Jun, Sang Beom
   Kim, Sung June
TI Liquid Crystal Polymer (LCP), an Attractive Substrate for Retinal
   Implant
SO SENSORS AND MATERIALS
LA English
DT Article
DE liquid crystal polymer; retinal implant; conformable structure; planar
   coil; retinal prosthesis; monolithic encapsulation; soak test
ID MICROELECTRODE ARRAYS; PROSTHESIS; STIMULATION; VISION; SYSTEM
AB Recently, there has been growing interest in liquid crystal polymer (LCP) as a new biomaterial for next-generation implantable neural prosthetic devices. LCP has a very low moisture absorption rate compared with other polymers such as polyimide or parylene-C, providing a superior long-term reliability in the human body. In addition, LCP film is compatible with semiconductor processes, and layer-to-layer lamination is possible simply by fusion bonding of multiple LCP sheets with heat and pressure without the use of adhesives. A monolithic system can be implemented by using LCP as the substrate of electrodes and printed circuit boards as well as packaging material. Therefore, the LCP-based system can achieve a much higher long-term reliability, while maintaining the merits of conventional polymer-based systems such as thinness, flexibility, and simple fabrication procedure. In the present study, we have shown the feasibility of LCP as a substrate and packaging material for a novel monolithic retinal prosthetic device. The patterns of printed circuits and a planar coil were formed on LCP films by thin-film processes, and eye-surface-conformable structure was achieved that enables the attachment of the whole retinal implant on the eyeball. It has been verified that the spherical deformation process did not adversely affect the electrical characteristics or the performance of the printed circuits and the planar coil. The long-term reliability of LCP-encapsulation was evaluated by an in vitro accelerated soak test, and possible failure mechanisms were investigated. The LCP-encapsulation could provide reliable electrical insulation for similar to 400 days in 75 degrees C phosphate-buffered solution (PBS).
C1 [Jeong, Joonsoo; Min, Kyou Sik; Shin, Soowon; Kim, Sung June] Seoul Natl Univ, Dept Elect Engn & Comp Sci, Seoul 151742, South Korea.
   [Jeong, Joonsoo; Min, Kyou Sik; Shin, Soowon; Kim, Sung June] Seoul Natl Univ, Interuniv Semicond Res Ctr, Seoul 151742, South Korea.
   [Lee, Seung Woo] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.
   [Jun, Sang Beom] Ewha Womans Univ, Dept Elect Engn, Seoul 120750, South Korea.
RP Kim, SJ (reprint author), Seoul Natl Univ, Dept Elect Engn & Comp Sci, 1 Gwanak Ro, Seoul 151742, South Korea.
EM kimsj@snu.ac.kr
RI Min, Kyou Sik/M-7373-2014
OI Lee, Seung Woo/0000-0003-4070-809X
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology [2011-0020987, SIRC-2011-0031866]; Department of
   Electrical Engineering, Seoul National University; National Research
   Foundation of Korea [2011-0007411]; Smart IT Convergence System Research
   Center
FX This work was supported in part by the Public Welfare & Safety research
   program through the National Research Foundation of Korea (NRF) funded
   by the Ministry of Education, Science and Technology (2011-0020987), in
   part by the Brain Korea 21 Project, the Department of Electrical
   Engineering, Seoul National University in 2011, in part by the project
   of the Global Ph.D. Fellowship conducted by National Research Foundation
   of Korea from 2011 (2011-0007411). This work was also supported by the
   Smart IT Convergence System Research Center funded by the Ministry of
   Education, Science and Technology as Global Frontier Project
   (SIRC-2011-0031866).
CR Chen MJ, 2006, IEEE T MICROW THEORY, V54, P4009, DOI 10.1109/TMTT.2006.884639
   Chow EY, 2010, IEEE T BIOMED CIRC S, V4, P340, DOI 10.1109/TBCAS.2010.2081364
   Dean RN, 2008, IEEE T COMPON PACK T, V31, P315, DOI 10.1109/TCAPT.2008.916790
   DEIASI R, 1971, J APPL POLYM SCI, V15, P2965, DOI 10.1002/app.1971.070151206
   Dodds C. W. D., 2009, P 4 INT IEEE EMBS C, P88
   Frisk L, 2005, MICROELECTRON RELIAB, V45, P583, DOI 10.1016/j.microrel.2004.10.009
   Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836
   Gerding H, 2007, J NEURAL ENG, V4, pS38, DOI 10.1088/1741-2560/4/1/S06
   Humayun M S, 2001, Trans Am Ophthalmol Soc, V99, P271
   Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7
   Jeong J., 2011, P 33 ANN INT C IEEE, P1097
   Kim ET, 2009, INVEST OPHTH VIS SCI, V50, P4337, DOI 10.1167/iovs.08-2500
   Lee CJ, 2004, MAT SCI ENG C-BIO S, V24, P265, DOI 10.1016/j.msec.2003.09.143
   Lee SW, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2136341
   Lee SW, 2009, INVEST OPHTH VIS SCI, V50, P5859, DOI 10.1167/iovs.09-3743
   Murray S, 2004, J ELECTRON PACKAGING, V126, P390, DOI 10.1115/1.1773853
   Nakauchi K, 2005, GRAEF ARCH CLIN EXP, V243, P169, DOI 10.1007/s00417-004-1060-2
   Rodger DC, 2008, SENSOR ACTUAT B-CHEM, V132, P449, DOI 10.1016/j.snb.2007.10.069
   Schanze T, 2007, IEEE T BIO-MED ENG, V54, P983, DOI 10.1109/TBME.2007.895866
   SCHMIDT EM, 1988, MED BIOL ENG COMPUT, V26, P96, DOI 10.1007/BF02441836
   Shire DB, 2009, IEEE T BIO-MED ENG, V56, P2502, DOI 10.1109/TBME.2009.2021401
   Sundaram V., 2011, P EL COMP TECH C SAN, P1308
   Walter P, 2005, INVEST OPHTH VIS SCI, V46, P1780, DOI 10.1167/iovs.04-0924
   Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435
   Zou G, 2002, IEEE T ADV PACKAGING, V25, P503, DOI 10.1109/TADVP.2002.807593
   Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996
NR 26
TC 20
Z9 20
U1 1
U2 23
PU MYU, SCIENTIFIC PUBLISHING DIVISION
PI TOKYO
PA 1-23-3-303 SENDAGI, TOKYO, 113-0022, JAPAN
SN 0914-4935
J9 SENSOR MATER
JI Sens. Mater.
PY 2012
VL 24
IS 4
SI SI
BP 189
EP 203
PG 15
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA 956MI
UT WOS:000305093400005
DA 2018-10-19
ER

PT J
AU Wu, H
   Pang, D
   Ma, C
   Li, Q
   Xiong, CD
AF Wu, Hang
   Pang, Di
   Ma, Chi
   Li, Qing
   Xiong, Chengdong
TI Composites of Hydroxyapatite Whiskers/poly(L-lactide-co-glycolide) with
   High Tensile Plasticity
SO JOURNAL OF MACROMOLECULAR SCIENCE PART B-PHYSICS
LA English
DT Article
DE 3-aminopropyltriethoxysilane; biomaterials; hydroxyapatite; poly
   (L-lactide-co-glycolide); toughness; whiskers
ID MECHANICAL-PROPERTIES; L-LACTIDE; POLYETHYLENE COMPOSITES;
   INTERNAL-FIXATION; CARBON NANOTUBES; BONE-FRACTURES; POLY(L-LACTIDE);
   BIOMATERIAL; PHOSPHATE; SCAFFOLDS
AB Hydroxyapatite whiskers (HAW) with a maximum aspect ratio of 20 were employed to improve the toughness of poly(L-lactide-co-glycolide) (PLGA). 3-Aminopropyltriethoxysilane (AMEO) was grafted on the surface of the hydroxyapatite whiskers (g-HAW) to improve its wetting in the PLGA matrix. Composites based on HAW, g-HAW, and PLGA were prepared. The structure and properties of the composites were subsequently investigated by powder X-ray diffraction (XRD), scanning electron microscopy, differential scanning calorimetry, and tensile testing. The g-HAW were distributed homogenously in the PLGA matrix because of improved wetting of g-HAW while the HAW were aggregated. The stronger interfacial bonding also gave rise to improved mechanical properties of the g-HAW/PLGA composites. The HAW/PLGA and g-HAW/PLGA composites failed in a tough manner with intensive plastic deformation. The g-HAW/PLGA composite (5 wt% g-HAW) failed at a maximum elongation of 366%, although the tensile strength dropped slightly. The g-HAW/PLGA composite (1 wt% g-HAW) maintained the initial tensile strength of neat PLGA but failed at an equally high elongation of 347%, whereas PLGA failed at an elongation of 11%.
C1 [Wu, Hang; Pang, Di; Ma, Chi; Li, Qing; Xiong, Chengdong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Wu, Hang; Pang, Di; Ma, Chi] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China.
RP Xiong, CD (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM xcd1633@yahoo.com.cn
CR Bai W, 2009, J BIOMED MATER RES B, V90B, P945, DOI 10.1002/jbm.b.31367
   Berger S, 2009, MATER LETT, V63, P2714, DOI 10.1016/j.matlet.2009.09.051
   Chen GX, 2008, POLYMER, V49, P943, DOI 10.1016/j.polymer.2008.01.014
   Converse GL, 2007, BIOMATERIALS, V28, P927, DOI 10.1016/j.biomaterials.2006.10.031
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   Deng C, 2008, MATER LETT, V62, P607, DOI 10.1016/j.matlet.2007.06.014
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Gojny FH, 2004, COMPOS SCI TECHNOL, V64, P2363, DOI 10.1016/j.compscitech.2004.04.002
   Gu SY, 2007, POLYM POLYM COMPOS, V15, P137, DOI 10.1177/096739110701500207
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Jacobsen S, 1999, POLYM ENG SCI, V39, P1303, DOI 10.1002/pen.11517
   Jiang L, 2007, POLYMER, V48, P7632, DOI 10.1016/j.polymer.2007.11.001
   Kim HS, 2010, J NANOSCI NANOTECHNO, V10, P3576, DOI 10.1166/jnn.2010.2233
   Kim SS, 2008, J BIOMED MATER RES A, V87A, P245, DOI 10.1002/jbm.a.31782
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Sawpan MA, 2011, COMPOS PART A-APPL S, V42, P310, DOI 10.1016/j.compositesa.2010.12.004
   Shen L, 2009, J MATER SCI-MATER M, V20, P2259, DOI 10.1007/s10856-009-3785-2
   Shieh YT, 2007, J POLYM SCI POL PHYS, V45, P1870, DOI 10.1002/polb.21184
   Stojanovic D, 2007, MATER SCI FORUM, V555, P479, DOI 10.4028/www.scientific.net/MSF.555.479
   Tas AC, 2007, J AM CERAM SOC, V90, P2358, DOI 10.1111/j.1551-2916.2007.01768.x
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Xu W, 2008, SMALL, V4, P662, DOI 10.1002/smll.200701231
   Yoon JT, 2010, COMPOS SCI TECHNOL, V70, P776, DOI 10.1016/j.compscitech.2010.01.011
   Yue WM, 2006, J MATER RES, V21, P2136, DOI 10.1557/JMR.2006.0263
   Zhang DJ, 2009, J MATER SCI-MATER M, V20, P1971, DOI 10.1007/s10856-009-3772-7
   Zhao N, 2010, CRYST RES TECHNOL, V45, P275, DOI 10.1002/crat.200900617
   Zou JP, 2010, J MACROMOL SCI B, V49, P781, DOI 10.1080/00222341003598422
NR 33
TC 4
Z9 4
U1 0
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0022-2348
EI 1525-609X
J9 J MACROMOL SCI B
JI J. Macromol. Sci. Part B-Phys.
PY 2012
VL 51
IS 6
BP 1242
EP 1255
DI 10.1080/00222348.2011.627824
PG 14
WC Polymer Science
SC Polymer Science
GA 947TL
UT WOS:000304453700019
DA 2018-10-19
ER

PT J
AU Hickman, GJ
   Rai, A
   Boocock, DJ
   Rees, RC
   Perry, CC
AF Hickman, Graham J.
   Rai, Akhilesh
   Boocock, David J.
   Rees, Robert C.
   Perry, Carole C.
TI Fabrication, characterisation and performance of hydrophilic and
   super-hydrophilic silica as cell culture surfaces
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; OXYGEN PLASMA TREATMENT; SOL-GEL
   ENCAPSULATION; IN-VITRO; BIOMATERIAL SURFACES; ELECTRON-MICROSCOPY;
   PROTEIN ADSORPTION; NANOMETER-SCALE; GOLD SURFACES; ADHESION
AB We demonstrate a straightforward procedure for the controlled formation of silica films on tissue culture polystyrene (PS) surfaces. The films were formed by sequentially treating PS with polyaniline, glutaric dialdehyde and protein prior to silica formation. The films could be tailored to exhibit super-hydrophilicity (contact angle < 5 degrees) which was retained for more than two months under ambient conditions. Both hydrophilic and super-hydrophilic silica coated surfaces were suitable for the culture of an adherent human melanoma cell line. Proliferation, toxicity and adhesion assays were used to compare cell behaviour. Cells on the silica surfaces showed enhanced adhesion and comparable rates of cell proliferation as compared to cells grown on conventional tissue culture plastic. The results obtained can be understood by considering the surface properties of the different materials and the ability of the silica coated surfaces to adsorb significantly higher levels of serum proteins from the growth medium. One of the outcomes of this study is a re-evaluation of the hydrophobicity/hydrophilicity characteristics required for good cell growth and the possibility of designing new tissue culture materials capable of greater control over cell populations.
C1 [Hickman, Graham J.; Rai, Akhilesh; Perry, Carole C.] Nottingham Trent Univ, Biomol & Mat Interface Res Grp, Nottingham, England.
   [Hickman, Graham J.; Boocock, David J.; Rees, Robert C.] Nottingham Trent Univ, John Geest Canc Res Ctr, Nottingham, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Biomol & Mat Interface Res Grp, Clifton Campus,Clifton Lane, Nottingham, England.
EM carole.perry@ntu.ac.uk
RI Boocock, David/I-4666-2015
OI Boocock, David/0000-0002-7333-3549; Perry, Professor
   Carole/0000-0003-1517-468X; Rai, Akhilesh/0000-0001-5352-5415
FU John van Geest Cancer research centre
FX The authors would like to acknowledge the contributions of Dr B.
   Matharoo- Ball in preliminary aspects of this study and helpful
   discussions with Dr David J. Belton. Funding was partially provided by
   the John van Geest Cancer research centre.
CR Ahmed I, 2006, J BIOMED MATER RES A, V76A, P851, DOI 10.1002/jbm.a.30587
   An YQ, 2007, J COLLOID INTERF SCI, V311, P507, DOI 10.1016/j.jcis.2007.02.084
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Beaulleu I, 2009, LANGMUIR, V25, P7169, DOI 10.1021/la9001972
   Belton DJ, 2005, J MATER CHEM, V15, P4629, DOI 10.1039/b509683a
   Besanger TR, 2004, ANAL CHEM, V76, P6470, DOI 10.1021/ac0488210
   Bico J, 1999, EUROPHYS LETT, V47, P743, DOI 10.1209/epl/i1999-00453-y
   Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4
   Bressler E, 2002, BIOTECHNOL PROGR, V18, P445, DOI 10.1021/bp010139t
   Carnes EC, 2009, J AM CHEM SOC, V131, P14255, DOI 10.1021/ja906055m
   Cebeci FC, 2006, LANGMUIR, V22, P2856, DOI 10.1021/la053182p
   Chow TS, 1997, PHYS REV LETT, V79, P1086, DOI 10.1103/PhysRevLett.79.1086
   Coiffier A, 2001, J MATER CHEM, V11, P2039, DOI 10.1039/b101308o
   Czeslik C, 2001, PHYS CHEM CHEM PHYS, V3, P235, DOI 10.1039/b005900p
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Eder F, 2009, APPL SURF SCI, V256, pS18, DOI 10.1016/j.apsusc.2009.04.043
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Ferrer ML, 2002, CHEM MATER, V14, P3619, DOI 10.1021/cm025562r
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gao CY, 2001, J APPL POLYM SCI, V81, P3523, DOI 10.1002/app.1808
   GEBERT PH, 1989, SYNTHETIC MET, V29, pE371
   Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048
   Han MG, 2002, SYNTHETIC MET, V126, P53, DOI 10.1016/S0379-6779(01)00494-5
   Han TY, 2007, THIN SOLID FILMS, V515, P4666, DOI 10.1016/j.tsf.2006.11.008
   Hassan PA, 2004, LANGMUIR, V20, P4874, DOI 10.1021/la0498096
   Heller DA, 2005, BIOMATERIALS, V26, P883, DOI 10.1016/j.biomaterials.2004.03.029
   Hong Q, 2009, ANALYST, V134, P593, DOI 10.1039/b813328j
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   HUANG WS, 1993, POLYMER, V34, P1833, DOI 10.1016/0032-3861(93)90424-9
   Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024
   Ingber DE, 2005, P NATL ACAD SCI USA, V102, P11571, DOI 10.1073/pnas.0505939102
   Jang JS, 2006, CHEM COMMUN, P1622, DOI 10.1039/b600167j
   Jedlicka SS, 2006, J MATER CHEM, V16, P3221, DOI 10.1039/b602008a
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Karir T, 2006, ANAL CHEM, V78, P3577, DOI 10.1021/ac052032g
   Khorasani MT, 2007, RADIAT PHYS CHEM, V76, P1011, DOI 10.1016/j.radphyschem.2006.10.002
   Kollias K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465304
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Liao H, 2003, J BIOL CHEM, V278, P76, DOI 10.1074/jbc.M208820200
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Liu XM, 2007, J COLLOID INTERF SCI, V314, P341, DOI 10.1016/j.jcis.2007.05.011
   Luo TJM, 2005, NAT MATER, V4, P220, DOI 10.1038/nmat1322
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198
   McNaughton SA, 2005, BRIT J NUTR, V94, P813, DOI 10.1079/BJN20051548
   Miller T, 2003, LANGMUIR, V19, P1723, DOI 10.1021/la0261500
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709
   Nguyen DT, 2002, CHEM MATER, V14, P4300, DOI 10.1021/cm020398t
   Notsu H, 2005, J MATER CHEM, V15, P1523, DOI 10.1039/b418884e
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Olsen A. C., 1995, SCAND J IMMUNOL, V14, P357
   Pajonk G. M., 1989, REV PHYS APPL, V24, pC4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Perullini M, 2008, CHEM MATER, V20, P3015, DOI 10.1021/cm703075b
   Peterson KP, 1998, P SOC EXP BIOL MED, V218, P365
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Premkumar J, 2005, CHEM COMMUN, P640, DOI 10.1039/b414418j
   Premkumar JR, 2001, ADV MATER, V13, P1773, DOI 10.1002/1521-4095(200112)13:23<1773::AID-ADMA1773>3.3.CO;2-Q
   Rai A, 2009, SILICON-NETH, V1, P91, DOI 10.1007/s12633-009-9012-4
   Rai A, 2010, LANGMUIR, V26, P4152, DOI 10.1021/la903366a
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Saltzman WM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P279, DOI 10.1016/B978-012370615-7/50024-X
   Sato O, 2009, ACCOUNTS CHEM RES, V42, P1, DOI 10.1021/ar700197v
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sglavo VM, 1999, J MATER SCI, V34, P3587, DOI 10.1023/A:1004626632730
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Shim HW, 2009, J NANOSCI NANOTECHNO, V9, P1204, DOI 10.1166/jnn.2009.C120
   Song J, 2004, J MATER CHEM, V14, P2643, DOI 10.1039/b408597n
   Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Triantafyllidis D, 2005, MAT SCI ENG A-STRUCT, V390, P271, DOI 10.1016/j.msea.2004.08.016
   Tuysuz H, 2008, J AM CHEM SOC, V130, P11510, DOI 10.1021/ja803362s
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Vetrone F., 2009, NANO LETT, V2, P659
   Wang ST, 2009, ANGEW CHEM INT EDIT, V48, P8970, DOI 10.1002/anie.200901668
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wendt D, 2009, ADV MATER, V21, P3352, DOI 10.1002/adma.200802748
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Xu TW, 2003, J COLLOID INTERF SCI, V262, P342, DOI 10.1016/S0021-9797(03)00208-X
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Zhao JX, 2006, BIOTECHNOL PROGR, V22, P32, DOI 10.1021/bp050154o
   Zimmermann J, 2002, BIOMATERIALS, V23, P2127, DOI 10.1016/S0142-9612(01)00343-X
   Zolkov C, 2004, J MATER CHEM, V14, P2200, DOI 10.1039/b401715n
NR 91
TC 3
Z9 3
U1 2
U2 48
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 24
BP 12141
EP 12148
DI 10.1039/c2jm31161e
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 949FK
UT WOS:000304561900039
DA 2018-10-19
ER

PT J
AU Zelzer, M
   McNamara, LE
   Scurr, DJ
   Alexander, MR
   Dalby, MJ
   Ulijn, RV
AF Zelzer, Mischa
   McNamara, Laura E.
   Scurr, David J.
   Alexander, Morgan R.
   Dalby, Matthew J.
   Ulijn, Rein V.
TI Phosphatase responsive peptide surfaces
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; CELL-ADHESION; STEM-CELLS; OSTEOGENIC
   DIFFERENTIATION; ENZYMATIC NANOLITHOGRAPHY; BIOMATERIALS; HYDROGELS;
   LIGANDS; LITHOGRAPHY; OSTEOBLASTS
AB The development of interactive surfaces able to respond to biological cues is of interest for the development of next generation biomaterials. We report the design, synthesis and characterisation of an enzyme responsive peptide based surface whose chemical properties change upon catalytic action of alkaline phosphatase (AP). AP is a membrane-anchored enzyme involved in osteogenesis (bone formation), making it a suitable biomolecule to facilitate interactivity between the cell and the biomaterial surface. Surface analysis is used to follow dephosphorylation and a phosphate assay is used to determine the amount of phosphate removed by the enzyme. This analysis reveals significant differences in the dephosphorylation rate at the surface compared to that in solution. The ability of the surface to respond to native enzymes expressed by mesenchymal stem cells (MSCs) was indirectly explored by assessing the response of the cells to phosphorylated, non-phosphorylated and enzymatically dephosphorylated surfaces. No differences were found between the surfaces, suggesting that cell expressed enzymes are able to dephosphorylate the peptide surfaces rapidly. This work presents the first phosphatase responsive surfaces whose phosphorylation state can be altered by native enzymes provided by the cells.
C1 [Zelzer, Mischa; Ulijn, Rein V.] Univ Strathclyde, WestCHEM, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland.
   [McNamara, Laura E.; Dalby, Matthew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   [Scurr, David J.; Alexander, Morgan R.] Univ Nottingham, Lab Biophys & Surface Anal, Sch Pharm, Nottingham NG7 2RD, England.
RP Zelzer, M (reprint author), Univ Strathclyde, WestCHEM, Dept Pure & Appl Chem, 295 Cathedral St, Glasgow G1 1XL, Lanark, Scotland.
EM mischa.zelzer@strath.ac.uk; laura.mcnamara@glasgow.ac.uk;
   Matthew.Dalby@glasgow.ac.uk; rein.ulijn@strath.ac.uk
RI Scurr, David/E-8441-2012; Alexander, Morgan/C-2506-2009; Dalby,
   Matthew/G-2426-2012
OI Scurr, David/0000-0003-0859-3886; Alexander, Morgan/0000-0001-5182-493X;
   Dalby, Matthew/0000-0002-0528-3359
FU Leverhulme Trust; ERC; EPSRC; Engineering and Physical Sciences Research
   Council [EP/G048703/1]
FX Funding from the Leverhulme Trust for MZ is gratefully acknowledged. We
   thank Andrew Urquhart for access to the water contact angle goniometer.
   RVU acknowledges support from the Leverhulme Trust (Leadership Award)
   and ERC (Starting Grant EMERGE). LEM and MJD are funded by EPSRC.
CR Aili D, 2010, CHEM SOC REV, V39, P3358, DOI 10.1039/b919461b
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Caponi PF, 2011, POLYM CHEM-UK, V2, P306, DOI 10.1039/c0py00291g
   Chan EWL, 2008, ANGEW CHEM INT EDIT, V47, P6267, DOI 10.1002/anie.200800166
   Clausen-Schaumann H, 1998, ADV MATER, V10, P949, DOI 10.1002/(SICI)1521-4095(199808)10:12<949::AID-ADMA949>3.0.CO;2-0
   Collier JH, 2006, P NATL ACAD SCI USA, V103, P2021, DOI 10.1073/pnas.0504349103
   Edahiro J, 2005, BIOMACROMOLECULES, V6, P970, DOI 10.1021/bm0493382
   Fuchise T., 2011, J AMINO ACIDS
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Guyomard-Lack A, 2011, LANGMUIR, V27, P7629, DOI 10.1021/la2007843
   Hatakeyama H, 2006, BIOMATERIALS, V27, P5069, DOI 10.1016/j.biomaterials.2006.05.019
   Hodneland CD, 2000, J AM CHEM SOC, V122, P4235, DOI 10.1021/ja000419p
   Hong CY, 2005, CHEM MATER, V17, P2247, DOI 10.1021/cm0480541
   Hyun J, 2004, J AM CHEM SOC, V126, P4770, DOI 10.1021/ja049956q
   Kambe Y, 2010, BIOMATERIALS, V31, P7503, DOI 10.1016/j.biomaterials.2010.06.045
   Kaur G, 2010, BIOMATERIALS, V31, P5813, DOI 10.1016/j.biomaterials.2010.04.017
   Kuhnle H, 2009, ANGEW CHEM INT EDIT, V48, P6431, DOI 10.1002/anie.200805768
   Li H, 2011, SMALL, V7, P226, DOI 10.1002/smll.201001977
   Liao XL, 2011, ANGEW CHEM INT EDIT, V50, P706, DOI 10.1002/anie.201005638
   Liu DB, 2009, ANGEW CHEM INT EDIT, V48, P4406, DOI 10.1002/anie.200901130
   Lowik DWPM, 2010, CHEM SOC REV, V39, P3394, DOI 10.1039/b914342b
   Luo XL, 2009, CHEM-EUR J, V15, P5191, DOI 10.1002/chem.200900433
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Nuttelman CR, 2006, BIOMATERIALS, V27, P1377, DOI 10.1016/j.biomaterials.2005.08.014
   Ohmuro-Matsuyama Y, 2008, ANGEW CHEM INT EDIT, V47, P7527, DOI 10.1002/anie.200802731
   Petersen S, 2008, ANGEW CHEM INT EDIT, V47, P3192, DOI 10.1002/anie.200704857
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   Rawsterne RE, 2006, SURF INTERFACE ANAL, V38, P1505, DOI 10.1002/sia.2492
   Riemenschneider L, 2005, NANO LETT, V5, P1643, DOI 10.1021/nl0484550
   Sadownik JW, 2011, CHEM COMMUN, V47, P728, DOI 10.1039/c0cc03796f
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Snyder PW, 2007, J ORG CHEM, V72, P7459, DOI 10.1021/jo0711541
   Takeda S, 2003, NANO LETT, V3, P1471, DOI 10.1021/nl034448k
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   Turner DC, 1997, LANGMUIR, V13, P4855, DOI 10.1021/la970324+
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Wang C, 2010, ANGEW CHEM INT EDIT, V49, P8612, DOI 10.1002/anie.201004253
   Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x
   Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yeo WS, 2003, ANGEW CHEM INT EDIT, V42, P3121, DOI 10.1002/anie.200250862
   Yousaf MN, 2001, ANGEW CHEM INT EDIT, V40, P1093, DOI 10.1002/1521-3773(20010316)40:6<1093::AID-ANIE10930>3.3.CO;2-H
   Yu X, 2005, ADV MATER, V17, P1289, DOI 10.1002/adma.200401646
   Zelzer M, 2012, ACS APPL MATER INTER, V4, P53, DOI 10.1021/am2015266
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 53
TC 13
Z9 13
U1 4
U2 66
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 24
BP 12229
EP 12237
DI 10.1039/c2jm31666h
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 949FK
UT WOS:000304561900051
DA 2018-10-19
ER

PT J
AU Canullo, L
   Dellavia, C
   Heinemann, F
AF Canullo, Luigi
   Dellavia, Claudia
   Heinemann, Friedhelm
TI Maxillary sinus floor augmentation using a nano-crystalline
   hydroxyapatite silica gel: Case series and 3-month preliminary
   histological results
SO ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
LA English
DT Article
DE Maxillary sinus floor augmentation; Bone regeneration; Nano-crystalline
   hydroxyapatite
ID BONE SUBSTITUTE; IMPLANTS; RIDGE; PLACEMENT; ELEVATION; AREAS
AB The aim of this case series is to histologically examine a new hydroxyapatite in sinus lift procedure after 3 months. Ten 2-stage sinus lifts were performed in 10 healthy patients having initial bone height of 1-2 mm and bone width of 5 mm, asking for a fixed implant-supported rehabilitation. After graft material augmentation, a rough-surfaced mini-implant was inserted to maintain stability of the sinus widow. A bioptical core containing a mini-implant was retrieved 3 months after maxillary sinus augmentation with NanoBone (R) and processed for undecalcified histology. From the histomorphometric analysis, NanoBone (R) residuals accounted for the 38.26%+/- 8.07% of the bioptical volume, marrow spaces for the 29.23%+/- 5.18% and bone for the 32.51%+/- 4.96% (new bone: 20.64%+/- 2.96%, native bone: 11.87%+/- 3.27%). Well-mineralized regenerated bone with lamellar parallel-fibred structure and Haversian systems surrounded the residual NanoBone (R) particles. The measured bone-to-implant contact amounted to 26.02%+/- 5.46%. No connective tissue was observed at the implant boundary surface. In conclusion, the tested material showed good histological outcomes also 3 months after surgery. In such critical conditions, the use of a rough-surfaced mini-implant showed BIC values supposed to be effective also in case of functional loading. Although longer follow-up and a wider patient size are needed, these preliminary results encourage further research on this biomaterial for implant load also under early stage and critical conditions. (C) 2011 Elsevier GmbH. All rights reserved.
C1 [Canullo, Luigi] Private Dent Off, I-00198 Rome, Italy.
   [Dellavia, Claudia] Univ Milan, Dept Human Morphol & Biomed Sci Citta Studi, I-20122 Milan, Italy.
   [Heinemann, Friedhelm] Ernst Moritz Arndt Univ Greifswald, Dept Prosthodont Gerodontol & Med Mat Sci, D-17475 Greifswald, Germany.
RP Canullo, L (reprint author), Private Dent Off, Via Nizza 46, I-00198 Rome, Italy.
EM luigicanullo@yahoo.com
CR Becker W, 1995, Int J Oral Maxillofac Implants, V10, P143
   Buser D, 1996, J ORAL MAXIL SURG, V54, P420, DOI 10.1016/S0278-2391(96)90113-5
   Cammack GV, 2005, INT J PERIODONT REST, V25, P231
   Canullo Luigi, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe7, DOI 10.1111/j.1708-8208.2008.00141.x
   Conner KA, 2003, J PERIODONTOL, V74, P658, DOI 10.1902/jop.2003.74.5.658
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Fugazzotto PA, 2007, IMPLANT DENT, V16, P369, DOI 10.1097/ID.0b013e318157086c
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Gedrange T, 2008, J PHYSIOL PHARMACOL, V59, P87
   Gerber T, 2006, EUR J TRAUMA, V32, P132
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Henkel KO, 2006, ORAL SURG ORAL MED O, V102, P606, DOI 10.1016/j.tripleo.2005.10.034
   Karabuda C, 2001, J PERIODONTOL, V72, P1436, DOI 10.1902/jop.2001.72.10.1436
   Kunert-Keil C., 2009, J PHYSL PHARM S8, V60
   Maiorana C, 2000, INT J ORAL MAX IMPL, V15, P873
   Palma VC, 2006, CLIN IMPLANT DENT R, V8, P11, DOI 10.2310/6480.2005.00026
   Tarnow DP, 2000, INT J PERIODONT REST, V20, P117
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Yaman F, 2007, J ORAL MAXIL SURG, V65, P1490, DOI 10.1016/j.joms.2006.1027
NR 22
TC 15
Z9 15
U1 0
U2 8
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-9602
J9 ANN ANAT
JI Ann. Anat.-Anat. Anz.
PY 2012
VL 194
IS 2
SI SI
BP 174
EP 178
DI 10.1016/j.aanat.2011.04.007
PG 5
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 946GQ
UT WOS:000304339900004
PM 21640571
DA 2018-10-19
ER

PT J
AU Gredes, T
   Heinemann, F
   Dominiak, M
   Mack, H
   Gedrange, T
   Spassov, A
   Klinke, T
   Kunert-Keil, C
AF Gredes, Tomasz
   Heinemann, Friedhelm
   Dominiak, Marzena
   Mack, Heike
   Gedrange, Tomasz
   Spassov, Alexander
   Klinke, Thomas
   Kunert-Keil, Christiane
TI Bone substitution materials on the basis of BONITmatrix (R) up-regulate
   mRNA expression of IGF1 and Col1a1
SO ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
LA English
DT Article
DE Bone defect; Quantitative RT-PCR; Collagen; IGF; Growth factors
ID GROWTH-FACTOR-I; OSTEOBLAST GENE-EXPRESSION; TRANSGENIC MICE;
   DIFFERENTIATION; CELLS; PROLIFERATION; MATRIX; HYDROXYAPATITE;
   REGENERATION; BIOMATERIAL
AB The aim of this study was to investigate the effects of BONITmatrix (R) and OSSA NOVA on the expression of growth factors and osteogenic differentiation. For this purpose, the mRNA expression of VEGF, IGF1, IGF2, collagen-1, collagen-2 and MMP8 was analysed in surgically created defects on the crania of adult male rats. Cranial samples were collected after implantation of BONITmatrix (R) or OSSA NOVA scaffolds for 4 weeks and determinations of gene expression were performed by quantitative RT-PCR. Real-time RT-PCR analyses showed a significantly higher expression of IGF1 in both groups treated with BONITmatrix (R) and OSSA NOVA compared to untreated controls, whereas type I collagen mRNA expression only increased in BONITmatrix (R) treated rats compared to controls. No changes in transcript expression of IGF2, VEGF, collagen-2 and MMP8 were detectable between the analysed groups. In conclusion, BONITmatrix (R) and OSSA NOVA stimulate the expression of growth factor IGF1, but only the granular dosage form is able to stimulate osteoblast differentiation. (C) 2011 Elsevier GmbH. All rights reserved.
C1 [Gredes, Tomasz; Heinemann, Friedhelm; Spassov, Alexander; Kunert-Keil, Christiane] Ernst Moritz Arndt Univ Greifswald, Dept Orthodont Prevent & Pediat Dent, D-17475 Greifswald, Germany.
   [Dominiak, Marzena] Silesian Piast Med Acad Wroclaw, Dept Oral Surg, PL-50425 Wroclaw, Poland.
   [Klinke, Thomas] Ernst Moritz Arndt Univ Greifswald, Dept Prosthodont Gerontol & Med Mat, D-17475 Greifswald, Germany.
   [Mack, Heike] Griffith Univ, Griffith Hlth, Nathan, Qld 4111, Australia.
   [Gedrange, Tomasz] Tech Univ Dresden, Dept Orthodont, D-01307 Dresden, Germany.
RP Gredes, T (reprint author), Rotgerberstr 8, D-17489 Greifswald, Germany.
EM thomasgredes@yahoo.de
CR BAGI CM, 1994, J BONE MINER RES, V9, P1301
   Baroth S, 2009, BIO-MED MATER ENG, V19, P71, DOI 10.3233/BME-2009-0565
   Bikle DD, 2008, OSTEOPOROSIS INT, V19, P1237, DOI 10.1007/s00198-008-0597-z
   BIRNBAUM RS, 1995, J ENDOCRINOL, V144, P251, DOI 10.1677/joe.0.1440251
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CANALIS E, 1991, ANNU REV MED, V42, P17, DOI 10.1146/annurev.me.42.020191.000313
   Canalis E., 1985, CLIN ORTHOP RELAT R, P46
   Cao Y, 2005, CANCER RES, V65, P1124, DOI 10.1158/0008-5472.CAN-04-2128
   Clarke SA, 2004, J ORTHOPAED RES, V22, P1016, DOI 10.1016/j.orthres.2004.01.010
   Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007
   Crespi R, 2009, J PERIODONTOL, V80, P586, DOI 10.1902/jop.2009.080466
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Govoni KE, 2007, ENDOCRINOLOGY, V148, P5706, DOI 10.1210/en.2007-0608
   Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849
   Jiang J, 2006, BONE, V39, P494, DOI 10.1016/j.bone.2006.02.068
   Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Kim SJ, 2007, GROWTH FACTORS, V25, P77, DOI 10.1080/08977190701398977
   Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003
   Kunert-Keil C, 2009, J PHYSIOL PHARMACOL, V60, P57
   Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Marquis ME, 2009, FRONT BIOSCI-LANDMRK, V14, P1023, DOI 10.2741/3293
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   MUNDY GR, 1994, RHEUM DIS CLIN N AM, V20, P577
   Nakao K, 2009, BIOCHEM BIOPH RES CO, V378, P462, DOI 10.1016/j.bbrc.2008.11.083
   Nieminen J, 2008, CALCIFIED TISSUE INT, V82, P229, DOI 10.1007/s00223-008-9110-0
   Niu TH, 2005, GENE, V361, P38, DOI 10.1016/j.gene.2005.07.016
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496
   Paccou J., 2011, JOINT BONE SPINE
   Papadopoulou AK, 2007, FEBS LETT, V581, P2041, DOI 10.1016/j.febslet.2007.04.037
   Parfitt AM, 1996, J BONE MINER RES, V11, P150
   Schmid C., 1992, INSULIN LIKE GROWTH, P229
   Schmidmaier G, 2003, J BIOMED MATER RES B, V65B, P157, DOI 10.1002/jbm.b.10513
   Sibilla P, 2006, J DENT RES, V85, P354, DOI 10.1177/154405910608500414
   Thimm BW, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015007
   Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085
   Xian CJ, 2004, BONE, V35, P739, DOI 10.1016/j.bone.2004.04.027
   Xu JL, 2009, BIOMATERIALS, V30, P5385, DOI 10.1016/j.biomaterials.2009.07.002
   Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200
   ZHOU H, 1993, J CELL PHYSIOL, V155, P112, DOI 10.1002/jcp.1041550115
   Zietek M, 2008, J PHYSIOL PHARMACOL, V59, P81
NR 46
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-9602
J9 ANN ANAT
JI Ann. Anat.-Anat. Anz.
PY 2012
VL 194
IS 2
SI SI
BP 179
EP 184
DI 10.1016/j.aanat.2011.10.003
PG 6
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 946GQ
UT WOS:000304339900005
PM 22055937
DA 2018-10-19
ER

PT J
AU Vukomanovic, M
   Zunic, V
   Otonicar, M
   Repnik, U
   Turk, B
   Skapin, SD
   Suvorov, D
AF Vukomanovic, Marija
   Zunic, Vojka
   Otonicar, Mojca
   Repnik, Urska
   Turk, Boris
   Skapin, Sreco Davor
   Suvorov, Danilo
TI Hydroxyapatite/platinum bio-photocatalyst: a biomaterial approach to
   self-cleaning
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID VISIBLE-LIGHT; PLATINUM NANOPARTICLES; SILVER NANOPARTICLES; AQUEOUS
   SUSPENSION; UV-IRRADIATION; TIO2; METAL; WATER; SPECTROSCOPY;
   DEGRADATION
AB A bio-inspired approach to photocatalysis with a selection of biologically acceptable building blocks that can be activated by non-toxic visible light is a direction of research for the design of advanced, biomaterials that are able to induce self-cleaning. Here we show that a combination of hydroxyapatite (HAp) with platinum (Pt-0 and Ptn+) is suitable to form a novel photocatalytically active material. The so-formed hybrid semiconductor/metallic nanocomposites made of apatite plates with Pt metallic nanoparticles attached to their surface and two different types of surface-adsorbed Pt-complexes are an innovative solution for the design of functional bioactive materials. This material can be activated by exposure to either ultraviolet (UV) or visible (Vis) light. UV activation is allowed by the semiconductor HAp phase, while the activity induced by Vis light is related to complexes adsorbed onto the HAp surface. Pt metallic nanoparticles have the ability to trap electrons, which provides an extension of the material's activity during the period when it is kept in the dark.
C1 [Vukomanovic, Marija; Zunic, Vojka; Otonicar, Mojca; Skapin, Sreco Davor; Suvorov, Danilo] Jozef Stefan Inst, Adv Mat Dept, Ljubljana 1000, Slovenia.
   [Repnik, Urska; Turk, Boris] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia.
RP Vukomanovic, M (reprint author), Jozef Stefan Inst, Adv Mat Dept, Jamova 39, Ljubljana 1000, Slovenia.
EM marija.vukomanovic@ijs.si
RI Vukomanovic, Marija/B-8062-2009
OI Vukomanovic, Marija/0000-0001-7034-0471
FU Slovenian Human Resources Development and Scholarship Fund
   [11011-20/2009]
FX This research was supported by the Slovenian Human Resources Development
   and Scholarship Fund under grant number: 11011-20/2009.
CR Aronov D, 2007, J EUR CERAM SOC, V27, P4181, DOI 10.1016/j.jeurceramsoc.2007.02.121
   Aronov D, 2007, J MATER SCI-MATER M, V18, P865, DOI 10.1007/s10856-006-0080-3
   Asharani PV, 2010, ADV FUNCT MATER, V20, P1233, DOI 10.1002/adfm.200901846
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Bracko I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085705
   Burgeth G, 2002, COORDIN CHEM REV, V230, P41, DOI 10.1016/S0010-8545(02)00095-4
   de Araujo T S, 2010, Journal of Physics: Conference Series, V249, DOI 10.1088/1742-6596/249/1/012012
   Diebold U, 2011, NAT CHEM, V3, P271, DOI 10.1038/nchem.1019
   DISDIER J, 1983, J CHEM SOC FARAD T 1, V79, P651, DOI 10.1039/f19837900651
   Dragnea B, 2008, NAT MATER, V7, P102, DOI 10.1038/nmat2108
   Eufinger K, 2007, J PHYS D APPL PHYS, V40, P5232, DOI 10.1088/0022-3727/40/17/033
   Funakoshi K, 2006, J AM CERAM SOC, V89, P944, DOI 10.1111/j.1551-2916.2005.00802.x
   Furube A, 2001, CHEM PHYS LETT, V336, P424, DOI 10.1016/S0009-2614(01)00128-2
   Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   Hiehata K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/8/084007
   Hikosaka K, 2008, COLLOID SURFACE B, V66, P195, DOI 10.1016/j.colsurfb.2008.06.008
   Hou YD, 2011, NAT MATER, V10, P434, DOI [10.1038/NMAT3008, 10.1038/nmat3008]
   Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   Iwata K, 2004, J PHYS CHEM B, V108, P20233, DOI 10.1021/jp047531k
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Kamat PV, 2002, PURE APPL CHEM, V74, P1693, DOI 10.1351/pac200274091693
   Kim S, 2005, J PHYS CHEM B, V109, P24260, DOI 10.1021/jp055278y
   Kim S, 2005, J PHYS CHEM B, V109, P5143, DOI 10.1021/jp045806q
   Linic S, 2011, NAT MATER, V10, P911, DOI [10.1038/NMAT3151, 10.1038/nmat3151]
   Liu Y, 2010, APPL SURF SCI, V256, P6390, DOI 10.1016/j.apsusc.2010.04.022
   Malagutti AR, 2009, APPL CATAL B-ENVIRON, V90, P205, DOI 10.1016/j.apcatb.2009.03.014
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Nam YS, 2010, NAT NANOTECHNOL, V5, P340, DOI [10.1038/nnano.2010.57, 10.1038/NNANO.2010.57]
   Nishikawa H, 2005, J MOL CATAL A-CHEM, V236, P145, DOI 10.1016/j.molcata.2005.04.013
   Nishikawa H, 2004, J MOL CATAL A-CHEM, V207, P149, DOI 10.1016/S1381-1169(03)00472-2
   Nishikawa H, 2004, MATER LETT, V58, P14, DOI 10.1016/S0167-577X(03)00396-3
   Nishikawa H, 2002, J MOL CATAL A-CHEM, V179, P193, DOI 10.1016/S1381-1169(01)00325-9
   Nishikawa H, 2003, J MOL CATAL A-CHEM, V206, P331, DOI 10.1016/S1381-1169(03)00414-X
   Nishikawa H, 2007, PHOSPHORUS RES B, V21, P97
   Paracchino A, 2011, NAT MATER, V10, P456, DOI [10.1038/NMAT3017, 10.1038/nmat3017]
   Park J, 2010, J ALLOY COMPD, V492, pL57, DOI 10.1016/j.jallcom.2009.11.172
   Reddy MP, 2007, APPL CATAL B-ENVIRON, V69, P164, DOI 10.1016/j.apcatb.2006.07.003
   Rulis P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155104
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653
   Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599
   Stroyuk AL, 2009, THEOR EXP CHEM+, V45, P209, DOI 10.1007/s11237-009-9095-4
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   Tsukada M, 2011, J MOL CATAL A-CHEM, V338, P18, DOI 10.1016/j.molcata.2011.01.017
   Vukomanovic M, 2012, COLLOID SURFACE B, V91, P144, DOI 10.1016/j.colsurfb.2011.10.049
   Vukomanovic M, 2011, CRYST GROWTH DES, V11, P3802, DOI 10.1021/cg2003436
   Vukomanovic M, 2011, COLLOID SURFACE B, V87, P226, DOI 10.1016/j.colsurfb.2011.05.023
   Vukomanovic M, 2011, COLLOID SURFACE B, V82, P404, DOI 10.1016/j.colsurfb.2010.09.011
   Vukomanovic M, 2011, COLLOID SURFACE B, V82, P414, DOI 10.1016/j.colsurfb.2010.09.012
   Wakamura M, 2003, LANGMUIR, V19, P3428, DOI 10.1021/la0208169
   Wang XC, 2009, NAT MATER, V8, P76, DOI 10.1038/NMAT2317
   Wong KKY, 2010, MEDCHEMCOMM, V1, P125, DOI 10.1039/c0md00069h
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Ye FX, 2007, J THERM SPRAY TECHN, V16, P776, DOI 10.1007/s11666-007-9126-4
   Yi ZG, 2010, NAT MATER, V9, P559, DOI [10.1038/NMAT2780, 10.1038/nmat2780]
   Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/nchem.687, 10.1038/NCHEM.687]
   Zunic V, 2011, APPL CATAL A-GEN, V397, P241, DOI 10.1016/j.apcata.2011.03.007
NR 58
TC 14
Z9 14
U1 0
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 21
BP 10571
EP 10580
DI 10.1039/c2jm00136e
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 939MV
UT WOS:000303816200027
DA 2018-10-19
ER

PT J
AU Kemal, E
   Deb, S
AF Kemal, Evren
   Deb, Sanjukta
TI Design and synthesis of three-dimensional hydrogel scaffolds for
   intervertebral disc repair
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID NUCLEUS-PULPOSUS; METHACRYLATE; REPLACEMENT; PHEMA; RAMAN
AB Intervertebral disc degeneration is a major cause of low back pain, which affects a large proportion of the population. Spinal fusion is one of the common solutions to restrict motion and stabilize, however biomechanical changes cause further problems. Although tissue engineered IVD structures and cell based therapies are being developed it is crucial that the structures are able to support spinal load. In this paper we report a biomaterial based regenerative approach with the first stage being the synthesis and characterisation of a group of hydrogels that has the potential to be further developed for cell-biomaterial based approaches. Copolymers of 2-hydroxyethylmethacrylate and a multifunctional comonomer, pyromellitic glycerol dimethacrylate p(HEMA/PMGDM) were synthesized and the effects of composition on the thermal behaviour and dynamic mechanical behaviour of these copolymeric hydrogels and the feasibility of use as biomaterials for IVD are reported. The HEMA-co-PMGDM copolymeric networks were shown to have highly controllable viscoelastic properties; the presence of a strong beta transition in the glassy region (in vivo temperature range) and the energy absorption and dissipation of the system (critical to disc function) could be easily controlled by tailoring the copolymer composition, crosslinking agent concentration and polymerisation methods, which is of great significance for the end use of these materials, as the essential function of the gelatinous nucleus is to resist, dampen and redistribute mechanical forces within the spine outwards towards the constricting annulus. To date there is no previous research incorporating PMGDM into hydrogel systems for biomedical applications.
C1 [Kemal, Evren; Deb, Sanjukta] Kings Coll London, Guys Hosp, Inst Dent, Dept Biomat, London SE1 9RT, England.
RP Kemal, E (reprint author), Kings Coll London, Guys Hosp, Inst Dent, Dept Biomat, Floor 17,Tower Wing, London SE1 9RT, England.
EM sanjukta.deb@kcl.ac.uk
FU EPSRC
FX We would like to thank Dr Paul Gabbot (Perkin Elmer) for helpful
   discussions on the DMA and the EPSRC for funding Evren Kemal.
CR Antonio Gloria, 2011, J BIOMATER APPL, V25, P795
   Boelen EJH, 2007, J BIOMED MATER RES B, V83B, P440, DOI 10.1002/jbm.b.30814
   Borges AC, 2010, COMPOS SCI TECHNOL, V70, P1847, DOI 10.1016/j.compscitech.2010.07.018
   Carl Allen, 2004, Spine J, V4, p325S, DOI 10.1016/j.spinee.2004.07.030
   Correia J. S., 2011, J TISSUE ENG REGEN M, V5, pe97
   Dehai L, 2007, ADV DRUG DELIVERY RE, V59, P1392
   Deng M., 2012, IEEE T NANOBIOSCI, V99, P1536
   Dong J, 1997, MACROMOLECULES, V30, P286, DOI 10.1021/ma9607168
   Evren Kemal, 2011, J MATER CHEM, V21, P2237
   Francisco Lopez-Suevos, 2008, DENT MATER, V24, P778
   Gabbott P., 2008, PRINCIPLES APPL THER
   Gates G, 2003, POLYMER, V44, P207, DOI 10.1016/S0032-3861(02)00725-5
   Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033
   Heijboer J., 1977, INT J POLYM MATER, P611
   Huang J., 2007, J MATER SCI-MATER M, V11, P2157
   Ji XL, 2003, J APPL POLYM SCI, V88, P3168, DOI 10.1002/app.12049
   Judith Juhasz, 2010, SCI TECHNOLOGY ADV M, V11
   Kandel R, 2008, EUR SPINE J, V17, pS480, DOI 10.1007/s00586-008-0746-2
   Laura Calderon, 2010, EUROPEAN CELLS MAT, V20, P134
   Li CQ, 2010, J MATER SCI-MATER M, V21, P741, DOI 10.1007/s10856-009-3871-5
   Mabilleau G, 2008, J RAMAN SPECTROSC, V39, P767, DOI 10.1002/jrs.1960
   Masahiro Nakajima, 2007, J BIOL CHEM, V44, P32185
   Meakin JR, 2003, J MATER SCI-MATER M, V14, P9, DOI 10.1023/A:1021589017753
   Meakin JR, 2001, CLIN BIOMECH, V16, P560, DOI 10.1016/S0268-0033(01)00042-0
   Nachemson, 1964, BONE J SURG A, V46A, P1077
   Nerurkar, 2010, J BIOMECH, V43, P1017
   Perova TS, 1997, COLLOID POLYM SCI, V275, P323, DOI 10.1007/s003960050089
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Shigeaki M, 2009, VIB SPECTROSC, V51, P28
   Tuncer Caykara, 2007, J APPL POLYM SCI, V103, P1602
   VENZ S, 1993, J DENT RES, V72, P582, DOI 10.1177/00220345930720030501
   Woods BI, 2010, OPER TECH ORTHOP, V20, P144, DOI 10.1053/j.oto.2009.10.009
   Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015
NR 33
TC 5
Z9 5
U1 3
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 21
BP 10725
EP 10735
DI 10.1039/c2jm30886j
PG 11
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 939MV
UT WOS:000303816200045
DA 2018-10-19
ER

PT J
AU Smith, EJ
   Xi, W
   Makarov, D
   Monch, I
   Harazim, S
   Quinones, VAB
   Schmidt, CK
   Mei, YF
   Sanchez, S
   Schmidt, OG
AF Smith, Elliot J.
   Xi, Wang
   Makarov, Denys
   Moench, Ingolf
   Harazim, Stefan
   Quinones, Vladimir A. Bolanos
   Schmidt, Christine K.
   Mei, Yongfeng
   Sanchez, Samuel
   Schmidt, Oliver G.
TI Lab-in-a-tube: ultracompact components for on-chip capture and detection
   of individual micro-/nanoorganisms
SO LAB ON A CHIP
LA English
DT Review
ID WHISPERING-GALLERY-MODE; EXTRACELLULAR-MATRIX; OPTICAL HYPERLENS; CARBON
   NANOTUBES; RING RESONATORS; SINGLE CELLS; ULTRASENSITIVE DETECTION;
   MAGNETOTACTIC BACTERIA; DIFFRACTION LIMIT; NERVOUS-SYSTEM
AB A review of present and future on-chip rolled-up devices, which can be used to develop lab-in-a-tube total analysis systems, is presented. Lab-in-a-tube is the integration of numerous rolled-up components into a single device constituting a microsystem of hundreds/thousands of independent units on a chip, each individually capable of sorting, detecting and analyzing singular organisms. Such a system allows for a scale-down of biosensing systems, while at the same time increasing the data collection through a large, smart array of individual biosensors. A close look at these ultracompact components which have been developed over the past decade is given. Methods for the capture of biomaterial are laid out and progress of cell culturing in three-dimensional scaffolding is detailed. Rolled-up optical sensors based on photoluminescence, optomechanics, optofluidics and metamaterials are presented. Magnetic sensors are introduced as well as electrical components including heating, energy storage and resistor devices.
C1 [Smith, Elliot J.; Xi, Wang; Makarov, Denys; Moench, Ingolf; Harazim, Stefan; Quinones, Vladimir A. Bolanos; Mei, Yongfeng; Sanchez, Samuel; Schmidt, Oliver G.] IFW Dresden, Inst Integrat Nanosci, D-01069 Dresden, Germany.
   [Schmidt, Christine K.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.
   [Schmidt, Oliver G.] Tech Univ Chemnitz, D-09107 Chemnitz, Germany.
RP Smith, EJ (reprint author), GlobalFoundries Inc, Wilschdorfer Landstr 101, D-01109 Dresden, Germany.
EM elliotjwsmith@gmail.com; schmidt@ifw-dresden.de
RI Xi, Wang/N-1887-2016; Smith, Elliot/G-4867-2011; Makarov,
   Denys/G-1025-2011; Sanchez, Samuel/B-6803-2015; Mei,
   Yongfeng/C-3632-2008
OI Xi, Wang/0000-0002-4231-6295; Makarov, Denys/0000-0002-7177-4308;
   Sanchez, Samuel/0000-0002-5845-8941; Mei, Yongfeng/0000-0002-3314-6108;
   Schmidt, Christine/0000-0002-8363-7933; Schmidt, Oliver
   G/0000-0001-9503-8367
FU Volkswagen Foundation [I/84 072]; Multidisciplinary University Research
   Initiative (MURI); U. S. Air Force Office of Scientific Research (AFOSR)
   [FA9550-09-0550]; German Science Foundation (DFG) [MO887/1-2,
   AR193/11-2]; DFG Research Unit 1713
FX This work was funded by the Volkswagen Foundation (I/84 072), by a
   Multidisciplinary University Research Initiative (MURI) sponsored by the
   U. S. Air Force Office of Scientific Research (AFOSR) (FA9550-09-0550)
   as well as by German Science Foundation (DFG) grants MO887/1-2,
   AR193/11-2 and DFG Research Unit 1713 "Sensoric Micro- and Nanosystems."
CR Ackermann DM, 2010, IEEE T NEUR SYS REH, V18, P658, DOI 10.1109/TNSRE.2010.2071882
   Andersson AS, 2003, EXP CELL RES, V288, P177, DOI 10.1016/S0014-4827(03)00159-9
   Arndt K.F., 2009, HYDROGELS BIOL PROPE
   ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156
   Azam A., 2010, BIOMED MICRODEVICES, V13, P51
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Ballhorn F., 2010, PHYS REV LETT, V104
   Barnes W. L., 2003, NATURE, V292, P77
   Baudry J, 2006, P NATL ACAD SCI USA, V103, P16076, DOI 10.1073/pnas.0607991103
   Bernardi A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2978239
   BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679
   Borja D, 2008, INVEST OPHTH VIS SCI, V49, P2541, DOI 10.1167/iovs.07-1385
   Bruyewicz D. A., 2008, LAB CHIP, V8, P663
   Bufon CCB, 2011, NANO LETT, V11, P3727, DOI 10.1021/nl201773d
   Bufon CCB, 2010, NANO LETT, V10, P2506, DOI 10.1021/nl1010367
   Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28
   Carlborg CF, 2010, LAB CHIP, V10, P281, DOI 10.1039/b914183a
   Cavallo F, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2992195
   Chabert M, 2008, P NATL ACAD SCI USA, V105, P3191, DOI 10.1073/pnas.0708321105
   Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature0383l
   Choi YH, 2004, SENSOR ACTUAT A-PHYS, V111, P8, DOI 10.1016/j.sna.2003.10.005
   Compston A, 1997, J ANAT, V190, P161, DOI 10.1046/j.1469-7580.1997.19020161.x
   Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265
   Crevillen AG, 2007, ANAL CHEM, V79, P7408, DOI 10.1021/ac071247i
   Crevillen AG, 2008, ELECTROPHORESIS, V29, P2997, DOI 10.1002/elps.200700947
   Crevillen AG, 2009, LAB CHIP, V9, P346, DOI 10.1039/b809963d
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   De Vos K, 2007, OPT EXPRESS, V15, P7610, DOI 10.1364/OE.15.007610
   Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   Di Carlo D, 2005, LAB CHIP, V5, P171, DOI 10.1039/b413139h
   Dietrich K, 2010, NANO LETT, V10, P627, DOI 10.1021/nl9036966
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Endo T, 2006, ANAL CHEM, V78, P6465, DOI 10.1021/ac0608321
   FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355
   Golod SV, 2001, SEMICOND SCI TECH, V16, P181, DOI 10.1088/0268-1242/16/3/311
   Gracias DH, 2000, SCIENCE, V289, P1170, DOI 10.1126/science.289.5482.1170
   Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009
   Harazim S., UNPUB
   Harazim SM, 2012, J MATER CHEM, V22, P2878, DOI 10.1039/c1jm14800a
   Hong J, 2009, DRUG DISCOV TODAY, V14, P134, DOI 10.1016/j.drudis.2008.10.001
   Hong YY, 2010, ADV FUNCT MATER, V20, P1568, DOI 10.1002/adfm.201000063
   Hosoda M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734878
   Huang GS, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3111813
   Huang GS, 2010, ACS NANO, V4, P3123, DOI 10.1021/nn100456r
   Huang GS, 2009, LAB CHIP, V9, P263, DOI 10.1039/b810419k
   Huang MH, 2011, NANOSCALE, V3, P96, DOI 10.1039/c0nr00648c
   Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289
   Ibele M, 2009, ANGEW CHEM INT EDIT, V48, P3308, DOI 10.1002/anie.200804704
   Ibele ME, 2007, J AM CHEM SOC, V129, P7762, DOI 10.1021/ja0726512
   Ingber DE, 2003, P NATL ACAD SCI USA, V100, P1472, DOI 10.1073/pnas.0530201100
   Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247
   Ji HX, 2010, ADV MATER, V22, P4591, DOI 10.1002/adma.201001422
   Ji HX, 2010, CHEM COMMUN, V46, P3881, DOI 10.1039/c003215h
   Khine M, 2005, LAB CHIP, V5, P38, DOI 10.1039/b408352k
   Kildishev AV, 2007, OPT LETT, V32, P3432, DOI 10.1364/OL.32.003432
   Kipp T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.077403
   Kippenberg TJ, 2010, NAT PHOTONICS, V4, P9, DOI 10.1038/nphoton.2009.246
   Kline TR, 2006, J PHYS CHEM B, V110, P24513, DOI 10.1021/jp064393l
   Kline TR, 2005, J AM CHEM SOC, V127, P17150, DOI 10.1021/ja056069u
   Klug ED, 1971, J POLYM SCI       PS, V36, P491, DOI DOI 10.1002/P0LC.5070360137
   Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714
   Lee H, 2007, OPT EXPRESS, V15, P15886, DOI 10.1364/OE.15.015886
   Lee SH, 2008, ADV MATER, V20, P788, DOI 10.1002/adma.200701475
   Lefevre F, 2012, LAB CHIP, V12, P787, DOI 10.1039/c2lc20998e
   Li F, 2009, ELECTRON LETT, V45, P645, DOI 10.1049/el.2009.1076
   Li F, 2009, OPT EXPRESS, V17, P19933, DOI 10.1364/OE.17.019933
   Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368
   Llopis X, 2009, LAB CHIP, V9, P213, DOI 10.1039/b816643a
   Ma CB, 2010, CHINESE SCI BULL, V55, P2618, DOI 10.1007/s11434-010-4014-6
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I
   Mazzei A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.173603
   Mei Y. F., 2008, VOLKSWAGEN PROJECT P
   Mei YF, 2008, ADV MATER, V20, P4085, DOI 10.1002/adma.200801589
   Mendach S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2186509
   Mendach S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3058764
   Millerot-Serrurot E, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-26
   Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008
   Monch I, 2007, J PHYS CONF SER, V61, P820, DOI 10.1088/1742-6596/61/1/164
   Monch I, 2011, ACS NANO, V5, P7436, DOI 10.1021/nn202351j
   Monch I, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/8/085016
   Molly M. S., 2005, SCIENCE, V310, P1135
   Monch I, 2005, J MAGN MAGN MATER, V290, P276, DOI 10.1016/j.jmmm.2004.11.208
   MONCH I, 2006, NANOTECHNOLOGIES LIF, V6, P259
   Muller C, 2011, J APPL PHYS, V110, DOI 10.1063/1.3625256
   Muller C, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095831
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Navarro X, 2005, J PERIPHER NERV SYST, V10, P229, DOI 10.1111/j.1085-9489.2005.10303.x
   Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Paxton WF, 2006, J AM CHEM SOC, V128, P14881, DOI 10.1021/ja0643164
   Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003
   Prinz VY, 2000, PHYSICA E, V6, P828, DOI 10.1016/S1386-9477(99)00249-0
   Pumera M, 2008, ELECTROPHORESIS, V29, P269, DOI 10.1002/elps.200700394
   Pumera M, 2011, CHEM COMMUN, V47, P5671, DOI 10.1039/c1cc11060h
   PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903
   Quinones VAB, 2009, OPT LETT, V34, P2345, DOI 10.1364/OL.34.002345
   Ramachandran A, 2008, BIOSENS BIOELECTRON, V23, P939, DOI 10.1016/j.bios.2007.09.007
   Randall CL, 2011, LAB CHIP, V11, P127, DOI [10.1039/c0lc00368a, 10.1039/c01c00368a]
   Rasband MN, 2010, NEUROSCI LETT, V486, P101, DOI 10.1016/j.neulet.2010.08.081
   Rho J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1148
   Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265
   ROGERS JA, 2011, NATURE, V447, P45
   Rytov S. M., 1955, SOV PHYS JETP, V29, P605
   Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103
   Sanchez S., 2011, J AM CHEM SOC, V36, P3840
   Sanchez S, 2010, J AM CHEM SOC, V132, P13144, DOI 10.1021/ja104362r
   Schiefer MA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026006
   Schmidt OG, 2001, ADV MATER, V13, P756, DOI 10.1002/1521-4095(200105)13:10<756::AID-ADMA756>3.0.CO;2-F
   Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525
   Scholten K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3645629
   Schulze S, 2010, ADV ENG MATER, V12, pB558, DOI 10.1002/adem.201080023
   Schwaiger S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155325
   Schwaiger S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.163903
   Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847
   Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743
   Smith EJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3211115
   Smith E. J., 2010, APPL PHYS LETT, V96
   Smith EJ, 2011, SOFT MATTER, V7, P11309, DOI 10.1039/c1sm06416a
   Smith EJ, 2011, NANO LETT, V11, P4037, DOI 10.1021/nl1036148
   Smith EJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.097204
   Smith EJ, 2011, PROC SPIE, V8031, DOI 10.1117/12.885246
   Smith EJ, 2010, NANO LETT, V10, P1, DOI [10.1021/n1900550J, 10.1021/nl900550j]
   Solovev A. A., 2011, ANGEW CHEM, V123, P11067
   Solovev AA, 2011, ANGEW CHEM INT EDIT, V50, P10875, DOI 10.1002/anie.201102096
   Solovev AA, 2011, PHYS CHEM CHEM PHYS, V13, P10131, DOI 10.1039/c1cp20542k
   Songmuang R, 2007, MICROELECTRON ENG, V84, P1427, DOI 10.1016/j.mee.2007.01.089
   Sorensen H., 1999, CHROMATOGRAPHY CAPIL, P181
   Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020
   Stockman M. I., 2011, PHYS TODAY, P39
   Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021
   Subramanian S, 2007, J PHYS CHEM C, V111, P11959, DOI 10.1021/jp072095y
   Sun T, 2007, BIOTECHNOL BIOENG, V97, P1318, DOI 10.1002/bit.21309
   Takashima A, 2010, ANAL CHEM, V82, P6870, DOI 10.1021/ac1009657
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786
   Thurmer DJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2396911
   Thurmer DJ, 2010, NANO LETT, V10, P3704, DOI 10.1021/nl1022145
   Tian ZB, 2011, OPT EXPRESS, V19, P12164, DOI 10.1364/OE.19.012164
   Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h
   Urena EB, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/055001
   VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699
   Vicknesh S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086333
   Vollmer F, 2008, P NATL ACAD SCI USA, V105, P20701, DOI 10.1073/pnas.0808988106
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wood B, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.115116
   Xi W., UNPUB
   Yu MR, 2011, ACS NANO, V5, P2447, DOI 10.1021/nn103618d
   Zakharchenko S, 2011, BIOMACROMOLECULES, V12, P2211, DOI 10.1021/bm2002945
   Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052
   Zhang XW, 2011, OPT EXPRESS, V19, P22242, DOI 10.1364/OE.19.022242
   Zhu HY, 2007, OPT EXPRESS, V15, P9139, DOI 10.1364/OE.15.009139
   Zhu JG, 2010, NAT PHOTONICS, V4, P46, DOI 10.1038/NPHOTON.2009.237
   Zhu YB, 2006, BIOMATERIALS, V27, P68, DOI 10.1016/j.biomaterials.2005.05.069
NR 159
TC 62
Z9 62
U1 3
U2 132
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2012
VL 12
IS 11
BP 1917
EP 1931
DI 10.1039/c2lc21175k
PG 15
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 945BN
UT WOS:000304247900002
PM 22437345
DA 2018-10-19
ER

PT J
AU Schultz, KM
   Furst, EM
AF Schultz, Kelly M.
   Furst, Eric M.
TI Microrheology of biomaterial hydrogelators
SO SOFT MATTER
LA English
DT Article
ID PARTICLE TRACKING MICRORHEOLOGY; ACTIN-FILAMENT NETWORKS; MOLECULAR-SIZE
   DISTRIBUTION; GROWTH-FACTOR DELIVERY; I COLLAGEN GELS; COMPLEX FLUIDS;
   EXTRACELLULAR MATRICES; 3-DIMENSIONAL POLYMERS; MICROFLUIDIC DEVICE;
   SOFT MATERIALS
AB Microrheology uses the motion of dispersed colloidal probe particles to measure the viscosity or viscoelastic moduli of soft materials. The distinct advantages of microrheology include small sample volume requirements, access to a large range of time scales for the dynamic response and short acquisition times. These advantages make microrheology important for studies of biomaterial hydrogelators. Recent advances have enabled the precise characterization of hydrogelator sol-gel transitions, measurements of rare and scarce materials and high-throughput screening of hydrogel rheology over a large composition space. In this review, we focus on multiple particle tracking microrheology, including the considerations that define its operating regimes and its recent applications. Those interested in biomaterial rheology will find these methods as accessible as bulk rheological measurements and straightforward to implement in their own work.
C1 [Furst, Eric M.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA.
   Univ Delaware, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA.
RP Furst, EM (reprint author), Univ Delaware, Dept Chem & Biomol Engn, 150 Acad St, Newark, DE 19716 USA.
EM furst@udel.edu
FU National Institutes of Health [2-P20-RR017716]; NSF; Procter and Gamble
   company
FX E.M.F. acknowledges financial support for biomaterial microrheology in
   his laboratory by the National Institutes of Health (Grant No.
   2-P20-RR017716). K.M.S. gratefully acknowledges financial support by the
   NSF Graduate Research Fellowship Program and the Procter and Gamble
   company.
CR Amin MS, 2007, OPT EXPRESS, V15, P17001, DOI 10.1364/OE.15.017001
   Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6
   Boehm H, 2009, SOFT MATTER, V5, P4331, DOI 10.1039/b905574f
   Breedveld V, 2003, J MATER SCI, V38, P4461, DOI 10.1023/A:1027321232318
   Cardinaux F., 2007, FOOD COLLOIDS SELF A
   Chae BS, 2005, LANGMUIR, V21, P3084, DOI 10.1021/la0480890
   Chen DTN, 2010, MACROMOLECULES, V43, P2048, DOI 10.1021/ma902230a
   Chen DT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108301
   Chung K, 2009, ANAL CHEM, V81, P991, DOI 10.1021/ac802031j
   Corrigan AM, 2009, EUR PHYS J E, V28, P457, DOI 10.1140/epje/i2008-10439-7
   Corrigan AM, 2009, LANGMUIR, V25, P8599, DOI 10.1021/la804208q
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Cucheval ASB, 2009, LANGMUIR, V25, P11827, DOI 10.1021/la901424w
   Cygan ZT, 2005, LANGMUIR, V21, P3629, DOI 10.1021/la0471137
   Dhar P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016001
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ewoldt RH, 2007, SOFT MATTER, V3, P634, DOI 10.1039/b615546d
   Fairbanks B. D., 2009, ADV MATER, V10, P3114
   Fairbanks BD, 2010, MACROMOLECULES, V43, P4113, DOI 10.1021/ma1002968
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Flory PJ, 1942, J PHYS CHEM-US, V46, P132, DOI 10.1021/j150415a016
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Freundlich H., 1922, Z PHYS CHEM, V104, P232
   Gao Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.078301
   Gardel MI, 2005, MICROSCALE DIAGNOSTI
   Garstecki P, 2006, LAB CHIP, V6, P437, DOI 10.1039/b510841a
   Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286
   Goodman A, 2002, J MOL BIOL, V323, P199, DOI 10.1013/S0022-2836(02)00893-8
   Hasnain IA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031901
   Heilbronn A., 1922, JB WISS BOT, V61, P284
   Heinemann C, 2004, CARBOHYD POLYM, V55, P155, DOI 10.1016/j.carbpol.2003.09.003
   Huh JY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031802
   Jo YS, 2009, SOFT MATTER, V5, P440, DOI 10.1039/b814584a
   Karg M, 2009, CURR OPIN COLLOID IN, V14, P438, DOI 10.1016/j.cocis.2009.08.002
   Kiick KL, 2008, SOFT MATTER, V4, P29, DOI 10.1039/b711319f
   Kloxin CJ, 2010, MACROMOLECULES, V43, P2084, DOI 10.1021/ma902571h
   Kozina A, 2012, SOFT MATTER, V8, P1033, DOI 10.1039/c1sm06285a
   Krayer J, 2006, SENSOR ACTUAT B-CHEM, V118, P20, DOI 10.1016/j.snb.2006.04.080
   Larsen T, 2008, KOREA-AUST RHEOL J, V20, P165
   Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001
   Larsen TH, 2009, MACROMOLECULES, V42, P8443, DOI 10.1021/ma901423n
   Latinovic O, 2010, J BIOMECH, V43, P500, DOI 10.1016/j.jbiomech.2009.09.041
   Le Goff L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018101
   Lee MH, 2010, LANGMUIR, V26, P2650, DOI 10.1021/la902881f
   Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mann B. K., 2001, BIOMATERIALS, V22, P2045
   Mason TG, 2000, J RHEOL, V44, P917, DOI 10.1122/1.551113
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250
   McGrath JL, 2000, BIOPHYS J, V79, P3258, DOI 10.1016/S0006-3495(00)76558-1
   Moccia M, 2009, J PEPT SCI, V15, P647, DOI 10.1002/psc.1162
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   Nordstrom KN, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021403
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Palmer A, 1998, RHEOL ACTA, V37, P97, DOI 10.1007/s003970050095
   Parekh A, 2007, ANN BIOMED ENG, V35, P1231, DOI 10.1007/s10439-007-9273-2
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536
   Raeber GP, 2007, ACTA BIOMATER, V3, P615, DOI 10.1016/j.actbio.2007.03.013
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Romer S, 2000, PHYS REV LETT, V85, P4980, DOI 10.1103/PhysRevLett.85.4980
   Rubinstein M., 2003, POLYM PHYS
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Salinas CN, 2009, J DENT RES, V88, P681, DOI 10.1177/0022034509341553
   Sato J, 2006, J RHEOL, V50, P1, DOI 10.1122/1.2135329
   Savin T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041106
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Savin T., 2008, APPL PHYS LETT, V93
   Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f
   Savin T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021501
   Schultz K. M., 2012, UNPUB
   Schultz KM, 2011, BIOMACROMOLECULES, V12, P4178, DOI 10.1021/bm201214r
   Schultz KM, 2011, LAB CHIP, V11, P3802, DOI 10.1039/c1lc20376b
   Schultz KM, 2009, MACROMOLECULES, V42, P5310, DOI 10.1021/ma900766u
   Schultz KM, 2009, SOFT MATTER, V5, P740, DOI 10.1039/b818178k
   Seal BL, 2006, MACROMOLECULES, V39, P2268, DOI 10.1021/ma0524528
   Seifriz W, 1924, BR J EXP BIOL, V1, P431
   Serra L, 2006, BIOMATERIALS, V27, P5440, DOI 10.1016/j.biomaterials.2006.06.011
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Slopek RP, 2006, POLYMER, V47, P2263, DOI 10.1016/j.polymer.2006.01.095
   Spero RC, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2976156
   Squires TM, 2010, ANNU REV FLUID MECH, V42, P413, DOI 10.1146/annurev-fluid-121108-145608
   Sriram I, 2012, SOFT MATTER, V8, P3335, DOI 10.1039/c2sm06784f
   Sriram I, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3450319
   STAUFFER D, 1982, ADV POLYM SCI, V44, P103
   Stockmayer WH, 1943, J CHEM PHYS, V11, P45, DOI 10.1063/1.1723803
   Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163
   Tibbitt MW, 2010, SOFT MATTER, V6, P5100, DOI 10.1039/c0sm00174k
   Topp S, 2006, J AM CHEM SOC, V128, P13994, DOI 10.1021/ja064546i
   Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200
   Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3
   Tu RS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041914
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   Velegol D, 2001, BIOPHYS J, V81, P1786, DOI 10.1016/S0006-3495(01)75829-8
   Vincent RR, 2009, CARBOHYD RES, V344, P1863, DOI 10.1016/j.carres.2008.11.021
   Weihs D, 2006, BIOPHYS J, V91, P4296, DOI 10.1529/biophysj.106.081109
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591
   Williams MAK, 2008, J NON-NEWTON FLUID, V149, P63, DOI 10.1016/j.jnnfm.2007.05.006
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
   Zheng Z., 2009, NATURE, V459, P230
NR 112
TC 39
Z9 39
U1 3
U2 71
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 23
BP 6198
EP 6205
DI 10.1039/c2sm25187f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 945XG
UT WOS:000304309300001
DA 2018-10-19
ER

PT J
AU Lefevre, T
   Pezolet, M
AF Lefevre, Thierry
   Pezolet, Michel
TI Unexpected beta-sheets and molecular orientation in flagelliform spider
   silk as revealed by Raman spectromicroscopy
SO SOFT MATTER
LA English
DT Article
ID ORB-WEBS; SEQUENCE; MICROSPECTROSCOPY; CONFORMATION; BIOMATERIAL;
   PROTEINS
AB Structural data relative to spider silk fibers such as the flagelliform (Flag) silk are fundamental to understand the origin of their outstanding mechanical properties. However, due to its small diameter and limited availability, experimental data relative to the structure of the Flag silk are almost nonexistent. Raman spectromicroscopy is one of the rare techniques that can provide structural information about this type of silk. We have thus used this technique to characterize Flag silk fibers spun by three orb-weaving spiders in their native state. The polarized spectra reveal that Flag fibers spun by Araneus diadematus and Argiope aurantia spiders unexpectedly contain beta-sheets and exhibit a certain level of molecular orientation. In contrast, the Flag silk from Nephila clavipes possesses very few beta-sheets and a low molecular orientation, the proteins being essentially disordered. These observations account for the higher strength and lower extensibility of Araneus diadematus and Argiope aurantia Flag fibers compared with Nephila clavipes. The analysis of the primary structure strongly suggests that the "spacer" motifs of the Flag silk are more prominent and have a higher beta-sheet propensity for spider species that spin fibers containing beta-sheets. These results nicely support the Raman data and provide the first hypothesis regarding the role played by these spacers in the structure of Flag silk. The structural data obtained provide a molecular basis for the tensile properties of these fibers showing that overall, considering the different types of spider silk, the beta-sheet appears to be a universal structural element used by nature to provide strength to fibers that exhibit dissimilar tensile properties.
C1 [Lefevre, Thierry; Pezolet, Michel] Univ Laval, Ctr Rech Mat Avances CERMA, Dept Chim, Quebec City, PQ G1V 0A6, Canada.
RP Lefevre, T (reprint author), Univ Laval, Ctr Rech Mat Avances CERMA, Dept Chim, Pavillon Alexandre Vachon, Quebec City, PQ G1V 0A6, Canada.
EM thierry.lefevre@chm.ulaval.ca
RI Lefevre, Thierry/B-6843-2011
OI Lefevre, Thierry/0000-0003-2696-250X
FU Canadian Foundation for Innovation; Natural Sciences and Engineering
   Research Council of Canada; Fonds Quebecois de Recherche sur la Nature
   et les Technologies
FX Funding for the Raman spectrometer was obtained through a grant from the
   Canadian Foundation for Innovation. This work was also supported by the
   Natural Sciences and Engineering Research Council of Canada and by the
   Fonds Quebecois de Recherche sur la Nature et les Technologies. The
   authors express their gratitude to Jean-Francois Rioux-Dube for his
   valuable technical support.
CR BERNE BJ, 1968, J CHEM PHYS, V49, P3125, DOI 10.1063/1.1670559
   BOWER DI, 1981, J POLYM SCI POL PHYS, V19, P93, DOI 10.1002/pol.1981.180190108
   Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
   DENNY M, 1976, J EXP BIOL, V65, P483
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Lefevre T., 2008, MOL CHARACTERIZATION, V53, P295
   Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517
   Lefevre T, 2006, APPL SPECTROSC, V60, P841, DOI 10.1366/000370206778062039
   Lefevre T, 2011, J MOL BIOL, V405, P238, DOI 10.1016/j.jmb.2010.10.052
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Ohgo K, 2006, BIOMACROMOLECULES, V7, P1210, DOI 10.1021/bm0600522
   Rousseau ME, 2009, BIOMACROMOLECULES, V10, P2945, DOI 10.1021/bm9007919
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
NR 21
TC 13
Z9 13
U1 2
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 23
BP 6350
EP 6357
DI 10.1039/c2sm25351h
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 945XG
UT WOS:000304309300019
DA 2018-10-19
ER

PT J
AU Koria, P
AF Koria, Piyush
TI Delivery of Growth Factors for Tissue Regeneration and Wound Healing
SO BIODRUGS
LA English
DT Review
ID BONE MORPHOGENETIC PROTEIN-2; SPINAL-CORD-INJURY; BETA-TRICALCIUM
   PHOSPHATE; DIABETIC FOOT ULCERS; FACTOR-LOADED NANOPARTICLES; LOCAL
   CONTROLLED-RELEASE; CLINICAL-TRIAL; DRUG-DELIVERY; COLLAGEN SCAFFOLDS;
   GELATIN HYDROGEL
AB Growth factors are soluble secreted proteins capable of affecting a variety of cellular processes important for tissue regeneration. Consequently, the self-healing capacity of patients can be augmented by artificially enhancing one or more processes important for healing through the application of growth factors. However, their application in clinics remains limited due to lack of robust delivery systems and biomaterial carriers. Interestingly, all clinically approved therapies involving growth factors utilize some sort of a biomaterial carrier for growth factor delivery. This suggests that biomaterial delivery systems are extremely important for successful usage of growth factors in regenerative medicine. This review outlines the role of growth factors in tissue regeneration, and their application in both pre-clinical animal models of regeneration and clinical trials is discussed. Additionally, current status of biomaterial substrates and sophisticated delivery systems such as nanoparticles for delivery of exogenous growth factors and peptides in humans are reviewed. Finally, issues and possible future research directions for growth factor therapy in regenerative medicine are discussed.
C1 Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
RP Koria, P (reprint author), Univ S Florida, Dept Chem & Biomed Engn, 4202 E Fowler Ave,ENB 118, Tampa, FL 33620 USA.
EM pkoria@usf.edu
FU University of South Florida
FX The author acknowledges funding from University of South Florida (New
   Faculty Start Up). The author has no conflicts of interest directly
   relevant to the content of this review.
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Andreadis ST, 2006, TRENDS BIOTECHNOL, V24, P331, DOI 10.1016/j.tibtech.2006.05.001
   Asamura S, 2010, ANN PLAS SURG, V64, P496, DOI 10.1097/SAP.0b013e31819b6c52
   Baiguera S, 2011, EXPERT REV RESP MED, V5, P487, DOI [10.1586/ers.11.42, 10.1586/ERS.11.42]
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P111, DOI 10.1163/092050610X545049
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Bing M, 2007, WOUND REPAIR REGEN, V15, P795, DOI 10.1111/j.1524-475X.2007.00307.x
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Bukovcan P, 2010, Acta Chir Plast, V52, P7
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chen FM, 2009, ACTA PHARMACOL SIN, V30, P485, DOI 10.1038/aps.2009.15
   Chu YJ, 2010, WOUND REPAIR REGEN, V18, P499, DOI 10.1111/j.1524-475X.2010.00612.x
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   d'Angelo I, MOL PHARM
   Davidson JM, 2008, J INVEST DERMATOL, V128, P1360, DOI 10.1038/jid.2008.128
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899
   Fernandez-Montequin Jose I, 2007, Int Wound J, V4, P333
   Fernandez-Montequin JI, 2009, INT WOUND J, V6, P432, DOI 10.1111/j.1742-481X.2009.00641.x
   Fernandez-Montequin JI, 2009, INT WOUND J, V6, P67, DOI 10.1111/j.1742-481X.2008.00561.x
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Fukumitsu K, 2011, TRANSPL P, V43, P2137, DOI 10.1016/j.transproceed.2011.05.014
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461
   Grefte S, 2010, REGEN MED, V5, P737, DOI 10.2217/RME.10.69
   Hammond JS, 2011, J HEPATOL, V54, P279, DOI 10.1016/j.jhep.2010.06.040
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hanft J R, 2008, J Wound Care, V17, P30
   Hanft JR, 2008, J WOUND CARE, V17, P4
   Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760
   Hayashi K, 2007, DENT MATER J, V26, P170, DOI 10.4012/dmj.26.170
   Heddleston JM, 2011, CURR PHARM DESIGN, V17, P2386
   Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Ishihara Masayuki, 2006, Current Drug Delivery, V3, P351, DOI 10.2174/156720106778559047
   Ishimatsu H, 2009, J ENDODONT, V35, P858, DOI 10.1016/j.joen.2009.03.049
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jansen RG, 2009, J ORAL PATHOL MED, V38, P630, DOI 10.1111/j.1600-0714.2009.00763.x
   Jayakumar A, 2011, J CLIN PERIODONTOL, V38, P163, DOI 10.1111/j.1600-051X.2010.01639.x
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Kang Derwent Jennifer J, 2008, Trans Am Ophthalmol Soc, V106, P206
   Kang Derwent JJ, 2008, J BIOMAT SCI-POLYM E, V106, P13
   Kawaguchi H, 2007, J ORTHOP RES, V25, P480, DOI 10.1002/jor.20315
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Kishimoto Y, 2010, LARYNGOSCOPE, V120, P108, DOI 10.1002/lary.20642
   Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616
   Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611
   Kobsa S, 2008, PEDIATR RES, V63, P513, DOI 10.1203/PDR.0b013e318165f14d
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P1301, DOI 10.1111/j.1600-0501.2010.01949.x
   Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698
   Landsman A, 2010, J AM PODIAT MED ASSN, V100, P155, DOI 10.7547/1000155
   Langer R, 1998, NATURE, V392, P5
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Lee J, 2011, ACTA BIOMATER, V7, P244, DOI 10.1016/j.actbio.2010.08.017
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Lim SM, 2010, J MATER SCI-MATER M, V21, P2593, DOI 10.1007/s10856-010-4118-1
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   Liu JJ, 2011, J BIOMED MATER RES A, V96A, P13, DOI 10.1002/jbm.a.32946
   Luca L, 2011, J BIOMED MATER RES A, V96A, P66, DOI 10.1002/jbm.a.32957
   Luo ZL, 2008, MACROMOL BIOSCI, V8, P785, DOI 10.1002/mabi.200800003
   Mabilleau G, 2008, BIOMATERIALS, V29, P1593, DOI 10.1016/j.biomaterials.2007.12.01
   Macri L, 2009, SKIN PHARMACOL PHYS, V22, P83, DOI 10.1159/000178867
   Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571
   Maire M, 2005, BIOMATERIALS, V26, P5085, DOI 10.1016/j.biomaterials.2005.01.020
   Margonar R, 2010, J CRANIOFAC SURG, V21, P1894, DOI 10.1097/SCS.0b013e3181f4af65
   McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965
   MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246
   MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048
   Morishita R, 2011, ARTERIOSCL THROM VAS, V31, P713, DOI 10.1161/ATVBAHA.110.219550
   Moshfeghi AA, 2005, ADV DRUG DELIVER REV, V57, P2047, DOI 10.1016/j.addr.2005.09.006
   Mulder G, 2009, WOUND REPAIR REGEN, V17, P772, DOI 10.1111/j.1524-475X.2009.00541.x
   Na K, 2006, BIOMATERIALS, V27, P5951, DOI 10.1016/j.biomaterials.2006.08.012
   Nakahara T, 2011, ODONTOLOGY, V99, P105, DOI 10.1007/s10266-011-0037-y
   Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517
   Obara K, 2005, WOUND REPAIR REGEN, V13, P390, DOI 10.1111/j.1067-1927.2005.130406.x
   Park JS, 2008, BIOMACROMOLECULES, V9, P2162, DOI 10.1021/bm800251x
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Park KH, 2009, J MICROBIOL BIOTECHN, V19, P1490, DOI 10.4014/jmb.0903.03002
   Park KH, 2009, BIOTECHNOL LETT, V31, P337, DOI 10.1007/s10529-008-9871-6
   Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Peres Juliana Alves, 2011, Braz. Dent. J., V22, P443, DOI 10.1590/S0103-64402011000600001
   Pulavendran S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-15
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052
   Ray Prabir, 2005, Proc Am Thorac Soc, V2, P221, DOI 10.1513/pats.200502-012AC
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   Saiga K, 2010, BIOCHEM BIOPH RES CO, V402, P329, DOI 10.1016/j.bbrc.2010.10.026
   Sarkar A, 2011, WOUND REPAIR REGEN, V19, P71, DOI 10.1111/j.1524-475X.2010.00646.x
   Schultz CL, 2010, CLIN EXP OPTOM, V93, P61, DOI 10.1111/j.1444-0938.2010.00459.x
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Shi CY, 2011, BIOMATERIALS, V32, P753, DOI 10.1016/j.biomaterials.2010.09.038
   Silva GA, 2007, TISSUE ENG, V13, P1259, DOI 10.1089/ten.2006.0194
   Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407
   Skaat H, 2011, BIOCONJUGATE CHEM, V22, P2600, DOI 10.1021/bc200454k
   Srouji S, 2005, J CRANIO MAXILL SURG, V33, P79, DOI 10.1016/j.jcms.2004.09.003
   Srouji S, 2011, TISSUE ENG PT A, V17, P269, DOI [10.1089/ten.tea.2010.0250, 10.1089/ten.TEA.2010.0250]
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088
   Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.tea.2010.0070, 10.1089/ten.TEA.2010.0070]
   Tang DW, 2010, BIOMATERIALS, V31, P9320, DOI 10.1016/j.biomaterials.2010.08.058
   Tatekawa Y, 2010, PEDIATR SURG INT, V26, P575, DOI 10.1007/s00383-010-2609-2
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Theiss HD, 2010, INT J CARDIOL, V145, P282, DOI 10.1016/j.ijcard.2009.09.555
   TOMPKINS RG, 1992, WORLD J SURG, V16, P47, DOI 10.1007/BF02067114
   Vonau RL, 2001, CLIN ORTHOP RELAT R, P243
   Wang GL, 2010, J DRUG TARGET, V18, P611, DOI 10.3109/10611861003622560
   Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0
   Wezel F, 2011, BJU INT, V108, P1046, DOI 10.1111/j.1464-410X.2011.10206.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Wu JC, 2008, J NEUROSURG-SPINE, V8, P208, DOI 10.3171/SPI/2008/8/3/208
   Wu JC, 2011, J NEUROSURG-SPINE, V15, P216, DOI 10.3171/2011.4.SPINE10404
   Xu XH, 2011, CNS DRUGS, V25, P555, DOI 10.2165/11587830-000000000-00000
   Yang P, 2010, J BIOMED MATER RES A, V92A, P626, DOI 10.1002/jbm.a.32403
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Ye L, 2011, BIOMATERIALS, V32, P2424, DOI 10.1016/j.biomaterials.2010.12.008
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Zavan B, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3566-3
   Zhang HZ, 2008, CURR NEUROVASC RES, V5, P112, DOI 10.2174/156720208784310204
   Zhang J, 2009, NANOSCALE RES LETT, V4, P1297, DOI 10.1007/s11671-009-9395-6
   Zhang LP, 2009, WOUND REPAIR REGEN, V17, P685, DOI 10.1111/j.1524-475X.2009.00526.x
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhao XJ, 2007, MACROMOL BIOSCI, V7, P13, DOI 10.1002/mabi.200600230
   Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042
NR 144
TC 35
Z9 37
U1 0
U2 76
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1173-8804
EI 1179-190X
J9 BIODRUGS
JI Biodrugs
PY 2012
VL 26
IS 3
BP 163
EP 175
DI 10.2165/11631850-000000000-00000
PG 13
WC Oncology; Immunology; Pharmacology & Pharmacy
SC Oncology; Immunology; Pharmacology & Pharmacy
GA 946FR
UT WOS:000304337400003
PM 22500904
DA 2018-10-19
ER

PT J
AU Palanisamy, PN
   Agalya, A
   Sivakumar, P
AF Palanisamy, P. N.
   Agalya, A.
   Sivakumar, P.
TI Polymer Composite-A Potential Biomaterial for the Removal of Reactive
   Dye
SO E-JOURNAL OF CHEMISTRY
LA English
DT Article
DE Euphorbia Tirucalli L saw dust; polymer composites; Reactive Red;
   isotherm studies; activation energy; isosteric heat of adsorption
ID AQUEOUS-SOLUTION; ACTIVATED CARBONS; ADSORPTION-KINETICS; WASTE-WATER;
   FLY-ASH; EQUILIBRIUM; ADSORBENTS; PERLITE; BLUE; RED
AB Poly Pyrrle saw dust composite was prepared by reinforcement of natural wood saw dust (obtained from Euphorbia Tirucalli L wood) and Poly Pyrrole matrix phase. The present study investigates the adsorption behaviour of Poly Pyrrole Saw dust Composite towards reactive dye. The batch adsorption studies were carried out by varying solution pH, initial dye concentration, contact time and temperature. The kinetic study showed that adsorption of Reactive Red by PPC was best represented by pseudo-second order kinetics with ion exchange adsorption. The equilibrium data were analyzed by Freundlich and Langmuir isotherm model. The equilibrium isotherm data were fitted well with Langmuir isotherm model. The maximum monolayer adsorption capacities calculated by Langmuir model were 204.08 mg/g for Reactive Red at 303 K. The thermodynamic parameters suggest the spontaneous, endothermic nature of ion exchange adsorption with weak Vader walls force of attraction. Activation energy for the adsorption of Reactive by Poly Pyrrole Composite was 11.6387 kJ/mole, Isosteric Heat of adsorption was 48.5454 kJ/mole also supported the ion exchange adsorption process in which forces of attraction between dye molecules and PPC is weak.
C1 [Palanisamy, P. N.] Kongu Engn Coll, Dept Chem, Erode 638052, Tamil Nadu, India.
   [Agalya, A.] Al Ameen Engn Coll, Dept Chem, Erode 638104, Tamil Nadu, India.
   [Sivakumar, P.] Arignar Anna Govt Arts Coll, Dept Chem, Namakkal 637002, TN, India.
RP Palanisamy, PN (reprint author), Kongu Engn Coll, Dept Chem, Erode 638052, Tamil Nadu, India.
EM agalarun@rediffmail.com
FU UGC, New Delhi
FX The first and third authors thank UGC, New Delhi for providing financial
   assistance under major research project scheme to carryout this research
   work.
CR Abdelwahab O, 2008, DESALINATION, V222, P357, DOI 10.1016/j.desal.2007.01.146
   Alkan M, 2003, FRESEN ENVIRON BULL, V12, P418
   Anirudhan TS, 2008, J CHEM THERMODYN, V40, P702, DOI 10.1016/j.jct.2007.10.005
   Ansari R., 2005, J ELECTROCHEM, V41, P950
   Chen SH, 2010, DESALINATION, V252, P149, DOI 10.1016/j.desal.2009.10.010
   Chiou MS, 2002, J HAZARD MATER, V93, P233, DOI 10.1016/S0304-3894(02)00030-4
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Dogan M, 2003, J COLLOID INTERF SCI, V267, P32, DOI 10.1016/S0021-9797(03)00579-4
   Eren Z, 2006, DESALINATION, V194, P1, DOI 10.1016/j.desal.2005.10.022
   Faust Samuel D., 1987, ADSORPTION PROCESSES
   Freundlich H. M., 1906, J PHYS CHEM, V57, P384
   Hameed BH, 2009, J HAZARD MATER, V162, P344, DOI 10.1016/j.jhazmat.2008.05.045
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Hsieh CT, 2000, J COLLOID INTERF SCI, V230, P171, DOI 10.1006/jcis.2000.7052
   ILHAN U, 2006, DYES PIGMENTS, V70, P76
   Kelleher BP, 2002, J CHEM TECHNOL BIOT, V77, P1212, DOI 10.1002/jctb.689
   Krishna D.G., 2002, APPL CLAY SCI, V20, P295
   Lagergren S., 1898, VETERNSKAPSAKAD HAND, V24, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li Q, 2009, J HAZARD MATER, V165, P1170, DOI 10.1016/j.jhazmat.2008.10.110
   Mahmoodi NM, 2010, DESALINATION, V264, P134, DOI 10.1016/j.desal.2010.07.017
   Mittal A, 2007, J HAZARD MATER, V148, P229, DOI 10.1016/j.jhazmat.2007.02.028
   Nollet H, 2003, CHEMOSPHERE, V53, P655, DOI 10.1016/S0045-6535(03)00517-4
   Ozcan A, 2006, COLLOID SURFACE A, V277, P90, DOI 10.1016/j.colsurfa.2005.11.017
   Renganathan S, 2009, CLEAN-SOIL AIR WATER, V37, P901, DOI 10.1002/clen.200900133
   Senthil kumar S, 2006, BIORESOURCE TECHNOL, V97, P1618
   Tunc O, 2009, J HAZARD MATER, V163, P187, DOI 10.1016/j.jhazmat.2008.06.078
   Vermeuln T, 1996, IND ENG CHEM FUND, V5, P221
   Vimonses V, 2009, APPL CLAY SCI, V43, P465, DOI 10.1016/j.clay.2008.11.008
   Wallac GG, 2003, HAND BOOK CONDUCTIVE
   Wang LX, 2001, REACT FUNCT POLYM, V47, P125, DOI 10.1016/S1381-5148(00)00079-1
   Wang SB, 2005, J COLLOID INTERF SCI, V284, P440, DOI 10.1016/j.jcis.2004.10.050
NR 32
TC 15
Z9 15
U1 0
U2 4
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 0973-4945
J9 E-J CHEM
JI E-J. Chem.
PY 2012
VL 9
IS 4
BP 1823
EP 1834
DI 10.1155/2012/518581
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 939AU
UT WOS:000303776600020
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Obiro, WC
   Ray, SS
   Emmambux, MN
AF Obiro, Wokadala Cuthbert
   Ray, Suprakas Sinha
   Emmambux, Mohammad Naushad
TI V-amylose Structural Characteristics, Methods of Preparation,
   Significance, and Potential Applications
SO FOOD REVIEWS INTERNATIONAL
LA English
DT Review
DE Nanoencapsulation; Starch digestibility; Starch nanoparticles; Starch
   rheology; Starch spherulites; V-amylose complexes
ID X-RAY-DIFFRACTION; VINE-TWINING POLYMERIZATION; LIPID COMPLEX-FORMATION;
   FATTY-ACID COMPLEXES; CONCENTRATION STARCH SYSTEMS; JET COOKED MIXTURES;
   FOOD MODEL SYSTEMS; SOLID-STATE NMR; INCLUSION COMPLEXES; MAIZE STARCH
AB The amylose component of starch can form complexes known as V-amylose with amphiphilic or hydrophobic ligands. The V-amylose complexes are single, left-handed helices that are arranged as crystalline and amorphous lamellae, which may form distinct nano- or micron-scale structures. V-amylose has potential as a biomaterial for nanoencapsulation of sensitive bioactive and flavor ingredients, modification of rheological behavior of starch-containing products, reduction of starch retrogradation, and postprandial hyperglycaemia in diabetics. Various aspects of V-amylose structure, methods of preparation, factors that affect its formation, and the significance and potential applications of the V-amylose complexes are reviewed.
C1 [Obiro, Wokadala Cuthbert; Emmambux, Mohammad Naushad] Univ Pretoria, Dept Food Sci, ZA-0002 Pretoria, South Africa.
   [Ray, Suprakas Sinha] CSIR, DST CSIR Nanotechnol Innovat Ctr, Natl Ctr Nanostruct Mat, Pretoria, South Africa.
RP Emmambux, MN (reprint author), Univ Pretoria, Dept Food Sci, ZA-0002 Pretoria, South Africa.
EM naushad.emmambux@up.ac.za
RI RAY, SUPRAKAS/E-7908-2011
OI RAY, SUPRAKAS/0000-0002-0007-2595; Emmambux, Mohammad
   Naushad/0000-0002-9377-6056
FU University of Pretoria; DST/CSIR Nanotechnology Innovation Centre;
   National Research Fund (NRF)
FX The authors gratefully acknowledge funding from the University of
   Pretoria Commonwealth Scholarship Programme, DST/CSIR Nanotechnology
   Innovation Centre, and National Research Fund (NRF) for the support of
   this study.
CR Ades H., 2007, INT WORKSH BIOENC VI
   Anil G., 2008, FOOD CHEM, V108, P14
   Bajner E.R., 2002, THESIS U PRETORIA PR
   Becker A, 2001, STARCH-STARKE, V53, P121, DOI 10.1002/1521-379X(200104)53:3/4<121::AID-STAR121>3.0.CO;2-Q
   BHATNAGAR S, 1994, CEREAL CHEM, V71, P587
   BHATNAGAR S, 1994, CEREAL CHEM, V71, P582
   Bhatnagar S., 2006, J FOOD SCI, V61, P778
   Bhosale RG, 2010, CARBOHYD POLYM, V80, P53, DOI 10.1016/j.carbpol.2009.10.069
   Biais B, 2006, CARBOHYD POLYM, V66, P306, DOI 10.1016/j.carbpol.2006.03.019
   BILIADERIS CG, 1990, CARBOHYD POLYM, V13, P185, DOI 10.1016/0144-8617(90)90083-5
   BILIADERIS CG, 1989, CARBOHYD RES, V189, P31, DOI 10.1016/0008-6215(89)84084-4
   BILIADERIS CG, 1985, CARBOHYD POLYM, V5, P367, DOI 10.1016/0144-8617(85)90044-X
   BILIADERIS CG, 1986, CARBOHYD POLYM, V6, P269, DOI 10.1016/0144-8617(86)90032-9
   Blazek J, 2009, CARBOHYD POLYM, V78, P131, DOI 10.1016/j.carbpol.2009.03.023
   BRISSON J, 1991, INT J BIOL MACROMOL, V13, P31, DOI 10.1016/0141-8130(91)90007-H
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   BULEON A, 1990, INT J BIOL MACROMOL, V12, P25, DOI 10.1016/0141-8130(90)90078-O
   Burger J.-M., 2009, THESIS U PRETORIA PR
   Byars JA, 2009, CEREAL CHEM, V86, P76, DOI 10.1094/CCHEM-86-1-0076
   Calson L.G., 1979, STARCH, V31, P222
   Cardoso MB, 2007, BIOMACROMOLECULES, V8, P1319, DOI 10.1021/bm0611174
   Cohen R, 2008, J AGR FOOD CHEM, V56, P4212, DOI 10.1021/jf800255c
   Cohen R, 2011, J AGR FOOD CHEM, V59, P7932, DOI 10.1021/jf2013277
   Colonna P., 1983, Carbohydrate Polymers, V3, P87, DOI 10.1016/0144-8617(83)90001-2
   Conde-Petit B, 2006, TRENDS FOOD SCI TECH, V17, P227, DOI 10.1016/j.tifs.2005.11.007
   Conde-Petit B., 2006, SELF ASS STARCH SPEH
   CONDEPETIT B, 1995, J RHEOL, V39, P1497, DOI 10.1122/1.550612
   CONDEPETIT B, 1992, FOOD HYDROCOLLOID, V6, P223, DOI 10.1016/S0268-005X(09)80361-5
   Cui R, 1999, FOOD CHEM, V65, P417, DOI 10.1016/S0308-8146(97)00174-X
   CZUCHAJOWSKA Z, 1991, CEREAL CHEM, V68, P537
   D'Silva T.V., 2009, THESIS U PRETORIA PR
   D'Silva TV, 2011, J CEREAL SCI, V53, P192, DOI 10.1016/j.jcs.2010.12.002
   Derycke V, 2005, J CEREAL SCI, V42, P334, DOI 10.1016/j.jcs.2005.05.002
   ELIASSON AC, 1985, J CEREAL SCI, V3, P239, DOI 10.1016/S0733-5210(85)80017-5
   ELIASSON AC, 1988, STARCH-STARKE, V40, P95, DOI 10.1002/star.19880400304
   Fanta G.F., 2005, CARBOHYD POLYM, V6, P22
   Fanta GF, 2008, CARBOHYD POLYM, V71, P253, DOI 10.1016/j.carbpol.2007.05.034
   Fanta GF, 2006, CARBOHYD POLYM, V66, P60, DOI 10.1016/j.carbpol.2006.02.017
   Fanta GF, 1999, CARBOHYD POLYM, V38, P1, DOI 10.1016/S0144-8617(98)00104-0
   Fanta GF, 2002, CARBOHYD POLYM, V48, P161, DOI 10.1016/S0144-8617(01)00230-2
   Fu C, 2007, MACROMOL RAPID COMM, V28, P2180, DOI 10.1002/marc.200700458
   GALLOWAY GI, 1989, J FOOD SCI, V54, P950, DOI 10.1111/j.1365-2621.1989.tb07920.x
   Gelders GG, 2006, J AGR FOOD CHEM, V54, P1493, DOI 10.1021/jf051743c
   Gelders GG, 2005, BIOMACROMOLECULES, V6, P2622, DOI 10.1021/bm0502011
   Gelders GG, 2005, CARBOHYD POLYM, V60, P379, DOI 10.1016/j.carbpol.2005.02.008
   Gelders GG, 2004, CARBOHYD POLYM, V56, P447, DOI 10.1016/j.carbpol.2004.03.012
   Genyi Zhang, 2004, Carbohydrate Polymers, V55, P419, DOI 10.1016/j.carbpol.2003.11.005
   Genyi Zhang, 2003, Journal of Agricultural and Food Chemistry, V51, P2801, DOI 10.1021/jf030035t
   Genyi Zhang, 2003, Journal of Agricultural and Food Chemistry, V51, P2797, DOI 10.1021/jf0300341
   GHIASI K, 1982, CEREAL CHEM, V59, P86
   GIDLEY MJ, 1988, J AM CHEM SOC, V110, P3820, DOI 10.1021/ja00220a016
   Godet M.C., 1995, CARBOHYD POLYM, V21, P41
   GODET MC, 1993, INT J BIOL MACROMOL, V15, P11, DOI 10.1016/S0141-8130(05)80082-0
   Godet MC, 1996, J FOOD SCI, V61, P1196, DOI 10.1111/j.1365-2621.1996.tb10959.x
   GODET MC, 1993, CARBOHYD POLYM, V21, P91, DOI 10.1016/0144-8617(93)90003-M
   Godet MC, 1995, INT J BIOL MACROMOL, V17, P405, DOI 10.1016/0141-8130(96)81853-8
   Gokmen V, 2011, J FOOD ENG, V105, P585, DOI 10.1016/j.jfoodeng.2011.03.021
   GUDMUNDSSON M, 1992, CARBOHYD POLYM, V17, P299, DOI 10.1016/0144-8617(92)90173-N
   Guraya S. H., 1997, CEREAL CHEM, V74, P561
   Heinemann C, 2005, LWT-FOOD SCI TECHNOL, V38, P885, DOI 10.1016/j.lwt.2004.08.016
   Heinemann C, 2003, CARBOHYD POLYM, V51, P159, DOI 10.1016/S0144-8617(02)00156-X
   Heinemann C, 2001, J AGR FOOD CHEM, V49, P1370, DOI 10.1021/jf001079u
   HELBERT W, 1994, INT J BIOL MACROMOL, V16, P207, DOI 10.1016/0141-8130(94)90052-3
   HINKLE ME, 1968, BIOPOLYMERS, V6, P1119, DOI 10.1002/bip.1968.360060807
   HOLM J, 1983, STARKE, V35, P294, DOI 10.1002/star.19830350902
   Immel S., 2000, STARCH, V1, P1
   Itthisoponkul T, 2007, CARBOHYD POLYM, V69, P106, DOI 10.1016/j.carbpol.2006.09.012
   Jane L J., 1984, CARBOHYD RES, V132, P105
   Jie L., 2009, CARBOHYD POLYM, V75, P351
   JOVANOVICH G, 1992, J AGR FOOD CHEM, V40, P1789, DOI 10.1021/jf00022a012
   Jovanovich G, 1999, BIOPOLYMERS, V49, P81, DOI 10.1002/(SICI)1097-0282(199901)49:1<81::AID-BIP8>3.0.CO;2-D
   Kadokawa J, 2003, MACROMOL CHEM PHYSIC, V204, P1451, DOI 10.1002/macp.200350004
   Kadokawa J, 2002, CHEM-EUR J, V8, P3321, DOI 10.1002/1521-3765(20020802)8:15<3321::AID-CHEM3321>3.0.CO;2-E
   Kadokawa J, 2001, MACROMOLECULES, V34, P6536, DOI 10.1021/ma010606n
   Kaneko K., 2008, MACROMOL CHEM PHYS, V209, P1037
   Kaneko Y, 2005, CHEM REC, V5, P36, DOI 10.1002/tcr.20031
   Kaneko Y, 2008, MACROMOLECULES, V41, P5665, DOI 10.1021/ma801002p
   KARKALAS J, 1995, CARBOHYD RES, V268, P233, DOI 10.1016/0008-6215(94)00336-E
   Kaur K, 2000, FOOD CHEM, V71, P511, DOI 10.1016/S0308-8146(00)00202-8
   Kawada J, 2004, STARCH-STARKE, V56, P13, DOI 10.1002/star.200300222
   Kim JY, 2009, CARBOHYD POLYM, V78, P626, DOI 10.1016/j.carbpol.2009.05.026
   Kim JY, 2009, CARBOHYD POLYM, V76, P110, DOI 10.1016/j.carbpol.2008.09.030
   Kim OK, 2003, J AM CHEM SOC, V125, P4426, DOI 10.1021/ja029233b
   Krog N., 1970, Journal of Food Technology, V5, P77
   KROG N, 1973, STARKE, V25, P22, DOI 10.1002/star.19730250105
   KUBIK S, 1993, STARCH-STARKE, V45, P220, DOI 10.1002/star.19930450607
   Kwasniewska K.I., 2008, FOOD SCI TECHNOL INT, V14, P29
   Lalush I, 2005, BIOMACROMOLECULES, V6, P121, DOI 10.1021/bm049644f
   Lamberts L, 2009, J AGR FOOD CHEM, V57, P3210, DOI 10.1021/jf803385m
   Lay-Ma U. V., 2011, CARBOHYD POLYM, V83, P1869, DOI DOI 10.1016/J.CARBPOL.2010.10.055
   Le Bail P, 2005, INT J BIOL MACROMOL, V35, P1, DOI 10.1016/j.ijbiomac.2004.09.001
   Le Bail P, 1999, BIOPOLYMERS, V50, P99, DOI 10.1002/(SICI)1097-0282(199907)50:1<99::AID-BIP9>3.3.CO;2-1
   Lebail P, 2000, CARBOHYD POLYM, V43, P317, DOI 10.1016/S0144-8617(00)00180-6
   Lesmes U, 2009, FOOD HYDROCOLLOID, V23, P667, DOI 10.1016/j.foodhyd.2008.04.003
   Lesmes U, 2008, INNOV FOOD SCI EMERG, V9, P507, DOI 10.1016/j.ifset.2007.12.008
   Liquin Y., 2008, CARBOHYD RES, V343, P2463
   Lopez-Rubio A, 2007, BIOMACROMOLECULES, V8, P1564, DOI 10.1021/bm061124s
   Luykx DMAM, 2008, J AGR FOOD CHEM, V56, P8231, DOI 10.1021/jf8013926
   Mantzari G, 2010, CARBOHYD POLYM, V79, P154, DOI 10.1016/j.carbpol.2009.07.043
   MERCIER C, 1980, CEREAL CHEM, V57, P4
   MORRISON WR, 1993, J CEREAL SCI, V18, P107, DOI 10.1006/jcrs.1993.1039
   Nakazawa Y, 2004, CARBOHYD POLYM, V57, P327, DOI 10.1016/j.carbpol.2004.05.011
   Navarro AS, 1996, FOOD SCI TECHNOL-LEB, V29, P632
   Nebesny E, 2005, STARCH-STARKE, V57, P378, DOI 10.1002/star.200400376
   Nelles EM, 2000, J CEREAL SCI, V31, P287, DOI 10.1006/jcrs.2000.0311
   Nelles EM, 2003, STARCH-STARKE, V55, P72, DOI 10.1002/star.200390019
   Nimz O, 2004, CARBOHYD RES, V339, P1427, DOI 10.1016/j.jcarres.2004.02.030
   Nuessli J, 1997, FOOD HYDROCOLLOID, V11, P27, DOI 10.1016/S0268-005X(97)80007-0
   Nuessli J, 2003, INT J BIOL MACROMOL, V33, P227, DOI 10.1016/j.ijbiomac.2003.08.009
   Nuessli J, 1995, CARBOHYD POLYM, V28, P167, DOI 10.1016/0144-8617(95)00109-3
   Pozo-Bayon MA, 2008, J AGR FOOD CHEM, V56, P6640, DOI 10.1021/jf800242r
   Putaux JL, 2011, MACROMOL SYMP, V303, DOI 10.1002/masy.201150501
   Putseys JA, 2010, J CEREAL SCI, V51, P238, DOI 10.1016/j.jcs.2010.01.011
   Putseys JA, 2010, J AGR FOOD CHEM, V58, P1939, DOI 10.1021/jf903523h
   Putseys JA, 2009, CARBOHYD POLYM, V78, P854, DOI 10.1016/j.carbpol.2009.07.002
   RAPHAELIDES S, 1988, CARBOHYD RES, V172, P65, DOI 10.1016/S0008-6215(00)90843-7
   Raphaelides SN, 2010, FOOD RES INT, V43, P329, DOI 10.1016/j.foodres.2009.10.016
   RAPHAELIDES SN, 1993, FOOD HYDROCOLLOID, V7, P479, DOI 10.1016/S0268-005X(09)80243-9
   Raphaelides SN, 2007, FOOD HYDROCOLLOID, V21, P1188, DOI 10.1016/j.foodhyd.2006.09.005
   Raphaelides SN, 2006, CARBOHYD POLYM, V65, P81, DOI 10.1016/j.carbpol.2005.12.028
   RAPPENECKER G, 1981, CARBOHYD RES, V89, P11, DOI 10.1016/S0008-6215(00)85225-8
   Richardson G, 2003, STARCH-STARKE, V55, P150, DOI 10.1002/star.200390029
   Rondeau-Mouro C., 2004, INT J BIOL MACROMOL, V34, P251
   RUTSCHMANN MA, 1990, LEBENSM WISS TECHNOL, V23, P84
   SARKO A, 1980, CARBOHYD RES, V79, P11, DOI 10.1016/S0008-6215(00)85127-7
   SENEVIRATNE HD, 1991, J CEREAL SCI, V13, P129, DOI 10.1016/S0733-5210(09)80030-1
   Shamai K, 2004, BIOMACROMOLECULES, V5, P219, DOI 10.1021/bm034332i
   Shimoni E., 2009, European Patent Application, Patent No. [EP20070736251, 20070736251]
   Shogren RL, 2006, CARBOHYD POLYM, V64, P444, DOI 10.1016/j.carbpol.2005.12.018
   Sievert C., 1993, CEREAL CHEM, V70, P333
   Singh J, 2002, J FOOD ENG, V52, P9, DOI 10.1016/S0260-8774(01)00078-4
   Siswoyo TA, 2003, FOOD RES INT, V36, P729, DOI 10.1016/S0963-9969(03)00053-X
   Siswoyo TA, 2002, FOOD RES INT, V35, P737, DOI 10.1016/S0963-9969(02)00069-8
   Snape CE, 1998, CARBOHYD POLYM, V36, P225, DOI 10.1016/S0144-8617(98)00010-1
   Tang MC, 2007, CARBOHYD POLYM, V67, P80, DOI 10.1016/j.carbpol.2006.04.016
   Tapanapunnitkul O, 2008, J AGR FOOD CHEM, V56, P220, DOI 10.1021/jf071619o
   Teresa De Pilli K.J., 2008, J FOOD ENG, V87, P495
   Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001
   Tian YQ, 2010, CARBOHYD POLYM, V80, P581, DOI 10.1016/j.carbpol.2009.12.010
   Toro-Vazquez JF, 2003, J CEREAL SCI, V38, P269, DOI 10.1016/S0733-5210(03)00026-2
   Tufvesson F, 2000, CARBOHYD POLYM, V43, P359, DOI 10.1016/S0144-8617(00)00179-X
   Tufvesson F, 2003, STARCH-STARKE, V55, P138, DOI 10.1002/star.200390028
   Tufvesson F, 2003, STARCH-STARKE, V55, P61, DOI 10.1002/star.200390018
   Tufvesson F, 2001, LEBENSM-WISS TECHNOL, V34, P131, DOI 10.1006/fstl.2000.0727
   Ubbink J, 2008, SOFT MATTER, V4, P1569, DOI 10.1039/b802183j
   Wulff G, 2005, J CEREAL SCI, V41, P239, DOI 10.1016/j.jcs.2004.06.002
   WULFF G, 1992, MAKROMOL CHEM, V193, P1071
   WYLER R, 1982, LEBENSM WISS TECHNOL, V15, P93
   Yang Y, 2009, J AGR FOOD CHEM, V57, P7125, DOI 10.1021/jf9016306
   Yotsawimonwat S, 2008, INT J BIOL MACROMOL, V43, P94, DOI 10.1016/j.ijbiomac.2008.03.006
   Zabar S., 2009, FOOD HYDROCOLLOIDS, V24, P347
   Zabar S, 2009, FOOD HYDROCOLLOID, V23, P1918, DOI 10.1016/j.foodhyd.2009.02.004
   ZOBEL HF, 1967, BIOPOLYMERS, V5, P837, DOI 10.1002/bip.1967.360050906
NR 153
TC 50
Z9 51
U1 6
U2 90
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 8755-9129
J9 FOOD REV INT
JI Food Rev. Int.
PY 2012
VL 28
IS 4
BP 412
EP 438
DI 10.1080/87559129.2012.660718
PG 27
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 945TP
UT WOS:000304299300004
DA 2018-10-19
ER

PT J
AU Seo, JH
   Kakinoki, S
   Inoue, Y
   Yamaoka, T
   Ishihara, K
   Yui, N
AF Seo, Ji-Hun
   Kakinoki, Sachiro
   Inoue, Yuuki
   Yamaoka, Tetsuji
   Ishihara, Kazuhiko
   Yui, Nobuhiko
TI Designing dynamic surfaces for regulation of biological responses
SO SOFT MATTER
LA English
DT Article
ID INDUCED CONFORMATIONAL-CHANGES; PROTEIN ADSORPTION; BIOCLEAVABLE
   POLYROTAXANE; ADSORBED FIBRINOGEN; FIBRONECTIN CONFORMATION;
   PLATELET-ADHESION; BLOCK-COPOLYMERS; ANTIBODY-BINDING; GENE DELIVERY;
   POLYPLEX
AB ABA block copolymers composed of highly methylated polyrotaxane and hydrophobic anchoring terminal segments containing 2-methacryloyloxyethyl phosphorylcholine (MPC) and n-butyl methacrylate (PMB) (OMe-PRX-PMB) were synthesized as a platform of molecularly dynamic biomaterials. A contact angle measurement indicated that polymer surfaces with higher molecular mobility factors (M-f) estimated from quartz crystal microbalance with dissipation (QCM-D) measurements showed more significant changes in hydrophilicity in response to an environmental change between air and water; the OMe-PRX-PMB surface showed the highest M-f among the prepared polymer surfaces. Fibrinogen adsorption and its conformational analysis estimated by QCM-D and enzyme-linked immunosorbent assay revealed that large amounts of fibrinogen adsorption occurred in a soft manner on the OMe-PRX-PMB surface and that the antibody binding to the C-terminus of the fibrinogen gamma chains responsible for platelet adhesion and activation decreased as the M-f value increased. Furthermore, it was found that the OMe-PRX-PMB surface showed low platelet adhesion and high fibroblast adhesion, suggesting that molecular movement on biomaterial surfaces could be one of the key parameters in the regulation of a non-specific biological response.
C1 [Seo, Ji-Hun; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
   [Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan.
   [Inoue, Yuuki; Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Tokyo 1138656, Japan.
   [Seo, Ji-Hun; Kakinoki, Sachiro; Inoue, Yuuki; Yamaoka, Tetsuji; Ishihara, Kazuhiko; Yui, Nobuhiko] JST CREST, Tokyo 1020076, Japan.
RP Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
EM yui.org@tmd.ac.jp
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   Brash JL, 1987, ACS S SERIES, V343
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Fischer TH, 2005, BIOMATERIALS, V26, P5433, DOI 10.1016/j.biomaterials.2005.01.023
   Futamura K, 2008, LANGMUIR, V24, P10340, DOI 10.1021/la801017h
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Hemmersam AG, 2008, J PHYS CHEM C, V112, P4180, DOI 10.1021/jp072413t
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Horbett TA, 1995, ACS S SERIES, V602
   Hyun H, 2011, MACROMOL RAPID COMM, V32, P326, DOI 10.1002/marc.201000631
   Hyun H, 2011, MACROMOL BIOSCI, V11, P765, DOI 10.1002/mabi.201000507
   Inoue Y, 2012, COLLOID SURFACE B, V89, P223, DOI 10.1016/j.colsurfb.2011.09.020
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Mitsukami Y, 2001, MACROMOLECULES, V34, P2248, DOI 10.1021/ma0018087
   Moulin AM, 1999, LANGMUIR, V15, P8776, DOI 10.1021/la990416u
   Ooya T, 2006, J AM CHEM SOC, V128, P3852, DOI 10.1021/ja055868+
   Ooya T, 2003, J AM CHEM SOC, V125, P13016, DOI 10.1021/ja034583z
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Tsai WB, 2003, J BIOMED MATER RES A, V67A, P1255, DOI 10.1002/jbm.a.20024
   Utsunomiya H, 2008, MACROMOL BIOSCI, V8, P665, DOI 10.1002/mabi.200700297
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yamada Y, 2012, CHEMPHYSCHEM, V13, P1161, DOI 10.1002/cphc.201100800
   Yamada Y, 2012, BIOMATERIALS, V33, P3952, DOI 10.1016/j.biomaterials.2012.01.049
   Yamada Y, 2010, BIOL PHARM BULL, V33, P1218, DOI 10.1248/bpb.33.1218
   Yamashita A, 2008, J CONTROL RELEASE, V131, P137, DOI 10.1016/j.jconrel.2008.07.011
   Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Yui N, 2006, CHEM-EUR J, V12, P6730, DOI 10.1002/chem.200600370
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
NR 37
TC 28
Z9 28
U1 2
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 20
BP 5477
EP 5485
DI 10.1039/c2sm25318f
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 941WN
UT WOS:000303998700010
DA 2018-10-19
ER

PT J
AU Li, W
   Liu, Y
   Brett, G
   Gunton, JD
AF Li, Wei
   Liu, Ya
   Brett, Genevieve
   Gunton, James D.
TI Encapsulation by Janus spheroids
SO SOFT MATTER
LA English
DT Article
ID DRUG-DELIVERY; COLLOIDAL PARTICLES; MICROSPHERES; SYSTEMS; SPHERES;
   SCAFFOLDS; CLUSTERS
AB Micro/nano encapsulation technology has acquired considerable attention in the fields of drug delivery, biomaterial engineering, and materials science. Based on recent advances in chemical particle synthesis, we propose a primitive model of an encapsulation system produced by the self-assembly of Janus oblate spheroids, particles with oblate spheroidal bodies and two hemi-surfaces coded with dissimilar chemical properties. Using Monte Carlo simulation, we investigate the encapsulation system with spherical particles as encapsulated guests, for different densities. We study the anisotropic effect due to the encapsulating agent's geometric shape and chemical composition on the encapsulation morphology and efficiency. Given the relatively high encapsulation efficiency we find from the simulations, we believe that this method of encapsulation has potential practical value.
C1 [Li, Wei; Liu, Ya; Gunton, James D.] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA.
   [Brett, Genevieve] Skidmore Coll, Dept Phys, Saratoga Springs, NY 12866 USA.
RP Li, W (reprint author), Lehigh Univ, Dept Phys, Bldg 16, Bethlehem, PA 18015 USA.
EM wel208@lehigh.edu
RI Liu, Ya/B-9799-2013; Li, Wei/R-1322-2016
OI Liu, Ya/0000-0002-3903-502X; Li, Wei/0000-0001-6573-5161; Brett,
   Genevieve/0000-0001-6170-8633
FU Mathers Foundation; NSF REU at Lehigh University; NSF
FX This work was supported by a grant from the Mathers Foundation. One of
   us (GB) was supported by the NSF REU Site Grant in Physics at Lehigh
   University. Simulation work was supported in part by the NSF through
   TeraGrid resources provided by Pittsburgh Supercomputing Center. We
   thank Wenping Wang at the University of Hong Kong for providing the
   ellipsoid code.
CR [Anonymous], 2002, NAT MED, V8, P27
   BERNE BJ, 1972, J CHEM PHYS, V56, P4213, DOI 10.1063/1.1677837
   Blaiszik BJ, 2009, POLYMER, V50, P990, DOI 10.1016/j.polymer.2008.12.040
   Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451
   Cho SH, 2009, ADV MATER, V21, P645, DOI 10.1002/adma.200802008
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   De Jong WH, 2008, INT J NANOMED, V3, P133
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Du JZ, 2011, CHEM SOC REV, V40, P2402, DOI 10.1039/c0cs00216j
   Fantoni R, 2011, SOFT MATTER, V7, P2419, DOI 10.1039/c0sm00995d
   Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949
   Hong L, 2008, LANGMUIR, V24, P621, DOI 10.1021/la7030818
   Hong L, 2006, NANO LETT, V6, P2510, DOI 10.1021/nl061857i
   Jaklenec A, 2008, BIOMATERIALS, V29, P185, DOI 10.1016/j.biomaterials.2007.09.017
   Jenekhe SA, 1998, SCIENCE, V279, P1903, DOI 10.1126/science.279.5358.1903
   Jiang S, 2010, ADV MATER, V22, P1060, DOI 10.1002/adma.200904094
   Kern N, 2003, J CHEM PHYS, V118, P9882, DOI 10.1063/1.1569473
   Leach KJP, 1998, BIOMATERIALS, V19, P1981
   Liu Y, 2012, LANGMUIR, V28, P3, DOI 10.1021/la2032303
   Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595
   Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Sciortino F, 2010, PHYS CHEM CHEM PHYS, V12, P11869, DOI 10.1039/c0cp00504e
   Sciortino F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237801
   Shi XT, 2011, PHARM RES-DORDR, V28, P1224, DOI 10.1007/s11095-010-0359-4
   Singh M, 2010, ACTA BIOMATER, V6, P137, DOI 10.1016/j.actbio.2009.07.042
   Sutton D, 2007, PHARM RES-DORDR, V24, P1029, DOI 10.1007/s11095-006-9223-y
   Tian JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3592712
   Tyrrell ZL, 2010, PROG POLYM SCI, V35, P1128, DOI 10.1016/j.progpolymsci.2010.06.003
   Wang YJ, 2010, ADV MATER, V22, P4293, DOI 10.1002/adma.201001497
   Yang SM, 2008, J MATER CHEM, V18, P2177, DOI 10.1039/b716393b
NR 32
TC 16
Z9 16
U1 0
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 22
BP 6027
EP 6032
DI 10.1039/c2sm00005a
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 943DO
UT WOS:000304100900009
DA 2018-10-19
ER

PT J
AU Zhao, N
   Ma, ZG
   Xiong, CD
AF Zhao, Na
   Ma, Zhigang
   Xiong, Chengdong
TI Effect of Poly(L-lactic acid) on Hydrolytic Degradation of Poly(glycolic
   acid)
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS
LA English
DT Article
DE compatibility; composite materials; hydrolytic degradation;
   microstructure; poly(glycolic acid)
ID POLY-L-LACTIDE; PLLA
AB The in-vitro degradation behavior of poly(glycolic acid) (PGA) rods and the composite rods containing poly(L-lactic acid) (PLLA) were investigated via mass loss, pH value change, scanning electron microscopy (SEM), thermogravimetric analysis (TGA), and differential scanning calorimetry (DSC). Since the degradation rate of PLLA is lower than that of PGA, PLLA/PGA composite rods exhibit a slower degradation rate in comparison with PGA. This finding indicated that it was possible to control the degradation rate of the composites by changing their composition. This result indicates that this kind of composite biomaterial may be applicable to devices for the need of prolonged degradation.
C1 [Zhao, Na; Ma, Zhigang] Huangshi Inst Technol, Sch Chem & Mat Engn, Huangshi 435003, Peoples R China.
   [Xiong, Chengdong] Chinese Acad Sci, Chengdu Organ Chem Co Ltd, Chengdu, Peoples R China.
RP Ma, ZG (reprint author), Huangshi Inst Technol, Sch Chem & Mat Engn, Huangshi 435003, Peoples R China.
EM ma.zg@163.com
FU Hubei Provincial Key Laboratory of Environmental Pollution Control and
   Resource Reuse
FX The authors would like to thank Hubei Provincial Key Laboratory of
   Environmental Pollution Control and Resource Reuse for the support of
   this research.
CR Choueka Jack, 1995, Journal of Biomedical Materials Research, V29, P1309, DOI 10.1002/jbm.820291102
   CHU CC, 1995, BIOMEDICAL ENG HDB, P611
   Gumargalieva K. Z., 1998, INT J POLYM MATER, V42, P83
   HERRMANN JB, 1970, ARCH SURG-CHICAGO, V100, P486
   Iannace S, 2001, POLYMER, V42, P3799, DOI 10.1016/S0032-3861(00)00744-8
   McDonald PF, 2010, POLYM-PLAST TECHNOL, V49, P678, DOI 10.1080/03602551003681846
   Montes de Oca H., 2006, POLYMER, V47, P7070
   PRIVALOVA LG, 1990, POLYM-PLAST TECHNOL, V29, P455, DOI 10.1080/03602559008049857
   Renouf-Glauser AC, 2005, BIOMATERIALS, V26, P2415, DOI 10.1016/j.biomaterials.2004.07.067
   Yeh J.T., 2009, POLYM-PLAST TECHNOL, V48, P578
   ZHANG X, 1993, REV MACROMOL CHEM C, V33, P81
   Zhao N, 2009, POLYM COMPOSITE, V30, P1771, DOI 10.1002/pc.20748
   Zhou ZH, 2008, INT J POLYM MATER, V57, P878, DOI 10.1080/00914030802089401
   Zhou ZH, 2008, INT J POLYM MATER, V57, P1026, DOI 10.1080/00914030802257438
NR 14
TC 7
Z9 7
U1 0
U2 12
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
J9 INT J POLYM MATER
JI Int. J. Polym. Mater.
PY 2012
VL 61
IS 8
BP 587
EP 595
DI 10.1080/00914037.2011.610040
PG 9
WC Polymer Science
SC Polymer Science
GA 936UL
UT WOS:000303615400002
DA 2018-10-19
ER

PT S
AU Li, FH
   Sun, Y
   Li, SX
   Ma, SJ
AF Li, Fenghong
   Sun, Yong
   Li, Sanxi
   Ma, Shaojun
BE Zhang, HX
   Han, Y
   Chen, F
   Wen, J
TI Synthesis and Characterization of Thermoplastic Biomaterial Based on
   Acylated Chitosan Oligosaccharide
SO MATERIALS AND COMPUTATIONAL MECHANICS, PTS 1-3
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Applied Mechanics, Materials and
   Manufacturing (ICAMMM 2011)
CY NOV 18-20, 2011
CL Shenzhen, PEOPLES R CHINA
DE chitosan oligosaccharide; thermoplastic biomaterial; acylation;
   characterization
ID DERIVATIVES; CHITIN; DEGRADATION; BLENDS; ACID
AB A series of acylated chitosan oligosaccharides (LCSOs) were synthesized by reacting chitosan oligosaccharide (CSO) with lauroyl chloride in methane sulfonic acid. The chemical structures of LCSOs were characterized by Fourier transform infrared. Differential scanning calorimetry (DSC) showed that LCSOs had two phase transitions during heating. Thermoplastic chitosan oligosaccharide (LCSO-4) has distinct melting temperature (T-m) at 64 degrees C and 110 degrees C. X-ray diffraction (XRD) analyses indicated that the crystal structure of CSO was changed through acylation and had created new crystal domains of lauroyl side chains. New strong diffraction peaks were observed around 2 theta values of 20.0 degrees, 21.5 degrees and 26.3 degrees for thermoplastic acylated chitosan oligosaccharide (LCSO-4). The melting and crystallization properties of thermoplastic acylated chitosan oligosaccharide were observed by polarized optical microscope (POM).
C1 [Li, Fenghong; Sun, Yong; Ma, Shaojun] Shenyang Univ Technol, Sch Petrochem Engn, Liaoyang 111003, Peoples R China.
   [Li, Sanxi] Shenyang Univ Technol, Sch Sci, Liaoyang 111003, Peoples R China.
RP Li, FH (reprint author), Shenyang Univ Technol, Sch Petrochem Engn, Liaoyang 111003, Peoples R China.
EM lfhby@yahoo.com.cn; sunyong0218@163.com; sanxili@hotmail.com;
   Mashaojun63@163.com
FU Liaoning Provincial Natural Science Foundation of China [20102172]
FX This work was financially supported by the Liaoning Provincial Natural
   Science Foundation of China (20102172).
CR Cabrera JC, 2005, BIOCHEM ENG J, V25, P165, DOI 10.1016/j.bej.2005.04.025
   Correlo VM, 2007, MACROMOL BIOSCI, V7, P354, DOI 10.1002/mabi.200600233
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Coutinho DF, 2008, BIOMACROMOLECULES, V9, P1139, DOI 10.1021/bm701268s
   Guan JJ, 2005, IND CROP PROD, V22, P109, DOI 10.1016/j.indcrop.2004.06.004
   Jiang GB, 2006, CARBOHYD POLYM, V66, P514, DOI 10.1016/j.carbpol.2006.04.008
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2000, MACROMOLECULES, V33, P4711, DOI 10.1021/ma992113c
   Li FH, 2011, ADV MATER RES-SWITZ, V183-185, P155, DOI 10.4028/www.scientific.net/AMR.183-185.155
   Ma GP, 2008, J APPL POLYM SCI, V109, P1093, DOI 10.1002/app.28223
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   NISHIMURA SI, 1990, CHEM LETT, P243, DOI 10.1246/cl.1990.243
   Sajomsang W, 2008, INT J BIOL MACROMOL, V43, P79, DOI 10.1016/j.ijbiomac.2008.03.010
   SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706
   Sashiwa H, 2002, BIOMACROMOLECULES, V3, P1126, DOI 10.1021/bm0200480
   Zong Z, 2000, POLYMER, V41, P899, DOI 10.1016/S0032-3861(99)00270-0
NR 17
TC 1
Z9 1
U1 1
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-280-4
J9 APPL MECH MATER
PY 2012
VL 117-119
BP 1433
EP +
DI 10.4028/www.scientific.net/AMM.117-119.1433
PN 1-3
PG 2
WC Engineering, Manufacturing; Mechanics
SC Engineering; Mechanics
GA BAA28
UT WOS:000303483600302
DA 2018-10-19
ER

PT S
AU Wessapan, T
   Borirak, T
AF Wessapan, Teerapot
   Borirak, Theerapong
BE Fan, W
TI An Experimental Study on Banana Drying using a Combined Rejected Heat
   from Split-type Air Conditioner and Solar Energy
SO MECHANICAL AND AEROSPACE ENGINEERING, PTS 1-7
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 2nd International Conference on Mechnaical and Aerospace Engineering
   (ICMAE 2011)
CY JUL 29-31, 2011
CL Bangkok, THAILAND
SP Int Assoc Comp Sci & Informat Technol
DE banana; biomaterial; drying kinetic; rejected heat; solar energy
AB This paper presents an experimental study of the effectiveness of using a combined solar energy and heat rejected from a split-type air conditioner, for drying biomaterials. The experiments were carried out on biomaterial dryer using the combined solar energy and heat rejected from a split-type air conditioner. The effectiveness was evaluated based on the comparison of various drying methods, in terms of drying kinetics of the biomaterial being dried, under Thailand's climate conditions. The banana was chosen as testing materials. The banana was dried by the dryer with using three drying methods: Heat rejected from an air conditioner; solar energy; and the combined solar energy and heat rejected from an air conditioner. The result shows that the combined solar energy and heat rejected for drying biomaterials were found to have a shorter drying time, higher energy efficiency, and more natural appearance of dried biomaterial compared to the conventional drying method.
C1 [Wessapan, Teerapot; Borirak, Theerapong] Eastern Asia Univ, Fac Engn, Dept Mech Engn, Pathum Thani, Thailand.
RP Wessapan, T (reprint author), Eastern Asia Univ, Fac Engn, Dept Mech Engn, Pathum Thani, Thailand.
EM teerapot@eau.ac.th
CR Aktas M., 2008, DESALINATION, V230, P266
   Ameen A, 2004, ENERG CONVERS MANAGE, V45, P1397, DOI 10.1016/j.enconman.2003.09.001
   Chua KJ, 2001, FOOD RES INT, V34, P721, DOI 10.1016/S0963-9969(01)00094-1
   Deng SM, 2004, APPL THERM ENG, V24, P2789, DOI 10.1016/j.applthermaleng.2004.03.016
   Fadhel A, 2005, DESALINATION, V185, P535, DOI 10.1016/j.desal.2005.05.012
   Sharma A, 2009, RENEW SUST ENERG REV, V13, P1185, DOI 10.1016/j.rser.2008.08.015
   Teekasap S., 2008, P IEEE ICSET 2008 SI, P728
   Teekasap S., 2010, P 2010 INT C MECH AE, P186
NR 8
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-262-0
J9 APPL MECH MATER
PY 2012
VL 110-116
BP 2170
EP 2176
DI 10.4028/www.scientific.net/AMM.110-116.2170
PN 1-7
PG 7
WC Engineering, Aerospace; Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BZY43
UT WOS:000303370301095
DA 2018-10-19
ER

PT J
AU Terai, N
   Spoerl, E
   Haustein, M
   Hornykewycz, K
   Haentzschel, J
   Pillunat, LE
AF Terai, Naim
   Spoerl, Eberhard
   Haustein, Michael
   Hornykewycz, Karin
   Haentzschel, Janek
   Pillunat, Lutz E.
TI Diabetes Mellitus Affects Biomechanical Properties of the Optic Nerve
   Head in the Rat
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Optic nerve head; Peripapillary sclera; Biomechanics; Stress-strain;
   Diabetes; Glaucoma; Advanced glycation end products
ID GLYCATION END-PRODUCTS; OPEN-ANGLE GLAUCOMA; ELEVATED
   INTRAOCULAR-PRESSURE; LAMINA-CRIBROSA; CROSS-LINKING; PERIPAPILLARY
   SCLERA; EXTRACELLULAR-MATRIX; RISK-FACTOR; COLLAGEN; DAMAGE
AB Background: To investigate the effect of diabetes on the biomechanical behavior of the optic nerve head (ONH) and the peripapillary sclera (ppSc) in streptozocine-induced diabetic rats. Methods: Diabetes mellitus was induced in 20 Wistar rats using streptozocine. Twenty-five nondiabetic rats served as controls. Eyes were enucleated after 12 weeks and 2 strips of one eye were prepared containing ONH or ppSc. The stress-strain relation was measured in the stress range of 0.05-10 MPa using a biomaterial tester. Results: At 5% strain the stress of the ONH in diabetic rats was 897 +/- 295 kPa and in the control group it was 671 +/- 246 kPa; there was a significant difference between both groups (p = 0.011). The stress of the diabetic ppSc (574 +/- 185 kPa) increased compared to that of the nondiabetic ppSc (477 +/- 171 kPa), but this did not reach statistical significance (p = 0.174). The calculated tangent modulus at 5% strain was 11.79 MPa in the diabetic ONH and 8.77 MPa in the nondiabetic ONH; there was a significant difference between both groups (p = 0.006). The calculated tangent modulus at 5% strain was 7.17 MPa in the diabetic ppSc and 6.12 MPa in the nondiabetic ppSc, without a statistically significant difference (p = 0.09). Conclusion: In contrast to the ppSc, the ONH of diabetic rats showed a significant increase in stiffness compared to nondiabetic rats, which might be explained by nonenzymatic collagen cross-linking mediated by advanced glycation end products due to high blood glucose levels in diabetes. Further studies are needed to investigate if these biomechanical changes represent a detrimental risk factor for intraocular pressure regulation in diabetic glaucoma patients. Copyright (C) 2011 S. Karger AG, Basel
C1 [Terai, Naim; Spoerl, Eberhard; Haustein, Michael; Hornykewycz, Karin; Haentzschel, Janek; Pillunat, Lutz E.] Carl Gustav Carus Univ Hosp, Dept Ophthalmol, DE-01307 Dresden, Germany.
RP Terai, N (reprint author), Carl Gustav Carus Univ Hosp, Dept Ophthalmol, Fetscherstr 74, DE-01307 Dresden, Germany.
EM naim.terai@uniklinikum-dresden.de
CR ALBON J, 1995, BRIT J OPHTHALMOL, V79, P368, DOI 10.1136/bjo.79.4.368
   Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318
   Amano S, 2001, BRIT J OPHTHALMOL, V85, P52, DOI 10.1136/bjo.85.1.52
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1280
   BOUZAS AG, 1971, ARCH OPHTHALMOL-CHIC, V85, P423, DOI 10.1001/archopht.1971.00990050425005
   Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001
   Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022
   Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3
   Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb
   Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114
   DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033
   Ellis JD, 2000, BRIT J OPHTHALMOL, V84, P1218, DOI 10.1136/bjo.84.11.1218
   Hammes HP, 1999, DIABETOLOGIA, V42, P728, DOI 10.1007/s001250051221
   Johnson EC, 1996, EXP EYE RES, V62, P663, DOI 10.1006/exer.1996.0077
   Kaji Y, 2000, INVEST OPHTH VIS SCI, V41, P362
   Kanamori A, 2004, CURR EYE RES, V28, P47, DOI 10.1076/ceyr.28.1.47.23487
   KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173
   Krueger RR, 2007, J REFRACT SURG, V23, P85
   Lapolla A, 2005, ANN NY ACAD SCI, V1043, P267, DOI 10.1196/annals.1333.032
   Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P1841, DOI 10.1167/iovs.03-1008
   MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202
   May CA, 2003, CURR EYE RES, V26, P347, DOI 10.1076/ceyr.26.5.347.15438
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   MIYATA S, 1992, J CLIN INVEST, V89, P1102, DOI 10.1172/JCI115690
   MONNIER VM, 1992, DIABETES, V41, P36, DOI 10.2337/diab.41.2.S36
   Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184
   Murata T, 1997, DIABETOLOGIA, V40, P764, DOI 10.1007/s001250050747
   Nakamura M, 2005, OPHTHALMOLOGICA, V219, P1, DOI 10.1159/000081775
   Odetti P, 1996, DIABETOLOGIA, V39, P1440, DOI 10.1007/s001250050596
   Reddy G, 2001, DIABETES RES CLIN PR, V54, P1, DOI 10.1016/S0168-8227(01)00273-X
   Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002
   Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541
   Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133
   Silt AW, 1998, INVEST OPHTH VIS SCI, V39, P2517
   Spoerl E, 2005, INVEST OPHTH VIS SCI, V46, P1286, DOI 10.1167/iovs.040978
   Tezel G, 2001, GLIA, V34, P178, DOI 10.1002/glia.1052
   Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737
   Thornton IL, 2009, INVEST OPHTH VIS SCI, V50, P1227, DOI 10.1167/iovs.08-1960
   TIELSCH JM, 1995, OPHTHALMOLOGY, V102, P48
   Traverso N, 1997, AGING-CLIN EXP RES, V9, P432
   ZEIMER RC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1232, DOI 10.1001/archopht.1989.01070020298042
NR 42
TC 9
Z9 9
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2012
VL 47
IS 4
BP 189
EP 194
DI 10.1159/000331990
PG 6
WC Ophthalmology
SC Ophthalmology
GA 936VE
UT WOS:000303617300002
PM 22156545
DA 2018-10-19
ER

PT S
AU Han, BC
   Zhang, C
   Yao, X
   Luo, XG
AF Han, Benchao
   Zhang, Chi
   Yao, Xue
   Luo, Xuegang
BE Zhang, C
TI Study of Konjac Glucomannan Esterification with Dicarboxylic anhydride
   and Effect of Degree of Esterification on Water Absorbency
SO PROGRESS IN POLYMER PROCESSING
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT Asian Workshop on Polymer Processing (AWPP2011)
CY NOV 04-07, 2011
CL Qingdao Univ Sci & Technol, Qingdao, PEOPLES R CHINA
SP Qingdao Municipal Govt, Natl Nat Sci Fdn China, Japan Soc Polymer Proc, Shandong Provincial Key Lab Polymer Mat Adv Mfg Technol
HO Qingdao Univ Sci & Technol
DE Esterification; water absorbency; konjac glucomannan(KGM)
ID ACETYLATION; MEDIA
AB Dicarboxylic anhydride esterified Konjac glucomannan (DCKGM) was prepared to reduce the unusual water absorbency of native Konjac Glucomannan (KGM). The dependence of degree of substitution (DS) on the reaction conditions and influence of the DS on water absorbency were studied. The esterification was conducted using refluxing KGM in hot acetic acid which contains phthalic anhydride and pyridine catalyst. The chemical structure and characteristic of DCKGM were analyzed by GPC-MALLS and FI-IR. The results showed that the water absorbency for DCKGM is inversely proportional to DS increase. DCKGM may be a promising biomaterial in application of drug carrier, heavy metal ion adsorption and functional packing materials.
C1 [Han, Benchao; Zhang, Chi; Yao, Xue; Luo, Xuegang] Minist Educ, Engn Res Ctr Biomass Mat, Beijing, Peoples R China.
RP Han, BC (reprint author), Minist Educ, Engn Res Ctr Biomass Mat, Beijing, Peoples R China.
EM hanbenchao@126.com; zcbomac@gmail.com; 1159286721@qq.com;
   lxg@swust.edu.cn; zcbomac@gmail.com
CR Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   Bassaid S, 2008, REACT FUNCT POLYM, V68, P483, DOI 10.1016/j.reactfunetpolym.2007.10.030
   Bin XB-j Li, 2004, SCI AGR SINICA, V37, P280
   Chen ZG, 2006, PROCESS BIOCHEM, V41, P1514, DOI 10.1016/j.procbio.2006.02.013
   Chi H, 2008, FOOD CHEM, V106, P923, DOI 10.1016/j.foodchem.2007.07.002
   GA Huseyin Deveci, 2009, J APPL POLYM SCI, V112, P1192
   Katsuraya K, 2003, CARBOHYD POLYM, V53, P183, DOI 10.1016/S0144-8617(03)00039-0
   Koroskenyi B, 2001, BIOMACROMOLECULES, V2, P824, DOI 10.1021/bm010014c
   Lin XY, 2010, CARBOHYD POLYM, V82, P167, DOI 10.1016/j.carbpol.2010.04.053
   Lu YS, 2002, IND ENG CHEM RES, V41, P1234, DOI 10.1021/ie001117z
   Lu YS, 2002, POLYMER, V43, P3979, DOI 10.1016/S0032-3861(02)00206-9
   Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025
   OHYA Y, 1994, CARBOHYD POLYM, V25, P123, DOI 10.1016/0144-8617(94)90148-1
   Yongshang Lu LZ, 2002, POLYMER, V43, P3979
   Zhang H, 2007, BIOFACTORS, V30, P227, DOI 10.1002/biof.5520300404
NR 15
TC 0
Z9 1
U1 1
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2012
VL 501
BP 42
EP 46
DI 10.4028/www.scientific.net/KEM.501.42
PG 5
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA BZY39
UT WOS:000303365600008
DA 2018-10-19
ER

PT S
AU Cunningham, BT
AF Cunningham, Brian T.
BE Kubby, J
   Reed, GT
TI Photonic crystals: a versatile platform for optics-based biological
   detection
SO SILICON PHOTONICS VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Silicon Photonics VII
CY JAN 22-25, 2012
CL San Francisco, CA
SP SPIE
DE photonic crystals; label-free biosensors; fluorescence enhancement;
   chemical imaging; Raman scattering; SERS
ID ENHANCED-FLUORESCENCE; CELL ATTACHMENT; SURFACE; MICROARRAYS; BIOSENSOR;
   SENSITIVITY; ELISA; ASSAY
AB Photonic crystal surfaces that can be fabricated inexpensively over large surface areas can be designed to produce optical resonances for any desired wavelength in the optical spectrum from ultraviolet to infrared. Label-free biosensing is obtained by measuring shifts in the resonant wavelength as biomaterial deposits on the photonic crystal, while the intensified electric fields that occur due to coupling of illumination at the resonant wavelength may be used to more effectively excite fluorescence or Raman scattering. Photon emitters, such as quantum dots, fluorescent dye molecules, and Raman scatters can efficiently couple their energy to detection instruments when they are in close proximity to a photonic crystal with a resonance that matches the emission wavelength. Finally, the narrowband optical filtering capability of photonic crystals can be effectively applied for infrared absorption imaging of biological specimens at discrete wavelengths. This talk will summarize recent activities in the Nano Sensors Group at the University of Illinois in which photonic crystals are used to address a variety of problems in biological sensing.
C1 Univ Illinois, Dept Elect & Comp Engn, Dept Bioengn, Urbana, IL 61801 USA.
RP Cunningham, BT (reprint author), Univ Illinois, Dept Elect & Comp Engn, Dept Bioengn, 1406 W Green St, Urbana, IL 61801 USA.
EM bcunning@illinois.edu
CR Bhargava R, 2001, APPL SPECTROSC, V55, P1079, DOI 10.1366/0003702011952983
   Block ID, 2009, APPL OPTICS, V48, P6567, DOI 10.1364/AO.48.006567
   Block ID, 2009, OPT EXPRESS, V17, P13222, DOI 10.1364/OE.17.013222
   Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V85, P219, DOI 10.1016/S0925-4005(02)00111-9
   Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604
   Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080
   GANESH N, 2006, APPL PHYS LETT, V89
   Ganesh N, 2007, NAT NANOTECHNOL, V2, P515, DOI 10.1038/nnano.2007.216
   Ganesh N, 2008, OPT EXPRESS, V16, P21626, DOI 10.1364/OE.16.021626
   Ganesh N, 2008, J APPL PHYS, V103, DOI 10.1063/1.2906175
   George S, 2010, ANAL CHEM, V82, P8551, DOI 10.1021/ac101551c
   Gonzalez RM, 2008, J PROTEOME RES, V7, P2406, DOI 10.1021/pr700822t
   Haynes CL, 2005, J RAMAN SPECTROSC, V36, P471, DOI 10.1002/jrs.1376
   Huang CS, 2011, ANAL CHEM, V83, P1425, DOI 10.1021/ac102989n
   Kim S. M., 2008, APPL PHYS LETT, V93
   Kim SM, 2010, OPT EXPRESS, V18, P4300, DOI 10.1364/OE.18.004300
   Kneipp K, 2002, J PHYS-CONDENS MAT, V14, pR597, DOI 10.1088/0953-8984/14/18/202
   Kodali AK, 2010, ANAL CHEM, V82, P5697, DOI 10.1021/ac1007128
   Lacowicz J. R., 2004, ANAL BIOCHEM, V324, P153
   Lakowicz JR, 2006, PLASMONICS, V1, P5, DOI 10.1007/s11468-005-9002-3
   Lakowicz JR, 2001, ANAL BIOCHEM, V298, P1, DOI 10.1006/abio.2001.5377
   Levin IW, 2003, ABSTR PAP AM CHEM S, V226, pU280
   Lidstone EA, 2011, ANALYST, V136, P3608, DOI 10.1039/c1an15171a
   Lin B, 2006, SENSOR ACTUAT B-CHEM, V114, P559, DOI 10.1016/j.snb.2005.04.022
   Liu J.-N., 2011, OPT EXPRESS, V5
   Mathias P. C., 2009, APPL PHYS LETT, V95
   Mathias PC, 2010, ANAL CHEM, V82, P6854, DOI 10.1021/ac100841d
   Mathias PC, 2008, ANAL CHEM, V80, P9013, DOI 10.1021/ac801377k
   Neviere M., 1973, Optics Communications, V9, P48, DOI 10.1016/0030-4018(73)90333-7
   Neviere M., 1973, Optics Communications, V8, P113, DOI 10.1016/0030-4018(73)90150-8
   Pokhriyal A., 2010, APPL PHYS LETT, V97
   Pokhriyal A, 2010, OPT EXPRESS, V18, P24793, DOI 10.1364/OE.18.024793
   Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562
   Rosenblatt D, 1997, IEEE J QUANTUM ELECT, V33, P2038, DOI 10.1109/3.641320
   Zangar R, 2003, FASEB J, V17, pA986
   Zangar R. C., 2007, FRONTIERS BIOSCIENCE, V12, P3956
   Zangar RC, 2005, DRUG METAB REV, V37, P473, DOI 10.1080/03602530500205309
   Zhang W, 2008, SENSOR ACTUAT B-CHEM, V131, P279, DOI 10.1016/j.snb.2007.11.017
NR 38
TC 1
Z9 1
U1 0
U2 15
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8909-8
J9 PROC SPIE
PY 2012
VL 8266
AR 826609
DI 10.1117/12.910192
PG 11
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BZY10
UT WOS:000303338000004
DA 2018-10-19
ER

PT J
AU Deng, YB
   Cai, JH
   Zhou, P
AF Deng, Yi-Bin
   Cai, Jian-Hua
   Zhou, Ping
TI Naturally Stable Free Radical in the Silk Fibroin and Its Structure
   Environment Studied by EPR and DFT
SO SPECTROSCOPY LETTERS
LA English
DT Article
DE conformation; DFT; protein; Tyrosyl radical
ID HYPERFINE COUPLING-CONSTANTS; DENSITY-FUNCTIONAL CALCULATIONS;
   PI-ELECTRON RADICALS; SOLID-STATE NMR; MAGNETIC-PROPERTIES; TYROSYL
   RADICALS; OXIDATIVE STRESS; G-TENSOR; PROTEINS; MODEL
AB EPR spectra of Bombyx mori silk fibroin show a singlet peak at g = 2.0030 +/- 0.0005, which is thought to be a signal of the naturally stable free radical. We found that the intensity of EPR signal increases with the increase in pH of the prepared samples and that the signal recorded at ambient temperature is more symmetric and sharper than that recorded at 100 K. We calculated the H-1 hyperfine coupling constants by the density functional theory (DFT) and simulated the EPR spectrum by the EasySpin software for the tyrosyl radical models. We found that the EPR spectrum of the tyrosyl radical models is dependent sensitively on the local structure of the protein. Furthermore, the calculation demonstrated that the EPR signal of the tyrosyl radical model is isotropic in the model silk fibroin in Silk I conformation, while the signal is anisotropic in the model silk fibroin in Silk II conformation. Therefore, we conclude that the naturally stable free-radical signals observed in the silk fibroin are most likely from the tyrosyl radicals and that the radicals reside in a highly hydrophobic silk fibroin domain in Silk I conformation. It is important to understand the formation mechanism and the lifetime of the free radicals caused by the external factors including molecular structure, pH, heat, light, mechanic force, and the like in the silk fibroin for development of silk applications in the biomaterial field.
C1 [Deng, Yi-Bin; Cai, Jian-Hua; Zhou, Ping] Fudan Univ, Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Zhou, P (reprint author), Fudan Univ, Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.
EM pingzhou@fudan.edu.cn
FU Natural Science Foundations of China [10475017, 20673022, 21074025];
   postdoctoral foundation from Shanghai
FX This work was supported by Natural Science Foundations of China (No.
   10475017, 20673022, and 21074025) and postdoctoral foundation from
   Shanghai. The authors give many thanks to High-End Computing Centre in
   Fudan University for the Gaussian calculation with 16 CPUs of Inter Xeon
   3.06 GHz and also thank Prof. Pan, Prof. Zhou, and Prof. Shi of Research
   Center of Analysis and Test in East China University of Science and
   Technology for their kind help in the EPR measurements.
CR Adamo C, 1999, J MOL STRUC-THEOCHEM, V493, P145, DOI 10.1016/S0166-1280(99)00235-3
   ANDROES GM, 1972, PHOTOCHEM PHOTOBIOL, V15, P375, DOI 10.1111/j.1751-1097.1972.tb06248.x
   Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337
   Barone V, 2008, CHEM PHYS LETT, V454, P139, DOI 10.1016/j.cplett.2008.01.080
   Bennett JP, 1999, J NEUROL SCI, V170, P75, DOI 10.1016/S0022-510X(99)00191-4
   Brynda M, 2007, RES CHEM INTERMEDIAT, V33, P863, DOI 10.1163/156856707782169426
   DEGRAY JA, 1992, J BIOL CHEM, V267, P23583
   Demura M, 1998, J AM CHEM SOC, V120, P1300, DOI 10.1021/ja972069l
   DUNLOP J. I., 1965, Photochemistry and Photobiology, V4, P881, DOI 10.1111/j.1751-1097.1965.tb07936.x
   Engstrom M, 2000, CHEM PHYS LETT, V319, P191, DOI 10.1016/S0009-2614(00)00144-5
   FOSSEY SA, 1991, BIOPOLYMERS, V31, P1529, DOI 10.1002/bip.360311309
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hermosilla L, 2007, CHEM PHYS, V340, P237, DOI 10.1016/j.chemphys.2007.09.004
   Himo F, 1997, BIOPHYS J, V72, P1556, DOI 10.1016/S0006-3495(97)78803-9
   Improta R, 2004, CHEM REV, V104, P1231, DOI 10.1021/cr960085f
   Kuzuya M, 1993, PLASMA SOURCES SCI T, V2, P51, DOI 10.1088/0963-0252/2/1/012
   Lahorte P, 1999, J PHYS CHEM A, V103, P6650, DOI 10.1021/jp990942u
   Liu YC, 1997, J APPL POLYM SCI, V66, P405, DOI 10.1002/(SICI)1097-4628(19971010)66:2<405::AID-APP21>3.0.CO;2-V
   Mamedov SV, 2002, BIOMATERIALS, V23, P3405, DOI 10.1016/S0142-9612(02)00041-8
   MCCONNELL HM, 1959, MOL PHYS, V2, P129, DOI 10.1080/00268975900100121
   MCCONNELL HM, 1958, J CHEM PHYS, V28, P107, DOI 10.1063/1.1744052
   MITA K, 1994, J MOL EVOL, V38, P583
   Munzarova M, 1999, J PHYS CHEM A, V103, P9966, DOI 10.1021/jp992303p
   PAILTHORPE MT, 1972, RADIAT RES, V49, P112, DOI 10.2307/3573376
   SEVILLA MD, 1973, J PHYS CHEM-US, V77, P2954, DOI 10.1021/j100643a006
   Sinnokrot MO, 2003, J PHYS CHEM A, V107, P8377, DOI 10.1021/jp030880e
   Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013
   Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875
   Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046
   Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004
   Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   WINDLE JJ, 1962, TEXT RES J, V32, P963
   WINDLE JJ, 1964, J APPL POLYM SCI, V8, P1531
   Xie X, 2004, CHEM J CHINESE U, V25, P961
   Yamaji T, 2007, J PHYS CHEM A, V111, P4612, DOI 10.1021/jp071263j
   YOSHIOKA H, 1974, B CHEM SOC JPN, V47, P2629, DOI 10.1246/bcsj.47.2629
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou P, 2001, J PHYS CHEM B, V105, P12469, DOI 10.1021/jp0125395
NR 41
TC 6
Z9 6
U1 1
U2 21
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0038-7010
EI 1532-2289
J9 SPECTROSC LETT
JI Spectr. Lett.
PY 2012
VL 45
IS 4
BP 285
EP 295
DI 10.1080/00387010.2011.610858
PG 11
WC Spectroscopy
SC Spectroscopy
GA 936LC
UT WOS:000303590900009
DA 2018-10-19
ER

PT J
AU Meleo, D
   Bedini, R
   Pecci, R
   Mangione, F
   Pacifici, L
AF Meleo, Deborah
   Bedini, Rossella
   Pecci, Raffaella
   Mangione, Francesca
   Pacifici, Luciano
TI Microtomographic and morphometric characterization of a bioceramic bone
   substitute in dental implantology
SO ANNALI DELL ISTITUTO SUPERIORE DI SANITA
LA English
DT Article
DE X-ray microtomography; biocompatible materials; tissue scaffolds; tissue
   engineering
ID MICRO-COMPUTED TOMOGRAPHY; X-RAY MICROTOMOGRAPHY; MARROW STROMAL CELLS;
   IN-VIVO; TRABECULAR BONE; MU-CT; HISTOMORPHOMETRY; SCAFFOLDS; TISSUE;
   MICRORADIOGRAPHY
AB In recent years, bone tissue regeneration studies have led to a deeper knowledge of chemical and structural features of the best biomaterials to be used as replacements for lost bone structures, with the autologus bone still today the only graft material able to ostegenerate, osteinduct and/or osteoconduct. The difficulties of the small available amount of autologus bone, together with morbidity of a second surgical operation on the same patient, have been overcome using both synthetic and biologic substitute bones. The possibility of investigating morphometric characteristics of substitute bones makes it possible to evaluate the predictability of regenerative processes and, so far, a range of different methods have been used for the purpose. X-ray microtomography (micro-CT) is a miniaturized form of conventional tomography, able to analyze the internal structure of small objects, performing three-dimensional images with high spatial resolution (<10 micron pixel size). For a correct analysis, samples need not be altered or treated in any way, as micro-CT is a non-invasive and non-destructive technique. It shows promising results in biomaterial studies and tissue engineering. This work shows the potential applications of this microtomographic technique by means of an in vitro analysis system, in characterizing morphometric features of human bone tissue, and contributes to the use of this technique in studies concerning biomaterials and bioscaffolds inserted in bone tissue.
C1 [Meleo, Deborah; Bedini, Rossella; Pecci, Raffaella] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy.
   [Mangione, Francesca; Pacifici, Luciano] Univ Roma La Sapienza, Dipartimento Sci Odontostomatol & Maxillo Faccial, Rome, Italy.
RP Meleo, D (reprint author), Ist Super Sanita, Dipartimento Tecnol & Salute, Viale Regina Elena 299, I-00161 Rome, Italy.
EM deborahhh@tin.it
RI Pecci, Raffaella/B-2508-2013; Bedini, Rossella/B-2465-2013
OI Bedini, Rossella/0000-0002-0830-6632
CR Basillais A, 2007, J ORTHOP SCI, V12, P141, DOI 10.1007/s00776-006-1104-z
   Beaupied H, 2006, PHYS MED BIOL, V51, P4621, DOI 10.1088/0031-9155/51/18/011
   Bedini R, 2010, 0910 ISTISAN
   Bedini R, 2005, 0537 ISTISAN
   Bedini R, 2009, ANN I SUPER SANITA, V45, P178
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205
   Chiapasco M, 2002, RIABILITAZIONE IMPLA
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   De Franco M, 2000, FATTORI CRESCITA BIO
   Di Stefano DA, 2008, CHIRURG OSSEA RICOST
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Gielkens PFM, 2008, ARCH ORAL BIOL, V53, P558, DOI 10.1016/j.archoralbio.2007.11.011
   Hangartner T. N., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P9
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Lin-Gibson S, 2007, BIOMACROMOLECULES, V8, P1511, DOI 10.1021/bm061139q
   Lindhe J., 2003, PARODONTOLOGIA CLIN
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Park YS, 2005, CLIN ORAL IMPLAN RES, V16, P156, DOI 10.1111/j.1600-0501.2004.01083.x
   Perilli E, 2006, J MICROSC-OXFORD, V222, P124, DOI 10.1111/j.1365-2818.2006.01580.x
   Regauer M, 2006, BONE, V38, P564, DOI 10.1016/j.bone.2005.09.005
   Tang SY, 2007, BONE, V40, P1259, DOI 10.1016/j.bone.2006.10.031
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
NR 28
TC 8
Z9 8
U1 0
U2 9
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0021-2571
J9 ANN I SUPER SANITA
JI Ann. Ist. Super. Sanita
PY 2012
VL 48
IS 1
BP 59
EP 64
DI 10.4415/ANN_12_01_10
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 931NR
UT WOS:000303227100010
PM 22456017
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Karademir, A
   Yenidogan, S
   Aydemir, C
   Kucuk, H
AF Karademir, Arif
   Yenidogan, Semiha
   Aydemir, Cem
   Kucuk, Haluk
TI Evaluation of Sound Absorption, Printability, and Some Mechanical
   Properties of Thin Recycled Cellulosic Sheets Containing Wool, Ceramic
   Fiber, and Cotton Dust
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS
LA English
DT Article
DE biomaterial; printability; recycling; sound absorbent; waste fibers
ID ACOUSTIC ABSORPTION; POROUS MATERIALS; PAPER; COMPOSITES; PERFORMANCE;
   MORPHOLOGY; NETWORKS; SURFACE; FILLER; WASTE
AB A number of thin biocomposites were produced from waste corrugated board pulp with 15% and 30% blending of wool fibers (WF), ceramic fibers (CF), and cotton dust (CD), respectively. The highest sound absorption value was obtained from samples containing 30% wool fibers. Printability of control sheets unfortunately was remarkably damaged. Ceramic fibers improved the thermal stability of control sheets, which was followed by WF and CD. Tensile and burst indexes of samples, however, were greatly reduced. It was furthermore found that CD, CF, and WF additions increased the air permeability values of resultant papers parallel to great reduction on densities.
C1 [Karademir, Arif] Fac Forestry, Dept Forest Product Engn, Maras, Turkey.
   [Yenidogan, Semiha; Aydemir, Cem] Marmara Univ, Fac Tech Educ, Dept Printing, Goztepe, Turkey.
   [Kucuk, Haluk] Marmara Univ, Fac Technol, Dept Mechatron Engn, Goztepe, Turkey.
RP Karademir, A (reprint author), Fac Forestry, Dept Forest Product Engn, Avsar Campus, TR-46100 K Maras, Turkey.
EM arifkarademir@yahoo.com
CR Aydemir C, 2010, INT J POLYM MATER, V59, P891, DOI 10.1080/00914037.2010.504154
   Bachmann J, 2000, SOIL SCI SOC AM J, V64, P564, DOI 10.2136/sssaj2000.642564x
   Caspersen L., 2000, ADV MAT P, P158
   Chen DK, 2010, COMPOS PART A-APPL S, V41, P1012, DOI 10.1016/j.compositesa.2010.04.007
   Chen WH, 2000, J SOUND VIB, V237, P337, DOI 10.1006/jsvi.2000.3029
   Ersoy S, 2007, APPL ACOUST, V70, P215
   Fatima S, 2011, APPL ACOUST, V72, P108, DOI 10.1016/j.apacoust.2010.10.005
   Fouladi MH, 2010, APPL ACOUST, V71, P241, DOI 10.1016/j.apacoust.2009.09.003
   Hong Z. B.L., 2007, J SOUND VIB, V42, P199
   Hur BY, 2005, MATER SCI FORUM, V475-479, P2687, DOI 10.4028/www.scientific.net/MSF.475-479.2687
   I'Anson SJ, 2006, APPITA J, V59, P297
   Ilgun A, 2010, SCI RES ESSAYS, V5, P1530
   Imamoglu S, 2006, APPITA J, V59, P218
   Johnson N.A.G., 2003, J TEXT I, V3, P26
   Kosuge K, 2005, J MATER SCI, V40, P5399, DOI 10.1007/s10853-005-4338-9
   Kwak SA, 2007, FIBER POLYM, V8, P130, DOI 10.1007/BF02908171
   la U., 2003, NORD PULP PAP RES J, V18, P413
   Murugan D, 2006, POLYM-PLAST TECHNOL, V45, P885, DOI 10.1080/03602550600611818
   Onen O, 2010, APPL ACOUST, V71, P79, DOI 10.1016/j.apacoust.2009.07.012
   Raquel A., 2010, J BIOBASED MATER BIO, V4, P129
   Senden TJ, 2000, NORD PULP PAP RES J, V15, P554
   Simpson W.S., 2002, SCI TECHNOL, P62
   Sjostrom E., 1981, WOOD CHEM FUNDAMENTA, P21
   Tserki V, 2003, J APPL POLYM SCI, V88, P1825, DOI 10.1002/app.11812
   Wang CN, 2001, APPL ACOUST, V62, P447, DOI 10.1016/S0003-682X(00)00043-8
   Wang J, 2008, J MEMBRANE SCI, V318, P280, DOI 10.1016/j.memsci.2008.02.060
   Wassilieff C, 1996, APPL ACOUST, V48, P339, DOI 10.1016/0003-682X(96)00013-8
   Yang HS, 2003, BIORESOURCE TECHNOL, V86, P117, DOI 10.1016/S0960-8524(02)00163-3
   Yang TL, 2001, J VIB CONTROL, V7, P675
   Yang X, 2007, MATER MANUF PROCESS, V22, P721, DOI 10.1080/10426910701385291
   Yenidogan S, 2010, ASIAN J CHEM, V22, P7865
   Yuhazri MY, 2010, INT J CIVIL ENV ENG, V10, P16
NR 32
TC 3
Z9 3
U1 1
U2 13
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
J9 INT J POLYM MATER
JI Int. J. Polym. Mater.
PY 2012
VL 61
IS 5
BP 357
EP 370
DI 10.1080/00914037.2011.584231
PG 14
WC Polymer Science
SC Polymer Science
GA 931QA
UT WOS:000303233200004
DA 2018-10-19
ER

PT J
AU Ruder, WC
   Pratt, ED
   Bakhru, S
   Sitti, M
   Zappe, S
   Cheng, CM
   Antaki, JF
   LeDuc, PR
AF Ruder, Warren C.
   Pratt, Erica D.
   Bakhru, Sasha
   Sitti, Metin
   Zappe, Stefan
   Cheng, Chao-Min
   Antaki, James F.
   LeDuc, Philip R.
TI Three-dimensional microfiber devices that mimic physiological
   environments to probe cell mechanics and signaling
SO LAB ON A CHIP
LA English
DT Article
ID ION CHANNELS; CA2+ ENTRY; CALCIUM; FIBROBLASTS; DYNAMICS; COMPLEX
AB Many physiological systems are regulated by cells that alter their behavior in response to changes in their biochemical and mechanical environment. These cells experience this dynamic environment through an endogenous biomaterial matrix that transmits mechanical force and permits chemical exchange with the surrounding tissue. As a result, in vitro systems that mimic three-dimensional, in vivo cellular environments can enable experiments that reveal the nuanced interplay between biomechanics and physiology. Here we report the development of a minimal-profile, three-dimensional (MP3D) experimental microdevice that confines cells to a single focal plane, while allowing the precise application of mechanical displacement to cells and concomitant access to the cell membrane for perfusion with biochemical agonists. The MP3D device - an ordered microfiber scaffold erected on glass - provides a cellular environment that induces physiological cell morphologies. Small manipulations of the scaffold's microfibers allow attached cells to be mechanically probed. Due to the scaffold's minimal height profile, MP3D devices confine cells to a single focal plane, facilitating observation with conventional epifluorescent microscopy. When examining fibroblasts within MP3D devices, we observed robust cellular calcium responses to both a chemical stimulus as well as mechanical displacement of the cell membrane. The observed response differed significantly from previously reported, mechanically-induced calcium responses in the same cell type. Our findings demonstrate a key link between environment, cell morphology, mechanics, and intracellular signal transduction. We anticipate that this device will broadly impact research in fields including biomaterials, tissue engineering, and biophysics.
C1 [Ruder, Warren C.; Pratt, Erica D.; Bakhru, Sasha; Sitti, Metin; Zappe, Stefan; Cheng, Chao-Min; Antaki, James F.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Pratt, Erica D.; Sitti, Metin; Cheng, Chao-Min; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
   [Sitti, Metin] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA.
   [Antaki, James F.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA.
   [LeDuc, Philip R.] Carnegie Mellon Univ, Dept Computat Biol, Pittsburgh, PA 15213 USA.
   [LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.
   [Cheng, Chao-Min] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu 300, Taiwan.
RP Antaki, JF (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM antaki@cmu.edu; prleduc@cmu.edu
RI LeDuc, Philip/M-1103-2014; Antaki, James/S-3051-2016; Pratt,
   Erica/H-6566-2015
OI LeDuc, Philip/0000-0001-6397-2905; Antaki, James/0000-0002-5430-7353; 
FU National Science Foundation [CMMI-0856187, CMMI-1013748]; Office of
   Naval Research [N000140910215]; Beckman Young Investigators Program;
   CMU; NIH-NIBIB [T32 EB0003392]; REU at the CMU Center for Bioimage
   Informatics [EF-0331657]
FX The authors thank Professor A. M. Hofer for expert technical instruction
   in manufacturing polypropylene microfibers and Professor Y.L. Wang for
   helpful scientific discussions. This work was supported in part by the
   National Science Foundation (CMMI-0856187, CMMI-1013748), the Office of
   Naval Research (N000140910215) and the Beckman Young Investigators
   Program (P. R. L.). W. C. R. was supported by a Dowd-ICES predoctoral
   fellowship awarded by CMU as well as by the NIH-NIBIB training grant T32
   EB0003392 entitled 'Biomechanics in Regenerative Medicine'. E. D. P. was
   supported in part by a REU supplement to NSF grant EF-0331657 at the CMU
   Center for Bioimage Informatics.
CR Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999
   Cheng CM, 2006, MOL BIOSYST, V2, P299, DOI 10.1039/b606496p
   Cheng CM, 2010, NAT PROTOC, V5, P714, DOI 10.1038/nprot.2010.15
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Ferri KF, 2000, EXP CELL RES, V261, P119, DOI 10.1006/excr.2000.5062
   Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Kuczenski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004847
   Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046
   Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   Rudolf R, 2003, NAT REV MOL CELL BIO, V4, P579, DOI 10.1038/nrm1153
   Takagi Mutsumi, 2003, J Artif Organs, V6, P222, DOI 10.1007/s10047-003-0218-8
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333
NR 19
TC 12
Z9 12
U1 2
U2 35
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2012
VL 12
IS 10
BP 1775
EP 1779
DI 10.1039/c2lc21117c
PG 5
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 930UL
UT WOS:000303167200006
PM 22374375
DA 2018-10-19
ER

PT J
AU Nitescu, M
   Dumitriu, AS
   Dumitru, SG
   Traistaru, M
   Burlibasa, M
AF Nitescu, Mihaela
   Dumitriu, Anca Silvia
   Dumitru, Simion Gheorghe
   Traistaru, Matei
   Burlibasa, Mihai
TI SURFACE TREATMENT METHODS FOR TITANIUM IMPLANTS
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE titanium implants; titianium alloys; surface
ID DENTAL IMPLANTS
AB Titanium and its alloys are used for dental implants due to favorable properties such as mechanical strength and biocompatibility. Final processing of implants requires certain surface treatments, performed in order to obtain more rapid tissue integration. The result of these treatments is to modify the surface characteristics such as topography, roughness and chemical composition, that influence the biomaterial osseoconductibility by stimulating osseointegration. The purpose of this paper is to present the current methods of implant surface treatment, providing a review of the literature data. Briefly are presented the characteristics of each method, and also their classification. In addition, are reported the results of different studies on the effectiveness of such methods, in terms of restoring the implants surrounding bone. Also, are presented new trends in this field. Since it is a vast field, there are still many unknowns, which will be studied in further research.
C1 [Nitescu, Mihaela; Dumitriu, Anca Silvia; Traistaru, Matei; Burlibasa, Mihai] Univ Med & Pharm Carol Davila Bucharest, Fac Dent, Bucharest, Romania.
   [Dumitru, Simion Gheorghe] UM 01751 Brasov, Brasov, Romania.
RP Nitescu, M (reprint author), Univ Med & Pharm Carol Davila Bucharest, Fac Dent, Bucharest, Romania.
EM mihaelantsc@yahoo.com; as_dumitriu@yahoo.com; dumitrugsimion@yahoo.com;
   matei.traistaru@gmail.com; mburlibasa@gmail.com
CR Balaji S.M., 2007, TXB PRAL MAXILLOFACI
   Bathla S., 2011, PERIODONTICS REV
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   Chaturvedi T.P., 2008, IMPLANTOLOGY MADE EA
   Dillow A., 2002, BIOMIMETIC MAT DESIG
   Drago C, 2007, IMPLANT RESTORATIONS
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   Gilbert J., 2007, MED DEVICE MAT
   Gilbert J., 2009, MED DEVICE MAT
   JASTY M, 1992, CLIN ORTHOP RELAT R, P300
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kim H.W., 2004, KEY ENG MATER, V254-256, P42
   Leewenburgh S, 2001, J BIOMED MATER RES, V56, P208
   Leon B., 2008, THIN CALCIUM PHOSPHA
   LEWANDOWSKI JA, 1989, J PROSTHET DENT, V62, P127, DOI 10.1016/0022-3913(89)90297-7
   Malet J., 2012, IMPLANT DENTISTRY AT
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Miloro M, 2004, PETERSONS PRINCIPLES
   Natali AN., 2003, DENTAL BIOMECHANICS
   Ong M., 2006, CHARACTERIZATION DEV, V58, P67
   Orsini G., 2000, INT J ORAL MAXILLOF, V15, P779
   Oshida Y., 2007, BIOSCIENCE BIOENGINE
   Piattelli A, 1993, Int J Oral Maxillofac Implants, V8, P309
   PILLIAR RM, 1991, J DENT RES, V70, P1338, DOI 10.1177/00220345910700100501
   Shrivastava S., 2003, MED DEV MAT P MAT PR
   SPIEKERMANN H, 1995, IMPLANTOLOGY
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Waqar A., 2012, MAT PROCESSES APPL
   Zhang S., 2011, BIOL BIOMEDICAL COAT
NR 29
TC 1
Z9 1
U1 0
U2 10
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2012
VL 17
IS 6
BP 147
EP 150
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 928ND
UT WOS:000302988700031
DA 2018-10-19
ER

PT J
AU Lee, JTY
   Chow, KL
AF Lee, Juliana Tsz Yan
   Chow, King Lau
TI SEM sample preparation for cells on 3D scaffolds by freeze-drying and
   HMDS
SO SCANNING
LA English
DT Article
DE scanning electron microscopy (SEM); biomaterials; calcium phosphates;
   freeze-drying; hexamethyldisilazane (HMDS)
ID MESENCHYMAL STEM-CELLS; SCANNING-ELECTRON-MICROSCOPY; BONE TISSUE
   REGENERATION; IN-VITRO; OSTEOGENIC DIFFERENTIATION; COMPOSITE SCAFFOLDS;
   CHITOSAN SCAFFOLDS; HYBRID SCAFFOLDS; MINERALIZATION; PROLIFERATION
AB Common dehydration methods of cells on biomaterials for scanning electron microscopy (SEM) include air drying, hexamethyldisilazane (HMDS) or tetramethysilane (TMS) treatment and critical point drying (CPD). On the other side, freeze-drying has been widely employed in dehydrating biological samples and also in preparing porous biomaterial scaffolds but not in preparing cells on three-dimensional (3D) biomaterials for SEM examination. In this study, we compare cells on porous hydroxyapatite (HA) prepared by air drying, HMDS and freeze-drying. The effects of fixation and using phosphate buffered saline (PBS) in the fixation were also assessed on three porous calcium phosphate (CaP) materials, namely, HA, a-tricalcium phosphate (a-TCP) and beta-tricalcium phosphate (beta-TCP) samples. There is no significant difference in samples prepared by HMDS treatment and freeze-drying viewed at low magnification. Besides, it is better not to use phosphate buffer in the fixation step for CaP materials to avoid undesirable spontaneous precipitation of CaPs. On the other hand, fewer exchanges of liquids are required for freeze-drying and hence chemical fixation may not be absolutely required for samples prepared by freeze-drying. Other technical details of the preparation were also investigated and discussed. This study suggests both HMDS and freeze-drying can be employed to dehydrate cells on 3D scaffolds for SEM examination. SCANNING 34: 1225, 2012. (c) 2011 Wiley Periodicals, Inc.
C1 [Lee, Juliana Tsz Yan; Chow, King Lau] Hong Kong Univ Sci & Technol, Bioengn Grad Program, Kowloon, Hong Kong, Peoples R China.
   [Chow, King Lau] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.
RP Lee, JTY (reprint author), Hong Kong Univ Sci & Technol, Bioengn Grad Program, Kowloon, Hong Kong, Peoples R China.
EM juliana@ust.hk
OI Lee, Juliana Tsz Yan/0000-0002-2249-1387
FU Hong Kong University of Science and Technology [RPC 07/08.EG02];
   Research Grants Council [HKUST660407]
FX Contract grant sponsor: Hong Kong University of Science and Technology;
   Contract grant number: RPC 07/08.EG02; Contract grant sponsor: Research
   Grants Council; Contract grant number: HKUST660407.
CR Alberts B., 2004, ESSENTIAL CELL BIOL
   Amaral M, 2008, J BIOMED MATER RES A, V87A, P91, DOI 10.1002/jbm.a.31742
   Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Antunes JC, 2010, J BIOMED MATER RES A, V94A, P856, DOI 10.1002/jbm.a.32753
   Bertoldi S, 2010, J MATER SCI-MATER M, V21, P1005, DOI 10.1007/s10856-009-3953-4
   Botes L, 2002, MICROSC RES TECHNIQ, V59, P128, DOI 10.1002/JEMT.10184
   Bozzola J.J., 1999, ELECT MICROSCOPY PRI
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Chevalier E, 2008, J PHARM SCI-US, V97, P1135, DOI 10.1002/jps.21059
   De Giglio E, 2010, ACTA BIOMATER, V6, P282, DOI 10.1016/j.actbio.2009.07.008
   De Nardo L, 2010, J MATER SCI-MATER M, V21, P2067, DOI 10.1007/s10856-010-4082-9
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DYKSTRA M J, 1992, BIOL ELECT MICROSCOP
   Echlin P., 2009, HDB SAMPLE PREPARATI
   Ehrenfest DMD, 2010, ARCH ORAL BIOL, V55, P185, DOI 10.1016/j.archoralbio.2010.01.004
   Cruz DMG, 2010, J BIOMED MATER RES A, V95A, P1182, DOI 10.1002/jbm.a.32906
   Hautamaki M, 2010, J MATER SCI-MATER M, V21, P1685, DOI 10.1007/s10856-010-4018-4
   Hayat M. A., 2000, PRINCIPLES TECHNIQUE
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Ji CD, 2011, ACTA BIOMATER, V7, P1653, DOI 10.1016/j.actbio.2010.11.043
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Jung SW, 2010, J APPL PHYCOL, V22, P313, DOI 10.1007/s10811-009-9461-6
   Kuo J., 2007, ELECT MICROSCOPY MET
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lee JTY, 2011, ACTA BIOMATER, V7, P2615, DOI 10.1016/j.actbio.2011.02.034
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Leng Y., 2008, MAT CHARACTERIZATION
   Liu LH, 2006, J MEMBRANE SCI, V280, P375, DOI 10.1016/j.memsci.2006.01.040
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   Pawley J. B., 2006, HDB BIOL CONFOCAL MI
   Pezeshki P, 2010, J BIOMED MATER RES A, V94A, P660, DOI 10.1002/jbm.a.32666
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050
   Qian L, 2011, J CHEM TECHNOL BIOT, V86, P172, DOI 10.1002/jctb.2495
   Rai B, 2010, BIOMATERIALS, V31, P7960, DOI 10.1016/j.biomaterials.2010.07.001
   Raucci MG, 2010, ACTA BIOMATER, V6, P4090, DOI 10.1016/j.actbio.2010.04.018
   Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Tallon C, 2011, J CERAM SOC JPN, V119, P147, DOI 10.2109/jcersj2.119.147
   Teixeira S, 2010, J BIOMED MATER RES A, V95A, P1, DOI 10.1002/jbm.a.32600
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Ubero-Pascal N, 2005, MICROSC RES TECHNIQ, V68, P264, DOI 10.1002/jemt.20248
   Velasco D, 2010, J SUPERCRIT FLUID, V54, P335, DOI 10.1016/j.supflu.2010.05.012
   Vemuri MC, 2007, STEM CELL ASSAYS
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Warnke PH, 2010, J BIOMED MATER RES B, V93B, P212, DOI 10.1002/jbm.b.31577
   Weir MD, 2010, J BIOMED MATER RES B, V93B, P93, DOI 10.1002/jbm.b.31563
   Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Xu CX, 2011, BIOMATERIALS, V32, P1051, DOI 10.1016/j.biomaterials.2010.09.068
   Xue DT, 2010, J BIOMED MATER RES A, V94A, P259, DOI 10.1002/jbm.a.32691
   Yonggang Y, 2007, CLIN ORAL IMPLAN RES, V18, P345
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
NR 58
TC 27
Z9 29
U1 2
U2 52
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0161-0457
J9 SCANNING
JI Scanning
PD JAN-FEB
PY 2012
VL 34
IS 1
BP 12
EP 25
DI 10.1002/sca.20271
PG 14
WC Instruments & Instrumentation; Microscopy
SC Instruments & Instrumentation; Microscopy
GA 931GA
UT WOS:000303203100003
PM 22532079
DA 2018-10-19
ER

PT S
AU Seramak, T
   Serbinski, W
   Zielinski, A
AF Seramak, Tomasz
   Serbinski, Waldemar
   Zielinski, Andrzej
BE Labanowski, J
   Zielinski, A
TI Formation of Porous Structure of the Metallic Materials Used on Bone
   Implants
SO ENVIRONMENTAL DEGRADATION OF ENGINEERING & MATERIALS ENGINEERING AND
   TECHNOLOGIES
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 4th International Conference on Environmental Degradation of Engineering
   Materials/5th International Conference on Materials Engineering and
   Technologies (EDEMET2011)
CY MAY 15-18, 2011
CL Gdansk, POLAND
DE biomaterial; porous material; implants; titanium alloy; biocompatibility
ID TOTAL HIP-ARTHROPLASTY; ELECTRODISCHARGE COMPACTION; ORTHOPEDIC
   IMPLANTS; TITANIUM; ATTACHMENT; POLYETHYLENE; COMPOSITES; STIFFNESS;
   FIXATION; INGROWTH
AB Research on improvement of structure and fabrication methods of the bone implants are carried out for many years. Research are aimed to shape the structures, that will have a Young's modulus value similar to the value of the human bones Young's modulus. Depending on the porosity, Young's moduli can even be tailored to match the modulus of bone closer than solid metals can, thus reducing the problems associated with stress shielding of a human bones. The designed structure should also be characterized by a high abrasion and corrosion resistance to and allow bone ingrowth in the implant material to make the best bone-implant fixation. For this purpose, implants should have a porous structure with an appropriate pore size and with open-cell porosity. Material for bone implants must also have a high biocompatibility and bioactivity. Following these requirements, the metallic porous materials appear to be the most suitable material for bone implants.
   In this paper a various methods of a porous materials fabrication for bone implants are listed. It was shown that titanium and its alloys (e.g. Ti6Al4V or Ti13Nb13Zr) are widely used as biomaterials for implants. Research in order to increase their wear and corrosion resistance and to improve their biocompatibility and bioactivity are still carried out. One of the most effective methods of manufacturing the porous materials is a powder metallurgy (PM).
   In this paper the results of research under shaping the structure of the porous titanium alloy Ti13Nb13Zr are also presented. As a manufacturing method of the porous material from the investigated and mentioned above Ti alloy, the powder metallurgy (PM) was choosen - with and without the use of a space holders. Method of fabrication a spherical powder from the aforementioned Ti alloy and results of its morphology research are discussed. The applied powder compaction method (with use and without use of space holders) and the influence of a sintering process on the final microstructure morphology of porous material obtained from Ti13Nb13Zr alloy are also presented and discussed.
C1 [Seramak, Tomasz; Serbinski, Waldemar; Zielinski, Andrzej] Gdansk Univ Technol, Fac Mech Engn, Dept Mat & Welding Engn, PL-80233 Gdansk, Poland.
RP Seramak, T (reprint author), Gdansk Univ Technol, Fac Mech Engn, Dept Mat & Welding Engn, Narutowicza 11-12, PL-80233 Gdansk, Poland.
EM tseramak@pg.gda.pl; wserbins@pg.gda.pl; azielins@wp.pl
CR Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Bobyn J., 1999, SCI EXH ANN AAOS AN
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   Ducheyne P., 1986, CLIN MATER, V1, P59
   Engh C A, 1986, Instr Course Lect, V35, P169
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   Karagienes M., 1973, BIOMAT MED DEV ARTIF, P171
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Korner C, 2000, ADV ENG MATER, V2, P159, DOI 10.1002/(SICI)1527-2648(200004)2:4<159::AID-ADEM159>3.0.CO;2-O
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   LIFLAND MI, 1994, CLIN MATER, V17, P203, DOI 10.1016/0267-6605(94)90037-X
   Markaki A.E., 2004, SPIE INT S SMART MAT
   MARTELL JM, 1993, J BONE JOINT SURG AM, V75A, P554, DOI 10.2106/00004623-199304000-00010
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   OKAZAKI K, 1991, J BIOMED MATER RES, V25, P1417, DOI 10.1002/jbm.820251202
   OTANI T, 1992, ORTHOP CLIN N AM, V23, P335
   PILLIAR RM, 1979, J BIOMED MATER RES, V13, P799, DOI 10.1002/jbm.820130510
   Qiu J, 1997, BIOMATERIALS, V18, P153, DOI 10.1016/S0142-9612(96)00097-X
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   Simancik F., 2002, HDB CELLULAR METALS, P1
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   Sychterz CJ, 2001, CLIN ORTHOP RELAT R, P218
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   WEBER JN, 1972, MATER RES BULL, V7, P1005, DOI 10.1016/0025-5408(72)90092-X
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
NR 38
TC 1
Z9 1
U1 0
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
J9 SOLID STATE PHENOMEN
PY 2012
VL 183
BP 155
EP 162
DI 10.4028/www.scientific.net/SSP.183.155
PG 8
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BZT84
UT WOS:000302926500024
DA 2018-10-19
ER

PT J
AU Goulle, F
AF Goulle, F.
TI Use of porcine small intestinal submucosa for corneal reconstruction in
   dogs and cats: 106 cases
SO JOURNAL OF SMALL ANIMAL PRACTICE
LA English
DT Article
ID AMNIOTIC MEMBRANE TRANSPLANTATION; POLYMERASE CHAIN-REACTION; REPAIR;
   GRAFT; HORSES; SEQUESTRA; DEFECTS; SURFACE; DISEASE; ULCERS
AB OBJECTIVES: To describe the efficacy of porcine small intestinal submucosa in corneal reconstructive surgery in dogs and cats through a large retrospective study.
   METHODS: A retrospective evaluation of 106 cases of surgical reconstruction of the cornea with small intestinal submucosa seen between May 2005 and January 2010 was carried out. The corneal defect was filled by microsurgical grafting of porcine small intestinal submucosa. The biomaterial implant was deposited in one or several layers depending on the depth of the defect. The animals were examined 3, 6 and 12 weeks after surgery.
   RESULTS: Vision was preserved in all eyes at three months post-surgery. In 74 cases (69.8%) the corneal scar was either transparent or discrete, whilst in 32 cases (30.2%) a mild or marked scar was observed. Minor complications occurred in 9 cases (8.5%) with partial integration of the small intestinal submucosa and in 24 cases (22.6%) with faint or mild corneal pigmentation, without impairing vision. In cases followed over a period longer than three months, major complications occurred in five dogs resulting in vision impairment because of pronounced pigmentation.
   CLINICAL SIGNIFICANCE: Corneal grafting of porcine small intestinal submucosa is an effective method for corneal reconstruction resulting in corneal transparency in most cases. It is an excellent alternative to conventional conjunctival grafts.
C1 Clin Vet Aquivet Serv Ophtalmol, F-33320 Foret Eysines, France.
RP Goulle, F (reprint author), Clin Vet Aquivet Serv Ophtalmol, Parc Activites Mermoz,Ave Foret Eysines, F-33320 Foret Eysines, France.
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Andrade Alexandre L., 1999, Veterinary Ophthalmology, V2, P79
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Barros P. S. M., 1997, Brazilian Journal of Veterinary Research and Animal Science, V34, P138
   Barros Paulo S. M., 1998, Veterinary Ophthalmology, V1, P119, DOI 10.1046/j.1463-5224.1998.00026.x
   Barros PSM, 2005, VET OPHTHALMOL, V8, P189, DOI 10.1111/j.1463-5224.2005.00391.x
   Barros PSM, 1995, BRAZ J VET RES ANIM, V32, P251
   Bussieres M, 2004, VET OPHTHALMOL, V7, P352, DOI 10.1111/j.1463-5224.2004.04055.x
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Featherstone H, 2000, VET REC, V146, P136, DOI 10.1136/vr.146.5.136
   Featherstone HJ, 2004, VET OPHTHALMOL, V7, P213, DOI 10.1111/j.1463-5224.2004.04028.x
   Featherstone HJ, 2001, VET OPHTHALMOL, V4, P147, DOI 10.1046/j.1463-5224.2001.00192.x
   GELATT K. N., 2003, SMALL ANIMAL OPHTHAL
   Gelatt KN, 1995, HDB SMALL ANIMAL OPH, V2
   Gilger BC, 1999, VETERINARY OPHTHALMOLOGY, 3RD EDITION, P675
   Gilger BC, 2007, VET OPHTHALMOLOGY, V2, P690
   Griguer F, 2001, REV MED VET-TOULOUSE, V152, P597
   HAKANSON NE, 1987, J AM ANIM HOSP ASSOC, V23, P641
   Hansen P. A., 1999, Veterinary Ophthalmology, V2, P233, DOI 10.1046/j.1463-5224.1999.00084.x
   HENDRIX DVH, 2007, VET OPHTHALMOLOGY, P662
   Lassaline ME, 2005, VET OPHTHALMOL, V8, P311, DOI 10.1111/j.1463-5224.2005.00405.x
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   Ollivier FJ, 2006, VET OPHTHALMOL, V9, P404, DOI 10.1111/j.1463-5224.2006.00480.x
   PENA GIMENEZ T., 1998, VET OPHTHALMOL, V1, P163
   ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x
   Stiles J, 1997, AM J VET RES, V58, P338
   Townsend WM, 2004, AM J VET RES, V65, P314, DOI 10.2460/ajvr.2004.65.314
   Vanore M, 2007, VET OPHTHALMOL, V10, P93, DOI 10.1111/j.1463-5224.2007.00515.x
   Whitley RD, 1999, VETERINARY OPHTHALMOLOGY, 3RD EDITION, P635
   WILKIE DA, 1991, J AM VET MED ASSOC, V198, P1019
NR 31
TC 22
Z9 25
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-4510
J9 J SMALL ANIM PRACT
JI J. Small Anim. Pract.
PD JAN
PY 2012
VL 53
IS 1
BP 34
EP 43
DI 10.1111/j.1748-5827.2011.01149.x
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 927VL
UT WOS:000302938300006
PM 22122191
OA Bronze
DA 2018-10-19
ER

PT S
AU Bordeaux-Rego, P
   Baratti, MO
   Duarte, ASS
   Ribeiro, TB
   Andreoli-Risso, MF
   Vidal, B
   Miranda, JB
   Adur, J
   de Thomaz, AA
   Pelegati, VB
   Costa, FF
   Carvalho, HF
   Cesar, CL
   Luzo, A
   Saad, STO
AF Bordeaux-Rego, P.
   Baratti, M. O.
   Duarte, A. S. S.
   Ribeiro, T. B.
   Andreoli-Risso, M. F.
   Vidal, B.
   Miranda, J. B.
   Adur, J.
   de Thomaz, A. A.
   Pelegati, V. B.
   Costa, F. F.
   Carvalho, H. F.
   Cesar, C. L.
   Luzo, A.
   Olalla Saad, S. T.
BE Periasamy, A
   Konig, K
   So, PTC
TI Use of the second harmonic generation microscopy to evaluate
   chondrogenic differentiation of mesenchymal stem cells for cartilage
   repair
SO MULTIPHOTON MICROSCOPY IN THE BIOMEDICAL SCIENCES XII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Multiphoton Microscopy in the Biomedical Sciences XII
CY JAN 22-24, 2012
CL San Francisco, CA
SP SPIE, Becker & Hickel GmbH, Boston Elect Corp, Carl Zeiss MicroImaging GmbH, Chroma Technol Corp, Coherent Inc, JenLab GmbH, Leica Microsyst, Multiphoton Laser Technol Inc, Newport-Spectra Phys, Olympus Amer Inc, Omega Opt, Inc, Semrock, Inc
DE Second Harmonic Generation; mesenchymal stem cell; cartilage repair
   collagen fibrils
ID BONE-MARROW; ARTICULAR-CARTILAGE; IN-VITRO; MATRIX; TISSUE;
   CHONDROCYTES; EXPRESSION; SITU
AB Articular cartilage injury remains one of the major concerns in orthopedic surgery. Mesenchymal stem cell (MSC) transplantation has been introduced to avoid some of the side effects and complications of current techniques.. With the aim to evaluate chondrogenic differentiation of mesenchymal stem cells, we used Second Harmonic Generation (SHG) microscopy to analyze the aggregation and orientation of collagen fibrils in the hyaline cartilage of rabbit knees. The experiment was performed using implants with type II collagen hydrogel (a biomaterial that mimics the microenvironment of the cartilage), one implant containing MSC and one other without MSC (control). After 10 weeks, the rabbit knees were dissected and fibril collagen distribution and spatial organization in the extracellular matrix of the lesions were verified by SHG. The result showed significant differences, whereas in histological sections of the cartilaginous lesions with MSC the collagen fibers are organized and regular; in the control sections the collagen fibers are more irregular, with absence of cells. A macroscopic analysis of the lesions confirmed this difference, showing a greater percentage of lesions filling in knees treated with MSC than in the knees used as controls. This study demonstrates that SHG microscopy will be an excellent tool to help in the evaluation of the effectiveness of MSC-based cell therapy for cartilage repair.
C1 [Bordeaux-Rego, P.; Baratti, M. O.; Duarte, A. S. S.; Ribeiro, T. B.; Andreoli-Risso, M. F.; Luzo, A.; Olalla Saad, S. T.] Univ Estadual Campinas, Hemoctr, Fac Med, Dept Clin Med, Campinas, SP, Brazil.
   [Baratti, M. O.; Vidal, B.; Miranda, J. B.] Univ Estadual Campinas, Inst Biol, Lab Biol Celular, Campinas, SP, Brazil.
   [Adur, J.; de Thomaz, A. A.; Pelegati, V. B.; Costa, F. F.; Carvalho, H. F.; Cesar, C. L.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Lab Aplicacoes Biomed Lasers, Campinas, SP, Brazil.
   [Adur, J.] UNER, Fac Ingn, Lab Microscopia Aplicada Estudios Mol & Celulares, Parana, Argentina.
RP Bordeaux-Rego, P (reprint author), Univ Estadual Campinas, Hemoctr, Fac Med, Dept Clin Med, Campinas, SP, Brazil.
EM pedrobordeaux@gmail.com
RI de Thomaz, Andre/G-7505-2014; Lenz Cesar, Carlos/F-2442-2018; Luzo,
   Angela/O-3827-2014
OI de Thomaz, Andre/0000-0002-8318-4428; Lenz Cesar,
   Carlos/0000-0001-5573-9636; Luzo, Angela/0000-0002-1422-9119
CR Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325
   Costa KD, 2003, TISSUE ENG, V9, P567, DOI 10.1089/107632703768247278
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   Lee JW, 2004, YONSEI MED J, V45, P41
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Schneider TO, 1999, J ORTHOPAED RES, V17, P192, DOI 10.1002/jor.1100170207
   Stark Y, 2006, EXP TOXICOL PATHOL, V57, P305, DOI 10.1016/j.etp.2005.10,005
   Stegemann JP, 2004, TISSUE ENG, V10, P189, DOI 10.1089/107632704322791844
   Torkian B. A., 2004, FACIAL PLAST SURG, V6, P180
   Wagenseil JE, 2004, ANN BIOMED ENG, V32, P720, DOI 10.1023/B:ABME.0000030237.20057.3e
NR 15
TC 1
Z9 1
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8869-5
J9 PROC SPIE
PY 2012
VL 8226
AR UNSP 82263N
DI 10.1117/12.909185
PG 9
WC Microscopy; Optics
SC Microscopy; Optics
GA BZR37
UT WOS:000302556900054
DA 2018-10-19
ER

PT S
AU Zhong, ZP
   Wan, S
AF Zhong, Zhi-Peng
   Wan, Shui
BE Lin, PP
   Zhang, CL
TI Composite Grid Method on computation of stress intensity factors of
   Biomaterial Interface Crack
SO VIBRATION, STRUCTURAL ENGINEERING AND MEASUREMENT I, PTS 1-3
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Vibration, Structural Engineering and
   Measurement (ICVSEM 2011)
CY OCT 21-23, 2011
CL Shanghai, PEOPLES R CHINA
SP Guangzhou Univ, Cleveland State Univ, Xian Jiaotong Univ, Tongji Univ, Hong Kong Polytechn Univ, Shanghai Jiaotong Univ, Ritsumeikan Univ, Univ Victoria
DE Stress intensity factors; Biomaterial interface crack; Composite grid
   method; Numerical extrapolation method
ID BOUNDARY-ELEMENT METHOD
AB The stress intensity factors (SIFs) of biomaterial interface crack were analyzed using the Composite Grid Method (CGM). Two different scale grids were adopted: a coarse mesh for the whole area without considering interface crack and a fine mesh for the local singular area considering the impact of interface crack. It solved the global coarse mesh problem and the local fine mesh problem iteratively and obtained the final results. The calculation was carried out by CGM but without the demand of dense mesh near the crack tip and special crack tip elements compared with other methods. The numerical extrapolation method of determining the SIFs to avoid the oscillation singularity of asymptotic fields of elastic interface crack. Reasonable agreement was achieved and efficiency of CGM for such kind of problem was displayed.
C1 [Zhong, Zhi-Peng; Wan, Shui] Southeast Univ, Sch Transportat, Nanjing 210096, Jiangsu, Peoples R China.
RP Zhong, ZP (reprint author), Southeast Univ, Sch Transportat, Nanjing 210096, Jiangsu, Peoples R China.
EM zpz_2006@163.com; wanshui60421@yahoo.com
CR CHO SB, 1992, ENG FRACT MECH, V43, P603
   Dundurs J., 1968, J APPL MECH, V35, P460
   GAO YL, 1992, ENG FRACT MECH, V41, P779, DOI 10.1016/0013-7944(92)90160-G
   HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63
   Jinquan Xu, 2006, MECH INTERFACE
   [马开平 Ma Kaiping], 2004, [应用数学和力学, Applied Mathematics and Mechanics], V25, P1135
   MIYAZAKI N, 1993, ENG FRACT MECH, V45, P599, DOI 10.1016/0013-7944(93)90266-U
   RICE JR, 1988, J APPL MECH-T ASME, V55, P98, DOI 10.1115/1.3173668
   Shi XQ, 2006, INT J ADHES ADHES, V26, P249, DOI 10.1016/j.ijadhadh.2005.02.007
   Wang D. S., 2002, COMPOSITE GRID METHO, P16
NR 10
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-264-4
J9 APPL MECH MATER
PY 2012
VL 105-107
BP 1591
EP 1596
DI 10.4028/www.scientific.net/AMM.105-107.1591
PN 1-3
PG 6
WC Engineering, Civil; Mechanics
SC Engineering; Mechanics
GA BZS07
UT WOS:000302666101001
DA 2018-10-19
ER

PT J
AU Liu, XC
   Zhao, MZ
   Lu, JX
   Ma, J
   Wei, J
   Wei, SC
AF Liu, Xiaochen
   Zhao, Minzhi
   Lu, Jingxiong
   Ma, Jian
   Wei, Jie
   Wei, Shicheng
TI Cell responses to two kinds of nanohydroxyapatite with different sizes
   and crystallinities
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanohydroxyapatite; osteoblast-like cells; cell viability; cell
   differentiation
ID IN-VITRO; HYDROTHERMAL METHOD; OSTEOBLAST PHENOTYPE; HYDROXYAPATITE;
   APOPTOSIS; PROLIFERATION; BIOCERAMICS; TEMPERATURE; DISSOLUTION;
   COATINGS
AB Introduction: Hydroxyapatite (HA) is the principal inorganic constituent of human bone. Due to its good biocompatibility and osteoconductivity, all kinds of HA particles were prepared by different methods. Numerous reports demonstrated that the properties of HA affected its biological effects.
   Methods: Two kinds of nanohydroxyapatite with different sizes and crystallinities were obtained via a hydrothermal treatment method under different temperatures. It was found that at a temperature of 140 C, a rod-like crystal (n-HA1) with a diameter of 23 +/- 5 nm, a length of 47 +/- 14 nm, and crystallinity of 85% +/- 5% was produced, while at a temperature of 80 degrees C, a -rod-like crystal (n-HA2) with a diameter of 16 +/- 3 nm, a length of 40 +/- 10 nm, and -crystallinity of 65% +/- 3% was produced. The influence of nanohydroxyapatite size and crystallinity on osteoblast viability was studied by MTT, scanning electron microscopy, and flow cytometry.
   Results: n-HA1 gave a better biological response than n-HA2 in promoting cell growth and inhibiting cell apoptosis, and also exhibited much more active cell morphology. Alkaline phosphatase activity for both n-HA2 and n-HA1 was obviously higher than for the control, and no significant difference was found between n-HA1 and n-HA2. The same trend was observed on Western blotting for expression of type I collagen and osteopontin. In addition, it was found by transmission electron microscopy that large quantities of n-HA2 entered into the cell and damaged the cellular morphology. Release of tumor necrosis factor alpha from n-HA2 was markedly higher than from n-HA1, indicating that n-HA2 might trigger a severe inflammatory response.
   Conclusion: This work indicates that not all nanohydroxyapatite should be considered a good biomaterial in future clinical applications.
C1 [Wei, Jie; Wei, Shicheng] Peking Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100081, Peoples R China.
   [Liu, Xiaochen; Zhao, Minzhi; Wei, Shicheng] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100081, Peoples R China.
   [Lu, Jingxiong; Wei, Jie] E China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
   [Ma, Jian] Tongji Univ, Hosp Stomatol, Shanghai 200092, Peoples R China.
RP Wei, J (reprint author), Peking Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100081, Peoples R China.
EM nic7505@263.net; sc-wei@pku.edu.cn
FU State Key Development Program for Basic Research of China
   [2007CB936103]; Fundamental Research Funds for the Central Universities;
   Peking University [985]; National Natural Science Foundation of China
   [30970720]; Key Medical Program of Science and Technology Development of
   Shanghai [09411954900]
FX This work was supported by the State Key Development Program for Basic
   Research of China (grant 2007CB936103), Fundamental Research Funds for
   the Central Universities, Peking University 985 grant, the National
   Natural Science Foundation of China (30970720), and Key Medical Program
   of Science and Technology Development of Shanghai (09411954900).
CR Aruna ST, 2000, J MATER CHEM, V10, P2388, DOI 10.1039/b001718n
   Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924
   Cimpan MR, 2000, ACTA ODONTOL SCAND, V58, P217, DOI 10.1080/000163500750051773
   David A, 2004, EUR J ORTHODONT, V26, P421, DOI 10.1093/ejo/26.4.421
   Fazan F, 2004, Med J Malaysia, V59 Suppl B, P69
   Georgiou P, 2009, J NANO RES, V6, P157, DOI 10.4028/www.scientific.net/JNanoR.6.157
   Guo YP, 2011, MATER LETT, V65, P2205, DOI 10.1016/j.matlet.2011.04.057
   Hahn BD, 2011, THIN SOLID FILMS, V519, P8085, DOI 10.1016/j.tsf.2011.07.008
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Lim GK, 1999, LANGMUIR, V15, P7472, DOI 10.1021/la981659+
   Liu F, 1997, EXP CELL RES, V232, P97, DOI 10.1006/excr.1997.3501
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   McComb RB, 1979, ALKALINE PHOSPHATASE
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Saunders R, 2007, J CELL BIOCHEM, V100, P703, DOI 10.1002/jcb.21001
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suchanek W, 1998, J MATER RES, V13, P84
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Tanaka H, 2010, MATER RES BULL, V45, P103, DOI 10.1016/j.materresbull.2009.10.004
   Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652
   Tuck L, 2008, J MATER SCI-MATER M, V19, P917, DOI 10.1007/s10856-007-0172-8
   Vallet-Regi M, 2008, RSC NANOSCIENCE NANO, P185
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Yang CY, 2009, J MED BIOL ENG, V29, P296
   Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3
NR 34
TC 37
Z9 40
U1 1
U2 15
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 1239
EP 1250
DI 10.2147/IJN.S28098
PG 12
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 924XI
UT WOS:000302724200001
PM 22419871
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Li, H
   Gong, M
   Yang, AP
   Ma, J
   Li, XD
   Yan, YG
AF Li, Hong
   Gong, Min
   Yang, Aiping
   Ma, Jian
   Li, Xiangde
   Yan, Yonggang
TI Degradable biocomposite of nano calcium-deficient
   hydroxyapatite-multi(amino acid) copolymer
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE calcium deficient hydroxyapatite; multi(amino acid) copolymer;
   biocomposite; degradability; cytocompatibility
ID IN-VITRO DEGRADATION; MECHANICAL-PROPERTIES; CELL-ADHESION;
   BIOCOMPATIBILITY; COMPOSITES; BIOMATERIALS; SCAFFOLDS; POLYMERS
AB Background and methods: A nano calcium-deficient hydroxyapatite (n-CDHA)-multi(amino acid) copolymer (MAC) composite bone substitute biomaterial was prepared using an in situ polymerization method. The composition, structure, and compressive strength of the composite was characterized, and the in vitro degradability in phosphate-buffered solution and preliminary cell responses to the composite were investigated.
   Results: The composite comprised n-CDHA and an amide linkage copolymer. The compressive strength of the composite was in the range of 88-129 MPa, varying with the amount of n-CDHA in the MAC (ranging from 10 wt% to 50 wt%). Weight loss from the composite increased (from 32.2 wt% to 44.3 wt%) with increasing n-CDHA content (from 10 wt% to 40 wt%) in the MAC after the composite was soaked in phosphate-buffered solution for 12 weeks. The pH of the soaking medium varied from 6.9 to 7.5. MG-63 cells with an osteogenic phenotype were well adhered and spread on the composite surface. Viability and differentiation increased with time, indicating that the composite had no negative effects on MG-63 cells.
   Conclusion: The n-CDHA-MAC composite had good cytocompatibility and has potential to be used as a bone substitute.
C1 [Li, Hong; Gong, Min; Yang, Aiping; Yan, Yonggang] Sichuan Univ, Sch Phys Sci & Technol, Chengdu 610064, Peoples R China.
   [Ma, Jian] Tongji Univ, Hosp Stomatol, Shanghai 200092, Peoples R China.
   [Li, Xiangde] E China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
RP Yang, AP (reprint author), Sichuan Univ, Sch Phys Sci & Technol, Chengdu 610064, Peoples R China.
EM hlisoft@yahoo.com.cn
FU National Natural Science Foundation of China [31070834]; Key Medical
   Program of Science and Technology Development of Shanghai [09411954900];
   Nano special program of Science and Technology Development of Shanghai
   [1052nm06600]
FX The authors are grateful for the financial support of the National
   Natural Science Foundation of China (31070834), the Key Medical Program
   of Science and Technology Development of Shanghai (09411954900), and the
   Nano special program of Science and Technology Development of Shanghai
   (1052nm06600).
CR Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Bianco A, 2009, MAT SCI ENG C-MATER, V29, P2063, DOI 10.1016/j.msec.2009.04.004
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   Dai CL, 2010, BIOMATERIALS, V31, P7620, DOI 10.1016/j.biomaterials.2010.06.049
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Greish YE, 2011, CERAM INT, V37, P1493, DOI 10.1016/j.ceramint.2011.01.007
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Hanifi A., 2008, IRANIAN J PHARM SCI, V4, P141
   Hofmann D., 2010, ADV SCI TECHNOL, V76, P16
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Lao LH, 2010, J MATER SCI-MATER M, V22, P4374
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li H, 2011, J MATER SCI-MATER M, V22, P2555, DOI 10.1007/s10856-011-4439-8
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Ribeiro N, 2010, J COLLOID INTERF SCI, V351, P398, DOI 10.1016/j.jcis.2010.08.013
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Shokrollahi P, 2010, J BIOMED MATER RES A, V95A, P209, DOI 10.1002/jbm.a.32828
   Siddharthan A., 2005, TRENDS BIOMATER ARTI, V18, P110
   Sun HL, 2011, BIOMACROMOLECULES, V12, P1937, DOI 10.1021/bm200043u
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   WEI J, 2004, EUR POLYM J, V40, P509, DOI DOI 10.1016/J.EURP0LYMJ.2003.10.028
   Wei J, 2008, J R SOC INTERFACE, V5, P617, DOI 10.1098/rsif.2007.1267
   Yuan XY, 2002, J APPL POLYM SCI, V85, P936, DOI 10.1002/app.10490
   Zhang W, 2010, J POLYM ENVIRON, V19, P177
   Zhang WP, 2009, J BIOMED MATER RES A, V94, P450
NR 32
TC 16
Z9 16
U1 1
U2 19
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 1287
EP 1295
DI 10.2147/IJN.S28978
PG 9
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 924XO
UT WOS:000302724800001
PM 22457591
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Pinheiro, ALB
   Soares, LGP
   Barbosa, AFS
   Silveira, L
AF Pinheiro, Antonio L. B.
   Soares, Luiz G. P.
   Barbosa, Artur Felipe S.
   Silveira Junior, Landulfo
BE Hamblin, MR
   Anders, J
   Carroll, JD
TI Effects of LED or Laser Phototherapy on Bone Defects Grafted with MTA
   and Irradiated with Laser or LED light: A Comparative Raman
   Spectroscopic Study
SO MECHANISMS FOR LOW-LIGHT THERAPY VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms for Low-Light Therapy VII
CY JAN 21, 2012
CL San Francisco, CA
SP SPIE
DE Biomaterial; Bone Repair; Light Emitting Diode; Mineral Trioxide
   Aggregate
ID MORPHOGENETIC PROTEINS; RODENT MODEL; IN-VIVO; DENTAL IMPLANTS; BOVINE
   BONE; REGENERATION; REPAIR; PHOTOBIOMODULATION; THERAPY; ASSOCIATION
AB We studied peaks of calcium hydroxyapatite - CHA on defects grafted with MTA, treated or not with Light Emitting Diode - LED or IR Laser. 54 rats were divided in 6 groups each subdivided into 3 subgroups (15,21,30d). LED (lambda 850 +/- 10nm) or IR Laser (lambda 850 nm) was applied over (LED) or in 4 points around the defect at 48 h intervals for 15 days. Raman readings were taken at the surface of the defect. The smaller overall intensity of the peak was found in Group MTA + Laser (1510.2 +/- 274.1) and the highest on Group LED (2322 +/- 715). There were no statistically significant differences between non-irradiated subjects on regards the CHA peaks. On the other hand, there were statistically significant differences between the Group Clot and LED, Clot and Laser, and Clot and MTA + Laser (p -0.01, p - 0.02, p = 0.003). There were no significant differences between Group MTA and MTA + LED (p=0.2) but significant differences were seen between Groups MTA and MTA + Laser (p=0.01). Significant differences were also observed between Groups LED and Laser (p <0.001) and between Groups MTA + LED and MTA + Laser (p=0.009). MTA, due to its characteristics, seemed to be directly affected by the light. However, the use of either phototherapy positively affected bone healing similarly as observed on different studies using other biomaterials. The overall analysis of our results indicated that the use of either light source resulted in a better, more advanced, and of quality bone repair.
C1 [Pinheiro, Antonio L. B.; Soares, Luiz G. P.; Barbosa, Artur Felipe S.] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.; Silveira Junior, Landulfo] Univ Camilo Castelo Branco, BR-12245230 Sao Jose Dos Campos, Brazil.
   [Pinheiro, Antonio L. B.] Nacl Inst Opt & Photon, BR-13560970 Sao Carlos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
RI Barbosa, Artur/G-3839-2012; Silveira, Landulfo/I-2474-2012; Pinheiro,
   Antonio Luiz/A-1962-2008
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321
CR Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Muschler GF, 1990, SPINAL FUSION SCI TE, P9
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   PROLO DJ, 1990, CLIN NEUR, V36, P135
   Recker RR, 1992, DISORDERS BONE MINER, P219
   Silva AN, 2002, J CLIN LASER MED SUR, V20, P83, DOI 10.1089/104454702753768061
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8854-1
J9 PROC SPIE
PY 2012
VL 8211
AR 821108
DI 10.1117/12.906003
PG 7
WC Optics
SC Optics
GA BZR70
UT WOS:000302602400005
DA 2018-10-19
ER

PT J
AU Radu, N
   Badea, MN
   Ferdes, M
   Rau, I
AF Radu, Nicoleta
   Badea, Maria Nicoleta
   Ferdes, Mariana
   Rau, Ileana
TI Antioxidant Properties of Fungal Biomaterial
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article
DE Antioxidant properties; biopigment; solid state submerged biosynthesis
ID RICE; CONSTITUENTS
AB The antioxidant properties of methanolic extracts from extract of parental and modified Monascus sp were studied and evaluated. The fungus was inoculated into different submerged media and the produced red pigment was separated by filtration and methanol extraction from the filtrate. The antioxidant or prooxidant properties of ethanolic extract was evaluated by measuring the quenching ratio of chemiluminescence intensity. The results obtained showed a quenching ration of 87.75% for parental strain, growth 96 h in culture media with 50% maltose. The mutant strain reveals less antioxidant properties, the value of quenching ratio being 4.91%. If the growth time increased, the extract showed a prooxidant activity. At the same time the extract of mutant strain grown 96 H in the culture media containing meat extract reveals excellent antioxidant property, quantified by quenching ratio of 93.36%. When the mutant strain is grown 96 H in a culture media, which contain 30% dextrose, the methanolic extract presents an antioxidant effect with quenching ratio of 98.55%.
C1 [Rau, Ileana] Univ Politehn Bucuresti, Fac Appl Chem, Bucharest 060042, Romania.
   [Radu, Nicoleta; Rau, Ileana] USAMV Cluj Napoca, Cluj Napoca 400372, Romania.
   [Radu, Nicoleta; Badea, Maria Nicoleta; Ferdes, Mariana] Univ Politehn Bucuresti, Fac Appl Chem, Bucharest 011062, Romania.
RP Rau, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem, Splaiul Independentei 313, Bucharest 060042, Romania.
EM nicolbiotec@yahoo.com; ileana_brandusa@yahoo.com
RI Radu, Nicoleta/B-5253-2017; RAU, ILEANA/A-8981-2008
OI RAU, ILEANA/0000-0002-0780-9502; Radu, Nicoleta/0000-0002-1106-0258
FU Institutional organization of a postdoctoral school of national interest
   "Applied biotechnology with impact in the Romanian economy"
   [POSDRU/89/1.5/S52432]; EU
FX The work was financially supported by the project POSDRU/89/1.5/S52432
   from 1.04.2010-Institutional organization of a postdoctoral school of
   national interest "Applied biotechnology with impact in the Romanian
   economy." The project was co funded by the EU Social Fund IN THE
   FRAMEWORK OF THE Sectorial Operational Programme 2007-2010 for Human
   Resources Development
CR Chen C. Y., 1997, J CHIN CHEM SOC-TAIP, V44, P13
   Chen CY, 1997, J CHIN CHEM SOC-TAIP, V44, P313, DOI 10.1002/jccs.199700047
   Iliuta I, 2007, REV CHIM-BUCHAREST, V58, P343
   Lin YL, 1998, J CHIN CHEM SOC-TAIP, V45, P213, DOI 10.1002/jccs.199800035
   Qiu Y, 2009, J AGR FOOD CHEM, V57, P7543, DOI 10.1021/jf901074b
   Samaras TS, 2005, J AGR FOOD CHEM, V53, P4938, DOI 10.1021/jf0501600
   Shih FF, 2003, J FOOD SCI, V68, P2672, DOI 10.1111/j.1365-2621.2003.tb05787.x
   Yang JH, 2006, LWT-FOOD SCI TECHNOL, V39, P740, DOI 10.1016/j.lwt.2005.06.002
NR 8
TC 0
Z9 0
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1542-1406
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2012
VL 555
SI SI
BP 202
EP 207
DI 10.1080/15421406.2012.635537
PG 6
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 919DE
UT WOS:000302300400022
DA 2018-10-19
ER

PT J
AU Aarne, N
   Kontturi, E
   Laine, J
AF Aarne, Niko
   Kontturi, Eero
   Laine, Janne
TI Influence of adsorbed polyelectrolytes on pore size distribution of a
   water-swollen biomaterial
SO SOFT MATTER
LA English
DT Article
ID DIFFERENTIAL SCANNING CALORIMETRY; CHARGED POROUS SUBSTRATE; PINE KRAFT
   PULP; CELLULOSIC FIBERS; ADSORPTION; WALL; SURFACES; POROSITY; PAPER;
   GELS
AB Many biomaterials exhibit pronounced swelling and consequently pronounced porous structure when exposed to water. Characterization and tuning of the porosity are important for the fundamental understanding of the behaviour of the biomaterials as well as for many of their applications, both traditional and novel. Here, the porous structure of cellulosic fibres (chemical wood pulp) was analysed in the wet state by differential scanning calorimetry (DSC) with and without adsorbed cationic polyelectrolytes. The polyelectrolytes were low molecular weight (M-w) high charge polybrene (hexadimethrine bromide) and two high M-w high charge PDADMACs (poly(diallyldimethyl ammonium chlorides)) with well-defined M-w distributions. The porosity changes upon adsorption of cationic polyelectrolytes in the wet-state were followed and the pore analysis gave insights into the distribution of the pores in the wet-state and into the changes of the porous structure in the surface as well as within the whole cell wall. By utilizing the well characterized polyelectrolytes we were able to detect subtle changes in the micropores of cellulosic fibres due to the adsorbed polyelectrolytes. The polymers did not affect the pore volumes in the 2.5-17 nm region upon drying, an important finding considering the porosity. Overall, the cationic polyelectrolytes decreased the pore volume by reducing the osmotic pressure. In addition, the results were compared to a physical state change, i.e., drying and rewetting, to observe and compare the wetting hysteresis of the aforementioned fibres.
C1 [Aarne, Niko; Kontturi, Eero; Laine, Janne] Aalto Univ, Dept Forest Prod Technol, Sch Chem Technol, Aalto 00076, Finland.
RP Kontturi, E (reprint author), Aalto Univ, Dept Forest Prod Technol, Sch Chem Technol, POB 16300, Aalto 00076, Finland.
EM eero.kontturi@aalto.fi
RI Laine, Janne/A-3337-2013; Kontturi, Eero/E-6210-2014
OI Laine, Janne/0000-0002-9125-3841; Kontturi, Eero/0000-0003-1690-5288
FU ChAD project-Botnia, Kemira; UPM, Andritz; Finnish Centre for Technology
   and Innovation (TEKES)
FX The assistance of Leena Nolvi with the thermoporosimetry measurements is
   kindly acknowledged. SEC measurements of the cationic polyelectrolytes
   by Jukka Rautiainen and Kemira Oyj are acknowledged. Financing from the
   ChAD project-Botnia, Kemira, UPM, Andritz and Finnish Centre for
   Technology and Innovation (TEKES)-is greatly acknowledged.
CR Alince B, 2002, NORD PULP PAP RES J, V17, P71
   Alince B., 1997, FUNDAMENTALS PAPERMA, V2, P771
   Bhardwaj NK, 2004, COLLOID SURFACE A, V236, P39, DOI 10.1016/j.colsurfa.2004.01.024
   Bohme U, 2007, J PHYS CHEM B, V111, P8348, DOI 10.1021/jp070611e
   Bracher PJ, 2010, SOFT MATTER, V6, P4303, DOI 10.1039/c0sm00031k
   Cheng CM, 2010, ANGEW CHEM INT EDIT, V49, P4771, DOI 10.1002/anie.201001005
   Delaney JL, 2011, ANAL CHEM, V83, P1300, DOI 10.1021/ac102392t
   Duchesne I, 1999, NORD PULP PAPER RES, V14, P129
   Fahlen J, 2005, BIOMACROMOLECULES, V6, P433, DOI 10.1021/bm040068x
   GRIGNON J, 1980, J APPL POLYM SCI, V25, P2829, DOI 10.1002/app.1980.070251215
   Haggkvist M, 1998, NORD PULP PAPER RES, V13, P292
   Horvath AE, 2006, LANGMUIR, V22, P824, DOI 10.1021/la052217i
   Horvath AT, 2008, LANGMUIR, V24, P7857, DOI 10.1021/la800093m
   Horvath AT, 2008, LANGMUIR, V24, P6585, DOI 10.1021/la800274w
   Hubbe MA, 2007, BIORESOURCES, V2, P739
   ISHIKIRIYAMA K, 1995, J COLLOID INTERF SCI, V171, P103, DOI 10.1006/jcis.1995.1155
   Iza M, 2000, POLYMER, V41, P5885, DOI 10.1016/S0032-3861(99)00776-4
   Kato KL, 1999, CELLULOSE, V6, P23, DOI 10.1023/A:1009292120151
   Kongdee A, 2004, CARBOHYD POLYM, V57, P39, DOI 10.1016/j.carbpol.2004.03.025
   Laine C, 2004, HOLZFORSCHUNG, V58, P233, DOI 10.1515/HF.2004.036
   Laivins G. V., 1993, 10 FUND RES S OXF, V2, P1235
   Laivins GV, 1996, J PULP PAP SCI, V22, pJ178
   lAlagberg L., 1989, NORD PULP PAP RES J, V4, P71, DOI DOI 10.3183/NPPRJ-1989-04-02-P071-076
   Landis FA, 2006, BIOMACROMOLECULES, V7, P1751, DOI 10.1021/bm0600466
   Maloney T., 1999, PRES ISWPC 10 REC AD, V1, P245
   Maloney T. C., 2001, SCI PAP T FUND RES S, V2, P897
   Maloney TC, 1998, NORD PULP PAPER RES, V13, P31
   Maloney TC, 1999, TAPPI J, V82, P125
   Mishael YG, 2007, LANGMUIR, V23, P2510, DOI 10.1021/la062314r
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/NNANO.2010.155, 10.1038/nnano.2010.155]
   Osterberg M, 2000, J COLLOID INTERF SCI, V229, P620, DOI 10.1006/jcis.2000.7054
   Panshin A. J., 1970, TXB WOOD TECHNOLOGY, P91
   Park S, 2006, CELLULOSE, V13, P23, DOI 10.1007/s10570-005-9009-0
   Park S, 2006, CARBOHYD POLYM, V66, P97, DOI 10.1016/j.carbpol.2006.02.026
   Perez DdS, 2002, 7 EWLP P, V1, P393
   Rovio S, 2008, J CHROMATOGR A, V1185, P139, DOI 10.1016/j.chroma.2008.01.031
   SALMEN L, 1997, FUNDAMENTALS PAPERMA, V2, P683
   SCALLAN AM, 1983, TAPPI J, V66, P73
   SCALLAN AM, 1979, SVEN PAPPERSTIDN, V82, P40
   SCALLAN AM, 1972, SVEN PAPPERSTIDN, V75, P699
   Stone J. E., 1966, Pulp and Paper in Canada, V67, pT263
   Swerin A., 1990, NORD PULP PAP RES J, V5, P188
   Swerin A., 1994, NORD PULP PAP RES J, V9, P18
   Tammelin T, 2006, CELLULOSE, V13, P519, DOI 10.1007/s10570-005-9002-7
   TANAKA H, 1979, TAPPI, V62, P41
   TELEMAN A, 1995, CARBOHYD RES, V272, P55, DOI 10.1016/0008-6215(95)96873-M
   Topgaard D, 2002, CELLULOSE, V9, P139, DOI 10.1023/A:1020158524621
   van de Ven TGM, 2000, NORD PULP PAP RES J, V15, P494
   Wagberg L, 2000, NORD PULP PAP RES J, V15, P586
   Wagberg L, 2001, LANGMUIR, V17, P1096, DOI 10.1021/la000629f
   WAGBERG L, 1989, NORD PULP PAP RES J, V4, P135
   Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v
   Wang XS, 2003, APPITA J, V56, P455
   Weber J, 2010, LANGMUIR, V26, P10158, DOI 10.1021/la100290j
   Weise U, 1998, PAP PUU-PAP TIM, V80, P110
   Wu N, 2009, BIORESOURCES, V4, P1222
   Yanez F, 2010, J MEMBRANE SCI, V365, P248, DOI 10.1016/j.memsci.2010.09.012
   Ye L, 2009, J MATER CHEM, V19, P2189, DOI 10.1039/b818410k
   Zugenmaier P, 2008, CRYSTALLINE CELLULOS
NR 59
TC 15
Z9 15
U1 1
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 17
BP 4740
EP 4749
DI 10.1039/c2sm07268h
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 920QH
UT WOS:000302421400025
DA 2018-10-19
ER

PT J
AU Soman, P
   Fozdar, DY
   Lee, JW
   Phadke, A
   Varghese, S
   Chen, SC
AF Soman, Pranav
   Fozdar, David Y.
   Lee, Jin Woo
   Phadke, Ameya
   Varghese, Shyni
   Chen, Shaochen
TI A three-dimensional polymer scaffolding material exhibiting a zero
   Poisson's ratio
SO SOFT MATTER
LA English
DT Article
ID TISSUE-ENGINEERING SCAFFOLDS; ARTICULAR-CARTILAGE; CELLULAR MATERIALS;
   MICROFABRICATION; MECHANICS; FOAMS
AB Poisson's ratio describes the degree to which a material contracts (expands) transversally when axially strained. A material with a zero Poisson's ratio does not transversally deform in response to an axial strain (stretching). In tissue engineering applications, scaffolding having a zero Poisson's ratio (ZPR) may be more suitable for emulating the behavior of native tissues and accommodating and transmitting forces to the host tissue site during wound healing (or tissue regrowth). For example, scaffolding with a zero Poisson's ratio may be beneficial in the engineering of cartilage, ligament, corneal, and brain tissues, which are known to possess Poisson's ratios of nearly zero. Here, we report a 3D biomaterial constructed from polyethylene glycol (PEG) exhibiting in-plane Poisson's ratios of zero for large values of axial strain. We use digital micro-mirror device projection printing (DMD-PP) to create single-and double-layer scaffolds composed of semi-re-entrant pores whose arrangement and deformation mechanisms contribute to the zero Poisson's ratio. Strain experiments prove the zero Poisson's behavior of the scaffolds and that the addition of layers does not change the Poisson's ratio. Human mesenchymal stem cells (hMSCs) cultured on biomaterials with zero Poisson's ratio demonstrate the feasibility of utilizing these novel materials for biological applications which require little to no transverse deformations resulting from axial strains. Techniques used in this work allow Poisson's ratio to be both scale-independent and independent of the choice of strut material for strains in the elastic regime, and therefore ZPR behavior can be imparted to a variety of photocurable biomaterials.
C1 [Soman, Pranav; Fozdar, David Y.; Lee, Jin Woo; Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
   [Phadke, Ameya; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP Chen, SC (reprint author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC 0448, La Jolla, CA 92093 USA.
EM chen168@ucsd.edu
FU National Institute of Biomedical Imaging and Bioengineering
   [R01EB012597]; National Science Foundation [CMMI-1130894]
FX The project described was supported by Award Number R01EB012597 from the
   National Institute of Biomedical Imaging and Bioengineering and a grant
   (CMMI-1130894) from the National Science Foundation. We thank the
   computer support from Intel's High Education Program.
CR ALDERSON KL, 1992, POLYMER, V33, P4435, DOI 10.1016/0032-3861(92)90294-7
   Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522
   BURNS S, 1987, SCIENCE, V238, P551, DOI 10.1126/science.238.4826.551
   CHOI JB, 1992, J MATER SCI, V27, P4678, DOI 10.1007/BF01166005
   CHOI JB, 1995, J COMPOS MATER, V29, P113, DOI 10.1177/002199839502900106
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Eisenstadt MM, 1971, INTRO MECH PROPERTIE
   EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0
   FATT I, 1968, EXP EYE RES, V7, P402, DOI 10.1016/S0014-4835(68)80055-7
   Fozdar D. Y., 2008, NANOTECHNOLOGY, V19, P1
   Fozdar DY, 2011, ADV FUNCT MATER, V21, P2712, DOI 10.1002/adfm.201002022
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087
   Grima JN, 2011, PHYS STATUS SOLIDI B, V248, P111, DOI 10.1002/pssb.201083979
   Han L. H., 2008, J MANUF SCI ENG T AS, V130
   Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]
   Jurvelin JS, 1997, J BIOMECH, V30, P235, DOI 10.1016/S0021-9290(96)00133-9
   Jurvelin JS, 2000, J BIOMECH, V33, P669, DOI 10.1016/S0021-9290(00)00007-5
   Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0
   Lakes R, 2000, SCIENCE, V288, P1976, DOI 10.1126/science.288.5473.1976
   LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038
   Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2
   ROTHENBURG L, 1991, NATURE, V354, P470, DOI 10.1038/354470a0
   Smith CW, 2000, ACTA MATER, V48, P4349, DOI 10.1016/S1359-6454(00)00269-X
NR 26
TC 21
Z9 22
U1 2
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 18
BP 4946
EP 4951
DI 10.1039/c2sm07354d
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 923RP
UT WOS:000302636700015
PM 24014252
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mouhyi, J
   Dohan, DM
   Albrektsson, T
AF Mouhyi, Jaafar
   Dohan, David M.
   Albrektsson, Tomas
TI The Peri-Implantitis: Implant Surfaces, Microstructure, and
   Physicochemical Aspects
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE dental implant; osseointegration; peri-implantitis; titanium surface
ID GUIDED BONE REGENERATION; DIFFERENT OXIDE THICKNESSES; MODIFIED TITANIUM
   IMPLANTS; TISSUE DENTAL SURGERY; CARBON-DIOXIDE LASER;
   HYDROGEN-PEROXIDE; SOFT-TISSUE; IN-VITRO; ELECTROPOLISHED IMPLANTS;
   BIOMATERIAL APPLICATIONS
AB There are two ways of looking at secondary failures of osseointegration; one is to reflect on possible causes for the failure, the other focuses on the pathology per se. In the first case, background factors such as mechanical trauma (adverse loading) or inflammations/infections are being discussed as the cause of failure. Then peri-implantitis is a term reserved for implant disturbance due to inflammation/infections only. However, irrespective of the original reason for the failure being adverse loading or inflammation/infection, the end result with bone resorption and inflammation may be very similar. Hence, in the present article, an alternative outlook has been chosen. Trigerring factors for peri-implantitis are generally gathered under four categories: lesions of peri-implant attachment, presence of aggressive bacteria, excessive mechanical stress, and corrosion. If only one of these factors would start a chain reaction leading to lesions, then the other factors may combine to worsen the condition. With other words, peri-implantitis is a general term dependent on a synergy of several factors, irrespective of the precise reason for first triggering off symptoms.
C1 [Mouhyi, Jaafar; Dohan, David M.; Albrektsson, Tomas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, S-41390 Gothenburg, Sweden.
   [Mouhyi, Jaafar] Univ So Calif, Los Angeles, CA USA.
   [Dohan, David M.] Univ Naples Federico 2, Dept OdontoStomatol & Maxillo Facial Sci, Naples, Italy.
   [Dohan, David M.] LoB5 Fdn Res, AP HP, Paris, France.
RP Dohan, DM (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Medicinaregatan 8B, S-41390 Gothenburg, Sweden.
EM lob5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
FU LoB5 Foundation for Research, AP-HP, Paris, France
FX This work was partially supported by a grant from the LoB5 Foundation
   for Research, AP-HP, Paris, France.
CR ADRIAN JC, 1979, J ORAL PATHOL MED, V8, P60, DOI 10.1111/j.1600-0714.1979.tb01623.x
   Ahariz M, 2000, J BIOMED MATER RES, V52, P567, DOI 10.1002/1097-4636(20001205)52:3<567::AID-JBM16>3.0.CO;2-K
   Albreksson T, 1986, J ORAL MAXILLOFAC IM, V1, P11
   Atassi Farhad, 2002, Implant Dent, V11, P356
   BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Choukroun J, 2008, IMPLANT DENT, V17, P257, DOI 10.1097/ID.0b013e318181349a
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   Coffelt DW, 1997, J CLIN PERIODONTOL, V24, P1, DOI 10.1111/j.1600-051X.1997.tb01177.x
   DANSER MM, 1994, J CLIN PERIODONTOL, V21, P484, DOI 10.1111/j.1600-051X.1994.tb00412.x
   DENNISON DK, 1994, J PERIODONTOL, V65, P942, DOI 10.1902/jop.1994.65.10.942
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   DUCHEYNE P, 1984, J BIOMED MATER RES, V18, P293, DOI 10.1002/jbm.820180306
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Ericsson I, 1996, CLIN ORAL IMPLAN RES, V7, P320, DOI 10.1034/j.1600-0501.1996.070404.x
   ERICSSON I, 1995, J CLIN PERIODONTOL, V22, P255
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Esposito M, 1999, INT J ORAL MAX IMPL, V14, P798
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   GANZ CH, 1994, J PROSTHET DENT, V71, P27, DOI 10.1016/0022-3913(94)90251-8
   Gothberg C, 2003, INT J PROSTHODONT, V16, P201
   Grunder U, 1993, Int J Oral Maxillofac Implants, V8, P282
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829
   Hurzeler M B, 1995, Int J Oral Maxillofac Implants, V10, P474
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Jovanovic S A, 1993, Int J Oral Maxillofac Implants, V8, P13
   JOVANOVIC SA, 1993, J PERIODONTOL, V64, P1176, DOI 10.1902/jop.1993.64.11s.1176
   Kasebo B., 1983, SWED DENT J S, V28, P19
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1988, BIOMATERIALS, V9, P277, DOI 10.1016/0142-9612(88)90098-1
   Lazzara RJ, 2006, INT J PERIODONT REST, V26, P9
   LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x
   Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x
   Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x
   Lorenzoni M, 1998, INT J ORAL MAX IMPL, V13, P639
   Masters LB, 1996, J PERIODONTOL, V67, P770, DOI 10.1902/jop.1996.67.8.770
   MIYAKE Y, 1995, J PERIODONTAL RES, V30, P290, DOI 10.1111/j.1600-0765.1995.tb02136.x
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x
   Mouhyi J, 2000, Clin Implant Dent Relat Res, V2, P190, DOI 10.1111/j.1708-8208.2000.tb00117.x
   Mouhyi J, 1999, CLIN ORAL IMPLAN RES, V10, P54, DOI 10.1034/j.1600-0501.1999.100107.x
   Mouhyi J, 1998, CLIN ORAL IMPLAN RES, V9, P185, DOI 10.1034/j.1600-0501.1998.090306.x
   Mouhyi J, 2000, CLIN ORAL IMPLAN RES, V11, P93, DOI 10.1034/j.1600-0501.2000.011002093.x
   Olmedo Daniel, 2003, Implant Dent, V12, P75
   Oyster DK, 1995, J PERIODONTOL, V66, P1017, DOI 10.1902/jop.1995.66.12.1017
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PARHAM P L JR, 1989, Journal of Oral Implantology, V15, P78
   Persson Leif G, 2004, Clin Implant Dent Relat Res, V6, P230, DOI 10.1111/j.1708-8208.2004.tb00039.x
   Persson LG, 1996, CLIN ORAL IMPLAN RES, V7, P366, DOI 10.1034/j.1600-0501.1996.070410.x
   PICK RM, 1987, LASER SURG MED, V7, P207, DOI 10.1002/lsm.1900070213
   PICK RM, 1993, J PERIODONTOL, V64, P589, DOI 10.1902/jop.1993.64.7.589
   Poulet PP, 1999, J CLIN PERIODONTOL, V26, P261, DOI 10.1034/j.1600-051X.1999.260411.x
   Quirynen M, 2003, PERIODONTOL 2000, V33, P129, DOI 10.1046/j.0906-6713.2002.03311.x
   Quirynen M, 1990, CLIN ORAL IMPLAN RES, V1, P8, DOI 10.1034/j.1600-0501.1990.010102.x
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Rosenberg ES, 1991, CLIN ORAL IMPLAN RES, V2, P135, DOI 10.1034/j.1600-0501.1991.020306.x
   Shibli JA, 2003, INT J ORAL MAX IMPL, V18, P383
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tonetti MS, 1998, PERIODONTOL 2000, V17, P55, DOI 10.1111/j.1600-0757.1998.tb00123.x
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Watzak G, 2006, CLIN ORAL IMPLAN RES, V17, P229, DOI 10.1111/j.1600-0501.2005.01217.x
   Wetzel AC, 1999, CLIN ORAL IMPLAN RES, V10, P111, DOI 10.1034/j.1600-0501.1999.100205.x
   WILLIAMS TM, 1995, INT J PERIODONT REST, V15, P497
   Zablotsky M H, 1992, Implant Dent, V1, P154
NR 79
TC 73
Z9 73
U1 4
U2 42
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2012
VL 14
IS 2
BP 170
EP 183
DI 10.1111/j.1708-8208.2009.00244.x
PG 14
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 914VI
UT WOS:000301980500002
PM 19843108
DA 2018-10-19
ER

PT J
AU Hiebl, B
   Cui, J
   Kratz, K
   Frank, O
   Schossig, M
   Richau, K
   Lee, S
   Jung, F
   Lendlein, A
AF Hiebl, B.
   Cui, J.
   Kratz, K.
   Frank, O.
   Schossig, M.
   Richau, K.
   Lee, S.
   Jung, F.
   Lendlein, A.
TI Viability, Morphology and Function of Primary Endothelial Cells on
   Poly(n-Butyl Acrylate) Networks Having Elastic Moduli Comparable to
   Arteries
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biomaterial; poly(n-butyl acrylate); soft polymer networks; adjustable
   mechanical properties; endothelial cells
ID INHIBITS PLATELET-AGGREGATION; COMMON CAROTID-ARTERY; ACTIN STRESS
   FIBERS; PROSTAGLANDIN ENDOPEROXIDES; FOCAL ADHESIONS;
   MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; VASCULAR GRAFTS;
   PROSTACYCLIN; DOGS
AB Soft hydrophobic poly(n-butyl acrylate) networks (cPnBA) were developed as entropy elastic substrates for passive mechanical stimulation of cells, where the elastic modulus of the cPnBAs could be systematically adjusted by variation of the cross-link density. The networks were synthesized by thermally-induced radical polymerization from n-butyl acrylate, with poly(propylene glycol) dimethacrylate (PPGDMA) acting as cross-linker, whereby the purity of the cPnBAs was confirmed by H-1-NMR spectroscopy and gas chromatography. In this work two cPnBA polymer networks with an elastic modulus around 200 kPa and 1 MPa were investigated having an elastic modulus similar to that of arteries. Both cPnBAs exhibited an almost smooth surface with a surface roughness (R-q) in the wet state ranging from 17 to 37 nm and a similar zeta-potential, indicating an almost identical chemical composition within the topmost surface layer in terms of functional groups. In contrast, wettability of the samples was found to be different with an advancing angle (theta(advancing)) of 123 +/- 3.8 degrees for cPnBA0250, while for cPnBA1100 significantly lower values for theta(advancing) (111 +/- 3.8 degrees) were obtained. First in vitro tests were performed with primary endothelial cells (HUVEC) to study its effects on vascular cell functions. Within the time period of cultivation (72 h), the cells on the cPnBA samples reached subconfluence and showed a viability rate of almost 100%. Although cell density differed after 72 h with more cells on cPnBA0250 than on cPnBA1100, both materials showed no significant effect on the cell morphology, the cellular LDH-release, which was used as marker for the integrity of the cell membrane, and the organisation of the VE-cadherin. However, lower cell density and less actin stress fibre formation on cPnBA1100 might indicate that cell-material interaction was weaker on cPnBA1100 than on cPnBA0250. The secretion of the vasoactive cytokines prostacyclin (PGI2) and thromboxane A2 (TXA2) was low compared to previously reported values. However, the anti-thrombogenic ratio of PGI2/TXA2 - which is balanced under physiological conditions - with much higher PGI2 compared to TXA2 (up to 17.6-fold after 72 h for cPnBA1100) suggests that this material might be effective to preventing thrombosis. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Hiebl, B.; Cui, J.; Kratz, K.; Frank, O.; Schossig, M.; Richau, K.; Lee, S.; Jung, F.; Lendlein, A.] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Teltow, Germany.
   [Hiebl, B.; Cui, J.; Kratz, K.; Frank, O.; Schossig, M.; Richau, K.; Lee, S.; Jung, F.; Lendlein, A.] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Jung, Friedrich/L-1301-2013; Kratz, Karl/K-7115-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Kratz, Karl/0000-0002-9229-4266;
   Lendlein, Andreas/0000-0003-4126-4670; Hiebl,
   Bernhard/0000-0002-6450-0675
FU Deutsche Forschungsgemeinschaft [SFB760]
FX This work was supported by Deutsche Forschungsgemeinschaft, SFB760,
   project B3.
CR Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8
   BUNTING S, 1976, PROSTAGLANDINS, V12, P897, DOI 10.1016/0090-6980(76)90125-8
   BURRIDGE K, 1981, NATURE, V294, P691, DOI 10.1038/294691a0
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Cavalca V, 2010, ANAL BIOCHEM, V397, P168, DOI 10.1016/j.ab.2009.10.014
   Chen F, 2009, J BIOMAT SCI-POLYM E, V20, P2117, DOI 10.1163/156856208X400492
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P180, DOI 10.1002/pat.1733
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   Derjaguin B. V., 1934, COLLOID POLYM SCI, V69, P155, DOI [DOI 10.1007/BF01433225, 10.1007/bf01433225]
   Salvado MD, 2009, ARTERIOSCL THROM VAS, V29, P1131, DOI 10.1161/ATVBAHA.109.188540
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Franke RP, 2009, CLIN HEMORHEOL MICRO, V43, P181, DOI 10.3233/CH-2009-1233
   Frey MT, 2007, METHOD CELL BIOL, V83, P47, DOI 10.1016/S0091-679X(07)83003-2
   Fuhrmann R., 1998, THESIS PHILIPPS U MA
   GABBIANI G, 1983, P NATL ACAD SCI-BIOL, V80, P2361, DOI 10.1073/pnas.80.8.2361
   Gallery EDM, 1999, HYPERTENS PREGNANCY, V18, P219, DOI 10.3109/10641959909016195
   GOSPODAROWICZ D, 1981, J CELL PHYSIOL, V109, P69, DOI 10.1002/jcp.1041090109
   GOTTLIEB AI, 1991, LAB INVEST, V65, P123
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   GRINNELL F, 1972, ARCH BIOCHEM BIOPHYS, V153, P193, DOI 10.1016/0003-9861(72)90436-5
   HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kawabe J, 2010, CIRC J, V74, P836, DOI 10.1253/circj.CJ-10-0195
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   KORBUT R, 1978, THROMB RES, V13, P489, DOI 10.1016/0049-3848(78)90134-2
   LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511
   LANGANGER G, 1986, J CELL BIOL, V102, P200, DOI 10.1083/jcb.102.1.200
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   LUM H, 1994, AM J PHYSIOL, V267, pL223
   Mochizuki A, 2009, J BIOMAT SCI-POLYM E, V20, P591, DOI 10.1163/156856209X426411
   MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0
   MONCADA S, 1977, THROMB RES, V11, P323, DOI 10.1016/0049-3848(77)90185-2
   Nelson CM, 2004, MOL BIOL CELL, V15, P2943, DOI 10.1091/mbc.E03-10-0745
   Neubert K, 1997, PROSTAGLANDINS, V54, P447, DOI 10.1016/S0090-6980(97)00063-4
   PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765
   PATEL DJ, 1970, CIRC RES, V27, P149, DOI 10.1161/01.RES.27.2.149
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   SIESS W, 1981, BIOCHEM BIOPH RES CO, V99, P608, DOI 10.1016/0006-291X(81)91788-5
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001
   WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xie XY, 2010, J BIOMAT SCI-POLYM E, V21, P1239, DOI 10.1163/092050609X12481751806295
   Zimmermann R, 2006, MICROFLUID NANOFLUID, V2, P367, DOI 10.1007/s10404-006-0087-6
NR 58
TC 16
Z9 16
U1 1
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 7
BP 901
EP 915
DI 10.1163/092050611X566144
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 921DB
UT WOS:000302457100005
PM 21457619
DA 2018-10-19
ER

PT J
AU Hao, YQ
   Yan, HQ
   Wang, XP
   Zhu, BS
   Ning, CQ
   Ge, SF
AF Hao, Yongqiang
   Yan, Huanqing
   Wang, Xuepeng
   Zhu, Bangshang
   Ning, Congqin
   Ge, Shengfang
TI Evaluation of Osteoinduction and Proliferation on Nano-Sr-HAP: A Novel
   Orthopedic Biomaterial for Bone Tissue Regeneration
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Osteoinduction; Strontium; Nano-Sr-HAP; Osteoblasts; Bone Marrow
   Mesenchymal Stem Cells (MSCs)
ID STRONTIUM RANELATE; OSTEOBLAST ADHESION; IN-VIVO; DIFFERENTIATION;
   OSTEOPOROSIS; PERSPECTIVE; STRENGTH; IMPLANTS; TITANIUM; FRACTURE
AB Hydroxyapatite (HAP), a CaP compound similar to the mineral phase present in bone, has excellent biocompatibility but little osseous inductivity. In this study, we evaluated the novel nano-Sr-HAP, in which the calcium of hydroxyapatite was substituted with strontium, which acts as a bone-forming agent. Its biocompatibility and osteoinduction were assayed using marrow mesenchymal stem cells (MSCs) and osteoblasts (OBs) in vitro. We were able to demonstrate that nano-Sr-HAP supported increased OB cell adhesion, proliferation and viability up to 4 days in culture when compared with nano-HAP. MSCs cultured with nano-Sr-HAP showed higher alkaline phosphatase (ALP) activity. More extracellular mineralized nodules were found with nano-Sr-HAP compared to nano-HAP, especially in images of ALP staining. We suggest that nano-Sr-HAP powders possess osteoconductive and osteoinductive properties and have the potential to be used in the repair of bone defects caused by osteoporotic fractures.
C1 [Hao, Yongqiang; Yan, Huanqing; Wang, Xuepeng] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai 200011, Peoples R China.
   [Zhu, Bangshang] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200240, Peoples R China.
   [Ning, Congqin] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   [Ge, Shengfang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, Sch Med, Shanghai 200011, Peoples R China.
RP Hao, YQ (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai 200011, Peoples R China.
OI ning, cong qin/0000-0002-3725-5600
FU National High Technology Research and Development Program of China (863
   program) [2009AA03Z311]; National Natural Science Foundation of China
   [81071472]; Shanghai Municipal Education Commission [J50206]
FX This work was supported by the National High Technology Research and
   Development Program of China (863 program; Grant no. 2009AA03Z311),
   National Natural Science Foundation of China (Grant no. 81071472) and
   Fund for Key Disciplines of Shanghai Municipal Education Commission
   (Grant no. J50206).
CR Bain SD, 2009, OSTEOPOROSIS INT, V20, P1417, DOI 10.1007/s00198-008-0815-8
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Boonen S, 2006, J AM GERIATR SOC, V54, P782, DOI 10.1111/j.1532-5415.2006.00695.x
   Burns K, 2009, J BIOMED MATER RES A, V88A, P561, DOI 10.1002/jbm.a.31899
   Duque G, 2007, J BONE MINER RES, V22, P1603, DOI 10.1359/JBMR.070701
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Lee SJ, 2007, J NANOSCI NANOTECHNO, V7, P4061, DOI 10.1166/jnn.2007.067
   Marie P J, 2006, Bone, V38, pS10
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Pande I, 2006, ANN RHEUM DIS, V65, P87, DOI 10.1136/ard.2004.034611
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Ruppel ME, 2008, OSTEOPOROSIS INT, V19, P1251, DOI 10.1007/s00198-008-0579-1
   Schnettler R, 2003, BIOMATERIALS, V24, P4603, DOI 10.1016/S0142-9612(03)00354-5
   Sepulveda P, 2002, J BIOMED MATER RES, V62, P587, DOI 10.1002/jbm.10173
   Shane A. C., 2004, J NANOSCI NANOTECHNO, V4, P986
   Yan H., 2007, J TISSU ENG RECONSTR, V3, P309
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Yu T, 2009, ACTA BIOMATER, V5, P2717, DOI 10.1016/j.actbio.2009.03.015
NR 26
TC 20
Z9 20
U1 2
U2 31
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JAN
PY 2012
VL 12
IS 1
BP 207
EP 212
DI 10.1166/jnn.2012.5125
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 914YT
UT WOS:000301990500024
PM 22523967
DA 2018-10-19
ER

PT J
AU Heo, S
   Yun, YS
   Cho, SY
   Jin, HJ
AF Heo, Semi
   Yun, Young Soo
   Cho, Se Youn
   Jin, Hyoung-Joon
TI Flexible Bio-Composites Based on Silks and Celluloses
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Asian Conference on Nanoscience and Nanotechnology (AsiaNANO)
CY NOV 01-03, 2010
CL Tokyo, JAPAN
DE Silk Fibroin; Cellulose; Biomaterial; Flexibility
ID MECHANICAL-PROPERTIES; CARBON NANOTUBES; SILKWORM SILK; FIBERS; FILMS;
   NANOFIBERS
AB Biomaterials have attracted worldwide attention due to the concerns regarding health and the environment. Silk, a natural protein produced by several species of insects, has been examined as a potential material for applications in many biotechnological and biomedical fields. However, regenerated silk fibroin has poor ductility and mechanical properties. Therefore, in this study, silk fibroin-cellulose composite films were prepared in an aqueous system to increase the ductility of regenerated silk fibroin. The morphology of the silk fibroin-cellulose composite film was observed by field emission scanning electron microscopy. The structure of the silk fibroin-cellulose composite films was examined by Fourier transform-infrared spectroscopy. The flexibility was analyzed using a bending test.
C1 [Heo, Semi; Yun, Young Soo; Cho, Se Youn; Jin, Hyoung-Joon] Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Jin, HJ (reprint author), Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RI Cho, Se Youn/M-9437-2017
OI Cho, Se Youn/0000-0002-4898-0488
FU Rural Development Administration, Republic of Korea [200810FTH010102001]
FX This study was supported by a grant (Code #200810FTH010102001) from
   BioGreen21 Program, Rural Development Administration, Republic of Korea.
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jung R, 2008, J POLYM SCI POL PHYS, V46, P1235, DOI 10.1002/polb.21457
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Kim Y, 2009, CURR APPL PHYS, V9, pS69, DOI 10.1016/j.cap.2008.08.010
   Liu GL, 2010, APPL SURF SCI, V256, P2546, DOI 10.1016/j.apsusc.2009.10.102
   Lue A, 2007, MACROMOL CHEM PHYSIC, V208, P2359, DOI 10.1002/macp.200700177
   Marsano E, 2007, J APPL POLYM SCI, V104, P2187, DOI 10.1002/app.24856
   Marsano E, 2008, INT J BIOL MACROMOL, V43, P106, DOI 10.1016/j.ijbiomac.2008.03.009
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Poole AJ, 2009, BIOMACROMOLECULES, V10, P1, DOI 10.1021/bm8010648
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
   Zabetakis D, 2005, ADV MATER, V17, P734, DOI 10.1002/adma.200400320
   Zhang LN, 2001, IND ENG CHEM RES, V40, P5923, DOI 10.1021/ie0010417
NR 21
TC 2
Z9 2
U1 5
U2 26
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JAN
PY 2012
VL 12
IS 1
BP 811
EP 814
DI 10.1166/jnn.2012.5369
PG 4
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 914YT
UT WOS:000301990500120
PM 22524062
DA 2018-10-19
ER

PT J
AU Jung, F
   Goers, J
   Roch, T
   Zaupa, A
   Pierce, BF
   Neffe, AT
   Lendlein, A
AF Jung, F.
   Goers, J.
   Roch, T.
   Zaupa, A.
   Pierce, B. F.
   Neffe, A. T.
   Lendlein, A.
TI Physically crosslinked gelatins functionalized with tyrosine moieties do
   not induce angiogenesis or thrombus formation in the developing
   vasculature in the avian chorioallantoic membrane
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE HETCAM; gelatin; angiogenesis; thrombosis; biomaterial; implant material
ID SHELL CONDUCTANCE; BIOMATERIALS; MODEL
AB Gelatins functionalized with desaminotyrosine or desaminotyrosyl tyrosine form physically crosslinked polymer networks due to the interactions between the introduced aromatic moeties. In the swollen state, their mechanical properties can be tailored in a range similar to the elasticity of soft tissues. The aim of this study was to evaluate their potential as biomaterials by determining whether these materials - in comparison to plain gelatin - induce bleedings, thrombotic processes, or angiogenesis. These investigations were performed using the hen's egg chorioallantoic membrane (HETCAM) assay. These results indicate that the gelatin-based hydrogels did not possess angiogenic effects and also did not induce bleedings, thrombotic processes or vessel destruction (avascular zones).
   The biocompatibility of the materials in vitro motivates the exploration of their application as matrix in local drug-release systems with short half-life times (1 hour up to several days).
C1 [Jung, F.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Neffe, Axel/H-6997-2013; Zaupa, Alessandro/I-2682-2013; Lendlein,
   Andreas/K-9553-2013; Roch, Toralf/K-9531-2013; Jung,
   Friedrich/L-1301-2013
OI Neffe, Axel/0000-0002-5056-3990; Zaupa, Alessandro/0000-0003-4062-403X;
   Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180; Roch, Toralf/0000-0003-2948-8700
FU Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 760];
   Bundesministerium fur Bildung und Forschung (BMBF) [0315696A 'Poly4Bio
   BB']
FX The authors are grateful to Anke Mayer and Melanie Pietsch for their
   technical assistance. We thank the Deutsche Forschungsgemeinschaft (DFG)
   for partial funding through the Sonderforschungsbereich 760 project B5
   as well as the Bundesministerium fur Bildung und Forschung (BMBF) for
   partial funding within project number 0315696A 'Poly4Bio BB'.
CR [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1
   Bahramsoltani M, 2010, CLIN HEMORHEOL MICRO, V46, P189, DOI 10.3233/CH-2010-1345
   Bayless KJ, 2011, J VASC RES, V48, P369, DOI 10.1159/000324751
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Hiebl B, 2010, CLIN HEMORHEOL MICRO, V46, P233, DOI 10.3233/CH-2010-1350
   Jung F, 2010, CLIN HEMORHEOL MICRO, V45, P79, DOI 10.3233/CH-2010-1312
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Lourens A, 2006, POULTRY SCI, V85, P1081, DOI 10.1093/ps/85.6.1081
   Mortola JP, 2010, COMP BIOCHEM PHYS A, V156, P373, DOI 10.1016/j.cbpa.2010.03.011
   Neffe AT, 2011, ACTA BIOMATER, V7, P1693, DOI 10.1016/j.actbio.2010.11.025
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Piluso S, 2011, INT J ARTIF ORGANS, V34, P192, DOI 10.5301/IJAO.2011.6394
   Reizis A, 2005, J EXP BIOL, V208, P2483, DOI 10.1242/jeb.01662
   Richter J, 2010, CLIN HEMORHEOL MICRO, V46, P37, DOI 10.3233/CH-2010-1331
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   ROLNIK VV, 1970, BIRD EMBRYOLOGY
   Romanoff AL, 1960, AVIAN EMBRYO STRUCTU
   Santos AOMT, 2011, CLIN HEMORHEOL MICRO, V47, P1, DOI 10.3233/CH-2010-1358
   SEYMOUR RS, 1988, J COMP PHYSIOL B, V158, P229, DOI 10.1007/BF01075837
   Shastri V.P., 2009, ADV MATER, V21, P2321
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   SPANELBOROWSKI K, 1989, RES EXP MED, V189, P69, DOI 10.1007/BF01856032
   Strick D.M., 1991, AM J PHYSIOL, V260, pH1389
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Wagner-Amos K, 2003, RESP PHYSIOL NEUROBI, V134, P155, DOI 10.1016/S1569-9048(02)00209-4
   West D.C., 2006, METHODS MOL MED, V46, P107
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
NR 32
TC 5
Z9 5
U1 1
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 50
IS 1-2
BP 55
EP 63
DI 10.3233/CH-2011-1443
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 913LN
UT WOS:000301879500006
PM 22538535
DA 2018-10-19
ER

PT J
AU Roch, T
   Cui, J
   Kratz, K
   Lendlein, A
   Jung, F
AF Roch, T.
   Cui, J.
   Kratz, K.
   Lendlein, A.
   Jung, F.
TI Immuno-compatibility of soft hydrophobic poly(n-butyl acrylate) networks
   with elastic moduli for regeneration of functional tissues
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Immuno-compatibility; endotoxins; polymer networks; butylacrylate;
   biomaterial
ID PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; ACTIVATED B-CELLS;
   COMPLEMENT ACTIVATION; BIOMATERIALS; SEPSIS; ROLES; ATHEROSCLEROSIS;
   COAGULATION; MECHANISMS
AB The need for engineered devices to treat cardiovascular diseases is increasing due to an aging population and a changing lifestyle. Soft poly(n-butyl acrylate) (cPnBA) networks were recently described as polymer networks with adjustable mechanical properties and suggested as soft substrates for cells, which could potentially be used for cardiovascular implants. Vascular prostheses designed to be implanted in arteries should have an elasticity similar to blood vessels (elastic modulus at body temperature between 100 and 1200 kPa). Therefore, cPnBA networks with E-moduli of 250 kPa (cPnBA0250) and 1100 kPa (cPnBA1100) were developed. Recently, it was shown that both materials were non-cytotoxic for murin fibroblasts, human primary endothelial cells and human monocytes.
   However, before such newly developed polymers can be used in vivo, it has to be assured that the sterilized materials have a very low endotoxin load to avoid an unspecific activation of the immune system, which otherwise might cause local or systemic inflammatory responses and could lead to severe pathologies.
   In this study we investigated the immuno-compatibility of sterilized cPnBA0250 and cPnBA1100 with the help of an immunocompetent macrophage cell line as well as with whole human blood.
C1 [Jung, F.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM Friedrich.Jung@hzg.de
RI Roch, Toralf/K-9531-2013; Jung, Friedrich/L-1301-2013; Lendlein,
   Andreas/K-9553-2013; Kratz, Karl/K-7115-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; Kratz, Karl/0000-0002-9229-4266; Roch,
   Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung (BMBF) [0315696A "Poly4bio
   BB"]
FX We thank the Bundesministerium fur Bildung und Forschung (BMBF) for
   funding within project number 0315696A "Poly4bio BB".
CR Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1, DOI 10.3233/CH-2010-1256A
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Booth J, 2011, CELL TISSUE RES, V343, P131, DOI 10.1007/s00441-010-1031-3
   Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   Cui J, 2011, TISSUE ENG PT A, V17, P563
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grasbeck R., 1981, REFERENCE VALUES LAB
   Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763
   Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x
   Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lendlein A, 2010, MACROMOL BIOSCI, V10, P993, DOI 10.1002/mabi.201000300
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Mayer A., 2011, ARTIF ORGAN IN PRESS, DOI 10.111/ j.1525-1594.2011.01410.x
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848
   Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854
   Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002
   Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007
   Williams K. L., 2007, ENDOTOXINS PYROGENS
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884
NR 52
TC 20
Z9 20
U1 1
U2 11
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2012
VL 50
IS 1-2
BP 131
EP 142
DI 10.3233/CH-2010-1449
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 913LN
UT WOS:000301879500012
PM 22538541
DA 2018-10-19
ER

PT J
AU Bartalena, G
   Loosli, Y
   Zambelli, T
   Snedeker, JG
AF Bartalena, G.
   Loosli, Y.
   Zambelli, T.
   Snedeker, J. G.
TI Biomaterial surface modifications can dominate cell-substrate mechanics:
   the impact of PDMS plasma treatment on a quantitative assay of cell
   stiffness
SO SOFT MATTER
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; MICROPILLAR INTERFACES; SILICONE MEMBRANES;
   MATRIX ELASTICITY; STEM-CELLS; IN-VITRO; ADHESION; STRAIN;
   POLYDIMETHYLSILOXANE; INDENTATION
AB Polydimethylsiloxane (PDMS) is a bioinert synthetic polymer with tunable elastic properties that is commonly used as a cell culture substrate. Although plasma treatments are widely used to bio-functionalize otherwise hydrophobic PDMS surfaces, plasma altered surface mechanical properties and implications for cell-substrate mechanical interactions are poorly understood. We performed a multi-scale mechanical characterization of PDMS following plasma treatment: spherical indentation tests were performed with a universal testing machine (indenter diameter, d = 4.75 mm) and atomic force microscopy (AFM) with round tips of 2 different diameters (d = 2 mm, d = 20 mu m). Results indicated substantial surface stiffening at indentation depths up to 1 micron, with exponentially decreasing effects to depths of 1 mm. AFM indentation results were analyzed using a finite element (FE) based optimization to determine the substrate material properties, and thus separate the confounding influence of the underlying substrate on surface indentation experiments. We found that a two-layer material model composed of a thin, stiff plasma-oxidized layer (296 nm and 3.66 MPa, respectively) superimposed on a thick layer of bulk polymer (elastic modulus of 10.5 kPa) was able to robustly fit the experimental data. We then investigated the repercussions of the biopolymer surface modifications on cell mechanics, using an inverse finite element model to interpret cell-matrix force exchange. Estimates of cell elastic modulus neglecting the mechanical effects of plasma treatment were more than an order of magnitude lower than estimates accounting for the surface layer (9.6 +/- 4.2 kPa vs. 124 +/- 55 kPa, respectively). This study thus highlights the need to accurately consider biomaterial surface modifications and how they may influence cell-biomaterial interaction. It further provides a novel approach to characterizing cell-relevant mechanical properties of a polymer substrate. These advances may lead to an improved quantitative assessment of actin cytoskeleton function, with potential relevance to biomaterial based therapies.
C1 [Bartalena, G.; Loosli, Y.; Snedeker, J. G.] Univ Zurich, Dept Orthoped, Orthoped Res Lab, Uniklin Balgrist, CH-8008 Zurich, Switzerland.
   [Bartalena, G.; Loosli, Y.; Snedeker, J. G.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.
   [Loosli, Y.] RMS Fdn, Bettlach, Switzerland.
   [Zambelli, T.] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland.
RP Snedeker, JG (reprint author), Univ Zurich, Dept Orthoped, Orthoped Res Lab, Uniklin Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.
EM snedeker@ethz.ch
RI Snedeker, Jess/C-2105-2009
OI Snedeker, Jess/0000-0002-8115-0275
FU Swiss National Science Foundation [205321-118036]
FX The authors gratefully acknowledge the funding of this study by Swiss
   National Science Foundation, grant number 205321-118036. We also thank
   Mr Matthias Muoth and Prof. Christofer Hierold for granting us access to
   their AFM for the post-hoc validation of the FE based material
   characterization.
CR Ahmed W. W., 2010, ACTA BIOMATER
   Appelman TP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003314
   Bar G, 2001, POLYMER, V42, P3627, DOI 10.1016/S0032-3861(00)00738-2
   Bartalena G, 2011, BIOMED MICRODEVICES, V13, P291, DOI 10.1007/s10544-010-9493-3
   Befahy S, 2010, LANGMUIR, V26, P3372, DOI 10.1021/la903154y
   Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195
   Butler J. P., 2002, AM J PHYSIOL-CELL PH, V282, pC595
   Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Caille N, 1998, ANN BIOMED ENG, V26, P409, DOI 10.1114/1.132
   Chen MH, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/50/505301
   Cheng CM, 2009, J BIOMECH, V42, P187, DOI 10.1016/j.jbiomech.2008.10.014
   Choi KM, 2003, J AM CHEM SOC, V125, P4060, DOI 10.1021/ja029973k
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x
   Dodge A, 2006, ANALYST, V131, P1122, DOI 10.1039/b606394b
   DONG C, 1991, BIORHEOLOGY, V28, P557
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feinberg AW, 2009, ACTA BIOMATER, V5, P2013, DOI 10.1016/j.actbio.2009.01.032
   Firkowska I, 2008, ADV FUNCT MATER, V18, P3765, DOI 10.1002/adfm.200800760
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   Gilchrist CL, 2007, J BIOMECH, V40, P786, DOI 10.1016/j.jbiomech.2006.03.013
   Gouldstone A, 2007, ACTA MATER, V55, P4015, DOI 10.1016/j.actamat.2006.08.044
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Haines SR, 2007, SURF INTERFACE ANAL, V39, P942, DOI 10.1002/sia.2646
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Hillborg H, 2000, POLYMER, V41, P6851, DOI 10.1016/S0032-3861(00)00039-2
   Lateef SS, 2002, BIOMATERIALS, V23, P3159, DOI 10.1016/S0142-9612(02)00062-5
   Lima R, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035005
   Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293
   Liu MC, 2011, BIOMED MICRODEVICES, V13, P191, DOI 10.1007/s10544-010-9484-4
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Loosli Y, 2010, PHILOS T R SOC A, V368, P2629, DOI 10.1098/rsta.2010.0069
   Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462
   Mattice JM, 2006, J MATER RES, V21, P2003, DOI 10.1557/JMR.2006.0243
   Mills KL, 2008, J MATER RES, V23, P37, DOI 10.1557/JMR.2008.0029
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Poulard C, 2011, SOFT MATTER, V7, P2543, DOI 10.1039/c0sm01099e
   Roos W, 2005, NANO LETT, V5, P2630, DOI 10.1021/nl051865j
   Roth J, 2008, LANGMUIR, V24, P12603, DOI 10.1021/la801970s
   Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670
   Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X
   Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046
   Steinberg T, 2007, NANO LETT, V7, P287, DOI [10.1021/nl062271z, 10.1021/nl06227z]
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Wipff PJ, 2009, BIOMATERIALS, V30, P1781, DOI 10.1016/j.biomaterials.2008.12.022
NR 53
TC 28
Z9 30
U1 3
U2 60
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2012
VL 8
IS 3
BP 673
EP 681
DI 10.1039/c1sm06250f
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 912JJ
UT WOS:000301793700013
DA 2018-10-19
ER

PT J
AU Tomporowski, A
AF Tomporowski, Andrzej
TI STREAM OF EFFICIENCY OF RICE GRAINS MULTI-DISC GRINDING
SO EKSPLOATACJA I NIEZAWODNOSC-MAINTENANCE AND RELIABILITY
LA English
DT Article
DE grinding; biomaterials; efficiency
AB A search for design solutions for grain grinding devices offering energy-saving production processes justify the research into the improvement of the theory and the design of grinders. The efficiency, functionality and performance of the rice grains grinding are significantly influenced by processes, difficult to describe, occurring within the working space of the grinder. Although there are some studies on the principles of the functionality and analysis of multi-disc grinders, an attempt has not been made so far at describing the influence of features and behaviour of ground material on efficiency, performance and usefulness of the biomaterial comminution/grinding process. The basis for the improvement of the functionality of a grinding device is an analysis of the potential of existing solutions and a determination of the scope of effective design features of the working unit within the permissible area. The criteria may be fulfilled by objective-oriented control of the design features of the multi-disc unit. In order for these actions to be effective, relevant relationships need to be explored and a mathematical description needs to be developed for the flow of ground grains through the working space of a multi-disc grinder, as a result variable of the structure and the operation of a working unit.
C1 Univ Technol & Life Sci Bydgoszcz, Fac Mech Engn, PL-85788 Bydgoszcz, Poland.
RP Tomporowski, A (reprint author), Univ Technol & Life Sci Bydgoszcz, Fac Mech Engn, Ul Prof S Kaliskiego 7,Bud 3-2 Pok 202, PL-85788 Bydgoszcz, Poland.
EM a.tomporowski@utp.edu.pl
FU National Centre for Research and Development
FX The research financed by the funds of the National Centre for Research
   and Development in 2010/2013 as a development project
CR Detyna J, 2011, EKSPLOAT NIEZAWODN, P78
   Flizikowski J., 1994, RAISING ENERGY EFFIC
   Flizikowski J, 2005, CONSTRUCTION FOOD GR
   Flizikowski J, Multidisc Grinder Especially for Grains. Patent., Patent No. [RP-144 566, 144566]
   Kaleta A., 2007, FOOD PROCESSING SELE
   Razavi SMA, 2008, INT AGROPHYS, V22, P353
NR 6
TC 8
Z9 8
U1 0
U2 0
PU POLISH MAINTENANCE SOC
PI LUBLIN
PA REDAKCJA KWARTALNIKA EKSPLOATACJA & NIEZAWODNOSC, UL NADBYSTRZYCKA 36,
   LUBLIN, 20-618, POLAND
SN 1507-2711
J9 EKSPLOAT NIEZAWODN
JI Eksploat. Niezawodn.
PY 2012
VL 14
IS 2
BP 150
EP 153
PG 4
WC Engineering, Multidisciplinary
SC Engineering
GA 905OX
UT WOS:000301283200009
DA 2018-10-19
ER

PT J
AU Roy, N
   Saha, N
   Kitano, T
   Lehocky, M
   Vitkova, E
   Saha, P
AF Roy, Niladri
   Saha, Nabanita
   Kitano, Takeshi
   Lehocky, Marian
   Vitkova, Eva
   Saha, Petr
TI Significant Characteristics of Medical-Grade Polymer Sheets and their
   Efficiency in Protecting Hydrogel Wound Dressings: A Soft Polymeric
   Biomaterial
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS
LA English
DT Article
DE antibacterial; breathable; hydrogel wound dressings; moisture retention;
   polymer sheet; wettability
ID POLY(VINYL ALCOHOL) HYDROGEL; RADIATION SYNTHESIS; DRUG-DELIVERY;
   RELEASE; SURFACE
AB Hydrogel dressings are soft biomaterials that need protection from external influences. Polymer sheets such as breathable film (BF) or breathable laminate (BL) were characterized in respect of water vapor transmission, water contact angle, microbial penetrability, and antimicrobial property to protect hydrogel dressings. The mechanical property and water retention ability of hydogels PVP-CMC and PVP-CMC-BA with and without BF and BL have been examined. Hydrogels covered with either BF or BL show better mechanical flexibility; however, their water retention capacity increases reasonably. The determined efficient properties of polymer sheets established that BF is better than BL as a protective sheet cover for hydrogel dressings.
C1 [Saha, Nabanita] Tomas Bata Univ Zlin, Ctr Polymer Syst, Ctr Polymer, Zlin 76001, Czech Republic.
   [Vitkova, Eva] Fatra As, Napajedla, Czech Republic.
RP Saha, N (reprint author), Tomas Bata Univ Zlin, Ctr Polymer Syst, Ctr Polymer, Nam TG Masaryka 5555, Zlin 76001, Czech Republic.
EM nabanitas@yahoo.com
RI Saha, Petr/F-3952-2016; Lehocky, Marian/H-1981-2012
OI Saha, Petr/0000-0002-1873-4163; SAHA, NABANITA/0000-0002-7549-2260;
   Lehocky, Marian/0000-0002-5368-5029
FU Ministry of Education, Youth, and Sports of the Czech Republic [MSM
   70088352101]; European Regional Development Fund (ERDF); national budget
   of the Czech Republic within Centre of Polymer Systems
   [CZ.1.05/2.1.00/03.0111]
FX The authors are thankful to the Ministry of Education, Youth, and Sports
   of the Czech Republic (MSM 70088352101) for financial support. This
   article was also created with the partial support of the Operational
   Programme Research and Development for Innovation, co-funded by the
   European Regional Development Fund (ERDF) and national budget of the
   Czech Republic within the framework of the Centre of Polymer Systems
   project (reg. number: CZ.1.05/2.1.00/03.0111).
CR Akhgari A, 2006, EUR J PHARM SCI, V28, P307, DOI 10.1016/j.ejps.2006.03.005
   [Anonymous], 2010, HYDROGEL BURN INJURY
   Asadinezhad A, 2010, MOLECULES, V15, P1007, DOI 10.3390/molecules15021007
   Benamer S, 2006, NUCL INSTRUM METH B, V248, P284, DOI 10.1016/j.nimb.2006.04.072
   Dabbagh MA, 2008, IRAN J PHARM RES, V7, P21
   Galya T, 2008, J APPL POLYM SCI, V110, P3178, DOI 10.1002/app.28908
   Gwon HJ, 2010, RADIAT PHYS CHEM, V79, P650, DOI 10.1016/j.radphyschem.2009.12.011
   Higa OZ, 1999, RADIAT PHYS CHEM, V55, P705, DOI 10.1016/S0969-806X(99)00215-7
   Ju HK, 2001, POLYMER, V42, P6851, DOI 10.1016/S0032-3861(01)00143-4
   Mahkam M, 2011, INT J POLYM MATER, V60, P1, DOI 10.1080/00914037.2010.504148
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   Mohanan A, 2009, INT J POLYM MATER, V58, P32, DOI 10.1080/00914030802461899
   More SM, 2010, J APPL POLYM SCI, V116, P1732, DOI 10.1002/app.31627
   Pal K, 2007, J MATER SCI-MATER M, V18, P1889, DOI 10.1007/s10856-007-3061-2
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Oviedo IR, 2008, INT J POLYM MATER, V57, P1095, DOI 10.1080/00914030802341661
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Roy N, 2010, SOFT MATER, V8, P307
   Roy N, 2011, PROG COLL POL SCI S, V138, P127, DOI 10.1007/978-3-642-19038-4_22
   Roy N, 2010, SOFT MATER, V8, P130, DOI 10.1080/15394451003756282
   Roy N, 2010, J APPL POLYM SCI, V117, P1703, DOI 10.1002/app.32056
   Saha P., 2011, END ZONE MEASURING A, Patent No. 302405 (UPV CR)
   SAHA P, 2011, Patent No. 302405
   Sen M, 2005, J BIOMED MATER RES A, V74A, P187, DOI 10.1002/jbm.a.30308
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Tomic SL, 2010, RADIAT PHYS CHEM, V79, P643, DOI 10.1016/j.radphyschem.2009.11.015
   Vogt PM, 2006, BURNS, V32, P698, DOI 10.1016/j.burns.2006.01.007
   Wang M, 2007, NUCL INSTRUM METH B, V265, P385, DOI 10.1016/j.nimb.2007.09.009
   WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0
   Yang SP, 2011, INT J POLYM MATER, V60, P62, DOI 10.1080/00914037.2010.504160
   Yang XM, 2010, RADIAT PHYS CHEM, V79, P606, DOI 10.1016/j.radphyschem.2009.12.017
   Zhai ML, 2002, CARBOHYD POLYM, V50, P295, DOI 10.1016/S0144-8617(02)00031-0
   Zhang BN, 2010, INT J POLYM MATER, V59, P1018, DOI 10.1080/00914031003760709
NR 35
TC 14
Z9 14
U1 3
U2 30
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
J9 INT J POLYM MATER
JI Int. J. Polym. Mater.
PD JAN-APR
PY 2012
VL 61
IS 1-4
BP 72
EP 88
DI 10.1080/00914037.2011.593058
PG 17
WC Polymer Science
SC Polymer Science
GA 902LD
UT WOS:000301038700006
DA 2018-10-19
ER

PT J
AU Naveena, N
   Venugopal, J
   Rajeswari, R
   Sundarrajan, S
   Sridhar, R
   Shayanti, M
   Narayanan, S
   Ramakrishna, S
AF Naveena, N.
   Venugopal, J.
   Rajeswari, R.
   Sundarrajan, S.
   Sridhar, R.
   Shayanti, M.
   Narayanan, S.
   Ramakrishna, S.
TI Biomimetic composites and stem cells interaction for bone and cartilage
   tissue regeneration
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID HUMAN ADIPOSE-TISSUE; IN-VITRO CHONDROGENESIS; AUTOLOGOUS CHONDROCYTE
   TRANSPLANTATION; MESENCHYMAL PROGENITOR CELLS; MARROW STROMAL CELLS;
   ARTICULAR-CARTILAGE; GROWTH-FACTOR; ENGINEERED CARTILAGE; PRECURSOR
   CELLS; MECHANICAL-PROPERTIES
AB Development of bone and cartilage are emerging as prominent techniques in the field of tissue engineering because of the abundance of problems caused by disease, injury and trauma. Bone is the main supporting system of the body, a biocomposite of elements and tissues which is responsible for the excellent tensile and loading strength. Cartilage is an avascular, aneural and alymphatic tissue and does not have regenerative capabilities, so a great amount of assistance is required from outside to repair the defect site. Autografts and allografts are useful in the case of bone defects, but still they require a second surgery from the donor, and transmission of diseases are also possible. The objective of this review is to discuss the approaches that have been taken in bone and cartilage tissue engineering with an emphasis on the cell sources such as embryonic stem cells, adipose derived stem cells, mesenchymal stem cells and progenitor stem cells. A potential scaffold is also important for the mechanical and cellular functions for bone and cartilage regeneration. Awareness will be spanned over different types of scaffolds such as biomaterial scaffolds, nanofibrous scaffolds and hydrogels. The ultimate aim is to focus on the basic aspects and the importance of various signaling and growth factors for tissue engineering, used for tissues that have a poor self healing capacity, such as cartilage, or when defects are too big for the body's capacity to heal itself, such as large bone defects.
C1 [Naveena, N.; Venugopal, J.; Rajeswari, R.; Sundarrajan, S.; Sridhar, R.; Shayanti, M.; Ramakrishna, S.] Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Healthcare & Energy Mat Lab, Singapore 117548, Singapore.
   [Naveena, N.; Narayanan, S.] Univ Madras, Natl Ctr Nanosci & Nanotechnol, Madras, Tamil Nadu, India.
RP Venugopal, J (reprint author), Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Healthcare & Energy Mat Lab, Singapore 117548, Singapore.
EM nnijrv@nus.edu.sg; seeram@nus.edu.sg
RI Radhakrishnan, Sridhar/B-7439-2013; Subramanian, Sundarrajan/E-8022-2011
OI Radhakrishnan, Sridhar/0000-0002-5068-3175; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-065-592]; Ministry of Education
   [R-265-000-318-112]; NUSNNI; National University of Singapore, Singapore
FX This study was supported by the NRF-Technion (R-398-001-065-592),
   Ministry of Education (R-265-000-318-112) and NUSNNI, National
   University of Singapore, Singapore.
CR Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Au A, 2003, J BIOMED MATER RES A, V67A, P1310, DOI 10.1002/jbm.a.10156
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   BAK B, 1990, ACTA ORTHOP SCAND, V61, P54, DOI 10.3109/17453679008993067
   Bakker D., 1989, POLYM MED SURG, P11
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burkoth AK, 2000, J BIOMED MATER RES, V51, P352
   Buxton AN, 2007, TISSUE ENG, V13, P2549, DOI 10.1089/ten.2007.0075
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chia SL, 2006, TISSUE ENG, V12, P1945, DOI 10.1089/ten.2006.12.1945
   Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Coleman RM, 2007, BIOMATERIALS, V28, P2077, DOI 10.1016/j.biomaterials.2007.01.010
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Cooper C, 1995, J Rheumatol Suppl, V43, P10
   Corr M, 2002, ANN RHEUM DIS, V61, P3, DOI 10.1136/ard.61.1.3
   Cui WU, 2007, J BIOMED MATER RES A, V82A, P831, DOI 10.1002/jbm.a.31187
   De Franceschi L, 2005, J BIOMED MATER RES A, V75A, P612, DOI 10.1002/jbm.a.30471
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   DEEPIKA G, 2009, BIOMATERIALS, V30, P2085, DOI DOI 10.1016/J.BIOMATERIALS.2008.12.079
   DEPORTER DA, 1988, CALCIFIED TISSUE INT, V42, P321, DOI 10.1007/BF02556367
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Dumas JE, 2010, ACTA BIOMATER, V6, P2394, DOI 10.1016/j.actbio.2010.01.030
   Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395
   Elabd C, 2007, BIOCHEM BIOPH RES CO, V361, P342, DOI 10.1016/j.bbrc.2007.06.180
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FREED LE, 1995, BIOMEDICAL ENG HDB, P1788
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   GROSS UM, 1993, INTRO BIOCERAMICS, P105
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9
   Halvorsen YC, 2000, INT J OBESITY, V24, pS41, DOI 10.1038/sj.ijo.0801503
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Hao JY, 2003, BIOMATERIALS, V24, P1531, DOI 10.1016/S0142-9612(02)00516-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Henriksen SS, 2011, J MATER SCI-MATER M, V22, P1111, DOI 10.1007/s10856-011-4290-y
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313
   Huang JI, 2005, J ORTHOP RES, V23, P1383, DOI 10.1016/j.orthres.2005.03.018
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Huin-Amargier C, 2006, J BIOMED MATER RES A, V76A, P416, DOI 10.1002/jbm.a.30536
   Hwang NS, 2011, CELL TISSUE RES, V344, P499, DOI 10.1007/s00441-011-1153-2
   Hwang YS, 2007, BIOTECHNOL BIOPROC E, V12, P15, DOI 10.1007/BF02931798
   Ikeda T, 2004, ARTHRITIS RHEUM, V50, P3561, DOI 10.1002/art.20611
   Ikoma T, 2000, KEY ENG MAT, V192-1, P487
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   JARCHO M, 1977, J BIOENG, V1, P79
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019
   Kikuchi M., 1997, BIOCERAMICS, V10, P407
   Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884
   Kim MS, 2005, STEM CELLS, V23, P113, DOI 10.1634/stemcells.2004-0110
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kroeze J. R., 2009, MATERIALS, V2, P833
   Kunisaki SM, 2006, STEM CELLS DEV, V15, P245, DOI 10.1089/scd.2006.15.245
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   Lee WK, 2003, J BIOMED MATER RES A, V67A, P1087, DOI 10.1002/jbm.a.10570
   Li HY, 2003, MATER LETT, V57, P2848, DOI 10.1016/S0167-577X(02)01386-1
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liu H, 2006, INT J NANOMED, V1, P541, DOI 10.2147/nano.2006.1.4.541
   Lum L, 2003, TOPICS TISSUE ENG, P1
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Mahmoudifar N, 2005, BIOTECHNOL BIOENG, V91, P338, DOI 10.1002/bit.20490
   Mahmoudifar N, 2010, BIOTECHNOL BIOENG, V107, P393, DOI 10.1002/bit.22798
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mao ZW, 2009, ACTA BIOMATER, V5, P2983, DOI 10.1016/j.actbio.2009.04.004
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Muggli DS, 1999, J BIOMED MATER RES, V46, P271, DOI 10.1002/(SICI)1097-4636(199908)46:2<271::AID-JBM17>3.0.CO;2-X
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   NASH TJ, 1994, BONE, V15, P203, DOI 10.1016/8756-3282(94)90709-9
   Nejati E, 2008, COMPOS PART A-APPL S, V39, P1589, DOI 10.1016/j.compositesa.2008.05.018
   Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nguyen LTH, 2012, J BIOMAT SCI-POLYM E, V23, P1771, DOI 10.1163/092050611X597807
   Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000
   Ohba S, 2007, FASEB J, V21, P1777, DOI 10.1096/fj.06-7571com
   OHTSUKI C, 2004, J CERAM SOC JPN S, V112, pS809
   Overgaard S, 1996, J ORTHOPAED RES, V14, P888, DOI 10.1002/jor.1100140607
   Paget Jr. X., 1853, HEALING CARTILAGE LE, V262, P1
   Pang YG, 2005, ARCH FACIAL PLAST S, V7, P7, DOI 10.1001/archfaci.7.1.7
   Park Y, 2005, OSTEOARTHR CARTILAGE, V13, P527, DOI 10.1016/j.joca.2005.02.006
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Piattelli A, 1997, BIOMATERIALS, V18, P629, DOI 10.1016/S0142-9612(96)00163-9
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Rameshbabu N, 2005, J MATER SCI, V40, P6319, DOI 10.1007/s10853-005-2957-9
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruff C. B., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P202
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Segura-Sanchez F, 2010, INT J PHARMACEUT, V387, P244, DOI 10.1016/j.ijpharm.2009.12.016
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Solchaga LA, 2004, METH MOLEC MED, V100, P53
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Sui YP, 2003, DIFFERENTIATION, V71, P578, DOI 10.1111/j.1432-0436.2003.07109001.x
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   Tarkka T, 2003, J GENE MED, V5, P560, DOI 10.1002/jgm.392
   THALLER SR, 1993, ANN PLAS SURG, V31, P429, DOI 10.1097/00000637-199311000-00007
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326
   Tritz-Schiavi J, 2010, BIO-MED MATER ENG, V20, P167, DOI 10.3233/BME-2010-0628
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Vacanti JP, 1999, LANCET, V354, pS32
   Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Venugopal J, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/5/055101
   Venugopal J, 2010, PHILOS T R SOC A, V368, P2065, DOI 10.1098/rsta.2010.0012
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vert M., 2008, J MATER SCI-MATER M, V20, P437
   Vinatier C, 2006, BIO-MED MATER ENG, V16, pS107
   Vinatier C, 2009, BIOTECHNOL BIOENG, V102, P1259, DOI 10.1002/bit.22137
   Walker JM, 1998, J ORTHOP SPORT PHYS, V28, P216, DOI 10.2519/jospt.1998.28.4.216
   Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029
   Wei K, 2011, J BIOMED MATER RES A, V97A, P272, DOI 10.1002/jbm.a.33054
   Weiss P, 2004, KEY ENG MATER, V254-2, P1107, DOI 10.4028/www.scientific.net/KEM.254-256.1107
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang ZJ, 2006, BIOCHEM BIOPH RES CO, V348, P421, DOI 10.1016/j.bbrc.2006.07.073
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130
NR 170
TC 28
Z9 29
U1 0
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 12
BP 5239
EP 5253
DI 10.1039/c1jm14401d
PG 15
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 899TC
UT WOS:000300838100001
DA 2018-10-19
ER

PT J
AU Sano, H
   Ichioka, S
   Kouraba, S
   Minamimura, A
   Sato, T
   Sekiya, N
   Yasuta, M
AF Sano, Hitomi
   Ichioka, Shigeru
   Kouraba, Sachio
   Minamimura, Ai
   Sato, Tomoya
   Sekiya, Naomi
   Yasuta, Masato
TI Treatment of venous ulcers with bone marrow-impregnated collagen matrix
SO JOURNAL OF PLASTIC SURGERY AND HAND SURGERY
LA English
DT Article
DE Bone marrow; wound healing; venous ulcer
ID LEG ULCERS; ARTIFICIAL DERMIS; CELLS; ANGIOGENESIS; WOUNDS; FIBROBLASTS;
   ACCELERATE; SURGERY
AB Bone marrow attracted our attention as a potentially beneficial material for the treatment of wounds, because it contains multipotential progenitor cells and produces growth factors. We impregnated autologous bone marrow cells on to a collagen matrix that had been used for the treatment of chronic wounds. The bone marrow-impregnated collagen matrix was then as a biomaterial scaffold for the treatment of wounds. This study was designed with the aim of clinically evaluating the effects of bone marrow-impregnated collagen matrix on wound healing of venous ulcers. We applied the matrix in 15 patients with chronic venous ulcers, and evaluated the transcutaneous oxygen tension (TcPO2) and vascular density. The application of the matrix induced healthy granulation tissue. All patients were given a split-thickness skin graft on to the induced granulation tissue, and have remained free from complications for more than eight months since the treatment. The mean (SD) vascular density at the ulcer base increased after the treatment (before 0.011 (0.006) mm(2)/mm(2), after 0.064 (0.036) mm(2)/mm(2), p < 0.001). The periwound TcPO2 values tended to increase (before 17.1 (12.7) mmHg, after 30.6 (13.4) mmHg, p < 0.001). Our results have shown the efficacy of bone marrow-impregnated collagen matrix for the treatment of intractable venous ulcers.
C1 [Sano, Hitomi; Ichioka, Shigeru; Minamimura, Ai; Sato, Tomoya; Sekiya, Naomi] Saitama Med Sch, Dept Plast & Reconstruct Surg, Moroyama, Saitama 3500495, Japan.
   [Kouraba, Sachio] Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sapporo, Hokkaido 060, Japan.
   [Yasuta, Masato] Univ Fukui, Dept Dermatol, Fukui 910, Japan.
RP Ichioka, S (reprint author), Saitama Med Sch, Dept Plast & Reconstruct Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.
EM ichoika2006@yahoo.co.jp
FU Japanese Ministry of Education, Sports and Culture [20592105]
FX We thank Professor Yuhei Yamamoto, Department of Plastic and
   Reconstructive Surgery, Hokkaido University of Hokkaido for his
   encouragement of our study. This study was supported by the Japanese
   Ministry of Education, Sports and Culture Grant 20592105.
CR Abbade LPF, 2005, INT J DERMATOL, V44, P449, DOI 10.1111/j.1365-4632.2004.02456.x
   Agren MS, 1999, J INVEST DERMATOL, V112, P463, DOI 10.1046/j.1523-1747.1999.00549.x
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260
   Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510
   Cianfarani F, 2006, BRIT J DERMATOL, V154, P34, DOI 10.1111/j.1365-2133.2005.06925.x
   Dantzer E, 2001, BRIT J PLAST SURG, V54, P659, DOI 10.1054/bjps.2001.3684
   Drinkwater SL, 2003, J VASC SURG, V38, P1106, DOI 10.1016/S0741-5214(03)01053-X
   Drinkwater SL, 2002, BRIT J SURG, V89, P709, DOI 10.1046/j.1365-2168.2002.02085.x
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812
   Grey JE, 2006, BRIT MED J, V332, P347, DOI 10.1136/bmj.332.7537.347
   Humpert PM, 2005, EXP CLIN ENDOCR DIAB, V113, P538, DOI 10.1055/s-2005-872886
   Ichioka S, 2005, BRIT J PLAST SURG, V58, P1124, DOI 10.1016/j.bjps.2005.04.054
   Ichioka S, 2004, ANN PLAS SURG, V52, P414, DOI 10.1097/01.sap.0000099709.95938.59
   Ichioka S, 2003, ANN PLAS SURG, V51, P383, DOI 10.1097/01.SAP.0000067971.90978.8F
   Ichioka S, 2009, WOUND REPAIR REGEN, V17, P492, DOI 10.1111/j.1524-475X.2009.00508.x
   Kubo K, 2004, ARTIF ORGANS, V28, P182, DOI 10.1111/j.1525-1594.2004.47219.x
   Ono I, 1998, J BIOMED MATER RES, V6, P621
   Pascarella L, 2005, ANN VASC SURG, V19, P921, DOI 10.1007/s10016-005-7661-3
   Simon DA, 2004, BRIT MED J, V328, P1358, DOI 10.1136/bmj.328.7452.1358
   Tateshita T, 2001, J DERMATOL SCI, V27, P104, DOI 10.1016/S0923-1811(01)00122-0
   Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x
   Yamaguchi Y, 2005, BRIT J DERMATOL, V152, P616, DOI 10.1111/j.1365-2133.2005.06402.x
NR 25
TC 3
Z9 3
U1 0
U2 1
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 2000-656X
J9 J PLAST SURG HAND SU
JI J. Plast. Surg. Hand Surg.
PY 2012
VL 46
IS 1
BP 37
EP 44
DI 10.3109/2000656X.2011.633392
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 904TA
UT WOS:000301219600007
PM 22455575
DA 2018-10-19
ER

PT J
AU Karimi, M
   Heuchel, M
   Weigel, T
   Schossig, M
   Hofmann, D
   Lendlein, A
AF Karimi, Mohammad
   Heuchel, Matthias
   Weigel, Thomas
   Schossig, Michael
   Hofmann, Dieter
   Lendlein, Andreas
TI Formation and size distribution of pores in poly(epsilon-caprolactone)
   foams prepared by pressure quenching using supercritical CO2
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE Foaming; Pore size distribution; Poly(epsilon-caprolactone);
   Supercritical CO2; Thermodynamics; Super-cooled melt; Scaffold
ID CARBON-DIOXIDE; MULTIBLOCK COPOLYMERS; REGENERATIVE MEDICINE;
   MORPHOLOGICAL-CHANGES; SHAPE-MEMORY; POLYMERS; NUCLEATION; SIMULATION;
   FLUIDS; POLYCAPROLACTONE
AB Many biomaterial-based regenerative therapies require foam structures, which temporarily mimic the extracellular matrix. The pore structure of these scaffolds needs to be tailored to the specific requirements of the clinical application. Poly(epsilon-caprolactone) (PCL) is a semi-crystalline, aliphatic polyester, which is applied as degradable implant material. In this paper we explored how thermodynamic and kinetic conditions in a supercritical CO2 (scCO(2)) supported foaming process influence the final morphology of the foam. With help of a view cell, we have systematically investigated the foaming with scCO(2) in the pressure range from 78 to 200 bar at temperatures between 25 and 50 degrees C. Foams were obtained both above the pressure dependent melting temperature (T-m) but also below this temperature, i.e. from supercooled melt states. Foams were characterized by mu CT X-ray computed tomography and scanning electron microscopy. The pore size distributions of the obtained foams show characteristic properties (widths, maxima) depending on the initial thermodynamic state of the CO2/PCL system before pressure quenching, the rate of the pressure decay, and the thermal history of the system. We try to rationalize the dependency of foam morphology and quench conditions with thermodynamic model calculations. The initial amount of CO2 in the PCL melt was calculated with the Sanchez-Lacombe equation of state. Pressure quenching with a slow pressure decay rate is considered an isothermal process where for a fast rate an adiabatic process is assumed. Both processes differ in their phase separation mechanism. It turned out that the CO2-induced melting point depression of the semi-crystalline polymer is an important factor. The variation of foaming conditions allows the preparation of scaffolds with specific morphological parameters (mean pore size, pore distribution, and pore connectivity). (C) 2011 Elsevier B.V. All rights reserved.
C1 [Karimi, Mohammad; Heuchel, Matthias; Weigel, Thomas; Schossig, Michael; Hofmann, Dieter; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Karimi, Mohammad] Amirkabir Univ Technol, Dept Text Engn, Tehran 15914, Iran.
RP Heuchel, M (reprint author), Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM matthias.heuchel@hzg.de
RI Lendlein, Andreas/K-9553-2013; Heuchel, Matthias/B-8271-2011
OI Lendlein, Andreas/0000-0003-4126-4670; Heuchel,
   Matthias/0000-0002-3860-1835
FU Helmholtz-Zentrum Geesthacht
FX M. Karimi thanks Helmholtz-Zentrum Geesthacht for financial support
   during this research project.
CR Baldwin DF, 1996, POLYM ENG SCI, V36, P1437, DOI 10.1002/pen.10538
   Balwin D.F., 1998, POLYM ENG SCI, V38, P674
   Barry JJA, 2006, PHILOS T ROY SOC A, V364, P249, DOI [10.1098/rsta.2005.1687, 10.1098/rsta.2000.1687]
   Beckman EJ, 2004, J SUPERCRIT FLUID, V28, P121, DOI 10.1016/S0896-8446(03)00029-9
   Byun HS, 2006, IND ENG CHEM RES, V45, P3366, DOI 10.1021/ie0507068
   Cao GP, 2010, J APPL POLYM SCI, V115, P2136, DOI 10.1002/app.31278
   Chung W.T., 2005, J POLYM RES, V12, P197
   COLTON JS, 1987, POLYM ENG SCI, V27, P500, DOI 10.1002/pen.760270704
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Cotugno S, 2005, IND ENG CHEM RES, V44, P1795, DOI 10.1021/ie049445c
   de Paz E, 2010, J CHEM ENG DATA, V55, P2781, DOI 10.1021/je900997t
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   Di Maio E, 2005, POLYM ENG SCI, V45, P432, DOI 10.1002/pen.20289
   Doghieri F, 1996, MACROMOLECULES, V29, P7885, DOI 10.1021/ma951366c
   Doghieri F., 2006, MAT SCI MEMBRANES GA, P137
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Fukne-Kokot K., 2000, FLUID PHASE EQUILIBR, V173, P183
   GOEL SK, 1994, POLYM ENG SCI, V34, P1137, DOI 10.1002/pen.760341407
   Guo QP, 2006, IND ENG CHEM RES, V45, P6153, DOI 10.1021/ie060105w
   Hofmann D, 2002, MACROMOLECULES, V35, P2129, DOI 10.1021/ma011360p
   Jacobs LJM, 2007, POLYMER, V48, P3771, DOI 10.1016/j.polymer.2007.05.002
   Jacobs LJM, 2008, GREEN CHEM, V10, P731, DOI 10.1039/b801895b
   Jenkins MJ, 2006, EUR POLYM J, V42, P3145, DOI 10.1016/j.eurpolymj.2006.07.022
   Kiran E, 2008, POLYMER, V49, P1853, DOI 10.1016/j.polymer.2008.02.017
   Kiran E, 2009, J SUPERCRIT FLUID, V47, P466, DOI 10.1016/j.supflu.2008.11.010
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Kulkarni A, 2007, LANGMUIR, V23, P12202, DOI 10.1021/la701523e
   Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Leung SN, 2006, IND ENG CHEM RES, V45, P7823, DOI 10.1021/ie060295a
   Lian ZY, 2006, J SUPERCRIT FLUID, V39, P107, DOI 10.1016/j.supflu.2006.02.001
   Lutzow K., 2007, J BIOMECH, V40, pS80
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Naguib HE, 2004, J APPL POLYM SCI, V91, P2661, DOI 10.1002/app.13448
   Nalawade SP, 2006, PROG POLYM SCI, V31, P19, DOI 10.1016/j.progpolymsci.2005.08.002
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Quinn TR, 2007, J BIOMED MATER RES B, V82B, P205, DOI 10.1002/jbm.b.30722
   Ramesh NS, 2004, POLYMER FOAMS SER, P73
   Sanchez C., 1977, POLYM LETT EDITION, V15, P71
   SANCHEZ IC, 1978, MACROMOLECULES, V11, P1145, DOI 10.1021/ma60066a017
   Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.16313161
   Shastri VP, 2010, MRS BULL, V35, P571, DOI 10.1557/mrs2010.524
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shieh YT, 2005, J SUPERCRIT FLUID, V33, P183, DOI 10.1016/j.supflu.2004.06.002
   Singh L, 2004, BIOMATERIALS, V25, P2611, DOI 10.1016/j.biomaterials.2003.09.040
   Sperling L.H., 2006, INTRO PHYS POLYM SCI, P299
   Stephen C, 2006, POLYM ENG SCI, V46, P751, DOI 10.1002/pen.20536
   Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z
   Uhlmann D.R., 1965, ACS SYM SER, P1
   Vukalovich M.P., 1963, Atomnaya Energiya, V15, P210
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeh CC, 2009, J MED BIOL ENG, V29, P92
   Zhai WT, 2009, INT J MOL SCI, V10, P5381, DOI 10.3390/ijms10125381
NR 55
TC 31
Z9 32
U1 5
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
EI 1872-8162
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JAN
PY 2012
VL 61
BP 175
EP 190
DI 10.1016/j.supflu.2011.09.022
PG 16
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 902CC
UT WOS:000301015200023
DA 2018-10-19
ER

PT J
AU Takayama, A
   Kadono, T
   Kawano, T
AF Takayama, Akiha
   Kadono, Takashi
   Kawano, Tomonori
TI Heme Redox Cycling in Soybean Peroxidase: Hypothetical Model and
   Supportive Data
SO SENSORS AND MATERIALS
LA English
DT Article
DE biomaterial; biosensor; plant; protein; enzyme
ID FUNGAL AUXIN ANTAGONIST; HORSERADISH-PEROXIDASE; PLANT PEROXIDASES;
   SUPEROXIDE GENERATION; SUSPENSION-CULTURE; CYTOSOLIC CALCIUM;
   COMPOUND-III; INCREASE; INHIBITION; INDUCTION
AB In plants, the peroxidase family is involved in a great deal of oxidation reactions essential for living cells, using H2O2 as an electron acceptor and a variety of substrates as electron donors. Nowadays, plant peroxidases are widely used as biological sensing materials in various areas such as medical diagnosis, biosensors, and nanotechnology. Among plant peroxidases, horseradish peroxidase (HRP) and soybean peroxiclase (SBP) are widely used as model enzymes applicable to various purposes. For the purpose of providing a basis for future innovation by using SBP as a sensing material,. we focus on the behavior of purified SBP in responses to known plant peroxidase substrates reportedly involved in superoxide-generating reactions. A chemiluminescence study showed that SBP can catalyze the generation of superoxide in the presence of salicylic acid and indole-3-acetic acid used as the tester substrates for examining the involvement of the conventional peroxidase cycle (involving native form, Compounds I and II) and oxygenase cycle (involving native form, ferrous form, and Compound III), respectively. Enzyme intermediates in the above two redox cycles were spectroscopically determined by recording the typical spectra reflecting the presence of Compound II (peroxidise cycle) and Compound III (oxygenase cycle). Interestingly, addition of nitric oxide in the absence of H2O2 resulted in the formation of an intermediate resembling Compound II, the catalytically active form in the peroxidase cycle; thus, the novel gaseous regulation of SBP-mediated reaction was proposed.
C1 [Kawano, Tomonori] Univ Kitakyushu, Lab Chem Biol & Bioengn, Fac Environm Engn, Kitakyushu, Fukuoka 8080135, Japan.
   Univ Kitakyushu, Lab Chem Biol & Bioengn, Grad Sch Environm Engn, Kitakyushu, Fukuoka 8080135, Japan.
RP Kawano, T (reprint author), Univ Kitakyushu, Lab Chem Biol & Bioengn, Fac Environm Engn, Kitakyushu, Fukuoka 8080135, Japan.
EM kawanotom@gmail.com
RI Kadono, Takashi/N-4561-2015
OI Kadono, Takashi/0000-0003-1710-9216; Kawano,
   Tomonori/0000-0002-6876-9399
CR Allen BL, 2009, J AM CHEM SOC, V131, P17194, DOI 10.1021/ja9083623
   Anderson MD, 1998, PHYTOCHEMISTRY, V47, P555, DOI 10.1016/S0031-9422(97)00726-7
   Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367
   Gazaryan IG, 1996, BIOCHEM J, V313, P841, DOI 10.1042/bj3130841
   Gozzo F, 2003, J AGR FOOD CHEM, V51, P4487, DOI 10.1021/jf030025s
   Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061
   Husain Q, 2010, REV ENVIRON SCI BIO, V9, P117, DOI 10.1007/s11157-009-9184-9
   Kawano T, 2000, J EXP BOT, V51, P685, DOI 10.1093/jexbot/51.345.685
   Kawano T, 2003, PLANT CELL REP, V21, P829, DOI 10.1007/s00299-003-0591-z
   Kawano T, 1998, PLANT CELL PHYSIOL, V39, P721, DOI 10.1093/oxfordjournals.pcp.a029426
   Kawano T, 2002, BIOCHEM BIOPH RES CO, V294, P553, DOI 10.1016/S0006-291X(02)00513-2
   Kawano T, 2002, BIOSCI BIOTECH BIOCH, V66, P646, DOI 10.1271/bbb.66.646
   Kawano T, 2002, BIOSCI BIOTECH BIOCH, V66, P1224, DOI 10.1271/bbb.66.1224
   Kawano T, 2001, BIOCHEM BIOPH RES CO, V288, P546, DOI 10.1006/bbrc.2001.5800
   Kawano T., 2004, PLANT BIOTECHNOL, V21, P319, DOI [10.5511/plantbiotechnology.21.319, DOI 10.5511/PLANTBI0TECHN0L0GY.21.319]
   Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6
   Penel C., 1992, PLANT PEROXIDASES 19
   Penel C, 2000, INTEGRATED PLANT SYS, P359
   Pizzariello A, 2002, BIOELECTROCHEMISTRY, V56, P99, DOI 10.1016/S1567-5394(02)00026-9
   Qiu HJ, 2010, BIORESOURCE TECHNOL, V101, P9415, DOI 10.1016/j.biortech.2010.07.097
   RUTTER R, 1983, BIOCHEMISTRY-US, V22, P4769, DOI 10.1021/bi00289a024
   Saleh L, 2010, NAT PROTOC, V5, P1627, DOI 10.1038/nprot.2010.120
   Savitsky PA, 1999, BIOCHEM J, V340, P579, DOI 10.1042/0264-6021:3400579
   Schnell JA, 2010, PLANT CELL REP, V29, P987, DOI 10.1007/s00299-010-0884-y
   SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033
   Tewari A, 2010, MACROMOL CHEM PHYS, V211, P1610, DOI 10.1002/macp.201000046
   Tiwari I, 2010, ANAL LETT, V43, P2019, DOI 10.1080/00032711003704263
   Vdovenko M. M., 2010, J IMMUNOL METHODS, V363, P127
   Yokawa K, 2011, PLANT SIGNAL BEHAV, V6, P477, DOI 10.4161/psb.6.4.14744
   Yoshioka H, 2008, PLANT SIGNAL BEHAV, V3, P153, DOI 10.4161/psb.3.3.5537
   Zhu ZH, 2010, MATER CHEM PHYS, V124, P488, DOI 10.1016/j.matchemphys.2010.06.071
NR 31
TC 5
Z9 5
U1 0
U2 5
PU MYU, SCIENTIFIC PUBLISHING DIVISION
PI TOKYO
PA 1-23-3-303 SENDAGI, TOKYO, 113-0022, JAPAN
SN 0914-4935
J9 SENSOR MATER
JI Sens. Mater.
PY 2012
VL 24
IS 2
BP 87
EP 97
PG 11
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA 902JL
UT WOS:000301034300003
DA 2018-10-19
ER

PT J
AU Salahshoor, M
   Guo, YB
AF Salahshoor, Meisam
   Guo, Yuebin
TI Biodegradable Orthopedic Magnesium-Calcium (MgCa) Alloys, Processing,
   and Corrosion Performance
SO MATERIALS
LA English
DT Review
DE magnesium; biomaterial; implant; manufacturing; surface integrity;
   corrosion
ID RESIDUAL-STRESS STABILITY; LOCKING COMPRESSION PLATE; STAINLESS-STEEL
   AISI-304; SURFACE INTEGRITY; IMPLANT ALLOYS; STRAIN-RATE; CA ALLOYS;
   MECHANICAL-PROPERTIES; FATIGUE FAILURE; TI-6AL-4V ALLOY
AB Magnesium-Calcium (Mg-Ca) alloy has received considerable attention as an emerging biodegradable implant material in orthopedic fixation applications. The biodegradable Mg-Ca alloys avoid stress shielding and secondary surgery inherent with permanent metallic implant materials. They also provide sufficient mechanical strength in load carrying applications as opposed to biopolymers. However, the key issue facing a biodegradable Mg-Ca implant is the fast corrosion in the human body environment. The ability to adjust degradation rate of Mg-Ca alloys is critical for the successful development of biodegradable orthopedic implants. This paper focuses on the functions and requirements of bone implants and critical issues of current implant biomaterials. Microstructures and mechanical properties of Mg-Ca alloys, and the unique properties of novel magnesium-calcium implant materials have been reviewed. Various manufacturing techniques to process Mg-Ca based alloys have been analyzed regarding their impacts on implant performance. Corrosion performance of Mg-Ca alloys processed by different manufacturing techniques was compared. In addition, the societal and economical impacts of developing biodegradable orthopedic implants have been emphasized.
C1 [Salahshoor, Meisam; Guo, Yuebin] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM msalahshoorpirsoltan@crimson.ua.edu; yguo@eng.ua.edu
CR Amel-Farzad H, 2007, ENG FAIL ANAL, V14, P1205, DOI 10.1016/j.engfailanal.2006.11.037
   Ataya S, 2007, THEOR APPL FRACT MEC, V47, P102, DOI 10.1016/j.tafmec.2006.11.002
   Au AG, 2007, J BIOMECH, V40, P1410, DOI 10.1016/j.jbiomech.2006.05.020
   Bach F. W., 2007, P 7 INT C MG ALL THE, P1076
   Benli S, 2008, J BIOMECH, V41, P3229, DOI 10.1016/j.jbiomech.2008.08.003
   Bergen G, 2008, INJURY US 2007 CHART
   Bozdana AT, 2008, MATER SCI TECH-LOND, V24, P1378, DOI 10.1179/174328408X302431
   Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006
   Completo A, 2008, EXP MECH, V48, P817, DOI 10.1007/s11340-007-9101-5
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2005, P 5 EUSP INT C MONTP
   Disegi J, 2009, P ASM MPMD MAT PROC
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   El-Magd E, 2006, INT J IMPACT ENG, V32, P741, DOI 10.1016/j.ijimpeng.2005.03.008
   El-Magd E, 2003, J PHYS IV, V110, P15, DOI 10.1051/jp4:20030663
   El-Magd E., 2000, MAGNESIUM ALLOYS THE, P324
   El-Magd E., 2004, P 6 INT C MAGN ALL T, P402
   ElMagd E, 1996, MATERIALWISS WERKST, V27, P408, DOI 10.1002/mawe.19960270814
   Essa YS, 2003, J MATER PROCESS TECH, V143, P856, DOI 10.1016/S0924-0136(03)00347-9
   Feser K, 2011, J BIOMATER APPL, V25, P685, DOI 10.1177/0885328209360424
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gill C.M., 2008, J PHYS D, V41, P174005
   Gu XN, 2009, ACTA BIOMATER, V5, P2790, DOI 10.1016/j.actbio.2009.01.048
   Gu X.N., 2009, BIOMED MATER, V4, P065011
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Hassel T, 2007, P 7 INT C MG ALL THE, P789
   Hassel T., 2007, P 7 INT C MG ALL THE, P432
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Isaksson H, 2003, P IEEE 29 ANN BIOENG, P1041
   Jayaraman N., 2007, P USAF AIRCR STRUCT
   Juijerm P, 2007, SCRIPTA MATER, V56, P745, DOI 10.1016/j.scriptamat.2007.01.021
   Kainer KU, 1998, MAGNESIUM ALLOYS THE, P369
   Kanchanomai C, 2008, ENG FAIL ANAL, V15, P521, DOI 10.1016/j.engfailanal.2007.04.001
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Li MH, 2011, J MATER SCI, V46, P2365, DOI 10.1007/s10853-010-5083-2
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   de Lacalle LNL, 2007, INT J ADV MANUF TECH, V32, P958, DOI [10.1007/s00170-005-0402-5, 10.1007/S00170-005-0402-5]
   Miller DL, 2007, CLIN BIOMECH, V22, P1049, DOI 10.1016/j.clinbiomech.2007.08.004
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nikitin I, 2008, MAT SCI ENG A-STRUCT, V491, P297, DOI 10.1016/j.msea.2008.03.034
   Nikitin I, 2008, SCRIPTA MATER, V58, P239, DOI 10.1016/j.scriptamat.2007.09.045
   Nikitin I, 2007, MAT SCI ENG A-STRUCT, V465, P176, DOI 10.1016/j.msea.2007.02.004
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Prevey P., 2009, P ASM MPMD MAT PROC
   Prevey PS, 2007, MATER SCI FORUM, V539-543, P3807, DOI 10.4028/www.scientific.net/MSF.539-543.3807
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057
   Rao DS, 2008, MATER MANUF PROCESS, V23, P295, DOI 10.1080/10426910801937306
   Roseler B, 2001, MATER CORROS, V52, P413, DOI 10.1002/1521-4176(200106)52:6<413::AID-MACO413>3.0.CO;2-#
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Scheel J.E., 2009, P PREL PROGR 2009 DO
   Schuh A, 2007, J BIOMED MATER RES B, V81B, P330, DOI 10.1002/jbm.b.30669
   Sealy MP, 2010, J MECH BEHAV BIOMED, V3, P488, DOI 10.1016/j.jmbbm.2010.05.003
   Seemikeri CY, 2008, TRIBOL INT, V41, P724, DOI 10.1016/j.triboint.2008.01.003
   Seemikeri C.Y., 2008, J MANUF SCI E-T ASME, V130, P021008
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Shi JF, 2007, P I MECH ENG H, V221, P903, DOI 10.1243/09544119JEIM256
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomann M, 2009, MATERIALWISS WERKST, V40, P82, DOI 10.1002/mawe.200800412
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Tonshoff HK, 2000, MG ALLOYS THEIR APP, P406
   Triantafyllidis GK, 2007, ENG FAIL ANAL, V14, P1346, DOI 10.1016/j.engfailanal.2006.11.010
   Tsuji N, 2008, MAT SCI ENG A-STRUCT, V488, P139, DOI 10.1016/j.msea.2007.11.079
   Tsuji N, 2009, MAT SCI ENG A-STRUCT, V499, P482, DOI 10.1016/j.msea.2008.09.008
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F., 2007, P 7 INT C MAGN ALL T, P958
   WOLFF J, 1986, LAW BONE REMODELING
   Zhang CY, 2010, SURF COAT TECH, V204, P3636, DOI 10.1016/j.surfcoat.2010.04.038
NR 75
TC 76
Z9 76
U1 3
U2 65
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JAN
PY 2012
VL 5
IS 1
BP 135
EP 155
DI 10.3390/ma5010135
PG 21
WC Materials Science, Multidisciplinary
SC Materials Science
GA 898FL
UT WOS:000300722400008
PM 28817036
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU San, NO
   Donmez, G
AF San, Nalan Oya
   Donmez, Gonul
TI Biosorption of chromium(VI), nickel(II) and Remazol Blue by Rhodotorula
   muciloginosa biomass
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biosorption; heavy metal; reactive dye; wastewater treatment; yeast
ID AQUEOUS-SOLUTIONS; HEAVY-METALS; DYE REMOVAL; CADMIUM; IONS; ADSORPTION;
   SORPTION; ZN(II); YEASTS; ALGAE
AB The passive removal of commonly used reactive dye and two heavy metals, from aqueous solutions by inexpensive biomaterial, yeast Rhodotorula muciloginosa biomass, termed biosorption, was studied with respect to pH, initial dye concentration and initial metal ion concentration. The biomass exhibited maximum dye and chromium(VI) uptake at pH 5 and pH 6 for nickel(II) in media containing 50 mg/L heavy metal and 50 mg/L remazol blue. It was found that the highest chromium(VI) removal yields measured were 31.3% for 49.0 mg/l initial chromium(VI) concentrations. The nickel(II) removal yield was 32.5% for 22.3 mg/L. Higher R. Blue removal yields were obtained, such as 77.1% for 117.5 mg/L. The maximum dye biosorption yield was investigated in medium with a constant dye (similar to 50 mg/L) and increasing heavy metal concentration. In the medium with 48.8, 103.8 and 151.8 mg/L chromium(VI) and constant dye concentration, the maximum chromium(VI) biosorption was 7.4, 9.3 and 17.1%, whereas the maximum dye biosorption was 61.6, 56.6 and 55.9%. The maximum nickel(II) biosorptions in the medium with dye were 38.1, 22.1 and 8.8% at 23.7, 37.7 and 60.1 mg/L nickel(II) concentrations. In these media, dye biosorptions were 93.9, 86.4 and 93.3%, respectively.
C1 [San, Nalan Oya; Donmez, Gonul] Fac Sci, Dept Biol, TR-06100 Besevler, Turkey.
   [San, Nalan Oya] Ankara Univ, Inst Biotechnol, TR-06100 Besevler, Turkey.
RP Donmez, G (reprint author), Fac Sci, Dept Biol, TR-06100 Besevler, Turkey.
EM gdonmez@ankara.edu.tr
RI San Keskin, Nalan Oya/D-6940-2017
OI San Keskin, Nalan Oya/0000-0001-6645-3561
FU Scientific and Technical Research Council of Turkey (TUBITAK-BIDEB)
FX Financial support was provided by the Scientific and Technical Research
   Council of Turkey (TUBITAK-BIDEB).
CR Ahmad A, 2010, CLEAN-SOIL AIR WATER, V38, P153, DOI 10.1002/clen.200900202
   Akar T, 2010, BIORESOURCE TECHNOL, V101, P7271, DOI 10.1016/j.biortech.2010.04.044
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2003, CHEMOSPHERE, V50, P1075, DOI 10.1016/S0045-6535(02)00623-9
   Aksu Z, 2000, J CHEM TECHNOL BIOT, V75, P847, DOI 10.1002/1097-4660(200009)75:9<847::AID-JCTB294>3.0.CO;2-X
   Aksu Z, 2010, CHEM ENG J, V158, P474, DOI 10.1016/j.cej.2010.01.029
   Apiratikul R, 2006, CHEM ENG J, V119, P135, DOI 10.1016/j.cej.2006.02.010
   Bai D., 2010, BIORESOURCE TECHNOLO, V79, P73
   BEVERIDGE TJ, 1989, ANNU REV MICROBIOL, V43, P147, DOI 10.1146/annurev.mi.43.100189.001051
   Biswas SK, 2001, INT J SYST EVOL MICR, V51, P1191, DOI 10.1099/00207713-51-3-1191
   Chapman D, 1996, WATER QUALITY ASSESS, P74
   Chatterjee SK, 2010, J HAZARD MATER, V175, P117, DOI 10.1016/j.jhazmat.2009.09.136
   Cho DH, 2003, BIOPROC BIOSYST ENG, V25, P271, DOI 10.1007/s00449-002-0315-8
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Ertugrul S, 2009, ECOL ENG, V35, P128, DOI 10.1016/j.ecoleng.2008.09.015
   Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2
   Fell J. W., 2000, INT J SYST EVOL MICR, V3, P1351
   Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074
   HOLAN ZR, 1994, BIOTECHNOL BIOENG, V43, P1001, DOI 10.1002/bit.260431102
   Ileri R., 1994, PROCESS SAF ENVIRON, V76, P249
   Li ZJ, 2006, APPL MICROBIOL BIOT, V73, P458, DOI 10.1007/s00253-006-0473-8
   Lloyd-Jones PJ, 2004, PROCESS SAF ENVIRON, V82, P301, DOI 10.1205/095758204323162328
   Mahony T. O., 2002, ENZYME MICROB TECHNO, V31, P456
   Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001
   Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060
   Ong SA, 2005, ACTA HYDROCH HYDROB, V33, P95, DOI 10.1002/aheh.200400559
   Ozcan AS, 2004, J COLLOID INTERF SCI, V276, P39, DOI 10.1016/j.jcis.2004.03.043
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Sloka Y. M., 1997, DYES PIGMENTS, V37, P335
   SNELL FD, 1959, COLORIMETRIC METHODS, V2
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Sumathi S, 2000, ENZYME MICROB TECH, V27, P347, DOI 10.1016/S0141-0229(00)00234-9
   Vasudevan P, 2003, BIORESOURCE TECHNOL, V89, P281, DOI 10.1016/S0960-8524(03)00067-1
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   Vijayaraghavan K, 2007, J HAZARD MATER, V141, P45, DOI 10.1016/j.jhazmat.2006.06.081
   Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2
   Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001
   Yalcin E, 2010, J ENVIRON SCI-CHINA, V22, P367, DOI 10.1016/S1001-0742(09)60117-0
   Yin H, 2008, J HAZARD MATER, V158, P568, DOI 10.1016/j.jhazmat.2008.01.113
NR 41
TC 11
Z9 11
U1 0
U2 12
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0273-1223
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 2012
VL 65
IS 3
BP 471
EP 477
DI 10.2166/wst.2012.872
PG 7
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA 891KE
UT WOS:000300214800010
PM 22258677
DA 2018-10-19
ER

PT J
AU Lasprilla, AJR
   Martinez, GAR
   Lunelli, BH
   Jardini, AL
   Maciel, R
AF Lasprilla, Astrid J. R.
   Martinez, Guillermo A. R.
   Lunelli, Betania H.
   Jardini, Andre L.
   Maciel Filho, Rubens
TI Poly-lactic acid synthesis for application in biomedical devices - A
   review
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Sugarcane; Lactic acid; Biomaterials; Renewable resources; Bioabsorbable
   polymer
ID BIOABSORBABLE FIXATION DEVICES; POLY(LACTIC ACID);
   MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); POLYLACTIC ACID; DIRECT
   POLYCONDENSATION; BIODEGRADABLE POLYMERS; FERMENTATION; BLENDS;
   POLYMERIZATION
AB Bioabsorbable polymers are considered a suitable alternative to the improvement and development of numerous applications in medicine. Poly-lactic acid (PLA,) is one of the most promising biopolymers due to the fact that the monomers may produced from non toxic renewable feedstock as well as is naturally occurring organic acid. Lactic acid can be made by fermentation of sugars obtained from renewable resources as such sugarcane. Therefore, PLA is an eco-friendly product with better features for use in the human body (nontoxicity). Lactic acid polymers can be synthesized by different processes so as to obtain products with an ample variety of chemical and mechanical properties. Due to their excellent biocompatibility and mechanical properties, PLA and their copolymers are becoming widely used in tissue engineering for function restoration of impaired tissues. In order to maximize the benefits of its use, it is necessary to understand the relationship between PLA material properties, the manufacturing process and the final product with desired characteristics. In this paper, the lactic acid production by fermentation and the polymer synthesis such biomaterial are reviewed. The paper intends to contribute to the critical knowledge and development of suitable use of PLA for biomedical applications. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Lasprilla, Astrid J. R.; Martinez, Guillermo A. R.; Lunelli, Betania H.; Jardini, Andre L.; Maciel Filho, Rubens] Univ Estadual Campinas, Sch Chem Engn, Lab Optimizat Design & Adv Control, Campinas, SP, Brazil.
   [Lasprilla, Astrid J. R.; Martinez, Guillermo A. R.; Jardini, Andre L.; Maciel Filho, Rubens] Inst Biofabricat, Campinas, SP, Brazil.
RP Maciel, R (reprint author), Univ Estadual Campinas, Sch Chem Engn, Lab Optimizat Design & Adv Control, Campinas, SP, Brazil.
EM maciel@feq.unicamp.br
RI Biofabris, Inct/I-2418-2013; Jardini, Andre Luiz/N-9963-2016; FAPESP,
   BIOEN/H-6149-2012
OI Jardini, Andre Luiz/0000-0002-9381-9335; 
FU FAPESP (The Scientific Research Foundation for the State of Sao Paulo);
   CNPq (National Council for Scientific and Technological Development);
   INCT-BIOFABRIS (National Institute of Science and Technology in
   Biofabrication)
FX The authors wish to acknowledge the financial support provided by FAPESP
   (The Scientific Research Foundation for the State of Sao Paulo), CNPq
   (National Council for Scientific and Technological Development) and
   INCT-BIOFABRIS (National Institute of Science and Technology in
   Biofabrication).
CR Achmad F, 2009, CHEM ENG J, V151, P342, DOI 10.1016/j.cej.2009.04.014
   Adsul MG, 2007, GREEN CHEM, V9, P58, DOI 10.1039/b605839f
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Auras RA, 2010, POLY LACTIC ACID SYN
   Axelsson L., 2004, LACTIC ACID BACTERIA
   Behonick DJ, 2007, PLOS ONE, V2, P1
   Bleach NC, 2001, J MATER SCI-MATER M, V12, P911, DOI 10.1023/A:1012884310027
   Bouapao L, 2009, POLYMER, V50, P4007, DOI 10.1016/j.polymer.2009.06.040
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Caplan AI, 2009, TISSUE ENG PART B-RE, V15, P195, DOI [10.1089/ten.teb.2008.0515, 10.1089/ten.TEB.2008.0515]
   CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   Chanfreau S, 2010, BIOPROC BIOSYST ENG, V33, P629, DOI 10.1007/s00449-009-0388-8
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen Y, 2006, SURF COAT TECH, V201, P575, DOI 10.1016/j.surfcoat.2005.12.005
   Cheng Y, 2009, FRONT CHEM CHINA, V4, P259, DOI DOI 10.1007/S11458-009-0092-X
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   Dearnaley G, 2007, SURF COAT TECH, V201, P8070, DOI 10.1016/j.surfcoat.2006.01.079
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   Dutkiewicz S, 2003, FIBRES TEXT EAST EUR, V11, P66
   Eenink MJD, 1987, THESIS TWENTE U NETH
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Fukushima K, 2008, J POLYM SCI A, V46, P3314
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   GARVIE EI, 1980, MICROBIOL REV, V44, P106
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gu S, 2008, POLYM INT, V57, P982, DOI 10.1002/pi.2435
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Henton DE, 2005, NATURAL FIBERS BIOPO, P528
   Hofvendahl K, 2000, ENZYME MICROB TECH, V26, P87, DOI 10.1016/S0141-0229(99)00155-6
   Imola MJ, 2009, LARYNGOSCOPE, V112, P1897
   John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6
   John RP, 2009, BIOTECHNOL ADV, V27, P145, DOI 10.1016/j.biotechadv.2008.10.004
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim E, 2009, J MOL CATAL A-CHEM, V298, P36, DOI 10.1016/j.molcata.2008.09.029
   Kim KW, 2002, MACROMOL CHEM PHYSIC, V203, P2245, DOI 10.1002/1521-3935(200211)203:15<2245::AID-MACP2245>3.0.CO;2-3
   Kinoshita Y., 2003, INT J ORAL MAXILL S1, V32, P117
   Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003
   Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   LINDQVIST C, 1992, J ORAL MAXIL SURG, V50, P942, DOI 10.1016/0278-2391(92)90051-Z
   Lovald ST, 2009, J CRANIOFAC SURG, V20, P389, DOI 10.1097/SCS.0b013e31819b96fb
   Lunelli BH, 2010, APPL BIOCHEM BIOTECH, V161, P227, DOI 10.1007/s12010-009-8828-0
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   Malmgren T, 2006, J THERM ANAL CALORIM, V83, P35, DOI 10.1007/s10973-005-7066-0
   Mehta R, 2005, J MACROMOL SCI-POL R, VC45, P325, DOI 10.1080/15321790500304148
   Mehta R, 2007, THESIS THAPAR I ENG
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Oyama HT, 2009, POLYM DEGRAD STABIL, V94, P1419, DOI 10.1016/j.polymdegradstab.2009.05.008
   Papenburg BJ, 2009, BIOMATERIALS, V30, P6228, DOI 10.1016/j.biomaterials.2009.07.057
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961
   Puaux JP, 2007, MACROMOL SYMP, V259, P318, DOI 10.1002/masy.200751336
   Quynh TM, 2008, CARBOHYD POLYM, V72, P673, DOI 10.1016/j.carbpol.2007.10.010
   Rojan PJ, 2005, BIOTECHNOL LETT, V27, P1685, DOI 10.1007/s10529-005-2731-8
   Seavey K. C., 2008, STEP GROWTH POLYM PR
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   Tan ML, 2010, PEPTIDES, V31, P184, DOI 10.1016/j.peptides.2009.10.002
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   THOMAS TD, 1979, J BACTERIOL, V138, P109
   Tsuji H, 2003, J APPL POLYM SCI, V87, P1628, DOI 10.1002/app.11605
   Valantin MA, 2003, AIDS, V17, P2471, DOI 10.1097/00002030-200311210-00009
   Varadarajan S, 1999, BIOTECHNOL PROGR, V15, P845, DOI 10.1021/bp9900965
   Wang SG, 1999, POLYM ADVAN TECHNOL, V10, P282, DOI 10.1002/(SICI)1099-1581(199905)10:5<282::AID-PAT876>3.3.CO;2-O
   Waris E, 2004, EXPERT REV MED DEVIC, V1, P229, DOI 10.1586/14734440.1.2.229
   Witzke DR, 1997, MACROMOLECULES, V30, P7075, DOI 10.1021/ma970631m
   Yamane H, 2003, POLYMER, V44, P2569, DOI 10.1016/S0032-3861(03)00092-2
   Yu YC, 2009, MACROMOLECULES, V42, P8187, DOI 10.1021/ma901359x
   ZHANG XC, 1994, J POLYM SCI POL CHEM, V32, P2965, DOI 10.1002/pola.1994.080321519
NR 72
TC 309
Z9 323
U1 16
U2 400
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD JAN-FEB
PY 2012
VL 30
IS 1
SI SI
BP 321
EP 328
DI 10.1016/j.biotechadv.2011.06.019
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 895EO
UT WOS:000300479200025
PM 21756992
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Martino, S
   D'Angelo, F
   Armentano, I
   Kenny, JM
   Orlacchio, A
AF Martino, Sabata
   D'Angelo, Francesco
   Armentano, Ilaria
   Maria Kenny, Jose
   Orlacchio, Aldo
TI Stem cell-biomaterial interactions for regenerative medicine
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Embryonic stem cells; Induced pluripotent stem cells; Adult stem cells;
   Biomaterials; Nanotopography; Bone tissue engineering; Neural tissue
   engineering; Skeletal and cardiac muscle tissue engineering
ID PERIPHERAL-NERVE REGENERATION; CALCIUM-DEFICIENT HYDROXYAPATITE;
   TISSUE-ENGINEERING APPLICATIONS; OSTEOBLAST-LIKE CELLS; IN-VITRO
   DEGRADATION; BONE-MARROW; SELF-RENEWAL; SUBVENTRICULAR ZONE; BIOMEDICAL
   APPLICATIONS; MECHANICAL-PROPERTIES
AB The synergism of stem cell biology and biomaterial technology promises to have a profound impact on stem-cell-based clinical applications for tissue regeneration. Biomaterials development is rapidly advancing to display properties that, in a precise and physiological fashion, could drive stem-cell fate both in vitro and in vivo. Thus, the design of novel materials is trying to recapitulate the molecular events involved in the production, clearance and interaction of molecules within tissue in pathologic conditions and regeneration of tissue/organs.
   In this review we will report on the challenges behind translating stem cell biology and biomaterial innovations into novel clinical therapeutic applications for tissue and organ replacements (graphical abstract). (C) 2011 Elsevier Inc. All rights reserved.
C1 [Martino, Sabata; D'Angelo, Francesco; Orlacchio, Aldo] Univ Perugia, Dept Expt Med & Biochem Sci, Sect Biochem & Mol Biol, I-06100 Perugia, Italy.
   [Armentano, Ilaria; Maria Kenny, Jose] Univ Perugia, NIPLAB, UdR INSTM, Mat Engn Ctr, Terni, Italy.
   [Maria Kenny, Jose] CSIC, Inst Polymer Sci & Technol, Madrid, Spain.
RP Martino, S (reprint author), Via Giochetto, I-06126 Perugia, Italy.
EM martinos@unipg.it; orly@unipg.it
RI Martino, Sabata/F-2309-2014; Kenny, Jose/F-9372-2010
OI Martino, Sabata/0000-0002-3942-237X; Kenny, Jose/0000-0001-6329-3048
FU Italian Fondazione Cassa di Risparmio di Perugia [2009.020.0050,
   2010.011.0445]; Italian Ministero dell'Istruzione, dell'Universita e
   della Ricerca [20084XRSBS_001]; Istituto Nazionale Biostrutture e
   Biosistemi
FX This study was supported by the Italian Fondazione Cassa di Risparmio di
   Perugia (grant no. 2009.020.0050 and 2010.011.0445 to A.O.), the Italian
   Ministero dell'Istruzione, dell'Universita e della Ricerca (grants: PRIN
   no. 20084XRSBS_001 to A.O.) and the Istituto Nazionale Biostrutture e
   Biosistemi.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177
   Ahern BJ, 2010, CTS-CLIN TRANSL SCI, V3, P112, DOI 10.1111/j.1752-8062.2010.00201.x
   da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   Alves da Silva ML, 2010, J TISSUE ENG RE 1229
   Amann PM, 2011, CURR MED CHEM, V18, P1405
   Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Arinzeh Treena Livingston, 2005, Foot Ankle Clin, V10, P651, DOI 10.1016/j.fcl.2005.06.004
   Armentano I, 2011, J BIOMAT SCI-POLYM E, V22, P541, DOI 10.1163/092050610X487873
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Armentano I, 2009, J APPL POLYM SCI, V114, P3602, DOI 10.1002/app.31008
   Armentano I, 2009, J MATER SCI, V44, P4789, DOI 10.1007/s10853-009-3721-3
   Arvidson K, 2010, J CELL MOL MED, DOI [10.1111/j.1582-4934.2010.01224.x.Dec3, DOI 10.1111/J.1582-4934.2010.01224.X]
   Astete CE, 2007, COLLOID SURFACE A, V299, P209, DOI 10.1016/j.colsurfa.2006.11.055
   Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004
   BASSER PJ, 1994, IEEE T BIO-MED ENG, V41, P601, DOI 10.1109/10.293248
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Belay E, 2010, STEM CELLS, V28, P1760, DOI 10.1002/stem.501
   Belicchi M, 2010, BIOMATERIALS, V31, P5385, DOI 10.1016/j.biomaterials.2010.03.021
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bianco A, 2010, INT J ARTIF ORGANS, V33, P271
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115
   Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7
   Brannen Heather, 2010, OR Manager, V26, P8
   Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118
   Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155
   Butler DL, 2010, NAT PROTOC, V5, P849, DOI 10.1038/nprot.2010.14
   Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839
   Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8
   Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36
   Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930
   Changoor A, 2006, J BIOMECH, V39, P2887, DOI 10.1016/j.jbiomech.2005.10.007
   Chaterji S, 2007, PROG POLYM SCI, V32, P1083, DOI 10.1016/j.progpolymsci.2007.05.018
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386
   Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   CLARK P, 1991, J CELL SCI, V99, P73
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Clokie CML, 2001, DENT IMPLANTS ART SC, V5, P59
   Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6
   Cosman Felicia, 2005, Curr Osteoporos Rep, V3, P143, DOI 10.1007/s11914-996-0017-2
   Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001
   Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216
   D'Angelo F, 2010, EUR CELLS MATER, V20, P231
   De Felici M, 2009, CURR STEM CELL RES T, V4, P87
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Develioglu H, 2010, J ORAL IMPLANTOL, V36, P167, DOI 10.1563/AAID-JOI-D-09-00064
   Dhawan Shivani, 2010, Indian J Dent Res, V21, P557, DOI 10.4103/0970-9290.74220
   Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072
   Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041
   Di Mundo R, 2010, PLASMA PROCESS POLYM, V7, P212, DOI 10.1002/ppap.200900112
   Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dobelin N, 2010, CHIMIA, V64, P723, DOI 10.2533/chimia.2010.723
   Dottori M, 2011, J APPL POLYM SCI, V119, P3544, DOI 10.1002/app.33033
   Dresselhaus M. S., 1996, SCI FULLERENES CARBO
   Durucan C, 2000, J BIOMED MATER RES, V51, P717, DOI 10.1002/1097-4636(20000915)51:4<717::AID-JBM21>3.0.CO;2-Q
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fortunati E, 2011, CARBON, V49, P2370, DOI 10.1016/j.carbon.2011.02.004
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P164, DOI 10.1002/jbm.a.32824
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Fukuzawa M, 2011, DEV GROWTH DIFFER, V53, P538, DOI 10.1111/j.1440-169X.2011.01269.x
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Galli R, 2000, NAT NEUROSCI, V3, P986
   Galli Rosselia, 2008, V438, P67, DOI 10.1007/978-1-59745-133-8_7
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Gaziova Ivana, 2007, Prog Mol Subcell Biol, V45, P143
   Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710
   Gentile P, 2010, J BIOMAT SCI-POLYM E, V21, P1207, DOI 10.1163/092050609X12481751806213
   Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119
   Gomes ME, 2002, POLYM BASED SYSTEMS
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   Gorrasi G, 2008, COMPOS SCI TECHNOL, V9, P627
   Gritti Angela, 2008, V438, P173, DOI 10.1007/978-1-59745-133-8_14
   Grodzinski J J, 2006, POLYM ADVAN TECHNOL, V17, P395
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011
   Han JW, 2010, INT J MOL MED, V25, P377, DOI 10.3892/ijmm_00000355
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Haynes David S, 2009, Trends Amplif, V13, P206, DOI 10.1177/1084713809346262
   Heming E, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/064001
   Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]
   Henricson A, 2010, ACTA ORTHOP, V81, P745, DOI 10.3109/17453674.2010.533936
   Herath HMTU, 2010, J APPL BIOMATER BIOM, V8, P89
   Hile DD, 2005, BIO-MED MATER ENG, V15, P219
   Hirao A, 2004, CELL CYCLE, V3, P1481, DOI 10.4161/cc.3.12.1281
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hosseinkhani H, 2010, J BIOMED MATER RES A, V94A, P1, DOI 10.1002/jbm.a.32676
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Ischenko I, 2008, CURR MED CHEM, V15, P3171, DOI 10.2174/092986708786848541
   Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016
   Jing X. B., 2004, POLYMER, V45, P6705
   Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535
   Kaji Hiroshi, 2005, Clin Calcium, V15, P611
   Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864
   Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140
   Kantawong F, 2010, ACTA BIOMATER, V6, P3694, DOI 10.1016/j.actbio.2010.02.038
   Kawase T, 2010, J PERIODONTOL, V81, P420, DOI 10.1902/jop.2009.090523
   Kelleher CM, 2010, J R SOC INTERFACE, V7, pS717, DOI 10.1098/rsif.2010.0345.focus
   KERNS JM, 1991, NEUROSCIENCE, V40, P93, DOI 10.1016/0306-4522(91)90177-P
   Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741
   Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Klocke R, 2008, CURR MED CHEM, V15, P968, DOI 10.2174/092986708784049649
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kochegarov A, 2009, EXPERT OPIN THER PAT, V19, P275, DOI 10.1517/13543770802709010
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Laflamme C, 2011, MED HYPOTHESES, V76, P489, DOI 10.1016/j.mehy.2010.11.031
   Lambrinoudaki I, 2006, ANN NY ACAD SCI, V1092, P397, DOI 10.1196/annals.1365.036
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lee PH, 2009, J CLIN NEUROL, V5, P1, DOI 10.3988/jcn.2009.5.1.1
   Lee W, 2009, PROG BRAIN RES, V180, P111, DOI 10.1016/S0079-6123(08)80006-4
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li J, 2008, APPL SURF SCI, V255, P494, DOI 10.1016/j.apsusc.2008.06.067
   Li J, 2011, BIOMACROMOLECUL 0505, DOI [10.1021/bm2004252, DOI 10.1021/BM2004252]
   Li QT, 2008, CELL STEM CELL, V2, P195, DOI 10.1016/j.stem.2008.02.008
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Liu G, 2011, J BIOMED MATER RES B, V96B, P360, DOI 10.1002/jbm.b.31779
   Liu J, 2010, STEM CELL REV   1222
   Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904
   Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma PX, 1995, MATER RES SOC SYMP P, V394, P99, DOI 10.1557/PROC-394-99
   Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056
   Martines E, 2004, IEEE T NANOBIOSCI, V3, P90, DOI [10.1109/TNB.2004.828268, 10.1109/10.1109/TNB.2004.828268]
   Martino S, 2009, TISSUE ENG PT A, V15, P3139, DOI [10.1089/ten.tea.2008.0552, 10.1089/ten.TEA.2008.0552]
   Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/410260
   Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/654346
   Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343
   Matsuo A, 2010, ODONTOLOGY, V98, P85, DOI 10.1007/s10266-009-0111-x
   Mazzonetto R, 2010, INT J ORAL MAX IMPL, V25, P821
   McCullen SD, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035002
   McKay RD, 2004, PHILOS T ROY SOC B, V359, P851, DOI 10.1098/rstb.2004.1472
   McKeon-Fischer KD, 2011, J TISSUE ENG REGEN M, V5, P560, DOI 10.1002/term.348
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   McPhee G, 2010, MED BIOL ENG COMPUT, V48, P1043, DOI 10.1007/s11517-010-0657-3
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI [10.1038/nbt.1684, 10.1038/nbt1684]
   Meng J, 2010, NANOSCALE, V2, P2565, DOI 10.1039/c0nr00178c
   MICHEL F, 2009, OPEN STEM CELL J, V1, P20
   Miliauskaite A, 2007, J PERIODONTOL, V78, P2043, DOI 10.1902/jop.2007.060492
   Misra SK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/7/075701
   Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3
   Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326
   Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009
   Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z
   Muller B, 2001, J VAC SCI TECHNOL B, V19, P1715, DOI 10.1116/1.1392402
   Munic G, 2011, J R SOC INTERFACE, V58, P678
   Murr R, 2010, ADV GENET, V70, P101, DOI [10.1016/S0065-2660(10)70005-5, 10.1016/B978-0-12-380866-0.60005-8]
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100
   Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5
   O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107
   Okuda T, 2008, BIOMATERIALS, V29, P2719, DOI 10.1016/j.biomaterials.2008.03.028
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Orlacchio A, 2010, CURR MED CHEM, V17, P595, DOI 10.2174/092986710790416272
   Orlacchio A, 2010, DISCOV MED, V9, P546
   Ortiz-Gonzalez XR, 2004, CURR NEUROVASC RES, V1, P207, DOI 10.2174/1567202043362342
   Parekh SH, 2011, BIOMATERIALS, V32, P2256, DOI 10.1016/j.biomaterials.2010.11.065
   Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003
   Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158
   Pickard MR, 2011, BIOMATERIALS, V32, P2274, DOI 10.1016/j.biomaterials.2010.12.007
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062
   Qiao R, 2009, COMPOS SCI TECHNOL, V69, P491, DOI 10.1016/j.compscitech.2008.11.022
   Reichert JC, 2010, INT ORTHOP      1207
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51
   Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rodolfa KT, 2006, CELL, V126, P652, DOI 10.1016/j.cell.2006.08.009
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rosa AI, 2010, J NEUROSCI, V30, P4573, DOI 10.1523/JNEUROSCI.5597-09.2010
   Rosellini E, 2010, INT J ARTIF ORGANS, V33, P885
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005
   Schwartz Z, 2008, CLIN ORAL IMPLAN RES, V19, P1233, DOI 10.1111/j.1600-0501.2008.01582.x
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P507, DOI 10.1111/j.1600-051X.2007.01084.x
   Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0
   Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018
   Sendtner M, 2009, NATURE, V457, P269, DOI 10.1038/457269a
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010
   Siddharthan A., 2005, TRENDS BIOMATER ARTI, V18, P110
   Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113
   Smith KE, 2010, J TISSUE ENG RE 1230
   Starnes LM, 2011, CURR STEM CELL RES T, V6, P142
   Subbaiah R, 2011, MED ORAL PATOL ORAL, V16, pE239, DOI 10.4317/medoral.16.e239
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Teixeira M, 2005, EUR J PHARM BIOPHARM, V59, P491, DOI 10.1016/j.ejpb.2004.09.002
   Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141
   Timperley AJ, 2010, ACTA ORTHOP, V81, P503, DOI 10.3109/17453674.2010.501740
   Tjong SC, 2006, MAT SCI ENG R, V53, P73, DOI 10.1016/j.mser.2006.06.001
   Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016
   Tsiftsoglou AS, 2009, PHARMACOL THERAPEUT, V122, P264, DOI 10.1016/j.pharmthera.2009.03.001
   Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7
   Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700
   Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079
   Venugopal J, 2008, J BIOMED MATER RES A, V85A, P408, DOI 10.1002/jbm.a.31538
   Venugopal JR, 2011, CELL BIOL INT, V35, P73, DOI 10.1042/CBI20090066
   Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang ET, 2003, EXP EYE RES, V76, P29, DOI 10.1016/S0014-4835(02)00257-9
   Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863
   Wutticharoenmongkol P, 2007, BIOMACROMOLECULES, V8, P2602, DOI 10.1021/bm700451p
   Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680
   Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083
   Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910
   Yamashita YM, 2009, PRION, V3, P84, DOI 10.4161/pri.3.2.8821
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535
   Yerushalmi R, 2005, J MATER CHEM, V15, P4480, DOI 10.1039/b505212b
   Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385
   Zhang JC, 2010, INT J ORAL MAX SURG, V39, P469, DOI 10.1016/j.ijom.2010.01.013
   Zhang R., 2001, METHODS TISSUE ENG, P715
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 272
TC 85
Z9 93
U1 3
U2 76
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD JAN-FEB
PY 2012
VL 30
IS 1
SI SI
BP 338
EP 351
DI 10.1016/j.biotechadv.2011.06.015
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 895EO
UT WOS:000300479200027
PM 21740963
DA 2018-10-19
ER

PT J
AU Tan, F
   Naciri, M
   Dowling, D
   Al-Rubeai, M
AF Tan, Fei
   Naciri, Mariam
   Dowling, Denis
   Al-Rubeai, Mohamed
TI In vitro and in vivo bioactivity of CoBlast hydroxyapatite coating and
   the effect of impaction on its osteoconductivity
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Biomaterial; Hydroxyapatite coating; CoBlast; Mesenchymal stem cells;
   Osteoconduction; Osseointegration; mRNA; PCR
ID MESENCHYMAL STEM-CELLS; OSTEOBLASTIC CELLS; MODIFIED TITANIUM; FATIGUE
   BEHAVIOR; GENE-EXPRESSION; COATED TITANIUM; SURFACE-ENERGY;
   SHEAR-STRENGTH; GROWTH; BONE
AB The novel non-thermal CoBlast process has been used recently to create a hydroxyapatite coating on metallic substrates with improved biological response compared to an uncoated implant. In this study, we compared the biological effect of coatings deposited by this process and the industrial standard technique - plasmaspray. Physicochemical properties of these two coatings have been found to be significantly different in that CoBlast HA is less rough but more hydrophilic than the plasma-spray HA as evidenced by data obtained from profilometry and goniometry. Mesenchymal stem cell attachment and adhesion are enhanced on CoBlast HA. Analysis by a combination of EDX and ICP suggests that the higher crystallinity retained by the CoBlast HA result in slower coating dissolution. Detailed in vitro evaluation reveals that plasma-spray HA might induce slightly faster cell proliferation and earlier osteogenic differentiation, but CoBlast HA becomes equivalent to it by the late osteogenic stage. PCR array facilitated the identification of differentially regulated genes involved in various functional aspects of in vitro osteogenesis by the CoBlast HA coating. The expression level of the functional protein products of these genes are in agreement with the PCR data. Coating metallic screws with HA significantly improves the in vivo osseointegration. By measuring of removal force using torque measurement instrument and analyzing the patterns found in X-ray images it is demonstrated that the two HA coatings elicit comparable osseointegration. Using simulated impaction model, CoBlast HA is shown to maintain better performance in cell attachment and mineralization than plasma-spray HA, especially following significant impactions. This might indicate a potentially greater osteoconductivity of CoBlast HA coating in shear-stress associated surgical applications. Collectively, it was demonstrated that CoBlast HA is an effective alternative to plasma-spray HA coating and a promising replacement for specialized surgical applications. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Tan, Fei; Naciri, Mariam; Al-Rubeai, Mohamed] Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 4, Ireland.
   [Tan, Fei; Naciri, Mariam; Al-Rubeai, Mohamed] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
   [Tan, Fei] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.
   [Dowling, Denis] Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 4, Ireland.
RP Al-Rubeai, M (reprint author), Univ Coll Dublin, Sch Chem & Bioproc Engn, Dublin 4, Ireland.
EM m.al-rubeai@ucd.ie
FU Science Foundation Ireland [08/SRC/11411]; University of Liverpool, UK
FX This work was supported by Science Foundation Ireland (grant No.
   08/SRC/11411). The authors would like to thank EnBIO (Cork, Ireland) for
   providing HA samples. We wish to thank Professor John Hunt (University
   of Liverpool, UK) for his generous support in initiating the in vivo
   study. Acknowledgement also goes to Dr Denis Dowling and his team
   (Surface Engineering Group, University College Dublin, Ireland).
   Finally, we would like to thank Dr Yuanqing He and his staff (Laboratory
   Animal Centre, Jiangsu University, China) for their help with the animal
   study.
CR Adachi N, 2005, J RHEUMATOL, V32, P1615
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bilezikian J. P., 2008, PRINCIPLES BONE BIOL
   Canale ST, 2007, CAMPBELLS OPERATIVE
   Clemens JAM, 1999, J BIOMED MATER RES, V48, P741, DOI 10.1002/(SICI)1097-4636(1999)48:5<741::AID-JBM21>3.3.CO;2-R
   Compston JE, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730387
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   GROSS KA, 1994, J MATER SCI-MATER M, V5, P219, DOI 10.1007/BF00121092
   HAYASHI K, 1994, BIOMATERIALS, V15, P1187, DOI 10.1016/0142-9612(94)90241-0
   HENCH LL, 1993, INTRO BIOCERAMICS
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kim HW, 2005, J BIOMED MATER RES A, V74A, P294, DOI 10.1002/jbm.a.30191
   Kokubo T, 2008, WOODHEAD PUBL MATER, P1
   Koshino T, 2001, BIOMATERIALS, V22, P1579, DOI 10.1016/S0142-9612(00)00318-5
   Kweh SWK, 2002, BIOMATERIALS, V23, P775, DOI 10.1016/S0142-9612(01)00183-1
   Landor I, 2007, ARCH ORTHOP TRAUM SU, V127, P81, DOI 10.1007/s00402-006-0235-1
   Leonor IB, 2009, MAT SCI ENG C-BIO S, V29, P913, DOI 10.1016/j.msec.2008.08.003
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lynn AK, 2002, BIOMATERIALS, V23, P1937, DOI 10.1016/S0142-9612(01)00321-0
   Moeller CW, 2010, OPER TECH OTOLARYNGO, V21, P147
   MORRIS DC, 1992, BONE MINER, V19, P287, DOI 10.1016/0169-6009(92)90877-G
   Mushipe MT, 2006, J ORTHOP RES, V24, P501, DOI 10.1002/jor.20044
   O'Hare P, 2010, BIOMATERIALS, V31, P515, DOI 10.1016/j.biomaterials.2009.09.067
   O'Neill L, 2009, SURF COAT TECH, V204, P484, DOI 10.1016/j.surfcoat.2009.08.014
   Overgaard S, 1999, J BONE JOINT SURG BR, V81B, P725, DOI 10.1302/0301-620X.81B4.9282
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Park Joon, 2008, BIOCERAMICS PROPERTI
   Pasha R, 2000, OTOLARYNG HEAD NECK, V123, P425, DOI 10.1067/mhn.2000.109369
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Quatela Vito C, 2008, Facial Plast Surg Clin North Am, V16, P1, DOI 10.1016/j.fsc.2007.09.002
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Sanden B, 2002, J BONE JOINT SURG BR, V84B, P387, DOI 10.1302/0301-620X.84B3.12388
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Sun JY, 2007, J TISSUE ENG REGEN M, V1, P281, DOI 10.1002/term.34
   Sun JY, 2009, BIOMED PHARMACOTHER, V63, P650, DOI 10.1016/j.biopha.2009.01.007
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sun LM, 2003, MAT SCI ENG A-STRUCT, V360, P70, DOI 10.1016/S0921-5093(03)00439-8
   Svehla M, 2002, J ARTHROPLASTY, V17, P304, DOI 10.1054/arth.2002.30410
   Tan F, 2011, BIOTECHNOL BIOENG, V108, P454, DOI 10.1002/bit.22955
   TANAKA Y, 1995, J BONE MINER RES, V10, P1462
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85
   Zambonin G, 1999, ACTA ORTHOP SCAND, V70, P217, DOI 10.3109/17453679909011266
NR 51
TC 26
Z9 26
U1 1
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD JAN-FEB
PY 2012
VL 30
IS 1
SI SI
BP 352
EP 362
DI 10.1016/j.biotechadv.2011.07.008
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 895EO
UT WOS:000300479200028
PM 21801828
DA 2018-10-19
ER

PT J
AU Ruderman, G
   Mogilner, IG
   Tolosa, EJ
   Massa, N
   Garavaglia, M
   Grigera, JR
AF Ruderman, G.
   Mogilner, I. G.
   Tolosa, E. J.
   Massa, N.
   Garavaglia, M.
   Grigera, J. R.
TI Ordered Collagen Membranes: Production and Characterization
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Collagen membranes; ordered biomaterial; antibiotic permeability
ID EXTRACELLULAR-MATRIX; MOLECULAR-STRUCTURE; I COLLAGEN; HYDRATION;
   PEPTIDE; ORIENTATION; ALIGNMENT; CRYSTAL
AB A collagen membrane with microscopic order is presented. The membranes were produced with acid-soluble collagen, using two different methods to obtain orientation. The product was characterized by mean of UV and IR spectra, scanning electronic microscopy, optical microscopy and laser diffractometry. The results clearly show a high level of order in the membranes obtained by both techniques. Permeability for rifamycin, ascorbic acid and NaCl was also measured. Due to the characteristics of the membranes, they have a potential application for treatment of surface injuries. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Ruderman, G.; Mogilner, I. G.; Tolosa, E. J.; Massa, N.; Garavaglia, M.; Grigera, J. R.] Inst Fis Liquidos & Sistemas Biol IFLY SIB CONICE, La Plata, Buenos Aires, Argentina.
   [Ruderman, G.; Mogilner, I. G.; Tolosa, E. J.; Massa, N.; Garavaglia, M.; Grigera, J. R.] Fac Ciencias Exactas UNLP, La Plata, Buenos Aires, Argentina.
RP Ruderman, G (reprint author), Inst Fis Liquidos & Sistemas Biol IFLY SIB CONICE, La Plata, Buenos Aires, Argentina.
EM gruder@iflysib.unlp.edu.ar
FU Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina
   (CONICET); Comision Cientifica de la Provincia de Buenos Aires (CIC);
   Universidad Nacional de La Plata
FX This work was partially supported by the Consejo Nacional de
   Investigaciones Cientificas y Tecnicas of Argentina (CONICET), the
   Comision Cientifica de la Provincia de Buenos Aires (CIC) and the
   Universidad Nacional de La Plata. G. R., N. M., M. G. and J. R. G. are
   members of the Carrera del Investigador of CONICET. I. G. M. is
   recipient of a grant from CONICET, E. J. T. is recipient of a grant from
   CIC.
CR [Anonymous], 2003, D607603 ASTM
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   CAILLABA EM, 1987, J SOC LEATH TECH CH, V71, P153
   Child FJ, 1999, BRIT J DERMATOL, V141, P512
   FUJIMORI E, 1985, EUR J BIOCHEM, V152, P299, DOI 10.1111/j.1432-1033.1985.tb09198.x
   Gay S., 1978, COLLAGEN PHYSL PATHO
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Glowacki J., 2007, BIOPOLYMERS, V89, P338, DOI DOI 10.1002/BIP.20871
   Grigera J. R., 1999, AR Patent, Patent No. 253249
   Grigera J. R., 2006, AR Patent, Patent No. 048387
   GRIGERA JR, 1979, BIOPOLYMERS, V18, P47, DOI 10.1002/bip.1979.360180106
   GRIGERA JR, 1979, BIOPOLYMERS, V18, P35, DOI 10.1002/bip.1979.360180105
   Gustavson K. H., 1956, CHEM REACTIVITY COLL, P202
   Heenan Peter J., 1997, P847
   Hue H., 1968, BIOCHIM BIOPHYS ACTA, V154, P408
   Kakar AK, 2006, J PAK ASS DERMA, V16, P97
   Kolacna L, 2007, PHYSIOL RES, V56, pS51
   Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849
   Lazovic G, 2005, Ann Burns Fire Disasters, V18, P151
   Mogilner IG, 2002, J MOL GRAPH MODEL, V21, P209, DOI 10.1016/S1093-3263(02)00145-6
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Rao R. C., 2005, P IEEE 31 ANN NE BIO, P108
   Rubbens MP, 2009, ANN BIOMED ENG, V37, P1263, DOI 10.1007/s10439-009-9698-x
   Ruderman G, 1998, J SOLUTION CHEM, V27, P935, DOI 10.1023/A:1022615329598
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V68, P147, DOI 10.1016/S0141-3910(99)00176-7
   Sionkowska A., 2006, INT J PHOTOENERGY, DOI [10.1155/29196, DOI 10.1155/29196]
   Stein W. D., 1969, MOVEMENT MOL CELL ME, P36
   Susi H., 1970, J AM LEATHER CHEM AS, V66, P508
   Tattini Jr Virgilio, 2007, Mat. Res., V10, P1, DOI 10.1590/S1516-14392007000100002
   Von Hippel P. H., 1967, TREATISE COLLAGEN, P253
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   WEIR CE, 1949, JALCA, V44, P108
NR 34
TC 2
Z9 2
U1 0
U2 9
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 6
BP 823
EP 832
DI 10.1163/092050611X560942
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 897LD
UT WOS:000300651300006
PM 21396177
DA 2018-10-19
ER

PT J
AU Hopp, B
   Smausz, T
   Szabo, G
   Kolozsvari, L
   Kafetzopoulos, D
   Fotakis, C
   Nogradi, A
AF Hopp, Bela
   Smausz, Tomi
   Szabo, Gabor
   Kolozsvari, Lajos
   Kafetzopoulos, Dimitris
   Fotakis, Costas
   Nogradi, Antal
TI Femtosecond laser printing of living cells using absorbing film-assisted
   laser-induced forward transfer
SO OPTICAL ENGINEERING
LA English
DT Article
DE femtosecond excimer laser; cell printing; absorbing layer; biomaterials
ID MAMMALIAN-CELLS; EXCIMER-LASER; PATTERNS; BIOMOLECULES; MICROARRAYS;
   DEPOSITION; CONIDIA
AB The applicability of a femtosecond KrF laser in absorbing film-assisted, laser-induced forward transfer of living cells was studied. The absorbing materials were 50-nm-thick metal films and biomaterials (gelatine, Matrigel, each 50 mu m thick, and polyhydroxybutyrate, 2 mu m). The used cell types were human neuroblastoma, chronic myeloid leukemia, and osteogenic sarcoma cell lines, and primary astroglial rat cells. Pulses of a 500-fs KrF excimer laser focused onto the absorbing layer in a 250-mu m diameter spot with 225 mJ/cm(2) fluence were used to transfer the cells to the acceptor plate placed at 0.6 mm distance, which was a glass slide either pure or covered with biomaterials. While the low-absorptivity biomaterial absorbing layers proved to be ineffective in transfer of cells, when applied on the surface of acceptor plate, the wet gelatine and Matrigel layers successfully ameliorated the impact of the cells, which otherwise did not survive the arrival onto a hard surface. The best short- and long-term survival rate was between 65% and 70% for neuroblastoma and astroglial cells. The long-term survival of the transferred osteosarcoma cells was low, while the myeloid leukemia cells did not tolerate the procedure under the applied experimental conditions. (C) 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.OE.51.1.014302]
C1 [Hopp, Bela] Hungarian Acad Sci, Res Grp Laser Phys, Szeged, Hungary.
   [Hopp, Bela] Univ Szeged, Res Grp Laser Phys, Szeged, Hungary.
   [Smausz, Tomi; Szabo, Gabor] Univ Szeged, Dept Opt & Quantum Elect, Szeged, Hungary.
   [Kolozsvari, Lajos; Nogradi, Antal] Univ Szeged, Dept Ophthalmol, Fac Med, Szeged, Hungary.
   [Kafetzopoulos, Dimitris] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.
   [Fotakis, Costas] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Greece.
   [Fotakis, Costas] Univ Crete, Dept Phys, Iraklion, Greece.
RP Hopp, B (reprint author), Hungarian Acad Sci, Res Grp Laser Phys, Szeged, Hungary.
EM bhopp@physx.u-szeged.hu
RI Fotakis, Costas/G-8751-2011; Nogradi, Antal/A-7045-2008
OI Nogradi, Antal/0000-0002-0520-5350; Smausz Kolumban,
   Tomi/0000-0002-5184-6124
FU European Commission [RII3-CT-2003-506350]; National Development Agency
   of Hungary; Research and Technology Innovation Fund [OTKA K67818,
   CNK-78549]
FX Our experiments were performed at the Ultraviolet Laser Facility
   operating at IESL-FORTH and have been supported in part by the European
   Commission through the Research Infrastructures activity of FP6
   ("Laserlab-Europe" RII3-CT-2003-506350). The authors gratefully
   acknowledge Mrs. E. Katona, Mrs. M. Kapsetaki, and Mr. A. Egglezis for
   their excellent technical assistance. The study was funded by the
   National Development Agency of Hungary with financial support from the
   Research and Technology Innovation Fund (OTKA K67818 and CNK-78549).
CR Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   BOHANDY J, 1986, J APPL PHYS, V60, P1538, DOI 10.1063/1.337287
   Dinca V, 2008, BIOMED MICRODEVICES, V10, P719, DOI 10.1007/s10544-008-9183-6
   Doraiswamy A, 2006, APPL SURF SCI, V252, P4743, DOI 10.1016/j.apsusc.2005.07.166
   Duocastella M, 2008, J LASER MICRO NANOEN, V3, P1, DOI 10.2961/jlmn.2008.01.0001
   Fernandez-Pradas JM, 2004, THIN SOLID FILMS, V453, P27, DOI 10.1016/j.tsf.2003.11.154
   Hopp B, 2005, J PHYS D APPL PHYS, V38, P833, DOI 10.1088/0022-3727/38/6/007
   Hopp B, 2004, J APPL PHYS, V96, P3478, DOI 10.1063/1.1782275
   Hopp B, 2005, TISSUE ENG, V11, P1817, DOI 10.1089/ten.2005.11.1817
   Horneffer V., 2007, J BIOMED OPT, V12, P054016
   Kaji T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753103
   KANTOR Z, 1994, APPL PHYS LETT, V64, P3506, DOI 10.1063/1.111255
   Kattamis NT, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799877
   Lin YF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3202388
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Ringeisen BR, 2002, BIOMATERIALS, V23, P161, DOI 10.1016/S0142-9612(01)00091-6
   SCHULTZE V, 1991, APPL SURF SCI, V52, P303, DOI 10.1016/0169-4332(91)90072-R
   Serra P, 2004, APPL PHYS A-MATER, V79, P949, DOI 10.1007/s00339-004-2577-2
   Takizawa N, 2008, P SOC PHOTO-OPT INS, V6854, P85411, DOI 10.1117/12.762584
   Yamada H, 2002, APPL SURF SCI, V197, P411, DOI 10.1016/S0169-4332(02)00351-3
   Zergioti I, 2005, APPL SURF SCI, V247, P584, DOI 10.1016/j.apsusc.2005.01.127
NR 22
TC 7
Z9 9
U1 1
U2 35
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JAN
PY 2012
VL 51
IS 1
AR 014302
DI 10.1117/1.OE.51.1.014302
PG 6
WC Optics
SC Optics
GA 896ZV
UT WOS:000300611300038
DA 2018-10-19
ER

PT J
AU Ciprandi, MTO
   Primo, BT
   Gassen, HT
   Closs, LQ
   Hernandez, PAG
   Silva, AN
AF Ortiz Ciprandi, Maria Teresa
   Primo, Bruno Tochetto
   Gassen, Humberto Thomazi
   Closs, Luciane Quadrado
   Gonzalez Hernandez, Pedro Antonio
   Silva, Aurelicio Novaes, Jr.
TI Calcium Phosphate Cement in Orbital Reconstructions
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Orbital fractures; bone replacement materials; biocompatible materials;
   bone graft
ID BONE CEMENTS; FRACTURES; IMPLANTS; DEFECTS; GRAFTS; PASTE
AB Treatment of facial trauma sequelae is a complex and challenging process. There is still controversy over suitable materials for orbital wall reconstruction. This study evaluated calcium phosphate cement (CPC) implants manufactured by rapid prototyping in the repair of orbital wall defects secondary to trauma. Computed tomographic scans of 5 patients were used for surgery planning and production of CPC implants. Implants were used to restore orbital wall anatomy, ocular alignment, and facial contour. Benefits resulting from the use of implants, such as a reduced operating time, patient response to biomaterial implantation, biomaterial integrity and stability, and patient satisfaction with treatment, were analyzed qualitatively. Our results suggest that CPC is an effective and safe material for orbital reconstruction because of its biocompatibility and easy production and placement.
C1 [Ortiz Ciprandi, Maria Teresa; Primo, Bruno Tochetto; Gassen, Humberto Thomazi; Gonzalez Hernandez, Pedro Antonio; Silva, Aurelicio Novaes, Jr.] Univ Luterana Brasil, Sch Dent, Dept Oral & Maxillofacial Surg, BR-92425900 Canoas, RS, Brazil.
   [Closs, Luciane Quadrado] Univ Luterana Brasil, Sch Dent, Dept Orthodont, BR-92425900 Canoas, RS, Brazil.
RP Silva, AN (reprint author), Univ Luterana Brasil, Fac Odontol, Dept Posgrad, Rua Farroupilha 8001,Predio 59, BR-92425900 Canoas, RS, Brazil.
EM aurelicio.junior@uol.com.br
FU PROMM Comercio de Materiais Cirurgicos Ltda; Centro de Pesquisas Renato
   Archer - CNPq; Laboratorio de Biomateriais; Universidade Federal do Rio
   Grande Sul, Brazil
FX The authors are grateful to Dr Eubirajara Medeiros, PROMM Comercio de
   Materiais Cirurgicos Ltda, Centro de Pesquisas Renato Archer - CNPq, and
   Dr Luiz Alberto dos Santos, Laboratorio de Biomateriais, Universidade
   Federal do Rio Grande Sul, Brazil, for their support in the development
   of this study.
CR Arisan V, 2010, INT J ORAL MAX SURG, V39, P463, DOI 10.1016/j.ijom.2010.01.004
   Biancon LA, 2011, ACTA CIR BRAS, V26, P2, DOI 10.1590/S0102-86502011000100002
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   dos Santos LA, 2002, BIOMATERIALS, V23, P2035, DOI 10.1016/S0142-9612(01)00333-7
   Ellis E, 2004, J ORAL MAXIL SURG, V62, P873, DOI 10.1016/j.joms.2003.12.025
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Hatoko M, 2005, J CRANIOFAC SURG, V16, P327, DOI 10.1097/00001665-200503000-00024
   Hwang K, 2009, J CRANIOFAC SURG, V20, P1218, DOI 10.1097/SCS.0b013e3181acde01
   Kontio R, 2004, J ORAL MAXIL SURG, V62, P863, DOI 10.1016/j.joms.2004.03.003
   Krishnan V, 1997, J ORAL MAXIL SURG, V55, P327, DOI 10.1016/S0278-2391(97)90117-8
   MAURIELLO JA, 1987, OPHTHALMOLOGY, V94, P248
   Mellonig JT, 2010, INT J PERIODONT REST, V30, P121
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   Nowinski D, 2010, J CRANIOFAC SURG, V21, P1033, DOI 10.1097/SCS.0b013e3181e4345d
   ONO I, 1994, SCAND J PLAST RECONS, V28, P193, DOI 10.3109/02844319409015980
   Potter JK, 2004, J ORAL MAXIL SURG, V62, P1280, DOI 10.1016/j.joms.2004.04.018
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   Sinikovic B, 2007, INT J ORAL MAX SURG, V36, P54, DOI 10.1016/j.ijom.2006.07.014
   Tanag MA, 2006, PLAST RECONSTR SURG, V117, P1186, DOI 10.1097/01.prs.0000204582.76322.05
NR 20
TC 5
Z9 5
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2012
VL 23
IS 1
BP 145
EP 148
DI 10.1097/SCS.0b013e3182413d31
PG 4
WC Surgery
SC Surgery
GA 891RS
UT WOS:000300234900058
PM 22337393
DA 2018-10-19
ER

PT J
AU Rogers, GF
   Greene, AK
AF Rogers, Gary F.
   Greene, Arin K.
TI Autogenous Bone Graft: Basic Science and Clinical Implications
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Autologous bone graft; craniofacial; basic science; particulate
ID CRANIOFACIAL SKELETON; HYDROXYAPATITE CEMENT; VOLUME MAINTENANCE;
   OSSEOUS DEFECTS; ILIAC BONE; CRANIOPLASTY; PERIOSTEUM; CALVARIAL;
   SURVIVAL; DURA
AB No single biomaterial is optimum for every craniomaxillofacial application. Instead, surgeons should consider the advantages and disadvantages of each alternative in a given clinical situation, and select the material with lowest overall cost and morbidity, and the highest likelihood of success. Autogenous bone is still considered the gold standard for most applications; it becomes vascularized and osseointegrates with surrounding bone, thus minimizing the risk of infection, dislodgement, or break-down. Limitations include added operative time for graft harvest, donor site morbidity, graft resorption, molding challenges, and limited availability, especially in the pediatric population. Numerous alternatives to bone graft have become available to address these limitations; unfortunately, most of these products are expensive, do not osseointegrate, and have unpredictable biologic activity. Understanding the physiologic behavior of autogenous bone graft can help clarify the indications for its use and provide a conceptual framework for achieving the best possible outcome when this alternative is chosen.
C1 [Rogers, Gary F.] Childrens Natl Med Ctr, Div Plast & Reconstruct Surg, Washington, DC USA.
   [Greene, Arin K.] Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA.
RP Rogers, GF (reprint author), Childrens Natl Med Ctr, Div Plast & Reconstruct Surg, 111 Michigan Ave NW, Washington, DC USA.
EM grogers@cnmc.org
CR ALBREKTSSON T, 1980, Scandinavian Journal of Plastic and Reconstructive Surgery, V14, P1
   BERGGREN A, 1982, PLAST RECONSTR SURG, V69, P19, DOI 10.1097/00006534-198269010-00003
   BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003
   CHEN NT, 1994, PLAST RECONSTR SURG, V93, P714, DOI 10.1097/00006534-199404000-00009
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Clune JE, 2011, J CRANIOFAC SURG, V22, P319, DOI 10.1097/SCS.0b013e3181f7e0e2
   Clune JE, 2010, PLAST RECONSTR SURG, V126, P1311, DOI 10.1097/PRS.0b013e3181ea4524
   DELEU J, 1965, J Bone Joint Surg Br, V47, P319
   ENNEKING WF, 1975, J BONE JOINT SURG AM, VA 57, P237, DOI 10.2106/00004623-197557020-00018
   Gao LL, 2010, J CRANIOFAC SURG, V21, P318, DOI 10.1097/SCS.0b013e3181cf5f8b
   Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51
   Gosain AK, 2011, PLAST RECONSTR SURG, V128, P85, DOI 10.1097/PRS.0b013e31821740cc
   Greenberg BM, 2005, ANN PLAS SURG, V55, P43, DOI 10.1097/01.sap.0000168157.10664.9c
   Greene AK, 2008, PLAST RECONSTR SURG, V122, P563, DOI 10.1097/PRS.0b013e31817d61c1
   Greene AK, 2007, PLAST RECONSTR SURG, V120, P1603, DOI 10.1097/01.prs.0000282106.75808.af
   HARDESTY RA, 1990, PLAST RECONSTR SURG, V85, P5, DOI 10.1097/00006534-199001000-00002
   Havlik RJ, 2002, PLAST RECONSTR SURG, V10, P1176
   Heino Terhi J, 2009, Technol Health Care, V17, P49, DOI 10.3233/THC-2009-0534
   Hopper RA, 2001, PLAST RECONSTR SURG, V107, P454, DOI 10.1097/00006534-200102000-00022
   KAMIJOU T, 1994, BONE, V15, P629, DOI 10.1016/8756-3282(94)90311-5
   Kim SH, 2009, CLIN ORAL IMPLAN RES, V20, P1124, DOI 10.1111/j.1600-0501.2009.01744.x
   KNIZE DM, 1974, PLAST RECONSTR SURG, V53, P190, DOI 10.1097/00006534-197402000-00011
   LATRENTA GS, 1989, PLAST RECONSTR SURG, V84, P578, DOI 10.1097/00006534-198984040-00004
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   LIN KY, 1990, PLAST RECONSTR SURG, V86, P449, DOI 10.1097/00006534-199009000-00010
   Matic D, 2002, PLAST RECONSTR SURG, V110, P1, DOI 10.1097/00006534-200207000-00001
   Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012
   Ochareon P, 2011, J ANAT, V218, P285, DOI 10.1111/j.1469-7580.2010.01336.x
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Ozaki W, 1999, ANN PLAST SURG, V43, P49
   Ozerdem OR, 2003, J CRANIOFAC SURG, V14, P371
   PINHOLT EM, 1994, ANN PLAS SURG, V33, P193, DOI 10.1097/00000637-199408000-00012
   PUCKETT CL, 1979, PLAST RECONSTR SURG, V64, P361, DOI 10.1097/00006534-197909000-00013
   Rogers GF, 2011, PLAST RECONSTR SURG, V127, P1631, DOI 10.1097/PRS.0b013e31821084f0
   ROMANA MC, 1990, PLAST RECONSTR SURG, V85, P587, DOI 10.1097/00006534-199004000-00014
   Rosenthal AH, 2003, PLAST RECONSTR SURG, V112, P802, DOI 10.1097/01.PRS.0000069713.62687.F5
   SULLIVAN WG, 1991, PLAST RECONSTR SURG, V87, P1105, DOI 10.1097/00006534-199106000-00013
   Tagil M, 2000, CLIN ORTHOP RELAT R, P240
   TESSIER P, 1982, CLIN PLAST SURG, V9, P531
   Tessier P, 2005, PLAST RECONSTR SURG, V116, p92S
   WILKES GH, 1985, ANN PLAS SURG, V15, P374, DOI 10.1097/00000637-198511000-00002
   Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599
   ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005
NR 43
TC 69
Z9 72
U1 0
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2012
VL 23
IS 1
BP 323
EP 327
DI 10.1097/SCS.0b013e318241dcba
PG 5
WC Surgery
SC Surgery
GA 891RS
UT WOS:000300234900100
PM 22337435
DA 2018-10-19
ER

PT J
AU Scheller, EL
   Villa-Diaz, LG
   Krebsbach, PH
AF Scheller, Erica L.
   Villa-Diaz, Luis G.
   Krebsbach, Paul H.
TI Gene Therapy: Implications for Craniofacial Regeneration
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Tissue engineering; gene therapy; bone; salivary gland; craniofacial
   regeneration
ID PLURIPOTENT STEM-CELLS; ARTIFICIAL SALIVARY-GLAND; HUMAN SOMATIC-CELLS;
   BONE REGENERATION; HUMAN FIBROBLASTS; DELIVERY-SYSTEMS; DEFINED FACTORS;
   STROMAL CELLS; IN-VIVO; GENERATION
AB Gene therapy in the craniofacial region provides a unique tool for delivery of DNA to coordinate protein production in both time and space. The drive to bring this technology to the clinic is derived from the fact that more than 85% of the global population may at one time require repair or replacement of a craniofacial structure. This need ranges from mild tooth decay and tooth loss to temporomandibular joint disorders and large-scale reconstructive surgery. Our ability to insert foreign DNA into a host cell has been developing since the early uses of gene therapy to alter bacterial properties for waste cleanup in the 1980s followed by successful human clinical trials in the 1990s to treat severe combined immunodeficiency. In the past 20 years, the emerging field of craniofacial tissue engineering has adopted these techniques to enhance regeneration of mineralized tissues, salivary gland, and periodontium and to reduce tumor burden of head and neck squamous cell carcinoma. Studies are currently pursuing research on both biomaterial-mediated gene delivery and more clinically efficacious, although potentially more hazardous, viral methods. Although hundreds of gene therapy clinical trials have taken place in the past 20 years, we must still work to ensure an ideal safety profile for each gene and delivery method combination. With adequate genotoxicity testing, we can expect gene therapy to augment protein delivery strategies and potentially allow for tissue-specific targeting, delivery of multiple signals, and increased spatial and temporal control with the goal of natural tissue replacement in the craniofacial complex.
C1 [Scheller, Erica L.; Villa-Diaz, Luis G.; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Krebsbach, PH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM paulk@umich.edu
OI Scheller, Erica/0000-0002-1551-3816; Villa-Diaz,
   Luis/0000-0001-5709-9054
FU National Institute of Dental and Craniofacial Research;  [R01 DE13835]; 
   [F30 DE019577]
FX Supported by R01 DE13835 (P.H.K.), F30 DE019577 (E.L.S.), and the
   National Institute of Dental and Craniofacial Research T32 Tissue
   Engineering and Regeneration Training Program (L.G.V.-D.).
CR Aframian DJ, 2008, TISSUE ENG PART B-RE, V14, P187, DOI 10.1089/ten.teb.2008.0044
   ANDERSON WF, 1990, HUM GENE THER, V1, P1, DOI 10.1089/hum.1990.1.1-1
   Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001
   [Anonymous], 2002, Hum Gene Ther, V13, P3
   Baum BJ, 2006, BBA-BIOMEMBRANES, V1758, P1071, DOI 10.1016/j.bbamem.2005.11.006
   Baum Bruce J, 2009, Handb Exp Pharmacol, P403, DOI 10.1007/978-3-540-79885-9_20
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Chang PC, 2010, GENE THER, V17, P95, DOI 10.1038/gt.2009.117
   Cho YW, 2003, J PHARM PHARMACOL, V55, P721, DOI 10.1211/0022357021206
   Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706
   Egusa H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012743
   Endo M, 2006, TISSUE ENG, V12, P489, DOI 10.1089/ten.2006.12.489
   Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204
   Gafni Y, 2004, MOL THER, V9, P587, DOI 10.1016/j.ymthe.2003.12.009
   GORLIN RJ, 1990, SYNDROMES HEAD NECK
   Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418
   Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016
   Kaiser J, 2003, SCIENCE, V299, P495, DOI 10.1126/science.299.5606.495
   Kang Y, 2007, ACTA PHARMACOL SIN, V28, P839, DOI 10.1111/j.1745-7254.2007.00583.x
   Kaufman HL, 2010, FUTURE ONCOL, V6, P941, DOI [10.2217/fon.10.66, 10.2217/FON.10.66]
   Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6
   Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436
   Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342
   KIVISAAR MA, 1989, J BACTERIOL, V171, P5111, DOI 10.1128/jb.171.9.5111-5116.1989
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312
   Lightfoot E, 1995, CRC HDB BIOMEDICAL E, P1656
   Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106
   Mahato RI, 2001, MOL THER, V4, P130, DOI 10.1006/mthe.2001.0425
   McKie R, 2000, GENE RES FACE CRISIS
   Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107
   National Institutes of Health, 2011, CLINICALTRIALS GOV D
   Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889
   Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Peng HR, 2004, MOL THER, V9, P885, DOI 10.1016/j.ymthe.2004.02.023
   Peters M, 1997, APPL ENVIRON MICROB, V63, P4899
   Pochampally RR, 2005, GENE THER, V12, P1119, DOI 10.1038/sj.gt.3302514
   Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667
   Rabie ABM, 2007, GENE THER, V14, P972, DOI 10.1038/sj.gt.3302943
   Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129
   Schek R M, 2005, Orthod Craniofac Res, V8, P313, DOI 10.1111/j.1601-6343.2005.00354.x
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   Scheller EL, 2009, J DENT RES, V88, P585, DOI 10.1177/0022034509337480
   Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846
   Tewfik TL, 1997, CONGENITAL ABNORMALI
   Tran SD, 2005, TISSUE ENG, V11, P172, DOI 10.1089/ten.2005.11.172
   Ulrich-Vinther M, 2007, ACTA ORTHOP, V78, P5
   Wu SM, 2011, NAT CELL BIOL, V13, P734, DOI 10.1038/ncb0611-734b
   Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180
   Yi Y, 2005, CURR GENE THER, V5, P25
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817
   Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223
   Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002
   Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005
NR 65
TC 12
Z9 13
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JAN
PY 2012
VL 23
IS 1
BP 333
EP 337
DI 10.1097/SCS.0b013e318241dc11
PG 5
WC Surgery
SC Surgery
GA 891RS
UT WOS:000300234900102
PM 22337437
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Guo, J
   Yang, RQ
AF Guo, Jing
   Yang, Renqiang
TI An OR logic gate based on two molecular beacons
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID DNA LOGIC; CHEMICAL INPUTS; COMPUTATION; CIRCUITS; QUADRUPLEX; PROTEINS;
   BINDING; DESIGN; ENZYME; PH
AB Design of elementary molecular logic gates is the key and the fundamental of performing complicated Boolean calculations. Herein, we report a strategy for constructing a DNA-based OR gate by using the mechanism of sequence recognition and the principle of fluorescence resonance energy transfer (FRET). In this system, the gate is entirely composed of a single strand of DNA (A, B and C) and the inputs are the molecular beacon probes (MB1 and MB2). Changes in fluorescence intensity confirm the realization of the OR logic operation and electrophoresis experiments verify these results. Our successful application of DNA to perform the binary operation represents that DNA can serve as an efficient biomaterial for designing molecular logic gates and devices.
C1 [Guo, Jing; Yang, Renqiang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Peoples R China.
RP Yang, RQ (reprint author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, 189 Songling Rd, Qingdao 266101, Peoples R China.
EM yangrq@qibebt.ac.cn
FU Chinese Academy of Sciences; Ministry of Science and Technology of China
   [2010DFA52310]
FX This work was supported by the Program of "One Hundred Talented
   Project'' of the Chinese Academy of Sciences, the Ministry of Science
   and Technology of China (Grant No. 2010DFA52310).
CR ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651
   Ashkenasy G, 2004, J AM CHEM SOC, V126, P11140, DOI 10.1021/ja046745c
   Bi S, 2010, ANGEW CHEM INT EDIT, V49, P4438, DOI 10.1002/anie.201000840
   Bozdemir OA, 2010, J AM CHEM SOC, V132, P8029, DOI 10.1021/ja1008163
   Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1
   BRYAN AJ, 1989, BIOSENSORS, V4, P169, DOI 10.1016/0265-928X(89)80018-5
   Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391
   Cox JC, 1999, TRENDS BIOTECHNOL, V17, P151, DOI 10.1016/S0167-7799(99)01312-8
   Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128
   de Silva AP, 2007, COORDIN CHEM REV, V251, P1623, DOI 10.1016/j.ccr.2007.03.001
   de Silva AP, 2009, CHEM COMMUN, P1386, DOI 10.1039/b822181b
   de Silva AP, 2004, CHEM-EUR J, V10, P574, DOI 10.1002/chem.200305054
   DE SILVA AP, 1993, NATURE, V364, P42, DOI 10.1038/364042a0
   Deonarine AS, 2003, FUTURE GENER COMP SY, V19, P87, DOI 10.1016/S0167-739X(02)00110-3
   Elbaz J, 2009, NANO LETT, V9, P4510, DOI 10.1021/nl902859m
   Gu HZ, 2010, J AM CHEM SOC, V132, P4352, DOI 10.1021/ja910188p
   Guo JH, 2010, BIOSENS BIOELECTRON, V26, P327, DOI 10.1016/j.bios.2010.08.020
   Konry T, 2009, J AM CHEM SOC, V131, P13232, DOI 10.1021/ja905125b
   Lake A, 2010, ANGEW CHEM INT EDIT, V49, P4459, DOI 10.1002/anie.200907135
   Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u
   Li T, 2009, J AM CHEM SOC, V131, P15082, DOI 10.1021/ja9051075
   Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7
   Liu DS, 2006, J AM CHEM SOC, V128, P2067, DOI 10.1021/ja0568300
   Liu DS, 2003, ANGEW CHEM INT EDIT, V42, P5734, DOI 10.1002/anie.200352402
   Magri DC, 2006, J AM CHEM SOC, V128, P4950, DOI 10.1021/ja058295+
   Magri DC, 2006, ANAL CHIM ACTA, V568, P156, DOI 10.1016/j.aca.2005.11.073
   Margulies D, 2004, J AM CHEM SOC, V126, P15400, DOI 10.1021/ja0453329
   Muller BK, 2006, NANO LETT, V6, P2814, DOI 10.1021/nl0619406
   Ogasawara S, 2007, CHEMBIOCHEM, V8, P1520, DOI 10.1002/cbic.200700319
   Ramalingam KI, 2009, BIOCHEM ENG J, V47, P38, DOI 10.1016/j.bej.2009.06.014
   Reif JH, 2002, SCIENCE, V296, P478, DOI 10.1126/science.1070978
   Ruben AJ, 2000, NAT REV MOL CELL BIO, V1, P69, DOI 10.1038/35036086
   Sannohe Y, 2010, J AM CHEM SOC, V132, P16311, DOI 10.1021/ja1058907
   Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493
   Shapiro E, 2008, SCIENCE, V322, P387, DOI 10.1126/science.1165665
   Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j
   Shlyahovsky B, 2009, ACS NANO, V3, P1831, DOI 10.1021/nn900085x
   Sivan S, 1999, BIOTECHNOL PROGR, V15, P964, DOI 10.1021/bp990075a
   Stojanovic MN, 2005, J AM CHEM SOC, V127, P6914, DOI 10.1021/ja0430003a
   Tang YL, 2006, ADV MATER, V18, P2105, DOI 10.1002/adma.200501534
   Uchiyama S, 2004, J AM CHEM SOC, V126, P3032, DOI 10.1021/ja039697p
   Voelcker NH, 2008, SMALL, V4, P427, DOI 10.1002/smll.200700113
   Wang XM, 2009, BIOELECTROCHEMISTRY, V77, P69, DOI 10.1016/j.bioelechem.2009.06.012
   Wang YJ, 2010, MACROMOL RAPID COMM, V31, P1473, DOI 10.1002/marc.201000165
   Willner I, 2006, LANGMUIR, V22, P1409, DOI 10.1021/la052551e
   Zhang C, 2010, LANGMUIR, V26, P1416, DOI 10.1021/la903137f
NR 46
TC 6
Z9 6
U1 1
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2012
VL 8
IS 3
BP 927
EP 930
DI 10.1039/c2mb05477a
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 889BM
UT WOS:000300048500028
PM 22278176
DA 2018-10-19
ER

PT J
AU Karakas, A
   Yoruc, ABH
   Erdogan, DC
   Dogan, M
AF Karakas, A.
   Yoruc, A. B. Hazar
   Erdogan, D. Ceylan
   Dogan, M.
TI Effect of Different Calcium Precursors on Biomimetic Hydroxyapatite
   Powder Properties
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 1st International Congress on Advances in Applied Physics and Materials
   Science (APMAS)
CY MAY 12-15, 2011
CL Antalya, TURKEY
SP Istanbul Kultur Univ, Gebze Inst Technol, Doga Nanobiotech Inc, Terra Lab Inc, LOT Oriel Grp, PHYWE, Delta Elekt Inc
ID MECHANICAL-PROPERTIES
AB Hydroxyapatite is the main component of human hard tissues such as bones and teeth. Because it has a great biocompatibility with human organism, it is used as biomaterial with the purpose of form and repair hard tissues. Hydroxyapatite is formulated as Ca-10(PO4)(6)(OH)(2) and shows high stability under physiological conditions. In this study, biomimetic hydroxyapatite powder has been synthesized using by synthetic body fluids which has the same composition as human blood plasma. Moreover, the effect of different precursors on properties of synthesized powders has been investigated. For that purpose calcium nitrate tetrahydrate [Ca(NO3)(2)center dot 4H(2)O], calcium chloride [CaCl2], calcium hydroxide [Ca(OH)(2)] and diammonium hydrogen phosphate [(NH4)(2)HPO4] were used as precursors. Mainly literature focused on the synthesis of hydroxyapatite powders was carried out using chemical method. However, in this study, the synthesis of hydroxyapatite powder is carried out using biomimetic method. Chemical structures of synthesized powders have been investigated by the Fourier transform infrared and X-ray diffraction methods. Results showed that synthesized powders have a pure hydroxyapatite structure. Surface area of the synthesized powders was measured by the Brunauer-Emmett-Teller method. Morphological structures have been characterized by using scanning electron microscopy. Furthermore, particle size of powders was calculated using the Brunauer-Emmett-Teller method. It was clearly seen that morphological properties of biomimetic hydroxyapatite have affected the use of different calcium precursors.
C1 [Karakas, A.; Dogan, M.] Yildiz Tech Univ, Dept Chem, Fac Arts & Sci, TR-34220 Istanbul, Turkey.
   [Yoruc, A. B. Hazar] Yildiz Tech Univ, Dept Met & Mat Engn, Fac Chem & Met Engn, TR-34210 Istanbul, Turkey.
   [Erdogan, D. Ceylan] Yildiz Tech Univ, Sci & Technol Applicat & Res Ctr, TR-34349 Istanbul, Turkey.
RP Karakas, A (reprint author), Yildiz Tech Univ, Dept Chem, Fac Arts & Sci, TR-34220 Istanbul, Turkey.
CR Baumann H, 2002, NUCL INSTRUM METH B, V196, P286, DOI 10.1016/S0168-583X(02)01298-3
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   BEST S, 1994, J MATER SCI-MATER M, V5, P516, DOI 10.1007/BF00124883
   Goubin M., 2009, CRYSTAL GROWTH DESIG, V9, P2991
   Menendez-Proupin E, 2011, J MECH BEHAV BIOMED, V4, P1011, DOI 10.1016/j.jmbbm.2011.03.001
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Ohtsuki C, 2007, J EUR CERAM SOC, V27, P1527, DOI 10.1016/j.jeurceramsoc.2006.04.018
   Oktar FN, 2007, CERAM INT, V33, P1309, DOI 10.1016/j.ceramint.2006.05.022
   Padmanabhan SK, 2009, PARTICUOLOGY, V7, P466, DOI 10.1016/j.partic.2009.06.008
   Roll S.J., 2010, THESIS NATL I TECH R
   Song JF, 2011, MAT SCI ENG A-STRUCT, V528, P5421, DOI 10.1016/j.msea.2011.03.078
   Tas A.C., 1997, Patent No. 990037
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tschoppe P, 2011, J DENT, V39, P430, DOI 10.1016/j.jdent.2011.03.008
   Yang C, 2010, T NONFERR METAL SOC, V20, P254, DOI 10.1016/S1003-6326(09)60131-X
NR 15
TC 9
Z9 9
U1 0
U2 9
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD JAN
PY 2012
VL 121
IS 1
BP 236
EP 239
DI 10.12693/APhysPolA.121.236
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 882ZS
UT WOS:000299603000074
OA Bronze
DA 2018-10-19
ER

PT J
AU Sun, HH
   Qu, TJ
   Zhang, XH
   Yu, Q
   Chen, FM
AF Sun, Hai-Hua
   Qu, Tie-Jun
   Zhang, Xian-Hua
   Yu, Qing
   Chen, Fa-Ming
TI Designing biomaterials for in situ periodontal tissue regeneration
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE cell homing; endogenous regeneration; tissue engineering; controlled
   release; regenerative medicine; biofunctionalized biomaterials
ID GROWTH-FACTOR-DELIVERY; BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL
   STEM-CELLS; OSTEOBLAST PROGENITOR CELLS; BLOOD-VESSEL FORMATION;
   MYOCARDIAL-INFARCTION; DRUG-DELIVERY; ENGINEERING SCAFFOLDS; ADENOVIRUS
   VECTORS; CONTROLLED-RELEASE
AB The regeneration of periodontal tissue poses a significant challenge to biomaterial scientists, tissue engineers and periodontal clinicians. Recent advances in this field have shifted the focus from the attempt to recreate tissue replacements/constructs ex vivo to the development of biofunctionalized biomaterials that incorporate and release regulatory signals in a precise and near-physiological fashion to achieve in situ regeneration. The molecular and physical information coded within the biomaterials define a local biochemical and mechanical niche with complex and dynamic regulation that establishes key interactions with host endogenous cells and, hence, may help to unlock latent regenerative pathways in the body by instructing cell homing and regulating cell proliferation/differentiation. In the future, these innovative principles and biomaterial devices promise to have a profound impact on periodontal reconstructive therapy and are also likely to reconcile the clinical and commercial pressures on other tissue engineering endeavors. (c) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012
C1 [Sun, Hai-Hua; Qu, Tie-Jun; Yu, Qing] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China.
   [Zhang, Xian-Hua] Chinese Peoples Liberat Army Gen Hosp, Periodontol Unit, Dept Stomatol, Beijing 100853, Peoples R China.
   [Chen, Fa-Ming] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol & Oral Med, Translat Res Team, Xian 710032, Shaanxi, Peoples R China.
RP Yu, Q (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China.
EM yuqing@fmmu.edu.cn; cfmsunhh@fmmu.edu.cn
FU National Natural Science Foundation of China [81071253/H1818,
   31170912/C1002]
FX Fundings from the National Natural Science Foundation of China
   (81071253/H1818; 31170912/C1002) for some of the work mentioned in the
   review is gratefully appreciated.
CR Al-Shammari KF, 2005, J PERIODONTOL, V76, P1910, DOI 10.1902/jop.2005.76.11.1910
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andreadis ST, 2006, TRENDS BIOTECHNOL, V24, P331, DOI 10.1016/j.tibtech.2006.05.001
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Blumenthal NM, 2002, J PERIODONTOL, V73, P1494, DOI 10.1902/jop.2002.73.12.1494
   Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Cao Cai-fang, 2009, Zhonghua Kou Qiang Yi Xue Za Zhi, V44, P321
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Carr AN, 2006, CARDIOVASC RES, V69, P925, DOI 10.1016/j.cardiores.2005.12.005
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079
   Chang PC, 2010, GENE THER, V17, P95, DOI 10.1038/gt.2009.117
   Chang PC, 2009, HUM GENE THER, V20, P486, DOI 10.1089/hum.2008.114
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen FM, 2009, CURR GENE THER, V9, P248, DOI 10.2174/156652309788921071
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chen WH, 2010, CURR PHARM DESIGN, V16, P2388, DOI 10.2174/138161210791920478
   Choi DH, 2010, J CONTROL RELEASE, V147, P193, DOI 10.1016/j.jconrel.2010.07.103
   De Marchis F, 2002, BLOOD, V99, P2045, DOI 10.1182/blood.V99.6.2045
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Ding G, 2010, STEM CELLS, V28, P1829, DOI 10.1002/stem.512
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Duan XJ, 2011, J CELL PHYSIOL, V226, P150, DOI 10.1002/jcp.22316
   Elangovan S, 2010, J BIOMATER APPL, V25, P3, DOI 10.1177/0885328210366490
   Evans CH, 2007, TISSUE ENG, V13, P1987, DOI 10.1089/ten.2006.0302
   Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101
   Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011
   Giannobile WV, 1996, J PERIODONTAL RES, V31, P301, DOI 10.1111/j.1600-0765.1996.tb00497.x
   Guldberg RE, 2009, J BONE MINER RES, V24, P1507, DOI [10.1359/JBMR.090801, 10.1359/jbmr.090801]
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hakki SS, 2010, J PERIODONTOL, V81, P1663, DOI 10.1902/jop.2010.100074
   Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341
   He XZ, 2010, INT J PHARMACEUT, V390, P107, DOI 10.1016/j.ijpharm.2009.12.063
   Herberg S, 2008, J CLIN PERIODONTOL, V35, P976, DOI 10.1111/j.1600-051X.2008.01323.x
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huang S, 2010, J CONTROL RELEASE, V142, P149, DOI 10.1016/j.jconrel.2009.10.018
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hughes-Fulford M, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-8
   Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kaigler Darnell, 2006, Expert Opin Drug Deliv, V3, P647, DOI 10.1517/17425247.3.5.647
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281
   Kerfoot SM, 2008, AM J PHYSIOL-HEART C, V294, pH2524, DOI 10.1152/ajpheart.00984.2007
   Khandwekar AP, 2010, J BIOMED MATER RES A, V95A, P413, DOI 10.1002/jbm.a.32852
   Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181
   Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803
   Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI 10.1089/ten.TEA.2009.0322
   Kimura Y, 2010, J BIOMAT SCI-POLYM E, V21, P37, DOI 10.1163/156856209X410193
   King GN, 2001, J CLIN PERIODONTOL, V28, P465, DOI 10.1034/j.1600-051x.2001.028005465.x
   Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103
   Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616
   Klopsch C, 2009, J CELL MOL MED, V13, P664, DOI 10.1111/j.1582-4934.2008.00546.x
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kumagai K, 2008, J ORTHOP RES, V26, P165, DOI 10.1002/jor.20477
   Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee DY, 2010, BONE, V46, P673, DOI 10.1016/j.bone.2009.10.018
   Lee Jaebum, 2010, Dent Clin North Am, V54, P93, DOI 10.1016/j.cden.2009.09.001
   Lee JY, CURR PHARM IN PRESS
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li HX, 2009, CELLS TISSUES ORGANS, V190, P94, DOI 10.1159/000166547
   Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mesure L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012949
   Min CK, 2011, J CLIN PERIODONTOL, V38, P261, DOI 10.1111/j.1600-051X.2010.01691.x
   Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019
   Muzzi L, 2006, J PERIODONTOL, V77, P2084, DOI 10.1902/jop.2006.050227
   Nagaoka M, 2010, ANN BIOMED ENG, V38, P683, DOI 10.1007/s10439-010-9935-3
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Odorfer KI, 2008, J CELL MOL MED, V12, P2867, DOI 10.1111/j.1582-4934.2008.00511.x
   Otsuki S, 2010, P NATL ACAD SCI USA, V107, P10202, DOI 10.1073/pnas.0913897107
   Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515
   Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Pizzo G, 2010, EUR J INTERN MED, V21, P496, DOI 10.1016/j.ejim.2010.07.011
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qu D, 2011, J BIOMED MATER RES A, V96A, P543, DOI 10.1002/jbm.a.33009
   Quaglia F, 2008, INT J PHARMACEUT, V364, P281, DOI 10.1016/j.ijpharm.2008.04.030
   Ratanavaraporn J, 2011, BIOMATERIALS, V32, P2797, DOI 10.1016/j.biomaterials.2010.12.052
   Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Reynolds Mark A, 2010, Dent Clin North Am, V54, P55, DOI 10.1016/j.cden.2009.09.003
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Shimabukuro Y, 2011, J CELL PHYSIOL, V226, P809, DOI 10.1002/jcp.22406
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   Sreejalekshmi KG, 2011, J BIOMED MATER RES A, V96A, P477, DOI 10.1002/jbm.a.32980
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sun HH, 2011, J TISSUE ENG REGEN M, V5, pE1, DOI 10.1002/term.369
   Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426
   Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Thieme S, 2009, TISSUE ENG PART C-ME, V15, P687, DOI 10.1089/ten.TEC.2008.0556
   Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048
   Tsumanuma Y, 2011, BIOMATERIALS, V32, P5819, DOI 10.1016/j.biomaterials.2011.04.071
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   Villar Cristina C, 2010, Dent Clin North Am, V54, P73, DOI 10.1016/j.cden.2009.08.011
   Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wikesjo Ulf M E, 2003, Clin Implant Dent Relat Res, V5, P112, DOI 10.1111/j.1708-8208.2003.tb00192.x
   Yan XZ, 2010, J PERIODONTOL, V81, P1289, DOI 10.1902/jop.2010.090655
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang Y, 2010, BIOMATERIALS, V31, P8574, DOI 10.1016/j.biomaterials.2010.06.026
   Ye Q, 2011, J TISSUE ENG REGEN M, V5, P264, DOI 10.1002/term.311
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
   Zhang YF, 2009, J CONTROL RELEASE, V136, P172, DOI 10.1016/j.jconrel.2009.02.016
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 144
TC 31
Z9 33
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JAN-FEB
PY 2012
VL 28
IS 1
BP 3
EP 20
DI 10.1002/btpr.698
PG 18
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 885JP
UT WOS:000299775500002
PM 21913341
DA 2018-10-19
ER

PT J
AU Boudko, SP
   Engel, J
   Bachinger, HP
AF Boudko, Sergei P.
   Engel, Juergen
   Baechinger, Hans Peter
TI The crucial role of trimerization domains in collagen folding
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Review
DE Protein folding; Collagen triple helix; Trimerization domain; Protein
   structure; Chain selection
ID SCHMID METAPHYSEAL CHONDRODYSPLASIA; CARBOXYL-TERMINAL PROPEPTIDE;
   EHLERS-DANLOS-SYNDROME; HUMAN TYPE-I; CRYSTAL-STRUCTURE; TRIPLE-HELIX;
   BASEMENT-MEMBRANE; X COLLAGEN; COILED-COIL; OSTEOGENESIS IMPERFECTA
AB Collagens contain large numbers of Gly-Xaa-Yaa peptide repeats that form the characteristic triple helix, where the individual chains fold into a polyproline II helix and three of these helices form a right-handed triple helix. For the proper folding of the triple helix collagens contain trimerization domains. These domains ensure a single starting point for triple helix formation and are also responsible for the chain selection in heterotrimeric collagens. Trimerization domains are non-collagenous domains of very different structures. The size of trimerization domains varies from 35 residues in type IX collagen to around 250 residues for the fibrillar collagens. These domains are not only crucial for biological functions, but they are also attractive tools for generating recombinant collagen fragments of interest as well as for general use in protein engineering and biomaterial design. Here we review the current knowledge of the structure and function of these trimerization domains. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
RP Engel, J (reprint author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM juergen.engel@unibas.ch; hpb@shcc.org
CR Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219
   AHMAD NN, 1995, ARCH OPHTHALMOL-CHIC, V113, P1454, DOI 10.1001/archopht.1995.01100110114034
   Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0
   Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200
   BATEMAN JF, 1989, J BIOL CHEM, V264, P10960
   Bateman JF, 2005, HUM MUTAT, V25, P525, DOI 10.1002/humu.20183
   Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012
   Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405
   Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057
   Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200
   Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551
   Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694
   Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014
   Chen M, 2001, J BIOL CHEM, V276, P21649, DOI 10.1074/jbc.M100180200
   Chen M, 2000, J BIOL CHEM, V275, P24429, DOI 10.1074/jbc.M003440200
   CHESSLER SD, 1993, J BIOL CHEM, V268, P18218
   David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001
   DAVIS JM, 1989, J BIOL CHEM, V264, P8956
   DePaepe A, 1997, AM J HUM GENET, V60, P547
   DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x
   EFIMOV VP, 1994, J MOL BIOL, V242, P470, DOI 10.1006/jmbi.1994.1595
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   EXPOSITO JY, 1993, J MOL EVOL, V37, P254, DOI 10.1007/BF00175502
   Fitzgerald J, 2008, BIOL CHEM, V283, P20170
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200
   Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200
   GIBSON GJ, 1985, J CELL BIOL, V101, P277, DOI 10.1083/jcb.101.1.277
   Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575
   GRANT WT, 1987, J BIOL CHEM, V262, P9844
   Greenhill NS, 2000, MATRIX BIOL, V19, P19, DOI 10.1016/S0945-053X(99)00053-0
   Grond-Ginsbach C, 2002, NEUROLOGY, V58, P1103, DOI 10.1212/WNL.58.7.1103
   Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404
   Hayward C P, 1995, Curr Opin Hematol, V2, P339
   HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246
   HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7
   Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843
   Jeschke G, 2006, ANGEW CHEM INT EDIT, V45, P1058, DOI 10.1002/anie.200503720
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200
   KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545
   Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233
   Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1
   KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597
   LABERMEIER U, 1983, EXP EYE RES, V37, P225, DOI 10.1016/0014-4835(83)90157-4
   Labourdette L, 1993, FEBS LETT, V320, P211
   LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642
   Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1047/jbc.M510192200
   Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Lobo VJSA, 2006, INT J CANCER, V119, P455, DOI 10.1002/ijc.21851
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Malone JP, 2005, BIOCHEMISTRY-US, V44, P15269, DOI 10.1021/bi0508338
   Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev
   MAZZORANA M, 1993, J BIOL CHEM, V268, P3029
   Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781
   Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026
   Milbradt AG, 2005, J MOL BIOL, V354, P591, DOI 10.1016/j.jmb.2005.09.080
   Mitchell AL, 2009, HUM MUTAT, V30, P995, DOI 10.1002/humu.21000
   Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019
   Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028
   MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721
   MYERS JC, 1992, P NATL ACAD SCI USA, V89, P10144, DOI 10.1073/pnas.89.21.10144
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   NINOMIYA Y, 1986, J BIOL CHEM, V261, P5041
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200
   Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443
   Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200
   Papanikolopoulou Katerina, 2008, V474, P15, DOI 10.1007/978-1-59745-480-3_2
   Pickup MJ, 2011, FORENSIC SCI MED PAT, V7, P192, DOI 10.1007/s12024-010-9205-6
   PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8
   Pokidysheva E, 2004, J BIOL CHEM, V279, P30395, DOI 10.1074/jbc.M403734200
   Pope F. M., 2010, J MED GENET S1, V47, P20
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   REHN M, 1994, J BIOL CHEM, V269, P13929
   REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234
   Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200
   Ricard-Blum S, 2005, PATHOL BIOL PARIS, V53, P430
   RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x
   SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577
   Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996
   Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249
   SCHMID TM, 1983, J BIOL CHEM, V258, P9504
   Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123
   Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2
   Shuttleworth CA, 1997, INT J BIOCHEM CELL B, V29, P1145, DOI 10.1016/S1357-2725(97)00033-2
   Stephan S, 2004, J BIOL CHEM, V279, P21469, DOI 10.1074/jbc.M305805200
   Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X
   Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499
   TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x
   UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713
   Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200
   Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811
   Verdone G, 2008, J BIOL CHEM, V283, P18947, DOI 10.1074/jbc.M801085200
   Verdone G, 2009, J BIOMOL NMR, V43, P79, DOI 10.1007/s10858-008-9290-y
   VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715
   WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x
   Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200
   Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005
   Woolfson DN, 2010, BIOPOLYMERS, V94, P118, DOI 10.1002/bip.21345
   YURCHENCO PD, 1990, FASEB J, V4, P1577
   Zhang Y, 1999, J BIOL CHEM, V274, P22409, DOI 10.1074/jbc.274.32.22409
NR 122
TC 29
Z9 31
U1 2
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JAN
PY 2012
VL 44
IS 1
BP 21
EP 32
DI 10.1016/j.biocel.2011.09.009
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 888CW
UT WOS:000299982400005
PM 22001560
DA 2018-10-19
ER

PT J
AU Gomes, S
   Leonor, IB
   Mano, JF
   Reis, RL
   Kaplan, DL
AF Gomes, Silvia
   Leonor, Isabel B.
   Mano, Joao F.
   Reis, Rui L.
   Kaplan, David L.
TI Natural and genetically engineered proteins for tissue engineering
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Biomaterials; Tissue engineering; Natural polymers; Recombinant
   technology; Chimeric proteins
ID BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; RECOMBINANT
   SPIDER SILK; YEAST PICHIA-PASTORIS; COLLAGEN-BINDING DOMAIN; FACTOR
   FUSION PROTEIN; BACULOVIRUS EXPRESSION SYSTEM; MESENCHYMAL STEM-CELLS;
   LAMININ ALPHA-1 CHAIN; ELASTIN-LIKE POLYMERS
AB To overcome the limitations of traditionally used autografts, allografts and, to a lesser extent, synthetic materials, there is the need to develop a new generation of scaffolds with adequate mechanical and structural support, control of cell attachment, migration, proliferation and differentiation and with bio-resorbable features. This suite of properties would allow the body to heal itself at the same rate as implant degradation. Genetic engineering offers a route to this level of control of biomaterial systems. The possibility of expressing biological components in nature and to modify or bioengineer them further, offers a path towards multifunctional biomaterial systems. This includes opportunities to generate new protein sequences, new self-assembling peptides or fusions of different bioactive domains or protein motifs. New protein sequences with tunable properties can be generated that can be used as new biomaterials.
   In this review we address some of the most frequently used proteins for tissue engineering and biomedical applications and describe the techniques most commonly used to functionalize protein-based biomaterials by combining them with bioactive molecules to enhance biological performance. We also highlight the use of genetic engineering, for protein heterologous expression and the synthesis of new protein-based biopolymers, focusing the advantages of these functionalized biopolymers when compared with their counterparts extracted directly from nature and modified by techniques such as physical adsorption or chemical modification. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Gomes, Silvia; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Gomes, Silvia; Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Gomes, Silvia; Kaplan, David L.] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
   [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] IBB Inst Biotechnol & Bioengn, PT Govt Associated Lab, Braga, Portugal.
   [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St,Rm 251, Medford, MA 02155 USA.
EM silvia.gomes@dep.uminho.pt; belinha@dep.uminho.pt; jmano@dep.uminho.pt;
   rgreis@dep.uminho.pt; David.Kaplan@tufts.edu
RI 李, 涵/B-4995-2012; Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009;
   Leonor, Isabel/B-5260-2011; Reis, Rui L./A-8938-2008; Gomes,
   Silvia/J-6099-2013
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Leonor,
   Isabel/0000-0002-4319-4883; Reis, Rui L./0000-0002-4295-6129; Gomes,
   Silvia/0000-0002-4881-7808
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/28603/2006]; EU-EC; FCT [PTDC/FIS/68517/2006]; FCT agency;
   Chimera project [PTDC/EBB-EBI/109093/2008]; NIH Tissue Engineering
   Resource Center [P41 EB002520]; NIH [EB003210, DE017207]
FX Silvia Gomes thanks the Portuguese Foundation for Science and Technology
   (FCT) for providing her a PhD Grant (SFRH/BD/28603/2006). This work was
   carried out under the scope of the FIND & BIND project funded by the
   agency EU-EC (FP7 program), the FCT R&D project Proteo-Light
   (PTDC/FIS/68517/2006) funded by the FCT agency, the Chimera project
   (PTDC/EBB-EBI/109093/2008) funded by the FCT agency, the NIH (P41
   EB002520) Tissue Engineering Resource Center and the NIH (EB003210 and
   DE017207).
CR Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI 10.1089/ten.TEA.2009.0708
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   Andrades JA, 2001, GROWTH FACTORS, V18, P261, DOI 10.3109/08977190109029115
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Arias FJ, 2006, BIOTECHNOL LETT, V28, P687, DOI 10.1007/s10529-006-9045-3
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Baez J, 2005, APPL MICROBIOL BIOT, V69, P245, DOI 10.1007/s00253-005-0180-x
   Barbosa JS, 2010, ADV ENG MATER, V12, pB37, DOI 10.1002/adem.200980152
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   Benesch J, 2008, TISSUE ENG PART B-RE, V14, P433, DOI 10.1089/ten.teb.2008.0121
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus
   Bie CD, 2007, REGEN MED, V2, P95
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   BLOMBACK B, 1976, THROMB RES, V8, P639, DOI 10.1016/0049-3848(76)90245-0
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Brewster LP, 2008, BIOMATERIALS, V29, P327, DOI 10.1016/j.biomaterials.2007.09.034
   Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200
   Bush KA, 2010, TISSUE ENG PT A, V16, P829, DOI [10.1089/ten.tea.2009.0514, 10.1089/ten.TEA.2009.0514]
   Butler SP, 2004, TRANSGENIC RES, V13, P437, DOI 10.1007/s11248-004-9589-8
   Campbell PG, 2005, BIOMATERIALS, V26, P6762, DOI 10.1016/j.biomaterials.2005.04.032
   Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709
   Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chatterjee S, 2009, APPL BIOCHEM BIOTECH, V157, P593, DOI 10.1007/s12010-008-8405-y
   Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Costa RR, 2009, ADV FUNCT MATER, V19, P3210, DOI 10.1002/adfm.200900568
   Cote MF, 2004, BIOMATERIALS, V25, P3761, DOI 10.1016/j.biomaterials.2003.10.026
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Dame M, 2008, IN VITRO CELL DEV-AN, V44, P407, DOI 10.1007/s11626-008-9139-4
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Degim IT, 2007, CURR PHARM DESIGN, V13, P99
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Dinerman AA, 2010, MACROMOL BIOSCI, V10, P1235, DOI 10.1002/mabi.201000061
   Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0
   Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fan H, 2006, INT J ARTIF ORGANS, V29, P602
   Fan HB, 2008, CELL TRANSPLANT, V17, P1389, DOI 10.3727/096368908787648047
   Faralli JA, 2009, EXP EYE RES, V88, P689, DOI 10.1016/j.exer.2008.08.019
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Gavenis K, 2007, J BIOMED MATER RES B, V82B, P275, DOI 10.1002/jbm.b.30731
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   George A, 2010, NANO TODAY, V5, P254, DOI 10.1016/j.nantod.2010.05.005
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Han DQ, 2008, MED HYPOTHESES, V71, P374, DOI 10.1016/j.mehy.2008.01.035
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   HASHI H, 1994, CELL STRUCT FUNCT, V19, P37, DOI 10.1247/csf.19.37
   Hassouneh W, 2010, CURRENT PROTOCOLS PR, P1, DOI 10.1002/0471140864.ps0611s61
   Hayashi M, 2001, BBA-GEN SUBJECTS, V1528, P187, DOI 10.1016/S0304-4165(01)00187-8
   He QF, 2011, ACTA BIOMATER, V7, P1084, DOI 10.1016/j.actbio.2010.10.022
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   Ito H, 2006, J BIOMED MATER RES A, V76A, P551, DOI 10.1002/jbm.a.30551
   Jang JH, 2004, BIOTECHNOL LETT, V26, P1837, DOI 10.1007/s10529-004-5278-1
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   Kambe Y, 2010, BIOMATERIALS, V31, P7503, DOI 10.1016/j.biomaterials.2010.06.045
   Kang S-W, 2010, BONE, V48, P298
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kastin AJ, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, pXXXIX, DOI 10.1016/B978-012369442-3/50002-7
   KAWASE Y, 1992, FEBS LETT, V298, P126, DOI 10.1016/0014-5793(92)80037-H
   Kawazoe N, 2010, BIOTECHNOL PROGR, V26, P819, DOI 10.1002/btpr.375
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kikkawa Y, 2009, BIOMATERIALS, V30, P6888, DOI 10.1016/j.biomaterials.2009.09.011
   Kilian O, 2009, J BIOMED MATER RES B, V90B, P210, DOI 10.1002/jbm.b.31275
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim M, 2010, BIOMATERIALS, V31, P3596, DOI 10.1016/j.biomaterials.2010.01.068
   Kim W, 2010, ADV DRUG DELIVER REV, V62, P1468, DOI 10.1016/j.addr.2010.04.007
   Kimura Y, 2010, J TISSUE ENG REGEN M, V4, P55, DOI 10.1002/term.218
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kleinheinz J, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-17
   Kleinmann G, 2007, OPHTHALMOLOGICA, V221, P51, DOI 10.1159/000096523
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kuo YC, 2007, BIOTECHNOL PROGR, V23, P238, DOI 10.1021/bp060253h
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee J, 2011, ACTA BIOMATER, V7, P244, DOI 10.1016/j.actbio.2010.08.017
   Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Lim S, 2010, BIOMATERIALS, V31, P3715, DOI 10.1016/j.biomaterials.2010.01.063
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Luan CH, 1999, POLYM DATA HDB, P78
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   MADSEN K, 1984, BIOCHEM J, V221, P189, DOI 10.1042/bj2210189
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   Mahoney DV, 1997, ACS SYM SER, P196
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mansell JR, 2002, IN VITRO CELL DEV-AN, V38, P518, DOI 10.1290/1071-2690(2002)038<0518:TICSBH>2.0.CO;2
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/o09-161, 10.1139/O09-161]
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Murphy JL, 2010, BIOMACROMOLECULES, V11, P2976, DOI 10.1021/bm1007794
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Nagaoka M, 2010, ANN BIOMED ENG, V38, P683, DOI 10.1007/s10439-010-9935-3
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   NICOL A, 1994, BIOTECHNOLOGY AND BIOACTIVE POLYMERS, P95
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Numata K, 2010, J CONTROL RELEASE, V146, P136, DOI 10.1016/j.jconrel.2010.05.006
   Ogawa T, 2010, J BIOMAT SCI-POLYM E, V21, P609, DOI 10.1163/156856209X434638
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Pang YG, 2010, BIOMATERIALS, V31, P878, DOI 10.1016/j.biomaterials.2009.10.007
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Park IS, 2009, J BIOMAT SCI-POLYM E, V20, P1645, DOI 10.1163/156856208X386237
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Pulkkinen HJ, 2010, OSTEOARTHR CARTILAGE, V18, P1077, DOI 10.1016/j.joca.2010.05.004
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Rexeisen EL, 2010, LANGMUIR, V26, P1953, DOI 10.1021/la902571q
   Rico P, 2010, COLLOID SURFACE B, V78, P310, DOI 10.1016/j.colsurfb.2010.03.019
   Rocha LB, 2006, J BIOMED MATER RES A, V79A, P237, DOI 10.1002/jbm.a.30782
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   ROMANO NH, 2010, BIOCHIM BIOPHYS ACTA, V1810, P339
   Royce SM, 2004, J BIOMAT SCI-POLYM E, V15, P1327, DOI 10.1163/1568562041960016
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Sallach RE, 2009, BIOTECHNOL PROGR, V25, P1810, DOI 10.1002/btpr.208
   Sarfati G, 2011, BIOMATERIALS, V32, P152, DOI 10.1016/j.biomaterials.2010.09.014
   Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Schleicher I, 2005, TISSUE ENG, V11, P1688, DOI 10.1089/ten.2005.11.1688
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Sehnal F, 2004, BIOMACROMOLECULES, V5, P666, DOI 10.1021/bm0344046
   Seo YK, 2009, J ORTHOP RES, V27, P495, DOI 10.1002/jor.20752
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Sheng Z, 2003, PROTEIN EXPRES PURIF, V27, P267, DOI 10.1016/S1046-5928(02)00601-0
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   SIEBENLIST KR, 1990, J BIOL CHEM, V265, P18650
   Silva SS, 2010, CRIT REV BIOTECHNOL, V30, P200, DOI 10.3109/07388551.2010.505561
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P570, DOI 10.1016/j.ijbiomac.2010.08.004
   SMITH GF, 1980, BIOCHEM J, V185, P1
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Srouji S, 2005, J CRANIO MAXILL SURG, V33, P79, DOI 10.1016/j.jcms.2004.09.003
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   Steplewski A, 2004, J MOL BIOL, V338, P989, DOI 10.1016/j.jmb.2004.03.037
   Sun B, 2009, J BIOMED MATER RES B, V91B, P366, DOI 10.1002/jbm.b.31411
   Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417
   Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Takeda Y, 2005, J BIOMED MATER RES A, V73A, P133, DOI 10.1002/jbm.a.30257
   Takezawa T, 2007, TISSUE ENG, V13, P1357, DOI 10.1089/ten.2006.0248
   Teixeira S, 2010, J MATER SCI-MATER M, V21, P2385, DOI 10.1007/s10856-010-4097-2
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x
   Tojo N, 2008, PROTEIN EXPRES PURIF, V59, P289, DOI 10.1016/j.pep.2008.02.010
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Tomita M, 1995, BIOCHEM J, V312, P847, DOI 10.1042/bj3120847
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Tomita M, 1997, J BIOCHEM-TOKYO, V121, P1061
   Tsubouchi M, 2008, HEALTH POLICY, V88, P62, DOI 10.1016/j.healthpol.2008.02.011
   Tuan TL, 1996, CONNECT TISSUE RES, V34, P1, DOI 10.3109/03008209609028888
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Urry DM., 1991, MOL CONFORMATION BIO, P555
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   Urry DW, 1993, BIOTECHNOLOGICAL POL, P82
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511
   Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   WAITE JH, 1992, BIOL BULL, V183, P178, DOI 10.2307/1542421
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, J BIOMED MATER RES B, V86B, P29, DOI 10.1002/jbm.b.30984
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Warner LR, 2007, PROTEIN EXPRES PURIF, V52, P403, DOI 10.1016/j.pep.2006.10.016
   Wehrhan F, 2010, DERMATOL SURG, V36, P919, DOI 10.1111/j.1524-4725.2010.01569.x
   Weir MD, 2010, J BIOMED MATER RES A, V94A, P223, DOI 10.1002/jbm.a.32665
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Werten MWT, 2009, BIOMACROMOLECULES, V10, P1106, DOI 10.1021/bm801299u
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Williams D. J., 2005, IEE Proceedings Nanobiotechnology, V152, P207, DOI 10.1049/ip-nbt:20050001
   Wise DL, 2000, BIOMATERIALS ENG DEV
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wright ER, 2002, ADV FUNCT MATER, V12, P149, DOI 10.1002/1616-3028(20020201)12:2<149::AID-ADFM149>3.0.CO;2-N
   Wu F, 2008, AAPS PHARMSCITECH, V9, P1218, DOI 10.1208/s12249-008-9148-3
   Wu JM, 2011, J MATER SCI-MATER M, V22, P107, DOI 10.1007/s10856-010-4176-4
   Wu W-Y, 2009, CISP 2009 TIANJ OCT, P1
   Wu XY, 2005, BIOMACROMOLECULES, V6, P3037, DOI 10.1021/bm0503468
   Yamaoka T, 2003, BIOMACROMOLECULES, V4, P1680, DOI 10.1021/bm0341201
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yan X, 2010, DIABETES RES CLIN PR, V90, P66, DOI 10.1016/j.diabres.2010.07.001
   Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93
   Zelzer M, 2010, CHEM SOC REV, V39, P3351, DOI 10.1039/c0cs00035c
   Zhang C, 2009, BIOTECHNOL PROGR, V25, P1660, DOI 10.1002/btpr.257
   Zhang YQ, 2006, J BIOMED MATER RES B, V79B, P275, DOI 10.1002/jbm.b.30539
   Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025
   Zhao JY, 2009, J BIOSCI BIOENG, V107, P318, DOI 10.1016/j.jbiosc.2008.10.007
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
   Zhao YN, 2009, J BIOMED MATER RES A, V88A, P725, DOI 10.1002/jbm.a.31928
   Zhou JA, 2010, INT J BIOL MACROMOL, V47, P514, DOI 10.1016/j.ijbiomac.2010.07.010
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
NR 286
TC 110
Z9 112
U1 5
U2 183
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JAN
PY 2012
VL 37
IS 1
BP 1
EP 17
DI 10.1016/j.progpolymsci.2011.07.003
PG 17
WC Polymer Science
SC Polymer Science
GA 888BO
UT WOS:000299979000001
PM 22058578
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, KY
   Mooney, DJ
AF Lee, Kuen Yong
   Mooney, David J.
TI Alginate: Properties and biomedical applications
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Biomaterial; Hydrogel; Wound dressing; Drug delivery; Tissue engineering
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; MICROSPHERE/HYDROGEL
   COMBINATION SYSTEM; POLY(ALDEHYDE GULURONATE) HYDROGELS; SYNTHETIC
   EXTRACELLULAR-MATRIX; PERIPHERAL-NERVE REGENERATION; MOLECULAR-WEIGHT
   DISTRIBUTION; RGD NANOPATTERNED HYDROGELS; PARTIALLY OXIDIZED ALGINATE;
   VITRO CONTROLLED-RELEASE
AB Alginate is a biomaterial that has found numerous applications in biomedical science and engineering due to its favorable properties, including biocompatibility and ease of gelation. Alginate hydrogels have been particularly attractive in wound healing, drug delivery, and tissue engineering applications to date, as these gels retain structural similarity to the extracellular matrices in tissues and can be manipulated to play several critical roles. This review will provide a comprehensive overview of general properties of alginate and its hydrogels. their biomedical applications, and suggest new perspectives for future studies with these polymers. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Lee, Kuen Yong; Mooney, David J.] Harvard Univ, Sch Engn Appl Sci, Cambridge, MA 02138 USA.
   [Lee, Kuen Yong; Mooney, David J.] Harvard Univ, Wyss Inst, Cambridge, MA 02138 USA.
   [Lee, Kuen Yong] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
   [Lee, Kuen Yong] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn Appl Sci, Pierce Hall Room 325,29 Oxford St, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI 李, 涵/B-4995-2012
OI Lee, Kuen Yong/0000-0002-5759-5952
FU Defense Advanced Research Projects Agency [W911NF-10-0113]; NIH [R01
   DE019917, R01 DE013349, R01 HL069957, R37 DE013033]; National Research
   Foundation of Korea [2010-0002086, 2010-0012608]; LG Yonam Foundation
FX The authors acknowledge financial support from the Defense Advanced
   Research Projects Agency (W911NF-10-0113), the NIH (R01 DE019917, R01
   DE013349, R01 HL069957, R37 DE013033), the National Research Foundation
   of Korea (2010-0002086, 2010-0012608), and the LG Yonam Foundation.
CR Agren MS, 1999, ARCH DERMATOL, V135, P1273, DOI 10.1001/archderm.135.10.1273-a
   Ali OA, 2008, J CONTROL RELEASE, V132, P273, DOI 10.1016/j.jconrel.2008.07.005
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Balakrishnan B, 2006, BIOMATERIALS, V27, P1355, DOI 10.1016/j.biomaterials.2005.08.021
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bogdanowich-Knipp SJ, 1999, J PEPT RES, V53, P530, DOI 10.1034/j.1399-3011.1999.00052.x
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bouhadir KH, 2001, BIOMATERIALS, V22, P2625, DOI 10.1016/S0142-9612(01)00003-5
   Calafiore R, 2003, EXPERT OPIN BIOL TH, V3, P201, DOI 10.1517/14712598.3.2.201
   Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chan AW, 2010, BIOMATERIALS, V31, P9040, DOI 10.1016/j.biomaterials.2010.07.111
   Chang CH, 2010, BIOMACROMOLECULES, V11, P133, DOI 10.1021/bm900985h
   Chang SCN, 2003, PLAST RECONSTR SURG, V112, P793, DOI 10.1097/01.PRS.0000069711.31021.94
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chueh BH, 2010, BIOMED MICRODEVICES, V12, P145, DOI 10.1007/s10544-009-9369-6
   Clark D. E., 1936, US Patent, Patent No. [2036922, US Patent 2,036,922]
   Colinet I, 2009, EUR J PHARM BIOPHARM, V73, P345, DOI 10.1016/j.ejpb.2009.07.008
   Colinet I, 2009, CARBOHYD POLYM, V75, P454, DOI 10.1016/j.carbpol.2008.08.002
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Crow BB, 2006, BIOPOLYMERS, V81, P419, DOI 10.1002/bip.20442
   Dashtdar H, 2011, J ORTHOP RES, V29, P1336, DOI 10.1002/jor.21413
   Degala S, 2011, ARCH BIOCHEM BIOPHYS, V505, P112, DOI 10.1016/j.abb.2010.08.003
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Diamond DA, 1998, PEDIATRICS 2 S, V102, p107A
   Drury JL, 2005, J BIOMECH ENG-T ASME, V127, P220, DOI 10.1118/1.1865194
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   FISCHER FG, 1955, H-S Z PHYSIOL CHEM, V302, P186, DOI 10.1515/bchm2.1955.302.1-2.186
   Gao CM, 2009, INT J PHARMACEUT, V371, P16, DOI 10.1016/j.ijpharm.2008.12.013
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Gu F, 2004, J CONTROL RELEASE, V96, P463, DOI 10.1016/j.jconrel.2004.02.021
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hashimoto T, 2005, J MATER SCI-MATER M, V16, P503, DOI 10.1007/s10856-005-0524-1
   Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y
   HAUG A, 1959, ACTA CHEM SCAND, V13, P601, DOI 10.3891/acta.chem.scand.13-0601
   Hay ID, 2010, J CHEM TECHNOL BIOT, V85, P752, DOI 10.1002/jctb.2372
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Igarashi T, 2010, J BIOMED MATER RES A, V94A, P844, DOI 10.1002/jbm.a.32762
   Ishak RAH, 2007, J CONTROL RELEASE, V119, P207, DOI 10.1016/j.jconrel.2007.02.012
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jin XB, 2007, BIOMATERIALS, V28, P2994, DOI 10.1016/j.biomaterials.2007.03.002
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Kedem A, 2005, TISSUE ENG, V11, P715, DOI 10.1089/ten.2005.11.715
   Kendall WF, 2004, J MICROENCAPSUL, V21, P821, DOI 10.1080/02652040400015452
   Kershen RT, 2000, WORLD J UROL, V18, P51, DOI 10.1007/PL00007072
   Koizumi T, 2007, CELL TRANSPLANT, V16, P67, DOI 10.3727/000000007783464489
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2008, PHARM RES, V25, P1230, DOI 10.1007/s11095-007-9526-7
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krebs MD, 2010, J BIOMED MATER RES A, V92A, P1131, DOI 10.1002/jbm.a.32441
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Lee JW, 2010, BIOMATERIALS, V31, P5545, DOI 10.1016/j.biomaterials.2010.03.063
   Lee J, 2010, PHARM RES-DORDR, V27, P767, DOI 10.1007/s11095-010-0067-0
   Lee J, 2009, MACROMOL BIOSCI, V9, P671, DOI 10.1002/mabi.200800317
   Lee J, 2009, J CONTROL RELEASE, V137, P196, DOI 10.1016/j.jconrel.2009.04.008
   Lee J, 2009, PHARM RES-DORD, V26, P1739, DOI 10.1007/s11095-009-9884-4
   Lee KY, 2008, MACROMOL BIOSCI, V8, P140, DOI 10.1002/mabi.200700169
   Lee KY, 2007, PROG POLYM SCI, V32, P669, DOI 10.1016/j.progpolymsci.2007.04.001
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2004, BIOMATERIALS, V25, P2461, DOI 10.1016/j.biomaterials.2003.09.030
   Lee KY, 2003, ADV MATER, V15, P1828, DOI 10.1002/adma.200305406
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   Leonard M, 2004, J CONTROL RELEASE, V98, P395, DOI 10.1016/j.jconrel.2004.05.009
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lira AAM, 2009, J MICROENCAPSUL, V26, P243, DOI 10.1080/02652040802305105
   Liu K, 2006, LANGMUIR, V22, P9453, DOI 10.1021/la061729+
   Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x
   Lopiz-Morales Y, 2010, EUR CELLS MATER, V20, P367
   Lu MZ, 2000, BIOTECHNOL BIOENG, V70, P479, DOI 10.1002/1097-0290(20001205)70:5<479::AID-BIT1>3.0.CO;2-E
   Lucinda-Silva RM, 2010, CARBOHYD POLYM, V81, P260, DOI 10.1016/j.carbpol.2010.02.016
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]
   Maiti S, 2009, PHARM DEV TECHNOL, V14, P461, DOI 10.1080/10837450802712658
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   OTTERLEI M, 1991, J IMMUNOTHER, V10, P286, DOI 10.1097/00002371-199108000-00007
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Park H, 2009, MACROMOL BIOSCI, V9, P895, DOI 10.1002/mabi.200800376
   Pelletier S, 2001, J BIOMED MATER RES, V54, P102, DOI 10.1002/1097-4636(200101)54:1<102::AID-JBM12>3.0.CO;2-1
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Qin YM, 2008, POLYM INT, V57, P171, DOI 10.1002/pi.2296
   Queen Douglas, 2004, Int Wound J, V1, P59, DOI 10.1111/j.1742-4801.2004.0009.x
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   RINAUDO M, 1992, POLYM BULL, V27, P585, DOI 10.1007/BF00300608
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, ADV MATER, V14, P886, DOI 10.1002/1521-4095(20020618)14:12<886::AID-ADMA886>3.0.CO;2-I
   Roy D, 2010, PROG POLYM SCI, V35, P278, DOI 10.1016/j.progpolymsci.2009.10.008
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006
   Sakai S, 2002, BIOMATERIALS, V23, P4177, DOI 10.1016/S0142-9612(02)00159-X
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   SANDFORD PA, 1991, ACS SYM SER, V467, P430
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   Sculean A, 2001, J CLIN PERIODONTOL, V28, P1074, DOI 10.1034/j.1600-051X.2001.281113.x
   Selden C, 2004, TRANSPL IMMUNOL, V12, P273, DOI 10.1016/j.trim.2003.12.008
   Silva CM, 2006, EUR J PHARM SCI, V29, P148, DOI 10.1016/j.ejps.2006.06.008
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sun QH, 2010, PHARM RES-DORD, V27, P264, DOI 10.1007/s11095-009-0014-0
   Suzuki K, 2000, J BIOMED MATER RES, V49, P528, DOI 10.1002/(SICI)1097-4636(20000315)49:4<528::AID-JBM11>3.0.CO;2-1
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   TANAKA H, 1972, J POLYM SCI POL CHEM, V10, P3279, DOI 10.1002/pol.1972.170101114
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048
   Vallee F, 2009, CARBOHYD RES, V344, P223, DOI 10.1016/j.carres.2008.10.029
   Varghese S, 2006, ADV POLYM SCI, P95, DOI 10.1007/12_072
   Wang FQ, 2010, DRUG DEV IND PHARM, V36, P867, DOI 10.3109/03639040903567117
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Weir MD, 2006, J BIOMED MATER RES A, V77A, P487, DOI 10.1002/jbm.a.30626
   Wells LA, 2007, EUR J PHARM BIOPHARM, V65, P329, DOI 10.1016/j.ejpb.2006.10.018
   Weng YL, 2006, TISSUE ENG, V12, P1503, DOI 10.1089/ten.2006.12.1503
   Wiegand C, 2009, WOUND REPAIR REGEN, V17, P511, DOI 10.1111/j.1524-475X.2009.00503.x
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Yang LQ, 2007, CARBOHYD POLYM, V68, P218, DOI 10.1016/j.carbpol.2006.12.020
   Yao BL, 2010, BIOPROC BIOSYST ENG, V33, P457, DOI 10.1007/s00449-009-0349-2
   Zhang XL, 2010, INT J BIOL MACROMOL, V47, P389, DOI 10.1016/j.ijbiomac.2010.06.003
   Zhao SP, 2010, CARBOHYD RES, V345, P425, DOI 10.1016/j.carres.2009.11.014
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zhao XH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3343265
   ZIMMERMANN U, 1992, ELECTROPHORESIS, V13, P269, DOI 10.1002/elps.1150130156
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 182
TC 1471
Z9 1520
U1 171
U2 1409
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JAN
PY 2012
VL 37
IS 1
BP 106
EP 126
DI 10.1016/j.progpolymsci.2011.06.003
PG 21
WC Polymer Science
SC Polymer Science
GA 888BO
UT WOS:000299979000004
PM 22125349
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Zhao, CQ
   Yang, QH
   Chen, WY
   Teng, B
AF Zhao, Changqing
   Yang, Qinhuan
   Chen, Wuyong
   Teng, Bo
TI Removal of hexavalent chromium in tannery wastewater by Bacillus cereus
SO CANADIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Bacillus cereus; chromium; tannery wastewater
ID CR(VI) REDUCTION; LANDFILL
AB Bacillus cereus was used to remove chromium (Cr(VI)) from medium containing tannery wastewater under different conditions. The maximum rate of Cr(VI) removal was attained at a temperature of 37 degrees C, pH of 7.0-9.0, and biomass of 20 g/L when the initial Cr(VI) concentration was less than 50 mg/L. Under the optimum conditions, the Cr(VI) in tannery wastewater was treated with each cellular component of B. cereus to detect its ability to reduce Cr(VI). The results showed that the removal rate of Cr(VI) for the cell-free extracts could reach 92.70%, which was close to that of the whole cells (96.85%), indicating that the Cr(VI) reductase generated by B. cereus is primarily intracellular. Additionally, during continuous culture of the B. cereus, the strain showed good consecutive growth and removal ability. After treatment of 20 mg/L Cr(VI) for 48 h, the B. cereus was observed by SEM and TEM-EDX. SEM images showed that the B. cereus used to treat Cr(VI) grew well and had a uniform cellular size. TEM-EDX analysis revealed large quantities of chromium in the B. cereus cells used to treat Cr(VI). Overall, the results presented herein demonstrate that B. cereus can be used as a new biomaterial to remove Cr(VI) from tannery wastewater.
C1 [Zhao, Changqing] Sichuan Univ Sci & Engn, Coll Bioengn, Zigong 643000, Sichuan, Peoples R China.
   [Zhao, Changqing; Chen, Wuyong; Teng, Bo] Sichuan Univ, Natl Engn Lab Clean Technol Leather Manufacture, Chengdu 610065, Peoples R China.
   [Yang, Qinhuan] Sichuan Univ Sci & Engn, Coll Mat & Chem Engn, Zigong 643000, Peoples R China.
RP Zhao, CQ (reprint author), Sichuan Univ Sci & Engn, Coll Bioengn, 180 Xueyuan St,Huixing Rd, Zigong 643000, Sichuan, Peoples R China.
EM zhaocq2010@163.com
FU Scientific Research for Sichuan University of Science and Engineering
   [2010XJKRL003]; Chinese Ministry of Education [211161]
FX This work was financially supported by the Startup Project of Scientific
   Research for Sichuan University of Science and Engineering (Item No.
   2010XJKRL003) and the Key Project of Chinese Ministry of Education (Item
   No. 211161).
CR Desai C, 2008, BIORESOURCE TECHNOL, V99, P6059, DOI 10.1016/j.biortech.2007.12.046
   Faisal M., 2006, RES J MICROBIOL, V1, P45, DOI [DOI 10.3923/JM.2006.45.50, 10.3923/jm.2006.45.50]
   FUDE L, 1994, APPL ENVIRON MICROB, V60, P1525
   Geng Z.X., 2003, CHEM ENG, V95, P6
   International Union of Leather Technologists and Chemists Societies, 1995, J SOC LEATHER TECHNO, V79, P57
   Liu YG, 2006, PROCESS BIOCHEM, V41, P1981, DOI 10.1016/j.procbio.2006.04.020
   Pal A, 2004, MICROBIOL RES, V159, P347, DOI 10.1016/j.micres.2004.08.001
   [瞿建国 Qu Jianguo], 2005, [化工环保, Environmental Protection of Chemical Industry], V25, P1
   Ucun H, 2002, BIORESOURCE TECHNOL, V85, P155, DOI 10.1016/S0960-8524(02)00086-X
   Xu C.S, 2005, W LEATHER, P15
NR 10
TC 11
Z9 12
U1 1
U2 9
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 1200 MONTREAL ROAD, BUILDING M-55, OTTAWA, ON K1A 0R6, CANADA
SN 0008-4166
J9 CAN J MICROBIOL
JI Can. J. Microbiol.
PD JAN
PY 2012
VL 58
IS 1
BP 23
EP 28
DI 10.1139/W11-096
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology; Microbiology
GA 885PM
UT WOS:000299791300003
PM 22149215
DA 2018-10-19
ER

PT J
AU Lindgren, C
   Mordenfeld, A
   Hallman, M
AF Lindgren, Christer
   Mordenfeld, Arne
   Hallman, Mats
TI A Prospective 1-Year Clinical and Radiographic Study of Implants Placed
   after Maxillary Sinus Floor Augmentation with Synthetic Biphasic Calcium
   Phosphate or Deproteinized Bovine Bone
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE augmentation; Bio-Oss (R); bone substitutes; BoneCeramic (R); dental
   implants; sinuslift
ID SPONGIFORM ENCEPHALOPATHY; TRICALCIUM PHOSPHATE; AUTOGENOUS BONE;
   FOLLOW-UP; CERAMICS; HYDROXYAPATITE; MINIPIGS; DEFECTS; SURFACE; RISK
AB Background: The technique of using bone grafts or different biomaterials for augmentation of the maxillary sinus prior to implant placement is well accepted by clinicians. However, clinical documentation of some bone substitutes is still lacking.
   Purpose: This prospective study was designed to evaluate the success rate of implants placed after maxillary sinus augmentation with a novel synthetic biphasic calcium phosphate (BCP) or deproteinized bovine bone (DBB), the latter acting as control.
   Material and Methods: Nine edentulous patients and two partially edentulous patients with a mean age of 67 years with a bilateral need for sinus augmentation, < 5 mm residual bone in the floor of the sinus and a crestal width 34 mm, were included in the study. After bilateral elevation of the Schneiderian membrane, all patients were randomized for augmentation with synthetic BCP in one side and DBB in the contralateral side. After 8 months of graft healing, 62 implants with an SLActive surface were placed. Implant survival, graft resorption, plaque index, bleeding on probing, sulcus bleeding index, probing pocket depth, and implant success rate were evaluated after 1 year of functional loading.
   Results: After a mean of 118 days, all patients received their fixed prosthetic constructions. One implant was lost in each biomaterial, giving an overall survival rate of 96.8%. Success rates for implants placed in BCP and DBB were 91.7 and 95.7%, respectively. No significant difference in marginal bone loss was found around implants placed in BCP, DBB, or residual bone, respectively. The mean graft resorption was 0.43 mm (BCP) and 0.29 mm (DBB).
   Conclusion: In this limited study, implant success rate was not dependent on the biomaterial used for maxillary sinus augmentation. Similar results were found after 1 year of functional loading for implants placed after sinus augmentation using BCP or DBB.
C1 [Lindgren, Christer] Linkoping Univ Hosp, Dept Oral & Maxillofacial Surg, SE-58185 Linkoping, Sweden.
   [Hallman, Mats] Umea Univ, Dept Oral & Maxillofacial Surg, Umea, Sweden.
   [Hallman, Mats] Uppsala Univ Gavleborg Cty, Ctr Res & Dev, Council, Sweden.
   [Mordenfeld, Arne] Gothenburg Univ, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.
RP Lindgren, C (reprint author), Linkoping Univ Hosp, Dept Oral & Maxillofacial Surg, SE-58185 Linkoping, Sweden.
EM christer.lindgren@lio.se
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Albreksson T, 1986, J ORAL MAXILLOFAC IM, V1, P11
   Berube P, 2005, J PERIODONTOL, V76, P1697, DOI 10.1902/jop.2005.76.10.1697
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Curran JM, 2005, BIOMATERIALS, V26, P5313, DOI [10.1016/j.biomaterials.2005.01.065, 10.1016/.jbiomaterials.2005.01.065]
   D'Arc MB, 2004, ANN OTO RHINOL LARYN, V113, P711, DOI 10.1177/000348940411300907
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Ganales J, 2008, CLIN ORAL IMPLAN RES, V19, P1119
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman M, 2002, J ORAL MAXIL SURG, V60, P277, DOI 10.1053/joms.2002.30576
   Honig JF, 1999, PLAST RECONSTR SURG, V103, P1324
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jensen SS, 2009, J BIOMED MATER RES B, V90B, P171, DOI 10.1002/jbm.b.31271
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Lindgren C, 2009, INT J ORAL MAX IMPL, V24, P1093
   Lundgren Stefan, 2003, Clin Implant Dent Relat Res, V5, P78, DOI 10.1111/j.1708-8208.2003.tb00187.x
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   Moy PK, 2005, INT J ORAL MAX IMPL, V20, P569
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   Sbordone L, 2009, INT J ORAL MAX IMPL, V24, P316
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   URIST M R, 1960, Instr Course Lect, V17, P184
   von Arx T, 2001, INT J ORAL MAX IMPL, V16, P343
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   Wannfors K, 2000, INT J ORAL MAX IMPL, V15, P625
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 35
TC 28
Z9 30
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2012
VL 14
IS 1
BP 41
EP 50
DI 10.1111/j.1708-8208.2010.00224.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 880NC
UT WOS:000299412900003
PM 20491816
DA 2018-10-19
ER

PT J
AU Anitua, E
   Prado, R
   Orive, G
AF Anitua, Eduardo
   Prado, Roberto
   Orive, Gorka
TI Bilateral Sinus Elevation Evaluating Plasma Rich in Growth Factors
   Technology: A Report of Five Cases
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE fibrin; PRGF; sinus elevation
ID MAXILLARY SINUS; TECHNICAL NOTE; BONE; FLOOR; AUGMENTATION;
   ANGIOGENESIS; REPAIR; CELLS
AB Purpose: The purpose of this study was to evaluate the potential effects of plasma rich in growth factors (PRGF) technology and its autologous formulations in five consecutive patients in which bilateral sinus lift augmentation was carried out.
   Material and Methods: Five consecutive patients received bilateral sinus floor augmentation. All patients presented a residual bone height of class D (1-3 mm). The effects of PRGF combined with bovine anorganic bone ( one side) were compared with the biomaterial alone ( contralateral side). The effects of using liquid PRGF to maintain the bone window and autologous fibrin membrane to seal the defect were evaluated. A complete histological and histomorphometrical analysis was performed 5 months after surgery.
   Results: One patient was excluded from the study as the Schneiderian membrane of the control side was perforated during the surgery. In two patients, the biopsies obtained from the control sides 5 months postsurgery were not acceptable for processing. PRGF technology facilitated the surgical approach of sinus floor elevation. The control area was more inflamed than the area treated with PRGF technology. Patients referred also to an increased sensation of pain in the control area. PRGF-treated samples had more new vital bone than controls. In patient number 1, image processing revealed 21.4% new vital bone in the PRGF area versus 8.4% in the control area, whereas in patient number 2, 28.4% new vital bone was quantified in the PRGF area compared with the 8.2% of the control side. The immunohistochemical processing of the biopsies revealed that the number of blood vessels per square millimeter of connective tissue was 116 vessels in the PRGF sample versus 7 in the control biopsy.
   Conclusions: These preliminary results suggest that from a practical point of view, PRGF may present a role in reducing tissue inflammation after surgery, increasing new bone formation and promoting the vascularization of bone tissue.
C1 [Anitua, Eduardo; Prado, Roberto; Orive, Gorka] Inst Eduardo Anitua, Inst Biotechnol, Vitoria 01007, Spain.
RP Anitua, E (reprint author), Inst Eduardo Anitua, Inst Biotechnol, C Jose Maria Cajigal 19, Vitoria 01007, Spain.
EM eduardoanitua@eduardoanitua.com
RI Prado, Roberto/R-5452-2016; Anitua, Eduardo/O-1154-2018
OI Prado, Roberto/0000-0003-4767-7206; Anitua, Eduardo/0000-0002-8386-5303
FU Basque government; Spanish government; BTI (Vitoria, Spain)
FX The work of this group is partially funded by the Basque and Spanish
   governments.; The funding for the present paper proceeds from the BTI
   (Vitoria, Spain). Authors of the manuscript are researchers with the
   company.
CR Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Anitua E, 2009, CLIN IMPLAN IN PRESS
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Anitua E, 2007, INT J ORAL MAX IMPL, V22, P138
   Bauer FJM, 2004, THESIS U MUNICH MUNI
   Becker ST, 2008, CLIN ORAL IMPLAN RES, V19, P1285, DOI 10.1111/j.1600-0501.2008.01612.x
   Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Consolo U, 2007, CLIN ORAL IMPLAN RES, V18, P252, DOI 10.1111/j.1600-0501.2006.01330.x
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   GRAVES DT, 1989, CONNECT TISSUE RES, V23, P209, DOI 10.3109/03008208909002419
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Khoury F, 1999, INT J ORAL MAX IMPL, V14, P557
   Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067
   Schaaf H, 2008, ORAL SURG ORAL MED O, V106, P673, DOI 10.1016/j.tripleo.2008.04.004
   Schnabel LV, 2007, J ORTHOP RES, V25, P230, DOI 10.1002/jor.20278
   Tatum H., 1986, DENT CLIN N AM, V30, P1207
   Torrella F, 1998, INT J ORAL MAX IMPL, V13, P697
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P487, DOI 10.1034/j.1600-0501.2000.011005487.x
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Woodall James Jr, 2008, Biomed Sci Instrum, V44, P489
NR 26
TC 33
Z9 33
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2012
VL 14
IS 1
BP 51
EP 60
DI 10.1111/j.1708-8208.2009.00233.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 880NC
UT WOS:000299412900004
PM 20626759
DA 2018-10-19
ER

PT J
AU Feyerabend, F
   Drucker, H
   Laipple, D
   Vogt, C
   Stekker, M
   Hort, N
   Willumeit, R
AF Feyerabend, Frank
   Druecker, Heiko
   Laipple, Daniel
   Vogt, Carla
   Stekker, Michael
   Hort, Norbert
   Willumeit, Regine
TI Ion release from magnesium materials in physiological solutions under
   different oxygen tensions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 24th Conference of the European-Society-for-Biomaterials (ESB)
CY SEP 04-08, 2011
CL Network Excellence Funct Biomat (NFB), Dublin, IRELAND
SP European Soc Biomat (ESB), Nanotechnol & Integrated Bioengn Ctr (NIBEC)
HO Network Excellence Funct Biomat (NFB)
ID SIMULATED BODY-FLUIDS; RARE-EARTH ALLOY; CORONARY-ARTERIES; IN-VITRO;
   CORROSION; DEGRADATION; STENTS; CELLS
AB Although magnesium as degradable biomaterial already showed clinical proof of concepts, the design of new alloys requires predictive in vitro methods, which are still lacking. Incubation under cell culture conditions to obtain "physiological" corrosion may be a solution. The aim of this study was to analyse the influence of different solutions, addition of proteins and of oxygen availability on the corrosion of different magnesium materials (pure Mg, WE43, and E11) with different surface finishing. Oxygen content in solution, pH, osmolality and ion release were determined. Corrosion led to a reduction of oxygen in solution. The influence of oxygen on pH was enhanced by proteins, while osmolality was not influenced. Magnesium ion release was solution-dependent and enhanced in the initial phase by proteins with delayed release of alloying elements. The main corrosion product formed was magnesium carbonate. Therefore, cell culture conditions are proposed as first step toward physiological corrosion.
C1 [Feyerabend, Frank; Willumeit, Regine] Helmholtz Zentrum Geesthacht, Inst Mat Res, Dept Macromol Struct Res, D-21502 Geesthacht, Germany.
   [Druecker, Heiko; Vogt, Carla] Leibniz Univ Hannover, Inst Inorgan Chem, D-30167 Hannover, Germany.
   [Stekker, Michael] MeKo, D-31157 Sarstedt Hannover, Germany.
RP Feyerabend, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Dept Macromol Struct Res, Max Planck Str 1, D-21502 Geesthacht, Germany.
EM frank.feyerabend@hzg.de
RI Hort, Norbert/G-1913-2011; Willumeit, Regine/I-8029-2013; Feyerabend,
   Frank/A-1124-2010
OI Hort, Norbert/0000-0002-6636-1568; Willumeit,
   Regine/0000-0002-6004-6946; Feyerabend, Frank/0000-0001-9532-0207
CR BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0
   Cundari TR, 2009, J CHEM INF MODEL, V49, P2111, DOI 10.1021/ci9002377
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235
   ELLISON G, 1958, CLIN CHEM, V4, P452
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Jonsson M, 2007, CORROS SCI, V49, P1540, DOI 10.1016/j.corsci.2006.08.004
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kloprogge JT, 2003, J MATER SCI LETT, V22, P825, DOI 10.1023/A:1023916326626
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Mueller W.D., 2007, MAT RES, V10, P5
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rettig R, 2009, J BIOMED MATER RES A, V88A, P359, DOI 10.1002/jbm.a.31887
   Tie D, 2010, ADV ENG MATER, V12, pB699, DOI 10.1002/adem.201080070
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
NR 29
TC 26
Z9 27
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2012
VL 23
IS 1
BP 9
EP 24
DI 10.1007/s10856-011-4490-5
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 884QW
UT WOS:000299724300003
PM 22138756
DA 2018-10-19
ER

PT J
AU Xu, F
   Wang, Y
   Jiang, X
   Tan, H
   Li, H
   Wang, KJ
AF Xu, Feng
   Wang, Yan
   Jiang, Xia
   Tan, Hong
   Li, Hong
   Wang, Kun-Jie
TI Effects of different biomaterials: Comparing the bladder smooth muscle
   cells on waterborne polyurethane or poly-lactic-co-glycolic acid
   membranes
SO KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Biodegradation; Bladder smooth muscle cells; Poly-e-caprolactone;
   Waterborne polyurethane
ID CHAIN EXTENDER; ALPHA-ACTIN; AUGMENTATION; MATRIX;
   POLY(EPSILON-CAPROLACTONE); BIOCOMPATIBILITY; DEGRADATION; ELASTOMERS;
   INDUCTION; STABILITY
AB Tissue engineering materials have often been used to repair bladder damage caused by conditions, such as infection, resection, inflammation, and trauma. However, the concept of generating a functional urinary bladder using autologous cells obtained from a biopsy specimen combined with a biomaterial scaffold remains a challenge. Previously, we presented a new method for synthesizing a biocompatible, mechanically sound, nontoxic, and cross-linked waterborne polyurethane (WBPU) as a potential material for bladder regeneration. Here, we further evaluated the response of bladder smooth muscle cells (BSMCs) seeded on WBPU membranes in comparison with the gold standard biomaterial, poly-lactic-co-glycolic acid. Specifically, we observed the BSMC: attachment, proliferation, and a alpha-actin distribution at 1 day, 3 days, and 5 days after membrane seeding. We found that significantly more cells attached and proliferated on the WBPU membranes after 3 days and 5 days of culture, and the cells exhibited greater organization and a wider distribution of a-actin compared with BSMCs cultured on poly-lactic-co-glycolic acid membranes. These preliminary data offer promise for the use of WBPU biomaterials in bladder tissue engineering. Copyright (C) 2011, Elsevier Taiwan LLC. All rights reserved.
C1 [Xu, Feng; Wang, Yan; Li, Hong; Wang, Kun-Jie] Sichuan Univ, Huaxi Clin Coll, W China Hosp, Dept Urol, Chengdu 610040, Sichuan, Peoples R China.
   [Jiang, Xia; Tan, Hong] Sichuan Univ, Coll Polymer Sci & Engn, State Key Lab Polymer Mat Engn, Chengdu 610040, Sichuan, Peoples R China.
RP Wang, KJ (reprint author), Sichuan Univ, Huaxi Clin Coll, W China Hosp, Dept Urol, Chengdu 610040, Sichuan, Peoples R China.
EM wangkunjie6602@163.com
FU National Natural Science Foundation of China [30872593]
FX The authors thank the National Natural Science Foundation of China
   (30872593) for supporting this work.
CR Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   *AM CANC SOC INC, 2004, CANC FACTS FIG
   Atala Anthony, 2002, Semin Pediatr Surg, V11, P134, DOI 10.1053/spsu.2002.31812
   Bouhout S, 2010, TISSUE ENG PT A, V16, P1539, DOI [10.1089/ten.tea.2009.0473, 10.1089/ten.TEA.2009.0473]
   Domingos ALA, 2009, INT BRAZ J UROL, V35, P217, DOI 10.1590/S1677-55382009000200012
   Drumm MR, 2010, UROLOGY, V75, P879, DOI 10.1016/j.urology.2009.08.050
   Falke G, 2000, WORLD J UROL, V18, P36, DOI 10.1007/s003450050007
   Frederiksen H, 2008, SCAND J UROL NEPHROL, V42, P205, DOI 10.1080/00365590701871641
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   Garat C, 2000, J BIOL CHEM, V275, P22537, DOI 10.1074/jbc.M003000200
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hsu SH, 2010, BIOMATERIALS, V31, P6796, DOI 10.1016/j.biomaterials.2010.05.015
   Jiang X, 2007, EUR POLYM J, V43, P1838, DOI 10.1016/j.eurpolymj.2007.02.029
   Kim BS, 2005, J APPL POLYM SCI, V97, P1961, DOI 10.1002/app.21984
   Lee SK, 2009, J COLLOID INTERF SCI, V336, P208, DOI 10.1016/j.jcis.2009.03.028
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Marcos-Fernandez A, 2006, POLYMER, V47, P785, DOI 10.1016/j.polymer.2005.12.007
   Miller Derick C, 2002, IEEE Trans Nanobioscience, V1, P61, DOI 10.1109/TNB.2002.806917
   Ram-Liebig G, 2006, WORLD J UROL, V24, P429, DOI 10.1007/s00345-006-0104-0
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Tock J, 2003, BIOCHEM BIOPH RES CO, V301, P1116, DOI 10.1016/S0006-291X(03)00087-1
   Walker BR, 2002, J UROLOGY, V168, P1534, DOI 10.1097/01.ju.0000028578.20822.a9
   Yang JE, 2002, J APPL POLYM SCI, V86, P2375, DOI 10.1002/app.11249
   Yeganeh H, 2005, J POLYM SCI POL CHEM, V43, P2985, DOI 10.1002/pola.20789
   Zani Danilo, 2009, Arch Ital Urol Androl, V81, P17
   Zhang SB, 2006, J APPL POLYM SCI, V101, P597, DOI 10.1002/app.23354
NR 29
TC 4
Z9 4
U1 0
U2 23
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1607-551X
J9 KAOHSIUNG J MED SCI
JI Kaohsiung J. Med. Sci.
PD JAN
PY 2012
VL 28
IS 1
BP 10
EP 15
DI 10.1016/j.kjms.2011.06.031
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 884NK
UT WOS:000299714600002
PM 22226056
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Itoh, H
   Sano, S
   Pouard, P
AF Itoh, H.
   Sano, S.
   Pouard, P.
TI Pediatric perfusion in Japan: 2010 practice survey
SO PERFUSION-UK
LA English
DT Article
DE perfusion; cardiopulmonary bypass; survey; pediatric; congenital heart
   surgery
ID HYPOTHERMIC CARDIOPULMONARY BYPASS; INFANT HEART-SURGERY; CIRCULATORY
   ARREST; RANDOMIZED-TRIAL; OXYGENATOR; HEMATOCRIT
AB We report here Japan's first pediatric perfusion survey. It covers practices from January 2007 through December 2009. Of the 70 congenital heart centers contacted, 53 (76%) completed the survey. They reported performing 3,379 pediatric cardiopulmonary bypass (CPB) procedures in 2009, 3,408 in 2008, and 3,358 in 2007. Twenty-eight percent of all centers used CPB circuits with a priming volume between 151-200 ml. All centers used pre-bypass ultrafiltration and only 6% used retrograde autologous priming. A biomaterial-coated circuit was used by 78% of the centers, a roller pump as the arterial pump by 91%, vacuum-assisted venous drainage by 39%, dilutional ultrafiltration by 48%, and modified ultrafiltration at the end of the procedure by 30%. A regional oxygen saturation monitor was used by 69% of the centers and high flow (150-200 ml/kg/min) management with alpha-stat blood gas control was standard during moderate to normothermic CPBs. Crystalloid cardioplegia solution was used as myocardial protection by 56% of the centers, electronic recording of monitoring data by 51%. The centers performed 98 pediatric extracorporeal membrane oxygenation procedures in 2007, 109 in 2008, and 119 in 2009; 58% of the centers used a centrifugal pump. This survey provides a description of the current practice in Japan. Future surveys will identify trends and rate of change in practice.
C1 [Itoh, H.; Sano, S.] Okayama Univ Hosp, Dept Cardiovasc Surg, Okayama 7008558, Japan.
   [Pouard, P.] Hosp Necker Enfants Malades, Dept Anesthesiol & Pediat Cardiac Surg, Paris, France.
RP Itoh, H (reprint author), Okayama Univ Hosp, Dept Cardiovasc Surg, 2-5-1 Shikata, Okayama 7008558, Japan.
EM grape@md.okayama-u.ac.jp
CR Baker Robert A, 2006, J Extra Corpor Technol, V38, P220
   Cecere G, 2002, PERFUSION-UK, V17, P83, DOI 10.1191/0264659102pf542oa
   Charriere Jean-Mathias, 2007, J Extra Corpor Technol, V39, P142
   Dickey J, 2008, CARDIOPULMONARY BYPA, P572
   Elliott M, 1993, PERFUSION, V8, P1
   GIBBON J H Jr, 1954, Minn Med, V37, P171
   GOTT VL, 1957, DIS CHEST, V32, P615, DOI 10.1378/chest.32.6.615
   Groom Robert C, 2005, J Extra Corpor Technol, V37, P343
   Groom Robert C., 1995, Perfusion, V10, P393, DOI 10.1177/026765919501000603
   Hill Aaron G., 1993, Perfusion, V8, P27, DOI 10.1177/026765919300800104
   Jacobs JP, 2008, CARDIOL YOUNG, V18, P1, DOI 10.1017/S104795110800334X
   JONAS RA, 1993, J THORAC CARDIOV SUR, V106, P362
   Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003
   Kazui T, 2006, GEN THORAC CARDIOVAS, V54, P363, DOI 10.1007/s11748-006-0008-x
   Kirklin JW, 1956, ANN SURG, P2
   Kirshbom PM, 1996, J THORAC CARDIOV SUR, V111, P147, DOI 10.1016/S0022-5223(96)70411-7
   LILLEHEI CW, 1956, DIS CHEST, V29, P1
   Newburger JW, 2008, J THORAC CARDIOV SUR, V135, P347, DOI 10.1016/j.jtcvs.2007.01.051
   Shann Kenneth G, 2010, J Extra Corpor Technol, V42, P177
   Tuble Sigrid C, 2009, J Extra Corpor Technol, V41, P64
   Wang S, 2008, JECT, V39, P249
   Wypij D, 2008, J THORAC CARDIOV SUR, V135, P355, DOI 10.1016/j.jtcvs.2007.03.067
NR 22
TC 4
Z9 4
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PD JAN
PY 2012
VL 27
IS 1
BP 72
EP 77
DI 10.1177/0267659111424638
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 882JB
UT WOS:000299558700016
PM 22005885
DA 2018-10-19
ER

PT J
AU Virkutyte, J
   Varma, RS
AF Virkutyte, Jurate
   Varma, Rajender S.
TI Visible light activity of Ag-loaded and guanidine nitrate-doped
   nano-TiO2: degradation of dichlorophenol and antibacterial properties
SO RSC ADVANCES
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; TITANIUM-DIOXIDE NANOMATERIALS;
   ENHANCED THERMAL-STABILITY; PHOTOCATALYTIC ACTIVITY; ORGANIC POLLUTANTS;
   BIOMATERIAL SYSTEM; VIBRIO-FISCHERI; ANATASE TIO2; NITROGEN; SILVER
AB To utilize visible light, Ag loaded and C, N-doped nano-TiO2 was prepared using a "one pot'' synthesis utilizing mild reaction conditions and benign precursors. The synthesis was optimized using appropriate experiment design that took the silver content and calcination temperature into account. The optimized nanocatalyst was characterized by XRD, BET, TEM, TGA, XPS as well as UV-DRS. Nanocatalysts were predominantly anatase as confirmed by XRD, thermally stable up to 1100 degrees C, as revealed by TGA studies and exhibited absorption in the visible light region as verified by UV-DRS analysis. Moreover, XPS results proved that Ag was dispersed on the surface of the TiO2 nanoparticles and nitrogen, as well as carbon from guanidine nitrate was interlaced into the matrix of TiO2. Co-doping of TiO2 suppressed charge recombination and improved the visible light photoactivity up to the complete degradation of dichlorophenol (DCP) in 4 h of the reaction. Degradation followed first order reaction kinetics with k(app) ranging from 1.1 to as high as 15.1 x 10(-3) min(-1) depending on the silver content and calcination temperature. Demineralization of the solution in terms of TOC was up to 92%. A complete elimination of Vibrio fischeri was accomplished with 1 mg L-1 of the nanocatalyst regardless of the Ag content.
C1 [Virkutyte, Jurate] Pegasus Tech Serv Inc, Cincinnati, OH 45221 USA.
   [Varma, Rajender S.] US EPA, Sustainable Technol Div, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA.
RP Virkutyte, J (reprint author), Pegasus Tech Serv Inc, 46 E Hollister St, Cincinnati, OH 45221 USA.
EM virkutyte.jurate@epa.gov; varma.rajender@epa.gov
RI Dom, Rekha/B-7113-2012
FU National Risk Management Research Laboratory of U.S. Environmental
   Protection Agency (EPA), Cincinnati, Ohio
FX This research was performed at the National Risk Management Research
   Laboratory of U.S. Environmental Protection Agency (EPA), Cincinnati,
   Ohio, while J.V. held a National Research Council Research Associateship
   Award. This paper has not been subjected to internal policy review of
   the U.S. EPA. Therefore, the research results do not necessarily reflect
   the views of the agency or its policy. Mention of trade names and
   commercial products does not constitute endorsement or recommendation
   for use.
CR Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   Bala T, 2011, J COLLOID INTERF SCI, V356, P395, DOI 10.1016/j.jcis.2011.01.044
   Braconnier B, 2009, MICROPOR MESOPOR MAT, V122, P247, DOI 10.1016/j.micromeso.2009.03.007
   Cai C, 2008, CATAL LETT, V123, P51, DOI 10.1007/s10562-007-9392-2
   Chao HE, 2003, J EUR CERAM SOC, V23, P1457, DOI 10.1016/S0955-2219(02)00356-4
   Chen QF, 2011, MATER CHEM PHYS, V125, P825, DOI 10.1016/j.matchemphys.2010.09.049
   Chen XB, 2005, ADV FUNCT MATER, V15, P41, DOI 10.1002/adfm.200400184
   Chen XB, 2004, J PHYS CHEM B, V108, P15446, DOI 10.1021/jp0469160
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Gombac V, 2007, CHEM PHYS, V339, P111, DOI 10.1016/j.chemphys.2007.05.024
   He JH, 2002, LANGMUIR, V18, P10005, DOI 10.1021/la0260584
   Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047
   Kim DJ, 2002, MATER LETT, V57, P355, DOI 10.1016/S0167-577X(02)00790-5
   Ko S, 2011, COMPOS PART B-ENG, V42, P579, DOI 10.1016/j.compositesb.2010.09.007
   Kowalska E, 2009, CHEM COMMUN, P241, DOI 10.1039/b815679d
   Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025
   Lappalainen J, 2001, CHEMOSPHERE, V45, P635, DOI 10.1016/S0045-6535(00)00579-8
   Li D, 2005, MAT SCI ENG B-SOLID, V117, P67, DOI 10.1016/j.mseb.2004.10.018
   Liu B, 2008, CHEM MATER, V20, P2711, DOI 10.1021/cm800040k
   Liu SH, 2009, ELECTROCHEM COMMUN, V11, P1748, DOI 10.1016/j.elecom.2009.07.007
   Nadagouda MN, 2010, GREEN CHEM, V12, P114, DOI 10.1039/b921203p
   Nolan NT, 2010, J PHYS CHEM C, V114, P13026, DOI 10.1021/jp1016054
   Popa M, 2010, MICROPOR MESOPOR MAT, V132, P80, DOI 10.1016/j.micromeso.2009.12.024
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465
   Sahoo C, 2005, DESALINATION, V181, P91, DOI 10.1016/j.desal.2005.02.014
   Sano T, 2000, J CATAL, V194, P71, DOI 10.1006/jcat.2000.2915
   Sathish M, 2007, APPL CATAL B-ENVIRON, V74, P307, DOI 10.1016/j.apcatb.2007.03.003
   SCLAFANI A, 1991, J PHOTOCH PHOTOBIO A, V59, P181, DOI 10.1016/1010-6030(91)87006-H
   Seery MK, 2007, J PHOTOCH PHOTOBIO A, V189, P258, DOI 10.1016/j.jphotochem.2007.02.010
   Senthilnathan J, 2010, CHEM ENG J, V161, P83, DOI 10.1016/j.cej.2010.04.034
   Sobana N, 2006, J MOL CATAL A-CHEM, V258, P124, DOI 10.1016/j.molcata.2006.05.013
   Su W, 2009, J HAZARD MATER, V172, P716, DOI 10.1016/j.jhazmat.2009.07.056
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Virkutyte J, 2010, NANOSCALE, V2, P1109, DOI 10.1039/c0nr00089b
   Virkutyte J, 2010, NEW J CHEM, V34, P1094, DOI 10.1039/c0nj00268b
   Xiong ZG, 2011, WATER RES, V45, P2095, DOI 10.1016/j.watres.2010.12.019
   Yuan YL, 2010, J NANOSCI NANOTECHNO, V10, P4868, DOI 10.1166/jnn.2010.2225
   Zhang QJ, 2010, ENVIRON SCI TECHNOL, V44, P8270, DOI 10.1021/es1019383
   Zhao JC, 2005, TOP CATAL, V35, P269, DOI 10.1007/s11244-005-3834-0
   Zhou JK, 2006, IND ENG CHEM RES, V45, P3503, DOI 10.1021/ie051098z
   Zielinska A, 2010, SEP PURIF TECHNOL, V72, P309, DOI 10.1016/j.seppur.2010.03.002
NR 43
TC 31
Z9 31
U1 2
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2012
VL 2
IS 4
BP 1533
EP 1539
DI 10.1039/c1ra00990g
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 884HK
UT WOS:000299695300043
DA 2018-10-19
ER

PT J
AU Elersic, K
   Pavlic, JI
   Iglic, A
   Vesel, A
   Mozetic, M
AF Elersic, Kristina
   Pavlic, Janez I.
   Iglic, Ales
   Vesel, Alenka
   Mozetic, Miran
TI Electric-field controlled liposome formation with embedded
   superparamagnetic iron oxide nanoparticles
SO CHEMISTRY AND PHYSICS OF LIPIDS
LA English
DT Article
DE Nanoparticles; Giant liposomes; Encapsulation; Electroformation
ID MAGNETOLIPOSOMES
AB Liposomes are one of the most promising biomaterial carriers to deliver DNA,(1) proteins, drugs and medicine in human bodies. However, artificially formed liposomes have to satisfy some crucial functions such as: (i) to efficiently carry drugs to targeted systems, (ii) to be biologically stable until they are removed from human body, (iii) to be biodegradable, and (iv) to be sufficiently small in size for effective drug delivery. Here, we report an efficient and novel method to simultaneously manufacture and incorporate super-paramagnetic iron-oxide nanoparticles (efficient target finder in the presence of external magnetic field) into the liposome's interior and its bilayer. In this technique, we use electric field to control the formation of liposomes and the incorporation of iron oxide nanoparticles. Our preparation procedure does not require any chemical or ultrasound treatments. Apart from that, we also provide further experimental investigations on the role of electric fields on the formation of liposomes using XPS2 and the magnetic-optical microscope. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Elersic, Kristina; Pavlic, Janez I.; Vesel, Alenka; Mozetic, Miran] Jozef Stefan Inst, Ljubljana 1000, Slovenia.
   [Iglic, Ales] Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia.
RP Pavlic, JI (reprint author), Jozef Stefan Inst, Jamova 39, Ljubljana 1000, Slovenia.
EM janez.pavlic@fe.uni-lj.si
RI Vesel, Alenka/I-3934-2014; Mozetic, Miran/K-8784-2014
OI Vesel, Alenka/0000-0003-3782-6001; 
FU Ministry of Higher Education, Science and Technology of the Republic of
   Slovenia [L2-2047]
FX The research was supported by Ministry of Higher Education, Science and
   Technology of the Republic of Slovenia (project L2-2047, Synthesis and
   functionalization of composite nanobeads for early diagnosis of
   neurodegenerative diseases).
CR ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Dauphas S, 2009, THIN SOLID FILMS, V517, P6016, DOI 10.1016/j.tsf.2009.05.014
   De Cuyper M, 2001, J MAGN MAGN MATER, V225, P89, DOI 10.1016/S0304-8853(00)01234-8
   DECUYPER M, 1988, EUR BIOPHYS J BIOPHY, V15, P311, DOI 10.1007/BF00256482
   DIMITROV DS, 1988, BIOELECTROCH BIOENER, V19, P323, DOI 10.1016/0302-4598(88)80013-8
   Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w
   Fortin-Ripoche JP, 2006, RADIOLOGY, V239, P415, DOI 10.1148/radiol.2392042110
   Giri J, 2005, J MAGN MAGN MATER, V293, P62, DOI 10.1016/j.jmmm.2005.01.044
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   HUELSHEGER H, 1983, Radiation and Environmental Biophysics, V22, P149
   Ismailova K. G., 2005, PHARM CHEM J, V39, P385
   Kaittanis C, 2007, NANO LETT, V7, P380, DOI 10.1021/nl062553z
   Lapinski MM, 2007, LANGMUIR, V23, P11677, DOI 10.1021/la7020963
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Sabate R, 2008, INT J PHARM, V347, P156, DOI 10.1016/j.ijpharm.2007.06.047
   Sangregorio C, 1999, J APPL PHYS, V85, P5699, DOI 10.1063/1.370256
   Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X
   Slomkowski S, 1998, PROG POLYM SCI, V23, P815, DOI 10.1016/S0079-6700(97)00053-1
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Velzenberger E, 2008, LANGMUIR, V24, P11734, DOI 10.1021/la801727p
   Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9
   Zhang LF, 2006, NANO LETT, V6, P694, DOI 10.1021/nl052455y
NR 24
TC 9
Z9 9
U1 2
U2 42
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-3084
EI 1873-2941
J9 CHEM PHYS LIPIDS
JI Chem. Phys. Lipids
PD JAN
PY 2012
VL 165
IS 1
BP 120
EP 124
DI 10.1016/j.chemphyslip.2011.11.006
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 882QW
UT WOS:000299580000013
PM 22133728
DA 2018-10-19
ER

PT J
AU Sanchez, O
   Rodriguez-Sureda, V
   Dominguez, C
   Fernandez-Figueras, T
   Vilches, A
   Llurba, E
   Alijotas-Reig, J
AF Sanchez, Olga
   Rodriguez-Sureda, Victor
   Dominguez, Carmen
   Fernandez-Figueras, Teresa
   Vilches, Angel
   Llurba, Elisa
   Alijotas-Reig, Jaume
TI Study of biomaterial-induced macrophage activation, cell-mediated immune
   response and molecular oxidative damage in patients with dermal
   bioimplants
SO IMMUNOBIOLOGY
LA English
DT Article
DE Bioimplants; Chitotriosidase; Dermal fillers; Innate immunity;
   Myeloperoxidase; Oxidative stress; YKL-40
ID HYALURONIC-ACID; PROTEIN PRODUCTS; LIPID-PEROXIDATION;
   ADVERSE-REACTIONS; FILLERS; MYELOPEROXIDASE; DISEASE; CHITOTRIOSIDASE;
   ATHEROSCLEROSIS; INFLAMMATION
AB Several soft-tissue dermal fillers have been reported to provoke immunogenicity and may cause adverse reactions despite claims regarding their safety. This study aimed to assess biomaterial-induced macrophage activation, cell-mediated immune response and oxidative stress in 169 patients with dermal bioimplants. To this end, we analysed plasma concentrations of myeloperoxidase (MPO), the chitinase-like proteins chitotriosidase and YKL-40 and molecular oxidative damage. The present study shows, for the first time, that the components of innate immunity: chitotriosidase and YKL-40, are significantly higher in patients with certain bioimplants and these markers of monocyte/macrophage activation rose progressively as adverse reactions (AR) evolved. Plasma MPO levels increased 4-fold in filler users with AR and 3-fold in those without. Analysis by filler type showed subjects injected with calcium hydroxylapatite, methacrylate, acrylamides and silicone to have values significantly above those of non-filler subjects for at least two plasma biomarkers, probably because the afore-mentioned biomaterials are permanent and prone to trigger AR in the long term. By contrast, hyaluronic acid alone elicited little immune response. Plasma concentrations of markers of oxidative damage to lipids and proteins were found to be significantly higher in users of four of the nine dermal fillers studied. These diffusible products of molecular peroxidation would stem from the reaction catalysed by MPO that generates potent oxidants, leading to cell oxidative damage which, in turn, may exert deleterious effects on the organism. Overall, the results of this study on the effects of a range of dermal fillers point to chronic activation of the immune response mediated by macrophages and PMNs. The increases in plasma of MPO, chitotriosidase and YKL-40 proteins and products of macromolecular peroxidation suggests that these molecules could serve as blood-based biochemical markers and alert to the risk of chronic immune system activation and development of adverse events that may arise from the use of certain bioimplants. (C) 2011 Elsevier GmbH. All rights reserved.
C1 [Sanchez, Olga; Rodriguez-Sureda, Victor; Dominguez, Carmen; Vilches, Angel; Llurba, Elisa; Alijotas-Reig, Jaume] Vall Hebron Univ Hosp, Biochem & Mol Biol Res Ctr Nanomed, Barcelona, Spain.
   [Rodriguez-Sureda, Victor; Dominguez, Carmen; Llurba, Elisa] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Barcelona, Spain.
   [Fernandez-Figueras, Teresa] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Barcelona, Spain.
   [Alijotas-Reig, Jaume] Univ Autonoma Barcelona, Syst Autoimmune Dis Unit, Dept Med, Vall Hebron Univ Hosp, Barcelona, Spain.
   [Sanchez, Olga; Llurba, Elisa] Inst Salud Carlos III, Maternal & Child Hlth & Dev Network SAMID, Barcelona, Spain.
RP Dominguez, C (reprint author), Hosp Maternoinfantil Vall dHebron, Ctr Invest Bioquim & B Mol Nanomed, Pl 14, Barcelona 08035, Spain.
EM mcdominguez@vhebron.net
RI Alijotas-Reig, Jaume/H-9262-2016
OI Alijotas-Reig, Jaume/0000-0002-9212-3619; Llurba Olive,
   Elisa/0000-0003-4048-6407
FU FIS [04/0574, 05/0870]; Maternal and Child Health and development
   Network (SAMID); FIS of the Carlos III Institute of Health, Spain
FX This work was supported by grants from FIS (04/0574, 05/0870) and Dr. O.
   Sanchez salary is supported by Maternal and Child Health and development
   Network (SAMID), financed by FIS of the Carlos III Institute of Health,
   Spain.
CR Alcalay J, 2003, DERMATOL SURG, V29, P859, DOI 10.1046/j.1524-4725.2003.29233.x
   Alijotas-Reig J, 2008, J EUR ACAD DERMATOL, V22, P150, DOI 10.1111/j.1468-3083.2007.02354.x
   Alijotas-Reig J, 2010, DERMATOLOGY, V221, P356, DOI 10.1159/000321329
   Alijotas-Reig J, 2010, J BIOMED MATER RES A, V95A, P180, DOI 10.1002/jbm.a.32794
   Andre P, 2005, J Cosmet Laser Ther, V7, P171, DOI 10.1080/14764170500344393
   Bachmann F., 2010, J EUR ACAD DERMATOL, DOI [10.1111/j.14683083.2010.03878.x, DOI 10.1111/J.14683083.2010.03878.X]
   Baskol G, 2006, CELL BIOCHEM FUNCT, V24, P307, DOI 10.1027/cbf.1257
   BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252
   Bussink AP, 2006, INT REV CYTOL, V252, P71, DOI 10.1016/S0074-7696(06)52001-7
   Chang LT, 2009, CIRC J, V73, P726, DOI 10.1253/circj.CJ-08-0577
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Clark CP, 2007, PLAST RECONSTR SURG, V120, p27S, DOI 10.1097/01.prs.0000248806.70402.7b
   Comabella M, 2009, CLIN IMMUNOL, V131, P216, DOI 10.1016/j.clim.2008.12.004
   De Boulle Koenraad, 2004, J Cosmet Dermatol, V3, P2, DOI 10.1111/j.1473-2130.2004.00058.x
   de Bree Remco, 2004, Arch Facial Plast Surg, V6, P204, DOI 10.1001/archfaci.6.3.204
   Dhiman M, 2009, CLIN VACCINE IMMUNOL, V16, P660, DOI 10.1128/CVI.00019-09
   Duffy DM, 2005, DERMATOL SURG, V31, P1626, DOI 10.2310/6350.2005.31251
   Edwards PC, 2007, CLIN INTERV AGING, V2, P509, DOI 10.2147/CIA.S382
   Engelman Dendy E, 2005, J Cosmet Laser Ther, V7, P29, DOI 10.1080/147641700510037716
   Gladstone HB, 2007, SEMIN CUTAN MED SURG, V26, P34, DOI 10.1016/j.sder.2006.12.008
   Glasgold Mark, 2007, Facial Plast Surg Clin North Am, V15, P461, DOI 10.1016/j.fsc.2007.07.002
   Golberg DJ, 2006, FILLERS COSMETIC DER, P81
   Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009
   HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084
   Johansen JS, 2006, DAN MED BULL, V53, P172
   Kaneda H, 2002, ATHEROSCLEROSIS, V162, P221, DOI 10.1016/S0021-9150(01)00706-7
   Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697
   Krzystek-Korpacka M, 2008, INFLAMM BOWEL DIS, V14, P794, DOI 10.1002/ibd.20383
   Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128
   Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023
   Lemperle G, 2009, PLAST RECONSTR SURG, V123, P1842, DOI 10.1097/PRS.0b013e31818236d7
   Lowe NJ, 2005, DERMATOL SURG, V31, P1616
   Margaritopoulos GA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-20
   Martin-Gallan P, 2007, J CELL MOL MED, V11, P1352, DOI 10.1111/j.1582-4934.2007.00068.x
   Matarasso S.L., 2007, PLAST RECONSTR SUR S, V120, P17
   Miro-Mur F, 2009, J BIOMED MATER RES B, V90B, P510, DOI 10.1002/jbm.b.31312
   Ogden A., 2008, BRIT J DERMATOL, V159, P1036
   Piacquadio D, 2008, DERMATOL SURG, V34, pS48, DOI 10.1111/j.1524-4725.2008.34242.x
   Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y
   Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61
   Rossner M, 2009, DERMATOL SURG, V35, P367, DOI 10.1111/j.1524-4725.2008.01062.x
   Sanchez-Carpintero I, 2010, ACTAS DERMO-SIFILOGR, V101, P381, DOI 10.1016/j.ad.2010.01.004
   SHIMASAKI H, 1994, METHOD ENZYMOL, V233, P338
   Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328
   Vleggaar Danny, 2004, J Drugs Dermatol, V3, P542
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
NR 48
TC 17
Z9 18
U1 1
U2 17
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD JAN
PY 2012
VL 217
IS 1
BP 44
EP 53
DI 10.1016/j.imbio.2011.08.003
PG 10
WC Immunology
SC Immunology
GA 880YB
UT WOS:000299445400007
PM 21903293
DA 2018-10-19
ER

PT J
AU Kocakulak, M
   Kocum, IC
   Ayhan, H
AF Kocakulak, Mustafa
   Kocum, I. Cengiz
   Ayhan, Hakan
TI Investigation of inflammatory response at blood-poly (2-methoxyethyl
   acrylate) (PMEA) interface in vivo via scanning tunneling microscope
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE inflammatory response; oxygenator fibers; extracorporeal circuits;
   immunoglobulin adsorption; STM imaging; leukocyte count;
   poly(2-methoxyethyl acrylate) (PMEA)
ID PEDIATRIC CARDIOPULMONARY BYPASS; COATED EXTRACORPOREAL CIRCUITS;
   COMPLEMENT ACTIVATION; 3-DIMENSIONAL STRUCTURE; CLINICAL-PERFORMANCE;
   SURFACES; BIOCOMPATIBILITY; IMMUNOGLOBULIN; ADHESION; COMPATIBILITY
AB The effects of an amphiphilic polymer coating of poly(2-methoxyethyl acrylate) (PMEA) on immunoglobulin adsorption and leukocyte adhesion were investigated. Forty patients were operated on using noncoated and PMEA-coated oxygenator fibers; leukocyte counts adhered onto the noncoated and coated fibers. It appears that the adsorbed immunoglobulin on noncoated fiber surfaces plays a role in leukocyte adhesion and complement activation by an alternative pathway, while the PMEA coating reduced the complement activation on the oxygenator hollow fibers. The biomaterial and blood interaction at the interface could potentially be used as an indicator for predicting the artificial devices long-term clinical performance.
C1 [Ayhan, Hakan] Mugla Univ, Dept Chem, Div Biochem, Mugla, Turkey.
   [Kocakulak, Mustafa; Kocum, I. Cengiz] Baskent Univ, Dept Biomed Engn, TR-06490 Ankara, Turkey.
RP Ayhan, H (reprint author), Mugla Univ, Dept Chem, Div Biochem, Mugla, Turkey.
EM hayhan@mu.edu.tr
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Ashraf SS, 1997, J CARDIOTHOR VASC AN, V11, P718
   BOHLER J, 1983, CONTRIB NEPHROL, V36, P15
   BURHOP KE, 1993, J LAB CLIN MED, V121, P276
   CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704
   COOPER NR, 1980, IMMUNOASSAYS CLIN LA, P393
   DEFRAIGNE JO, 2000, CYTOKINE, V69, P1084
   Demirkilic U, 2004, J BIOACT COMPAT POL, V19, P395, DOI 10.1177/0883911504046690
   FRENG L, 1989, SCANNING MICROSCOPY, V3, P399
   Gunaydin S, 2002, ANN THORAC SURG, V74, P819, DOI 10.1016/S0003-4975(02)03796-7
   GYONGYOSSYISSA MIC, 1994, J LAB CLIN MED, V123, P859
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   Horton SB, 1999, ANN THORAC SURG, V68, P1751, DOI 10.1016/S0003-4975(99)01066-8
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Kagisaki K, 1997, ARTIF ORGANS, V21, P836, DOI 10.1111/j.1525-1594.1997.tb03753.x
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Kocakulak M, 2002, J BIOACT COMPAT POL, V17, P343, DOI 10.1106/088391102029554
   Kocum C, 2004, J BIOMAT SCI-POLYM E, V15, P1513, DOI 10.1163/1568562042459706
   KOCUM IC, 2000, THESIS HACETTEPE U A
   LABARRE DJ, 1990, INT J ARTIF ORGANS, V13, P651
   LEATHERBARROW RJ, 1991, J MOL BIOL, V221, P361, DOI 10.1016/0022-2836(91)80056-Z
   Loos M., 1998, COMPLEMENT SYSTEM, P1
   MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1
   MARQUART M, 1982, IMMUNOL TODAY, V3, P160, DOI 10.1016/0167-5699(82)90107-4
   Ozawa T, 2000, ANN THORAC SURG, V69, P584, DOI 10.1016/S0003-4975(99)01336-3
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140
   TAMIYA T, 1988, ANN THORAC SURG, V46, P47, DOI 10.1016/S0003-4975(10)65851-1
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   VALENTINE RC, 1967, J MOL BIOL, V27, P615, DOI 10.1016/0022-2836(67)90063-0
   Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4
   ZAREIE MH, 1995, THESIS HACETTEPE U A
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 34
TC 0
Z9 0
U1 1
U2 23
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2012
VL 27
IS 1
BP 45
EP 53
DI 10.1177/0883911511426759
PG 9
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 878QJ
UT WOS:000299271300004
DA 2018-10-19
ER

PT J
AU Dittmer, NT
   Hiromasa, Y
   Tomich, JM
   Lu, NY
   Beeman, RW
   Kramer, KJ
   Kanost, MR
AF Dittmer, Neal T.
   Hiromasa, Yasuaki
   Tomich, John M.
   Lu, Nanyan
   Beeman, Richard W.
   Kramer, Karl J.
   Kanost, Michael R.
TI Proteomic and Transcriptomic Analyses of Rigid and Membranous Cuticles
   and Epidermis from the Elytra and Hindwings of the Red Flour Beetle,
   Tribolium castaneum
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE cuticle; cuticular proteins; elytra; hindwings; insect; microarray;
   proteomics; Tribolium castaneum
ID RUBBER-LIKE PROTEIN; CUTICULAR PROTEINS; INSECT-CUTICLE;
   PROPHENOLOXIDASE III; MANDUCA-SEXTA; BOMBYX-MORI; CROSS-LINKS;
   DROSOPHILA; RESILIN; GENOME
AB The insect cuticle is a composite biomaterial made up primarily of chitin) and proteins. The physical properties of the cuticle can vary greatly from hard and rigid to soft and flexible. Understanding how different cuticle types are assembled can aid in the development of novel biomimetic materials for use in medicine and technology. Toward this goal, we have taken a combined proteomics and transcriptomics approach with the red flour beetle, Tribolium castaneum, to examine the protein and gene expression profiles of the elytra and hindwings, appendages that contain rigid and soft cuticles, respectively. Two-dimensional gel electrophoresis analysis revealed distinct differences in the protein profiles between elytra and hindwings, with four highly abundant proteins dominating the elytral cuticle extract. MALDI/TOF mass spectrometry identified 19 proteins homologous to known or hypothesized cuticular proteins (CPs), including a novel low complexity protein enriched in charged residues. Microarray analysis identified 372 genes with a 10-fold or greater difference in transcript levels between elytra and hindwings. CP genes with higher expression in the elytra belonged to the Rebers and Riddiford family (CPR) type 2, or cuticular proteins of low complexity (CPLC) enriched in glycine or proline. In contrast, a majority of the CP genes with higher expression in hindwings were classified as CPR type 1, cuticular proteins analogous to peritrophins (CPAP), or members of the Tweedle family. This research shows that the elyra and hindwings, representatives of rigid and soft cuticles, have different protein and gene expression profiles for structural proteins that may influence the mechanical properties of these cuticles.
C1 [Dittmer, Neal T.; Hiromasa, Yasuaki; Tomich, John M.; Kramer, Karl J.; Kanost, Michael R.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.
   [Lu, Nanyan] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA.
   [Beeman, Richard W.; Kramer, Karl J.] Agr Res Serv, Ctr Grain & Anim Hlth Res, USDA, Manhattan, KS 66502 USA.
RP Dittmer, NT (reprint author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.
EM ndittmer@ksu.edu
OI TOMICH, JOHN/0000-0001-7848-8307
FU NSF [IOS0726425]; Kansas Agricultural Experiment Station [11-411-J]
FX We thank Dr. Yoonseong Park for design of the microarray chip, and
   Xiaohong Li and Dr. Nigel Cooper at the Gene Microarray Core Facility at
   the University of Louisville for performing the chip hybridization. This
   research was supported by NSF grant IOS0726425, and is contribution
   11-411-J of the Kansas Agricultural Experiment Station. Mention of trade
   names or commercial products in this publication is solely for the
   purpose of providing specific information and does not imply
   recommendation or endorsement by the U.S. Department of Agriculture. The
   USDA is an equal opportunity provider and employer.
CR AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7
   ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2
   Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1
   Andersen SO, 1999, COMP BIOCHEM PHYS A, V123, P203, DOI 10.1016/S1095-6433(99)00051-3
   ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J
   ANDERSEN SO, 1963, BIOCHIM BIOPHYS ACTA, V69, P249, DOI 10.1016/0006-3002(63)91258-7
   ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145
   Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007
   Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102
   Arakane Y, 2010, INSECT BIOCHEM MOLEC, V40, P259, DOI 10.1016/j.ibmb.2010.01.012
   Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200
   Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200
   ASHIDA M, 1997, MOL MECH IMMUNE RESP, P135
   Barry MK, 1999, INSECT BIOCHEM MOLEC, V29, P319, DOI 10.1016/S0965-1748(99)00004-1
   BEEMAN RW, 1990, J ECON ENTOMOL, V83, P1745, DOI 10.1093/jee/83.5.1745
   Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   COX DL, 1985, INSECT BIOCHEM, V15, P349, DOI 10.1016/0020-1790(85)90026-5
   Dixit R., 2008, INSECT BIOCHEM MOLEC, V38, P449
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007
   Gorb SN, 1999, NATURWISSENSCHAFTEN, V86, P552, DOI 10.1007/s001140050674
   Grimaldi David, 2005, pi
   GROSS AJ, 1959, J BIOL CHEM, V234, P1611
   Gu SB, 2003, INSECT BIOCHEM MOLEC, V33, P1177, DOI 10.1016/j.ibmb.2003.06.010
   Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103
   Haas F, 2000, P ROY SOC B-BIOL SCI, V267, P1375, DOI 10.1098/rspb.2000.1153
   Haas F, 2000, ARTHROPOD STRUCT DEV, V29, P137, DOI 10.1016/S1467-8039(00)00025-6
   HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717
   He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011
   Hopkins TL, 2000, INSECT BIOCHEM MOLEC, V30, P19, DOI 10.1016/S0965-1748(99)00091-0
   Horton P, 2006, SER ADV BIOINFORM, P39
   Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011
   Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9
   Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Locke M, 2001, J INSECT PHYSIOL, V47, P495, DOI 10.1016/S0022-1910(00)00123-2
   Lomakin J, 2011, BIOMACROMOLECULES, V12, P321, DOI 10.1021/bm1009156
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Miessner M, 2001, BIOMACROMOLECULES, V2, P369, DOI 10.1021/bm005652u
   Missios S, 2000, INSECT BIOCHEM MOLEC, V30, P47, DOI 10.1016/S0965-1748(99)00096-X
   Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z
   Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5
   Sugumaran M, 2010, ADV INSECT PHYSIOL, V39, P151, DOI 10.1016/S0065-2806(10)39005-9
   Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010
   Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272
   Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10
   Tribolium Genonne Sequencing Consortium, 2008, NATURE, V452, P949
   Tsao IY, 2010, J MED ENTOMOL, V47, P495, DOI 10.1603/ME08114
   Tsao IY, 2009, INSECT BIOCHEM MOLEC, V39, P96, DOI 10.1016/j.ibmb.2008.10.007
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Vincent JFV, 2009, J ADHESION, V85, P755, DOI 10.1080/00218460903291296
   Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   WILLIS JH, 2005, COMPREHENSIVE MOL IN, V4, P79
   Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001
   Yamauchi A, 2009, MACROMOL BIOSCI, V9, P875, DOI 10.1002/mabi.200900032
NR 60
TC 32
Z9 37
U1 2
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
J9 J PROTEOME RES
JI J. Proteome Res.
PD JAN
PY 2012
VL 11
IS 1
BP 269
EP 278
DI 10.1021/pr2009803
PG 10
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 872RT
UT WOS:000298827700025
PM 22087475
DA 2018-10-19
ER

PT J
AU Bitar, KN
   Raghavan, S
AF Bitar, K. N.
   Raghavan, S.
TI Intestinal tissue engineering: current concepts and future vision of
   regenerative medicine in the gut
SO NEUROGASTROENTEROLOGY AND MOTILITY
LA English
DT Review
DE autologous cells; biomaterials; enteric nervous system; functional
   tissue engineering; smooth muscle
ID INTERNAL ANAL-SPHINCTER; SMOOTH-MUSCLE-CELLS; LOWER ESOPHAGEAL
   SPHINCTER; SYNTHETIC EXTRACELLULAR MATRICES; STEM-CELLS; NERVOUS-SYSTEM;
   GROWTH-FACTOR; SMALL-BOWEL; IN-VITRO; SUCCESSFUL IMPLANTATION
AB Background and Purpose Functional tissue engineering of the gastrointestinal (GI) tract is a complex process aiming to aid the regeneration of structural layers of smooth muscle, intrinsic enteric neuronal plexuses, specialized mucosa, and epithelial cells as well as interstitial cells. The final tissue-engineered construct is intended to mimic the native GI tract anatomically and physiologically. Physiological functionality of tissue-engineered constructs is of utmost importance while considering clinical translation. The construct comprises of cellular components as well as biomaterial scaffolding components. Together, these determine the immune response a tissue-engineered construct would elicit from a host upon implantation. Over the last decade, significant advances have been made to mitigate adverse host reactions. These include a quest for identifying autologous cell sources like embryonic and adult stem cells, bone marrow-derived cells, neural crest-derived cells, and muscle derived-stem cells. Scaffolding biomaterials have been fabricated with increasing biocompatibility and biodegradability. Manufacturing processes have advanced to allow for precise spatial architecture of scaffolds to mimic in vivo milieu closely and achieve neovascularization. This review will focus on the current concepts and the future vision of functional tissue engineering of the diverse neuromuscular structures of the GI tract from the esophagus to the internal anal sphincter.
C1 [Bitar, K. N.; Raghavan, S.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.
RP Bitar, KN (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, 391 Technol Way, Winston Salem, NC 27101 USA.
EM kbitar@wakehealth.edu
OI Raghavan, Shreya/0000-0002-4631-7762
FU NIH/NIDDK [DK071614, 1RC1DK08715]
FX This work was supported by NIH/NIDDK DK071614 and 1RC1DK08715.
CR Araki M, 2009, ARTIF ORGANS, V33, P818, DOI 10.1111/j.1525-1594.2009.00808.x
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Bonavina L, 2008, J GASTROINTEST SURG, V12, P2133, DOI 10.1007/s11605-008-0698-1
   Cao BH, 2004, CELL CYCLE, V3, P104
   CASTELL DO, 1975, ANN INTERN MED, V83, P390, DOI 10.7326/0003-4819-83-3-390
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463
   Feretis C, 2001, GASTROINTEST ENDOSC, V53, P423, DOI 10.1067/mge.2001.113912
   Fockens P, 2004, ENDOSCOPY, V36, P682, DOI 10.1055/s-2004-825665
   Freud E, 1999, J BIOMED MATER RES, V45, P84, DOI 10.1002/(SICI)1097-4636(199905)45:2<84::AID-JBM2>3.0.CO;2-O
   Goyal RK, 2008, J CLIN GASTROENTEROL, V42, P610, DOI 10.1097/MCG.0b013e31816b444d
   Grikscheit TC, 2004, ANN SURG, V240, P748, DOI 10.1097/01.sla.0000143246.07277.73
   Grikscheit TC, 2003, ANN SURG, V238, P35, DOI 10.1097/01.SLA.0000074964.77367.4a
   Hajivassiliou CA, 1997, DIS COLON RECTUM, V40, P711, DOI 10.1007/BF02140902
   Hayashi K, 2004, ASAIO J, V50, P261, DOI 10.1097/01.MAT.0000123688.45717.A4
   Hecker L, 2005, AM J PHYSIOL-GASTR L, V289, pG188, DOI 10.1152/ajpgi.00335.2004
   Hori Y, 2002, ARTIF ORGANS, V26, P868, DOI 10.1046/j.1525-1594.2002.07006.x
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hwang JH, 2004, MOL CELLS, V17, P57
   Jansen PL, 2004, EUR SURG RES, V36, P104, DOI 10.1159/000076650
   Kaihara S, 1999, TRANSPLANTATION, V67, P241, DOI 10.1097/00007890-199901270-00009
   Kang SB, 2008, DIS COLON RECTUM, V51, P1367, DOI 10.1007/s10350-008-9360-y
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim SS, 1999, TRANSPLANTATION, V67, P227, DOI 10.1097/00007890-199901270-00007
   Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9
   Kulkarni S, 2012, GUT, V61, P613, DOI 10.1136/gut.2010.235614
   Kulkarni S, 2011, AM J PHYSIOL-GASTR L, V301, pG644, DOI 10.1152/ajpgi.00123.2011
   Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225
   Lee KY, 2000, NATURE, V408, P998
   Lee M, 2008, TISSUE ENG PT A, V14, P1395, DOI 10.1089/ten.tea.2007.0232
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Maemura T, 2003, TRANSPLANTATION, V76, P61, DOI 10.1097/01.TP.000006803.63554.1B
   Metharom P, 2010, ARTERIOSCL THROM VAS, V30, P533, DOI 10.1161/ATVBAHA.109.200097
   Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038
   Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048
   Micci MA, 2005, GASTROENTEROLOGY, V129, P1817, DOI 10.1053/j.gastro.2005.08.055
   Miyasaka EA, 2011, PEDIATR SURG INT, V27, P137, DOI 10.1007/s00383-010-2786-z
   Nakase Y, 2006, TISSUE ENG, V12, P403, DOI 10.1089/ten.2006.12.403
   Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027
   Pan WK, 2011, J SURG RES, V167, pE221, DOI 10.1016/j.jss.2011.01.016
   Pasricha PJ, 2009, GASTROINTEST ENDOSC, V70, P1231, DOI 10.1016/j.gie.2009.05.014
   Raghavan S, 2011, GASTROENTEROLOGY, V141, P310, DOI 10.1053/j.gastro.2011.03.056
   Raghavan S, 2010, AM J PHYSIOL-GASTR L, V299, pG430, DOI 10.1152/ajpgi.00269.2009
   Rattan S, 2005, NEUROGASTROENT MOTIL, V17, P50, DOI 10.1111/j.1365-2982.2005.00659.x
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   SARNA SK, 1991, DIGEST DIS SCI, V36, P827, DOI 10.1007/BF01311244
   SARNA SK, 1988, PHARMACOLOGY, V36, P7, DOI 10.1159/000138415
   Sato M, 1994, ASAIO J, V40, pM389, DOI 10.1097/00002480-199407000-00028
   Saxena AK, 2009, J GASTROINTEST SURG, V13, P1037, DOI 10.1007/s11605-009-0836-4
   Schafer KH, 2009, NEUROGASTROENT MOTIL, V21, P103, DOI 10.1111/j.1365-2982.2008.01257.x
   Schauerte P, 2006, HERZ, V31, P96, DOI 10.1007/s00059-006-2781-2
   Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Somara S, 2009, GASTROENTEROLOGY, V137, P53, DOI 10.1053/j.gastro.2009.03.036
   Szymanski PT, 1998, AM J PHYSIOL-CELL PH, V275, pC684, DOI 10.1152/ajpcell.1998.275.3.C684
   Takimoto Y, 1998, J THORAC CARDIOV SUR, V116, P98, DOI 10.1016/S0022-5223(98)70247-8
   Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848
   Tian H, 2009, TISSUE ENG PART A, V16, P1769
   Watanabe M, 2005, ASAIO J, V51, P158, DOI 10.1097/01.MAT.0000154644.44891.F1
   Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1
   Xie Yuan-cai, 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P6675
   Young HM, 2005, GASTROENTEROLOGY, V129, P2092, DOI 10.1053/j.gastro.2005.10.033
NR 66
TC 26
Z9 26
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1350-1925
EI 1365-2982
J9 NEUROGASTROENT MOTIL
JI Neurogastroenterol. Motil.
PD JAN
PY 2012
VL 24
IS 1
BP 7
EP 19
DI 10.1111/j.1365-2982.2011.01843.x
PG 13
WC Gastroenterology & Hepatology; Clinical Neurology; Neurosciences
SC Gastroenterology & Hepatology; Neurosciences & Neurology
GA 876HZ
UT WOS:000299099700008
PM 22188325
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Terai, N
   Schlotzer-Schrehardt, U
   Spoerl, E
   Hornykewycz, K
   Haentzschel, J
   Haustein, M
   Pillunat, LE
AF Terai, Naim
   Schloetzer-Schrehardt, Ursula
   Spoerl, Eberhard
   Hornykewycz, Karin
   Haentzschel, Janek
   Haustein, Michael
   Pillunat, Lutz E.
TI Biomechanical and Morphological Differences between the Sclera Canal
   Ring and a Peripheral Sclera Ring in the Porcine Eye
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Sclera canal ring; Biomechanics; Hysteresis; Optic nerve head; Glaucoma
ID OPTIC-NERVE HEAD; LAMINA-CRIBROSA; EXTRACELLULAR-MATRIX; GLAUCOMA;
   ELASTIN; COLLAGEN
AB Aim: To investigate a possible association between the biomechanical load and unload behaviour and the elastin content of the sclera canal ring (SCR) and a superiorly localized sclera ring (SPS) in the porcine eye. Methods: Two sclera rings were trephined from each of 40 porcine eyes, one containing the SCR and the other an SPS. The load and the unload curves were measured in the extension range of 0-2.0 mm by a biomaterial tester. Hysteresis was determined from the area enclosed by the loading and unloading curve. Histochemical staining with resorcin-fuchsin and morphometric analysis of paraffin-embedded sections of both rings were performed to detect the area occupied by elastin fibres. Results: At 1 mm extension, the mean load of the SCR was 0.89 +/- 0.22 N and that of the SPS 1.13 +/- 0.19 N, which was not significantly different between both rings (p > 0.05). Mean hysteresis in the SCR was 1.55 +/- 0.30 N x mm and 1.90 +/- 0.18 N x mm in the SPS, which was significantly different between both rings (p = 0.01). Mean sclera thickness was 986 mu m in the SCR (range: 900-1,060 mu m) and 971 mu m in the SPS (range: 800-1,200 mu m) without a statistically significant difference between both sclera rings (p = 0.78). The area occupied by elastin fibres was 15.5 +/- 3.4% in the SCR and 4.5 +/- 1.5% in the SPS, which was significantly different between both rings (p = 0.0001). Conclusion: Hysteresis in the SCR was significantly lower than in the SPS, indicating a higher elasticity of the SCR in the porcine eye. This effect could be explained by a higher content of elastin in the surrounding ring of the peripapillary optic nerve head providing reversible contraction in cases of intra-ocular pressure variations. Copyright (C) 2011 S. Karger AG, Basel
C1 [Terai, Naim; Spoerl, Eberhard; Hornykewycz, Karin; Haentzschel, Janek; Haustein, Michael; Pillunat, Lutz E.] Carl Gustav Carus Univ Hosp, Dept Ophthalmol, DE-01307 Dresden, Germany.
   [Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany.
RP Terai, N (reprint author), Carl Gustav Carus Univ Hosp, Dept Ophthalmol, Fetscherstr 74, DE-01307 Dresden, Germany.
EM naim.terai@uniklinikum-dresden.de
CR Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991
   Clark G, 1973, STAINING PROCEDURES, P60
   Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb
   Elsheikh A, 2005, J ROY SOC INTERFACE, V2, P177, DOI 10.1098/rsif.2005.0034
   Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010
   Gelman S, 2010, EXP EYE RES, V90, P210, DOI 10.1016/j.exer.2009.10.007
   HERNANDEZ MR, 1993, ANN MED, V25, P309, DOI 10.3109/07853899309147290
   HERNANDEZ MR, 1992, INVEST OPHTH VIS SCI, V33, P2891
   HERNANDEZ MR, 1989, AM J OPHTHALMOL, V107, P476, DOI 10.1016/0002-9394(89)90491-1
   Lillie MA, 2007, BIOMATERIALS, V28, P2021, DOI 10.1016/j.biomaterials.2007.01.016
   LILLIE MA, 1994, CONNECT TISSUE RES, V31, P23, DOI 10.3109/03008209409005632
   Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001
   Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539
   Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303
   QUIGLEY HA, 1991, CURR EYE RES, V10, P877, DOI 10.3109/02713689109013884
   QUIGLEY HA, 1991, BRIT J OPHTHALMOL, V75, P552, DOI 10.1136/bjo.75.9.552
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541
   Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003
   Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4
NR 20
TC 2
Z9 2
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2012
VL 47
IS 2
BP 61
EP 65
DI 10.1159/000328983
PG 5
WC Ophthalmology
SC Ophthalmology
GA 883WF
UT WOS:000299664900002
PM 21720187
OA Green Published
DA 2018-10-19
ER

PT J
AU Liang, SL
   Cook, WD
   Chen, QZ
AF Liang, Shuling
   Cook, Wayne D.
   Chen, Qizhi
TI Physical characterization of poly(glycerol sebacate)/Bioglass (R)
   composites
SO POLYMER INTERNATIONAL
LA English
DT Article
DE biomaterial; polyester; DSC; DMTA; XRD; composite; ionic crosslinks
ID MECHANICAL-PROPERTIES; BIODEGRADABLE POLYMER; SEBACATE); TISSUE;
   ELASTOMER; SCAFFOLDS; XYLITOL
AB Differential scanning calorimetry (DSC), dynamic mechanical thermal analysis (DMTA) and X-ray diffraction have been used to characterize the structure of a crosslinked polyester (poly(glycerol sebacate), PGS), prepared from a molar ratio of a diacid (sebacic acid) and a triol (glycerol), and their composites formed with an alkaline reactive filler, Bioglass (R). The Bioglass reacts with the sebacic acid carboxylate groups during the composite synthesis, resulting in elastomers that are linked by ionic and covalent crosslinks. Due to its relatively low crosslink density, the unfilled PGS polymer can crystallize below room temperature but is an amorphous elastomer at room temperature. The DSC results show that the Bioglass composites are also semicrystalline below room temperature but the crystallinity is disrupted by the ionic linkages. DMTA of the dry PGS and PGS-Bioglass composites confirms the semicrystalline nature of the materials and comparison with specimens that had been saturated with water vapour shows that the ionic crosslinks are dissociated by hydration by water molecules. Copyright (C) 2011 Society of Chemical Industry
C1 [Liang, Shuling; Cook, Wayne D.; Chen, Qizhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
RP Cook, WD (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM wayne.cook@monash.edu; qizhi.chen@monash.edu
CR BAKER D, 1968, POLYMER, V9, P437, DOI 10.1016/0032-3861(68)90053-0
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bicerano J., 1993, PREDICTION POLYM PRO
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   ELLWOOD KC, 1995, AM J CLIN NUTR, V62, P1169
   Jaafar IH, 2010, J MATER SCI, V45, P2525, DOI 10.1007/s10853-010-4259-0
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Natah SS, 1997, AM J CLIN NUTR, V65, P947
   NIELSEN LE, 1966, J APPL POLYM SCI, V10, P97, DOI 10.1002/app.1966.070100107
   Schick C, 2003, LECT NOTE PHYS, P252
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SESTOFT L, 1985, ACTA ANAESTH SCAND, V29, P19, DOI 10.1111/j.1399-6576.1985.tb02336.x
   Stamboulis A, 2002, J MATER SCI-MATER M, V13, P843, DOI 10.1023/A:1016544211478
   Stuckey DJ, 2010, TISSUE ENG PT A, V16, P3395, DOI 10.1089/ten.TEA.2010.0213
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   SURYANARAYANA C, 1998, XRAY DIFFRACTION PRA
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
NR 22
TC 13
Z9 13
U1 2
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JAN
PY 2012
VL 61
IS 1
BP 17
EP 22
DI 10.1002/pi.3165
PG 6
WC Polymer Science
SC Polymer Science
GA 869JH
UT WOS:000298593700005
DA 2018-10-19
ER

PT J
AU Choi, JS
   Kim, BS
   Kim, JD
   Choi, YC
   Lee, HY
   Cho, YW
AF Choi, Ji Suk
   Kim, Beob Soo
   Kim, Jae Dong
   Choi, Young Chan
   Lee, Hee Young
   Cho, Yong Woo
TI In Vitro Cartilage Tissue Engineering Using Adipose-Derived
   Extracellular Matrix Scaffolds Seeded with Adipose-Derived Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CHONDROGENIC DIFFERENTIATION; REPAIR; BONE; DECELLULARIZATION;
   REGENERATION; PCL
AB Extracellular matrix (ECM) secreted from the resident cell of tissue is an ideal biomaterial evolved by nature. Cartilage is also built from well-organized ECM components in a gel-like structure with a high collagen and proteoglycan content. Here, we explored cartilage tissue engineering using ECM scaffolds seeded with stem cells. Both scaffolds and stem cells were isolated from human adipose tissue, which is abundant and easily harvested in the human body. The human ECM scaffolds contained various endogenous bioactive factors, including transforming growth factor-beta1 (TGF-beta 1, 8782 +/- 4989 pg/g, dry ECM), insulin growth factor-1 (13319 +/- 1388 pg/g, dry ECM), basic fibroblast growth factor (82373 +/- 9572 pg/g, dry ECM), and vascular endothelial growth factor (25647 +/- 2749 pg/g, dry ECM). A composite of ECM and stem cells was prepared and cultured in chondrogenic medium (with 10 ng/mL TGF-beta 1 or not) for 45 days. The volumes and weights of the composites increased during culture and the surface gradually became smooth. Cell viability remained high throughout the 45 days of in vitro culture. Composites showed the formation of cartilage-like tissue with the synthesis of cartilage-specific proteins such as collagen and glycosaminoglycan. Important chondrogenic markers were expressed including Sox-9, aggrecan, and collagen type II and XI. These results demonstrate that a cell/ECM composite containing endogenous bioactive factors could provide biochemical cues for the promotion of cartilage formation.
C1 [Choi, Ji Suk; Kim, Beob Soo; Kim, Jae Dong; Choi, Young Chan; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, South Korea.
   [Choi, Ji Suk; Kim, Beob Soo; Kim, Jae Dong; Choi, Young Chan; Cho, Yong Woo] Hanyang Univ, Dept Bionanotechnol, Ansan 426791, South Korea.
   [Lee, Hee Young] Kangnam Plast Surg Clin, Seoul, South Korea.
RP Cho, YW (reprint author), Hanyang Univ, Dept Chem Engn, Ansan 426791, South Korea.
EM ywcho7@hanyang.ac.kr
FU Basic Science Research Program [2009-0075546]; National Research
   Foundation of Korea (NRF) [R11-2008-044-02001-0]; Ministry of Education,
   Science and Technology; Human Resources Development of the Korea
   Institute of Energy Technology Evaluation and Planning [20104010100620];
   Ministry of Knowledge Economy, Republic of Korea
FX This work was supported by the Basic Science Research Program (Grant No.
   2009-0075546) and the Engineering Research Center Program (Grant No.
   R11-2008-044-02001-0) through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Education, Science and Technology. This
   work was also supported by the Human Resources Development of the Korea
   Institute of Energy Technology Evaluation and Planning (Grant No.
   20104010100620) grant funded by the Ministry of Knowledge Economy,
   Republic of Korea.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Ateshian GA, 2007, NAT MATER, V6, P89, DOI 10.1038/nmat1830
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Davies LC, 2008, TISSUE ENG PT A, V14, P1251, DOI [10.1089/ten.tea.2007.0211, 10.1089/tea.2007.0211]
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   Diekman B O, 2009, TISSUE ENG PART A, V16, P523
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Emans PJ, 2010, P NATL ACAD SCI USA, V107, P3418, DOI 10.1073/pnas.0907774107
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Fan HB, 2008, BIOMACROMOLECULES, V9, P927, DOI 10.1021/bm7013203
   Fan JB, 2010, ACTA BIOMATER, V6, P1178, DOI 10.1016/j.actbio.2009.08.042
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Gaissmaier C., 2008, INJURY, V39, P88, DOI DOI 10.1016/J.INJURY.2008.01.035
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Haberhauer M, 2008, ADV MATER, V20, P2061, DOI 10.1002/adma.200701344
   Hardingham T., 2002, ARTHRITIS RES S3, V3z, P63
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ito H, 2006, J BIOMED MATER RES A, V76A, P551, DOI 10.1002/jbm.a.30551
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Kim BS, 2010, CELL PROLIFERAT, V43, P249, DOI 10.1111/j.1365-2184.2010.00680.x
   Kim HJ, 2010, J BIOMED MATER RES A, V92A, P659, DOI 10.1002/jbm.a.32414
   Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766
   Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674
   Lee CT, 2006, BIOMACROMOLECULES, V7, P2200, DOI 10.1021/bm060451x
   Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Merceron C, 2008, JOINT BONE SPINE, V75, P672, DOI 10.1016/j.jbspin.2008.07.007
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1046/j.1432-0436.1998.6340193.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001
NR 50
TC 22
Z9 24
U1 1
U2 25
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2012
VL 18
IS 1-2
BP 80
EP 92
DI 10.1089/ten.tea.2011.0103
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 876ML
UT WOS:000299111500008
PM 21905881
OA Green Published
DA 2018-10-19
ER

PT J
AU Ribeiro, A
   Vargo, S
   Powell, EM
   Leach, JB
AF Ribeiro, Andreia
   Vargo, Shelby
   Powell, Elizabeth M.
   Leach, Jennie B.
TI Substrate Three-Dimensionality Induces Elemental Morphological
   Transformation of Sensory Neurons on a Physiologic Timescale
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID DORSAL-ROOT GANGLION; NERVE GROWTH-FACTOR; MOUSE SPINAL-CORD; NEURITE
   EXTENSION; IN-VIVO; GEL STIFFNESS; CELLS; CULTURE; INNERVATION;
   OUTGROWTH
AB The natural environment of a neuron is the three-dimensional (3D) tissue. In vivo, embryonic sensory neurons transiently express a bipolar morphology with two opposing neurites before undergoing cytoplasmic and cytoskeletal rearrangement to a more mature pseudo-unipolar axonal arbor before birth. The unipolar morphology is crucial in the adult for correct information transmission from the periphery to the central nervous system. On two-dimensional (2D) substrates this transformation is delayed significantly or absent. We report that a 3D culture platform can invoke the characteristic transformation to the unipolar axonal arbor within a time frame similar to in vivo, overcoming the loss of this essential milestone in 2D substrates. Additionally, 3D substrates alone provided an environment that promoted axonal branching features that reflect morphological patterns observed in vivo. We have also analyzed the involvement of soluble cues in these morphogenic processes by culturing the neurons in the presence and absence of nerve growth factor (NGF), a molecule that plays distinct roles in the development of the peripheral and central nervous systems. Without NGF, both 2D and 3D cultures had significant decreases in the relative population of unipolar neurons as well as shorter neurite lengths and fewer branch points compared to cultures with NGF. Interestingly, branching features of neurons cultured in 3D without NGF resemble those of neurons cultured in 2D with NGF. Therefore, neurons cultured in 3D without NGF lost the ability to differentiate into unipolar neurons, suggesting that this morphological hallmark requires not only presentation of soluble cues like NGF, but also the surrounding 3D presentation of adhesive ligands to allow for realization of the innate morphogenic program. We propose that in a 3D environment, various matrix and soluble cues are presented toward all surfaces of the cell; this optimized milieu allows neurons to elaborate their genuine phenotype and follow programmed instructions that are intrinsic to the neuron, but disrupted when cells were dissected from the embryo. Thus, this study presents quantitative data supporting that 3D substrates are critical for sustaining the in vivo ontogeny of neurons and deciphering signaling mechanisms necessary for designing biomaterial scaffolds for nerve generation and repair.
C1 [Ribeiro, Andreia; Vargo, Shelby; Leach, Jennie B.] UMBC, Dept Chem & Biochem Engn, Baltimore, MD 21250 USA.
   [Powell, Elizabeth M.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.
   [Powell, Elizabeth M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA.
   [Powell, Elizabeth M.] Univ Maryland, Sch Med, Dept Bioengn, Baltimore, MD 21201 USA.
RP Leach, JB (reprint author), UMBC, Dept Chem & Biochem Engn, Eng 314,1000 Hilltop Circle, Baltimore, MD 21250 USA.
EM jleach@umbc.edu
RI Powell, Elizabeth/C-3153-2013
OI Powell, Elizabeth/0000-0002-7529-9057
FU NIH-NINDS [R01NS065205]; Henry Luce Foundation; Wyeth; UMBC
FX We thank C. Petty for assistance with confocal microscopy; Dr. A. Puche
   for assistance with Neurolucida software and analysis; Dr. J. Loehe for
   advice on statistical analysis; and Dr. D. Bloomberg for generous access
   to the long working distance objective. This work was supported by
   NIH-NINDS R01NS065205, the Henry Luce Foundation, a Wyeth Graduate
   Fellowship (A.R.), and a UMBC Undergraduate Research Award (S.V.).
CR Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   BANKER GA, 1998, CULTURING NERVE CELL
   BARBER RP, 1986, J NEUROCYTOL, V15, P207, DOI 10.1007/BF01611657
   Benson DL, 1996, J NEUROSCI, V16, P6424
   Berg JS, 2000, DEV BRAIN RES, V125, P21, DOI 10.1016/S0165-3806(00)00124-3
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370
   CALVET MC, 1992, BRAIN RES, V584, P1, DOI 10.1016/0006-8993(92)90871-6
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Gelain F., 2006, PLOS ONE, Ve119, P1
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   HERNANDEZ MA, 1989, NEUROSCIENCE, V29, P471, DOI 10.1016/0306-4522(89)90074-2
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   Kollins KM, 2005, BRANCHING MORPHOGENE
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Lerman O, 2007, MOL CELL NEUROSCI, V36, P222, DOI 10.1016/j.mcn.2007.07.003
   LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   LUSCHER C, 1994, J NEUROPHYSIOL, V72, P622
   MALGRANGE B, 1994, J NEUROSCI METH, V53, P111, DOI 10.1016/0165-0270(94)90151-1
   Matsuda S, 1996, ANAT EMBRYOL, V193, P475
   MUDGE AW, 1984, NATURE, V309, P367, DOI 10.1038/309367a0
   Ozaki S, 1997, J COMP NEUROL, V380, P215
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Ramon y Cajal S., 1904, TRAB LAB INVEST BIOL, V3, P65
   Renaudin A, 1999, J NEUROSCI RES, V55, P458, DOI 10.1002/(SICI)1097-4547(19990215)55:4<458::AID-JNR6>3.0.CO;2-D
   Sann SB, 2008, J NEUROSCI, V28, P2366, DOI 10.1523/JNEUROSCI.3828-07.2008
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Takahashi K., 1987, PROG NEUROBIOL, V29, P397
   TANAKA M, 1990, AGE, V13, P57, DOI 10.1007/BF02432390
   Tucker BA, 2005, J COMP NEUROL, V486, P267, DOI 10.1002/cne.20518
   Watson KK, 2006, NEUROSCIENCE, V141, P1107, DOI 10.1016/j.neuroscience.2006.04.084
   Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   YASUDA T, 1990, BRAIN RES, V524, P54, DOI 10.1016/0006-8993(90)90491-S
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 45
TC 21
Z9 21
U1 1
U2 9
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2012
VL 18
IS 1-2
BP 93
EP 102
DI 10.1089/ten.tea.2011.0221
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 876ML
UT WOS:000299111500009
PM 21910606
OA Green Published
DA 2018-10-19
ER

PT J
AU White, LJ
   Hutter, V
   Tai, HY
   Howdle, SM
   Shakesheff, KM
AF White, Lisa J.
   Hutter, Victoria
   Tai, Hongyun
   Howdle, Steven M.
   Shakesheff, Kevin M.
TI The effect of processing variables on morphological and mechanical
   properties of supercritical CO2 foamed scaffolds for tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Supercritical carbon dioxide (scCO(2)); Poly(DL-lactic acid) (P(DL)LA);
   Foaming; Scaffolds; Biomaterial
ID GROWTH-FACTOR DELIVERY; BIODEGRADABLE POLYMER SCAFFOLDS; CARBON-DIOXIDE;
   IN-VITRO; COMPOSITE SCAFFOLDS; CELLULAR MATERIALS; ACID) SCAFFOLDS;
   DRUG-DELIVERY; BONE; INTERCONNECTIVITY
AB The porous structure of a scaffold determines the ability of bone to regenerate within this environment. In situations where the scaffold is required to provide mechanical function, balance must be achieved between optimizing porosity and maximizing mechanical strength. Supercritical CO2 foaming can produce open-cell, interconnected structures in a low-temperature, solvent-free process. In this work, we report on foams of varying structural and mechanical properties fabricated from different molecular weights of poly(DL-lactic acid) P(DL)LA (57,25 and 15 kDa) and by varying the depressurization rate. Rapid depressurization rates produced scaffolds with homogeneous pore distributions and some closed pores. Decreasing the depressurization rate produced scaffolds with wider pore size distributions and larger, more interconnected pores. In compressive testing, scaffolds produced from 57 kDa P(DL)LA exhibited typical stress-strain curves for elastomeric open-cell foams whereas scaffolds fabricated from 25 and 15 kDa P,LA behaved as brittle foams. The structural and mechanical properties of scaffolds produced from 57 kDa P(DL)LA by scCO(2) ensure that these scaffolds are suitable for potential applications in bone tissue engineering. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [White, Lisa J.; Hutter, Victoria; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Tai, Hongyun] Bangor Univ, Sch Chem, Bangor LL57 2UW, Gwynedd, Wales.
   [Howdle, Steven M.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
RP White, LJ (reprint author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
EM lisa.white@nottingham.ac.uk
RI Tai, Hongyun/A-6572-2012; Shakesheff, Kevin/O-6371-2018
OI Tai, Hongyun/0000-0002-1480-7484; Shakesheff, Kevin/0000-0003-3236-2439;
   White, Lisa/0000-0003-0571-999X
FU Engineering and Physical Sciences Research Council, UK [EP/C534257/1];
   Engineering and Physical Sciences Research Council [GR/S27269/01]
FX This work was supported by the Engineering and Physical Sciences
   Research Council, UK, through the "REMEDI" project, Grant No.
   EP/C534257/1. The authors thank Dr. D.Y.S. Chau, Dr. D. Howard, Dr. G.
   Kirkham and Dr. L. Hamilton for scientific discussions, and Mr. R.
   Wilson and Mr. P. Fields for technical assistance.
CR Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   Barry JJA, 2006, J MATER SCI, V41, P4197, DOI 10.1007/s10853-006-7023-8
   BREZNY R, 1990, ACTA METALL MATER, V38, P2517, DOI 10.1016/0956-7151(90)90263-G
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   Collins NJ, 2010, ACTA BIOMATER, V6, P1055, DOI 10.1016/j.actbio.2009.08.013
   Cooper A, 2000, MATER WORLD, V8, P10
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Darling AL, 2004, J BIOMED MATER RES B, V70B, P311, DOI 10.1002/jbm.b.30050
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   GOEL SK, 1994, POLYM ENG SCI, V34, P1137, DOI 10.1002/pen.760341407
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gualandi C, 2010, ACTA BIOMATER, V6, P130, DOI 10.1016/j.actbio.2009.07.020
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   HOWDLE SM, 1998, Patent No. 9581347
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2004, J BIOMED MATER RES B, V68B, P36, DOI 10.1002/jbm.b.10071
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Kanczler JM, 2007, BIOCHEM BIOPH RES CO, V352, P135, DOI 10.1016/j.bbrc.2006.10.187
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lopez-Periago AM, 2008, J MATER SCI, V43, P1939, DOI 10.1007/s10853-008-2461-0
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   MANDEL FS, 1998, 5 M SUP FLUIDS INT S, P45
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Mathieu LM, 2005, J BIOMED MATER RES A, V75A, P89, DOI 10.1002/jbm.a.30385
   Montjovent MO, 2007, J BIOMED MATER RES A, V83A, P41, DOI 10.1002/jbm.a.31208
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Muller R, 1997, MAT RES S C, V461, P217
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   SHAKESHEFF KM, 2000, 7 M SUP FLUIDS ISASF, P267
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Stafford CM, 1999, MACROMOLECULES, V32, P7610, DOI 10.1021/ma9902100
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Tai HY, 2010, POLYMER, V51, P1425, DOI 10.1016/j.polymer.2010.01.065
   Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018
NR 64
TC 41
Z9 44
U1 7
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 61
EP 71
DI 10.1016/j.actbio.2011.07.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500007
PM 21855663
OA Other Gold
DA 2018-10-19
ER

PT J
AU Xu, LC
   Siedlecki, CA
AF Xu, Li-Chong
   Siedlecki, Christopher A.
TI Submicron-textured biomaterial surface reduces staphylococcal bacterial
   adhesion and biofilm formation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Textured biomaterials; Bacterial adhesion; Biofilm formation;
   Staphylococci; Polyurethane
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CARE-ASSOCIATED INFECTIONS;
   DEVICE-RELATED INFECTIONS; FIBROBLAST RESPONSE; PLATELET-ADHESION;
   IMPLANT MATERIALS; BLOOD-CONTACT; AUREUS; EPIDERMIDIS; ATTACHMENT
AB Staphylococci are among the most important pathogens causing bloodstream infections associated with implanted medical devices. Control of bacterial adhesion to material surfaces is important for prevention of biofilm formation and biomaterial-associated infections. In this study, we hypothesized that submicron (staphylococcal bacterial dimension) surface textures may reduce the bacterial adhesion via a decrease in surface area that bacteria can contact, and subsequently inhibit biofilm formation. Poly(urethane urea) films were textured with two different sizes of submicron pillars via a two-stage replication process. Adhesion of two bacterial strains (Staphylococcus epidermidis RP62A and S. aureus Newman) was assessed over a shear stress range of 0-13.2 dyn cm(-2) using a rotating disk system in physiological buffer solutions. Significant decreases in bacterial adhesion were observed on textured surfaces for both strains compared with smooth controls. Biofilm formation was further tested on surfaces incubated in solution for either 2 or 5 days and it was found that biofilm formation was dramatically inhibited on textured surfaces. The results of the approaches used in this work demonstrate that patterned surface texturing of biomaterials provides an effective means to reduce staphylococcal adhesion and biofilm formation on biomaterial surfaces, and thus to prevent biomaterial-associated infections. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Siedlecki, Christopher A.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Surg, Hershey, PA 17033 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Coll Med, Inst Biomed Engn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Surg, H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU Department of Surgery Feasibility Grant at the Penn State College of
   Medicine
FX The authors would like to acknowledge Dr. Leslie Parent of the Penn
   State College of Medicine for valuable discussions. Financial support
   was from a Department of Surgery Feasibility Grant at the Penn State
   College of Medicine.
CR Arrecubieta C, 2006, J INFECT DIS, V193, P1109, DOI 10.1086/501366
   Basak P, 2009, J MATER SCI-MATER M, V20, P213, DOI 10.1007/s10856-008-3521-3
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Clubb FJ, 1999, ASAIO J, V45, P281
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   De Prijck K, 2010, MYCOPATHOLOGIA, V170, P213, DOI 10.1007/s11046-010-9316-3
   FEWSTER SD, 1994, NANOBIOLOGY, V3, P201
   Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Fujisawa N, 1999, BIOMATERIALS, V20, P955, DOI 10.1016/S0142-9612(98)00251-8
   Fujisawa N, 2000, J BIOMED MATER RES, V52, P517, DOI 10.1002/1097-4636(20001205)52:3<517::AID-JBM10>3.0.CO;2-G
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Gordon AT, 2007, AM J PHYS MED REHAB, V86, P225, DOI 10.1097/PHM.0b013e318031eela
   Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591
   Guerrero G, 2009, PATHOL BIOL, V57, P36, DOI 10.1016/j.patbio.2008.07.032
   Harris L. G., 2002, European Cells & Materials, V4, P39
   Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   Kostenko V, 2010, FEMS IMMUNOL MED MIC, V59, P421, DOI 10.1111/j.1574-695X.2010.00694.x
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078
   Lelievre C, 2002, CHEM ENG SCI, V57, P1287, DOI 10.1016/S0009-2509(02)00019-2
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4
   Milner KR, 2007, INT J NANOMED, V2, P201
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Milner KR, 2005, ASAIO J, V51, P578, DOI 10.1097/01.mat.0000171594.44974.89
   Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431
   Otto K, 2008, RES MICROBIOL, V159, P415, DOI 10.1016/j.resmic.2008.04.007
   Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Wenzel RP, 2007, CLIN INFECT DIS, V45, P85, DOI 10.1086/518136
   Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 53
TC 73
Z9 74
U1 3
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 72
EP 81
DI 10.1016/j.actbio.2011.08.009
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500008
PM 21884831
DA 2018-10-19
ER

PT J
AU Battiston, KG
   McBane, JE
   Labow, RS
   Santerre, JP
AF Battiston, Kyle G.
   McBane, Joanne E.
   Labow, Rosalind S.
   Santerre, J. Paul
TI Differences in protein binding and cytokine release from monocytes on
   commercially sourced tissue culture polystyrene
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue culture polystyrene; Monocytes; Cell culture; Surface properties;
   Protein adsorption
ID SELF-ASSEMBLED MONOLAYERS; CELL-ADHESION; SURFACE-CHEMISTRY;
   APOLIPOPROTEIN-E; IN-VITRO; ENDOTHELIAL-CELLS; HUMAN MACROPHAGES;
   ADSORPTION; BIOMATERIAL; FIBRONECTIN
AB Tissue culture polystyrene (TCPS) is a ubiquitous substrate used by many researchers in the biomedical and biological sciences. Different parameters involved in the production of TCPS, including the treatment time and the use of reactive gases and chemical agents, can have a significant influence on the ultimate surface properties achieved. The assumption that they will all yield a consistent and controlled product has not proven to be true. To provide a better insight into the bioactivity differences in TCPS supplied by different manufacturers, TCPS from three different companies (Sarstedt, Wisent Corp., and Becton Dickinson (BD)) were analyzed for their surface properties, protein adsorption characteristics, and interactions with human monocytes. Marked differences were observed in terms of surface wettability and surface chemistry. Furthermore, Wisent TCPS adsorbed more than twice the amount of serum proteins compared with BD and Sarstedt TCPS. Sarstedt showed significantly more cell retention (more DNA) compared with both BD and Wisent TCPS brands over a 7 day culture period. Cytokine release from monocytes adherent on the three different TCPS also differed significantly, suggesting that the differences in the surface properties were sufficient to differentially mediate monocyte activation. These results have important implications for TCPS research use, in terms of appreciating the interpretation of the data when TCPS is used as a control substrate as well as when it is used where a pre-conditioned state would influence the outcome of the study. (C) 2011 Published by Elsevier Ltd. on behalf of Acts Materialia Inc.
C1 [Battiston, Kyle G.; McBane, Joanne E.; Santerre, J. Paul] Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON M5G 1G6, Canada.
   [Battiston, Kyle G.; McBane, Joanne E.; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [McBane, Joanne E.; Labow, Rosalind S.] Univ Ottawa, Div Cardiac Surg, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, 124 Edward St,Room 464D, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU NSERC/CIHR [337246/83459]; Canadian Heart and Stroke Foundation; CIHR
   [STP-53877]
FX Special thanks are due to Dr. Eric Yang of Sunnybrook Hospital's
   proteomics facility for discussions and help with the 2-DE, in gel
   digestion, LC-MS/MS, and protein identification. This study was funded
   by NSERC/CIHR collaborative grant no. 337246/83459 (J.P.S. and R.S.L.).
   J.E.M. was funded by a Canadian Heart and Stroke Foundation Focus on
   Stroke post-doctoral fellowship. K.G.B. was funded by a CIHR Strategic
   Training Fellowship in Cell Signaling in Mucosal Inflammation and Pain
   (STP-53877).
CR Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   AMSTEIN CF, 1975, J CLIN MICROBIOL, V2, P46
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P12, DOI 10.1002/jbm.a.32480
   Barker Susan L., 1994, Journal of Tissue Culture Methods, V16, P151, DOI 10.1007/BF01540642
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Becton-Dickinson and Co, 1983, PRIM TISS CULT LABW
   Benton JA, 2008, J HEART VALVE DIS, V17, P689
   Bhattacharyya D, 2010, J BIOMED MATER RES A, V94A, P640, DOI 10.1002/jbm.a.32713
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Candiano G, 2009, ELECTROPHORESIS, V30, P2405, DOI 10.1002/elps.200800762
   Clinchy B, 2003, J IMMUNOL METHODS, V282, P53, DOI 10.1016/j.jim.2003.07.013
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Derkaoui SM, 2010, ACTA BIOMATER, V6, P3506, DOI 10.1016/j.actbio.2010.03.043
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Galvani M, 2001, ELECTROPHORESIS, V22, P2158
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   Iba K, 2009, WOUND REPAIR REGEN, V17, P108, DOI 10.1111/j.1524-475X.2008.00447.x
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jozefowicz M, 1997, BIOMATERIALS, V18, P1633, DOI 10.1016/S0142-9612(97)00145-2
   Kawamura A, 2007, ARTERIOSCL THROM VAS, V27, P1610, DOI 10.1161/ATVBAHA.106.129957
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim JK, 2005, J BIOMED MATER RES A, V75A, P199, DOI 10.1002/jbm.a.30424
   KLEINSOYER C, 1989, BIOMATERIALS, V10, P85, DOI 10.1016/0142-9612(89)90036-7
   LASTER SM, 1988, J IMMUNOL, V141, P2629
   Loh J H, 1999, Med Device Technol, V10, P24
   MAROUDAS NG, 1977, J CELL PHYSIOL, V90, P511, DOI 10.1002/jcp.1040900314
   MARTIN GR, 1974, EXP CELL RES, V85, P319, DOI 10.1016/0014-4827(74)90133-5
   Matheson LA, 2007, BIOTECHNIQUES, V42, P744, DOI 10.2144/000112460
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   NIELSEN H, 1993, SCAND J IMMUNOL, V37, P39, DOI 10.1111/j.1365-3083.1993.tb01662.x
   REPOUX M, 1992, SURF INTERFACE ANAL, V18, P567, DOI 10.1002/sia.740180719
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Sangsanoh P, 2007, BIOMACROMOLECULES, V8, P1587, DOI 10.1021/bm061152a
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Silverman DJ, 1986, BDL MONOGRAPH
   Soskolne WA, 2002, CLIN ORAL IMPLAN RES, V13, P86, DOI 10.1034/j.1600-0501.2002.130111.x
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Vitek MP, 1997, BIOCHEM BIOPH RES CO, V240, P391, DOI 10.1006/bbrc.1997.7408
   Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2
   White ES, 2001, J IMMUNOL, V167, P5362, DOI 10.4049/jimmunol.167.9.5362
   Yoshida Y, 1999, J INVEST DERMATOL, V113, P49, DOI 10.1046/j.1523-1747.1999.00623.x
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   Zhu YJ, 2010, BIOCHEM J, V428, P47, DOI 10.1042/BJ20100016
NR 55
TC 10
Z9 10
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 89
EP 98
DI 10.1016/j.actbio.2011.09.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500010
PM 21963405
DA 2018-10-19
ER

PT J
AU McKenna, KA
   Hinds, MT
   Sarao, RC
   Wu, PC
   Maslen, CL
   Glanville, RW
   Babcock, D
   Gregory, KW
AF McKenna, Kathryn A.
   Hinds, Monica T.
   Sarao, Rebecca C.
   Wu, Ping-Cheng
   Maslen, Cheryl L.
   Glanville, Robert W.
   Babcock, Darcie
   Gregory, Kenton W.
TI Mechanical property characterization of electrospun recombinant human
   tropoelastin for vascular graft biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tropoelastin; Electrospinning; Mechanical properties; Vascular grafts;
   Tissue engineering
ID SUPRAVALVULAR AORTIC-STENOSIS; TISSUE ENGINEERING APPLICATIONS;
   BLOOD-VESSELS; CROSS-LINKING; TENSILE-STRENGTH; ELASTIN GENE; IN-VITRO;
   EXTRACELLULAR-MATRIX; NANOFIBER SCAFFOLDS; COMPLIANCE MISMATCH
AB The development of vascular grafts has focused on finding a biomaterial that is non-thrombogenic, minimizes intimal hyperplasia, matches the mechanical properties of native vessels and allows for regeneration of arterial tissue. In this study, the structural and mechanical properties and the vascular cell compatibility of electrospun recombinant human tropoelastin (rTE) were evaluated as a potential vascular graft support matrix. Disuccinimidyl suberate (DSS) was used to cross-link electrospun rTE fibers to produce a polymeric recombinant tropoelastin (prTE) matrix that is stable in aqueous environments. Tubular 1 cm diameter prTE samples were constructed for uniaxial tensile testing and 4 mm small-diameter prTE tubular scaffolds were produced for burst pressure and cell compatibility evaluations from 15 wt.% rTE solutions. Uniaxial tensile tests demonstrated an average ultimate tensile strength (UTS) of 0.36 +/- 0.05 MPa and elastic moduli of 0.15 +/- 0.04 and 0.91 +/- 0.16 MPa, which were comparable to extracted native elastin. Burst pressures of 485 +/- 25 mm Hg were obtained from 4 mm internal diameter scaffolds with 453 +/- 74 mu m average wall thickness. prTE supported endothelial cell growth with typical endothelial cell cobblestone morphology after 48 h in culture. Cross-linked electrospun rTE has promising properties for utilization as a vascular graft biomaterial with customizable dimensions, a compliant matrix and vascular cell compatibility. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [McKenna, Kathryn A.; Hinds, Monica T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97239 USA.
   [McKenna, Kathryn A.; Sarao, Rebecca C.; Wu, Ping-Cheng; Glanville, Robert W.; Gregory, Kenton W.] Providence St Vincent Med Ctr, Oregon Med Laser Ctr, Portland, OR 97225 USA.
   [Maslen, Cheryl L.; Babcock, Darcie] Oregon Hlth & Sci Univ, Div Cardiovasc Med, Portland, OR 97239 USA.
RP Hinds, MT (reprint author), Oregon Hlth & Sci Univ, Dept Biomed Engn, 3303 SW Bond Ave,Mailcode CH13B, Portland, OR 97239 USA.
EM hindsm@ohsu.edu
FU NIH [R01-HL095474, R01-HL103728]; Department of the Army
   [W81XWH-04-1-0841, W81XWH-05-1-0586]
FX We would like to thank Dr. Michael Rutten for isolation of the bone
   marrow mononuclear cells and Dr. Sean Kirkpatrick for assistance with
   fiber orientation code development. Tropoelastin was produced with the
   excellent technical assistance of Amy Jay, Cher Hawkey, and Rose Merten.
   This work was funded in part by the NIH R01-HL095474, NIH R01-HL103728,
   and the Department of the Army, Grant Nos. W81XWH-04-1-0841 and
   W81XWH-05-1-0586. This work does not necessarily reflect the policy of
   the government and no official endorsement should be inferred.
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Abbott WM, 2004, VASCULAR SURG PRINCI, P611
   Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   [Anonymous], 2001, 719819982001 ANSIAAM
   BAIRD RN, 1976, LANCET, V2, P948
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   BAXTER BT, 1992, J VASC SURG, V16, P192, DOI 10.1016/0741-5214(92)90107-J
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Bonani W, 2011, J BIOMED MATER RES B, V96B, P276, DOI 10.1002/jbm.b.31763
   Brennan MP, 2008, ANN SURG, V248, P370, DOI 10.1097/SLA.0b013e318184dcbd
   BREWSTER DC, 1995, VASCULAR SURG, P492
   Buttafoco L, 2005, J CONTROL RELEASE, V101, P322
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Campbell JH, 1999, CIRC RES, V85, P1173
   Cao Y, 2008, J BIOMED MATER RES A, V87A, P719, DOI 10.1002/jbm.a.31781
   Carta L, 2009, ARTERIOSCL THROM VAS, V29, P2083, DOI 10.1161/ATVBAHA.109.193227
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   CLARK RE, 1976, SURG FORUM, V27, P208
   COHEN J, 1972, J SURG RES, V13, P321, DOI 10.1016/0022-4804(72)90083-2
   COULSON WF, 1971, BIOCHIM BIOPHYS ACTA, V237, P378, DOI 10.1016/0304-4165(71)90334-5
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   El-Kurdi MS, 2008, BIOMATERIALS, V29, P3213, DOI 10.1016/j.biomaterials.2008.04.009
   EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057
   Farand P, 2007, MICROVASC RES, V73, P95, DOI 10.1016/j.mvr.2006.10.005
   Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028
   GANDHI RH, 1994, SURGERY, V115, P617
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   HAUT RC, 1980, J BIOMECH ENG-T ASME, V102, P98, DOI 10.1115/1.3138222
   HAYASHI K, 1982, BIORHEOLOGY, V19, P425
   Hinds MT, 2006, J BIOMED MATER RES A, V77A, P458, DOI 10.1002/jbm.a.30571
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Hunter G C, 1980, Curr Surg, V37, P439
   HUNTER GC, 1991, P SOC EXP BIOL MED, V196, P273
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   KIDSON IG, 1978, CIRCULATION, V58, P1
   KIDSON IG, 1983, ANN ROY COLL SURG, V65, P24
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021
   Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   LITWIN SB, 1973, J SURG RES, V15, P198, DOI 10.1016/0022-4804(73)90077-2
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   McKenna KA, 2012, J BIOMATER APPL, V27, P219, DOI 10.1177/0885328211399480
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nam J, 2008, J APPL POLYM SCI, V107, P1547, DOI 10.1002/app.27063
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   OKUHN SP, 1989, J VASC SURG, V9, P35, DOI 10.1067/mva.1989.vs0090035
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   PURSLOW PP, 1983, J BIOMECH, V16, P947, DOI 10.1016/0021-9290(83)90058-1
   RIZZO RJ, 1989, J VASC SURG, V10, P365
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Rutten M., 2010, OPEN STEM CELL J, V2, P25
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   SAWYER PN, 1987, AM J SURG, V154, P533, DOI 10.1016/0002-9610(87)90272-8
   Sell SA, 2006, BIOMED MATER, V1, P72, DOI 10.1088/1748-6041/1/2/004
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Stickler P, 2010, ACTA BIOMATER, V6, P2448, DOI 10.1016/j.actbio.2010.01.041
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Strobel R, 1996, EUR J VASC ENDOVASC, V11, P417, DOI 10.1016/S1078-5884(96)80173-0
   UCHIDA N, 1993, J BIOMED MATER RES, V27, P1269, DOI 10.1002/jbm.820271007
   Urban Z, 1999, HUM GENET, V104, P135, DOI 10.1007/s004390050926
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wu M H, 1993, Ann Vasc Surg, V7, P156, DOI 10.1007/BF02001010
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang X, 2010, BIOMATERIALS, V31, P4376, DOI 10.1016/j.biomaterials.2010.02.017
   Zhang X, 2010, J MATER SCI-MATER M, V21, P541, DOI 10.1007/s10856-009-3922-y
NR 100
TC 56
Z9 56
U1 2
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 225
EP 233
DI 10.1016/j.actbio.2011.08.001
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500025
PM 21846510
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Richter, JR
   de Guzman, RC
   Greengauz-Roberts, OK
   Van Dyke, M
AF Richter, Jillian R.
   de Guzman, Roche C.
   Greengauz-Roberts, Olga K.
   Van Dyke, Mark
TI Structure-property relationships of meta-kerateine biomaterials derived
   from human hair
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Keratin; Naturally derived biomaterial; Protein characterization;
   Cell-biomaterial interactions
ID KERATIN-ASSOCIATED PROTEINS; CELL-ADHESION; REGENERATION; SEQUENCE;
   MATRIX; MODEL; FILMS
AB The structure-property relationships of kerateine materials were studied by separating crude hair extracts into two protein sub-fractions, referred to as alpha- and gamma-kerateines, followed by their de novo recombination into meta-kerateine hydrogels, sponges and films. The kerateine fractions were characterized using electrophoresis and mass spectrometry, which revealed that the alpha-fraction contained complexes of type I and type II keratins and that the gamma-fraction was primarily protein fragments of the alpha-fraction along with three proteins of the KAP-1 family. Meta-kerateine materials with increased amounts of gamma-kerateines showed diminished physical, mechanical and biological characteristics. Most notably, materials with higher gamma-content formed less elastic and less solid-like hydrogels and sponges that were less hydrolytically stable. In addition, a model biological assay showed that meta-kerateine films with greater amounts of gamma-kerateines were less supportive of hepatocyte attachment. Investigation into the mechanism of attachment revealed that hepatocyte adhesion to meta-kerateines is not mediated by the pi integrin subunit, despite the presence of LDV binding motifs within the type I alpha-keratins. This work to define the role of protein composition on biomaterial function is essential for the optimization of keratin biomaterials for biomedical applications. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Richter, Jillian R.; de Guzman, Roche C.; Greengauz-Roberts, Olga K.; Van Dyke, Mark] Wake Forest Univ Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Van Dyke, M (reprint author), Wake Forest Univ Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
EM mavandyk@wfubmc.edu
RI Richter, Jillian/I-3723-2012; de Guzman, Roche/K-8832-2015; Richter,
   Jillian/C-1914-2013
OI Richter, Jillian/0000-0002-2233-1711; de Guzman,
   Roche/0000-0001-6051-4765; 
FU KeraNetics LLC
FX Funding for this project was provided by KeraNetics LLC. The authors
   thank Maria Bahawdory for her assistance with sample preparation, the
   Food Science Department at North Carolina State University for the use
   of their rheological equipment, Dr Randall McClelland from SciKon
   Innovation Inc. for exceptional technical and material assistance with
   hepatocyte culture, Dr Pedro Baptista for his contributions to the
   hepatocyte experiments, and Dr Sarah Schwartz from the David H. Murdock
   Research Institute for significant help with mass spectrometry
   identification of proteins. Mark Van Dyke holds stock and is an officer
   in the company KeraNetics LLC who has provided funding for this
   research. Wake Forest Health Sciences has potential financial interests
   in KeraNetics LLC through licensing agreements.
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Aluigi A, 2007, J APPL POLYM SCI, V104, P863, DOI 10.1002/app.25623
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   BREINL F, 1907, Z PHYSL CHEM, V52, P158
   Bryant S. J., 2006, SCAFFOLDING TISSUE E, P71
   Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FRASER RDB, 1986, P NATL ACAD SCI USA, V83, P1179, DOI 10.1073/pnas.83.5.1179
   Fujii T, 2004, BIOL PHARM BULL, V27, P1433, DOI 10.1248/bpb.27.1433
   Goddard DR, 1935, J BIOL CHEM, V112, P361
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   KOMORIYA A, 1991, J BIOL CHEM, V266, P15075
   Lee JH, 2008, J POLYM SCI POL PHYS, V46, P1450, DOI 10.1002/polb.21481
   Lissizin T., 1928, Z PHYSL CHEM, V173, P309
   Lissizin T., 1915, BIOCH B, V4, P18
   LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593
   Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6
   PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X
   Parry DAD, 2006, J STRUCT BIOL, V155, P361, DOI 10.1016/j.jsb.2006.03.018
   Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sudhakaran PR, 1999, P INDIAN AS-CHEM SCI, V111, P331
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tonin C, 2007, J THERM ANAL CALORIM, V89, P601, DOI 10.1007/s10973-006-7557-7
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Yamauchi K, 2003, MAT SCI ENG C-BIO S, V23, P467, DOI 10.1016/S09284931(02)00280-1
   YU JL, 1993, J INVEST DERMATOL, V101, pS56, DOI 10.1111/1523-1747.ep12362635
   Zoccola M, 2007, E-POLYMERS
NR 37
TC 19
Z9 19
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 274
EP 281
DI 10.1016/j.actbio.2011.08.020
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500030
PM 21911088
DA 2018-10-19
ER

PT J
AU Peitl, O
   Zanotto, ED
   Serbena, FC
   Hench, LL
AF Peitl, Oscar
   Zanotto, Edgar D.
   Serbena, Francisco C.
   Hench, Larry L.
TI Compositional and microstructural design of highly bioactive
   P2O5-Na2O-CaO-SiO2 glass-ceramics
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bioactive; Glass; Glass-ceramic; Biomaterial design; Mechanical
   properties
ID FRACTURE-TOUGHNESS TEST; INTERNAL RESIDUAL-STRESSES; VICKERS
   INDENTATION; CRYSTAL NUCLEATION; MATRIX COMPOSITE; FORMING ABILITY;
   FLEXURE METHOD; SURFACE-CRACK; CRYSTALLIZATION; STRENGTH
AB Bioactive glasses having chemical compositions between 1Na(2)O-2CaO-3SiO(2) (1N2C3S) and 1.5Na(2)O-1.5CaO-3SiO(2) (1N1C2S) containing 0, 4 and 6 wt.% P2O5 were crystallized through two stage thermal treatments. By carefully controlling these treatments we separately studied the effects on the mechanical properties of two important microstructural features not studied before, crystallized volume fraction and crystal size. Fracture strength, elastic modulus and indentation fracture toughness were measured as a function of crystallized volume fraction for a constant crystal size. Glass-ceramics with a crystalline volume fraction between 34% and 60% exhibited a three-fold improvement in fracture strength and an increase of 40% in indentation fracture toughness compared with the parent glass. For the optimal crystalline concentration (34% and 60%) these mechanical properties were then measured for different grain sizes, from 5 to 21 mu m. The glass-ceramic with the highest fracture strength and indentation fracture toughness was that with 34% crystallized volume fracture and 13 mu m crystals. Compared with the parent glass, the average fracture strength of this glass-ceramic was increased from 80 to 210 MPa, and the fracture toughness from 0.60 to 0.95 MPa.m(1/2). The increase in indentation fracture toughness was analyzed using different theoretical models, which demonstrated that it is due to crack deflection. Fortunately, the elastic modulus E increased only slightly: from 60 to 70 GPa (the elastic modulus of biomaterials should be as close as possible to that of cortical bone). In summary, the flexural strength of our best material (215 MPa) is significantly greater than that of cortical bone and comparable with that of apatite-wollastonite (A/W) bioglass ceramics, with the advantage that it shows a much lower elastic modulus. These results thus provide a relevant guide for the design of bioactive glass-ceramics with improved microstructure. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Serbena, Francisco C.] Univ Estadual Ponta Grossa, Dept Phys, BR-84030900 Ponta Grossa, PR, Brazil.
   [Peitl, Oscar; Zanotto, Edgar D.] Univ Fed Sao Carlos, Dept Mat Engn, Vitreous Mat Lab, BR-13565905 Sao Carlos, SP, Brazil.
   [Hench, Larry L.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL USA.
RP Serbena, FC (reprint author), Univ Estadual Ponta Grossa, Dept Phys, BR-84030900 Ponta Grossa, PR, Brazil.
EM fserbena@uepg.br
RI Zanotto, Edgar/A-7992-2011
OI Zanotto, Edgar/0000-0003-4931-4505
FU CNPq; Capes (NanoBiotech research network); Fapesp [07/08179-9]
FX The authors are grateful to the Brazilian funding agencies CNPq, Capes
   (NanoBiotech research network) and Fapesp (thematic Grant No.
   07/08179-9).
CR ARORA A, 1979, J NON-CRYST SOLIDS, V31, P415, DOI 10.1016/0022-3093(79)90154-6
   *ASTM INT, 1994, C15895 ASTM INT
   BAIKOVA GL, 1993, GLASS PHYS CHEM+, V19, P252
   BOROM MP, 1975, J AM CERAM SOC, V58, P385, DOI 10.1111/j.1151-2916.1975.tb19004.x
   Cabral AA, 2003, J NON-CRYST SOLIDS, V320, P1, DOI 10.1016/S0022-3093(03)00079-6
   CHANTIKUL P, 1981, J AM CERAM SOC, V64, P539, DOI 10.1111/j.1151-2916.1981.tb10321.x
   Davidge RW, 1968, J MATER SCI, V3, P629, DOI 10.1007/BF00757910
   DEHOFF RT, 1961, T METALL SOC AIME, V221, P975
   FABER KT, 1983, ACTA METALL MATER, V31, P565, DOI 10.1016/0001-6160(83)90046-9
   Fokin VM, 2007, J NON-CRYST SOLIDS, V353, P2459, DOI 10.1016/j.jnoncrysol.2007.04.014
   FREIMAN SW, 1968, J AM CERAM SOC, V51, P382, DOI 10.1111/j.1151-2916.1968.tb11898.x
   GONZALEZOLIVER CJR, 1980, J NON-CRYST SOLIDS, V38-9, P699, DOI 10.1016/0022-3093(80)90518-9
   GREEN DJ, 1981, J AM CERAM SOC, V64, P138, DOI 10.1111/j.1151-2916.1981.tb10244.x
   GREEN DJ, 1983, J AM CERAM SOC, V66
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hench LL, 1997, Bioactive ceramic composition useful in load-bearing prosthetic devices-comprises silicon dioxide, calcium oxide, sodium oxide and phosphorus pentoxide, and forms hydroxy-carbonate apatite layer on implanted surface, Patent No. [US5981412-A, 5981412]
   HENCH LL, 1997, Patent No. 9792561462111
   Hsueh CH, 1996, MAT SCI ENG A-STRUCT, V212, P22, DOI 10.1016/0921-5093(96)10176-3
   JABUR OR, 2008, INT C IMPL RIB PRET
   KALININA AM, 1980, J NON-CRYST SOLIDS, V38-9, P723, DOI 10.1016/0022-3093(80)90522-0
   KOKUBO T, 2009, COMMUNICATION
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   Kotoul M, 2008, ACTA MATER, V56, P2908, DOI 10.1016/j.actamat.2008.02.024
   Levi E. A., 1980, Soviet Physics - Doklady, V25, P882
   Mastelaro VR, 1996, J NON-CRYST SOLIDS, V194, P297, DOI 10.1016/0022-3093(95)00509-9
   Mecholsky J. J., 1983, FRACTURE MECHANICS C, V6, P165
   Michel MD, 2006, J NON-CRYST SOLIDS, V352, P3550, DOI 10.1016/j.jnoncrysol.2006.02.113
   MIYATA N, 1983, FRACTURE MECHANICS C, V5, P609
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nascimento MLF, 2005, J NON-CRYST SOLIDS, V351, P3296, DOI 10.1016/j.jnoncrysol.2005.08.013
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Peitl O, 2010, J AM CERAM SOC, V93, P2359, DOI 10.1111/j.1551-2916.2010.03717.x
   PONTON CB, 1989, MATER SCI TECH SER, V5, P865, DOI 10.1179/mst.1989.5.9.865
   PONTON CB, 1989, MATER SCI TECH SER, V5, P961, DOI 10.1179/mst.1989.5.10.961
   Quinn GD, 2002, J AM CERAM SOC, V85, P873
   Quinn GD, 2007, J AM CERAM SOC, V90, P673, DOI 10.1111/j.1551-2916.2006.01482.x
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   SAMBELL RA, 1992, J MATER SCI, V7, P663
   Serbena FC, 2011, J AM CERAM SOC, V94, P1206, DOI 10.1111/j.1551-2916.2010.04220.x
   Serbena FC, 2011, J AM CERAM SOC, V94, P671, DOI 10.1111/j.1551-2916.2010.04372.x
   SHI WD, 1994, J MATER SCI, V29, P824, DOI 10.1007/BF00445999
   Swab JJ, 1998, J AM CERAM SOC, V81, P2261
   TANAKA ME, 2007, THESIS U SAO PAULO B
   TAYA M, 1990, J AM CERAM SOC, V73, P1382, DOI 10.1111/j.1151-2916.1990.tb05209.x
   Thompson Joseph Conan, 1995, THESIS U FLORIDA
   Zanotto ED, 2010, AM CERAM SOC BULL, V89, P19
NR 47
TC 37
Z9 39
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 321
EP 332
DI 10.1016/j.actbio.2011.10.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500035
PM 22032913
DA 2018-10-19
ER

PT J
AU Alt, V
   Kogelmaier, DV
   Lips, KS
   Witt, V
   Pacholke, S
   Heiss, C
   Kampschulte, M
   Heinemann, S
   Hanke, T
   Thormann, U
   Schnettler, R
   Langheinrich, AC
AF Alt, Volker
   Koegelmaier, Daniela Vera
   Lips, Katrin S.
   Witt, Vera
   Pacholke, Sabine
   Heiss, Christian
   Kampschulte, Marian
   Heinemann, Sascha
   Hanke, Thomas
   Thormann, Ulrich
   Schnettler, Reinhard
   Langheinrich, Alexander C.
TI Assessment of angiogenesis in osseointegration of a silica-collagen
   biomaterial using 3D-nano-CT (vol 7, pg 3773, 2011)
SO ACTA BIOMATERIALIA
LA English
DT Correction
C1 [Alt, Volker; Witt, Vera; Pacholke, Sabine; Heiss, Christian; Thormann, Ulrich; Schnettler, Reinhard] Univ Giessen, Dept Trauma Surg, D-35385 Giessen, Germany.
   [Alt, Volker; Lips, Katrin S.; Witt, Vera; Pacholke, Sabine; Heiss, Christian; Thormann, Ulrich; Schnettler, Reinhard] Univ Giessen, Lab Expt Trauma Surg, D-35385 Giessen, Germany.
   [Koegelmaier, Daniela Vera; Kampschulte, Marian; Langheinrich, Alexander C.] Univ Giessen, Dept Radiol, D-35385 Giessen, Germany.
   [Heinemann, Sascha; Hanke, Thomas] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, Dresden, Germany.
RP Alt, V (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim Str 7, D-35385 Giessen, Germany.
EM volker.alt@chiru.med.uni-giessen.de
CR Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024
NR 1
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2012
VL 8
IS 1
BP 457
EP 457
DI 10.1016/j.actbio.2011.09.025
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 871UP
UT WOS:000298763500049
DA 2018-10-19
ER

PT J
AU Kandra, P
   Challa, MM
   Jyothi, HKP
AF Kandra, Prameela
   Challa, Murali Mohan
   Jyothi, Hemalatha Kalangi Padma
TI Efficient use of shrimp waste: present and future trends
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Shrimp waste; Toxic chemicals; Chitin; Pigments; Therapies
ID N-ACETYLCHITOOLIGOSACCHARIDE ELICITOR; RESPONSE-SURFACE METHODOLOGY;
   PENAEUS-MONODON FABRICIUS; AFFINITY BINDING-PROTEIN; LACTIC-ACID
   FERMENTATION; JUVENILE MARINE SHRIMP; CRUSTACEAN SHELL WASTE; PROCESSING
   DISCARDS; CHITIN PRODUCTION; CLOSTRIDIUM-PARAPUTRIFICUM
AB The production of shrimp waste from shrimp processing industries has undergone a dramatic increase in recent years. Continued production of this biomaterial without corresponding development of utilizing technology has resulted in waste collection, disposal, and pollution problems. Currently used chemical process releases toxic chemicals such as HCl, acetic acid, and NaOH into aquatic ecosystem as byproducts which will spoil the aquatic flora and fauna. Environmental protection regulations have become stricter. Now, there is a need to treat and utilize the waste in most efficient manner. The shrimp waste contains several bioactive compounds such as chitin, pigments, amino acids, and fatty acids. These bioactive compounds have a wide range of applications including medical, therapies, cosmetics, paper, pulp and textile industries, biotechnology, and food applications. This current review article present the utilization of shrimp waste as well as an alternative technology to replace hazardous chemical method that address the future trends in total utilization of shrimp waste for recovery of bioactive compounds.
C1 [Kandra, Prameela; Challa, Murali Mohan] GITAM Univ, GITAM Inst Technol, Dept Biotechnol, Visakhapatnam 530045, Andhra Pradesh, India.
   [Jyothi, Hemalatha Kalangi Padma] Andhra Univ, Coll Sci & Technol, Dept Biochem, Visakhapatnam 530045, Andhra Pradesh, India.
RP Kandra, P (reprint author), GITAM Univ, GITAM Inst Technol, Dept Biotechnol, Visakhapatnam 530045, Andhra Pradesh, India.
EM chprameela5@gmail.com; drmurali@gitam.edu; hemalathakpj@gmail.com
CR Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Al-Azab AA, 2005, EGYPT NUTR FEEDS, V8, P1145
   Amar B, 2000, AQUACULT NUTR, V12, P433
   Anderson LK, 1975, SEMARNAP ANUARIO EST, Patent No. 3906112
   [Anonymous], 1997, SEMARNAP. Anuario Estadistico de Pesca, Patent No. 3906112
   ARCIDIACONO S, 1992, BIOTECHNOL BIOENG, V39, P281, DOI 10.1002/bit.260390305
   Armenta-Lopez R, 2002, J FOOD SCI, V67, P1002, DOI 10.1111/j.1365-2621.2002.tb09443.x
   Bautista J, 2001, PROCESS BIOCHEM, V37, P229, DOI 10.1016/S0032-9592(01)00202-3
   Bhaskar N, 2007, ENZYME MICROB TECH, V40, P1427, DOI 10.1016/j.enzmictec.2006.10.019
   Bhaskar N, 2010, WASTE MANAGE RES, V28, P64
   Blanco M., 2007, Trends in Food Science & Technology, V18, P29, DOI 10.1016/j.tifs.2006.07.015
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   Bragagnolo L, 2001, J FOOD COMPOS ANAL, V14, P359
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Britton G, 1997, PURE APPL CHEM, V69, P2027
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   CANOLOPEZ A, 1987, J FOOD SCI, V52, P503, DOI 10.1111/j.1365-2621.1987.tb06656.x
   Carr FJ, 2002, CRIT REV MICROBIOL, V28, P281, DOI 10.1080/1040-840291046759
   Castillo R, 1982, CAROTENOID CHEM BIOC, P211
   CHEN HM, 1982, J FOOD SCI, V47, P892, DOI 10.1111/j.1365-2621.1982.tb12739.x
   Cheng JC, 2008, J MICROELECTROMECH S, V17, P402, DOI 10.1109/JMEMS.2008.916325
   Cira LA, 2002, PROCESS BIOCHEM, V37, P1359, DOI 10.1016/S0032-9592(02)00008-0
   Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P393, DOI 10.1128/AAC.00760-08
   Dapkevicius MDLE, 1998, FOOD CHEM, V63, P147
   DAVIES BH, 1985, PURE APPL CHEM, V57, P679, DOI 10.1351/pac198557050679
   DEJONG AJ, 1993, PLANT CELL, V5, P615, DOI 10.1105/tpc.5.6.615
   ELGHAOUTH A, 1992, MYCOL RES, V96, P769, DOI 10.1016/S0953-7562(09)80447-4
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Evvyernie D, 2000, J BIOSCI BIOENG, V89, P596, DOI 10.1016/S1389-1723(00)80063-8
   Fagbenro OA, 1996, FOOD RES INT, V29, P595, DOI 10.1016/S0963-9969(96)00077-4
   FAO/WHO, 1985, EN PROT REQ, V724, P116
   Feisal K., 2010, MAR DRUGS, V8, P1988
   Felix G, 1998, PLANT PHYSIOL, V117, P643, DOI 10.1104/pp.117.2.643
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Fuchs J., 1999, EC FISHERIES B, V12, P9
   Gildberg A, 2001, PROCESS BIOCHEM, V36, P809, DOI 10.1016/S0032-9592(00)00278-8
   Gildberg A., 2002, SAFETY QUALITY ISSUE, P425
   Gimeno M, 2007, J AGR FOOD CHEM, V55, P10345, DOI 10.1021/jf071469h
   Gong YP, 2009, MICROSURG, V29, P650, DOI 10.1002/micr.20686
   Gopalan N. K., 2003, BIOMACROMOLECULES, V4, P657, DOI DOI 10.1021/BM020127B
   Guerard F, 2007, PROCESS BIOCHEM, V42, P1486, DOI 10.1016/j.procbio.2007.07.016
   Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7
   GUILLOU A, 1995, AQUACULTURE, V130, P351, DOI 10.1016/0044-8486(94)00324-H
   Haidar ZS, 2008, BIOMATERIALS, V29, P1207, DOI 10.1016/j.biomaterials.2007.11.012
   Hakim L, 2008, TALANTA, V76, P1256, DOI 10.1016/j.talanta.2008.05.025
   Hakim L, 2008, TALANTA, V74, P977, DOI 10.1016/j.talanta.2007.08.012
   HALL GM, 1992, ADVANCES IN CHITIN AND CHITOSAN, P633
   He H, 2006, BIORESOURCE TECHNOL, V97, P85
   Healy M, 2003, ACTA BIOTECHNOL, V23, P151, DOI 10.1002/abio.200390023
   HEALY MG, 1994, RESOUR CONSERV RECY, V11, P139, DOI 10.1016/0921-3449(94)90085-X
   Holanda HDD, 2006, J FOOD SCI, V71, P298
   Holland CR, 1986, THESIS QUEENS U BELG
   Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x
   Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X
   Je JY, 2006, BIOORG MED CHEM LETT, V16, P1884, DOI 10.1016/j.bmcl.2005.12.077
   Jeuniaux C., 1996, ADV CHITIN SCI, P1
   Jolles P., 1999, CHITIN CHITINASES
   KATAYAMA T, 1971, B JPN SOC SCI FISH, V37, P614
   Kelleher K, 2005, N470 FAO, P131
   Klokkevold PR, 1999, J ORAL MAXIL SURG, V57, P49, DOI 10.1016/S0278-2391(99)90632-8
   Knapczyk J, 1982, THESIS NICHOLAS COPE
   KNORR D, 1991, FOOD TECHNOL-CHICAGO, V45, P114
   Lang G, 1985, USE CHITOSAN COSMETI
   Latscha T, 1990, ANIMAL NUTR HLTH, P110
   LAURA RC, 2006, PROCESS BIOCHEM, V41, P1106, DOI DOI 10.1016/J.PROCBIO.2005.11.021
   Legarrenta GI, 1996, ADV CHITIN SCI, V1, P399
   Li HX, 2005, J CHROMATOGR B, V816, P49, DOI 10.1016/j.jchromb.2004.11.005
   Liang TW, 2007, PROCESS BIOCHEM, V42, P527, DOI [10.1016/j.procbio.2006.10.005, 10.1016/j.procbio.2006.10.002]
   Luis S.J.T., 2003, J FOOD SCI, V68, P1454
   MAEZAKI Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1439, DOI 10.1271/bbb.57.1439
   Mahmoud NS, 2007, AM J BIOCH BIOTECHNO, V3, P1, DOI [10.3844/ajbbsp.2007.1.9, DOI 10.3844/AJBBSP.2007.1.9]
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Maryam M, 2005, FOOD SCI TECHNOL INT, V11, P49
   Mathew P, 2006, FISH TECHNOL, V43, P59
   MATHUR NK, 1990, J CHEM EDUC, V67, P938, DOI 10.1021/ed067p938
   MERAZ M, 1992, J SCI FOOD AGR, V60, P457, DOI 10.1002/jsfa.2740600409
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Millamena OM, 1996, AQUACULT NUTR, V2, P129, DOI 10.1111/j.1365-2095.1996.tb00051.x
   Millamena OM, 1998, AQUACULTURE, V164, P95, DOI 10.1016/S0044-8486(98)00179-3
   Millamena OM, 1997, AQUACULTURE, V151, P9, DOI 10.1016/S0044-8486(96)01486-X
   Millamena OM, 1999, AQUACULTURE, V179, P169, DOI 10.1016/S0044-8486(99)00160-X
   Millamena OM, 1996, AQUACULTURE, V143, P403, DOI 10.1016/0044-8486(96)01270-7
   Minami E, 1996, MOL PLANT MICROBE IN, V9, P574, DOI 10.1094/MPMI-9-0574
   Minami S, 1998, CARBOHYD POLYM, V36, P151, DOI 10.1016/S0144-8617(98)00015-0
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Mizani AM, 2007, P EUR C CHEM ENG ECC, P16
   MORGAN LE, 2003, SHIFTING GEARS ADDRE
   Morimoto K, 2005, FEMS MICROBIOL LETT, V246, P229, DOI 10.1016/j.femsle.2005.04.014
   MUKUNDAN MK, 1986, FISH RES, V4, P259, DOI 10.1016/0165-7836(86)90007-X
   Muzzarelli RAA, 2009, WOODHEAD PUBL FOOD S, P849, DOI 10.1533/9781845695873.849
   Muzzarelli RAA, 1997, CHITIN, P97
   Naguib YMA, 2000, J AGR FOOD CHEM, V48, P1150, DOI 10.1021/jf991106k
   National Research Council (NRC), 1993, NUTR REQ FISH, P124
   NEGRESADARGUES G, 1993, AQUACULTURE, V110, P151, DOI 10.1016/0044-8486(93)90269-5
   Neith P, 2009, BIORESOURCE TECHNOLO, V100, P2849
   Nwanna L. C., 2003, Pakistan Journal of Nutrition, V2, P339
   Oh KT, 2007, PROCESS BIOCHEM, V42, P1069, DOI 10.1016/j.procbio.2007.04.007
   Okada M, 2001, J PLANT PHYSIOL, V158, P121, DOI 10.1078/0176-1617-00231
   Omum JV, 1992, INFO FISH INT, V6, P48
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Oshita K, 2008, ANAL BIOANAL CHEM, V390, P1927, DOI 10.1007/s00216-008-1931-1
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Park SH, 2005, KOREAN J CHITIN CHIT, V10, P55
   Patat SA, 2004, EUR J BIOCHEM, V271, P4825, DOI 10.1111/j.1432-1033.2004.04448.x
   Patidar P, 2005, PROCESS BIOCHEM, V40, P2962, DOI 10.1016/j.procbio.2005.01.013
   Peiselt da Silva KM, 2004, COLLOID SURF A, V237, P15
   Percot A, 2003, BIOMACROMOLECULES, V4, P12, DOI 10.1021/bm025602k
   Prameela K., 2010, INT J APPL BIOL PHAR, V1, P903
   Prameela K, 2010, J PHARM RES, V3, P2888
   Prameela K, 2010, INT J CHEMTECH RES, V2, P1924
   Prameela K, 2010, J PHARM RES, V3, P2393
   Rao MS, 2006, FOOD TECHNOL BIOTECH, V44, P83
   Rao MS, 2005, J CHEM TECHNOL BIOT, V80, P1080, DOI 10.1002/jctb.1286
   Rao MS, 2000, APPL MICROBIOL BIOT, V54, P808, DOI 10.1007/s002530000449
   Rao MS, 2002, ADV CHITIN SCI, VV, P40
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Roberts G. A. F., 1992, CHITIN CHEM, P85
   Rockway SW, 2000, ABSORBITOL FAT BINDI, P1
   Rosenberry B, 1998, WORLD SHRIMP FARMING, P328
   Sachindra NM, 2007, BIORESOURCE TECHNOL, V98, P1642, DOI 10.1016/j.biortech.2006.05.041
   Sachindra NM, 2006, WASTE MANAGE, V26, P1092, DOI 10.1016/j.wasman.2005.07.002
   Sachindra NM, 2008, BIORESOURCE TECHNOL, V99, P9013, DOI 10.1016/j.biortech.2008.04.036
   Sachindra NM, 2005, J SCI FOOD AGR, V85, P167, DOI 10.1002/jsfa.1977
   Sachindra NM, 2005, BIORESOURCE TECHNOL, V96, P1195, DOI 10.1016/j.biortech.2004.09.018
   SAKAGUCHI T, 1981, AGR BIOL CHEM TOKYO, V45, P2191, DOI 10.1080/00021369.1981.10864862
   Shahidi F, 1998, CRIT REV FOOD SCI, V38, P1, DOI 10.1080/10408699891274165
   SHAHIDI F, 1991, J AGR FOOD CHEM, V39, P1527, DOI 10.1021/jf00008a032
   Shirai K, 2001, ENZYME MICROB TECH, V28, P446, DOI 10.1016/S0141-0229(00)00338-0
   Shirai K, 1997, ADV CHITIN SCI, VII, P56
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   SIMPSON B K, 1985, Journal of Applied Biochemistry, V7, P212
   Soltan M. A., 2008, Global Veterinaria, V2, P80
   Stanford PA, 1987, CHITOSAN COMMERCIAL
   Stepnowski P, 2004, CHEMOSPHERE, V54, P413, DOI 10.1016/S0045-6535(03)00718-5
   Struszczyk MH, 2006, GLOBAL REQUIREMENTS, P95
   Subashinge S., 1999, INFOFISH INT, V3, P58
   SUZUKI K, 1986, CARBOHYD RES, V151, P403, DOI 10.1016/S0008-6215(00)90359-8
   Synowiecki J, 2000, FOOD CHEM, V68, P147, DOI 10.1016/S0308-8146(99)00165-X
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   Taco A. G. J., 1997, ADV WOR AQUAC, V6, P411
   Taha SMA, 2002, NAHRUNG, V46, P337, DOI 10.1002/1521-3803(20020901)46:5<337::AID-FOOD337>3.0.CO;2-3
   TANAKA T, 1994, CARCINOGENESIS, V15, P15, DOI 10.1093/carcin/15.1.15
   Vannuccini S, 2004, OVERVIEW FISH PRODUC
   Wang BL, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025606
   Wang SL, 2008, BIORESOURCE TECHNOL, V99, P4386, DOI 10.1016/j.biortech.2007.08.035
   Wang SL, 2006, CARBOHYD RES, V341, P2507, DOI 10.1016/j.carres.2006.06.027
   Wang SL, 1998, ENZYME MICROB TECH, V22, P629, DOI 10.1016/S0141-0229(97)00264-0
   Wenhong C, 2009, FOOD SCI TECHNOL-LEB, V42, P244
   Woods B, 1998, MICROBIOLOGY FERMENT, V1
   Yamazaki S, 2009, ELECTROCHEM COMMUN, V11, P68, DOI 10.1016/j.elecom.2008.10.039
   Yang JK, 2000, ENZYME MICROB TECH, V26, P406, DOI 10.1016/S0141-0229(99)00164-7
   Zakaria Z, 1998, PROCESS BIOCHEM, V33, P1, DOI 10.1016/S0032-9592(97)00069-1
   Zia KM, 2009, COLLOID SURFACE B, V72, P248, DOI 10.1016/j.colsurfb.2009.04.011
NR 153
TC 37
Z9 39
U1 0
U2 66
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JAN
PY 2012
VL 93
IS 1
BP 17
EP 29
DI 10.1007/s00253-011-3651-2
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 873AS
UT WOS:000298853600002
PM 22052390
DA 2018-10-19
ER

PT J
AU Rossi, AL
   Barreto, IC
   Maciel, WQ
   Rosa, FP
   Rocha-Leao, MH
   Werckmann, J
   Rossi, AM
   Borojevic, R
   Farina, M
AF Rossi, Andre L.
   Barreto, Isabela C.
   Maciel, William Q.
   Rosa, Fabiana P.
   Rocha-Leao, Maria H.
   Werckmann, Jacques
   Rossi, Alexandre M.
   Borojevic, Radovan
   Farina, Marcos
TI Ultrastructure of regenerated bone mineral surrounding
   hydroxyapatite-alginate composite and sintered hydroxyapatite
SO BONE
LA English
DT Article
DE Bone implant; Hydroxyapatite-alginate composite; Bone ultrastructure;
   Biomaterials; Biomineralization; HRTEM
ID CRYSTAL-GROWTH MECHANISMS; ELECTRON-MICROSCOPY; IN-VITRO;
   CALCIUM-PHOSPHATE; TRABECULAR BONE; LAMELLAR BONE; COLLAGEN;
   ORGANIZATION; ZEBRAFISH; INTERFACE
AB We report the ultrastructure of regenerated bone surrounding two types of biomaterials: hydroxyapatite-alginate composite and sintered hydroxyapatite. Critical defects in the calvaria of Wistar rats were filled with micrometer-sized spherical biomaterials and analyzed after 90 and 120 days of implantation by high-resolution transmission electron microscopy and Fourier transform infrared attenuated total reflectance microscopy, respectively. Infrared spectroscopy showed that hydroxyapatite of both biomaterials became more disordered after implantation in the rat calvaria, indicating that the biological environment induced modifications in biomaterials structure. We observed that the regenerated bone surrounding both biomaterials had a lamellar structure with type I collagen fibers alternating in adjacent lamella with angles of approximately 90 degrees. In each lamella, plate-like apatite crystals were aligned in the c-axis direction, although a rotation around the c-axis could be present. Bone plate-like crystal dimensions were similar in regenerated bone around biomaterials and pre-existing bone in the rat calvaria. No epitaxial growth was observed around any of the biomaterials. A distinct mineralized layer was observed between new bone and hydroxyapatite-alginate biomaterial. This region presented a particular ultrastructure with crystallites smaller than those of the bulk of the biomaterial, and was possibly formed during the synthesis of alginate-containing composite or in the biological environment after implantation. Round nanoparticles were observed in regions of newly formed bone. The findings of this work contribute to a better understanding of the role of hydroxyapatite based biomaterials in bone regeneration processes at the nanoscale. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Farina, Marcos] Univ Fed Rio de Janeiro, CCS, ICB, Lab Biomineralizacao,Inst Biomed Sci, BR-21941902 Rio de Janeiro, RJ, Brazil.
   [Barreto, Isabela C.; Rosa, Fabiana P.] Univ Fed Bahia, Inst Hlth Sci, BR-41170290 Salvador, BA, Brazil.
   [Rocha-Leao, Maria H.] Univ Fed Rio de Janeiro, Sch Chem, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Farina, M (reprint author), Univ Fed Rio de Janeiro, CCS, ICB, Lab Biomineralizacao,Inst Biomed Sci, BR-21941902 Rio de Janeiro, RJ, Brazil.
EM mfarina@anato.ufrj.br
RI Querido, William/I-4130-2014; Farina, Marcos/I-3744-2014; Rossi,
   Andre/E-8149-2013
OI Querido, William/0000-0002-1484-2415; Rossi, Andre/0000-0002-9920-4411;
   Borojevic, Radovan/0000-0002-2393-7280
FU LME/LNNano/CNPEM; CNPq Brazilian agency; FAPERJ Brazilian agency
FX We thank Jefferson Bettini and LME/LNNano/CNPEM for the technical
   support during the electron microscopy work performed on the EM-3010 URP
   and the Brazilian Center for Physics Research for FTIR analyses. We
   thank CNPq and FAPERJ Brazilian agencies for financial support.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134
   Bonucci E, 2002, J BONE MINER METAB, V20, P249, DOI 10.1007/s007740200037
   CUISINIER FJG, 1995, J CRYST GROWTH, V156, P443, DOI 10.1016/0022-0248(95)00237-5
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Davies JE, 1996, ANAT REC, V245, P426
   De Paula F. L., 2009, Frontiers of Materials Science in China, V3, P145, DOI 10.1007/s11706-009-0029-9
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9
   Hemmerle J, 1997, J DENT RES, V76, P682, DOI 10.1177/00220345970760020901
   Hong SI, 2009, J MATER SCI-MATER M, V20, P1419, DOI 10.1007/s10856-009-3708-2
   Izquierdo-Barba I, 2008, J NANOMATER, DOI 10.1155/2008/106970
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Landis WJ, 2002, COMP BIOCHEM PHYS A, V133, P1135, DOI 10.1016/S1095-6433(02)00248-9
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105
   Mann S., 2001, BIOMINERALIZATION PR
   Mavropoulos E, 2007, J MATER RES, V22, P3371, DOI 10.1557/JMR.2007.0419
   Neumann M, 2006, EUR J TRAUMA, V32, P125, DOI DOI 10.1007/S00068-006-6044-Y
   Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h
   Ozawa H., 2008, J ORAL BIOSCI, V50, P1
   Parhi P, 2006, J APPL POLYM SCI, V102, P5162, DOI 10.1002/app.24706
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   Thian ES, 2002, BIOMATERIALS, V23, P2927, DOI 10.1016/S0142-9612(01)00422-7
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F
   WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0
   Yang L, 2007, BIOMED MATER, V2, P21, DOI 10.1088/1748-6041/2/1/004
   ZHOU H, 1994, J BONE MINER RES, V9, P367
   Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X
NR 37
TC 14
Z9 15
U1 1
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD JAN
PY 2012
VL 50
IS 1
BP 301
EP 310
DI 10.1016/j.bone.2011.10.022
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 875VV
UT WOS:000299064200038
PM 22057083
DA 2018-10-19
ER

PT J
AU Pramod, K
   Shanavas, S
   Ansari, SH
   Ali, J
AF Pramod, K.
   Shanavas, S.
   Ansari, Shahid H.
   Ali, Javed
TI Sol-gel behavior of a novel nanodroplet biomaterial for drug delivery
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Eugenol; Nanodroplet; Frequency sweep; Creep recovery; Thixotropy
ID RHEOLOGICAL PROPERTIES; CARBOPOL GELS; FORMULATIONS; THIXOTROPY;
   TRANSITION; EMULSIONS; PH
AB Nanodroplets can be considered as those nano/microemulsions in which the oil itself forms the active agent and the droplet size ambits in the nanometer range. Eugenol is an anti-inflammatory agent and its nanodroplet gel (NDG) has immense potential for topical use. Topical gels oblige some rheological characteristics to nail down the demands of proper application, stability and storage. Thus, the purpose of our study was to comprehend the effect of eugenol on the sol-gel tranisition properties of its NDGs. Towards this goal nanodroplets of eugenol were prepared and evaluated and the three selected nanodroplet formulations with 5, 10 and 5% v/v eugenol were converted into topical gel formulation using 1% w/w Carbopol 940. The NDGs were characterized using frequency sweep, creep recovery and thixotropy. All these tests pointed out that eugenol concentration has significant effect on the sol-gel behavior of NDGs. The NDGs exhibited more viscous (sol) properties than elastic (gel) properties as observed from the frequency sweep studies. The thixotropy of the NDGs was found to decrease with increase in eugenol concentration. Efforts have been made to explain the study results using mechanistic approach. The outcomes of our research studies could be of great use in future endeavors towards development of a topical NDG of eugenol with tailored sol-gel behavior.
C1 [Pramod, K.; Ali, Javed] Jamia Hamdard, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India.
   [Shanavas, S.] Cent Tuber Crops Res Inst, Starch Characterizat Lab, Div Crop Utilizat, Thiruvananthapuram 695017, Kerala, India.
   [Ansari, Shahid H.] Jamia Hamdard, Fac Pharm, Dept Pharmacognosy & Phytochem, New Delhi 110062, India.
RP Ali, J (reprint author), Jamia Hamdard, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India.
EM javedaali@yahoo.com
OI Pramod, Kannissery/0000-0002-8689-3369; Ali, Javed/0000-0001-5308-0655
FU Indian Council of Medical Research (ICMR), New Delhi, India
   [35/3/10/NAN/BMS]
FX Mr. Pramod K gratefully acknowledges Indian Council of Medical Research
   (ICMR), New Delhi, India, for providing Senior Research Fellowship (No.
   35/3/10/NAN/BMS).
CR Armelin E, 2006, PROG ORG COAT, V57, P229, DOI 10.1016/j.porgcoat.2006.09.002
   Audebrand M, 2006, BIOMACROMOLECULES, V7, P2811, DOI 10.1021/bm060297e
   Bali V, 2010, J DRUG TARGET, V18, P506, DOI 10.3109/10611860903548362
   Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9
   BARRY BW, 1979, INT J PHARM, V2, P27, DOI 10.1016/0378-5173(79)90026-7
   BARRY BW, 1979, INT J PHARMACEUT, V2, P1, DOI 10.1016/0378-5173(79)90025-5
   Baudez JC, 2006, J ENVIRON MANAGE, V78, P232, DOI 10.1016/j.jenvman.2005.04.020
   Bonacucina G, 2004, INT J PHARM, V282, P115, DOI 10.1016/j.ijpharm.2004.06.012
   Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691
   Guibaud G, 2005, PROCESS BIOCHEM, V40, P2671, DOI 10.1016/j.procbio.2004.12.014
   Islam MT, 2004, PHARM RES, V21, P1192, DOI 10.1023/B:PHAM.0000033006.11619.07
   Kim JY, 2003, COLLOID POLYM SCI, V281, P614, DOI 10.1007/s00396-002-0808-7
   Lapasin R, 2001, RHEOL ACTA, V40, P185, DOI 10.1007/s003970000151
   Lee CH, 2009, J CONTROL RELEASE, V136, P88, DOI 10.1016/j.jconrel.2009.02.013
   Masalova I, 2007, COLLOID J+, V69, P185, DOI 10.1134/S1061933X0702007X
   Mewis J, 2009, ADV COLLOID INTERFAC, V147-48, P214, DOI 10.1016/j.cis.2008.09.005
   OLDROYD JG, 1955, PROC R SOC LON SER-A, V232, P567, DOI 10.1098/rspa.1955.0240
   Ozturk A., 2005, European Journal of General Medicine, V2, P159
   Pramod K, 2010, NAT PROD COMMUN, V5, P1999
   Russell J.L., 1936, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V154, P540, DOI 10.1098/rspa.1936.0066
   Steffe J. F., 1996, RHEOLOGICAL METHODS
   Valenta C, 2004, J CONTROL RELEASE, V95, P257, DOI 10.1016/j.jconrel.2003.11.020
   Wilking JN, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041407
NR 23
TC 2
Z9 2
U1 0
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JAN
PY 2012
VL 61
IS 1
BP 161
EP 168
DI 10.1007/s10971-011-2605-6
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 876CD
UT WOS:000299083700023
DA 2018-10-19
ER

PT J
AU Popp, JR
   Laflin, KE
   Love, BJ
   Goldstein, AS
AF Popp, Jenni R.
   Laflin, Kate E.
   Love, Brian J.
   Goldstein, Aaron S.
TI Fabrication and characterization of poly(lactic-co-glycolic acid)
   microsphere/amorphous calcium phosphate scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE ACP; HAP; ion release; zinc; zirconia
ID BONE-FORMATION; METAL-IONS; IN-VITRO; HYDROXYAPATITE; TRANSFORMATION;
   PRECIPITATION; CERAMICS
AB Although hydroxyapatite (HAP) and beta-tricalcium phosphate have been used extensively as osteoconductive minerals in biomaterial scaffolds for bone regeneration, they lack the capacity to stimulate osteoblastic differentiation of progenitor cells. In contrast, amorphous calcium phosphates (ACPs), which convert to HAP under aqueous conditions, have the potential to facilitate osteoblastic differentiation through the transient local release of calcium and phosphate ions. Therefore, in this study ACPs were synthesized using zinc and zirconia divalent cations as stabilizers (denoted ZnACP and ZrACP, respectively) and compared to HAP. Analysis of ion release into serum-containing cell culture medium revealed transiently elevated levels of calcium and phosphorous, consistent with the enhanced solubility of ZrACP and ZnACP relative to HAP. In addition, X-ray diffraction analysis revealed partial conversion of ZrACP to HAP but no conversion of ZnACP after 96 h. Next, scaffolds were fabricated by sintering mixtures of 300500 mu m poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres and 0.5 wt% calcium phosphate mineral (HAP, ZrACP or ZnACP) at 70 degrees C for 24 h. Scanning electron microscopy revealed a porous microsphere matrix with calcium phosphate particulates clinging to the microsphere surfaces both prior to and after 14 days in culture medium. Finally, the incorporation of calcium phosphate resulted in a lower compressive modulus in the range 127 to 7489 MPa. Taken together, these results indicate that ZrACP, ZnACP and HAP minerals exhibit very different properties, and therefore may elicit different osteoblastic responses in vitro. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Laflin, Kate E.; Goldstein, Aaron S.] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   [Popp, Jenni R.; Love, Brian J.; Goldstein, Aaron S.] Virginia Polytech Inst & State Univ, Virginia Tech Wake Forest Sch Biomed Engn, Blacksburg, VA 24061 USA.
   [Love, Brian J.] Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
RI Love, Brian/A-8702-2008
OI Love, Brian/0000-0002-7319-5481
FU Institute for Critical Technologies and Applied Sciences at Virginia
   Tech
FX The authors would like to thank Dr Drago Skrtic for his assistance with
   ACP synthesis. This work was supported by funds from the Institute for
   Critical Technologies and Applied Sciences at Virginia Tech.
CR Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Clesceri L.S., 1998, STANDARD METHODS EXA
   Cushnie EK, 2008, J BIOMED MATER RES A, V84A, P54, DOI 10.1002/jbm.a.31380
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Eanes E D, 2001, Monogr Oral Sci, V18, P130
   Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200
   Hayakawa T, 2010, J MATER SCI-MATER M, V21, P251, DOI 10.1007/s10856-009-3830-1
   HIDAKA S, 1994, J BIOMED MATER RES, V28, P175, DOI 10.1002/jbm.820280206
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   JEFFERY H, 1991, INT J PHARM, V77, P169, DOI 10.1016/0378-5173(91)90314-E
   Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018
   Kim SS, 2007, J BIOMED MATER RES A, V80A, P206, DOI 10.1002/jbm.a.30836
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Laflin KE, 2010, J TISSUE ENG REGEN M, DOI [10.1002/term376, DOI 10.1002/TERM376]
   Lee KY, 2006, BIOMED MATER, V1, pR31, DOI 10.1088/1748-6041/1/2/R01
   Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037
   Mendes SC, 2002, J MATER SCI-MATER M, V13, P575, DOI 10.1023/A:1015178827323
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Ogata K, 2005, J BIOMED MATER RES A, V72A, P127, DOI 10.1002/jbm.a.30146
   OKAMOTO Y, 1994, J BIOMED MATER RES, V28, P1403, DOI 10.1002/jbm.820281204
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   Skrtic D, 2002, J BIOMED MATER RES, V59, P597, DOI 10.1002/jbm.10017
   ter Brugge PJ, 2003, CLIN ORAL IMPLAN RES, V14, P472, DOI 10.1034/j.1600-0501.2003.00886.x
   Whited BM, 2006, J BIOMED MATER RES A, V76A, P596, DOI 10.1002/jbm.a.30573
NR 26
TC 7
Z9 7
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2012
VL 6
IS 1
BP 12
EP 20
DI 10.1002/term.390
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 871JS
UT WOS:000298734700002
PM 21312335
DA 2018-10-19
ER

PT J
AU Cheema, U
   Rong, ZM
   Kirresh, O
   MacRobert, AJ
   Vadgama, P
   Brown, RA
AF Cheema, Umber
   Rong, Zimei
   Kirresh, Omar
   MacRobert, Alexander J.
   Vadgama, Pankaj
   Brown, Robert A.
TI Oxygen diffusion through collagen scaffolds at defined densities:
   implications for cell survival in tissue models
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE collagen scaffold; oxygen diffusion; oxygen permeability; photochemical
   crosslinking
ID NEEDLE ENZYME ELECTRODE; IN-VIVO; 3-DIMENSIONAL SCAFFOLDS;
   SKELETAL-MUSCLE; COMPRESSION; CONSTRUCTS; GRADIENTS; KINETICS; MATRICES;
   GROWTH
AB For the success of any biomaterial for tissue engineering, its mechanical properties and ability to support nutrient diffusion will be critical. Collagen scaffolds are ideal candidates, due to their ability to immerse cells in a biomimetic nanofibrous matrix. We have established O2 diffusion coefficients through native, dense collagen scaffolds at two tissue-like densities, with and without photo-chemical crosslinking, by adapting an optical fibre-based system for real-time core O2 monitoring deep within collagen constructs. Using a Fick's law model, we then derived O2 diffusion coefficients; 4.5 x 10(-6) cm2/s for 11% density collagen scaffolds; 1.7 x 10(-6) cm2/s for 34% collagen scaffolds; 3.4 x 10(-6) cm2/s for photochemically crosslinked collagen scaffolds at 11%. Both O2 diffusion coefficients of the 11% collagen fall within the range of native intestinal submucosa. The high diffusion coefficients of these collagen scaffolds, as well as their material properties, render them viable tissue-engineering matrices for tissue replacement. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Cheema, Umber; Kirresh, Omar; Brown, Robert A.] UCL, UCL Div Surg & Intervent Sci, Inst Orthopaed & Musculoskeletal Sci, Tissue Repair & Engn Ctr, London HA7 4LP, England.
   [Rong, Zimei; Vadgama, Pankaj] Queen Mary Univ London, IRC Biomed Mat, London, England.
   [MacRobert, Alexander J.] UCL, UCL Div Surg & Intervent Sci, Natl Med Laser Ctr, London HA7 4LP, England.
RP Cheema, U (reprint author), UCL, UCL Div Surg & Intervent Sci, Inst Orthopaed & Musculoskeletal Sci, Tissue Repair & Engn Ctr, Stanmore Campus,Brockley Hill, London HA7 4LP, England.
EM u.cheema@ucl.ac.uk
OI Rong, Zimei/0000-0002-7642-3160; vadgama, pankaj/0000-0001-6696-6017
FU BBSRC, UK; Biotechnology and Biological Sciences Research Council
   [BB/F023774/1, E18399]
FX Umber Cheema is a BBSRC David Phillips Fellow and is funded through this
   route. This work was additionally supported by the BBSRC, UK. We would
   like to acknowledge Mike Wiseman for his help with the SEM images.
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Afoke A, 1998, J HAND SURG-BRIT EUR, V23B, P291, DOI 10.1016/S0266-7681(98)80043-0
   Aguilar-Armenta G, 2001, J PHYS CHEM B, V105, P1313, DOI 10.1021/jp9934331
   Androjna C, 2008, TISSUE ENG PT A, V14, P559, DOI 10.1089/tea.2006.0361
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Cheema U, 2008, CELL MOL LIFE SCI, V65, P177, DOI 10.1007/s00018-007-7356-8
   Cheema U, 2007, BIOTECHNOL BIOPROC E, V12, P9, DOI 10.1007/BF02931797
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Dunn JCY, 2006, TISSUE ENG, V12, P705, DOI 10.1089/ten.2006.12.705
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Huang R, 2004, J FOOD SCI, V69, pC726
   Ibusuki S, 2007, TISSUE ENG, V13, P1995, DOI 10.1089/ten.2006.0153
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   KAWASHIRO T, 1975, PFLUG ARCH EUR J PHY, V359, P219, DOI 10.1007/BF00587381
   Lelong G, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1884989
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Mudera V, 2007, J TISSUE ENG REGEN M, V1, P192, DOI 10.1002/term.25
   NYBERG SL, 1991, BIOTECHNOL TECH, V5, P449
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Rong ZM, 2008, IEEE SENS J, V8, P113, DOI 10.1109/JSEN.2007.912919
   Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f
   Seddon BM, 2001, RADIAT RES, V155, P837, DOI 10.1667/0033-7587(2001)155[0837:MOTOIV]2.0.CO;2
   Valentin JE, 2009, J BIOMED MATER RES A, V91A, P1010, DOI 10.1002/jbm.a.32328
   VIVIAN JE, 1964, AICHE J, V10, P220, DOI 10.1002/aic.690100217
   WOLLWEBER L, 1981, J MICROSC-OXFORD, V121, P185, DOI 10.1111/j.1365-2818.1981.tb01211.x
   Woo SLY, 1991, INJURY REPAIR MUSCUL, P86
NR 26
TC 31
Z9 31
U1 1
U2 43
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2012
VL 6
IS 1
BP 77
EP 84
DI 10.1002/term.402
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 871JS
UT WOS:000298734700009
PM 21312340
DA 2018-10-19
ER

PT J
AU Heard, A
   Socrate, S
   Burke, K
   Norwitz, E
   Kaplan, D
   House, M
AF Heard, Asha
   Socrate, Simona
   Burke, Kelly
   Norwitz, Errol
   Kaplan, David
   House, Michael
TI A silk-based injectable biomaterial as an alternative to cervical
   cerclage: an in-vitro study
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 32nd Annual Scientific Meeting/Pregnancy Meeting of
   Society-for-Maternal-Fetal-Medicine
CY FEB 06-11, 2012
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Heard, Asha; House, Michael] Tufts Med Ctr, Div Maternal Fetal Med, Boston, MA USA.
   [Socrate, Simona] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Burke, Kelly; Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Norwitz, Errol] Tufts Univ, Sch Med, Medford, MA 02155 USA.
NR 0
TC 0
Z9 0
U1 1
U2 11
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2012
VL 206
IS 1
SU S
MA 644
BP S288
EP S288
DI 10.1016/j.ajog.2011.10.662
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 873NL
UT WOS:000298889900642
OA Green Published
DA 2018-10-19
ER

PT J
AU Olsson, ALJ
   Sharma, PK
   van der Mei, HC
   Busscher, HJ
AF Olsson, Adam L. J.
   Sharma, Prashant K.
   van der Mei, Henny C.
   Busscher, Henk J.
TI Adhesive Bond Stiffness of Staphylococcus aureus with and without
   Proteins That Bind to an Adsorbed Fibronectin Film
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; QCM-D; ADHERENCE; ADSORPTION; BIOSENSOR;
   FREQUENCY; SURFACES; GENES
AB Staphylococcus aureus is known to cause biomaterial-associated infections of implants and devices once it has breached the skin and mucosal barriers. Adhesion is the initial step in the development of a biomaterial-associated infection, and strategies to prevent staphylococcal adhesion and thus biomaterial-associated infections require understanding of the adhesive bond. The aim of this study was to compare the adhesive bond stiffnesses of two S. aureus strains with and without fibronectin-binding proteins (FnBPs) adhering to a fibronectin-coated quartz crystal microbalance (QCM) sensor surface on the basis of a coupled- resonance model. Both fibronectin adsorption and staphylococcal adhesion were accompanied by negative frequency shifts, regardless of the absence or presence of FnBPs on the staphylococcal cell surfaces. This is the opposite of the positive frequency shifts often observed for other bacterial strains adhering to bare sensor surfaces. Most likely, adhering staphylococci sink into and deform the adsorbed protein layer, creating stiff binding with the sensor surface due to an increased bacterium-substratum contact area. S. aureus 8325-4 possesses FnBPs and yields less negative frequency shifts (Delta f) that are further away from the zero-crossing frequency than S. aureus DU5883. This suggests that FnBPs on S. aureus 8325-4 create a stiffer bond to the fibronectin coating than has been observed for S. aureus DU5883. Due to a limited window of observation, as defined by the available resonance frequencies in QCM, we could not determine exact stiffness values.
C1 [Sharma, Prashant K.] Univ Med Ctr, Dept Biomed Engn, WJ Kolff Inst, Groningen, Netherlands.
   Univ Groningen, Groningen, Netherlands.
RP Sharma, PK (reprint author), Univ Med Ctr, Dept Biomed Engn, WJ Kolff Inst, Groningen, Netherlands.
EM p.k.sharma@umcg.nl
FU ZON-MW [91107008]
FX We thank ZON-MW for grant 91107008, enabling the purchase of the quartz
   crystal microbalance Qsense-E1 and -E4.
CR Berglin M, 2008, MACROMOL BIOSCI, V8, P410, DOI 10.1002/mabi.200700218
   DYBWAD GL, 1985, J APPL PHYS, V58, P2789, DOI 10.1063/1.335874
   Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   Johannsmann D, 1999, MACROMOL CHEM PHYS, V200, P501
   Kwon KD, 2006, ENVIRON SCI TECHNOL, V40, P7739, DOI 10.1021/es061715q
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Molino PJ, 2008, LANGMUIR, V24, P6730, DOI 10.1021/la800672h
   Olofsson AC, 2005, APPL ENVIRON MICROB, V71, P2705, DOI 10.1128/AEM.71.5.2705-2712.2005
   Olsen EV, 2003, J MICROBIOL METH, V53, P273, DOI 10.1016/S0167-7012(03)00031-9
   Olsson ALJ, 2011, J COLLOID INTERF SCI, V357, P135, DOI 10.1016/j.jcis.2011.01.035
   Olsson ALJ, 2009, LANGMUIR, V25, P1627, DOI 10.1021/la803301q
   Peacock SJ, 1999, MICROBIOL-UK, V145, P3477, DOI 10.1099/00221287-145-12-3477
   Poitras C, 2009, BIOSENS BIOELECTRON, V24, P2137, DOI 10.1016/j.bios.2008.11.016
   Poitras C, 2009, WATER RES, V43, P2631, DOI 10.1016/j.watres.2009.03.021
   Pomorska A, 2010, ANAL CHEM, V82, P2237, DOI 10.1021/ac902012e
   Rawle RJ, 2007, LANGMUIR, V23, P9563, DOI 10.1021/la702043t
   Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494
   SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   Vaughan RD, 2001, ENZYME MICROB TECH, V29, P635, DOI 10.1016/S0141-0229(01)00449-5
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08
NR 25
TC 11
Z9 11
U1 2
U2 23
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JAN
PY 2012
VL 78
IS 1
BP 99
EP 102
DI 10.1128/AEM.06912-11
PG 4
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 866QR
UT WOS:000298396700013
PM 22038608
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Su, HL
   Xu, J
   Chen, JJ
   Moon, WJ
   Zhang, D
AF Su, Huilan
   Xu, Jia
   Chen, Jianjun
   Moon, Won-Jin
   Zhang, Di
TI In situ formation and assembly of CdS nanocrystallites into polyhedrons
   on Eggshell membrane at room temperature
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID SILICON-CARBIDE CERAMICS; QUANTUM DOTS; NANOWIRES; NANOCLUSTERS;
   TEMPLATES; PROTEIN; MATRIX; GROWTH; WOOD
AB A room-temperature soakage procedure was carried out to successfully form and assemble CdS nanocrystallites into polyhedrons on the eggshell membrane (ESM). Based on the biomaterial ESM served as the reactive substrate and some ESM biomacromolecules acted as the surfactants, CdS nanocrystallites were in situ formed, further assembled into well-distributed polyhedrons, and finally performed CdS-ESM hybrid nanocomposites. This moderate bioinspired strategy would also be of great value to prepare novel functional nanocomposites.
C1 [Su, Huilan; Xu, Jia; Chen, Jianjun; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
   [Moon, Won-Jin] Korea Basic Sci Inst, Gwangjun Ctr, Kwangju 500757, South Korea.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
EM hlsu@sjtu.edu.cn; zhangdi@sjtu.edu.cn
FU NSFC [51102165]; Shanghai Science and Technology Committee [10JC1407600,
   09ZR1414700, 09520703400]; MOST of China [2009DFA52410]; KBSI [T31903];
   973 National Project
FX Financial support of the 973 National Project, NSFC (Grant No.
   51102165), the Shanghai Science and Technology Committee (Nos.
   10JC1407600, 09ZR1414700, 09520703400), Sino-French Project of MOST of
   China (No. 2009DFA52410), and KBSI grant (T31903) to W.-J. Moon is
   gratefully acknowledged.
CR Ahmad A, 2002, J AM CHEM SOC, V124, P12108, DOI 10.1021/ja0272960o
   Ajikumar PK, 2003, BIOMACROMOLECULES, V4, P1321, DOI 10.1021/bm034101b
   Chen YF, 2002, ANAL CHEM, V74, P5132, DOI 10.1021/ac0258251
   DAMERON CT, 1990, INORG CHEM, V29, P1343, DOI 10.1021/ic00332a011
   Dong LF, 2003, CHEM PHYS LETT, V376, P653, DOI 10.1016/S0009-2614(03)01059-5
   Du H, 2002, CHEM MATER, V14, P4473, DOI 10.1021/cm010622z
   Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Fernando G.T., 2010, ACTA BIOMATER, V6, P3687
   Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3
   Greil P, 2001, J EUR CERAM SOC, V21, P105, DOI 10.1016/S0955-2219(00)00179-5
   Greil P, 1998, J EUR CERAM SOC, V18, P1975, DOI 10.1016/S0955-2219(98)00155-1
   Huang J.G., 2003, J AM CHEM SOC, V125, P11843
   Jun YW, 2001, J AM CHEM SOC, V123, P5150, DOI 10.1021/ja0157595
   LEACH RM, 1982, POULTRY SCI, V61, P2040, DOI 10.3382/ps.0612040
   Levina L, 2005, ADV MATER, V17, P1854, DOI 10.1002/adma.200401197
   Meldrum FC, 2000, CHEM COMMUN, P29, DOI 10.1039/a907074e
   Nakano T, 2001, POULTRY SCI, V80, P681, DOI 10.1093/ps/80.5.681
   Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m
   Routkevitch D, 1996, J PHYS CHEM-US, V100, P14037, DOI 10.1021/jp952910m
   Sapra S, 2001, CHEM COMMUN, P2188, DOI 10.1039/b106420g
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Shin YS, 2001, ADV MATER, V13, P728, DOI 10.1002/1521-4095(200105)13:10<728::AID-ADMA728>3.0.CO;2-J
   Sikes CS, 1998, BIOL BULL-US, V194, P304, DOI 10.2307/1543100
   Su HL, 2006, J MEMBRANE SCI, V283, P7, DOI 10.1016/j.memsci.2006.07.010
   Su HL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/02/025601
   Wang CW, 2004, LANGMUIR, V20, P11784, DOI 10.1021/la048390g
   Xu DS, 2000, ADV MATER, V12, P520, DOI 10.1002/(SICI)1521-4095(200004)12:7<520::AID-ADMA520>3.0.CO;2-#
   Yao WT, 2006, J PHYS CHEM B, V110, P11704, DOI 10.1021/jp060164n
   Zhan JH, 2000, ADV MATER, V12, P1348, DOI 10.1002/1521-4095(200009)12:18<1348::AID-ADMA1348>3.0.CO;2-X
NR 30
TC 10
Z9 11
U1 1
U2 26
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JAN
PY 2012
VL 106
IS 1
BP 93
EP 97
DI 10.1007/s00339-011-6561-3
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 870BM
UT WOS:000298644100013
DA 2018-10-19
ER

PT J
AU Kiyan, Y
   Limbourg, A
   Kiyan, R
   Tkachuk, S
   Limbourg, FP
   Ovsianikov, A
   Chichkov, BN
   Haller, H
   Dumler, I
AF Kiyan, Yulia
   Limbourg, Anne
   Kiyan, Roman
   Tkachuk, Sergey
   Limbourg, Florian P.
   Ovsianikov, Aleksandr
   Chichkov, Boris N.
   Haller, Hermann
   Dumler, Inna
TI Urokinase Receptor Associates With Myocardin to Control Vascular Smooth
   Muscle Cells Phenotype in Vascular Disease
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article
DE plasminogen activators; receptors; vascular muscle; remodeling;
   urokinase
ID PLASMINOGEN-ACTIVATOR RECEPTOR; SERUM RESPONSE FACTOR; NEOINTIMA
   FORMATION; GENE-EXPRESSION; DEFICIENT MICE; MATRIX-METALLOPROTEINASE;
   NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; PDGFR-BETA; DIFFERENTIATION
AB Objective-The urokinase-type plasminogen activator (uPA) and its specific receptor (uPAR) are a potent multifunctional system involved in vascular remodeling. The goal of the study was to unravel the mechanisms of uPA/uPAR-directed vascular smooth muscle cell (VSMC) differentiation.
   Methods and Results-Using cultured human primary VSMCs, we identified a new molecular mechanism controlling phenotypic modulation in vitro and in vivo. We found that the urokinase-type plasminogen activator receptor (uPAR) acts together with the transcriptional coactivator myocardin to regulate the VSMC phenotype. uPAR, a glycosylphosphatidylinositol-anchored cell-surface receptor family member, undergoes ligand-induced internalization and nuclear transport in VSMCs. Platelet-derived growth factor receptor beta and SUMOylated RanGAP1 mediate this trafficking. Nuclear uPAR associates with myocardin, which is then recruited from the promoters of serum response factor target genes and undergoes proteasomal degradation. This chain of events initiates the synthetic VSMC phenotype. Using mouse carotid artery ligation model, we show that this mechanism contributes to adverse vascular remodeling after injury in vivo. We then cultured cells on a microstructured biomaterial and found that substrate topography induced uPAR-mediated VSMC differentiation.
   Conclusion-These findings reveal the transcriptional activity of uPAR, controlling the differentiation of VSMCs in a vascular disease model. They also suggest a new role for uPAR as a therapeutic target and as a marker for VSMC phenotyping on prosthetic biomaterials. (Arterioscler Thromb Vasc Biol. 2012;32:110-122.)
C1 [Kiyan, Yulia; Tkachuk, Sergey; Haller, Hermann; Dumler, Inna] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany.
   [Limbourg, Anne] Hannover Med Sch, Integrated Res & Treatment Ctr, Dept Cardiol & Angiol, D-30625 Hannover, Germany.
   [Limbourg, Florian P.] Hannover Med Sch, Jr Res Grp Regenerat Agents, Excellence Cluster REBIRTH Dept Cardiol & Angiol, D-30625 Hannover, Germany.
   [Kiyan, Roman; Ovsianikov, Aleksandr; Chichkov, Boris N.] Laser Zentrum Hannover eV, Nanotechnol Dept, Hannover, Germany.
RP Kiyan, Y (reprint author), Hannover Med Sch, Dept Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM kiian.ioulia@mh-hannover.de
RI Ovsianikov, Aleksandr/K-8128-2015; Chichkov, Boris/M-4112-2015
OI Ovsianikov, Aleksandr/0000-0001-5846-0198; Chichkov,
   Boris/0000-0002-8129-7373; Kiyan, Yulia/0000-0002-2063-6327
FU Bundesministerium fur Bildung und Forschung [01 ET 0802]; Else
   Kroener-Fresenius-Stiftung [P59/10//A101/10]; Integrated Research and
   Treatment Center; Deutsche Forschungsgemeinschaft [DU 344/6-1, DU
   344/7-1]; Junior Research Group Regenerative Agents; Cluster of
   Excellence REBIRTH (From Regenerative Biology to Reconstructive
   Therapy);  [Sonderforschungsbereich Transregio 37]
FX This work was supported by an ERA-AGE FLARE grant financed by
   Bundesministerium fur Bildung und Forschung (01 ET 0802); Grant
   P59/10//A101/10 from Else Kroener-Fresenius-Stiftung; Integrated
   Research and Treatment Center; Grants DU 344/6-1 and DU 344/7-1 from the
   Deutsche Forschungsgemeinschaft; Junior Research Group Regenerative
   Agents; the Cluster of Excellence REBIRTH (From Regenerative Biology to
   Reconstructive Therapy); and Sonderforschungsbereich Transregio 37.
CR Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912
   Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669
   Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977
   Bryer SC, 2007, AM J PHYSIOL-REG I, V293, pR1152, DOI 10.1152/ajpregu.00132.2007
   Carmeliet P, 1998, THROMB RES, V91, P255, DOI 10.1016/S0049-3848(98)00122-4
   Carmeliet P, 1997, CIRC RES, V81, P829
   Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086
   Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41
   CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609
   Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730
   Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467
   Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489
   FALLIERBECKER P, 1990, CELL CULTURE TECHNIQ, P247
   Farsari M, 2009, NAT PHOTONICS, V3, P450, DOI 10.1038/nphoton.2009.131
   Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220
   Gu JM, 2005, J CELL PHYSIOL, V204, P73, DOI 10.1002/jcp.20262
   Jerke U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008302
   Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960
   Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959
   Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541
   Kiian I, 2003, THROMB HAEMOSTASIS, V89, P904
   Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669
   Kiyan J, 2007, ATHEROSCLEROSIS, V195, P254, DOI 10.1016/j.atherosclerosis.2006.12.030
   Kiyan J, 2009, BIOCHEM J, V423, P343, DOI 10.1042/BJ20090447
   Kunigal S, 2003, BLOOD, V102, P4377, DOI 10.1182/blood-203-12-3872
   Kusch A, 2000, J BIOL CHEM, V275, P39466, DOI 10.1074/jbc.M003626200
   Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc/E02-03-0122
   Lamfers MLM, 2002, CIRC RES, V91, P945, DOI 10.1161/01.RES.0000041418.51906.57
   Li HJ, 2007, P NATL ACAD SCI USA, V104, P4065, DOI 10.1073/pnas.0611639104
   Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100
   Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017
   Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X
   Mukai Y, 2006, J CLIN INVEST, V116, P334, DOI 10.1172/JCI26223
   Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006
   Quax PHA, 2001, CIRCULATION, V103, P562, DOI 10.1161/01.CIR.103.4.562
   Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   Shushakova N, 2005, J IMMUNOL, V175, P4060, DOI 10.4049/jimmunol.175.6.4060
   Steggerda SM, 2002, INT REV CYTOL, V217, P41
   Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56
   Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455
   Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200
   van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013
   Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4
   Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100
   Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08
   Yin H, 2011, J CELL PHYSIOL, V226, P1897, DOI 10.1002/jcp.22519
NR 50
TC 15
Z9 20
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1079-5642
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD JAN
PY 2012
VL 32
IS 1
BP 110
EP 122
DI 10.1161/ATVBAHA.111.234369
PG 13
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 865CP
UT WOS:000298288700016
PM 22075245
OA Bronze
DA 2018-10-19
ER

PT J
AU Tan, HL
   Peng, ZX
   Li, QT
   Xu, XF
   Guo, SR
   Tang, TT
AF Tan, Honglue
   Peng, Zhaoxiang
   Li, Qingtian
   Xu, Xiaofen
   Guo, Shengrong
   Tang, Tingting
TI The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation
   and downregulate the virulence-associated gene expression of
   antibiotic-resistant staphylococcus
SO BIOMATERIALS
LA English
DT Article
DE PMMA bone cement; Quaternised chitosan; Antibiotic-resistant
   staphylococcus; Biofilm formation; Ica genes; MecA genes
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; REDUCING BACTERIAL ADHESION;
   BONE-CEMENT; IN-VITRO; METHICILLIN RESISTANCE; MECHANICAL-PROPERTIES;
   OSTEOBLAST FUNCTIONS; BIOMEDICAL POLYMERS; TOTAL HIP; EPIDERMIDIS
AB Biomaterial-associated infections remain a serious complication in orthopaedic surgery. Treatments, including the local use of antibiotic-loaded polymethylmethacrylate (PMMA) bone cement, are not always successful because of multiantibiotic-resistant organisms. In this study, we synthesised a new quaternised chitosan derivative (hydroxypropyltrimethyl ammonium chloride chitosan, HACC) that contains a series of substitutions of quaternary ammonium and demonstrated that HACC with a 26% degree of substitution (DS; referred to as 26%HACC) had a strong antibacterial activity and simultaneously good biocompatibility with osteogenic cells. We loaded 26%HACC at 20% by weight into PMMA bone cement to investigate whether HACC in PMMA prevents bacterial biofilm formation on the surface of bone cements. Chitosan-loaded PMMA (at the same weight ratio), gentamicin-loaded PMMA and PMMA with no antibiotic were also investigated and compared. Two clinical isolates, Staphylococcus epidermidis 389 and methicillin-resistant S. epidermidis (MRSE287), and two standard strains, S. epidermidis (ATCC35984) and methicillin-resistant Staphylococcus aureus (ATCC43300), were selected to evaluate the bacterial biofilm formation at 6,12 and 24 h using the spread plate method, confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). The results showed that 26% HACC-loaded PMMA inhibited biofilm formation on its surface, while the PMMA control and chitosan-loaded PMMA were unable to inhibit biofilm formation. The gentamicin-loaded PMMA decreased the number of viable methicillin-resistant Staphylococcus strains, but its ability to inhibit biofilm formation was lower than 26%HACC-loaded PMMA. Real-time PCR demonstrated that 26%HACC-loaded PMMA markedly downregulated the expression of icaAD, which encodes essential enzymes for polysaccharide intercellular adhesion (PIA) biosynthesis, upregulated the expression level of icaR, which negatively mediates icaAD expression, and also downregulated the expression of MecA, which encodes membrane-bound enzymes known to be penicillin-binding proteins. Our study indicates that 26%HACC-loaded PMMA prevents biofilm formation of Staphylococcus, including antibiotic-resistant strains, on the surface of bone cement, and downregulates the virulence-associated gene expression of antibiotic-resistant staphylococcus, thus providing a promising new strategy for combating implant infections and osteomyelitis. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tan, Honglue; Peng, Zhaoxiang; Tang, Tingting] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed Surg, Shanghai Key Lab Orthopaed Implant,Sch Med, Shanghai, Peoples R China.
   [Li, Qingtian] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China.
   [Xu, Xiaofen; Guo, Shengrong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China.
RP Tang, TT (reprint author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed Surg, Shanghai Key Lab Orthopaed Implant,Sch Med, Shanghai, Peoples R China.
EM tingtingtang@hotmail.com
RI Tang, Tingting/B-1361-2013
OI Tang, Tingting/0000-0002-1670-7452; yan, wei/0000-0001-5575-7017
FU Shanghai Science and Technology Development Fund [08jc1414200,
   09441900107, 1052nm04600]; Shanghai Municipal Education Commission;
   Shanghai Municipal Education Commission [050206]; National Natural
   Science Foundation of China [81000708]
FX This research was supported by grants from the Shanghai Science and
   Technology Development Fund (08jc1414200, 09441900107, 1052nm04600), the
   continuing support program for Shu-guang scholars of the Shanghai
   Municipal Education Commission, the Program for Key Disciplines of the
   Shanghai Municipal Education Commission 050206) and the National Natural
   Science Foundation of China (81000708).
CR Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Arciola CR, 2006, J BIOMED MATER RES A, V76A, P425, DOI 10.1002/jbm.a.30552
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Bjerkan G, 2009, ACTA ORTHOP, V80, P245, DOI 10.3109/17453670902947457
   Bourne RB, 2004, J ARTHROPLASTY, V19, P69, DOI 10.1016/j.arth.2004.03.005
   Cabanillas PF, 2000, INT J PHARM, V209, P15
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372
   Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dunne N, 2007, ACTA ORTHOP, V78, P774, DOI 10.1080/17453670710014545
   Dunne N, 2008, ACTA ORTHOP, V79, P851, DOI 10.1080/17453670810016957
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Hu XF, 2010, BIOMATERIALS, V31, P8854, DOI 10.1016/j.biomaterials.2010.08.006
   Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006
   Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004
   Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176
   Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kelechi CE, 2011, J ORTHOP SURG RES, V6, P2
   Kim JH, 2008, J MICROBIOL BIOTECHN, V18, P28
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Laurentin A, 2003, ANAL BIOCHEM, V315, P143, DOI 10.1016/S0003-2697(02)00704-2
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Lepretre S, 2009, BIOMATERIALS, V30, P6086, DOI 10.1016/j.biomaterials.2009.07.045
   Lonn-Stensrud J, 2009, J ANTIMICROB CHEMOTH, V63, P309, DOI 10.1093/jac/dkn501
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   Montali A, 2006, INJURY, V37, P81, DOI 10.1016/j.injury.2006.04.013
   Nijhof MW, 1997, J MATER SCI-MATER M, V8, P799, DOI 10.1023/A:1018577032259
   Park Y, 2008, J MICROBIOL BIOTECHN, V18, P1729
   Peng ZX, 2011, ANTIMICROB AGENTS CH, V55, P860, DOI 10.1128/AAC.01005-10
   Peng ZX, 2010, CARBOHYD POLYM, V81, P275, DOI 10.1016/j.carbpol.2010.02.008
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Scherertz J, 1990, J CLIN MICROBIOL, V28, P76
   Shi ZL, 2008, INT J ARTIF ORGANS, V31, P777
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Tayel AA, 2010, INT J BIOL MACROMOL, V47, P454, DOI 10.1016/j.ijbiomac.2010.06.011
   Tsubakishita S, 2010, ANTIMICROB AGENTS CH, V54, P4352, DOI 10.1128/AAC.00356-10
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   van de Belt H, 2001, BIOMATERIALS, V22, P1607, DOI 10.1016/S0142-9612(00)00313-6
   Virto MR, 2003, BIOMATERIALS, V24, P79, DOI 10.1016/S0142-9612(02)00254-5
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   WAHLIG H, 1984, J BONE JOINT SURG BR, V66, P175
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Widmer A. F., 2001, CLIN INFECT DIS   S2, V33, P94, DOI [10.1086/32186311486305, DOI 10.1086/321863]
   Zhang F, 2008, BIOMATERIALS, V29, P4751, DOI 10.1016/j.biomaterials.2008.08.043
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zou Q, 2008, J BIOMED MATER RES A, V9, P1108
NR 59
TC 113
Z9 118
U1 4
U2 126
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 2
BP 365
EP 377
DI 10.1016/j.biomaterials.2011.09.084
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 859LZ
UT WOS:000297879200002
PM 22014946
DA 2018-10-19
ER

PT J
AU Beduer, A
   Vieu, C
   Arnauduc, F
   Sol, JC
   Loubinoux, I
   Vaysse, L
AF Beduer, Amelie
   Vieu, Christophe
   Arnauduc, Florent
   Sol, Jean-Christophe
   Loubinoux, Isabelle
   Vaysse, Laurence
TI Engineering of adult human neural stem cells differentiation through
   surface micropatterning
SO BIOMATERIALS
LA English
DT Article
DE Adult human neural stem cells; Neurite outgrowth; Microtopography; Cell
   interactions; Polymer; Bioimplant
ID HUMAN BRAIN; SPINAL-CORD; PROGENITOR CELLS; GROWTH; ORIENTATION;
   NEURONS; INJURY; REPAIR; MICROTOPOGRAPHY; TRANSPLANTATION
AB Interaction between differentiating neural stem cells and the extracellular environment guides the establishment of cell polarity during nervous system development. Developing neurons read the physical properties of the local substrate in a contact-dependent manner and retrieve essential guidance cues. To restore damage brain area by tissue engineering, the biomaterial scaffold has to mimic this microenvironment to allow organized tissue regeneration. To establish the validity of using microgrooved surfaces in order to simultaneously provide to primary adult human neural stem cells a permissive growth environment and a guide for neurite outgrowth in a pre-established direction, we have studied the long-term culture of adult human neural stem cells from patient biopsies on microgrooved polymers. By exploiting polymer moulding techniques, we engineered non-cytotoxic deep microstructured surfaces of polydimethylsiloxane (PDMS) exhibiting microchannels of various widths. Our results demonstrate that precoated micropatterned PDMS surfaces can serve as effective neurite guidance surfaces for human neural stem cells. Immunocytochemistry analysis show that channel width can impact strongly development and differentiation. In particular we found an optimal microchannel width, that conciliates a high differentiation rate with a pronounced alignment of neurites along the edges of the microchannels. The impact of the microstructures on neurite orientation turned out to be strongly influenced by cell density, attesting that cell/surface interactions at the origin of the alignment effect, are in competition with cell/cell interactions tending to promote interconnected networks of cells. Considering all these effects, we have been able to design appropriate structures allowing to obtain neuron development and differentiation rate comparable to a plane unpatterned surface, with an efficient neurite guidance and a long-term cell viability. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Beduer, Amelie; Vieu, Christophe] CNRS LAAS, F-31077 Toulouse, France.
   [Beduer, Amelie; Vieu, Christophe] Univ Toulouse, UPS, INSA, INP,ISAE,LAAS, F-31059 Toulouse, France.
   [Sol, Jean-Christophe; Loubinoux, Isabelle; Vaysse, Laurence] INSERM, Imagerie Cerebrale & Handicaps Neurol UMR 825, F-31059 Toulouse, France.
   [Arnauduc, Florent; Loubinoux, Isabelle; Vaysse, Laurence] Univ Toulouse, Imagerie Cerebrale & Handicaps Neurol UMR 825, UPS, CHU Purpan, F-31059 Toulouse, France.
   [Sol, Jean-Christophe] Ctr Hosp Univ Toulouse, CHU Rangueil, Toulouse, France.
   [Beduer, Amelie] CNRS, ITAV UMS3039, F-31106 Toulouse, France.
RP Beduer, A (reprint author), CNRS LAAS, 7Ave Colonel Roche, F-31077 Toulouse, France.
EM abeduer@laas.fr
RI Loubinoux, Isabelle/E-5537-2016; Arnauduc, Florent/G-2970-2017; Vieu,
   Christophe/A-8127-2013
OI Loubinoux, Isabelle/0000-0003-4461-0890; 
FU Sanofi-Aventis
FX Vaysse L. was supported by Sanofi-Aventis. We also want to thank the
   Centre d'Investigation Clinique Biotherapies (Toulouse, France) for
   their technical assistance.
CR ABRAMOFF MD, 2004, IMAGE PROCESSING IMA, V11, P36
   Altomare L, 2010, ACTA BIOMATER, V6, P1948, DOI 10.1016/j.actbio.2009.12.040
   Barnett SC, 2007, NAT CLIN PRACT NEURO, V3, P152, DOI 10.1038/ncpneuro0447
   Beduer A, 2011, MICROELECTRON ENG, V88, P1668, DOI 10.1016/j.mee.2010.12.049
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bregman BS, 2002, PROG BRAIN RES, V137, P257
   Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409
   Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   Delcroix GJ, 2010, BIOMATERIALS, V31, P20105
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Farin A, 2009, NEUROSURGERY, V65, P859
   Farin A, 2009, NEUROSURGERY, V65, P831, DOI 10.1227/01.NEU.0000351721.81175.0B
   Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032
   Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Hsu SH, 2005, BIOTECHNOL BIOENG, V92, P579, DOI 10.1002/bit.20634
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678
   Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000
   Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007
   Lovchik RD, 2009, BIOMED MICRODEVICES, V12, P275
   Lu D., 2007, NEUROSURGERY, V61, P602
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Man Ryul Lee KWK, 2010, BIOMATERIALS, V31, P4360
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574
   Morelli S, 2010, BIOMATERIALS, V31, P7000, DOI 10.1016/j.biomaterials.2010.05.079
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1007/BF03206629
   Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087
   Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   Sorensen A, 2007, BIOMATERIALS, V28, P5498, DOI 10.1016/j.biomaterials.2007.08.034
   Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X
   Xu XM, 2009, RESP PHYSIOL NEUROBI, V169, P171, DOI 10.1016/j.resp.2009.07.016
NR 48
TC 95
Z9 99
U1 4
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 2
BP 504
EP 514
DI 10.1016/j.biomaterials.2011.09.073
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 859LZ
UT WOS:000297879200015
PM 22014459
DA 2018-10-19
ER

PT J
AU Re'em, T
   Kaminer-Israeli, Y
   Ruvinov, E
   Cohen, S
AF Re'em, Tali
   Kaminer-Israeli, Yael
   Ruvinov, Emil
   Cohen, Smadar
TI Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Affinity-binding; Alginate-sulfate; Alginate scaffold; Chondrogenesis;
   Human mesenchymal stem cells; TGF-betal
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; IN-VITRO; ALGINATE BIOMATERIAL;
   SEQUENTIAL DELIVERY; DIFFERENTIATION; BINDING; CARTILAGE; REPAIR; MODEL
AB Herein we describe a bio-inspired, affinity binding alginate-sulfate scaffold, designed for the presentation and sustained release of transforming growth factor beta 1 (TGF-beta 1), and examine its effects on the chondrogenesis of human mesenchymal stem cells (hMSCs). When attached to matrix via affinity interactions with alginate sulfate, TGF-beta 1 loading was significantly greater and its initial release from the scaffold was attenuated compared to its burst release (>90%) from scaffolds lacking alginate-sulfate. The sustained TGF-beta 1 release was further supported by the prolonged activation (14 d) of Smad-dependent (Smad2) and Smad-independent (ERK1/2) signaling pathways in the seeded hMSCs. Such presentation of TGF-beta 1 led to hMSC chondrogenic differentiation; differentiated chondrocytes with deposited collagen type II were seen within three weeks of in vitro hMSC seeding. By contrast, in scaffolds lacking alginate-sulfate, the effect of TGF-beta 1 was short-term and hMSCs could not reach a similar differentiation degree. When hMSC constructs were subcutaneously implanted in nude mice, chondrocytes with deposited type II collagen and aggrecan typical of the articular cartilage were found in the TGF-beta 1 affinity-bound constructs. Our results highlight the fundamental importance of appropriate factor presentation to its biological activity, namely - inducing efficient stem cell differentiation. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Re'em, Tali; Kaminer-Israeli, Yael; Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
EM scohen@bgumail.bgu.ac.il
RI COHEN, SMADAR/F-1901-2012
FU "Genesis" Israeli consortium; Ministry of Trade and Industry; Azrieli
   Foundation
FX The research was supported by the "Genesis" Israeli consortium sponsored
   by Magnet Program of the Ministry of Trade and Industry, and by the
   Azrieli Foundation (Tali Re'em). We thank Oren Levy for his excellent
   technical assistance with the Western blot analyses and Olga Kryukov for
   her crucial help with the confocal microscopy studies. This work was
   done in partial fulfillment of the requirements for a PhD degree (Tali
   Re'em) at the Department of Biotechnology Engineering, Ben-Gurion
   University of the Negev, Israel. Prof. Cohen holds the Clair and Harold
   Oshry Professor Chair in Biotechnology.
CR Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   BILLS CE, 1971, J HOPKINS MED J, V128, P194
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113
   CHEN BL, 1994, J PHARM SCI, V83, P1657, DOI 10.1002/jps.2600831204
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108
   Hodneland CD, 2002, P NATL ACAD SCI USA, V99, P5048, DOI 10.1073/pnas.072685299
   JOHN P, 2002, PRINCIPLES BONE BIOL
   Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048
   Levy O, 2008, INT J BIOCHEM CELL B, V40, P2606, DOI 10.1016/j.biocel.2008.05.010
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   Metzger W, 2007, TISSUE ENG, V13, P2751, DOI 10.1089/ten.2007.0015
   MIURA Y, 1994, CLIN ORTHOP RELAT R, P271
   Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a
   Park SH, 2011, TISSUE ENG PT A, V17, P1277, DOI [10.1089/ten.tea.2010.0337, 10.1089/ten.TEA.2010.0337]
   Petersen W, 2002, J ANAT, V201, P153, DOI 10.1046/j.1469-7580.2002.00085.x
   RAVINDRAN S, 2011, BIOMATERIALS
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066
NR 34
TC 51
Z9 51
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 3
BP 751
EP 761
DI 10.1016/j.biomaterials.2011.10.007
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864BQ
UT WOS:000298212400003
PM 22019120
DA 2018-10-19
ER

PT J
AU Masand, SN
   Perron, IJ
   Schachner, M
   Shreiber, DI
AF Masand, Shirley N.
   Perron, Isaac J.
   Schachner, Melitta
   Shreiber, David I.
TI Neural cell type-specific responses to glycomimetic functionalized
   collagen
SO BIOMATERIALS
LA English
DT Article
DE Nerve regeneration; PSA; HNK-1; Glycans
ID PERIPHERAL-NERVE REGENERATION; POLYSIALIC ACID; SCHWANN-CELLS; L2/HNK-1
   CARBOHYDRATE; NEURITE OUTGROWTH; ADHESION MOLECULE; MOTOR-NEURONS;
   GROWTH-FACTOR; RGD PEPTIDES; RECOVERY
AB Despite their noted functional role, glycans have had limited therapeutic use due to difficulties in synthesis and quick degradation in vivo. The recent discovery of glycomimetics has provided new opportunities for their application. In this study, we have functionalized type I collagen with peptide mimics of two glycans: (1) polysialic acid (PSA) and (2) an epitope first discovered on human natural killer cells (HNK-1). These glycans and their glycomimetic counterparts have been shown to be important regulators of repair following injury through their unique and phenotypically specific effects on neural behavior. We show that these molecules retain their bioactivity following functionalization to the collagen backbone. Grafted HNK-1 encouraged motor neuron outgrowth, while grafted PSA encouraged sensory and motor neuron outgrowth and enhanced Schwann cell proliferation and process extension. These data support the potential of glycomimetic-functionalized collagen as a biomaterial strategy to increase the efficiency of synaptic reconnection following nervous system injury. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Masand, Shirley N.; Perron, Isaac J.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.
   [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.
RP Shreiber, DI (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM shreiber@rci.rutgers.edu
OI Shreiber, David/0000-0001-8248-419X
FU National Institutes of Health (NIH) [1R21EB009245-01A1]; US Army
   [W81XWH-04-2-0031]; Rutgers-UMDNJ (NIH) [5T32GM008339-20]; National
   Science Foundation (NSF) [DGE 0801620]; Aresty Research Center for
   Undergraduates
FX Funding for these studies was provided by the National Institutes of
   Health (NIH 1R21EB009245-01A1) and US Army contract #W81XWH-04-2-0031,
   and fellowships from the Rutgers-UMDNJ Biotechnology Training Program
   (NIH Grant Number 5T32GM008339-20), the National Science Foundation (NSF
   DGE 0801620, IGERT on the Integrated Science and Engineering of Stem
   Cells), and the Aresty Research Center for Undergraduates. We confirm
   that all studies involving experimental animals were conducted under the
   ethical approval of all relevant bodies.
CR ABO T, 1981, J IMMUNOL, V127, P1024
   Assmann U, 2010, J MATER SCI-MATER M, V21, P2115, DOI 10.1007/s10856-010-4072-y
   BAICI A, 1980, ANAL BIOCHEM, V108, P230, DOI 10.1016/0003-2697(80)90574-6
   BANKER GA, 1998, CULTURING NERVE CELL
   BEER JH, 1992, BLOOD, V79, P117
   Bock P, 2007, J COMP NEUROL, V505, P572, DOI 10.1002/cne.21519
   BRUSHART TME, 1993, J NEUROSCI, V13, P2730
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018
   Eggett CJ, 2000, J NEUROCHEM, V74, P1895, DOI 10.1046/j.1471-4159.2000.0741895.x
   El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103
   Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852
   Florian C, 2006, LEARN MEMORY, V13, P335, DOI 10.1101/lm.187506
   Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005
   Franz CK, 2008, BRAIN, V131, P1492, DOI 10.1093/brain/awn039
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006
   Jiang XY, 2006, J NEUROSCI METH, V158, P13, DOI 10.1016/j.jneumeth.2006.05.014
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   Kupershmidt L, 2009, FASEB J, V23, P3766, DOI 10.1096/fj.09-130047
   Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x
   Luo J, 2010, GLIA
   Magnani John L, 2009, Discov Med, V8, P247
   Marino P, 2009, EXP NEUROL, V219, P163, DOI 10.1016/j.expneurol.2009.05.009
   MARTINI R, 1994, J NEUROSCI, V14, P7180
   MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813
   Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235
   Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128
   Monteiro GA, 2009, TISSUE ENG A
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Ratcliffe EM, 2008, DEV NEUROBIOL, V68, P960, DOI 10.1002/dneu.20634
   Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2
   Simon-Haldi M, 2002, J NEUROCHEM, V83, P1380, DOI 10.1046/j.1471-4159.2002.01247.x
   Simova O, 2006, ANN NEUROL, V60, P430, DOI 10.1002/ana.20948
   Steinhaus S, 2010, J MATER SCI-MATER M, V21, P1371, DOI 10.1007/s10856-009-3981-0
   Sundararaghavan HG, 2011, J NEUROTRAUM, V28, P2377, DOI 10.1089/neu.2010.1606
   Torregrossa P, 2004, J BIOL CHEM, V279, P30707, DOI 10.1074/jbc.M403935200
NR 42
TC 19
Z9 20
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 3
BP 790
EP 797
DI 10.1016/j.biomaterials.2011.10.013
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864BQ
UT WOS:000298212400007
PM 22027596
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ravichandran, R
   Venugopal, JR
   Sundarrajan, S
   Mukherjee, S
   Ramakrishna, S
AF Ravichandran, Rajeswari
   Venugopal, Jayarama Reddy
   Sundarrajan, Subramanian
   Mukherjee, Shayanti
   Ramakrishna, Seeram
TI Precipitation of nanohydroxyapatite on PLIA/PBLG/Collagen nanofibrous
   structures for the differentiation of adipose derived stem cells to
   osteogenic lineage
SO BIOMATERIALS
LA English
DT Article
DE Adipose derived stem cells; Nanohydroxyapatite; Osteogenic
   differentiation; Mineralization; Bone tissue engineering
ID MARROW STROMAL CELLS; GENE-EXPRESSION; BONE-TISSUE; COMPOSITE SCAFFOLDS;
   EXTRACELLULAR-MATRIX; IN-VITRO; OSTEOBLAST ADHESION; NANOPHASE CERAMICS;
   SURFACES; COLLAGEN
AB Tissue engineering and nanotechnology have enabled engineering of nanostructured materials to meet the current challenges in bone treatment owing to rising occurrence of bone diseases, accidental damages and defects. Poly(L-lactic acid)/Poly-benzyl-L-glutamate/Collagen (PLLA/PBLG/Col) scaffolds were fabricated by electrospinning and nanohydroxyapatite (n-HA) was deposited by calcium-phosphate dipping method for bone tissue engineering (BTE). The abundance and accessibility of adipose derived stem cells (ADSC) may prove to be novel cell therapeutics for bone repair and regeneration. ADSCs were cultured on these scaffolds and were induced to undergo osteogenic differentiation in the presence of PBLG/n-HA for BTE. The cell-biomaterial interactions were analyzed using cell proliferation, SEM and CMFDA dye extraction techniques. Osteogenic differentiation of ADSC was confirmed using alkaline phosphatase activity (ALP), mineralization (ARS) and dual immunofluorescent staining using both ADSC marker protein and Osteocalcin, which is a bone specific protein. The utmost significance of this study is the bioactive PBLG/n-HA biomolecule introduced on the polymeric nanofibers to regulate and improve specific biological functions like adhesion, proliferation and differentiation of ADSC into osteogenic lineage. This was evident from the immunostaining and CMFDA images of ADSCs showing cuboidal morphology, characteristic of osteogenic lineage. The observed results proved that the PLLA/PBLG/Col/n-HA scaffolds promoted greater osteogenic differentiation of ADSC as evident from the enzyme activity and mineralization profiles for bone tissue engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Ravichandran, Rajeswari; Venugopal, Jayarama Reddy; Sundarrajan, Subramanian; Mukherjee, Shayanti; Ramakrishna, Seeram] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Healthcare & Energy Mat Lab, Singapore 117576, Singapore.
   [Ravichandran, Rajeswari; Sundarrajan, Subramanian; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Venugopal, JR (reprint author), Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Fac Engn, Healthcare & Energy Mat Lab, Block E3,05-12,2 Engn Dr 3, Singapore 117576, Singapore.
EM nnijrv@nus.edu.sg
RI Ravichandran, Rajeswari/C-9313-2012; Subramanian,
   Sundarrajan/E-8022-2011
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-065-592]; Ministry of Education
   [R-265-000-318-112]; NUSNNI, National University of Singapore, Singapore
FX This study was supported by the NRF-Technion (R-398-001-065-592),
   Ministry of Education (R-265-000-318-112) and NUSNNI, National
   University of Singapore, Singapore.
CR Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Boskey A., 2007, BIOMATERIALS, V28, P2464
   Brevi BC, 2010, J PEDIATR SURG, V45, pE17, DOI 10.1016/j.jpedsurg.2010.01.011
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Conway JD, 2010, ORTHOP CLIN N AM, V41, P75, DOI 10.1016/j.ocl.2009.07.006
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HABAL MB, 1994, CLIN PLAST SURG, V21, P525
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Heo SJ, 2009, TISSUE ENG PT A, V15, P977, DOI 10.1089/ten.tea.2008.0190
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Kohn D, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P219, DOI 10.1007/BF01845591
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376
   Liu YK, 2009, J BIOMED MATER RES A, V90A, P1083, DOI 10.1002/jbm.a.32192
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020
   Nejati E, 2008, COMPOS PART A-APPL S, V39, P1589, DOI 10.1016/j.compositesa.2008.05.018
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   POOT M, 1991, CYTOMETRY, V12, P184, DOI 10.1002/cyto.990120214
   Popat KC, 2006, J ORTHOP RES, V24, P619, DOI 10.1002/jor.20105
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Ravichandran R., 2010, TISSUE ENG PART A, V17, P1363
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Riminucci M, 2003, BRAZ J MED BIOL RES, V36, P1027, DOI 10.1590/S0100-879X2003000800008
   RODBELL M, 1966, J BIOL CHEM, V241, P130
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Segura-Sanchez F, 2010, INT J PHARMACEUT, V387, P244, DOI 10.1016/j.ijpharm.2009.12.016
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
   Yu HS, 2009, MATER CHEM PHYS, V113, P873, DOI 10.1016/j.matchemphys.2008.08.061
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   ZHANG YZ, 1992, FASEB J, V6, pA1835
   ZHANG YZ, 1991, FASEB J, V5, P3108
   Zuk P. A., 2001, TISSUE ENG, V7, P209
NR 51
TC 137
Z9 140
U1 9
U2 84
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 3
BP 846
EP 855
DI 10.1016/j.biomaterials.2011.10.030
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864BQ
UT WOS:000298212400013
PM 22048006
DA 2018-10-19
ER

PT J
AU Ko, CY
   Wu, LX
   Nair, AM
   Tsai, YT
   Lin, VK
   Tang, LP
AF Ko, Cheng-Yu
   Wu, Lanxiao
   Nair, Ashwin M.
   Tsai, Yi-Ting
   Lin, Victor K.
   Tang, Liping
TI The use of chemokine-releasing tissue engineering scaffolds in a model
   of inflammatory response-mediated melanoma cancer metastasis
SO BIOMATERIALS
LA English
DT Article
DE Cancer metastasis; Inflammation; Foreign body reactions; B16F10 melanoma
   cells; Mice; Animal model
ID FOREIGN-BODY REACTIONS; LYMPH-NODE METASTASIS; BREAST-CANCER; IN-VIVO;
   PROMOTES PROGRESSION; BIOMATERIAL IMPLANTS; PROGNOSTIC-FACTORS;
   COLORECTAL-CANCER; TUMOR-METASTASIS; RECEPTOR CCR6
AB Inflammatory responses and associated products have been implicated in cancer metastasis. However, the relationship between these two processes is uncertain due to the lack of a suitable model. Taking advantage of localized and controllable inflammatory responses induced by biomaterial implantation and the capability of tissue scaffolds to release a wide variety of chemokines, we report a novel system for studying the molecular mechanisms of inflammation-mediated cancer metastasis. The animal model is comprised of an initial subcutaneous implantation of biomaterial microspheres which prompt localized inflammatory responses, followed by the transplantation of metastatic cancer cells into the peritoneal cavity or blood circulation. Histological results demonstrated that substantial numbers of B16F10 cells were recruited to the site nearby biomaterial implants. There was a strong correlation between the degree of biomaterial-mediated inflammatory responses and number of recruited cancer cells. Inflammation-mediated cancer cell migration was inhibited by small molecule inhibitors of CXCR4 but not by neutralizing antibody against CCL21. Using chemokine-releasing scaffolds, further studies were carried out to explore the possibility of enhancing cancer cell recruitment. Interestingly, erythropoietin (EPO) releasing scaffolds, but not stromal cell-derived factor-1 alpha-releasing scaffolds, were found to accumulate substantially more melanoma cells than controls. Rather unexpectedly, perhaps by indirectly reducing circulating cancer cells, mice implanted with EPO-releasing scaffolds had similar to 30% longer life span than other groups. These results suggest that chemokine-releasing scaffolds may potentially function as implantable cancer traps and serve as powerful tools for studying cancer distraction and even selective annihilation of circulating metastatic cancer cells. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Ko, Cheng-Yu; Wu, Lanxiao; Nair, Ashwin M.; Tsai, Yi-Ting; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Lin, Victor K.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM Itang@uta.edu
RI Nair, Ashwin/B-8307-2011
OI Nair, Ashwin/0000-0002-7334-3114
FU NIH [RO1 EB007271]
FX This work was supported by NIH grant RO1 EB007271. The authors would
   like to acknowledge Professor John W. Eaton for his critical review of
   this work.
CR Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029
   Arcasoy MO, 2003, BIOCHEM BIOPH RES CO, V307, P999, DOI 10.1016/S0006-291X(03)01303-2
   Arias JI, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-29
   Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622
   Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5
   Bhardwaj Upkar, 2007, J Diabetes Sci Technol, V1, P8
   Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4
   Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835
   Cespedes M V, 2006, Clin Transl Oncol, V8, P318
   Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865
   Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x
   Darling G, 2009, J SURG ONCOL, V99, P189, DOI 10.1002/jso.21209
   Das S, 2008, ANN NY ACAD SCI, V1131, P235, DOI 10.1196/annals.1413.021
   FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0
   Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098
   Folkman J, 1992, Semin Cancer Biol, V3, P65
   Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222
   Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014
   Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822
   Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468
   Gomperts BN, 2006, CONTRIB MICROBIOL, V13, P170
   Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104
   Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9
   Hippo Y, 2001, CANCER RES, V61, P889
   Ikebe M, 2009, J SURG ONCOL, V100, P725, DOI 10.1002/jso.21392
   Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Katz O, 2007, EUR J IMMUNOL, V37, P1584, DOI 10.1002/eji.200637025
   Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261
   Koller FL, 2010, CARCINOGENESIS, V31, P1010, DOI 10.1093/carcin/bgq044
   Lappin TR, 2002, STEM CELLS, V20, P485, DOI 10.1634/stemcells.20-6-485
   Lee AS, 2011, CANCER RES, V71, P4506, DOI 10.1158/0008-5472.CAN-10-3787
   Lee SS, 2000, AM SURGEON, V66, P837
   Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727
   Longo-Imedio MI, 2005, INT J CANCER, V117, P861, DOI 10.1002/ijc.21269
   Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8
   Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261
   Luboshits G, 1999, CANCER RES, V59, P4681
   Maekawa S, 2008, ONCOL REP, V19, P1461
   Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966
   Melnikova VO, 2009, PIGM CELL MELANOMA R, V22, P257, DOI 10.1111/j.1755-148X.2009.00570.x
   Mirmohammadsadegh A, 2010, J INVEST DERMATOL, V130, P201, DOI 10.1038/jid.2009.162
   Mochizuki Y, 2004, CLIN EXP METASTAS, V21, P39, DOI 10.1023/B:CLIN.0000017181.01474.35
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016
   Murakami T, 2002, CANCER RES, V62, P7328
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nair A, 2010, TISSUE ENG PART C-ME, V16, P23, DOI 10.1089/ten.TEC.2009.0094
   Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622
   Pathi SP, 2011, BIOMATERIALS, V32, P5112, DOI 10.1016/j.biomaterials.2011.03.055
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256
   Pugliese MS, 2009, ANN SURG ONCOL, V16, P113, DOI 10.1245/s10434-008-0121-x
   Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781
   Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114
   Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018
   Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469
   TACHIBANA T, 1986, CANCER METAST REV, V5, P55, DOI 10.1007/BF00046422
   Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049
   Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Uharcek P, 2008, J OBSTET GYNAECOL RE, V34, P776, DOI 10.1111/j.1447-0756.2008.00796.x
   Weiss MJ, 2003, ONCOLOGIST, V8, P18
   Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638
   Yamamoto M, 2008, CANCER RES, V68, P9754, DOI 10.1158/0008-5472.CAN-08-1748
   Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004
NR 76
TC 8
Z9 8
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 3
BP 876
EP 885
DI 10.1016/j.biomaterials.2011.10.002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864BQ
UT WOS:000298212400016
PM 22019117
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Fernandes, S
   Kuklok, S
   McGonigle, J
   Reinecke, H
   Murry, CE
AF Fernandes, Sarah
   Kuklok, Shannon
   McGonigle, Joe
   Reinecke, Hans
   Murry, Charles E.
TI Synthetic Matrices to Serve as Niches for Muscle Cell Transplantation
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Biomaterial; Heart; Cellular therapy
ID SKELETAL MYOBLAST TRANSPLANTATION; LEFT-VENTRICULAR FUNCTION; CARDIAC
   PROGENITOR CELLS; MYOCARDIAL-INFARCTION; ISCHEMIC-MYOCARDIUM;
   STEM-CELLS; SUBSTRATE STIFFNESS; PEPTIDE NANOFIBERS; RAT HEARTS; IN-VIVO
AB Poor cell retention and limited cell survival after grafting are major limitations of cell therapy. Recent studies showed that the use of matrices as vehicles at the time of cell injection can significantly improve cell engraftment by providing an appropriate structure and physical support for the injected cells. Properly designed matrices can also promote the organization of the cells into a functioning cardiac-like tissue and enhance integration between the host and the engrafted tissue. Furthermore, the use of an injectable biomaterial provides an opportunity to release in situ bioactive molecules that can further enhance the beneficial effects of cell transplantation. In this article we review a large variety of biologically derived synthetic and hybrid materials that have been tested as matrices for cardiac repair. We summarize the optimal parameters required for an ideal matrix including biocompatibility, injectability, degradation rate, and mechanical properties. Using an in vivo subcutaneous grafting model, we also provide novel data involving a side-by-side comparison of six synthetic matrices derived from maltodextrin. By systematically varying polymer molecular weight, cross-link density, and availability of cell adhesion motifs, a synthetic matrix was identified that supported skeletal myotube formation similar to Matrigel (TM). Our results emphasize not only the need to have a range of tunable matrices for cardiac cell therapy but also the importance of further characterizing the physical properties required for an ideal injectable matrix. Copyright (C) 2011 S. Karger AG, Basel
C1 [Fernandes, Sarah; Reinecke, Hans; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA.
   [Fernandes, Sarah; Reinecke, Hans; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.
   [Fernandes, Sarah; Reinecke, Hans; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA.
   [Murry, Charles E.] Univ Washington, Dept Bioengn & Med Cardiol, Seattle, WA 98109 USA.
   [Kuklok, Shannon; McGonigle, Joe] SurModics Inc, Eden Prairie, MN USA.
RP Murry, CE (reprint author), Univ Washington, Ctr Cardiovasc Biol, 815 Mercer St,Room 453, Seattle, WA 98109 USA.
EM murry@u.washington.edu
RI Fernandes, Sarah/H-1298-2011
FU NHLBI NIH HHS [R01 HL084642]
CR Anderl JN, 2009, J BIOMED MATER RES A, V88A, P704, DOI 10.1002/jbm.a.31917
   Bajaj P, 2010, J BIOMED MATER RES A, V95A, P1261, DOI 10.1002/jbm.a.32951
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   BENDER DA, 2005, DICT FOOD NUTR
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cornelison DDW, 2008, J CELL BIOCHEM, V105, P663, DOI 10.1002/jcb.21892
   Dai WD, 2010, METHODS MOL BIOL, V660, P99, DOI 10.1007/978-1-60761-705-1_7
   Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003
   Forest VF, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt4
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545
   Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x
   Jain M, 2001, CIRCULATION, V103, P1920
   Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   LaNasa SM, 2009, ACTA BIOMATER, V5, P2929, DOI 10.1016/j.actbio.2009.05.011
   Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 1996, CIRCULATION, V94, P332
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Levy-Mishali M, 2009, TISSUE ENG PT A, V15, P935, DOI 10.1089/ten.tea.2008.0111
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   Ono Y, 2006, J CELL BIOCHEM, V98, P642, DOI 10.1002/jeb.20804
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Pouzet B, 2001, CIRCULATION, V104, pI223
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Robey TE, 2008, CARDIOVASC PATHOL, V17, P6, DOI 10.1016/j.carpath.2007.01.005
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   Scorsin M, 2000, J THORAC CARDIOV SUR, V119, P1169, DOI 10.1067/mtc.2000.104865
   Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035
   Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905
   van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Yasuda T, 2005, AM J PHYSIOL-REG I, V289, pR1083, DOI 10.1152/ajpregu.00112.2005
   Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
NR 60
TC 8
Z9 8
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2012
VL 195
IS 1-2
BP 48
EP 59
DI 10.1159/000331414
PG 12
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 867QI
UT WOS:000298468500006
PM 22005610
OA Green Published
DA 2018-10-19
ER

PT J
AU Peck, M
   Gebhart, D
   Dusserre, N
   McAllister, TN
   L'Heureux, N
AF Peck, Marissa
   Gebhart, David
   Dusserre, Nathalie
   McAllister, Todd N.
   L'Heureux, Nicolas
TI The Evolution of Vascular Tissue Engineering and Current State of the
   Art
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Tissue engineering; Small-diameter vascular graft; Blood vessel;
   Hemodialysis access; Self-assembly; Human; Bioreactor; Mechanical
   strength; Extracellular matrix; Review
ID SMOOTH-MUSCLE-CELLS; MESENCHYMAL STEM-CELLS; ADULT ARTERIAL
   REVASCULARIZATION; HUMAN DERMAL FIBROBLASTS; HUMAN-ENDOTHELIAL CELLS;
   HUMAN BLOOD-VESSEL; FETAL CALF SERUM; BONE-MARROW; IN-VITRO;
   ASCORBIC-ACID
AB Dacron (R) (polyethylene terephthalate) and Goretex (R) (expanded polytetrafluoroethylene) vascular grafts have been very successful in replacing obstructed blood vessels of large and medium diameters. However, as diameters decrease below 6 mm, these grafts are clearly outperformed by transposed autologous veins and, particularly, arteries. With approximately 8 million individuals with peripheral arterial disease, over 500,000 patients diagnosed with end-stage renal disease, and over 250,000 patients per year undergoing coronary bypass in the USA alone, there is a critical clinical need for a functional small-diameter conduit [Lloyd-Jones et al., Circulation 2010; 121:e46-e215]. Over the last decade, we have witnessed a dramatic paradigm shift in cardiovascular tissue engineering that has driven the field away from biomaterial-focused approaches and towards more biology-driven strategies. In this article, we review the preclinical and clinical efforts in the quest for a tissue-engineered blood vessel that is free of permanent synthetic scaffolds but has the mechanical strength to become a successful arterial graft. Special emphasis is given to the tissue engineering by self-assembly (TESA) approach, which has been the only one to reach clinical trials for applications under arterial pressure. Copyright (C) 2011 S. Karger AG, Basel
C1 [Peck, Marissa; Gebhart, David; Dusserre, Nathalie; McAllister, Todd N.; L'Heureux, Nicolas] Cytograft Tissue Engn Inc, Novato, CA 94949 USA.
   [McAllister, Todd N.; L'Heureux, Nicolas] St Josephs Translat Res Inst, Atlanta, GA USA.
RP L'Heureux, N (reprint author), Cytograft Tissue Engn Inc, 3 Hamilton Landing,Ste 220, Novato, CA 94949 USA.
EM nico@cytograft.com
FU NIH/NHLBI/SBIR [R44HL064462, R43HL105010]
FX We thank Casey Mount for his contribution to the figures. We also thank
   the NIH/NHLBI/SBIR program for their critical and continued financial
   support (R44HL064462 and R43HL105010).
CR Asher D M, 1999, Dev Biol Stand, V99, P41
   Asher D M, 1999, Dev Biol Stand, V100, P103
   Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Campbell JH, 1999, CIRC RES, V85, P1173
   Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725
   Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003
   Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426
   DECLERCK YA, 1980, BIOCHEM J, V186, P217, DOI 10.1042/bj1860217
   Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   *FDA CBER, 2009, GUID IND CU IN PRESS, P59
   FOX D, 1999, TISSUE ENG VASCULAR, P489
   Garolla A, 2009, AM J GASTROENTEROL, V104, P2500, DOI 10.1038/ajg.2009.332
   Garrido SA, 2009, LANCET, V374, P201, DOI 10.1016/S0140-6736(09)61330-1
   Gibson KD, 2001, J VASC SURG, V34, P694, DOI 10.1067/mva.2001.117890
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   Gong ZD, 2011, METHODS MOL BIOL, V698, P279, DOI 10.1007/978-1-60761-999-4_21
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   GRINNELL F, 1989, EXP CELL RES, V181, P483, DOI 10.1016/0014-4827(89)90105-5
   GUIDOIN R, 1984, J MAL VASCUL, V9, P277
   Haisch A, 2000, MED BIOL ENG COMPUT, V38, P686, DOI 10.1007/BF02344876
   Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104
   He W, 2010, BIOMATERIALS, V31, P8235, DOI 10.1016/j.biomaterials.2010.07.034
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, J VASC SURG, V1, P279, DOI 10.1067/mva.1984.avs0010279
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hirai J, 1994, ASAIO J, V40, pM383, DOI 10.1097/00002480-199407000-00027
   Hirai J, 1996, CELL TRANSPLANT, V5, P93, DOI 10.1016/0963-6897(95)02002-0
   Hsiang Y, 1990, J Invest Surg, V3, P11, DOI 10.3109/08941939009140332
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   KADLETZ M, 1987, THORAC CARDIOV SURG, V35, P143, DOI 10.1055/s-2007-1020277
   Kanda K, 1993, ASAIO J, V39, pM561
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   Krenning G, 2009, AM J PHYSIOL-RENAL, V296, pF1314, DOI 10.1152/ajprenal.90755.2008
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   Lamm P, 2001, CIRCULATION, V104, pI108
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   LHEUREUX N, 1996, C TISS ENG WOUND HEA
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Ma N, 2011, J MATER SCI-MATER M, V22, P1037, DOI 10.1007/s10856-011-4257-z
   MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420
   MANSFIELD PB, 1975, T AM SOC ART INT ORG, V21, P264
   MATSUDA T, 1995, J THORAC CARDIOV SUR, V110, P988, DOI 10.1016/S0022-5223(05)80166-7
   Matsuda T, 1988, ASAIO Trans, V34, P640
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847
   Michel M, 1996, J CELL SCI, V109, P1017
   Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035
   Mogford JE, 2002, J CELL PHYSIOL, V190, P259, DOI 10.1002/JCP.10060
   Mogues T, 2005, J IMMUNOL METHODS, V300, P1, DOI 10.1016/j.jim.2005.01.022
   Morimoto N, 2005, J SURG RES, V125, P56, DOI 10.1016/j.jss.2004.11.012
   MULLERGLAUSER W, 1993, EUR J VASCULAR SURG, V7, P324, DOI 10.1016/S0950-821X(05)80017-9
   MURAD S, 1983, J INVEST DERMATOL, V81, P158, DOI 10.1111/1523-1747.ep12543573
   Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI 10.1089/ten.TEA.2009.0427
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OCONNOR NE, 1981, LANCET, V1, P75
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41
   Peng HF, 2011, TISSUE ENG PT A, V17, P981, DOI [10.1089/ten.tea.2010.0109, 10.1089/ten.TEA.2010.0109]
   Perera GB, 2004, ANN VASC SURG, V18, P66, DOI 10.1007/s10016-003-0094-y
   PHILLIPS CL, 1994, J INVEST DERMATOL, V103, P228, DOI 10.1111/1523-1747.ep12393187
   Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9
   RHEINWALD JG, 1974, CELL, V2, P287, DOI 10.1016/0092-8674(74)90023-3
   Rosas SE, 2003, J VASC SURG, V37, P1036, DOI 10.1067/mva.2003.257
   SCHILLING J, 1961, ARCH PATHOL, V71, P548
   SCHILLING JA, 1964, ANN SURG, V159, P819, DOI 10.1097/00000658-196406000-00001
   Selvaggi TA, 1997, BLOOD, V89, P776
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Sparks C H, 1969, Ann Thorac Surg, V8, P104
   SPARKS CH, 1973, ANN SURG, V177, P293, DOI 10.1097/00000658-197303000-00009
   Stickler P, 2010, ACTA BIOMATER, V6, P2448, DOI 10.1016/j.actbio.2010.01.041
   Stoclet JC, 1996, CELL BIOL TOXICOL, V12, P223, DOI 10.1007/BF00438149
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Syedain ZH, 2011, BIOMATERIALS, V32, P714, DOI 10.1016/j.biomaterials.2010.09.019
   THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659
   Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039
   Tschoeke B, 2009, TISSUE ENG PT A, V15, P1909, DOI 10.1089/ten.tea.2008.0499
   Tuschong L, 2002, HUM GENE THER, V13, P1605, DOI 10.1089/10430340260201699
   von Rheinbaben Friedrich, 2004, Contrib Microbiol, V11, P193
   Watanabe T, 2010, J BIOMED MATER RES B, V92B, P236, DOI 10.1002/jbm.b.31510
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Westerweel PE, 2009, NAT REV RHEUMATOL, V5, P332, DOI 10.1038/nrrheum.2009.81
   WIGHT TN, 1996, ATHEROSCLEROSIS CORO, P421
   Wystrychowski W, 2011, J VASC ACCESS, V12, P67, DOI 10.5301/JVA.2011.6360
   Yao L, 2008, PHARM RES-DORDR, V25, P1212, DOI 10.1007/s11095-007-9499-6
   Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
   Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005
   ZILLA P, 1987, J VASC SURG, V6, P535, DOI 10.1067/mva.1987.avs0060535
   ZILLA P, 1989, SURGERY, V105, P515
NR 101
TC 82
Z9 86
U1 2
U2 55
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2012
VL 195
IS 1-2
BP 144
EP 158
DI 10.1159/000331406
PG 15
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 867QI
UT WOS:000298468500013
PM 21996786
OA Green Published
DA 2018-10-19
ER

PT J
AU Nazir, R
   Iqbal, N
   Khan, AS
   Akram, A
   Asif, A
   Chaudhry, AA
   Rehman, IU
   Hussain, R
AF Nazir, Rabia
   Iqbal, Nida
   Khan, Abdul S.
   Akram, Aftab
   Asif, Anila
   Chaudhry, Aqif A.
   Rehman, Ihtesham Ur.
   Hussain, Rafaqat
TI Rapid synthesis of thermally stable hydroxyapaptite
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Microwave; Rapid synthesis; Hydroxyapatite; Biomaterial
ID CALCIUM-PHOSPHATE CERAMICS; MICROWAVE IRRADIATION; NANOCRYSTALLINE
   HYDROXYAPATITE; MORPHOLOGIES; ROUTE
AB We have optimized the wet precipitation synthesis of hydroxyapaptite to obtain thermally stable powder in the short time span of 3 min. Exposure of the reaction mixture to 1000 W microwave for 3 min furnished hydroxyapatite, which was thermally stable at temperatures up to 1200 degrees C. Powders were analyzed for phase purity using X-ray crystallography; chemical composition was studied using Fourier transform infrared spectroscopy while particle morphology was analyzed using scanning electron microscopy. (C) 2011 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Hussain, Rafaqat] Univ Teknol Malaysia, Dept Chem, Utm Skudai 81310, Johor Darul Taz, Malaysia.
   [Nazir, Rabia; Iqbal, Nida; Khan, Abdul S.; Asif, Anila; Chaudhry, Aqif A.] COMSATS Inst Informat Technol, Interdisciplinary Res Ctr Biomed Mat, Lahore 56000, Pakistan.
   [Akram, Aftab] Natl Univ Sci & Technol, Sch Chem & Mat Engn, Islamabad, Pakistan.
   [Rehman, Ihtesham Ur.] Univ Sheffield, Dept Mat Sci & Engn, Katto Res Inst, Sheffield S3 7HQ, S Yorkshire, England.
RP Hussain, R (reprint author), Univ Teknol Malaysia, Dept Chem, Utm Skudai 81310, Johor Darul Taz, Malaysia.
EM rafaqat@kimials.utm.my
RI Akram, Muhammad Aftab/A-6160-2015; iqbal, nida/F-8852-2014
OI Akram, Muhammad Aftab/0000-0002-1645-7852; iqbal,
   nida/0000-0002-8502-4954; Hussain, Rafaqat/0000-0003-4810-4776
CR Arami H, 2009, J ALLOY COMPD, V469, P391, DOI 10.1016/j.jallcom.2008.01.116
   Bi JH, 2009, J ALLOY COMPD, V480, P684, DOI 10.1016/j.jallcom.2009.02.029
   Bose S, 2010, ACTA BIOMATER, V6, P3782, DOI 10.1016/j.actbio.2010.03.016
   Chanda A, 2009, MAT SCI ENG C-BIO S, V29, P1144, DOI 10.1016/j.msec.2008.09.008
   Chen DP, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025607
   Das S, 2009, B MATER SCI, V32, P1, DOI 10.1007/s12034-009-0001-4
   FANG Y, 1994, J MATER RES, V9, P180, DOI 10.1557/JMR.1994.0180
   Farzadi A., 2010, CERAM INT, V26, P1006
   Ikoma T, 1999, J MATER SCI LETT, V18, P1225, DOI 10.1023/A:1006610521173
   Jalota S, 2004, J MATER RES, V19, P1876, DOI 10.1557/JMR.2004.0230
   Jiang Y, 2006, MATER LETT, V60, P2294, DOI 10.1016/j.matlet.2005.12.127
   Kalita SJ, 2010, MAT SCI ENG C-MATER, V30, P295, DOI 10.1016/j.msec.2009.11.007
   Klinkaewnarong J, 2010, CURR APPL PHYS, V10, P521, DOI 10.1016/j.cap.2009.07.014
   Klinkamnarong J, 2009, SOLID STATE SCI, V11, P1023, DOI 10.1016/j.solidstatesciences.2009.02.003
   Krishna DSR, 2007, J MATER SCI-MATER M, V18, P1735, DOI 10.1007/s10856-007-3069-7
   Kumar TSS, 2000, BIOMATERIALS, V21, P1623
   LERNER E, 1991, J MATER SCI-MATER M, V2, P138, DOI 10.1007/BF00692971
   Liu JB, 2005, NANOTECHNOLOGY, V16, P82, DOI 10.1088/0957-4484/16/1/017
   Ma MG, 2008, MATER LETT, V62, P507, DOI 10.1016/j.matlet.2007.05.072
   Park YM, 2008, MATER CHEM PHYS, V109, P440, DOI 10.1016/j.matchemphys.2007.12.013
   PURNENDU P, 2006, AM J BIOCH BIOTECHNO, V2, P61
   Quilitz M, 2010, J MATER SCI-MATER M, V21, P399, DOI 10.1007/s10856-009-3875-1
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Rameshbabu N., 2009, Current Applied Physics, V9, P29
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   Shi S., 2003, J MINER MAT CHARACT, V2, P101
   Siddharthan A, 2006, SCRIPTA MATER, V55, P175, DOI 10.1016/j.scriptamat.2006.03.044
   Silva CC, 2009, PHYSICA B, V404, P1503, DOI 10.1016/j.physb.2009.01.015
   Teoreanu I, 2008, J MATER SCI-MATER M, V19, P517, DOI 10.1007/s10856-006-0038-5
   Thostenson ET, 1999, COMPOS PART A-APPL S, V30, P1055, DOI 10.1016/S1359-835X(99)00020-2
   Veljovic D, 2010, J MATER SCI, V45, P3175, DOI 10.1007/s10853-010-4324-8
   Verma S., 2007, THESIS U FLORIDA
   Yang ZW, 2004, MATER LETT, V58, P3586, DOI 10.1016/j.matlet.2004.06.046
NR 33
TC 14
Z9 14
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PD JAN
PY 2012
VL 38
IS 1
BP 457
EP 462
DI 10.1016/j.ceramint.2011.07.027
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 871VX
UT WOS:000298766900062
DA 2018-10-19
ER

PT J
AU Stavropoulos, A
   Sima, C
   Sima, A
   Nyengaard, J
   Karring, T
   Sculean, A
AF Stavropoulos, Andreas
   Sima, Catalin
   Sima, Andrea
   Nyengaard, Jens
   Karring, Thorkild
   Sculean, Anton
TI Histological evaluation of healing after transalveolar maxillary sinus
   augmentation with bioglass and autogenous bone
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE autogenous bone bioglass; histology; human; sinus augmentation
ID BIOACTIVE GLASS PARTICLES; NARROW SIZE RANGE; GUIDED TISSUE
   REGENERATION; FLOOR ELEVATION; IMPLANT PLACEMENT; SURVIVAL RATES; BOVINE
   BONE; PART I; DEFECTS; COMBINATION
AB Objectives: The aim was to evaluate histologically the outcome of a bioglass and autogenous bone (at 1 : 1 ratio) composite implantation for transalveolar sinus augmentation. Methods: In 31 patients, during implant installation ca. 4 months after sinus augmentation, biopsies were harvested through the transalveolar osteotomy by means of a trephine bur and non-decalcified sections through the long axis of the cylinder were produced. After a strict selection process, taking into account the presurgical residual bone height and biopsy length, 8 and 15 biopsies representing the new tissues formed inside the sinus and the transalveolar osteotomy, respectively, qualified for analysis. The tissue fractions occupied by newly formed bone (mineralized tissue_bone marrow), soft connective tissue, residual biomaterial_empty spaces, and debris inside the sinus cavity or the transalveolar osteotomy were estimated. Results: Bone and connective tissue fraction in the newly formed tissues inside the sinus cavity averaged 23.4 +/- 13.2% and 54.1 +/- 23.5%, respectively. Residual biomaterial, empty spaces, and debris averaged 1.9 +/- 3.5%, 10.5 +/- 6.3%, and 8.4 +/- 14.5%, respectively. In the transalveolar osteotomy, bone and connective tissue fraction averaged 41.6 +/- 14.3% and 46.1 +/- 13%, respectively, while the amount of residual biomaterial, empty spaces, and debris was 2.8 +/- 5%, 4.7 +/- 1.9%, and 3.2 +/- 2.6%, respectively. Statistically significant differences between the sinus cavity and the transalveolar osteotomy were found only for bone and empty spaces' values (P = 0.02 and 0.04, respectively). Conclusion: Sinus augmentation with a bioglass and autogenous bone composite is compatible with bone formation that, in a short distance from the floor of the sinus, shows similar density as that reported previously for other commonly used bone substitutes. New bone fraction inside the transalveolar osteotomy was almost twice as much as in the sinus cavity, while the amount of residual biomaterial was much less than that inside the sinus.
C1 [Stavropoulos, Andreas; Karring, Thorkild] Univ Aarhus, Sch Dent, Dept Periodontol, DK-8000 Aarhus C, Denmark.
   [Stavropoulos, Andreas] Ctr Expt & Preclin Biomed Res CEPBR, Athens, Greece.
   [Sima, Catalin; Sima, Andrea] Private Dent Off, Mulheim, Germany.
   [Nyengaard, Jens] Univ Aarhus, Ctr Stochast Geometry & Adv bioimaging, Stereol & Lab, DK-8000 Aarhus C, Denmark.
   [Sculean, Anton] Univ Bern, Sch Dent, Dept Periodontol, Bern, Switzerland.
RP Stavropoulos, A (reprint author), Univ Aarhus, Sch Dent, Dept Periodontol, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.
EM stavropoulos@odont.au.dk
FU Biomet 3i Inc. (Palm Beach, FL, USA)
FX The present study was partially supported by Biomet 3i Inc. (Palm Beach,
   FL, USA). The assistance of Dr L. Kostopoulos, PhD, in performing some
   of the surgeries is hereby acknowledged.
CR Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105
   Calixto RFE, 2007, IMPLANT DENT, V16, P260, DOI 10.1097/ID.0b013e3180500b95
   Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035
   Cancian DCJ, 1999, INT J ORAL MAX IMPL, V14, P859
   Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Ferrigno N, 2002, CLIN ORAL IMPLAN RES, V13, P260, DOI 10.1034/j.1600-0501.2002.130305.x
   Furlaneto FAC, 2007, CLIN ORAL IMPLAN RES, V18, P311, DOI 10.1111/j.1600-0501.2006.01331.x
   Furusawa T, 1998, INT J ORAL MAX IMPL, V13, P672
   Furusawa T, 1997, Implant Dent, V6, P93, DOI 10.1097/00008505-199700620-00003
   GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   Melo LGN, 2005, CLIN ORAL IMPLAN RES, V16, P683, DOI 10.1111/j.1600-0501.2004.01090.x
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Renouard F, 2006, CLIN ORAL IMPLAN RES, V17, P35, DOI 10.1111/j.1600-0501.2006.01349.x
   Rosenberg E S, 2000, J Esthet Dent, V12, P248, DOI 10.1111/j.1708-8240.2000.tb00231.x
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Schepers E, 1998, INT J ORAL MAX IMPL, V13, P655
   Schepers E J, 1993, Implant Dent, V2, P151, DOI 10.1097/00008505-199309000-00002
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Stavropoulos A, 2004, J CLIN PERIODONTOL, V31, P30, DOI 10.1111/j.0303-6979.2004.00434.x
   Stavropoulos A, 2003, J CLIN PERIODONTOL, V30, P636, DOI 10.1034/j.1600-051X.2003.00093.x
   Stavropoulos A, 2007, CLIN ORAL IMPLAN RES, V18, P95, DOI 10.1111/j.1600-0501.2006.01289.x
   Stvrtecky R, 2003, J PROSTHET DENT, V90, P424, DOI 10.1016/j.prosdent.2003.08.004
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   Tan WC, 2008, J CLIN PERIODONTOL, V35, P241, DOI 10.1111/j.1600-051X.2008.01273.x
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Trisi P, 2006, INT J PERIODONT REST, V26, P113
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.3.CO;2-S
   Winkler S, 2000, Ann Periodontol, V5, P22, DOI 10.1902/annals.2000.5.1.22
NR 35
TC 7
Z9 7
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2012
VL 23
IS 1
BP 125
EP 131
DI 10.1111/j.1600-0501.2011.02161.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 868TP
UT WOS:000298548900020
PM 21504477
DA 2018-10-19
ER

PT J
AU Frohlich, EM
   Zhang, X
   Charest, JL
AF Frohlich, Else M.
   Zhang, Xin
   Charest, Joseph L.
TI The use of controlled surface topography and flow-induced shear stress
   to influence renal epithelial cell function
SO INTEGRATIVE BIOLOGY
LA English
DT Article
ID SCANNING-ELECTRON-MICROSCOPY; BASEMENT-MEMBRANES; SUBSTRATE TOPOGRAPHY;
   ENDOTHELIAL-CELLS; COLLECTING DUCT; TUBULAR CELLS; STEM-CELLS;
   NANOSCALE; KIDNEY; DIFFERENTIATION
AB Physiologically-representative and well-controlled in vitro models of human tissue provide a means to safely, accurately, and rapidly develop therapies for disease. Current in vitro models do not possess appropriate levels of cell function, resulting in an inaccurate representation of in vivo physiology. Mechanical parameters, such as sub-micron topography and flow-induced shear stress (FSS), influence cell functions such as alignment, migration, differentiation and phenotypic expression. Combining, and independently controlling, biomaterial surface topography and FSS in a cell culture device would provide a means to control cell function resulting in more physiologically-representative in vitro models of human tissue. Here we develop the Microscale Tissue Modeling Device (MTMD) which couples a topographically-patterned substrate with a microfluidic chamber to control both topographic and FSS cues to cells. Cells from the human renal proximal tubule cell line HK-2 were cultured in the MTMD and exposed to topographic patterns and several levels of FSS simultaneously. Results show that the biomaterial property of surface topography and FSS work in concert to elicit cell alignment and influence tight junction (TJ) formation, with topography enhancing cell response to FSS. By administering independently-controlled mechanical parameters to cell populations, the MTMD creates a more realistic in vitro model of human renal tissue.
C1 [Frohlich, Else M.; Charest, Joseph L.] Charles Stark Draper Lab Inc, Cambridge, MA 02139 USA.
   [Frohlich, Else M.; Zhang, Xin] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.
RP Frohlich, EM (reprint author), Charles Stark Draper Lab Inc, 555 Technol Sq, Cambridge, MA 02139 USA.
RI Zhang, Xin/B-9244-2009
OI Zhang, Xin/0000-0002-4413-5084
FU Charles Stark Draper Laboratory
FX The authors would like to thank William A. Teynor for guidance in MEMS
   fabrication, James C. Hsiao and Joseph M. Bauer for technical
   consultation, and Joan Kelly for cell culture assistance. This work was
   supported by a Charles Stark Draper Laboratory Internal Research and
   Development Grant.
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Alberts B, 2000, MOL BIOL CELL
   ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Blattmann A, 2008, BIOMATERIALS, V29, P2749, DOI 10.1016/j.biomaterials.2008.03.019
   BONVALET JP, 1981, J PHYSIOL-LONDON, V318, P85
   Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Charest JL, 2008, MEMS REF SHELF, P251, DOI 10.1007/978-0-387-46283-7_10
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Drummond I, 2003, TRENDS CELL BIOL, V13, P357, DOI 10.1016/S0962-8924(03)00124-7
   Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105
   Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001
   Essig M, 2001, AM J PHYSIOL-RENAL, V281, pF751
   Essig M., 2010, RENAL PHYSL, V281, P751
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Glossop JR, 2009, GENE EXPR PATTERNS, V9, P381, DOI 10.1016/j.gep.2009.01.001
   HIRONAKA K, 1993, KIDNEY INT, V43, P334, DOI 10.1038/ki.1993.51
   Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c
   Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a
   Junqueira LC, 2005, BASIC HISTOLOGY
   Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1
   Kawai Y, 1996, BLOOD, V87, P2314
   Kumar V., 2005, ROBBINS COTRAN PATHO
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Liliensiek SJ, 2009, TISSUE ENG PT A, V15, P2643, DOI [10.1089/ten.tea.2008.0284, 10.1089/ten.TEA.2008.0284]
   Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003
   Minuth WW, 2009, LANGMUIR, V25, P4621, DOI 10.1021/la803858q
   Ogawa S, 1999, AM J NEPHROL, V19, P686, DOI 10.1159/000013543
   Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006
   Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039
   Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196
   Saito A., 2011, INT J NEPHROL, DOI DOI 10.4061/2011/957164
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x
   Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009
   WEISS P, 1958, INT REV CYTOL, V7, P391, DOI 10.1016/S0074-7696(08)62692-3
   YAMASAKI Y, 1994, NEPHRON, V66, P189, DOI 10.1159/000187800
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   YURCHENCO PD, 1990, ANN NY ACAD SCI, V580, P195, DOI 10.1111/j.1749-6632.1990.tb17929.x
NR 49
TC 32
Z9 33
U1 3
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2012
VL 4
IS 1
BP 75
EP 83
DI 10.1039/c1ib00096a
PG 9
WC Cell Biology
SC Cell Biology
GA 871ST
UT WOS:000298758700007
PM 22139064
DA 2018-10-19
ER

PT J
AU Thakurta, SG
   Miller, R
   Subramanian, A
AF Thakurta, Sanjukta Guha
   Miller, Robert
   Subramanian, Anuradha
TI Investigation of Platelet Responses and Clotting Characteristics of in
   situ Albumin Binding Surfaces
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE blood-biomaterial interaction; albumin affinity surface; hemolysis; PTT;
   PT; TT; platelet adhesion; blood compatibility
ID ACUTE INFLAMMATORY RESPONSES; PROTEIN ADSORPTION; PLASMA-PROTEINS;
   BLOOD; BIOMATERIALS; COAGULATION; POLYMERS; CONTACT; ACTIVATION;
   ADHESION
AB The response of biomaterial surfaces when exposed to blood is in part dependent upon the nature and composition of the adsorbed layer of proteins. Surfaces passivated with albumin have been shown to reduce platelet adhesion and activation. In an attempt to develop surfaces that can selectively and specifically bind albumin, silicon-based surfaces were functionalized with linear peptides and chemical ligands that displayed an affinity for albumin. Peptide functionalized surfaces were observed to preferentially bind albumin when compared to human immunoglobulin and human fibrinogen, which possess low densities of surface adsorbed platelets. The platelet morphology was noted to be discoid on the peptide modified surface. Both the unmodified control and SCL functionalized surfaces had high densities of surface adhered platelets with spread out morphology. The peptide and SCL functionalized surfaces were noted to have no impact on PTT and PT clotting times, indicating that the extrinsic and intrinsic pathways were unperturbed by the surfaces generated.
C1 [Thakurta, Sanjukta Guha; Miller, Robert; Subramanian, Anuradha] Univ Nebraska, Lincoln, NE 68588 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Othmer Hall, Lincoln, NE 68588 USA.
EM asubramanian2@unl.edu
FU NSF [CTS-0411632]; Army Research Laboratory [W911NF-04-2-0011]
FX This work was partially supported by NSF grant CTS-0411632 and Army
   Research Laboratory W911NF-04-2-0011. We are thankful to Gaye Homer of
   University Health Center for helping us with platelet counting. The
   training and assistance of Dr H. Chen of the microscopy facility at the
   Center of Biotechnology, University of Nebraska, Lincoln is highly
   appreciated. We are also grateful to Dr W. H. Velander for letting us
   use the hemostasis analyzer.
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Autian J., 1975, POLYM SCI TECHNOL, P181
   AUTIAN J, 2010, J MAT SCI MA M UNPUB
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BRASH JL, 1988, MAKROMOL CHEM-M SYMP, V17, P441, DOI 10.1002/masy.19880170133
   Cao L, 2006, J BIOMED MATER RES A, V79A, P788, DOI 10.1002/jbm.a.30908
   Chatterjee K, 2006, BIOMATERIALS, V27, P5643, DOI 10.1016/j.biomaterials.2006.07.025
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Keogh James R., 1996, Cells and Materials, V6, P209
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Keogh JR, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P94
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   Lyman D J, 1972, Adv Nephrol Necker Hosp, V2, P97
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1969, J BIOMED MATER RES, V3, P175
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   PACKHAM MA, 1988, P SOC EXP BIOL MED, V189, P261
   PARKS PJ, 1999, HDB BIOMATERIALS EVA, P341
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Stephen R, 2004, BIOMATERIALS SCI INT, P367
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   THAKURTA SG, 2007, J ELECTROCHEM SOC, V154, P136
   THAKURTA SG, 2009, DESIGN DEV IN SITU A
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
NR 30
TC 4
Z9 4
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2012
VL 26
IS 5
BP 529
EP 547
DI 10.1177/0885328210377535
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 874MW
UT WOS:000298963600002
PM 20819918
DA 2018-10-19
ER

PT J
AU Langenbach, F
   Naujoks, C
   Laser, A
   Kelz, M
   Kersten-Thiele, P
   Berr, K
   Depprich, R
   Kubler, N
   Kogler, G
   Handschel, J
AF Langenbach, Fabian
   Naujoks, Christian
   Laser, Andrea
   Kelz, Michael
   Kersten-Thiele, Pia
   Berr, Karin
   Depprich, Rita
   Kuebler, Norbert
   Koegler, Gesine
   Handschel, Joerg
TI Improvement of the Cell-loading Efficiency of Biomaterials by
   Inoculation with Stem Cell-based Microspheres, in Osteogenesis
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biocompatibility; bone tissue engineering; scaffold; stem cell;
   mineralization
ID BONE RECONSTRUCTION THERAPIES; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS;
   IN-VIVO; DIFFERENTIATION; SPARC; EXPRESSION; SCAFFOLDS; ADHESION;
   DENSITY
AB In critical-size bone defects, autologous or allogenic cells are required in addition to compatible biomaterials for the successful defect healing. State of the art inoculation methods of biomaterials are based on the application of cell suspensions to the biomaterial. However, only less amounts of cells can be applied and sufficient adhesion to the material is required. Therefore, it was investigated whether the advantages of stem cell-based microspheres and insoluble collagenous bone matrix (ICBM) scaffolds can be combined which can lead to an advancement in cell seeding on biomaterials. Microspheres were produced from unrestricted somatic stem cells from human umbilical cord blood and were mounted on ICBM scaffolds. Following the incubation with osteogenic or control medium, the constructs were analyzed histologically after 3, 7, 14, and 28 days. Alizarin Red S and von Kossa staining revealed microsphere mineralization after 3 days in osteogenic and after 14 days in control medium. Meanwhile, a time-dependent increase in tissue, growing out of the microspheres, was detected. Our results provide evidence that microsphere-ICBM constructs are promising candidates for approaches of bone regeneration. They allow the transfer of substantially high numbers of cells in partially mineralized constructs.
C1 [Langenbach, Fabian; Naujoks, Christian; Laser, Andrea; Kelz, Michael; Kersten-Thiele, Pia; Berr, Karin; Depprich, Rita; Kuebler, Norbert; Handschel, Joerg] Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, D-40225 Dusseldorf, Germany.
   [Koegler, Gesine] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany.
RP Naujoks, C (reprint author), Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM christian.naujoks@med.uni-duesseldorf.de
RI Langenbach, Fabian/F-4011-2012
OI Langenbach, Fabian/0000-0002-0836-6512
FU DFG [HA 3228/2-1]
FX Fabian Langenbach was supported by a DFG grant (HA 3228/2-1). The
   authors thank Prof. Dr G. Kogler, Jose Carreras Stammzellbank of the
   Heinrich-Heine-University, Dusseldorf, Germany, for providing USSCs. We
   thank Petra Scholtysek for her contribution to this manuscript.
CR Aktas M, 2008, CYTOTHERAPY, V10, P203, DOI 10.1080/14653240701851324
   Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HANDSCHEL J, 2010, TISSUE ENG A
   Handschel J, 2006, INT J ORAL MAX IMPL, V21, P890
   Handschel J, 2009, J BIOMATER APPL, V23, P549, DOI 10.1177/0885328208094305
   Handschel Jorg, 2008, Head Face Med, V4, P10, DOI 10.1186/1746-160X-4-10
   Handschel Jorg G K, 2007, Head Face Med, V3, P4, DOI 10.1186/1746-160X-3-4
   Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   IruelaArispe ML, 1996, DEV DYNAM, V207, P171, DOI 10.1002/(SICI)1097-0177(199610)207:2<171::AID-AJA5>3.0.CO;2-E
   Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440
   Kogler G, 2009, FUNDAMENTALS TISSUE, P167
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Langenbach F, 2010, TISSUE ENG PT A, V16, P759, DOI [10.1089/ten.tea.2009.0131, 10.1089/ten.TEA.2009.0131]
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192
   Meyer U, 2006, INT J ORAL MAX IMPL, V21, P899
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   NAUJOKS C, 2010, J BIOMATER APPL
   Rokkanen PU, 1998, ANN CHIR GYNAECOL FE, V87, P13
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   TULI SM, 1981, J TRAUMA, V21, P894, DOI 10.1097/00005373-198110000-00011
   VANDENBERK LC, 2010, J LEUKOCYTE BIOL, V87, P281
   Walker PS, 1996, CLIN ORTHOP RELAT R, pS4
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Wilson CE, 2002, J MATER SCI-MATER M, V13, P1265, DOI 10.1023/A:1021139415528
   WINTER M, 2008, J CELL MOL MED, V13, P2465
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Yazar S, 2004, PLAST RECONSTR SURG, V114, P1457, DOI 10.1097/01.PRS.0000138811.88807.65
NR 37
TC 6
Z9 7
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2012
VL 26
IS 5
BP 549
EP 564
DI 10.1177/0885328210377675
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 874MW
UT WOS:000298963600003
PM 20819916
DA 2018-10-19
ER

PT J
AU Pierson, D
   Edick, J
   Tauscher, A
   Pokorney, E
   Bowen, P
   Gelbaugh, J
   Stinson, J
   Getty, H
   Lee, CH
   Drelich, J
   Goldman, J
AF Pierson, Daniel
   Edick, Jacob
   Tauscher, Aaron
   Pokorney, Ellen
   Bowen, Patrick
   Gelbaugh, Jesse
   Stinson, Jon
   Getty, Heather
   Lee, Chee Huei
   Drelich, Jaroslaw
   Goldman, Jeremy
TI A simplified in vivo approach for evaluating the bioabsorbable behavior
   of candidate stent materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE vascular stents; blood-material interaction; biodegradation;
   biocompatibility; soft tissue
ID MUSCLE-CELL CALCIFICATION; PORCINE CORONARY-ARTERIES; IRON-OXIDES;
   ELUTING STENTS; PHOSPHATE; CORROSION; BIOMATERIAL; DEGRADATION;
   RESTENOSIS; 6-MONTH
AB Metal stents are commonly used to revascularize occluded arteries. A bioabsorbable metal stent that harmlessly erodes away over time may minimize the normal chronic risks associated with permanent implants. However, there is no simple, low-cost method of introducing candidate materials into the arterial environment. Here, we developed a novel experimental model where a biomaterial wire is implanted into a rat artery lumen (simulating bioabsorbable stent blood contact) or artery wall (simulating bioabsorbable stent matrix contact). We use this model to clarify the corrosion mechanism of iron (=99.5 wt %), which is a candidate bioabsorbable stent material due to its biocompatibility and mechanical strength. We found that iron wire encapsulation within the arterial wall extracellular matrix resulted in substantial biocorrosion by 22 days, with a voluminous corrosion product retained within the vessel wall at 9 months. In contrast, the blood-contacting luminal implant experienced minimal biocorrosion at 9 months. The importance of arterial blood versus arterial wall contact for regulating biocorrosion was confirmed with magnesium wires. We found that magnesium was highly corroded when placed in the arterial wall but was not corroded when exposed to blood in the arterial lumen for 3 weeks. The results demonstrate the capability of the vascular implantation model to conduct rapid in vivo assessments of vascular biomaterial corrosion behavior and to predict long-term biocorrosion behavior from material analyses. The results also highlight the critical role of the arterial environment (blood vs. matrix contact) in directing the corrosion behavior of biodegradable metals. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Pierson, Daniel; Tauscher, Aaron; Pokorney, Ellen; Goldman, Jeremy] Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA.
   [Edick, Jacob; Bowen, Patrick; Gelbaugh, Jesse; Drelich, Jaroslaw] Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA.
   [Stinson, Jon; Getty, Heather] Boston Sci Corp, Maple Grove, MN 55311 USA.
   [Lee, Chee Huei] Michigan Technol Univ, Dept Phys, Houghton, MI 49931 USA.
RP Goldman, J (reprint author), Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA.
EM jgoldman@mtu.edu
RI Lee, Chee Huei/C-3718-2014
OI Bowen, Patrick/0000-0003-2868-9359
FU Boston Scientific Corporation; National Institutes of Health
   [R21-HL-093568, R15-HL-093705]
FX Contract grant sponsor: Boston Scientific Corporation and National
   Institutes of Health; contract grant number: R21-HL-093568 and
   R15-HL-093705
CR Bersani D, 1999, J RAMAN SPECTROSC, V30, P355, DOI 10.1002/(SICI)1097-4555(199905)30:5<355::AID-JRS398>3.0.CO;2-C
   Camenzind E, 2006, NEW ENGL J MED, V355, P2149, DOI 10.1056/NEJMe068215
   Colombo A, 2000, CIRCULATION, V102, P371
   deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644
   Grube E, 2004, CIRCULATION, V109, P2168, DOI 10.1161/01.CIR.0000128850.84227.FD
   Hanesch M, 2009, GEOPHYS J INT, V177, P941, DOI 10.1111/j.1365-246X.2009.04122.x
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Larroumet D, 2007, J RAMAN SPECTROSC, V38, P1577, DOI 10.1002/jrs.1810
   Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Oh SJ, 1998, HYPERFINE INTERACT, V112, P59, DOI 10.1023/A:1011076308501
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Ramcharitar S, 2008, AM J CARDIOVASC DRUG, V8, P305, DOI 10.2165/00129784-200808050-00003
   Schlepp E, 2010, HEMATITE R050300 RRU
   Scott M, 2010, MAGNETITE R061111 RR
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Tamai H, 2000, CIRCULATION, V102, P399
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Yun YH, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70273-1
NR 33
TC 65
Z9 68
U1 4
U2 67
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2012
VL 100B
IS 1
BP 58
EP 67
DI 10.1002/jbm.b.31922
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860LM
UT WOS:000297949800007
PM 21905215
DA 2018-10-19
ER

PT J
AU Weaver, JD
   Ku, DN
AF Weaver, Jason D.
   Ku, David N.
TI Biomaterial testing for covered stent membranes: Evaluating thrombosis
   and restenosis potential
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE thrombogenicity; covered stents; in vitro testing; restenosis; polyvinyl
   alcohol cryogel
ID DRUG-ELUTING STENTS; FEMOROPOPLITEAL ARTERY; SYSTEM; GRAFT;
   THROMBOGENICITY; MODEL; TRIAL; OBSTRUCTIONS; EXPERIENCE; MIGRATION
AB Covered stents may be able to prevent both thrombosis and restenosis, but new mechanically suitable and biocompatible materials are needed before this treatment option can become a reality. Hydrophilic polyvinyl alcohol (PVA) cryogels have desirable mechanical properties for covered stent membranes and may be able to provide a physical barrier to restenosis with low thrombogenicity. An in vitro flow loop with porcine blood was used to compare thrombus formation on different blood-contacting biomaterials. PVA cryogels were found to maintain blood flow with low thrombogenicity and were significantly less thrombogenic than polyester (p < 0.05). The ability to prevent hyperplasic in-growth was evaluated using a modified Boyden chamber cellular migration assay. PVA cryogel membranes used as a physical barrier were found to nearly eliminate cellular migration (p < 0.05) without cellular toxicity. Overall, this article demonstrates pivotal feasibility results for a covered stent membrane material that could prevent restenosis by means of a hydrogel barrier with low thrombogenicity. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Ku, David N.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.
   [Weaver, Jason D.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Weaver, Jason D.] Emory Univ, Atlanta, GA 30322 USA.
RP Ku, DN (reprint author), Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.
EM david.ku@me.gatech.edu
OI Weaver, Jason D./0000-0003-4344-8772
FU Carlos and Marguerite Mason Foundation; L. P. Huang Chair Professorship
FX Contract grant sponsors: Carlos and Marguerite Mason Foundation and the
   L. P. Huang Chair Professorship
CR Ahmadi R, 2002, RADIOLOGY, V223, P345, DOI 10.1148/radiol.2232010971
   Ansel GM, 2009, J ENDOVASC THER, V16, P82, DOI 10.1583/08-2654.1
   Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023
   BEYTHIEN C, 1994, THROMB RES, V75, P581, DOI 10.1016/0049-3848(94)90170-8
   Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739
   Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47
   He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948
   Henry M, 1996, RADIOLOGY, V201, P717, DOI 10.1148/radiology.201.3.8939221
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   Jahnke T, 2003, J VASC INTERV RADIOL, V14, P41, DOI 10.1097/01.RVI.0000052290.26939.cb
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Kasaoka S, 1998, J AM COLL CARDIOL, V32, P1630, DOI 10.1016/S0735-1097(98)00404-5
   Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3
   Ku DN, 2007, BIORHEOLOGY, V44, P273
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   Ku DN, 2001, [US Patent, Poly (vinyl alcohol) hydrogel], Patent No. 6231605
   Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416
   Lowe HC, 2002, J AM COLL CARDIOL, V39, P183, DOI 10.1016/S0735-1097(01)01742-9
   Maynar M, 1997, J VASC INTERV RADIOL, V8, P203, DOI 10.1016/S1051-0443(97)70540-2
   Mewissen MW, 2009, J ENDOVASC THER, V16, P63, DOI 10.1583/08-2658.1
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Olsen AK, 1999, SCAND J LAB ANIM SCI, V26, P214
   Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6
   Saxon RR, 2007, J VASC INTERV RADIOL, V18, P1341, DOI 10.1016/j.jvir.2007.07.011
   Saxon RR, 2003, J VASC INTERV RADIOL, V14, P303, DOI 10.1097/01.RVI.0000058425.01661.d0
   Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5
   Schwarzwalder U, 2009, J CARDIOVASC SURG, V50, P627
   Shaw Leslie M, 2005, Methods Mol Biol, V294, P97
   SHEEHAN DC, 1980, THEORY PRACTICE HIST, P481
   Slavin Leo, 2007, Cardiol Rev, V15, P1, DOI 10.1097/01.crd.0000200844.16899.fc
   Streller U, 2003, J BIOMED MATER RES B, V66B, P379, DOI 10.1002/jbm.b.10016
   STRZINAR I, 1992, J BIOMED MATER RES, V26, P577, DOI 10.1002/jbm.820260503
   Tepe G, 2002, J VASC INTERV RADIOL, V13, P1029, DOI 10.1016/S1051-0443(07)61868-5
   Topol EJ, 1998, CIRCULATION, V98, P1802, DOI 10.1161/01.CIR.98.17.1802
   Voisard R, 1999, ATHEROSCLEROSIS, V144, P123, DOI 10.1016/S0021-9150(99)00046-5
   Weaver JD, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001863
NR 37
TC 5
Z9 5
U1 3
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2012
VL 100B
IS 1
BP 103
EP 110
DI 10.1002/jbm.b.31927
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860LM
UT WOS:000297949800012
PM 21954071
DA 2018-10-19
ER

PT J
AU Smith, MR
   Atkinson, P
   White, D
   Piersma, T
   Gutierrez, G
   Rossini, G
   Desai, S
   Wellinghoff, S
   Yu, H
   Cheng, XG
AF Smith, Montserrat Rabago
   Atkinson, Patrick
   White, Desiree
   Piersma, Tyler
   Gutierrez, Gloria
   Rossini, Gianny
   Desai, Sapna
   Wellinghoff, Stephen
   Yu, Hui
   Cheng, Xingguo
TI Design and assessment of a wrapped cylindrical Ca-P AZ31 Mg alloy for
   critical-size ulna defect repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone repair; magnesium; scaffolds; in vivo test; biocompatibility;
   biodegradation
ID IN-VIVO CORROSION; MAGNESIUM ALLOYS; CALCIUM-PHOSPHATE; BONE DEFECTS;
   ORTHOPEDIC IMPLANTS; OSTEOTOMY MODEL; RARE-EARTH; VITRO; DEGRADATION;
   BIOCOMPATIBILITY
AB Recently, magnesium has been investigated as a promising bioresorbable orthopedic biomaterial. Its mechanical properties are very similar to natural bone, making it appropriate for load-bearing orthopedic fracture repair applications. However, significant hurdles remain regarding the design of practical implants and methods to control degradation and enhance biocompatibility. Although attempts have been made to hinder magnesium's rapid corrosion via alloying and coating, these studies have used solid monoliths. In an effort to reduce the amount of alloy used for implantation in a shape that mimics cortical bone shape, this study used a thin sheet of Mg AZ31 which was rolled into hollow cylindrical scaffolds. The scaffold was coated with different amounts of Ca-P; this implant demonstrated slowed corrosion in simulated body fluid (SBF) as well as enhanced biocompatibility for mesenchymal stem cells (MSC). In vivo implantation of magnesium alloy scaffold adjacent to the rat femur showed significant biointegration with further deposition of complex Mg-Ca phosphates/carbonates typical of natural bone. Finally, the implant was placed in a critical-size ulna defect in live rabbits, which lead to radiographic union and partial restoration of biomechanical strength in the defect. This study demonstrated that a thin sheet of coated Mg alloy that was spirally wrapped wound be a promising orthopedic biomaterial for bone repair. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Gutierrez, Gloria; Rossini, Gianny; Desai, Sapna; Wellinghoff, Stephen; Yu, Hui; Cheng, Xingguo] SW Res Inst, Dept Microencapsulat & Nanomat, San Antonio, TX 78251 USA.
   [Smith, Montserrat Rabago; Atkinson, Patrick; White, Desiree; Piersma, Tyler] Kettering Univ, Dept Chem & Biochem, Flint, MI 48504 USA.
RP Cheng, XG (reprint author), SW Res Inst, Dept Microencapsulat & Nanomat, 6220 Culebra Rd, San Antonio, TX 78251 USA.
EM xcheng@swri.org
FU Southwest Research Institute Advisory Committee for Internal Research
FX Contract grant sponsor: Southwest Research Institute Advisory Committee
   for Internal Research
CR Arnaud MJ, 2008, BRIT J NUTR, V99, pS24, DOI 10.1017/S000711450800682X
   Bertone AL, 2004, J ORTHOP RES, V22, P1261, DOI 10.1016/j.orthres.2004.03.014
   Brar HS, 2009, JOM-US, V61, P31, DOI 10.1007/s11837-009-0129-0
   BRUCE DW, 1963, TOXICOL APPL PHARM, V5, P750, DOI 10.1016/0041-008X(63)90067-X
   CHENG PT, 1988, MAGNESIUM, V7, P123
   Cheng XG, 2007, INT J NANOMED, V2, P667
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Eisenmeier G, 2001, MAT SCI ENG A-STRUCT, V319, P578, DOI 10.1016/S0921-5093(01)01105-4
   ELIN RJ, 1987, CLIN CHEM, V33, P1965
   Feyerabend F, 2007, REGEN MED, V2, P612
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Gere J. M., 1984, MECH MAT
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.3.CO;2-1
   Gray-Munro JE, 2008, J BIOMED MATER RES A, V91A, P221
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014
   He YH, 2009, CHINESE SCI BULL, V54, P484, DOI 10.1007/s11434-009-0080-z
   Huang SC, 1997, J FORMOS MED ASSOC, V96, P23
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y
   Kim WJ, 2001, ACTA MATER, V49, P3337, DOI 10.1016/S1359-6454(01)00008-8
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Kroese-Deutman HC, 2010, TISSUE ENG PART C-ME, V16, P1051, DOI [10.1089/ten.tec.2009.0071, 10.1089/ten.TEC.2009.0071]
   Lambert JB, 1998, ORGANIC STRUCTURAL S
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niemeyer P, 2010, ACTA BIOMATER, V6, P900, DOI 10.1016/j.actbio.2009.09.007
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.1432-1033.2004.04277.x
   PIERSON DL, 1980, J BIOL CHEM, V255, P7891
   Pietak A, 2008, J MATER SCI-MATER M, V19, P407, DOI 10.1007/s10856-007-3172-9
   SAVORY J, 1986, ACTA PHARMACOL TOX, V59, P282
   Sheller MR, 2004, J ORTHOPAED RES, V22, P1094, DOI 10.1016/j.orthres.2004.03.009
   Singh M, 2007, VACCINE ADJUVANTS DE
   Song G, 2003, ADV ENG MATER, V5
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tro N, 2008, CHEM MOL APPROACH
   TULI SM, 1981, J TRAUMA, V21, P894, DOI 10.1097/00005373-198110000-00011
   Williams David, 2006, Med Device Technol, V17, P9
   Wise O, 2010, NACE BIOC C CORR PRE
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Wong KHM, 2009, 55 ANN M ORTH RES SO
   Xin YC, 2009, J BIOMED MATER RES A, V89A, P717, DOI 10.1002/jbm.a.32006
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yang JX, 2008, SURF COAT TECH, V202, P5733, DOI 10.1016/j.surfcoat.2008.06.035
   Zeng R., 2008, ADV BIOMATER, pB3
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
NR 55
TC 8
Z9 11
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2012
VL 100B
IS 1
BP 206
EP 216
DI 10.1002/jbm.b.31940
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860LM
UT WOS:000297949800024
PM 22102519
DA 2018-10-19
ER

PT J
AU Shankarraman, V
   Davis-Gorman, G
   Copeland, JG
   Caplan, MR
   McDonagh, PF
AF Shankarraman, Venkat
   Davis-Gorman, Grace
   Copeland, Jack G.
   Caplan, Michael R.
   McDonagh, Paul F.
TI Standardized methods to quantify thrombogenicity of blood-contacting
   materials via thromboelastography
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE thromboelastogram; biocompatible materials; vascular graft; blood
   coagulation; endothelial cells
ID IN-VITRO; BIOMATERIALS; COAGULATION; SURFACE; PLASMA;
   THROMBELASTOGRAPHY; THROMBOEMBOLISM; NANOPARTICLES; GLUCOSAMINE;
   ACTIVATION
AB Blood coagulation is the most significant complication of vascular biomaterials. A straightforward, sensitive, and standard measure of the compatibility of these materials with whole blood (hemocompatibility) is necessary to avoid coagulation. Current techniques used quantify only individual clotting components and are poor predictors of coagulation. The thromboelastograph (TEG) provides a measure of overall clot formation from whole blood. Although TEG is very common in clinical settings, its application to biomaterials is limited partly due to difficulty in sample preparation. In this protocol, whole blood samples are incubated with (1) biomaterials (tube with clamped ends) and (2) endothelial cells cultured on biomaterial surfaces (12-well plate) under controlled shearing conditions (10 rpm on rocker, at 37 degrees C), and then the blood is transferred to the TEG to measure clot formation. TEG clearly discriminates among the R-times (time until initial clot formation) of expanded poly(tetrafluoroethylene), poly(urethane), and Tygon tubing. Marked differences in R-time are also seen when endothelial cells are cultured on various extracellular matrix proteins and proteoglycans. Thus, R-time provides a robust metric of overall thrombogenicity of biomaterials, and these procedures provide a standardized method for TEG to facilitate direct comparison among candidate biomaterials undergoing in-vitro testing. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2012.
C1 [Davis-Gorman, Grace; Copeland, Jack G.; McDonagh, Paul F.] Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ 85719 USA.
   [Davis-Gorman, Grace; Copeland, Jack G.; McDonagh, Paul F.] Univ Arizona, Hlth Sci Ctr, Sarver Heart Ctr, Tucson, AZ USA.
   [Shankarraman, Venkat; Caplan, Michael R.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA.
RP McDonagh, PF (reprint author), Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ 85719 USA.
EM mcdonagh@surgery.arizona.edu
FU American Heart Association; Arizona Biomedical Research Commission
   [0903]; Sarver Heart Center Hudson/Lovaas Endowment Fund
FX Contract grant sponsor: American Heart Association and Arizona
   Biomedical Research Commission; contract grant number: 0903; The authors
   thank Bard Peripheral Vascular (Tempe, AZ) for generously providing the
   ePTFE and PU tubing. The authors also wish to acknowledge support from
   the Sarver Heart Center Hudson/Lovaas Endowment Fund.
CR Artang R, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-14
   BIRD RL, 1988, THROMB RES, V51, P471
   BIRD RL, 1989, J BIOMED ENG, V11, P231, DOI 10.1016/0141-5425(89)90148-9
   Bridges AW, 2010, J BIOMED MATER RES A, V94A, P252, DOI 10.1002/jbm.a.32669
   CHEPUROV A K, 1980, Byulleten' Eksperimental'noi Biologii i Meditsiny, V89, P296
   Chevallier P, 2005, MACROMOL BIOSCI, V5, P829, DOI 10.1002/mabi.200500088
   Copeland JG, 1996, ANN THORAC SURG, V61, P376, DOI 10.1016/0003-4975(95)00995-7
   Copeland JG, 1999, ANN THORAC SURG, V68, P756, DOI 10.1016/S0003-4975(99)00526-3
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   DAVIDSON GWR, 1984, BIOMATERIALS, V5, P227, DOI 10.1016/0142-9612(84)90020-6
   Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Haemoscope Corporation, 2002, TEG 5000 US MAN, P1
   Hyers TM, 2001, CHEST, V119, p176S, DOI 10.1378/chest.119.1_suppl.176S
   Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011
   KLOCKING HP, 1993, THROMB RES, V72, P501, DOI 10.1016/0049-3848(93)90110-A
   Kopp R, 2010, ARTIF ORGANS, V34, P13, DOI 10.1111/j.1525-1594.2009.00791.x
   Koster A, 2002, ASAIO J, V48, P106, DOI 10.1097/00002480-200201000-00021
   Lee DW, 2004, CARBOHYD POLYM, V58, P371, DOI 10.1016/j.carbpol.2004.06.033
   Lee DW, 2004, BIOMACROMOLECULES, V5, P1310, DOI 10.1021/bm049935o
   Lippi G, 2008, SEMIN THROMB HEMOST, V34, P604, DOI 10.1055/s-0028-1104539
   Liu WG, 2004, J MATER SCI-MATER M, V15, P1199, DOI 10.1007/s10856-004-5672-1
   Luddington RJ, 2005, CLIN LAB HAEMATOL, V27, P81, DOI 10.1111/j.1365-2257.2005.00681.x
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Morey TE, 2004, J NANOPART RES, V6, P159, DOI 10.1023/B:NANO.0000034625.30336.c1
   Mortier E, 1997, ANAESTHESIA, V52, P1061, DOI 10.1111/j.1365-2044.1997.220-az0354.x
   Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468
   Murugesan S, 2006, J BIOMED MATER RES B, V79B, P298, DOI 10.1002/jbm.b.30542
   Nelson GN, 2008, ARCH SURG-CHICAGO, V143, P488, DOI 10.1001/archsurg.143.5.488
   Niemi TT, 2005, ACTA ANAESTH SCAND, V49, P373, DOI 10.1111/j.1399-6576.2004.00619.x
   Peng HT, 2010, J BIOMED MATER RES B, V94B, P469, DOI 10.1002/jbm.b.31626
   Peng HT, 2009, J BIOMED MATER RES B, V89B, P199, DOI 10.1002/jbm.b.31206
   Portner PM, 1996, ANN THORAC SURG, V61, P378
   Prasad CK, 2007, J BIOMED MATER RES A, V80A, P644, DOI 10.1002/jbm.a.30968
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Ravi S, 2009, VASCULAR, V17, pS45, DOI 10.2310/6670.2008.00084
   Riley JB, 1992, J EXTRA-CORP TECHNOL, V23, P112
   Senzolo M, 2007, BLOOD COAGUL FIBRIN, V18, P227, DOI 10.1097/MBC.0b013e328010bd3d
   Shankarraman V, 2010, CELL MOL BIOENG, V3, P229, DOI 10.1007/s12195-010-0122-2
   Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006
   Valeri CR, 2004, J TRAUMA, V57, pS22, DOI 10.1097/01.TA.0000136744.12440.47
   VALERI CR, 2004, J TRAUMA, V57, pS25
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Ye SH, 2009, COLLOID SURFACE B, V74, P96, DOI 10.1016/j.colsurfb.2009.06.032
   Ye SH, 2009, J BIOMED MATER RES A, V91A, P18, DOI 10.1002/jbm.a.32184
NR 45
TC 17
Z9 18
U1 0
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2012
VL 100B
IS 1
BP 230
EP 238
DI 10.1002/jbm.b.31942
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860LM
UT WOS:000297949800026
PM 22102528
DA 2018-10-19
ER

PT J
AU Corpuz, M
   Shofler, D
   Labovitz, J
   Hodor, L
   Yu, K
AF Corpuz, Michael
   Shofler, David
   Labovitz, Jonathan
   Hodor, Lawrence
   Yu, Kelly
TI Fracture of the Talus as a Complication of Subtalar Arthroereisis
SO JOURNAL OF FOOT & ANKLE SURGERY
LA English
DT Article
DE bone graft; explant; flatfoot; MBA (R) implant; pediatric; planovalgus;
   surgery
AB Subtalar joint arthroereisis remains a popular procedure for a flexible flatfoot deformity. Potential complications of the procedure have been discussed in published reports and are often believed to have resulted from shortcomings related to the mechanical properties of the biomaterial, implant size, and/or implant placement. In the present report, we describe the case of a talar neck fracture with migration of the implant after subtalar joint arthroereisis performed 10 years earlier. The 19-year-old patient was treated with implant removal and open reduction internal fixation and bone void filler and recovered unremarkably thereafter. (C) 2012 by the American College of Foot and Ankle Surgeons. All rights reserved.
C1 [Labovitz, Jonathan] Western Univ Hlth Sci, Coll Podiatr Med, Dept Med, Pomona, CA 91766 USA.
   [Labovitz, Jonathan] Western Univ Hlth Sci, Coll Podiatr Med, Dept Surg, Pomona, CA 91766 USA.
   [Labovitz, Jonathan] Western Univ Hlth Sci, Coll Podiatr Med, Dept Biomech, Pomona, CA 91766 USA.
   [Hodor, Lawrence; Yu, Kelly] Lakewood Reg Med Ctr, Lakewood, CA USA.
RP Labovitz, J (reprint author), Western Univ Hlth Sci, Coll Podiatr Med, Dept Med, 309 E 2nd St, Pomona, CA 91766 USA.
EM jonathan_labovitz@hotmail.com
CR CHAMBERS E F S, 1946, West J Surg Obstet Gynecol, V54, P77
   KUWADA G T, 1988, Journal of Foot Surgery, V27, P236
   Needleman RL, 2006, FOOT ANKLE INT, V27, P9, DOI 10.1177/107110070602700103
   OLOFF L M, 1987, Journal of Foot Surgery, V26, P136
   Rockett A K, 1998, J Foot Ankle Surg, V37, P421
   Scharer Brandon M, 2010, Foot Ankle Spec, V3, P67, DOI 10.1177/1938640010362262
   Scher David M, 2007, HSS J, V3, P177, DOI 10.1007/s11420-007-9057-0
   Schon Lew C, 2007, Foot Ankle Clin, V12, P329, DOI 10.1016/j.fcl.2007.03.011
   Siff TE, 2000, FOOT ANKLE INT, V21, P247, DOI 10.1177/107110070002100311
   Soomekh David J, 2006, Clin Podiatr Med Surg, V23, P695
   Viladot R, 2003, FOOT ANKLE INT, V24, P600, DOI 10.1177/107110070302400806
NR 11
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1067-2516
J9 J FOOT ANKLE SURG
JI J. Foot Ankle Surg.
PD JAN-FEB
PY 2012
VL 51
IS 1
BP 91
EP 94
DI 10.1053/j.jfas.2011.08.008
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 866HU
UT WOS:000298372100020
PM 21962334
DA 2018-10-19
ER

PT J
AU Lee, H
   Choi, BG
   Moon, HJ
   Choi, J
   Park, K
   Jeong, B
   Han, DK
AF Lee, Hyesun
   Choi, Bo Gyu
   Moon, Hyo Jung
   Choi, Jiyeon
   Park, Kwideok
   Jeong, Byeongmoon
   Han, Dong Keun
TI Chondrocyte 3D-culture in RGD-modified crosslinked hydrogel with
   temperature-controllable modulus
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE stimuli-sensitive polymers; biomimetic; modulus; hydrogel; biomaterial
ID COPOLYMER; ADHESION
AB Based on the thermosensitivity of PluronicA (R) F127 and the cytointeractability of Arg-Gly-Asp (RGD) sequences, RGD-modified F127 dimethacrylate (FM-RGD) hydrogel was investigated as a 3-dimensional culture matrix for chondrocytes. Chondrocytes were encapsulated in the hydrogel by radical copolymerization of FM-RGD and FM in the presence of cells. The FM-RGD hydrogel modulus could be modulated by temperature variation from 15 A degrees C (1,300 Pa) to the culture temperature of 37 A degrees C (8,900 Pa), at which the hydrogel provided a condrocyte-compatible microenvironment. Compared with the hydrogel prepared from F127 dimethacrylate (FM) without RGD, the RGD-modified hydrogel produced significant (p < 0.01) improvements in cell proliferation, DNA production, and viability while allowing the chondrocytes to maintain their original spherical phenotypes.
C1 [Lee, Hyesun; Choi, Bo Gyu; Moon, Hyo Jung; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci WCU, Seoul 120750, South Korea.
   [Lee, Hyesun; Choi, Jiyeon; Park, Kwideok; Han, Dong Keun] Korea Inst Sci & Technol, Ctr Biomat, Seoul 130650, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci WCU, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr; dkh@kist.re.kr
OI Han, Dong Keun/0000-0003-4641-7883
FU Pioneer Research Center through National Research Foundation of Korea;
   Ministry of Education, Science and Technology [2011-0001696];
   Fundamental R&D Program for Core Technology of Materials; Ministry of
   Knowledge Economy, Republic of Korea [K0006028]; KIST [2E22360];
   National Research Foundation of Korea [2011-0000376, 2011-0001340]
FX This study was supported by the Pioneer Research Center Program through
   the National Research Foundation of Korea funded by the Ministry of
   Education, Science and Technology (2011-0001696), a grant from the
   Fundamental R&D Program for Core Technology of Materials funded by the
   Ministry of Knowledge Economy, Republic of Korea (K0006028), KIST grant
   (2E22360), and National Research Foundation of Korea (Grant number:
   2011-0000376 & 2011-0001340).
CR Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Cha MH, 2011, J COLLOID INTERF SCI, V360, P78, DOI 10.1016/j.jcis.2011.04.041
   Choi BG, 2011, SOFT MATTER, V7, P456, DOI 10.1039/c0sm00611d
   Choi BG, 2011, MACROMOLECULES, V44, P2269, DOI 10.1021/ma200003b
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lee H, 2009, J BIOMED MATER RES A, V88A, P797, DOI 10.1002/jbm.a.31983
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   MALMSTEN M, 1992, MACROMOLECULES, V25, P5446, DOI 10.1021/ma00046a050
   Mark K., 1977, NATURE, V267, P531
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MORTENSEN K, 1993, MACROMOLECULES, V26, P805, DOI 10.1021/ma00056a035
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Robb SA, 2007, BIOMACROMOLECULES, V8, P2294, DOI 10.1021/bm070267r
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 28
TC 8
Z9 8
U1 1
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD JAN
PY 2012
VL 20
IS 1
BP 106
EP 111
DI 10.1007/s13233-012-0074-6
PG 6
WC Polymer Science
SC Polymer Science
GA 873KV
UT WOS:000298883100015
DA 2018-10-19
ER

PT J
AU Tosun, G
   Orhan, N
   Ozler, L
AF Tosun, Gul
   Orhan, Nuri
   Ozler, Latif
TI Investigation of combustion channel in fabrication of porous NiTi alloy
   implants by SHS
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; NiTi; Combustion channel; SHS
ID SHAPE-MEMORY ALLOYS; MECHANISM; MICROSTRUCTURE; TRANSFORMATION;
   TEMPERATURE; POROSITY
AB In this study, NiTi alloy was conducted under varying cold compaction pressure, preheating temperature and heating rate. The distance between the adjacent striations was increased when the cold compaction pressure or green density was increased. The threshold-heating rate was determined as 60 degrees C/min for this study. It was observed that when the amount of liquid phase excessively increased, porosity decreased and the specimen deformed. This situation occurred with increase in heating rates (>= 60 degrees C/min), preheating temperatures (>250 degrees C) and cold compaction pressures (>7 MPa). (C) 2011 Elsevier B.V. All rights reserved.
C1 [Tosun, Gul] Firat Univ, Tech Vocat Sch, TR-23119 Elazig, Turkey.
   [Orhan, Nuri] Firat Univ, Fac Technol, Met & Mat Engn Dept, TR-23119 Elazig, Turkey.
   [Ozler, Latif] Firat Univ, Fac Engn, Dept Mech Engn, TR-23119 Elazig, Turkey.
RP Tosun, G (reprint author), Firat Univ, Tech Vocat Sch, TR-23119 Elazig, Turkey.
EM gultosun@firat.edu.tr
FU Firat University Scientific Research Projects Foundation [FUBAP-1137]
FX The authors would like to acknowledge the Firat University Scientific
   Research Projects Foundation (FUBAP-1137) for financial support for this
   study.
CR Bertolino N, 2003, INTERMETALLICS, V11, P41, DOI 10.1016/S0966-9795(02)00128-0
   Biswas A, 2005, ACTA MATER, V53, P1415, DOI 10.1016/j.actamat.2004.11.036
   Chu CL, 2005, J MATER PROCESS TECH, V169, P103, DOI 10.1016/j.jmatprotec.2005.03.002
   Chu CL, 2005, MATER LETT, V59, P404, DOI 10.1016/j.matlet.2004.08.036
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   Frankhouser W. L., 1985, GASLESS COMBUSTION S
   Ganesh I, 2005, CERAM INT, V31, P67, DOI 10.1016/j.ceramint.2004.03.036
   Kaya M, 2010, MATER SCI TECH-LOND, V26, P522, DOI 10.1179/174328409X410809
   Kaya M, 2010, CURR OPIN SOLID ST M, V14, P21, DOI 10.1016/j.cossms.2009.07.002
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Tosun G, 2009, J ALLOY COMPD, V487, P605, DOI 10.1016/j.jallcom.2009.08.023
   Yeh CL, 2004, J ALLOY COMPD, V376, P79, DOI 10.1016/j.jallcom.2003.12.016
NR 14
TC 8
Z9 8
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JAN
PY 2012
VL 66
IS 1
BP 138
EP 140
DI 10.1016/j.matlet.2011.08.023
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 856RE
UT WOS:000297660300041
DA 2018-10-19
ER

PT J
AU Gordin, DM
   Gloriant, T
   Nemtoi, G
   Chelariu, R
   Aelenei, N
   Guillou, A
   Ansel, D
AF Gordin, D. M.
   Gloriant, T.
   Nemtoi, Gh
   Chelariu, R.
   Aelenei, N.
   Guillou, A.
   Ansel, D.
TI Synthesis, structure and electrochemical behaviour of a beta Ti-12Mo-5Ta
   alloy as new biomaterial (vol 59, pg 2959, 2005)
SO MATERIALS LETTERS
LA English
DT Correction
C1 [Gordin, D. M.; Gloriant, T.; Guillou, A.; Ansel, D.] INSA Rennes, GRCM, EA2620, F-35043 Rennes, France.
   [Nemtoi, Gh] Alexandru Ioan Cuza Univ, Fac Chem, Phys & Theoret Chem Dept, Iasi 70050, Romania.
   [Chelariu, R.] Gh Asachi Tech Univ, Fac Mat Sci & Engn, Dept Mat Sci, Iasi 70050, Romania.
   [Aelenei, N.] Gh Asachi Tech Univ, Fac Ind Chem, Dept Chem Phys, Iasi 70050, Romania.
RP Gloriant, T (reprint author), INSA Rennes, GRCM, EA2620, 20 Ave Buttes Coesmes, F-35043 Rennes, France.
OI Gordin, Doina Margareta/0000-0003-2200-9930
CR Gordin DM, 2005, MATER LETT, V59, P2959, DOI 10.1016/j.matlet.2004.09.064
NR 1
TC 0
Z9 0
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JAN
PY 2012
VL 66
IS 1
BP 385
EP 385
DI 10.1016/j.matlet.2011.09.085
PG 1
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 856RE
UT WOS:000297660300115
DA 2018-10-19
ER

PT J
AU Su, JF
   Yuan, XY
   Huang, Z
   Wang, XY
   Lu, XZ
   Zhang, LD
   Wang, SB
AF Su, Jun-Feng
   Yuan, Xiao-Yan
   Huang, Zhen
   Wang, Xin-Yu
   Lu, Xu-Zhen
   Zhang, Li-Dan
   Wang, Sheng-Bao
TI Physicochemical properties of soy protein isolate/carboxymethyl
   cellulose blend films crosslinked by Maillard reactions: Color,
   transparency and heat-sealing ability
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Soy protein isolate; Carboxymethyl cellulose; Color; Transparency;
   Heat-sealing ability
ID MODEL SYSTEMS; ISOLATE; TEMPERATURE; PH; KINETICS; TENSILE
AB Soy protein isolate (SPI) films have many potential applications in the biomaterial field as surgical dressings for burns, films for reduction of wound inflammation, and facial masks. The appearance and the sealing ability are important physicochemical properties that greatly influence consumer acceptance of such protein-based films. The aim of the present work was to investigate the chemical structure and the physical properties associated with color, transparency and heat-sealing ability for SPI/carboxymethyl cellulose (CMC) blend films prepared by solution casting, with weight proportions 90/10. 80/20, 70/30 and 60/40. Fourier transform infra-red (FTIR) and solid-state C-13 nuclear magnetic resonance (NMR) spectra confirmed that Maillard reactions occurred between SPI and CMC. The Hunter color value (I., a, b) and transparency of films were affected by varying the proportions of SPI and CMC. With increasing degree of crosslinking of SPI and CMC, the yellow color of the films was diluted and transparency was improved. Peel strength and tensile strength measurements showed that the Maillard reactions had the main effect of enhancing the heat-sealing ability above the melting temperature. These results indicated that the structure and properties of SPI-based films could be modified and improved by blending with CMC. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Su, Jun-Feng; Huang, Zhen; Wang, Xin-Yu; Lu, Xu-Zhen; Zhang, Li-Dan] Tianjin Univ Commerce, Inst Mat Sci & Chem Engn, Dept Packaging Engn, Tianjin 300134, Peoples R China.
   [Su, Jun-Feng; Yuan, Xiao-Yan; Wang, Sheng-Bao] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Su, JF (reprint author), Tianjin Univ Commerce, Inst Mat Sci & Chem Engn, Dept Packaging Engn, Tianjin 300134, Peoples R China.
EM sujunfeng2000@yahoo.com.cn
FU National Key Technology R&D Program of China [2006BAD05A05]
FX The authors gratefully acknowledge the support of National Key
   Technology R&D Program of China (No. 2006BAD05A05) and the NMR tests
   with the help of Dr. Kong-Ying Zhu in the Tianjin University Testing
   Center.
CR Aaslyng MD, 1999, Z LEBENSM UNTERS F A, V208, P355, DOI 10.1007/s002170050429
   Ajandouz EH, 2008, FOOD CHEM, V107, P1244, DOI 10.1016/j.foodchem.2007.09.062
   Alaiz M, 1999, J AGR FOOD CHEM, V47, P748, DOI 10.1021/jf980733r
   Bosch L, 2007, FOOD CHEM, V105, P1135, DOI 10.1016/j.foodchem.2007.02.016
   Choi WY, 2006, LWT-FOOD SCI TECHNOL, V39, P591, DOI 10.1016/j.lwt.2005.04.012
   Fang XW, 2009, J AGR FOOD CHEM, V57, P10701, DOI 10.1021/jf9020587
   Gamage GR, 2009, FOOD RES INT, V42, P832, DOI 10.1016/j.foodres.2009.03.012
   Hashimoto Y, 2006, POLYM ENG SCI, V46, P205, DOI 10.1002/pen.20452
   Hernandez-Izquierdo VM, 2008, J FOOD SCI, V73, pR30, DOI 10.1111/j.1750-3841.2007.00636.x
   Hofmann T, 1998, CARBOHYD RES, V313, P203, DOI 10.1016/S0008-6215(98)00279-1
   Lee M, 2005, RADIAT PHYS CHEM, V72, P35, DOI 10.1016/j.radphyschem.2004.01.006
   Liu SC, 2008, FOOD CHEM, V108, P533, DOI 10.1016/j.foodchem.2007.11.006
   Liu Y, 2009, IRAN POLYM J, V18, P339
   Lodha P, 2005, IND CROP PROD, V21, P49, DOI 10.1016/j.indcrop.2003.12.006
   Manconia M, 2009, J PHARM PHARMACOL, V61, P423, DOI 10.1211/jpp/61.04.0002
   Nayak P, 2008, POLYM-PLAST TECHNOL, V47, P466, DOI 10.1080/03602550801949728
   Park SK, 2003, FOOD SCI BIOTECHNOL, V12, P385
   Ralston BE, 2008, PLAST ENG, V64, P36, DOI 10.1002/j.1941-9635.2008.tb00292.x
   Rhim JW, 2000, J AGR FOOD CHEM, V48, P4937, DOI 10.1021/jf0005418
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Rhim JW, 2006, IND ENG CHEM RES, V45, P3059, DOI 10.1021/ie051207+
   Sothornvit R, 2007, J FOOD ENG, V78, P855, DOI 10.1016/j.jfoodeng.2005.12.002
   Su JF, 2010, POLYM DEGRAD STABIL, V95, P1226, DOI 10.1016/j.polymdegradstab.2010.03.035
   Su JF, 2010, J APPL POLYM SCI, V115, P1901, DOI 10.1002/app.31150
   Su JF, 2010, CARBOHYD POLYM, V79, P145, DOI 10.1016/j.carbpol.2009.07.035
   Vaz CM, 2003, POLYMER, V44, P5983, DOI 10.1016/S0032-3861(03)00549-4
   Xu KK, 2009, LANGMUIR, V25, P9714, DOI 10.1021/la900960g
   Zheng H, 2007, J APPL POLYM SCI, V106, P1034, DOI 10.1002/app.26725
NR 28
TC 23
Z9 29
U1 5
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2012
VL 32
IS 1
BP 40
EP 46
DI 10.1016/j.msec.2011.09.009
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 867ON
UT WOS:000298463800007
PM 23177770
DA 2018-10-19
ER

PT J
AU Verma, MS
   Liu, SY
   Chen, YY
   Meerasa, A
   Gu, FX
AF Verma, Mohit S.
   Liu, Shengyan
   Chen, Yih Y.
   Meerasa, Ameena
   Gu, Frank X.
TI Size-tunable nanoparticles composed of dextran-b-poly(D,L-lactide) for
   drug delivery applications
SO NANO RESEARCH
LA English
DT Article
DE Dextran; nanoparticles; biodistribution; pharmacokinetics; controlled
   drug delivery; in vivo
ID CORE-SHELL NANOPARTICLES; BLOCK-COPOLYMERS; IN-VITRO; POLYMERIC
   NANOPARTICLES; TARGETED NANOPARTICLES; POLY(ETHYLENE GLYCOL);
   DOXORUBICIN DELIVERY; PLGA NANOPARTICLES; PEG NANOPARTICLES; PLA
   NANOPARTICLES
AB Nanoparticles (NPs) formulated using self-assembly of block copolymers have attracted significant attention as nano-scaled drug delivery vehicles. Here we report the development of a biodegradable NP using self-assembly of a linear amphiphilic block copolymer, Dex-b-PLA, composed of poly(D,L-lactide), and dextran. The size of the NPs can be precisely tuned between 15 and 70 nm by altering the molecular weight (M (W)) of the two polymer chains. Using doxorubicin as a model drug, we demonstrated that the NPs can carry up to 21% (w/w) of the drug payload. The release profile of doxorubicin from NPs showed sustained release for over 6 days. Using a rat model, we explored the pharmacokinetics profiles of Dex-b-PLA NPs, and showed proof-of-concept that long circulation lifetime of the NPs can be achieved by tuning the M (W) of Dex-b-PLA block copolymer. While the terminal half-life of Dex-b-PLA NPs (29.8 h) was similar to that observed in poly(ethylene glycol)-coated (PEG-coated) NPs (27.0 h), 90% of the injected Dex-b-PLA NPs were retained in the blood circulation for 38.3 h after injection, almost eight times longer than the PEG-coated NPs. The area under curve (AUC) of Dex-b-PLA NPs was almost four times higher than PEG-based NPs. The biodistribution study showed lower accumulation of Dex-b-PLA NPs in the spleen with 19.5% initial dose per gram tissue (IDGT) after 24 h compared to PEG-coated poly(lactide-co-glycolide) (PLGA) NPs (29.8% IDGT). These studies show that Dex-b-PLA block copolymer is a promising new biomaterial for making controlled nanoparticles as drug delivery vehicles.
C1 [Verma, Mohit S.; Liu, Shengyan; Chen, Yih Y.; Meerasa, Ameena; Gu, Frank X.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
   [Gu, Frank X.] Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada.
RP Gu, FX (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
EM frank.gu@uwaterloo.ca
OI Gu, Frank/0000-0001-8749-9075; Verma, Mohit/0000-0002-6374-3333
FU Natural Sciences and Engineering Research Council of Canada
FX This work was financially supported by Natural Sciences and Engineering
   Research Council of Canada.
CR ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1068, P133, DOI 10.1016/0005-2736(91)90201-I
   ALPERT AJ, 1990, J CHROMATOGR, V499, P177, DOI 10.1016/S0021-9673(00)96972-3
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   Chittasupho C, 2009, EUR J PHARM SCI, V37, P141, DOI 10.1016/j.ejps.2009.02.008
   Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105
   Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615
   Dong Y, 2007, BIOMATERIALS, V28, P4154, DOI 10.1016/j.biomaterials.2007.05.026
   Drummond DC, 1999, PHARMACOL REV, V51, P691
   Esmaeili F, 2008, J DRUG TARGET, V16, P415, DOI [10.1080/10611860802088630, 10.1080/10611860802088630 ]
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Gaucher G, 2010, J CONTROL RELEASE, V143, P2, DOI 10.1016/j.jconrel.2009.11.012
   Gaucher G, 2009, BIOMACROMOLECULES, V10, P408, DOI 10.1021/bm801178f
   Gaur U, 2000, INT J PHARM, V202, P1, DOI 10.1016/S0378-5173(99)00447-0
   Goodwin AP, 2009, J AM CHEM SOC, V131, P289, DOI 10.1021/ja807307e
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Gu F, 2008, P NATL ACAD SCI USA, V105, P2586, DOI 10.1073/pnas.0711714105
   Gu FX, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70083-X
   Gursahani H, 2009, J PHARM SCI-US, V98, P2847, DOI 10.1002/jps.21635
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   He YY, 2010, J MATER SCI-MATER M, V21, P567, DOI 10.1007/s10856-009-3887-x
   Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Kailasan A, 2010, ACTA BIOMATER, V6, P1131, DOI 10.1016/j.actbio.2009.08.036
   Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim D, 2005, COLLOID SURFACE B, V40, P83, DOI 10.1016/j.colsurfb.2004.05.007
   Kim DK, 2009, J MATER CHEM, V19, P6294, DOI 10.1039/b902711b
   KusnierzGlaz CR, 1997, BLOOD, V89, P2586
   Lee H, 2010, MOL PHARMACEUT, V7, P1195, DOI 10.1021/mp100038h
   Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016
   Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w
   MAGENHEIM B, 1993, INT J PHARMACEUT, V94, P115, DOI 10.1016/0378-5173(93)90015-8
   Meerasa A, 2011, CURR DRUG DELIV, V8, P290, DOI 10.2174/156720111795256165
   Missirlis D, 2006, EUR J PHARM SCI, V29, P120, DOI 10.1016/j.ejps.2006.06.003
   Nouvel C, 2004, MACROMOLECULES, V37, P4981, DOI 10.1021/ma049857x
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Passirani C, 1998, PHARM RES-DORDR, V15, P1046, DOI 10.1023/A:1011930127562
   Peracchia MT, 1999, J CONTROL RELEASE, V60, P121, DOI 10.1016/S0168-3659(99)00063-2
   Portet D, 2001, DRUG DEVELOP RES, V54, P173, DOI 10.1002/ddr.10027
   Pridgen EM, 2007, NANOMEDICINE-UK, V2, P669, DOI 10.2217/17435889.2.5.669
   Rehor A, 2008, BIOMATERIALS, V29, P1958, DOI 10.1016/j.biomaterials.2007.12.035
   Riley T, 1999, COLLOID SURFACE B, V16, P147, DOI 10.1016/S0927-7765(99)00066-1
   Riley T, 2001, LANGMUIR, V17, P3168, DOI 10.1021/la001226i
   Sacco JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008933
   Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693
   Shuai XT, 2004, J CONTROL RELEASE, V98, P415, DOI 10.1016/j.jconrel.2004.06.003
   Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033
   Yang J, 2008, J BIOMED MATER RES A, V84A, P273, DOI 10.1002/jbm.a.31312
   Yang Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/16/165101
   Zahr AS, 2006, LANGMUIR, V22, P8178, DOI 10.1021/la060951b
NR 52
TC 34
Z9 35
U1 5
U2 51
PU TSINGHUA UNIV PRESS
PI BEIJING
PA TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA
SN 1998-0124
J9 NANO RES
JI Nano Res.
PD JAN
PY 2012
VL 5
IS 1
BP 49
EP 61
DI 10.1007/s12274-011-0184-z
PG 13
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 876CQ
UT WOS:000299085200007
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Rodriguez, M
   Gomez-Gil, V
   Sotomayor, S
   Bujan, J
   Pascual, G
AF Bellon, Juan M.
   Rodriguez, Marta
   Gomez-Gil, Veronica
   Sotomayor, Sandra
   Bujan, Julia
   Pascual, Gemma
TI Postimplant intraperitoneal behavior of collagen-based meshes followed
   by laparoscopy
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Collagen mesh; Intraperitoneal; Peritoneal adhesions; Laparoscopy;
   Hernia repair; Abdominal wall; Biomeshes
ID ABDOMINAL-WALL RECONSTRUCTION; SMALL-INTESTINAL SUBMUCOSA;
   INGUINAL-HERNIA REPAIR; BIOLOGICAL TISSUE; ADHESIONS; IMPLANTS;
   PROSTHESES; POLYTETRAFLUOROETHYLENE; BIOMATERIAL; DEFECTS
AB Background When repairing an abdominal wall defect, sometimes a prosthetic mesh needs to be placed directly on the parietal peritoneum. Although the standard mesh for this purpose is the laminar implant expanded polytetrafluoroethylene (PTFE), it is gradually being replaced by the laminar collagen-based meshes. This study was designed to assess the intraperitoneal behavior of three of these biomeshes, mainly in terms of their susceptibility to adhesion formation.
   Methods Two 3-cm x 3-cm fragments of prosthetic material were placed on the parietal peritoneum in male New Zealand White rabbits in the following combinations: PTFE and CollaMend(A (R)), PTFE and Permacol(A (R)), or PTFE and Surgisis(A (R)). The meshes were fixed at the four corners with individual 4/0 polypropylene sutures. Adhesion formation was quantified by sequential laparoscopy and image analysis performed at 3, 7, 14, and 90 days postimplant. All animals were killed at 90 days and the mesh specimens were subjected to microscopy and immunohistochemistry.
   Results Intensely vascularized adhesions to all the implants were observed, although Surgisis showed the lowest percentage of adhesions at each follow-up time. Adhesions had stabilized by 7-14 days. The PTFE meshes were enveloped by a layer of macrophages and connective tissue, bounded by a monolayer of mesothelial cells. Permacol and CollaMend showed similar histological behavior, including cell ingrowth through their fenestrations with no signs of degradation detected at 90 days. In contrast, the Surgisis mesh at 90 days was practically replaced with neoformed tissue.
   Conclusions No difference in susceptibility to adhesion formation was noted in the crosslinked collagen meshes compared to PTFE meshes. The noncrosslinked collagen mesh Surgisis showed the best behavior in that it induced fewer adhesions. Ninety days after implant, a more intense macrophage response was observed in CollaMend and Permacol than in PTFE or Surgisis.
C1 [Bellon, Juan M.; Rodriguez, Marta; Gomez-Gil, Veronica; Sotomayor, Sandra] Univ Alcala De Henares, Fac Med, Dept Surg, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid 28871, Spain.
   [Bujan, Julia; Pascual, Gemma] Univ Alcala De Henares, Fac Med, Dept Med Special, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid 28871, Spain.
RP Bellon, JM (reprint author), Univ Alcala De Henares, Fac Med, Dept Surg, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Km 33,600, Madrid 28871, Spain.
EM juanm.bellon@uah.es
OI PASCUAL, GEMMA/0000-0002-1623-4384; BELLON, JUAN M./0000-0002-6071-5011;
   bujan, Julia/0000-0003-2419-2476; Gomez-Gil,
   Veronica/0000-0002-6642-5912
FU Fundacion Mutua Madrilena [FMM08]
FX This study was supported by a grant from the Fundacion Mutua Madrilena
   2008 (FMM08).
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   AVELLA D, 2010, AM J SURG, V199, P12
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X
   Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618
   Bellon JM, 2002, J BIOMED MATER RES, V63, P182, DOI 10.1002/jbm.10123
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Bellows CF, 2006, EXPERT REV MED DEVIC, V3, P657, DOI 10.1586/17434440.3.5.657
   Butler CE, 2004, PLAST RECONSTR SURG, V114, P464, DOI 10.1097/01.PRS.0000132670.81794.7E
   CANDAGE R, 2008, SURGERY, V44, P703
   Carbajo MA, 1999, SURG ENDOSC-ULTRAS, V13, P250, DOI 10.1007/s004649900956
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   Conze J, 2004, Hernia, V8, P365, DOI 10.1007/s10029-004-0268-8
   Felemovicious I, 2004, J AM COLL SURGEONS, V198, P53
   Franklin M E Jr, 2004, Hernia, V8, P186
   Franklin M E Jr, 2002, Hernia, V6, P171
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gaertner WB, 2010, HERNIA, V14, P375, DOI 10.1007/s10029-010-0659-y
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Ishiguro Y, 2009, SURGERY, V145, P120, DOI 10.1016/j.surg.2007.07.028
   Kaleya Ronald N, 2005, Hernia, V9, P269, DOI 10.1007/s10029-005-0003-0
   LeBlanc K A, 2001, Hernia, V5, P41, DOI 10.1007/BF01576164
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Limpert JN, 2009, AM J SURG, V198, P60
   Lin HJ, 2009, AM J SURG, V197, P599, DOI 10.1016/j.amjsurg.2008.12.022
   MATEWS BD, 2003, J SURG RES, V114, P126
   Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B
   Petter-Puchner AH, 2006, SURG ENDOSC, V20, P942, DOI 10.1007/s00464-005-0568-9
   Petter-Puchner AH, 2010, J SURG RES, V161, P264, DOI 10.1016/j.jss.2009.04.007
   POMAHAC B, 2010, AM J SURG, V19, P22
   Rauth TP, 2007, J SURG RES, V143, P43, DOI 10.1016/j.jss.2007.04.079
NR 34
TC 11
Z9 12
U1 4
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD JAN
PY 2012
VL 26
IS 1
BP 27
EP 35
DI 10.1007/s00464-011-1823-x
PG 9
WC Surgery
SC Surgery
GA 865HH
UT WOS:000298301300004
PM 21789645
DA 2018-10-19
ER

PT J
AU Javadpour, F
   Jeje, A
AF Javadpour, Farzam
   Jeje, Ayodeji
TI Modeling Filtration of Platelet-Rich Plasma in Fibrous Filters
SO TRANSPORT IN POROUS MEDIA
LA English
DT Article
DE Leukocyte; Platelet; Atomic force microscopy (AFM); Dispersion; Fiber;
   Biomaterial; Cell adhesion; Surface forces
ID POROUS FILTERS; DISPERSION; PARTICLES; MEDIA
AB Removing leukocytes (white cells) from blood products such as platelet-rich plasma (PRP) prevents serious problems for the PRP recipients. We present a model to study selective separation of leukocytes from a dilute suspension of leukocytes and platelets (PRP) using fibrous filters. A selective PRP filter permits platelets to pass but bars the way for leukocytes. In PRP filters, fine synthetic fibers are packed randomly and interstices are larger than cells. Interactive forces between the suspended cells and fibers determine cell capture yield, i.e., deep-bed filtration process. Our model is based on a hierarchical set of differential equations corresponding to porescale and macroscale. At the porescale, we model movement and interaction of cells with fibers. A single cell entering the interstitial space encounters drag and surface forces. We define a unit bed element (UBE) composed of a fiber and interstitial space, where fiber diameter corrected for the size of the cells. We add measured surface forces between cells and fibers (electrostatic, van der Waals, fluid expression resistance, and biological responses) to the cell velocity equation. We then transform pore scale events into macroscale continuum by imposing periodic boundary conditions for contiguous UBEs and applying macrotransport theory. At macroscale, two independent coefficients: mean cell velocity vector U* and mean cell capture yield constant K*characterize cell filtration efficiency. Our model showed reasonable match with experimental data. Model results showed that diameter of fibers, injection velocity, bed porosity, and bed thickness control selective capture of leukocytes. Our model showed that it is merely impossible to filter out all leukocytes without capturing platelets. Based on our model, an optimized filter can capture 90% of leukocytes and pass through 45% of platelets.
C1 [Javadpour, Farzam] Univ Texas Austin, Jackson Sch Geosci, Bur Econ Geol, Austin, TX 78713 USA.
   [Jeje, Ayodeji] Univ Calgary, Dept Chem & Petr Engn, Schulich Sch Engn, Calgary, AB T2N 1N4, Canada.
RP Javadpour, F (reprint author), Univ Texas Austin, Jackson Sch Geosci, Bur Econ Geol, Univ Stn,Box X, Austin, TX 78713 USA.
EM farzam.javadpour@beg.utexas.edu
FU University of Calgary
FX We appreciate Dr. Matthias Amrein's (University of Calgary) support and
   comments on AFM data collection and interpretation.
CR [Anonymous], 2005, COMSOL MULTIPHYSICS
   Barbe LL, 2001, BRIT J HAEMATOL, V115, P664, DOI 10.1046/j.1365-2141.2001.03137.x
   Brenner H., 1993, MACROTRANSPORT PROCE
   DAILEY JF, 1998, BLOOD
   Davies C. N., 1973, AIR FILTRATION
   DAVIES CN, 1966, AEROSOL SCI
   Dzik Sunny, 1993, Transfusion Medicine Reviews, V7, P65, DOI 10.1016/S0887-7963(93)70125-X
   GILL WN, 1971, P ROY SOC LOND A MAT, V327, P191
   Happel J., 1965, LOW REYNOLDS NUMBER
   Israels L.G., 2002, MECH HEMATOLOGY
   Javadpour F, 2009, TRANSPORT POROUS MED, V79, P87, DOI 10.1007/s11242-008-9289-6
   JAVADPOUR F, 2006, THESIS U CALGARY CAN
   JEFFREY DJ, 1984, Z ANGEW MATH PHYS, V35, P634, DOI 10.1007/BF00952109
   Li YC, 1999, CHEM ENG SCI, V54, P633, DOI 10.1016/S0009-2509(98)00266-8
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Nightingale Stephen D., 2001, Transfusion (Bethesda), V41, P1306, DOI 10.1046/j.1537-2995.2001.41101306.x
   NITSCHE LC, 1988, SIAM J MATH ANAL, V19, P153, DOI 10.1137/0519012
   OHNO H, 1985, JPN J EXP MED, V55, P207
   Parsegian VA, 2006, VANDERWAALS FORCES H
   Probstein R. F., 1988, PHYSICOCHEMICAL HYDR
   SHAPIRO M, 1989, J AEROSOL SCI, V20, P951, DOI 10.1016/0021-8502(89)90734-9
   SHAPIRO M, 1990, J AEROSOL SCI, V21, P97, DOI 10.1016/0021-8502(90)90026-T
   Spielman L, 1968, ENVIRON SCI TECHNOL, V2, P279
   SWEENEY JD, 1995, TRANSFUSION, V35, P131, DOI 10.1046/j.1537-2995.1995.35295125735.x
   Tien C., 1989, GRANULAR FILTRATION
   Xu SP, 2008, ENVIRON SCI TECHNOL, V42, P771, DOI 10.1021/es071328w
   Yazer MH, 2004, TRANSFUSION, V44, P10, DOI 10.1046/j.0041-1132.2003.00518.x
NR 27
TC 4
Z9 4
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0169-3913
J9 TRANSPORT POROUS MED
JI Transp. Porous Media
PD JAN
PY 2012
VL 91
IS 2
BP 677
EP 696
DI 10.1007/s11242-011-9866-y
PG 20
WC Engineering, Chemical
SC Engineering
GA 865FP
UT WOS:000298296700016
DA 2018-10-19
ER

PT J
AU Tastan, BE
   Duygu, E
   Donmez, G
AF Tastan, Burcu Ertit
   Duygu, Ergin
   Donmez, Gonul
TI Boron bioremoval by a newly isolated Chlorella sp and its stimulation by
   growth stimulators
SO WATER RESEARCH
LA English
DT Article
DE Microalgae; Boron; Bioremoval; Growth stimulators; Wastewater treatment
ID WASTE-WATER; HEAVY-METALS; REMOVAL; TOXICITY; VULGARIS; TRIACONTANOL;
   MICROALGAE; DUCKWEED; CHLAMYDOMONAS; ANTIOXIDANT
AB It has been well documented that excess concentrations of boron (B) causes toxic effects on many of the environmental systems. Although Chlorella sp. has been studied to remove pollutants from water, its capacity to remove B has not been investigated yet. Boron removal levels of newly isolated Chlorella sp. were investigated in BG 11 media with stimulators as triacontanol (TRIA) and/or sodium bicarbonate (NaHCO3) and without them, to test if they could increase the removal efficiency by increasing biomass. The assays were performed to determine the effect of different medial compositions, B concentrations, pH and biomass concentrations onto removal efficiency. Boron removal was investigated at 5-10 mg/L range at pH 8 in different medial compositions and maximum removal yield was found as 32.95% at 5.45 mg/L B in media with TRIA and NaHCO3. The effect of different pH values on the maximum removal yield was investigated at pH 5-9, and the optimum pH was found again 8. The interactive effect of biomass concentration and B removal yield was also investigated at 0.386-1.061 g wet weight/L biomass. The highest removal yield was found as 38.03% at the highest biomass range. This study highlights the importance of using new isolate Chlorella sp. as a new biomaterial for B removal process of waters containing B. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tastan, Burcu Ertit; Duygu, Ergin; Donmez, Gonul] Ankara Univ, Fac Sci, Dept Biol, TR-06100 Ankara, Turkey.
RP Donmez, G (reprint author), Ankara Univ, Fac Sci, Dept Biol, TR-06100 Ankara, Turkey.
EM gdonmez@ankara.edu.tr
RI Ertit Tastan, Burcu/O-6365-2015
OI Ertit Tastan, Burcu/0000-0003-4644-8305
FU Scientific and Technological Research Council of Turkey (TUBITAK-BIDEB)
FX Financial support was gratefully acknowledged by the Scientific and
   Technological Research Council of Turkey (TUBITAK-BIDEB). The authors
   also wish to express their gratitude to reviewers for their valuable
   comments.
CR Abu-Hamed T, 2007, SOL ENERGY, V81, P93, DOI 10.1016/j.solener.2006.06.012
   Adams V.D, 1990, WATER WASTEWATER EXA, V247
   Bursali EA, 2009, CHEM ENG J, V150, P385, DOI 10.1016/j.cej.2009.01.016
   Cervilla LM, 2009, PLANT BIOLOGY, V11, P671, DOI 10.1111/j.1438-8677.2008.00167.x
   Chong MF, 2009, WATER RES, V43, P3326, DOI 10.1016/j.watres.2009.04.044
   Christogerou A, 2009, CERAM INT, V35, P447, DOI 10.1016/j.ceramint.2007.12.001
   Coughlin JR, 1998, BIOL TRACE ELEM RES, V66, P87, DOI 10.1007/BF02783129
   Crawford CL, 2007, J ALLOY COMPD, V444, P569, DOI 10.1016/j.jallcom.2007.02.164
   Davis SM, 2002, CHEMOSPHERE, V48, P615, DOI 10.1016/S0045-6535(02)00024-3
   de-Bashan LE, 2010, BIORESOURCE TECHNOL, V101, P1611, DOI 10.1016/j.biortech.2009.09.043
   El-Sheekh MM, 2005, ENVIRON TOXICOL PHAR, V19, P357, DOI 10.1016/j.etap.2004.09.005
   FRICK H, 1985, J PLANT NUTR, V8, P1123, DOI 10.1080/01904168509363411
   Gonzalez LE, 1997, BIORESOURCE TECHNOL, V60, P259, DOI 10.1016/S0960-8524(97)00029-1
   Gunes A, 2006, SCI HORTIC-AMSTERDAM, V110, P279, DOI 10.1016/j.scienta.2006.07.014
   HANAGATA N, 1992, PHYTOCHEMISTRY, V31, P3345, DOI 10.1016/0031-9422(92)83682-O
   HOUTZ RL, 1985, PLANT PHYSIOL, V79, P365, DOI 10.1104/pp.79.2.365
   HOUTZ RL, 1985, PLANT PHYSIOL, V79, P357, DOI 10.1104/pp.79.2.357
   Ip PF, 2005, PROCESS BIOCHEM, V40, P733, DOI 10.1016/j.procbio.2004.01.039
   Itakura T, 2005, WATER RES, V39, P2543, DOI 10.1016/j.watres.2005.04.035
   Karacakaya P, 2009, J HAZARD MATER, V172, P1635, DOI 10.1016/j.jhazmat.2009.08.037
   Kavak D, 2009, J HAZARD MATER, V163, P308, DOI 10.1016/j.jhazmat.2008.06.093
   Lee JS, 2002, BIORESOURCE TECHNOL, V82, P1, DOI 10.1016/S0960-8524(01)00158-4
   Lee SH, 2009, SCI HORTIC-AMSTERDAM, V122, P77, DOI 10.1016/j.scienta.2009.04.006
   Lim SL, 2010, BIORESOURCE TECHNOL, V101, P7314, DOI 10.1016/j.biortech.2010.04.092
   Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.005
   Marin CMDC, 2007, WATER RES, V41, P4579, DOI 10.1016/j.watres.2007.06.051
   Morioka A, 2007, J NUCL MATER, V367, P1085, DOI 10.1016/j.nucmat.2007.03.198
   Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886
   Ozturk N, 2008, DESALINATION, V223, P1, DOI 10.1016/j.desal.2007.01.178
   OKAY O, 1985, WATER RES, V19, P857, DOI 10.1016/0043-1354(85)90143-5
   PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0
   RIES S, 1983, HORTSCIENCE, V18, P654
   RIPPKA R, 1988, METHOD ENZYMOL, V167, P28
   Ruangsomboon S, 2006, AQUAT TOXICOL, V78, P15, DOI 10.1016/j.aquatox.2006.01.015
   Sasmaz A, 2009, ECOL ENG, V35, P1564, DOI 10.1016/j.ecoleng.2009.06.007
   Sheng O, 2009, SCI HORTIC-AMSTERDAM, V121, P278, DOI 10.1016/j.scienta.2009.02.009
   Simonnot MO, 2000, WATER RES, V34, P109, DOI 10.1016/S0043-1354(99)00130-X
   Sung KD, 1999, BIORESOURCE TECHNOL, V68, P269, DOI 10.1016/S0960-8524(98)00152-7
   Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tastan BE, 2010, BIORESOURCE TECHNOL, V101, P870, DOI 10.1016/j.biortech.2009.08.099
   Valderrama LT, 2002, WATER RES, V36, P4185, DOI 10.1016/S0043-1354(02)00143-4
   WAGGOTT A, 1969, WATER RES, V3, P749, DOI 10.1016/0043-1354(69)90039-6
   Wang B, 2008, APPL MICROBIOL BIOT, V79, P707, DOI 10.1007/s00253-008-1518-y
   Wang HM, 2010, PROCESS BIOCHEM, V45, P1865, DOI 10.1016/j.procbio.2010.05.023
   Wojcik P, 2008, SCI HORTIC-AMSTERDAM, V116, P58, DOI 10.1016/j.scienta.2007.10.032
   Xu J, 2009, J CATAL, V261, P158, DOI 10.1016/j.jcat.2008.11.007
   Yilmaz AE, 2008, DESALINATION, V230, P288, DOI 10.1016/j.desal.2007.11.031
NR 48
TC 22
Z9 22
U1 3
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0043-1354
J9 WATER RES
JI Water Res.
PD JAN 1
PY 2012
VL 46
IS 1
BP 167
EP 175
DI 10.1016/j.watres.2011.10.045
PG 9
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA 868ML
UT WOS:000298527300017
PM 22078227
DA 2018-10-19
ER

PT S
AU Ciba, P
   Bohmert, B
   Lermen, D
   Fuhr, GR
   Kruse, C
AF Ciba, P.
   Boehmert, B.
   Lermen, D.
   Fuhr, G. R.
   Kruse, C.
GP Icaris Ltd
TI Biological and Technological Challenges Establishing a Future-Proof
   Cryogenic Biomaterialbank
SO 12TH CRYOGENICS 2012 IIR INTERNATIONAL CONFERENCE
SE Refrigeration Science and Technology
LA English
DT Proceedings Paper
CT 12th Cryogenics IIR International Conference
CY SEP 11-14, 2012
CL Dresden, GERMANY
SP Int Inst Refrigerat
AB To establish and maintain a cross generational cryogenic collection of rare animal biomaterial resources, several technological precautions need to be considered to ensure the usability of the stored samples at long-term. In the German Cell Bank for Wildlife "Alfred Brehm" (short: "CRYO-BREHM") different biotechnological and cryotechnological features are applied that allow a sustainable scientific usability of the sample material. Further, a safe long-term storage of living cellular material and the sample related information is ensured.
C1 [Ciba, P.; Boehmert, B.; Kruse, C.] Fraunhofer Res Inst Marine Biotechnol, Paul Ehrlich Str 1-3, D-23562 Lubeck, Germany.
   [Lermen, D.; Fuhr, G. R.] Fraunhofer Inst Biomed Engn, D-66386 St Ingbert, Germany.
RP Ciba, P (reprint author), Fraunhofer Res Inst Marine Biotechnol, Paul Ehrlich Str 1-3, D-23562 Lubeck, Germany.
CR Ciba P, 2008, FISH PHYSIOL BIOCHEM, V34, P367, DOI 10.1007/s10695-007-9196-8
   Ciba Philipp, 2010, Zoologische Garten, V79, P132
   Ihmig FR, 2009, ENG LIFE SCI, V9, P376, DOI 10.1002/elsc.200800121
   Kruse C, 2004, APPL PHYS A-MATER, V79, P1617, DOI 10.1007/s00339-004-2816-6
   Lermen D, 2009, MOL ECOL, V18, P1030, DOI 10.1111/j.1365-294X.2008.04062.x
   Shirley SG, 2009, CRYOGENICS, V49, P638, DOI 10.1016/j.cryogenics.2008.12.022
NR 6
TC 0
Z9 0
U1 0
U2 0
PU INT INST REFRIGERATION
PI PARIS
PA 177 BLVD MALESHERBES, F-75017 PARIS, FRANCE
SN 0151-1637
BN 978-2-913149-93-9
J9 REFR SCI T
PY 2012
BP 252
EP +
PG 2
WC Thermodynamics
SC Thermodynamics
GA BB3AB
UT WOS:000342588600040
DA 2018-10-19
ER

PT B
AU Laakel, M
   Neesham-Grenon, E
   Maltais, A
AF Laakel, Mohamed
   Neesham-Grenon, Eve
   Maltais, Anne
BA Anonymous
BF Anonymous
TI Development of a Composite Antibacterial Chitosan-Alginate Bio-Packaging
SO 18TH IAPRI WORLD PACKAGING CONFERENCE
LA English
DT Proceedings Paper
CT 18th IAPRI World Conference on Packaging
CY JUN 17-21, 2012
CL Calif Polytechn State Univ, Orfalea Coll Business, Packaging Program,
   San Luis Obispo, CA
SP Int Assoc Packaging Res Inst, Lansmont, Innovated Packaging Co Inc, Packaging World, West, PTIS, Tobii, GREIF, Bay Cities, BEMIS, Anheuser Busch, Mitsubishi Electr, Ista, Corrugated Packaging Alliance, Morning Star, Fox Packaging, Packaging Fores Associates Inc, Mocon, Dow, Westpak Inc, Epson, Multisorb Technologies, Landsberg, Amcor
HO Calif Polytechn State Univ, Orfalea Coll Business, Packaging Program
DE Active packaging; biomaterial; chitosan-alginate; nisin; antimicrobial
   activity
ID FILMS; NISIN; MEMBRANES
AB To resolve some economic problems and join a spirit of environmental protection, the industry of the packaging tends to replace non renewable fossil resources by renewable and biodegradable raw materials. The chitosan and the alginate, used individually, are among polysaccharides the most used in the coating of foodstuffs. These polysaccharides are linear, available, little expensive and non toxic polymers. The strategic approach targeted by this project consists in creating and developing new materials of eco-responsible packaging. The mixture chitosan-alginate would give rise to a complex, bio-composite, more stable matrix and with improved properties. In the current study, we worked on the various renewable sea raw materials to obtain a composite bio-film with chitosan-alginate. We elaborated and produced several types of films with different concentrations and ratios of chitosan and alginate. The impact of the presence or absence of a plasticizing as glycerol was studied. The chemical structure and morphology of these bio-composite films were characterized. Afterward, the antimicrobial agents, such as nisin and lysozyme, were incorporated within these bio-films and their antimicrobial efficiency against some bacterial strains and particularly the pathogenic as Bacillus subtilis, Staphyloccocus aureus and Listeria monocytogenes was demonstrated. The role of the glycerol as plasticizing and its implication not only on the quality of the produced bio-composite films but also in the incorporation of the antibacterial agent and its liberation were demonstrated. This study showed that enhanced antimicrobial activity of chitosan-alginate composite films can be achieved by incorporating nisin, thus broadening their applications by coating some food products and ensuring food quality and safety.
C1 [Laakel, Mohamed; Neesham-Grenon, Eve; Maltais, Anne] Inst Technol Emballages & Genie Alimentaire, Montreal, PQ H1N 1C1, Canada.
RP Laakel, M (reprint author), Inst Technol Emballages & Genie Alimentaire, 6220 Sherbrooke Est, Montreal, PQ H1N 1C1, Canada.
EM mlaakel@cmaisonneuve.qc.ca; amaltais@cmaisonneuve.qc.ca
CR Benavides S, 2012, J FOOD ENG, V110, P232, DOI 10.1016/j.jfoodeng.2011.05.023
   Brody AL, 2001, ACTIVE PACKAGING FOO, P218
   Coma V, 2002, J FOOD SCI, V67, P1162, DOI 10.1111/j.1365-2621.2002.tb09470.x
   DARMADJI P, 1994, MEAT SCI, V38, P243, DOI 10.1016/0309-1740(94)90114-7
   Moreira MD, 2011, J FOOD SCI, V76, pM54, DOI 10.1111/j.1750-3841.2010.01910.x
   DUTKIEWICZ J, 1992, ADVANCES IN CHITIN AND CHITOSAN, P496
   Guerra NP, 2005, LETT APPL MICROBIOL, V40, P106, DOI 10.1111/j.1472-765X.2004.01649.x
   Jin T, 2008, J FOOD SCI, V73, pM127, DOI 10.1111/j.1750-3841.2008-00681.x
   Ko S, 2001, J FOOD SCI, V66, P1006, DOI 10.1111/j.1365-2621.2001.tb08226.x
   Kunte LA, 1997, CEREAL CHEM, V74, P115, DOI 10.1094/CCHEM.1997.74.2.115
   Meng X, 2010, J MATER SCI-MATER M, V21, P1751, DOI 10.1007/s10856-010-3996-6
   Ostrowska-Czubenko J, 2009, CARBOHYD POLYM, V77, P590, DOI 10.1016/j.carbpol.2009.01.036
   Park SY, 2002, J FOOD SCI, V67, P194, DOI 10.1111/j.1365-2621.2002.tb11382.x
   RHIM JW, 1998, FOOD SCI BIOTECHNOL, V7, P263
   Rosenquist H, 1998, J APPL MICROBIOL, V85, P621, DOI 10.1046/j.1365-2672.1998.853540.x
   Smidsrod O, 1974, CHEM SOC, V57, P263, DOI DOI 10.1039/DC9745700263
   URAGAMI T, 1994, J MEMBRANE SCI, V88, P243, DOI 10.1016/0376-7388(94)87010-1
   WANG GH, 1992, J FOOD PROTECT, V55, P916, DOI 10.4315/0362-028X-55.11.916
NR 18
TC 0
Z9 0
U1 2
U2 8
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-084-6
PY 2012
BP 385
EP 392
PG 8
WC Engineering, Multidisciplinary; Engineering, Manufacturing; Operations
   Research & Management Science; Materials Science, Multidisciplinary
SC Engineering; Operations Research & Management Science; Materials Science
GA BC3SR
UT WOS:000351916500067
DA 2018-10-19
ER

PT B
AU Cui, CJ
   Han, F
   He, CL
   Wu, CC
   Mo, XM
   Wang, HS
AF Cui Cheng-jun
   Han Feng
   He Chuang-long
   Wu Chun-chen
   Mo Xiu-mei
   Wang Hong-sheng
GP College of Textiles, Donghua Univ
TI Fabrication of Liposome-Loaded Silk Fibroin Nanofiber Mats by
   Electrospinning
SO 2012 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials (IFBMTM)
CY JUN 08-09, 2012
CL Donghua Univ, Shanghai, PEOPLES R CHINA
SP Chinese Govt
HO Donghua Univ
DE Silk Fibroin; Liposome; Electrospinning; Nanofiber scaffolds
ID MATRICES
AB Liposome is widely used in biomedical field owing to its remarkable ability of delivery drugs. Thus, the introduction of liposomal drug delivery systems into tissue engineering scaffolds may result in good effect on tissue regeneration. In this study, we successfully fabricated a novel liposome-loaded SF nanofiber based on the eco-friendly method. The electrospun SF fibers were ribbon-shaped and the liposome-loaded SF nanofibers showed no obvious change compared with the pure silk fibroin nanofibers as showed by scanning electron microscopy (SEM). While the Fourier Transform Infrares (FTIR) spectra showed some difference between pure SF nanofibers and Liposome loaded SF nanofibers. Transmission electron microscopy (TEM) showed that liposome distributed on the liposome-loaded SF nanofibers. This novel liposome loaded SF nanofiber mats can be a promising biomaterial in tissue engineering and universally used in medical field.
C1 [Cui Cheng-jun; Han Feng; He Chuang-long; Wu Chun-chen; Mo Xiu-mei; Wang Hong-sheng] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China.
RP Wang, HS (reprint author), Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China.
EM whs@dhu.edu.cn
RI mo, xiumei/C-9340-2013
FU Fundamental Research Funds for the Central Universities; 111 project
   [B07024]; Open Foundation of State Key Laboratory for Modification of
   Chemical Fibers and Polymer Materials [LK1111]
FX Fundamental Research Funds for the Central Universities, 111 project
   (B07024), Open Foundation of State Key Laboratory for Modification of
   Chemical Fibers and Polymer Materials (LK1111).
CR Fan LP, 2012, RSC ADV, V2, P4110, DOI 10.1039/c2ra20302b
   Fan LP, 2012, J BIOMAT SCI-POLYM E, V23, P497, DOI 10.1163/092050610X552771
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Kulkarni M, 2009, CELL, V10, P28
   Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Zhang KH, 2009, J BIOMEDICAL MAT R A, P976
NR 8
TC 0
Z9 0
U1 1
U2 1
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-5669-0166-8
PY 2012
BP 157
EP 160
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BH2ET
UT WOS:000398877800031
DA 2018-10-19
ER

PT S
AU Baila, D
AF Baila, Diana
BE Katalinic, B
TI BIOMATERIALS PROCESSING BY RP TECHNOLOGIES (RAPID PROTOTYPING) USED IN
   THE IMPLANTS MANUFACTURING
SO ANNALS OF DAAAM FOR 2012 & PROCEEDINGS OF THE 23RD INTERNATIONAL DAAAM
   SYMPOSIUM - INTELLIGENT MANUFACTURING AND AUTOMATION - FOCUS ON
   SUSTAINABILITY
SE Annals of DAAAM and Proceedings
LA English
DT Proceedings Paper
CT 23rd International DAAAM Symposium on Intelligent Manufacturing and
   Automation - Focus on Sustainability
CY OCT 24-27, 2012
CL Zadar, CROATIA
SP Danube Adria Assoc Automat & Mfg Int, Univ Studiorum Jadertina, Univ Zadar, Int Acad Engn, Vienna Univ Technol, Austrian Soc Engineers & Architects OIAV 1848, Univ Appl Sci Technikum Wien, Danube Rectors Conf, Danube Adria Assoc Automat & Mfg Int, Rectors Honor Comm
DE biomaterial; computerized tomography; selective laser sintering;
   hydroxyapathite
AB Biomaterials used to selective laser sintering process are made by powders of stainless steel, titanium powders and composite powders titan-hydroxyapathite.
   The titan alloy TA6V is used frequently in ortopaedic prothesis because presents a good resistance to corrosion due to the titanium oxide layer on the surface of the metal who prevents the achievement of reactions between titanium and surrounding environment and it's not toxic for human body.
   The hydroxyapathite contains collagen like the structure of bone and can be more easy to integrate the implantsto human body.
CR Baila D., 2009, THESIS
   Berce P., 2000, FABRICAREA RAPIDA PR
   CHUA CK, 1997, RAPID PROTOTYPING PR
   Dickens PM, 1995, P ENG MAN ISBN NOTT, P261
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Werner S., 1997, POWDER METALLURG PRO
NR 6
TC 0
Z9 0
U1 0
U2 0
PU DAAAM INT VIENNA
PI WIEN
PA VIENNA UNIV TECHNOLOGY, KARLSPLATZ 13, WIEN, A-1040, AUSTRIA
SN 1726-9679
BN 978-3-901509-91-9
J9 ANN DAAAM
PY 2012
VL 23
BP 285
EP 288
PG 4
WC Automation & Control Systems; Engineering, Multidisciplinary
SC Automation & Control Systems; Engineering
GA BG8LR
UT WOS:000392423800066
DA 2018-10-19
ER

PT J
AU Terada, D
   Yoshikawa, C
   Hattori, S
   Teramoto, H
   Kameda, T
   Tamada, Y
   Kobayashi, H
AF Terada, Dohiko
   Yoshikawa, Chiaki
   Hattori, Shinya
   Teramoto, Hidetoshi
   Kameda, Tsunenori
   Tamada, Yasushi
   Kobayashi, Hisatoshi
TI Silk nanofibre arranging improves its fibre mat transparency
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article; Book Chapter
DE biomaterial; biomimicry; nanomaterial
AB Silk fibroin, produced by the silkworm Bombyx mori, has been receiving full recognition as a biomaterial. Since nanofibres are generally in similar dimensions to biological fibres in extracellular matrices, characteristic interaction of nanofibres with cells is widely known, which is different from the conventional materials in micron scale. In the current study, nanofibre mats were produced from silk fibroins. Although silk fibroin does not absorb any visible light, silk fibroin nanofibre mats were opaque and lost transparency to visible light. This is a disadvantage to scaffolds used in cornea tissue engineering although silk nanofibres are still attractive as biomaterial. We tried to improve the transparency of silk fibroin nanofibre mats to visible light, mimicking the mechanism adopted in biological cornea tissues. The objective of this study is to increase the transmittance of silk fibroin nanofibre mats to visible light by modifying the nanofibre orientation in the mats. We showed that by increasing the orientation of nanofibres, there was an increased transmittance to the long wavelength range of the visible light. However, the transmittance to short wavelength range did not increase. One way to improve transparency would be to orient the nanofibres in its non- woven mats.
C1 [Terada, Dohiko; Yoshikawa, Chiaki; Hattori, Shinya; Kobayashi, Hisatoshi] Natl Inst Mat Sci, Biofunct Mat Grp, Biomat Unit, Int Ctr Mat Nanoarchitecton,Nanobio Field, Tsukuba, Ibaraki, Japan.
   [Teramoto, Hidetoshi; Kameda, Tsunenori; Tamada, Yasushi] Natl Inst Agrobiol Sci, Silk Mat Res Unit, Genet Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan.
RP Terada, D (reprint author), Natl Inst Mat Sci, Biofunct Mat Grp, Biomat Unit, Int Ctr Mat Nanoarchitecton,Nanobio Field, Tsukuba, Ibaraki, Japan.
RI kobayashi, hisatoshi/H-2720-2011
OI kobayashi, hisatoshi/0000-0001-9487-0725
FU Ministry of Agriculture, Forestry and Fisheries; Ministry of Education,
   Culture, Sports, Science and Technology (MEXT); Core Research of
   Evolutional Science & Technology (CREST)
FX The authors are grateful to the Ministry of Agriculture, Forestry and
   Fisheries; Grants-in-Aid for Scientific Research (B) of Ministry of
   Education, Culture, Sports, Science and Technology (MEXT) and Core
   Research of Evolutional Science & Technology (CREST) for their financial
   support.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Ameen DB, 1998, BIOPHYS J, V75, P2520, DOI 10.1016/S0006-3495(98)77697-0
   Baker BM, 2010, BIOMATERIALS, V31, P6190, DOI 10.1016/j.biomaterials.2010.04.036
   Benedek GB, 1971, APPL OPTICS, V10, P495
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kamlangkla K, 2011, SURF COAT TECH, V205, P3755, DOI 10.1016/j.surfcoat.2011.01.006
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Ma K, 2011, TISSUE ENG PT A, V17, P1413, DOI [10.1089/ten.tea.2010.0373, 10.1089/ten.TEA.2010.0373]
   MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nogueira GM, 2011, MAT SCI ENG C-MATER, V31, P997, DOI 10.1016/j.msec.2011.02.019
   Peng F, 2011, ACTA BIOMATER, V7, P2585, DOI 10.1016/j.actbio.2011.02.021
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Teh TKH, 2011, TISSUE ENG PART C-ME, V17, P687, DOI 10.1089/ten.tec.2010.0513
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wheeldon I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/212001
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Zhang F, 2009, J MATER SCI, V44, P5682, DOI 10.1007/s10853-009-3800-5
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhengzhong S, 2002, NATURE, V418, P741
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
NR 33
TC 1
Z9 2
U1 0
U2 9
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2012
VL 1
IS 1
BP 57
EP 61
DI 10.1680/bbn.11.00004
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA V32EQ
UT WOS:000208934900007
DA 2018-10-19
ER

PT J
AU Hattori, S
   Terada, D
   Bintang, AB
   Honda, T
   Yoshikawa, C
   Teramoto, H
   Kameda, T
   Tamada, Y
   Kobayashi, H
AF Hattori, Shinya
   Terada, Dohiko
   Bintang, Andreana Bibin
   Honda, Takako
   Yoshikawa, Chiaki
   Teramoto, Hidetoshi
   Kameda, Tsunenori
   Tamada, Yasushi
   Kobayashi, Hisatoshi
TI Influence of sterilisations on silk protein-based materials
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article; Book Chapter
DE biomaterial; protein; scaffold
AB The authors investigated the influence of sterilisations on silk protein- based materials using the sericin gel films (SS-GFs) made from the Sericin Hope cocoons and the hornet silk cast films ( HS-CFs) made from hornet cocoons. These two kinds of silk films seem to have a great potential as biomaterials for cornea engineering because they are transparent, have mechanical properties withstanding a surgical handling and have flexibility. These silk films inspired the authors to develop a novel artificial cornea, utilising the advantageous properties. An autoclave, an ethyleneoxide gas, an autoclave followed by an ethylene oxide gas, an ethanol solution and dry heat treatments were performed on the silk films . These sterilisation methods have different influences on cell adhesion in both of the SS-GFs and HS-CFs. The authors must consider the influence of denaturation while applying silk materials in biological evaluation or clinical use as a biomaterial. Although cell compatibility of SS-GFs and HS-CFs was affected by sterilisation processes, the sterilised films managed to retain transparency after any sterilisation process. In view of these points, SS- GFs and HS-CFs have a potential as a substitute for the corneal stroma.
C1 [Hattori, Shinya; Terada, Dohiko; Bintang, Andreana Bibin; Honda, Takako; Yoshikawa, Chiaki; Kobayashi, Hisatoshi] Natl Inst Mat Sci, Biofunct Mat Grp, Int Ctr Mat Nanoarchitecton, Biomat Unit,Nanobio Field, Tsukuba, Ibaraki, Japan.
   [Teramoto, Hidetoshi; Kameda, Tsunenori; Tamada, Yasushi] Natl Inst Agrobiol Sci, Silk Mat Res Unit, Genet Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan.
   [Kobayashi, Hisatoshi] JST CREST, Chiyoda Ku, Hiroshima, Japan.
RP Hattori, S (reprint author), Natl Inst Mat Sci, Biofunct Mat Grp, Int Ctr Mat Nanoarchitecton, Biomat Unit,Nanobio Field, Tsukuba, Ibaraki, Japan.
RI kobayashi, hisatoshi/H-2720-2011
OI kobayashi, hisatoshi/0000-0001-9487-0725; Teramoto,
   Hidetoshi/0000-0002-2075-0218
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT);
   Core Research of Evolutional Science & Technology (CREST)
FX The authors are grateful to the Ministry of Agriculture, Forestry and
   Fisheries; Grants-in-Aid for Scientific Research (B) of Ministry of
   Education, Culture, Sports, Science and Technology (MEXT) and Core
   Research of Evolutional Science & Technology (CREST) for their financial
   support.
CR Amano S, 2008, DECELLULARIZING CORN
   Ameen DB, 1998, BIOPHYS J, V75, P2520, DOI 10.1016/S0006-3495(98)77697-0
   Benedek GB, 1971, APPL OPTICS, V10, P495
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Fu C., 2009, CHEM COMMUN, P6515
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122
   Kameda T, 2005, Z NATURFORSCH C, V60, P906
   Kameda T, 2007, ANAL BIOANAL CHEM, V387, P2895, DOI 10.1007/s00216-007-1137-y
   Kameda T, 2010, BIOMACROMOLECULES, V11, P1009, DOI 10.1021/bm901472a
   Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Sasaki S, 2009, MOL VIS, V15, P2022
   Sezutsu H, 2007, BIOSCI BIOTECH BIOCH, V71, P2725, DOI 10.1271/bbb.70326
   Sumida T, 2006, J FEDERATION AM SOC, V20, P392
   Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 23
TC 4
Z9 4
U1 0
U2 4
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2012
VL 1
IS 3
BP 195
EP 199
DI 10.1680/bbn.11.00006
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA V32ES
UT WOS:000208935100007
DA 2018-10-19
ER

PT J
AU Sher, P
   Mano, JF
AF Sher, Praveen
   Mano, Joao F.
TI Multilayers as 3D nanostructured porous constructs
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article; Book Chapter
DE alginate; biomaterial; nanostructures; porous; self assembly; scaffold;
   template
AB In this work, the authors propose to explore the binding potential of nonostructured multilayers produced by layer-by-layer self-assembly based on perfusion technique, which was otherwise limited to coating only. Random spherical wax templates of same size were transformed into moldable soft three-dimensional (3D) core material with different external geometries. Placement of template spheres with different sizes by sequential stacking along multiple space axes in a single construct induced internal variations leading to different patterns. Stable porous interconnected nanostructured soft 3D macroconstructs made of natural based polyelectrolytes with a controlled external shape and different internal patterns were developed after removing wax template. Such highly porous structures with hierarchical organization could be used, for example, as scaffolds for tissue engineering applications.
C1 [Sher, Praveen; Mano, Joao F.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Taipas, Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Sher, Praveen/A-2721-2016
OI Sher, Praveen/0000-0003-2235-7855; Mano, Joao/0000-0002-2342-3765
FU FCT postdoc fellowship [SFRH/BPD/489948/2008]; European Union Seventh
   Framework Programme (FP7) [NMP4-SL-2009-229292]; "Fundacao para a
   Ciencia Technologia" (Portugal) [PTDC/QUI/68804/2006]
FX Praveen Sher is grateful for the financial support from FCT postdoc
   fellowship SFRH/BPD/489948/2008. The research, leading to these results,
   has received funding from the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no NMP4-SL-2009-229292. This work
   was partially supported by "Fundacao para a Ciencia Technologia"
   (Portugal) under project PTDC/QUI/68804/2006. Also discussions with
   Gabriela Martins are highly appreciated.
CR Bernsmann F, 2008, SOFT MATTER, V4, P1621, DOI 10.1039/b806649c
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Choi SW, 2009, ADV MATER, V21, P2997, DOI 10.1002/adma.200803504
   del Mercato LL, 2010, NANOSCALE, V2, P458, DOI 10.1039/b9nr00341j
   Dziomkina NV, 2005, SOFT MATTER, V1, P265, DOI 10.1039/b503145c
   Johnston APR, 2010, ANGEW CHEM INT EDIT, V49, P2664, DOI 10.1002/anie.200906840
   Kozlovskaya V, 2009, SOFT MATTER, V5, P4077, DOI 10.1039/b912168d
   Lee J, 2009, SMALL, V5, P1008, DOI 10.1002/smll.200801242
   Ling XY, 2009, CHEM COMMUN, P5521, DOI 10.1039/b909918b
   Ling XY, 2009, SMALL, V5, P1428, DOI 10.1002/smll.200900068
   Ling XY, 2009, ANGEW CHEM INT EDIT, V48, P983, DOI 10.1002/anie.200804596
   Mamedov AA, 2000, LANGMUIR, V16, P5530, DOI 10.1021/1a000560b
   Matsusaki M, 2009, EXPERT OPIN DRUG DEL, V6, P1207, DOI 10.1517/17425240903280414
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176
   Quinn JF, 2004, LANGMUIR, V20, P20, DOI 10.1021/la0360310
   Schanze KS, 2009, LANGMUIR, V25, P13698, DOI 10.1021/la903785g
   Schlenoff JB, 2009, LANGMUIR, V25, P14007, DOI 10.1021/la901950c
   Sher P., 2010, SMALL, V6, P2643
   Siqueira JR, 2010, BIOSENS BIOELECTRON, V25, P1254, DOI 10.1016/j.bios.2009.09.043
   Smith RC, 2009, ANGEW CHEM INT EDIT, V48, P8974, DOI 10.1002/anie.200902782
   Stadler B, 2009, NANOSCALE, V1, P68, DOI 10.1039/b9nr00143c
   Sukhorukov GB, 1996, THIN SOLID FILMS, V284, P220, DOI 10.1016/S0040-6090(95)08309-X
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tiemann M, 2008, CHEM MATER, V20, P961, DOI 10.1021/cm702050s
   Vendamme R, 2006, NAT MATER, V5, P494, DOI 10.1038/nmat1655
   Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813
   Watanabe H, 2007, ADV MATER, V19, P909, DOI 10.1002/adma.200601630
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 30
TC 2
Z9 2
U1 0
U2 3
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2012
VL 1
IS 4
BP 245
EP 251
DI 10.1680/bbn.12.00013
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA V32ET
UT WOS:000208935200006
DA 2018-10-19
ER

PT S
AU Chemani, B
   Chemani, H
AF Chemani, B.
   Chemani, H.
BE Kluson, P
TI Physico - chemical and mechanical analysis of dental biomaterial "cement
   orthophosphate zinc"
SO CHISA 2012
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 20th International Congress of Chemical and Process Engineering CHISA
CY AUG 25-29, 2012
CL Prague, CZECH REPUBLIC
DE Cement; biomaterial; oxy-zinc phosphate
AB Causes mechanical, thermal, chemical, electrochemical related to the oral environment are effects ranging from simple weathering of biomaterial to the final break, through irreversible deformation, the more invisible and insidious. Study closer to all of these requirements and how to reconcile them is the goal of our work involves the development and analysis of the cements commonly used by dentists and especially cement oxy - zinc phosphate. The powder of zinc phosphate cement is typically made of zinc oxide annealing, alone or mixed with other oxides. The choice and dosage of these oxides must reflect the requirements presented to the concrete (resistance to crushing, shear, acidity, toxicity, solubility, etc...). Thus the formulation of the composition cement needs to have an optimal mix of different components to achieve desired quality cement. Therefore, we limited the number of formulas or mixtures confined to the study of a unique blend of high purity raw materials which we have subjected three regimes of firing at a fixed temperature of 1350 degrees C. The test results show that the cement produced is of very good quality and meets the required standards. (C) 2012 Published by Elsevier Ltd.
C1 [Chemani, H.] Hamed Bougara Univ Boumerdes, Lab Minerals Mat & Composites, Boumerdes 35000, Algeria.
   [Chemani, B.] Hamed Bougara Univ Boumerdes, Lab Proc & Shaping Polymers, Boumerdes 35000, Algeria.
RP Chemani, H (reprint author), Hamed Bougara Univ Boumerdes, Lab Minerals Mat & Composites, Boumerdes 35000, Algeria.
EM chemani_ba@yahoo.fr
CR Auzias F, 1989, ENCY MED CHIR EDITIO, P1
   Combe EC, 2002, NOTES DENT MAT
   FAKIHA ZA, 1992, J PROSTHET DENT, V67, P52, DOI 10.1016/0022-3913(92)90049-G
   FREICHE R, 1977, ACTUAL ODONTO-STOMAT, P457
   Gregory W A, 1991, Am J Dent, V4, P29
   Noort RV, 1994, INTRO DENT MAT, P126
   Skinner EW, 1991, SCI MATERIAUX DENTAI, P479
   SMITH DC, 1986, J AM DENT ASSOC, V112, P654, DOI 10.14219/jada.archive.1986.0069
   Souder W, 1992, NATL BUREAU STANDA C, P105
   Yacolare F, 1993, ENCYCL MED CHIR, P1
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2012
VL 42
BP 1396
EP 1401
DI 10.1016/j.proeng.2012.07.533
PG 6
WC Engineering, Chemical
SC Engineering
GA BG8ZH
UT WOS:000392862500144
OA Other Gold
DA 2018-10-19
ER

PT S
AU Tricarico, S
   Barbaglio, A
   Burlini, N
   Del Giacco, L
   Ghilardi, A
   Sugni, M
   Di Benedetto, C
   Bonasoro, F
   Wilkie, IC
   Carnevali, MDC
AF Tricarico, Serena
   Barbaglio, Alice
   Burlini, Nedda
   Del Giacco, Luca
   Ghilardi, Anna
   Sugni, Michela
   Di Benedetto, Cristiano
   Bonasoro, Francesco
   Wilkie, Iain C.
   Carnevali, Maria Daniela Candia
BE Kroh, A
   Reich, M
TI New insights into the mutable collagenous tissue of Paracentrotus
   lividus: preliminary results
SO ECHINODERM RESEARCH 2010: PROCEEDINGS OF THE SEVENTH EUROPEAN CONFERENCE
   ON ECHINODERMS
SE Zoosymposia
LA English
DT Proceedings Paper
CT 7th European Conference on Echinoderms
CY OCT 02-09, 2010
CL Georg August Univ Gottingen, Gottingen, GERMANY
HO Georg August Univ Gottingen
DE Mutable Collagenous Tissue; Echinodermata; Echinoidea; glycoproteins;
   mechanical properties
ID CONNECTIVE-TISSUE; SEA-CUCUMBER; FIBRILS; CATCH
AB The mechanically adaptable connective tissue of echinoderms (Mutable Collagenous Tissue-MCT), which can undergo drastic nervously-mediated changes in mechanical properties, represents a promising model for biomaterial design and biomedical applications. MCT could be a source of, or an inspiration for, new composite materials whose molecular interactions and structural conformation can be changed in response to external stimuli. MCT is composed mostly of collagen fibrils, comparable to those of mammals, plus a variety of other components, including other fibrillar structures, proteo-glycans and glycoproteins. This contribution presents the preliminary results of a detailed analysis of MCT components in the sea-urchin Paracentrotus lividus, focusing on biochemical characterization of the fibrils and biomolecular analysis of the presumptive glycoproteins involved. The final aims will be to confirm the presence and the role of these glycoproteins in echinoids and to manipulate simpler components in order to produce a composite with mutable mechanical properties.
C1 [Tricarico, Serena; Barbaglio, Alice; Burlini, Nedda; Del Giacco, Luca; Ghilardi, Anna; Sugni, Michela; Di Benedetto, Cristiano; Bonasoro, Francesco; Carnevali, Maria Daniela Candia] Univ Milan, Dept Biosci, Milan, Italy.
   [Wilkie, Iain C.] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow, Lanark, Scotland.
RP Tricarico, S (reprint author), Univ Milan, Dept Biosci, Milan, Italy.
EM serena.tricarico@unimi.it
RI Candia Carnevali, M. Daniela/I-8048-2015
OI Candia Carnevali, M. Daniela/0000-0002-0215-8843
FU Cariplo Foundation
FX The present work has received financial support from the Cariplo
   Foundation ( MIMESIS Project).
CR BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   MATSUMUR.T, 1973, J BIOCHEM-TOKYO, V73, P155
   MATSUMURA T, 1974, CONNECT TISSUE RES, V2, P117, DOI 10.3109/03008207409152097
   MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x
   Sheehan DC, 1980, THEORY PRACTICE HIST
   Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178
   Taskiran D., 1999, ANAL BIOCHEM, V150, P86
   Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2
   Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1
   TROTTER JA, 1989, CELL TISSUE RES, V258, P527
   Wilkie I.C., 2004, P371, DOI 10.1201/9780203970881.ch61
   WILKIE IC, 1993, COMP BIOCHEM PHYS A, V105, P493, DOI 10.1016/0300-9629(93)90425-4
NR 12
TC 2
Z9 2
U1 0
U2 2
PU MAGNOLIA PRESS
PI AUCKLAND
PA PO BOX 41383, AUCKLAND, ST LUKES 1346, NEW ZEALAND
SN 1178-9913
BN 978-1-77557-035-6
J9 ZOOSYMPOSIA
JI Zoosymposia
PY 2012
VL 7
BP 279
EP 285
PG 7
WC Marine & Freshwater Biology; Zoology
SC Marine & Freshwater Biology; Zoology
GA BB7YT
UT WOS:000346130200025
DA 2018-10-19
ER

PT J
AU Brunelli, G
   Carinci, F
   Girardi, A
   Palmieri, A
   Caccianiga, GL
   Saggese, V
   Sollazzo, V
AF Brunelli, G.
   Carinci, F.
   Girardi, A.
   Palmieri, A.
   Caccianiga, G. L.
   Saggese, V.
   Sollazzo, V.
TI MEDPOREO (R) STIMULATES OSTEOBLASTS DIFFERENTIATION IN DENTAL PULP
   DERIVED STEM CELLS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Medpore; dental pulp; stem cells; RT-PCR; osteoblast differentiation
AB Medpor (R) is an alloplastic material largely employed hi craniofacial reconstruction due to its characteristics of biological compatibility, easy morphological adaptability and mantaining it's initial volume after beeing positioned. To better understand how Medpor (R) promotes bone formation we analyzed the expression levels of bone related genes in stem cells isolated from dental pulp after 15 and 30 days of exposure to the biomaterial. To this aim we focused on the expression levels of bone related genes (RUNX2, SP7, ALPL, SPP1, COL1A1, COL3A1 and FOSL1) and mesenchymal stem cells marker (ENG). Our results suggest that Medpor (R) induces osteoblast phenotype expression in human DPSCs as demonstrated by the activation of osteoblast related genes FOSL1, RUNX2 and COL3A1 and the disappearance of the mesenchymal stem cells marker, ENG.
C1 [Brunelli, G.; Caccianiga, G. L.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Carinci, F.; Palmieri, A.; Saggese, V.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
CR Brunelli G, 2011, EUROPEAN S2 IN PRESS
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Frodel JL, 1998, ARCH OTOLARYNGOL, V124, P1219, DOI 10.1001/archotol.124.11.1219
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   Hwang YC, 2008, J MOL HISTOL, V39, P153, DOI 10.1007/s10735-007-9148-8
   Liu J, 2007, IN VITRO CELL DEV-AN, V43, P120, DOI 10.1007/s11626-007-9022-8
   Sollazzo Vincenzo, 2011, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V9, P1, DOI 10.4028/www.scientific.net/JBBTE.9.1
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
NR 9
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2012
VL 10
IS 1
SU S
BP 23
EP 26
PG 4
WC Immunology
SC Immunology
GA V37BL
UT WOS:000209251200005
DA 2018-10-19
ER

PT J
AU Brunelli, G
   Carinci, F
   Girardi, A
   Palmieri, A
   Caccianiga, GL
   Sollazzo, V
AF Brunelli, G.
   Carinci, F.
   Girardi, A.
   Palmieri, A.
   Caccianiga, G. L.
   Sollazzo, V.
TI OSTEOPLANT (R) INFLUENCES OSTEOGENIC DIFFERENTIATION OF DENTAL PULP STEM
   CELLS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Osteoplant (R); dental pulp; stem cells; gene expression; osteoblast
   differentiation
AB Osteoplant (R) (Bioteck SRL, Vicenza, Italy) is an equine cortical and spongy bone tissue, used to fill bone defects in orthopedic, maxillofacial and dental surgery. To study the mechanism by which Osteoplant (R) induces the reabsorption and the substitution of the graft with new bone, the expression of genes related to the osteoblast differentiation were analyzed using cultures of stem cells derived from dental pulp stem cells (ADSCs) treated with this biomaterial. The up-regulation of bone related genes like SP1, FOSL1, RUNX2 and SPP1 and the disappearance of the mesenchymal stem cell marker ENG demonstrated that this biomaterial is conducive in osteoblast and osteoclast. In particular the up-regulation of SPP1 demonstrated that this bone substitute material was actively resorbed by human osteoclasts. Our results confirmed that Osteoplant (R) has high potential for use as bone tissue scaffold in bone tissue engineering.
C1 [Brunelli, G.; Caccianiga, G. L.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Carinci, F.; Palmieri, A.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
CR Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Hwang YC, 2008, J MOL HISTOL, V39, P153, DOI 10.1007/s10735-007-9148-8
   Liu J, 2007, IN VITRO CELL DEV-AN, V43, P120, DOI 10.1007/s11626-007-9022-8
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Sollazzo Vincenzo, 2011, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V9, P1, DOI 10.4028/www.scientific.net/JBBTE.9.1
   Sollazzo V, 2011, EUROPEAN S3 IN PRESS
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
NR 7
TC 0
Z9 0
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2012
VL 10
IS 1
SU S
BP 31
EP 35
PG 5
WC Immunology
SC Immunology
GA V37BL
UT WOS:000209251200007
DA 2018-10-19
ER

PT J
AU Girardi, A
   Palmieri, A
   Cura, F
   Carinci, F
   Zollino, I
   Hassanipour, A
   Saggese, V
   Piras, A
   Zamboni, P
   Brunelli, G
AF Girardi, A.
   Palmieri, A.
   Cura, F.
   Carinci, F.
   Zollino, I.
   Hassanipour, A.
   Saggese, V.
   Piras, A.
   Zamboni, P.
   Brunelli, G.
TI EFFECT OF ALGIPORE (R) ON BONE MARROW STEM CELLS: AN IN VITRO STUDY
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Algipore; bone marrow; stem cells; gene expression; osteoblast
   differentiation
AB Cell-based bone and cartilage replacement is an evolving therapy aiming at the treatment of craniofacial and orthopedic defects (limb amputation, damaged tissues, bone and cartilage-related disorders and dental and maxillofacial reconstructive surgery). Autologous cell transplantation in combination With a biodegradable scaffold is a useful and safe option Algipore, a hydroxyapatite ceramic obtained from red alga, is largely employed as scaffolds in bone regeneration. Here we studied how this biomaterial promote osteoblast differentiation in stem cells derived from bone marrow, measuring the expression levels of bone related genes and mesenchymal stem cells marker by Real Time Reverse Transcription-Polymerase Chain Reaction. Algipore induces osteoblast differentiation in stem cells derived from bone marrow, as indicated by the activation of osteoblast related genes SPP1, ALPL, RUNX2 and SP7.
C1 [Girardi, A.; Cura, F.] Univ Bologna, Dept Histol Embryol & Appl Biol, Ctr Mol Genet, CARISBO Fdn, Bologna, Italy.
   [Palmieri, A.; Carinci, F.; Zollino, I.; Hassanipour, A.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Saggese, V.] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Milan, Italy.
   [Piras, A.; Brunelli, G.] Univ Cagliari, Dent Clin, I-09124 Cagliari, Italy.
   [Zamboni, P.] Univ Ferrara, Dept Radiol Anesthesiol & Surg, I-44100 Ferrara, Italy.
   [Brunelli, G.] Don Orione Inst, Dept Dent & Maxillofacial & Plast Surg, Bergamo, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU FAR from the University of Ferrara, Ferrara, Italy; Don Orione Service
   s.r.l., Bergamo, Italy
FX This work was supported by FAR (2011) from the University of Ferrara
   (FC), Ferrara, Italy and by Don Orione Service s.r.l., Bergamo, Italy.
CR Chan TF, 2008, GENOMICS, V91, P307, DOI 10.1016/j.ygeno.2007.12.008
   Ewers R, 2005, J ORAL MAXIL SURG, V63, P1712, DOI 10.1016/j.joms.2005.08.020
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MCKEE MD, 1993, J BONE MINER RES, V8, P485
   Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022
   Ohtsuki C, 2009, J R SOC INTERFACE S3, V6, P8349
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Suuriniemi M, 2006, BONE, V39, P591, DOI 10.1016/j.bone.2006.02.053
   Turhani D, 2005, J ORAL MAXIL SURG, V63, P673, DOI 10.1016/j.joms.2005.01.006
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
NR 14
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2012
VL 10
IS 1
SU 3
BP 59
EP 64
PG 6
WC Immunology
SC Immunology
GA V37BN
UT WOS:000209251400013
DA 2018-10-19
ER

PT J
AU Girardi, A
   Palmieri, A
   Cura, F
   Carinci, F
   Zollino, I
   Hassanipour, A
   Saggese, V
   Piras, A
   Zamboni, P
   Brunelli, G
AF Girardi, A.
   Palmieri, A.
   Cura, F.
   Carinci, F.
   Zollino, I.
   Hassanipour, A.
   Saggese, V.
   Piras, A.
   Zamboni, P.
   Brunelli, G.
TI BIO-OSS (R) ACTS ON BONE MARROW DERIVED STEM CELLS PROMOTING OSTEOBLAST
   DIFFERENTIATION
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Stem Cells; biomaterial; Bio-Oss (R); differentiation; bone
AB Bio-Oss (R) a deproteinized anorganic bovine bone is widely used as scaffold for autologous cells in several bone regeneration procedures. To study how Bio-Oss (R) can induce osteoblast differentiation in mesenchymal stem cells, the expression levels of bone related genes and mesenchymal stem cells marker were analyzed, using real time Reverse Transcription-Polymerase Chain Reaction. Bio-Oss (R) caused an induction of osteoblast related genes ALPL, FOSL1 and SPP1 The obtained results can be relevant to better understand the molecular mechanism by wich Bio-Oss (R) induce osteoblast differentiation and bone regeneration.
C1 [Girardi, A.; Cura, F.] Univ Bologna, Dept Histol Embryol & Appl Biol, Ctr Mol Genet, CARISBO Fdn, Bologna, Italy.
   [Palmieri, A.; Carinci, F.; Zollino, I.; Hassanipour, A.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Saggese, V.] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Milan, Italy.
   [Piras, A.; Brunelli, G.] Univ Cagliari, Dent Clin, I-09124 Cagliari, Italy.
   [Zamboni, P.] Univ Ferrara, Dept Radiol Anesthesiol & Surg, I-44100 Ferrara, Italy.
   [Brunelli, G.] Don Orione Inst, Dept Dent & Maxillofacial & Plast Surg, Bergamo, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU FAR from the University of Ferrara, Ferrara, Italy; Don Orione Service
   s.r.l., Bergamo, Italy
FX This work was supported by FAR (2011) from the University of Ferrara
   (FC), Ferrara, Italy and by Don Orione Service s.r.l., Bergamo, Italy.
CR Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Carinci F, 2007, INT J PERIODONT REST, V27, P596
   Chan TF, 2008, GENOMICS, V91, P307, DOI 10.1016/j.ygeno.2007.12.008
   DODDS RA, 1995, J BONE MINER RES, V10, P1666
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Zheng H, 2004, CALCIFIED TISSUE INT, V74, P194, DOI 10.1007/s00223-003-0004-x
NR 19
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2012
VL 10
IS 1
SU 3
BP 71
EP 76
PG 6
WC Immunology
SC Immunology
GA V37BN
UT WOS:000209251400015
DA 2018-10-19
ER

PT J
AU Lauritano, D
   Carinci, F
   Zollino, I
   Hassanipour, A
   Saggese, V
   Palmieri, A
   Girardi, A
   Cura, F
   Piras, A
   Zamboni, P
   Brunelli, G
AF Lauritano, D.
   Carinci, F.
   Zollino, I.
   Hassanipour, A.
   Saggese, V.
   Palmieri, A.
   Girardi, A.
   Cura, F.
   Piras, A.
   Zamboni, P.
   Brunelli, G.
TI P15 (R) INDUCES RUNX2 IN BONE MARROW DERIVED STEM CELLS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE stem cell; biomaterial; P-15; differentiation; bone
AB Peptide-15 (P-15) is. P-15 an analog of the cell binding domain of collagen, has been shown to facilitate physiological process in a way similar to collagen, to serve as anchorage for cells, and to promote the binding, migration and differentiation of cells. However, how P-15 alters osteoblast activity to promote bone formation is poorly understood. In this study we investigated the osteo-inductives properties of P15 on stem cells derived from bone marrow. In Real Time Reverse Transcription-Polymerase Chain Reaction (real time RT-PCR) we quantified the mRNA expression of specific genes, like transcriptional factors (RUNX2 and SP7), bone related genes (SPP1, COL1A1, COL3A1, ALPL, and FOSL1) and mesenchymal stem cells marker (ENG). Gene expression in BMSC was then compared with the gene expression in Human Osteoblasts (HOb) treated with P15, to evaluate the potential effect of this biomaterial in osteoblasts differentiation.
C1 [Lauritano, D.; Saggese, V.] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Milan, Italy.
   [Carinci, F.; Zollino, I.; Hassanipour, A.; Palmieri, A.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Girardi, A.; Cura, F.] Univ Bologna, Ctr Mol Genet, Dept Histol Embryol & Appl Biol, CARISBO Fdn, Bologna, Italy.
   [Piras, A.; Brunelli, G.] Univ Cagliari, Dent Clin, I-09124 Cagliari, Italy.
   [Zamboni, P.] Univ Ferrara, Dept Radiol Anesthesiol & Surg, I-44100 Ferrara, Italy.
   [Brunelli, G.] Don Orione Inst, Dept Dent & Maxillofacial & Plast Surg, Bergamo, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU FAR from the University of Ferrara, Ferrara, Italy; Don Orione Service
   s.r.l., Bergamo, Italy
FX This work was supported by FAR (2011) from the University of Ferrara
   (FC), Ferrara, Italy and by Don Orione Service s.r.l., Bergamo, Italy.
CR Barboza EP, 2002, J PERIODONTOL, V73, P1153, DOI 10.1902/jop.2002.73.10.1153
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Krauser J T, 2000, Implant Dent, V9, P298, DOI 10.1097/00008505-200009040-00004
   Lallier TE, 2001, J PERIODONTOL, V72, P990, DOI 10.1902/jop.2001.72.8.990
   LIAN JB, 2003, PRIMER METABOLIC BON, P13
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Schilephake H., 2002, INT J ORAL MAXILLOF, V31, P469, DOI DOI 10.1054/IJOM.2002.0244
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna Raymonda, 2002, Int J Periodontics Restorative Dent, V22, P146
NR 16
TC 8
Z9 8
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2012
VL 10
IS 1
SU 3
BP 95
EP 100
PG 6
WC Immunology
SC Immunology
GA V37BN
UT WOS:000209251400019
DA 2018-10-19
ER

PT J
AU Brunelli, G
   Carinci, F
   Girardi, A
   Palmieri, A
   Brugnati, C
   Saggese, V
   Sollazzo, V
AF Brunelli, G.
   Carinci, F.
   Girardi, A.
   Palmieri, A.
   Brugnati, C.
   Saggese, V.
   Sollazzo, V.
TI AN IN VITRO STUDY ABOUT THE EFFECT OF ENGIPORE (R) ON DENTAL PULP STEM
   CELLS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Engipore (R); dental pulp; stem cells; gene expression; osteoblast
   differentiation
AB Engipore (R) is a porous hydroxyapatite (HA) biomaterial with a trabecular structure similar to natural bone. We analyzed the quantitative expression of mRNA of specific genes, first in DPSCs and then in Human Osteoblasts (HOb), after 15 and 30 days of treatment with Engipore (R), to detect if this biomaterial stimulates Dental Pulp Stem Cells (DPSCs) towards osteoblast differentiation. The obtained results demonstrated that Engipore (R) induces osteoblast phenotype expression and extracellular matrix deposition and mineralization in DPSCs, by the activation of osteoblast related genes SPP1, RUNX2 and FOSL1.
C1 [Brunelli, G.; Brugnati, C.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Carinci, F.; Palmieri, A.; Saggese, V.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
CR Brunelli G, 2011, EUROPEAN S2 IN PRESS
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192
   Kim IS, 2008, DEV GROWTH DIFFER, V50, P553, DOI 10.1111/j.1440-169X.2008.01052.x
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sollazzo Vincenzo, 2011, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V9, P1, DOI 10.4028/www.scientific.net/JBBTE.9.1
   STAHL SS, 1987, J PERIODONTOL, V58, P689, DOI 10.1902/jop.1987.58.10.689
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2012
VL 10
IS 1
SU S
BP 101
EP 105
PG 5
WC Immunology
SC Immunology
GA V37BL
UT WOS:000209251200020
DA 2018-10-19
ER

PT J
AU Gao, WJ
   Lai, JCK
   Leung, SW
AF Gao, Wenjuan
   Lai, James C. K.
   Leung, Solomon W.
TI Functional enhancement of chitosan and nanoparticles in cell culture,
   tissue engineering, and pharmaceutical applications
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Review
DE chitosan; nanoparticles; tissue engineering; biocompatibility;
   nanotoxicity
AB As a biomaterial, chitosan has been widely used in tissue engineering, wound healing, drug delivery, and other biomedical applications. It can be formulated in a variety of forms, such as powder, film, sphere, gel, and fiber. These features make chitosan an almost ideal biomaterial in cell culture applications, and cell cultures arguably constitute the most practical way to evaluate biocompatibility and biotoxicity. The advantages of cell cultures are that they can be performed under totally controlled environments, allow high throughput functional screening, and are less costly, as compared to other assessment methods. Chitosan can also be modified into multilayer composite by combining with other polymers and moieties to alter the properties of chitosan for particular biomedical applications. This review briefly depicts and discusses applications of chitosan and nanoparticles in cell culture, in particular, the effects of chitosan and nanoparticles on cell adhesion, cell survival, and the underlying molecular mechanisms: both stimulatory and inhibitory influences are discussed. Our aim is to update the current status of how nanoparticles can be utilized to modify the properties of chitosan to advance the art of tissue engineering by using cell cultures
C1 [Gao, Wenjuan; Leung, Solomon W.] Idaho State Univ, Sch Engn, Dept Civil & Environm Engn, Pocatello, ID 83209 USA.
   [Lai, James C. K.] Idaho State Univ, Coll Pharm, Dept Biomed & Pharmaceut Sci, Pocatello, ID 83209 USA.
   [Lai, James C. K.; Leung, Solomon W.] Idaho State Univ, Biomed Res Inst, Pocatello, ID 83209 USA.
RP Leung, SW (reprint author), Idaho State Univ, Sch Engn, Dept Civil & Environm Engn, Pocatello, ID 83209 USA.
EM leunsolo@isu.edu
FU DoD USAMRMC [W81XW1-T-07-2-0078]
FX Our research was supported by a DoD USAMRMC Project Grant (Contract
   #W81XW1-T-07-2-0078).
CR Agharkar V. A., 2008, ENV HLTH TOXICOLOGY, V2, P122
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Amarnath K, 2012, COLLOID SURFACE B, V92, P254, DOI 10.1016/j.colsurfb.2011.11.049
   Berrada M, 2005, BIOMATERIALS, V26, P2115, DOI 10.1016/j.biomaterials.2004.06.013
   Bettini R, 2008, EUR J PHARM BIOPHARM, V68, P74, DOI 10.1016/j.ejpb.2007.03.026
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bodnar M, 2005, BIOMACROMOLECULES, V6, P2521, DOI 10.1021/bm0502258
   Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i
   Charernsriwilaiwat N, 2012, INT J PHARMACEUT, V427, P379, DOI 10.1016/j.ijpharm.2012.02.010
   Chen AZ, 2012, J APPL POLYM SCI, V124, P3728, DOI 10.1002/app.35371
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Chen YL, 2006, BIOMATERIALS, V27, P2222, DOI 10.1016/j.biomaterials.2005.10.029
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI 10.1089/ten.TEA.2009.0229
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   Di Pasqua AJ, 2008, J INORG BIOCHEM, V102, P1416, DOI 10.1016/j.jinorgbio.2007.12.028
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Dorj B, 2012, MATER LETT, V73, P119, DOI 10.1016/j.matlet.2011.12.107
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Fakhry A, 2004, BIOMATERIALS, V25, P2075, DOI 10.1016/j.biomaterials.2003.08.068
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Fuente J. M., 2006, LANGMUIR, V22, P3286
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Grenha A, 2007, EUR J PHARM SCI, V31, P73, DOI 10.1016/j.ejps.2007.02.008
   Gu HY, 2006, ANAL LETT, V39, P2849, DOI 10.1080/00032710600867457
   Gu HY, 2001, J ELECTROANAL CHEM, V516, P119, DOI 10.1016/S0022-0728(01)00669-6
   Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048
   Gu HY, 2003, CHEM LETT, V32, P934, DOI 10.1246/cl.2003.934
   Gu HY, 2002, ANAL LETT, V35, P647, DOI 10.1081/AL-120003167
   Guo R, 2008, LANGMUIR, V24, P3459, DOI 10.1021/la703080j
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hu JL, 2012, ACTA BIOMATER, V8, P1730, DOI 10.1016/j.actbio.2012.01.029
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Hwang HY, 2008, J CONTROL RELEASE, V128, P23, DOI 10.1016/j.jconrel.2008.02.003
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Iyer P, 2012, BIOTECHNOL BIOENG, V109, P1314, DOI 10.1002/bit.24396
   Jain A., 2011, ENV HLTH SAFETY, V3, P545
   Jaiswal A., 2010, ENV HLTH SAFETY, V3, P527
   Jaiswal A. R., 2011, ENV HLTH SAFETY, V3, P541
   Jandhyam S., 2008, ENV HLTH TOXICOLOGY, V2, P126
   Ji S. H., 2008, NANOMEDICINE NEUROLO, V2, P491
   Ji Z. F., 2011, J COLLOID INTERF SCI, V365, P143
   Jiao YP, 2007, J BIOMED MATER RES A, V80A, P820, DOI 10.1002/jbm.a.31061
   Karakecili AG, 2007, J BIOSCI BIOENG, V104, P69, DOI 10.1263/jbb.104.69
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim JH, 2008, BIOMATERIALS, V29, P1920, DOI 10.1016/j.biomaterials.2007.12.038
   Kirchner C, 2005, TALANTA, V67, P486, DOI 10.1016/j.talanta.2005.06.042
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kumar S, 2012, INT J BIOL MACROMOL, V50, P493, DOI 10.1016/j.ijbiomac.2012.01.015
   Kumari S, 2012, INT J BIOL MACROMOL, V50, P878, DOI 10.1016/j.ijbiomac.2011.10.014
   Kuo YC, 2012, COLLOID SURFACE B, V93, P85, DOI 10.1016/j.colsurfb.2011.12.011
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lai J. C. K., 2007, BIOMATERIALS TISSUES, V2, P741
   Lai J. C. K., 2011, NANOMEDICAL SCI NEUR, V3, P440
   Lai J. C. K., 2005, ENCY BIOMATERIALS BI, P1
   Lai JCK, 2010, INT J NANOMED, V5, P715, DOI 10.2147/IJN.S5238
   Lai JCK, 2008, INT J NANOMED, V3, P533
   Lai JCK, 2008, P 12 WORLD MULT SYST, VII, P10
   Lai M. B., 2009, NANOMEDICINE, V2, P135
   Lai M. B., 2008, ENV HLTH TOXICOLOGY, V2, P130
   Lee A. R., 2008, NANOMEDICINE NEUROLO, V2, P531
   Li XY, 2012, INT J BIOL MACROMOL, V50, P43, DOI 10.1016/j.ijbiomac.2011.09.021
   Liang XF, 2012, J APPL POLYM SCI, V125, P1302, DOI 10.1002/app.35171
   Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o
   Liu X., 2008, BIOMARKERS NANOPARTI, V2, P256
   Loh J. W., 2008, SOFT NANOTECHNOLOGY, V2, P669
   Lu S. Y., 2011, ENV HLTH SAFETY, V3, P533
   Lu SY, 2010, COLLOID SURFACE B, V81, P406, DOI 10.1016/j.colsurfb.2010.06.019
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Ma GP, 2010, CARBOHYD POLYM, V79, P620, DOI 10.1016/j.carbpol.2009.09.015
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Mansur HS, 2009, MAT SCI ENG C-BIO S, V29, P1574, DOI 10.1016/j.msec.2008.12.012
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mei N, 2005, J BIOMATER APPL, V19, P323, DOI 10.1177/0885328205048630
   Memisoglu-Bilensoy E, 2006, J PHARM PHARMACOL, V58, P585, DOI 10.1211/jpp.58.5.0002
   Minoura N, 1998, MAT SCI ENG C-BIO S, V6, P275, DOI 10.1016/S0928-4931(98)00062-9
   Moreau JL, 2009, BIOMATERIALS, V30, P2675, DOI 10.1016/j.biomaterials.2009.01.022
   Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482
   Muzzarelli RAA, 2005, BIOMATERIALS, V26, P5844, DOI 10.1016/j.biomaterials.2005.03.006
   Nafee N, 2009, INT J PHARMACEUT, V381, P130, DOI 10.1016/j.ijpharm.2009.04.049
   Nagahama H, 2009, CARBOHYD POLYM, V76, P255, DOI 10.1016/j.carbpol.2008.10.015
   Nahar M, 2006, CRIT REV THER DRUG, V23, P259, DOI 10.1615/CritRevTherDrugCarrierSyst.v23.i4.10
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Perez J. M., 2008, BIO CHEM SENSORS, V2, P593
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Ramis-Castelltort M., 2008, BIOMARKERS NANOPARTI, V2, P286
   Rekha MR, 2009, J CONTROL RELEASE, V135, P144, DOI 10.1016/j.jconrel.2009.01.011
   Rustogi R, 2005, BURNS, V31, P878, DOI 10.1016/j.burns.2005.04.030
   Sarmento B, 2007, PHARM RES, V24, P2198, DOI 10.1007/s11095-007-9367-4
   Sarmento B, 2007, BIOMACROMOLECULES, V8, P3054, DOI 10.1021/bm0703923
   Sashiwa H, 2000, CHEM LETT, P596, DOI 10.1246/cl.2000.596
   Sasmazel HT, 2011, INT J BIOL MACROMOL, V49, P838, DOI 10.1016/j.ijbiomac.2011.07.022
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Shavandi Z, 2011, IMMUNOPHARM IMMUNOT, V33, P135, DOI 10.3109/08923973.2010.487489
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Suzuki T, 1999, J BIOSCI BIOENG, V88, P194, DOI 10.1016/S1389-1723(99)80201-1
   Ta HT, 2009, INT J PHARM, V371, P134, DOI 10.1016/j.ijpharm.2009.01.018
   Tan WB, 2005, J BIOMED MATER RES A, V75A, P56, DOI 10.1002/jbm.a.30410
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694
   Tigli RS, 2009, J MATER SCI-MATER M, V20, P699, DOI 10.1007/s10856-008-3624-x
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ulkur E, 2005, BURNS, V31, P874, DOI 10.1016/j.burns.2005.05.002
   Valmikinathan CM, 2012, SOFT MATTER, V8, P1964, DOI 10.1039/c1sm06629c
   Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032
   Wang T, 2012, CARBOHYD POLYM, V88, P75, DOI 10.1016/j.carbpol.2011.11.069
   Whelove OE, 2011, J BIOMED MATER RES B, V99B, P142, DOI 10.1002/jbm.b.31881
   Whitby M., 2008, NANOMEDICINE NEUROLO, V2, P516
   Winterowd Jack G., 1995, V67, P441
   Yang Z, 2012, TISSUE ENG PT A, V18, P242, DOI [10.1089/ten.tea.2011.0315, 10.1089/ten.TEA.2011.0315]
   Yao FL, 2003, POLYMER, V44, P6435, DOI 10.1016/S0032-3861(03)000676-1
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zhang Y, 2009, MAT SCI ENG C-BIO S, V29, P908, DOI 10.1016/j.msec.2008.07.040
   Zhang Z, 2012, MOLECULES, V17, P3243, DOI 10.3390/molecules17033243
   Zhao JH, 2012, J MATER SCI-MATER M, V23, P517, DOI 10.1007/s10856-011-4468-3
   Zheng HX, 2012, CURR APPL PHYS, V12, P826, DOI 10.1016/j.cap.2011.11.014
   Zheng L, 2003, PROG BIOCHEM BIOPHYS, V30, P314
   Zheng ZH, 2009, J BIOMED MATER RES A, V89A, P453, DOI 10.1002/jbm.a.31979
NR 128
TC 18
Z9 18
U1 2
U2 14
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PY 2012
VL 3
AR UNSP 321
DI 10.3389/fphys.2012.00321
PG 13
WC Physiology
SC Physiology
GA V35UH
UT WOS:000209173000315
PM 22934070
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Chen, KS
   Liao, SC
   Lin, SW
   Hung, TS
   Tsao, SH
   Wu, HM
   Inagaki, N
   Chen, WY
AF Chen, Ko-Shao
   Liao, Shu-Chuan
   Lin, Shen-Wei
   Hung, Tsui-Shan
   Tsao, Shao-Hsuan
   Wu, Hsin-Ming
   Inagaki, Norihiro
   Chen, Wei-Yu
TI Improvement of Thermoplastic Polyurethane Nonwoven Hydrophilicity by
   Atmospheric Pressure Plasma Treatment with He and N-2 Mixed Gases
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID GRAFT-POLYMERIZATION; SURFACE MODIFICATION; DISCHARGE; MEMBRANES; FILMS
AB Thermoplastic polyurethane (TPU) nonwoven has good mechanical properties for use in biomaterial. However, its inherent hydrophobic nature restricts its application. In this study, atmospheric pressure plasma treatment with He and N-2 gases was employed to TPU nonwoven material to improve the surface hydrophilicity while retaining the hydrophobicility on the back side of the material. The surface wettability was measured by water contact angle analysis, and the surface chemical composition was analyzed by X-ray photoelectron spectroscopy (XPS). The surface morphology was examined using scanning electron microscopy (SEM). The experimental results reveal that oxygen-containing groups such as C-O and O-C=O are generated on the plasma-treated TPU surface, leading to improved wettablility of the material. (C) 2012 The Japan Society of Applied Physics
C1 [Chen, Ko-Shao; Liao, Shu-Chuan; Lin, Shen-Wei; Hung, Tsui-Shan; Tsao, Shao-Hsuan; Wu, Hsin-Ming] Tatung Univ, Dept Mat Engn, Taipei 104, Taiwan.
   [Inagaki, Norihiro] Shizuoka Univ, Fac Engn, Polymer Chem Lab, Hamamatsu, Shizuoka 4328561, Japan.
   [Chen, Wei-Yu] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10617, Taiwan.
   [Liao, Shu-Chuan] Mingchi Univ Technol, Ctr Thin Film Technol & Applicat, New Taipei 24301, Taiwan.
RP Chen, KS (reprint author), Tatung Univ, Dept Mat Engn, Taipei 104, Taiwan.
FU AMED Co., Ltd. [E 9905-T15-055]
FX This work is supported by the AMED Co., Ltd. under contract No. E
   9905-T15-055.
CR Carlberg B, 2010, LANGMUIR, V26, P2235, DOI 10.1021/la9045447
   IWATA H, 1988, J POLYM SCI POL CHEM, V26, P3309, DOI 10.1002/pola.1988.080261216
   Kaczmarek H, 2002, SURF SCI, V507, P883, DOI 10.1016/S0039-6028(02)01367-5
   Kima M. C., 2003, SURF COAT TECH, V174, P839
   Kou RQ, 2003, LANGMUIR, V19, P6869, DOI 10.1021/la0345486
   Kuo Y. L., 2010, THIN SOLID FILMS, V518, P7557
   Kuo YL, 2010, THIN SOLID FILMS, V518, P7568, DOI 10.1016/j.tsf.2010.05.047
   Liu L, 2006, MAT SCI ENG A-STRUCT, V435, P309, DOI 10.1016/j.msea.2006.07.064
   Orlicki JA, 2007, POLYMER, V48, P2818, DOI 10.1016/jpolymer.2007.03.021
   Park J, 2001, J APPL PHYS, V89, P20, DOI 10.1063/1.1323753
NR 10
TC 2
Z9 2
U1 1
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD JAN
PY 2012
VL 51
IS 1
AR 01AJ06
DI 10.1143/JJAP.51.01AJ06
PN 2
PG 3
WC Physics, Applied
SC Physics
GA 934XU
UT WOS:000303480900056
DA 2018-10-19
ER

PT J
AU Kasputis, T
   Pannier, AK
AF Kasputis, Tadas
   Pannier, Angela K.
TI The role of surface chemistry-induced cell characteristics on nonviral
   gene delivery to mouse fibroblasts
SO JOURNAL OF BIOLOGICAL ENGINEERING
LA English
DT Article
DE Nonviral gene delivery; Transfection; Self assembled monolayers; Cell
   material interactions
AB Background: Gene delivery approaches serve as a platform to modify gene expression of a cell population with applications including functional genomics, tissue engineering, and gene therapy. The delivery of exogenous genetic material via nonviral vectors has proven to be less toxic and to cause less of an immune response in comparison to viral vectors, but with decreased efficiency of gene transfer. Attempts have been made to improve nonviral gene transfer efficiency by modifying physicochemical properties of gene delivery vectors as well as developing new delivery techniques. In order to further improve and understand nonviral gene delivery, our approach focuses on the cell-material interface, since materials are known to modulate cell behavior, potentially rendering cells more responsive to nonviral gene transfer. In this study, self-assembled monolayers of alkanethiols on gold were employed as model biomaterial interfaces with varying surface chemistries. NIH/3T3 mouse fibroblasts were seeded on the modified surfaces and transfected using either lipid-or polymer-based complexing agents.
   Results: Transfection was increased in cells on charged hydrophilic surfaces presenting carboxylic acid terminal functional groups, while cells on uncharged hydrophobic surfaces presenting methyl terminations demonstrated reduced transfection for both complexing agents. Surface-induced cellular characteristics that were hypothesized to affect nonviral gene transfer were subsequently investigated. Cells on charged hydrophilic surfaces presented higher cell densities, more cell spreading, more cells with ellipsoid morphologies, and increased quantities of focal adhesions and cytoskeleton features within cells, in contrast to cell on uncharged hydrophobic surfaces, and these cell behaviors were subsequently correlated to transfection characteristics.
   Conclusions: Extracellular influences on nonviral gene delivery were investigated by evaluating the upregulation and downregulation of transgene expression as a function of the cell behaviors induced by changes in the cells' microenvronments. This study demonstrates that simple surface modifications can lead to changes in the efficiency of nonviral gene delivery. In addition, statistically significant differences in various surface-induced cell characteristics were statistically correlated to transfection trends in fibroblasts using both lipid and polymer mediated DNA delivery approaches. The correlations between the evaluated complexing agents and cell behaviors (cell density, spreading, shape, cytoskeleton, focal adhesions, and viability) suggest that polymer-mediated transfection is correlated to cell morphological traits while lipid-mediated transfection correlates to proliferative characteristics.
C1 [Kasputis, Tadas] Univ Nebraska, Biomed Engn Program, Lincoln, NE 68583 USA.
   [Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA.
   [Pannier, Angela K.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68583 USA.
   [Kasputis, Tadas; Pannier, Angela K.] Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68583 USA.
RP Pannier, AK (reprint author), Univ Nebraska, Dept Biol Syst Engn, 231 LW Chase Hall, Lincoln, NE 68583 USA.
EM apannier2@unl.edu
FU American Heart Association; University of Nebraska Foundation (Layman
   Funds); Nebraska Research Initiative; J.A. Woollam Company; NSF EPSCoR
   First Award; USDA CSREES-Nebraska [NEB-21-146]; Institute of Agriculture
   and Natural Resources Seed Grant Program
FX Support for this research was provided in part by funds from the
   American Heart Association, the University of Nebraska Foundation
   (Layman Funds), the Nebraska Research Initiative, the J.A. Woollam
   Company, the NSF EPSCoR First Award, USDA CSREES-Nebraska (NEB-21-146),
   and the Institute of Agriculture and Natural Resources Seed Grant
   Program. Confocal microscopy was performed at the University of
   Nebraska-Lincoln's Center for Biotechnology Morrison Microscopy Core
   Research Facility and we thank Dr. You Zhou for assistance with imaging.
   We thank Dr. Mathias Schubert for the use of his goniometer. We thank
   Dr. Tatiana Segura (UCLA) for gold-coated slides.
CR Adler AF, 2010, NANO TODAY, V5, P553, DOI 10.1016/j.nantod.2010.10.007
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   CARMICHAEL J, 1987, CANCER RES, V47, P936
   Dent P, 1999, MOL BIOL CELL, V10, P2493, DOI 10.1091/mbc.10.8.2493
   Dhaliwal A, 2010, ACTA BIOMATER, V6, P3436, DOI 10.1016/j.actbio.2010.03.038
   Dowdy S., 2004, STAT RES
   Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084
   Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Fasbender A, 1997, GENE THER, V4, P1173, DOI 10.1038/sj.gt.3300524
   Geiger RC, 2006, GENE THER, V13, P725, DOI 10.1038/sj.gt.3302693
   Goda T, 2010, ANAL CHEM, V82, P1803, DOI 10.1021/ac902401y
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Godin M, 2004, LANGMUIR, V20, P7090, DOI 10.1021/la030257l
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   Kong HJ, 2007, NANO LETT, V7, P161, DOI 10.1021/nl062485g
   Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Lam AP, 2010, GENE THER, V17, P439, DOI 10.1038/gt.2010.31
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Mani G, 2008, BIOMATERIALS, V29, P4561, DOI 10.1016/j.biomaterials.2008.08.014
   Matsui H, 1997, J BIOL CHEM, V272, P1117, DOI 10.1074/jbc.272.2.1117
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pennisi CP, 2011, COLLOID SURFACE B, V85, P189, DOI 10.1016/j.colsurfb.2011.02.028
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Plautz SA, 2011, MOL THER, V19, P2144, DOI 10.1038/mt.2011.161
   Pompe T, 2005, BIOPHYS J, V88, P527, DOI [10.1529/biophysj.104.048074, 10.1529/biophysj.104.049074]
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Sang HX, 2005, CANCER GENE THER, V12, P427, DOI 10.1038/sj.cgt.7700809
   Saravia V, 2009, MICROSC RES TECHNIQ, V72, P957, DOI 10.1002/jemt.20742
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Segal G, 2001, J CELL SCI, V114, P119
   van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20
   VISTICA DT, 1991, CANCER RES, V51, P2515
   Wang H, 2006, J BIOMED MATER RES A, V77A, P672, DOI 10.1002/jbm.a.30586
   Wang YH, 2011, BIOMACROMOLECULES, V12, P1032, DOI 10.1021/bm101364f
   Wiethoff CM, 2003, J PHARM SCI, V92, P203, DOI 10.1002/jps.10286
   Wilke M, 1996, GENE THER, V3, P1133
   Wu HM, 2011, BIOMATERIALS, V32, P1619, DOI 10.1016/j.biomaterials.2010.09.045
   Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571
   Zhai XY, 2011, J APPL POLYM SCI, V121, P3569, DOI 10.1002/app.34156
   Zhang BQ, 2011, ACTA BIOMATER, V7, P1580, DOI 10.1016/j.actbio.2010.11.033
   Zhao D, 2011, INT J PHARMACEUT, V413, P260, DOI 10.1016/j.ijpharm.2011.04.040
   Zhao N, 2011, INT J PHARMACEUT, V411, P197, DOI 10.1016/j.ijpharm.2011.03.038
NR 59
TC 7
Z9 7
U1 1
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1754-1611
J9 J BIOL ENG
JI J. Biol. Eng.
PY 2012
VL 6
IS 1
AR 17
DI 10.1186/1754-1611-6-17
PG 11
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA V31TG
UT WOS:000208905300017
PM 22967455
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Liedmann, A
   Rolfs, A
   Frech, MJ
AF Liedmann, Andrea
   Rolfs, Arndt
   Frech, Moritz J.
TI Cultivation of Human Neural Progenitor Cells in a 3-dimensional
   Self-assembling Peptide Hydrogel
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 59; PuraMatrix; RADA16; 3D-scaffold; ReNcell VM;
   human neural progenitor cells; quantification
ID COMPLEMENTARY OLIGOPEPTIDE; NANOFIBER SCAFFOLDS; STEM-CELLS;
   DIFFERENTIATION; PROLIFERATION; CULTURES
AB The influence of 3-dimensional (3D) scaffolds on growth, proliferation and finally neuronal differentiation is of great interest in order to find new methods for cell-based and standardised therapies in neurological disorders or neurodegenerative diseases. 3D structures are expected to provide an environment much closer to the in vivo situation than 2D cultures. In the context of regenerative medicine, the combination of biomaterial scaffolds with neural stem and progenitor cells holds great promise as a therapeutic tool. (1-5)Culture systems emulating a three dimensional environment have been shown to influence proliferation and differentiation in different types of stem and progenitor cells. Herein, the formation and functionalisation of the 3D-microenviroment is important to determine the survival and fate of the embedded cells. (6-8)Here we used PuraMatrix(9.10) (RADA16, PM), a peptide based hydrogel scaffold, which is well described and used to study the influence of a 3D-environment on different cell types.(7,11-14) PuraMatrix can be customised easily and the synthetic fabrication of the nano-fibers provides a 3D-culture system of high reliability, which is in addition xeno-free.
   Recently we have studied the influence of the PM-concentration on the formation of the scaffold.(13) In this study the used concentrations of PM had a direct impact on the formation of the 3D-structure, which was demonstrated by atomic force microscopy. A subsequent analysis of the survival and differentiation of the hNPCs revealed an influence of the used concentrations of PM on the fate of the embedded cells. However, the analysis of survival or neuronal differentiation by means of immunofluorescence techniques posses some hurdles. To gain reliable data, one has to determine the total number of cells within a matrix to obtain the relative number of e.g. neuronal cells marked by beta III-tubulin. This prerequisites a technique to analyse the scaffolds in all 3-dimensions by a confocal microscope or a comparable technique like fluorescence microscopes able to take z-stacks of the specimen. Furthermore this kind of analysis is extremely time consuming.
   Here we demonstrate a method to release cells from the 3D-scaffolds for the later analysis e.g. by flow cytometry. In this protocol human neural progenitor cells (hNPCs) of the ReNcell VM cell line (Millipore USA) were cultured and differentiated in 3D-scaffolds consisting of PuraMatrix (PM) or PuraMatrix supplemented with laminin (PML). In our hands a PM-concentration of 0.25% was optimal for the cultivation of the cells(13), however the concentration might be adapted to other cell types.(12) The released cells can be used for e.g. immunocytochemical studies and subsequently analysed by flow cytometry. This speeds up the analysis and more over, the obtained data rest upon a wider base, improving the reliability of the data.
C1 [Liedmann, Andrea; Rolfs, Arndt; Frech, Moritz J.] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany.
RP Frech, MJ (reprint author), Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany.
EM moritz.frech@med.uni-rostock.de
CR Abu-Yousif Adnan O, 2009, J Vis Exp, DOI 10.3791/1692
   BD PuraMatrix Peptide Hydrogel, 2006, GUID US
   Blow N, 2009, NAT METHODS, V6, P619, DOI 10.1038/nmeth0809-619
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Giese AK, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-94
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Morgan PJ, 2009, NEUROREPORT, V20, P1225, DOI 10.1097/WNR.0b013e32832fbf49
   Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70
   Schmole AC, 2010, BIOORGAN MED CHEM, V18, P6785, DOI 10.1016/j.bmc.2010.07.045
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 18
TC 7
Z9 9
U1 1
U2 14
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JAN
PY 2012
IS 59
AR e3830
DI 10.3791/3830
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36PD
UT WOS:000209222600052
PM 22258286
OA Green Published
DA 2018-10-19
ER

PT S
AU Ma, JS
   Wang, F
   Zhou, QH
   Chen, Y
   Xu, GY
   Zhang, XT
   Feng, C
   Li, F
AF Ma, Jinshu
   Wang, Fang
   Zhou, Qinghai
   Chen, Yu
   Xu, Guangyu
   Zhang, Xiaotian
   Feng, Chao
   Li, Fan
BE Zhu, R
TI Toxicology evaluation and properties of a new biodegradable medical
   biomaterial
SO MEDICAL MATERIALS AND ENGINEERING
SE Advances in Sciences and Engineering
LA English
DT Proceedings Paper
CT 2nd SREE Workshop on Medical Materials and Engineering, WMME 2012
CY SEP 15-16, 2012
CL Soc Resources Environm Engn, Hong Kong, PEOPLES R CHINA
SP Soc Resources Environm Engn
HO Soc Resources Environm Engn
DE Porous modified-PPC; Composites; Mechanical properties
ID MESENCHYMAL STEM-CELLS; CARBON-DIOXIDE; POLY(PROPYLENE CARBONATE);
   MECHANICAL-PROPERTIES; PROPYLENE-OXIDE; IN-VIVO; BLENDS; COMPOSITES;
   COPOLYMERIZATION; BEHAVIOR
AB Background Poly (propylene carbonate) (PPC) synthesized from carbon dioxide and propylene oxide has attracted considerable research attention recently. To explore the potential application of these new polymers for bone repair, it is necessary to use other biodegradable polymers to enhance the properties of PPC. Poly (3-hydroxybutyrate) was used in this study to modify the mechanical properties and biocompatibility of PPC. Methods Poly (propylene carbonate) (PPC) was melt-mixed with 30% poly (3-hydroxybutyrate) to enhance its physical properties, while maintaining the inherently high structural integrity and ductility. The mechanical strength, porosity, morphologies and biocompatibility of porous modified-PPC (PM-PPC) were fully investigated using tensile tester, hammering method, scanning electron microscopy, cytotoxicity test for its biocompatibility. Results The PM-PPC was measured by mechanical tests for its compressive strength, elongation module and tensile strength, with the results being 43 Mpa, 725 Mpa and 32 Mpa respectively. The data showed that the mechanical properties of PM-PPC were significantly improved compared with PPC. The mean porosity of PM-PPC was 15%, as determined by hammering method. The biocompatibility test of PM-PPC showed that it has excellent potential for use as a biomedical material. Conclusions In conclusion, the PM-PPC showed improved mechanical properties, and an acceptable biocompatibility supporting its potential for use in patients. Thus, PM-PPC is a promising candidate for use as a novel medical material.
C1 [Ma, Jinshu; Wang, Fang; Chen, Yu; Xu, Guangyu; Zhang, Xiaotian; Feng, Chao; Li, Fan] Jilin Univ, Dept Pathogenobiol, Norman Bethune Coll Med, 126 Xinmin St, Changchun 130021, Peoples R China.
   [Zhou, Qinghai] Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   [Xu, Guangyu] Beihua Univ, Pharmaceut Coll, Jilin 132013, Peoples R China.
RP Li, F (reprint author), Jilin Univ, Dept Pathogenobiol, Norman Bethune Coll Med, 126 Xinmin St, Changchun 130021, Peoples R China.
EM majs10@mailsjlu.edu.cn; wf@jlu.edu.cn; coelove@gmail.com;
   yuchen09@mails.jlu.edu.cn; xuguangyu2005@163.com;
   zhangxiaotian0906@163.com; chenen7815@163.com; fanli_liu@sina.com
FU China National Science and Technology Support Program [2007BAE42B06]
FX This work was supported by the China National Science and Technology
   Support Program (grant number 2007BAE42B06). We thank Professor Rick C
   Nicholson at Mothers and Babies Research Center, Hunter Medical Research
   Institute, John Hunter Hospital, Newcastle, Australia for his language
   assistance and structure design in this paper.
CR Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022
   Chen SM, 2004, POLYMER, V45, P3045, DOI 10.1016/j.polymer.2004.02.049
   Chiellini E, 2001, BIOMACROMOLECULES, V2, P1029, DOI 10.1021/bm010084j
   Cho SW, 2005, BIOMATERIALS, V26, P1915, DOI 10.1016/j.biomaterials.2004.06.018
   Du LC, 2004, J APPL POLYM SCI, V92, P1840, DOI 10.1002/app.20165
   Ge XC, 2006, J APPL POLYM SCI, V99, P782, DOI 10.1002/app.22557
   Ge XC, 2005, COMPOS SCI TECHNOL, V65, P2219, DOI 10.1016/j.compscitech.2005.04.052
   Guo CH, 2009, J PHYS CHEM A, V113, P6710, DOI 10.1021/jp809471s
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hirotsu T, 2000, POLYM DEGRAD STABIL, V68, P311, DOI 10.1016/S0141-3910(99)00156-1
   Huang SP, 2008, J MATER SCI-MATER M, V19, P437, DOI 10.1007/s10856-006-0104-z
   Huang YN, 2010, MUTAT RES-GEN TOX EN, V696, P101, DOI 10.1016/j.mrgentox.2009.12.016
   INOUE S, 1969, J POLYM SCI POL LETT, V7, P287, DOI 10.1002/pol.1969.110070408
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Li XH, 2004, J APPL POLYM SCI, V94, P711, DOI 10.1002/app.20938
   Li XH, 2004, J POLYM SCI POL PHYS, V42, P666, DOI 10.1002/polb.10761
   Li YJ, 2009, ACS APPL MATER INTER, V1, P1650, DOI 10.1021/am900314k
   Lu XB, 2004, ANGEW CHEM INT EDIT, V43, P3574, DOI 10.1002/anie.200453998
   Lu XL, 2006, J BIOMED MATER RES A, V77A, P653, DOI 10.1002/jbm.a.30664
   Ma XF, 2006, J POLYM SCI POL PHYS, V44, P94, DOI 10.1002/polb.20669
   Meng YZ, 2002, J POLYM SCI POL CHEM, V40, P3579, DOI 10.1002/pola.10452
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Peng SW, 2004, J APPL POLYM SCI, V91, P1374, DOI 10.1002/app.2383
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Qin YS, 2010, BIOTECHNOL J, V5, P1164, DOI 10.1002/biot.201000134
   Ree M, 1999, J POLYM SCI POL CHEM, V37, P1863, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1863::AID-POLA16>3.0.CO;2-K
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   Tan XC, 2005, ANAL BIOCHEM, V337, P111, DOI 10.1016/j.ab.2004.10.040
   Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   Wang XY, 2005, COLLOID POLYM SCI, V284, P167, DOI 10.1007/s00396-005-1353-y
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Yang DZ, 2008, J APPL POLYM SCI, V109, P1635, DOI 10.1002/app.28002
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang ZH, 2002, J POLYM SCI POL PHYS, V40, P1957, DOI 10.1002/polb.10252
NR 37
TC 0
Z9 0
U1 0
U2 0
PU SOCIETY RESOURCES ENVIRONMENT & ENGINEERING
PI LONDON
PA 145-157 ST JOHN ST, LONDON, EC1V 4PW, ENGLAND
SN 2046-0392
BN 978-1-908074-16-4
J9 ADV SCI ENG
PY 2012
VL 5
BP 21
EP 30
PG 10
WC Engineering, Biomedical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BH1BE
UT WOS:000397484200005
DA 2018-10-19
ER

PT B
AU Domingos, RN
   de Angelis, DF
   Domingos, RN
   Corso, CR
   Menegario, AA
AF Domingos, R. N.
   de Angelis, D. F.
   Domingos, R. N.
   Corso, C. R.
   Menegario, A. A.
BE MendezVilas, A
TI Ultrasonic waves: Bioeffects on yeast cells
SO MICROBES IN APPLIED RESEARCH: CURRENT ADVANCES AND CHALLENGES
LA English
DT Proceedings Paper
CT 4th International Conference on Environmental, Industrial and Applied
   Microbiology (BioMicroWorld)
CY SEP 14-16, 2011
CL Malaga, SPAIN
DE Ultrasound; Saccharomyces cerevisiae; sonochemical catalysis;
   fermentation; ethanol
AB Applications of ultrasound were starting from 1912 with the primary objective the detection of icebergs on prevention of maritime accidents. Algae, fish deaths and destruction were observed in the vicinity of sonar that equipped ships and submarines during the First World War.
   The evolutions of research and studies with ultrasound have big advances following the discovery of piezoelectric transducers in science and technology. As an example we can mention its application in microsurgery, fatigue detection in aerospace mechanics, catalysis sonochemical, biotechnology and others.
   The work presented here aims to demonstrate the application of ultrasonic in pulsed mode beams in biotechnology with the aim of improving the fermentation of a culture broth containing biological agents. In these experiments we used as ultrasound equipment and oscilator Sonics VCX-600 (20KHz), probe type wave guide. The experiments were conducted in a glass reactor of 200 mL of biomaterial containing cane juice and Saccharomyces cerevisiae in suspension. The parameters analyzed were related to the content Alcohlic (FID gas chromatography), and cell viability (Neubauer chamber), TRS (refractometry). Analysis of results showed that the total production exceeded in irradiated samples compared to normal fermentation (without ultrasound), suggesting additional advantage of ultrasound activation. Lastin Trials 1400 min, showed ethanol production systems 12% more than non-enabled systems. In this context alternatives for ethanol production, bio fuel and many other byproducts of the alcohol industries and chemicals could benefit from the use of ultrasound beams in this range of frequencies.
C1 [Domingos, R. N.; Menegario, A. A.] UNESP Univ Estadual Paulista, Ctr Estudos Ambientais, Campus Rio Claro,Av 24 A 1515, BR-13506900 Sao Paulo, Brazil.
   [Domingos, R. N.] UNESP Univ Estadual Paulista, Inst Geocincias Cincias Exatas, IGCE, Dept Fis, BR-13506900 Sao Paulo, Brazil.
   [de Angelis, D. F.; Corso, C. R.] UNESP Univ Estadual Paulista, Inst Biocincias, Dept Bioquim Microbiol, BR-13506900 Sao Paulo, Brazil.
   [Domingos, R. N.] UNITINS Fundacao Univ Tocantins, Palmas, Brazil.
RP Domingos, RN (reprint author), UNESP Univ Estadual Paulista, Ctr Estudos Ambientais, Campus Rio Claro,Av 24 A 1515, BR-13506900 Sao Paulo, Brazil.
CR BUCALON J.A., 1991, UNTRASONICS INT C P, P91
   BUCALON J.A., 1987, ULTRASONICS INT C P, P745
   CHURCH B.D., 1986, NATURE, V183, P123
   CLARKE PR, 1969, EXP CELL RES, V58, P443, DOI 10.1016/0014-4827(69)90529-1
   OLIVEIRA J.E., 1984, RELATORIO TECNICO
   WILLIAMS A.R., 1983, ULTRASOUND BIOL EFFE, P157
   WILLIAMS AR, 1970, SCIENCE, V169, P871, DOI 10.1126/science.169.3948.871
NR 7
TC 0
Z9 0
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-4405-03-4
PY 2012
BP 451
EP 453
PG 3
WC Microbiology
SC Microbiology
GA BA9JG
UT WOS:000339479900092
DA 2018-10-19
ER

PT S
AU Mihailescu, A
   Doroftei, F
   Ioanid, EG
   Mihailescu, C
AF Mihailescu, Andrei
   Doroftei, Florica
   Ioanid, Emil Ghiocel
   Mihailescu, Camelia
BE Nedelcu, D
   Slatineanu, L
   Mazuru, S
   Milosevic, O
TI SURFACE PROPERTIES OF SURGICAL MATERIALS
SO MODTECH 2012: NEW FACE OF T M C R, VOLS I AND II
SE International Conference ModTech Proceedings
LA English
DT Proceedings Paper
CT 16th International Conference on Modern Technologies, Quality and
   Innovation
CY MAY 24-26, 2012
CL Sinaia, ROMANIA
SP Dept Machine Mfg Techn, Profession Assoc Modern Mfg Technol, MuS, Machine & Cutting Tools Dept
DE surface properties; surgical biomaterial; ESEM electronic microscopy;
   contact angles
ID SUTURE MATERIALS; TISSUE-REACTIONS
AB Surgical sutures are one of the most frequently used medical devices and their resorption under different conditions has been studied during the last years. Degradation in vitro (in simulated biologic fluid- SBF) of polyglycolide (PGA) multifilament sutures was studied using scanning electron microscopy (SEM), IR spectroscopy, contact angle measurements. Also, mechanical properties as tensile strength and elongation at brake, were determined. It was found that the biodegradation process includes a steady state and accelerated stages. It was also established the important role of intermolecular hydrogen bonds in the suture stability.
   The biostability of the suture depends on polymer morphology and changes widely with the suture draw ratio. The modification in the polymer chain results in the increase of suture usefulness without significant changes of complete polymer degradation time.
C1 [Mihailescu, Andrei] Gr T Popa Univ Med & Pharm, Iasi, Romania.
   [Doroftei, Florica; Ioanid, Emil Ghiocel] P Poni Inst Macromol Chem, Iasi, Romania.
   [Mihailescu, Camelia] Tech Univ Gheorghe Asachi Iasi Romania, Dept Nat & Synthet Polymers, Iasi, Romania.
RP Mihailescu, C (reprint author), Tech Univ Gheorghe Asachi Iasi Romania, Dept Nat & Synthet Polymers, Iasi, Romania.
EM cmihail@ch.tuiasi.ro
CR Chauvet D, 2011, ACTA NEUROCHIR, V153, P2465, DOI 10.1007/s00701-011-1197-9
   Chung E, 2009, J SURG EDUC, V66, P208, DOI 10.1016/j.jsurg.2009.06.007
   Esenyel CZ, 2009, ACTA ORTHOP TRAUMATO, V43, P366, DOI 10.3944/AOTT.2009.366
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kosan M, 2007, EUR UROL SUPPL, V6, P113, DOI 10.1016/S1569-9056(07)60363-7
   Pillai CKS, 2010, J BIOMATER APPL, V25, P291, DOI 10.1177/0885328210384890
   Pla-Berenguer P., 2010, ANN U ORADEA FASCICL, VI, P22
NR 7
TC 0
Z9 0
U1 0
U2 0
PU MODTECH PUBLISHING HOUSE
PI IASI
PA BLVD CAROL I, NO 28A, IASI, 00000, ROMANIA
SN 2069-6736
J9 INT CONF MODTECH PR
PY 2012
BP 557
EP 560
PG 4
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BG8EA
UT WOS:000392261800140
DA 2018-10-19
ER

PT J
AU Peterson, DM
   Stone, J
   Oyefusi, A
   Traisawatwong, P
   Carson, L
   Oki, A
   Regisford, G
AF Peterson, D. M.
   Stone, J.
   Oyefusi, A.
   Traisawatwong, P.
   Carson, L.
   Oki, A.
   Regisford, G.
TI Osteopontin Expression in Human Fetal Osteoblastic Cells Grown on a
   Chitosan Composite Biomaterial.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Peterson, D. M.; Regisford, G.] Prairie View A&M Univ, Biol, Prairie View, TX USA.
   [Stone, J.; Traisawatwong, P.; Carson, L.] Prairie View A&M Univ, CARC, Prairie View, TX USA.
   [Oyefusi, A.; Oki, A.] Prairie View A&M Univ, Chem, Prairie View, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 777
PG 1
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348602409
DA 2018-10-19
ER

PT B
AU Yue, X
   Zhou, GR
   Hur, B
AF Yue, Xuezheng
   Zhou, GuoRong
   Hur, Boyoung
BE Hur, BY
   Kim, BK
   Kim, SE
   Hyun, SK
TI Study on the Structure and Mechanical Properties of Open-cell Mg-Al
   Alloy Metal Foam
SO POROUS METALS AND METALLIC FOAMS, METFOAM 2011
LA English
DT Proceedings Paper
CT 7th International Conference on Porous Metals and Metal Foams
CY SEP 18-21, 2011
CL Busan, SOUTH KOREA
DE Open-cell foam; Porous metal; Mg-Al alloy; Investment Casting method
AB Metal foam is energy-saving and environment-friendly materials for their relatively new class of structural characteristics. The open-cell Mg-Al alloy foam has a complex microstructure consisting of an interconnected network. The different pore size and relative density determine the complex microstructure and the mechanical properties. The Mg-Al alloy foam has not only characteristics of metal, but also a new class of properties of novel physical, mechanical, thermal, electrical, and acoustic[1]. Open-cell foam is also valuable to be a body-bone as a degradable biomaterial. It usually is used as heat exchangers, because they have a high coefficient of thenual conductivity, increased surface area. The process weak is that Mg is easy to burn. In this paper, open-cell foam was fabricated by investment casting method with the mixing gas of SF6 and CO2. These gases well solve the problem that magnesium is easy to burn. In order to apply metal foams in various fields and use them effectively, the Structure and Mechanical Properties of material must be investigated.
C1 [Yue, Xuezheng; Hur, Boyoung] 1Gyeongsang Natl Univ, I Cube Ctr, 1ERI, 900 Gajwa Dong, Jinju 660701, Gyeongnam, South Korea.
   [Zhou, GuoRong] Univ Jinan, Sch Mat Sci & Engn, Jinan 250022, Peoples R China.
RP Yue, X (reprint author), 1Gyeongsang Natl Univ, I Cube Ctr, 1ERI, 900 Gajwa Dong, Jinju 660701, Gyeongnam, South Korea.
FU ministry of education and human resources development thought the i-Cube
   Center, Brain Korea 21 (BK21) program; ERI of Gyeongsang National
   University
FX This research was supported by the ministry of education and human
   resources development thought the i-Cube Center, Brain Korea 21 (BK21)
   program and the ERI of Gyeongsang National University.
CR Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Chevillotte F, 2010, J ACOUST SOC AM, V128, P1766, DOI 10.1121/1.3473696
   Hur BY, 2012, APPL MECH MATER, V121-126, P75, DOI 10.4028/www.scientific.net/AMM.121-126.75
   Kim Hyung Sun, 2003, FLOW MODELING NEGATI, V439
   Park Pu-Keoun, 2005, MECH PROPERTIES OPEN, P1
   Sevilla P, 2007, J ALLOY COMPD, V439, P67, DOI [10.1016/j.jallcom.2006.08.069, 10.1016/j.jallcom.2006.008.069]
   Song Y, 2007, SOLID STATE PHENOMEN, V124-126, P1841, DOI 10.4028/www.scientific.net/SSP.124-126.1841
   Zhao Rui, 2011, J MAT RES, V21
NR 8
TC 0
Z9 0
U1 0
U2 0
PU GS INTERVISION
PI SEOUL
PA 448 6 SINSU DONG MAPO GU, SEOUL, 00000, SOUTH KOREA
BN 978-89-97231-39-3
PY 2012
BP 463
EP 467
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BG9XF
UT WOS:000394068500073
DA 2018-10-19
ER

PT B
AU Takala, M
   Helkio, H
   Sundholm, J
   Genina, N
   Kiviluoma, P
   Widmaier, T
   Sandler, N
   Kuosmanen, P
AF Takala, M.
   Helkio, H.
   Sundholm, J.
   Genina, N.
   Kiviluoma, P.
   Widmaier, T.
   Sandler, N.
   Kuosmanen, P.
BE Otto, T
TI INK-JET PRINTING OF PHARMACEUTICALS
SO PROCEEDINGS OF THE 8TH INTERNATIONAL CONFERENCE OF DAAAM BALTIC
   INDUSTRIAL ENGINEERING, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 8th International Conference of DAAAM Baltic Industrial Engineering
   (DAAAM-Baltic)
CY APR 19-21, 2012
CL Tallinn, ESTONIA
SP Danube Adria Assoc Automat & Mfg Int, BALTECH Consortium, Estonian Acad Sci, Federat Estonian Engn Ind, Assoc Estonian Mech Engineer, Danube Adria Assoc Automat & Mfg Baltic
DE thermal; piezoelectric; print head; paracetamol; riboflavin;
   personalized dosing
AB Traditional tablet manufacturing process has multiple powder handling and mixing phases. It is time consuming and limits individualized dosing. Furthermore, uniformity of the dose is difficult to achieve. Modern ink-jet printing technology has been successfully applied to polymer electronics and biomaterial applications. It has many advantages that could be utilized in drug manufacturing process, such as faster production cycle with fewer processing steps, precise dosing, on-demand individualized dosing and possibility for on-line quality control. This study examines how well current printer technologies function in printing different types of drug solutions on paper-like substrate. Preliminary tests were carried out with paracetamol and riboflavin-water solutions. The study denoted that printing medicines and biopolymer coating was possible, the accuracy of dose was very satisfying and personalized dosing was easy to achieve. Further studies with specially manufactured printers are still needed to determine the suitability of the ink-jet printing process in commercial drug manufacturing.
C1 [Genina, N.; Sandler, N.] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland.
RP Kiviluoma, P (reprint author), Aalto Univ, Sch Engn, Dept Engn Design & Prod, POB 14100, Aalto 00076, Finland.
EM marko.takala@aalto.fi; henri.helkio@aalto.fi; joni.sundholm@aalto.fi;
   natalja.genina@abo.com; panu.kiviluoma@aalto.fi;
   thomas.widmaier@aalto.fi; niklas.sandler@abo.fi;
   petri.kuosmanen@aalto.fi
OI Genina, Natalja/0000-0002-9947-6900
CR Magdassi S., 2010, CHEM INKJET INKS
   MIT Tech Talk, 1997, MED AR PRINT PILLS
   Sandler N, 2011, J PHARM SCI-US, V100, P3386, DOI 10.1002/jps.22526
   Sen AK, 2007, J MICROMECH MICROENG, V17, P1420, DOI 10.1088/0960-1317/17/8/002
   Tyson J., 2001, INKJET PRINTER WORKS
   University Of Leeds News, 2010, NEW RES SAF DRUGS PU
   Wijshoff H, 2010, PHYS REP, V491, P77, DOI 10.1016/j.physrep.2010.03.003
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TALLINN UNIV TECHNOLOGY
PI TAILLINN
PA DAAAM BALTIC, EHITAJATE TEE 5, TAILLINN, 19086, ESTONIA
BN 978-9949-23-265-9
PY 2012
BP 233
EP 239
PG 7
WC Engineering, Industrial; Engineering, Mechanical
SC Engineering
GA BG8OE
UT WOS:000392535600038
DA 2018-10-19
ER

PT S
AU Muller, TH
AF Mueller, Thomas H.
BE Mantas, J
   Andersen, SK
   Mazzoleni, MC
   Blobel, B
   Quaglini, S
   Moen, A
TI Key-Linked On-line Databases for Clinical Research
SO QUALITY OF LIFE THROUGH QUALITY OF INFORMATION
SE Studies in Health Technology and Informatics
LA English
DT Proceedings Paper
CT 24th Medical Informatics in Europe Conference (MIE)
CY AUG 26-29, 2012
CL Pisa, ITALY
SP European Federat Med Informat, Italian Med Informat Assoc, Italian E Hlth Community
DE Electronic Data Capture; World Wide Web; Clinical Registries; Biobanks;
   Data Protection
AB Separating patient identification data from clinical data and/or information about biomaterial samples is an effective data protection measure, especially in clinical research employing "on-line", i.e., web-based, data capture. In this paper, we show that this specialised technique can be generalised into a network architecture of interconnected on-line databases potentially serving a variety of purposes. The basic idea of this approach consists of maintaining logical links, i.e., common record keys, between corresponding data structures in pairs of databases while keeping the actual key values hidden from clients. For client systems, simultaneous access to corresponding records is mediated by temporary access tokens. At the relational level, these links are represented by arbitrary unique record keys common to both databases. This architecture allows for integration of related data in different databases without replicating or permanently sharing this data in one place. Each participating on-line database can determine the degree of integration by specifying linkage keys only for those data structures that may be logically connected to other data. Logical links can de designed for specific use cases. In addition, each database controls user access by enforcing its own authorisation scheme. Another advantage is that individual database owners retain considerable leeway in adapting to changing local requirements without compromising the integration into the network. Beyond protecting individual subject identification data, this architecture permits splitting a cooperatively used data pool to achieve many kinds of objectives. Application examples could be clinical registries needing subject contact information for follow-up, biomaterial banks with or without genetic information, and automatic or assisted integration of data from electronic medical records into research data.
C1 [Mueller, Thomas H.] Univ Munich, IBE Inst Med Informat Biometry & Epidemiol, Marchioninistr 15, D-81377 Munich, Germany.
RP Muller, TH (reprint author), Univ Munich, IBE Inst Med Informat Biometry & Epidemiol, Marchioninistr 15, D-81377 Munich, Germany.
EM mueller@ibe.med.uni-muenchen.de
CR Kuhn KA, 2009, GI EDITION LECT NOTE, P698
   Muller TH, 2002, ST HEAL T, V90, P246
   Pommerening K, 2008, EHEALTH COMBINING HL, P5
   Pommerening Klaus, 2004, Stud Health Technol Inform, V103, P441
   Reng C-M, 2006, GENERISCHE LOSUNGEN
   Reng CM, 2003, VERNETZTE MED FORSCH, V100, pA2134
NR 6
TC 1
Z9 1
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0926-9630
BN 978-1-61499-101-4
J9 STUD HEALTH TECHNOL
PY 2012
VL 180
BP 524
EP 528
DI 10.3233/978-1-61499-101-4-524
PG 5
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA BA3ZL
UT WOS:000335219500102
PM 22874246
DA 2018-10-19
ER

PT J
AU Fuoco, C
   Salvatori, ML
   Biondo, A
   Shapira-Schweitzer, K
   Santoleri, S
   Antonini, S
   Bernardini, S
   Tedesco, FS
   Cannata, S
   Seliktar, D
   Cossu, G
   Gargioli, C
AF Fuoco, Claudia
   Salvatori, Maria Lavinia
   Biondo, Antonella
   Shapira-Schweitzer, Keren
   Santoleri, Sabrina
   Antonini, Stefania
   Bernardini, Sergio
   Tedesco, Francesco Saverio
   Cannata, Stefano
   Seliktar, Dror
   Cossu, Giulio
   Gargioli, Cesare
TI Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves
   survival and differentiation of transplanted mesoangioblasts in acute
   and chronic skeletal-muscle degeneration
SO SKELETAL MUSCLE
LA English
DT Article
DE Stem cells; Mesoangioblasts; Hydrogel; Muscular dystrophy; Muscle
   regeneration; Cell therapy; Tissue engineering
AB Background: Cell-transplantation therapies have attracted attention as treatments for skeletal-muscle disorders; however, such research has been severely limited by poor cell survival. Tissue engineering offers a potential solution to this problem by providing biomaterial adjuvants that improve survival and engraftment of donor cells.
   Methods: In this study, we investigated the use of intra-muscular transplantation of mesoangioblasts (vessel-associated progenitor cells), delivered with an injectable hydrogel biomaterial directly into the tibialis anterior (TA) muscle of acutely injured or dystrophic mice. The hydrogel cell carrier, made from a polyethylene glycol-fibrinogen (PF) matrix, is polymerized in situ together with mesoangioblasts to form a resorbable cellularized implant.
   Results: Mice treated with PF and mesoangioblasts showed enhanced cell engraftment as a result of increased survival and differentiation compared with the same cell population injected in aqueous saline solution.
   Conclusion: Both PF and mesoangioblasts are currently undergoing separate clinical trials: their combined use may increase chances of efficacy for localized disorders of skeletal muscle.
C1 [Fuoco, Claudia; Salvatori, Maria Lavinia; Bernardini, Sergio; Cannata, Stefano; Gargioli, Cesare] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Biondo, Antonella; Santoleri, Sabrina; Tedesco, Francesco Saverio; Cossu, Giulio] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy.
   [Shapira-Schweitzer, Keren; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel.
   [Antonini, Stefania; Tedesco, Francesco Saverio; Cossu, Giulio] UCL, Dept Cell & Dev Biol, London, England.
   [Gargioli, Cesare] IRCCS MultiMed, Milan, Italy.
RP Cannata, S (reprint author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
EM cannata@uniroma2.it; g.cossu@ucl.ac.uk; cesare.gargioli@uniroma2.it
OI Cossu, Giulio/0000-0001-5863-9593; Gargioli, Cesare/0000-0003-1742-3969
FU Fondazione Roma; Telethon; Duchenne Parent Project Italia; EC-IP FP7
   grant Angioscaff; EC-IP FP7 grant Biodesign; EC-IP FP7 grant Optistem;
   Medical Research Council [MR/J006785/1]
FX We thank M. Coletta for his valuable technical help and D. Leonardi for
   Scanning Electron Microscopy images. This work was supported by EC-IP
   FP7 grants Angioscaff and Biodesign (to DS and GC) and Optistem, and by
   Fondazione Roma, Telethon and Duchenne Parent Project Italia to GC.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113
   CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0
   CARLSON BM, 1973, AM J ANAT, V137, P119, DOI 10.1002/aja.1001370202
   Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007
   Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542
   Diaz-Manera J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.35
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Guerette B, 1997, TRANSPLANT P, V29, P1932, DOI 10.1016/S0041-1345(97)00166-8
   Guttinger M, 2006, EXP CELL RES, V312, P3872, DOI 10.1016/j.yexcr.2006.08.012
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   Minasi MG, 2002, DEVELOPMENT, V129, P2773
   Mouly V, 2005, Acta Myol, V24, P128
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Rossi CA, 2010, ORGANOGENESIS, V6, P167, DOI 10.4161/org.6.3.12419
   Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254
   Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541
   Wernig A, 2000, J PHYSIOL-LONDON, V522, P333, DOI 10.1111/j.1469-7793.2000.t01-2-00333.x
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
NR 30
TC 35
Z9 35
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2044-5040
J9 SKELET MUSCLE
JI Skeletal Muscle
PY 2012
VL 2
AR 24
DI 10.1186/2044-5040-2-24
PG 14
WC Cell Biology
SC Cell Biology
GA V39PM
UT WOS:000209422900023
PM 23181356
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT B
AU Serbinski, W
   Seramak, T
   Sobieszczyk, S
   Zielinski, A
AF Serbinski, Waldemar
   Seramak, Tomasz
   Sobieszczyk, Sylwia
   Zielinski, Andrzej
BE Zhou, L
   Chang, H
   Lu, Y
   Xu, D
TI Fabrication and Microstructure Characteristics of Sintered Porous
   Biomaterial Based on Titanium Alloy for Orthopedic Applications
SO TI-2011: PROCEEDINGS OF THE 12TH WORLD CONFERENCE ON TITANIUM, VOL I
LA English
DT Proceedings Paper
CT 12th World Conference on Titanium (Ti-2011)
CY JUN 19-24, 2011
CL Nonferrous Met Soc China, Beijing, PEOPLES R CHINA
SP NW Inst Nonferrous Met Res, NW Polytechn Univ, Baoti Grp Ltd, Beijing Inst Aeronaut Mat, Chinese Acad Sci, Inst Met Res
HO Nonferrous Met Soc China
DE Titanium alloy (Ti alloy); implants; porous materials; biocompatibility
ID TOTAL HIP-ARTHROPLASTY; BONE INGROWTH; POLYETHYLENE; STIFFNESS;
   FIXATION; GROWTH; METALS; CARBON
AB Currently, titanium and its alloys (Ti-6A1-4V or Ti-13Nb-13Zr) are one of the basic metallic materials, which are used as biomaterials in orthopedics. Research under their best corrosion and wear resistance, biocompatibility and bioactivity are still being conducted. Orthopedic implants continue to pose a big problem because of their mechanical properties are too high in relation to the properties of human bones, for example Young's modulus. Young's modulus of bone is between 10-30 GPa and the solid metals is placed between 110 GPa for Ti and 230 GPa for Co-Cr alloys. Nowadays, many researches is focused on the design, manufacturing and characterisation of the porous materials based on e.g. Ti-6Al-4V or Ti-13Nb-13Zr alloys, which would be applied for implants. Currently, there are several known methods of producing porous materials. The most common methods include: the powder metallurgy, conventional or with an use of space holders (removed by temperature or chemical treatment),plasma spraying, laser remelting, rapid prototyping, metal foam manufacturing or heat and chemical treatments. The aim of this work was to conduct the powder preparation, pressing and sintering by conventional or with space holders processes in order to obtain the porous structure material made of the Ti-13Nb-13Zr alloy. In this paper, the size and shape of the Ti-13Nb-13Zr alloy powders obtained by machining and plasma atomization processes are presented. The pressing parameters, type of space holders, in that mainly unit pressure as well as temperature and time of the sintering processes are described. The investigation results of the microstructure morphology, pore size and porosity, in dependence of the selected type space holders, pressing and sintering parameters are shown and discussed. It is expected, that the porous material with defined porosity made of the Ti-13Nb-13Zr alloy and its applications for orthopedic applications allows obtaining their high biocompatibility and bioactivity as well as cause an increase wear and corrosion resistance in contact with human body.
C1 [Serbinski, Waldemar; Seramak, Tomasz; Sobieszczyk, Sylwia; Zielinski, Andrzej] Gdansk Univ Technol, Fac Mech Engn, G Narutowicza Str 11-12, PL-80233 Gdansk, Poland.
RP Serbinski, W (reprint author), Gdansk Univ Technol, Fac Mech Engn, G Narutowicza Str 11-12, PL-80233 Gdansk, Poland.
CR BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   Engh C A, 1986, Instr Course Lect, V35, P169
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   OTANI T, 1992, ORTHOP CLIN N AM, V23, P335
   PILLIAR RM, 1979, J BIOMED MATER RES, V13, P799, DOI 10.1002/jbm.820130510
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Simancik F., 2002, HDB CELLULAR METALS, P1
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   Sychterz CJ, 2001, CLIN ORTHOP RELAT R, P218
   WEBER JN, 1972, MATER RES BULL, V7, P1005, DOI 10.1016/0025-5408(72)90092-X
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
NR 19
TC 0
Z9 0
U1 0
U2 1
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 978-7-03-033899-0
PY 2012
BP 614
EP 619
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BH1LG
UT WOS:000398119600134
DA 2018-10-19
ER

PT B
AU Salehi, M
   Verdian, MM
   Raeissi, K
AF Salehi, M.
   Verdian, M. M.
   Raeissi, K.
BE Zhou, L
   Chang, H
   Lu, Y
   Xu, D
TI Synthesis of Amorphous/Nanocrystalline Ni-Ti Biomaterial Powders by
   Mechanical Alloying
SO TI-2011: PROCEEDINGS OF THE 12TH WORLD CONFERENCE ON TITANIUM, VOL III
LA English
DT Proceedings Paper
CT 12th World Conference on Titanium (Ti-2011)
CY JUN 19-24, 2011
CL Nonferrous Met Soc China, Beijing, PEOPLES R CHINA
SP NW Inst Nonferrous Met Res, NW Polytechn Univ, Baoti Grp Ltd, Beijing Inst Aeronaut Mat, Chinese Acad Sci, Inst Met Res
HO Nonferrous Met Soc China
DE Mechanical alloying; amorphization; intermetallics
ID BEHAVIOR
AB An amorphous/nanocrystalline 50Ni-50Ti powder was produced from elemental Ti and Ni powders by solid state synthesis utilizing low energy mechanical alloying with times up to 100 hr. The morphology, microstructure and phase composition of the milling products were evaluated by using scanning electron microscopy (SEM) and X-ray diffraction (XRD) analysis. The results indicated that there was no chemical reaction between the elements during the milling process, which led to the direct for mation of an amorphous/nanocrystalline structure without any intermediate phase (intermetallic and/or solid solution phase) formation. It seems that the second kind of amorphization process proposed by Weeber and Bakker is governed. It was shown that the formation of amorphous phase was started after 80hr and developed during the milling for 100hr.
C1 [Salehi, M.; Verdian, M. M.; Raeissi, K.] Isfahan Univ Technol, Dept Mat Engn, POB 84156-83111, Esfahan, Iran.
RP Salehi, M (reprint author), Isfahan Univ Technol, Dept Mat Engn, POB 84156-83111, Esfahan, Iran.
OI Verdian, Mehdi/0000-0002-2394-8764
CR Arciniegas A, 2008, J ALLOY COMPD, V460, P213, DOI 10.1016/j.jallcom.2007.05.069
   Benedictus R, 1998, ACTA MATER, V46, P5491, DOI 10.1016/S1359-6454(98)00191-8
   Chen YL, 2009, J ALLOY COMPD, V477, P696, DOI 10.1016/j.jallcom.2008.10.111
   Gu YW, 2005, MAT SCI ENG A-STRUCT, V392, P222, DOI 10.1016/j.msea.2004.09.025
   Kawashima A, 2001, MAT SCI ENG A-STRUCT, V304, P753, DOI 10.1016/S0921-5093(00)01587-2
   Li DY, 1998, WEAR, V221, P116, DOI 10.1016/S0043-1648(98)00269-5
   Li DY, 2000, MATER DESIGN, V21, P551, DOI 10.1016/S0261-3069(00)00015-7
   Lin HC, 1997, METALL MATER TRANS A, V28, P1871, DOI 10.1007/s11661-997-0117-3
   Liu W, 2004, METALL MATER TRANS A, V35A, P356, DOI 10.1007/s11661-004-0139-z
   Mousavi T, 2008, MAT SCI ENG A-STRUCT, V487, P46, DOI 10.1016/j.msea.2007.09.051
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Takasaki A, 1998, PHYS STATUS SOLIDI A, V169, P183, DOI 10.1002/(SICI)1521-396X(199810)169:2<183::AID-PSSA183>3.0.CO;2-N
   Varin RA, 1999, INTERMETALLICS, V7, P785, DOI 10.1016/S0966-9795(98)00127-7
   Wang AP, 2007, J ALLOY COMPD, V440, P225, DOI 10.1016/j.jallcom.2006.09.003
   WEEBER AW, 1988, PHYSICA B, V153, P93, DOI 10.1016/0921-4526(88)90038-5
   Wu SK, 2000, WEAR, V244, P85, DOI 10.1016/S0043-1648(00)00443-9
   Ye LL, 1998, MAT SCI ENG A-STRUCT, V241, P290, DOI 10.1016/S0921-5093(97)00505-4
   Zhang TC, 2000, MAT SCI ENG A-STRUCT, V293, P208, DOI 10.1016/S0921-5093(00)01044-3
NR 18
TC 0
Z9 0
U1 1
U2 2
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 978-7-03-033894-5
PY 2012
BP 1704
EP 1708
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BH1LI
UT WOS:000398128800002
DA 2018-10-19
ER

PT B
AU Zhou, X
   Kou, HC
   Wang, J
   Li, JS
   Blandin, JJ
   Zhou, L
AF Zhou, X.
   Kou, H. C.
   Wang, J.
   Li, J. S.
   Blandin, J. J.
   Zhou, L.
BE Zhou, L
   Chang, H
   Lu, Y
   Xu, D
TI Homogeneous Flow and Superplastic Forming Process of Ti-Zr-Cu-Pd-Sn Bulk
   Metallic Glass in Supercooled Liquid Region
SO TI-2011: PROCEEDINGS OF THE 12TH WORLD CONFERENCE ON TITANIUM, VOL III
LA English
DT Proceedings Paper
CT 12th World Conference on Titanium (Ti-2011)
CY JUN 19-24, 2011
CL Nonferrous Met Soc China, Beijing, PEOPLES R CHINA
SP NW Inst Nonferrous Met Res, NW Polytechn Univ, Baoti Grp Ltd, Beijing Inst Aeronaut Mat, Chinese Acad Sci, Inst Met Res
HO Nonferrous Met Soc China
DE Ti-based bulk metallic glass; superplastic forming process; homogeneous
   de formation behavior
ID MECHANICAL-PROPERTIES; NEWTONIAN VISCOSITY; AMORPHOUS-ALLOYS;
   DEFORMATION; CRYSTALLIZATION; TRANSITION; ABILITY
AB The Ti-Zr-Cu-Pd-Sn bulk metallic glasses have some advantages of high yield strength about 2000Mpa, good corrosion resistance and absence of toxic element, such as Al,Ni and Be. So the Ti-based metallic glass is regarded as a promising biomaterial and lightweight material. The homogenous deformation and superplastic forming process of Ti-Zr-Cu-Pd-Sn-Sn bulk metallic glass was investigated. The homogeneous deformation behavior is strongly dependent on the strain rate. The metallic glass exhibits Newtonian behavior at relative low strain rate and non-Newtonian behavior at relative high strain rate. The micro-gear was successfully extruded by superplastic forming process, indicating that the Ti-Zr-Cu-Pd-Sn bulk metallic glass processes good workability in supercooled liquid region. The deformed metallic glass was investigated by X-ray diffraction (XRD), demonstrating that no detectable crystalline phase precipitated during superplastic forming.
C1 [Zhou, X.; Kou, H. C.; Wang, J.; Li, J. S.; Zhou, L.] Northwestern Polytech Univ, State Key Lab Solidificat Proc, Xian 710072, Shaanxi Provinc, Peoples R China.
   [Blandin, J. J.] CNRS, Inst Neel CRETA, 25 Ave Martyrs ,BP 166, F-38042 Grenoble 9, France.
RP Zhou, X (reprint author), Northwestern Polytech Univ, State Key Lab Solidificat Proc, Xian 710072, Shaanxi Provinc, Peoples R China.
OI WANG, Jun/0000-0001-8101-2967; Li, Jinshan/0000-0002-6894-9760
FU funds of the Fundamental Research Project of National Defense of China
   [A2720110010]; Program of Introducing Talents of Discipline to
   Universities [B08040]; State Key Laboratory of Solidification Processing
   in NWPU [26-TZ-2010]
FX This work was supported by the funds of the Fundamental Research Project
   of National Defense of China (A2720110010), the Program of Introducing
   Talents of Discipline to Universities (B08040) and the State Key
   Laboratory of Solidification Processing in NWPU (26-TZ-2010).
CR AMIYA K, 1994, MAT SCI ENG A-STRUCT, V179, P692, DOI 10.1016/0921-5093(94)90294-1
   Busch R, 1998, ACTA MATER, V46, P4725, DOI 10.1016/S1359-6454(98)00122-0
   Chiang CL, 2004, INTERMETALLICS, V12, P1057, DOI 10.1016/j.internet.2004.04.012
   De Hey P, 1998, ACTA MATER, V46, P5873, DOI 10.1016/S1359-6454(98)00234-1
   Duan G, 2008, SCRIPTA MATER, V58, P465, DOI 10.1016/j.scriptamat.2007.10.040
   Huang YJ, 2010, J ALLOY COMPD, V504, pS82, DOI 10.1016/j.jallcom.2010.02.163
   Kato H, 1998, APPL PHYS LETT, V73, P3665, DOI 10.1063/1.122856
   Kawamura Y, 2000, APPL PHYS LETT, V77, P1114, DOI 10.1063/1.1289502
   Kawamura Y, 2001, MAT SCI ENG A-STRUCT, V304, P674, DOI 10.1016/S0921-5093(00)01562-8
   Kim YC, 2004, MAT SCI ENG A-STRUCT, V375, P127, DOI 10.1016/j.msea.2003.10.115
   Lu J, 2003, ACTA MATER, V51, P3429, DOI 10.1016/S1359-6454(03)00164-2
   Nieh TG, 2006, SCRIPTA MATER, V54, P387, DOI 10.1016/j.scriptamat.2005.04.052
   Schroers J., 2009, ADV MATER, V21, P1
   Wang Q, 2006, MAT SCI ENG A-STRUCT, V435, P405, DOI 10.1016/j.msea.2006.07.050
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhu SL, 2008, INTERMETALLICS, V16, P1031, DOI 10.1016/j.intermet.2008.05.006
NR 16
TC 0
Z9 0
U1 0
U2 0
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 978-7-03-033894-5
PY 2012
BP 1808
EP 1811
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BH1LI
UT WOS:000398128800026
DA 2018-10-19
ER

PT B
AU Wadood, A
   Inamura, T
   Hosoda, H
   Miyazaki, S
AF Wadood, A.
   Inamura, T.
   Hosoda, H.
   Miyazaki, S.
BE Zhou, L
   Chang, H
   Lu, Y
   Xu, D
TI Comparative Study of Ti-6Cr-3Sn Biomedical Alloy in Solution Treated and
   473K-Aged Conditions
SO TI-2011: PROCEEDINGS OF THE 12TH WORLD CONFERENCE ON TITANIUM, VOL III
LA English
DT Proceedings Paper
CT 12th World Conference on Titanium (Ti-2011)
CY JUN 19-24, 2011
CL Nonferrous Met Soc China, Beijing, PEOPLES R CHINA
SP NW Inst Nonferrous Met Res, NW Polytechn Univ, Baoti Grp Ltd, Beijing Inst Aeronaut Mat, Chinese Acad Sci, Inst Met Res
HO Nonferrous Met Soc China
DE Ti-6Cr-3Sn; biomaterial; ageing; phase trans formation,mechanical
   properties; pseudoelasticity
ID BASE SHAPE-MEMORY; MECHANICAL-PROPERTIES; BEHAVIOR; PHASE
AB Recently titanium and its alloys are finding extensive use as biomaterials due to their excellent mechanical properties, corrosion resistance and biocompatibility. Cr is a beta phase stabilizing element and Sn is also a non-toxic element. Recently, we found that cold workability of Ti-xCr-3Sn alloys was improved with Cr additions due to beta phase stabilization. In this study, mechanical properties and shape memory effect of metastable beta Ti-6Cr-3Sn alloy in solution-treated and 473K-aged conditions were. investigated. Ti-6Cr-3Sn alloy was developed by arc-melting method, homogenized at 1273K for 7. 2ks, cold rolled successfully to 96% reduction and solution-treated at 1273K for 1. 8ks followed by quenching into water. Ageing treatment was carried out at 473K for 3. 6ks followed by quenching into water. Ti-6Cr-3Sn alloy (beta phase) in solution treated conditions exhibited 585MPa UTS,41% fracture strain, HV260 hardness,305MPa yield stress and 57% shape recovery ratio. However by ageing at 473K for 3. 6ks,Ti-6Cr-35n alloy showed brittle fracture (2% fracture strain), high yield stress (440MPa), high hardness (HV329) with no shape memory effect due to omega (hexagonal) phase precipitation. In cyclic loading-unloading tensile testing with a constant strain increment, Ti-6Cr-3Sn alloy in the solution treated conditions showed pseudo elastic response. However Ti-6Cr-3Sn alloy aged at 473K for 3. 6ks did not show pseudo elastic response. It is concluded that Ti-6Cr-3Sn alloy in solution-treated conditions has potential for biomedical applications. However mechanical, shape memory and pseoudoelastic properties were drastically reduced by ageing at 473K.
C1 [Wadood, A.; Inamura, T.; Hosoda, H.] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259-R2-27, Yokohama, Kanagawa 2268503, Japan.
   [Miyazaki, S.] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Wadood, A (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259-R2-27, Yokohama, Kanagawa 2268503, Japan.
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT)
   Japan; Cabinet Office, Government of Japan;  [20360310];  [21390522]
FX This work was partially supported by a Grant-in Aid for Fundamental
   Scientific Research Kiban B no. 20360310,2008-2010 and no.
   21390522,2009-2011, and the Global COE program from the Ministry of
   Education, Culture, Sports, Science and Technology (MEXT) Japan. This
   work was also partially supported by Funding Program for Next Generation
   World-Leading Researchers from Cabinet Office, Government of Japan.
CR Al-Zain Y, 2011, ACTA MATER, V59, P1464, DOI 10.1016/j.actamat.2010.11.008
   Banerjee S, 1996, ACTA MATER, V44, P3667, DOI 10.1016/1359-6454(96)00012-2
   HANSEN M, 1958, CONSTITUTION BINARY, P1265
   Ho WF, 2009, J ALLOY COMPD, V468, P533, DOI 10.1016/j.jallcom.2008.01.046
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V438, P839, DOI 10.1016/j.msea.2006.02.136
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kusano Y, 2010, MATER SCI FORUM, V654-656, P2118, DOI 10.4028/www.scientific.net/MSF.654-656.2118
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Ng HP, 2010, MAT SCI ENG A-STRUCT, V527, P7017, DOI 10.1016/j.msea.2010.07.055
   Wadood A., 2010, 2010 SPRING M JAP I, P429
   Yamabe-Mitarai Y, 2010, INTERMETALLICS, V18, P2275, DOI 10.1016/j.intermet.2010.07.011
   Zhang XD, 1999, SCRIPTA MATER, V41, P659, DOI 10.1016/S1359-6462(99)00111-6
NR 13
TC 0
Z9 0
U1 0
U2 1
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 978-7-03-033894-5
PY 2012
BP 2086
EP 2089
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BH1LI
UT WOS:000398128800088
DA 2018-10-19
ER

PT B
AU Nakai, M
   Niinomi, M
AF Nakai, Masaaki
   Niinomi, Mitsuo
BE Zhou, L
   Chang, H
   Lu, Y
   Xu, D
TI Improvement in Fatigue Strength with Maintaining Young' s Modulus Low by
   Controlling omega-phase Precipitation in beta-type Ti-Nb-Ta-Zr Alloy
SO TI-2011: PROCEEDINGS OF THE 12TH WORLD CONFERENCE ON TITANIUM, VOL III
LA English
DT Proceedings Paper
CT 12th World Conference on Titanium (Ti-2011)
CY JUN 19-24, 2011
CL Nonferrous Met Soc China, Beijing, PEOPLES R CHINA
SP NW Inst Nonferrous Met Res, NW Polytechn Univ, Baoti Grp Ltd, Beijing Inst Aeronaut Mat, Chinese Acad Sci, Inst Met Res
HO Nonferrous Met Soc China
DE Titanium alloy; biomaterial; microstructure; omega phase; aging; low
   Young's modulus; fatigue strength
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS;
   TI-29NB-13TA-4.6ZR; CRYSTALS
AB In order to improve the fatigue strength with maintaining low Young's modulus of a biomedical beta-type titanium alloy, Ti-29Nb-13Ta-4 center dot 6Zr, a short-time aging combined with severe cold rolling was investigated. An a, phase was employed for precipitation strengthening. Because the rolling texture of beta phase is formed by the cold rolling, such the omega phase may be preferentially oriented to a direction that is effective for inhibiting the increase in Young's modulus. TNTZ aged at 573 K for 3.6 ks or 10.8 ks after cold rolling exhibits high tensile strength and acceptable elongation with relatively low Young's modulus. However, the fatigue strength of TNTZ aged at 573 K for 3.6 ks is not significantly improved. On the other hand, the fatigue strength of the TNTZ sample aged at 573 K for 10.8 ks is improved as well as its tensile strength.
C1 [Nakai, Masaaki; Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
FU Industrial Technology Research Grant Program from New Energy and
   Industrial Technology Development Organization (NEDO) of Japan
FX This work was supported in part by the Industrial Technology Research
   Grant Program in 2009 from the New Energy and Industrial Technology
   Development Organization (NEDO) of Japan.
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Akahori T, 2006, J JPN I MET, V70, P295, DOI 10.2320/jinstmet.70.295
   Furuhara T, 2001, J MATER PROCESS TECH, V117, P318, DOI 10.1016/S0924-0136(01)00790-7
   Hao YJ, 2010, SOLID STATE SCI, V12, P1473, DOI 10.1016/j.solidstatesciences.2010.06.010
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Niinomi M, 2007, INT J FATIGUE, V29, P992, DOI 10.1016/j.ijfatigue.2006.09.021
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Tane M, 2008, ACTA MATER, V56, P2856, DOI 10.1016/j.actamat.2008.02.017
   Zhang JM, 2007, THIN SOLID FILMS, V515, P7020, DOI 10.1016/j.tsf.2007.01.045
NR 11
TC 0
Z9 0
U1 1
U2 1
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 978-7-03-033894-5
PY 2012
BP 2102
EP 2105
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BH1LI
UT WOS:000398128800092
DA 2018-10-19
ER

PT B
AU Xu, YF
   Yi, DQ
   Liu, HQ
   Wang, B
   Yang, FL
AF Xu, Y. F.
   Yi, D. Q.
   Liu, H. Q.
   Wang, B.
   Yang, F. L.
BE Zhou, L
   Chang, H
   Lu, Y
   Xu, D
TI Effect of Aging Temperature on Microstructure and Mechanical Properties
   of Ti-Nb-Ta-Zr-Fe Alloy for Biomedical Applications
SO TI-2011: PROCEEDINGS OF THE 12TH WORLD CONFERENCE ON TITANIUM, VOL III
LA English
DT Proceedings Paper
CT 12th World Conference on Titanium (Ti-2011)
CY JUN 19-24, 2011
CL Nonferrous Met Soc China, Beijing, PEOPLES R CHINA
SP NW Inst Nonferrous Met Res, NW Polytechn Univ, Baoti Grp Ltd, Beijing Inst Aeronaut Mat, Chinese Acad Sci, Inst Met Res
HO Nonferrous Met Soc China
DE Microstructure; mechanical property; aging; omega phase; biomaterial
ID OMEGA-PHASE; YOUNGS MODULUS; TI-29NB-13TA-4.6ZR; TRANSFORMATIONS;
   ALPHA''; MARTENSITE; BEHAVIOR
AB The effect of aging temperature on microstructure and mechanical properties of Ti-25Nb-10Ta-1Zr-0.2Fe alloy was investigated. The results showed that the solution treated sample possesses good plasticity behavior. The deformation mechanism of the solution treated sample during tensile process is stress induced martensite transformation from beta phase to alpha" phase. An increase in yield strength as well as a great decrease in plasticity is observed in the alloy after aging treatments owing to the precipitates forming barriers against dislocation slip. The precipitation of omega phase in (3 phase at relatively lower aging temperature between 150-400 degrees C leads to low strength-to-modulus ratio and low elongation, whereas the precipitation of a phase at relatively higher aging temperature of 550 degrees C results in high strength, low Young's modulus and moderate elongation.
C1 [Xu, Y. F.; Yi, D. Q.; Liu, H. Q.; Wang, B.; Yang, F. L.] Cent S Univ, Sch Mat Sci & Engn, Changsha 410083, Hunan, Peoples R China.
   [Xu, Y. F.; Liu, H. Q.] Xiangtan Univ, Key Lab Mat Design & Preparat Technol Hunan Prov, Xiangtan 411105, Peoples R China.
   [Yi, D. Q.; Liu, H. Q.; Wang, B.; Yang, F. L.] Cent S Univ, Key Lab Nonferrous Mat, Minist Educ, Changsha 410083, Hunan, Peoples R China.
RP Yi, DQ (reprint author), Cent S Univ, Sch Mat Sci & Engn, Changsha 410083, Hunan, Peoples R China.
CR Akahori T, 2006, J JPN I MET, V70, P295, DOI 10.2320/jinstmet.70.295
   Cui CY, 2009, J ALLOY COMPD, V471, P248, DOI 10.1016/j.jallcom.2008.03.057
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Matsumoto H, 2007, J ALLOY COMPD, V439, P146, DOI 10.1016/j.jallcom.2006.08.267
   Mishra A.K., 1993, TI 13NB 13ZR NEW LOW, P61
   Niinomi M, 2007, MAT SCI ENG C-BIO S, V27, P154, DOI 10.1016/j.msec.2006.04.008
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   Prima F, 2006, SCRIPTA MATER, V54, P645, DOI 10.1016/j.scriptamat.2005.10.024
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   SIKKA SK, 1982, PROG MATER SCI, V27, P245, DOI 10.1016/0079-6425(82)90002-0
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   WANG K, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2697
   WILLIAMS JC, 1971, METALL TRANS, V2, P1913
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
NR 20
TC 0
Z9 0
U1 0
U2 0
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 978-7-03-033894-5
PY 2012
BP 2126
EP 2129
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BH1LI
UT WOS:000398128800097
DA 2018-10-19
ER

PT J
AU Waldeck, H
   Wang, XT
   Joyce, E
   Kao, WJ
AF Waldeck, Heather
   Wang, Xintong
   Joyce, Evan
   Kao, Weiyuan John
TI Active leukocyte detachment and apoptosis/necrosis on PEG hydrogels and
   the implication in the host inflammatory response
SO BIOMATERIALS
LA English
DT Article
DE Apoptosis; Cell adhesion; Cell culture; Hydrogel; Monocyte
ID TUMOR-NECROSIS-FACTOR; MATRIX METALLOPROTEINASES; BLOOD MONOCYTES;
   CELL-DEATH; CALPAIN CLEAVAGE; WOUND REPAIR; MACROPHAGE; INTEGRIN;
   ADHESION; INHIBITORS
AB Monocytes/Macrophages have long been recognized as key players in inflammation and wound healing and are often employed in vitro to gain an understanding of the inflammatory response to biomaterials. Previous work has demonstrated a drastic decrease in primary monocyte adherent density on biomaterial surfaces coupled with a change in monocyte behavior over time. However, the mechanism responsible for this decrease remains unclear. In this study, we explored active detachment and cellular death as possible regulating factors. Specifically, extracellular TNF-alpha and ROS production were analyzed as potential endogenous stimulators of cell death. MMPs, but not calpains, were found to play a key role in active monocyte detachment. Monocyte death was found to peak at 24 h and occur by both apoptosis and necrosis as opposed to polymorphonuclear leukocyte death which mainly occurred through apoptosis. Finally, TNF-alpha and ROS production were not found to have a causal relationship with monocyte death on TCPS or PEG surfaces. The occurrence of primary monocyte apoptosis/necrosis as well as active detachment from a material surface has implications not only in in vitro study, but also in the translation of the in vitro inflammatory response of these cells to in vivo applications. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kao, Weiyuan John] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   [Waldeck, Heather; Joyce, Evan; Kao, Weiyuan John] Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
   [Wang, Xintong] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Kao, Weiyuan John] Univ Wisconsin, Dept Surg, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM hmwaldeck@wisc.edu; wang2571@umn.edu; ejoyce@wisc.edu;
   wjkao@pharmacy.wisc.edu
RI Wang, Xintong/I-8169-2013
FU NIH [R01 EB6613]
FX The authors would like to thank David Cantu for his assistance with
   phlebotomy procedures. This work was supported by NIH Grant R01 EB6613.
CR Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866
   Bartneck M, 2010, NANO LETT, V10, P59, DOI 10.1021/nl902830x
   Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0
   Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023
   Cape JL, 2009, ARCH BIOCHEM BIOPHYS, V484, P190, DOI 10.1016/j.abb.2009.01.010
   Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619
   Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8
   Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363
   Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118
   Chung A, 2007, BIOMATERIALS, V28, P285, DOI 10.1016/j.biomaterials.2006.08.038
   Chung AS, 2009, J BIOMED MATER RES A, V91A, P742, DOI 10.1002/jbm.a.32259
   Chung AS, 2009, J BIOMED MATER RES A, V89A, P841, DOI 10.1002/jbm.a.32431
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   Cristofanon S, 2008, BIOCHEM PHARMACOL, V76, P1533, DOI 10.1016/j.bcp.2008.07.042
   Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003
   DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   FAIST E, 1992, SURGERY, V112, P562
   Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021
   Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562
   FRANKLIN JP, 1982, IMMUNOL COMMUN, V11, P477, DOI 10.3109/08820138209050744
   Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027
   Gantner F, 1997, BRIT J PHARMACOL, V121, P221, DOI 10.1038/sj.bjp.0701124
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   HuffLonergan E, 1996, J ANIM SCI, V74, P993
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Kasahara Y, 1997, BLOOD, V89, P1748
   Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Levy DE, 1998, J MED CHEM, V41, P199, DOI 10.1021/jm970494j
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Majewska E, 2000, SCAND J IMMUNOL, V52, P496, DOI 10.1046/j.1365-3083.2000.00802.x
   Manso AM, 2006, CARDIOVASC RES, V69, P574, DOI 10.1016/j.cardiores.2005.09.004
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MOLLOY RG, 1993, J IMMUNOL, V151, P2142
   Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.3.CO;2-V
   Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Patel VA, 2009, AUTOIMMUNITY, V42, P317, DOI 10.1080/08916930902832124
   Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8
   Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048
   Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200
   Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179
   Schmidt D, 2011, ACTA BIOMATER, V7, P515, DOI 10.1016/j.actbio.2010.08.022
   Serrano K, 2004, CELL MOTIL CYTOSKEL, V58, P242, DOI 10.1002/cm.20011
   Shastry S, 2004, J CELL BIOCHEM, V93, P207, DOI 10.1002/jcb.20137
   Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002
   Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427
   Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363
   SUTER PM, 1992, AM REV RESPIR DIS, V145, P1016, DOI 10.1164/ajrccm/145.5.1016
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Vaisar T, 2009, MOL CELL PROTEOMICS, V8, P1044, DOI 10.1074/mcp.M800449-MCP200
   Wang KKW, 1996, ADV EXP MED BIOL, V389, P95
   WANG X, 2010, J BIOMATER SCI  0630
   Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714
   Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015
NR 67
TC 17
Z9 17
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 1
BP 29
EP 37
DI 10.1016/j.biomaterials.2011.09.044
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 853AX
UT WOS:000297399700004
PM 21963150
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Huang, W
   Begum, R
   Barber, T
   Ibba, V
   Tee, NCH
   Hussain, M
   Arastoo, M
   Yang, Q
   Robson, LG
   Lesage, S
   Gheysens, T
   Skaer, NJV
   Knight, DP
   Priestley, JV
AF Huang, W.
   Begum, R.
   Barber, T.
   Ibba, V.
   Tee, N. C. H.
   Hussain, M.
   Arastoo, M.
   Yang, Q.
   Robson, L. G.
   Lesage, S.
   Gheysens, T.
   Skaer, Nicholas J. V.
   Knight, D. P.
   Priestley, J. V.
TI Regenerative potential of silk conduits in repair of peripheral nerve
   injury in adult rats
SO BIOMATERIALS
LA English
DT Article
DE Silk; Axonal regeneration; Peripheral nerve injury; Conduit; Catwalk;
   Target innervations
ID AUTOGENOUS VEIN GRAFT; ROOT GANGLION NEURONS; POLYGLYCOLIC ACID;
   SCIATIC-NERVE; IN-VITRO; HYALURONIC-ACID; CELL-ADHESION; COLLAGEN TUBE;
   GROWTH-FACTOR; ULNAR NERVES
AB Various attempts have been made to develop artificial conduits for nerve repair, but with limited success. We describe here conduits made from Bombyx mori regenerated silk protein, and containing luminal fibres of Spidrex (R), a silk-based biomaterial with properties similar to those of spider silk. Assessment in vitro demonstrated that Spidrex (R) fibres support neurite outgrowth. For evaluation in vivo, silk conduits 10 mm in length and containing 0, 100, 200 or 300 luminal Spidrex (R) fibres, were implanted to bridge an 8 mm gap in the rat sciatic nerve. At 4 weeks, conduits containing 200 luminal Spidrex (R) fibres (PN200) supported 62% and 59% as much axon growth as autologous nerve graft controls at mid-conduit and distal nerve respectively. Furthermore, Spidrex (R) conduits displayed similar Schwann cell support and macrophage response to controls. At 12 weeks, animals implanted with PN200 conduits showed similar numbers of myelinated axons (81%) to controls, similar gastrocnemius muscle innervation, and similar hindpaw stance assessed by Catwalk footprint analysis. Plantar skin innervation was 73% of that of controls. PN200 Spidrex (R) conduits were also effective at bridging longer (11 and 13 mm) gaps. Our results show that Spidrex (R) conduits promote excellent axonal regeneration and function recovery, and may have potential for clinical application. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Huang, W.; Begum, R.; Barber, T.; Ibba, V.; Tee, N. C. H.; Hussain, M.; Arastoo, M.; Yang, Q.; Robson, L. G.; Priestley, J. V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Neurosci & Trauma, London E1 2AT, England.
   [Huang, W.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Sect Anaesthet Pain Med & Intens Care, London SW10 9NH, England.
   [Lesage, S.; Gheysens, T.; Skaer, Nicholas J. V.; Knight, D. P.] Oxford Biomat Ltd, Magdalen Ctr, Oxford OX4 4GA, England.
RP Priestley, JV (reprint author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Neurosci & Trauma, 4 Newark St, London E1 2AT, England.
EM j.v.priestley@qmul.ac.uk
RI gheysens, tom/J-5001-2012; Huang, Wenlong/P-2025-2016; Gheysens,
   Tom/J-8792-2014
OI gheysens, tom/0000-0002-8185-8986; Gheysens, Tom/0000-0002-8185-8986;
   Barber, Thomas/0000-0003-4850-9677
FU ICUK; Kinetique Biomedical Seed Fund
FX We thank Ms. Sharon Averill for advice and help on immunohistochemistry
   and Mr Keith Pell and Mr Mick Willis for assistance with SEM analysis.
   This work was supported by ICUK and by an award from Kinetique
   Biomedical Seed Fund to Neurotex Ltd. DPK and JVP are directors of
   Neurotex Ltd.
CR Ahmed MR, 2005, J PERIPHER NERV SYST, V10, P390, DOI 10.1111/j.1085-9489.2005.00055.x
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2000, SCAND J PLAST RECONS, V34, P101
   Azhar M M, 2004, Med J Malaysia, V59, P578
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   BRADSHAW RA, 1994, PROTEIN SCI, V3, P1901, DOI 10.1002/pro.5560031102
   Braga-Silva J, 1999, J HAND SURG-BRIT EUR, V24B, P703, DOI 10.1054/jhsb.1999.0276
   BRUNELLI GA, 1994, MICROSURG, V15, P176, DOI 10.1002/micr.1920150307
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   CHIU DTW, 1982, SURGERY, V91, P226
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510
   Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x
   Gladman SJ, 2010, NEUROSCIENCE, V171, P577, DOI 10.1016/j.neuroscience.2010.07.009
   HAASE J, 1980, J NEUROSURG, V53, P73, DOI 10.3171/jns.1980.53.1.0073
   Hakimi O., 2005, EUR CELLS MAT S2, V10, P46
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hazari A, 1999, BRIT J PLAST SURG, V52, P653, DOI 10.1054/bjps.1999.3184
   Huang WL, 2006, EUR J NEUROSCI, V23, P273, DOI 10.1111/j.1460-9568.2005.04530.x
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   JENQ CB, 1987, BRAIN RES, V408, P239, DOI 10.1016/0006-8993(87)90379-9
   KAUPPILA T, 1993, EXP NEUROL, V123, P181, DOI 10.1006/exnr.1993.1151
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   KIYOTANI T, 1995, ASAIO J, V41, pM657, DOI 10.1097/00002480-199507000-00092
   KNIGHT DP, 2008, Patent No. 0807868
   KNIGHT DP, 2002, Patent No. 0229993
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   LIM CHT, 2008, SOC NEUR ABS, V351
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MILLESI H, 1984, CLIN PLAST SURG, V11, P105
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   PRIESTLEY JV, 2005, Patent No. 2006030182
   Pu LLQ, 1999, PLAST RECONSTR SURG, V104, P1379, DOI 10.1097/00006534-199910000-00021
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SCHLOSSHAUER B, 2004, ENCY BIOMATERIALS BI, P1043
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   SECKEL BR, 1995, J NEUROSCI RES, V40, P318, DOI 10.1002/jnr.490400305
   SELTZER Z, 1989, PAIN, V37, P245, DOI 10.1016/0304-3959(89)90136-X
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stang F, 2005, BIO-MED MATER ENG, V15, P3
   Stang F, 2009, MATERIALS, V2, P1480, DOI 10.3390/ma2041480
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   WALTON RL, 1989, PLAST RECONSTR SURG, V84, P944, DOI 10.1097/00006534-198912000-00013
   Wang KK, 1998, MICROSURG, V18, P270, DOI 10.1002/(SICI)1098-2752(1998)18:4<270::AID-MICR11>3.0.CO;2-V
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   WEBER RA, 1993, MICROSURG, V14, P323, DOI 10.1002/micr.1920140507
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Yan H, 2009, INT REV NEUROBIOL, V87, P199, DOI 10.1016/S0074-7742(09)87010-4
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 68
TC 65
Z9 69
U1 3
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 1
BP 59
EP 71
DI 10.1016/j.biomaterials.2011.09.030
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 853AX
UT WOS:000297399700007
PM 22005069
DA 2018-10-19
ER

PT J
AU Rustad, KC
   Wong, VW
   Sorkin, M
   Glotzbach, JP
   Major, MR
   Rajadas, J
   Longaker, MT
   Gurtner, GC
AF Rustad, Kristine C.
   Wong, Victor W.
   Sorkin, Michael
   Glotzbach, Jason P.
   Major, Melanie R.
   Rajadas, Jayakumar
   Longaker, Michael T.
   Gurtner, Geoffrey C.
TI Enhancement of mesenchymal stem cell angiogenic capacity and stemness by
   a biomimetic hydrogel scaffold
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cell; Hydrogel; Wound healing; Growth factors
ID WOUND REPAIR; STROMAL CELLS; SELF-RENEWAL; TISSUE; SKIN;
   DIFFERENTIATION; ENGRAFTMENT; DELIVERY; MURINE; MORPHOGENESIS
AB In this study, we examined the capacity of a biomimetic pullulan collagen hydrogel to create a functional biomaterial-based stem cell niche for the delivery of mesenchymal stem cells (MSCs) into wounds. Murine bone marrow-derived MSCs were seeded into hydrogels and compared to MSCs grown in standard culture conditions. Hydrogels induced MSC secretion of angiogenic cytokines and expression of transcription factors associated with maintenance of pluripotency and self-renewal (Oct4, Sox2, Klf4) when compared to MSCs grown in standard conditions. An excisonal wound healing model was used to compare the ability of MSC-hydrogel constructs versus MSC injection alone to accelerate wound healing. Injection of MSCs did not significantly improve time to wound closure. In contrast, wounds treated with MSC-seeded hydrogels showed significantly accelerated healing and a return of skin appendages. Bioluminescence imaging and FACS analysis of luciferase+/GFP+ MSCs indicated that stem cells delivered within the hydrogel remained viable longer and demonstrated enhanced engraftment efficiency than those delivered via injection. Engrafted MSCs were found to differentiate into fibroblasts, pericytes and endothelial cells but did not contribute to the epidermis. Wounds treated with MSC-seeded hydrogels demonstrated significantly enhanced angiogenesis, which was associated with increased levels of VEGF and other angiogenic cytokines within the wounds. Our data suggest that biomimetic hydrogels provide a functional niche capable of augmenting MSC regenerative potential and enhancing wound healing. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Rustad, Kristine C.; Wong, Victor W.; Sorkin, Michael; Glotzbach, Jason P.; Major, Melanie R.; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA.
   [Rajadas, Jayakumar] Biomat & Adv Drug Delivery Serv Ctr, Stanford, CA USA.
RP Gurtner, GC (reprint author), Stanford Univ, Dept Surg, 257 Campus Dr,GK 201, Stanford, CA 94305 USA.
EM ggurtner@stanford.edu
OI Glotzbach, Jason/0000-0002-8002-9422
FU Armed Forces Institute of Regenerative Medicine DOD [W81XWH-08-2-0032];
   Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation
FX This work was supported by a grant to GCG and MTL from the Armed Forces
   Institute of Regenerative Medicine DOD #W81XWH-08-2-0032, the Hagey
   Laboratory for Pediatric Regenerative Medicine and the Oak Foundation.
   We gratefully acknowledge Mrs. Yujin Park for histologic processing, and
   Mr. Dean Nehama and Ms. Jessica Trang of the Stanford BioADD Center for
   assistance with hydrogel preparation.
CR Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337
   Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260
   Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003
   Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318
   Chang EI, 2009, FASEB J, V23, P906, DOI 10.1096/fj.08-114868
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Deng WM, 2005, TISSUE ENG, V11, P110, DOI 10.1089/ten.2005.11.110
   Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hamou C, 2009, PLAST RECONSTR SURG, V123, p45S, DOI 10.1097/PRS.0b013e318191be4a
   Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009
   Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045
   Kataoka K, 2003, AM J PATHOL, V163, P1227, DOI 10.1016/S0002-9440(10)63482-7
   Kuroda K, 2004, J CUTAN PATHOL, V31, P241, DOI 10.1111/j.0303-6987.2003.00166.x
   Kutschka I, 2006, CIRCULATION, V114, P1167
   Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Liu P, 2008, ARTIF ORGANS, V32, P925, DOI 10.1111/j.1525-1594.2008.00654.x
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400
   Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200
   Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104
   Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581
   Satoh H, 2004, CELL TRANSPLANT, V13, P405, DOI 10.3727/000000004783983765
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   SUURONEN EJ, 2006, CIRCULATION, V114, P1138
   Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053
   Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64
   Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009
   Wang CM, 2008, ANAL BIOCHEM, V380, P333, DOI 10.1016/j.ab.2008.06.005
   Wong VW, 2011, TISSUE ENG PT A, V17, P631, DOI [10.1089/ten.tea.2010.0298, 10.1089/ten.TEA.2010.0298]
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang HN, 2009, BIOMATERIALS, V30, P6374, DOI 10.1016/j.biomaterials.2009.07.062
NR 44
TC 139
Z9 146
U1 5
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 1
BP 80
EP 90
DI 10.1016/j.biomaterials.2011.09.041
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 853AX
UT WOS:000297399700009
PM 21963148
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Daly, KA
   Liu, S
   Agrawal, V
   Brown, BN
   Johnson, SA
   Medberry, CJ
   Badylak, SF
AF Daly, K. A.
   Liu, S.
   Agrawal, V.
   Brown, B. N.
   Johnson, S. A.
   Medberry, C. J.
   Badylak, S. F.
TI Damage associated molecular patterns within xenogeneic biologic
   scaffolds and their effects on host remodeling
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix; Immune response; Immunomodulation; Monocyte
ID MOBILITY GROUP BOX-1; EXTRACELLULAR-MATRIX SCAFFOLDS; SKELETAL-MUSCLE
   REGENERATION; SMALL-INTESTINAL SUBMUCOSA; TOLL-LIKE RECEPTORS;
   HIGH-MOBILITY-GROUP-BOX-1 PROTEIN; IN-VIVO; DEGRADATION-PRODUCTS;
   MACROPHAGE PHENOTYPE; IMMUNE-RESPONSE
AB The immune response is an important determinant of the downstream remodeling of xenogeneic biologic scaffolds in vivo. Pro-inflammatory responses have been correlated with encapsulation and a foreign body reaction, while anti-inflammatory reactions are associated with constructive remodeling. However, the bioactive and bioinductive molecules within the extracellular matrix (ECM) that induce this polarization are unclear, although it is likely that cellular remnants such as damage associated molecular patterns (DAMPs) retained within the scaffold may play a role. The present study investigated the immunomodulatory effects of common ECM scaffolds. Results showed that tissue source, decellularization method and chemical crosslinking modifications affect the presence of the well characterized DAMP - HMGB1. In addition, these factors were correlated with differences in cell proliferation, death, secretion of the chemokines CCL2 and CCL4, and up regulation of the pro-inflammatory signaling receptor toll-like receptor 4 (TLR4). Inhibition of HMGB1 with glycyrrhizin increased the pro-inflammatory response, increasing cell death and up regulating chemokine and TLR4 mRNA expression. The present study suggests the importance of HMGB1 and other DAMPS as bioinductive molecules within the ECM scaffold. Identification and evaluation of other ECM bioactive molecules will be an area of future interest for new biomaterial development. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Daly, K. A.; Badylak, S. F.] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Liu, S.; Medberry, C. J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Agrawal, V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Med Scientist Training Program, Pittsburgh, PA 15219 USA.
   [Brown, B. N.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NHLBI NIH HHS [F30 HL102990-03]
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Badylak SF, 2003, J BIOMED MATER RES B, V67B, P648, DOI 10.1002/jbm.b.10062
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Biswas SK, 2002, J INTERF CYTOK RES, V22, P527, DOI 10.1089/10799900252982007
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brennan EP, 2008, J TISSUE ENG REGEN M, V2, P491, DOI 10.1002/term.123
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chen HA, 2010, BIOMATERIALS, V31, P8172, DOI 10.1016/j.biomaterials.2010.07.056
   Choi J, 2011, TUMORI, V97, P196, DOI 10.1700/667.7783
   Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI [10.1089/ten.tea.2009.0089, 10.1089/ten.TEA.2009.0089]
   Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699
   De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429
   Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2008, J SURG RES
   Hoffmann KF, 2001, FASEB J, V15, P2545, DOI 10.1096/fj.01-0306fje
   Isoda K, 2008, ATHEROSCLEROSIS, V198, P307, DOI 10.1016/j.atherosclerosis.2007.10.035
   Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0
   Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161
   Konishi H, 2004, HUM REPROD, V19, P2156, DOI 10.1093/humrep/deh389
   Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939
   Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579
   Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009
   Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007
   Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje
   Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Sabbatucci M, 2011, IMMUNOBIOLOGY
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212
   Tarrab E., 2011, J SURG RES
   Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395
   Tiainen J, 2004, J BIOMED MATER RES B, V70B, P49, DOI 10.1002/jbm.b.30013
   Tiainen J, 2006, J MATER SCI-MATER M, V17, P1315, DOI 10.1007/s10856-006-0606-8
   Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457
   Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Wang SJ, 2010, DIS MODEL MECH, V3, P92, DOI 10.1242/dmm.003533
   Yahiaoui L, 2008, J PHYSIOL-LONDON, V586, P3991, DOI 10.1113/jphysiol.2008.152090
   Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180
   Zimmermann K, 2004, INFLAMMATION, V28, P221, DOI 10.1023/B:IFLA.0000049047.61014.e3
NR 57
TC 49
Z9 51
U1 2
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 1
BP 91
EP 101
DI 10.1016/j.biomaterials.2011.09.040
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 853AX
UT WOS:000297399700010
PM 21967802
DA 2018-10-19
ER

PT J
AU Feshitan, JA
   Vlachos, F
   Sirsi, SR
   Konofagou, EE
   Borden, MA
AF Feshitan, Jameel A.
   Vlachos, Fotis
   Sirsi, Shashank R.
   Konofagou, Elisa E.
   Borden, Mark A.
TI Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound
   surgery
SO BIOMATERIALS
LA English
DT Article
DE Blood-brain barrier opening; Lanthanide; DOTA; Phospholipid;
   Perfluorobutane; Cavitation
ID BLOOD-BRAIN-BARRIER; CONTRAST AGENTS; DRUG-DELIVERY; IN-VIVO; SIZE;
   CAVITATION; RELAXIVITY; CHEMISTRY; ABLATION; LENGTH
AB We have synthesized a biomaterial consisting of Gd(III) ions chelated to lipid-coated, size-selected microbubbles for utility in both magnetic resonance and ultrasound imaging. The macrocyclic ligand DOTA-NHS was bound to PE headgroups on the lipid shell of pre-synthesized microbubbles. Gd(III) was then chelated to DOTA on the microbubble shell. The reaction temperature was optimized to increase the rate of Gd(111) chelation while maintaining microbubble stability. ICP-OES analysis of the microbubbles determined a surface density of 7.5 x 10(5) 3.0 x 10(5) Gd(III)/mu m(2) after chelation at 50 degrees C. The Gd(III)-bound microbubbles were found to be echogenic in vivo during high-frequency ultrasound imaging of the mouse kidney. The Gd(III)-bound microbubbles also were characterized by magnetic resonance imaging (MRI) at 9.4 T by a spin-echo technique and, surprisingly, both the longitudinal and transverse proton relaxation rates were found to be roughly equal to that of no-Gd(III) control microbubbles and saline. However, the relaxation rates increased significantly, and in a dose-dependent manner, after sonication was used to fragment the Gd(III)-bound microbubbles into non-gas-containing lipid bilayer remnants. The longitudinal (r(1)) and transverse (r(2)) molar relaxivities were 4.0 +/- 0.4 and 120 +/- 18 mM(-1)s(-1), respectively, based on Gd(III) content. The Gd(III)-bound microbubbles may find application in the measurement of cavitation events during MRI-guided focused ultrasound therapy and to track the biodistribution of shell remnants. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Feshitan, Jameel A.; Sirsi, Shashank R.; Borden, Mark A.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   [Feshitan, Jameel A.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   [Vlachos, Fotis; Konofagou, Elisa E.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
RP Borden, MA (reprint author), Univ Colorado, Dept Mech Engn, 1111 Engn Dr, Boulder, CO 80309 USA.
EM mark.borden@colorado.edu
FU NIH [R01EB009041]; University of Colorado
FX The authors would like to thank Huangjing Zhao, Edward Swanson and
   Alissa Park at Columbia University for their help with the ICP-OES
   sample characterization, as well as Kelly Ambler of the University of
   Colorado and Nuno Sacadura of Visualsonics for help with the ultrasound
   imaging. This work was funded by NIH R01EB009041 and the University of
   Colorado.
CR Aime S, 2005, ADV INORG CHEM, V57, P173, DOI 10.1016/S0898-8838(05)57004-1
   Ao M, 2010, J BIOMED MATER RES B, V93B, P551, DOI 10.1002/jbm.b.31614
   BERNS DH, 1991, J COMPUT ASSIST TOMO, V15, P233, DOI 10.1097/00004728-199103000-00008
   Bloch SH, 2004, APPL PHYS LETT, V84, P631, DOI 10.1063/1.1643544
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   CEVC G, 1985, BIOPHYS J, V47, P21, DOI 10.1016/S0006-3495(85)83872-8
   Chen CC, 2011, BIOMATERIALS, V32, P6579, DOI 10.1016/j.biomaterials.2011.05.027
   Chen CC, 2010, LANGMUIR, V26, P13183, DOI 10.1021/la101796p
   Cheung JS, 2009, NEUROIMAGE, V46, P658, DOI 10.1016/j.neuroimage.2009.02.037
   Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018
   CHOI JJ, IEEE T BIOMED ENG, V57, P145
   CHOW AM, MAGNET RESON MED, V63, P224
   CLINE HE, 1992, J COMPUT ASSIST TOMO, V16, P956, DOI 10.1097/00004728-199211000-00024
   De Leon-Rodriguez LM, 2008, BIOCONJUGATE CHEM, V19, P391, DOI 10.1021/bc700328s
   Duncan PB, 2004, LANGMUIR, V20, P2567, DOI 10.1021/la034930i
   Farny CH, 2009, ULTRASOUND MED BIOL, V35, P603, DOI 10.1016/j.ultrasmedbio.2008.09.025
   Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852
   Ferrara KW, 2009, ACCOUNTS CHEM RES, V42, P881, DOI 10.1021/ar8002442
   Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066
   GHAGHADA KB, 2009, PLOS ONE, P4
   Ghaghada K, 2008, ACAD RADIOL, V15, P1259, DOI 10.1016/j.acra.2008.04.018
   Hak S, 2009, EUR J PHARM BIOPHARM, V72, P397, DOI 10.1016/j.ejpb.2008.09.017
   Hermann P, 2008, DALTON T, P3027, DOI 10.1039/b719704g
   Hoff L, 2000, J ACOUST SOC AM, V107, P2272, DOI 10.1121/1.428557
   Hsieh CY, 2011, ULTRASOUND MED BIOL, V37, P1134, DOI 10.1016/j.ultrasmedbio.2011.04.011
   Huang JW, 2010, BIOMATERIALS, V31, P1278, DOI 10.1016/j.biomaterials.2009.11.008
   Hudson SBA, 2008, CLIN OBSTET GYNECOL, V51, P159, DOI 10.1097/GRF.0b013e318161e91f
   HYNYNEN K, 1993, MED PHYS, V20, P107, DOI 10.1118/1.597093
   Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Jolesz FA, 2008, J MAGN RESON IMAGING, V27, P391, DOI 10.1002/jmri.21261
   Jolesz FA, 2009, ANNU REV MED, V60, P417, DOI 10.1146/annurev.med.60.041707.170303
   Kamaly N, 2010, ORG BIOMOL CHEM, V8, P201, DOI 10.1039/b910561a
   Kaneko Y, 2005, EUR RADIOL, V15, P1415, DOI 10.1007/s00330-005-2663-7
   Kim DH, 2003, LANGMUIR, V19, P8455, DOI 10.1021/la034779c
   Klibanov AL, 2005, BIOCONJUGATE CHEM, V16, P9, DOI 10.1021/bc049898y
   LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2
   Liu Z, 2011, BIOMATERIALS, V32, P6155, DOI 10.1016/j.biomaterials.2011.05.019
   Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2
   O'Reilly MA, 2010, IEEE T BIO-MED ENG, V57, P2286, DOI 10.1109/TBME.2010.2050483
   Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9
   Saad SMI, 2009, LANGMUIR, V25, P10907, DOI 10.1021/la901250z
   Sherry AD, 2009, J MAGN RESON IMAGING, V30, P1240, DOI 10.1002/jmri.21966
   Sirsi S, 2010, ULTRASOUND MED BIOL, V36, P935, DOI 10.1016/j.ultrasmedbio.2010.03.015
   Streeter JE, 2010, MOL IMAGING, V9, P87, DOI 10.2310/7290.2010.00005
   Terreno E, 2008, CHEM BIODIVERS, V5, P1901, DOI 10.1002/cbdv.200890178
   Toth E, 2002, TOP CURR CHEM, V221, P61
   Tran BC, 2003, IEEE T ULTRASON FERR, V50, P1296, DOI 10.1109/TUFFC.2003.1244746
   Tung YS, 2006, ULTRASOUND MED BIOL, V32, P1103, DOI 10.1016/j.ultrasmedbio.2006.04.005
   Tung YS, 2011, APPL PHYS LETT, P98
   Unger EC, 2004, ADV DRUG DELIVER REV, V56, P1291, DOI 10.1016/j.addr.2003.12.006
   Wong KK, 2004, MAGN RESON MED, V52, P445, DOI 10.1002/mrm.20181
   Yang F, 2008, PHYS MED BIOL, V53, P6129, DOI 10.1088/0031-9155/53/21/016
   Yang F, 2009, BIOMATERIALS, V30, P3882, DOI 10.1016/j.biomaterials.2009.03.051
   Yu TH, 2008, WORLD J UROL, V26, P631, DOI 10.1007/s00345-008-0290-z
NR 55
TC 36
Z9 38
U1 5
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2012
VL 33
IS 1
BP 247
EP 255
DI 10.1016/j.biomaterials.2011.09.026
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 853AX
UT WOS:000297399700025
PM 21993236
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, YL
   Lu, XY
   Liu, QQ
   Li, MC
   Yang, ZQ
   Ma, JG
AF Zhang, Ya-li
   Lu, Xiao-yun
   Liu, Qian-qian
   Li, Ming-chuan
   Yang, Zhi-qian
   Ma, Jian-gang
TI Production and characterization of
   poly(3-hydroxybutyrateco-3-hydroxyhexanoate)-poly(ethylene glycol)
   hybird copolymer with adjustable molecular weight
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE Biopolyester; Biodegradable; Molecular weight; Polyhydroxyalkanoates;
   Polyethylene glycol
ID MICROBIAL POLYHYDROXYALKANOATES; POLY(ETHYLENE GLYCOL); BACTERIAL
   POLYHYDROXYALKANOATES; CHAIN-LENGTH;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); BIOCOMPATIBILITY;
   BIODEGRADATION; POLY(BETA-HYDROXYBUTYRATE); PROLIFERATION; NANOCARRIERS
AB A novel natural-synthetic hybrid block copolymer was synthesized by Aeromonas hydrophila 4AK4 in poly(ethylene glycol) (PEG, M (n) = 200) modified fermentation. This hybrid biomaterial consists of the natural hydrophobic polymer poly(3-hydroxybutyrat-co-3-hydroxyhexanoate) (PHBHHx) end-capped with hydrophilic PEG, which has the increased flexibility as well as the improved thermal stability. Addition of diethylene glycol (DEG) and ethylene glycol could not result in the accumulation of hybrid block copolymer. DEG and ethylene glycol, together with PEG-200, could cause a reduction of molar mass of PHBHHx, resulting in a series of low molecular weight polymer and the reduction of the polymer yield as well as the cellular productivity. In vitro degradation of PHBHHx and PHBHHx-PEG with different molecular weight showed that the decrease of molecular weight accelerated the degradation of copolymers, but PEG modification has little effect on its degradation rate. The results in this study provided a convenient and direct method to produce a series of PHBHHx and PHBHHx-PEG materials with adjustable molecular weight and broad molecular weight distribution which will be very useful for the biomedical applications.
C1 [Zhang, Ya-li; Lu, Xiao-yun; Liu, Qian-qian; Li, Ming-chuan; Yang, Zhi-qian; Ma, Jian-gang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Dept Biol Sci & Bioengn,Minist Educ, Xian 710049, Peoples R China.
RP Lu, XY (reprint author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Dept Biol Sci & Bioengn,Minist Educ, Xian 710049, Peoples R China.
EM luxy05@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [30801059]; Ministry of
   Education of China [200806981053]
FX This work was financially supported by the National Natural Science
   Foundation of China (No. 30801059) and Doctoral Fund of Ministry of
   Education of China (No. 200806981053).
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Ashby RD, 2002, APPL MICROBIOL BIOT, V60, P154, DOI 10.1007/s00253-002-1110-9
   Ashby RD, 1997, TETRAHEDRON, V53, P15209, DOI 10.1016/S0040-4020(97)00958-7
   Ashby RD, 1999, BIOTECHNOL BIOENG, V62, P106, DOI 10.1002/(SICI)1097-0290(19990105)62:1<106::AID-BIT12>3.0.CO;2-X
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   FERNANDEZCASTILLO R, 1986, APPL ENVIRON MICROB, V51, P214
   Foster LJR, 2005, POLYMER, V46, P6587, DOI 10.1016/j.polymer.2005.05.012
   Gan DJ, 2004, EUR POLYM J, V40, P2481, DOI 10.1016/j.eurpolymj.2004.07.006
   Huynh NT, 2010, NANOMEDICINE-UK, V5, P1415, DOI 10.2217/NNM.10.113
   Kato M, 1996, APPL MICROBIOL BIOT, V45, P363, DOI 10.1007/s002530050697
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   RAMSAY JA, 1994, BIOTECHNOL TECH, V8, P589, DOI 10.1007/BF00152152
   Saha SP, 2006, J IND MICROBIOL BIOT, V33, P377, DOI 10.1007/s10295-006-0079-2
   Shan C, 2006, POLYM DEGRAD STABIL, V91, P3191, DOI 10.1016/j.polymdegradstab.2006.07.010
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Shell K.D., 1998, U.S. Patent, Patent No. [5,811,272, 5811272]
   Shi FY, 1996, MACROMOLECULES, V29, P7753, DOI 10.1021/ma960805k
   van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Xie WP, 2008, BIOCHEM ENG J, V38, P384, DOI 10.1016/j.bej.2007.08.002
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Yoshie N, 2001, MACROMOLECULES, V34, P8953, DOI 10.1021/ma0113071
   Zanzig J, 2003, J POLYM ENVIRON, V11, P145, DOI 10.1023/A:1026000330625
   Zhao K, 2002, J MATER SCI-MATER M, V13, P849, DOI 10.1023/A:1016596228316
NR 32
TC 1
Z9 2
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD JAN
PY 2012
VL 30
IS 1
BP 101
EP 111
DI 10.1007/s10118-012-1095-5
PG 11
WC Polymer Science
SC Polymer Science
GA 859GU
UT WOS:000297865700011
DA 2018-10-19
ER

PT J
AU Khan, F
   Dahman, Y
AF Khan, Faiz
   Dahman, Yaser
TI A Novel Approach for the Utilization of Biocellulose Nanofibres in
   Polyurethane Nanocomposites for Potential Applications in Bone Tissue
   Implants
SO DESIGNED MONOMERS AND POLYMERS
LA English
DT Review
DE Carbon nanotubes; carbon nanofibres; biocellulose nanofibres;
   polyurethane composites; bone implants
ID CARBON NANOTUBE/POLYMER NANOCOMPOSITES; BUTADIENE SOFT SEGMENTS; X-RAY
   INVESTIGATIONS; BACTERIAL CELLULOSE; MECHANICAL-PROPERTIES;
   HARD-SEGMENT; MICROBIAL CELLULOSE; BIOMEDICAL APPLICATIONS;
   ACETOBACTER-XYLINUM; THERMOPLASTIC POLYURETHANES
AB With the increasing number of surgical bone grafts per year, the application of biomaterials in tissue engineering has become a popular issue. In the present work, the potential of biocellulose-nanofibre-reinforced polyurethane nanocomposites to act as bone scaffold implants is established. Investigating properties of polyurethane shows that this widely applied biomaterial group cannot fulfil all properties required for bone implants in a stand-alone fashion. Bone implants require a high Young's modulus and tensile strength but low strain which makes it difficult to find a suitable polyurethane since higher hard segment content will reduce tensile strength and lower hard segment content will reduce the Young's modulus. Other factors such as biodegradation also become important. A literature review on carbon nanotube and nanofibre composites with polyurethanes shows that nanofibrous reinforcement leads to favourable implant properties. Young's modulus and tensile strength increase dramatically. Other properties such as thermal conductivity and viscosity are also affected. These types of nanofibrous materials, however, are the subject of an ongoing debate about toxicity and their use in bone implants is questionable. Biocellulose nanofibres formed from bacteria (also called bacterial cellulose (BC)) possess favourable mechanical properties and are highly biocompatible. A survey on works done on BC nanofibres and their composites show that nanostructured biocomposites that contains the nanofibres reinforced in polymer composites result in changes that are comparable to those of carbon nanotubes in regards to bone scaffold applications. Showing improvement on biocompatibility and mechanical properties, biocellulose nanofibre reinforcement on polyurethanes possesses strong potential for bone implants and other tissue-engineering applications. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Khan, Faiz; Dahman, Yaser] Ryerson Univ, Dept Chem Engn, Toronto, ON M5B 2K3, Canada.
RP Dahman, Y (reprint author), Ryerson Univ, Dept Chem Engn, Toronto, ON M5B 2K3, Canada.
EM ydahman@ryerson.ca
FU Agriculture and Agri-Food Canada through the Agricultural Bioproducts
   Innovation Network (ABIN)
FX This work was financially supported by Agriculture and Agri-Food Canada
   through the Agricultural Bioproducts Innovation Network (ABIN) in
   addition to Ryerson University in Toronto, Canada.
CR AGGARWAL SL, 1984, BLOCK POLYM
   ARNOLD RG, 1957, CHEM REV, V57, P47, DOI 10.1021/cr50013a002
   Bayer O., 1937, Ger. Pat. DRP, Patent No. [DE728981, 728981, DRP 728981]
   BECKER R, 1996, POLYM MAT ENCY, V9, P6940
   BENGTSON B, 1985, POLYMER, V26, P895, DOI 10.1016/0032-3861(85)90134-X
   BONART R, 1974, J MACROMOL SCI PHYS, VB  9, P447, DOI 10.1080/00222347408204548
   BONART R, 1969, J MACROMOL SCI PHYS, VB  3, P337, DOI 10.1080/00222346908205099
   Bonart R., 1968, J MACROMOL SCI PHY B, V2, P115
   BRUNETTE CM, 1981, POLYM ENG SCI, V21, P668, DOI 10.1002/pen.760211108
   Buist J. M., 1968, ADV POLYURETHANE TEC
   BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Chang AL, 1979, ACS ADV CHEM SER, V176, P31
   CHEN CHY, 1983, POLYMER, V24, P1333, DOI 10.1016/0032-3861(83)90069-1
   Chen TK, 1997, MACROMOLECULES, V30, P5068, DOI 10.1021/ma9618639
   Clough S. B., 1968, J MACROMOL SCI PHY B, V2, P553, DOI DOI 10.1080/00222346808212458
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Doyle E. N., 1971, DEV USE POLYURETHANE
   Erfle DJ, 1997, CARDIOVASC PATHOL, V6, P333, DOI 10.1016/S1054-8807(97)00031-8
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gindl W, 2004, COMPOS SCI TECHNOL, V64, P2407, DOI 10.1016/j.compscitech.2004.05.001
   Gogolewski S, 2007, J BIOMED MATER RES A, V80A, P94, DOI 10.1002/jbm.a.30834
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Gorna K, 2006, J BIOMED MATER RES A, V79A, P128, DOI 10.1002/jbm.a.30708
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Grunert M., 2000, POLYM MAT SCI ENG, V82, P232
   Heijkants RGJC, 2005, BIOMATERIALS, V26, P4219, DOI 10.1016/j.biomaterials.2004.11.005
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Higgins BA, 2005, EUR POLYM J, V41, P889, DOI 10.1016/j.eurpolymj.2004.11.040
   HOENICH N, 2006, BIORESOURCES, V2, P270
   HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796
   Hornback J. M., 2006, ORGANIC CHEM
   Hsieh YC, 2008, CELLULOSE, V15, P507, DOI 10.1007/s10570-008-9206-8
   Huang S. J., 1986, J BIOACT COMPAT POLY, V1, P61
   Hubbe M. A., 2008, BioResources, V3, P929
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishikawa Atsushi, 1995, Bioscience Biotechnology and Biochemistry, V59, P2259
   JELL G, 2008, J MATER CHEM, V18, P1821
   Jimenez GA, 2007, CARBON, V45, P2079, DOI 10.1016/j.carbon.2007.05.015
   Jimenez GA, 2009, POLYM ENG SCI, V49, P2020, DOI 10.1002/pen.21442
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kabir ME, 2007, MAT SCI ENG A-STRUCT, V459, P111, DOI 10.1016/j.msea.2007.01.031
   KANEYOSHI A, 2007, POLYURETHANE RELATED
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Khudyakov IV, 2009, DES MONOMERS POLYM, V12, P279, DOI 10.1163/156855509X448253
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   KOUTSKY JA, 1970, J POLYM SCI POL LETT, V8, P353, DOI 10.1002/pol.1970.110080508
   Kuan HC, 2005, COMPOS SCI TECHNOL, V65, P1703, DOI 10.1016/j.compscitech.2005.02.017
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   LEUNG LM, 1986, MACROMOLECULES, V19, P668
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Li ZQ, 2010, POLYM-PLAST TECHNOL, V49, P141, DOI 10.1080/03602550903284198
   Li ZM, 2007, POLYM-PLAST TECHNOL, V46, P129, DOI 10.1080/036025506011152929
   Luo ZP, 2008, MATER LETT, V62, P3493, DOI 10.1016/j.matlet.2008.03.010
   LYMAN DJ, 1966, REV MACROMOL CHEM, V1, P191
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   MAIKO M, 2010, DESIGNED MONOMERS PO, V13, P387
   Martins IMG, 2009, COMPOS SCI TECHNOL, V69, P2163, DOI 10.1016/j.compscitech.2009.05.012
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   MASAOKA S, 1993, J FERMENT BIOENG, V75, P18, DOI 10.1016/0922-338X(93)90171-4
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   Min CY, 2010, POLYM-PLAST TECHNOL, V49, P1172, DOI 10.1080/03602559.2010.496405
   MOSEKILDE L, 1985, BONE, V6, P291, DOI 10.1016/8756-3282(85)90317-5
   Orts WJ, 2005, J POLYM ENVIRON, V13, P301, DOI 10.1007/s10924-005-5514-3
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   OZAKI S, 1972, CHEM REV, V72, P457, DOI 10.1021/cr60279a002
   Park TJ, 2008, CARBON MATER-CHEM PH, V1, P283
   Phillips R E, 1988, J Biomater Appl, V3, P207, DOI 10.1177/088532828800300204
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500
   Ratner BD, 2004, BIOMATERIALS SCI INT
   RUSTAD NE, 1974, J APPL POLYM SCI, V18, P401, DOI 10.1002/app.1974.070180208
   Sanchez-Adsuar MS, 1998, J ADHESION, V67, P327, DOI 10.1080/00218469808011115
   Sanchez-Garcia MD, 2008, CARBOHYD POLYM, V71, P235, DOI 10.1016/j.carbpol.2007.05.041
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Santerre JP, 1995, ACS SYM SER, V602, P352
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SAUNDERS JH, 1948, CHEM REV, V43, P203, DOI 10.1021/cr60135a001
   SCHNEIDER NS, 1977, POLYM ENG SCI, V17, P73, DOI 10.1002/pen.760170203
   SCHNEIDER NS, 1975, J MACROMOL SCI PHYS, VB 11, P527, DOI 10.1080/00222347508219422
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   Sen R, 2004, NANO LETT, V4, P459, DOI 10.1021/nl035135s
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Silva AL, 2004, CATAL REV, V46, P31, DOI 10.1081/CR-120027049
   Silva EE, 2009, NANO RES, V2, P462, DOI [10.1007/s12274-009-9042-7, DOI 10.1007/S12274-009-9042-7]
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   Song YM, 1996, J APPL POLYM SCI, V62, P827, DOI 10.1002/(SICI)1097-4628(19961031)62:5<827::AID-APP15>3.3.CO;2-M
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Sudhakar H, 2010, DES MONOMERS POLYM, V13, P287, DOI 10.1163/138577210X12634700595095
   Surma-Slusarska B, 2008, FIBRES TEXT EAST EUR, V16, P108
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   SYTURCOVA A, 2005, BIOMACROMOLECULES, V6, P1055
   TASHIRO K, 1985, POLYM BULL, V14, P213
   Thoma R J, 1987, J Biomater Appl, V1, P449
   Tran PA, 2009, ADV DRUG DELIVER REV, V61, P1097, DOI 10.1016/j.addr.2009.07.010
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   VRATSANOS MS, 1996, POLYM MAT ENCY, V9, P6947
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Xia HS, 2005, SOFT MATTER, V1, P386, DOI 10.1039/b509038e
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zanetta M, 2009, ACTA BIOMATER, V5, P1126, DOI 10.1016/j.actbio.2008.12.003
   ZAWADZAK E, 2009, BIOMED MATER, V4, P1
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   ZDRAHALA RJ, 1979, J APPL POLYM SCI, V24, P2041, DOI 10.1002/app.1979.070240912
NR 113
TC 32
Z9 32
U1 0
U2 82
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1385-772X
J9 DES MONOMERS POLYM
JI Des. Monomers Polym.
PY 2012
VL 15
IS 1
BP 1
EP 29
DI 10.1163/156855511X606119
PG 29
WC Polymer Science
SC Polymer Science
GA 858NP
UT WOS:000297806800001
OA Bronze
DA 2018-10-19
ER

PT J
AU Martin-Lopez, E
   Alonso, FR
   Nieto-Diaz, M
   Nieto-Sampedro, M
AF Martin-Lopez, Eduardo
   Rubio Alonso, Fausto
   Nieto-Diaz, Manuel
   Nieto-Sampedro, Manuel
TI Chitosan, Gelatin and Poly(L-Lysine) Polyelectrolyte-Based Scaffolds and
   Films for Neural Tissue Engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Polyelectrolytes; porosity; composite films; neural cells; neurite
   extension; nerve repair
ID NERVE-CELL AFFINITY; POLY-L-LYSINE; IN-VITRO; SURFACE MODIFICATION;
   HIPPOCAMPAL-NEURONS; OLFACTORY-BULB; SPINAL-CORD; REGENERATION; CULTURE;
   COMPLEXES
AB Biomaterial implants are a promising strategy to replace neural tissue that is lost after traumatic nerve damage. Chitosan (Ch) is a suitable material for nerve implantation when it is used at a minimum amount of 2% (w/v). The goal of this study was to determine the best mixture of 2% Ch with gelatin (G) and poly(L-lysine) (PLL) for use in neural tissue engineering. Using different physicochemical approaches we showed that all mixtures formed polyelectrolyte complexes with distinct electrostatic interactions between their compounds. This gave rise to different gel morphologies, among which Ch + G exhibited a significantly smaller pore size, unlike Ch + G + PLL. However, thermal resistance to degradation and the wettability of the Ch-based films were not affected. Additionally, these differences affected glial cells growth in long-term (14 days) cultures performed on Ch-based films. Astrocytes and olfactory ensheathing cells proliferated on G and Ch + G films which induced both flattened and spindle cell morphologies. Meanwhile, cortical and hippocampal neurons were similarly viable in all studied films and significantly lower than those observed in controls. Lastly, neurites from dorsal root ganglia extended the most on Ch + G films. These results show that a Ch + G mixture is a promising candidate for use in neural tissue engineering. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Martin-Lopez, Eduardo; Nieto-Sampedro, Manuel] CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, E-28002 Madrid, Spain.
   [Rubio Alonso, Fausto] CSIC, Dept Chem Phys Surfaces & Proc, Ceram & Glass Inst, E-28002 Madrid, Spain.
   [Nieto-Diaz, Manuel; Nieto-Sampedro, Manuel] Hosp Nacl Paraplej SESCAM, Expt Neurol Unit, Toledo, Spain.
RP Nieto-Sampedro, M (reprint author), CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, Ave Doctor Arce 37, E-28002 Madrid, Spain.
EM mns@cajal.csic.es
RI Rubio Alonso, Fausto/B-2267-2008; Nieto-Diaz, Manuel/R-5163-2017
OI Rubio Alonso, Fausto/0000-0001-8230-1357; 
FU Spanish Ministry of Education and Science [SAF 2006-11224]; Community of
   Madrid; Hospital Nacional de Paraplejicos de Toledo Foundation for
   Integration and Research (FUHNPAIIN, SESCAM)
FX This research was funded by grant SAF 2006-11224 from Spanish Ministry
   of Education and Science. E. M.-L. was supported by a doctoral
   fellowship from the Community of Madrid and the Hospital Nacional de
   Paraplejicos de Toledo Foundation for Integration and Research
   (FUHNPAIIN, SESCAM). We thank Marta Navarrete for helpful comments on
   the manuscript and Ashley Venzel for editorial assistance.
CR ANTHONSEN MW, 1993, CARBOHYD POLYM, V22, P193, DOI 10.1016/0144-8617(93)90140-Y
   ASSOULINE JG, 1989, DEV BRAIN RES, V45, P1, DOI 10.1016/0165-3806(89)90002-3
   bdel-Fattah W.I., 2007, ACTA BIOMATER, V3, P503
   BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CAEL JJ, 1974, CARBOHYD RES, V32, P79, DOI 10.1016/S0008-6215(00)82465-9
   Cheng MY, 2004, J BIOMATER APPL, V19, P59, DOI 10.1177/0885328204043450
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Fan WM, 2008, MICROSURG, V28, P238, DOI 10.1002/micr.20488
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   GudinoCabrera G, 1996, RESTOR NEUROL NEUROS, V10, P25, DOI 10.3233/RNN-1996-10104
   He QR, 2009, J MATER SCI-MATER M, V20, P1457, DOI 10.1007/s10856-009-3702-8
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Johnson R.E., 1969, SURF COLLOID SCI, V2, P85
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Majling J, 1995, J POROUS MAT, V1, P91, DOI 10.1007/BF00486528
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Martin-Lopez E, 2010, J BIOMATER IN PRESS
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   MOSKOWITZ PF, 1993, J NEUROSCI RES, V34, P129, DOI 10.1002/jnr.490340113
   Nieto-Sampedro M, 2003, NEUROCHEM RES, V28, P1659, DOI 10.1023/A:1026056921037
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pfister LA, 2007, J BIOMED MATER RES A, V80A, P932, DOI 10.1002/jbm.a.31052
   PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X
   RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099
   Rege PR, 2003, INT J PHARM, V252, P41, DOI 10.1016/S0378-5173(02)00604-X
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   SIEGEL SM, 1966, PLANT PHYSIOL, V41, P1429, DOI 10.1104/pp.41.9.1429
   STONE AL, 1977, BIOCHIM BIOPHYS ACTA, V497, P298, DOI 10.1016/0304-4165(77)90163-5
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Taylor J S, 2001, Prog Brain Res, V132, P641
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   YAVIN Z, 1980, DEV BIOL, V75, P454, DOI 10.1016/0012-1606(80)90176-1
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 53
TC 7
Z9 7
U1 0
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 1-4
BP 207
EP 232
DI 10.1163/092050610X546426
PG 26
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 858OI
UT WOS:000297809800012
PM 21192838
DA 2018-10-19
ER

PT J
AU Yeh, HY
   Lin, JC
AF Yeh, Hsi-Yi
   Lin, Jui-Che
TI Surface Phosphorylation for Polyelectrolyte Complex of Chitosan and Its
   Sulfonated Derivative: Surface Analysis, Blood Compatibility and Adipose
   Derived Stem Cell Contact Properties
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Chitosan; phosphorylation; sulfonation; polyelectrolyte; blood
   compatibility; adipose-derived stem cell
ID CALCIUM-PHOSPHATE CEMENTS; IN-VITRO; PLATELET COMPATIBILITY; SCAFFOLDS;
   DEACETYLATION; HYDROGEL; BIOMATERIAL; RESPONSES; RABBITS; CHITIN
AB Many studies have tried to look for the application of chitosan in tissue engineering since its structure is similar to glycoaminoglycans, the main components of the extracellular matrix. Previous studies had indicated that the incorporation of sulfonic or phosphonic functionalities would be beneficial to the growth of certain cells. However, no study has explored the effect of incorporation of both above-mentioned anionic functionalities onto the chitosan structure. In this study, we have surface-phosphorylated the polyelectrolyte film formed by chitosan and water-soluble sulfonated chitosan with the aim to incorporate phosphonic and sulfonic functionalities onto the film surface. Surface analyses by ESCA and ATR-FT-IR have shown that these two functional groups have been successfully grafted onto the surface, and that the ratio of P/S was dependent upon the weight ratio of phosphorylation agents added. Blood compatibility evaluation indicated that phosphorylated polyelectrolyte complexes extended the plasma recalcification time as compared to non-treated chitosan and direct-phosphorylated chitosan film. In addition, these phosphorylated polyelectrolyte complexes showed similar or slightly less platelet reactivity than the non-phosphorylated counterpart. In contrast, significant platelet activation and adhesion were noted on the direct-phosphorylated chitosan. This implicated the incorporation of sulfonic acid onto the phosphorylated surface can increase the platelet compatibility. An adipose-derived stem cell incubation study has demonstrated that the incorporation of both phosphonic and sulfonic acid functionalities onto the chitosan surface can enhance the stem cell growth. Therefore, the phosphorylated polyelectrolyte complexes were not only blood compatible but also stem cell compatible, and could be a novel biomaterial in tissue-engineering applications. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Yeh, Hsi-Yi; Lin, Jui-Che] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan.
EM jclin@mail.ncku.edu.tw
RI Lin, Jui-Che/C-8230-2012
OI Lin, Jui-Che/0000-0003-4436-655X
FU National Science Council, Taiwan [NSC 94-2213-E-006-088, NSC
   95-2221-E-006-018-MY3]
FX The financial support from the National Science Council, Taiwan, under
   grant NSC 94-2213-E-006-088 and NSC 95-2221-E-006-018-MY3 is greatly
   appreciated. We also appreciate the assistance of Dr. T.-M. Lee and Dr.
   Y.-C. Wu (Institute of Oral Medicine, College of Medicine, National
   Cheng Kung University, Taiwan) in cell-related experiments. We are
   thankful for the gift of adipose derived stem cells from Dr. Sheng-Che
   Lin (Department of Plastic Surgery, National Cheng Kung University
   Hospital, Taiwan) and the supply of platelets and plasma by the Tainan
   Blood Donation Center.
CR Amaral F, 2005, J BIOMAT SCI-POLYM E, V16, P1575
   Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897
   Cerrai P, 1996, MACROMOL CHEM PHYSIC, V197, P3567, DOI 10.1002/macp.1996.021971107
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chesnutt BM, 2007, J BIOMED MATER RES A, V82A, P343, DOI 10.1002/jbm.a.31070
   GIROUX TA, 1991, J APPL POLYM SCI, V43, P145, DOI 10.1002/app.1991.070430112
   Gong ZC, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055005
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Janvikul W, 2006, J APPL POLYM SCI, V102, P445, DOI 10.1002/app.24192
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Klokkevold PR, 1999, J ORAL MAXIL SURG, V57, P49, DOI 10.1016/S0278-2391(99)90632-8
   Li QL, 2007, J BIOMED MATER RES B, V82B, P481, DOI 10.1002/jbm.b.30753
   Lin CW, 2001, J BIOMAT SCI-POLYM E, V12, P543, DOI 10.1163/156856201300194270
   Liu TY, 2010, ACTA BIOMATER, V6, P1423, DOI 10.1016/j.actbio.2009.10.010
   Liu ZH, 2007, J BIOMED MATER RES A, V83A, P1110, DOI 10.1002/jbm.a.31453
   Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307
   Marti EM, 2004, LANGMUIR, V20, P10223, DOI 10.1021/la048952w
   Mori T, 1998, J BIOMED MATER RES, V43, P469
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Qu ZW, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065001
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Rubenstein DA, 2010, J BIOMAT SCI-POLYM E, V21, P1713, DOI 10.1163/092050609X12559317149363
   Sagnella S, 2005, COLLOID SURFACE B, V42, P147, DOI 10.1016/j.colsurfb.2004.07.001
   Sarukawa J, 2011, J BIOMAT SCI-POLYM E, V22, P717, DOI 10.1163/092050610X491067
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Suphasiriroj W, 2009, J MATER SCI-MATER M, V20, P309, DOI 10.1007/s10856-008-3575-2
   Tai BCU, 2010, BIOMATERIALS, V31, P48, DOI 10.1016/j.biomaterials.2009.09.022
   Tigli RS, 2007, J MATER SCI-MATER M, V18, P1665, DOI [10.1007/s10856-007-3066, 10.1007/s10856-007-3066-x]
   Vongchan P, 2002, CARBOHYD RES, V337, P1239, DOI 10.1016/S0008-6215(02)00098-8
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yeh HY, 2008, J BIOMAT SCI-POLYM E, V19, P291, DOI 10.1163/156856208783720985
   Yin LC, 2007, BIOMATERIALS, V28, P1258, DOI 10.1016/j.biomaterials.2006.11.008
   Zhang KH, 2011, J BIOMAT SCI-POLYM E, V22, P1069, DOI 10.1163/092050610X498204
   Zhu AP, 2009, ACTA BIOMATER, V5, P2033, DOI 10.1016/j.actbio.2009.02.016
NR 37
TC 6
Z9 6
U1 0
U2 18
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 1-4
BP 233
EP 250
DI 10.1163/092050610X547001
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 858OI
UT WOS:000297809800013
PM 21244720
DA 2018-10-19
ER

PT J
AU Banerjee, I
   Mishra, D
   Das, T
   Maiti, S
   Maiti, TK
AF Banerjee, Indranil
   Mishra, Debasish
   Das, Tamal
   Maiti, Swatilekha
   Maiti, Tapas K.
TI Caprine (Goat) Collagen: A Potential Biomaterial for Skin Tissue
   Engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Collagen; goat; wound healing; cell adhesion; traction force microscopy
ID ACID-SOLUBLE COLLAGEN; TRACTION FORCE; CELL; CYTOCOMPATIBILITY;
   IMMUNOGENICITY; IMPLANTATION; SUBSTITUTES; PROTEINS; ADHESION; GELATIN
AB Collagens presently used in tissue engineering are primarily of bovine or porcine origin. However, a risk of a spongiform encephalopathy epidemic has limited the use of collagen from these sources. Keeping the aforementioned perspective in mind, we explored the possibility of using domestic goat available in the subcontinent as a potential source of collagen for tissue-engineering application. This article delineates the isolation, physico-chemical characterization, biocompatibility study and wound healing application of acid soluble caprine (goat) tendon collagen (GTC). Physico-chemical characterization of 1% acetic acid extracted GTC was done by SDS-PAGE, amino-acid composition analysis, FT-IR and CD spectroscopy. Results revealed that GTC was comprised of type-I collagen. Biocompatibility study showed that GTC augmented cell adhesion, cell cycle progression and proliferation. Immuno-cytochemical analysis in conjugation with traction force microscopy further confirmed a superior focal adhesion complex mediated cell-substrate interaction in GTC. Finally, in vivo study in mice model revealed that GTC has low immunogenicity and it augments healing process significantly. Throughout the study, calf skin collagen (CSC) was used as standard for comparative evaluation. In conclusion, it can be said that GTC may find its application as biomaterial in skin tissue engineering. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Banerjee, Indranil; Mishra, Debasish; Das, Tamal; Maiti, Swatilekha; Maiti, Tapas K.] Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India.
RP Maiti, TK (reprint author), Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India.
EM tkmaiti@hijli.iitkgp.ernet.in
OI Mishra, Debasish/0000-0002-1222-4656; Banerjee,
   Indranil/0000-0003-3634-8765
FU Department of Biotechnology, Government of India; Department of Science
   and Technology
FX The work was funded by Department of Biotechnology, Government of India.
   Authors would like to thank Department of Science and Technology for
   providing fund for Improvement of S&T Infrastructure in Higher
   Educational Institutions (FIST) which was utilized to develop confocal
   microscopy facility.
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Arnesen JA, 2007, BIORESOURCE TECHNOL, V98, P53, DOI 10.1016/j.biortech.2005.11.021
   Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Baez J, 2005, APPL MICROBIOL BIOT, V69, P245, DOI 10.1007/s00253-005-0180-x
   Banerjee I, 2009, INT J BIOMATER, DOI 10.1155/2009/143659
   Brown EM, 2000, J PROTEIN CHEM, V19, P85, DOI 10.1023/A:1007074314686
   Bulleid NJ, 2000, BIOCHEM SOC T, V28, P350, DOI 10.1042/0300-5127:0280350
   Dafforn TR, 2004, BIOPHYS J, V86, P404, DOI 10.1016/S0006-3495(04)74116-8
   Das T, 2008, LAB CHIP, V8, P1308, DOI 10.1039/b803925a
   Deyl Z, 2003, J CHROMATOGR B, V790, P245, DOI 10.1016/S1570-0232(03)00158-2
   Garcia JL, 2010, MOLECULES, V15, P2845, DOI 10.3390/molecules15042845
   Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   ILIAN C, 2008, PEDIATR RES, V63, P492
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kumar KVSS, 2002, J BIOMED MATER RES, V61, P197, DOI 10.1002/jbm.10016
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Manuelidis L, 2009, J CELL BIOCHEM, V106, P220, DOI 10.1002/jcb.21988
   MCCLAIN PE, 1970, INT J BIOCHEM, V2, P167
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai N, 2008, J BIOMATER APPL, V23, P275, DOI 10.1177/0885328208092109
   Nagai N, 2008, J BIOMED MATER RES B, V87B, P432, DOI 10.1002/jbm.b.31121
   Nagai T, 2000, FOOD CHEM, V70, P205, DOI 10.1016/S0308-8146(00)00081-9
   Orge L, 2004, J GEN VIROL, V85, P3487, DOI 10.1099/vir.0.80246-0
   Ozawa T., 1970, J THERM ANAL, V3, P301, DOI DOI 10.1007/BF01911411
   PALSON BQ, 2003, TISSUE ENG
   Pandiyan G D V, 2005, J Vet Sci, V6, P273
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877
   Pati F, 2010, BIORESOURCE TECHNOL, V101, P3737, DOI 10.1016/j.biortech.2009.12.133
   PENKOVA RK, 1999, BIOPHYS CHEM, V83, P185
   Powell HM, 2007, BIOMATERIALS, V28, P1084, DOI 10.1016/j.biomaterials.2006.10.011
   Rousseau CF, 2002, BIOMATERIALS, V23, P1503, DOI 10.1016/S0142-9612(01)00276-9
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   SPIRO RC, 2002, EURO CELLS MAT, V4, P16
   Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009031
   Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wu KJ, 2004, ARCH ORAL BIOL, V49, P305, DOI 10.1016/j.archoralbio.2003.10.002
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang C, 2009, J AGR FOOD CHEM, V57, P880, DOI 10.1021/jf8026205
   Zhang JJ, 2009, FOOD CHEM, V116, P318, DOI 10.1016/j.foodchem.2009.02.053
NR 52
TC 13
Z9 13
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 1-4
BP 355
EP 373
DI 10.1163/092050610X551943
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 858OI
UT WOS:000297809800020
PM 21294966
DA 2018-10-19
ER

PT J
AU Osaki, S
   Chen, M
   Zamora, PO
AF Osaki, Shigemasa (Gem)
   Chen, Meng
   Zamora, Paul O.
TI Controlled Drug Release through a Plasma Polymerized
   Tetramethylcyclo-tetrasiloxane Coating Barrier
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Plasma polymerization; drug release; coating barrier thickness; atomic
   force microscopy (AFM); stainless steel; cytotoxicity;
   thrombo-resistance; biocompatibility
ID CANCER-CELLS; IN-VITRO; DELIVERY; MICROSPHERES; LIPOSOMES; HYDROGELS;
   DESIGN; STENTS; RATES; FILMS
AB A plasma polymerized tetramethylcyclo-tetrasiloxane (TMCTS) coating was deposited onto a metallic biomaterial, 316 stainless steel, to control the release rate of drugs, including daunomycin, rapamycin and NPC-15199 (N-(9-fluorenylmethoxy-carbonyl)-leucine), from the substrate surface. The plasma-state polymerized TMCTS thin film was deposited in a vacuum plasma reactor operated at a radio-frequency of 13.56 MHz, and was highly adhesive to the stainless steel, providing a smooth and hard coating layer for drugs coated on the substrate. To investigate the influence of plasma coating thickness on the drug diffusion profile, coatings were deposited at various time lengths from 20 s to 6 min, depending on the type of drug. Atomic force spectroscopy (AFM) was utilized to characterize coating thickness. Drug elution was measured using a spectrophotometer or high-performance liquid chromatography (HPLC) system. The experimental results indicate that plasma polymerized TMCTS can be used as an over-coating to control drug elution at the desired release rate. The drug-release rate was also found to be dependent on the molecular weight of the drug with plasma coating barrier on top of it. The in vitro cytotoxicity test result suggested that the TMCTS plasma coatings did not produce a cytotoxic response to mammalian cells. The non-cytotoxicity of TMCTS coating plus its high thrombo-resistance and biocompatibility are very beneficial to drug-eluting devices that contact blood. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Osaki, Shigemasa (Gem); Chen, Meng; Zamora, Paul O.] BioSurface Engn Technol BioSET Inc, Rockville, MD 20850 USA.
RP Chen, M (reprint author), ExcelCoat LLC, 30670 Ardmore Ct, Novi, MI 48377 USA.
EM mengchen2002slc@yahoo.com
CR Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   Boztas AO, 2009, BIOMACROMOLECULES, V10, P2135, DOI 10.1021/bm900299b
   Brazel CS, 1999, BIOMATERIALS, V20, P721, DOI 10.1016/S0142-9612(98)00215-4
   Chen M, 2003, J APPL POLYM SCI, V89, P1875, DOI 10.1002/app.12490
   Chouhan Raje, 2009, Journal of Nanobiotechnology, V7, P5, DOI 10.1186/1477-3155-7-5
   David A, 2004, EUR J CANCER, V40, P148, DOI 10.1016/j.ejca.2003.07.001
   Greco F, 2009, ADV DRUG DELIVER REV, V61, P1203, DOI 10.1016/j.addr.2009.05.006
   Hariharan M, 2002, J MICROENCAPSUL, V19, P95, DOI 10.1080/02652040110081398
   Hu C.Z., 1995, Hydrocyclosiloxane membrane prepared by plasma polymerization process, Patent No. [USP 5463010, 5463010]
   Jia YM, 2008, INT J PHARM, V359, P254, DOI 10.1016/j.ijpharm.2008.03.035
   Kwok CS, 1999, J CONTROL RELEASE, V62, P301, DOI 10.1016/S0168-3659(99)00105-4
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   LEWIS KJ, 1995, J CONTROL RELEASE, V37, P173, DOI 10.1016/0168-3659(95)00100-M
   Li X, 2009, J BIOMED MATER RES B, V89B, P148, DOI 10.1002/jbm.b.31197
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004
   Mandal TK, 2001, EUR J PHARM BIOPHARM, V52, P91, DOI 10.1016/S0939-6411(01)00150-3
   Meyer JD, 1998, J PHARM SCI, V87, P1149, DOI 10.1021/js970419w
   Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008
   Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010
   Peptu C, 2008, J NANOSCI NANOTECHNO, V8, P2249, DOI 10.1166/jnn.2008.169
   Prior S, 2004, J ANTIMICROB CHEMOTH, V53, P981, DOI 10.1093/jac/dkh227
   Regar E, 2001, BRIT MED BULL, V59, P227, DOI 10.1093/bmb/59.1.227
   Rihova B, 2009, ADV DRUG DELIVER REV, V61, P1149, DOI 10.1016/j.addr.2008.12.017
   Salam AM, 2006, CURR PROB CARDIOLOGY, V31, P8, DOI 10.1016/j.cpcardiol.2005.09.002
   Simovic S, 2010, CHEM COMMUN, V46, P1317, DOI 10.1039/b919840g
   Simpson-Abelson MR, 2009, CLIN IMMUNOL, V132, P71, DOI 10.1016/j.clim.2009.03.516
   Sivak WN, 2009, ACTA BIOMATER, V5, P2398, DOI 10.1016/j.actbio.2009.03.036
   Stahli Barbara E, 2009, Ther Adv Cardiovasc Dis, V3, P45, DOI 10.1177/1753944708096280
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Tanaka K, 2006, THIN SOLID FILMS, V506, P159, DOI 10.1016/j.tsf.2005.08.194
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   Yang WJ, 2009, EUR J MED CHEM, V44, P862, DOI 10.1016/j.ejmech.2008.04.021
   Yasuda H., 1985, PLASMA POLYM
   YOKOYAMA M, 1994, J CONTROL RELEASE, V28, P59
   Yuan Y, 2007, SURF COAT TECH, V201, P6861, DOI 10.1016/j.surfcoat.2006.09.020
   Zahedi P, 2007, EUR J PHARM BIOPHARM, V65, P320, DOI 10.1016/j.ejpb.2006.10.025
NR 37
TC 8
Z9 8
U1 1
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 1-4
BP 483
EP 496
DI 10.1163/092050610X552753
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 858OI
UT WOS:000297809800027
PM 21294969
DA 2018-10-19
ER

PT J
AU Fan, LP
   Wang, HS
   Zhang, KH
   He, CL
   Cai, ZX
   Mo, XM
AF Fan, Linpeng
   Wang, Hongsheng
   Zhang, Kuihua
   He, Chuanglong
   Cai, Zengxiao
   Mo, Xiumei
TI Regenerated Silk Fibroin Nanofibrous Matrices Treated with 75% Ethanol
   Vapor for Tissue-Engineering Applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Electrospinning; silk fibroin; nanofiber; post-spin treatment;
   sterilization processing; green processing
ID BOMBYX-MORI SILK; IN-VITRO; CELLULAR COMPATIBILITY; SCAFFOLDS;
   RESPONSES; CELLS; BIOMATERIALS; DEGRADATION; BEHAVIOR
AB As an excellent biocompatible and biodegradable protein polymer, silk fibroin (SF) has found wide applications, particularly serving as therapeutic agent for tissue-engineering applications, on which both post-spin treatment and sterilization processing are crucial to drug-loaded matrices. To find a safe, effective and appropriate post-spin treatment and sterilization approach for drug-loaded biomaterial matrices is one of the major problems in the field of tissue engineering at present. In this work, a simple, safe and effective approach skillfully integrating post-spin treatment with sterilization processing was developed to drug-loaded SF nanofibrous matrices. Electrospun SF nanofibrous matrices from its aqueous solution were post-treated with 75% ethanol vapor. C-13-NMR and WAXD analysis demonstrated that such post-spin treatment rendered the structure of SF nanofibrous matrices transform from the silk I form to the silk II form. Furthermore, biological assays suggested that as-treated SF nanofibrous matrices significantly promoted the development of murine connective tissue fibroblasts. Skillfully integrated with novel sterilization processing, 75% ethanol vapor treatment could be a potential approach to designing and fabricating diverse drug-loaded SF nanofibrous matrices serving as therapeutic agents for tissue-engineering applications in that it can effectively protect the drug from losing compared with traditional post-spin treatment and sterilization processing. (C) Koninklijke Brill NV, Leiden, 2012
C1 [Fan, Linpeng; Wang, Hongsheng; Zhang, Kuihua; He, Chuanglong; Cai, Zengxiao; Mo, Xiumei] Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
   [Fan, Linpeng; Wang, Hongsheng; Zhang, Kuihua; He, Chuanglong; Cai, Zengxiao; Mo, Xiumei] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 201620, Peoples R China.
   [Zhang, Kuihua] Jiaxing Coll, Coll Biol Engn & Chem Engn, Jiaxing 314001, Zhejiang, Peoples R China.
RP Wang, HS (reprint author), Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
EM myqige@gmail.com
RI mo, xiumei/C-9340-2013; He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
FU Shanghai-Unilever Research and Development [08520750100]; National High
   Technology Research and Development Program (863 Program)
   [2008AA03Z305]; '111 Project' Biomedical Textile Materials Science and
   Technology [B07024]; Ministry of Education of China [200802551014];
   State Key Laboratory of Bioreactor Engineering; Open Foundation of State
   Key Laboratory for Modification of Chemical Fibers and Polymer Materials
   [LK0804, LZ0906]
FX This research was supported by the Shanghai-Unilever Research and
   Development Fund (08520750100), National High Technology Research and
   Development Program (863 Program, 2008AA03Z305), '111 Project'
   Biomedical Textile Materials Science and Technology (B07024), Doctoral
   Fund of Ministry of Education of China (200802551014), Open Funding
   Project of the State Key Laboratory of Bioreactor Engineering and Open
   Foundation of State Key Laboratory for Modification of Chemical Fibers
   and Polymer Materials (LK0804 and LZ0906).
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Cao H, 2009, MAT SCI ENG C-MATER, V29, P2270, DOI 10.1016/j.msec.2009.05.012
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kawahara Y, 2008, J APPL POLYM SCI, V107, P3681, DOI 10.1002/app.27539
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu Q, 2009, MAT SCI ENG C-MATER, V29, P2239, DOI 10.1016/j.msec.2009.05.014
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Zarkoob S, 2004, POLYMER, V45, P3973, DOI 10.1016/j.polymer.2003.10.102
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   Zhou P, 2001, J PHYS CHEM B, V105, P12469, DOI 10.1021/jp0125395
NR 29
TC 17
Z9 19
U1 1
U2 36
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2012
VL 23
IS 1-4
BP 497
EP 508
DI 10.1163/092050610X552771
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 858OI
UT WOS:000297809800028
PM 21294970
DA 2018-10-19
ER

PT J
AU Zhang, LJ
   Webster, TJ
AF Zhang, Lijuan
   Webster, Thomas J.
TI Decreased lung carcinoma cell functions on select polymer nanometer
   surface features
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nano-topography; cancer; lung carcinoma cell; PLGA
ID NANO-STRUCTURED SURFACES; MORPHOLOGY; CANCER; BEHAVIOR
AB Biomaterial nanotopographies have been proposed as a means to significantly influence cell functions (including osteoblasts, fibroblasts, endothelial cells, chondrocytes, immune cells, and bacteria). In this study, lung epithelial carcinoma cell functions including adhesion (up to 4 h), proliferation (up to 3 days), apoptosis (up to 5 days), and vascular endothelial growth factor (VEGF) synthesis (up to 5 days) on poly-lactic-co-glycolic (PLGA) films with various nanotopographies were systematically investigated. Importantly, this study created PLGA films with various nanotopographies (specifically, nano-smooth, 23, 300, and 400 nm hemispherical surface features) but similar surface chemistry in order to focus only on the effect of PLGA topography on cancer cell functions. Simple and effective cast-molding and solvent evaporation methods were used to accomplish this. Atomic force microscopy, electron spectroscopy for chemical analysis, and water contact angle measurements verified similar surface chemistry and energy but varied topographies for all of the PLGA films prepared in this study. Lung epithelial carcinoma cell adhesion, proliferation, and morphology results indicated less cell growth and spreading on nano-smooth and 400 nm surface-featured PLGA compared to any other samples. However, results also demonstrated decreased lung epithelial carcinoma cell VEGF (a key growth factor secreted for the vascularization of tumors) synthesis on the 23 nm surface-featured PLGA compared to the nano-smooth substrates for up to 5 days. In summary, these results provided the first insights into understanding the role that PLGA nanotography may play in mediating lung carcinoma cell functions for a wide range of applications in regenerative medicine. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 94-102, 2012.
C1 [Webster, Thomas J.] Brown Univ, Sch Engn, Dept Orthopaed, Providence, RI 02912 USA.
   [Zhang, Lijuan] Brown Univ, Sch Engn, Dept Chem, Providence, RI 02912 USA.
RP Webster, TJ (reprint author), Brown Univ, Sch Engn, Dept Orthopaed, Providence, RI 02912 USA.
EM thomas_webster@brown.edu
FU Hermann Foundation; NCRR SIG [1S10RR021051-01A2]
FX Contract grant sponsor: Hermann Foundation; Contract grant sponsor: NCRR
   SIG; contract grant number: 1S10RR021051-01A2
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093
   CARPENTER J, 2008, NANOTECHNOLOGY, V19, P5110
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   El-Said WA, 2010, ULTRAMICROSCOPY, V110, P676, DOI 10.1016/j.ultramic.2010.02.031
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Rami-Porta R, 2009, EUR RESPIR J, V33, P426, DOI 10.1183/09031936.00099808
   ROSENBERG MD, 1962, P NATL ACAD SCI USA, V48, P1342, DOI 10.1073/pnas.48.8.1342
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002
   Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Vricella LA, 2002, ANN THORAC SURG, V74, P13, DOI 10.1016/S0003-4975(02)03634-2
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yang L, 2009, BIOMATERIALS, V30, P3458, DOI 10.1016/j.biomaterials.2009.03.014
   Zhang LJ, 2010, INT J NANOMED, V5, P269
NR 23
TC 9
Z9 9
U1 0
U2 19
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2012
VL 100A
IS 1
BP 94
EP 102
DI 10.1002/jbm.a.33217
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857SV
UT WOS:000297740800010
PM 21987490
DA 2018-10-19
ER

PT J
AU Kokkonen, H
   Verhoef, R
   Kauppinen, K
   Muhonen, V
   Jorgensen, B
   Damager, I
   Schols, HA
   Morra, M
   Ulvskov, P
   Tuukkanen, J
AF Kokkonen, Hanna
   Verhoef, Rene
   Kauppinen, Kyosti
   Muhonen, Virpi
   Jorgensen, Bodil
   Damager, Iben
   Schols, Henk A.
   Morra, Marco
   Ulvskov, Peter
   Tuukkanen, Juha
TI Affecting osteoblastic responses with in vivo engineered potato pectin
   fragments
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; focal adhesion; genetic engineering; osteoblast;
   pectin
ID ENZYMATICALLY-TAILORED PECTINS; HAIRY RAMIFIED REGIONS; PLANT-CELL WALL;
   RHAMNOGALACTURONAN-I; CITRUS PECTIN; DIFFERENTIATION; VITRO;
   MINERALIZATION; PROLIFERATION; ARCHITECTURE
AB Pectins, complex plant-derived polysaccharides, are novel candidates for biomaterial nanocoatings. Pectic rhamnogalacturonan-I regions (RG-I) can be enzymatically treated to so-called modified hairy regions (MHR). We surveyed the growth and differentiation of murine preosteoblastic MC3T3-E1 cells on Petri dishes coated with RG-Is from native or genetically engineered potato tubers. Uncoated tissue culture polystyrene (TCPS) and aminated (AMI) dishes served as controls. MHRPTR_GAL sample was depleted of galactose (9 mol % galactose; 23 mol % arabinose) and MHRPTR_ARA of arabinose (61 mol % galactose; 6 mol % arabinose). Wild-type (modified hairy region from potato pectin (MHRP)_WT) fragment contained default amounts (58 mol % galactose; 13 mol % arabinose) of both sugars. Focal adhesions (FAs) indicating cellular attachment were quantified. Reverse transcriptase polymerase chain reaction (RT-PCR) of alkaline phosphatase and osteocalcin genes indicating osteoblastic differentiation was performed along with staining the produced calcium with tetracycline as an indicator of osteoblastic differentiation. Osteoblasts proliferated on all the samples to some extent. The control surfaces performed better than any of the pectin samples, of which the MHRP_WT seemed to function best. FA length was greater on MHRPTR_GAL than on other pectin samples, otherwise the mutants did not significantly deviate. RT-PCR results indicate that differences between the samples at the gene expression level might be even subtler. However, tetracycline-stained calcium-containing mineral was detected merely only on uncoated TCPS. These results indicate the possibility to affect bone cell growth with in vivo-modified pectin fragments, consecutively providing information on the significance of certain monosaccharides on the biocompatibility of these polysaccharides. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 111-119, 2012.
C1 [Kokkonen, Hanna; Kauppinen, Kyosti; Muhonen, Virpi; Tuukkanen, Juha] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu 90014, Finland.
   [Verhoef, Rene; Schols, Henk A.] Wageningen Univ, Food Chem Lab, NL-6703 HD Wageningen, Netherlands.
   [Jorgensen, Bodil; Damager, Iben; Ulvskov, Peter] Univ Aarhus, Dept Genet & Biotechnol, Biotechnol Grp, Aarhus, Denmark.
   [Morra, Marco] Nobil Bio Ric, I-14037 Portacomaro, Italy.
RP Kokkonen, H (reprint author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, POB 5000, Oulu 90014, Finland.
EM hanna.kokkonen@oulu.fi
RI Ulvskov, Peter/I-1228-2014; Tuukkanen, Juha/R-3728-2018; Jorgensen,
   Bodil/F-6551-2014
OI Ulvskov, Peter/0000-0003-3776-818X; Tuukkanen, Juha/0000-0002-1723-6461;
   Jorgensen, Bodil/0000-0002-0453-1277
FU EC [NMP4-CT-2005-517036]; National Doctoral Programme of Musculoskeletal
   Disorders and Biomaterials (TBDP); Academy of Finland [130795]
FX Contract grant sponsor: EC-project PectiCoat; contract grant number:
   NMP4-CT-2005-517036; Contract grant sponsor: National Doctoral Programme
   of Musculoskeletal Disorders and Biomaterials (TBDP); Contract grant
   sponsor: The Academy of Finland; contract grant number: 130795
CR Aubin JE, 1995, BONE, V17, P77
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Bussy C, 2008, J BIOMED MATER RES A, V86A, P597, DOI 10.1002/jbm.a.31729
   Cavalcanti-Adam Elisabetta Ada, 2005, Prog Orthod, V6, P232
   Chen CH, 2006, BIOCHEM PHARMACOL, V72, P1001, DOI 10.1016/j.bcp.2006.07.001
   FRY SC, 1993, PLANT PHYSIOL, V103, P1, DOI 10.1104/pp.103.1.1
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Kokkonen HE, 2007, BIOMACROMOLECULES, V8, P509, DOI 10.1021/bm060614h
   McCann MC, 2001, PHYTOCHEMISTRY, V57, P811, DOI 10.1016/S0031-9422(01)00144-3
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Munarin F, 2010, J MATER SCI-MATER M, V21, P365, DOI 10.1007/s10856-009-3860-8
   Mutter M, 1998, PLANT PHYSIOL, V117, P153, DOI 10.1104/pp.117.1.153
   Nagel MD, 2008, BBA-GEN SUBJECTS, V1780, P995, DOI 10.1016/j.bbagen.2008.04.002
   O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Qu Q, 1998, BONE, V22, P201, DOI 10.1016/S8756-3282(97)00276-7
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Redondo-Nevado J, 2001, J EXP BOT, V52, P1941, DOI 10.1093/jexbot/52.362.1941
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Salman H, 2008, BIOMED PHARMACOTHER, V62, P579, DOI 10.1016/j.biopha.2008.07.058
   SCHOLS HA, 1995, CARBOHYD RES, V275, P343, DOI 10.1016/0008-6215(95)00155-M
   SCHOLS HA, 1994, CARBOHYD RES, V256, P97, DOI 10.1016/0008-6215(94)84230-2
   SCHOLS HA, 1990, CARBOHYD RES, V206, P117, DOI 10.1016/0008-6215(90)84011-I
   Skjot M, 2002, PLANT PHYSIOL, V129, P95, DOI 10.1104/pp.010948
   Sorensen SO, 2000, P NATL ACAD SCI USA, V97, P7639
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   van Alebeek GJWM, 2003, BIOCHEM J, V372, P211, DOI 10.1042/BJ20021471
   VERHOEF R, 2009, CARBOHYD RES, V28, P1808
   Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350
   Walboomers XF, 2004, J BIOMED MATER RES A, V69A, P131, DOI 10.1002/jbm.a.20127
   Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148
   Zhao Y, 2005, BIOL PHARM BULL, V28, P1371, DOI 10.1248/bpb.28.1371
NR 34
TC 8
Z9 8
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2012
VL 100A
IS 1
BP 111
EP 119
DI 10.1002/jbm.a.33240
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857SV
UT WOS:000297740800012
PM 21997868
DA 2018-10-19
ER

PT J
AU McCanless, JD
   Jennings, LK
   Cole, JA
   Bumgardner, JD
   Haggard, WO
AF McCanless, Jonathan D.
   Jennings, Lisa K.
   Cole, Judith A.
   Bumgardner, Joel D.
   Haggard, Warren O.
TI In vitro differentiation and biocompatibility of mesenchymal stem cells
   on a novel platelet releasate-containing injectable composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE platelet releasate; tricalcium phosphate; alginate; osteochondrogenesis;
   mesenchymal stem cell
ID INTERVERTEBRAL DISC DEGENERATION; GROWTH-FACTORS; UP-REGULATION;
   TGF-BETA; BONE; PROLIFERATION; PATHOGENESIS; ULCERS; CYSTS; GENE
AB Underlying changes in subchondral and cancellous bone precede joint degeneration in spinal discs, knees, hips, and other joints. We hypothesize that an early bone remodeling intervention therapy may alleviate or postpone the later manifestation of joint failure. Utilization of a novel biomaterial for injection deliverability to the underlying subchondral and cancellous bone during the onset of osseous changes, before severe cartilaginous damage, is proposed. In this preliminary study, we introduced novel platelet releasate-containing alginate/calcium phosphate composites for this intervention therapy and evaluated them in vitro through mesenchymal stem cell biocompatibility and induction of osteochondral differentiation. DNA quantification and gene expression profiles suggested mesenchymal stem cells were directed along an osteochondral differentiation pathway, more specifically, to the immature nonhypertrophic chondrocyte phenotype. These conclusions were based on reduced mitogenic activity, a rapid upregulation followed by suppression of Runx2 transcription factor mRNA, sustained upregulation of Sox9 transcription factor mRNA and the absence of late marker expressions for both mature articular chondrocytes and osteoblasts over the course of 14 days. Initial findings in regard to the use of these materials for bone remodeling were positive and support the execution of future studies evaluating the inflammatory and angiogenic aspects of the materials. In this study, we have considered one of the many aspects of the endochondral ossification process; neovascularization and resorption of bone with an irregular physiology need to be evaluated. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 220-229, 2012.
C1 [McCanless, Jonathan D.; Bumgardner, Joel D.; Haggard, Warren O.] Univ Memphis, Dept Biomed Engn, Herff Coll Engn, Memphis, TN 38152 USA.
   [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Internal Med, Memphis, TN 38163 USA.
   [Jennings, Lisa K.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA.
   [Cole, Judith A.] Univ Memphis, Dept Biol Sci, Coll Arts & Sci, Memphis, TN 38152 USA.
   [Bumgardner, Joel D.] Univ Tennessee, Hlth Sci Ctr, Sch Dent, Memphis, TN 38163 USA.
   [Bumgardner, Joel D.] Univ Tennessee, Hlth Sci Ctr, Dept Plast Surg, Sch Med, Memphis, TN 38163 USA.
RP Haggard, WO (reprint author), Univ Memphis, Dept Biomed Engn, Herff Coll Engn, Memphis, TN 38152 USA.
EM whaggrd1@memphis.edu
CR Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   AMSTEIN C, 1985, SURFACE INTERFACIAL
   Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015
   Bancroft LW, 2004, RADIOL CLIN N AM, V42, P73, DOI 10.1016/S0033-8389(03)00165-9
   Beamer Brandon, 2010, HSS J, V6, P85, DOI 10.1007/s11420-009-9129-4
   Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09
   BRANDT KD, 2000, DIAGNOSIS NONSURGICA
   Carrino JA, 2006, OSTEOARTHR CARTILAGE, V14, P1081, DOI 10.1016/j.joca.2006.05.011
   Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174
   Danielpour D, 1989, Growth Factors, V2, P61, DOI 10.3109/08977198909069082
   Dennis J E, 1992, Cell Transplant, V1, P23
   EHRENFREUNDKLEI.T, 2006, SCAFFOLDING TISSUE E, P27
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Ferro F, 2010, TISSUE ENG PT A, V16, P3657, DOI [10.1089/ten.tea.2009.0750, 10.1089/ten.TEA.2009.0750]
   Goldring SR, 2008, RHEUM DIS CLIN N AM, V34, P561, DOI 10.1016/j.rdc.2008.07.001
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   HAGGARD WO, 2011, US PROVISIONAL PATEN
   Hudis M., 1974, Techniques and applications of plasma chemistry, P113
   Kalfas IH, 2001, NEUROSURG FOCUS, V10, P1, DOI DOI 10.3171/FOC.2001.10.4.2
   Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0
   Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021
   Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075
   KNIGHTON DR, 1990, SURG GYNECOL OBSTET, V170, P56
   KNIGHTON DR, 1986, ANN SURG, V204, P322, DOI 10.1097/00000658-198609000-00011
   Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687
   Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048
   Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081
   Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030
   MCCANLESS JD, 2010, 56 ANN M ORTH RES SO
   MCCANLESS JD, 2011, SPINE PHILA PA  0209
   Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f
   Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113
   Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697
   Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008
   Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068
   Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258
   Remedios A, 1999, VET CLIN N AM-SMALL, V29, P1029, DOI 10.1016/S0195-5616(99)50101-0
   Shankaran H, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-48
   STEED DL, 1992, DIABETES CARE, V15, P1598, DOI 10.2337/diacare.15.11.1598
   Sun H, 2008, TRANSPL P, V40, P2645, DOI 10.1016/j.transproceed.2008.07.096
   Wang Li, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P233
   WEN Q, 2011, J CELL MOL MED  0810
   Whitelaw M. A., 1999, V69, P99
   Worster AA, 2000, AM J VET RES, V61, P1003, DOI 10.2460/ajvr.2000.61.1003
   Xia B, 2011, BIOLOGICALS, V39, P217, DOI 10.1016/j.biologicals.2011.04.004
   Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008
NR 47
TC 4
Z9 5
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2012
VL 100A
IS 1
BP 220
EP 229
DI 10.1002/jbm.a.33256
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857SV
UT WOS:000297740800026
PM 22042623
DA 2018-10-19
ER

PT J
AU Salgado, CL
   Sanchez, EMS
   Zavaglia, CAC
   Granja, PL
AF Salgado, Christiane L.
   Sanchez, Elisabete M. S.
   Zavaglia, Cecilia A. C.
   Granja, Pedro L.
TI Biocompatibility and biodegradation of polycaprolactone-sebacic acid
   blended gels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polycaprolactone; sebacic acid; biodegradable; injectable; biomaterial;
   tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VIVO EFFICACY; POLY(EPSILON-CAPROLACTONE)
   FILMS; ALGINATE MICROSPHERES; SCAFFOLD DEGRADATION; LACTIC-ACID; BONE;
   VITRO; GROWTH; COPOLYMERS
AB Tissue engineering aims at creating biological body parts as an alternative for transplanting tissues and organs. A current new approach for such materials consists in injectable biodegradable polymers. Their major advantages are the ability to fill-in defects, easy incorporation of therapeutic agents or cells, and the possibility of minimal invasive surgical procedures. Polycaprolactone (PCL) is a promising biodegradable and elastic biomaterial, with the drawback of low-degradation kinetics in vivo. In this work a biodegradable injectable gel of PCL blended with sebacic acid (SA) was prepared, to improve the degradation rate of the biomaterial. SA is known for its high degradation rate, although in high concentrations it could originate a pH decrease and thus disturb the biocompatibility of PCL. Degradation tests on phosphate buffered saline were carried out using 5% of SA on the blend and the biomaterial stability was evaluated after degradation using differential scanning calorimetry, dynamical mechanical analysis, and scanning electronic microscopy. After degradation the elastic properties of the blend decreased and the material became more crystalline and stiffer, although at a lower extent when compared with pure PCL. The blend also degraded faster with a loss of the crystalline phase on the beginning (30 days), although its thermal and mechanical properties remained comparable with those of the pure material, thus showing that it achieved the intended objectives. After cell assays the PCL-SA gel was shown to be cytocompatible and capable of maintaining high cell viability (over 90%). (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 243-251, 2012.
C1 [Salgado, Christiane L.; Granja, Pedro L.] Univ Porto, INEB Biomed Engn Inst, P-4100 Oporto, Portugal.
   [Salgado, Christiane L.; Granja, Pedro L.] Univ Porto FEUP, Fac Engn, Oporto, Portugal.
   [Sanchez, Elisabete M. S.; Zavaglia, Cecilia A. C.] State Univ Campinas UNICAMP, Fac Mech Engn, Sao Paulo, Brazil.
RP Salgado, CL (reprint author), Univ Porto, INEB Biomed Engn Inst, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM chris@fe.up.pt
RI Salgado, Christiane/K-5498-2013; Granja, Pedro/B-1685-2008
OI Salgado, Christiane/0000-0002-3844-1667; Granja,
   Pedro/0000-0003-2761-4929
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   [CAPES-4633-06-7]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico [CNPq-142956/2005-8]; Financiadora de Estudos e Projetos
   (FINEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX Contract grant sponsor: Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior; contract grant number: CAPES-4633-06-7; Contract grant
   sponsor: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico;
   contract grant number: CNPq-142956/2005-8; Contract grant sponsor:
   Financiadora de Estudos e Projetos (FINEP) and Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
CR ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Barrias CC, 2005, J BIOMED MATER RES A, V72A, P57, DOI 10.1002/jbm.a.30217
   Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   CHU CC, 1999, BIODEGRADABLE POLYM, P41
   Costa CAD, 2003, BIOMATERIALS, V24, P3853, DOI 10.1016/S0142-9612(03)00253-9
   De Kesel C, 1999, POLYMER, V40, P1969, DOI 10.1016/S0032-3861(98)00253-5
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Gryglewicz S, 2003, ENZYME MICROB TECH, V33, P952, DOI 10.1016/S0141-0229(03)00249-7
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054
   *INT ORG STAND, 1999, BIOL EV MED DEV, V5
   Jeong JH, 2005, COLLOID SURFACE A, V264, P187, DOI [10.1016/j.colsurfa.2005.05.019, 10.1016/j.colsurfa.2005.019]
   Kang YM, 2011, BIOMATERIALS, V32, P4556, DOI 10.1016/j.biomaterials.2011.03.007
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Laine P, 2004, INT J ORAL MAX SURG, V33, P240, DOI 10.1016/j.ijom.2003.0510
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Le Ray AM, 2003, BIOMATERIALS, V24, P443, DOI 10.1016/S0142-9612(02)00357-5
   Le Renard PE, 2010, BIOMATERIALS, V31, P691, DOI 10.1016/j.biomaterials.2009.09.091
   Lee JY, 2010, INT J PHARMACEUT, V392, P51, DOI 10.1016/j.ijpharm.2010.03.033
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   MANRICH S, 2005, PROCESSAMENTO TERMOP, P431
   Modi S, 2006, EUR J PHARM BIOPHARM, V64, P277, DOI 10.1016/j.ejpb.2006.05.013
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Pena J, 2006, POLYM DEGRAD STABIL, V91, P1424, DOI 10.1016/j.polymdegradstab.2005.10.016
   Raimo M, 2007, PROG POLYM SCI, V32, P597, DOI 10.1016/j.progpolymsci.2007.02.001
   RATNER BD, 1995, BIOMATERIALS SCI INT
   SALGADO CL, 2009, Patent No. 018080059526
   Saltzman W. M., 2000, PRINCIPLES TISSUE EN, P221
   Santos JL, 2010, MOL PHARMACEUT, V7, P763, DOI 10.1021/mp9002877
   Schagemann JC, 2010, J BIOMED MATER RES A, V93A, P454, DOI 10.1002/jbm.a.32521
   Schweikl H, 1996, EUR J ORAL SCI, V104, P292, DOI 10.1111/j.1600-0722.1996.tb00080.x
   Seol YJ, 2010, J BIOMED MATER RES A, V94A, P649, DOI 10.1002/jbm.a.32738
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shikanov A, 2005, J CONTROL RELEASE, V105, P52, DOI 10.1016/j.jconrel.2005.02.018
   Sletten GBG, 1999, ACTA ODONTOL SCAND, V57, P316, DOI 10.1080/000163599428544
   Slivniak R, 2002, BIOMACROMOLECULES, V3, P754, DOI 10.1021/bm0200128
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   VERMES I, 1995, CLIN CHEM, V41, pS91
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 51
TC 15
Z9 15
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2012
VL 100A
IS 1
BP 243
EP 251
DI 10.1002/jbm.a.33272
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857SV
UT WOS:000297740800029
PM 22042691
DA 2018-10-19
ER

PT J
AU Wang, TJ
   Wang, IJ
   Chen, YH
   Lu, JN
   Young, TH
AF Wang, Tsung-Jen
   Wang, I-Jong
   Chen, Yi-Hsin
   Lu, Jui-Nan
   Young, Tai-Horng
TI Polyvinylidene fluoride for proliferation and preservation of bovine
   corneal endothelial cells by enhancing type IV collagen production and
   deposition
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE corneal endothelial cells (CECs); polyvinylidene fluoride (PVDF); type
   IV collagen
ID TOOTH GERM-CELLS; TISSUE-CULTURE; EX-VIVO; TRANSPLANTATION; MEMBRANE;
   CARRIER; GROWTH; ASSAY; DIFFERENTIATION; BIOMATERIALS
AB In this study, biomaterials with different hydrophobic properties including polyvinyl alcohol (PVA), poly(ethylene-co-vinyl alcohol) (EVAL), tissue culture polystyrene (TCPS), and polyvinylidene fluoride (PVDF) were examined in the bovine corneal endothelial cells (BCECs) culture system to elucidate their possible impact on clinical demand and scientific interest. It was found that BCECs were inhibited to attach onto the PVA surface. Conversely, relatively more hydrophobic biomaterials EVAL, TCPS, and PVDF successfully initiate BCEC adhesion. Compared to EVAL, cultured BCECs on TCPS and PVDF exhibited higher viability. Furthermore, fibroblastic transformation on EVAL and TCPS was observed at day 17, but BCECs maintained typical hexagonal shape on the PVDF surface at day 21. This phenomenon can be rescued by previously coating type IV collagen on TCPS but not on EVAL. In addition, when BCECs were cultured on PVDF, the expressions of gap junction connexin-43, differentiation marker N-cadherin, and tight junction ZO-1 were well-developed, resembling the physiological phenotypes. After examining the type IV collagen expression by Western blot analysis and protein absorption test, a possible explanation for the better proliferation and preservation of BCECs on the PVDF substrate is that PVDF is a bioactive substratum which enables BCECs to synthesize and reserve more extracellular matrix type IV collagen, paving an important way to provide a more preferential environment for BCEC cultures. Accordingly, promoting CEC growth effects after cell-biomaterial association may be applied to the tissue engineering of corneal endothelium. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 252-260, 2012.
C1 [Wang, Tsung-Jen; Lu, Jui-Nan; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan.
   [Wang, Tsung-Jen; Lu, Jui-Nan; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Wang, Tsung-Jen] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Wang, Tsung-Jen] Taipei Med Univ, Dept Ophthalmol, Sch Med, Coll Med, Taipei, Taiwan.
   [Wang, Tsung-Jen; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Chen, Yi-Hsin; Young, Tai-Horng] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan.
EM thyoung@ntu.edu.tw
OI Wang, I-Jong/0000-0002-3045-0614
FU National Science Council, Taipei, Taiwan [NCS 99-2320-B-038-010];
   National Taipei University of Technology and Taipei Medical University
   [NTUT-TMU-98-16]
FX Contract grant sponsor: National Science Council, Taipei, Taiwan;
   contract grant number: NCS 99-2320-B-038-010; Contract grant sponsor:
   National Taipei University of Technology and Taipei Medical University;
   contract grant number: NTUT-TMU-98-16
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L
   Breinholt V, 1998, CHEM RES TOXICOL, V11, P622, DOI 10.1021/tx970170y
   Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012
   Chen MH, 2005, J BIOMED MATER RES A, V74A, P254, DOI 10.1002/jbm.a.30376
   Chen RS, 2007, J BIOMED MATER RES A, V83A, P241, DOI 10.1002/jbm.a.31475
   Chen RS, 2009, BIOMATERIALS, V30, P541, DOI 10.1016/j.biomaterials.2008.09.054
   ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656
   Gao XS, 2008, J MATER SCI-MATER M, V19, P3611, DOI 10.1007/s10856-008-3508-0
   GRINNELL F, 1979, CELL, V17, P117, DOI 10.1016/0092-8674(79)90300-3
   HUDSON BG, 1993, J BIOL CHEM, V268, P26033
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   JUMBLATT MM, 1980, TRANSPLANTATION, V29, P499, DOI 10.1097/00007890-198006000-00013
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Ko MHK, 2002, MOL VIS, V8, P1
   Koh SWM, 2008, INVEST OPHTH VIS SCI, V49, P3491, DOI 10.1167/iovs.07-1543
   Koh SWM, 2009, INVEST OPHTH VIS SCI, V50, P1801, DOI 10.1167/iovs.08-2590
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   LAING RA, 1984, OPHTHALMOLOGY, V91, P1129
   LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126
   MCCULLEY JP, 1980, OPHTHALMOLOGY, V87, P194
   Merjava S, 2009, EXP EYE RES, V88, P945, DOI 10.1016/j.exer.2008.12.017
   Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174
   NAYAK SK, 1984, INVEST OPHTH VIS SCI, V25, P1213
   PLUSKAL MG, 1986, BIOTECHNIQUES, V4, P272
   Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje
   Terry MA, 2003, OPHTHALMOLOGY, V110, P755, DOI 10.1016/S0161-6420(02)01939-5
   TSENG SCG, 1981, J BIOL CHEM, V256, P3361
   Yang TL, 2010, BIOMATERIALS, V31, P288, DOI 10.1016/j.biomaterials.2009.09.052
   Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
   YUE BYJT, 1989, INVEST OPHTH VIS SCI, V30, P248
   Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693
NR 42
TC 9
Z9 10
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2012
VL 100A
IS 1
BP 252
EP 260
DI 10.1002/jbm.a.33274
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857SV
UT WOS:000297740800030
PM 22042711
DA 2018-10-19
ER

PT J
AU Rupp, F
   Haupt, M
   Eichler, M
   Doering, C
   Klostermann, H
   Scheideler, L
   Lachmann, S
   Oehr, C
   Wendel, HP
   Decker, E
   Geis-Gerstorfer, J
   von Ohle, C
AF Rupp, F.
   Haupt, M.
   Eichler, M.
   Doering, C.
   Klostermann, H.
   Scheideler, L.
   Lachmann, S.
   Oehr, C.
   Wendel, H. P.
   Decker, E.
   Geis-Gerstorfer, J.
   von Ohle, C.
TI Formation and Photocatalytic Decomposition of a Pellicle on Anatase
   Surfaces
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE dental pellicle; biofilm; photocatalytic decomposition; titanium
   dioxide; quartz crystal microbalance (QCM); X-ray photoelectron
   spectroscopy XPS
ID PROTEIN ADSORPTION; IN-VIVO; TITANIUM; TOPOGRAPHY; ADHESION; FILMS
AB The acquired dental pellicle plays a critical role in the adhesion and detachment of dental plaque bacteria. It has been reported that titanium dioxide biomaterials decompose single-protein films by photocatalysis. However, it is not known whether this can also be achieved with complex structured pellicle films. This in vitro study investigated in real-time the formation and photocatalytic decomposition of human pellicle at anatase-saliva interfaces. Nanostructured polycrystalline anatase layers were deposited on titanium-coated quartz crystals by magnetron-sputtering, serving as a model for titanium implant surfaces. The quartz crystals were used as acoustic sensors in a quartz-crystal microbalance (QCM) system with dissipation. In situ UV irradiation of pellicle-covered anatase caused a statistically significant decrease of the adsorbed salivary mass. In contrast, photocatalytic decomposition of pellicle could not be observed on reference titanium surfaces. Wettability characterization revealed superhydrophilicity of anatase upon UV irradiation, whereas titanium was unaffected. XPS measurements provide further information concerning the decomposition of the salivary films. The results suggest that the photocatalytic activity of polycrystalline anatase-modified biomaterial surfaces is able to decompose complex structured macromolecular pellicle films. Therefore, this study opens the way to surface modifications supporting therapeutic approaches of biofilm removal.
C1 [Rupp, F.; Eichler, M.; Doering, C.; Scheideler, L.; Lachmann, S.; Geis-Gerstorfer, J.] Univ Tubingen Hosp, Dept Prosthet Dent, Sect Med Mat & Technol, D-72076 Tubingen, Germany.
   [Haupt, M.; Oehr, C.] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, D-70569 Stuttgart, Germany.
   [Klostermann, H.] Fraunhofer Inst Electron Beam & Plasma Technol FE, D-01277 Dresden, Germany.
   [Wendel, H. P.] Univ Tubingen, Univ Childrens Hosp, Div Congenital & Paediat Cardiac Surg, D-72076 Tubingen, Germany.
   [Decker, E.; von Ohle, C.] Univ Tubingen Hosp, Dept Conservat Dent, D-72076 Tubingen, Germany.
RP Rupp, F (reprint author), Univ Tubingen Hosp, Dept Prosthet Dent, Sect Med Mat & Technol, Osianderstr 2-8, D-72076 Tubingen, Germany.
EM frank.rupp@med.uni-tuebingen.de
RI Rupp, Frank/G-4725-2012
FU Baden-Wurttemberg Stiftung
FX This work was supported by the Baden-Wurttemberg Stiftung (Research
   Program "Biomaterials/Biocompatibility"). We thank Dr. O. Zywitzki for
   the SEM analysis and I. Stephan for technical assistance. The authors
   declare no potential conflicts of interest with respect to the
   authorship and/or publication of this article.
CR Ahn SJ, 2011, INT J ORAL MAX IMPL, V26, P39
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cardenas M, 2007, BIOMACROMOLECULES, V8, P65, DOI 10.1021/bm060492t
   Dixon Matthew C, 2008, J Biomol Tech, V19, P151
   Frach P, 2006, VACUUM, V80, P679, DOI 10.1016/j.vacuum.2005.11.001
   Gocke Reinhard, 2002, Clin Oral Investig, V6, P227, DOI 10.1007/s00784-002-0176-1
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Hannig M, 1997, EUR J ORAL SCI, V105, P422, DOI 10.1111/j.1600-0722.1997.tb02139.x
   Hara AT, 2006, J DENT RES, V85, P612, DOI 10.1177/154405910608500706
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   KOHAVI D, 1995, J PROSTHET DENT, V74, P531, DOI 10.1016/S0022-3913(05)80357-9
   Lamkin MS, 1996, J DENT RES, V75, P803, DOI 10.1177/00220345960750021101
   Lendenmann U, 2000, Adv Dent Res, V14, P22
   Lubarsky GV, 2007, BIOSENS BIOELECTRON, V22, P1275, DOI 10.1016/j.bios.2006.05.024
   Macakova L, 2010, COLLOID SURFACE B, V77, P31, DOI 10.1016/j.colsurfb.2009.12.022
   Muszkat L, 2001, J PHOTOCH PHOTOBIO B, V60, P32, DOI 10.1016/S1011-1344(01)00113-0
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Rupp F, 2010, ACTA BIOMATER, V6, P4566, DOI 10.1016/j.actbio.2010.06.021
   Santos O, 2010, BIOFOULING, V26, P697, DOI 10.1080/08927014.2010.506609
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Skjorland KK, 1995, ACTA ODONTOL SCAND, V53, P358, DOI 10.3109/00016359509006001
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tran TH, 2006, J PHYS CHEM B, V110, P25525, DOI 10.1021/jp065255z
   Vitkov L, 2004, EUR J ORAL SCI, V112, P320, DOI 10.1111/j.1600-0722.2004.00138.x
   VONOHLE C, 2007, J PARODONTOL IMPLANT, V26, P213
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Zhang LW, 2008, ADV FUNCT MATER, V18, P2180, DOI 10.1002/adfm.200701478
NR 30
TC 16
Z9 17
U1 0
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD JAN
PY 2012
VL 91
IS 1
BP 104
EP 109
DI 10.1177/0022034511424901
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 858XI
UT WOS:000297836100016
PM 21979134
DA 2018-10-19
ER

PT J
AU Elashmawi, IS
   Baieth, HEA
AF Elashmawi, I. S.
   Baieth, H. E. Abdel
TI Spectroscopic studies of hydroxyapatite in PVP/PVA polymeric matrix as
   biomaterial
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE Polymer blend; HAp; X-ray; EDX; Thermal stability
ID POLY(VINYL PYRROLIDONE); ALCOHOL); COMPOSITES; BEHAVIOR; MORPHOLOGY;
   HYDROGELS; RELEASE; FILMS; DSC
AB This system is focusing on characterization and spectroscopic studies of PVA and PVP blend and the blend filled with various mass fractions (2.5, 5 and 10%) of HAp because it has great potential for applications in the medical purposes. The films have been prepared by solution casting technique. The characteristic properties of the films were examined by FT-IR, X-ray, SEM, TGA and DSC techniques from room temperature to 500 degrees C. XRD scans reveal the semicrystalline nature of the prepared films and demonstrated that complexation between the blend and the HAp were occur. SEM and thermal studies confirmed these results. Three main weight loss regions were observed in TGA thermograms that reveal reduction in the thermal stability of the prepared samples as HAp content increases. Three main transition peaks were observed in DSC with a single T(g) which indicates a good miscibility of the films. The ratio Ca:P is 1.65:1 which confirm the formation of hydroxyapatite. So, the present work can be used in various bio-applications. (C) 2011 Elsevier B. V. All rights reserved.
C1 [Elashmawi, I. S.] Natl Res Ctr, Div Phys, Dept Spect, Giza, Egypt.
   [Baieth, H. E. Abdel] Benha Univ, Fac Sci, Dept Phys, Banha, Egypt.
RP Elashmawi, IS (reprint author), Natl Res Ctr, Div Phys, Dept Spect, Elbohooth St, Giza, Egypt.
EM islam_shukri2000@yahoo.com
OI Eashmawi, Islam/0000-0003-1277-2617
CR Abdelrazek EM, 2010, PHYSICA B, V405, P808, DOI 10.1016/j.physb.2009.06.129
   Abou-Taleb MH, 2009, J APPL POLYM SCI, V114, P1202, DOI 10.1002/app.30082
   Bhajantri RF, 2006, POLYMER, V47, P3591, DOI 10.1016/j.polymer.2006.03.054
   Cassu SN, 1997, POLYMER, V38, P3907, DOI 10.1016/S0032-3861(96)00959-7
   Chen F, 2010, ACTA BIOMATER, V6, P3013, DOI 10.1016/j.actbio.2010.02.015
   Chrissafis K, 2008, J APPL POLYM SCI, V110, P1739, DOI 10.1002/app.28818
   COATS AW, 1964, NATURE, V201, P68, DOI 10.1038/201068a0
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Furuichi K, 2006, SCI TECHNOL ADV MAT, V7, P219, DOI 10.1016/j.stam.2005.10.008
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   JAYA S, 2009, J COMPOS MATER, V43, P13
   Kundu PP, 2003, EUR POLYM J, V39, P1585, DOI 10.1016/S0014-3057(03)00056-9
   Laot CM, 1999, POLYMER, V40, P1095, DOI 10.1016/S0032-3861(98)80003-7
   LI X, 2001, POLYMER, V42, P6869
   LIA X, 2000, POLYMER, V41, P6563
   Liu T, 2001, POLYMER, V42, P6453, DOI 10.1016/S0032-3861(01)00173-2
   Miura K, 1999, CARBOHYD POLYM, V39, P139, DOI 10.1016/S0144-8617(98)00162-3
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Pan HB, 2010, J R SOC INTERFACE, V7, P1025, DOI 10.1098/rsif.2009.0504
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Sang SB, 2008, ELECTROCHIM ACTA, V53, P5065, DOI 10.1016/j.electacta.2007.11.033
   Sanli O, 2006, J APPL POLYM SCI, V102, P1244, DOI 10.1002/app.24453
   Sedlarik V, 2006, POLYM COMPOSITE, V27, P147, DOI 10.1002/pc.20197
   Tan CY, 2008, IFMBE PROC, V21, P326
   Wang JJ, 2010, J APPL POLYM SCI, V117, P1851, DOI 10.1002/app.32150
   Wei CL, 2003, POLYMER, V44, P8185, DOI 10.1016/j.polymer.2003.10.009
   Wu G, 2008, MATER CHEM PHYS, V107, P364, DOI 10.1016/j.matchemphys.2007.07.028
   Wu HD, 2001, POLYMER, V42, P555, DOI 10.1016/S0032-3861(00)00213-5
   Wu KH, 2003, POLYM DEGRAD STABIL, V79, P195, DOI 10.1016/S0141-3910(02)00261-6
   Yasuniwa M, 2003, THERMOCHIM ACTA, V396, P75, DOI 10.1016/S0040-6031(02)00531-2
   Zheng YD, 2007, J COMPOS MATER, V41, P2071, DOI 10.1177/0021998307074126
   Zou GX, 2008, J ELASTOM PLAST, V40, P303, DOI 10.1177/0095244307085787
NR 32
TC 24
Z9 25
U1 3
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JAN
PY 2012
VL 12
IS 1
BP 141
EP 146
DI 10.1016/j.cap.2011.05.011
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 841PV
UT WOS:000296525700026
DA 2018-10-19
ER

PT J
AU Wu, SX
   Jiang, W
   Zhang, XJ
   Sun, H
   Zhang, WY
   Dai, JJ
   Liu, L
   Chen, XL
   Li, FS
AF Wu, Shixi
   Jiang, Wei
   Zhang, Xiaojuan
   Sun, Huan
   Zhang, Wenyao
   Dai, Junjun
   Liu, Li
   Chen, Xiaolong
   Li, Fengsheng
TI A sonochemical route for the encapsulation of drug in magnetic
   microspheres
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE Nanocomposite; Nanoparticle; Biomaterial; Magnetic material; Antibiotic
   effect
AB This study focused on the preparation and characterization of magnetic targeted antibiotic microspheres (MTAMs). MTAMs were prepared by a sonochemical method in the presence of hydrophobic Fe(3)O(4) nanoparticles and tetracycline. The properties of MTAMs were characterized by transmission electron microscopy, Fourier-transform infrared spectrum, thermogravimetric analysis, vibration sample magnetometry, and bacteriostatic experiment. The results indicated that the superparamagnetic microspheres have ultrafine size (below 230 nm), high saturation magnetization (80.90 emu/g), high biocompatibility, biodegradability, controlled-release, and antibiotic effect. It has been proved that MTAMs can carry out the function of magnetic targeted drugs delivery system by putting together magnetic materials and antibiotics. The possible formation mechanism of MTAMs was also discussed. In summary, MTAMs had potential in medical imaging, drug targeting, and catalysis. (c) 2011 Elsevier B.V. All rights reserved.
C1 [Wu, Shixi; Jiang, Wei; Sun, Huan; Zhang, Wenyao; Dai, Junjun; Liu, Li; Chen, Xiaolong; Li, Fengsheng] Nanjing Univ Sci & Technol, Natl Special Superfine Powder Engn Res Ctr, Nanjing 210094, Peoples R China.
   [Zhang, Xiaojuan] Jinling Inst Technol, Sch Mat Engn, Nanjing 211169, Peoples R China.
RP Li, FS (reprint author), Nanjing Univ Sci & Technol, Natl Special Superfine Powder Engn Res Ctr, Nanjing 210094, Peoples R China.
EM wushixi_308@yahoo.com.cn
FU National Natural Science Foundation of China [50602024, 50972060]; NJUST
   [2010ZDJH06]; Jiangsu Applied Chemistry and Materials Graduate Center
   for Innovation and Academic Communication Foundation [2010ACMC07]
FX The authors are grateful for the financial support of National Natural
   Science Foundation of China (nos. 50602024, 50972060), NJUST Research
   Funding (no. 2010ZDJH06), and the Jiangsu Applied Chemistry and
   Materials Graduate Center for Innovation and Academic Communication
   Foundation (no. 2010ACMC07).
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Ashiq MN, 2011, J MAGN MAGN MATER, V323, P259, DOI 10.1016/j.jmmm.2010.08.054
   Avivi S, 2003, J AM CHEM SOC, V125, P15712, DOI 10.1021/ja036834+
   Avivi S, 2002, BIOCHEM J, V366, P705, DOI 10.1042/BJ20020676
   AVIVI S, 2005, SONOCHEMISTRY, V12, P405
   Darling SB, 2005, J MATER CHEM, V15, P4189, DOI 10.1039/b506357d
   Kim DK, 2001, SCRIPTA MATER, V44, P1713, DOI 10.1016/S1359-6462(01)00870-3
   Kratz F, 1997, EUR J CANCER, V33, pS175
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Stamopoulos D, 2009, CURR NANOSCI, V5, P177, DOI 10.2174/157341309788185424
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   SUSLICK KS, 1994, ULTRASON SONOCHEM, V1, pS56
   TAKAKURA Y, 1990, PHARMACEUT RES, V7, P339, DOI 10.1023/A:1015807119753
   WONG M, 1995, MATER RES SOC SYMP P, V372, P89
   Wu SX, 2011, J MAGN MAGN MATER, V323, P2170, DOI 10.1016/j.jmmm.2011.03.025
   Zhang XJ, 2010, MATER LETT, V64, P119, DOI 10.1016/j.matlet.2009.10.002
   Zheng WM, 2005, J MAGN MAGN MATER, V288, P403, DOI 10.1016/j.jmmm.2004.09.125
NR 17
TC 7
Z9 7
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD JAN
PY 2012
VL 324
IS 2
BP 124
EP 127
DI 10.1016/j.jmmm.2011.07.038
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 827YL
UT WOS:000295466200004
DA 2018-10-19
ER

PT J
AU Hussein, RO
   Zhang, P
   Nie, X
   Xia, Y
   Northwood, DO
AF Hussein, R. O.
   Zhang, P.
   Nie, X.
   Xia, Y.
   Northwood, D. O.
TI The effect of current mode and discharge type on the corrosion
   resistance of plasma electrolytic oxidation (PEO) coated magnesium alloy
   AJ62
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Magnesium; Corrosion; Plasma electrolyte oxidation; OES
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; MG ALLOY; COATINGS; BEHAVIOR;
   SILICATE; AZ91D; MICROSTRUCTURE; ALUMINUM
AB Magnesium alloys are increasingly being used as lightweight materials in the automotive, defense, electronics, biomaterial and aerospace industries. However, their inherently poor corrosion and wear resistance have, so far, limited their application. Plasma electrolytic oxidation (PEO) in an environmentally friendly aluminates electrolyte has been used to produce oxide coatings with thicknesses of similar to 80 mu m on an AJ62 magnesium alloy. Optical emission spectroscopy (OES) in the visible and near ultraviolet (NUV) band (285 nm-800 nm) was employed to characterize the PEO plasma. Scanning electron microscopy (SEM) and X-ray diffraction (XRD) were used to characterize the coated materials, and potentiodynamic polarization and electrochemical impedance spectroscopy (EIS) in a 3.5% NaCl solution were used to determine the corrosion behavior. It was found that the plasma discharge behavior significantly influenced the microstructure and the morphology of the oxide coatings and, hence the corrosion resistance. The corrosion resistance of the coated alloy was increased by changing the current mode from unipolar to bipolar, where the strong plasma discharges had been reduced or eliminated. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Hussein, R. O.; Zhang, P.; Nie, X.; Xia, Y.; Northwood, D. O.] Univ Windsor, Dept Mech Automot & Mat Engn, Windsor, ON N9B 3P4, Canada.
   [Xia, Y.] Chinese Acad Sci, Inst Mech, Beijing 100190, Peoples R China.
RP Nie, X (reprint author), Univ Windsor, Dept Mech Automot & Mat Engn, Windsor, ON N9B 3P4, Canada.
EM xnie@uwindsor.ca; dnorthwo@uwindsor.ca
FU Ontario Centres of Excellence (OCE); Natural Sciences and Engineering
   Research Council of Canada (NSERC)
FX This research was supported by Ontario Centres of Excellence (OCE) and
   the Natural Sciences and Engineering Research Council of Canada (NSERC).
   Dr. Y Xia was a Senior Visiting Scholar at the University of Windsor
   during this research project.
CR Altun H, 2005, SURF COAT TECH, V197, P193, DOI 10.1016/j.surfcoat.2004.06.001
   [Anonymous], 1998, MAGN CAST HDB
   [Anonymous], 2010, EC LAB SOFTW US MAN
   Arrabal R, 2009, SURF COAT TECH, V203, P2207, DOI 10.1016/j.surfcoat.2009.02.011
   Blawert C, 2006, ADV ENG MATER, V8, P511, DOI 10.1002/adem.200500257
   Cakmak E, 2010, SURF COAT TECH, V204, P1305, DOI 10.1016/j.surfcoat.2009.10.012
   Curran JA, 2005, SURF COAT TECH, V199, P168, DOI 10.1016/j.surfcoat.2004.09.037
   Ghasemi A, 2008, SURF COAT TECH, V202, P3513, DOI 10.1016/j.surfcoat.2007.12.033
   Ghasemi A, 2010, SURF COAT TECH, V204, P1469, DOI 10.1016/j.surfcoat.2009.09.069
   Gnedenkov SV, 2010, SURF COAT TECH, V204, P2316, DOI 10.1016/j.surfcoat.2009.12.024
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Griem H. R., 1964, PLASMA SPECTROSCOPY
   Gu CD, 2006, SURF COAT TECH, V200, P5413, DOI 10.1016/j.surfcoat.2005.07.001
   HIHARA LH, 1994, INT MATER REV, V39, P245, DOI 10.1179/imr.1994.39.6.245
   Hussein RO, 2010, SURF COAT TECH, V205, P1659, DOI 10.1016/j.surfcoat.2010.08.059
   Hussein R, 2010, J VAC SCI TECHNOL A, V28, P766, DOI 10.1116/1.3429583
   Hussein RO, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/10/105203
   Hussein R.O., 2010, 037 AUSTR CORR ASS I, P1
   Hwang DY, 2009, MATER TRANS, V50, P671, DOI 10.2320/matertrans.MER2008345
   Jorcin JB, 2006, ELECTROCHIM ACTA, V51, P1473, DOI 10.1016/j.electacta.2005.02.128
   KIELBUS A, 2007, ARCH MAT SCI ENG, V28, P345
   Ko YG, 2010, SURF COAT TECH, V205, P2525, DOI 10.1016/j.surfcoat.2010.09.055
   Kulekci MK, 2008, INT J ADV MANUF TECH, V39, P851, DOI 10.1007/s00170-007-1279-2
   Kunst M, 2009, MAT SCI ENG A-STRUCT, V510-11, P387, DOI 10.1016/j.msea.2008.07.078
   Liang J, 2009, ELECTROCHIM ACTA, V54, P3842, DOI 10.1016/j.electacta.2009.02.004
   Luo HH, 2008, J ALLOY COMPD, V464, P537, DOI 10.1016/j.jallcom.2007.10.072
   Ma Y, 2006, THIN SOLID FILMS, V494, P296, DOI 10.1016/j.tsf.2005.08.156
   Ma Y, 2004, THIN SOLID FILMS, V469, P472, DOI 10.1016/j.tsf.2004.06.168
   Nie X, 2004, SURF COAT TECH, V188, P207, DOI 10.1016/j.surfcoat.2004.08.025
   Nocedal J., 1999, NUMERICAL OPTIMIZATI
   Osborne Robin, 2007, P IMA 2000 MAGN C VA, P1
   PEKGULERYUZ MO, 2004, MAGNESIUM, P74
   Revie R. Winston, 2000, UHLIGS CORROSION HDB
   Ryu HS, 2011, J ELECTROCHEM SOC, V158, pC23, DOI 10.1149/1.3525271
   Ryu HS, 2010, J ELECTROCHEM SOC, V157, pC131, DOI 10.1149/1.3301829
   Sansonetti JE, 2005, J PHYS CHEM REF DATA, V34, P1559, DOI 10.1063/1.1800011
   Sinebryukhov SL, 2010, SURF COAT TECH, V205, P1697, DOI 10.1016/j.surfcoat.2010.05.048
   Srinivasan PB, 2009, APPL SURF SCI, V255, P4212, DOI 10.1016/j.apsusc.2008.11.008
   Yerokhin AL, 2005, SURF COAT TECH, V199, P150, DOI 10.1016/j.surfcoat.2004.10.147
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yerokhin L, 2003, J PHYS D APPL PHYS, V36, P2110, DOI 10.1088/0022-3727/36/17/314
   Zhang P, 2010, SURF COAT TECH, V205, P1508, DOI 10.1016/j.surfcoat.2010.10.015
   Zhang P, 2009, SURF COAT TECH, V203, P3271, DOI 10.1016/j.surfcoat.2009.04.012
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
NR 44
TC 86
Z9 91
U1 0
U2 66
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 25
PY 2011
VL 206
IS 7
BP 1990
EP 1997
DI 10.1016/j.surfcoat.2011.08.060
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 871BB
UT WOS:000298711500072
OA Green Published
DA 2018-10-19
ER

PT J
AU Patwardhan, SV
   Tilburey, GE
   Perry, CC
AF Patwardhan, Siddharth V.
   Tilburey, Graham E.
   Perry, Carole C.
TI Interactions of Amines with Silicon Species in Undersaturated Solutions
   Leads to Dissolution and/or Precipitation of Silica
SO LANGMUIR
LA English
DT Article
ID LONG-CHAIN POLYAMINES; BIOGENIC SILICA; AMORPHOUS SILICA; IN-VITRO;
   QUARTZ DISSOLUTION; KINETICS; WATER; SILICIFICATION; SYSTEMS;
   BIOSILICIFICATION
AB The biogeochemical silicon cycle is the focus for many researchers studying the dissolution of silicon species from quartz, amorphous, and biogenic silica. Furthermore, the precipitation of biogenic silica by diatoms, radiolarian, sponges, and plants is also a popular focus for research. The ornate silica structures created by these species has attracted interest from biomaterial scientists and biochemists who have studied mineral formation in an attempt to understand how biogenic silica is formed, often in the presence of proteins and long chain polyamines. This article is at the interface of these seemingly distinct research areas. Here we investigate the effect of a range of amines in globally undersaturated silicon environments. Results are presented on the effect of amine-containing molecules on the formation of silica from undersaturated solutions of orthosilicic acid and globally undersaturated silicon environments. We sought to address two questions: can silica be precipitated/harvested from undersaturated solutions, and can we identify the silicon species that are most active in silica formation? We demonstrate that none of the bioinspired additives investigated here (e.g., poly(allylamine hydrochloride), pentaethylenehexamine, and propylamines) have any influence on orthosilicic acid at undersaturated concentrations. However, under globally undersaturated silicon concentrations, small molecules and polymers containing amine groups were able to interact with oligomers of silicic acid to either generate aggregated materials that can be isolated from solution or increase rates of oligomer dissolution back to orthosilicic acid. Additional outcomes of this study include an extended understanding of how polyelectrolytes and small molecules can promote and/or inhibit silica dissolution and a new method to explore how (bio)organic molecules interact with a forming mineral phase.
C1 [Patwardhan, Siddharth V.; Tilburey, Graham E.; Perry, Carole C.] Nottingham Trent Univ, Biomol & Mat Interface Res Grp, Sch Sci & Technol, Nottingham NG11 8NS, England.
RP Perry, CC (reprint author), Nottingham Trent Univ, Biomol & Mat Interface Res Grp, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.
EM Carole.Perry@ntu.ac.uk
OI Perry, Professor Carole/0000-0003-1517-468X
FU American Air Force Office of Scientific Research
FX We thank Dr. D. J. Belton for helpful discussions and acknowledge
   financial support from the American Air Force Office of Scientific
   Research.
CR Amjad Z., 1995, MINERAL SCALE FORMAT
   Annenkov VV, 2008, J MATER CHEM, V18, P553, DOI 10.1039/b716367n
   Annenkov VV, 2006, CHEM COMMUN, P1521, DOI 10.1039/b515967a
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Beck L, 2002, NUCL INSTRUM METH B, V189, P180, DOI 10.1016/S0168-583X(01)01035-7
   Belton D, 2005, CHEM COMMUN, P3475, DOI 10.1039/b504310g
   Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f
   Belton D., 2005, INFLUENCE SMALL MOLE
   Belton DJ, 2008, P NATL ACAD SCI USA, V105, P5963, DOI 10.1073/pnas.0710809105
   Belton DJ, 2010, J PHYS CHEM B, V114, P9947, DOI 10.1021/jp101347q
   Belton DJ, 2005, J MATER CHEM, V15, P4629, DOI 10.1039/b509683a
   BENNETT P, 1987, NATURE, V326, P684, DOI 10.1038/326684a0
   BENNETT PC, 1988, GEOCHIM COSMOCHIM AC, V52, P1521, DOI 10.1016/0016-7037(88)90222-0
   BENNETT PC, 1991, GEOCHIM COSMOCHIM AC, V55, P1781, DOI 10.1016/0016-7037(91)90023-X
   Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351
   Bidle KD, 2003, LIMNOL OCEANOGR, V48, P1855, DOI 10.4319/lo.2003.48.5.1855
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Cowan J.C., 1976, WATER FORMED SCALE D
   Demadis KD, 2006, IND ENG CHEM RES, V45, P4436, DOI 10.1021/ie0602254
   Demadis KD, 2005, DESALINATION, V179, P281, DOI 10.1016/j.desal.2004.11.074
   Demadis KD, 2005, J CHEM TECHNOL BIOT, V80, P630, DOI 10.1002/jctb.1242
   Demadis KD, 2008, BIOMACROMOLECULES, V9, P3288, DOI 10.1021/bm800872n
   Demadis KD, 2007, CHEM MATER, V19, P581, DOI 10.1021/cm062370d
   Demadis KD, 2005, ENVIRON CHEM LETT, V3, P127, DOI 10.1007/s10311-005-0015-0
   Demadis KD, 2009, ADV COLLOID INTERFAC, V151, P33, DOI 10.1016/j.cis.2009.07.005
   Dixit S, 2001, MAR CHEM, V73, P333, DOI 10.1016/S0304-4203(00)00118-3
   Dove P. M., 2003, BIOMINERALIZATION RE, V54
   Dove PM, 2008, P NATL ACAD SCI USA, V105, P9903, DOI 10.1073/pnas.0803798105
   Dove PM, 2005, P NATL ACAD SCI USA, V102, P15357, DOI 10.1073/pnas.0507777102
   Dove PM, 1997, GEOCHIM COSMOCHIM AC, V61, P3329, DOI 10.1016/S0016-7037(97)00217-2
   Dove PM, 1999, GEOCHIM COSMOCHIM AC, V63, P3715, DOI 10.1016/S0016-7037(99)00218-5
   Ehrlich H, 2010, CHEM REV, V110, P4656, DOI 10.1021/cr900334y
   Exley Christopher, 2009, V47, P173, DOI 10.1007/978-3-540-88552-8_7
   Fidalgo A, 2001, J NON-CRYST SOLIDS, V283, P144, DOI 10.1016/S0022-3093(01)00418-5
   Greenwood JE, 2001, PROG OCEANOGR, V48, P1, DOI 10.1016/S0079-6611(00)00046-X
   HARRISON CC, 1995, J CHEM SOC FARADAY T, V91, P4287, DOI 10.1039/ft9959104287
   Hildebrand M, 2000, BIOMINERALIZATION BI, P171
   Icenhower JP, 2000, GEOCHIM COSMOCHIM AC, V64, P4193, DOI 10.1016/S0016-7037(00)00487-7
   Iler R, 1979, CHEM SILICA
   Leng MJ, 2009, SILICON-NETH, V1, P65, DOI 10.1007/s12633-009-9014-2
   Loucaides S., 2011, SILICON, DOI [10.1007/s12633, DOI 10.1007/S12633]
   Matsunaga S, 2007, CHEMBIOCHEM, V8, P1729, DOI 10.1002/cbic.200700305
   Mavredaki E, 2005, IND ENG CHEM RES, V44, P7019, DOI 10.1021/ie0501982
   Neofofistou E, 2004, DESALINATION, V167, P257, DOI 10.1016/j.desal.2004.06
   Neofotistou E, 2004, COLLOID SURFACE A, V242, P213, DOI 10.1016/j.colsurfa.2004.04.067
   Patwardhan S. V., 2002, SILICON CHEM, V1, P47, DOI [10.1023/A:1016026927401, DOI 10.1023/A:1016026927401]
   Patwardhan S. V., 2002, SILICON CHEM, V1, P207, DOI [DOI 10.1023/A:1021243810915, 10.1023/A:1021243810915]
   Patwardhan SV, 2011, CHEM COMMUN, V47, P7567, DOI 10.1039/c0cc05648k
   Patwardhan SV, 2006, BIOMACROMOLECULES, V7, P491, DOI 10.1021/bn050717k
   Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c
   Patwardhan SV, 2003, CHEM COMMUN, P1122, DOI 10.1039/b302056h
   Patwardhan SV, 2002, POLYM BULL, V48, P367, DOI 10.1007/s00289-002-0043-x
   Rickert D, 2002, GEOCHIM COSMOCHIM AC, V66, P439, DOI 10.1016/S0016-7037(01)00757-8
   Sjoberg S, 1996, J NON-CRYST SOLIDS, V196, P51, DOI 10.1016/0022-3093(95)00562-5
   Stoll S, 2002, MACROMOLECULES, V35, P9556, DOI 10.1021/ma020272h
   Struyf E, 2009, SILICON-NETH, V1, P207, DOI 10.1007/s12633-010-9035-x
   Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k
   Swann GEA, 2011, CLIM PAST, V7, P65, DOI 10.5194/cp-7-65-2011
   TESTER JW, 1994, GEOCHIM COSMOCHIM AC, V58, P2407, DOI 10.1016/0016-7037(94)90020-5
   TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375
   Wallace AF, 2010, J PHYS CHEM A, V114, P2534, DOI 10.1021/jp907851u
   WIRTH GS, 1979, J COLLOID INTERF SCI, V68, P492, DOI 10.1016/0021-9797(79)90307-2
NR 62
TC 12
Z9 12
U1 2
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 20
PY 2011
VL 27
IS 24
BP 15135
EP 15145
DI 10.1021/la204180r
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 862UB
UT WOS:000298118500051
PM 22085267
DA 2018-10-19
ER

PT J
AU Pandey, JK
   Takagi, H
AF Pandey, Jitendra Kumar
   Takagi, Hitoshi
TI SELF HEALING POTENTIAL OF GREEN NANOCOMPOSITES FROM CRYSTALLINE
   CELLULOSE
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS B
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Advanced Materials Processing and
   Development (AMDP)
CY JUL 15-18, 2011
CL Tokushima, JAPAN
DE Functional biomaterial; surface modification; self-healing composites
ID COMPOSITES
AB In plant cell walls, stiff semicrystalline nano dimensional cellulose microfibrils are embedded in a pliable amorphous matrix where the size and shape of the cellulose fibrils are controlled by the dimensions of crystalline regions, providing them a unique structural and physical combination to be applied as load-bearing constituent in composites. The qualities such as specific orientation under magnetic field, extraction through simple process, abundantly available source from nature and desirable modifications have deliberately directed the intense research efforts in a number of disciplines ranging from commodity to higher applications, not only in the area of high performance polymer based composites but also to develop biosensors, magnetic strips and optical devices. The present work is focused on the use of cellulose nano-fillers for creating the self-healing function and their effect on material properties of resulting composites. The present work is in initial stage and reviews the use of cellulose nano-fillers for creating the self-healing function and their effect on material properties of resulting composites.
C1 [Pandey, Jitendra Kumar; Takagi, Hitoshi] Univ Tokushima, Adv Mat Div, Inst Sci & Technol, Minamijosanjima, Tokushima 7708506, Japan.
RP Takagi, H (reprint author), Univ Tokushima, Adv Mat Div, Inst Sci & Technol, Minamijosanjima, Tokushima 7708506, Japan.
EM jitendra@me.tokushima-u.ac.jp; takagi@me.tokushima-u.ac.jp
RI Takagi, Hitoshi/E-8946-2012
OI Takagi, Hitoshi/0000-0003-0228-226X
CR Kessler MR, 2007, P I MECH ENG G-J AER, V221, P479, DOI 10.1243/09544100JAERO172
   Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268
   Mauldin TC, 2010, INT MATER REV, V55, P317, DOI 10.1179/095066010X12646898728408
   Murphy EB, 2010, PROG POLYM SCI, V35, P223, DOI 10.1016/j.progpolymsci.2009.10.006
   Pandey JK, 2010, MACROMOL MATER ENG, V295, P975, DOI 10.1002/mame.201000095
   Pandey JK, 2010, J APPL POLYM SCI, V115, P2493, DOI 10.1002/app.31205
   Sameer M. A. S. A., 2005, BIOMACROMOLECULES, V6, P612
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   Takagi H, 2008, COMPOS PART A-APPL S, V39, P685, DOI 10.1016/j.compositesa.2007.08.019
NR 9
TC 2
Z9 3
U1 3
U2 25
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9792
J9 INT J MOD PHYS B
JI Int. J. Mod. Phys. B
PD DEC 20
PY 2011
VL 25
IS 31
SI SI
BP 4216
EP 4219
DI 10.1142/S0217979211066611
PG 4
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 871PZ
UT WOS:000298751500018
DA 2018-10-19
ER

PT J
AU Zhou, WJ
   Du, GJ
   Hu, PG
   Yin, YQ
   Li, JH
   Yu, JH
   Wang, GC
   Wang, JX
   Liu, H
   Wang, JY
   Zhang, H
AF Zhou, Weijia
   Du, Guojun
   Hu, Peiguang
   Yin, Yongquan
   Li, Jianhua
   Yu, Jiahong
   Wang, Guancong
   Wang, Jinxia
   Liu, Hong
   Wang, Jiyang
   Zhang, Hua
TI Nanopaper based on Ag/TiO2 nanobelts heterostructure for continuous-flow
   photocatalytic treatment of liquid and gas phase pollutants
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE TiO2 nanobelts; Heterostructures; Nanopapers; Continuous photocatalysis;
   Antibacterial property
ID SILVER NANOPARTICLES; DOPED TIO2; WATER; OXIDATION; DEGRADATION;
   CATALYSTS; MEMBRANE; BACTERIA; NANOTUBE; REACTOR
AB The Ag/TiO2 nanobelt heterostructures were prepared by the acid-assisted hydrothermal method followed by an in situ photo-reduction process. The photocatalytic activity of TiO2 nanobelts was evidently enhanced by the heterostructures between Ag nanoparticles and TiO2 nanobelts. The nanopapers based on Ag/Ti O-2 nanobelt heterostructures were fabricated via a modified paper-making process. A novel continuous photocatalytic reactor was designed, and MO removal rate of Ag/C-TiO2 nanopaper was achieved to 100% in 40 min for single layer and only in 6 min for three layers. The self-supported TiO2 nanopapers with porous structures also showed an excellent continuous photocatalytic performance for toluene gas under UV light irradiation, and the corresponding degradation rate was 69.5% in 184 min. Moreover, the Ag/TiO2 nanobelts nanopaper showed a good antibacterial effect. The multifunctional TiO2 nanopapers modified by the heterostuctures could have potential applications in the environmental and biomaterial fields. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
C1 [Zhou, Weijia; Du, Guojun; Hu, Peiguang; Li, Jianhua; Wang, Guancong; Liu, Hong; Wang, Jiyang] Shandong Univ, Ctr Bio & Micro Nano Funct Mat, State Key Lab Crystal Mat, Jinan 250100, Peoples R China.
   [Yin, Yongquan; Yu, Jiahong] Shandong Univ, Sch Environm Sci & Engn, Jinan 250100, Peoples R China.
   [Wang, Jinxia] Shandong Polytech Univ, Sch Light Chem & Environm Engn, Jinan 250353, Peoples R China.
   [Zhang, Hua] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
RP Liu, H (reprint author), Shandong Univ, Ctr Bio & Micro Nano Funct Mat, State Key Lab Crystal Mat, 27 Shandanan Rd, Jinan 250100, Peoples R China.
EM hongliu@sdu.edu.cn; jywang@icm.sdu.edu.cn
RI zhou, weijia/E-5314-2015; Zhang, Hua/A-1302-2009; SDU, Environ
   Res/P-4462-2015
OI Zhang, Hua/0000-0001-9518-740X; Li, Jianhua/0000-0001-5227-8627
FU NSFC (NSFDYS) [50925205, 50872070, 60974117, 50990303, 51021062];
   Program of Introducing Talents of Discipline to Universities in China
   (111 Program) [b06015]; Independent Innovation Foundation of Shandong
   University [2009JC011]; Graduate Independent Innovation Foundation of
   Shandong University (GIIFSDU)
FX This research was supported by NSFC (NSFDYS: 50925205, 50872070,
   60974117, grant 50990303; IRG: 51021062), the Program of Introducing
   Talents of Discipline to Universities in China (111 Program b06015),
   Independent Innovation Foundation of Shandong University (2009JC011) and
   Graduate Independent Innovation Foundation of Shandong University
   (GIIFSDU).
CR Arana J, 2008, APPL CATAL B-ENVIRON, V78, P355, DOI 10.1016/j.apcatb.2007.09.023
   Chen LM, 2010, SURF COAT TECH, V204, P3871, DOI 10.1016/j.surfcoat.2010.05.003
   Dong WJ, 2006, J PHYS CHEM B, V110, P16819, DOI 10.1021/jp0637633
   Einaga H, 2002, APPL CATAL B-ENVIRON, V38, P215, DOI 10.1016/S0926-3373(02)00056-5
   Fei HL, 2007, MICROPOR MESOPOR MAT, V102, P318, DOI 10.1016/j.micromeso.2007.01.021
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Grieken R., 2009, APPL CATAL B-ENVIRON, V93, P112
   Herbig B, 2004, J PHOTOCH PHOTOBIO A, V163, P359, DOI 10.1016/j.jphotochem.2004.01.005
   HOFSTADLER K, 1994, ENVIRON SCI TECHNOL, V28, P670, DOI 10.1021/es00053a021
   Kasuga T, 1998, LANGMUIR, V14, P3160, DOI 10.1021/la9713816
   Li FB, 2004, APPL CATAL B-ENVIRON, V54, P275, DOI 10.1016/j.apcatb.2004.09.006
   Maira AJ, 2001, APPL CATAL B-ENVIRON, V29, P327, DOI 10.1016/S0926-3373(00)00211-3
   Mohamed MM, 2011, MICROPOR MESOPOR MAT, V142, P130, DOI 10.1016/j.micromeso.2010.11.026
   Muruganandham M, 2006, DYES PIGMENTS, V68, P133, DOI 10.1016/j.dyepig.2005.01.004
   Ochuma IJ, 2007, CATAL TODAY, V128, P100, DOI 10.1016/j.cattod.2007.05.015
   Pal A, 2008, IND ENG CHEM RES, V47, P7580, DOI 10.1021/ie701739g
   Park JH, 2006, NANO LETT, V6, P24, DOI 10.1021/nl051807y
   Portjanskaja E, 2004, ENVIRON CHEM LETT, V2, P123, DOI 10.1007/s10311-004-0078-3
   Sobana N, 2006, J MOL CATAL A-CHEM, V258, P124, DOI 10.1016/j.molcata.2006.05.013
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   TANG J, 2004, CHEM COMMUN, V167
   Wang Y., 2008, ADV FUNCT MATER, V18, P1
   Xin BF, 2005, J PHYS CHEM B, V109, P2805, DOI 10.1021/jp0469618
   Zhang FX, 2005, J CATAL, V232, P424, DOI 10.1016/j.jcat.2005.04.014
   Zhang XW, 2008, J MEMBRANE SCI, V313, P44, DOI 10.1016/j.memsci.2007.12.045
   Zhou WJ, 2011, J MATER CHEM, V21, P7937, DOI 10.1039/c1jm10588d
   ZHOU WJ, 2011, CRYSTENGCOMM, DOI DOI 10.1039/C1CE05638G
   Zhu HY, 2005, J AM CHEM SOC, V127, P6730, DOI 10.1021/ja044689+
NR 28
TC 44
Z9 46
U1 5
U2 97
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD DEC 15
PY 2011
VL 197
BP 19
EP 25
DI 10.1016/j.jhazmat.2011.09.051
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 863XA
UT WOS:000298200400003
PM 21978584
DA 2018-10-19
ER

PT J
AU Jurczyk, K
   Jurczyk, MU
   Niespodziana, K
   Jakubowicz, J
   Jurczyk, M
AF Jurczyk, K.
   Jurczyk, M. U.
   Niespodziana, K.
   Jakubowicz, J.
   Jurczyk, M.
TI Titanium-10 wt% 45S5 Bioglass nanocomposite for biomedical applications
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Composite materials; Powder metallurgy; Sintering
ID BIOACTIVE GLASS 45S5; OSTEOBLAST ADHESION; HYDROXYAPATITE; BIOMATERIALS;
   CRYSTALLIZATION; NANOTECHNOLOGY; FABRICATION; COMPOSITES; IMPLANTS;
   BEHAVIOR
AB In the present study, titanium-10 wt% 4555 Bioglass nanocomposite was successfully synthesized by the combination of mechanical alloying and powder metallurgy process. The structure, mechanical and corrosion properties of this material were investigated. Microhardness test showed that the obtained material exhibits Vickers' microhardness as high as 620 HV(0.2), which is two times higher than that of a conventional microcrystalline titanium (225 HV(0.2)). Additionally, titanium-10 wt% of 4555 Bioglass nanocomposites (i(c) = 1.20 x 10(-7) A cm(-2), E(c) = -0.42 V vs. SCE) were more corrosion resistant than microcrystalline titanium (i(c) = 2.27 x 10(-6) A cm(-2), E(c) = -0.36 V vs. SCE). The electrochemical treatment in phosphoric acid electrolyte results in porous surface, attractive for tissue fixing and growth. In vitro cytocompatibility of these materials was evaluated and compared with a conventional microcrystalline titanium, where normal human osteoblast (NHOst) cells from Cambrex (CC-2538) were cultured on the discs of the materials and cell growth was examined. On porous surface, the cells adhered with their whole surface to the insert penetrating the porous structure, while on the polished surface, more spherical cells were observed with a smaller surface of adhesion. On the other hand, the morphology of the cell cultures obtained on Ti-10 wt% 45S5 Bioglass nanocomposite was similar to those obtained on the microcrystalline titanium. The present study has demonstrated that porous titanium-10 wt% 4555 Bioglass nanocomposite is a promising biomaterial for bone tissue engineering due to its appropriate microstructure, high hardness, low E modulus, better corrosion resistance and good cytocompatibility. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Niespodziana, K.; Jakubowicz, J.; Jurczyk, M.] Poznan Tech Univ, Inst Mat Sci & Engn, PL-60695 Poznan, Poland.
   [Jurczyk, K.] Karol Marcinkowski Univ Med Sci, Dept Conservat Dent & Periodontol, PL-60812 Poznan, Poland.
   [Jurczyk, M. U.] Karol Marcinkowski Univ Med Sci, Div Mothers & Childs Hlth, PL-60535 Poznan, Poland.
RP Jurczyk, M (reprint author), Poznan Tech Univ, Inst Mat Sci & Engn, M Sklodowska Curie Sq 5, PL-60695 Poznan, Poland.
EM mieczyslaw.jurczyk@put.poznan.pl
RI Niespodziana, Kasia/N-7507-2013; Jurczyk, Mieczyslawa/F-9465-2014;
   Jakubowicz, Jaroslaw/F-7836-2014; Jurczyk, Mieczyslaw/F-8616-2014
OI Niespodziana, Kasia/0000-0001-9827-9879; Jurczyk,
   Mieczyslawa/0000-0002-8250-5138; Jakubowicz,
   Jaroslaw/0000-0001-6339-0796; Jurczyk, Mieczyslaw/0000-0001-5989-8298
FU Polish Ministry of Education and Science [N N507 295039]
FX The financial support of the Polish Ministry of Education and Science
   under the contract no. N N507 295039 is gratefully acknowledged.
CR [Anonymous], 2006, US Patent, Patent No. [993.406, 993406]
   Ban S, 2006, DENT MATER, V22, P1115, DOI 10.1016/j.dental.2005.09.007
   BENJAMIN JS, 1976, SCI AM, V234, P40, DOI 10.1038/scientificamerican0576-40
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Chu CL, 2006, J MATER SCI-MATER M, V17, P245, DOI 10.1007/s10856-006-7310-6
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   DAVIES JE, 1991, P BON BIOM INT WORKS, P214
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guehennec L., 2007, DENT MATER, V23, P844, DOI DOI 10.1016/J.DENTAL.2006.06.025
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Jakubowicz J, 2008, ELECTROCHEM COMMUN, V10, P735, DOI 10.1016/j.elecom.2008.02.027
   Jakubowicz J, 2009, ELECTROCHEM COMMUN, V11, P461, DOI 10.1016/j.elecom.2008.12.024
   Jurczyk MU, 2011, MATER DESIGN, V32, P4882, DOI 10.1016/j.matdes.2011.06.005
   Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Lefebvre L, 2007, ACTA MATER, V55, P3305, DOI 10.1016/j.actamat.2007.01.029
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Niespodziana K, 2010, MATER CHEM PHYS, V123, P160, DOI 10.1016/j.matchemphys.2010.03.076
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   Obinata I., 1960, T ASM, V52, P1072
   Postiglione L, 2003, J DENT RES, V82, P692, DOI 10.1177/154405910308200907
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Rizkalla AS, 1996, J BIOMED MATER RES, V32, P119, DOI 10.1002/(SICI)1097-4636(199609)32:1<119::AID-JBM14>3.0.CO;2-H
   Stylios G, 2007, INJURY, V38, pS63, DOI 10.1016/j.injury.2007.02.011
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Tulinski M, 2010, PHYS STATUS SOLIDI C, V7, P1359, DOI 10.1002/pssc.200983351
   Tulinski M, 2009, SOL ST PHEN, V151, P213, DOI 10.4028/www.scientific.net/SSP.151.213
   Wang Z. L., 2003, HDB NANOPHASE NANOST, V1
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 33
TC 8
Z9 8
U1 2
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD DEC 15
PY 2011
VL 131
IS 1-2
BP 540
EP 546
DI 10.1016/j.matchemphys.2011.10.020
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 871VC
UT WOS:000298764800085
DA 2018-10-19
ER

PT J
AU Moravej, M
   Amira, S
   Prima, F
   Rahem, A
   Fiset, M
   Mantovani, D
AF Moravej, Maryam
   Amira, Sofiene
   Prima, Frederic
   Rahem, Ahmed
   Fiset, Michel
   Mantovani, Diego
TI Effect of electrodeposition current density on the microstructure and
   the degradation of electroformed iron for degradable stents
SO MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE
   MATERIALS
LA English
DT Article
DE Electrodeposition; Electroforming; Degradable stents; Microstructure;
   Texture; Corrosion
ID CORROSION-RESISTANCE; PURE IRON; MORPHOLOGY; FILMS; RECRYSTALLIZATION;
   BIOMATERIAL; COATINGS; COPPER
AB Pure iron has become one of the most interesting candidate materials for degradable metallic stents due to its high mechanical properties and moderate degradation. In this work we studied the effect of electrodeposition current density on microstructure and degradation of pure iron films electrodeposited on Ti alloy substrate for degradable metallic stent application. Iron sheets were produced by electrodeposition using four different current densities 1, 2, 5 and 10 A dm(-2). The films were then studied by SEM (scanning electron microscope) and EBSD (electron backscatter diffraction) to observe the surface morphology, grain size and orientation. Potentiodynamic polarization and static immersion tests were used to determine the corrosion rate and to study the degradation behavior of iron films, respectively. The current density was found to significantly influence the texture, the grain size and the grain shape of the electrodeposited iron. At current densities of 1, 5 and 10 A dm(-2), weak textures corresponding to < 1 0 1 >, < 1 1 1 > and < 1 1 2 > in the normal (electrodeposition) direction were obtained, respectively. At these current densities, average grain sizes smaller than 3 mu m were also obtained. However, at 2 A dm(-2), a strong < 1 1 1 >//ND texture with density of 7.4 MUD was obtained with larger average grain size of 4.4 mu m. The microstructure of iron samples changed after annealing at 550 degrees C because of the induced recrystallization. Different corrosion rates were obtained from potentiodynamic polarization curves of iron films deposited at different current densities because of their microstructures. Fe-2 showed the lowest corrosion rate due to its larger grains size and its texture. The corrosion rates of all iron samples decreased after annealing. Static degradation showed lower corrosion rates for iron because of the formation of a degradation layer on samples surface which reduced the degradation reaction rate. The degradation morphology was uniform for Fe-2 due to its strong texture. On the other hand, microscopic pits were found for Fe-1, Fe-5 and Fe-10. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Moravej, Maryam; Mantovani, Diego] Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, Quebec City, PQ G1V 0A6, Canada.
   [Moravej, Maryam; Mantovani, Diego] Univ Laval, Univ Hosp Res Ctr, Quebec City, PQ G1V 0A6, Canada.
   [Amira, Sofiene; Rahem, Ahmed] Natl Res Council Canada, Inst Ind Mat, Aluminium Technol Ctr, Saguenay, PQ G7H 8C3, Canada.
   [Prima, Frederic] Univ Paris 06, Met Phys Lab, Ecole Natl Super Chim Paris, F-75252 Paris 05, France.
RP Mantovani, D (reprint author), Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, Pav Adrien Pouliot 1745-E,1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.
EM Diego.Mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
FU National Science and Engineering Research Council of Canada; Hydro
   Quebec
FX The authors would like to acknowledge the collaboration of Andre
   Ferland, the technician of the Department of Mining, Metallurgy and
   Materials Eng. of Universite Laval for the scanning electron microscopy
   studies. The collaboration of Helene Gregoire and Genevieve Simard from
   Aluminum Technology Centre, National Research Council Canada for sample
   preparation and EBSD studies is highly appreciated. This work was
   financially supported by the National Science and Engineering Research
   Council of Canada and M. Moravej's PhD grant by Hydro Quebec.
CR [Anonymous], 2009, G5997 ASTM INT, DOI [10.1520/G0059-97R09, DOI 10.1520/G0059-97R09]
   [Anonymous], 2004, G3172 ASTM INT, DOI [10.1520/G0031-72R04, DOI 10.1520/G0031-72R04]
   Asgari H, 2007, APPL SURF SCI, V253, P6769, DOI 10.1016/j.apsusc.2007.01.093
   Colombo A, 2000, CIRCULATION, V102, P371
   Dini J. W., 1993, ELECTRODEPOSITION MA
   Ebrahimi F, 2003, J APPL ELECTROCHEM, V33, P733, DOI 10.1023/A:1025049802635
   Enriquez JP, 2005, J MATER SCI-MATER EL, V16, P617, DOI 10.1007/s10854-005-3237-9
   Enriquez JP, 2003, J CRYST GROWTH, V259, P215, DOI 10.1016/j.jcrysgro.2003.07.001
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Hansen K, 2008, SCRIPTA MATER, V58, P96, DOI 10.1016/j.scriptamat.2007.09.033
   Hermawan H., 2009, ACTA MAT, V6, P1693
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hill M., RELATIONSHIP CRYSTAL
   HUTCHINSON WB, 1989, ACTA METALL MATER, V37, P1047, DOI 10.1016/0001-6160(89)90101-6
   Jartych E, 2002, APPL SURF SCI, V193, P210, DOI 10.1016/S0169-4332(02)00474-9
   Kanani N., 2005, ELECTROPLATING BASIC
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li DY, 1997, J MATER SCI, V32, P5513, DOI 10.1023/A:1018612205196
   MacGeough JA, 2001, CIRP ANN-MANUF TECHN, V50, P499, DOI 10.1016/S0007-8506(07)62990-4
   Matsushima H, 2007, J SOLID STATE ELECTR, V11, P737, DOI 10.1007/s10008-006-0210-3
   MERCHANT HD, 1995, J ELECTRON MATER, V24, P919, DOI 10.1007/BF02652962
   MERCHANT HD, 1993, J ELECTRON MATER, V22, P631, DOI 10.1007/BF02666409
   Meyer-Kobbe C., WHY ANNEALING 316LVM
   Moore J., 2004, BIOMEDICAL TECHNOLOG
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   PONCIN P, 2003, STENT TUBING UNDERST, V253
   Qi B, 1996, J ELECTROCHEM SOC, V143, P517, DOI 10.1149/1.1836474
   Ramanauskas R, 1997, SURF COAT TECH, V92, P16, DOI 10.1016/S0257-8972(96)03125-8
   Schlesinger M, 2000, MODERN ELECTROPLATIN
   Schreiber A, 2007, ELECTROCHIM ACTA, V52, P7738, DOI 10.1016/j.electacta.2006.12.062
   Schreiber A, 2006, ELECTROCHIM ACTA, V51, P2625, DOI 10.1016/j.electacta.2005.07.052
   Wang YD, 2005, ADV MATER, V17, P1221, DOI 10.1002/adma.200401420
   YOSHIMURA S, 1994, ELECTROCHIM ACTA, V39, P589, DOI 10.1016/0013-4686(94)80105-3
NR 35
TC 30
Z9 31
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-5107
J9 MATER SCI ENG B-ADV
JI Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.
PD DEC 15
PY 2011
VL 176
IS 20
SI SI
BP 1812
EP 1822
DI 10.1016/j.mseb.2011.02.031
PG 11
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 859LG
UT WOS:000297877300031
DA 2018-10-19
ER

PT J
AU Rai, R
   Boccaccini, AR
   Knowles, JC
   Mordon, N
   Salih, V
   Locke, IC
   Moshrefi-Torbati, M
   Keshavarz, T
   Roy, I
AF Rai, Ranjana
   Boccaccini, Aldo R.
   Knowles, Jonathan C.
   Mordon, Nicola
   Salih, Vehid
   Locke, Ian C.
   Moshrefi-Torbati, M.
   Keshavarz, Tajalli
   Roy, Ipsita
TI The Homopolymer Poly(3-hydroxyoctanoate) as a Matrix Material for Soft
   Tissue Engineering
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Times of Polymers (TOP) and Composites
CY JUN 20-23, 2010
CL Ischia, ITALY
SP Second Univ Naples, Univ Naples Federico II
DE biopolymer; polyester; elastomer; biodegradable
ID MECHANICAL-PROPERTIES; HYDROLYTIC DEGRADATION; MYOCARDIAL STIFFNESS;
   STARCH BLENDS; IN-VITRO; POLYHYDROXYALKANOATES; POLYMERS; ELASTOMER;
   COMPOSITE; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE)
AB The homopolymer poly(3-hydroxyoctanoate), produced from Pseudomonas mendocina with octanoate as a carbon feed, was studied as a potential biomaterial for soft tissue engineering, that is, as a cardiac patch and as matrices for skin tissue engineering. The polymer was fabricated into neat solvent-cast films of 5 and 10 wt Microstructural studies revealed the films as having a smooth surface topography with a root mean square value of 0.238 mu m. The films also possessed moderate hydrophilicity when compared to other monomers of the polyhydroxyalkanoate family. Stress-strain curves of the films obtained was typical of that of elastomeric polymers. This elastomeric and flexible nature of the films makes them promising candidates for the proposed applications. Biocompatibility studies with the human adult low calcium temperature keratinocytes (HaCaT) keratinocyte cell line showed that the films were able to support the attachment, differentiation, and maturation of the HaCaT cells. In vitro degradation studies over a period of 4 months showed that the water absorption and weight loss increased progressively with time for the films. The films underwent hydrolytic degradation initiated on the surface and also showed an aging effect. (C) 2011 Wiley Periodicals, Inc. J Appl Polym Sci 122: 3606-3617, 2011
C1 [Rai, Ranjana; Keshavarz, Tajalli; Roy, Ipsita] Univ Westminster, Sch Life Sci, Dept Mol & Appl Bio Sci, London W1W 6UW, England.
   [Boccaccini, Aldo R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
   [Knowles, Jonathan C.; Mordon, Nicola; Salih, Vehid] UCL, Eastman Dent Inst, Div Biomt & Tissue Engn, London WCIX 8LD, England.
   [Knowles, Jonathan C.] Dankook Univ, WCU, Res Ctr Nanobiomed Sci, Cheonan Si 330714, Chungnam, South Korea.
   [Locke, Ian C.] Univ Westminster, Sch Life Sci, Dept Biomed Sci, London W1W 6UW, England.
   [Moshrefi-Torbati, M.] Univ Southampton, Sch Engn Sci, Southampton SO17 1BJ, Hants, England.
RP Roy, I (reprint author), Univ Westminster, Sch Life Sci, Dept Mol & Appl Bio Sci, London W1W 6UW, England.
EM royips@gmail.com
RI Boccaccini, Aldo/C-7905-2013; Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; Locke,
   Ian/0000-0003-1875-5965
CR Alata H, 2007, MACROMOLECULES, V40, P4546, DOI 10.1021/ma070418i
   Anderson A.J., 1990, MICROBIOL REV, V54, P50
   Asrar J, 2002, BIOMACROMOLECULES, V3, P1006, DOI 10.1021/bm025543a
   Biddlestone F, 1996, POLYM INT, V39, P221
   BING OHL, 1971, CIRC RES, V28, P234, DOI 10.1161/01.RES.28.2.234
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   DOI Y, 1989, MAKROMOL CHEM-RAPID, V10, P227
   FURRER P, 2006, EUR CELLS MATER, V11, P4
   GAGNON KD, 1992, RUBBER CHEM TECHNOL, V65, P761, DOI 10.5254/1.3538640
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUTCHINSON JM, 1995, PROG POLYM SCI, V20, P703, DOI 10.1016/0079-6700(94)00001-I
   Ji Y, 2008, BIOMATERIALS, V29, P3807, DOI 10.1016/j.biomaterials.2008.06.008
   Kim HW, 2002, INT J BIOL MACROMOL, V30, P129, DOI 10.1016/S0141-8130(02)00012-0
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Lin FH, 2000, MATER CHEM PHYS, V64, P189, DOI 10.1016/S0254-0584(99)00262-X
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Marcal H, 2008, BIOMACROMOLECULES, V9, P2719, DOI 10.1021/bm800418e
   MARCHESSAULT RH, 1990, INT J BIOL MACROMOL, V12, P158
   Marois Y, 2000, J BIOMED MATER RES, V49, P216, DOI 10.1002/(SICI)1097-4636(200002)49:2<216::AID-JBM9>3.0.CO;2-X
   Mashelkar R.A., 1977, INT J POLYM MATER, V5, P317
   Misof K, 1997, J CLIN INVEST, V100, P40, DOI 10.1172/JCI119519
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Misra SK, 2007, BIOMACROMOLECULES, V8, P2112, DOI 10.1021/bm0701954
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352
   Navarro M, 2006, ADV POLYM SCI, V200, P209, DOI 10.1007/12_068
   Ouyang SP, 2007, BIOMACROMOLECULES, V8, P2504, DOI 10.1021/bm0702307
   Parulekar Y, 2007, MACROMOL MATER ENG, V292, P1218, DOI 10.1002/mame.200700125
   Peschel G., 2007, J BIOMED MATER RES, P1073
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Prashar A, 2004, CELL PROLIFERAT, V37, P221, DOI 10.1111/j.1365-2184.2004.00307.x
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Rai R, 2010, BIOSYNTHESIS POLYHYD
   RAMSAY BA, 1993, APPL ENVIRON MICROB, V59, P1242
   Renard E, 2004, POLYM DEGRAD STABIL, V85, P779, DOI 10.1016/j.pllymdegradstab.2003.11.019
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Scott G, 1995, DEGRADABLE POLYM PRI
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, P1
   Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011
   Tang HY, 2008, BIOMATERIALS, V29, P1307
   Terskikh VV, 1999, INT REV CYTOL, V188, P41
   Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P1181, DOI 10.1023/B:BILE.0000036599.15302.e5
   VACANTI CA, 2000, PRINCIPLES TISSUE EN
   VALAPPIL SP, 2007, J APPL MICROBIOL, V104, P1624
   Volova TG, 2004, POLYHYDROXYALKANOATE
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   YIN FCP, 1980, CIRC RES, V46, P292, DOI 10.1161/01.RES.46.2.292
   YUNG A, 2010, STRUCTURE SKIN
   Zhang L., 2003, J APPL POLYM SCI, V56, P103
   ZHONG SP, 2010, WILEY INTERDISCIP RE, V5, P510
NR 61
TC 7
Z9 8
U1 0
U2 23
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 15
PY 2011
VL 122
IS 6
SI SI
BP 3606
EP 3617
DI 10.1002/app.34772
PG 12
WC Polymer Science
SC Polymer Science
GA 827PT
UT WOS:000295441100016
DA 2018-10-19
ER

PT J
AU Zou, L
   Nair, A
   Weng, H
   Tsai, YT
   Hu, ZB
   Tang, LP
AF Zou, Ling
   Nair, Ashwin
   Weng, Hong
   Tsai, Yi-Ting
   Hu, Zhibing
   Tang, Liping
TI Intraocular Pressure Changes: An Important Determinant of the
   Biocompatibility of Intravitreous Implants
SO PLOS ONE
LA English
DT Article
ID OCULAR DRUG-DELIVERY; CYTOMEGALOVIRUS RETINITIS; INTRAVENOUS CIDOFOVIR;
   ALBUMIN NANOPARTICLES; TRABECULAR MESHWORK; ANTERIOR UVEITIS; TISSUE
   RESPONSES; RISK-FACTORS; IN-VITRO; GLAUCOMA
AB Background: In recent years, research efforts exploring the possibility of using biomaterial nanoparticles for intravitreous drug delivery has increased significantly. However, little is known about the effect of material properties on intravitreous tissue responses.
   Principal Findings: To find the answer, nanoparticles made of hyaluronic acid (HA), poly (l-lactic acid) (PLLA), polystyrene (PS), and Poly N-isopropyl acrylamide (PNIPAM) were tested using intravitreous rabbit implantation model. Shortly after implantation, we found that most of the implants accumulated in the trabecular meshwork area followed by clearance from the vitreous. Interestingly, substantial reduction of intraocular pressure (IOP) was observed in eyes implanted with particles made of PS, PNIPAM and PLLA, but not HA nanoparticles and buffered salt solution control. On the other hand, based on histology, we found that the particle implantation had no influence on cornea, iris and even retina. Surprisingly, substantial CD11b+ inflammatory cells were found to accumulate in the trabecular meshwork area in some animals. In addition, there was a good relationship between recruited CD11b+ cells and IOP reduction.
   Conclusions: Overall, the results reveal the potential influence of nanoparticle material properties on IOP reduction and inflammatory responses in trabecular meshwork. Such interactions may be critical for the development of future ocular nanodevices with improved safety and perhaps efficacy.
C1 [Zou, Ling; Nair, Ashwin; Weng, Hong; Tsai, Yi-Ting; Tang, Liping] Univ Texas SW Med Ctr Dallas, Joint Program Bioengn, Dallas, TX 75390 USA.
   [Zou, Ling; Nair, Ashwin; Weng, Hong; Tsai, Yi-Ting; Tang, Liping] Univ Texas Arlington, Arlington, TX 76019 USA.
   [Hu, Zhibing] Univ N Texas, Dept Phys, Denton, TX 76203 USA.
   [Hu, Zhibing] Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA.
RP Zou, L (reprint author), Univ Texas SW Med Ctr Dallas, Joint Program Bioengn, Dallas, TX 75390 USA.
EM ltang@uta.edu
RI Nair, Ashwin/B-8307-2011
OI Nair, Ashwin/0000-0002-7334-3114
FU National Institutes of Health [EB007271]
FX This work was supported by National Institutes of Health grant EB007271.
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akler ME, 1998, OPHTHALMOLOGY, V105, P651, DOI 10.1016/S0161-6420(98)94019-2
   Ambati J, 1999, BRIT J OPHTHALMOL, V83, P1153, DOI 10.1136/bjo.83.10.1153
   Amrite AC, 2005, J PHARM PHARMACOL, V57, P1555, DOI 10.1211/jpp.57.12.0005
   AMRITE AC, 2003, DRUG DEV DELIVERY, V3
   Amrite AC, 2008, MOL VIS, V14, P150
   Avitabile T, 2001, BIOMATERIALS, V22, P195, DOI 10.1016/S0142-9612(00)00169-1
   Beeley NRF, 2005, J BIOMED MATER RES A, V73A, P437, DOI 10.1002/jbm.a.30294
   BINKHORST CD, 1980, AM INTRAOCULAR IMPLA, V6, P340
   Bourges JL, 2003, INVEST OPHTH VIS SCI, V44, P3562, DOI 10.1167/iovs.02-1068
   Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009
   Cejkova J, 2010, J COLLOID INTERF SCI, V346, P352, DOI 10.1016/j.jcis.2010.02.060
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Choonara YE, 2010, J PHARM SCI-US, V99, P2219, DOI 10.1002/jps.21987
   Davis JL, 1997, ARCH OPHTHALMOL-CHIC, V115, P733, DOI 10.1001/archopht.1997.01100150735008
   De Jesus OLP, 2002, BIOCONJUGATE CHEM, V13, P453, DOI 10.1021/bc010103m
   Dietlein TS, 2003, OPHTHALMOLOGE, V100, P991, DOI 10.1007/s00347-003-0831-1
   Einmahl S, 2003, J BIOMED MATER RES A, V67A, P44, DOI 10.1002/jbm.a.10597
   Fernandez-Cossio S, 2006, PLAST RECONSTR SURG, V117, P1789, DOI 10.1097/01.prs.0000214656.07273.b0
   FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0
   FESSI H, 1986, Patent No. 2
   Fitzpatrick SD, 2010, BIOMACROMOLECULES, V11, P2261, DOI 10.1021/bm100299j
   Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060
   Gao QX, 2009, POLYMER, V50, P2587, DOI 10.1016/j.polymer.2009.03.049
   GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797
   Herbert HM, 2004, J GLAUCOMA, V13, P96, DOI 10.1097/00061198-200404000-00003
   Hsiue GH, 2002, BIOMATERIALS, V23, P457, DOI 10.1016/S0142-9612(01)00127-2
   Hsu J, 2007, CURR OPIN OPHTHALMOL, V18, P235, DOI 10.1097/ICU.0b013e3281108000
   HU Z, 2009, PROCESS SYNTHESIZING
   Huhtala A, 2008, J MATER SCI-MATER M, V19, P645, DOI 10.1007/s10856-007-3192-5
   INSLER MS, 1987, ARCH OPHTHALMOL-CHIC, V105, P922
   Irache JM, 2005, MINI-REV MED CHEM, V5, P293, DOI 10.2174/1389557053175335
   Janoria KG, 2007, EXPERT OPIN DRUG DEL, V4, P371, DOI 10.1517/17425247.4.4.371
   JOHNSON M, 1978, ARCH OPHTHALMOL-CHIC, V96, P664
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   KANEKO M, 1987, OPHTHALMIC RES, V19, P330, DOI 10.1159/000265517
   Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473
   Kawakami S, 2004, INT J PHARM, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013
   KAWASHIMA Y, 1989, J PHARM SCI, V78, P68, DOI 10.1002/jps.2600780118
   KHOOBEHI B, 1991, OPHTHALMIC SURG LAS, V22, P175
   KINSHUCK D, 1991, BRIT J OPHTHALMOL, V75, P575, DOI 10.1136/bjo.75.9.575
   Kymionis GD, 2008, J REFRACT SURG, V24, P633
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Li H, 2006, EXP EYE RES, V83, P824, DOI 10.1016/j.exer.2006.04.014
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Lim JI, 1999, AM J OPHTHALMOL, V127, P288, DOI 10.1016/S0002-9394(98)00443-7
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   MA WJ, 2011, LASERS MED SCI
   Merodio M, 2002, BIOMATERIALS, V23, P1587, DOI 10.1016/S0142-9612(01)00284-8
   Musa F, 2006, J CATARACT REFR SURG, V32, P177, DOI 10.1016/j.jcrs.2005.11.024
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nair A, 2010, TISSUE ENG PART C-ME, V16, P23, DOI 10.1089/ten.TEC.2009.0094
   Nair A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/48/485102
   Nair A, 2008, J BIOMED NANOTECHNOL, V4, P410, DOI 10.1166/jbn.2008.004
   Nguyen KT, 2009, J BIOMED MATER RES A, V88A, P1022, DOI 10.1002/jbm.a.31734
   Nishida K, 2011, GRAEF ARCH CLIN EXP, V249, P833, DOI 10.1007/s00417-010-1566-8
   OHNO S, 1989, OPHTHALMOLOGICA, V199, P41, DOI 10.1159/000310013
   Pignatello R, 2002, BIOMATERIALS, V23, P3247, DOI 10.1016/S0142-9612(02)00080-7
   PONTE F, 1994, DOC OPHTHALMOL, V85, P203, DOI 10.1007/BF01664928
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Raju HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017452
   Riley T, 1999, COLLOID SURFACE B, V16, P147, DOI 10.1016/S0927-7765(99)00066-1
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rosa N, 2011, OPHTHALMOLOGY, V118, P260, DOI 10.1016/j.ophtha.2010.06.020
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Sakuma S, 1999, INT J PHARM, V177, P161, DOI 10.1016/S0378-5173(98)00346-9
   Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638
   Stoiber J, 2005, OPHTHAL SURG LAS IM, V36, P471
   Taniguchi T, 1998, CURR EYE RES, V17, P308, DOI 10.1076/ceyr.17.3.308.5225
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Ueda J, 1998, JPN J OPHTHALMOL, V42, P337, DOI 10.1016/S0021-5155(98)00026-4
   Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025
   Vandervoort J, 2007, NANOMEDICINE-UK, V2, P11, DOI 10.2217/17435889.2.1.11
   Vega E, 2006, J PHARM SCI-US, V95, P2393, DOI 10.1002/jps.20685
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   WILLIAMSON J, 1981, T OPHTHAL SOC UK, V101, P27
   Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005
NR 82
TC 6
Z9 6
U1 1
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2011
VL 6
IS 12
AR e28720
DI 10.1371/journal.pone.0028720
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 866GS
UT WOS:000298369100085
PM 22194895
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rane, AA
   Christman, KL
AF Rane, Aboli A.
   Christman, Karen L.
TI Biomaterials for the Treatment of Myocardial Infarction
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Review
DE biomaterial; cardiac patch; injectable; left ventricular remodeling;
   left ventricular restraint; myocardial infarction
ID FIBROBLAST-GROWTH-FACTOR; SMALL-INTESTINAL SUBMUCOSA; STEM-CELL
   TRANSPLANTATION; CARDIAC-FUNCTION; INJECTABLE HYDROGEL; RAT HEARTS;
   FIBRIN SCAFFOLD; EXTRACELLULAR-MATRIX; ISCHEMIC-MYOCARDIUM; PEPTIDE
   NANOFIBERS
AB The first review on biomaterials for the treatment of myocardial infarction (MI) was written in 2006. In the last 5 years, the general approaches for biomaterial treatment of MI and subsequent left ventricular remodeling remain the same, namely, left ventricular restraints, epicardial patches, and injectable therapies. Nonetheless, there have been significant developments in this field, including advancement of biomaterial therapies to large animal pre-clinical studies and, more recently, to clinical trials. This review focuses on the progress made in the field of cardiac biomaterial treatments for MI over the last 5 years. (J Am Coll Cardiol 2011;58:2615-29) (C) 2011 by the American College of Cardiology Foundation
C1 [Rane, Aboli A.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,MC 0412, La Jolla, CA 92093 USA.
EM christman@bioeng.ucsd.edu
CR BioLineRx L., 2009, NCT00557531 BIOLINER
   Blom AS, 2007, ANN THORAC SURG, V84, P2004, DOI 10.1016/j.athoracsur.2007.06.062
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cortes-Morichetti M, 2007, TISSUE ENG, V13, P2681, DOI 10.1089/ten.2006.0447
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   George I, 2007, EUR J CARDIO-THORAC, V31, P55, DOI 10.1016/j.ejcts.2006.09.024
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x
   Giraud MN, 2010, ARTIF ORGANS, V34, pE184, DOI 10.1111/j.1525-1594.2009.00979.x
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Herpel E, 2006, HISTOPATHOLOGY, V48, P736, DOI 10.1111/j.1365-2559.2006.02398.x
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu W, 2006, AM J PHYSIOL-HEART C, V291, pH2515, DOI 10.1152/ajpheart.01016.2005
   Liu Y, 2006, EUR J CARDIO-THORAC, V30, P103, DOI 10.1016/j.ejcts.2006.03.043
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lue S, 2010, TISSUE ENG PART A, V16, P1303
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Magovern JA, 2006, ASAIO J, V52, P196, DOI 10.1097/01.mat.0000199751.51424.78
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005
   Nie SP, 2010, J ZHEJIANG UNIV-SC B, V11, P895, DOI 10.1631/jzus.B1000302
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Pilla JJ, 2005, ANN THORAC SURG, V80, P2257, DOI 10.1016/j.athoracsur.2005.05.089
   Pozzobon M, 2010, CELL TRANSPLANT, V19, P1247, DOI 10.3727/096368910X505864
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Sarig U, 2011, EXPERT OPIN BIOL TH, V11, P1055, DOI 10.1517/14712598.2011.578574
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2011, J CARDIOVASC TRANSL, V4, P545, DOI 10.1007/s12265-011-9293-z
   Shao ZQ, 2006, CIRC J, V70, P471, DOI 10.1253/circj.70.471
   Siepe M, 2006, J THORAC CARDIOV SUR, V132, P124, DOI 10.1016/j.jtcvs.2006.01.052
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Singelyn JM, 2011, J AM COLL C IN PRESS
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tan MY, 2009, BIOMATERIALS, V30, P3234, DOI 10.1016/j.biomaterials.2009.02.013
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580
   Yng HS, 2011, CELL TRANSPLANT 0607
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yu J, 2010, BIOMATERIALS, V27, P7012
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 86
TC 111
Z9 113
U1 5
U2 81
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD DEC 13
PY 2011
VL 58
IS 25
BP 2615
EP 2629
DI 10.1016/j.jacc.2011.11.001
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 863DP
UT WOS:000298143300003
PM 22152947
OA Bronze
DA 2018-10-19
ER

PT J
AU Malik, AF
   Hoque, R
   Ouyang, XS
   Ghani, A
   Hong, EP
   Khan, K
   Moore, LB
   Ng, G
   Munro, F
   Flavell, RA
   Shi, Y
   Kyriakides, TR
   Mehal, WZ
AF Malik, Ahsan F.
   Hoque, Rafaz
   Ouyang, Xinshou
   Ghani, Ayaz
   Hong, Enping
   Khan, Khadija
   Moore, Laura Beth
   Ng, Gilbert
   Munro, Fay
   Flavell, Richard A.
   Shi, Yan
   Kyriakides, Themis R.
   Mehal, Wajahat Z.
TI Inflammasome components Asc and caspase-1 mediate biomaterial-induced
   inflammation and foreign body response
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID NALP3 INFLAMMASOME; DENDRITIC CELLS; DANGER SIGNAL; URIC-ACID;
   ACTIVATION; MACROPHAGE; CRYSTALS; SURFACES; ASPIRIN; FUSION
AB Implantation of biomaterials and devices into soft tissues leads to the development of the foreign body response (FBR), which can interfere with implant function and eventually lead to failure. The FBR consists of overlapping acute and persistent inflammatory phases coupled with collagenous encapsulation and currently there are no therapeutic options. Initiation of the FBR involves macrophage activation, proceeding to giant cell formation, fibroblast activation, and collagen matrix deposition. Despite the recognition of this sequence of events, the molecular pathways required for the FBR have not been elucidated. We have identified that the acute inflammatory response to biomaterials requires nucleotide-binding domain and leucine-rich repeat-containing 3 (Nlrp3), apoptosis-associated speck-like protein containing CARD (Asc), and caspase-1, as well as plasma membrane cholesterol, and Syk signaling. Full development of the FBR is dependent on Asc and caspase-1, but not Nlrp3. The common antiinflammatory drug aspirin can reduce inflammasome activation and significantly reduce the FBR. Taken together, these findings expand the role of the inflammasome from one of sensing damage associated molecular patterns (DAMPs) to sensing all particulate matter irrespective of size. In addition, implication of the inflammasome in biomaterial recognition identifies key pathways, which can be targeted to limit the FBR.
C1 [Hong, Enping; Khan, Khadija; Moore, Laura Beth; Kyriakides, Themis R.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA.
   [Hong, Enping; Khan, Khadija; Moore, Laura Beth; Kyriakides, Themis R.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
   [Malik, Ahsan F.; Hoque, Rafaz; Ouyang, Xinshou; Ghani, Ayaz; Mehal, Wajahat Z.] Yale Univ, Sect Digest Dis, New Haven, CT 06520 USA.
   [Ng, Gilbert; Munro, Fay; Shi, Yan] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada.
   [Flavell, Richard A.; Mehal, Wajahat Z.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA.
   [Mehal, Wajahat Z.] Dept Vet Affairs Connecticut Healthcare, Sect Digest Dis, West Haven, CT 06516 USA.
RP Kyriakides, TR (reprint author), Yale Univ, Dept Pathol, New Haven, CT 06520 USA.
EM themis.kyriakides@yale.edu; wajahat.mehal@yale.edu
FU National Institutes of Health [R01DK076674-01A2]; Veterans
   Administration Merit Award;  [RO1 GM072194-01];  [R21AI089963]; 
   [1K08DK092281-01]
FX We thank Eleni A. Skokos and Salma Kamal for technical assistance and
   Drs. Jordan Pober and Tarek Fahmy for a critical reading of the
   manuscript. This work was supported by National Institutes of Health
   Grant R01DK076674-01A2 and a Veterans Administration Merit Award (to
   W.Z.M.) and RO1 GM072194-01 (to T.R.K.), R21AI089963 (to Y.S.), and
   1K08DK092281-01 (to R.H.). R.A.F. is an Investigator for the Howard
   Hughes Medical Institute.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4
   Chiang Nan, 2006, Comprehensive Therapy, V32, P150, DOI 10.1385/COMP:32:3:150
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306
   Flower R, 2003, BRIT MED J, V327, P572, DOI 10.1136/bmj.327.7415.572
   Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958
   Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013
   Novak MT, 2010, ANAL BIOANAL CHEM, V398, P1695, DOI 10.1007/s00216-010-4097-6
   Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Szott LM, 2011, J BIOMED MATER RES A, V96A, P150, DOI 10.1002/jbm.a.32954
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143
   Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008
NR 30
TC 50
Z9 50
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 13
PY 2011
VL 108
IS 50
BP 20095
EP 20100
DI 10.1073/pnas.1105152108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 861QR
UT WOS:000298034800054
PM 22109549
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Roy, RS
   Roy, B
   Sengupta, S
AF Roy, Rituparna Sinha
   Roy, Bhaskar
   Sengupta, Shiladitya
TI Emerging technologies for enabling proangiogenic therapy
SO NANOTECHNOLOGY
LA English
DT Review
ID GROWTH FACTOR/SCATTER FACTOR; FACTOR-INDUCED ANGIOGENESIS; DRUG-DELIVERY
   VEHICLES; PDGF-BB; CARDIOVASCULAR-DISEASE; CONTROLLED-RELEASE;
   MYOCARDIAL-INFARCTION; REGENERATIVE MEDICINE; PLGA MICROSPHERES;
   SUSTAINED-RELEASE
AB Ischemic disease causes a large number of deaths and significant clinical problems worldwide. Therapeutic angiogenesis, strengthened by advances in growth-factor-based therapies, is a promising solution to ischemic pathologies. Major challenges in therapeutic angiogenesis are the lack of stability of native angiogenic proteins and also providing sustained delivery of biologically active proteins at the ischemic sites. This paper will discuss various protein engineering strategies to develop stabilized proangiogenic proteins and several biomaterial technologies used to amplify the angiogenic outcome by delivering biologically active growth factors in a sustained manner.
C1 [Roy, Rituparna Sinha] Indian Inst Sci Educ & Res, Dept Biol & Chem Sci, Kolkata 741252, W Bengal, India.
   [Roy, Bhaskar] Indian Inst Technol Kharagpur, Kharagpur 721302, W Bengal, India.
   [Roy, Bhaskar; Sengupta, Shiladitya] Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Roy, Bhaskar; Sengupta, Shiladitya] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Sengupta, Shiladitya] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Roy, RS (reprint author), Indian Inst Sci Educ & Res, Dept Biol & Chem Sci, Mohanpur Campus,P O BCKV Campus Mail Off, Kolkata 741252, W Bengal, India.
EM rituparna@iiserkol.ac.in; royrituparna@gmail.com; shiladit@mit.edu
CR Amsden BG, 2010, MACROMOL BIOSCI, V10, P825, DOI 10.1002/mabi.200900465
   Amsden BG, 2010, J CONTROL RELEASE, V145, P109, DOI 10.1016/j.jconrel.2010.03.029
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004
   Bhise NS, 2011, EXPERT OPIN DRUG DEL, V8, P485, DOI 10.1517/17425247.2011.558082
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Burke PA, 2000, HDB PHARM CONTROLLED, P661
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Cao Y, 2009, CURR MOL MED, V9, P967, DOI 10.2174/156652409789712747
   Cao YH, 2005, CARDIOVASC RES, V65, P639, DOI 10.1016/j.cardiores.2004.11.020
   Cao YH, 2010, DISCOV MED, V9, P179
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chapanian R, 2010, J CONTROL RELEASE, V143, P53, DOI 10.1016/j.jconrel.2009.11.025
   Chappell JC, 2008, SMALL, V4, P1769, DOI 10.1002/smll.200800806
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chung HJ, 2007, ADV DRUG DELIVER REV, V59, P249, DOI 10.1016/j.addr.2007.03.015
   Chung YI, 2010, J CONTROL RELEASE, V143, P282, DOI 10.1016/j.jconrel.2010.01.010
   Cleland JL, 2001, J CONTROL RELEASE, V72, P13, DOI 10.1016/S0168-3659(01)00258-9
   d'Angelo I, 2010, MOL PHARMACEUT, V7, P1724, DOI 10.1021/mp1001262
   Ding AG, 2008, PHARM RES-DORD, V25, P2041, DOI 10.1007/s11095-008-9594-3
   Domb A. J., 1998, HDB BIODEGRADABLE PO
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Ekholm M, 1999, BIOMATERIALS, V20, P1257, DOI 10.1016/S0142-9612(97)00080-X
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Fischer C, 2006, Handb Exp Pharmacol, P157
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103
   Gilbert S F, DEV BIOL 3
   Golub JS, 2010, AM J PHYSIOL-HEART C, V298, pH1959, DOI 10.1152/ajpheart.00199.2009
   Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.085405.095329
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hile DD, 2004, DRUG DELIV, V11, P287, DOI 10.1080/10717540490493961
   Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061
   Huang M, 2007, BIOMACROMOLECULES, V8, P1607, DOI 10.1021/bm061211k
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Jacobs J, 2007, DRUG DISCOV TODAY, V12, P1040, DOI 10.1016/j.drudis.2007.08.018
   Jahanshahi M, 2008, AFR J BIOTECHNOL, V7, P4926
   Jiang WL, 2001, PHARMACEUT RES, V18, P878, DOI 10.1023/A:1011009117586
   Jin HK, 2003, J PHARMACOL EXP THER, V304, P654, DOI 10.1124/jpet.102.041772
   Jones DS, 2008, TRENDS BIOTECHNOL, V26, P498, DOI 10.1016/j.tibtech.2008.05.009
   Kubo M, 2009, ARTERIOSCL THROM VAS, V29, P796, DOI 10.1161/ATVBAHA.108.182584
   Kutryk M J B, 2001, CARDIOL ROUNDS, VVI, P1
   Layman H, 2009, ACTA BIOMATER, V5, P230, DOI 10.1016/j.actbio.2008.07.024
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543
   McKinnon H, 2006, AM J PATHOL, V168, P340, DOI 10.2353/ajpath.2006.050379
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Mulder WJM, 2008, ARTERIOSCL THROM VAS, V28, P801, DOI 10.1161/ATVBAHA.108.165332
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Parajo Y, 2010, DRUG DELIV, V17, P596, DOI 10.3109/10717544.2010.509357
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Roy RS, 2010, P NATL ACAD SCI USA, V107, P13608, DOI 10.1073/pnas.1006007107
   Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709
   Sengupta S, 2003, CANCER RES, V63, P8351
   Sengupta S, 2003, CIRCULATION, V107, P2955, DOI 10.1161/01.CIR.0000077501.19266.E5
   Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0
   Shenderova A, 1997, PHARMACEUT RES, V14, P1406, DOI 10.1023/A:1012172722246
   Shetty R C, 2006, US CARDIOVASC DIS, P3
   Simons M, 2000, CIRCULATION, V102, pE73, DOI 10.1161/01.CIR.102.11.e73
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sneider EB, 2009, J CELL BIOCHEM, V108, P753, DOI 10.1002/jcb.22315
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Sun QH, 2010, PHARM RES-DORD, V27, P264, DOI 10.1007/s11095-009-0014-0
   Szlachcic A, 2009, ACTA CRYSTALLOGR D, V65, P67, DOI 10.1107/S0907444908039486
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   Van de Weert M, 2002, J PHARM SCI, V91, P1065, DOI 10.1002/jps.10109
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Zachary I, 2011, HEART, V97, P181, DOI 10.1136/hrt.2009.180414
   Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066
   Zakrzewska M, 2004, PROTEIN ENG DES SEL, V17, P603, DOI 10.1093/protein/gzh076
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
   Zhu XH, 2009, J BIOMED MATER RES A, V89A, P411, DOI 10.1002/jbm.a.31978
   Ziegler J, 2002, J BIOMED MATER RES, V59, P422, DOI 10.1002/jbm.1258
NR 85
TC 8
Z9 8
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD DEC 9
PY 2011
VL 22
IS 49
AR 494004
DI 10.1088/0957-4484/22/49/494004
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 852PU
UT WOS:000297370700005
PM 22101316
DA 2018-10-19
ER

PT J
AU Appel, WPJ
   Meijer, EW
   Dankers, PYW
AF Appel, Wilco P. J.
   Meijer, E. W.
   Dankers, Patricia Y. W.
TI Enzymatic Activity at the Surface of Biomaterials via Supramolecular
   Anchoring of Peptides: The Effect of Material Processing
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; enzymes; hydrogen bonding; peptides; supramolecular
   structures
ID TISSUE ENGINEERING APPLICATIONS; RIBONUCLEASE-S; FIBROUS SCAFFOLDS; CELL
   ATTACHMENT; PROTEIN; ELECTROSPUN; THERMODYNAMICS; FIBRONECTIN;
   NANOFIBERS; MEMBRANES
AB Supramolecular polymers allow for a modular approach to bioactive biomaterials. Here the effect of processing on the bioactivation of supramolecular biomaterials using a RNase S assay is investigated. Incorporation of S-peptides into supramolecular polymers by solvent casting shows a clear organic-solvent dependency. Although a significant release of the S-peptides is observed, RNase S activity can be measured indicating successful S-peptide surface immobilization. Additionally, the effect of electrospinning on the biomaterial's bioactivity is studied, showing that the fibrous meshes developed were bioactive. The results show the importance of solvent choice, and illustrate the potency of rendering supramolecular biomaterial films and meshes bioactive via a modular approach.
C1 [Appel, Wilco P. J.; Meijer, E. W.; Dankers, Patricia Y. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands.
   [Appel, Wilco P. J.; Meijer, E. W.; Dankers, Patricia Y. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
RP Dankers, PYW (reprint author), Eindhoven Univ Technol, Inst Complex Mol Syst, Biol Chem Lab, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM p.y.w.dankers@tue.nl
RI Meijer, E.W./K-7632-2013
OI Meijer, E.W./0000-0003-4126-7492
FU Council for Chemical Sciences of The Netherlands Organization for
   Scientific Research (CW-NWO)
FX The authors would like to thank Jan Kolijn for electrospinning and SEM
   measurements, and Maarten Merkx for useful discussions. This work was
   supported by the Council for Chemical Sciences of The Netherlands
   Organization for Scientific Research (CW-NWO).
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   Bandiera A, 2010, BIOMACROMOLECULES, V11, P3256, DOI 10.1021/bm100644m
   Chen R, 2010, COLLOID SURFACE B, V79, P315, DOI 10.1016/j.colsurfb.2010.03.043
   Cini N, 2009, BIOORGAN MED CHEM, V17, P1542, DOI 10.1016/j.bmc.2009.01.006
   CONNELLY PR, 1990, BIOCHEMISTRY-US, V29, P6108, DOI 10.1021/bi00477a031
   Dankers PYW, 2006, MACROMOLECULES, V39, P8763, DOI 10.1021/ma061078o
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245
   DRAKE SL, 1993, J BIOL CHEM, V268, P15859
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   George MC, 2009, ANGEW CHEM INT EDIT, V48, P8606, DOI 10.1002/anie.200904089
   Grafahrend D, 2008, J MATER SCI-MATER M, V19, P1479, DOI 10.1007/s10856-007-3299-8
   Grafahrend D, 2010, MACROMOL BIOSCI, V10, P1022, DOI 10.1002/mabi.201000068
   Green A., 2009, BIOMATERIALS, V30, P3637
   HEARN RP, 1971, BIOCHEMISTRY-US, V10, P806
   James DA, 1998, ANAL BIOCHEM, V264, P26, DOI 10.1006/abio.1998.2824
   Ji W, 2010, ACTA BIOMATER, V6, P4199, DOI 10.1016/j.actbio.2010.05.025
   Jiang T, 2010, BIOMACROMOLECULES, V11, P1254, DOI 10.1021/bm100050d
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z
   Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696
   KIM EE, 1992, BIOCHEMISTRY-US, V31, P12304, DOI 10.1021/bi00164a004
   Kreiner M, 2009, SOFT MATTER, V5, P3954, DOI 10.1039/b908706k
   LABHARDT AM, 1979, J MOL BIOL, V135, P231, DOI 10.1016/0022-2836(79)90349-8
   Lempens EHM, 2009, CHEM-EUR J, V15, P8760, DOI 10.1002/chem.200900748
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Nadig G, 1996, PROTEIN SCI, V5, P2104, DOI 10.1002/pro.5560051017
   Ozkan S, 2009, BIOMATERIALS, V30, P4336, DOI 10.1016/j.biomaterials.2009.04.050
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   RICHARDS FM, 1959, J BIOL CHEM, V234, P1459
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   SCHREIER AA, 1976, J MOL BIOL, V105, P409, DOI 10.1016/0022-2836(76)90101-7
   Shalumon KT, 2011, J MACROMOL SCI A, V48, P21, DOI 10.1080/10601325.2011.528288
   Shokrollahi P, 2010, POLYMER, V51, P6303, DOI 10.1016/j.polymer.2010.10.039
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sontjens SHM, 2000, J AM CHEM SOC, V122, P7487, DOI 10.1021/ja000435m
   van Beek DJM, 2007, MACROMOLECULES, V40, P8464, DOI 10.1021/ma0712394CCC:$37.00
   van Beek DJM, 2007, MACROMOLECULES, V40, P6340, DOI 10.1021/ma0705927
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Wang YC, 2010, BIOMATERIALS, V31, P848, DOI 10.1016/j.biomaterials.2009.09.098
   Wisse E, 2011, J POLYM SCI POL CHEM, V49, P1764, DOI 10.1002/pola.24598
   Yen C, 2010, INT J POLYM MATER, V59, P923, DOI 10.1080/00914037.2010.504162
   Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052
NR 47
TC 5
Z9 5
U1 1
U2 28
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 8
PY 2011
VL 11
IS 12
SI SI
BP 1706
EP 1712
DI 10.1002/mabi.201100225
PG 7
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 862AX
UT WOS:000298063300010
PM 21919208
DA 2018-10-19
ER

PT J
AU Fathima, NN
   Rao, JR
   Nair, BU
AF Fathima, Nishter Nishad
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Effect of UV irradiation on the physico-chemical properties of iron
   crosslinked collagen
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Collagen; UV radiation; Circular dichroism (CD); Fluorescence;
   Absorption; Iron
ID ULTRAVIOLET-LIGHT; TANNED COLLAGEN; I COLLAGEN; LINKING; RADIATION;
   STABILITY; DEGRADATION; ALDEHYDES; ELASTIN; FIBERS
AB Collagen is the main component of connective tissue and finds immense applications as a biomaterial. In this study, effect of UV irradiation on collagen crosslinked with iron has been carried out. The physical and optical properties of crosslinked collagen affected by UV irradiation were analyzed using electrospectral and fluorescence studies. The electronic spectral studies showed that the photoproducts formed on UV radiation decrease in the presence of iron. Circular dichroic studies revealed that the conformational changes brought about in the protein due to UV irradiation have been reduced owing to the crosslinking with iron. However, prolonged irradiation does bring about conformational changes to the protein. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Fathima, Nishter Nishad; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Fathima, NN (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM nishad.naveed@gmail.com
RI Fathima, Nishad/B-7919-2009; Rao, Jonnalagadda/B-8486-2009
CR CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   COOPER DR, 1965, BIOCHEM J, V97, P139, DOI 10.1042/bj0970139
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Fathima NN, 2011, INT J BIOL MACROMOL, V48, P67, DOI 10.1016/j.ijbiomac.2010.09.017
   Fathima NN, 2010, INT J BIOL MACROMOL, V47, P590, DOI 10.1016/j.ijbiomac.2010.08.003
   Fathima NN, 2008, J AM LEATHER CHEM AS, V103, P422
   Fathima NN, 2009, INT J BIOL MACROMOL, V45, P274, DOI 10.1016/j.ijbiomac.2009.06.003
   Fathima NN, 2009, J CHEM SCI, V121, P509
   Fathima NN, 2008, COLLOID SURFACE B, V62, P11, DOI 10.1016/j.colsurfb.2007.09.006
   Fathima NN, 2007, J APPL POLYM SCI, V106, P3382, DOI 10.1002/app.26973
   Fathima NN, 2007, J APPL POLYM SCI, V104, P3642, DOI 10.1002/app.26129
   Fathima NN, 2006, J INORG BIOCHEM, V100, P1774, DOI 10.1016/j.jinorgbio.2006.06.014
   Fathima NN, 2010, J CHEM SCI, V122, P881, DOI 10.1007/s12039-010-0076-x
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Fathima NN, 2003, J INORG BIOCHEM, V95, P47, DOI 10.1016/S0162-0134(03)00071-0
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   GARDI C, 2002, J BIOCH PHARM, V6, P1139
   Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2
   Metreveli NO, 2010, ECOTOX ENVIRON SAFE, V73, P448, DOI 10.1016/j.ecoenv.2009.12.005
   Miles CA, 2000, J BIOL CHEM, V275, P33014, DOI 10.1074/jbc.M002346200
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Rajan N, 2008, BIOTECHNOL PROGR, V24, P884, DOI 10.1002/btpr.3
   Sionkowska A, 1999, J PHOTOCH PHOTOBIO A, V120, P207, DOI 10.1016/S1010-6030(98)00427-4
   Sionkowska A, 2007, J PHOTOCH PHOTOBIO B, V86, P186, DOI 10.1016/j.jphotobiol.2006.09.004
   Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 27
TC 7
Z9 10
U1 2
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD DEC 2
PY 2011
VL 105
IS 3
BP 203
EP 206
DI 10.1016/j.jphotobiol.2011.09.003
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 859QV
UT WOS:000297891800006
PM 22000623
DA 2018-10-19
ER

PT J
AU Bagri, LP
   Bajpai, J
   Bajpai, AK
AF Bagri, L. P.
   Bajpai, J.
   Bajpai, A. K.
TI Evaluation of starch based cryogels as potential biomaterials for
   controlled release of antibiotic drugs
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Cryogels; freeze-thaw; drug delivery; macroporous; ciprofloxacin
   hydrochloride
ID IN-VITRO RELEASE; POLY(VINYL ALCOHOL) HYDROGELS; BIOMEDICAL
   APPLICATIONS; POLYVINYL-ALCOHOL; DELIVERY; NANOPARTICLES; TRANSPORT;
   BEHAVIOR; SYSTEMS
AB In the present study starch has been blended with poly(vinyl alcohol) to design macroporous architectures following a repeated freeze-thaw method. These macroporous cryogels were loaded with an antibiotic drug, ciprofloxacin hydrochloride (Cfx), and evaluated for its in vitro delivery in a completely controlled manner thus exploring possibilities to use it as a biomaterial in burn or wound healing applications. The key advantage of the present system is that cryogels formed do not contain any chemical crosslinking agent which is often harmful to organic compounds. These Cfx loaded cryogels were characterized by infrared (FTIR) spectroscopy and scanning electron microscopy (SEM) techniques. The controlled release of Cfx drug from cryogels was investigated under varying experimental conditions such as percent loading of the antibiotic drug, chemical architecture of the cryogels and pH, temperature, and nature of the release media. The prepared cryogels show promise to provide a possible pathway for controlling delivery of antibiotic drug thus minimizing the known side effects and improving efficacy also.
C1 [Bagri, L. P.; Bajpai, J.; Bajpai, A. K.] Govt Autonomous Sci Coll, Dept Chem, Jabalpur 482001, India.
RP Bajpai, AK (reprint author), Govt Autonomous Sci Coll, Dept Chem, Jabalpur 482001, India.
EM akbmrl@yahoo.co.in
CR Bagri LP, 2009, J MACROMOL SCI A, V46, P1060, DOI 10.1080/10601320903252025
   Bajpai AK, 2007, J APPL POLYM SCI, V104, P1559, DOI 10.1002/app.25580
   Bajpai AK, 2006, J APPL POLYM SCI, V101, P2320, DOI 10.1002/app.23761
   Bajpai AK, 2005, POLYM INT, V54, P1233, DOI 10.1002/pi.1813
   Bajpai AK, 2008, XPRESS POLYM LETT, V2, P201
   BASMADJIAN D, 1983, J BIOMED MATER RES, V17, P509, DOI 10.1002/jbm.820170310
   CHEN DH, 1994, J CHEM TECHNOL BIOT, V61, P351, DOI 10.1002/jctb.280610411
   Chouhan R, 2009, J MATER SCI-MATER M, V20, P1103, DOI 10.1007/s10856-008-3677-x
   Colombo P., 1985, J CONTROL RELEASE, V1, P283, DOI [10.1016/0168-3659(85)90004-5, DOI 10.1016/0168-3659(85)90004-5]
   Desevaux C, 2002, J CONTROL RELEASE, V82, P83, DOI 10.1016/S0168-3659(02)00133-5
   Dimitrov Milen, 2003, Acta Pharmaceutica (Zagreb), V53, P25
   Dredan J, 1998, INT J PHARMACEUT, P160
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Gruber E, 1974, J POLYM SCI S, V14, P44105
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Juang H, 1996, TRANSPLANTATION, V61, P1557
   Knop K, 1996, EUR J PHARM SCI, V4, P293, DOI 10.1016/0928-0987(96)00176-5
   KORSMEYER RW, 1981, J MEMBRANE SCI, V9, P211, DOI 10.1016/S0376-7388(00)80265-3
   Kosmidis K, 2003, INT J PHARM, V254, P183, DOI 10.1016/S0378-5173(03)00030-9
   Lia JK, 1998, J CONTROLL REL, V56, P117
   McGann MJ, 2009, INT J PHARMACEUT, V372, P154, DOI 10.1016/j.ijpharm.2009.01.008
   O'Brien S, 2009, CARBOHYD POLYM, V76, P557, DOI 10.1016/j.carbpol.2008.11.024
   Peppas NA, 1996, BIOMATERIALS SCI INT, P62
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RAO KVR, 1988, INT J PHARM, V48, P1
   Roy A, 2009, CARBOHYD POLYM, V10, P1016
   Szepes A, 2008, CARBOHYD POLYM, V72, P571, DOI 10.1016/j.carbpol.2007.09.028
   THANOO BC, 1993, J PHARM PHARMACOL, V45, P16, DOI 10.1111/j.2042-7158.1993.tb03671.x
   Tong X, 2007, MATER LETT, V61, P1704, DOI 10.1016/j.matlet.2006.07.115
   Vilches AP, 2002, INT J PHARM, V246, P17, DOI 10.1016/S0378-5173(02)00333-2
   Wu LU, 2001, NEW CHEM MAT, P29
NR 33
TC 2
Z9 2
U1 0
U2 18
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD DEC
PY 2011
VL 34
IS 7
BP 1739
EP 1748
DI 10.1007/s12034-011-0385-9
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 945NE
UT WOS:000304282400070
DA 2018-10-19
ER

PT J
AU Techatanawat, S
   Surarit, R
   Suddhasthira, T
   Khovidhunkit, SOP
AF Techatanawat, Suteera
   Surarit, Rudee
   Suddhasthira, Theeralaksna
   Khovidhunkit, Siribang-on Piboonniyom
TI Type I collagen extracted from rat-tail and bovine Achilles tendon for
   dental application: a comparative study
SO ASIAN BIOMEDICINE
LA English
DT Article
DE Biocompatibility; bovine Achilles tendon; collagen; human gingival
   fibroblasts; human oral keratinocytes; rat tail
ID MECHANICAL-PROPERTIES; GAG SCAFFOLDS; PORE-SIZE; MATRICES; FIBROBLASTS;
   BIOMATERIAL; LATTICES
AB Background: Collagen has attracted great interest as a biomaterial for various dental and medical uses.
   Objective: Investigate the characteristics and biocompatibility of type I collagen extracted from rat-tail tendon and bovine Achilles tendon for dental application.
   Materials and methods: Type-I collagen was extracted from rat-tail and bovine Achilles tendon using pepsin. The purity of collagen extracts was examined using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The biocompatibility with human gingival fibroblasts (HGFs) and human oral keratinocytes (HOKs) was examined using an MU (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Scanning electron microscope (SEM) illustrations of purified collagen alone and collagen with HGFs and HOKs were presented. A three-dimensional wound-healing model of fibroblast populated collagen lattice (FPCL) was used to determine the capability of both sources of collagen to induce wound healing in vitro. Cellular collagen lattices were fabricated to examine the contraction rate of these collagens.
   Results: The average yield of collagen extracted from rat-tail and bovine Achilles tendon were 21.8 +/- 14.9% and 5.4 +/- 0.4%, respectively. The SDS-PAGE analysis showed that the extracts were composed of alpha 1, alpha 2 and beta chains with little contamination of other small proteins. The MTT assay showed good proliferation of cells cultured with each collagen extract, indicating that collagen extracts were non-toxic to the cells. SEM and the FPCL analysis showed that both types of collagen were biocompatible with both HGFs and HOKs, inducing good contraction in the in vitro model.
   Conclusion: Type-I collagen extracted from rat-tail and bovine Achilles tendon appeared to be biocompatible with HGFs and HOKs. Both biomaterials may be of use in dental practice.
C1 [Techatanawat, Suteera; Khovidhunkit, Siribang-on Piboonniyom] Mahidol Univ, Dept Adv Gen Dent, Fac Dent, Bangkok 10400, Thailand.
   [Surarit, Rudee] Mahidol Univ, Dept Oral Biol, Fac Dent, Bangkok 10400, Thailand.
   [Suddhasthira, Theeralaksna] Mahidol Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Bangkok 10400, Thailand.
RP Khovidhunkit, SOP (reprint author), Mahidol Univ, Dept Adv Gen Dent, Fac Dent, Bangkok 10400, Thailand.
EM dtspb@mahidol.ac.th
FU Mahidol University
FX This research is supported by Mahidol University Grant. The authors have
   no conflict of interest to report.
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Dallon JC, 2008, WOUND REPAIR REGEN, V16, P472, DOI 10.1111/j.1524-475X.2008.00392.x
   Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9
   Faraj KA, 2007, TISSUE ENG, V13, P2387, DOI 10.1089/ten.2006.0320
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Huang YC, 2005, J BIOMED SCI, V12, P855, DOI 10.1007/s11373-005-9018-x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053
   Lynn IVY, 2004, J BIOMEDICAL MAT R B, V71B, P343
   MOSMANN, 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   O'Leary R, 2003, IN VITRO CELL DEV-AN, V39, P204
   Piboonniyom SO, 2002, ORAL ONCOL, V38, P179, DOI 10.1016/S1368-8375(01)00042-2
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006
   Shanmugasundaram N, 2004, J BIOMATER APPL, V18, P247, DOI 10.1177/0885328204040945
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
NR 23
TC 7
Z9 8
U1 0
U2 23
PU CHULALONGKORN UNIV, FAC MED
PI BANGKOK
PA CHULALONGKORN UNIV, FAC MED, 1873, RAMA 4, BANGKOK, 10330, THAILAND
SN 1905-7415
J9 ASIAN BIOMED
JI Asian Biomed.
PD DEC
PY 2011
VL 5
IS 6
BP 787
EP 798
DI 10.5372/1905-7415.0506.111
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 894ZS
UT WOS:000300466600007
DA 2018-10-19
ER

PT J
AU Ionita, D
   Grecu, M
   Ungureanu, C
   Demetrescu, I
AF Ionita, Daniela
   Grecu, Mihaela
   Ungureanu, Camelia
   Demetrescu, Ioana
TI Antimicrobial activity of the surface coatings on TiAlZr implant
   biomaterial
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Antimicrobial effect; TiAlZr; Silver nanoparticles; Implant; Size
   dimensions
ID SILVER NANOPARTICLES; ANTIBACTERIAL; TITANIUM
AB This study is devoted to antimicrobial activity of new surface coatings on TiAlZr. Ti alloys such as TiAlZr are used as implant biomaterials, but, despite the good behavior of such alloys in simulated conditions, bacterial infections appear after the introduction of an implant into the body. The infections are typically caused by the adherence and colonization of bacteria on the surfaces of the implants. The study presents preparation and surface morphology characterization of coatings obtained via anodizing, as well as biomimetic coatings with hydroxyapatite and silver ions with and without antibiotic. The percentage inhibition of Escherichia coli bacteria growth was evaluated for each of the studied coating, and a Trojan-horse model of silver nanoparticles (nAg) antibacterial activity at interface was proposed. Such coatings could be more important taking into account that antibacterial treatments with antibiotics are becoming less effective due to their intensive use. (C) 2011, The Society for Biotechnology, Japan. All rights reserved.
C1 [Ionita, Daniela; Grecu, Mihaela; Ungureanu, Camelia; Demetrescu, Ioana] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, 1-7 Polizu Str, Bucharest 011061, Romania.
EM i_demetrescu@chim.upb.ro
FU CNCSIS-UEFISCSU [PNII - IDEI PCCE 248/2010]
FX This work was supported by CNCSIS-UEFISCSU, project number PNII - IDEI
   PCCE 248/2010.
CR Ballouche Mathieu, 2009, Recent Pat Antiinfect Drug Discov, V4, P190
   Casey JT, 2004, J MICROBIOL METH, V58, P327, DOI 10.1016/j.mimet.2004.04.017
   Chen YK, 2008, J MATER SCI-MATER M, V19, P3603, DOI 10.1007/s10856-008-3529-8
   Cheng QL, 2006, APPL SURF SCI, V252, P4154, DOI 10.1016/j.apsusc.2005.06.022
   Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096
   Liu F, 2005, J BIOSCI BIOENG, V100, P100, DOI 10.1263/jbb.100.100
   Liu X., 2004, MATER SCI ENG, V47, P47
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Popescu S, 2007, J MATER SCI-MATER M, V18, P2075, DOI 10.1007/s10856-007-3133-3
   Prodana M, 2011, DIG J NANOMATER BIOS, V6, P549
   Saha S, 2010, DIG J NANOMATER BIOS, V5, P887
   Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Watari F, 2010, NANOBIOMEDICINE, V1, P2
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 20
TC 15
Z9 15
U1 0
U2 18
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD DEC
PY 2011
VL 112
IS 6
BP 630
EP 634
DI 10.1016/j.jbiosc.2011.07.022
PG 5
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 893CH
UT WOS:000300332700020
PM 21889399
DA 2018-10-19
ER

PT J
AU Liu, M
   Yue, XL
   Dong, S
   Ma, Y
   Zha, ZB
   Dai, ZF
AF Liu, Meng
   Yue, Xiuli
   Dong, Shen
   Ma, Yan
   Zha, Zhengbao
   Dai, Zhifei
TI Nanocoating of Diazoresin/Polysaccharides Multilayer Boosts
   Biocompatibility of Nitinol Biomedical Devices
SO CURRENT NANOSCIENCE
LA English
DT Article
DE Layer-by-layer; biocompatibility; alginate; heparin; Nitinol; thrombin
ID IN-VITRO BIOCOMPATIBILITY; PLATELET-ADHESION; BIOMATERIAL SURFACES;
   PROTEIN ADSORPTION; FIBRINOGEN ADSORPTION; NICKEL-TITANIUM; POLYURETHANE
   SURFACES; COMPLEMENT ACTIVATION; IMMOBILIZED HEPARIN; POLYMERIC
   MATERIALS
AB The surface of a biomaterial and a biological environment are key factors determining the biocompatibility of the material. Determining biocompatibility of medical implants is a critical step toward approval and clinical application. In this study, the biocompatibility of a covalently attached nanocoating of alginate(Alg)/diazoresin(DR)/heparin(Hep) multilayer has been evaluated by thrombin inactivation, protein adsorption, leukocyte adhesion, cytotoxicity in vitro and subcutaneous implantation in vivo. It was found that the outermost layer of the coating played a key role on anticoagulant activity. No significant difference was seen in albumin adsorption between uncoated and coated one. However, the fibrinogen adsorption on DR/polysaccharides coatings was lower than the uncoated Nitinol. Compared with the uncoated Nitinol surface, DR/polysaccharides multilayer coating presented a drastically reduced adhesion in vitro of polymorphonuclear neutrophil leukocytes (PMN) and peripheral blood mononuclear cells (PBMC). Cell biocompatibility tests indicated that the nanocoating of DR/polysaccharides multilayer did not lead to an increase in the cytotoxicity of the Nitinol and the adherent cells maintained good viability. Subcutaneous implantation in C57BL/6 mice suggested that the coated Nitinol had good tissue biocompatibility. The use of alginate interlayer for heparin immobilization instead of proteins such as albumin, collagen, and gelatin may avoid the risk of contamination with pathogenic agents. Hence, the nanocoating of covalently attached DR/polysaccharide multilayer boosts the biocompatibility of Nitinol biomedical devices.
C1 [Liu, Meng; Yue, Xiuli; Ma, Yan; Zha, Zhengbao; Dai, Zhifei] Harbin Inst Technol, Nanomed & Biosensor Lab, Sch Sci, State Key Lab Urban Water Resources & Environm, Harbin 150001, Peoples R China.
   [Dong, Shen] Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Peoples R China.
RP Yue, XL (reprint author), Harbin Inst Technol, Nanomed & Biosensor Lab, Sch Sci, State Key Lab Urban Water Resources & Environm, Harbin 150001, Peoples R China.
EM xiulidx@yahoo.com.cn; zhifei.dai@hit.edu.cn
RI Dai, Zhifei/B-1812-2012
FU National Natural Science Foundation of China [NSFC-20977021, 30970829];
   National High Technology Research and Development Program of China
   [2007AA03Z316]; National Natural Science Foundation of Heilongjiang
   Province [E-2007-12]
FX This research was financially supported by National Natural Science
   Foundation of China (NSFC-20977021 and 30970829), National High
   Technology Research and Development Program of China (No.2007AA03Z316)
   and National Natural Science Foundation of Heilongjiang Province
   (E-2007-12).
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Andersson M, 2008, J BIOMED MATER RES A, V84A, P652, DOI 10.1002/jbm.a.31389
   Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   BAGNALL RD, 1978, J BIOMED MATER RES, V12, P707, DOI 10.1002/jbm.820120511
   BALE MD, 1989, BLOOD, V74, P2698
   Bannan S, 1997, ANN THORAC SURG, V63, P663, DOI 10.1016/S0003-4975(96)01054-5
   Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   Belboul A, 1997, PERFUSION-UK, V12, P385, DOI 10.1177/026765919701200607
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   BOISSONVIDAL C, 1991, J BIOMED MATER RES, V25, P67, DOI 10.1002/jbm.820250106
   BRASH JL, 1989, J BIOMED MATER RES, V23, P157, DOI 10.1002/jbm.820230203
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   BRUIL A, 1994, J BIOMAT SCI-POLYM E, V5, P263, DOI 10.1163/156856294X00013
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   Cohen J, 1998, J BONE JOINT SURG AM, V80A, P1554, DOI 10.2106/00004623-199810000-00027
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Dai ZF, 2004, CHEM-EUR J, V10, P6369, DOI 10.1002/chem.200400579
   Dai Z, 2007, MAT SCI ENG C-BIO S, V27, P402, DOI 10.1016/j.msec.2006.05.042
   DeScheerder I, 1997, CIRCULATION, V95, P1549
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   DION I, 1992, INT J ARTIF ORGANS, V15, P617
   Ditter D. S., 1961, BLOOD OTHER BODY FLU
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Fukutomi M, 1996, ARTIF ORGANS, V20, P767, DOI 10.1111/j.1525-1594.1996.tb04538.x
   GISSER KRC, 1994, J CHEM EDUC, V71, P334, DOI 10.1021/ed071p334
   GLUSZKO P, 1987, AM J PHYSIOL, V252, pH615
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   Horbett T. A., 1986, TECHNIQUES PROTEIN A, V2
   International Organization for Standardization, 1992, 109935 ISO 5
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   Knetsch MLW, 2007, J BIOMED MATER RES A, V82A, P947, DOI 10.1002/ibm.a.31212
   Koller M, 2001, INFLAMMATION, V25, P331, DOI 10.1023/A:1012883916991
   Kong XQ, 2002, BIOMATERIALS, V23, P1775, DOI 10.1016/S0142-9612(01)00304-0
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Liu M, 2007, LANGMUIR, V23, P9378, DOI 10.1021/la7002996
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   Niimi Y, 1997, ASAIO J, V43, pM706
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Poot A.A., 1991, PROTEIN ADSORPTION R
   RIBEIRO PA, 1993, AM HEART J, V125, P501, DOI 10.1016/0002-8703(93)90032-5
   SANCHEZ J, 1995, J BIOMED MATER RES, V29, P655, DOI 10.1002/jbm.820290513
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   SEEGER J M, 1988, Journal of Vascular Surgery, V8, P476, DOI 10.1067/mva.1988.avs0080476
   SHARMA CP, 1990, BIOMATERIALS, V11, P255, DOI 10.1016/0142-9612(90)90006-C
   Sperling C, 2006, J BIOMED MATER RES A, V76A, P681, DOI 10.1002/jbm.a.30519
   Sun JQ, 1998, CHEM COMMUN, P1853, DOI 10.1039/a804623i
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   VROMAN L, 1983, J THEOR BIOL, V105, P541, DOI 10.1016/0022-5193(83)90192-3
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
   Zhang YJ, 2002, NEW J CHEM, V26, P617, DOI 10.1039/b111722j
   Zhao C, 1998, ANGEW MAKROMOL CHEM, V259, P77
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 70
TC 0
Z9 0
U1 0
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
J9 CURR NANOSCI
JI Curr. Nanosci.
PD DEC
PY 2011
VL 7
IS 6
BP 856
EP 865
DI 10.2174/157341311798220745
PG 10
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 884AZ
UT WOS:000299678600005
DA 2018-10-19
ER

PT J
AU Wei, J
   Lu, JX
   Yan, YG
   Li, H
   Ma, J
   Wu, XH
   Dai, CL
   Liu, CS
AF Wei, Jie
   Lu, Jingxiong
   Yan, Yonggang
   Li, Hong
   Ma, Jian
   Wu, Xiaohui
   Dai, Chenglong
   Liu, Changsheng
TI Preparation and Characterization of Well Ordered Mesoporous Diopside
   Nanobiomaterial
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd IEEE International NanoElectronics Conference (INEC)/Symposium on
   Nanoscience and Nanotechnology in China
CY JAN 03-08, 2010
CL City Univ Hong Kong, Hong Kong, PEOPLES R CHINA
SP IEEE
HO City Univ Hong Kong
DE Ordered Mesoporous; Diopside; Apatite Formation; Hemostatic Activity
ID WOLLASTONITE; COMPOSITE; SCAFFOLD; RELEASE
AB Well ordered mesoporous diopside (OMD) nanobiomaterial was synthesized by a sol gel process. The in vitro bioactivity of the OMD was evaluated by investigating the apatite-forming ability in simulated body fluid (SBF), and the hemostatic activity of the OMD was determined by measuring the activated partial thromboplastin time (APTT) and prothrombin time (PT) in vitro. The results suggested that the OMD exhibited excellent in vitro bioactivity, with surface apatite formation for OMD exceeding that of non-mesoporous diopside (n-MD) at 7 days. Moreover, the OMD with high surface area possessed good hemostatic property because it could absorb a large number of water from the blood. In conclusion, the prepared OMD had excellent bioactivity and hemostatic activity, which can not only be applied as bone repair biomaterial for bone regeneration, but also as hemostatic agent for surgery hemostasis.
C1 [Yan, Yonggang; Li, Hong] Sichuan Univ, Sch Phys Sci & Technol, Chengdu 610064, Peoples R China.
   [Wei, Jie; Lu, Jingxiong; Wu, Xiaohui; Dai, Chenglong; Liu, Changsheng] E China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
   [Ma, Jian] Tongji Univ, Hosp Stomatol, Shanghai 200072, Peoples R China.
RP Yan, YG (reprint author), Sichuan Univ, Sch Phys Sci & Technol, Chengdu 610064, Peoples R China.
CR Dai CL, 2009, BIOMATERIALS, V30, P5364, DOI 10.1016/j.biomaterials.2009.06.052
   Erokhina S, 2009, J AM CHEM SOC, V131, P9800, DOI 10.1021/ja903066s
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wei J, 2009, J AM CERAM SOC, V92, P1017, DOI 10.1111/j.1551-2916.2009.03002.x
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   Wit X. H., 2009, BIOMED MATER, V4, P4
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Zhu YC, 2007, ANGEW CHEM INT EDIT, V46, P2241, DOI 10.1002/anie.200604850
NR 10
TC 10
Z9 10
U1 0
U2 19
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD DEC
PY 2011
VL 11
IS 12
BP 10746
EP 10749
DI 10.1166/jnn.2011.3940
PG 4
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 882TF
UT WOS:000299586100089
PM 22408987
DA 2018-10-19
ER

PT J
AU Ebrahimian-Hosseinabadi, M
   Ashrafizadeh, F
   Etemadifar, M
   Venkatraman, SS
AF Ebrahimian-Hosseinabadi, M.
   Ashrafizadeh, F.
   Etemadifar, M.
   Venkatraman, Subbu S.
TI Evaluating and Modeling the Mechanical Properties of the Prepared
   PLGA/nano-BCP Composite Scaffolds for Bone Tissue Engineering
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Scaffold; Bone tissue engineering; Poly (lactide-co-glycolide) (PLGA);
   Biphasic calcium phosphate; Porous composite
ID DRUG-DELIVERY; BIOMATERIAL; CERAMICS
AB In this paper, preparation of nano-biphasic calcium phosphate (nBCP), mechanical behavior and load-bearing of poly (lactide-co-glycolide) (PLGA) and PLGA/nBCP are presented. The nBCP with composition of 63/37 (w/w) HA/beta-TCP (hydroxyapatite/beta-tricalcium phosphate) was produced by heating of bovine bone at 700 degrees C. Composite scaffolds were made by using PLGA matrix and 10-50 wt% nBCP powders as reinforcement material. All scaffolds were prepared by thermally induced solid liquid phase separation (TIPS) at -60 degrees C under 4 Pa (0.04 mbar) vacuum. The results of elastic modulus testing were adjusted with Ishai-Cohen and Narkis models for rigid polymeric matrix and compared to each other. PLGA/nBCP scaffolds with 30 wt% nBCP showed the highest value of yield strength among the scaffolds. In addition, it was found that by increasing the nBCP in scaffolds to 50 wt%, the modulus of elasticity was highly enhanced. However, the optimum value of yield strength was obtained at 30 wt% nBCP, and the agglomeration of reinforcing particles at higher percentages caused a reduction in yield strength. It is clear that the elastic modulus of matrix has the significant role in elastic modulus of scaffolds, as also the size of the filler particles in the matrix.
C1 [Ebrahimian-Hosseinabadi, M.; Ashrafizadeh, F.] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
   [Ebrahimian-Hosseinabadi, M.] Isfahan Univ Med Sci, Esfahan 8174673461, Iran.
   [Etemadifar, M.] Isfahan Univ Med Sci, Dept Orthoped, Sch Med, Esfahan 8174673461, Iran.
   [Venkatraman, Subbu S.] Nanyang Technol Univ, Mat Sci & Engn Sch, Singapore 637819, Singapore.
RP Ebrahimian-Hosseinabadi, M (reprint author), Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
EM mebrahimian@ma.iut.ac.ir
RI Venkatraman, Subramanian/A-2228-2011
OI Venkatraman, Subramanian/0000-0002-8693-1070; Etemadifar, Mohammad
   Reza/0000-0003-1702-6066
FU Isfahan University of Technology; Ministry of Sciences, Research &
   Technology in Iran; Materials Science & Engineering School of Nanyang
   Technological University in Singapore
FX This work was supported by Isfahan University of Technology and Ministry
   of Sciences, Research & Technology in Iran and Materials Science &
   Engineering School of Nanyang Technological University in Singapore.
CR AHMED S, 1990, J MATER SCI, V25, P4933, DOI 10.1007/BF00580110
   Barbucci R., 2002, INTEGRATED BIOMATERI, P599
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bronner F., 2007, ENG FUNCTIONAL SKELE, P95
   Christenson E.M., 2006, J ORTHOP RES, V1, P11
   Crosby AJ, 2007, POLYM REV, V47, P217, DOI 10.1080/15583720701271278
   Deng C, 2008, MATER LETT, V62, P607, DOI 10.1016/j.matlet.2007.06.014
   Fathi MH, 2009, MATER LETT, V63, P1455, DOI 10.1016/j.matlet.2009.03.040
   Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034
   Fisher J.P., 2007, TISSUE ENG, P21
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Huang J, 2007, J MATER SCI-MATER M, V18, P2151, DOI 10.1007/s10856-007-3201-8
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   Ma P.X., 2004, MATER TODAY, V30, P5
   Ma P.X., 2006, SCAFFOLDING TISSUE E, P241
   Nalwa H.S., 2005, HDB NANOSTRUCTURED B, P393
   Nilsen L.E., 1994, MECH PROPERTIES POLY
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   Reis R.L., 2005, LEARNING NATURE DESI, P57
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rothon R.N., 2003, PARTICULATE FILLED P, P424
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
NR 28
TC 13
Z9 13
U1 1
U2 14
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD DEC
PY 2011
VL 27
IS 12
BP 1105
EP 1112
DI 10.1016/S1005-0302(12)60004-8
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 879SP
UT WOS:000299352800004
DA 2018-10-19
ER

PT J
AU Vasilev, K
   Poulter, N
   Martinek, P
   Griesser, HJ
AF Vasilev, Krasimir
   Poulter, Neil
   Martinek, Petr
   Griesser, Hans J.
TI Controlled Release of Levofloxacin Sandwiched between Two Plasma
   Polymerized Layers on a Solid Carrier
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE drug delivery; controlled release; plasma polymerization; n-heptylamine;
   levofloxacin; Staphylococcus aureus; biofilm; antibacterial surface
ID CONTROLLED DRUG-DELIVERY; ANTIBACTERIAL COATINGS; INFECTION; SYSTEMS;
   IMPLANTS; GROWTH; AMINE; FILMS
AB Targeted delivery and controlled local release of drugs has a number of advantages over conventional systemic drug delivery approaches. Novel platforms for local delivery from solid drug carriers are needed to satisfy the requirements of various medical applications, in particular for the incorporation and release of hydrophilic drugs from a solid carrier material. We have utilized the plasma polymerization of n-heptylamine for the generation of two thin coated layers that serve two distinct purposes. First, an n-heptylamine plasma polymer layer is applied onto the surface of the solid carrier material in order to facilitate spreading of the drug, which is applied by solvent casting; levofloxacin in ethanol was used for this study. A second n-heptylarnine plasma polymer coating then serves as a thin barrier coating to control the release. We show that the rate of release can be adjusted via the thickness of the plasma polymer overlayer. We also show that this modality of controlled release of levofloxacin completely inhibits Methicillin-resistant Staphylococcus aureus (MRSA) colonization and bioffirn formation on and near the coated biomaterial surface.
C1 [Vasilev, Krasimir; Poulter, Neil] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Poulter, Neil; Martinek, Petr; Griesser, Hans J.] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia.
RP Vasilev, K (reprint author), Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
EM krasimir.vasilev@unisa.edu.au
RI Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863
FU Australian Government under NHMRC [1000737]; Australian Research Council
   [FT100100292]
FX This work was supported in part by the Australian Government under NHMRC
   grant 1000737. KV acknowledges the Australian Research Council for
   support through fellowship FT100100292.
CR Anderson EM, 2009, BIOMATERIALS, V30, P5675, DOI 10.1016/j.biomaterials.2009.06.047
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Colilla M, 2008, INT J NANOMED, V3, P403
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Degim IT, 2007, CURR PHARM DESIGN, V13, P99
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   Husseini GA, 2008, ADV DRUG DELIVER REV, V60, P1137, DOI 10.1016/j.addr.2008.03.008
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Lebedeva OV, 2005, J COLLOID INTERF SCI, V284, P455, DOI 10.1016/j.jcis.2004.10.040
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Simovic S, 2010, CHEM COMMUN, V46, P1317, DOI 10.1039/b919840g
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vandijck DM, 2008, INT J ANTIMICROB AG, V31, P161, DOI 10.1016/j.ijantimicag.2007.10.015
   Vasilev K, 2008, J PHYS CHEM B, V112, P10915, DOI 10.1021/jp803678w
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Vasilev K, 2009, J PHYS CHEM B, V113, P7059, DOI 10.1021/jp807986k
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zhou J, 2010, J AM CHEM SOC, V132, P6566, DOI 10.1021/ja101554a
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 32
TC 28
Z9 28
U1 4
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD DEC
PY 2011
VL 3
IS 12
BP 4831
EP 4836
DI 10.1021/am201320a
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 865WJ
UT WOS:000298341300040
PM 22103351
DA 2018-10-19
ER

PT J
AU Ha, NS
   Jin, TL
   Goo, NS
   Park, HC
AF Ha, N. S.
   Jin, T. L.
   Goo, N. S.
   Park, H. C.
TI Anisotropy and non-homogeneity of an Allomyrina Dichotoma beetle hind
   wing membrane
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Article
ID DIGITAL IMAGE CORRELATION; UNSTEADY AERODYNAMIC PERFORMANCE;
   FINITE-ELEMENT-ANALYSIS; HOVERING INSECT FLIGHT; LOW REYNOLDS-NUMBERS;
   DESERT LOCUST; MECHANICAL-PROPERTIES; FLAPPING FLIGHT; FLEXURAL
   STIFFNESS; DEFORMATION
AB Biomimetics is one of the most important paradigms as researchers seek to invent better engineering designs over human history. However, the observation of insect flight is a relatively recent work. Several researchers have tried to address the aerodynamic performance of flapping creatures and other natural properties of insects, although there are still many unsolved questions. In this study, we try to answer the questions related to the mechanical properties of a beetle's hind wing, which consists of a stiff vein structure and a flexible membrane. The membrane of a beetle's hind wing is small and flexible to the point that conventional methods cannot adequately quantify the material properties. The digital image correlation method, a non-contact displacement measurement method, is used along with a specially designed mini-tensile testing system. To reduce the end effects, we developed an experimental method that can deal with specimens with as high an aspect ratio as possible. Young's modulus varies over the area in the wing and ranges from 2.97 to 4.5 GPa in the chordwise direction and from 1.63 to 2.24 GPa in the spanwise direction. Furthermore, Poisson's ratio in the chordwise direction is 0.63-0.73 and approximately twice as large as that in the spanwise direction (0.33-0.39). From these results, we can conclude that the membrane of a beetle's hind wing is an anisotropic and non-homogeneous material. Our results will provide a better understanding of the flapping mechanism through the formulation of a fluid-structure interaction analysis or aero-elasticity analysis and meritorious data for biomaterial properties database as well as a creative design concept for a micro aerial flapper that mimics an insect.
C1 [Ha, N. S.; Jin, T. L.; Goo, N. S.; Park, H. C.] Konkuk Univ, Dept Adv Technol Fus, Biomimet & Intelligent Microsyst Lab, Seoul 143701, South Korea.
RP Goo, NS (reprint author), Konkuk Univ, Dept Adv Technol Fus, Biomimet & Intelligent Microsyst Lab, Seoul 143701, South Korea.
EM nsgoo@konkuk.ac.kr
RI Goo, Nam Seo/D-6665-2011
FU National Research Foundation of Korea; Ministry of Education, Science
   and Technology [2010-0018884]
FX The authors are grateful for the support provided by the Basic Science
   Research Program of the National Research Foundation of Korea, which was
   funded by the Ministry of Education, Science and Technology (grant no
   2010-0018884).
CR Aono H, 2010, AIAA C CHIC IL, P5082
   Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649
   Bos FM, 2008, J FLUID MECH, V594, P341, DOI 10.1017/S0022112007009172
   BRUCK HA, 1989, EXP MECH, V29, P261, DOI 10.1007/BF02321405
   Chandrashekar N, 2011, KNEE IN PRESS
   Combes SA, 2003, J EXP BIOL, V206, P2999, DOI 10.1242/jeb.00502
   Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523
   Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524
   Dai Z, 2009, J BIONIC ENG, V7, P6
   Dalton S., 1975, BORNE WIND EXTRAORDI
   Darvizeh M, 2009, INT J MULTIPHYSICS, V3, P101, DOI 10.1260/175095409787924454
   Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954
   DICKINSON MH, 1994, J EXP BIOL, V192, P179
   DICKINSON MH, 1993, J EXP BIOL, V174, P45
   DICKSON G, 1967, J DENT RES, V46, P1475, DOI 10.1177/00220345670460065901
   Du G, 2008, APPL MATH MECH-ENGL, V29, P731, DOI 10.1007/s10483-008-0605-9
   Du G, 2010, J EXP BIOL, V213, P2273, DOI 10.1242/jeb.040295
   Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0
   ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049
   Ellington CP, 1999, J EXP BIOL, V202, P3439
   ENNOS AR, 1988, J EXP BIOL, V140, P137
   FARAH JW, 1989, J ORAL REHABIL, V16, P603, DOI 10.1111/j.1365-2842.1989.tb01384.x
   Ganguli R, 2010, EXP MECH, V50, P1183, DOI 10.1007/s11340-009-9316-8
   GOSLINE JM, 1980, MECH PROPERTIES BIOL, P331
   Haas F, 2000, P ROY SOC B-BIOL SCI, V267, P1375, DOI 10.1098/rspb.2000.1153
   Herbert RC, 2000, J EXP BIOL, V203, P2945
   Ishihara D, 2009, J EXP BIOL, V212, P1, DOI 10.1242/jeb.020404
   Isogai K, 2004, AIAA J, V42, P2053, DOI 10.2514/1.6274
   JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008
   Jin T, 2010, J BIONIC ENG, V7, pS145, DOI 10.1016/S1672-6529(09)60228-6
   Jin T, 2009, J BIONIC ENG, V6, P224, DOI 10.1016/S1672-6529(08)60105-5
   Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x
   Kesel AB, 1998, COMPUT BIOL MED, V28, P423, DOI 10.1016/S0010-4825(98)00018-3
   Kreuz P., 2000, Biona Report, V14, P16
   Lake SP, 2009, J ORTHOP RES, V27, P1596, DOI 10.1002/jor.20938
   Le TQ, 2010, J THEOR BIOL, V266, P485, DOI 10.1016/j.jtbi.2010.07.013
   Liu H, 1998, J EXP BIOL, V201, P461
   Mengesha TE, 2011, BIOINSPIR BIOMIM, V6
   Mengesha TE, 2009, BIOINSPIR BIOMIM, V4
   Mountcastle AM, 2009, EXP FLUIDS, V46, P873, DOI 10.1007/s00348-008-0607-0
   Muhammad A, 2009, CHINESE SCI BULL, V54, P2416, DOI 10.1007/s11434-009-0242-z
   NASSAF H., 2002, P INT COUNC AER SCI
   Nguyen QV, 2010, J BIONIC ENG, V7, P77, DOI 10.1016/S1672-6529(09)60195-5
   POWERS JM, 1972, POLYM ENG SCI, V12, P432, DOI 10.1002/pen.760120608
   Ramamurti R, 2007, J EXP BIOL, V210, P881, DOI 10.1242/jeb.02704
   Ranson WF, 1987, HDB EXPT MECH, P388
   Rees JCC, 1975, NATURE, V256, P200
   Ruck S, 2010, J EXP BIOL, V213, P4180, DOI 10.1242/jeb.041285
   Sachs C, 2008, J STRUCT BIOL, V161, P120, DOI 10.1016/j.jsb.2007.09.022
   Sachs C, 2006, J STRUCT BIOL, V155, P409, DOI 10.1016/j.jsb.2006.06.004
   Sane SP, 2002, J EXP BIOL, V205, P1087
   Sane SP, 2001, J EXP BIOL, V204, P2607
   Sato H., 2009, FRONT INTEGR NEUROSC, V3, P1
   Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199
   Schmidt T, 2003, EXP TECHNIQUES, V27, P47, DOI 10.1111/j.1747-1567.2003.tb00115.x
   Shang JK, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/3/036002
   Smith CW, 2000, J EXP BIOL, V203, P2933
   Song F, 2007, MAT SCI ENG A-STRUCT, V457, P254, DOI 10.1016/j.msea.2007.01.136
   Song F, 2004, J EXP BIOL, V207, P3035, DOI 10.1242/jeb.01122
   Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223
   Sun JY, 2010, IET NANOBIOTECHNOL, V4, P10, DOI 10.1049/iet-nbt.2009.0009
   Tanaka H, 2010, J MICROMECH MICROENG, V20
   Tanaka H, 2007, J MICROMECH MICROENG, V17, P2485, DOI 10.1088/0960-1317/17/12/014
   Tanaka K, 2010, WIT TRANS BUILT ENV, V112, P197, DOI 10.2495/HPSM100191
   Tran H. T, 2010, 3 DIMENSIONAL UNPUB
   Vanella M, 2009, J EXP BIOL, V212, P95, DOI 10.1242/jeb.016428
   Vendroux G, 1998, EXP MECH, V38, P86, DOI 10.1007/BF02321649
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Vincent JVF, 1992, BIOMECHANICS MAT PRA
   Vinson J. R., 2002, BEHAV STRUCTURES COM
   Wainwright S. A., 1976, MECH DESIGN ORGANISM
   Walker JA, 2002, J EXP BIOL, V205, P3783
   Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435
   Wang ZJ, 2008, J EXP BIOL, V211, P234, DOI 10.1242/jeb.013797
   Wang ZJ, 2004, J EXP BIOL, V207, P449, DOI 10.1242/jeb.00739
   Watanabe H, 1995, KAW MILL WORKSH TOKY
   WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P415, DOI 10.1098/rstb.1956.0007
   Wootton RJ, 2000, J EXP BIOL, V203, P2921
   Wootton RJ, 2003, PHILOS T ROY SOC B, V358, P1577, DOI 10.1098/rstb.2003.1351
   WOOTTON RJ, 1990, SCI AM, V263, P114, DOI 10.1038/scientificamerican1190-114
   WOOTTON RJ, 1995, P ROY SOC B-BIOL SCI, V262, P181, DOI 10.1098/rspb.1995.0194
   Young J, 2008, AIAA J, V46, P918, DOI 10.2514/1.31610
   Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928
   Zhao L, 2010, J R SOC INTERFACE, V7, P485, DOI 10.1098/rsif.2009.0200
NR 84
TC 17
Z9 17
U1 0
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD DEC
PY 2011
VL 6
IS 4
AR 046003
DI 10.1088/1748-3182/6/4/046003
PG 15
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 863CF
UT WOS:000298139700010
PM 21992989
DA 2018-10-19
ER

PT J
AU Lenaghan, SC
   Serpersu, K
   Xia, L
   He, W
   Zhang, M
AF Lenaghan, S. C.
   Serpersu, K.
   Xia, L.
   He, W.
   Zhang, M.
TI A naturally occurring nanomaterial from the Sundew (Drosera) for tissue
   engineering
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Article
ID CELL ATTACHMENT; GROWTH-FACTOR; IN-VITRO; CHITOSAN; SCAFFOLDS;
   POLYSACCHARIDE; ANTIBACTERIAL; REGENERATION; STIMULATION; FIBROBLASTS
AB In recent years advances have been made in the design of novel materials for tissue engineering through the use of polysaccharides. This study evaluated the ability of a naturally secreted polysaccharide adhesive from the Sundew (Drosera capensis) as a support for cell growth. The Sundew adhesive has several advantages including its high elasticity and antibiotic nature. By coating glass cover slips with the Sundew adhesive, a network of nanofibers was generated that was capable of promoting attachment and differentiation of a model neuronal cell line, PC-12. We also demonstrated the potential of this material for repairing bone and soft tissue injuries, by testing attachment of osteoblasts and endothelial cells. Finally, it was determined that the Sundew biomaterial was stable through testing by atomic force microscopy and prolonged cell growth. This work has proven the capabilities of using a nanomaterial derived from the Sundew adhesive for the purpose of tissue engineering.
C1 [Lenaghan, S. C.; Xia, L.; He, W.; Zhang, M.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
   [Serpersu, K.; He, W.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
RP He, W (reprint author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
EM whe5@utk.edu; mjzhang@utk.edu
RI He, Wei/K-7218-2013
OI He, Wei/0000-0002-6638-9691; Lenaghan, Scott/0000-0002-7539-1726
FU University of Tennessee, Knoxville
FX We would like to thank the University of Tennessee, Knoxville for
   partial support of this study.
CR ARREGUI CO, 1994, J NEUROSCI, V14, P6967
   Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Didry N, 1998, J ETHNOPHARMACOL, V60, P91, DOI 10.1016/S0378-8741(97)00129-3
   Fakhry A, 2004, BIOMATERIALS, V25, P2075, DOI 10.1016/j.biomaterials.2003.08.068
   Galois L, 2004, BIORHEOLOGY, V41, P433
   GOWDA DC, 1982, PHYTOCHEMISTRY, V21, P2297, DOI 10.1016/0031-9422(82)85194-7
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Krolicka A, 2008, ENZYME MICROB TECH, V42, P216, DOI 10.1016/j.enzmictec.2007.09.011
   Krolicka A, 2009, BIOTECHNOL APPL BIOC, V53, P175, DOI 10.1042/BA20080088
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Madhavan V, 2009, PHARM BIOL, V47, P128, DOI 10.1080/13880200802437149
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   Matsunaga T, 2006, J BIOMED MATER RES A, V76A, P711, DOI 10.1002/jbm.a.30588
   MCKEEHAN WL, 1976, J CELL BIOL, V71, P727, DOI 10.1083/jcb.71.3.727
   MINETT TW, 1984, CELL BIOL INT REP, V8, P151, DOI 10.1016/0309-1651(84)90082-1
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Park YJ, 2000, BIOMATERIALS, V21, P153
   ROST K, 1977, PHYTOCHEMISTRY, V16, P1365, DOI 10.1016/S0031-9422(00)88783-X
   Scott J, 2003, HERBS TREATMENT CHIL, P249
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499
   Zhang Mingjun, 2010, Journal of Nanobiotechnology, V8, P20, DOI 10.1186/1477-3155-8-20
   Ziaratnia SM, 2009, S AFR J BOT, V75, P97, DOI 10.1016/j.sajb.2008.08.001
NR 25
TC 9
Z9 9
U1 1
U2 36
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD DEC
PY 2011
VL 6
IS 4
AR 046009
DI 10.1088/1748-3182/6/4/046009
PG 8
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 863CF
UT WOS:000298139700016
PM 22064887
DA 2018-10-19
ER

PT J
AU Kumbar, SG
   Toti, US
   Deng, M
   James, R
   Laurencin, CT
   Aravamudhan, A
   Harmon, M
   Ramos, DM
AF Kumbar, S. G.
   Toti, U. S.
   Deng, M.
   James, R.
   Laurencin, C. T.
   Aravamudhan, A.
   Harmon, M.
   Ramos, D. M.
TI Novel mechanically competent polysaccharide scaffolds for bone tissue
   engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID DIPEPTIDE-BASED POLYPHOSPHAZENE; MICROSPHERE-BASED SCAFFOLDS; MARROW
   STROMAL CELLS; ACID-GLYCOLIC ACID); IN-VITRO EVALUATION; OSTEOGENIC
   DIFFERENTIATION; REGENERATIVE MEDICINE; OXIDIZED CELLULOSE; POLYESTER
   BLENDS; DEGRADATION
AB The success of the scaffold-based bone regeneration approach critically depends on the biomaterial's mechanical and biological properties. Cellulose and its derivatives are inherently associated with exceptional strength and biocompatibility due to their beta-glycosidic linkage and extensive hydrogen bonding. This polymer class has a long medical history as a dialysis membrane, wound care system and pharmaceutical excipient. Recently cellulose-based scaffolds have been developed and evaluated for a variety of tissue engineering applications. In general porous polysaccharide scaffolds in spite of many merits lack the necessary mechanical competence needed for load-bearing applications. The present study reports the fabrication and characterization of three-dimensional (3D) porous sintered microsphere scaffolds based on cellulose derivatives using a solvent/non-solvent sintering approach for load-bearing applications. These 3D scaffolds exhibited a compressive modulus and strength in the mid-range of human trabecular bone and underwent degradation resulting in a weight loss of 10-15% after 24 weeks. A typical stress-strain curve for these scaffolds showed an initial elastic region and a less-stiff post-yield region similar to that of native bone. Human osteoblasts cultured on these scaffolds showed progressive growth with time and maintained expression of osteoblast phenotype markers. Further, the elevated expression of alkaline phosphatase and mineralization at early time points as compared to heat-sintered poly(lactic acid-glycolic acid) control scaffolds with identical pore properties affirmed the advantages of polysaccharides and their potential for scaffold-based bone regeneration.
C1 [Kumbar, S. G.; Toti, U. S.; Deng, M.; James, R.; Laurencin, C. T.; Aravamudhan, A.; Harmon, M.; Ramos, D. M.] Univ Connecticut, Inst Regenerat Engn, Ctr Hlth, Farmington, CT 06030 USA.
   [Kumbar, S. G.; Toti, U. S.; Deng, M.; James, R.; Laurencin, C. T.; Aravamudhan, A.; Harmon, M.; Ramos, D. M.] Univ Connecticut, New England Musculoskeletal Inst, Ctr Hlth, Farmington, CT 06030 USA.
   [Kumbar, S. G.; Toti, U. S.; Deng, M.; James, R.; Laurencin, C. T.; Aravamudhan, A.; Harmon, M.; Ramos, D. M.] Univ Connecticut, Dept Orthopaed Surg, Ctr Hlth, Farmington, CT 06030 USA.
   [Kumbar, S. G.; Laurencin, C. T.; Harmon, M.; Ramos, D. M.] Univ Connecticut, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
RP Kumbar, SG (reprint author), Univ Connecticut, Inst Regenerat Engn, Ctr Hlth, Farmington, CT 06030 USA.
EM Kumbar@uchc.edu
RI James, Roshan/J-3163-2014
OI James, Roshan/0000-0002-2951-9637
FU Institute of Regenerative Engineering; Center for Science and Technology
   Commercialization, University of Connecticut
FX The authors would like to acknowledge financial support from the
   Institute of Regenerative Engineering and the Center for Science and
   Technology Commercialization, University of Connecticut. We thank Mr
   Jack Charles Burns II and Mr Brad Allen Jr for their assistance with
   this work.
CR Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Attawia MA, 1996, J ORTHOPAED RES, V14, P445, DOI 10.1002/jor.1100140315
   Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Brown JL, 2008, J BIOMED MATER RES B, V86B, P396, DOI 10.1002/jbm.b.31033
   Brown JL, 2010, J BIOMED MATER RES A, V95A, P1150, DOI 10.1002/jbm.a.32934
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   Deng M, 2011, RECENT PAT BIOMED EN, V4, P168
   Deng M, 2008, BIOMATERIALS, V29, P337, DOI 10.1016/j.biomaterials.2007.09.029
   Deng M, 2011, ADV FUNCT MATER, V21, P2641, DOI 10.1002/adfm.201100275
   Deng M, 2010, ADV FUNCT MATER, V20, P2794, DOI 10.1002/adfm.201000968
   Deng M, 2010, SOFT MATTER, V6, P3119, DOI 10.1039/b926402g
   Deng M, 2010, BIOMATERIALS, V31, P4898, DOI 10.1016/j.biomaterials.2010.02.058
   Deng M, 2010, J BIOMED MATER RES A, V92A, P114, DOI 10.1002/jbm.a.32334
   Dias GJ, 2003, J MATER SCI-MATER M, V14, P739, DOI 10.1023/A:1025076002948
   Dumitriu S., 1996, POLYSACCHARIDES MED
   Elcin AE, 2006, ARTIF CELL BLOOD SUB, V34, P407, DOI 10.1080/10731190600769701
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   FRANZ G, 1986, ADV POLYM SCI, V76, P1
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   GALGUT PN, 1990, BIOMATERIALS, V11, P561, DOI 10.1016/0142-9612(90)90078-5
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Guohua Z., 2006, POLYM DEGRAD STABIL, V91, P703, DOI DOI 10.1016/J.P0LYMDEGRADSTAB.2005.06.008
   Hamadouche M, 2000, J BONE JOINT SURG BR, V82B, P1095, DOI 10.1302/0301-620X.82B8.11744
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   JAHANGIR AAN, 2008, AAOS NOW, V2
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Kofron MD, 2007, J BIOMED MATER RES A, V82A, P415, DOI 10.1002/jbm.a.31148
   Kofron MD, 2009, ADV FUNCT MATER, V19, P1351, DOI 10.1002/adfm.200801327
   KRASSIG H, 1965, GRAFT COPOLYMERIZATI, P111
   Kucharska M, 2010, MATER LETT, V64, P1059, DOI 10.1016/j.matlet.2010.02.012
   Kumbar SG, 2006, J INORG ORGANOMET P, V16, P365, DOI 10.1007/s10904-006-9071-6
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lv Q, 2009, J BIOMED MATER RES A, V91A, P679, DOI 10.1002/jbm.a.32302
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Martins AM, 2009, TISSUE ENG PT A, V15, P1953, DOI 10.1089/ten.tea.2008.0023
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   Spence J, 1941, J PHYS CHEM-US, V45, P401, DOI 10.1021/j150408a005
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Uysal A, 2003, PLAST RECONSTR SURG, V112, P540, DOI 10.1097/01.PRS.0000070967.06488.63
   Voet D, 2006, FUNDAMENTALS BIOCH L
   Yanoso-Scholl L, 2010, J BIOMED MATER RES A, V95A, P717, DOI 10.1002/jbm.a.32868
   Zhang C, 2006, BIOMED MATER, V1, P56, DOI 10.1088/1748-6041/1/2/002
   ZIGANG G, 2008, BIOMED MATER, V3
NR 55
TC 27
Z9 27
U1 1
U2 32
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2011
VL 6
IS 6
AR 065005
DI 10.1088/1748-6041/6/6/065005
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864LP
UT WOS:000298241800005
PM 22089383
DA 2018-10-19
ER

PT J
AU Pettersson, S
   Wettero, J
   Tengvall, P
   Kratz, G
AF Pettersson, Sofia
   Wettero, Jonas
   Tengvall, Pentti
   Kratz, Gunnar
TI Cell expansion of human articular chondrocytes on macroporous gelatine
   scaffolds-impact of microcarrier selection on cell proliferation
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID LOW-OXYGEN TENSION; IN-VITRO; CROSS-LINKING; PORE-SIZE;
   SUSPENSION-CULTURE; MONOLAYER-CULTURE; GROWTH-FACTORS; CARTILAGE;
   TISSUE; REDIFFERENTIATION
AB This study investigates human chondrocyte expansion on four macroporous gelatine microcarriers (CultiSpher) differing with respect to two manufacturing processes-the amount of emulsifier used during initial preparation and the gelatine cross-linking medium. Monolayer-expanded articular chondrocytes from three donors were seeded onto the microcarriers and cultured in spinner flask systems for a total of 15 days. Samples were extracted every other day to monitor cell viability and establish cell counts, which were analysed using analysis of variance and piecewise linear regression. Chondrocyte densities increased according to a linear pattern for all microcarriers, indicating an ongoing, though limited, cell proliferation. A strong chondrocyte donor effect was seen during the initial expansion phase. The final cell yield differed significantly between the microcarriers and our results indicate that manufacturing differences affected chondrocyte densities at this point. Remaining cells stained positive for chondrogenic markers SOX-9 and S-100 but extracellular matrix formation was modest to undetectable. In conclusion, the four gelatine microcarriers supported chondrocyte adhesion and proliferation over a two week period. The best yield was observed for microcarriers produced with low emulsifier content and cross-linked in water and acetone. These results add to the identification of optimal biomaterial parameters for specific cellular processes and populations.
C1 [Pettersson, Sofia; Kratz, Gunnar] Linkoping Univ, Lab Reconstruct Plast Surg, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.
   [Wettero, Jonas] Linkoping Univ, Rheumatol AIR, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.
   [Tengvall, Pentti] Univ Gothenburg, Inst Clin Sci, Dept Biomat, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden.
   [Kratz, Gunnar] Linkoping Univ Hosp, Dept Hand Plast & Burn Surg, SE-58185 Linkoping, Sweden.
RP Pettersson, S (reprint author), Linkoping Univ, Div Informat Coding, Dept Elect Engn, SE-58183 Linkoping, Sweden.
EM sofia.pettersson@liu.se
RI Wettero, Jonas/C-9578-2009; Tengvall, Pentti/D-3696-2013
OI Wettero, Jonas/0000-0002-6916-5490; 
FU Swedish foundation for strategic research [A302:319]; Linkoping
   University and Landstinget i Ostergotland
FX The authors would like to thank Dr Olle Eriksson for his help with the
   statistical analysis. This study was funded by the Swedish foundation
   for strategic research (grant no A302:319) and the Materials in Medicine
   strategic research area (Linkoping University and Landstinget i
   Ostergotland). Experimental work was performed at the Laboratory for
   Reconstructive Plastic Surgery, Dept of Clinical and Experimental
   Medicine, Linkoping University, Linkoping, Sweden.
CR Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0
   Bancel S, 1996, J FERMENT BIOENG, V81, P437, DOI 10.1016/0922-338X(96)85145-2
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Borg DJ, 2009, J BIOMED MATER RES A, V88A, P184, DOI 10.1002/jbm.a.31864
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chung HJ, 2008, TISSUE ENG PT A, V14, P607, DOI 10.1089/tea.2007.0263
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164
   Dinarvand R, 2005, J MICROENCAPSUL, V22, P139, DOI 10.1080/02652040400026392
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Esposito E, 1996, BIOMATERIALS, V17, P2009, DOI 10.1016/0142-9612(95)00325-8
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Gigout A, 2005, OSTEOARTHR CARTILAGE, V13, P1012, DOI 10.1016/j.joca.2005.06.003
   Grad S, 2003, J BIOMED MATER RES A, V66A, P571, DOI 10.1002/jbm.a.10007
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533
   Huss FRM, 2007, J PLAST RECONSTR AES, V60, P543, DOI 10.1016/j.bjps.2005.10.031
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Jones JR, 2003, J MATER SCI, V38, P3783, DOI 10.1023/A:1025988301542
   Kong D, 1999, Cytotechnology, V29, P151, DOI 10.1023/A:1008053421462
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   LEE SJ, 1994, J APPL POLYM SCI, V92, P2784
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   LIM HS, 1992, BIOTECHNOL PROGR, V8, P486, DOI 10.1021/bp00018a003
   Lippens E, 2010, CELLS TISSUES ORGANS, V192, P177, DOI 10.1159/000313419
   Liu JY, 2004, WOUND REPAIR REGEN, V12, P148, DOI 10.1111/j.1067-1927.2004.012205.x
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j/joca.2003.12.001
   Malda J, 2003, TISSUE ENG, V9, P939, DOI 10.1089/107632703322495583
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Melero-Martin JM, 2006, BIOMATERIALS, V27, P2970, DOI 10.1016/j.biomaterials.2006.01.023
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   NAIMARK WA, 1995, J MATER SCI-MATER M, V6, P235, DOI 10.1007/BF00146862
   Nilsson K, 1988, Biotechnol Genet Eng Rev, V6, P403
   NILSSON K, 2008, Patent No. 7404971
   Ogasawara K, 2002, J IMMUNOL, V169, P3676, DOI 10.4049/jimmunol.169.7.3676
   OHLSON S, 1994, CYTOTECHNOLOGY, V14, P67, DOI 10.1007/BF00772197
   Pettersson S, 2009, J TISSUE ENG REGEN M, V3, P450, DOI 10.1002/term.179
   Phi-Wilson Janette, 2001, American Biotechnology Laboratory, V19, P36
   Schrobback K, 2011, J ORTHOP RES, V29, P539, DOI 10.1002/jor.21264
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Smith RL, 1995, J ORTHOPAED RES, V13, P824, DOI 10.1002/jor.1100130604
   Sommar P, 2010, J PLAST RECONSTR AES, V63, P1036, DOI 10.1016/j.bjps.2009.02.072
   Tsai CL, 2002, ARTIF ORGANS, V26, P18, DOI 10.1046/j.1525-1594.2002.06732.x
   VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wehrli BM, 2003, HUM PATHOL, V34, P263, DOI 10.1053/hupa.2003.41
   Werner A, 2000, BIOTECHNOL BIOENG, V68, P59, DOI 10.1002/(SICI)1097-0290(20000405)68:1<59::AID-BIT7>3.0.CO;2-N
   WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106
   Wu H, 2008, ACTA BIOMATER, V4, P76, DOI 10.1016/j.actbio.2007.06.010
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
   Yoon BH, 2008, J MATER SCI-MATER M, V19, P2287, DOI 10.1007/s10856-007-3332-y
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 59
TC 9
Z9 9
U1 0
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2011
VL 6
IS 6
AR 065001
DI 10.1088/1748-6041/6/6/065001
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 864LP
UT WOS:000298241800001
PM 21959554
DA 2018-10-19
ER

PT J
AU Betsiou, M
   Bantsis, G
   Zoi, I
   Sikalidis, C
AF Betsiou, M.
   Bantsis, G.
   Zoi, I.
   Sikalidis, C.
TI Anticancer drugs loading into and in vitro release from faujasite
SO CLAY MINERALS
LA English
DT Article
DE biomaterial; drug carrier; anticancer drugs; adsorption and release
   kinetics; molecular electrostatic potential; faujasite; zeolite
ID NATURAL ZEOLITES; CLINOPTILOLITE; OXALIPLATIN; GEMCITABINE; ADSORPTION;
   DELIVERY; THERAPY; TOOL
AB This investigation was carried out to determine whether the adsorptive and ion-exchange properties of faujasite (FAU) could be used to delivery locally the anticancer drugs gemcitanine hydrochloride (dFdU.HCl) and oxaliplatin (DACH-Pt). A soaking procedure was used for the determination of the maximum adsorption capacity of FAU and the mechanism described here was achieved. 274 mg dFdU. HCl/g FAU were adsorbed in 16 h, while 48 h were needed for the adsorption of 79.7 mg DACH-Pt/g FAU. Drug release studies were carried out by soaking the samples of loaded FAU in simulation body fluids (SBF). After only one hour 76% of dFdU. HCl was released while the release of DACH-Pt from the FAU was more normal since 38% of DACH-Pt was released in the first 24 h.
C1 [Betsiou, M.; Bantsis, G.; Sikalidis, C.] Aristotle Univ Thessaloniki, Dept Chem Engn, Thessaloniki, Greece.
   [Zoi, I.] Aristotle Univ Thessaloniki, Dept Chem, Thessaloniki, Greece.
RP Sikalidis, C (reprint author), Aristotle Univ Thessaloniki, Dept Chem Engn, Thessaloniki, Greece.
EM sikalidi@auth.gr
RI Zoi, Ioanna/L-7811-2014
OI Zoi, Ioanna/0000-0001-9388-034X
CR Ali SM, 2005, BIOORG MED CHEM LETT, V15, P2571, DOI 10.1016/j.bmcl.2005.03.046
   [Anonymous], 2009, GAUSS 09
   [Anonymous], 2006, CACHE 7 5
   Barroug A, 2002, J ORTHOPAED RES, V20, P274, DOI 10.1016/S0736-0266(01)00105-X
   Becouarn Y, 2001, CRIT REV ONCOL HEMAT, V40, P265, DOI 10.1016/S1040-8428(01)00169-X
   Bonferoni MC, 2007, APPL CLAY SCI, V36, P95, DOI 10.1016/j.clay.2006.04.014
   Brannon-Peppas L, 1997, MED PLASTICS BIOMATE
   Carrato A, 2002, CRIT REV ONCOL HEMAT, V44, P29, DOI 10.1016/S1040-8428(01)00192-5
   Colella C, 2011, CLAY MINER, V46, P295, DOI 10.1180/claymin.2011.046.2.295
   Dahm A, 2004, J BIOTECHNOL, V111, P279, DOI 10.1016/j.jbiotec.2004.04.008
   Dyer A, 2000, J HELMINTHOL, V74, P137, DOI 10.1017/S0022149X00000184
   Elmore AR, 2003, INT J TOXICOL, V22, P37, DOI 10.1177/1091581803022S115
   Faghihian H, 2009, CLAY MINER, V44, P405, DOI 10.1180/claymin.2009.044.3.405
   Farias T, 2003, MICROPOR MESOPOR MAT, V61, P117, DOI 10.1016/S1387-1811(03)00391-3
   FREEMAN KB, 1995, J CHROMATOGR B, V665, P171, DOI 10.1016/0378-4347(94)00521-6
   Frising T, 2008, MICROPOR MESOPOR MAT, V114, P27, DOI 10.1016/j.micromeso.2007.12.024
   Horcajada P, 2006, SOLID STATE SCI, V8, P1459, DOI 10.1016/j.solidstatesciences.2006.07.016
   JOBICM H, 1997, DIFFUSION ZEOLITES C
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kralj M, 2003, EMBO REP, V4, P1008, DOI 10.1038/sj.embor.7400017
   Lobo R. F., 2003, HDB ZEOLITE SCI TECH, P63
   Mumpton FA, 1999, P NATL ACAD SCI USA, V96, P3463, DOI 10.1073/pnas.96.7.3463
   Pavelic K, 2001, J MOL MED-JMM, V78, P708, DOI 10.1007/s001090000176
   Pavelic K., 2003, HDB ZEOLITE SCI TECH, P1128
   Pearce HL, 2005, ADV ENZYME REGUL, V45, P229, DOI 10.1016/j.advenzreg.2005.02.017
   Rimoli MG, 2008, J BIOMED MATER RES A, V87A, P156, DOI 10.1002/jbm.a.31763
   Rivera A, 2005, MICROPOR MESOPOR MAT, V80, P337, DOI 10.1016/j.micromeso.2005.01.011
   Slejko F. L., 1985, ADSORPTION TECHNOLOG, P13
   Tyagi P, 2008, POLYHEDRON, V27, P3567, DOI 10.1016/j.poly.2008.08.025
   Yang R. T., 2003, ADSORBENTS FUNDAMENT, P157
   GEMZAR INDICATIONS D
   ELOXATIN PRESCRIBING
NR 32
TC 3
Z9 3
U1 0
U2 22
PU MINERALOGICAL SOC
PI TWICKENHAM
PA 12 BAYLIS MEWS, AMYAND PARK ROAD,, TWICKENHAM TW1 3HQ, MIDDLESEX,
   ENGLAND
SN 0009-8558
J9 CLAY MINER
JI Clay Min.
PD DEC
PY 2011
VL 46
IS 4
BP 613
EP 619
DI 10.1180/claymin.2011.046.4.613
PG 7
WC Chemistry, Physical; Geosciences, Multidisciplinary; Mineralogy
SC Chemistry; Geology; Mineralogy
GA 863PK
UT WOS:000298177700007
DA 2018-10-19
ER

PT J
AU Wu, XY
   Liu, XS
   Wang, SL
AF Wu, Xiaoyun
   Liu, Xiaoshuai
   Wang, Shili
TI Implantation of biomaterial as an efficient method to harvest
   mesenchymal stem cells
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE mesenchymal stem cells; implantation; biomaterial; multilineage
   differentiation; hematopoiesis-supportive
ID HUMAN BONE-MARROW; SKELETAL-MUSCLE; PROGENITOR CELLS; ADIPOSE-TISSUE;
   CARTILAGE; GELATIN; THERAPY; ORIGIN; DIFFERENTIATION; ENGRAFTMENT
AB Autologous mesenchymal stem cell (MSC) transplants have been used successfully to treat a number of diseases, and patients undergoing cell transplantation must have stem cells collected before transplantation. In this study, we developed a new method to harvest MSCs. Biomaterials were implanted into the spatium intermuscular of mice hind limbs, and a large number of migrating cells (MCs) were isolated from the transplanted biomaterials. The adherent cells in MCs showed the characteristics of MSCs. Further comparative study demonstrated that the characteristics of MC-MSCs were similar to that of bone marrow (BM)-MSCs, including morphology, phenotype, proliferation potential, multilineage differentiation capacity and hematopoiesis-supportive function. The colony-forming unit-fibroblast frequency of the MCs was equivalent to approximately 20-fold of that of the BM. In addition, a BM transplantation experiment demonstrated that MC-MSCs were derived from the peripheral blood. In conclusion, we successfully establish an efficient method to harvest MSCs, and together with the distinct advantages of this method, such as accessibility and possibility for autologous cell therapy, we conclude that our efficient method may be a promising alternative for clinical application.
C1 [Wu, Xiaoyun; Liu, Xiaoshuai; Wang, Shili] Shandong Acad Med Sci, Minist Hlth, Prov Lab Modern Med & Technol Shandong, Jinan 250062, Shandong, Peoples R China.
   [Wang, Shili] Shandong Acad Med Sci, Minist Hlth, Lab Biodrugs, Jinan 250062, Shandong, Peoples R China.
   [Wu, Xiaoyun; Liu, Xiaoshuai] Shandong Acad Med Sci, Minist Hlth, Shandong Med Biotechnol Ctr, Jinan 250062, Shandong, Peoples R China.
RP Wang, SL (reprint author), Shandong Acad Med Sci, Minist Hlth, Prov Lab Modern Med & Technol Shandong, Jingshi Rd 18877, Jinan 250062, Shandong, Peoples R China.
EM aoppolle@126.com
FU National Natural Science Foundation of China [30940065, 30571766];
   Shandong Province Natural Science Foundation [Y2008C06]
FX This work was supported by grants from the National Natural Science
   Foundation of China (grant nos. 30940065 and 30571766) and the Shandong
   Province Natural Science Foundation (grant no. Y2008C06).
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014
   Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Elvenes J, 2009, J ORTHOP SCI, V14, P410, DOI 10.1007/s00776-009-1349-4
   Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142
   Howell JC, 2003, ANN NY ACAD SCI, V996, P158, DOI 10.1111/j.1749-6632.2003.tb03244.x
   Huang JI, 2005, J ORTHOP RES, V23, P1383, DOI 10.1016/j.orthres.2005.03.018
   Kallestad KM, 2010, J CELL PHYSIOL, V222, P676, DOI 10.1002/jcp.21989
   Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777
   Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108
   Li JL, 2008, HISTOCHEM CELL BIOL, V130, P741, DOI 10.1007/s00418-008-0446-3
   Liu W, 2007, BIOMATERIALS, V28, P5078, DOI 10.1016/j.biomaterials.2007.07.028
   McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217
   Prather WR, 2008, EXPERT OPIN BIOL TH, V8, P1241, DOI [10.1517/14712598.8.8.1241 , 10.1517/14712590802233669]
   Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164
   Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y
   Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Tsuboi K, 2005, LEUKEMIA RES, V29, P317, DOI 10.1016/j.leukres.2004.08.005
   Verfaillie Catherine M., 2005, V265, P55
   Verfaillie CM, 2005, NOVART FDN SYMP, V265, P5
   VERFAILLIE CM, 2005, NOVART FDN SYMP, V265, P92
   Vieira NM, 2009, CELL TRANSPLANT, V19, P279
   Watanabe M, 2010, TISSUE ENG PT A, V16, P1645, DOI [10.1089/ten.tea.2009.0532, 10.1089/ten.TEA.2009.0532]
   Wu XY, 2010, CELL TISSUE RES, V340, P549, DOI 10.1007/s00441-010-0978-4
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
NR 36
TC 5
Z9 5
U1 0
U2 2
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 1535-3702
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD DEC
PY 2011
VL 236
IS 12
BP 1477
EP 1484
DI 10.1258/ebm.2011.011061
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 875KI
UT WOS:000299028400018
PM 22075553
DA 2018-10-19
ER

PT J
AU Cheng, XZ
   Shao, K
   Shen, SY
   Hu, SH
   Qiu, HO
AF Cheng, Xianzhong
   Shao, Kun
   Shen, Shangyue
   Hu, Shenghong
   Qiu, Haiou
TI Determination of Trace Silver in Polymetallic Ore Samples by Flame
   Atomic Absorption Spectrometry after Solid-Phase Extraction Using a
   Microcolumn Comprising Eggshell Membrane
SO GEOSTANDARDS AND GEOANALYTICAL RESEARCH
LA English
DT Article
DE eggshell membrane; separation and pre-concentration; FAAS; silver;
   polymetallic ore; membrane coquille d'oe uf; separation et
   preconcentration; FAAS; argent; minerai polymetallique
ID PLASMA-MASS SPECTROMETRY; CLOUD POINT EXTRACTION; EMISSION-SPECTROMETRY;
   WATER SAMPLES; ENVIRONMENTAL-SAMPLES; ANIMAL BIOPOLYMERS; GEOLOGICAL
   SAMPLES; SILICA-GEL; PRECONCENTRATION; SEPARATION
AB A rapid and inexpensive method was developed for the determination of trace silver in polymetallic ore samples by use of eggshell membrane (ESM), a natural biomaterial, as the solid-phase extraction (SPE) adsorbent coupled with flame atomic absorption spectrometry (FAAS). The ESM was used for the separation/pre-concentration of silver, and the parameters affecting sensitivity, such as pH, sample flow rate, eluent volume and eluent flow rate, were carefully investigated. ESM was found to be an effective solid phase extractant for the adsorption of trace silver over a wide range of acidity from 0.02 to 0.50 mol l-1 HNO3. The sample solution in 0.4 mol l-1 HNO3 was pumped through an ESM microcolumn at the rate of 1.0 ml min-1. Silver was absorbed, and then eluted with a solution of 1.0% m/v thiourea0.5% v/v HCl. Under these optimal conditions, ESM exhibited a good enrichment efficiency for silver with a dynamic adsorption capacity of 1.7 mg g-1. The proposed method was applied to the FAAS determination of trace silver in polymetallic ores and geological reference materials, GSO-2, 3 and 5, and GSD-11, GSD-12, and the determined values were in good agreement with certified values.
C1 [Cheng, Xianzhong; Shao, Kun] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan 430023, Peoples R China.
   [Shen, Shangyue; Qiu, Haiou] China Univ Geosci, Fac Mat Sci & Chem Engn, Wuhan 430074, Peoples R China.
   [Hu, Shenghong] China Univ Geosci, Fac Earth Sci, Minist Educ, Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.
RP Cheng, XZ (reprint author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan 430023, Peoples R China.
EM whcxz502@163.com
FU National Natural Science Foundation of China [20575061]; Education
   Department Foundation of Hubei Provincial in China [D200718005]
FX This work was supported by the National Natural Science Foundation of
   China (No. 20575061) and the Education Department Foundation of Hubei
   Provincial in China (No. D200718005).
CR Absalan G, 2007, SEP PURIF TECHNOL, V56, P231, DOI 10.1016/j.seppur.2007.01.036
   Zou AM, 2008, J ANAL ATOM SPECTROM, V23, P412, DOI 10.1039/b714535g
   Akhond M, 2006, SEP PURIF TECHNOL, V52, P53, DOI 10.1016/j.seppur.2006.03.014
   Arami M, 2006, CHEMOSPHERE, V65, P1999, DOI 10.1016/j.chemosphere.2006.06.074
   Burham N, 2009, DESALINATION, V249, P1199, DOI 10.1016/j.desal.2009.04.009
   Chang CC, 2003, ANAL CHIM ACTA, V493, P213, DOI 10.1016/S0003-2670(03)00875-4
   Chen XW, 2009, TALANTA, V78, P71, DOI 10.1016/j.talanta.2008.10.039
   Christou CK, 2009, TALANTA, V78, P144, DOI 10.1016/j.talanta.2008.10.050
   Dauphin Y, 2006, ANAL BIOANAL CHEM, V386, P1761, DOI 10.1007/s00216-006-0784-8
   Fan ZF, 2007, ATOM SPECTROSC, V28, P30
   Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1
   Ishikawa SI, 2004, BIOL TRACE ELEM RES, V102, P113, DOI 10.1385/BTER:102:1-3:113
   Ishikawa SI, 2002, BIOL TRACE ELEM RES, V86, P227, DOI 10.1385/BTER:86:3:227
   Jibrin SS, 2009, GEOSTAND GEOANAL RES, V33, P469, DOI 10.1111/j.1751-908X.2009.00006.x
   Kojima I, 1996, J ANAL ATOM SPECTROM, V11, P607, DOI 10.1039/ja9961100607
   Kuznetsova AI, 2007, GEOSTAND GEOANAL RES, V31, P251, DOI 10.1111/j.1751-908X.2007.00831.x
   Liang P, 2009, GEOSTAND GEOANAL RES, V33, P63, DOI 10.1111/j.1751-908X.2009.00900.x
   Madrakian T, 2006, J HAZARD MATER, V128, P67, DOI 10.1016/j.jhazmat.2005.07.031
   Manzoori JL, 2007, J HAZARD MATER, V144, P458, DOI 10.1016/j.jhazmat.2006.10.084
   PAVIA DL, 1987, INTRO SPECTROSCOPY G, P30
   PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001
   Sant'Ana OD, 2002, TALANTA, V56, P673, DOI 10.1016/S0039-9140(01)00604-X
   SUYAMA K, 1994, APPL BIOCHEM BIOTECH, V45-6, P871, DOI 10.1007/BF02941856
   Thomas AM, 2008, ATOM SPECTROSC, V29, P69
   Trojanowicz M, 2006, TRAC-TREND ANAL CHEM, V25, P480, DOI 10.1016/j.trac.2005.11.008
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Tunceli A, 2000, TALANTA, V51, P889, DOI 10.1016/S0039-9140(99)00348-3
   Tuzen M, 2009, J HAZARD MATER, V164, P1428, DOI 10.1016/j.jhazmat.2008.09.050
   Wu YW, 2004, GEOSTAND GEOANAL RES, V28, P383, DOI 10.1111/j.1751-908X.2004.tb00757.x
   Xu J, 2008, CHINESE J ANAL CHEM, V36, P1493, DOI 10.1016/S1872-2040(09)60002-5
   Yan MC, 2007, GEOSTAND GEOANAL RES, V31, P301, DOI 10.1111/j.1751-908X.2007.00133.x
   Zhang YJ, 2010, TALANTA, V80, P1907, DOI 10.1016/j.talanta.2009.10.042
NR 32
TC 11
Z9 12
U1 1
U2 14
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1639-4488
J9 GEOSTAND GEOANAL RES
JI Geostand. Geoanal. Res.
PD DEC
PY 2011
VL 35
IS 4
BP 461
EP 469
DI 10.1111/j.1751-908X.2011.00101.x
PG 9
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA 866CW
UT WOS:000298358400004
DA 2018-10-19
ER

PT J
AU Wang, HY
   Lin, SL
   Chung, CK
   Chuang, SF
AF Wang, H. Y.
   Lin, S. L.
   Chung, C. K.
   Chuang, S. F.
TI Experiment and simulation of resistance of nanoporous dentin biomaterial
   to CO2 laser irradiation
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
ID GARNET LASER IRRADIATION; ENAMEL
AB The resistance of nanoporous dentin biomaterial to CO2 laser irradiation was investigated by experiment and simulation for potential tooth hypersensitivity treatment. The controlled parameters including laser power of 0.03-0.150 W, scanning speeds of 11.4-34.2 mm/s and focus/defocus modes were used for studying interaction between laser energy and dentin of human tooth. Most of the dentin specimens were etched after CO2 laser irradiation with the power larger than 0.12 W at a scanning speed of 11.4 mm/s. Compared with the simulation results of temperature distribution, the maximum temperature at laser powers from 0.12 to 0.15 W is increased from 1961 to 2245 degrees C, which exceeded the melting point (1570 degrees C) of dentin's main content hydroxyapatite (HA). Increasing scanning speed can reduce the linear density of laser output energy for just locally melting porous microstructure of dentin surface without etching. Varying focus mode can also improve the damage of nanoporous dentin microstructure. At parameters of 0.150 W power and 34.2 mm/s scanning speed under defocus operation, laser treatment was successfully performed on the nano-HA coated dentin with well-molten sealing on tubules of porous microstructure at a simulate surface temperature of about 574 degrees C, which was the potential for dentin hypersensitivity cure application.
C1 [Wang, H. Y.; Lin, S. L.; Chung, C. K.] Natl Cheng Kung Univ, Dept Mech Engn, Ctr Micro Nano Sci & Technol, Tainan 70101, Taiwan.
   [Wang, H. Y.; Lin, S. L.; Chung, C. K.] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan 70101, Taiwan.
   [Chuang, S. F.] Natl Cheng Kung Univ, Med Coll Inst Oral Med, Tainan 70101, Taiwan.
RP Wang, HY (reprint author), Natl Cheng Kung Univ, Dept Mech Engn, Ctr Micro Nano Sci & Technol, Tainan 70101, Taiwan.
EM ckchung@mail.ncku.edu.tw
FU National Science Council (NSC) [NSC 95-2221-E-006-047-MY3]
FX This work is partially sponsored by National Science Council (NSC) under
   contract no. NSC 95-2221-E-006-047-MY3. We pay our great thanks to the
   Centre for Micro/Nano Science and Technology (CMNST) in National Cheng
   Kung University for the access of process and analysis equipments.
CR Chiang YC, 2008, LASER MED SCI, V23, P41, DOI 10.1007/s10103-007-0453-y
   Chung CK, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/6/065023
   Colucci V, 2009, LASER MED SCI, V24, P811, DOI 10.1007/s10103-008-0563-1
   Coluzzi Donald J, 2004, Dent Clin North Am, V48, P751, DOI 10.1016/j.cden.2004.05.003
   Romano ACCC, 2011, LASER MED SCI, V26, P35, DOI 10.1007/s10103-009-0746-4
   de Mollo M.A., 2011, LASER MED SCI, V26, P143
   He ZD, 2009, LASER MED SCI, V24, P507, DOI 10.1007/s10103-008-0553-3
   Lizarelli RFZ, 2008, LASER PHYS LETT, V5, P63, DOI 10.1002/lapl.200710082
   Ziskind D, 2010, DENT MATER, V26, P179, DOI 10.1016/j.dental.2009.09.012
NR 9
TC 0
Z9 0
U1 0
U2 4
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD DEC
PY 2011
VL 5
IS 4
BP 148
EP 151
DI 10.1049/iet-nbt.2011.0025
PG 4
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA 863BB
UT WOS:000298136700009
PM 22149872
DA 2018-10-19
ER

PT J
AU Gaitan, AS
   Mora, PAR
   Narvaez, DM
   Moreno, LMM
AF Samper Gaitan, Angela
   Rojas Mora, Pabio Arturo
   Maria Narvaez, Diana
   Mendez Moreno, Luis Miguel
TI Characterising structural, mechanical and cytotoxic properties of
   coral-based composite material intended for bone implant applications
SO INGENIERIA E INVESTIGACION
LA English
DT Article
DE Porites asteroides coral; bone implant; composite material; calcium
   sulphate; biomaterial characterisation
ID CALCIUM-SULFATE; GRAFT SUBSTITUTES; HYDROXYAPATITE; OSTEOGENESIS;
   RESORPTION
AB Studies concerning the application of Porites asteroides coral for bone implant purposes have demonstrated the biological viability of its use. As a complement to previous research regarding the development of bone-powder based composite materials which are useful for such applications, this study was aimed at developing a coral powder-based composite material which would be able to satisfy the appropriate structural, mechanical and cytotoxic properties required for its use. A composite material made of coral powder, calcium sulphate powder and water was therefore developed, and its properties were tested in different compositions. The results showed how the resulting composite material had properties which were comparable to those of human cortical bone (from both a structural and mechanical point of view), as well as being non-toxic below a 0.35 mg/ml critical composite material concentration.
C1 [Samper Gaitan, Angela; Rojas Mora, Pabio Arturo; Maria Narvaez, Diana; Mendez Moreno, Luis Miguel] Univ Los Andes, Bogota, Colombia.
   [Samper Gaitan, Angela] McKinsey & Co Inc, New York, NY USA.
   [Rojas Mora, Pabio Arturo] Univ Fed Santa Catarina, BR-88040900 Florianopolis, SC, Brazil.
   [Mendez Moreno, Luis Miguel] Univ Nacl Colombia, Bogota, Colombia.
RP Gaitan, AS (reprint author), Univ Los Andes, Bogota, Colombia.
EM angela_samper@mckinsey.com; farojas@uniandes.edu.co;
   di-narva@hotmail.com; lmmendezm@unal.edu.co
CR BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Ben-Nissan B, 2003, CURR OPIN SOLID ST M, V7, P283, DOI 10.1016/j.cossms.2003.10.001
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Cho BC, 2005, J ORAL MAXIL SURG, V63, P1753, DOI 10.1016/j.joms.2004.10.011
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Jung HM, 2010, BIOMATERIALS, V31, P29, DOI 10.1016/j.biomaterials.2009.09.019
   Khavari F, 1993, Biomed Sci Instrum, V29, P65
   Lugo S., 2009, THESIS U LOS ANDES
   Micheletti G.F., 1980, TECNOLOGIA MECANICA
   Mosmann T., 1983, J IMMUNOL
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Penaloza J., 2007, THESIS U LOS ANDES
   Quevedo S. M., 2004, THESIS U LOS ANDES
   Reina D. Y., 2005, THESIS U LOS ANDES
   Ripamonti U, 2009, BIOMATERIALS, V30, P1428, DOI 10.1016/j.biomaterials.2008.10.065
   Rojas F.A., 2000, THESIS U FEDERAL SAN
   Salazar A., 2009, THESIS U LOS ANDES
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
NR 19
TC 0
Z9 0
U1 0
U2 1
PU UNIV NAC COLOMBIA, FAC INGENIERIA
PI BOGOTA
PA CALLE 44, NO 45-67, UNIDAD CAMILO TORRES, BLOQUE B5, OFICINA 401,
   BOGOTA, 00000, COLOMBIA
SN 0120-5609
J9 ING INVEST
JI Ing. Invest.
PD DEC
PY 2011
VL 31
IS 3
BP 135
EP 141
PG 7
WC Engineering, Multidisciplinary
SC Engineering
GA 872SJ
UT WOS:000298829400015
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Lin, HS
   Huang, TH
   Mao, SW
   Tai, YS
   Chiu, HT
   Cheng, KYB
   Yang, RS
AF Lin, Hsin-Shih
   Huang, Tsang-Hai
   Mao, Shih-Wei
   Tai, Yuh-Shiou
   Chiu, Hung-Ta
   Cheng, Kuang-You B.
   Yang, Rong-Sen
TI A SHORT-TERM FREE-FALL LANDING ENHANCES BONE FORMATION AND BONE MATERIAL
   PROPERTIES
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Bone; landing; mechanical load; bone formation; biomaterial
ID HIGH-IMPACT EXERCISE; CORTICAL BONE; MECHANICAL-PROPERTIES; IN-VIVO;
   OSTEOGENIC RESPONSE; COMPACT-BONE; RAT ULNA; STRENGTH; COLLAGEN; GROWTH
AB To investigate the effects of a short-term free-fall landing course on local bone metabolism and biomaterial properties, 32 female Wistar rats (7 week old) were randomly assigned to three groups: L30 (n = 11), L10 (n = 11) and CON (n = 10). Animals in the L30 and L10 groups were subjected to 30 and 10 free-fall landings per day, respectively, from a height of 40 cm for five consecutive days. Animals' ulnae were studied using methods of dynamic histomorphometry, tissue geometry, biomaterial measurements and collagen fiber orientation (CFO) analysis. In dynamic histomorphometry analysis, periosteal as well as endosteal mineral apposition rates (MAR, mu m/day) were significantly higher in L30 group than in the CON group (p < 0.05). In addition, the periosteal bone formation rate (BFR/BS, mu m(2)/mu m(3)/year) was significantly higher in the L10 and L30 groups (p < 0.05). The ulnae of the animals in the two landing groups were higher in post-yield energy without significant changes in CFO, tissue size or tissue weight measurements. In conclusion, a short-term free-fall landing training produced a slight, but significant, higher bone formation in the ulnae of young female rats. Enhanced tissue biomaterial properties did not accompany size-related changes, suggesting that bone adapting to mechanical loading begins with changes in tissue-level properties.
C1 [Lin, Hsin-Shih] Natl Taiwan Normal Univ, Dept Phys Educ, Taipei 10610, Taiwan.
   [Lin, Hsin-Shih; Huang, Tsang-Hai; Chiu, Hung-Ta; Cheng, Kuang-You B.] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 70101, Taiwan.
   [Mao, Shih-Wei] ROC Mil Acad, Dept Mech Engn, Kaohsiung, Taiwan.
   [Tai, Yuh-Shiou] ROC Mil Acad, Dept Civil Engn, Kaohsiung, Taiwan.
   [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Dept Orthopaed, Taipei, Taiwan.
RP Lin, HS (reprint author), Natl Taiwan Normal Univ, Dept Phys Educ, Taipei 10610, Taiwan.
EM tsanghai@mail.ncku.edu.tw
RI Tai, Yuh-Shiou/C-7784-2018
OI Tai, Yuh-Shiou/0000-0002-7106-7080; Yang, Rong-Sen/0000-0002-0553-4779
FU National Science Council, Taiwan [NSC-94-2314-B-006-033]
FX This study was supported by a grant from the National Science Council
   (NSC-94-2314-B-006-033, Taiwan). Miss Jae Cody is appreciated for her
   editorial assistance in English.
CR Bellew James W, 2006, Pediatr Phys Ther, V18, P19, DOI 10.1097/01.pep.0000200952.63544.16
   Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330
   Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X
   CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129
   Creighton DL, 2001, J APPL PHYSIOL, V90, P565
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   Duncan CS, 2002, MED SCI SPORT EXER, V34, P286, DOI 10.1097/00005768-200202000-00017
   Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119
   Garnero P, 2006, BONE, V38, P300, DOI 10.1016/j.bone.2005.09.014
   Godfrey RJ, 2003, SPORTS MED, V33, P599, DOI 10.2165/00007256-200333080-00005
   Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688
   Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291
   Huang TH, 2008, J BONE MINER METAB, V26, P350, DOI 10.1007/s00774-007-0831-3
   Isaksson H, 2009, CALCIFIED TISSUE INT, V85, P247, DOI 10.1007/s00223-009-9273-3
   Judex S, 2000, J APPL PHYSIOL, V88, P2183
   Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452
   Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717
   Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6
   Martin RB, 1996, J BIOMECH, V29, P1515, DOI 10.1016/S0021-9290(96)80002-9
   Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x
   McKay H, 2005, BRIT J SPORT MED, V39, P10, DOI 10.1136/bjsm.2003.008615
   Nagasawa S, 2008, J BONE MINER METAB, V26, P226, DOI 10.1007/s00774-007-0812-6
   New SA, 2001, P NUTR SOC, V60, P265
   Ohashi N, 2002, J BONE MINER RES, V17, P284, DOI 10.1359/jbmr.2002.17.2.284
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Robling AG, 2001, BONE, V29, P105, DOI 10.1016/S8756-3282(01)00488-4
   Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545
   RUTH EB, 1953, AM J ANAT, V93, P429, DOI 10.1002/aja.1000930306
   Silva MJ, 2007, J ORTHOP RES, V25, P252, DOI 10.1002/jor.20320
   Skedros JG, 1996, ANAT RECORD, V246, P47
   Skedros JG, 2006, J EXP BIOL, V209, P3025, DOI 10.1242/jeb.02304
   TURNER CH, 1994, J BONE MINER RES, V9, P87
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   TURNER CH, 1991, BONE, V12, P73, DOI 10.1016/8756-3282(91)90003-2
   Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039
   Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480
   Uthgenannt BA, 2007, J BIOMECH, V40, P317, DOI 10.1016/j.jbiomech.2006.01.005
   Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8
   Welch JM, 2008, BONE, V42, P660, DOI 10.1016/j.bone.2007.12.220
   Welch JM, 2004, J APPL PHYSIOL, V97, P1859, DOI 10.1152/japplphysiol.00438.2004
   Wohl GR, 2009, BONE, V44, P320, DOI 10.1016/j.bone.2008.09.010
NR 41
TC 4
Z9 4
U1 0
U2 7
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD DEC
PY 2011
VL 11
IS 5
BP 1125
EP 1139
DI 10.1142/S0219519411004356
PG 15
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 874CE
UT WOS:000298931800016
DA 2018-10-19
ER

PT J
AU Rohanizadeh, R
   Chung, K
AF Rohanizadeh, Ramin
   Chung, Kimberly
TI Hydroxyapatite as a Carrier for Bone Morphogenetic Protein
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE hydroxyapatite; bone morphogenetic protein; drug delivery; carrier
ID TRICALCIUM PHOSPHATE; PRECIPITATION; REGENERATION; DELIVERY; RHBMP-2;
   BMP-2; IMPLANTS; COATINGS; TRANSFORMATION; ENHANCEMENT
AB Bone morphogenetic proteins (BMPs) can induce the formation of new bone in numerous orthopedic and dental applications in which loss of bone is the main issue. The combination of BMP with a biomaterial that can carry and deliver proteins has been demonstrated to maximize the therapeutic effects of BMPs. However, no ideal candidate with optimal characteristics as a carrier has emerged for clinical use of BMPs. Hydroxyapatite (HA) is a potential BMP carrier with its osteoconductive properties and desirable characteristics as a bone graft biomaterial. In this study, 3 different methods to load BMP into HA materials were characterized and compared based on the BMP uptake and release profile. BMP was loaded into HA in 3 ways: (1) incorporation of BMP during HA precipitation, (2) HA immersion in BMP solution, and (3) BMP incorporation during dicalcium phosphate dihydrate (DCPD) conversion to HA. The size of HA crystals decreased when BMP was loaded during HA precipitation and HA immersion in BMP solution; however, it did not change when BMP was loaded during DCPD-to-HA conversion. The highest BMP uptake was achieved using the immersion method followed by HA precipitation, and the lowest via DCPD conversion. It is interesting to note that BMP loading during HA precipitation resulted in sustained and prolonged BMP release compared with the 2 other BMP loading methods. In conclusion, BMP incorporation during HA precipitation revealed itself to be the best loading method.
C1 [Rohanizadeh, Ramin; Chung, Kimberly] Univ Sydney, Fac Pharm, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia.
RP Rohanizadeh, R (reprint author), Univ Sydney, Fac Pharm, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia.
EM ramin.rohanizadeh@sydney.edu.au
RI Rohanizadeh, Ramin/J-5719-2016
OI Rohanizadeh, Ramin/0000-0002-7967-5515
FU American Academy of Implant Dentistry Research Foundation
FX This work was supported by a research grant from American Academy of
   Implant Dentistry Research Foundation.
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Arifuzzaman SM, 2004, J CRYST GROWTH, V267, P624, DOI 10.1016/j.jcrysgro.2004.04.024
   Azevedo HS, 2005, MAT SCI ENG C-BIO S, V25, P169, DOI 10.1016/j.msec.2005.01.007
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boix T, 2005, J INORG BIOCHEM, V99, P1043, DOI 10.1016/j.jinorgbio.2005.01.011
   BRINGHURST FR, 2007, HARRISONS PRINCIPLES
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Da Silva MHP, 2001, SURF COAT TECH, V137, P270
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Freilich M, 2008, BONE, V43, P781, DOI 10.1016/j.bone.2008.05.021
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kikawa T, 2009, ACTA BIOMATER, V5, P1756, DOI 10.1016/j.actbio.2008.12.008
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   LEGEROS RZ, 1991, MONOGRAPHS ORAL MED, V15
   Leonor IB, 2009, MAT SCI ENG C-BIO S, V29, P913, DOI 10.1016/j.msec.2008.08.003
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114
   Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Ohta H, 2005, J BONE MINER METAB, V23, P420, DOI 10.1007/s00774-005-0623-6
   Ono I, 1998, J BONE MINER METAB, V16, P81, DOI 10.1007/s007740050030
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.3.CO;2-Y
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Shih WJ, 2004, J CRYST GROWTH, V270, P211, DOI 10.1016/j.jcrysgro.2004.06.023
   Stulajterova R, 2008, COLLOID SURFACE A, V316, P104, DOI 10.1016/j.colsurfa.2007.08.036
   Thamariselvi T. V, 2006, ARTIF ORGANS, V19, P81
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Zhao JY, 2009, J BIOSCI BIOENG, V107, P318, DOI 10.1016/j.jbiosc.2008.10.007
   Zou XN, 2009, BIOMATERIALS, V30, P991, DOI 10.1016/j.biomaterials.2008.10.061
NR 38
TC 17
Z9 18
U1 0
U2 10
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD DEC
PY 2011
VL 37
IS 6
BP 659
EP 672
DI 10.1563/AAID-JOI-D-10-00005
PG 14
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 864ZC
UT WOS:000298278000005
PM 20662667
DA 2018-10-19
ER

PT J
AU Sammartino, G
   Ehrenfest, DMD
   Carile, F
   Tia, M
   Bucci, P
AF Sammartino, Gilberto
   Ehrenfest, David M. Dohan
   Carile, Francesco
   Tia, Mariano
   Bucci, Paolo
TI Prevention of Hemorrhagic Complications After Dental Extractions Into
   Open Heart Surgery Patients Under Anticoagulant Therapy: The Use of
   Leukocyte- and Platelet-Rich Fibrin
SO JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Article
DE platelet-rich fibrin; heart surgery patient; anticoagulant therapy;
   hemorrhagic complications; dental avulsion; dental extraction
ID TRANEXAMIC ACID MOUTHWASH; SINUS FLOOR AUGMENTATION; SOLE GRAFTING
   MATERIAL; ORAL-SURGERY; BONE REGENERATION; MICROTHREADED IMPLANTS;
   TREATED PATIENTS; L-PRF; PLASMA; THROMBOSPONDIN-1
AB Leukocyte-and platelet-rich fibrin (L-PRF) is a biomaterial commonly used in periodontology and implant dentistry to improve healing and tissue regeneration, particularly as filling material in alveolar sockets to regenerate bone for optimal dental implant placement. The objective of this work was to evaluate the use of L-PRF as a safe filling and hemostatic material after dental extractions (or avulsions) for the prevention of hemorrhagic complications in heart surgery patients without modification of the anticoagulant oral therapy. Fifty heart surgery patients under oral anticoagulant therapy who needed dental extractions were selected for the study. Patients were treated with L-PRF clots placed into 168 postextraction sockets without modification of anticoagulant therapy (mean international normalized ratio = 3.16 +/- 0.39). Only 2 patients reported hemorrhagic complications (4%), all of which resolved a few hours after the surgery by compression and hemostatic topical agents. Ten patients (20%) showed mild bleeding, which spontaneously resolved or was resolved by minimal compression less than 2 hours after surgery. No case of delayed bleeding was reported. The remaining 38 patients (76%) showed an adequate hemostasis after the dental extractions. In all cases, no alveolitis or painful events were reported, soft tissue healing was quick, and wound closure was always complete at the time of suture removal one week after surgery. The proposed protocol is a reliable therapeutic option to avoid significant bleeding after dental extractions without the suspension of the continuous oral anticoagulant therapy in heart surgery patients. Other applications of the hemostatic and healing properties of L-PRF should be investigated in oral implantology.
C1 [Ehrenfest, David M. Dohan] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Unit LoB5, Kwangju, South Korea.
   [Sammartino, Gilberto; Ehrenfest, David M. Dohan; Carile, Francesco; Tia, Mariano; Bucci, Paolo] Univ Naples Federico II, Dept Odontostomatol & Maxillofacial Sci, Naples, Italy.
RP Ehrenfest, DMD (reprint author), Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Unit LoB5, Kwangju, South Korea.
EM LoB5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
CR Acocella A, 2009, J ORAL IMPLANTOL, V35, P37, DOI 10.1563/1548-1336-35.1.37
   Adibrad M, 2009, J ORAL IMPLANTOL, V35, P232, DOI 10.1563/AAID-JOI-D-09-00035.1
   BAILEY BMW, 1983, BRIT DENT J, V155, P308, DOI 10.1038/sj.bdj.4805221
   Beirne OR, 2005, J ORAL MAXIL SURG, V63, P540, DOI 10.1016/j.joms.2004.12.009
   Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856
   BOREA G, 1993, ORAL SURG ORAL MED O, V75, P29, DOI 10.1016/0030-4220(93)90401-O
   Braccini F, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P255
   Campbell JH, 2000, J ORAL MAXIL SURG, V58, P131, DOI 10.1016/S0278-2391(00)90324-0
   Carter G, 2003, INT J ORAL MAX SURG, V32, P504, DOI 10.1054/ijom.2002.0414
   Carter G, 2003, J ORAL MAXIL SURG, V61, P1432, DOI 10.1016/j.joms.2003.01.001
   Charrier J B, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P313
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J., 2001, IMPLANTODONTIE, V42, P55
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   DECLERCK D, 1992, J DENT RES, V71, P387, DOI 10.1177/00220345920710020701
   Del Corso M, 2009, J PERIODONTOL, V80, P1694, DOI 10.1902/jop.2009.090253
   Della Valle A, 2003, J ORAL MAXIL SURG, V61, P1275, DOI 10.1016/S0278-2391(03)00727-4
   Devani P, 1998, BRIT J ORAL MAX SURG, V36, P107, DOI 10.1016/S0266-4356(98)90177-2
   Develioglu H, 2010, J ORAL IMPLANTOL, V36, P167, DOI 10.1563/AAID-JOI-D-09-00064
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Eby Ben W, 2002, J Oral Implantol, V28, P297, DOI 10.1563/1548-1336(2002)028<0297:PPHWAS>2.3.CO;2
   Ehrenfest DMD, 2008, IMPLANT DENT, V17, P4, DOI [10.1097/lD.0b013e31816760b4, 10.1097/ID.0b013e31816760b4]
   Ehrenfest DMD, 2010, J PERIODONTOL, V81, P546, DOI 10.1902/jop.2009.090531
   Ehrenfest DMD, 2010, ORAL SURG ORAL MED O, V110, P275, DOI 10.1016/j.tripleo.2010.05.048
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Ehrenfest DMD, 2010, ARCH ORAL BIOL, V55, P185, DOI 10.1016/j.archoralbio.2010.01.004
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Garcia RV, 2010, J ORAL IMPLANTOL, V36, P281, DOI 10.1563/AAID-JOI-D-09-00056
   Gaspar R, 1997, Quintessence Int, V28, P375
   Jang ES, 2010, ORAL SURG ORAL MED O, V109, P831, DOI 10.1016/j.tripleo.2009.10.038
   Jurk K, 2003, FASEB J, V17, P1490, DOI 10.1096/fj.02-0830fje
   Lee CYS, 2009, J ORAL IMPLANTOL, V35, P164, DOI 10.1563/1548-1336-35.4.164
   Lee EH, 2010, ORAL SURG ORAL MED O, V109, pE33, DOI 10.1016/j.tripleo.2009.12.043
   Little JW, 2002, ORAL SURG ORAL MED O, V93, P544, DOI 10.1067/moe.2002.121391
   Mangano C, 2010, J ORAL IMPLANTOL, V36, P491, DOI 10.1563/AAID-JOI-D-09-00028
   Marei MK, 2009, J ORAL IMPLANTOL, V35, P106, DOI 10.1563/1548-1336-35.3.106
   MARTINOWITZ U, 1990, ORAL SURG ORAL MED O, V70, P274, DOI 10.1016/0030-4220(90)90139-J
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   Oktay EO, 2010, J ORAL IMPLANTOL, V36, P175, DOI 10.1563/AAID-JOI-D-09-00023
   Podaropoulos L, 2009, J ORAL IMPLANTOL, V35, P28, DOI 10.1563/1548-1336-35.1.28
   Potijanyakul P, 2010, J ORAL IMPLANTOL, V36, P195, DOI 10.1563/AAID-JOI-D-09-00042
   RAKOCZ M, 1993, ORAL SURG ORAL MED O, V75, P280, DOI 10.1016/0030-4220(93)90135-Q
   RAMSTROM G, 1993, J ORAL MAXIL SURG, V51, P1211, DOI 10.1016/S0278-2391(10)80291-5
   Rutkowski JL, 2010, J ORAL IMPLANTOL, V36, P11, DOI 10.1563/AAID-JOI-09-00063
   Rutkowski James L, 2008, J Oral Implantol, V34, P25, DOI 10.1563/1548-1336(2008)34[25:AAOARS]2.0.CO;2
   Scully C, 2002, ORAL SURG ORAL MED O, V94, P57, DOI 10.1067/moe.2002.123828
   Silverstein LH, 2009, J ORAL IMPLANTOL, V35, P82, DOI 10.1563/1548-1336-35.2.82
   Simonpieri A, 2011, IMPLANT DENT, V20, P2, DOI 10.1097/ID.0b013e3181faa8af
   Simonpieri A, 2009, IMPLANT DENT, V18, P220, DOI 10.1097/ID.0b013e31819b5e3f
   Simonpieri A, 2009, IMPLANT DENT, V18, P102, DOI 10.1097/ID.0b013e318198cf00
   SINDETPEDERSEN S, 1989, NEW ENGL J MED, V320, P840, DOI 10.1056/NEJM198903303201305
   Souto JC, 1996, J ORAL MAXIL SURG, V54, P27, DOI 10.1016/S0278-2391(96)90297-9
   Souto JC, 1996, J ORAL MAXILLOFAC SU, V54, P323
   Toscano N, 2010, J ORAL IMPLANTOL, V36, P467, DOI 10.1563/AAID-JOI-D-09-00100
   Trindade-Suedam IK, 2010, J ORAL IMPLANTOL, V36, P333, DOI 10.1563/AAID-JOI-D-09-00072
   Urban I, 2009, J ORAL IMPLANTOL, V35, P251, DOI 10.1563/AAID-JOI-D-09-00004.1
   Wahl MJ, 1998, ARCH INTERN MED, V158, P1610, DOI 10.1001/archinte.158.15.1610
   Wahl MJ, 2000, J AM DENT ASSOC, V131, P77, DOI 10.14219/jada.archive.2000.0024
   Winkler S, 2009, J ORAL IMPLANTOL, V35, P3, DOI 10.1563/1548-1336-35.1.3
   Zanon E, 2000, HAEMOPHILIA, V6, P533
NR 66
TC 19
Z9 22
U1 1
U2 14
PU ALLEN PRESS INC
PI LAWRENCE
PA 810 E 10TH ST, LAWRENCE, KS 66044 USA
SN 0160-6972
EI 1548-1336
J9 J ORAL IMPLANTOL
JI J. Oral Implant.
PD DEC
PY 2011
VL 37
IS 6
BP 681
EP 690
DI 10.1563/AAID-JOI-D-11-00001
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 864ZC
UT WOS:000298278000007
PM 21718187
DA 2018-10-19
ER

PT J
AU Li, YJ
   Li, N
   Tu, JC
   Li, XT
   Wang, BB
   Chi, Y
   Liu, DR
   Yang, DF
AF Li, Yanjuan
   Li, Nan
   Tu, Jinchun
   Li, Xiaotian
   Wang, Beibei
   Chi, Yue
   Liu, Darui
   Yang, Dianfan
TI TiO2 supported on rod-like mesoporous silica SBA-15: Preparation,
   characterization and photocatalytic behaviour
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE Oxides; Chemical synthesis; X-ray diffraction; Catalytic properties
ID COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; MAGNETIC CORE; TITANIA;
   DEGRADATION; TEMPERATURE; MATRIX; SHELL
AB TiO2 nanoparticles have been successfully incorporated in the pores of mesoporous silica SBA-15 with different morphologies by a wet impregnation method. The composites were characterized by powder X-ray diffraction (XRD), scanning electron microscopy (SEM), inductively coupled plasma (ICP) emission spectroscopy, transmission electron microscopy (TEM), N-2-sorption and UV-Vis diffuse reflectance spectroscopy. The photodegradation of methyl orange (MO) was used to study their photocatalytic property. It is indicated that the morphology of SBA-15 had a great influence on the photocatalytic activity of the composites. When TiO2/SBA-15 composite was prepared by loading TiO2 nanoparticles on uniform rod-like SBA-15 of 1 mu m length, it showed higher photocatalytic degradation rate than that on less regular but much larger SBA-15 support. This difference was rationalized in terms of the homogeneously distributed and shorter channels of rod-like SBA-15, which favored mass transport and improved the efficient utilization of the pore surface. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Li, Yanjuan; Li, Nan; Tu, Jinchun; Li, Xiaotian; Wang, Beibei; Chi, Yue; Liu, Darui; Yang, Dianfan] Jilin Univ, Coll Mat Sci & Engn, Key Lab Automobile Mat, Minist Educ, Changchun 130012, Peoples R China.
   [Tu, Jinchun] Hainan Univ, Minist Educ, Coll Mat & Chem Engn, Key Lab Trop Biol Resources, Haikou 570228, Peoples R China.
RP Yang, DF (reprint author), Jilin Univ, Coll Mat Sci & Engn, Key Lab Automobile Mat, Minist Educ, 2699 Qianjin St, Changchun 130012, Peoples R China.
EM lin@jlu.edu.cn
RI Tu, Jinchun/D-2718-2018
OI Tu, Jinchun/0000-0001-8793-4727; Li, Nan/0000-0002-3614-9558; Li,
   Xiaotian/0000-0002-1513-2300
FU National Natural Science Foundation of China [21076094]
FX This work was supported by National Natural Science Foundation of China
   (No. 21076094).
CR Artkla S, 2009, APPL CATAL B-ENVIRON, V91, P157, DOI 10.1016/j.apcatb.2009.05.019
   Beyers E, 2009, APPL CATAL B-ENVIRON, V88, P515, DOI 10.1016/j.apcatb.2008.10.009
   HENGLEIN A, 1989, CHEM REV, V89, P1861, DOI 10.1021/cr00098a010
   Ishibashi K, 2000, J PHOTOCH PHOTOBIO A, V134, P139, DOI 10.1016/S1010-6030(00)00264-1
   Kitano M, 2007, APPL CATAL A-GEN, V325, P1, DOI 10.1016/j.apcata.2007.03.013
   Lim CS, 2010, J CERAM PROCESS RES, V11, P736
   Qiao WT, 2009, MAT SCI ENG C-BIO S, V29, P1498, DOI 10.1016/j.msec.2008.12.010
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sahu DR, 2009, MICROPOR MESOPOR MAT, V117, P640, DOI 10.1016/j.micromeso.2008.08.013
   Sayari A, 2004, J AM CHEM SOC, V126, P14348, DOI 10.1021/ja0478734
   Sharma MVP, 2008, CHEMOSPHERE, V73, P1562, DOI [10.1016/j.chemosphere.2008.08.033, 10.1016/j.chemosphere.2008.07.081]
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Termnak S, 2009, J CERAM PROCESS RES, V10, P491
   VARTULI JC, 1994, CHEM MATER, V6, P2317, DOI 10.1021/cm00048a018
   Zhang LL, 2011, APPL CLAY SCI, V51, P68, DOI 10.1016/j.clay.2010.11.003
   Zhang ML, 2010, MATER LETT, V64, P1883, DOI 10.1016/j.matlet.2010.05.054
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao L, 2006, J COLLOID INTERF SCI, V304, P84, DOI 10.1016/j.jcis.2006.08.042
   Zhong JB, 2011, MATER LETT, V65, P1995, DOI 10.1016/j.matlet.2011.03.063
   Zukerman R, 2008, MICROPOR MESOPOR MAT, V116, P237, DOI 10.1016/j.micromeso.2008.04.011
NR 22
TC 14
Z9 14
U1 1
U2 56
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
J9 MATER RES BULL
JI Mater. Res. Bull.
PD DEC
PY 2011
VL 46
IS 12
BP 2317
EP 2322
DI 10.1016/j.materresbull.2011.08.044
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 862YM
UT WOS:000298130000023
DA 2018-10-19
ER

PT J
AU Schricker, SR
   Palacio, MLB
   Bhushan, B
AF Schricker, Scott R.
   Palacio, Manuel L. B.
   Bhushan, Bharat
TI Antibody sensed protein surface conformation
SO MATERIALS TODAY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SILICON-BASED SURFACES; CELL-ADHESION;
   FIBRONECTIN CONFORMATION; COPOLYMER SURFACES; ADSORPTION; BIOMOLECULES;
   DIBLOCK; BINDING; EVENTS
AB Upon implantation into a living host, biomaterial surfaces are rapidly coated with a dynamic protein layer. The interactions of this protein layer and cells with biomaterial surfaces are widely studied because of their implications to a wide range of applications, such as the development of new materials for cell culture, dental and surgical implants(1-5), and biosensors(6-10). The deposited protein layer helps to facilitate the adhesion, proliferation, and differentiation of cells on synthetic biomaterials and is composed of many proteins, including extracellular matrix (ECM) and serum proteins such as fibronectin, laminin, and collagen. The behavior of these proteins, including their conformation, are known to be highly dependent on surface chemistry, topography, and rigidity of the substrate, and for in vitro situations, the solvent used to disperse the proteins(3,11,12). These factors influence the conformation of the adsorbed proteins, thus, affecting the cell behavior upon exposure to the biomaterial surface. Therefore, it is possible to control cellular adhesion and differentiation on a given polymer surface by controlling the nano-morphology, and hence, the protein conformation.
C1 [Schricker, Scott R.] Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
   [Palacio, Manuel L. B.; Bhushan, Bharat] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
RP Schricker, SR (reprint author), Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
EM Schricker.1@osu.edu; Bhushan.2@osu.edu
RI Bhushan, Bharat/A-9684-2013; Schricker, Scott/A-3957-2008
OI Bhushan, Bharat/0000-0001-7161-6601; Schricker,
   Scott/0000-0003-1982-1282
CR Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bhushan B, 2006, ACTA BIOMATER, V2, P39, DOI 10.1016/j.actbio.2005.08.010
   Bhushan B, 2011, NANOTRIBOLOGY NANOME, VII
   Bhushan B, 2008, J R SOC INTERFACE, V6, P719
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Bhushan B, 2011, NANOTRIBOLOGY NANOME, VI
   Bushnak IA, 2010, BIOFOULING, V26, P387, DOI 10.1080/08927011003646809
   DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P795
   Giamblanco N, 2011, LANGMUIR, V27, P312, DOI 10.1021/la104127q
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kienberger F, 2005, J MOL BIOL, V347, P597, DOI 10.1016/j.jmb.2005.01.042
   Klein F, 2011, ADV MATER, V23, P1341, DOI 10.1002/adma.201004060
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014
   Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003
   Liu XL, 2010, COLLOID SURFACE B, V79, P452, DOI 10.1016/j.colsurfb.2010.05.011
   Matsushita N, 2006, J ORTHOP SCI, V11, P505, DOI 10.1007/s00776-006-1048-3
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Nikonenko NA, 2009, APPL SPECTROSC, V63, P889, DOI 10.1366/000370209788964449
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Parker JATC, 2002, BIOMATERIALS, V23, P3545, DOI 10.1016/S0142-9612(02)00033-9
   Scarpa G, 2010, MACROMOL BIOSCI, V10, P378, DOI 10.1002/mabi.200900412
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024
   Yang XZ, 2009, BIOMACROMOLECULES, V10, P2213, DOI 10.1021/bm900390k
   Zhao LZ, 2010, BIOMATERIALS, V31, P8341, DOI 10.1016/j.biomaterials.2010.07.036
NR 31
TC 3
Z9 3
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
J9 MATER TODAY
JI Mater. Today
PD DEC
PY 2011
VL 14
IS 12
BP 616
EP 621
DI 10.1016/S1369-7021(11)70303-0
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 874OT
UT WOS:000298968600017
OA Other Gold
DA 2018-10-19
ER

PT J
AU Zhang, WD
   Chen, SC
AF Zhang, Wande
   Chen, Shaochen
TI Femtosecond laser nanofabrication of hydrogel biomaterial
SO MRS BULLETIN
LA English
DT Article
ID PORE-SIZE; SCAFFOLDS; CELL; FABRICATION; TOPOGRAPHY; NANOSCALE; FIBERS;
   GROWTH; SITES
AB In recent years, biomaterial investigators have increasingly focused their research on hydrogels and their capability to be fabricated into tissue engineering scaffolds. Although several fabrication methods have been used to produce hydrogel scaffolds, those methods are unable to routinely produce three-dimensional submicron and nanoscale scaffolds with precise control of the geometry, a crucial factor necessitated by the recent developments in the field of tissue engineering. Femtosecond laser-induced two-photon polymerization is a promising technique that fulfills these requirements. In our work, we used a femtosecond laser to fabricate three-dimensional submicron-scale scaffolds with poly(ethylene glycol) (PEG). The modulus, dimensions, and shape of the scaffold can be readily adjusted by changing both the laser parameters and the molecular weight of the PEG prepolymer. With the femtosecond laser, we also fabricated two-dimensional topographical patterns, which have important applications in basic biological research. To improve the throughput of femtosecond laser fabrication, we integrated the femtosecond direct-write process with a nano-imprint process by which the femtosecond laser is used to produce nano-patterned molds. We then carried out nanoimprinting to transfer the nanofeatures in the mold to the hydrogel in a massively parallel fashion.
C1 [Zhang, Wande] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.
   [Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
RP Zhang, WD (reprint author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.
EM wazhang@ucsd.edu; shc064@ucsd.edu
FU Office of Naval Research [N00014-07-1-0609]; National Science Foundation
   [CMMI 1130894]
FX This work is supported by grants from the Office of Naval Research
   (N00014-07-1-0609) and the National Science Foundation (CMMI 1130894) to
   S.C.
CR Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Cai ZJ, 2003, J MATER SCI LETT, V22, P153, DOI 10.1023/A:1021891626262
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273
   GRIMSTAD IA, 1987, EXP CELL RES, V173, P515, DOI 10.1016/0014-4827(87)90291-6
   Huang JT, 2010, OPT LETT, V35, P2711, DOI 10.1364/OL.35.002711
   Jang JW, 2004, POLYM-KOREA, V28, P382
   Jintang H., 2010, J MICROMECH MICROENG, V20
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Miller ED, 2011, BIOMATERIALS, V32, P2775, DOI 10.1016/j.biomaterials.2010.12.005
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   NICOLSON GL, 1988, BIOCHIM BIOPHYS ACTA, V948, P175, DOI 10.1016/0304-419X(88)90010-8
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ovsianikov A, 2010, ACTA BIOMATER, V7, P967
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Qiu J., 2009, P SPIE, V7203
   Qiu J., 2010, J BIOMED OPT, V15, P5
   Qiu JZ, 2010, J BIOPHOTONICS, V3, P277, DOI 10.1002/jbio.200900104
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   Vidovic E., 2010, J APPL POLYM SCI, V119, P1322
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Xie CQ, 2011, BIOMATERIALS, V32, P4369, DOI 10.1016/j.biomaterials.2011.02.049
   Yamanlar S, 2011, BIOMATERIALS, V32, P5590, DOI 10.1016/j.biomaterials.2011.04.030
   Zhang WD, 2010, J MANUF SCI E-T ASME, V132, DOI 10.1115/1.4001661
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 34
TC 17
Z9 18
U1 3
U2 36
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD DEC
PY 2011
VL 36
IS 12
BP 1028
EP 1033
DI 10.1557/mrs.2011.275
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 878DB
UT WOS:000299231900024
DA 2018-10-19
ER

PT J
AU Riggs, BC
   Dias, AD
   Schiele, NR
   Cristescu, R
   Huang, Y
   Corr, DT
   Chrisey, DB
AF Riggs, B. C.
   Dias, A. D.
   Schiele, N. R.
   Cristescu, R.
   Huang, Y.
   Corr, D. T.
   Chrisey, D. B.
TI Matrix-assisted pulsed laser methods for biofabrication
SO MRS BULLETIN
LA English
DT Article
ID STEM-CELL DIFFERENTIATION; BIOMATERIAL THIN-FILMS; MAPLE DIRECT WRITE;
   EVAPORATION MAPLE; POLYMER-FILMS; SUBSTRATE-TEMPERATURE;
   EXTRACELLULAR-MATRIX; SOLVENT PARAMETERS; SURFACE-ROUGHNESS; CIRCUIT
   ELEMENTS
AB Controlling the spatial arrangement of biomaterials, including living cells, with high resolution (+/-5 mu m) provides the foundation for fabricating complex biologic systems for studies ranging from the fundamentals of cell-cell and cell-matrix interactions to applications in tissue engineering. However, the level of spatial control required cannot be obtained through conventional cell processing techniques (e.g., pipetting of or even ink-jetting cells), as they lack the precision, reproducibility, and speed required for the rapid fabrication of idealized engineered constructs. Laser direct-write approaches (e.g., matrix-assisted pulsed-laser evaporation direct-write [MAPLE DW]), previously employed for the rapid prototyping of electronics, have shown reliable patterning of biomaterials with a spatial resolution of +/-5 mu m. Moreover, recent advances allow the rapid, precise deposition of viable mammalian cells and pluripotent stem cells on well-defined substrates, enabling the laser direct-writing platform to advance manipulation of the in vitro cellular microenvironment (e.g., the stem cell niche). Herein, we review the mechanisms and recent advances demonstrating the versatility and biofabrication potential of one particular laser-based technique, MAPLE DW.
C1 [Riggs, B. C.; Dias, A. D.; Schiele, N. R.; Corr, D. T.; Chrisey, D. B.] Rensselaer Polytech Inst, Troy, NY 12181 USA.
   [Cristescu, R.] Natl Inst Lasers Plasma Radiat Phys, Lasers Dept, Laser Surface Plasma Interact Lab, Bucharest, Romania.
   [Huang, Y.] Clemson Univ, Dept Mech Engn, Clemson, SC 29631 USA.
RP Riggs, BC (reprint author), Rensselaer Polytech Inst, Troy, NY 12181 USA.
EM riggsb2@rpi.edu; diasa@rpi.edu; schien@rpi.edu;
   rodica.cristescu@inflpr.ro; yongh@clemson.edu; chrisd@rpi.edu
RI Cristescu, Rodica/F-1961-2010
OI Cristescu, Rodica/0000-0002-3092-6168; Riggs, Brian/0000-0003-0796-4905
CR Barron JA, 2005, ANN BIOMED ENG, V33, P121, DOI 10.1007/s10439-005-8971-x
   Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   Barron JA, 2004, BIOSENS BIOELECTRON, V20, P246, DOI [10.1016/j.bios.2004.01.011, 10.1016/j.bios..2004.01.011]
   Bigi A, 2009, BIOMATERIALS, V30, P6168, DOI 10.1016/j.biomaterials.2009.07.066
   Bloisi F, 2007, MAT SCI ENG C-BIO S, V27, P1185, DOI 10.1016/j.msec.2006.12.005
   Bloisi F, 2011, J APPL PHYS, V110, DOI 10.1063/1.3602084
   Bubb D.-D., 2007, PULSED LASER DEPOSIT, P35
   Bubb DM, 2007, CHEM PHYS LETT, V448, P194, DOI 10.1016/j.cplett.2007.10.002
   Bubb DM, 2002, J APPL PHYS, V91, P9809, DOI 10.1063/1.1478136
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Bubb DM, 2001, J APPL PHYS, V89, P5739, DOI 10.1063/1.1362405
   Caricato AP, 2010, APPL PHYS A-MATER, V101, P759, DOI 10.1007/s00339-010-5990-8
   Caricato AP, 2009, SENSORS-BASEL, V9, P2682, DOI 10.3390/s90402682
   Chrisey DB, 2000, APPL SURF SCI, V154, P593, DOI 10.1016/S0169-4332(99)00465-1
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Chrisey DB, 2000, APPL SURF SCI, V168, P345, DOI 10.1016/S0169-4332(00)00824-2
   Constantinescu C, 2009, APPL SURF SCI, V255, P5491, DOI 10.1016/j.apsusc.2008.07.163
   Cooper GM, 2010, TISSUE ENG PT A, V16, P1749, DOI [10.1089/ten.tea.2009.0650, 10.1089/ten.TEA.2009.0650]
   Cristescu R, 2005, APPL SURF SCI, V247, P217, DOI 10.1016/j.apsusc.2005.01.066
   Cristescu R, 2004, APPL PHYS A-MATER, V79, P1023, DOI 10.1007/s00339-004-2619-9
   Cristescu R, 2011, APPL SURF SCI, V257, P5287, DOI 10.1016/j.apsusc.2010.11.141
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Doraiswamy A, 2006, APPL SURF SCI, V252, P4743, DOI 10.1016/j.apsusc.2005.07.166
   Duocastella M, 2007, APPL SURF SCI, V253, P7855, DOI 10.1016/j.apsusc.2007.02.097
   Edwards GS, 2005, PHOTOCHEM PHOTOBIOL, V81, P711, DOI 10.1562/2004-11-08-IR-363R.1
   Fardel R, 2008, APPL PHYS A-MATER, V90, P661, DOI 10.1007/s00339-007-4334-9
   Fernandez-Pradas JM, 2004, THIN SOLID FILMS, V453, P27, DOI 10.1016/j.tsf.2003.11.154
   Fitz-Gerald JM, 2000, MATER RES SOC SYMP P, V625, P99, DOI 10.1557/PROC-625-99
   FOGARASSY E, 1989, J MATER RES, V4, P1082, DOI 10.1557/JMR.1989.1082
   Frycek R, 2006, THIN SOLID FILMS, V495, P308, DOI 10.1016/j.tsf.2005.08.178
   Gutierrez-Llorente A, 2004, ORG ELECTRON, V5, P29, DOI 10.1016/j.orgel.2003.11.003
   Gyorgy E, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266670
   HOFFMAN RM, 1991, CANCER CELL-MON REV, V3, P86
   Houser EJ, 2006, APPL SURF SCI, V252, P4871, DOI 10.1016/j.apsusc.2005.07.159
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Hunter CN, 2008, SURF COAT TECH, V203, P300, DOI 10.1016/j.surfcoat.2008.09.003
   Inui A, 2010, INT ORTHOP, V34, P1327, DOI 10.1007/s00264-009-0917-8
   Jelinek M, 2007, LASER PHYS, V17, P66, DOI 10.1134/S1054660X0702003X
   Johnson SL, 2007, APPL SURF SCI, V253, P6430, DOI 10.1016/j.apsusc.2007.01.084
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]
   Kokkinaki O, 2007, DIG J NANOMATER BIOS, V2, P221
   Kopecky D, 2009, THIN SOLID FILMS, V517, P2083, DOI 10.1016/j.tsf.2008.10.047
   Lee S, 1999, IEEE J SEL TOP QUANT, V5, P997, DOI 10.1109/2944.796322
   Liberski AR, 2011, ACS COMB SCI, V13, P190, DOI 10.1021/co100061c
   Lin YF, 2010, RAPID PROTOTYPING J, V16, P202, DOI 10.1108/13552541011034870
   Lin YF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3202388
   Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0
   McGill R.A., 2000, METHOD PRODUCING FIL
   Miller ED, 2011, BIOMATERIALS, V32, P2775, DOI 10.1016/j.biomaterials.2010.12.005
   Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Negroiu G, 2008, J MATER SCI-MATER M, V19, P1537, DOI 10.1007/s10856-007-3300-6
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   Pate R, 2009, CHEM PHYS LETT, V477, P406, DOI 10.1016/j.cplett.2009.07.038
   Patz TM, 2007, MAT SCI ENG C-BIO S, V27, P514, DOI 10.1016/j.msec.2006.05.039
   Patz TM, 2006, J BIOMED MATER RES B, V78B, P124, DOI 10.1002/jbm.b.30473
   Pique A, 2002, APPL SURF SCI, V186, P408, DOI 10.1016/S0169-4332(01)00704-8
   Pique A., 2007, PULSED LASER DEPOSIT
   Popescu C., 2011, J MAT RES, V815
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Purice A, 2007, CHEM PHYS LETT, V435, P350, DOI 10.1016/j.cplett.2006.12.078
   Raof NA, 2011, BIOMATERIALS, V32, P1802, DOI 10.1016/j.biomaterials.2010.11.015
   Rella R, 2007, SENSOR ACTUAT B-CHEM, V127, P426, DOI 10.1016/j.snb.2007.04.048
   Ringeisen B.R., 2002, PHOTON PROCESS MICRO, V698, P341
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Rodrigo K, 2006, APPL SURF SCI, V252, P4824, DOI 10.1016/j.apsusc.2005.07.143
   Rotaru A, 2008, J THERM ANAL CALORIM, V92, P279, DOI 10.1007/s10973-007-8818-9
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schiele NR, 2011, TISSUE ENG PART C-ME, V17, P289, DOI [10.1089/ten.tec.2010.0442, 10.1089/ten.TEC.2010.0442]
   Schiele NR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/032001
   Schiele NR, 2009, APPL SURF SCI, V255, P5444, DOI 10.1016/j.apsusc.2008.10.054
   Sellinger AT, 2008, THIN SOLID FILMS, V516, P6033, DOI 10.1016/j.tsf.2007.10.131
   Smausz T, 2009, THIN SOLID FILMS, V517, P4299, DOI 10.1016/j.tsf.2008.11.141
   Socol G, 2009, APPL SURF SCI, V255, P5611, DOI 10.1016/j.apsusc.2008.07.206
   Song W, 2011, J BIOACT COMPAT POL, V26, P242, DOI 10.1177/0883911511406327
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Toftmann B, 2005, APPL SURF SCI, V247, P211, DOI 10.1016/j.apsusc.2005.01.175
   Toftmann B, 2004, THIN SOLID FILMS, V453, P177, DOI 10.1016/j.tsf.2003.11.099
   Torres RD, 2011, CRIT REV SOLID STATE, V36, P16, DOI 10.1080/10408436.2011.547761
   VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q
   Wang W, 2007, T NAMRI SME, V35, P217
   Wang W, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000101
   Wang W, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896118
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wu PK, 2003, REV SCI INSTRUM, V74, P2546, DOI 10.1063/1.1544081
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
   Young D, 2001, APPL PHYS LETT, V78, P3169, DOI 10.1063/1.1372200
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 92
TC 44
Z9 44
U1 0
U2 56
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD DEC
PY 2011
VL 36
IS 12
BP 1043
EP 1050
DI 10.1557/mrs.2011.276
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 878DB
UT WOS:000299231900026
DA 2018-10-19
ER

PT J
AU Bonanno, LM
   Segal, E
AF Bonanno, Lisa M.
   Segal, Ester
TI Nanostructured porous silicon-polymer-based hybrids: from biosensing to
   drug delivery
SO NANOMEDICINE
LA English
DT Review
DE biosensor; drug delivery; hybrid; hydrogel; nanobiotechnology;
   nanomaterial; optical sensor; porous silicon
ID FOURIER-TRANSFORM SPECTROSCOPY; PHOTONIC CRYSTALS; RESPONSIVE HYDROGEL;
   MESOPOROUS SILICON; OPTICAL-PROPERTIES; CONFINEMENT; FILMS; SIO2;
   NANOPARTICLES; FABRICATION
AB Organic-inorganic hybrids with controlled morphology at the nanometer scale represent an exciting class of materials that can display unique properties that are culminated by the characteristics of each building block. Recent research highlights their potential as biomimetic composites and application in biosensing, lab-on-chip devices, drug delivery and tissue engineering. Here we focus on the emerging class of biomaterials that integrate polymers with nanostructured porous silicon and emphasize the design of advanced 'smart' functions. Porous silicon is an appealing biomaterial due to the ease of tuning its many attractive properties, including pore morphology, photonic properties, biocompatibility, biodegradation and surface chemistry. An overview is presented of the principle concepts of design and fabrication of porous silicon-polymer hybrids. Current achievements in biomedical applications are reviewed and future prospects and challenges for healthcare technologies are discussed.
C1 [Bonanno, Lisa M.; Segal, Ester] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.
   [Segal, Ester] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.
RP Segal, E (reprint author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.
EM esegal@tx.technion.ac.il
RI Segal, Ester/B-4437-2012
OI Segal, Ester/0000-0001-9472-754X
FU Israel Science Foundation [1118/08]; European Union
FX This work was supported by the Israel Science Foundation (Grant
   1118/08). E Segal greatly appreciates the financial support of the Marie
   Curie Reintegration Grant (NANOPACK) administered by the European Union.
   LM Bonanno gratefully acknowledges the Lady Davis Postdoctoral
   Fellowship. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript apart from those disclosed.
CR Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01
   Alvarez SD, 2007, PHYS STATUS SOLIDI A, V204, P1439, DOI 10.1002/pssa.200674379
   Anderson MA, 2003, PHYS STATUS SOLIDI A, V197, P528, DOI 10.1002/pssa.200306558
   Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Batra I, 2006, BIOMED MICRODEVICES, V8, P93, DOI 10.1007/s10544-006-7704-8
   Berger MG, 1997, THIN SOLID FILMS, V297, P237, DOI 10.1016/S0040-6090(96)09361-3
   Bonanno LM, 2007, BIOSENS BIOELECTRON, V23, P444, DOI 10.1016/j.bios.2007.05.008
   Bonanno LM, 2009, PROC SPIE, V7167, DOI 10.1117/12.809201
   Bonanno LM, 2010, ADV FUNCT MATER, V20, P573, DOI 10.1002/adfm.200901694
   Bonanno LM, 2010, ANAL CHEM, V82, P714, DOI 10.1021/ac902453h
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Buriak JM, 2002, CHEM REV, V102, P1271, DOI 10.1021/cr000064s
   Burnham MR, 2006, BIOMATERIALS, V27, P5883, DOI 10.1016/j.biomaterials.2006.08.001
   Cacciuto A, 2006, NANO LETT, V6, P901, DOI 10.1021/nl052351n
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 2000, PHYS STATUS SOLIDI A, V182, P521, DOI 10.1002/1521-396X(200011)182:1<521::AID-PSSA521>3.0.CO;2-7
   CANHAM LT, 1997, PROPERTIES POROUS SI, P371
   Cazzanelli M, 2001, SILICON BASED MAT DE, P124
   Chatterjee AN, 2003, J AEROSPACE ENG, V16, P55, DOI 10.1061/(ASCE)0893-1321(2003)16:2(55)
   Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702
   DeLouise LA, 2005, ADV MATER, V17, P2199, DOI 10.1002/adma.200500261
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Foll H, 2002, MAT SCI ENG R, V39, P93, DOI 10.1016/S0927-796X(02)00090-6
   Frisk ML, 2007, CHEM MATER, V19, P5842, DOI 10.1021/cm7021032
   Gao LZ, 2008, ANAL CHEM, V80, P1468, DOI 10.1021/ac701870y
   Gorman CB, 2008, MACROMOLECULES, V41, P4856, DOI 10.1021/ma8004857
   Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284
   HEINRICH JL, 1992, SCIENCE, V255, P66, DOI 10.1126/science.255.5040.66
   HEINRICH JL, 1995, MATER RES SOC SYMP P, V358, P605
   Hendrickson GR, 2009, SOFT MATTER, V5, P29, DOI 10.1039/b811620b
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Holtz JH, 1997, NATURE, V389, P829
   Jane A, 2009, TRENDS BIOTECHNOL, V27, P230, DOI 10.1016/j.tibtech.2008.12.004
   JANE AO, 2007, SPIE
   Janshoff A, 1998, J AM CHEM SOC, V120, P12108, DOI 10.1021/ja9826237
   Kashanian S, 2010, ACTA BIOMATER, V6, P3566, DOI 10.1016/j.actbio.2010.03.031
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Khardani M, 2007, PHYS STATUS SOLIDI C, V4, P1986, DOI 10.1002/pssc.200674420
   Kilian KA, 2009, NANO LETT, V9, P2021, DOI 10.1021/nl900283j
   Kilian KA, 2009, CHEM COMMUN, P630, DOI 10.1039/b815449j
   Kim J, 2008, COLLOID SURFACE A, V313, P484, DOI 10.1016/j.colsurfa.2007.04.167
   Kim JS, 2006, ANGEW CHEM INT EDIT, V45, P1446, DOI 10.1002/anie.200503102
   Kiser PF, 1998, NATURE, V394, P459
   Koh Y, 2008, COLLOID SURFACE A, V313, P328, DOI 10.1016/j.colsurfa.2007.04.103
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kruk M, 2008, MACROMOLECULES, V41, P8584, DOI 10.1021/ma801643r
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   Lapeyre V, 2006, BIOMACROMOLECULES, V7, P3356, DOI 10.1021/bm060588n
   Li YY, 2005, ADV MATER, V17, P1249, DOI 10.1002/adma.200401760
   Li YY, 2003, SCIENCE, V299, P2045, DOI 10.1126/science.1081298
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Massad-Ivanir N, 2011, ANAL CHEM, V83, P3282, DOI 10.1021/ac200407w
   Massad-Ivanir N, 2010, ADV FUNCT MATER, V20, P2269, DOI 10.1002/adfm.201000406
   MASSADIVANIR N, 2011, NANOBIOTECH IN PRESS
   McInnes SJP, 2009, J COLLOID INTERF SCI, V332, P336, DOI 10.1016/j.jcis.2008.12.073
   MICHALEK J, 2010, BIOMEDICAL APPL HYDR, V303, P15
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Mukherjee P, 2006, BIOMED MICRODEVICES, V8, P9, DOI 10.1007/s10544-006-6377-7
   Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u
   Orosco MM, 2006, ADV MATER, V18, P1393, DOI 10.1002/adma.200502420
   Ouyang H, 2007, ANAL CHEM, V79, P1502, DOI 10.1021/ac0608366
   Pacholski C, 2005, J AM CHEM SOC, V127, P11636, DOI 10.1021/ja0511671
   Pacholski C, 2006, J AM CHEM SOC, V128, P4250, DOI 10.1021/ja056702b
   Park JS, 2007, PHYS STATUS SOLIDI A, V204, P1383, DOI 10.1002/pssa.200674351
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   PAVESI L, 1995, APPL PHYS LETT, V67, P3280, DOI 10.1063/1.115220
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Perelman LA, 2010, ADV FUNCT MATER, V20, P826, DOI 10.1002/adfm.200900822
   Populaire C, 2003, APPL PHYS LETT, V83, P1370, DOI 10.1063/1.1603336
   SAAR A, 2009, J NANOPHOTONICS, V3
   Sailor MJ, 2009, ADV FUNCT MATER, V19, P3195, DOI 10.1002/adfm.200900535
   Sailor MJ, 2007, ACS NANO, V1, P248, DOI 10.1021/nn700340u
   Sailor MJ, 2005, CHEM COMMUN, P1375, DOI 10.1039/b417554a
   Salonen J, 2008, CHEM ENG J, V137, P162, DOI 10.1016/j.cej.2007.09.001
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   Schwartz MP, 2006, LANGMUIR, V22, P7084, DOI 10.1021/la060420n
   Sciacca B, 2011, J MATER CHEM, V21, P2294, DOI 10.1039/c0jm02904a
   Segal E, 2007, ADV FUNCT MATER, V17, P1153, DOI 10.1002/adfm.200601077
   Segal E, 2009, PHYS STATUS SOLIDI C, V6, P1717, DOI 10.1002/pssc.200881074
   Sirbuly DJ, 2003, ADV MATER, V15, P149, DOI 10.1002/adma.200390031
   Snow PA, 1999, J APPL PHYS, V86, P1781, DOI 10.1063/1.370968
   Sorrell CD, 2011, ADV FUNCT MATER, V21, P425, DOI 10.1002/adfm.201001714
   SYCHEV FY, 2009, APPL PHYS LETT, V95
   Tokarev I, 2009, SOFT MATTER, V5, P511, DOI 10.1039/b813827c
   Turgman-Cohen S, 2010, MACROMOLECULES, V43, P9567, DOI 10.1021/ma102046q
   Wang ZH, 2011, J MATER CHEM, V21, P1264, DOI 10.1039/c0jm02655g
   Wu J, 2009, ADV FUNCT MATER, V19, P733, DOI 10.1002/adfm.200800921
   Yoon MS, 2003, CHEM COMMUN, P680, DOI 10.1039/b300937h
NR 91
TC 59
Z9 59
U1 9
U2 153
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD DEC
PY 2011
VL 6
IS 10
BP 1755
EP 1770
DI 10.2217/NNM.11.153
PG 16
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 867XW
UT WOS:000298489100013
PM 22122584
DA 2018-10-19
ER

PT J
AU Fu, Q
   Huang, WH
   Jia, WT
   Rahaman, MN
   Liu, X
   Tomsia, AP
AF Fu, Qiang
   Huang, Wenhai
   Jia, Weitao
   Rahaman, Mohamed N.
   Liu, Xin
   Tomsia, Antoni P.
TI Three-Dimensional Visualization of Bioactive Glass-Bone Integration in a
   Rabbit Tibia Model Using Synchrotron X-Ray Microcomputed Tomography
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID RADIATION MICROTOMOGRAPHY; HUMAN OSTEOBLASTS; BIOGLASS(R) 45S5;
   CANCELLOUS BONE; DENTAL IMPLANTS; IONIC PRODUCTS; ILIAC CREST;
   SCAFFOLDS; BORATE; OSTEOMYELITIS
AB Synchrotron X-ray microcomputed tomography (SR microCT), with a micron resolution, was used to evaluate the osteoconduction and osteointegration by borate bioactive glass after implantation 12 weeks in a rabbit tibia model. The study focused on the biomaterial-bone interface. Results from SR microCT two-dimensional and three-dimensional (3D) reconstructions provided precise imaging of the biomaterial-bone integration and detailed microarchitecture of both the bone-like glass graft and the newly formed trabecular bone. Osteoconduction, the formation of new trabecular bone within a tibia defect, occurred only in the tibiae implanted with teicoplanin-loaded borate glass but not in those with teicoplanin-loaded CaSO(4) beads, indicating the excellent biocompatibility of the glass implants. 3D reconstruction of the tibiae also showed the infiltration of vascular tissue in both the bioactive glass graft and the new trabecular bone. This study indicates that SR microCT can serve as a valuable complementary technique for imaging bone repair when using bioactive glass implants.
C1 [Fu, Qiang; Tomsia, Antoni P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
   [Huang, Wenhai] Tongji Univ, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.
   [Jia, Weitao] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200030, Peoples R China.
   [Rahaman, Mohamed N.; Liu, Xin] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Ctr Bone & Tissue Repair & Regenerat, Rolla, MO USA.
RP Fu, Q (reprint author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
EM qfu@lbl.gov
RI Fu, Qiang/B-1972-2013
FU National Institutes of Health/National Institute of Dental and
   Craniofacial Research [1 R01 DE015633]; Shanghai Committee of Science
   and Technology of China [084411900500, 0952nm03400]; NNFC of China
   [51072133]; Department of Energy [DE-AC02-05CH11231]
FX This work was supported by the National Institutes of Health/National
   Institute of Dental and Craniofacial Research Grant No. 1 R01 DE015633;
   the Shanghai Committee of Science and Technology of China through the
   major project Grant No. 084411900500 and for special projects of
   nanotechnology Grant No. 0952nm03400; and the NNFC of China Grant No.
   51072133. We acknowledge support from the dedicated X-ray tomography
   beamline 8.3.2 at the Advanced Light Source, funded by Department of
   Energy under Contract No. DE-AC02-05CH11231.
CR Atwood RC, 2004, SCRIPTA MATER, V51, P1029, DOI 10.1016/j.scriptamat.2004.08.014
   Bernhardt R, 2004, Eur Cell Mater, V7, P42
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Ding M, 2000, BONE, V26, P291, DOI 10.1016/S8756-3282(99)00281-1
   Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485
   Fartash B, 1990, CLIN ORAL IMPLAN RES, V1, P13, DOI 10.1034/j.1600-0501.1990.010103.x
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Fu Q., 2011, MAT SCI ENG IN PRESS
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P172, DOI 10.1002/jbm.a.32823
   Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   Heijink A, 2006, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000229319.45416.81
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Jung H, 2003, INT J ORAL MAX IMPL, V18, P121
   KINNEY JH, 1992, ANNU REV MATER SCI, V22, P121, DOI 10.1146/annurev.ms.22.080192.001005
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Leu A, 2008, PHARM RES, V25, P1222, DOI 10.1007/s11095-007-9508-9
   Liu X, 2009, J MATER SCI-MATER M, V20, P1237, DOI 10.1007/s10856-009-3691-7
   Nelson CL, 2002, J ORTHOPAED RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4
   Nuzzo S, 2002, MED PHYS, V29, P2672, DOI 10.1118/1.1513161
   Nuzzo S, 2002, J BONE MINER RES, V17, P1372, DOI 10.1359/jbmr.2002.17.8.1372
   PAZZAGLIA UE, 1994, BIOMATERIALS, V15, P273, DOI 10.1016/0142-9612(94)90051-5
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zhang X, 2010, BIOMATERIALS, V31, P5865, DOI 10.1016/j.biomaterials.2010.04.005
NR 37
TC 10
Z9 12
U1 0
U2 9
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2011
VL 17
IS 23-24
BP 3077
EP 3084
DI 10.1089/ten.tea.2011.0068
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 862GN
UT WOS:000298077900018
PM 21875330
OA Green Published
DA 2018-10-19
ER

PT J
AU Shikanov, A
   Zhang, Z
   Xu, M
   Smith, RM
   Rajan, A
   Woodruff, TK
   Shea, LD
AF Shikanov, Ariella
   Zhang, Zheng
   Xu, Min
   Smith, Rachel M.
   Rajan, Aniruddha
   Woodruff, Teresa K.
   Shea, Lonnie D.
TI Fibrin Encapsulation and Vascular Endothelial Growth Factor Delivery
   Promotes Ovarian Graft Survival in Mice
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ORTHOTOPIC TRANSPLANTATION; FERTILITY PRESERVATION;
   EXTRACELLULAR-MATRIX; FOLLICLE DEVELOPMENT; CONTROLLED-RELEASE; IMMATURE
   MOUSE; TISSUE; AUTOTRANSPLANTATION; VITRIFICATION; ANGIOGENESIS
AB Ovarian cryopreservation before chemotherapy and autotransplantation post-treatment can restore fertility to women with premature ovarian failure. Although the majority of primordial follicles survive the cryopreservation cycle, the follicular pool is reduced after transplantation due to ischemic death. Therefore, we engineered a biomaterial-based system to promote angiogenesis in a mouse model of ovarian transplantation. To mimic the clinical situation of sterility, a bilateral ovariectomy was performed 2 weeks before transplantation, during which time serum levels of follicular stimulating hormone rose to menopausal levels. Before transplantation, vitrified/thawed ovarian tissue from 12-day-old C57Bl/6J pups was encapsulated in fibrin modified with heparin-binding peptide (HBP), heparin, and loaded with 0.5 mu g vascular endothelial growth factor (VEGF). The group transplanted with fibrin-HBP-VEGF had twice as many surviving primordial follicles and an increased number of blood vessels relative to the no biomaterial control. Transplanted tissue was viable and supported natural conception that led to live and healthy offspring. The timeline of live births with VEGF delivery suggested that primary follicles survived transplantation, and provided the gametes for the first litter. Thus, VEGF delivery from fibrin supported integration of the transplant with the host, promoted angiogenesis, and enhanced engraftment and function of the tissue.
C1 [Shikanov, Ariella; Smith, Rachel M.; Rajan, Aniruddha; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shikanov, Ariella; Shea, Lonnie D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Evanston, IL 60208 USA.
   [Zhang, Zheng] Northwestern Univ, Feinberg Sch Med, Comprehens Transplant Ctr, Evanston, IL 60208 USA.
   [Zhang, Zheng] Northwestern Univ, Dept Surg, Feinberg Sch Med, Evanston, IL 60208 USA.
   [Xu, Min; Woodruff, Teresa K.] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Evanston, IL 60208 USA.
   [Xu, Min; Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2170 Campus Dr,3619 Silverman Hall, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
OI Woodruff, Teresa/0000-0002-1197-3399; Shikanov,
   Ariella/0000-0003-0159-6419
FU Baxter Early Career Development award; Biomedical Core Oncofertility
   Consortium Roadmap from the NIH:NIBIB National Institute of Biomedical
   Imaging and Bioengineering [U54-HD41857, PL1EB008542]; Eunice Kennedy
   Shriver NICHD/NIH (SCCPIR) [U54-HD28934]
FX This work was supported by the Baxter Early Career Development award,
   U54-HD41857 and PL1EB008542: Biomedical Core Oncofertility Consortium
   Roadmap grant from the NIH:NIBIB National Institute of Biomedical
   Imaging and Bioengineering. The hormone assays were performed at the
   University of Virginia Center for Research in Reproduction Ligand Assay
   and Analysis Core and was supported by the Eunice Kennedy Shriver
   NICHD/NIH (SCCPIR) Grant U54-HD28934. We would like to acknowledge Prof.
   Shelly Sakiyama-Elbert for providing the protocols for HBP synthesis and
   fibrin matrix fabrication.
CR Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244
   Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462
   Campbell BK, 2004, ENDOCRINOLOGY, V145, P1870, DOI 10.1210/en.2003-1138
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   DEJANA E, 1985, J CLIN INVEST, V75, P11, DOI 10.1172/JCI111661
   Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437
   DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146
   Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X
   Donnez J, 2011, FERTIL STERIL, V95, P1787, DOI DOI 10.1016/J.FERTNSTERT.2010.11.041
   Donnez J, 2009, SEMIN REPROD MED, V27, P472, DOI 10.1055/s-0029-1241057
   Ernst E, 2010, HUM REPROD, V25, P1280, DOI 10.1093/humrep/deq033
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Gougeon A, 2000, MOL CELL ENDOCRINOL, V163, P33, DOI 10.1016/S0303-7207(00)00220-3
   Hall H, 2005, MATERIALWISS WERKST, V36, P768, DOI 10.1002/mawe.200500966
   Jee BC, 2009, FERTIL STERIL, V92, P1153, DOI 10.1016/j.fertnstert.2009.02.030
   Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Kagawa N, 2009, REPROD BIOMED ONLINE, V18, P568, DOI 10.1016/S1472-6483(10)60136-8
   Kim TJ, 2010, FERTIL STERIL, V93, P467, DOI 10.1016/j.fertnstert.2008.12.094
   Kreeger PK, 2003, MOL CELL ENDOCRINOL, V205, P1, DOI 10.1016/S0303-7207(03)00209-0
   Liu L, 2008, HUM REPROD, V23, P122, DOI 10.1093/humrep/dem348
   Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237
   Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3
   PEDERSEN T, 1970, J REPROD FERTIL, V21, P81
   Piver P, 2009, 25 ANN M ESHRE AMST
   Redding GP, 2007, REPRODUCTION, V133, P1095, DOI 10.1530/REP-06-0171
   Redmer D A, 1996, Rev Reprod, V1, P182
   ROBERTS WG, 1995, J CELL SCI, V108, P2369
   Roux C, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.12.022
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sanchez-Serrano M, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.09.046
   Schnorr J, 2002, HUM REPROD, V17, P612, DOI 10.1093/humrep/17.3.612
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032
   Silber S, 2010, FERTIL STERIL, V94, P2191, DOI 10.1016/j.fertnstert.2009.12.073
   Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056
   Soleimani R, 2008, HUM REPROD, V23, P619, DOI 10.1093/humrep/dem405
   Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048
   Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086
NR 43
TC 51
Z9 52
U1 1
U2 12
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2011
VL 17
IS 23-24
BP 3095
EP 3104
DI 10.1089/ten.tea.2011.0204
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 862GN
UT WOS:000298077900020
PM 21740332
OA Green Published
DA 2018-10-19
ER

PT J
AU Schmidt, T
   Stachon, S
   Mack, A
   Rohde, M
   Just, L
AF Schmidt, Timo
   Stachon, Susanne
   Mack, Andreas
   Rohde, Manfred
   Just, Lothar
TI Evaluation of a Thin and Mechanically Stable Collagen Cell Carrier
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID IN-VITRO; DEHYDROTHERMAL TREATMENT; TISSUE-CULTURES; SCAFFOLDS; FIBERS;
   SYSTEM; MATRIX; DIFFERENTIATION; FIBROBLASTS; MEMBRANES
AB The biological function of adherent cell populations strongly depends on the physical and biochemical properties of extracellular matrix molecules. Therefore, numerous biocompatible cell carriers have been developed to specifically influence cell attachment, proliferation, cellular differentiation, and tissue formation for diverse cell culture applications and cell-based therapies. In the present study, we evaluated the mechanical and the cell biological properties of a novel, thin, and planar collagen scaffold. The cell carrier is based on fibrillar bovine collagen type I and exhibits a low material thickness coupled with a high mechanical stability as measured by tensile tests. The influence of this new biomaterial on cell viability, proliferation, and cell differentiation was analyzed using 5-bromo-2-deoxyuridine (BrdU) proliferation assay, immunocytochemistry, water-soluble tetrazolium salt-1 assay (WST-1), live cell imaging, and electron microscopy. Cell culture experiments with the human osteosarcoma cell line Saos-2, human mesenchymal stem cells, and rodent cardiomyocytes demonstrated the in vitro biocompatibility of this chemically noncrosslinked scaffold. Both the mechanical characteristics and the in vitro biocompatibility of this collagen type I carrier facilitate the engineering of thin transferable tissue constructs and offer new possibilities in the fields of cell culture techniques, tissue engineering, and regenerative medicine.
C1 [Schmidt, Timo; Stachon, Susanne; Mack, Andreas; Just, Lothar] Univ Tubingen, Ctr Regenerat Biol & Med, Inst Anat, D-72074 Tubingen, Germany.
   [Rohde, Manfred] Helmholtz Ctr Infect Res, Braunschweig, Germany.
RP Just, L (reprint author), Univ Tubingen, Ctr Regenerat Biol & Med, Inst Anat, Oesterbergstr 3, D-72074 Tubingen, Germany.
EM ljust@anatom.uni-tuebingen.de
FU University of Tuebingen [1557-0-0]; Viscofan BioEngineering
FX This research was supported by University of Tuebingen Fortuene Grant
   1557-0-0 and by Viscofan BioEngineering. We would like to thank Andrea
   Wizenmann for her helpful comments on the article, Wilhelm Aicher for
   kindly providing the human mesenchymal stem cells, and Gerd Geiger for
   technical assistance in electron microscopy.
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Bareiss PM, 2008, HISTOCHEM CELL BIOL, V129, P795, DOI 10.1007/s00418-008-0405-z
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Eschenhagen T, 1997, FASEB J, V11, P683
   Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Just L, 2006, DEV DYNAM, V235, P2200, DOI 10.1002/dvdy.20871
   Kino-Oka M, 2005, TISSUE ENG, V11, P597, DOI 10.1089/ten.2005.11.597
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Metzger M, 2007, J NEUROCHEM, V103, P2665, DOI 10.1111/j.1471-4159.2007.04994.x
   Micol LA, 2011, BIOMATERIALS, V32, P1543, DOI 10.1016/j.biomaterials.2010.10.028
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   Ranucci CS, 2000, BIOMATERIALS, V21, P783, DOI 10.1016/S0142-9612(99)00238-0
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221
   Sumanasinghe RD, 2009, J BIOMED MATER RES A, V88A, P778, DOI 10.1002/jbm.a.31913
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
   Taguchi Y, 2005, BIOMATERIALS, V26, P6158, DOI 10.1016/j.biomaterials.2005.03.023
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Vernon RB, 2005, BIOMATERIALS, V26, P1109, DOI 10.1016/j.biomaterials.2004.04.019
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yost MJ, 2004, TISSUE ENG, V10, P273, DOI 10.1089/107632704322791916
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 36
TC 21
Z9 21
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD DEC
PY 2011
VL 17
IS 12
BP 1161
EP 1170
DI 10.1089/ten.tec.2011.0201
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 862GR
UT WOS:000298078300002
PM 21902619
OA Green Published
DA 2018-10-19
ER

PT J
AU Kao, ECY
   McCanna, DJ
   Jones, LW
AF Kao, Elizabeth C. Y.
   McCanna, David J.
   Jones, Lyndon W.
TI Utilization of in vitro methods to determine the biocompatibility of
   intraocular lens materials
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE PCO; Confocal; Calcein-AM; Ethidium homodimer-1; Crystal violet; Human
   lens epithelial cells
ID POSTERIOR CAPSULE OPACIFICATION; OCULAR IRRITANCY; BOVINE LENS;
   MEMBRANES; SURFACE; TOXICITY; CULTURE; CELLS; MODEL
AB In vitro methods for measuring the adhesion and viability of lens epithelial cells on implant devices are needed to assess material biocompatibility. We investigated whether the use of confocal microscopy and spectrophotometric methods could determine the viability and adhesion of cells on a silicone biomaterial. Human lens epithelial cells adhered to silicone were treated with 0.01% benzalkonium chloride (cationic surfactant), 0.1% sodium dodecyl sulfate (anionic surfactant), and 10% Tween 20 (nonionic surfactant). Cell viability was then assessed using two fluorescent dyes (calcein and ethidium homodimer-1). Adhesion was determined directly by measuring the number of attached cells after surfactant treatment and by an indirect method that utilized the colorimetric agent crystal violet. The number of viable cells remaining on the biomaterial was determined both immediately after exposure and after the cells were allowed to grow for 1 day following surfactant exposure. The measurements for adhesion showed that the anionic surfactant weakened cell surface binding more than the cationic or nonionic surfactant. This study demonstrated that confocal microscopy in conjunction with crystal violet as an indirect colorimetric indicator can quantify the viability and adhesion of human lens epithelial cells attached to a material surface. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kao, Elizabeth C. Y.; McCanna, David J.; Jones, Lyndon W.] Univ Waterloo, Sch Optometry, Waterloo, ON N2L 3G1, Canada.
RP Kao, ECY (reprint author), Univ Waterloo, Sch Optometry, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM cyekao@uwaterloo.ca
OI McCanna, David/0000-0001-8060-096X; Jones, Lyndon/0000-0002-7409-7349
FU 20/20 NSERC Ophthalmic Materials Network
FX This research was funded by the 20/20 NSERC Ophthalmic Materials
   Network.
CR Ayaki M, 2007, J CATARACT REFR SURG, V33, P122, DOI 10.1016/j.icrs.2006.08.058
   Bantseev V, 2003, TOXICOL SCI, V73, P98, DOI 10.1093/toxsci/kfg060
   Bennett ES, 2005, CLIN CONTACT LENS PR
   Brenes O, 2010, EXP MOL PATHOL, V88, P424, DOI 10.1016/j.yexmp.2010.02.002
   Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x
   David T, 1998, PHYS MED BIOL, V43, P1385, DOI 10.1088/0031-9155/43/6/001
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7
   Ho L, 2008, TOXICOL IN VITRO, V22, P450, DOI 10.1016/j.tiv.2007.09.011
   Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14
   Jarrell JD, 2007, J BIOMED MATER RES A, V83A, P853, DOI 10.1002/jbm.a.31446
   Katayama Y, 2007, OPHTHAL RES, V39, P276, DOI 10.1159/000108121
   KLENKLER BJ, 2009, J BIOMED MATER RES A, V93, P1043
   KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0
   MAJNO G, 1995, AM J PATHOL, V146, P3
   Nishi O, 1999, J CATARACT REFR SURG, V25, P106, DOI 10.1016/S0886-3350(99)80020-0
   Pisella PJ, 2000, OPHTHALMIC RES, V32, P3, DOI 10.1159/000055579
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Schmidbauer JM, 2001, INT OPHTHALMOL CLIN, V41, P109, DOI 10.1097/00004397-200107000-00010
   Schreier S, 2000, BBA-BIOMEMBRANES, V1508, P210, DOI 10.1016/S0304-4157(00)00012-5
   SIVAK JG, 1994, TOXICOL METHOD, V4, P56, DOI 10.3109/15376519409049113
   Trivedi RH, 2002, EYE, V16, P217, DOI 10.1038/sj/eye/6700066
   Werner L, 2008, CURR OPIN OPHTHALMOL, V19, P41, DOI 10.1097/ICU.0b013e3282f20132
   Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2
   Yao K, 2006, J BIOMED MATER RES A, V78A, P684, DOI 10.1002/jbm.a.30741
   Youn HY, 2004, TOXICOL IN VITRO, V18, P841, DOI 10.1016/j.tiv.2004.04.007
NR 29
TC 3
Z9 3
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD DEC
PY 2011
VL 25
IS 8
BP 1906
EP 1911
DI 10.1016/j.tiv.2011.06.005
PG 6
WC Toxicology
SC Toxicology
GA 866EE
UT WOS:000298362500050
PM 21703342
DA 2018-10-19
ER

PT J
AU Di Girolamo, N
AF Di Girolamo, Nick
TI Stem cells of the human cornea
SO BRITISH MEDICAL BULLETIN
LA English
DT Article
DE cornea; stem cells; limbus; epithelium; blindness; stroma
ID OCULAR SURFACE RECONSTRUCTION; HUMAN CONJUNCTIVAL EPITHELIUM; HUMAN
   LIMBAL; IN-VITRO; AMNIOTIC MEMBRANE; BASEMENT-MEMBRANE; DAMAGED CORNEA;
   RECEPTOR P75; TRANSPLANTATION; EXPRESSION
AB Introduction: Blindness affects 50 million individuals worldwide; a significant proportion of them require a cell or tissue-based repair or replacement strategy to mend their damaged or diseased cornea. This review will focus on the epithelial stem cell (ESC) population of the cornea, where they reside, how they are identified and what alternative cells can be used as functional substitutes.
   Source of data: Data for this review were collated after performing literature searches by inserting key words (cornea, limbal, stem cells (SCs), epithelium, stroma, and endothelium) into the search engine PubMed.
   Areas of agreement: The prevailing notion is that corneal ESCs reside in an exclusive niche and their activation is dictated by niche-specific signals.
   Areas of controversy: Recent studies refute this hypothesis, as the central cornea of many animal species also possesses similar proliferative and clonogenic activity. The other area of controversy is in relation to the use of autologous and/or allogeneic cell therapies which are mostly contaminated with xenogeneic factors, potentially exposing the recipient to potentially harmful foreign infection.
   Growing points: Due to the shortage of donor corneal biomaterial, alternative cellular sources are being sought, discovered and trialed.
   Areas timely for developing research: With the exception of conjunctival and oral mucosal epithelium, no other cell type has been successfully used to treat patients with severe corneal epithelial defects. Embryonic and foetal SCs may have the greatest potential of all; however there are moral, legal, religious and scientific hurdles to overcome before they become routinely used in the clinic.
C1 Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW 2052, Australia.
RP Di Girolamo, N (reprint author), Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW 2052, Australia.
EM n.digirolamo@unsw.edu.au
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU National Health and Medical Research Council of Australia [455358];
   University of NSW; Australian Stem Cell Centre
FX NDG is supported by a Career Development Award (no. 455358) from the
   National Health and Medical Research Council of Australia. Other grants
   supporting this study are University of NSW GoldStar Award and
   Australian Stem Cell Centre Strategic Development Award.
CR Ahmad S, 2007, STEM CELLS, V25, P1145, DOI 10.1634/stemcells.2006-0516
   ANG LP, 2005, STEM CELLS BENCH BED, P421
   Balaram M, 2005, OCUL SURF, V3, P203, DOI 10.1016/S1542-0124(12)70207-0
   BAUM JL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1136
   Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721
   Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001
   Chee KYH, 2006, CLIN EXP OPHTHALMOL, V34, P64, DOI 10.1111/j.1442-9071.2006.1147.x
   Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355
   CLAUSEN H, 1986, J INVEST DERMATOL, V86, P249, DOI 10.1111/1523-1747.ep12285369
   Collinson JM, 2003, DEV BIOL, V255, P303, DOI 10.1016/S0012-1606(02)00095-7
   COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C
   COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6
   DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0
   Davies SB, 2010, STEM CELLS DEV, V19, P1651, DOI 10.1089/scd.2010.0201
   Davies SB, 2009, STEM CELLS, V27, P2781, DOI 10.1002/stem.209
   De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148
   Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2
   Di Girolamo N, 2008, J CELL MOL MED, V12, P2799, DOI 10.1111/j.1582-4934.2008.00290.x
   Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102
   Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256
   Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91
   Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742
   DUA HS, 1990, AM J OPHTHALMOL, V110, P646, DOI 10.1016/S0002-9394(14)77062-X
   Duke-Elder S, 1963, SYSTEM OPHTHALMOLOGY
   Espana EM, 2002, OPHTHALMOLOGY, V109, P2004, DOI 10.1016/S0161-6420(02)01250-2
   Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584
   Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346
   Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155
   Graw J, 1996, DEV GENET, V18, P181, DOI 10.1002/(SICI)1520-6408(1996)18:3<181::AID-DVG1>3.0.CO;2-5
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023
   Homma R, 2004, INVEST OPHTH VIS SCI, V45, P4320, DOI 10.1167/iovs.04-0044
   Hon C, 2004, BONE MARROW TRANSPL, V34, P181, DOI 10.1038/sj.bmt.1704544
   Hultman SC, 1996, J TRAUMA, V41, P51
   Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003
   Inatomi T, 1996, INVEST OPHTH VIS SCI, V37, P1684
   INSLER MS, 1986, CURR EYE RES, V5, P967, DOI 10.3109/02713688608995178
   JOHNSON M C, 1990, Journal of Burn Care and Rehabilitation, V11, P504
   Kawamura M, 2002, ANN THORAC SURG, V73, P1098, DOI 10.1016/S0003-4975(02)03415-X
   Kawasaki S, 2006, INVEST OPHTH VIS SCI, V47, P1359, DOI 10.1167/iovs.05-1084
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   Klyce SD, 2004, SMOLIN THOFTS CORNEA
   Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165
   Kumagai Y, 2010, CORNEA, V29, P432, DOI 10.1097/ICO.0b013e3181b9ffcc
   KURPAKUS MA, 1992, DEV BIOL, V150, P243, DOI 10.1016/0012-1606(92)90239-D
   KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448
   Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097
   Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137
   Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514
   LJUBIMOV AV, 1995, LAB INVEST, V72, P461
   Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046
   Madhira SL, 2008, MOL VIS, V14, P189
   Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406
   Mann I., 1944, BRIT JOUR OPHTHALMOL, V28, P26, DOI 10.1136/bjo.28.1.26
   MEYER AA, 1988, J TRAUMA, V28, P1054, DOI 10.1097/00005373-198807000-00023
   Meyer-Blazejewska EA, 2011, STEM CELLS, V29, P57, DOI 10.1002/stem.550
   Mills AA, 1999, NATURE, V398, P708
   MISHIMA S, 1982, OPHTHALMOLOGY, V89, P525
   Monteiro BG, 2009, CELL PROLIFERAT, V42, P587, DOI 10.1111/j.1365-2184.2009.00623.x
   Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494
   Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634
   Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qi H, 2007, MOL VIS, V13, P1934
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Riordan-Eva P., 2008, VAUGHAN ASBURYS GEN
   RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x
   Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020
   SCHOFIELD R, 1983, BIOMED PHARMACOTHER, V37, P375
   Sevel D, 1988, Trans Am Ophthalmol Soc, V86, P178
   Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013
   Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580
   Tabbara KF, 2009, OPHTHALMOLOGY, V116, P1624, DOI 10.1016/j.ophtha.2009.04.054
   Tan DTH, 2004, TRANSPLANTATION, V77, P1729, DOI 10.1097/01.TP.0000127593.65888.A6
   Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293
   Tao Q, 2009, CELL BIOCHEM FUNCT, V27, P535, DOI 10.1002/cbf.1612
   Thill M, 2007, STEM CELLS DEV, V16, P733, DOI 10.1089/scd.2006.0084
   THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442
   Townsend W M, 1991, Trans Am Ophthalmol Soc, V89, P721
   Valentina M.FokinaEIF, 2006, DEV DYNAM, V235, P496
   Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102
   Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064
   Watson SL, 2010, BRIT J OPHTHALMOL, V94, P1067, DOI 10.1136/bjo.2009.165837
   WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814
   WILEY L, 1991, INVEST OPHTH VIS SCI, V32, P594
   WULLE KG, 1978, GRAEFES ARCH CLIN EX, V209, P39
   Xu YG, 2008, MOL VIS, V14, P2180
   Yang XY, 2008, MOL VIS, V14, P1064
   Ye J, 2006, EYE, V20, P482, DOI 10.1308/sj.eye.6701913
   Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263
   Zhao X, 2008, STEM CELLS, V26, P939, DOI 10.1634/stemcells.2007-0727
   Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028
   Zhou SY, 2010, CURR EYE RES, V35, P978, DOI 10.3109/02713683.2010.516465
NR 100
TC 12
Z9 12
U1 2
U2 23
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
J9 BRIT MED BULL
JI Br. Med. Bull.
PD DEC
PY 2011
VL 100
IS 1
BP 191
EP 207
DI 10.1093/bmb/ldr026
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA 859EA
UT WOS:000297856800011
PM 21680602
OA Bronze
DA 2018-10-19
ER

PT J
AU Schultz, KM
   Bayles, AV
   Baldwin, AD
   Kiick, KL
   Furst, EM
AF Schultz, Kelly M.
   Bayles, Alexandra V.
   Baldwin, Aaron D.
   Kiick, Kristi L.
   Furst, Eric M.
TI Rapid, High Resolution Screening of Biomaterial Hydrogelators by
   mu(2)Rheology
SO BIOMACROMOLECULES
LA English
DT Article
ID MOLECULAR-SIZE DISTRIBUTION; 3-DIMENSIONAL POLYMERS; DELIVERY-SYSTEMS;
   PEG HYDROGELS; GELATION; MICRORHEOLOGY; MICROFLUIDICS; COMPONENTS;
   RHEOLOGY; PEPTIDE
AB A combination of sample manipulation and rheological characterization at the microscale is used to identify the gelation of poly(ethylene glycol)-heparin hydrogels over a wide range of compositions. A microfluidic device produces 50-100 droplet samples, each with a different composition. Multiple particle tracking microrheology is used to measure the rheological state of each sample. This combination requires little material and enables efficient and rapid screening of gelation conditions. The high resolution data identifies the gelation reaction percolation boundaries and a lower limit of the total hydrogelator concentration for gelation to occur, which can be used for the subsequent engineering, testing, and processing of these materials.
C1 [Schultz, Kelly M.; Bayles, Alexandra V.; Furst, Eric M.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   [Schultz, Kelly M.; Bayles, Alexandra V.; Furst, Eric M.] Univ Delaware, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA.
   [Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Furst, EM (reprint author), Univ Delaware, Dept Chem Engn, 150 Acad St, Newark, DE 19716 USA.
EM furst@udel.edu
RI Bayles, Alexandra/J-2689-2014
OI Bayles, Alexandra/0000-0001-9689-9361
FU National Science Foundation [CBET-0730292, DGE-0221651]; National
   Institutes of Health [5-P20-RR016472-10]; Procter and Gamble Company
FX We thank P. T. Spicer, K. T. Beers, S. D. Hudson, and J. Vermant for
   helpful discussions. Funding for this work from the National Science
   Foundation (Grant Nos. CBET-0730292 and DGE-0221651), the National
   Institutes of Health (5-P20-RR016472-10), and the Procter and Gamble
   Company is gratefully acknowledged. K.M.S. acknowledges financial
   support by the NSF Graduate Research Fellowship Program.
CR Abate AR, 2008, LAB CHIP, V8, P516, DOI 10.1039/b800001h
   Amis EJ, 2004, NAT MATER, V3, P83, DOI 10.1038/nmat1064
   Breedveld V, 2003, J MATER SCI, V38, P4461, DOI 10.1023/A:1027321232318
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Flory PJ, 1942, J PHYS CHEM-US, V46, P132, DOI 10.1021/j150415a016
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   Freundlich H., 1922, Z PHYS CHEM, V104, P232
   Garstecki P, 2006, LAB CHIP, V6, P437, DOI 10.1039/b510841a
   Harrison C, 2004, J MICROMECH MICROENG, V14, P153, DOI 10.1088/0960-1317/14/1/021
   Heilbronn A., 1922, JB WISS BOT, V61, P284
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.3.CO;2-V
   Kiick KL, 2008, SOFT MATTER, V4, P29, DOI 10.1039/b711319f
   Kiick KL, 2007, SCIENCE, V317, P1182, DOI 10.1126/science.1145951
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kopecek J, 2010, ADV DRUG DELIVER REV, V62, P122, DOI 10.1016/j.addr.2009.10.004
   Krayer J, 2006, SENSOR ACTUAT B-CHEM, V118, P20, DOI 10.1016/j.snb.2006.04.080
   Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   MANZ A, 1992, J CHROMATOGR, V593, P253, DOI 10.1016/0021-9673(92)80293-4
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rubinstein M., 2003, POLYM PHYS
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sato J, 2006, J RHEOL, V50, P1, DOI 10.1122/1.2135329
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Schultz KM, 2011, LAB CHIP, V11, P3802, DOI 10.1039/c1lc20376b
   Schultz KM, 2009, MACROMOLECULES, V42, P5310, DOI 10.1021/ma900766u
   Schultz KM, 2009, SOFT MATTER, V5, P740, DOI 10.1039/b818178k
   SEIFRIZ W, 1924, J EXP BIOL, V1, P431
   Simon C. G., 2010, ADV MATER, V23, P369
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Stockmayer WH, 1943, J CHEM PHYS, V11, P45, DOI 10.1063/1.1723803
   Tu RS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041914
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
   Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591
   Xiao H, 2006, LAB CHIP, V6, P1067, DOI 10.1039/b600374e
NR 44
TC 15
Z9 15
U1 0
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2011
VL 12
IS 12
BP 4178
EP 4182
DI 10.1021/bm201214r
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 858FU
UT WOS:000297782100002
PM 22023267
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Antunes, JC
   Pereira, CL
   Molinos, M
   Ferreira-da-Silva, F
   Dessi, M
   Gloria, A
   Ambrosio, L
   Goncalves, RM
   Barbosa, MA
AF Antunes, Joana C.
   Pereira, Catarina Leite
   Molinos, Maria
   Ferreira-da-Silva, Frederico
   Dessi, Mariagemiliana
   Gloria, Antonio
   Ambrosio, Luigi
   Goncalves, Raquel M.
   Barbosa, Mario A.
TI Layer-by-Layer Self-Assembly of Chitosan and Poly(gamma-glutamic acid)
   into Polyelectrolyte Complexes
SO BIOMACROMOLECULES
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; POLY-GAMMA-GLUTAMATE; BIOMEDICAL
   APPLICATIONS; VISCOELASTIC PROPERTIES; BACILLUS-ANTHRACIS; POLYPEPTIDE
   FILMS; MULTILAYER FILMS; HYALURONIC-ACID; ADSORPTION; BUILDUP
AB Chitosan (Ch) is a nontoxic and biocompatible polysaccharide extensively used in biomedical applications. Ch, as a polycation, can be combined with anionic polymers by layer-by-layer (LbL) self-assembly, giving rise to multilayered complexed architectures. These structures can be used in tissue engineering strategies, as drug delivery systems, or artificial matrices mimicking the extracellular microenvironment. In this work, Ch was combined with poly(gamma-glutamic acid) (gamma-PGA). gamma-PGA is a polyanion, which was microbially produced, and is known for its low immunogenic reaction and low cytotoxicity. Multilayered ultrathin films were assembled by LbL, with a maximum of six layers. The interaction between both polymers was analyzed by ellipsometry, quartz crystal microbalance with dissipation, Fourier transform infrared spectroscopy, atomic force microscopy, and zeta potential measurements. Ch/gamma-PGA polyelectrolyte multilayers (PEMs) revealed no cytotoxicity according to ISO 10993-5. Overall, this study demonstrates that Ch can interact electrostatically with gamma-PGA forming multilayered films Furthermore, this study provides a comprehensive characterization of Ch/gamma-PGA PEM structures, elucidating the contribution of each layer for the nanostructured films. These model surfaces can be useful substrates to study cell-biomaterial interactions in tissue regeneration.
C1 [Antunes, Joana C.; Pereira, Catarina Leite; Molinos, Maria; Goncalves, Raquel M.; Barbosa, Mario A.] Univ Porto, INEB Inst Engn Biomed, P-4100 Oporto, Portugal.
   [Antunes, Joana C.] Univ Porto, Fac Engn, P-4100 Oporto, Portugal.
   [Barbosa, Mario A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal.
   [Ferreira-da-Silva, Frederico] IBMC Inst Biol Mol & Celular, Oporto, Portugal.
   [Dessi, Mariagemiliana; Gloria, Antonio; Ambrosio, Luigi; Barbosa, Mario A.] CNR, Inst Composite & Biomed Mat, I-80125 Naples, Italy.
RP Antunes, JC (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
EM joana.antunes@ineb.up.pt
RI Silva, Frederico/K-3820-2013; Goncalves, Raquel/C-5940-2012; ANTUNES,
   Joana/R-9445-2018; Barbosa, Mario/F-5964-2011
OI Silva, Frederico/0000-0002-8890-4228; Goncalves,
   Raquel/0000-0003-2841-0485; ANTUNES, Joana/0000-0003-2036-2730; Barbosa,
   Mario/0000-0003-3568-7482; AMBROSIO, LUIGI/0000-0002-8367-2405; Leite
   Pereira, Catarina/0000-0001-8703-1245
FU FEDER funds through the Programa Operacional Factores de Competitividade
   - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia
   [PEst-C/SAU/LA0002/2011, SFRH/BD/48554/2008]; DISC Regeneration project
   [NMP3-LA-2008-213904]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade - COMPETE, by Portuguese funds through FCT -
   Fundacao para a Ciencia e a Tecnologia in the framework of the project
   PEst-C/SAU/LA0002/2011 and by DISC Regeneration project, with the grant
   agreement no. NMP3-LA-2008-213904 (FP7). Joana Antunes is grateful to
   FCT for the Ph.D. grant SFRH/BD/48554/2008. We gratefully acknowledge
   several INEB members: Dr. Isabel F. Amaral, Dr. Ma Cristina L. Martins,
   Dr. Cristina C. Barrias, Dr. Cristina C. Ribeiro, the research
   technicians Manuela Bras and Ricardo V. Silva, for their contribution in
   the materials characterization, and Dr. Ana Paula Pego and Dr. Hugo
   Oliveira for providing the mouse embryonic fibroblast cell line
   (NIH3T3). We would like also to thank Dr. Ana Azevedo and Prof. Dr. Joao
   Costa Pessoa from Instituto Superior Tecnico - Universidade Tecnica de
   Lisboa for providing the access to Circular Dichroism technique and the
   help on results analysis; Eng. Renate Kohl from Anton Paar GmbH, Dr.
   Jurgen Schlutter from LOT-Oriel GmbH & Co. KG and Dr. Fredrik Andersson
   from Q-Sense for the technical support, for the help in the EKA and
   QCM-D analyses, and results discussion; and to the Laboratory for
   Scanning Probe Microscopy, at CEMUP, for their help in the AFM
   measurements.
CR Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195
   Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a
   Ashiuchi M, 1999, BIOCHEM BIOPH RES CO, V263, P6, DOI 10.1006/bbrc.1999.1298
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Bonazzola C, 2003, LANGMUIR, V19, P5279, DOI 10.1021/la026528u
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Boulmedais F, 2003, LANGMUIR, V19, P440, DOI 10.1021/la0264522
   Boulmedais F, 2003, LANGMUIR, V19, P9873, DOI 10.1021/la0348259
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458
   Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x
   Chan YHM, 2003, LANGMUIR, V19, P7380, DOI 10.1021/la0343977
   Chua PH, 2008, J BIOMED MATER RES A, V87A, P1061, DOI 10.1002/jbm.a.31854
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   De Geest BG, 2006, LANGMUIR, V22, P5070, DOI 10.1021/la053368o
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dimitrova M, 2008, P NATL ACAD SCI USA, V105, P16320, DOI 10.1073/pnas.0800156105
   Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a
   Dutta AK, 2008, J COLLOID INTERF SCI, V324, P55, DOI 10.1016/j.jcis.2008.04.065
   EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194
   Fairbrother F, 1924, J CHEM SOC, V125, P2319, DOI 10.1039/ct9242502319
   Gehanno V, 1999, IEEE T MAGN, V35, P4361, DOI 10.1109/20.799086
   Giesbers M, 2002, J COLLOID INTERF SCI, V248, P88, DOI 10.1006/jcis.2001.8144
   Guzman E, 2010, LANGMUIR, V26, P11494, DOI 10.1021/la101043z
   Hajdu I, 2008, COLLOID POLYM SCI, V286, P343, DOI 10.1007/s00396-007-1785-7
   He LM, 2000, ENVIRON SCI TECHNOL, V34, P1694, DOI 10.1021/es991119e
   He LZ, 2006, CHEM ENG SCI, V61, P989, DOI 10.1016/j.ces.2005.05.064
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   HORCAS I, 2007, REV SCI INSTRUM, V78, P1
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   Imoto T, 2010, MACROMOL BIOSCI, V10, P271, DOI 10.1002/mabi.200900272
   Kang HS, 2007, J APPL POLYM SCI, V103, P386, DOI 10.1002/app.24623
   Kim DK, 1999, THIN SOLID FILMS, V350, P153, DOI 10.1016/S0040-6090(99)00351-X
   Krayukhina MA, 2008, USP KHIM+, V77, P854
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   KUNIOKA M, 1994, APPL MICROBIOL BIOT, V40, P867, DOI 10.1007/s002530050082
   Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n
   Lin YH, 2005, BIOMACROMOLECULES, V6, P1104, DOI 10.1021/bm049312a
   Martins MCL, 2011, ACTA BIOMATER, V7, P1949, DOI 10.1016/j.actbio.2011.01.013
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Nelson DL, 2005, LEHNINGER PRINCIPLES, P78
   Ozin GA, 2009, MATER TODAY, V12, P12, DOI 10.1016/S1369-7021(09)70156-7
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   PRESCOTT AG, 2005, Patent No. 20050095679
   Prodhomme EJF, 2003, BIOCONJUGATE CHEM, V14, P1148, DOI 10.1021/bc020019m
   Rhie GE, 2003, P NATL ACAD SCI USA, V100, P10925, DOI 10.1073/pnas.1834478100
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Salomaki M, 2004, MACROMOLECULES, V37, P9585, DOI 10.1021/ma048701u
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schlenoff JB, 2001, MACROMOLECULES, V34, P592, DOI 10.1021/ma0003093
   Schlenoff JB, 1998, J AM CHEM SOC, V120, P7626, DOI 10.1021/ja980350+
   Schlenoff JB, 2009, LANGMUIR, V25, P14007, DOI 10.1021/la901950c
   Schneerson R, 2003, P NATL ACAD SCI USA, V100, P8945, DOI 10.1073/pnas.1633512100
   Schonhoff M, 2003, J PHYS-CONDENS MAT, V15, pR1781, DOI 10.1088/0953-8984/15/49/R01
   Scolnik Y, 2006, PHYS CHEM CHEM PHYS, V8, P333, DOI 10.1039/b513974k
   Serizawa T, 1999, J POLYM SCI POL CHEM, V37, P801, DOI 10.1002/(SICI)1099-0518(19990315)37:6<801::AID-POLA15>3.0.CO;2-O
   SHIH L, 2004, MINI-REV MED CHEM, V4, P179
   Sogias IA, 2010, MACROMOL CHEM PHYS, V211, P426, DOI 10.1002/macp.200900385
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Sutherland MD, 2008, INFECT IMMUN, V76, P899, DOI 10.1128/IAI.01176-07
   Tachaboonyakiat W, 2000, POLYM J, V32, P481, DOI 10.1295/polymj.32.481
   Terbojevich M, 1996, CARBOHYD POLYM, V29, P63, DOI 10.1016/0144-8617(95)00147-6
   Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034
   Tsao CT, 2010, CARBOHYD RES, V345, P1774, DOI 10.1016/j.carres.2010.06.002
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   von Klitzing R, 2006, PHYS CHEM CHEM PHYS, V8, P5012, DOI 10.1039/b607760a
   Werner C, 1999, COLLOID SURFACE A, V159, P519, DOI 10.1016/S0927-7757(99)00290-3
   Yamaguchi F, 1996, BIOSCI BIOTECH BIOCH, V60, P255, DOI 10.1271/bbb.60.255
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Zhang X, 2007, CHEM COMMUN, P1395, DOI 10.1039/b615590a
NR 79
TC 59
Z9 62
U1 2
U2 86
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2011
VL 12
IS 12
BP 4183
EP 4195
DI 10.1021/bm2008235
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 858FU
UT WOS:000297782100003
PM 22032302
DA 2018-10-19
ER

PT J
AU Liao, XL
   Lu, SY
   Zhuo, Y
   Winter, C
   Xu, WF
   Li, B
   Wang, YX
AF Liao, Xiaoling
   Lu, Shaoying
   Zhuo, Yue
   Winter, Christina
   Xu, Wenfeng
   Li, Bo
   Wang, Yingxiao
TI Bone Physiology, Biomaterial and the Effect of Mechanical/Physical
   Microenvironment on Mesenchymal Stem Cell Osteogenesis
SO CELLULAR AND MOLECULAR BIOENGINEERING
LA English
DT Article
DE Mechanical environment; Bone repair; Tissue engineering; Scaffolds; Bone
   cells
ID MARROW STROMAL CELLS; FLUID SHEAR-STRESS; REGENERATIVE MEDICINE;
   SURFACE-ROUGHNESS; IN-VITRO; SKELETAL DEVELOPMENT; TITANIUM SURFACES;
   GENE DELIVERY; TISSUE; SCAFFOLDS
AB In this review, we summarize the research progress in understanding the physiology of bone cells interacting with different mechanical/physical environments during bone tissue regeneration/repair. We first introduce the cellular composition of the bone tissue and the mechanism of the physiological bone regeneration/repair process. We then describe the properties and development of biomaterials for bone tissue engineering, followed by the highlighting of research progresses on the cellular response to mechanical environmental cues. Finally, several latest advancements in bone tissue regeneration and remaining challenges in the field are discussed for future research directions.
C1 [Liao, Xiaoling; Lu, Shaoying; Zhuo, Yue; Winter, Christina; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Liao, Xiaoling; Lu, Shaoying; Zhuo, Yue; Winter, Christina; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.
   [Liao, Xiaoling; Xu, Wenfeng; Li, Bo] Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Sch Met & Mat Engn, Chongqing 401331, Peoples R China.
   [Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Dept Integrat & Mol Physiol, Inst Genom Biol, Urbana, IL 61801 USA.
RP Wang, YX (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM yingxiao@uiuc.edu
RI Zhuo, Yue/I-5526-2017
OI Zhuo, Yue/0000-0002-5739-1896
FU NIH [HL098472, NS063405]; NSF [CBET0846429]; National Natural Foundation
   of China [81101154]
FX This work is supported in part by grants from NIH HL098472, NS063405,
   NSF CBET0846429 (Y. W.), and National Natural Foundation of China No.
   81101154 (X. L., W. X. and B. L.).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   ALBRIGHT F, 1947, RECENT PROG HORM RES, V1, P293
   Aydemir ABC, 2010, BONE, V46, P167, DOI 10.1016/j.bone.2009.08.061
   Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138
   Bakker AD, 2006, OSTEOPOROSIS INT, V17, P827, DOI 10.1007/s00198-006-0072-7
   Blecha LD, 2010, J BIOMECH, V43, P933, DOI 10.1016/j.jbiomech.2009.11.004
   Blecha LD, 2009, J ORTHOP RES, V27, P1082, DOI 10.1002/jor.20836
   Boyce BF, 2009, CRIT REV EUKAR GENE, V19, P171, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.10
   Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2009, TISSUE ENG PART B-RE, V15, P195, DOI [10.1089/ten.teb.2008.0515, 10.1089/ten.TEB.2008.0515]
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   CHRISTOPH R, 2009, HEAD FACE MED, V5, P1
   Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Donahue TLH, 2003, J BIOMECH, V36, P1363, DOI 10.1016/S0021-9290(03)00118-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Fu HH, 2007, J BIOMED MATER RES A, V83A, P770, DOI 10.1002/jbm.a.31356
   Gao J, 2003, Chir Organi Mov, V88, P305
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Haasper C, 2008, EXP TOXICOL PATHOL, V59, P355, DOI [10.1016/j.etp.2007.11.008, 10.1016/j.etp.2007.11.013]
   Hacking SA, 2008, J ORTHOP RES, V26, P1347, DOI 10.1002/jor.20622
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Huber FX, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-164
   Huesa C, 2010, J BIOMECH, V43, P1182, DOI 10.1016/j.jbiomech.2009.11.029
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0
   Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kuczumow A, 2010, J ARCHAEOL SCI, V37, P107, DOI 10.1016/j.jas.2009.09.020
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kwon RY, 2007, J BIOMECH, V40, P3162, DOI 10.1016/j.jbiomech.2007.04.003
   Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001
   Li YC, 2010, J ALLOY COMPD, V494, P323, DOI 10.1016/j.jallcom.2010.01.026
   LIU L, 2010, BIOMECH MODEL MECHAN
   LONG F, 2009, CELL, V139, P1044
   LUTWAK L, 1974, ANN INTERN MED, V80, P630, DOI 10.7326/0003-4819-80-5-630
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Martin RB, 2000, BONE, V26, P1, DOI 10.1016/S8756-3282(99)00241-0
   Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047
   McGarry JG, 2004, FASEB J, V18, P482, DOI 10.1096/fj.04-2210fje
   Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Mullender MG, 1997, BONE, V20, P527, DOI 10.1016/S8756-3282(97)00036-7
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239
   Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8
   Puckett S, 2008, INT J NANOMED, V3, P229
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ren J, 2007, J BIOMAT SCI-POLYM E, V18, P505, DOI 10.1163/156856207780852578
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rimondini L, 2009, Minerva Stomatol, V58, P483
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   RYDZIEL S, 1994, ENDOCRINOLOGY, V134, P2541, DOI 10.1210/en.134.6.2541
   Sa JC, 2009, SURF COAT TECH, V203, P1765, DOI 10.1016/j.surfcoat.2008.12.017
   Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998
   Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Steinmuller-Nethl D, 2006, BIOMATERIALS, V27, P4547, DOI 10.1016/j.biomaterials.2006.04.036
   Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122
   Tsai SW, 2008, ACTA BIOMATER, V4, P1332, DOI 10.1016/j.actbio.2008.03.015
   Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020
   Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus
   Webster TJ, 2001, ADV CHEM ENG, V27, P125
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yao C, 2007, INT J NANOMED, V2, P487
   Zhang HW, 2010, EXPERT REV PROTEOMIC, V7, P103, DOI 10.1586/EPR.09.90
NR 106
TC 7
Z9 7
U1 0
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1865-5025
EI 1865-5033
J9 CELL MOL BIOENG
JI Cell. Mol. Bioeng.
PD DEC
PY 2011
VL 4
IS 4
SI SI
BP 579
EP 590
DI 10.1007/s12195-011-0204-9
PG 12
WC Cell & Tissue Engineering; Biophysics; Cell Biology
SC Cell Biology; Biophysics
GA 859GW
UT WOS:000297865900008
PM 25580165
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bullers, S
   Berry, H
   Ingham, E
   Southgate, J
AF Bullers, S.
   Berry, H.
   Ingham, E.
   Southgate, J.
TI The role of macrophages in biomaterial-tissue regeneration
SO IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Congress of the British-Society-for-Immunology
CY DEC 05-08, 2011
CL Liverpool, ENGLAND
SP British Soc Immunol
C1 [Bullers, S.; Southgate, J.] Univ York, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
   [Berry, H.] Tissue Regenix Grp, York, N Yorkshire, England.
   [Ingham, E.] Univ Leeds, Inst Med & Biol Engn, Leeds, W Yorkshire, England.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2011
VL 135
SU 1
SI SI
BP 110
EP 110
PG 1
WC Immunology
SC Immunology
GA 854PQ
UT WOS:000297507100325
DA 2018-10-19
ER

PT J
AU Oughlis, S
   Lessim, S
   Changotade, S
   Bollotte, F
   Poirier, F
   Helary, G
   Lataillade, JJ
   Migonney, V
   Lutomski, D
AF Oughlis, S.
   Lessim, S.
   Changotade, S.
   Bollotte, F.
   Poirier, F.
   Helary, G.
   Lataillade, J. J.
   Migonney, V.
   Lutomski, D.
TI Development of proteomic tools to study protein adsorption on a
   biomaterial, titanium grafted with poly(sodium styrene sulfonate)
SO JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES
LA English
DT Article
DE Liquid chromatography; Biomaterial; Titanium; Proteomic; Platelets rich
   plasma
ID SURFACE-PLASMON RESONANCE; CELL-ADHESION; IMPLANTS; DIFFERENTIATION;
   IMMOBILIZATION; ELLIPSOMETRY; PRETREATMENT; SERUM; METAL
AB It is known that protein adsorption is the initial interaction between implanted biomaterials and biological environment. Generally, a complex protein layer will be formed on material surfaces within a few minutes and the composition of this layer at the interface determines the biological response to the implanted material, and therefore the long-term compatibility of the biomaterial. Despite different techniques exist to observe protein adsorption on biomaterials, none of them led to the identification of adsorbed proteins. In this paper, we report a chromatographic technique coupled to proteomics to analyse and identify proteins from complex biological samples adsorbed on biomaterial surfaces. This approach is based on (1) elaboration of the chromatographic support containing the biomaterial (2) a chromatography step involving adsorption of proteins on the biomaterial (3) the high-resolution separation of eluted proteins by 2-DE gel and (4) the identification of proteins by mass spectrometry. Experiments were performed with proteins from platelets rich plasma (PRP) adsorbed on a biomaterial which consist in titanium bioactivated with PolyNaSS. Our results show that chromatographic approach combined to 2-DE gels and mass spectrometry provides a powerful tool for the analysis and identification of proteins adsorbed on various surfaces. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Oughlis, S.; Lessim, S.; Changotade, S.; Bollotte, F.; Poirier, F.; Helary, G.; Migonney, V.; Lutomski, D.] Univ Paris 13, CNRS, CSPBAT, LBPS,UFR SMBH,UMR 7244, Bobigny, France.
   [Bollotte, F.; Lataillade, J. J.] Ctr Transfus Sanguine Armees Jean Julliard, Unite Therapie Cellulaire, Clamart, France.
   [Bollotte, F.] EFS Nord France, Lille, France.
RP Lutomski, D (reprint author), Univ Paris 13, CNRS, CSPBAT, LBPS,UFR SMBH,UMR 7244, Bobigny, France.
EM lutomski@smbh.univ-paris13.fr
OI MIGONNEY, VERONIQUE/0000-0002-1055-3720
FU Ministere de l'Education Nationale, de la Recherche et de la Technologie
   (MENRT); CNRS
FX This work was supported by grants from the Ministere de l'Education
   Nationale, de la Recherche et de la Technologie (MENRT) and CNRS.
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Caceres M, 2008, J PERIODONTOL, V79, P714, DOI [10.1902/jop.2008.070395, 10.1902/jop.2008.070395 ]
   Choi S, 2008, BIOSENS BIOELECTRON, V24, P893, DOI 10.1016/j.bios.2008.07.036
   Cranin A N, 1997, J Oral Implantol, V23, P21
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P384
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Helary G, 2008, BIO-MED MATER ENG, V18, P237, DOI 10.3233/BME-2008-0531
   Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175
   Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028
   Kawakami H, 2003, J BIOMED MATER RES A, V67A, P1393, DOI 10.1002/jbm.a.20052
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   MAYINGI J, 2007, C P IEEE ENG MED BIO, P5119
   Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   Nagassa ME, 2008, CLIN ORAL IMPLAN RES, V19, P1317, DOI 10.1111/j.1600-0501.2008.01611.x
   Nakajima H, 1996, Dent Mater J, V15, P77
   Nonckreman CJ, 2007, J BIOMED MATER RES A, V81A, P791, DOI 10.1002/jbm.a.31111
   Pavon-Djavid G, 2007, BIOMACROMOLECULES, V8, P3317, DOI 10.1021/bm070344i
   Poksinski M, 2007, OPT LETT, V32, P1308, DOI 10.1364/OL.32.001308
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Smith D C, 1993, Int J Prosthodont, V6, P106
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yoshimoto K, 2009, LANGMUIR, V25, P12243, DOI 10.1021/la901143h
   ZHOU J, 2007, C P IEEE ENG MED BIO, P5115
NR 30
TC 14
Z9 14
U1 1
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-0232
EI 1873-376X
J9 J CHROMATOGR B
JI J. Chromatogr. B
PD DEC 1
PY 2011
VL 879
IS 31
BP 3681
EP 3687
DI 10.1016/j.jchromb.2011.10.006
PG 7
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 858VF
UT WOS:000297830600002
PM 22036657
DA 2018-10-19
ER

PT J
AU Fukushima, T
   Ohno, J
   Imayoshi, R
   Mori, N
   Sakagami, R
   Mitarai, M
   Hayakawa, T
AF Fukushima, Tadao
   Ohno, Jun
   Imayoshi, Rieko
   Mori, Nana
   Sakagami, Ryuji
   Mitarai, Makoto
   Hayakawa, Tohru
TI DNA/protamine complex paste for an injectable dental material
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DNA-CHITOSAN COMPLEXES; PROTAMINE; POROSITY
AB A DNA/protamine complex powder was prepared by reaction between DNA and protamine sulfate solution with stirring in order to develop a new injectable biomaterials for dental therapy. The powder of DNA/protamine complex became paste by kneading the complex powder and distilled water. Complex formation was confirmed by FT-IR measurement. The complex paste had a porous structure and its viscosity was approximately 280.1 Pas. The paste could easily pass through a needle of 0.25 mm internal diameter. It seemed that DNA/protamine complex paste has suitable viscosity for clinical use as an injectable biomaterial. Although, the complex paste delayed the growth speed of Staphylococcus aureus, Pseudomonas aeruginosa, Porphyromonas gingivalis and Prevotella intermedia for limited periods, it cannot kill and inhibit growing bacteria. The complex paste disk showed a mild tissue response and gradually degraded after the implantation into the soft tissue of rats. These results suggested that this DNA/protamine complex paste could be a useful material for a biodegradable biomaterial. In particular, this paste will be applicable as an injectable biomaterial using syringe for the repair of defects of living tissue, GBR treatment and/or GTR treatment in dentistry.
C1 [Fukushima, Tadao] Fukuoka Dent Coll, Ctr Regenerat Med, Sawara Ku, Fukuoka 8140193, Japan.
   [Ohno, Jun] Fukuoka Dent Coll, Dept Morphol Biol, Pathol Sect, Sawara Ku, Fukuoka 8140193, Japan.
   [Imayoshi, Rieko] Fukuoka Dent Coll, Dept Funct Biosci, Infect Biol Sect, Sawara Ku, Fukuoka 8140193, Japan.
   [Mori, Nana; Sakagami, Ryuji] Fukuoka Dent Coll, Dept Odontol, Periodontol Sect, Sawara Ku, Fukuoka 8140193, Japan.
   [Mitarai, Makoto] Maruha Nichiro Holdings Inc, Cent Res Inst, Tsukuba, Ibaraki 3004247, Japan.
   [Hayakawa, Tohru] Tsurumi Univ, Sch Dent Med, Dept Dent Engn, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan.
RP Fukushima, T (reprint author), Fukuoka Dent Coll, Ctr Regenerat Med, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.
EM tadaof@college.fdcnet.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [19390505, 23390455, S1001059]
FX This study was supported in part by Grants-in-aid for Scientific
   Research (B) (19390505 and 23390455) and by a Grant-in-aid for strategic
   study base formation support business (S1001059) from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan.
CR Fukushima T, 2006, J BIOMED MATER RES B, V76B, P121, DOI 10.1002/jbm.b.30334
   Fukushima T, 2005, DENT MATER J, V24, P414, DOI 10.4012/dmj.24.414
   Fukushima T, 2008, J ORAL TISSUE ENG, V6, P24
   Fukushima T, 2010, DENT MATER J, V29, P529, DOI 10.4012/dmj.2009-131
   Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451
   Goldman A., 1996, NUCL ACIDS CHEM BIOL, P375
   HORROW JC, 1985, ANESTH ANALG, V64, P348
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Jie W, 2004, EUR POLYM J, V40, P509, DOI 10.1016/j.eurpolymj.2003.10.028
   JOHANSEN C, 1995, J APPL BACTERIOL, V78, P297, DOI 10.1111/j.1365-2672.1995.tb05029.x
   JOHSON GH, 2002, RESTORATIVE DENT MAT, P359
   McMichael A. J., 1992, OXFORD TXB PATHOLOGY, P198
   Miura T, 2010, J ORAL TISSUE ENG, V8, P30
   Miura T., 2010, J BIOMED SCI ENG, V3, P1069
   Nakao H, 2003, DENT MATER J, V22, P262, DOI 10.4012/dmj.22.262
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778
   Wilson W. D., 1996, NUCL ACIDS CHEM BIOL, P329
NR 19
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2011
VL 22
IS 12
BP 2607
EP 2615
DI 10.1007/s10856-011-4446-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856EX
UT WOS:000297621700003
PM 21922330
DA 2018-10-19
ER

PT J
AU Guo, DG
   Mao, MM
   Qi, WL
   Li, HY
   Ni, PF
   Gao, GH
   Xu, KW
AF Guo, Dagang
   Mao, Mengmeng
   Qi, Wenli
   Li, Hongyuan
   Ni, Pengfei
   Gao, Guohan
   Xu, Kewei
TI The influence of Sr and H3PO4 concentration on the hydration of SrCaHA
   bone cement
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENTS; HYDROXYAPATITE; MECHANISMS
AB Sr-contained calcium hydroxyapatite (SrCaHA) cement is a potential biomaterial for in vivo bone repair and surgery fixation due to its excellent biodegradability, bioactivity, biocompatibility, easily shaping and self-hardening. We had ever reported the in vitro physiochemical properties, biocompatibility and in vivo degradability of the SrCaHA cement obtained by mixing a cement powder of Ca-4(PO4)(2)O/CaHPO4/SrHPO4 and a cement liquid of diluted H3PO4 aqueous solution. In the present study, we intensively studied the influences of both Sr content and H3PO4 concentration in diluted phosphoric acid aqueous solution on the setting time, hydration heat-liberation behaviours, and real-time microstructure and phase evolutions of the SrCaHA cement. The results show that both PO4 (3-) and H+ ions in PA solution attended the hydration reaction as reactants, and thus the increase of the PA concentration not only promoted the dissolution of Ca-4(PO4)(2)O but also pushed the hydration progress of SrCaHA bone cement. Sr content exhibits a remarkable retardation role on the apatite transformation of the SrCaHA cement pastes which probably attributed to its higher degree of supersaturation for yielding apatite crystals and lower transformation rate when exposed to the Sr2+-containing hydration system. This present results contribute to a better understanding on the hydration mechanism of the new SrCaHA cement and help to the more precisely controlling of its hydration process.
C1 [Guo, Dagang; Mao, Mengmeng; Qi, Wenli; Li, Hongyuan; Ni, Pengfei; Gao, Guohan; Xu, Kewei] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Mat Sci & Engn, Xian 710049, Peoples R China.
   [Xu, Kewei] Xian Univ Arts & Sci, Xian 710065, Peoples R China.
RP Guo, DG (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Mat Sci & Engn, Xian 710049, Peoples R China.
EM guodagang@mail.xjtu.edu.cn
FU Fundamental Research Funds for the Central University; National Natural
   Science Foundation of China [50702043, 51072159]; Chinese Ministry of
   Education [NCET-08-0444 (2301G107aaa)]
FX This work was supported by "the Fundamental Research Funds for the
   Central University", the National Natural Science Foundation of China
   (No: 50702043; 51072159) and Program for New Century Excellent Talents
   in Universities (Chinese Ministry of Education, NCET-08-0444
   (2301G107aaa)).
CR Brown WE, 1987, CEMENTS RES PROGR 19, P352
   CAO WC, 1996, SILICATE TECHNIQUE, P69
   CHAPUY MC, 1995, AGING-CLIN EXP RES, V7, P164, DOI 10.1007/BF03324331
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Ding JA, 1996, CEMENT CONCRETE RES, V26, P799, DOI 10.1016/S0008-8846(96)85017-4
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GUILHEM R, 2010, ACTA BIOMATER, V6, P3208
   Guo DG, 2008, J BIOMED MATER RES A, V86A, P947, DOI 10.1002/jbm.a.31687
   Guo DG, 2006, MATER SCI FORUM, V510-511, P846, DOI 10.4028/www.scientific.net/MSF.510-511.846
   Guo DG, 2005, RARE METAL MAT ENG, V34, P799
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Guo YJ, 2004, BEIJING J STOMA, V12, P73
   Hatim Z, 1998, ANN CHIM-SCI MAT, V23, P65, DOI 10.1016/S0151-9107(98)80024-X
   Leroux L, 2001, J MATER RES, V16, P171, DOI 10.1557/JMR.2001.0028
   Liu CS, 2003, BIOMATERIALS, V24, P2995, DOI 10.1016/S0142-9612(03)00125-X
   ROBERTS JT, 2002, P 44 ANN ASTRO M
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   TENHUISEN KS, 1994, J MATER SCI-MATER M, V5, P291, DOI 10.1007/BF00122399
   Wong CT, 2004, J BIOMED MATER RES A, V68A, P513, DOI 10.1002/jbm.a.20089
   Wrong CT, 2004, J BIOMED MATER RES A, V70A, P428
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yue J, 2009, RARE METAL MAT ENG, V38, P617
   ZINEB H, 1998, THESIS I NATL POLYTE
NR 23
TC 4
Z9 4
U1 2
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2011
VL 22
IS 12
BP 2631
EP 2640
DI 10.1007/s10856-011-4448-7
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856EX
UT WOS:000297621700005
PM 21979165
DA 2018-10-19
ER

PT J
AU Wang, JJ
   Liu, F
AF Wang, Jing Jing
   Liu, Fang
TI Photoinduced graft polymerization of 2-methacryloyloxyethyl
   phosphorylcholine on silicone hydrogels for reducing protein adsorption
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SURFACE MODIFICATION; PHOSPHOLIPID POLYMERS; POLY(ETHYLENE GLYCOL);
   MEMBRANE-SURFACE; GLOW-DISCHARGE; CONTACT-LENSES; CELL-ADHESION;
   RESISTANCE; WATER; POLYDIMETHYLSILOXANE
AB The biomimetic synthetic methacrylate monomer containing a phosphorylcholine group, 2-methacryloyloxyethyl phosphorylcholine (MPC), has been widely used to improve the surface property of biomaterials. In the current report, both hydrophilic and antifouling surfaces were prepared on silicone hydrogels with MPC grafted by UV-induced free radical polymerization. The MPC-grafted silicone hydrogels were characterized by graft yield and static water contact angle (SCA) measurements. According to the results, the graft yield reached a maximum at 5 min of UV exposure time and 8 wt% MPC concentration. The modified silicone hydrogels possessed hydrophilic surfaces with the lowest water contact angle of 20A(0). The oxygen permeability of the MPC-grafted silicone hydrogels was as high as the unmodified silicone hydrogel. The mechanical property of silicone hydrogels was maintained at about 95% of the tensile strength and elastic modulus after the MPC grafting. The results of the in vitro single protein adsorption on the MPC-grafted silicone hydrogels were in agreement with the SCA measurements. The smaller the water contact angle, the greater was the protein repelling ability. The MPC-grafted silicone hydrogel is expected to be a novel biomaterial which possesses excellent surface hydrophilicity, antifouling property, oxygen permeability and mechanical property.
C1 [Wang, Jing Jing; Liu, Fang] Yancheng Inst Technol, Dept Polymer Mat & Engn, Sch Mat Engn, Key Lab Adv Technol Environm Protect Jiangsu Prov, Yancheng 224051, Peoples R China.
RP Wang, JJ (reprint author), Yancheng Inst Technol, Dept Polymer Mat & Engn, Sch Mat Engn, Key Lab Adv Technol Environm Protect Jiangsu Prov, Yancheng 224051, Peoples R China.
EM jjwang3@hotmail.com
FU education department of Jiangsu Province [11KJB430013]; Yancheng
   Institute of Technology [XKR2011010]; Key Laboratory for Advanced
   Technology in Environmental Protection of Jiangsu Province [AE201069]
FX We express our gratitude to the education department of Jiangsu Province
   (natural science fund for colleges and universities, NO: 11KJB430013)
   and the Yancheng Institute of Technology (natural research fund, NO:
   XKR2011010). The project was supported by research fund of Key
   Laboratory for Advanced Technology in Environmental Protection of
   Jiangsu Province (NO: AE201069).
CR Bozukova D, 2008, LANGMUIR, V24, P6649, DOI 10.1021/la7033774
   Bozukova D, 2007, BIOMACROMOLECULES, V8, P2379, DOI 10.1021/bm0701649
   Brynda E, 2009, J MATER SCI-MATER M, V20, P909, DOI 10.1007/s10856-008-3625-9
   Erdodi G, 2005, J POLYM SCI POL CHEM, V43, P3491, DOI 10.1002/pola.20791
   Goda T, 2006, EXPERT REV MED DEVIC, V3, P167, DOI 10.1586/17434440.3.2.167
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Inoue Y, 2010, COLLOID SURFACE B, V81, P350, DOI 10.1016/j.colsurfb.2010.07.030
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7
   Kang JS, 2003, J APPL POLYM SCI, V88, P3188, DOI 10.1002/app.12148
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kobayashi T, 2007, SURF COAT TECH, V201, P8039, DOI 10.1016/j.surfcoat.2006.02.056
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6
   Monge S, 2011, BIOMACROMOLECULES, V12, P1973, DOI 10.1021/bm2004803
   Moro T, 2010, OSTEOARTHR CARTILAGE, V18, P1174, DOI 10.1016/j.joca.2010.05.019
   Peng HT, 2008, J MATER SCI-MATER M, V19, P1803, DOI 10.1007/s10856-007-3324-y
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002
   Selan L, 2009, AM J OPHTHALMOL, V147, P134, DOI 10.1016/j.ajo.2008.07.032
   Shimizu T, 2010, BIOMATERIALS, V31, P3274, DOI 10.1016/j.biomaterials.2010.01.026
   Sugiura S, 2008, COLLOID SURFACE B, V63, P301, DOI 10.1016/j.colsurfb.2007.12.013
   Sun FQ, 2010, CHINESE J POLYM SCI, V28, P547, DOI 10.1007/s10118-010-9082-1
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Thissen H, 2010, BIOMATERIALS, V31, P5510, DOI 10.1016/j.biomaterials.2010.03.040
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Watanabe T., 2003, US Patent, Patent No. [0,125,500, 0125500]
   Wavhal DS, 2003, LANGMUIR, V19, P79, DOI 10.1021/la020653o
   Willis SL, 2001, BIOMATERIALS, V22, P3261, DOI 10.1016/S0142-9612(01)00164-8
   Yao K, 2006, J BIOMED MATER RES A, V78A, P684, DOI 10.1002/jbm.a.30741
   Zeplin PH, 2010, ANN PLAS SURG, V65, P560, DOI 10.1097/SAP.0b013e3181d6e326
NR 30
TC 8
Z9 9
U1 5
U2 64
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2011
VL 22
IS 12
BP 2651
EP 2657
DI 10.1007/s10856-011-4452-y
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856EX
UT WOS:000297621700007
PM 22020548
DA 2018-10-19
ER

PT J
AU Kim, M
   Kraft, JJ
   Volk, AC
   Pugarelli, J
   Pleshko, N
   Dodge, GR
AF Kim, Minwook
   Kraft, Jeffrey J.
   Volk, Andrew C.
   Pugarelli, Joan
   Pleshko, Nancy
   Dodge, George R.
TI Characterization of a Cartilage-Like Engineered Biomass Using a
   Self-Aggregating Suspension Culture Model: Molecular Composition Using
   FT-IRIS
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE cartilage tissue engineering; biomaterials; self-aggregating suspension
   culture; cartilage tissue analog; Fourier transform-infrared imaging
   spectroscopy
ID ARTICULAR-CARTILAGE; CHONDROCYTES; MATRIX; REPAIR; PROTEOGLYCAN;
   CONSTRUCTS; SCAFFOLDS; COLLAGEN; CELLS
AB Maintenance of chondrocyte phenotype and robust expression and organization of macromolecular components with suitable cartilaginous properties is an ultimate goal in cartilage tissue engineering. We used a self-aggregating suspension culture (SASC) method to produce an engineered cartilage, "cartilage tissue analog" (CTA). With an objective of understanding the stability of phenotype of the CTA over long periods, we cultured chondrocytes up to 4 years and analyzed the matrix. Both early (eCTAs) (6 months) and aged (aCTAs) (4 years) showed type II collagen throughout with higher concentrations near the edge. Using Fourier transform-infrared imaging spectroscopy (FT-IRIS), proteoglycan/collagen ratio of eCTA was 2.8 times greater than native cartilage at 1 week, but the ratio was balanced to native level (p = 0.017) by 36 weeks. Surprisingly, aCTAs maintained the hyaline characteristics, but there was evidence of calcification within the tissue with a distinct range of intensities. Mineral/matrix ratio of those aCTA with "intensive" calcification was significantly higher (p = 0.017) than the "partial," but when compared to native bone the ratio of "intensive" aCTAs was 2.4 times lower. In this study we utilized the imaging approach of FT-IRIS and have shown that a biomaterial formed is compositionally closely related to natural cartilage for long periods in culture. We show that this culture platform can maintain a CTA for extended periods of time (4 years) and under those conditions signs of mineralization can be found. This method of cartilage tissue engineering is a promising method to generate cartilaginous biomaterial and may have potential to be utilized in both cartilage and boney repairs. (C) 2011 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29: 1881-1887, 2011.
C1 [Kim, Minwook; Kraft, Jeffrey J.; Volk, Andrew C.; Pugarelli, Joan; Dodge, George R.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.
   [Kim, Minwook; Dodge, George R.] Univ Delaware, McKay Orthopaed Res Lab, Dept Orthopaed Surg, Newark, DE USA.
   [Pleshko, Nancy] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.
RP Dodge, GR (reprint author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.
EM gdodge@upenn.edu
FU NIH [AR046121]; Nemours Foundation;  [NIHARO56145]
FX This work utilized the FT-IRIS imaging Core at the Hospital for Special
   Surgery, a NIH funded Core Facility (AR046121). The study was in part
   supported by the Nemours Foundation and by NIHARO56145.
CR Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]
   Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892
   Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043
   Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O
   CARNEY SL, 1988, PHYSIOL REV, V68, P858
   Chen CT, 2003, ARTHRITIS RHEUM, V48, P1047, DOI 10.1002/art.10991
   Clair Benjamin L, 2009, Foot Ankle Spec, V2, P179, DOI 10.1177/1938640009342272
   Connelly JT, 2008, OSTEOARTHR CARTILAGE, V16, P1092, DOI 10.1016/j.joca.2008.01.004
   Dodge GR, 1998, ARTHRITIS RHEUM, V41, P274
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Estrada LE, 2001, OSTEOARTHR CARTILAGE, V9, P169, DOI 10.1053/joca.2000.0373
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171
   Kim M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922329
   Kim M, 2006, 6 S INT CART REP SOC, P3
   Kraft JJ, 2010, EFFECTS HYDROSTATIC
   Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008
   Mow VC, 1999, OSTEOARTHR CARTILAGE, V7, P41, DOI 10.1053/joca.1998.0161
   Novotny JE, 2006, TISSUE ENG, V12, P2755, DOI 10.1089/ten.2006.12.2755
   Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795
   Pagnotto MR, 2007, GENE THER, V14, P804, DOI 10.1038/sj.gt.3302938
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62070
   Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81
   West PA, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854131
   Zhang ZJ, 2004, J ANAT, V205, P229, DOI 10.1111/j.0021-8782.2004.00327.x
NR 30
TC 10
Z9 10
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD DEC
PY 2011
VL 29
IS 12
BP 1881
EP 1887
DI 10.1002/jor.21467
PG 7
WC Orthopedics
SC Orthopedics
GA 859ZC
UT WOS:000297913500013
PM 21630329
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Russell, TA
AF Russell, Thomas A.
TI Intramedullary Nailing: Evolutions of Femoral Intramedullary Nailing:
   First to Fourth Generations
SO JOURNAL OF ORTHOPAEDIC TRAUMA
LA English
DT Article
DE intramedullary ailing; femur fracture; history; orthopaedic surgery
ID SHAFT FRACTURES; BLOCKING SCREWS; POLLER SCREWS; FIXATION; RETROGRADE;
   INSERTION; TRACTION; TRAUMA; TABLE; FEMUR
AB Intramedullary femoral nailing is the gold standard for femoral shaft fixation but only in the past 27 years. This rapid replacement of closed traction and cast techniques in North America was a controversial and contentious evolution in surgery. As we enter the fourth generation of implant design, capabilities, and surgical technique, it is important to understand the driving forces for this technology. These forces included changes in radiographic imaging capabilities, biomaterial design and computer-assisted manufacturing, and the recognition of the importance of mobilization of the trauma patient to avoid systemic complications and optimize functional recovery.
C1 Univ Tennessee, Ctr Hlth Sci, Campbell Clin, Dept Orthopaed Surg,Elvis Presley Trauma Ctr, Memphis, TN 38028 USA.
RP Russell, TA (reprint author), Univ Tennessee, Ctr Hlth Sci, Campbell Clin, Dept Orthopaed Surg,Elvis Presley Trauma Ctr, Memphis, TN 38028 USA.
EM tarmd@aol.com
CR Bircher H, 1886, ARCH KLIN CHIR, V34, P410
   BONE LB, 2008, CLIN ORTHOP RELAT R, V422, P11
   Bosse MJ, 1997, J BONE JOINT SURG AM, V79A, P799, DOI 10.2106/00004623-199706000-00001
   Boyer MI, 1996, J TRAUMA, V41, P279, DOI 10.1097/00005373-199608000-00014
   BRUMBACK RJ, 1988, J BONE JOINT SURG AM, V70A, P1453, DOI 10.2106/00004623-198870100-00003
   BUTT MS, 1995, INJURY, V26, P615, DOI 10.1016/0020-1383(95)00126-T
   DUHAMEL HL, 1742, MEM ACAD INSCRIPTION, V2, P481
   FARILL J, 1952, J BONE JOINT SURG AM, V34-A, P506, DOI 10.2106/00004623-195234030-00002
   GLUCK T, 1890, BERL KLIN WOCHENSCHR, P19
   GOODSIR J, 1868, 1845 ANATOMICAL MEMO, P1
   HALLER A, 1763, OPERA MINORA, V2, P400
   Henry S L, 1991, Contemp Orthop, V22, P631
   Hey Groves EW, 1914, BRIT J SURG, V2, P429
   Hoglund E. J., 1917, SURG GYNECOL OBSTET, V24, P243
   IANNACONE WM, 1994, J ORTHOP TRAUMA, V8, P322, DOI 10.1097/00005131-199408000-00008
   JOHNSON KD, 1984, J BONE JOINT SURG AM, V66A, P1222, DOI 10.2106/00004623-198466080-00010
   KARPOS PAG, 1995, J ORTHOP TRAUMA, V9, P57, DOI 10.1097/00005131-199502000-00009
   KEMPF MD, 1995, J BONE JOINT SURG AM, V5, P67
   KLEMM K, 1972, MONATSSCHR UNFALL, V12, P568
   Krettek C, 1999, J ORTHOP TRAUMA, V13, P550, DOI 10.1097/00005131-199911000-00006
   Krettek C, 1999, J BONE JOINT SURG BR, V81B, P963, DOI 10.1302/0301-620X.81B6.10000
   Kuntscher G, 2006, MARROW NAILING METHO
   Kuntscher G., 1940, ARCH KLIN CHIR, V200, P443
   KUNTSCHER GBG, 1958, J BONE JOINT SURG AM, V40, P17
   Ostrum RF, 1998, J ORTHOP TRAUMA, V12, P464, DOI 10.1097/00005131-199809000-00006
   PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010
   PAPE HC, 1994, J ORTHOP TRAUMA, V8, P300, DOI 10.1097/00005131-199408000-00005
   Ricci WM, 2001, J ORTHOP TRAUMA, V15, P161, DOI 10.1097/00005131-200103000-00003
   Russell T A, 1991, J Orthop Trauma, V5, P332, DOI 10.1097/00005131-199109000-00013
   RUSSELL TA, 2008, J ORTHOP TRAUMA, V22, P1
   RUSSELL TA, 1991, INT J ORTHOP TRAUMA, V1, P35
   Russell TA, 2008, J ORTHOP TRAUMA, V22, P391, DOI 10.1097/BOT.0b013e31817713fe
   Seifert J, 2003, J ORTHOP TRAUMA, V17, P488, DOI 10.1097/00005131-200308000-00003
   SLATER JC, 1991, ORTHOP T, V15, P774
   SMITH H, 1950, J BONE JOINT SURG AM, V32-A, P464
   Smith-Petersen MN, 1937, SURG GYNECOL OBSTET, V64, P287
   TAYLOR JC, 1987, ORTHOP T, V3, P491
   WINQUIST RA, 1984, J BONE JOINT SURG AM, V66A, P529, DOI 10.2106/00004623-198466040-00006
   Wolinsky PR, 1998, J ORTHOP TRAUMA, V12, P485, DOI 10.1097/00005131-199809000-00010
NR 39
TC 2
Z9 2
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0890-5339
J9 J ORTHOP TRAUMA
JI J. Orthop. Trauma
PD DEC
PY 2011
VL 25
SU S
BP S135
EP S138
DI 10.1097/BOT.0b013e318237b2eb
PG 4
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 855OX
UT WOS:000297575200012
PM 22089849
OA Bronze
DA 2018-10-19
ER

PT J
AU Martino, VP
   Pollet, E
   Averous, L
AF Martino, Veronica P.
   Pollet, Eric
   Averous, Luc
TI Novative Biomaterials Based on Chitosan and Poly(epsilon-Caprolactone):
   Elaboration of Porous Structures
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE Chitosan; Polycaprolactone; Blend; Porous materials; Biomaterial;
   Biopolymer
ID TISSUE ENGINEERING APPLICATIONS; MECHANICAL-PROPERTIES;
   THERMAL-PROPERTIES; POLYCAPROLACTONE; BLENDS; FILMS; CHITIN; SCAFFOLDS;
   BEHAVIOR
AB The swelling capability of chitosan was explored in order to use water both, as volatile plasticizer and as pore-forming agent. Chitosan powder was swelled in acidic aqueous solution and melt blended with poly(epsilon-caprolactone) (PCL). After stabilization at 57% RH and 25 A degrees C, samples suffered a water mass loss of around 30 wt% without dimensions variation. Despite the low miscibility of these biopolymers, quite homogeneous dispersion of chitosan within the polyester matrix was obtained. Some interactions between both biopolymers could be observed. To obtain chitosan phase with a thermoplastic-like behaviour, the plasticization effect was also studied by the addition of 25 wt% glycerol as non volatile plasticizer. The equilibrium moisture content of samples increased with the incorporation of glycerol due to its hydrophilic nature. Morphology, thermal and mechanical properties of the blends were determined after stabilization. The preparation of rich PCL blends allowed the formation of macroporous structures since samples were not contracted after water loss and stabilization. These biomaterials with such a porous structure could be used for biomedical applications.
C1 [Martino, Veronica P.; Pollet, Eric; Averous, Luc] Univ Strasbourg, LIPHT ECPM, EAc CNRS 4379, F-67087 Strasbourg 2, France.
RP Averous, L (reprint author), Univ Strasbourg, LIPHT ECPM, EAc CNRS 4379, 25 Rue Becquerel, F-67087 Strasbourg 2, France.
EM luc.averous@unistra.fr
RI Averous, Luc/B-3471-2008; Pollet, Eric/F-2581-2010
OI Averous, Luc/0000-0002-2797-226X; Pollet, Eric/0000-0002-4920-7024
FU EU [026515-2]
FX Authors would like to express their gratitude to the DCMI-IPCMS
   (Strasbourg) for the access to X-ray diffractometer. Thanks are also
   extended to Prof. Alfonso Jimenez Migallon (University of Alicante,
   Spain) for the access to the SEM. This work was financed by EU via the
   Integrated Project (IP) no. 026515-2: Bioproduction-Sustainable
   Microbial and Biocatalytic Production of Advanced Functional Materials.
CR da Silva MLA, 2010, ACTA BIOMATER, V6, P1149, DOI 10.1016/j.actbio.2009.09.006
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bodek KH, 1999, EUR J PHARM BIOPHARM, V48, P141, DOI 10.1016/S0939-6411(99)00036-3
   Chirkov SN, 2002, APPL BIOCHEM MICRO+, V38, P1, DOI 10.1023/A:1013206517442
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   EPURE V, 2010, CARBOHYD POLYM, V83, P947
   Honma T, 2003, POLYM INT, V52, P1839, DOI 10.1002/pi.1380
   HP H, 2002, Mol Biotechnol, V90, P27
   Hsu CM, 2004, J MATER SCI, V39, P3003, DOI 10.1023/B:JMSC.0000025826.36080.cf
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kittur FS, 2003, CARBOHYD RES, V338, P1283, DOI 10.1016/S0008-6215(03)00175-7
   Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k
   Lopez FA, 2008, J THERM ANAL CALORIM, V91, P633, DOI 10.1007/s10973-007-8321-3
   Montembault A, 2005, BIOMATERIALS, V26, P933, DOI 10.1016/j.biomaterials.2004.03.033
   Neto CGT, 2005, CARBOHYD POLYM, V62, P97, DOI 10.1016/j.carbpol.2005.02.022
   Ng KW, 2007, J BIOMAT SCI-POLYM E, V18, P925, DOI 10.1163/156856207781367693
   Quijada-Garrido I, 2007, CARBOHYD POLYM, V68, P173, DOI 10.1016/j.carbpol.2006.07.025
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shalumon KT, 2010, CARBOHYD POLYM, V80, P413, DOI 10.1016/j.carbpol.2009.11.039
   She HD, 2007, J MATER SCI, V42, P8113, DOI 10.1007/s10853-007-1706-7
   Talja RA, 2007, CARBOHYD POLYM, V67, P288, DOI 10.1016/j.carbpol.2006.05.019
   Thakhiew W, 2010, J FOOD ENG, V99, P216, DOI 10.1016/j.jfoodeng.2010.02.025
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wu CS, 2005, POLYMER, V46, P147, DOI 10.1016/j.polymer.2004.11.013
   You B, 2008, MACROMOLECULES, V41, P6624, DOI 10.1021/ma801417c
NR 29
TC 16
Z9 16
U1 0
U2 20
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD DEC
PY 2011
VL 19
IS 4
BP 819
EP 826
DI 10.1007/s10924-011-0354-9
PG 8
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA 852PO
UT WOS:000297370100001
DA 2018-10-19
ER

PT J
AU Ogawa, S
   Onodera, J
   Honda, R
   Fujimoto, I
AF Ogawa, Shingo
   Onodera, Jun
   Honda, Rika
   Fujimoto, Ichiro
TI Influence of systemic administration of atelocollagen on mouse livers:
   an ideal biomaterial for systemic multidrug delivery
SO JOURNAL OF TOXICOLOGICAL SCIENCES
LA English
DT Article
DE Atelocollagen (AC); Drug delivery system (DDS); Toxicity; Systemic
   administration; Cationic liposome; Gene ontology (GO)
ID SMALL INTERFERING RNA; INNATE IMMUNE-RESPONSE; I COLLAGEN; GROWTH;
   CANCER; COMPLEXES; TOXICITY; PROTEIN; IDENTIFICATION; MECHANISMS
AB Atelocollagen (AC), a biomaterial with low antigenicity and high bioaffinity, has been widely used in implantable materials in clinical practice. Preclinical studies have demonstrated that AC is a potential drug carrier for local and systemic delivery of cytokines, growth factors, plasmid DNA, small interfering RNA, and microRNA. AC is also believed to have low systemic toxicity on the basis of the safety of implant usage; however, this is not enough determined. Therefore, we performed whole genome expression profiling in mouse liver after systemic administration of AC or the cationic liposome carrier DOTAP/cholesterol (LP) and compared the changes of gene expressions associated with hepatotoxicity. Microarray analysis revealed that systemic LP administration significantly increased expression of toxicity-related genes, i.e., those for lipocalin-2, cyclin-dependent kinase inhibitor 1A, serum amyloid A isoforms, chemokine ligands, and granzyme B. Alternatively, AC administration did not alter the expression of any of these genes. Further gene ontology (GO) enrichment analysis highlighted the characteristic annotations extracted from genes upregulated after LP administration, and most of them were related to toxicity annotations such as immune response, inflammatory response, and apoptosis induction. In contrast, GO enrichment analysis of genes induced after AC administration revealed that only three annotations, all of which were unrelated to toxicity. These findings indicate that AC is potentially far less hepatotoxic than LP after systemic administration, suggesting that AC may be an excellent biomaterial for nontoxic drug delivery system carriers.
C1 [Ogawa, Shingo; Onodera, Jun; Honda, Rika; Fujimoto, Ichiro] Koken Co Ltd, Koken Res Inst, Kita Ku, Tokyo 1150051, Japan.
RP Fujimoto, I (reprint author), Koken Co Ltd, Koken Res Inst, Kita Ku, 2-13-10 Ukima, Tokyo 1150051, Japan.
EM fujimoto@kokenmpc.co.jp
CR Amin RA, 2004, ENVIRON HEALTH PERSP, V112, P465, DOI 10.1289/txg.6683
   Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017
   Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838
   Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   GOMES SA, 1991, TOXICOL LETT, V56, P229, DOI 10.1016/0378-4274(91)90110-R
   Hardiman Gary, 2008, V448, P21, DOI 10.1007/978-1-59745-205-2_2
   Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145
   Higaki M, 2001, VACCINE, V19, P3091, DOI 10.1016/S0264-410X(01)00039-1
   Honma K, 2008, NAT MED, V14, P939, DOI 10.1038/nm.1858
   Hosokawa R, 2000, CLIN ORAL IMPLAN RES, V11, P345, DOI 10.1034/j.1600-0501.2000.011004345.x
   Ito Y, 2009, EUR J PHARM BIOPHARM, V71, P303, DOI 10.1016/j.ejpb.2008.09.005
   Kawata E, 2008, MOL CANCER THER, V7, P2904, DOI 10.1158/1535-7163.MCT-08-0473
   Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24
   Lonez C, 2008, EUR J PHARM BIOPHARM, V69, P817, DOI 10.1016/j.ejpb.2008.01.035
   Maeda H, 2003, J CONTROL RELEASE, V91, P281, DOI 10.1016/S0168-3659(03)00247-5
   MAEDA H, 1996, DRUG DELIV SYST, V11, P175
   McLean JW, 1997, AM J PHYSIOL-HEART C, V273, pH387
   MILLER JM, 1964, ARCH SURG-CHICAGO, V88, P167, DOI 10.1001/archsurg.1964.01310200005002
   Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093
   Nakazawa K, 2007, CANCER, V109, P993, DOI 10.1002/cncr.22483
   Ochiya T, 1999, NAT MED, V5, P707
   Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525
   Quinton LJ, 2009, INFECT IMMUN, V77, P2417, DOI 10.1128/IAI.01300-08
   Sakurai H, 2007, J CONTROL RELEASE, V117, P430, DOI 10.1016/j.jconrel.2006.11.030
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045
   SIMBERG D, 1984, DOTAP OTHER CATIONIC, P257
   Smyth MJ, 1996, J LEUKOCYTE BIOL, V60, P555
   Steiner G, 2004, ENVIRON HEALTH PERSP, V112, P1236, DOI 10.1289/txg.7036
   Takei Y, 2006, CANCER, V107, P864, DOI 10.1002/cncr.22068
   Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104
   Thukral SK, 2005, TOXICOL PATHOL, V33, P343, DOI 10.1080/01926230590927230
   Trapani JA, 1996, J BIOL CHEM, V271, P4127
   Yamazaki CM, 2010, BIOMATERIALS, V31, P1925, DOI 10.1016/j.biomaterials.2009.10.014
NR 38
TC 5
Z9 5
U1 0
U2 4
PU JAPANESE SOC TOXICOLOGICAL SCIENCES
PI TOKYO
PA INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35
   SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN
SN 0388-1350
EI 1880-3989
J9 J TOXICOL SCI
JI J. Toxicol. Sci.
PD DEC
PY 2011
VL 36
IS 6
BP 751
EP 762
DI 10.2131/jts.36.751
PG 12
WC Toxicology
SC Toxicology
GA 855ZR
UT WOS:000297606200006
PM 22129739
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhang, BP
   Hou, YL
   Wang, XD
   Wang, Y
   Geng, L
AF Zhang, Baoping
   Hou, Yunlong
   Wang, Xiaodan
   Wang, Yin
   Geng, Lin
TI Mechanical properties, degradation performance and cytotoxicity of
   Mg-Zn-Ca biomedical alloys with different compositions
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Cytotoxicity; Magnesium; Microstructure; Mechanical
   properties
ID IN-VIVO CORROSION; MAGNESIUM ALLOYS; VITRO; BEHAVIOR; BONE; AZ91D
AB In this paper, ternary Mg-Zn-Ca magnesium alloys were investigated as degradable biomedical material. Tensile results showed that the mechanical properties of the alloys can be modulated by controlling Zn content. With increasing Zn contents, yield strength (YS), ultimate tensile strength (UTS) and ductility of the materials are increased at first and then decreased. In-vitro corrosion tests in Hank's simulated body fluid presented that the composition and microstructure of Mg-Zn-Ca alloys strongly affected their corrosion behavior. An increasing content of Zn element can lead to a high corrosion potential and bad corrosion resistance. The cytotoxicity evaluated by neutral red kits on L-929 cells revealed that Mg-1.0 Zn-1.0Ca, Mg-2.0 Zn-1.0 Ca, and Mg-3.0 Zn-1.0 Ca alloys did not induce toxicity in cells. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Wang, Yin; Geng, Lin] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
   [Zhang, Baoping] Chinese Acad Sci, Inst Coal Chem, Natl Engn Lab Carbon Fiber Technol, Taiyuan 030001, Peoples R China.
   [Hou, Yunlong; Wang, Xiaodan] Harbin Med Coll, Dept Pharmacol, Labs Biomed Pharmaceut China, Harbin 150086, Peoples R China.
RP Geng, L (reprint author), Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
EM hitzhbp@gmail.com
CR Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2
   ANSI/AAMI, 1999, 109935 ANSIAAMI ISO
   ASTM, 2004, ANN BOOK ASTM STAND
   Avedesian M. M., 1999, ASM SPECIALTY HDB MA, P14
   Ben-Hamu G, 2007, MAT SCI ENG A-STRUCT, V447, P35, DOI 10.1016/j.msea.2006.10.059
   Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001
   Geng L, 2009, MATER LETT, V63, P557, DOI 10.1016/j.matlet.2008.11.044
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Jardim PM, 2004, MAT SCI ENG A-STRUCT, V381, P196, DOI 10.1016/j.msea.2004.04.043
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   [毛丽贺 MAO Li-he], 2009, [金属热处理, Heat Treatment of Metals], V34, P19
   Mark P. S., 2006, BIOMATERIALS, V27, P1728
   Okamoto H, 1994, J PHASE EQUILIB, V15, P129, DOI DOI 10.1007/BF02667700
   Ortega Y, 2008, J ALLOY COMPD, V463, P62, DOI 10.1016/j.jallcom.2007.09.044
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Song GL, 2004, MAT SCI ENG A-STRUCT, V366, P74, DOI 10.1016/j.msea.2003.08.060
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin YC, 2010, J ELECTROCHEM SOC, V157, pC238, DOI 10.1149/1.3421651
   Xin YC, 2009, J MATER RES, V24, P2711, DOI 10.1557/JMR.2009.0323
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 28
TC 74
Z9 75
U1 1
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2011
VL 31
IS 8
BP 1667
EP 1673
DI 10.1016/j.msec.2011.07.015
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA 853BI
UT WOS:000297400800008
DA 2018-10-19
ER

PT J
AU Dittrick, S
   Balla, VK
   Bose, S
   Bandyopadhyay, A
AF Dittrick, Stanley
   Balla, Vamsi Krishna
   Bose, Susmita
   Bandyopadhyay, Amit
TI Wear performance of laser processed tantalum coatings
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Laser deposition; Wear; Biomaterial; Tantalum; In vitro
ID LOAD-BEARING IMPLANTS; TITANIUM; METAL; BONE; FABRICATION;
   MICROSTRUCTURE; SOLIDIFICATION; ALLOY; LENS
AB This first generation investigation evaluates the in vitro tribological performance of laser-processed Ta coatings on Ti for load-bearing implant applications. Linear reciprocating wear tests in simulated body fluid showed one order of magnitude less wear rate, of the order of 10(-4) mm(3)(N.m)(-1), for Ta coatings compared to Ti. Our results demonstrate that Ta coatings can potentially minimize the early-stage bone-implant interface micro-motion induced wear debris generation due to their excellent bioactivity comparable to that of hydroxyapatite (HA), high wear resistance and toughness compared to popular HA coatings. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Dittrick, Stanley; Balla, Vamsi Krishna; Bose, Susmita; Bandyopadhyay, Amit] Washington State Univ, Sch Mech & Mat Engn, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
RP Bandyopadhyay, A (reprint author), Washington State Univ, Sch Mech & Mat Engn, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
EM amitband@wsu.edu
RI Bandyopadhyay, Amit/A-7780-2012; Balla, Vamsi/A-7287-2010
OI Bandyopadhyay, Amit/0000-0003-0992-5387; Balla,
   Vamsi/0000-0003-2796-7302
FU W. M. Keck Foundation; M. J. Murdock Charitable Trust; National Science
   Foundation NSF [CMMI 0728348]; National Institutes of Health
   [NIH-R01-EB-007351]
FX Authors would like to acknowledge the financial support from the W. M.
   Keck Foundation to establish a Biomedical Materials Research Lab at WSU.
   Authors also acknowledge the financial support from the M. J. Murdock
   Charitable Trust, National Science Foundation NSF (Grant No. CMMI
   0728348) and National Institutes of Health (Grant No.
   NIH-R01-EB-007351).
CR AKIHIKO C, 2007, ACTA MAT, V55, P1309
   Balla V.K., 2008, JOM, V60, P45
   Balla VK, 2010, JOM-US, V62, P61, DOI 10.1007/s11837-010-0110-y
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Balla VK, 2009, ACTA BIOMATER, V5, P2800, DOI 10.1016/j.actbio.2009.03.032
   Balla VK, 2009, ACTA BIOMATER, V5, P1831, DOI 10.1016/j.actbio.2009.01.011
   BALLA VK, 2009, J BIOMED MATER RES B, V89, P481
   Bermudez MD, 2005, WEAR, V258, P693, DOI 10.1016/j.wear.2004.09.023
   Bodhak S, 2011, J MATER SCI-MATER M, V22, P1511, DOI 10.1007/s10856-011-4332-5
   Bontha S, 2006, J MATER PROCESS TECH, V178, P135, DOI 10.1016/j.jmatprotec.2006.03.155
   David S.A., 1992, C P TRENDS WELD RES, P147
   Dittrick S, 2011, MAT SCI ENG C-MATER, V31, P809, DOI 10.1016/j.msec.2010.07.009
   Fukunishi S, 1995, Nihon Seikeigeka Gakkai Zasshi, V69, P53
   Gaumann M, 1999, MAT SCI ENG A-STRUCT, V271, P232, DOI 10.1016/S0921-5093(99)00202-6
   Hao L, 2005, LASER SURFACE TREATMENT OF BIO-IMPLANT MATERIALS, P1, DOI 10.1002/0470033975
   Hofmeister W, 2001, JOM-J MIN MET MAT S, V53, P30, DOI 10.1007/s11837-001-0066-z
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Liu C, 2003, SURF COAT TECH, V163, P597, DOI 10.1016/S0257-8972(02)00630-8
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Platon F, 2001, WEAR, V250, P227, DOI 10.1016/S0043-1648(01)00651-2
   Roy M, 2008, ACTA BIOMATER, V4, P324, DOI 10.1016/j.actbio.2007.09.008
   Roy M, 2010, ADV ENG MATER, V12, pB637, DOI 10.1002/adem.201080017
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   St John KR, 2004, J BIOMED MATER RES B, V68B, P1, DOI 10.1002/jbm.b.10053
   WEINANS H, 1993, J BIOMECH, V26, P1271, DOI 10.1016/0021-9290(93)90351-E
NR 26
TC 12
Z9 12
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2011
VL 31
IS 8
BP 1832
EP 1835
DI 10.1016/j.msec.2011.08.017
PG 4
WC Materials Science, Biomaterials
SC Materials Science
GA 853BI
UT WOS:000297400800032
PM 22058608
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bai, XT
   Chen, YC
   Chen, WZ
   Lei, HP
   Gao, FF
   Qin, YJ
   Zheng, JJ
   Shi, GG
AF Bai, Xueting
   Chen, Yicun
   Chen, Weizhou
   Lei, Huaping
   Gao, Fenfei
   Qin, Yongjie
   Zheng, Jiaojiao
   Shi, Ganggang
TI The effect of black coral extraction on acute lung inflammation induced
   by cigarette smoke in mice
SO EXPERIMENTAL LUNG RESEARCH
LA English
DT Article
DE anti-inflammatory; antioxidant; acute lung injury; exposure; inhalation;
   malondialdehyde; myeloperoxidase; superoxide dismutase
ID INDUCED OXIDATIVE DAMAGE; VITAMIN-C; ANTIOXIDANT; CHEMISTRY; DISEASE;
   ENZYMES; SITES
AB Short-term exposure to cigarette smoke (CS) introduces an abundance of free radicals into the lungs, causing oxidative stress and inflammation. CS is an important risk factor related to the pathogenesis of several pulmonary diseases, especially chronic obstructive pulmonary disease. Black coral (BC) is a marine biomaterial commonly used for cigarette holders in southeast China. The purpose of the present study was to evaluate the in vivo bioactivity of BC extract (BCE). Groups of mice (male Kunming) were subjected to ultrasonic atomizing inhalation of BCE (0.3, 1.5, and 3 mg/mL) before being exposed to CS (10 cigarettes per day for 4 days). The control group and the CS group were administered normal saline rather than BCE prior to CS exposure. Superoxide dismutase (SOD), malondialdehyde (MDA), and myeloperoxidase (MPO) levels were measured in lung homogenates. Histologic and morphologic studies of the right upper lung were performed. SOD activity increased 1.32 times in the CS+BCE (3 mg/mL) group (P < .001) compared with the CS group. The MDA content increased 4% (P < .001) in the CS+BCE (3 mg/mL) group compared with the control group. MPO was reduced 40% in the CS+BCE (3 mg/mL) group compared with the CS group (P < .001). Histologic analysis revealed decreased inflammation in the BCE group compared with the CS group. These results suggest that BCE has antioxidant and anti-inflammatory activity in vivo. BCE may protect against lung injury in smokers.
C1 [Bai, Xueting; Chen, Yicun; Gao, Fenfei; Qin, Yongjie; Zheng, Jiaojiao; Shi, Ganggang] Shantou Univ, Coll Med, Dept Pharmacol, Shantou, Peoples R China.
   [Chen, Weizhou] Shantou Univ, Inst Marine Biol, Shantou, Peoples R China.
   [Lei, Huaping] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.
RP Shi, GG (reprint author), Shantou Univ, Coll Med, Dept Pharmacol, 22 Xin Ling Rd, Shantou, Peoples R China.
EM ggshi@stu.edu.cn
OI Gao, Fen-Fei/0000-0003-4144-8891
FU Guangdong Natural Science Foundation [9351503102000001]; 211 project of
   Guangdong province
FX This work was undertaken and supported within the teamwork projects
   funded by the Guangdong Natural Science Foundation (9351503102000001)
   and the 211 project of Guangdong province.
CR Banerjee Shuvojit, 2007, J Inflamm (Lond), V4, P3, DOI 10.1186/1476-9255-4-3
   Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21
   Bezerra FS, 2006, NUTRITION, V22, P1192, DOI 10.1016/j.nut.2006.08.016
   CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003
   Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8
   GOLDBERG WM, 1991, HYDROBIOLOGIA, V216, P403, DOI 10.1007/BF00026493
   GRAZIANO MJ, 1985, DRUG NUTR INTERACT, V3, P213
   Guan HS, 2009, CHINESE MARINE MATER, P46
   He M, 2007, AM J PHYSIOL-GASTR L, V292, pG1173, DOI 10.1152/ajpgi.00420.2006
   Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028
   Kimrua T, 2004, STATUS CORAL REEFS W, V1, P277
   Kinnula VL, 2005, THORAX, V60, P693, DOI 10.1136/thx.2004.037473
   Lanzetti M, 2008, NUTRITION, V24, P375, DOI 10.1016/j.nut.2008.01.002
   Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218
   MCCORMICK ML, 1994, J BIOL CHEM, V269, P27914
   Namati E, 2008, AM J RESP CELL MOL, V38, P572, DOI 10.1165/rcmb.2007-0120OC
   Nikula KJ, 1997, FUND APPL TOXICOL, V37, P37, DOI 10.1006/faat.1997.2297
   Onizawa S, 2009, PULM PHARMACOL THER, V22, P340, DOI 10.1016/j.pupt.2008.12.015
   Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5
   PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x
   Rahman I, 2006, CURR DRUG TARGETS, V7, P707, DOI 10.2174/138945006777435254
   Uneri C, 2006, LARYNGOSCOPE, V116, P97, DOI 10.1097/01.mlg.0000186504.53216.d1
   van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468
   Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC
   Wood LG, 2010, ANTIOXID REDOX SIGN, V13, P1535, DOI 10.1089/ars.2009.3064
   Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200
NR 26
TC 3
Z9 4
U1 0
U2 9
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0190-2148
EI 1521-0499
J9 EXP LUNG RES
JI Exp. Lung Res.
PD DEC
PY 2011
VL 37
IS 10
BP 627
EP 632
DI 10.3109/01902148.2011.627084
PG 6
WC Respiratory System
SC Respiratory System
GA 848NF
UT WOS:000297057600006
PM 22044439
DA 2018-10-19
ER

PT J
AU Raman, N
   Sudharsan, S
AF Raman, N.
   Sudharsan, S.
TI Phase-assisted synthesis and DNA unpacking evaluation of biologically
   inspired metallo nanocomplexes using peptide as unique building block
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Nanocomplex; Peptide; Brust-Schiffrin; DNA unpacking; Biological
   inspiration
ID PLATINUM NANOCRYSTALS; GOLD NANOPARTICLES; OPTICAL-PROPERTIES; CU(II)
   COMPLEXES; IN-VIVO; MN(II); NI(II); LIGAND; CO(II)
AB The goal of nanomaterials' surface modification using a biomaterial is to preserve the materials' bulk properties while modifying only their surface to possess desired recognition and specificity. Here, we have developed a phase-assisted, modified Brust-Schiffrin methodological synthesis of metallo nanocomplexes anchored by a peptide, N,N'-(1,3-propylene)-bis-hippuricamide. The spectral, thermal and morphological characterizations assure the formation of nanocomplexes. Therapeutic behavior of all the nanocomplexes has been well sighted by evaluating their DNA unpacking skills. In addition, we demonstrate their biological inspiration by targeting few bacterial and fungal strains. The in vitro antimicrobial investigation reports that all the nanocomplexes disrupt microbial cell walls/membranes efficiently and inhibit the growth of microbes. These sorts of nanocomplexes synthesized in large quantities and at low cost, deliver versatile biomedical applications, and can be used to treat various diseases which may often cause high mortality. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Raman, N.; Sudharsan, S.] VHNSN Coll, Dept Chem Res, Virudunagar 626001, India.
RP Raman, N (reprint author), VHNSN Coll, Dept Chem Res, Virudunagar 626001, India.
EM drn_raman@yahoo.co.in
OI S, Sudharsan/0000-0002-8801-2334; Natarajan, Raman/0000-0003-1788-6349
FU Directorate of Collegiate Education, Tamilnadu
FX The authors are grateful to the Managing Board, Principal and Head of
   the Department of Chemistry, VHNSN College, Virudhunagar for providing
   research facilities and constant encouragement. The authors also express
   their sincere thanks to the Head, Department of Microbiology, VHNSN
   College, Virudhunagar for providing microbial strains. One of the
   authors (S.S.) thanks the Directorate of Collegiate Education, Tamilnadu
   for financial assistance.
CR Bi L, 2011, J CONTROL RELEASE, V150, P150, DOI 10.1016/j.jconrel.2010.11.024
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655
   Carter JD, 2011, ACS NANO, V5, P2200, DOI 10.1021/nn1033983
   Chandra S, 2004, SPECTROCHIM ACTA A, V60, P2411, DOI 10.1016/j.saa.2003.12.016
   Chandra S, 2004, SPECTROCHIM ACTA A, V60, P1751, DOI 10.1016/j.saa.2003.07.011
   Chen Y, 2008, BIOORGAN MED CHEM, V16, P5914, DOI 10.1016/j.bmc.2008.04.064
   Chiu CY, 2011, NAT CHEM, V3, P393, DOI [10.1038/nchem.1025, 10.1038/NCHEM.1025]
   CREIGHTON JA, 1991, J CHEM SOC FARADAY T, V87, P3881, DOI 10.1039/ft9918703881
   Dash N. A., 1998, CHEM MATER, V10, P1446
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   Franco E, 2000, POLYHEDRON, V19, P441, DOI 10.1016/S0277-5387(99)00383-6
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Kang JH, 2007, B KOREAN CHEM SOC, V28, P2329
   KECK MV, 1992, J AM CHEM SOC, V114, P3386, DOI 10.1021/ja00035a033
   Klug H. P., 1962, XRAY DIFFRACTION PRO
   Kreibig U., 1995, SPRINGER SERIES MAT
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   Lever A. B. P., 1968, INORGANIC ELECT SPEC
   Li YJ, 2010, ADV MATER, V22, P1921, DOI 10.1002/adma.200903944
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Lu Y, 2008, J SOLID STATE CHEM, V181, P1530, DOI 10.1016/j.jssc.2008.02.016
   LUCAS EV, 2004, J CONTROL RELEASE, V96, P207
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]
   Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/NCHEM.1012, 10.1038/nchem.1012]
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309
   Rica R. D. L., 2010, CHEM SOC REV, V39, P3499
   SHOCKMAN GD, 1983, ANNU REV MICROBIOL, V37, P501, DOI 10.1146/annurev.mi.37.100183.002441
   Ung T, 2001, J PHYS CHEM B, V105, P3441, DOI 10.1021/jp003500n
   Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202
   VOGEL AI, 1961, TXB QUANTITATIVE INO
   Yadav SC, 2011, PEPTIDES, V32, P173, DOI 10.1016/j.peptides.2010.10.003
   Zhang WX, 2007, APPL SURF SCI, V253, P6063, DOI 10.1016/j.apsusc.2007.01.005
   ZHOU, 2010, BIOMACROMOLECULES, V11, P60
NR 35
TC 5
Z9 5
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD DEC 1
PY 2011
VL 364
IS 1
BP 140
EP 147
DI 10.1016/j.jcis.2011.08.034
PG 8
WC Chemistry, Physical
SC Chemistry
GA 835LT
UT WOS:000296038600020
PM 21906747
DA 2018-10-19
ER

PT J
AU Liao, S
   Ramakrishna, S
   Ramalingam, M
AF Liao, Susan
   Ramakrishna, Seeram
   Ramalingam, Murugan
TI Development of Nanofiber Biomaterials and Stem Cells in Tissue
   Engineering
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Biomaterials; Nanofibers; Stem Cells; Extracellular Matrix; Tissue
   Engineering
ID PEPTIDE-AMPHIPHILE NANOFIBERS; IN-VITRO; EXTRACELLULAR-MATRIX;
   OSTEOBLAST ADHESION; CONTROLLED-RELEASE; ENDOTHELIAL-CELLS; BONE
   REGENERATION; SCAFFOLD; DIFFERENTIATION; FABRICATION
AB Tissue engineering has been progressed rapidly due to availability of numerous technologies pertaining to scaffold's fabrication, cell culture techniques and improved understanding of cell-scaffold interactions, both in vitro and in vivo. Recently, biomaterials in the form of nanofibers have been introduced as tissue scaffolds after their successful fabrication by various methods such as electrospinning, self-assembly and phase separation. The scaffolds made of nanofiber biomaterials have widely used in various soft and hard tissue engineering applications. However, full replication (biomimicking) of natural extracellular matrix (ECM) in vitro is still a challengeable task to biomaterial scientists and engineers. In this paper, we summarized the various types of multi-functional biomaterials that have been used for the fabrication of nanofibrous scaffolds, their fabrication techniques, and their application in tissue engineering. On the other hand, the discovery of several types of stem cells and their response to nanofiber biomaterials further help in advancing tissue engineering research. Of particular interest, impact of stem cells behaviors such as isolation, adhesion, proliferation and differentiation onto nanofibrous scaffolds has been discussed in the context of tissue engineering and regeneration. Future prospects of nanofiber biomaterials in tissue engineering are also discussed.
C1 [Liao, Susan] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   [Ramalingam, Murugan] Univ Strasbourg, Fac Med, Inst Natl Sante & Rech Med, U977, F-670085 Strasbourg, France.
   [Ramalingam, Murugan] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Liao, S (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
CR [Anonymous], 2009, NAT MAT, V8, P444
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Campbell N. A., 2005, BIOLOGY, P119
   Chan CK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035006
   Cochran D, 2007, J PERIODONTOL, V78, P974, DOI 10.1902/jop.2007.060294
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dong YX, 2010, TISSUE ENG PT A, V16, P283, DOI 10.1089/ten.tea.2008.0537
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng L, 2003, SYNTHETIC MET, V135, P817, DOI 10.1016/S0379-6779(02)00909-8
   Gu DD, 2008, APPL SURF SCI, V255, P1880, DOI 10.1016/j.apsusc.2008.06.118
   Gu YW, 2006, J BIOMED MATER RES A, V78A, P316, DOI 10.1002/jbm.a.30743
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   He W, 2009, J BIOMED MATER RES A, V90A, P205, DOI 10.1002/jbm.a.32081
   Hoffman S., 2006, TISSUE ENG, V12, P2729
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Hu J, 2008, BIOMATERIALS, V29, P3815, DOI 10.1016/j.biomaterials.2008.06.015
   Hu JA, 2010, BIOMATERIALS, V31, P7971, DOI 10.1016/j.biomaterials.2010.07.028
   Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013
   Hua FJ, 2002, J BIOMED MATER RES, V63, P161, DOI 10.1002/jbm.10121
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Koh HS, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046003
   Lanfer B, 2008, BIOMATERIALS, V29, P3888, DOI 10.1016/j.biomaterials.2008.06.016
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee K, 2009, J ARTHROPLASTY, V24, P43, DOI 10.1016/j.arth.2008.01.133
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li W. J., 2006, TISSUE CELL ORGAN EN
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li X, 2009, MATER LETT, V63, P403, DOI 10.1016/j.matlet.2008.10.065
   Liao S., 2010, FRONT MAT SCI CHINA, V4, P29
   Liao S., 2007, J BIONANOSCI, V1, P1
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Ma K, 2008, BIOMATERIALS, V29, P2096, DOI 10.1016/j.biomaterials.2008.01.024
   Ma K, 2011, TISSUE ENG PT A, V17, P1413, DOI [10.1089/ten.tea.2010.0373, 10.1089/ten.TEA.2010.0373]
   Ma K, 2009, BIOMATERIALS, V30, P3251, DOI 10.1016/j.biomaterials.2009.02.025
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023
   Mata A, 2009, SOFT MATTER, V5, P1228, DOI 10.1039/b819002j
   Meng J, 2010, J BIOMED MATER RES A, V95A, P312, DOI 10.1002/jbm.a.32845
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Murphy M. B., 2007, PRINCIPLES TISSUE EN
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Murugan R, 2007, AM J BIOCH BIOTECH, V3, P118, DOI DOI 10.3844/AJBBSP.2007.118.124
   Neuss S, 2009, BIOMATERIALS, V30, P1697, DOI 10.1016/j.biomaterials.2008.12.027
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nigam M., 2009, TISSUE ENG PART A, V15, P535
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ondarcuhu T, 1998, EUROPHYS LETT, V42, P215, DOI 10.1209/epl/i1998-00233-9
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Ratna D, 2008, J MATER SCI, V43, P254, DOI 10.1007/s10853-007-2176-7
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Sahoo S, 2010, DIFFERENTIATION, V79, P102, DOI 10.1016/j.diff.2009.11.001
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh R, 2009, ACTA BIOMATER, V5, P477, DOI 10.1016/j.actbio.2008.06.014
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Spoerke ED, 2005, BIOMATERIALS, V26, P5120, DOI 10.1016/j.biomaterials.2005.01.039
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Teo WE, 2011, ACTA BIOMATER, V7, P193, DOI 10.1016/j.actbio.2010.07.041
   Teo WE, 2009, COMPOS SCI TECHNOL, V69, P1804, DOI 10.1016/j.compscitech.2009.04.015
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Venugopal JR, 2006, ARTIF ORGANS, V30, P440, DOI 10.1111/j.1525-1594.2006.00239.x
   Vernon B, 2000, J BIOMED MATER RES, V51, P69
   Wang P, 2009, BIOMATERIALS, V30, P2735, DOI 10.1016/j.biomaterials.2009.01.037
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 103
TC 16
Z9 17
U1 3
U2 46
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2011
VL 1
IS 2
BP 111
EP 128
DI 10.1166/jbt.2011.1015
PG 18
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NP
UT WOS:000312570600001
DA 2018-10-19
ER

PT J
AU Seidi, A
   Ramalingam, M
AF Seidi, Azadeh
   Ramalingam, Murugan
TI Engineering of Gradient Biomaterials as Biomimetic Systems for Tissue
   Engineering
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Biomaterials; Gradient; Tissue Engineering; Scaffolds; Biomimetic
ID PORE-SIZE GRADIENT; GROWTH-FACTOR; CELL DIFFERENTIATION; COMPOSITE
   SCAFFOLD; POLYMER SCAFFOLDS; IN-VITRO; HYDROGELS; SUBSTRATE; RIGIDITY;
   ARCHITECTURE
AB Developments during the past decade in gradient biomaterials have resulted in a tremendous upsurge of interest in generating spatially and temporally complex cell microenvironmental features at different length scales. Micro- and nanotechnological innovations have enabled the manipulation of such gradient biomaterials suitable for numerous biomaterial applications including basic cell studies, drug screening, and tissue engineering. Gradient biomaterials have recently been used to repair or regenerate complex tissues such as soft to hard interface tissues, which fail to recover their function through conventional tissue engineering approaches used for homogenous tissues. In this regard, there is a great need for the development of improved biomaterial systems with gradient in material composition and properties that encourage the differentiation of multiple cell phenotypes and tissue development, which can help engineering more complex tissues. The purpose of this review is to describe various gradient biomaterials employed in tissue engineering, their methods of fabrication, and challenges that must be met in order for them to reach their full potential. This review is expected to be useful for readers to gain knowledge on the state-of-the-art of tissue engineering using gradient biomaterials.
C1 [Seidi, Azadeh] Okinawa Inst Sci & Technol, Ctr Technol, Onna Son, Okinawa 9040412, Japan.
   [Ramalingam, Murugan] Univ Strasbourg, Fac Med, Natl Inst Hlth & Med Res, U977, F-67085 Strasbourg, France.
   [Ramalingam, Murugan] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Seidi, A (reprint author), Okinawa Inst Sci & Technol, Ctr Technol, Onna Son, Okinawa 9040412, Japan.
CR Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chung BG, 2007, EXPERT OPIN DRUG DIS, V2, P1653, DOI 10.1517/17460441.2.12.1653
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Clarke PR, 2005, SCIENCE, V309, P1334, DOI 10.1126/science.1117842
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   Du Y., 2009, MICROFLUIDICS BIOL A
   Du YN, 2010, BIOMATERIALS, V31, P2686, DOI 10.1016/j.biomaterials.2009.12.012
   Du Y, 2009, LAB CHIP, V9, P761, DOI 10.1039/b815990d
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Guarnieri D, 2008, MACROMOL SYMP, V266, P36, DOI 10.1002/masy.200850607
   Hall SJ, 2006, BASIC BIOMECHANICS
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   He JK, 2011, BIOTECHNOL BIOENG, V108, P175, DOI 10.1002/bit.22901
   He JK, 2010, ADV FUNCT MATER, V20, P131, DOI 10.1002/adfm.200901311
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Isbister CM, 2003, J NEUROSCI, V23, P193
   Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712
   Kang LF, 2008, DRUG DISCOV TODAY, V13, P1, DOI 10.1016/j.drudis.2007.10.003
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364
   Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Mahto SK, 2009, BIOMED MICRODEVICES, V11, P401, DOI 10.1007/s10544-008-9246-8
   Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304
   Malda J, 2004, BIOMATERIALS, V25, P5773, DOI 10.1016/j.biomaterials.2004.01.028
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Murugan R, 2009, INT J BIOMED ENG TEC, V2, P104, DOI 10.1504/IJBET.2009.022911
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Orsi S, 2010, J MATER SCI-MATER M, V21, P1013, DOI 10.1007/s10856-009-3972-1
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Schwarz U, 2007, SOFT MATTER, V3, P263, DOI 10.1039/b606409d
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Swartz MA, 2003, CURR OPIN BIOTECH, V14, P547, DOI 10.1016/j.copbio.2003.09.003
   Tirella A, 2008, TOXICOL IN VITRO, V22, P1957, DOI 10.1016/j.tiv.2008.09.016
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Wu JD, 2009, CHINESE SCI BULL, V54, P3174, DOI [10.1007/s11434-009-0215-2, 10.1007/S11434-009-0215-2]
   Yamamoto M, 2010, MATERIALS, V3, P2393, DOI 10.3390/ma3042393
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 71
TC 5
Z9 5
U1 1
U2 49
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2011
VL 1
IS 2
BP 139
EP 148
DI 10.1166/jbt.2011.1020
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 057NP
UT WOS:000312570600003
DA 2018-10-19
ER

PT J
AU Weisshaar, CL
   Winer, JP
   Guarino, BB
   Janmey, PA
   Winkelstein, BA
AF Weisshaar, Christine L.
   Winer, Jessamine P.
   Guarino, Benjamin B.
   Janmey, Paul A.
   Winkelstein, Beth A.
TI The potential for salmon fibrin and thrombin to mitigate pain subsequent
   to cervical nerve root injury
SO BIOMATERIALS
LA English
DT Article
DE Fibrin; Thrombin; Inflammation; Astrocyte; Pain; Macrophage
ID SPINAL GLIAL ACTIVATION; NEUROPATHIC PAIN; BACK-PAIN; NECK PAIN; RAT
   MODEL; BEHAVIORAL HYPERSENSITIVITY; BOVINE THROMBIN; DISC HERNIATION;
   COMPRESSION; NEURONS
AB Nerve root compression is a common cause of radiculopathy and induces persistent pain. Mammalian fibrin is used clinically as a coagulant but presents a variety of risks. Fish fibrin is a potential biomaterial for neural injury treatment because it promotes neurite outgrowth, is non-toxic, and clots readily at lower temperatures. This study administered salmon fibrin and thrombin following nerve root compression and measured behavioral sensitivity and glial activation in a rat pain model. Fibrin and thrombin each significantly reduced mechanical allodynia compared to injury alone (p < 0.02). Painful compression with fibrin exhibited allodynia that was not different from sham for any day using stimulation by a 2 g filament; allodynia was only significantly different (p < 0.043) from sham using the 4 g filament on days 1 and 3. By day 5, responses for fibrin treatment decreased to sham levels. Allodynia following compression with thrombin treatment were unchanged from sham at any time point. Macrophage infiltration at the nerve root and spinal microglial activation were only mildly modified by salmon treatments. Spinal astrocytic expression decreased significantly with fibrin (p < 0.0001) but was unchanged from injury responses for thrombin treatment. Results suggest that salmon fibrin and thrombin may be suitable biomaterials to mitigate pain. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Winer, Jessamine P.; Winkelstein, Beth A.] Univ Penn, Dept Bioengn, Vagelos Res Labs 1010, Philadelphia, PA 19104 USA.
   [Weisshaar, Christine L.; Guarino, Benjamin B.; Winkelstein, Beth A.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.
   [Janmey, Paul A.] Univ Penn, Dept Physiol, Vagelos Res Labs 1010, Philadelphia, PA 19104 USA.
RP Winkelstein, BA (reprint author), Univ Penn, Dept Bioengn, Vagelos Res Labs 1010, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM weissha@seas.upenn.edu; jpwiner@gmail.com; bguarino@seas.upenn.edu;
   janmey@mail.med.upenn.edu; winkelst@seas.upenn.edu
OI winer-jones, Jessamine/0000-0002-6412-4139
FU NIH [R44NS048734-02]; Catharine D. Sharpe Foundation
FX The authors gratefully acknowledge Dr. Evelyn Sawyer (Sea Run Holdings,
   Inc., Freeport, ME) for supplying the salmon fibrin and thrombin used in
   this study and Dr. La'Toya Latney for her assistance with statistical
   analysis. This work was funded by the NIH (R44NS048734-02) and the
   Catharine D. Sharpe Foundation.
CR Albala DM, 2006, J AM COLL SURGEONS, V202, P685, DOI 10.1016/j.jamcollsurg.2005.11.027
   Asfaha S, 2002, BRIT J PHARMACOL, V135, P1101, DOI 10.1038/sj.bjp.0704568
   Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a
   Beierlein W, 2000, TRANSFUSION, V40, P302, DOI 10.1046/j.1537-2995.2000.40030302.x
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009
   Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065
   Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7
   Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015
   Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004
   Freeman MD, 1999, SPINE, V24, P86, DOI 10.1097/00007632-199901010-00022
   FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506
   Garcia PS, 2010, THROMB HAEMOSTASIS, V103, P1145, DOI 10.1160/TH09-12-0848
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Haldeman S, 2008, SPINE, V33, pS5
   HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003
   Hashizume H, 2000, SPINE, V25, P1206, DOI 10.1097/00007632-200005150-00003
   Hubbard RD, 2008, EXP NEUROL, V212, P482, DOI 10.1016/j.expneurol.2008.04.042
   Hubbard RD, 2009, J ORTHOP RES, V27, P120, DOI 10.1002/jor.20710
   Hubbard RD, 2005, SPINE, V30, P1924, DOI 10.1097/01.brs.0000176239.72928.00
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008
   Kivell BM, 2000, DEV BRAIN RES, V120, P199, DOI 10.1016/S0165-3806(00)00010-9
   Kobayashi S, 2005, ARCH PHYS MED REHAB, V86, P527, DOI 10.1016/j.apmr.2004.03.037
   Laidmae I, 2006, BIOMATERIALS, V27, P5771, DOI 10.1016/j.biomaterials.2006.07.035
   Laidmae I, 2010, J BIOMED MATER RES A, V93A, P29, DOI 10.1002/jbm.a.32505
   Majluf-Cruz A, 2004, CLIN APPL THROMB-HEM, V10, P19, DOI 10.1177/107602960401000104
   Martin L, 2009, PAIN, V146, P121, DOI 10.1016/j.pain.2009.07.016
   Meyer RA, 2008, WALL MELZACKS TXB PA, P3
   Michaud SE, 2002, THROMB RES, V107, P245, DOI 10.1016/S0049-3848(02)00333-X
   Ohnmeiss DD, 1997, SPINE, V22, P1600, DOI 10.1097/00007632-199707150-00015
   OLMARKER K, 1989, SPINE, V14, P569, DOI 10.1097/00007632-198906000-00003
   Ortel TL, 2001, ANN SURG, V233, P88, DOI 10.1097/00000658-200101000-00014
   Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004
   Rothman SM, 2007, BRAIN RES, V1181, P30, DOI 10.1016/j.brainres.2007.08.064
   Rothman SM, 2010, ANN BIOMED ENG, V38, P2563, DOI 10.1007/s10439-010-0012-8
   Rothman SM, 2010, J NEUROTRAUM, V27, P803, DOI 10.1089/neu.2009.1045
   Rothman SM, 2009, J PAIN, V10, P90, DOI 10.1016/j.jpain.2008.07.008
   Rothman SM, 2009, J NEUROSCI RES, V87, P2709, DOI 10.1002/jnr.22090
   Rothman SM, 2005, SPINE, V30, P2491, DOI 10.1097/01.brs.0000186316.38111.4b
   Rothwell SW, 2010, BIOLOGICALS, V38, P619, DOI 10.1016/j.biologicals.2010.07.001
   Rothwell SW, 2009, J MATER SCI-MATER M, V20, P2155, DOI 10.1007/s10856-009-3769-2
   Rothwell SW, 2005, J TRAUMA, V59, P143, DOI 10.1097/01.TA.0000171528.43746.53
   Rutkowski MD, 2002, SPINE, V27, P1604, DOI 10.1097/01.BRS.0000018792.91620.9E
   Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x
   Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x
   Schoenecker JG, 2001, AM J PATHOL, V159, P1957, DOI 10.1016/S0002-9440(10)63043-X
   Shirai T, 2005, INTERNAL MED, V44, P1088, DOI 10.2169/internalmedicine.44.1088
   Stanworth SJ, 1998, HAEMOPHILIA, V4, P109
   Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002
   Thorek DLJ, 2011, MOL IMAGING, V10, P206, DOI 10.2310/7290.2010.00042
   Uibo R, 2009, BBA-MOL CELL RES, V1793, P924, DOI 10.1016/j.bbamcr.2009.01.007
   VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389
   Wang LZ, 2000, THROMB RES, V100, P537, DOI 10.1016/S0049-3848(00)00362-5
   WEISEL JW, 1997, HDB BIODEGRADABLE PO, P347
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   WOLF K, 1988, FISH VIRUSES FISH VI
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 58
TC 5
Z9 6
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 36
BP 9738
EP 9746
DI 10.1016/j.biomaterials.2011.09.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845KO
UT WOS:000296821800020
PM 21944723
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Haider, MA
   Olander, JE
   Arnold, RF
   Marous, DR
   McLamb, AJ
   Thompson, KC
   Woodruff, WR
   Haugh, JM
AF Haider, Mansoor A.
   Olander, Jeffrey E.
   Arnold, Rachel F.
   Marous, Daniel R.
   McLamb, April J.
   Thompson, Karmethia C.
   Woodruff, William R.
   Haugh, Janine M.
TI A phenomenological mixture model for biosynthesis and linking of
   cartilage extracellular matrix in scaffolds seeded with chondrocytes
SO BIOMECHANICS AND MODELING IN MECHANOBIOLOGY
LA English
DT Article
DE Tissue engineering; Articular cartilage; Mathematical model; Degradation
ID TISSUE-ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE; GROWTH
AB A phenomenological mixture model is presented for interactions between biosynthesis of extracellular matrix (ECM) constituents and ECM linking in a scaffold seeded with chondrocytes. A system of three ordinary differential equations for average apparent densities of unlinked ECM, linked ECM and scaffold is developed along with associated initial conditions for scaffold material properties. Equations for unlinked ECM synthesis and ECM linking include an inhibitory mechanism where associated rates decrease as unlinked ECM concentration in the interstitial fluid increases. Linking rates are proposed to depend on average porosity in the evolving tissue construct. The resulting initial value problem contains nine independent parameters that account for scaffold biomaterial properties and interacting mechanisms in the engineered system. Effects of parameter variations on model variables are analyzed relative to a baseline case with emphasis on the evolution of solid phase apparent density, which is often correlated with the compressive elastic modulus of the tissue construct. The new model provides an additional quantitative framework for assessing and optimizing the design of engineered cell-scaffold systems and guiding strategies for articular cartilage tissue engineering.
C1 [Haider, Mansoor A.; Olander, Jeffrey E.; Arnold, Rachel F.; Marous, Daniel R.; McLamb, April J.; Thompson, Karmethia C.; Woodruff, William R.; Haugh, Janine M.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA.
RP Haider, MA (reprint author), N Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.
EM m_haider@ncsu.edu
OI Marous, Daniel/0000-0002-8161-3057
FU National Science Foundation [DMS-0552571, DMS-636590]; National
   Institutes of Health [AG15768]
FX This work has been supported in part by funding from the National
   Science Foundation (DMS-0552571, DMS-636590) and the National Institutes
   of Health (AG15768). R.F.A., D.R.M., A.J.M., K.C.T. and W.R.W. were
   participants in the 2008 NSF Research Experiences for Undergraduates
   program in the Mathematics Department at NCSU.
CR Ateshian GA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192138
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Dimicco MA, 2003, TRANSPORT POROUS MED, V50, P57, DOI 10.1023/A:1020677829069
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Galban CJ, 1997, BIOTECHNOL BIOENG, V56, P422, DOI 10.1002/(SICI)1097-0290(19971120)56:4<422::AID-BIT7>3.0.CO;2-Q
   HANDLEY S, 1977, BIOCHIM BIOPHYS ACTA, V500, P132
   Mauck RL, 2003, J BIOMECH ENG-T ASME, V125, P602, DOI 10.1115/1.1611512
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   NIKOLAEV NI, 2009, BIOTECHNOL BIOENG, V105, P842
   Obradovic B, 2000, AICHE J, V46, P1860, DOI 10.1002/aic.690460914
   PODRAZKY V, 1966, EXPERIENTIA, V22, P792, DOI 10.1007/BF01897416
   Saha AK, 2004, ANN BIOMED ENG, V32, P871, DOI 10.1023/B:ABME.0000030262.82626.9c
   Sengers BG, 2004, ANN BIOMED ENG, V32, P1718, DOI 10.1007/s10439-004-7824-3
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Soltz MA, 2000, J BIOMECH ENG-T ASME, V122, P576, DOI 10.1115/1.1324669
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Trewenack AJ, 2009, MATH MED BIOL, V26, P241, DOI 10.1093/imammb/dqp013
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wilson CG, 2002, ARCH BIOCHEM BIOPHYS, V408, P246, DOI 10.1016/S0003-9861(02)00562-3
NR 19
TC 11
Z9 11
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1617-7959
J9 BIOMECH MODEL MECHAN
JI Biomech. Model. Mechanobiol.
PD DEC
PY 2011
VL 10
IS 6
BP 915
EP 924
DI 10.1007/s10237-010-0282-y
PG 10
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 842XB
UT WOS:000296634000008
PM 21213013
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Mayanagi, G
   Igarashi, K
   Washio, J
   Nakajo, K
   Domon-Tawaraya, H
   Takahashi, N
AF Mayanagi, G.
   Igarashi, K.
   Washio, J.
   Nakajo, K.
   Domon-Tawaraya, H.
   Takahashi, N.
TI Evaluation of pH at the Bacteria-Dental Cement Interface
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE pH; ISFET pH electrode; Streptococcus; glass-ionomer cement; fluoride;
   interface
ID STREPTOCOCCUS-MUTANS; GLASS-IONOMER; FLUORIDE RELEASE; ANTIBACTERIAL
   PROPERTIES; RESTORATIVE MATERIALS; ARTIFICIAL FISSURES; ACID PRODUCTION;
   IN-VITRO; PLAQUE; DIFFUSION
AB Physiochemical assessment of the parasite-biomaterial interface is essential in the development of new biomaterials. The purpose of this study was to develop a method to evaluate pH at the bacteriadental cement interface and to demonstrate physiochemical interaction at the interface. The experimental apparatus with a well (4.0 mm in diameter and 2.0 mm deep) was made of polymethyl methacrylate with dental cement or polymethyl methacrylate (control) at the bottom. Three representative dental cements (glass-ionomer, zinc phosphate, and zinc oxide-eugenol cements) were used. Each specimen was immersed in 2 mM potassium phosphate buffer for 10 min, 24 hrs, 1 wk, or 4 wks. The well was packed with Streptococcus mutans NCTC 10449, and a miniature pH electrode was placed at the interface between bacterial cells and dental cement. The pH was monitored after the addition of 1% glucose, and the fluoride contained in the cells was quantified. Glass-ionomer cement inhibited the bacteria-induced pH fall significantly compared with polymethyl methacrylate (control) at the interface (10 min, 5.16 +/- 0.19 vs. 4.50 +/- 0.07; 24 hrs, 5.20 +/- 0.07 vs. 4.59 +/- 0.11; 1 wk, 5.34 +/- 0.14 vs. 4.57 +/- 0.11; and 4 wks, 4.95 +/- 0.27 vs. 4.40 +/- 0.14), probably due to the fluoride released from the cement. This method could be useful for the assessment of pH at the parasite-biomaterial interface.
C1 [Mayanagi, G.; Igarashi, K.; Washio, J.; Nakajo, K.; Domon-Tawaraya, H.; Takahashi, N.] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Div Oral Ecol & Biochem,Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Mayanagi, G.] Tohoku Univ, Grad Sch Dent, Res Unit Interface Oral Hlth Sci, Sendai, Miyagi 9808575, Japan.
   [Domon-Tawaraya, H.] Tohoku Univ, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi 9808575, Japan.
RP Takahashi, N (reprint author), Tohoku Univ, Dept Oral Biol, Div Oral Ecol & Biochem,Aoba Ku, Grad Sch Dent, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM nobu-t@dent.tohoku.ac.jp
FU MEXT, Japan; Ministry of Education, Culture, Sports, Science and
   Technology, Japan [22792104]
FX This study was supported in part by Research and Education Funding for
   Inter-University Research Project (Highly-functional Interface Science:
   Innovation of Biomaterials with Highly-Functional Interface to Host and
   Parasite), MEXT, Japan, and in part by a Grant-in-Aid for Young
   Scientist B (22792104) from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan. The authors declare no potential
   conflicts of interest with respect to the authorship and/or publication
   of this article.
CR Al-Naimi OT, 2008, J MATER SCI-MATER M, V19, P1243, DOI 10.1007/s10856-006-0023-z
   BENDER GR, 1985, J DENT RES, V64, P90, DOI 10.1177/00220345850640021701
   Boeckh C, 2002, CARIES RES, V36, P101, DOI 10.1159/000057867
   CHIDA R, 1986, J DENT RES, V65, P448, DOI 10.1177/00220345860650031501
   COOGAN MM, 1993, INT ENDOD J, V26, P355, DOI 10.1111/j.1365-2591.1993.tb00769.x
   DAWES C, 1986, J DENT RES, V65, P89, DOI 10.1177/00220345860650021701
   DeMoor RJG, 1996, DENT MATER, V12, P88, DOI 10.1016/S0109-5641(96)80074-1
   Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025
   ESASHI M, 1978, IEEE T BIO-MED ENG, V25, P184, DOI 10.1109/TBME.1978.326245
   GUTKNECHT J, 1981, BIOCHIM BIOPHYS ACTA, V644, P153, DOI 10.1016/0005-2736(81)90071-7
   HALLSWORTH AS, 1976, ANAL CHEM, V48, P1660, DOI 10.1021/ac50006a009
   Hata S, 2003, ARCH ORAL BIOL, V48, P431, DOI 10.1016/S0003-9969(03)0032-3
   Hiraishi N, 2003, INT ENDOD J, V36, P622, DOI 10.1046/j.1365-2591.2003.00700.x
   HUTHER FJ, 1990, INFECT IMMUN, V58, P1043
   IGARASHI K, 1990, CARIES RES, V24, P52, DOI 10.1159/000261239
   IGARASHI K, 1989, CARIES RES, V23, P417, DOI 10.1159/000261220
   IGARASHI K, 1981, ARCH ORAL BIOL, V26, P203, DOI 10.1016/0003-9969(81)90131-X
   Kantovitz KR, 2009, J APPL ORAL SCI, V17, P294, DOI 10.1590/S1678-77572009000400006
   KAUFMANN M, 1992, CARIES RES, V26, P110, DOI 10.1159/000261494
   Lee SY, 2000, J ORAL REHABIL, V27, P576, DOI 10.1046/j.1365-2842.2000.00554.x
   Lewinstein I, 2005, J PROSTHET DENT, V93, P364, DOI 10.1016/j.prosdent.2005.01.008
   Marczuk-Kolada Grazyna, 2006, Postepy Hig Med Dosw (Online), V60, P416
   Moreau JL, 2010, DENT MATER, V26, pE227, DOI 10.1016/j.dental.2010.07.004
   Nakajo K, 2009, DENT MATER, V25, P703, DOI [10.1016/j.dental.2008.10.014, 10.1016/j.denta1.2008.10.014]
   Persson A, 2005, CARIES RES, V39, P201, DOI 10.1159/000084799
   SEPPA L, 1992, CARIES RES, V26, P434, DOI 10.1159/000261483
   Shaw AJ, 1998, J DENT, V26, P355, DOI 10.1016/S0300-5712(97)00016-X
   STURR MG, 1990, ARCH MICROBIOL, V155, P22, DOI 10.1007/BF00291269
   Takahashi-Abbe S, 2001, ORAL MICROBIOL IMMUN, V16, P94, DOI 10.1034/j.1399-302x.2001.016002094.x
   Vermeersch G, 2005, J ORAL REHABIL, V32, P368, DOI 10.1111/j.1365-2842.2004.01300.x
NR 30
TC 13
Z9 13
U1 1
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2011
VL 90
IS 12
BP 1446
EP 1450
DI 10.1177/0022034511423392
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 847OR
UT WOS:000296982800013
PM 21933936
OA Green Published
DA 2018-10-19
ER

PT J
AU Hu, XL
   Ho, B
   Lim, CT
   Hsu, CS
AF Hu, X. L.
   Ho, B.
   Lim, C. T.
   Hsu, C. S.
TI Thermal Treatments Modulate Bacterial Adhesion to Dental Enamel
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE enamel; bacteria; microscopy; bacterial adhesion; dental caries
   susceptibility; non-ablative laser treatment
ID HUMAN TOOTH ENAMEL; BIOMATERIAL SURFACES; ORAL STREPTOCOCCI; COATED
   SURFACES; FORCES; PROTEINS; COLLAGEN; MATRIX; ENERGY
AB Numerous studies have demonstrated the effects of laser-induced heat on demineralization of enamel; however, no studies have investigated the link between heat/laser-induced changes in physicochemical properties and bacterial adhesion. In this study, we investigated the effects of thermal treatment on surface properties of enamel such as hydrophobicity and zeta potential. Bacterial adhesion to treated surfaces was characterized by confocal laser scanning microscopy, and adhesion force was quantified by atomic force microscopy. The hydrophobicity of enamel increased after heating (p < 0.05), and the zeta potential of heated enamel became more negative than that of the control (p < 0.01). Streptococcus oralis and S. mitis were more hydrophilic than S. sanguis, with more negative zeta potential (all p < 0.01). S. mitis and S. oralis occupied significantly less area on enamel after being heated (p < 0.05). Heating reduced the adhesion force of both S. mitis and S. oralis to enamel with or without saliva coating. Reduction of adhesion force was statistically significant for S. mitis (p < 0.01), whereas that of S. oralis was not statistically significant (p > 0.05). Heating did not affect the adhesion of S. sanguis with or without saliva coating. In conclusion, thermal treatment and photothermal/laser treatments may modulate the physicochemical properties of enamel, preventing the adhesion of some bacterial species.
C1 [Hsu, C. S.] Natl Univ Singapore, Dept Prevent Dent, Singapore 119074, Singapore.
   [Hsu, C. S.] Natl Univ Singapore Hosp, Singapore 119074, Singapore.
   [Hu, X. L.] Sun Yat Sen Univ, Guanghua Coll Stomatol, Dept Prevent Dent, Guangzhou 510060, Guangdong, Peoples R China.
   [Ho, B.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore.
   [Lim, C. T.] Natl Univ Singapore, Fac Engn, Dept Bioengn, Mechanobiol Inst, Singapore 117576, Singapore.
   [Lim, C. T.] Natl Univ Singapore, Fac Engn, Dept Mech Engn, Singapore 117576, Singapore.
RP Hsu, CS (reprint author), Natl Univ Singapore, Dept Prevent Dent, Singapore 119074, Singapore.
EM pndhsus@nus.edu.sg
RI Lim, Chwee Teck/B-3307-2011; Hsu, Chin-ying/E-7855-2016
OI Hsu, Chin-ying/0000-0001-7367-3204; Lim, Chwee Teck/0000-0003-4019-9782
FU Biomedical Research Council [R-222-000-015-305]; NUS [R-222-000-028-112]
FX This work was supported by a Biomedical Research Council Grant
   (R-222-000-015-305) and the NUS Academic Research Fund
   (R-222-000-028-112). We affirm that we have no financial affiliation
   (e.g., employment, direct payment, stockholding, retainers,
   consultantships, patent licensing arrangements, or honoraria) or
   involvement with any commercial organization with direct financial
   interest. Any other potential conflict of interest is disclosed.
CR Acil Y, 2005, CALCIFIED TISSUE INT, V76, P121, DOI 10.1007/s00223-004-0122-0
   Elliott D, 2003, ORAL MICROBIOL IMMUN, V18, P114, DOI 10.1034/j.1399-302X.2003.00052.x
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   FOWLER BO, 1986, CALCIFIED TISSUE INT, V38, P197, DOI 10.1007/BF02556711
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Haraguchi K, 2008, J COLLOID INTERF SCI, V326, P41, DOI 10.1016/j.jcis.2008.06.060
   HOLCOMB DW, 1980, CALCIFIED TISSUE INT, V31, P189, DOI 10.1007/BF02407181
   Hsu CYS, 2001, J DENT RES, V80, P1797, DOI 10.1177/00220345010800090501
   Ju ZY, 2001, J FOOD SCI, V66, P229, DOI 10.1111/j.1365-2621.2001.tb11322.x
   Konishi N, 2003, J ORAL REHABIL, V30, P790, DOI 10.1046/j.1365-2842.2003.01129.x
   Lenander-Lumikari M, 2000, Adv Dent Res, V14, P40
   Maung NL, 2007, J DENT, V35, P794, DOI 10.1016/j.jdent.2007.07.012
   Mei L, 2009, J DENT RES, V88, P841, DOI 10.1177/0022034509342523
   Mei L, 2009, EUR J ORAL SCI, V117, P419, DOI 10.1111/j.1600-0722.2009.00648.x
   ODUTUGA AA, 1974, ARCH ORAL BIOL, V19, P729, DOI 10.1016/0003-9969(74)90143-5
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PRATTTERPSTRA IH, 1987, J GEN MICROBIOL, V133, P3199
   Sardin S, 2004, J ORAL REHABIL, V31, P140, DOI 10.1046/j.0305-182X.2003.01136.x
   Sheng XX, 2007, J COLLOID INTERF SCI, V310, P661, DOI 10.1016/j.jcis.2007.01.084
   Tanaka Jefferson Luis Oshiro, 2008, Braz. oral res., V22, P346, DOI 10.1590/S1806-83242008000400011
   Valdes TI, 2008, BIOMATERIALS, V29, P1356, DOI 10.1016/j.biomaterials.2007.11.035
   VANDIJK J, 1987, J CLIN PERIODONTOL, V14, P300
   VATASSER.GT, 1970, CALC TISS RES, V5, P183, DOI 10.1007/BF02017547
   Venegas C, 2006, J DENT RES, V85, P1124, DOI 10.1177/154405910608501211
   vom Smoluchowski M, 1918, Z PHYS CHEM, V92, P129
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   Xu LC, 2005, LANGMUIR, V21, P7491, DOI 10.1021/la0509091
   Yang Y, 2003, J Oral Implantol, V29, P270, DOI 10.1563/1548-1336(2003)029<0270:CADBOS>2.3.CO;2
NR 28
TC 7
Z9 8
U1 2
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2011
VL 90
IS 12
BP 1451
EP 1456
DI 10.1177/0022034511424155
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 847OR
UT WOS:000296982800014
PM 21960683
DA 2018-10-19
ER

PT J
AU Eichler, M
   Katzur, V
   Scheideler, L
   Haupt, M
   Geis-Gerstorfer, J
   Schmalz, G
   Ruhl, S
   Muller, R
   Rupp, F
AF Eichler, Mirjam
   Katzur, Verena
   Scheideler, Lutz
   Haupt, Michael
   Geis-Gerstorfer, Juergen
   Schmalz, Gottfried
   Ruhl, Stefan
   Mueller, Rainer
   Rupp, Frank
TI The impact of dendrimer-grafted modifications to model silicon surfaces
   on protein adsorption and bacterial adhesion
SO BIOMATERIALS
LA English
DT Article
DE Polyamidoamine (PAMAM) dendrimer; Saliva conditioning film; Quartz
   crystal microbalance (QCM-D); Bacterial adhesion; Streptococcus gordonii
   DL1; Dental implant
ID SELF-ASSEMBLED MONOLAYERS; LIPID-BILAYER DISRUPTION; POLY(AMIDOAMINE)
   DENDRIMERS; BIOMEDICAL APPLICATIONS; STREPTOCOCCUS-GORDONII; ORAL
   STREPTOCOCCI; DENTAL MATERIALS; SALIVARY FILMS; IDENTIFICATION;
   INTERFACES
AB In the oral cavity, omnipresent salivary protein films (pellicle) mediate bacterial adhesion and biofilm formation on natural tissues as well as on artificial implant surfaces, which may cause serious infectious diseases like periimplantitis. The purpose of this in vitro study was to investigate the adsorption/desorption behaviour of human saliva on model surfaces grafted with polyamidoamine (PAMAM) dendrimer molecules compared to self-assembled monolayers (SAMs) exhibiting the same terminal functions (-NH2, -COOH) by two complementary analytical methods. Furthermore, the role of saliva conditioning of PAMAM and analogous SAM modifications on the adhesion of Streptococcus gordonii DL1, an early oral colonizer, was investigated. In contrast to SAMs. PAMAM-grafted surfaces showed reduced streptococcal adherence in the absence of pre-adsorbed saliva similar to the level obtained for poly(ethylene glycol) (PEG) coatings. Moreover, coatings of PAMAM-NH2 maintained their bacteria-repellent behaviour even after saliva-conditioning. As a general outcome, it was found that lower amounts of protein adsorbed on PAMAM coatings than on analogous SAMs. Since this study demonstrates that covalently bound PAMAM dendrimers can modulate the oral bacterial response, this approach has significant potential for the development of anti-adhesive biomaterial surfaces that are conditioned with proteinaceous films. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Eichler, Mirjam; Scheideler, Lutz; Geis-Gerstorfer, Juergen; Rupp, Frank] Univ Hosp Tuebingen, Sect Med Mat & Technol, Dept Prosthet Dent, D-72076 Tubingen, Germany.
   [Eichler, Mirjam; Katzur, Verena; Mueller, Rainer] Univ Regensburg, Inst Phys & Theoret Chem, D-93053 Regensburg, Germany.
   [Haupt, Michael] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, D-70569 Stuttgart, Germany.
   [Schmalz, Gottfried] Univ Regensburg, Dept Operat Dent & Periodontol, D-93053 Regensburg, Germany.
   [Ruhl, Stefan] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA.
RP Rupp, F (reprint author), Univ Hosp Tuebingen, Sect Med Mat & Technol, Dept Prosthet Dent, Osianderstr 2-8, D-72076 Tubingen, Germany.
EM frank.rupp@med.uni-tuebingen.de
RI Rupp, Frank/G-4725-2012; Mueller, Rainer/D-3326-2009
OI Mueller, Rainer/0000-0001-9641-7780; Ruhl, Stefan/0000-0003-3888-4908
FU Deutsche Forschungsgemeinschaft (DFG) [RU 920/2-2, MU 2787/1-2, RU
   409/9-1, SCHW 431/12-2]
FX The authors acknowledge the Deutsche Forschungsgemeinschaft (DFG) for
   financial support (RU 920/2-2, MU 2787/1-2, RU 409/9-1, and SCHW
   431/12-2). We thank H. Schweikl for fruitful discussions of the
   manuscript. Furthermore, we would like to thank I. Stephan, M. Sahin, U.
   Vogl, A. Matschass, E.-M. Scholl, and A. Eidt for excellent technical
   assistance.
CR Ahn SJ, 2003, AM J ORTHOD DENTOFAC, V124, P198, DOI 10.1016/S0889-5406(03)00346-9
   Ahn SJ, 2002, J DENT RES, V81, P411, DOI 10.1177/154405910208100611
   Ajikumar PK, 2007, LANGMUIR, V23, P5670, DOI 10.1021/la063717u
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   Betley TA, 2001, LANGMUIR, V17, P2768, DOI 10.1021/la001297h
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Calabretta MK, 2007, BIOMACROMOLECULES, V8, P1807, DOI 10.1021/bm0701088
   Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davies JR, 2009, MICROBIOL-SGM, V155, P1977, DOI 10.1099/mic.0.027854-0
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   DETTRE RH, 1964, CONTACT ANGLE WETTAB, P136
   Du LD, 2000, INFECT IMMUN, V68, P4834, DOI 10.1128/IAI.68.8.4834-4837.2000
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Hannig C, 2005, EUR J ORAL SCI, V113, P2, DOI 10.1111/j.1600-0722.2004.00180.x
   Heise A, 1997, LANGMUIR, V13, P723, DOI 10.1021/la960467g
   Herdt GC, 1996, SURF SCI, V355, pL371, DOI 10.1016/0039-6028(96)00312-3
   Hierlemann A, 1998, J AM CHEM SOC, V120, P5323, DOI 10.1021/ja974283f
   Hou SY, 2009, BIOORG MED CHEM LETT, V19, P5478, DOI 10.1016/j.bmcl.2009.07.077
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jang WD, 2009, PROG POLYM SCI, V34, P1, DOI 10.1016/j.progpolymsci.2008.08.003
   JENDRESEN MD, 1981, ACTA ODONTOL SCAND, V39, P39, DOI 10.3109/00016358109162257
   Jenkinson HF, 1997, CRIT REV ORAL BIOL M, V8, P175, DOI 10.1177/10454411970080020601
   Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443
   Khor HL, 2007, BIOMACROMOLECULES, V8, P1530, DOI 10.1021/bm0611533
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   Kotsovilis S, 2008, J CLIN PERIODONTOL, V35, P621, DOI 10.1111/j.1600-051X.2008.01240.x
   Lendenmann U, 2000, Adv Dent Res, V14, P22
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Ma CF, 2010, J POLYM SCI POL PHYS, V48, P1987, DOI 10.1002/polb.22077
   Macakova L, 2010, COLLOID SURFACE B, V77, P31, DOI 10.1016/j.colsurfb.2009.12.022
   Mecke A, 2005, LANGMUIR, V21, P10348, DOI 10.1021/la0506291
   Mecke A, 2004, CHEM PHYS LIPIDS, V132, P3, DOI 10.1016/j.chemphyslip.2004.09.001
   Mecke A, 2004, EUR PHYS J E, V14, P7, DOI 10.1140/epje/i2003-10087-5
   Muller R, 2009, BIOMATERIALS, V30, P4921, DOI 10.1016/j.biomaterials.2009.05.079
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   Ploux L, 2010, J ADHES SCI TECHNOL, V24, P2165, DOI 10.1163/016942410X511079
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Quirynen M, 2003, PERIODONTOL 2000, V33, P119, DOI 10.1046/j.0906-6713.2003.03310.x
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Ruhl S, 2011, APPL ENVIRON MICROB, V77, P749, DOI 10.1128/AEM.01374-10
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   Santos O, 2010, BIOFOULING, V26, P697, DOI 10.1080/08927014.2010.506609
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Svendsen IE, 2009, BIOFOULING, V25, P255, DOI 10.1080/08927010802712861
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Vasilev K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215102
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   WILHELMY L, 1863, ANN PHYS CHEM, V189, P177
NR 54
TC 24
Z9 25
U1 3
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 35
BP 9168
EP 9179
DI 10.1016/j.biomaterials.2011.08.063
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 843PK
UT WOS:000296684200003
PM 21906807
DA 2018-10-19
ER

PT J
AU Reis, ECC
   Borges, APB
   Araujo, MVF
   Mendes, VC
   Guan, LM
   Davies, JE
AF Reis, Emily C. Carlo
   Borges, Andrea P. B.
   Araujo, Michel V. F.
   Mendes, Vanessa C.
   Guan, Limin
   Davies, John E.
TI Periodontal regeneration using a bilayered PLGA/calcium phosphate
   construct
SO BIOMATERIALS
LA English
DT Article
DE Periodontal tissue regeneration; PLGA/CaP construct; Macroporous
   topography; Clot retention; Class II furcation; Canine
ID GUIDED TISSUE REGENERATION; II FURCATION DEFECTS; PLATELET-RICH PLASMA;
   BEAGLE DOGS; BONE REGENERATION; ACID MEMBRANE; ANIMAL-MODELS; IN-VITRO;
   DISEASE; MATRIX
AB The regeneration of tissues affected by periodontal disease is a complex process; it encompasses the formation of bone, cementum and periodontal ligament. We developed a semi-rigid PLGA (polylactide-co-glycolide acid)/CaP (calcium phosphate) bilayered biomaterial construct to promote periodontal regeneration, which has a continuous outer barrier membrane and an inner topographically complex component. Our experimental model compared periodontal prophylaxis alone with prophylaxis and biomaterial implantation in the treatment of class II furcation defects in dogs. Clinical evaluation, micro-computed tomography, histology and backscattered electron imaging were used for data analysis. Healing occurred uneventfully and bone volumetric values, trabecular number and trabecular thickness were all significantly greater in the treated group; while trabecular separation was significantly greater in the control group. New cementum, bone, and periodontal ligament with Sharpey fibre insertions were only seen in the treated group. Although periodontal regeneration has been reported elsewhere, the advantages of employing our bilayered PLGA + CaP construct are twofold: 1)it did not collapse into the defect; and, 2) its inner side was able to retain the blood clot throughout the buccal defect. The result was greater periodontal regeneration than has previously been reported with traditional flexible membranes. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Reis, Emily C. Carlo; Araujo, Michel V. F.; Mendes, Vanessa C.; Davies, John E.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Reis, Emily C. Carlo; Borges, Andrea P. B.] Univ Fed Vicosa, Dept Vet, BR-36570000 Vicosa, MG, Brazil.
   [Guan, Limin; Davies, John E.] Tissue Regenerat Therapeut, Toronto, ON M5G 1N8, Canada.
RP Davies, JE (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.
EM davies@ecf.utoronto.ca
OI Borges, Andrea Pacheco Batista/0000-0002-7489-3847
FU CAPES; CNPq; Virbac do Brasil
FX The authors would like to thank CAPES for Dr. Carlo Reis' scholarship,
   CNPq for funding this project and Virbac do Brasil for their support. We
   would also like to express our gratitude to FeryalSarraf (U of T), Nancy
   Valiquette (U of T) and both Claudia AlencarVanetti and Karla Veloso
   Goncalves Ribeiro from the Nude de Microscopia Eletronica e
   Microanalises (CCB/UFV) for their valuable assistance.
CR Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x
   Amano Y, 2004, ORAL SURG ORAL MED O, V97, P155, DOI 10.1016/j.tripleo.2003.9.009
   Araujo MG, 1998, J CLIN PERIODONTOL, V25, P524, DOI 10.1111/j.1600-051X.1998.tb02482.x
   Araujo MG, 1997, J CLIN PERIODONTOL, V24, P738, DOI 10.1111/j.1600-051X.1997.tb00191.x
   BECKER W, 2000, PERIODONTOL, V1993, P46
   Bosshardt DD, 2000, PERIODONTOL, V2009, P208
   Brown LJ, 2002, PERIODONTOL 2000, V29, P223, DOI 10.1034/j.1600-0757.2002.290111.x
   CAFFESSE RG, 1990, J PERIODONTOL, V61, P510, DOI 10.1902/jop.1990.61.8.510
   Camargo PM, 2002, J PERIODONTAL RES, V37, P300, DOI 10.1034/j.1600-0765.2002.01001.x
   Carlo E. C., 2006, Revista Ceres, V53, P350
   Chang CY, 2000, J PERIODONTOL, V71, P1086, DOI 10.1902/jop.2000.71.7.1086
   Cho WJ, 2009, J BIOMED MATER RES A, V91A, P400, DOI 10.1002/jbm.a.32264
   Christgau M, 2007, J CLIN PERIODONTOL, V34, P691, DOI 10.1111/j.1600-051X.2007.01097.x
   Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7
   Craig RG, 2008, ORAL DIS, V14, P1, DOI 10.1111/j.1601-0825.2007.01430.x
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2010, ORGANOGENESIS, V6, P161, DOI 10.4161/org.6.3.12392
   de Vicente JC, 2006, INT J ORAL MAX SURG, V35, P1047, DOI 10.1016/j.ijom.2006.06.008
   DeBowes L J, 1996, J Vet Dent, V13, P57
   DeForge D H, 1997, J Vet Dent, V14, P141
   Deliberador TM, 2006, J PERIODONTOL, V77, P780, DOI 10.1902/jop.2006.050209
   GIANNOBILE WV, 1994, J PERIODONTOL, V65, P1158, DOI 10.1902/jop.1994.65.12.1158
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Hale FA, 2002, J VET DENT, V19, P22, DOI 10.1177/089875640201900104
   Harris RJ, 2002, INT J PERIODONT REST, V22, P381
   Harvey CE, 1998, VET CLIN N AM-SMALL, V28, P1111, DOI 10.1016/S0195-5616(98)50105-2
   HULL PS, 1974, J COMP PATHOL, V84, P143, DOI 10.1016/0021-9975(74)90055-3
   Inanc B, 2009, J BIOMED MATER RES A, V90A, P186, DOI 10.1002/jbm.a.32066
   Keles GC, 2009, CLIN ORAL INVEST, V13, P393, DOI 10.1007/s00784-008-0245-1
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Kim EJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055001
   KINANE DF, 2008, CLIN PERIODONTOLOGY, P286
   Kortegaard HE, 2008, J SMALL ANIM PRACT, V49, P610, DOI 10.1111/j.1748-5827.2008.00609.x
   Kurtis B, 2002, J PERIODONTOL, V73, P694, DOI 10.1902/jop.2002.73.7.694
   Lawrence BJ, 2009, J BIOMED MATER RES A, V88A, P634, DOI 10.1002/jbm.a.31903
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   LOE H, 1978, J PERIODONTOL, V49, P607, DOI 10.1902/jop.1978.49.12.607
   Lyons LC, 2008, J PERIODONTOL, V79, P72, DOI [10.1902/jop.2008.070161, 10.1902/jop.2008.070161 ]
   Mardas N, 2003, CLIN ORAL IMPLAN RES, V14, P812, DOI 10.1046/j.0905-7161.2003.00966.x
   MARRETA SM, 2001, P ATL COAST VET C 20
   MCCULLOCH CAG, 1985, ANAT REC, V211, P258, DOI 10.1002/ar.1092110305
   Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x
   Nahas D, 1974, Estomatol Cult, V8, P287
   Niemiec BA, 2008, TOP COMPANION ANIM M, V23, P81, DOI 10.1053/j.tcam.2008.02.004
   Oprea WE, 2003, J CRANIOFAC SURG, V14, P292, DOI 10.1097/00001665-200305000-00006
   Owen GR, 2010, J BIOMED MATER RES A, V95A, P857, DOI 10.1002/jbm.a.32865
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x
   Park JK, 2009, ACTA BIOMATER, V5, P3394, DOI 10.1016/j.actbio.2009.05.019
   Pavlica Z, 2008, J VET DENT, V25, P97, DOI 10.1177/089875640802500210
   Pradeep AR, 2009, J CLIN PERIODONTOL, V36, P581, DOI 10.1111/j.1600-051X.2009.01428.x
   Pretzl B, 2009, J CLIN PERIODONTOL, V36, P349, DOI 10.1111/j.1600-051X.2009.01378.x
   ROBERT PM, 1994, J PERIODONTOL, V65, P414, DOI 10.1902/jop.1994.65.5.414
   Roriz VM, 2006, J PERIODONTOL, V77, P490, DOI 10.1902/jop.2006.050081
   Santana RB, 2009, J PERIODONTOL, V80, P1756, DOI 10.1902/jop.2009.080605
   Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17
   Shoukry M, 2007, J VET DENT, V24, P152, DOI 10.1177/089875640702400303
   Smith M M, 1995, J Vet Dent, V12, P59
   Watanabe K, 2003, J VET MED SCI, V65, P1007, DOI 10.1292/jvms.65.1007
   Weinberg MA, 1999, J CLIN PERIODONTOL, V26, P335, DOI 10.1034/j.1600-051X.1999.260601.x
   Wiggs RB, 1997, VET DENT PRINCIPLES, P186
   Wikesjo U M, 1995, J Calif Dent Assoc, V23, P30
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
NR 64
TC 38
Z9 39
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 35
BP 9244
EP 9253
DI 10.1016/j.biomaterials.2011.08.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 843PK
UT WOS:000296684200010
PM 21885122
DA 2018-10-19
ER

PT J
AU Shen, DL
   Wang, XF
   Zhang, L
   Zhao, XY
   Li, JY
   Cheng, K
   Zhang, JY
AF Shen, Deliang
   Wang, Xiaofang
   Zhang, Li
   Zhao, Xiaoyan
   Li, Jingyi
   Cheng, Ke
   Zhang, Jinying
TI The amelioration of cardiac dysfunction after myocardial infarction by
   the injection of keratin biomaterials derived from human hair
SO BIOMATERIALS
LA English
DT Article
DE Heart; Keratin; Scaffold; Angiogenesis; Cardiac tissue engineering
ID HEART; CELLS; REGENERATION; SCAFFOLDS; TISSUE; MODEL; MOUSE;
   CARDIOMYOCYTES; ANGIOGENESIS; THERAPY
AB Cardiac dysfunction following acute myocardial infarction is a major cause of advanced cardiomyopathy. Conventional pharmacological therapies rely on prompt reperfusion and prevention of repetitive maladaptive pathways. Keratin biomaterials can be manufactured in an autologous fashion and are effective in various models of tissue regeneration. However, its potential application in cardiac regeneration has not been tested. Keratin biomaterials were derived from human hair and its structure morphology, carryover of beneficial factors, biocompatibility with cardiomyocytes, and in vivo degradation profile were characterized. After delivery into infarcted rat hearts, the keratin scaffolds were efficiently infiltrated by cardiomyocytes and endothelial cells. Injection of keratin biomaterials promotes angiogenesis but does not exacerbate inflammation in the post-MI hearts. Compared to control-injected animals, keratin biomaterials-injected animals exhibited preservation of cardiac function and attenuation of adverse ventricular remodeling over the 8 week following time course. Tissue western blot analysis revealed up-regulation of beneficial factors (BMP4, NGF, TGF-beta) in the keratin-injected hearts. The salient functional benefits, the simplicity of manufacturing and the potentially autologous nature of this biomaterial provide impetus for further translation to the clinic. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Cheng, Ke] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.
   [Cheng, Ke] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90048 USA.
   [Shen, Deliang; Wang, Xiaofang; Zhang, Li; Zhao, Xiaoyan; Zhang, Jinying] Zhengzhou Univ, Coll Med, Dept Cardiol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China.
   [Li, Jingyi] Chinese Acad Med Sci, Plast Surg Hosp, Beijing 100041, Peoples R China.
   [Li, Jingyi] Peking Union Med Coll, Beijing 100041, Peoples R China.
RP Cheng, K (reprint author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.
EM ke.cheng@cshs.org; jyzhang@zzu.edu.cn
FU Medical Science and Technology Research Projects of Henan Province
   [20103021]; Henan Province Funds for Distinguished Young Scientists
   [094100510017]
FX This study was supported by grants from the Medical Science and
   Technology Research Projects of Henan Province (No. 20103021) and Henan
   Province Funds for Distinguished Young Scientists (No. 094100510017).
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Balaji S, 2012, POLYM ADVAN TECHNOL, V23, P500, DOI 10.1002/pat.1905
   BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204
   Cheng K., 2010, CIRCULATION, V122
   Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015
   Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589
   Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DEGUZMAN RC, 2011, MECH BIOL PROPERTIES
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Grausova L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020943
   Heinke J, 2008, CIRC RES, V103, P804, DOI 10.1161/CIRCRESAHA.108.178434
   JONES CM, 1991, DEVELOPMENT, V111, P531
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee WY, 2011, BIOMATERIALS, V32, P5558, DOI 10.1016/j.biomaterials.2011.04.031
   LYONS KM, 1990, DEVELOPMENT, V109, P833
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Migrino RQ, 1997, CIRCULATION, V96, P116
   Nelson D.M., 2010, ACTA BIOMATER, V7, P1, DOI DOI 10.1016/J.ACTBIO.2010.06.039
   Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006
   Romon R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-157
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Stenn KS, 1996, DERMATOL CLIN, V14, P543, DOI 10.1016/S0733-8635(05)70383-1
   STENN KS, 1994, J DERMATOL SCI, V7, P109
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   White SM, 2005, AM J PHYSIOL-HEART C, V288, pH670, DOI 10.1152/ajpheart.00841.2004
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
   Zhu H, 2000, CELL DEATH DIFFER, V7, P773, DOI 10.1038/sj.cdd.4400721
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 40
TC 36
Z9 37
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 35
BP 9290
EP 9299
DI 10.1016/j.biomaterials.2011.08.057
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 843PK
UT WOS:000296684200015
PM 21885119
DA 2018-10-19
ER

PT J
AU Zhou, J
   Tsai, YT
   Weng, H
   Baker, DW
   Tang, LP
AF Zhou, Jun
   Tsai, Yi-Ting
   Weng, Hong
   Baker, David W.
   Tang, Liping
TI Real time monitoring of biomaterial-mediated inflammatory responses via
   macrophage-targeting NIR nanoprobes
SO BIOMATERIALS
LA English
DT Article
DE In vivo imaging; Nanoparticle; Macrophage; Inflammation;
   Biocompatibility
ID NEAR-INFRARED FLUORESCENCE; RAT C6 GLIOMA; FOLATE RECEPTOR; ACTIVATED
   MACROPHAGES; THERMORESPONSIVE MICROGELS; EXPERIMENTAL ARTHRITIS;
   RHEUMATOID-ARTHRITIS; OPTICAL NANOSENSORS; CHEMICAL-ANALYSIS; PH
   MEASUREMENTS
AB Medical implant-mediated inflammatory responses, often involving high levels of macrophages, are typically determined by histological analyses. These methods however are time consuming and require many animals to monitor the kinetics of inflammatory reactions and to generate reproducible outcomes. Recent studies have shown that activated macrophages in inflamed tissue express high levels of folate receptor (FR). In this study, FR-targeting NIR nanoprobes were fabricated and then tested for their ability to detect and quantify the extent of biomaterial-mediated inflammatory responses in vivo. Indeed, FR-targeting nanoprobes preferentially accumulate on activated macrophage surfaces. When administered intravenously, we found that the FR-targeting nanoprobes distinctively gathered in the inflamed tissues and that a different extent of FR-targeting nanoprobe gathering could be found in tissues implanted with different types of biomaterials. Most importantly, we found that there was a good relationship between the extent of inflammatory reactions and the intensity of nanoprobe-associated NIR signal in tissue. Our results support that FR-targeting NIR nanoprobes can be used to monitor and quantify the extent of macrophage recruitment and the degree of an implants' biocompatibility in real time. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zhou, Jun; Tsai, Yi-Ting; Weng, Hong; Baker, David W.; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
RI Zhou, Jun/H-3484-2013
FU NIH [EB007271]
FX This work was supported by NIH grant EB007271. The authors would like to
   thank Drs. Wei Chen and Digant Dave for their facility support to carry
   out some of the experimental works.
CR Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Antohe F, 2005, CELL TISSUE RES, V320, P277, DOI 10.1007/s00441-004-1071-7
   Baker DW, 2011, BIOMACROMOLECULES, V12, P997, DOI 10.1021/bm1013487
   Blackburn WH, 2008, COLLOID POLYM SCI, V286, P563, DOI 10.1007/s00396-007-1805-7
   BODMEIER R, 1988, J MICROENCAPSUL, V5, P325, DOI 10.3109/02652048809036729
   Brasuel M, 2001, ANAL CHEM, V73, P2221, DOI 10.1021/ac0012041
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Cai T, 2007, LANGMUIR, V23, P8663, DOI 10.1021/la700923r
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Chen WT, 2005, ARTHRITIS RES THER, V7, pR310, DOI 10.1186/ar1483
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Dube D, 2002, BIOCONJUGATE CHEM, V13, P685, DOI 10.1021/bc010084g
   Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   Hansch A, 2004, ARTHRITIS RHEUM, V50, P961, DOI 10.1002/art.20112
   Hattori Y, 2006, BIOL PHARM BULL, V29, P1516, DOI 10.1248/bpb.29.1516
   Hellweg T, 2004, LANGMUIR, V20, P4330, DOI 10.1021/la0354786
   Henne WA, 2006, ANAL CHEM, V78, P4880, DOI 10.1021/ac060324r
   Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457
   Ji J, 2000, ANAL CHEM, V72, P3497, DOI 10.1021/ac000080p
   Ji T, 2010, BIOCONJUGATE CHEM, V21, P427, DOI 10.1021/bc900295v
   Koning GA, 2006, ARTHRITIS RHEUM, V54, P1198, DOI 10.1002/art.21719
   Lang CH, 2003, SHOCK, V19, P538, DOI 10.1097/01.shk.0000055237.25446.80
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745
   Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815
   Lu YJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3304
   Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010
   McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631
   McNamara KP, 2001, ANAL CHEM, V73, P3240, DOI 10.1021/ac0102314
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Naha PC, 2010, TOXICOL LETT, V198, P134, DOI 10.1016/j.toxlet.2010.06.011
   Nakashima-Matsushita N, 1999, ARTHRITIS RHEUM-US, V42, P1609, DOI 10.1002/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L
   Narayan R, 2009, BIOMEDICAL MATERIALS, P1, DOI 10.1007/978-0-387-84872-3
   Nayak S, 2004, J AM CHEM SOC, V126, P10258, DOI 10.1021/ja0474143
   Oreffo ROC, 1999, J MATER SCI-MATER M, V10, P607, DOI 10.1023/A:1008931607002
   Paulos CM, 2004, ADV DRUG DELIVER REV, V56, P1205, DOI 10.1016/j.addr.2004.01.012
   Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Ruan G, 2003, BIOMATERIALS, V24, P5037, DOI 10.1016/S0142-9612(03)00419-8
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Setiadi AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012420
   Shapira L, 1996, INFECT IMMUN, V64, P825
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Sutton D, 2007, PHARM RES-DORDR, V24, P1029, DOI 10.1007/s11095-006-9223-y
   Tan MQ, 2004, J MATER CHEM, V14, P2896, DOI 10.1039/b407535h
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Truijers M, 2008, J ENDOVASC THER, V15, P462, DOI 10.1583/08-2447.1
   Turk MJ, 2002, ARTHRITIS RHEUM, V46, P1947, DOI 10.1002/art.10405
   Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028
   Vaidya B., 2009, CANC THER, V7, P141
   Wang L, 2005, NANO LETT, V5, P37, DOI 10.1021/nl048417g
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Wu CF, 2006, LANGMUIR, V22, P2956, DOI 10.1021/la060188l
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Yi YS, 2009, MOL PHARMACEUT, V6, P1228, DOI 10.1021/mp900070b
   Zhang J, 2008, J CONTROL RELEASE, V131, P34, DOI 10.1016/j.jconrel.2008.07.019
   Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 65
TC 24
Z9 25
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 35
BP 9383
EP 9390
DI 10.1016/j.biomaterials.2011.08.064
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 843PK
UT WOS:000296684200024
PM 21893338
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, WJ
   Wang, XL
   Wang, SY
   Zhao, J
   Xu, LY
   Zhu, C
   Zeng, DL
   Chen, J
   Zhang, ZY
   Kaplan, DL
   Jiang, XQ
AF Zhang, Wenjie
   Wang, Xiuli
   Wang, Shaoyi
   Zhao, Jun
   Xu, Lianyi
   Zhu, Chao
   Zeng, Deliang
   Chen, Jake
   Zhang, Zhiyuan
   Kaplan, David L.
   Jiang, Xinquan
TI The use of injectable sonication-induced silk hydrogel for VEGF(165) and
   BMP-2 delivery for elevation of the maxillary sinus floor
SO BIOMATERIALS
LA English
DT Article
DE Silk fibron; Hydrogels; Sonication; VEGF; BMP-2; Maxillary sinus
   augmentation
ID BONE MORPHOGENETIC PROTEIN-2; TISSUE-ENGINEERED BONE; IN-VIVO; FIBROIN
   SCAFFOLDS; AUGMENTATION; REPAIR; VEGF; BIOMATERIALS; ANGIOGENESIS;
   REGENERATION
AB Sonication-induced silk hydrogels were previously prepared as an injectable bone replacement biomaterial, with a need to improve osteogenic features. Vascular endothelial growth factor (VEGF(165)) and bone morphogenic protein-2 (BMP-2) are key regulators of angiogenesis and osteogenesis, respectively, during bone regeneration. Therefore, the present study aimed at evaluating in situ forming silk hydrogels as a vehicle to encapsulate dual factors for rabbit maxillary sinus floor augmentation. Sonication-induced silk hydrogels were prepared in vitro and the slow release of VEGF(165) and BMP-2 from these silk gels was evaluated by ELISA. For in vivo studies for each time point (4 and 12 weeks), 24 sinus floors elevation surgeries were made bilaterally in 12 rabbits for the following four treatment groups: silk gel (group Silk gel), silk gel/VEGF(165) (group VEGF), silk gel/BMP-2 (group BMP-2), silk gel/VEGF(165)/BMP-2 (group V + B) (n = 6 per group). Sequential florescent labeling and radiographic observations were used to record new bone formation and mineralization, along with histological and histomorphometric analysis. At week 4, VEGF(165) promoted more tissue infiltration into the gel and accelerated the degradation of the gel material. At this time point, the bone area in group V + B was significantly larger than those in the other three groups. At week 12, elevated sinus floor heights of groups BMP-2 and V + B were larger than those of the Silk gel and VEGF groups, and the V + B group had the largest new bone area among all groups. In addition, a larger blood vessel area formed in the remaining gel areas in groups VEGF and V + B. In conclusion, VEGF(165) and BMP-2 released from injectable and biodegradable silk gels promoted angiogenesis and new bone formation, with the two factors demonstrating an additive effect on bone regeneration. These results indicate that silk hydrogels can be used as an injectable vehicle to deliver multiple growth factors in a minimally invasive approach to regenerate irregular bony cavities. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Jiang, Xinquan] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Prosthodont, Shanghai 200011, Peoples R China.
   [Zhang, Wenjie; Xu, Lianyi; Zeng, Deliang; Jiang, Xinquan] Shanghai Jiao Tong Univ, Oral Bioengn & Regenerat Med Lab, Shanghai Res Inst Stomatol, Sch Med,Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200011, Peoples R China.
   [Wang, Xiuli] Chinese Acad Sci, Dalian Inst Chem & Phys, Dalian 116023, Peoples R China.
   [Wang, Xiuli; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Sch Engn, Medford, MA 02155 USA.
   [Wang, Shaoyi; Zhao, Jun; Zhu, Chao; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Maxillofacial Surg, Peoples Hosp 9, Shanghai 200011, Peoples R China.
   [Chen, Jake] Tufts Univ, Sch Dent Med, Div Oral Biol, Boston, MA 02111 USA.
RP Jiang, XQ (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Prosthodont, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
EM david.kaplan@tufts.edu; xinquanj@yahoo.cn
FU National Natural Science Foundation of China [30772431, 30973342];
   Science and Technology Commission of Shanghai Municipality [08410706400,
   0952nm04000, 10dz2211600]; Program for New Century Excellent Talents in
   University [NCET-08-0353]; Shanghai Education Committee [07SG19]; NIH
   (DK) [DE017207, EB003210, EB002520, DE16710, DE21464]
FX The authors appreciate Carmen Preda for the preparation of the silk
   solutions for the study. This work was supported by National Natural
   Science Foundation of China 30772431, 30973342, Science and Technology
   Commission of Shanghai Municipality 08410706400, 0952nm04000,
   10dz2211600, Program for New Century Excellent Talents in University
   NCET-08-0353, Shanghai Education Committee 07SG19. We also thank the NIH
   (DK) [DE017207, EB003210, EB002520, DE16710 and DE21464] for support of
   these studies.
CR Aral A, 2008, CLIN ORAL IMPLAN RES, V19, P612, DOI 10.1111/j.1600-0501.2007.01518.x
   Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Boeck-Neto RJ, 2009, ORAL DIS, V15, P148, DOI 10.1111/j.1601-0825.2008.01502.x
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Degidi M, 2006, ORAL DIS, V12, P469, DOI 10.1111/j.1601-0825.2006.01222.x
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gil ES, 2005, BIOMACROMOLECULES, V6, P3079, DOI 10.1021/bm050396c
   Gutwald R, 2010, J CRANIO MAXILL SURG, V38, P571, DOI 10.1016/j.jcms.2010.02.010
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hansen-Algenstaedt N, 2006, ACTA ORTHOP, V77, P429, DOI 10.1080/17453670610046361
   Hirsch JM, 1991, CLIN ORAL IMPLAN RES, V2, P91, DOI 10.1034/j.1600-0501.1991.020207.x
   Jiang XQ, 2009, CLIN ORAL IMPLAN RES, V20, P1333, DOI 10.1111/j.1600-0501.2009.01755.x
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KUMLIEN J, 1985, ACTA OTO-LARYNGOL, V99, P122, DOI 10.3109/00016488509119154
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mangano Carlo, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe92, DOI 10.1111/j.1708-8208.2009.00227.x
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024
   Samee M, 2008, J PHARMACOL SCI, V108, P18, DOI 10.1254/jphs.08036FP
   Schliephake H, 2008, BIOMATERIALS, V29, P103, DOI 10.1016/j.biomaterials.2007.09.019
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013
   Vlassis J M, 1993, Pract Periodontics Aesthet Dent, V5, P15
   Vlassis JM, 1993, PRACT PERIODONTICS A, V5, P24
   Wang SY, 2011, BIOMATERIALS, V32, P4546, DOI 10.1016/j.biomaterials.2011.03.014
   Wang SY, 2010, BONE, V46, P91, DOI 10.1016/j.bone.2009.09.008
   Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhao J, 2010, ORAL DIS, V16, P46, DOI 10.1111/j.1601-0825.2009.01602.x
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhou M, 2010, BIOMATERIALS, V31, P4935, DOI 10.1016/j.biomaterials.2010.02.072
   Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037
   Zou DR, 2010, CLIN ORAL IMPLAN RES, V21, P65, DOI 10.1111/j.1600-0501.2009.01844.x
NR 50
TC 119
Z9 129
U1 11
U2 151
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 35
BP 9415
EP 9424
DI 10.1016/j.biomaterials.2011.08.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 843PK
UT WOS:000296684200027
PM 21889205
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Brandt, CJ
   Kammer, D
   Fiebeler, A
   Klinge, U
AF Brandt, Christopher J.
   Kammer, Daniel
   Fiebeler, Anette
   Klinge, Uwe
TI Beneficial effects of hydrocortisone or spironolactone coating on
   foreign body response to mesh biomaterial in a mouse model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glucocorticoid; mineralocorticoid; foreign body reaction; inflammation
ID RANDOMIZED CONTROLLED-TRIAL; TERM-FOLLOW-UP; INCISIONAL HERNIA;
   TISSUE-RESPONSE; DIABETIC-RATS; SUTURE; REPAIR; FIBROSIS; ALDOSTERONE;
   INTERFACE
AB Prosthetic reinforcements markedly reduce the risk of hernia recurrence. However, the implantation of meshes is related to an inflammatory foreign body reaction (FBR) with serious complications (i.e., persistent seroma, wound infection, mesh migration, entrapment, chronic pain). Adrenal hormones profoundly modify inflammatory response. Their effects on FBR however, remain ill defined. We therefore studied the FBR to polyvinylidenfluoride (PVDF) mesh material that was coated with four different substances: hydrocortisone (COR) or mifepristone (MIF), which respectively stimulate and block the glucocorticoid receptor, and aldosterone (ALD) or spironolactone (SPI), which respectively stimulate and block the mineralocorticoid receptor. The coated substances were released from the meshes within 24 h. Seven, 21, and 90 days after implantation, the specimen was evaluated for collagen formation, granuloma size, inflammatory activity, and angiogenesis. COR and SPI coating protected from inflammatory response, while ALD and MIF coating showed little difference to the control group. The COR and SPI groups showed smaller granuloma sizes at all time points, as well as a reduced number of inflammatory cells (p < 0.001) at day 90, and decreased collagen formation starting after 21 days (p < 0.05). There was a negative correlation for angiogenesis with inflammation around foreign body structures. In summary, these results suggest that early and temporary stimulation of the glucocorticoid receptor or blockade of the mineralocorticoid receptor have beneficial effects on FBR in the long term. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 335-343, 2011.
C1 [Kammer, Daniel; Klinge, Uwe] Rhein Westfal TH Aachen, Dept Surg, Univ Hosp, D-52074 Aachen, Germany.
   [Brandt, Christopher J.] UVA AMC, Univ Hosp, Dept Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Fiebeler, Anette] Hannover Med Sch, Clin Nephrol, Hannover, Germany.
RP Klinge, U (reprint author), Rhein Westfal TH Aachen, Dept Surg, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany.
EM uklinge@ukaachen.de
FU European Section of the Aldosterone Council (ESAC)
FX Contract grant sponsor: European Section of the Aldosterone Council
   (ESAC) to D.K. and U.K.
CR Bellon JM, 2006, J AM COLL SURGEONS, V203, P490, DOI 10.1016/j.jamcollsurg.2006.06.023
   Bitar MS, 1999, J SURG RES, V82, P234, DOI 10.1006/jsre.1998.5541
   Burger JWA, 2004, ANN SURG, V240, P578
   Burger JWA, 2004, ANN SURG, V240, P583
   deScheerder I, 1996, CORONARY ARTERY DIS, V7, P161, DOI 10.1097/00019501-199602000-00011
   Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9
   Fiebeler A, 2007, CURR OPIN NEPHROL HY, V16, P134
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Han KH, 2006, KIDNEY INT, V70, P111, DOI 10.1038/sj.ki.5000438
   Han SY, 2006, J AM SOC NEPHROL, V17, P1362, DOI 10.1681/ASN.2005111196
   Junge K, 2007, LANGENBECK ARCH SURG, V392, P465, DOI 10.1007/s00423-006-0138-1
   JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267
   Kang YM, 2006, CIRC RES, V99, P758, DOI 10.1161/01.RES.0000244092.95152.86
   Klinge U, 1999, EUR J SURG, V165, P665
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klinge U, 2010, LANGENBECK ARCH SURG, V395, P429, DOI 10.1007/s00423-009-0473-0
   Legrand M, 2010, J MOL MED-JMM, V88, P127, DOI 10.1007/s00109-009-0585-6
   Li Xiangshi, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P487
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163
   Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479
   Rickard AJ, 2007, ENDOCRINOLOGY, V148, P4829, DOI 10.1210/en.2007-0209
   Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254
   Schmidt T, 2010, NATURE, V465, P697, DOI 10.1038/465697a
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Sgueglia GA, 2011, CARDIOVASC REVASC ME
   Shahbaz AU, 2010, J HYPERTENS, V28, pS25, DOI 10.1097/01.hjh.0000388491.35836.d2
   Shin D, 2005, ANN SURG, V241, P553, DOI 10.1097/01.sla.0000157318.13975.2a
   Young M, 2004, ENDOCRINOLOGY, V145, P3153, DOI 10.1210/en.2004-0005
NR 31
TC 11
Z9 11
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2011
VL 99A
IS 3
BP 335
EP 343
DI 10.1002/jbm.a.33136
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 842ON
UT WOS:000296608900002
PM 22021181
DA 2018-10-19
ER

PT J
AU Parreira, P
   Magalhaes, A
   Goncalves, IC
   Gomes, J
   Vidal, R
   Reis, CA
   Leckband, DE
   Martins, MCL
AF Parreira, Paula
   Magalhaes, Ana
   Goncalves, Ines C.
   Gomes, Joana
   Vidal, Ricardo
   Reis, Celso A.
   Leckband, Deborah E.
   Martins, M. Cristina L.
TI Effect of surface chemistry on bacterial adhesion, viability, and
   morphology
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bacterial adhesion; self-assembled monolayers; SAMs; nanostructured
   surfaces; Helicobacter pylori; biomaterials
ID SELF-ASSEMBLED MONOLAYERS; STRESSED HELICOBACTER-PYLORI; BLOOD-GROUP
   ANTIGENS; PROTEIN ADSORPTION; PLATELET-ADHESION; COCCOID FORMS;
   FREE-ENERGY; CELLS; BIOMATERIAL; WATER
AB Helicobacter pylori (H. pylori) is one of the most common infectious agents in the world and it is thought to colonize the gastric mucosa of about half of the world's population causing several gastric diseases. In this work, the effect of surface chemistry on H. pylori nonspecific adhesion, viability, and morphology was evaluated using three H. pylori strains with different adhesins expression profile. Self-assembled monolayers (SAMs) of alkanethiols on gold were used to obtain surfaces exposing different functional groups: OH, CH3, and ethylene glycol (EG4). Bacterial adhesion onto the surfaces reached a plateau at 2 h. There was a correlation between adhesion and the exposed surface group, with bacterial cells adhering preferentially to CH3-SAMs while EG4-SAMs prevented H. pylori adhesion during the entire adhesion test (24 h). Surfaces that presented the EG4 group were also the only ones that significantly reduced the viability of adhered bacteria. Surface chemistry also influenced the morphology of adhered bacteria. The H. pylori rod shape observed in the control (Tissue Culture Polyethylene-TCPE) was only retrieved on CH3-SAMs. This work demonstrates that surface chemistry, namely specific functional groups on the material, influence the nonspecific adsorption of H. pylori. Moreover, the features of the bacterial strain and the surface chemistry can alter the adhesion kinetics, as well as the morphology and viability of attached bacteria. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 344-353, 2011.
C1 [Parreira, Paula; Goncalves, Ines C.; Vidal, Ricardo; Martins, M. Cristina L.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Parreira, Paula] Univ Porto, Fac Engn, P-4150180 Oporto, Portugal.
   [Magalhaes, Ana; Gomes, Joana; Reis, Celso A.] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4150180 Oporto, Portugal.
   [Reis, Celso A.] Univ Porto, Fac Med, P-4150180 Oporto, Portugal.
   [Leckband, Deborah E.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Martins, MCL (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM cmartins@ineb.up.pt
RI REIS, Celso/B-9969-2008; Martins, M. Cristina/J-8284-2013; Goncalves,
   Ines/K-4147-2012; Magalhaes, Ana/I-1510-2013; Gomes, Joana/K-9031-2013
OI REIS, Celso/0000-0002-0286-6639; Martins, M.
   Cristina/0000-0002-6574-4794; Goncalves, Ines/0000-0001-9759-4965;
   Magalhaes, Ana/0000-0003-4863-6668; Gomes, Joana/0000-0002-8832-2703;
   Parreira, Paula/0000-0001-6158-217X
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/65330/2006, SFRH/BD/39931/2007, SFRH/BD/36339/2007,
   SFRH/BD/40563/2007, SFRH/BPD/63722/2009]; NSF [DMR 08735]
FX Contract grant sponsor: Portuguese Foundation for Science and Technology
   (FCT); contract grant numbers PTDC/CTM/65330/2006, SFRH/BD/39931/2007,
   SFRH/BD/36339/2007, SFRH/BD/40563/2007, SFRH/BPD/63722/2009; Contract
   grant sponsor: NSF; contract grant number DMR 08735
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110
   Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125
   Azevedo NF, 2007, APPL ENVIRON MICROB, V73, P3423, DOI 10.1128/AEM.00047-07
   Azevedo NF, 2006, J APPL MICROBIOL, V101, P718, DOI 10.1111/j.1365-2672.2006.03029.x
   Azevedo NF, 2006, APPL ENVIRON MICROB, V72, P2936, DOI 10.1128/AEM.74.4.2936-2941.2006
   BERRY V, 1995, ANTIMICROB AGENTS CH, V39, P1859, DOI 10.1128/AAC.39.8.1859
   BODE G, 1993, EPIDEMIOL INFECT, V111, P483, DOI 10.1017/S0950268800057216
   BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Bumann D, 2004, INFECT IMMUN, V72, P6738, DOI 10.1128/IAI.72.11.6738-6742.2004
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Catrenich CE, 1991, SCAND J GASTROENTE S, V181, P58
   CELLINI L, 1994, MICROBIOL IMMUNOL, V38, P25, DOI 10.1111/j.1348-0421.1994.tb01740.x
   Chan YHM, 2003, LANGMUIR, V19, P7380, DOI 10.1021/la0343977
   Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097
   Cole SP, 1997, INFECT IMMUN, V65, P843
   Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Enroth H, 1999, HELICOBACTER, V4, P7, DOI 10.1046/j.1523-5378.1999.09034.x
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Freitas SC, 2010, BIOMATERIALS, V31, P3772, DOI 10.1016/j.biomaterials.2010.01.097
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373
   Johnston E., 1998, IMMOBILIZED BIOMOLEC, P79
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, J MATER SCI-MATER M, V21, P963, DOI 10.1007/s10856-009-3975-y
   Kusters JG, 1997, INFECT IMMUN, V65, P3672
   LODER TC, 1985, LIMNOL OCEANOGR, V30, P418, DOI 10.4319/lo.1985.30.2.0418
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Magalhaes A, 2009, GLYCOBIOLOGY, V19, P1525, DOI 10.1093/glycob/cwp131
   Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076
   MARSHALL B, 1983, LANCET, V1, P1273
   MARSHALL BJ, 1984, LANCET, V1, P1311
   Martins MCL, 2011, ACTA BIOMATER, V7, P1949, DOI 10.1016/j.actbio.2011.01.013
   Martins MCL, 2009, J BIOMED MATER RES A, V88A, P162, DOI 10.1002/jbm.a.31849
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Megraud F, 2004, DRUGS, V64, P1893
   Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   REYNOLDS DJ, 1994, MICROBIOL-UK, V140, P2649, DOI 10.1099/00221287-140-10-2649
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Saito N, 2003, J INFECTION, V46, P49, DOI 10.1053/jinf.2002.1047
   Schweiss R, 2001, LANGMUIR, V17, P4304, DOI 10.1021/la001741g
   Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259
   SHAHAMAT M, 1993, APPL ENVIRON MICROB, V59, P1231
   Silin V, 1997, J COLLOID INTERF SCI, V185, P94, DOI 10.1006/jcis.1996.4586
   Sorberg M, 1996, EUR J CLIN MICROBIOL, V15, P216, DOI 10.1007/BF01591357
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   Werner C, 1999, COLLOID SURFACE A, V159, P519, DOI 10.1016/S0927-7757(99)00290-3
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
NR 58
TC 20
Z9 21
U1 2
U2 51
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2011
VL 99A
IS 3
BP 344
EP 353
DI 10.1002/jbm.a.33178
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 842ON
UT WOS:000296608900003
PM 22021182
DA 2018-10-19
ER

PT J
AU Krishnamurithy, G
   Shilpa, PN
   Ahmad, RE
   Sulaiman, S
   Ng, CLL
   Kamarul, T
AF Krishnamurithy, G.
   Shilpa, P. N.
   Ahmad, R. E.
   Sulaiman, Sofiah
   Ng, C. L. L.
   Kamarul, T.
TI Human amniotic membrane as a chondrocyte carrier vehicle/substrate: In
   vitro study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human amniotic membrane; articular chondrocytes; tissue engineering;
   orthopaedics; biomaterials
ID OCULAR SURFACE RECONSTRUCTION; EXTRACELLULAR-MATRIX; CARTILAGE TISSUE;
   FETAL MEMBRANES; CULTURE-SYSTEM; STEM-CELLS; TRANSPLANTATION; RECEPTORS;
   SUBSTRATE; PAXILLIN
AB Human amniotic membrane (HAM) is an established biomaterial used in many clinical applications. However, its use for tissue engineering purposes has not been fully realized. A study was therefore conducted to evaluate the feasibility of using HAM as a chondrocyte substrate/carrier. HAMs were obtained from fresh human placenta and were process to produced air dried HAM (AdHAM) and freeze dried HAM (FdHAM). Rabbit chondrocytes were isolated and expanded in vitro and seeded onto these preparations. Cell proliferation, GAG expression and GAG/cell expression were measured at days 3, 6, 9, 12, 15, 21, and 28. These were compared to chondrocytes seeded onto plastic surfaces. Histological analysis and scanning electron microscopy was performed to observe cell attachment. There was significantly higher cell proliferation rates observed between AdHAM (13-51%, P=0.001) or FdHAM (18-48%, p=0.001) to chondrocytes in monolayer. Similarly, GAG and GAG/cell expressed in AdHAM (33-82%, p=0.001; 22-60%, p=0.001) or FdHAM (41-81%, p=0.001: 28-60%, p=0.001) were significantly higher than monolayer cultures. However, no significant differences were observed in the proliferation rates (p=0.576), GAG expression (p=0.476) and GAG/cell expression (p=0.135) between AdHAM and FdHAM. The histology and scanning electron microscopy assessments demonstrates good chondrocyte attachments on both HAMs. In conclusion, both AdHAM and FdHAM provide superior chondrocyte proliferation, GAG expression, and attachment than monolayer cultures making it a potential substrate/carrier for cell based cartilage therapy and transplantation. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 500-506, 2011.
C1 [Krishnamurithy, G.; Shilpa, P. N.; Kamarul, T.] Univ Malaya, NOCERAL, Dept Orthopaed Surg, Tissue Engn Grp, Kuala Lumpur 50603, Malaysia.
   [Ahmad, R. E.] Univ Malaya, Dept Physiol, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Sulaiman, Sofiah] Univ Malaya, Dept Obstet & Gynaecol, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Ng, C. L. L.] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur 50603, Malaysia.
RP Kamarul, T (reprint author), Univ Malaya, NOCERAL, Dept Orthopaed Surg, Tissue Engn Grp, Kuala Lumpur 50603, Malaysia.
EM tkzrea@um.edu.my
RI SULAIMAN, SOFIAH/B-9824-2010; RAJA AHMAD, RAJA ELINA AFZAN/B-9541-2010;
   Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI RAJA AHMAD, RAJA ELINA AFZAN/0000-0001-8048-4217; Tunku Zainol Abidin,
   Tunku Kamarul Zaman/0000-0002-6028-1313
FU University of Malaya [RG019/09HTM]; Short-Term Research Grant
   [FS125/2008A]; University of Malaya HIR-MOHE
FX Contract grant sponsor: University of Malaya Research Grant (UMRG);
   contract grant number: RG019/09HTM; Contract grant sponsor: Short-Term
   Research Grant; contract grant number: FS125/2008A; Contract grant
   sponsor: University of Malaya HIR-MOHE
CR Ang LPK, 2004, INVEST OPHTH VIS SCI, V45, P1789, DOI 10.1167/iovs-03-1361
   ARORA M, 1994, EUR J OBSTET GYN R B, V55, P179, DOI 10.1016/0028-2243(94)90035-3
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   Calvin SE, 2007, ANN NY ACAD SCI, V1101, P166, DOI 10.1196/annals.1389.009
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Ferruzi A, 2008, J BONE JOINT SURG AM, V90A, P90, DOI 10.2106/JBJS.H.00633
   Greenwood Heather L., 2006, International Journal of Biotechnology, V8, P60
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Kim WJH, 2000, YONSEI MED J, V41, P692, DOI 10.3349/ymj.2000.41.6.692
   King AE, 2007, PLACENTA, V28, P161, DOI 10.1016/j.placenta.2006.01.006
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   KOIZUMI N, 2001, CULTIVATED CORNEAL E
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   NHO RS, J BIOL CHEM, V285, P14195
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006
   QUINBY WC, 1982, PLASTIC RECONSTRUCT, V70, P717
   RICHARD FL, 2002, BIORHEOLOGY, V39, P119
   Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027
   SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181
   Sengers BG, 2006, BIOMECH MODEL MECHAN, V5, P111, DOI [10.1007/s10237-006-0023-4, 10.1007/s10237-006-0029-y]
   Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615
   SILBERMANN M, 1987, J ANAT, V151, P169
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   SUBRAHMANYAM M, 1995, BRIT J PLAST SURG, V48, P477, DOI 10.1016/0007-1226(95)90123-X
   TAN SL, 2010, J CELL TISSUE BANKIN, V12, P59
   Ti SE, 2002, INVEST OPHTH VIS SCI, V43, P2584
   Vial X., 2009, CURR RHEUMATOL REV, V5, P51, DOI DOI 10.2174/157339709787315366
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   You Y, 2006, MATER LETT, V60, P757, DOI 10.1016/j.matlet.2005.10.007
NR 37
TC 9
Z9 10
U1 1
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2011
VL 99A
IS 3
BP 500
EP 506
DI 10.1002/jbm.a.33184
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 842ON
UT WOS:000296608900019
PM 21913317
DA 2018-10-19
ER

PT J
AU Kim, IL
   Mauck, RL
   Burdick, JA
AF Kim, Iris L.
   Mauck, Robert L.
   Burdick, Jason A.
TI Hydrogel design for cartilage tissue engineering: A case study with
   hyaluronic acid
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Mesenchymal stem cells; Hyaluronic acid; Chondrogenesis;
   Cartilage; Biomaterial
ID MESENCHYMAL STEM-CELLS; CYCLIC HYDROSTATIC-PRESSURE; INTERSTITIAL FLUID
   PRESSURIZATION; POLY(ETHYLENE GLYCOL) HYDROGELS; EXTRACELLULAR-MATRIX
   PRODUCTION; SELF-ASSEMBLING PEPTIDE; IN-VITRO CHONDROGENESIS;
   GROWTH-FACTOR-BETA; ARTICULAR-CARTILAGE; STROMAL CELLS
AB Hyaline cartilage serves as a low-friction and wear-resistant articulating surface in load-bearing, diarthrodial joints. Unfortunately, as the avascular, alymphatic nature of cartilage significantly impedes the body's natural ability to regenerate, damage resulting from trauma and osteoarthritis necessitates repair attempts. Current clinical methods are generally limited in their ability to regenerate functional cartilage, and so research in recent years has focused on tissue engineering solutions in which the regeneration of cartilage is pursued through combinations of cells (e.g., chondrocytes or stem cells) paired with scaffolds (e.g., hydrogels, sponges, and meshes) in conjunction with stimulatory growth factors and bioreactors. A variety of synthetic and natural materials have been employed, most commonly in the form of hydrogels, and these systems have been tuned for optimal nutrient diffusion, connectivity of deposited matrix, degradation, soluble factor delivery, and mechanical loading for enhanced matrix production and organization. Even with these promising advances, the complex mechanical properties and biochemical composition of native cartilage have not been achieved, and engineering cartilage tissue still remains a significant challenge. Using hyaluronic acid hydrogels as an example, this review will follow the progress of material design specific to cartilage tissue engineering and propose possible future directions for the field. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kim, Iris L.; Mauck, Robert L.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Mauck, Robert L.] Univ Penn, Dept Orthoped Surg, Mckay Orthoped Res Lab, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
OI Mauck, Robert/0000-0002-9537-603X
FU National Institutes of Health [R01 EB008722]; National Science
   Foundation
FX This work was supported by National Institutes of Health grant R01
   EB008722 and a National Science Foundation Graduate Research Fellowship
   to ILK.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9
   Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Becerra J, 2010, TISSUE ENG PART B-RE, V16, P617, DOI 10.1089/ten.TEB.2010.0191
   Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895
   Bertram H, 2009, STEM CELLS DEV, V18, P881, DOI 10.1089/scd.2008.0306
   Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1
   CATERSON EJ, 2001, MEDGENMED, V3, pE1
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Coates EE, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P279, DOI 10.1007/978-3-7091-0385-2_10
   Cockman MD, 2006, OSTEOARTHR CARTILAGE, V14, P210, DOI 10.1016/j.joca.2005.08.010
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Csaki C, 2008, ANN ANAT, V190, P395, DOI 10.1016/j.aanat.2008.07.007
   Degat MC, 2009, J BIOMED MATER RES A, V91A, P1178, DOI 10.1002/jbm.a.32278
   Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673
   Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Erickson IE, CLIN ORTHOP IN PRESS
   Erickson IE, 2011, T ORTHOPAEDIC RES SO
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Finger AR, 2007, TISSUE ENG, V13, P1151, DOI 10.1089/ten.2006.0290
   Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565
   Galle J, 2010, CURR MED CHEM, V17, P2274, DOI 10.2174/092986710791331095
   Galois L, 2006, BIOMATERIALS, V27, P79, DOI 10.1016/j.biomaterials.2005.05.098
   Gleghorn JP, 2007, EUR CELLS MATER, V14, P20, DOI 10.22203/eCM.v014a02
   Goebel JC, 2010, BIO-MED MATER ENG, V20, P189, DOI 10.3233/BME-2010-0631
   Guilak F., 2005, BASIC ORTHOPAEDIC BI, P259
   Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4
   Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534
   Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005
   Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4
   Huang AH, 2009, TISSUE ENG PT A, V15, P3461, DOI [10.1089/ten.tea.2009.0198, 10.1089/ten.TEA.2009.0198]
   Huang AH, 2010, TISSUE ENG PT A, V16, P2699, DOI [10.1089/ten.tea.2010.0042, 10.1089/ten.TEA.2010.0042]
   Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ifkovits JL, 2009, J VIS EXP, P32
   Ifkovits JL, 2010, P SOC BIOM ANN M APR
   IWASAKI M, 1993, ENDOCRINOLOGY, V132, P1603, DOI 10.1210/en.132.4.1603
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kisiday JD, 2009, TISSUE ENG PT A, V15, P2817, DOI [10.1089/ten.tea.2008.0357, 10.1089/ten.TEA.2008.0357]
   Klein TJ, 2009, MACROMOL BIOSCI, V9, P1049, DOI 10.1002/mabi.200900176
   Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a
   Knudson Cheryl B., 2003, Birth Defects Research, V69, P174, DOI 10.1002/bdrc.10013
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   Krishnan R, 2003, J BIOMECH ENG-T ASME, V125, P569, DOI 10.1115/1.1610018
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Leeb C, 2011, CELL PROLIFERAT, V44, P9, DOI 10.1111/j.1365-2184.2010.00725.x
   Mansour JM, 2003, KINESIOLOGY MECH PAT, P1992
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   McCall JD, 2011, BIOMACROMOLECULES, V12, P1051, DOI 10.1021/bm101379v
   Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004
   Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229
   Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Nerurkar NL, 2011, ACTA BIOMATER, V7, P485, DOI 10.1016/j.actbio.2010.08.011
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Ohno S, 2002, J DENT RES, V81, P822, DOI 10.1177/154405910208101205
   Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103
   Park JS, 2011, BIOMATERIALS, V32, P1495, DOI 10.1016/j.biomaterials.2010.11.003
   Park K, 2009, MACROMOL BIOSCI, V9, P221, DOI 10.1002/mabi.200800187
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   ROSEN DM, 1988, J CELL PHYSIOL, V134, P337, DOI 10.1002/jcp.1041340304
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Salinas CN, 2009, J BIOMED MATER RES A, V90A, P456, DOI 10.1002/jbm.a.32112
   Schinagl RM, 1996, ANN BIOMED ENG, V24, P500, DOI 10.1007/BF02648112
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Soltz MA, 2000, ANN BIOMED ENG, V28, P150, DOI 10.1114/1.239
   Steinmetz NJ, ACTA BIOMAT IN PRESS
   Sundararaghavan HG, 2011, BIOMACROMOLECULES, V12, P2344, DOI 10.1021/bm200415g
   Sundararaghavan HG, 2010, MACROMOL BIOSCI, V10, P265, DOI 10.1002/mabi.200900363
   Swieszkowski W, 2007, BIOMOL ENG, V24, P489, DOI 10.1016/j.bioeng.2007.07.014
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tous E, 2011, P SOC BIOM ANN M APR
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Waese EYL, 2011, STEM CELL RES, V6, P34, DOI 10.1016/j.scr.2010.08.007
   Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5
   Wang CCB, 2001, J BIOMECH, V34, P75, DOI 10.1016/S0021-9290(00)00137-8
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5
   Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1
NR 118
TC 216
Z9 219
U1 32
U2 352
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 34
BP 8771
EP 8782
DI 10.1016/j.biomaterials.2011.08.073
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 836LP
UT WOS:000296113500003
PM 21903262
OA Green Accepted
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Talukdar, S
   Nguyen, QT
   Chen, AC
   Sah, RL
   Kundu, SC
AF Talukdar, Sarmistha
   Nguyen, Quynhhoa T.
   Chen, Albert C.
   Sah, Robert L.
   Kundu, Subhas C.
TI Effect of initial cell seeding density on 3D-engineered silk fibroin
   scaffolds for articular cartilage tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Chondrocyte; 3D scaffold; ECM; Articular cartilage; Tissue
   engineering
ID EXTRACELLULAR-MATRIX; 3D SCAFFOLDS; IN-VITRO; UNCONFINED COMPRESSION;
   MECHANICAL-PROPERTIES; DYNAMIC COMPRESSION; BIPHASIC MODEL;
   ADULT-RABBITS; NON-MULBERRY; FLUID-FLOW
AB The repair of articular cartilage defects poses a continuing challenge. Cartilage tissue engineering through the culture of chondrocytes seeded in 3D porous scaffolds has the potential for generating constructs that repair successfully. It also provides a platform to study scaffold-cell and cell cell interactions. The scaffold affects the growth and morphology of cells growing on it, and concomitantly, cells affect the properties of the resultant tissue construct. Silk fibroin protein from Antheraea mylitta, a non-mulberry Indian tropical tasar silkworm, is a potential biomaterial for diverse applications due to its widespread versatility as a mechanically robust, biocompatible, tissue engineering material. Analysis of silk fibroin scaffolds seeded with varying initial densities (25, 50 and 100 million cells/ml) and cultured for 2 weeks showed that thickness and wet weight increased by 60-70% for the highest cell density, and DNA, GAG and collagen content of the cartilaginous constructs increased with increasing cell density. Mechanical characterization of the constructs elucidated that the highest density constructs had compressive stiffness and modulus 4-5 times that of cell-free scaffolds. The present results indicate the importance of cell seeding density in the rapid formation of a functional cartilaginous tissue. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Nguyen, Quynhhoa T.; Chen, Albert C.; Sah, Robert L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Talukdar, Sarmistha; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Sah, RL (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
EM rsah@ucsd.edu; kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Indo-US Science and Technology Forum, New Delhi,; Department of
   Biotechnology; Department of Science and Technology, Government of
   India; National Institutes of Health; Howard Hughes Medical Institute
FX The work was financially supported by Indo-US Science and Technology
   Forum (SCK, RLS), New Delhi, Department of Biotechnology (SCK and
   Fellowship to ST) and Department of Science and Technology (SCK),
   Government of India, the National Institutes of Health (RLS), and a
   grant to University of California-San Diego, from the Howard Hughes
   Medical Institute through the HHMI Professors Program (RLS). We (SCK and
   ST) are indebted to RLS for the support during our visits to his
   laboratory. We (RLS and QTN) are also grateful for our short visits to
   the laboratory of SCK at Indian Institute of Technology Kharagpur.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   Almarza AJ, 2005, ANN BIOMED ENG, V33, P943, DOI 10.1007/s10439-005-3311-8
   da Silva MLA, 2010, ACTA BIOMATER, V6, P1149, DOI 10.1016/j.actbio.2009.09.006
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   BROWN TD, 1983, J BIOMECH, V16, P373, DOI 10.1016/0021-9290(83)90071-4
   Buckley CT, 2009, J MECH BEHAV BIOMED, V2, P512, DOI 10.1016/j.jmbbm.2008.12.007
   Buschmann MD, 1999, ARCH BIOCHEM BIOPHYS, V366, P1, DOI 10.1006/abbi.1999.1197
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   Concaro S, 2008, J TISSUE ENG REGEN M, V2, P14, DOI 10.1002/term.60
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   EGGLI PS, 1988, ANAT REC, V222, P217, DOI 10.1002/ar.1092220302
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Francioli SE, 2010, J BIOMED MATER RES A, V95A, P924, DOI 10.1002/jbm.a.32917
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Gohring AR, 2010, BIOTECHNOL PROGR, V26, P1116, DOI 10.1002/btpr.402
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hsu SH, 2011, TISSUE ENG PT A, V17, P1549, DOI [10.1089/ten.tea.2010.0419, 10.1089/ten.TEA.2010.0419]
   Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005
   Kang SW, 2005, TISSUE ENG, V11, P438, DOI 10.1089/ten.2005.11.438
   Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   KIM YJ, 1995, J BIOMECH, V28, P1055, DOI 10.1016/0021-9290(94)00159-2
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794
   MIZRAHI J, 1986, BIORHEOLOGY, V23, P311
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   PAL S, 1981, COLLAGEN REL RES, V1, P151
   Ragetly GR, 2010, J BIOMED MATER RES A, V93A, P46, DOI 10.1002/jbm.a.32514
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Revell CM, 2008, ANN BIOMED ENG, V36, P1441, DOI 10.1007/s10439-008-9524-x
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   Soltz MA, 2000, J BIOMECH ENG-T ASME, V122, P576, DOI 10.1115/1.1324669
   Soulhat J, 1999, J BIOMECH ENG-T ASME, V121, P340, DOI 10.1115/1.2798330
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CZ, 2011, MAT SCI ENG C-MATER, V31, P1343, DOI 10.1016/j.msec.2011.04.019
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Williams GM, 2005, ACTA BIOMATER, V1, P625, DOI 10.1016/j.actbio.2005.07.009
   Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5
   Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Xie J, 2010, J BIOMED MATER RES B, V94B, P80, DOI 10.1002/jbm.b.31627
NR 59
TC 58
Z9 60
U1 4
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2011
VL 32
IS 34
BP 8927
EP 8937
DI 10.1016/j.biomaterials.2011.08.027
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 836LP
UT WOS:000296113500017
PM 21906805
OA Green Accepted
DA 2018-10-19
ER

EF